PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wu, J; Kim, S; Kwak, MS; Jeong, JB; Min, HJ; Yoon, HG; Ahn, JH; Shin, JS				Wu, Jie; Kim, Sol; Kwak, Man Sup; Jeong, Jang Bin; Min, Hyun Jin; Yoon, Ho-Geun; Ahn, Jin-Hyun; Shin, Jeon-Soo			High Mobility Group Nucleosomal Binding Domain 2 (HMGN2) SUMOylation by the SUMO E3 Ligase PIAS1 Decreases the Binding Affinity to Nucleosome Core Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL-PROTEINS HMG-14; LIVING CELLS; POSTTRANSLATIONAL MODIFICATIONS; MITOTIC PHOSPHORYLATION; CHROMATIN; DYNAMICS; HMGB1; REGULATOR; SECRETION; DISTINCT	High mobility group nucleosomal binding domain 2 (HMGN2) is a small and unique non-histone protein that has many functions in a variety of cellular processes, including regulation of chromatin structure, transcription, and DNA repair. In addition, it may have other roles in antimicrobial activity, cell homing, and regulating cytokine release. Although the biochemical properties of HMGN2 protein are regulated by acetylation and phosphorylation, it is not yet known whether HMGN2 activity can also be regulated by SUMOylation. In this study, we demonstrated for the first time that HMGN2 is modified by covalent attachment of small ubiquitin-related modifier 1 (SUMO1) by pro-inflammatory signal and identified the major SUMOylated lysine residues that localize to the HMGN2 nucleosome-binding domain at Lys-17 and Lys-35. SENP1 can deSUMOylate SUMOylated HMGN2, and PIAS1 is the E3 ligase responsible for SUMOylation of HMGN2. Finally, using SUMO1-conjugated HMGN2 purified from a basal SUMOylation system in Escherichia coli, we demonstrated that SUMOylated HMGN2 has decreased the binding affinity to nucleosome core particles in comparison to unSUMOylated HMGN2. These observations potentially provide new perspectives for understanding the functions of HMGN2 in inflammatory reaction.	[Wu, Jie; Kim, Sol; Kwak, Man Sup; Jeong, Jang Bin; Min, Hyun Jin; Shin, Jeon-Soo] Yonsei Univ, Dept Microbiol, Coll Med, Seoul 120752, South Korea; [Wu, Jie; Jeong, Jang Bin; Min, Hyun Jin; Yoon, Ho-Geun; Shin, Jeon-Soo] Yonsei Univ, Brain Korea Plus Project Med Sci 21, Coll Med, Seoul 120752, South Korea; [Shin, Jeon-Soo] Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul 120752, South Korea; [Shin, Jeon-Soo] Yonsei Univ, Inst Immunol & Immunol Dis, Coll Med, Seoul 120752, South Korea; [Yoon, Ho-Geun] Yonsei Univ, Dept Biochem & Mol Biol, Coll Med, Seoul 120752, South Korea; [Wu, Jie] Harbin Med Univ, Med Genet Lab, Harbin 150086, Peoples R China; [Ahn, Jin-Hyun] Sungkyunkwan Univ, Dept Mol Cell Biol, Sch Med, Suwon 440746, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Harbin Medical University; Sungkyunkwan University (SKKU)	Shin, JS (corresponding author), Yonsei Univ, Dept Microbiol, Coll Med, 50-1 Yonsei Ro, Seoul 120752, South Korea.	jsshin6203@yuhs.ac	kim, sol/I-2198-2019; Chung-ang, HyunJin/AAO-9395-2020	, Man Sup Kwak/0000-0002-3989-3016; Yoon, Ho-Geun Yoon/0000-0003-2718-3372; Shin, Jeon-Soo/0000-0002-8294-3234	National Research Foundation of Korea (NRF) - Korean government (MEST) [2011-0017611, 2014R1A4A1008625]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This work was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (MEST) (2011-0017611 and 2014R1A4A1008625).	Amen M, 2008, NUCLEIC ACIDS RES, V36, P462, DOI 10.1093/nar/gkm1047; AUSIO J, 1989, J MOL BIOL, V206, P451, DOI 10.1016/0022-2836(89)90493-2; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P431, DOI 10.1016/S0968-0004(01)01855-2; Cao XF, 2008, MOL CANCER THER, V7, P923, DOI 10.1158/1535-7163.MCT-07-0540; Catez F, 2003, BIOCHEM CELL BIOL, V81, P113, DOI 10.1139/o03-040; Deng LX, 2011, FEBS J, V278, P2152, DOI 10.1111/j.1742-4658.2011.08132.x; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Feng Y, 2005, J LEUKOCYTE BIOL, V78, P1136, DOI 10.1189/jlb.0505280; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gerlitz G, 2010, BBA-GENE REGUL MECH, V1799, P80, DOI 10.1016/j.bbagrm.2009.10.007; Gerlitz G, 2009, BIOCHEM CELL BIOL, V87, P127, DOI 10.1139/O08-110; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Herrera JE, 1999, MOL CELL BIOL, V19, P3466; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Kato H, 2011, P NATL ACAD SCI USA, V108, P12283, DOI 10.1073/pnas.1105848108; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; MARDIAN JKW, 1980, SCIENCE, V209, P1534, DOI 10.1126/science.7433974; Messner S, 2009, FASEB J, V23, P3978, DOI 10.1096/fj.09-137695; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Pogna EA, 2010, BBA-GENE REGUL MECH, V1799, P93, DOI 10.1016/j.bbagrm.2009.11.018; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; Prymakowska-Bosak M, 2002, MOL CELL BIOL, V22, P6809, DOI 10.1128/MCB.22.19.6809-6819.2002; Prymakowska-Bosak M, 2001, MOL CELL BIOL, V21, P5169, DOI 10.1128/MCB.21.15.5169-5178.2001; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Terada K, 2010, DEV BIOL, V347, P180, DOI 10.1016/j.ydbio.2010.08.023; TRIESCHMANN L, 1995, MOL CELL BIOL, V15, P6663; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Ueda T, 2006, J BIOL CHEM, V281, P10182, DOI 10.1074/jbc.M600821200; Ueda T, 2008, MOL CELL BIOL, V28, P2872, DOI 10.1128/MCB.02181-07; Wang HH, 2001, AM J RESP CRIT CARE, V164, P1768, DOI 10.1164/ajrccm.164.10.2106117; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Witty J, 2010, BIOCHEM J, V428, P247, DOI 10.1042/BJ20091948; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889; Zhang QC, 2008, BBA-PROTEINS PROTEOM, V1784, P1159, DOI 10.1016/j.bbapap.2008.04.028	42	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20000	20011		10.1074/jbc.M114.555425	http://dx.doi.org/10.1074/jbc.M114.555425			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24872413	Green Published, hybrid			2022-12-25	WOS:000339395200016
J	Gonzalez-Vallinas, M; Molina, S; Vicente, G; Zarza, V; Martin-Hernandez, R; Garcia-Risco, MR; Fornari, T; Reglero, G; de Molina, AR				Gonzalez-Vallinas, Margarita; Molina, Susana; Vicente, Gonzalo; Zarza, Virginia; Martin-Hernandez, Roberto; Garcia-Risco, Monica R.; Fornari, Tiziana; Reglero, Guillermo; Ramirez de Molina, Ana			Expression of MicroRNA-15b and the Glycosyltransferase GCNT3 Correlates with Antitumor Efficacy of Rosemary Diterpenes in Colon and Pancreatic Cancer	PLOS ONE			English	Article							ROSMARINUS-OFFICINALIS; CARNOSIC ACID; ANTIOXIDANT; EXTRACTS; INHIBITION; ANTICANCER; GROWTH	Colorectal and pancreatic cancers remain important contributors to cancer mortality burden and, therefore, new therapeutic approaches are urgently needed. Rosemary (Rosmarinus officinalis L.) extracts and its components have been reported as natural potent antiproliferative agents against cancer cells. However, to potentially apply rosemary as a complementary approach for cancer therapy, additional information regarding the most effective composition, its antitumor effect in vivo and its main molecular mediators is still needed. In this work, five carnosic acid-rich supercritical rosemary extracts with different chemical compositions have been assayed for their antitumor activity both in vivo (in nude mice) and in vitro against colon and pancreatic cancer cells. We found that the antitumor effect of carnosic acid together with carnosol was higher than the sum of their effects separately, which supports the use of the rosemary extract as a whole. In addition, gene and microRNA expression analyses have been performed to ascertain its antitumor mechanism, revealing that up-regulation of the metabolic-related gene GCNT3 and down-regulation of its potential epigenetic modulator miR-15b correlate with the antitumor effect of rosemary. Moreover, plasmatic miR-15b down-regulation was detected after in vivo treatment with rosemary. Our results support the use of carnosic acid-rich rosemary extract as a complementary approach in colon and pancreatic cancer and indicate that GCNT3 expression may be involved in its antitumor mechanism and that miR-15b might be used as a non-invasive biomarker to monitor rosemary anticancer effect.	[Gonzalez-Vallinas, Margarita; Molina, Susana; Zarza, Virginia; Martin-Hernandez, Roberto; Reglero, Guillermo; Ramirez de Molina, Ana] Madrid Inst Adv Studies Food IMDEA Food, Unit Mol Oncol & Nutr Genom Canc, Madrid, Spain; [Vicente, Gonzalo; Garcia-Risco, Monica R.; Fornari, Tiziana; Reglero, Guillermo] Inst Food Sci Res CIAL, Dept Prod & Characterizat Novel Foods, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM - Instituto de Investigacion en Ciencias de la Alimentacion (CIAL)	de Molina, AR (corresponding author), Madrid Inst Adv Studies Food IMDEA Food, Unit Mol Oncol & Nutr Genom Canc, Campus Int Excellence UAM CSIC, Madrid, Spain.	ana.ramirez@imdea.org	de Molina, Ana Ramirez/AAA-3848-2019; Molina, Susana/M-8969-2014; Rodríguez, Mónica/AAA-7138-2019; González-Vallinas, Margarita/K-3506-2016; MARTIN-HERNANDEZ, ROBERTO/M-8161-2014; Reglero, Guillermo/K-6658-2014	Molina, Susana/0000-0001-7737-5562; González-Vallinas, Margarita/0000-0003-4968-6675; MARTIN-HERNANDEZ, ROBERTO/0000-0002-2723-6289; Reglero, Guillermo/0000-0002-7730-3486; Rodriguez Garcia-Risco, Monica/0000-0002-1384-6342; Djaoud, Kahina/0000-0002-6736-367X	Spanish Ministry of Science and Innovation (Plan Nacional I+D+i) [AGL2010-21565, RyC 2008-03734, IPT-2011-1248-060000]; Comunidad de Madrid (ALIBIRD) [S2009/AGR-1469]; European Union	Spanish Ministry of Science and Innovation (Plan Nacional I+D+i)(Spanish Government); Comunidad de Madrid (ALIBIRD)(Comunidad de Madrid); European Union(European Commission)	This work was supported by the Spanish Ministry of Science and Innovation (Plan Nacional I+D+i AGL2010-21565, RyC 2008-03734; IPT-2011-1248-060000); Comunidad de Madrid (ALIBIRD, S2009/AGR-1469); and European Union Structural Funds. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bai NS, 2010, J AGR FOOD CHEM, V58, P5363, DOI 10.1021/jf100332w; Chen CC, 2011, ACTA PHARMACOL SIN, V32, P62, DOI 10.1038/aps.2010.181; Cheung S, 2007, ONCOL REP, V17, P1525; Giraldez MD, 2012, CLIN GASTROENTEROLOG; Gonzalez-Vallinas M, 2013, PHARMACOL RES, V72, P61, DOI 10.1016/j.phrs.2013.03.010; Hernando E, 2009, ONCOGENE, V28, P2425, DOI 10.1038/onc.2009.91; Huang MC, 2006, ONCOGENE, V25, P3267, DOI 10.1038/sj.onc.1209350; HUANG MT, 1994, CANCER RES, V54, P701; Ibanez C, 2012, J CHROMATOGR A, V1248, P139, DOI 10.1016/j.chroma.2012.06.008; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jordan MJ, 2012, J AGR FOOD CHEM, V60, P9603, DOI 10.1021/jf302881t; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Mothana RAA, 2011, PHARM BIOL, V49, P200, DOI 10.3109/13880209.2010.512295; Palanca V, 2006, NUTR HOSP, V21, P199; Peng CH, 2007, BIOSCI BIOTECH BIOCH, V71, P2223, DOI 10.1271/bbb.70199; Posadas SJ, 2009, EXP GERONTOL, V44, P383, DOI 10.1016/j.exger.2009.02.015; Sharabani H, 2006, INT J CANCER, V118, P3012, DOI 10.1002/ijc.21736; Singletary K, 1996, CANCER LETT, V104, P43, DOI 10.1016/0304-3835(96)04227-9; Singletary KW, 1997, PLANT FOOD HUM NUTR, V50, P47, DOI 10.1007/BF02436042; Slamenova D, 2002, CANCER LETT, V177, P145, DOI 10.1016/S0304-3835(01)00784-4; Tai J, 2012, PHYTOMEDICINE, V19, P436, DOI 10.1016/j.phymed.2011.12.012; Tu Z, 2013, J AGR FOOD CHEM; Valdes A, 2013, GENES NUTR, V8, P43, DOI 10.1007/s12263-012-0311-9; Vicente G, 2013, J SUPERCRIT FLUID, V79, P101, DOI 10.1016/j.supflu.2012.07.006; Wang W, 2012, MOLECULES, V17, P2704, DOI 10.3390/molecules17032704; Yeo TP, 2012, CANCER J, V18, P477, DOI 10.1097/PPO.0b013e3182756803; Yesil-Celiktas O, 2010, PLANT FOOD HUM NUTR, V65, P158, DOI 10.1007/s11130-010-0166-4; Yi WG, 2011, J SCI FOOD AGR, V91, P1849, DOI 10.1002/jsfa.4394	29	58	62	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98556	10.1371/journal.pone.0098556	http://dx.doi.org/10.1371/journal.pone.0098556			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892299	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400065
J	Kerac, M; Bunn, J; Chagaluka, G; Bahwere, P; Tomkins, A; Collins, S; Seal, A				Kerac, Marko; Bunn, James; Chagaluka, George; Bahwere, Paluku; Tomkins, Andrew; Collins, Steve; Seal, Andrew			Follow-Up of Post-Discharge Growth and Mortality after Treatment for Severe Acute Malnutrition (FuSAM Study): A Prospective Cohort Study	PLOS ONE			English	Article							NUTRITION REHABILITATION; MALNOURISHED CHILDREN; HIV PREVALENCE; EFFICACY; MALAWI; MANAGEMENT; SURVIVAL; OUTCOMES; TIME	Background: Management of Severe Acute Malnutrition (SAM) plays a vital role in achieving global child survival targets. Effective treatment programmes are available but little is known about longer term outcomes following programme discharge. Methods: From July 2006 to March 2007, 1024 children (median age 21.5 months, IQR 15-32) contributed 1187 admission episodes to an inpatient-based SAM treatment centre in Blantyre, Malawi. Long term outcomes, were determined in a longitudinal cohort study, a year or more after initial programme discharge. We found information on 88%(899/1024). Results: In total, 42%(427/1024) children died during or after treatment. 25%(105/427) of deaths occurred after normal programme discharge, >90 days after admission. Mortality was greatest among HIV seropositive children: 62%(274/445). Other risk factors included age,12 months; severity of malnutrition at admission; and disability. In survivors, weight-for-height and weight-for-age improved but height-for-age remained low, mean -22.97 z-scores (SD 1.3). Conclusions: Although SAM mortality in this setting was unacceptably high, our findings offer important lessons for future programming, policy and research. First is the need for improved programme evaluation: most routine reporting systems would have missed late deaths and underestimated total mortality due to SAM. Second, a more holistic view of SAM is needed: while treatment will always focus on nutritional interventions, it is vital to also identify and manage underlying clinical conditions such as HIV and disability. Finally early identification and treatment of SAM should be emphasised: our results suggest that this could improve longer term as well as short term outcomes. As international policy and programming becomes increasingly focused on stunting and post-malnutrition chronic disease outcomes, SAM should not be forgotten. Proactive prevention and treatment services are essential, not only to reduce mortality in the short term but also because they have potential to impact on longer term morbidity, growth and development of survivors.	[Kerac, Marko; Bahwere, Paluku; Collins, Steve] Valid Int, Oxford, England; [Kerac, Marko; Bunn, James; Chagaluka, George] Coll Med, Dept Paediat & Child Hlth, Blantyre, Malawi; [Kerac, Marko; Tomkins, Andrew; Seal, Andrew] UCL, Inst Global Hlth, London, England; [Kerac, Marko] UCL, Leonard Cheshire Disabil & Inclus Dev Ctr, London, England; [Bunn, James] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Bahwere, Paluku] Univ Libre Brussels, Ctr Res Epidemiol Biostat & Clin Res, Brussels, Belgium	University of Malawi; University of London; University College London; University of London; University College London; Liverpool School of Tropical Medicine; University of Liverpool; Universite Libre de Bruxelles	Kerac, M (corresponding author), Valid Int, Oxford, England.	marko.kerac@gmail.com	Kerac, Marko/GQR-1136-2022; Kerac, Marko/G-1777-2010; Seal, Andrew/C-8550-2014	Kerac, Marko/0000-0002-3745-7317; Seal, Andrew/0000-0003-3656-4054	UNICEF Malawi; NIHR; National Institute for Health Research [CL-2012-18-005, ACF-2008-18-010] Funding Source: researchfish	UNICEF Malawi; NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	UNICEF Malawi funded this study. Valid International provided support in the form of salaries for authors MK (from end 2005 to Jan 2008 only - the 'baseline' period of this study) PB, and SC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. MK gratefully acknowledges NIHR for funding his current UCL Academic Clinical Lecturer post.	[Anonymous], 2009, WHO CHILD GROWTH STA; Bahwere P., 2012, Journal of Public Health and Epidemiology, V4, P215; Bahwere P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-106; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Collins S, 2003, LANCET, V362, P249, DOI 10.1016/S0140-6736(03)13926-8; Collins S, 2001, LANCET, V358, P498, DOI 10.1016/S0140-6736(01)05630-6; Collins S, 2007, ARCH DIS CHILD, V92, P453, DOI 10.1136/adc.2006.098327; Collins S, 2006, FOOD NUTR BULL, V27, pS49, DOI 10.1177/15648265060273S304; de Onis M, 2009, ARCH PEDIATRIE, V16, P47, DOI 10.1016/j.arcped.2008.10.010; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; Dulloo AG, 2008, BEST PRACT RES CL EN, V22, P155, DOI 10.1016/j.beem.2007.08.001; Fergusson P, 2009, INT HEALTH, V1, P10, DOI 10.1016/j.inhe.2009.03.001; Fergusson P, 2009, T ROY SOC TROP MED H, V103, P541, DOI 10.1016/j.trstmh.2008.10.029; Gillespie SHL, 2003, IFPRI REPORT; *GOV MAL, 2007, INT GUID MAN AC MALN; Grobler-Tanner C, 2004, 8 FANTA; Groce NE, 2013, LANCET GLOB HEALTH, V1, pE180, DOI 10.1016/S2214-109X(13)70056-1; HENNART P, 1987, J TROP PEDIATRICS, V33, P10, DOI 10.1093/tropej/33.1.10; Kerac M, 2011, THESIS UCL; Kerac M, 2009, LANCET, V374, P136, DOI 10.1016/S0140-6736(09)60884-9; PECOUL B, 1992, ANN TROP PAEDIATR, V12, P47, DOI 10.1080/02724936.1992.11747546; PERRA A, 1995, EUR J CLIN NUTR, V49, P353; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Sadler K, 2008, J TROP PEDIATRICS, V54, P364, DOI 10.1093/tropej/fmn029; SPHERE, 2011, SPHER PROJ HUM CHART; Stettler N, 2010, CURR OPIN CLIN NUTR, V13, P294, DOI 10.1097/MCO.0b013e328337d7b9; Thurstans S, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-22; UNICEF, 2013, UNICEF GLOB PARTN CH; VANROOSMALENWIEBENGA MW, 1987, J TROP PEDIATRICS, V33, P24, DOI 10.1093/tropej/33.1.24; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; *WHO WFP UNSCN UNI, 2007, COMM BAS MAN SEV AC; World Health Organization, 2006, WHO CAS DEF HIV SURV	32	108	109	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e96030	10.1371/journal.pone.0096030	http://dx.doi.org/10.1371/journal.pone.0096030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892281	Green Published, gold, Green Accepted			2022-12-25	WOS:000336911400005
J	LaPensee, CR; Lin, G; Dent, AL; Schwartz, J				LaPensee, Christopher R.; Lin, Grace; Dent, Alexander L.; Schwartz, Jessica			Deficiency of the Transcriptional Repressor B Cell Lymphoma 6 (Bcl6) Is Accompanied by Dysregulated Lipid Metabolism	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; GERMINAL CENTER FORMATION; ACID SYNTHASE PROMOTER; GROWTH-HORMONE; GENE-EXPRESSION; PPAR-ALPHA; REGULATED TRANSCRIPTION; ADIPOCYTE DIFFERENTIATION; INSULIN-RESISTANCE; HEPATIC STEATOSIS	The transcriptional repressor B-cell Lymphoma 6 (Bcl6) was recently identified in a profile of genes regulated in adipocytes, suggesting a relationship between Bcl6 and metabolic regulation. As a representative target gene repressed by Bcl6, Suppressor of Cytokine Signaling (Socs) 2 expression was elevated in Bcl6 deficient (KO) mice, including metabolic tissues liver, adipose tissue and muscle, as well as in spleen and thymus. Bcl6 occupied the Socs2 promoter in wild-type, but not Bcl6 KO mice, suggesting direct regulation of Socs2 by Bcl6 in vivo. Mice deficient in Bcl6 were found to exhibit multiple features of dysregulated lipid metabolism. Adipose tissue mass was dramatically reduced or absent in Bcl6 KO mice. Further, hepatic and serum triglycerides were low. Bcl6 deficiency was accompanied by decreased hepatic expression of Stearoyl-CoA desaturase 1 (Scd1) and Fatty acid synthase (Fasn) genes which encode lipogenic enzymes. Expression of the gene for the transcription factor Carbohydrate-Responsive Element Binding Protein (Chrebp), which regulates expression of lipogenic genes, was also reduced in liver of Bcl6 KO mice. Bcl6 deficiency disrupted fasting-induced increases in hepatic triglyceride deposition, but not decreases in lipogenic gene expression. Taken together, these findings suggest that in addition to its well-recognized roles in immune regulation, Bcl6 plays a role in regulatory events of lipid metabolism, and that in the absence of Bcl6, lipid metabolism in liver and adipose tissue is dysregulated.	[LaPensee, Christopher R.; Schwartz, Jessica] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Lin, Grace; Schwartz, Jessica] Univ Michigan, Grad Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Dent, Alexander L.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Indiana University System; Indiana University Bloomington	Schwartz, J (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	jeschwar@umich.edu			American Diabetes Association [7-09-BS-168]; NIH [R01DK46072, T32 GM07315]; NIAID [R21AI079349, R21AI090150, R21AI092212]; Center for Organogenesis at the University of Michigan [NIH T32 HD007505]; Univ Michigan Cancer Center; Rackham Predoctoral Fellowship, Univ Michigan; MIP [R25 DK088752]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R25DK088752, R01DK046072, P60DK020572, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008322, T32GM007315] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for Organogenesis at the University of Michigan; Univ Michigan Cancer Center; Rackham Predoctoral Fellowship, Univ Michigan; MIP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant 7-09-BS-168 from the American Diabetes Association and Grant R01DK46072 from NIH (to JS) and NIAID grants R21AI079349, R21AI090150 and R21AI092212 to ALD. CRL was supported by a postdoctoral fellowship from the Center for Organogenesis (NIH T32 HD007505) at the University of Michigan. GL was supported by NIH T32 GM07315, Director's and Loeb Fellowships from Univ Michigan Cancer Center and by a Rackham Predoctoral Fellowship, Univ Michigan. Aaron Taylor, recipient of a MIP summer fellowship (R25 DK088752) assisted with MSC preparation. Serum analysis was performed by the Chemistry Core of the Michigan Diabetes Research Center (NIH5P30 DK20572) at the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Berryman DE, 2004, GROWTH HORM IGF RES, V14, P309, DOI 10.1016/j.ghir.2004.02.005; Bhatt AP, 2012, P NATL ACAD SCI USA, V109, P11818, DOI 10.1073/pnas.1205995109; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chen YL, 2009, ENDOCRINOLOGY, V150, P3645, DOI 10.1210/en.2009-0212; Chia DJ, 2010, MOL ENDOCRINOL, V24, P2038, DOI 10.1210/me.2010-0234; Ci WM, 2009, BLOOD, V113, P5536, DOI 10.1182/blood-2008-12-193037; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Cui TX, 2005, MOL ENDOCRINOL, V19, P2175, DOI 10.1210/me.2004-0502; DAVIDSON MB, 1987, ENDOCR REV, V8, P115, DOI 10.1210/edrv-8-2-115; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Dentin R, 2006, DIABETES, V55, P2159, DOI 10.2337/db06-0200; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Flores-Morales A, 2006, MOL ENDOCRINOL, V20, P241, DOI 10.1210/me.2005-0170; Frederiksen KS, 2004, J LIPID RES, V45, P592, DOI 10.1194/jlr.M300239-JLR200; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Glauser DA, 2009, J RECEPT SIGNAL TRAN; Goodman HM, 1974, HDB PHYSL, P211; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; Hatzi K, 2013, CELL REP, V4, P578, DOI 10.1016/j.celrep.2013.06.016; Hollister K, 2013, J IMMUNOL, V191, P3705, DOI 10.4049/jimmunol.1300378; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huang JF, 2013, BBA-MOL CELL BIOL L, V1831, P1555, DOI 10.1016/j.bbalip.2013.04.012; Huynh KD, 2000, GENE DEV, V14, P1810; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kojima S, 2001, DEVELOPMENT, V128, P57; Krebs CJ, 2009, PHYSIOL GENOMICS, V38, P16, DOI 10.1152/physiolgenomics.90391.2008; LaPensee CR, 2006, ENDOCRINOLOGY, V147, P4638, DOI 10.1210/en.2006-0487; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Liao J, 1999, J BIOL CHEM, V274, P31597, DOI 10.1074/jbc.274.44.31597; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Mendez LM, 2008, MOL CELL BIOL, V28, P2175, DOI 10.1128/MCB.01400-07; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Meyer RD, 2009, MOL ENDOCRINOL, V23, P1914, DOI 10.1210/me.2009-0242; Miyazaki M, 2004, J BIOL CHEM, V279, P35017, DOI 10.1074/jbc.M405327200; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Mori H, 2012, J CLIN INVEST, V122, P2405, DOI 10.1172/JCI63604; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Nelson EA, 2013, MOL CELL BIOL; New EP, 2003, J BIOL CHEM, V278, P51664; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Oliphant CJ, 2011, IMMUNOLOGY, V134, P378, DOI 10.1111/j.1365-2567.2011.03499.x; Roder K, 2007, FEBS LETT, V581, P2715, DOI 10.1016/j.febslet.2007.05.022; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Schebesta M, 2002, CURR OPIN IMMUNOL, V14, P216, DOI 10.1016/S0952-7915(02)00324-2; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Staudt L M, 1999, Int Rev Immunol, V18, P381, DOI 10.3109/08830189909088490; Tabor DE, 1999, J BIOL CHEM, V274, P20603, DOI 10.1074/jbc.274.29.20603; Toney LM, 2000, NAT IMMUNOL, V1, P214, DOI 10.1038/79749; Tyagi S, 2011, J ADV PHARM TECHNOL, V2, P236, DOI 10.4103/2231-4040.90879; Vidal OM, 2007, MOL ENDOCRINOL, V21, P293, DOI 10.1210/me.2006-0096; Walker SR, 2007, ONCOGENE, V26, P224, DOI 10.1038/sj.onc.1209775; Wang X, 2002, P NATL ACAD SCI USA, V99, P15018, DOI 10.1073/pnas.232581199; Wei F, 2009, MOL CELL BIOL, V29, P4612, DOI 10.1128/MCB.00234-09; White UA, 2009, MOL CELL ENDOCRINOL; Yang HL, 2013, MOL BIOL REP, V40, P2319, DOI 10.1007/s11033-012-2313-5; Zadjali F, 2012, FASEB J, V26, P3282, DOI 10.1096/fj.12-205583; Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11	72	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97090	10.1371/journal.pone.0097090	http://dx.doi.org/10.1371/journal.pone.0097090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892698	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400009
J	Beyer, K; Poetschke, C; Partecke, LI; von Bernstorff, W; Maier, S; Broeker, BM; Heidecke, CD				Beyer, Katharina; Poetschke, Christian; Partecke, Lars Ivo; von Bernstorff, Wolfram; Maier, Stefan; Broeker, Barbara M.; Heidecke, Claus-Dieter			TRAIL Induces Neutrophil Apoptosis and Dampens Sepsis-Induced Organ Injury in Murine Colon Ascendens Stent Peritonitis	PLOS ONE			English	Article							ANIMAL-MODELS; MODULATION; PREVENTION; RESPONSES; SURVIVAL; CELLS	TNF-related apoptosis inducing ligand (TRAIL) influences several inflammatory reactions by partially still unknown mechanisms. TRAIL is produced and expressed by several cells of the immune system. Murine Colon Ascendens Stent Peritonitis (CASP) represents a hyperinflammatory model of diffuse peritonitis. As we have shown previously, TRAIL strongly improves survival in murine CASP. This is accompanied by a significantly reduced infiltration of neutrophils in the associated lymphoid tissue. Additionally, it is known that TRAIL induces apoptosis in neutrophils and acceleration of neutrophil apoptosis enhances resolution of inflammatory reactions. In this study, we investigated the correlation of the protective effect of TRAIL in sepsis and its influence on neutrophils. We found that neutrophils infiltrating the lymphoid organs express the TRAIL-receptor DR5 at high density. Furthermore, we demonstrated that TRAIL-treatment enhances apoptosis of neutrophils in the spleen, lung and liver and decreases organ injury during sepsis. To further examine a role for neutrophils in TRAIL-mediated protection in CASP, we have depleted neutrophils 24 hours prior to CASP. In these depleted mice, administration of TRAIL was ineffective. We conclude that TRAIL induces apoptosis in tissue-infiltrating neutrophils thereby protecting organs from sepsis-induced injury.	[Beyer, Katharina; Poetschke, Christian; Partecke, Lars Ivo; von Bernstorff, Wolfram; Maier, Stefan; Broeker, Barbara M.; Heidecke, Claus-Dieter] Univ Med Greifswald, Klin Allgemein Viszeral Thorax & Gefasschirurg, Greifswald, Germany; [Poetschke, Christian; Broeker, Barbara M.] Univ Med Greifswald, Immunol Abt, Greifswald, Germany	Greifswald Medical School; Greifswald Medical School	Beyer, K (corresponding author), Univ Med Greifswald, Klin Allgemein Viszeral Thorax & Gefasschirurg, Greifswald, Germany.	cziupka@uni-greifswald.de	Maier, Stefan/V-2883-2019	Maier, Stefan/0000-0001-9704-7902				Almyroudis NG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00045; Barrera G, 2011, INFECT IMMUN, V79, P1280, DOI 10.1128/IAI.01127-10; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Collison A, 2009, CLIN EXP PHARMACOL P, V36, P1049, DOI 10.1111/j.1440-1681.2009.05258.x; Cziupka K, 2010, CRIT CARE MED; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Frasch SC, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.181800; Gurung P, 2011, J IMMUNOL, V187, P2148, DOI 10.4049/jimmunol.1101180; Hayakawa Y, 2004, J IMMUNOL, V172, P123, DOI 10.4049/jimmunol.172.1.123; Hoesel LM, 2005, SHOCK, V24, P40, DOI 10.1097/01.shk.0000170353.80318.d5; Hoffmann O, 2007, J CLIN INVEST, V117, P2004, DOI 10.1172/JCI30356; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 2005, CLIN INFECT DIS, V41, pS465, DOI 10.1086/431998; Kelly KJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1309, DOI 10.1152/ajpcell.00353.2002; Lum JJ, 2005, J IMMUNOL, V175, P1232, DOI 10.4049/jimmunol.175.2.1232; Maier S, 2004, SHOCK, V21, P505, DOI 10.1097/01.shk.0000126906.52367.dd; McGrath EE, 2011, J LEUKOCYTE BIOL, V90, P855, DOI 10.1189/jlb.0211062; Muenzer JT, 2010, INFECT IMMUN, V78, P1582, DOI 10.1128/IAI.01213-09; Remick DG, 2005, INFECT IMMUN, V73, P2751, DOI 10.1128/IAI.73.5.2751-2757.2005; Renshaw SA, 2003, J IMMUNOL, V170, P1027, DOI 10.4049/jimmunol.170.2.1027; Salomao R, 2012, SHOCK, V38, P227, DOI 10.1097/SHK.0b013e318262c4b0; Sarangi PP, 2012, SHOCK, V38, P281, DOI 10.1097/SHK.0b013e31826136f8; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Unsinger J, 2010, J IMMUNOL, V184, P6766, DOI 10.4049/jimmunol.0904054; Wu Z, 2011, INFECT IMMUN, V79, P2865, DOI 10.1128/IAI.01317-10; Xiao H, 2011, J CLIN IMMUNOL, V31, P1112, DOI 10.1007/s10875-011-9559-x; Zantl N, 1998, INFECT IMMUN, V66, P2300, DOI 10.1128/IAI.66.5.2300-2309.1998	29	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97451	10.1371/journal.pone.0097451	http://dx.doi.org/10.1371/journal.pone.0097451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887152	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300018
J	Shi, JH; Li, J; Guan, H; Cai, WX; Bai, XZ; Fang, XB; Hu, XL; Wang, YJ; Wang, HT; Zheng, Z; Su, LL; Hu, DH; Zhu, XX				Shi, Jihong; Li, Jun; Guan, Hao; Cai, Weixia; Bai, Xiaozhi; Fang, Xiaobing; Hu, Xiaolong; Wang, Yaojun; Wang, Hongtao; Zheng, Zhao; Su, Linlin; Hu, Dahai; Zhu, Xiongxiang			Anti-Fibrotic Actions of Interleukin-10 against Hypertrophic Scarring by Activation of PI3K/AKT and STAT3 Signaling Pathways in Scar-Forming Fibroblasts	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; GENE-EXPRESSION; I COLLAGEN; TGF-BETA; KELOIDS; IL-10; MODEL; MICE	Background: The hypertrophic scar (HS) is a serious fibrotic skin condition and a major clinical problem. Interleukin-10 (IL-10) has been identified as a prospective scar-improving compound based on preclinical trials. Our previous work showed that IL-10 has anti-fibrotic effects in transforming growth factor (TGF)-beta 1-stimulated fibroblasts, as well as potential therapeutic benefits for the prevention and reduction of scar formation. However, relatively little is known about the mechanisms underlying IL-10-mediated anti-fibrotic and scar-improvement actions. Objective: To explore the expression of the IL-10 receptor in human HS tissue and primary HS fibroblasts (HSFs), and the molecular mechanisms contributing to the anti-fibrotic and scar-improvement capabilities of IL-10. Methods: Expression of the IL-10 receptor was assessed in HS tissue and HSFs by immunohistochemistry, immunofluorescence microscopy, and polymerase chain reaction analysis. Primary HSFs were treated with IL-10, a specific phosphatidylinositol 3 kinase (PI3K) inhibitor (LY294002) or a function-blocking antibody against the IL-10 receptor (IL-10RB). Next, Western blot analysis was used to evaluate changes in the phosphorylation status of AKT and signal transducers and activators of transcription (STAT) 3, as well as the expression levels of fibrosis-related proteins. Results: HS tissue and primary HSFs were characterized by expression of the IL-10 receptor and by high expression of fibrotic markers relative to normal controls. Primary HSFs expressed the IL-10 receptor, while IL-10 induced AKT and STAT3 phosphorylation in these cells. In addition, LY294002 blocked AKT and STAT phosphorylation, and also up-regulated expression levels of type I and type III collagen (Col 1 and Col 3) and alpha-smooth muscle actin (alpha-SMA) in IL-10-treated cells. Similarly, IL-10RB reduced STAT3/AKT phosphorylation and blocked the IL-10-mediated mitigation of fibrosis in HSFs. Conclusion: IL-10 apparently inhibits fibrosis by activating AKT and STAT3 phosphorylation downstream of the IL-10 receptor, and by facilitating crosstalk between the PI3K/AKT and STAT3 signal transduction pathways.	[Shi, Jihong; Li, Jun; Guan, Hao; Cai, Weixia; Bai, Xiaozhi; Fang, Xiaobing; Hu, Xiaolong; Wang, Yaojun; Wang, Hongtao; Zheng, Zhao; Su, Linlin; Hu, Dahai; Zhu, Xiongxiang] Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Peoples R China	Air Force Military Medical University	Hu, DH (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Burns & Cutaneous Surg, Xian 710032, Peoples R China.	biojhshi@126.com; zhuxiang@fmmu.edu.cn		/0000-0002-3640-6729; Li, Jun/0000-0001-8702-8054	National Natural Science Foundation of China [81272098, 81171811]; Xijing Hospital [XJZT12D01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xijing Hospital	The work was supported by the National Natural Science Foundation of China (Grant Number: 81272098, 81171811) and the Grant-in-Aid for scientific research from Xijing Hospital assist in 2012 (XJZT12D01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi S, 2007, PLOS MED, V4, P1464, DOI 10.1371/journal.pmed.0040234; Arai T, 2000, AM J PHYSIOL-LUNG C, V278, pL914, DOI 10.1152/ajplung.2000.278.5.L914; Bayat A, 2003, BRIT MED J, V326, P88, DOI 10.1136/bmj.326.7380.88; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Brown BC, 2008, J PLAST RECONSTR AES, V61, P1049, DOI 10.1016/j.bjps.2008.03.020; Campaner AB, 2006, J INVEST DERMATOL, V126, P1168, DOI 10.1038/sj.jid.5700200; Diao JS, 2011, ARCH DERMATOL RES, V303, P573, DOI 10.1007/s00403-011-1140-1; Donnelly RP, 1999, J INTERF CYTOK RES, V19, P563, DOI 10.1089/107999099313695; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Franke TF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe29; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Glocker EO, 2011, ANN NY ACAD SCI, V1246, P102, DOI 10.1111/j.1749-6632.2011.06339.x; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Hsu YC, 2010, ARCH DERMATOL RES, V302, P717, DOI 10.1007/s00403-010-1075-y; Hu XL, 2013, ARCH DERMATOL RES, V305, P433, DOI 10.1007/s00403-013-1334-9; Kircik LH, 2013, J DRUGS DERMATOL, V12, P86; Liechty KW, 2000, J PEDIATR SURG, V35, P866, DOI 10.1053/jpsu.2000.6868; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.immunol.11.1.165; Mrowietz U, 2009, ACTAS DERMO-SIFILOGR, V100, P75, DOI 10.1016/S0001-7310(09)73382-4; Nakagome K, 2006, THORAX, V61, P886, DOI 10.1136/thx.2005.056317; Niessen FB, 1999, PLAST RECONSTR SURG, V104, P1435, DOI 10.1097/00006534-199910000-00031; Occleston NL, 2008, DRUG DISCOV TODAY, V13, P973, DOI 10.1016/j.drudis.2008.08.009; Ong CT, 2007, EXP DERMATOL, V16, P394, DOI 10.1111/j.1600-0625.2007.00550.x; Park HJ, 2011, MOL IMMUNOL, V48, P720, DOI 10.1016/j.molimm.2010.10.020; Peranteau WH, 2008, J INVEST DERMATOL, V128, P1852, DOI 10.1038/sj.jid.5701232; REITAMO S, 1994, J CLIN INVEST, V94, P2489, DOI 10.1172/JCI117618; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Saito M, 2012, ARCH DERMATOL RES, V304, P217, DOI 10.1007/s00403-011-1184-2; Seifert O, 2009, ARCH DERMATOL RES, V301, P259, DOI 10.1007/s00403-009-0952-8; Shi JH, 2013, ARCH DERMATOL RES, V305, P341, DOI 10.1007/s00403-013-1314-0; Shi JH, 2012, ARCH DERMATOL RES, V304, P209, DOI 10.1007/s00403-012-1204-x; Sidgwick GP, 2012, J EUR ACAD DERMATOL, V26, P141, DOI 10.1111/j.1468-3083.2011.04200.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Tang B, 2011, ARCH DERMATOL RES, V303, P563, DOI 10.1007/s00403-010-1114-8; van der Veer WM, 2009, BURNS, V35, P15, DOI 10.1016/j.burns.2008.06.020; Weiss E, 2004, J AM ACAD DERMATOL, V50, P657, DOI 10.1016/j.jaad.2003.11.075; Wolfram D, 2009, DERMATOL SURG, V35, P171, DOI 10.1111/j.1524-4725.2008.34406.x; Yamamoto T, 2001, BIOCHEM BIOPH RES CO, V281, P200, DOI 10.1006/bbrc.2001.4321; Yuan WH, 2001, J BIOL CHEM, V276, P38502, DOI 10.1074/jbc.M107081200; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031157; Zhang ZF, 2011, BURNS, V37, P665, DOI 10.1016/j.burns.2010.12.001	43	72	75	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98228	10.1371/journal.pone.0098228	http://dx.doi.org/10.1371/journal.pone.0098228			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878845	Green Published, Green Submitted, gold			2022-12-25	WOS:000338101500040
J	Haberle, SG; Bowman, DMJS; Newnham, RM; Johnston, FH; Beggs, PJ; Buters, J; Campbell, B; Erbas, B; Godwin, I; Green, BJ; Huete, A; Jaggard, AK; Medek, D; Murray, F; Newbigin, E; Thibaudon, M; Vicendese, D; Williamson, GJ; Davies, JM				Haberle, Simon G.; Bowman, David M. J. S.; Newnham, Rewi M.; Johnston, Fay H.; Beggs, Paul J.; Buters, Jeroen; Campbell, Bradley; Erbas, Bircan; Godwin, Ian; Green, Brett J.; Huete, Alfredo; Jaggard, Alison K.; Medek, Danielle; Murray, Frank; Newbigin, Ed; Thibaudon, Michel; Vicendese, Don; Williamson, Grant J.; Davies, Janet M.			The Macroecology of Airborne Pollen in Australian and New Zealand Urban Areas	PLOS ONE			English	Article							BIRCH POLLEN; GRASS-POLLEN; SEASONAL DISTRIBUTION; EASTERN AUSTRALIA; CLIMATE-CHANGE; BETULA POLLEN; ATMOSPHERE; SOUTH; ALLERGENS; AEROALLERGENS	The composition and relative abundance of airborne pollen in urban areas of Australia and New Zealand are strongly influenced by geographical location, climate and land use. There is mounting evidence that the diversity and quality of airborne pollen is substantially modified by climate change and land-use yet there are insufficient data to project the future nature of these changes. Our study highlights the need for long-term aerobiological monitoring in Australian and New Zealand urban areas in a systematic, standardised, and sustained way, and provides a framework for targeting the most clinically significant taxa in terms of abundance, allergenic effects and public health burden.	[Haberle, Simon G.] Australian Natl Univ, Coll Asia & Pacific, Dept Archaeol & Nat Hist, Canberra, ACT, Australia; [Bowman, David M. J. S.; Williamson, Grant J.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia; [Newnham, Rewi M.] Victoria Univ Wellington, Sch Geog Environm & Earth Sci, Wellington, New Zealand; [Johnston, Fay H.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas, Australia; [Beggs, Paul J.; Jaggard, Alison K.] Macquarie Univ, Fac Sci, Dept Geog & Environm, Sydney, NSW 2109, Australia; [Buters, Jeroen] Tech Univ Munich, Ctr Allergy & Environm, D-80290 Munich, Germany; [Campbell, Bradley; Godwin, Ian] Univ Queensland, Sch Agr & Food Sci, St Lucia, Qld, Australia; [Erbas, Bircan; Vicendese, Don] La Trobe Univ, Sch Publ Hlth & Human Biosci, Bundoora, Vic, Australia; [Green, Brett J.] NIOSH, Allergy & Clin Immunol Branch, Hlth Effects Lab Div, Ctr Dis Control & Prevent, Morgantown, WV USA; [Huete, Alfredo] Univ Technol Sydney, Sydney, NSW 2007, Australia; [Medek, Danielle] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Murray, Frank] Murdoch Univ, Sch Environm Sci, Murdoch, WA 6150, Australia; [Newbigin, Ed] Univ Melbourne, Sch Bot, Melbourne, Vic, Australia; [Thibaudon, Michel] European Aerobiol Soc, Reseau Natl Surveillance Aerobiol, Lyon, Rhone Alpes, France; [Davies, Janet M.] Univ Queensland, Sch Med, Lung & Allergy Res Ctr, Woolloongabba, Qld, Australia; [Davies, Janet M.] Univ Queensland, Translat Res Inst, Woolloongabba, Qld, Australia	Australian National University; University of Tasmania; Victoria University Wellington; University of Tasmania; Macquarie University; Technical University of Munich; University of Queensland; La Trobe University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); University of Technology Sydney; Australian National University; Murdoch University; University of Melbourne; University of Queensland; University of Queensland	Haberle, SG (corresponding author), Australian Natl Univ, Coll Asia & Pacific, Dept Archaeol & Nat Hist, Canberra, ACT, Australia.	simon.haberle@anu.edu.au	Campbell, Bradley C./AAV-7020-2020; Bowman, David M.J.S./A-2930-2011; Huete, Alfredo R/C-1294-2008; Haberle, Simon/U-4118-2019; BUTERS, JEROEN/AAF-6949-2020; Buters, Jeroen T/G-5070-2011; Williamson, Grant/J-7514-2014; Davies, Janet/C-7989-2009	Campbell, Bradley C./0000-0003-0815-930X; Bowman, David M.J.S./0000-0001-8075-124X; Huete, Alfredo R/0000-0003-2809-2376; Williamson, Grant/0000-0002-3469-7550; Davies, Janet/0000-0002-6378-4119; Beggs, Paul/0000-0001-9949-1783; Vicendese, Don/0000-0002-0176-0314; Godwin, Ian/0000-0002-4006-4426; Buters, Jeroen/0000-0003-3581-5472; Johnston, Fay Helena/0000-0002-5150-8678; Haberle, Simon/0000-0001-5802-6535; Newbigin, Ed/0000-0002-9644-302X	Australian Centre for Ecological Analysis and Synthesis (ACEAS)	Australian Centre for Ecological Analysis and Synthesis (ACEAS)	Funding support for the Working Group came from the Australian Centre for Ecological Analysis and Synthesis (ACEAS). Terrestrial Ecosystem Research Network ( TERN). Merck Sharp and Dohme provided additional independent untied co-sponsorship for the Working Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Access Economics PL, 2007, EC IMP ALL DIS AUSTR; Altintas Derya Ufuk, 2004, Clin Dev Immunol, V11, P87, DOI 10.1080/10446670410001670544; Baldo BA, 1984, MED J AUSTRALIA, V141, pS12; Bass D, 1997, GRANA, V36, P293, DOI 10.1080/00173139709362620; Bass DJ, 2000, ANN ALLERG ASTHMA IM, V85, P374, DOI 10.1016/S1081-1206(10)62549-5; Bass DJ, 2000, AEROBIOLOGIA, V16, P107, DOI DOI 10.1023/A:1007696112953; Beggs PJ, 2005, ENVIRON HEALTH PERSP, V113, P915, DOI 10.1289/ehp.7724; Beggs PJ, 2004, CLIN EXP ALLERGY, V34, P1507, DOI 10.1111/j.1365-2222.2004.02061.x; Burbach GJ, 2009, ALLERGY, V64, P1507, DOI 10.1111/j.1398-9995.2009.02089.x; Buters JTM, 2012, ATMOS ENVIRON, V55, P496, DOI 10.1016/j.atmosenv.2012.01.054; Chapman JA, 1982, IMMUNOL ALLERGY PRAC, V4, P13; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Comtois P., 1999, Aerobiologia, V15, P19, DOI 10.1023/A:1007501017470; Comtois P, 1997, AEROBIOLOGIA, V13, P149, DOI DOI 10.1007/BF02694501; Cuneo Peter, 2006, Cunninghamia, V9, P545; D'Amato G, 2002, ALLERGY, V57, P35, DOI 10.1034/j.1398-9995.2002.057s71035.x; Davies Janet Mary, 2012, Clin Transl Allergy, V2, P4, DOI 10.1186/2045-7022-2-4; DCosta D, 1997, AUST J BOT, V45, P583, DOI 10.1071/BT96046; Emberlin J, 2002, INT J BIOMETEOROL, V46, P159, DOI 10.1007/s00484-002-0139-x; Emberlin J, 1999, CLIN EXP ALLERGY, V29, P347, DOI 10.1046/j.1365-2222.1999.00369.x; Fletcher MS, 2007, REV PALAEOBOT PALYNO, V146, P146, DOI 10.1016/j.revpalbo.2007.03.002; Giri C, 2005, REMOTE SENS ENVIRON, V94, P123, DOI 10.1016/j.rse.2004.09.005; Green BJ, 2002, GRANA, V41, P242, DOI 10.1080/001731302321012031; Green Brett James, 2004, Aerobiologia, V20, P43, DOI 10.1023/B:AERO.0000022983.13951.e8; Greiner AN, 2011, LANCET, V378, P2112, DOI 10.1016/S0140-6736(11)60130-X; Group European Aerobiology Society Quality Control Working, 2011, INT AEROBIOLOGY NEWS, V72, P1; Hanigan IC, 2007, CLIN EXP ALLERGY, V37, P1556, DOI 10.1111/j.1365-2222.2007.02800.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HIRST JM, 1952, ANN APPL BIOL, V39, P257, DOI 10.1111/j.1744-7348.1952.tb00904.x; Hjelmroos M, 1999, AIRBORNE ALLERGENS I; HOWLETT BJ, 1982, CLIN ALLERGY, V12, P259, DOI 10.1111/j.1365-2222.1982.tb02526.x; Hutchinson MF, 2005, GLOBAL ECOL BIOGEOGR, V14, P197, DOI [10.1111/j.1466-822X.2005.00154.x, 10.1111/j.1466-822x.2005.00154.x]; Jato V, 2006, AEROBIOLOGIA, V22, P13, DOI 10.1007/s10453-005-9011-x; Johnston FH, 2009, ECOHEALTH, V6, P99, DOI 10.1007/s10393-009-0225-1; Knox RB, 1979, POLLEN ALLERGY; Lacey ME., 2006, AIR SPORA MANUAL CAT; LAZARIDES M, 1991, Australian Systematic Botany, V4, P591, DOI 10.1071/SB9910591; Liam CK, 2002, RESPIROLOGY, V7, P345, DOI 10.1046/j.1440-1843.2002.00409.x; Medek DE, 2012, ECOHEALTH, V9, P440, DOI 10.1007/s10393-012-0787-1; Newnham RM, 2013, INT J BIOMETEOROL, V57, P391, DOI 10.1007/s00484-012-0563-5; Newnham R.M, 1995, AEROBIOLOGIA, V11, P239; NEWNHAM RM, 1999, AEROBIOLOGIA, V15, P87, DOI DOI 10.1023/A:1007595615115; NILSSON S, 1981, Grana, V20, P179, DOI 10.1080/00173138109427661; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Ong E. K., 1995, Aerobiologia, V11, P51, DOI 10.1007/BF02136145; ONG EK, 1995, GRANA, V34, P58, DOI 10.1080/00173139509429034; Patel NJ, 2000, IMMUNOL ALLERGY CLIN, V20, P323, DOI 10.1016/S0889-8561(05)70151-X; Rodriguez-Rajo FJ, 2003, INT J BIOMETEOROL, V47, P117, DOI 10.1007/s00484-002-0153-z; Rutherford S, 2001, AIR POLLUTION ASTHMA; Schappi GF, 1998, AEROBIOLOGIA, V14, P29, DOI DOI 10.1007/BF02694592; Smith M, 2009, AEROBIOLOGIA, V25, P321, DOI 10.1007/s10453-009-9136-4; Sofiev M, 2013, INT J BIOMETEOROL, V57, P45, DOI 10.1007/s00484-012-0532-z; Spangler RE, 2003, AUST SYST BOT, V16, P279, DOI 10.1071/SB01006; SPIEKSMA FTM, 1995, GRANA, V34, P51, DOI 10.1080/00173139509429033; Sritipsukho P, 2004, ASIAN PAC J ALLERGY, V22, P91; Stevenson J, 2007, GRANA, V46, P34, DOI 10.1080/00173130601178250; SWEENEY M, 1994, INT ARCH ALLERGY IMM, V105, P289, DOI 10.1159/000236771; Tng DYP, 2010, AUST J BOT, V58, P440, DOI 10.1071/BT10095; White JF, 2003, ANN ALLERG ASTHMA IM, V91, P425, DOI 10.1016/S1081-1206(10)61509-8; Wilmshurst JM, 2005, REV PALAEOBOT PALYNO, V136, P1, DOI 10.1016/j.revpalbo.2005.03.007; Ziello C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034076; Ziska L, 2011, P NATL ACAD SCI USA, V108, P4248, DOI 10.1073/pnas.1014107108; Ziska LH, 2012, J ALLERGY CLIN IMMUN, V129, P27, DOI 10.1016/j.jaci.2011.10.032	63	47	49	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97925	10.1371/journal.pone.0097925	http://dx.doi.org/10.1371/journal.pone.0097925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874807	Green Published, Green Submitted, gold			2022-12-25	WOS:000336790800015
J	Palmer, GD; Attur, MG; Yang, Q; Liu, J; Moon, P; Beier, F; Abramson, SB				Palmer, Glyn D.; Attur, Mukundan G.; Yang, Qing; Liu, James; Moon, Paxton; Beier, Frank; Abramson, Steven B.			F-Spondin Deficient Mice Have a High Bone Mass Phenotype	PLOS ONE			English	Article							TGF-BETA; ACID-PHOSPHATASE; GENE-EXPRESSION; DIFFERENTIATION; PROTEIN; MATURATION; DIFFER; CELLS	F-spondin is a pericellular matrix protein upregulated in developing growth plate cartilage and articular cartilage during osteoarthritis. To address its function in bone and cartilage in vivo, we generated mice that were deficient for the F-spondin gene, Spon1. Spon1(-/-) mice were viable and developed normally to adulthood with no major skeletal abnormalities. At 6 months, femurs and tibiae of Spon1(-/-) mice exhibited increased bone mass, evidenced by histological staining and micro CT analyses, which persisted up to 12 months. In contrast, no major abnormalities were observed in articular cartilage at any age group. Immunohistochemical staining of femurs and tibiae revealed increased levels of periostin, alkaline phosphate and tartrate resistant acid phosphatase (TRAP) activity in the growth plate region of Spon1(-/-) mice, suggesting elevated bone synthesis and turnover. However, there were no differences in serum levels of TRAP, the bone resorption marker, CTX-1, or osteoclast differentiation potential between genotypes. Knockout mice also exhibited reduced levels of TGF-beta 1 in serum and cultured costal chondrocytes relative to wild type. This was accompanied by increased levels of the BMP-regulatory SMADs, P-SMAD1/5 in tibiae and chondrocytes. Our findings indicate a previously unrecognized role for Spon1 as a negative regulator of bone mass. We speculate that Spon1 deletion leads to a local and systemic reduction of TGF-beta levels resulting in increased BMP signaling and increased bone deposition in adult mice.	[Palmer, Glyn D.; Attur, Mukundan G.; Yang, Qing; Liu, James; Abramson, Steven B.] NYU, Sch Med, Div Rheumatol, New York, NY USA; [Palmer, Glyn D.; Attur, Mukundan G.; Yang, Qing; Liu, James; Abramson, Steven B.] NYU, Hosp Joint Dis, New York, NY USA; [Moon, Paxton; Beier, Frank] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON, Canada	New York University; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; Western University (University of Western Ontario)	Palmer, GD (corresponding author), Univ Florida, Dept Orthopaed & Rehabil, Gainesville, FL 32611 USA.	palmegd@ortho.ufl.edu	Beier, Frank/G-4595-2013; Beier, Frank/T-4734-2019; Attur, Mukundan/O-1578-2019	Beier, Frank/0000-0002-8505-7537; Beier, Frank/0000-0002-8505-7537; Attur, Mukundan/0000-0001-7080-8118; Abramson, Steven/0000-0002-0668-6344	National Institute of Health [AR054817]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054817] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding for the project was provided by National Institute of Health grant AR054817 (SBA), www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P1854, DOI 10.1002/art.22711; Attur MG, 2009, FASEB J, V23, P79, DOI 10.1096/fj.08-114363; BARKA T, 1962, J HISTOCHEM CYTOCHEM, V10, P741, DOI 10.1177/10.6.741; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Dabovic B, 2005, BONE, V37, P25, DOI 10.1016/j.bone.2005.02.021; Delany AM, 2009, J CELL COMMUN SIGNAL, V3, P227, DOI 10.1007/s12079-009-0076-0; Ehnert S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-101; Feinstein Y, 1999, DEVELOPMENT, V126, P3637; Ferguson CM, 2000, ENDOCRINOLOGY, V141, P4728, DOI 10.1210/en.141.12.4728; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hankenson KD, 2005, MOL CELL BIOL, V25, P5599, DOI 10.1128/MCB.25.13.5599-5606.2005; Hoe HS, 2005, MOL CELL BIOL, V25, P9259, DOI 10.1128/MCB.25.21.9259-9268.2005; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200; Kawamura I, 2012, J BIOL CHEM, V287, P29101, DOI 10.1074/jbc.M112.349415; Kitagawa M, 2006, BIOCHEM BIOPH RES CO, V349, P1050, DOI 10.1016/j.bbrc.2006.08.142; Kitagawa M, 2012, BIOCHEM BIOPH RES CO, V418, P229, DOI 10.1016/j.bbrc.2011.12.155; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; LIU CC, 1987, J HISTOCHEM CYTOCHEM, V35, P1355, DOI 10.1177/35.12.3680930; Matsumoto Y, 2012, MOL CELL ENDOCRINOL, V350, P78, DOI 10.1016/j.mce.2011.11.023; Miyamoto K, 2001, ARCH BIOCHEM BIOPHYS, V390, P93, DOI 10.1006/abbi.2001.2367; Nistala H, 2010, J CELL BIOL, V190, P1107, DOI 10.1083/jcb.201003089; Oka H, 2011, J PERIODONTOL, V82, P1776, DOI 10.1902/jop.2011.110111; Palmer GD, 2010, J ORTHOP RES, V28, P1323, DOI 10.1002/jor.21130; Peterziel H, 2011, MOL CELL NEUROSCI, V46, P483, DOI 10.1016/j.mcn.2010.12.001; Ribeiro SMF, 1999, J BIOL CHEM, V274, P13586, DOI 10.1074/jbc.274.19.13586; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tzarfati-Majar V, 2001, P NATL ACAD SCI USA, V98, P4722, DOI 10.1073/pnas.081062398; Ulici V, 2009, BONE, V45, P1133, DOI 10.1016/j.bone.2009.08.003; van der Kraan PM, 2009, OSTEOARTHR CARTILAGE, V17, P1539, DOI 10.1016/j.joca.2009.06.008; Wang GY, 2007, DEV BIOL, V306, P612, DOI 10.1016/j.ydbio.2007.03.520; Xiao Y, 2007, BONE, V40, P700, DOI 10.1016/j.bone.2006.10.021; Zuscik MJ, 2004, J CELL BIOCHEM, V92, P316, DOI 10.1002/jcb.20050	34	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98388	10.1371/journal.pone.0098388	http://dx.doi.org/10.1371/journal.pone.0098388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875054	gold, Green Published, Green Submitted			2022-12-25	WOS:000336790800038
J	Shimozato, O; Waraya, M; Nakashima, K; Souda, H; Takiguchi, N; Yamamoto, H; Takenobu, H; Uehara, H; Ikeda, E; Matsushita, S; Kubo, N; Nakagawara, A; Ozaki, T; Kamijo, T				Shimozato, O.; Waraya, M.; Nakashima, K.; Souda, H.; Takiguchi, N.; Yamamoto, H.; Takenobu, H.; Uehara, H.; Ikeda, E.; Matsushita, S.; Kubo, N.; Nakagawara, A.; Ozaki, T.; Kamijo, T.			Receptor-type protein tyrosine phosphatase. directly dephosphorylates CD133 and regulates downstream AKT activation	ONCOGENE			English	Article							CANCER STEM-CELLS; GROWTH-FACTOR RECEPTOR; R-PTP-KAPPA; BETA-CATENIN; HEMATOPOIETIC STEM; MARKER CD133; PATHWAY; EXPRESSION; PHOSPHORYLATION; DIFFERENTIATION	Although CD133 has been considered to be a molecular marker for cancer stem cells, its functional roles in tumorigenesis remain unclear. We here examined the molecular basis behind CD133-mediated signaling. Knockdown of CD133 resulted in the retardation of xenograft tumor growth of colon cancer-derived HT-29 and LoVo cells accompanied by hypophosphorylation of AKT, which diminished beta-catenin/T-cell factor-mediated CD44 expression. As tyrosine residues of CD133 at positions 828 and 852 were phosphorylated in HT-29 and SW480 cells, we further addressed the significance of this phosphorylation in the tumorigenesis of SW480 cells expressing mutant CD133, with substitution of these tyrosine residues by glutamate (CD133-EE) or phenylalanine (CD133-FF). Forced expression of CD133-EE promoted much more aggressive xenograft tumor growth relative to wild-type CD133-expressing cells accompanied by hyperphosphorylation of AKT; however, CD133-FF expression had negligible effects on AKT phosphorylation and xenograft tumor formation. Intriguingly, the tyrosine phosphorylation status of CD133 was closely linked to the growth of SW480-derived spheroids. Using yeast two-hybrid screening, we finally identified receptor-type protein tyrosine phosphatase. (PTPRK) as a binding partner of CD133. In vitro studies demonstrated that PTPRK associates with the carboxyl-terminal region of CD133 through its intracellular phosphatase domains and also catalyzes dephosphorylation of CD133 at tyrosine-828/tyrosine-852. Silencing of PTPRK elevated the tyrosine phosphorylation of CD133, whereas forced expression of PTPRK reduced its phosphorylation level markedly and abrogated CD133-mediated AKT phosphorylation. Endogenous CD133 expression was also closely associated with higher AKT phosphorylation in primary colon cancer cells, and ectopic expression of CD133 enhanced AKT phosphorylation. Furthermore, lower PTPRK expression significantly correlated with the poor prognosis of colon cancer patients with high expression of CD133. Thus, our present findings strongly indicate that the tyrosine phosphorylation of CD133, which is dephosphorylated by PTPRK, regulates AKT signaling and has a critical role in colon cancer progression.	[Shimozato, O.; Waraya, M.; Nakashima, K.; Takenobu, H.; Uehara, H.; Ikeda, E.; Kamijo, T.] Chiba Canc Ctr Res Inst, Div Biochem & Mol Carcinogenesis, Chiba, Japan; [Souda, H.; Takiguchi, N.; Yamamoto, H.] Chiba Canc Ctr Hosp, Dept Gastrointestinal Surg, Chiba, Japan; [Matsushita, S.; Kubo, N.; Ozaki, T.] Chiba Canc Ctr Res, Lab DNA Damage Signaling, Chiba, Japan; [Nakagawara, A.] Chiba Canc Ctr Res Inst, Div Biochem & Innovat Canc Therapeut, Chiba, Japan; [Kamijo, T.] Saitama Canc Ctr, Res Inst Clin Oncol, Saitama 3620806, Japan	Chiba Cancer Center; Chiba Cancer Center; Chiba Cancer Center; Chiba Cancer Center	Kamijo, T (corresponding author), Saitama Canc Ctr, Res Inst Clin Oncol, 818 Komuro, Saitama 3620806, Japan.	tkamijo@cancer-c.pref.saitama.jp		Takenobu, Hisanori/0000-0001-7355-1565	JSPS [21790397, 23591978, 24390269]; National Cancer Center Research and Development Fund [25-B-3]; Grants-in-Aid for Scientific Research [15K08412, 23591978] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Cancer Center Research and Development Fund(National Cancer Center - Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Ms Kumiko Sakurai for technical assistance, Mr Daniel Mrozek (Medical English Service, Kyoto, Japan) for English editorial assistance and Dr Takafumi Nakamura (Graduate School of Medical Sciences, Tottori University Faculty of Medicine) for pHR lentiviral vectors. This work was supported in part by grants-in-aid from JSPS for Young Scientists (B) and for Scientific Research (C) (Grant numbers: 21790397 and 23591978, respectively), a grant-in-aid for Scientific Research (B) from JSPS (24390269) and a grant-in-aid from the National Cancer Center Research and Development Fund (25-B-3).	Allgayer H, 2002, CANCER, V94, P344, DOI 10.1002/cncr.10221; Anders L, 2006, MOL CELL BIOL, V26, P3917, DOI 10.1128/MCB.26.10.3917-3934.2006; Arora D, 2011, J BIOL CHEM, V286, P10918, DOI 10.1074/jbc.M110.205021; Artells R, 2010, EUR J CANCER, V46, P642, DOI 10.1016/j.ejca.2009.11.003; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Blaker H, 2008, GENE CHROMOSOME CANC, V47, P159, DOI 10.1002/gcc.20516; Boivin D, 2009, BIOCHEMISTRY-US, V48, P3998, DOI 10.1021/bi900159d; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Chu P, 2009, INT J CANCER, V124, P1312, DOI 10.1002/ijc.24061; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dubrovska A, 2009, P NATL ACAD SCI USA, V106, P268, DOI 10.1073/pnas.0810956106; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fuchs M, 1996, J BIOL CHEM, V271, P16712, DOI 10.1074/jbc.271.28.16712; Horst D, 2009, J PATHOL, V219, P427, DOI 10.1002/path.2597; Hu LM, 2000, CLIN CANCER RES, V6, P880; JIANG YP, 1993, MOL CELL BIOL, V13, P2942, DOI 10.1128/MCB.13.5.2942; Kojima M, 2008, CANCER SCI, V99, P1578, DOI 10.1111/j.1349-7006.2008.00849.x; Komatsu S, 2009, ONCOGENE, V28, P3631, DOI 10.1038/onc.2009.216; Kondo J, 2011, P NATL ACAD SCI USA, V108, P6235, DOI 10.1073/pnas.1015938108; Kraus S, 2003, J BIOL CHEM, V278, P32618, DOI 10.1074/jbc.M303886200; Kubo N, 2013, BIOCHEM BIOPH RES CO, V430, P1034, DOI 10.1016/j.bbrc.2012.11.121; Kurata K, 2008, ONCOGENE, V27, P741, DOI 10.1038/sj.onc.1210672; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lombardo Y, 2011, GASTROENTEROLOGY, V140, P297, DOI 10.1053/j.gastro.2010.10.005; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Mak AB, 2012, CELL REP, V2, P951, DOI 10.1016/j.celrep.2012.09.016; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Nikolova T, 2007, DIFFERENTIATION, V75, P100, DOI 10.1111/j.1432-0436.2006.00119.x; Novellino L, 2008, CELL SIGNAL, V20, P872, DOI 10.1016/j.cellsig.2007.12.024; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ochiai H, 2010, ONCOGENE, V29, P2681, DOI 10.1038/onc.2010.22; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ricci-Vitiani L, 2010, FASEB J, V24, P4291, DOI 10.1096/fj.10-159970; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Takenobu H, 2011, ONCOGENE, V30, P97, DOI 10.1038/onc.2010.383; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Uddin S, 2006, BLOOD, V108, P4178, DOI 10.1182/blood-2006-04-016907; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Wielenga VJM, 1999, AM J PATHOL, V154, P515, DOI 10.1016/S0002-9440(10)65297-2; Xu YR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.212597; Yang Y, 1997, GENE, V186, P77, DOI 10.1016/S0378-1119(96)00684-1; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	61	36	38	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 9	2015	34	15					1949	1960		10.1038/onc.2014.141	http://dx.doi.org/10.1038/onc.2014.141			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CF7GY	24882578				2022-12-25	WOS:000352725600009
J	Hirose, Y; Johnson, ZI; Schoepflin, ZR; Markova, DZ; Chiba, K; Toyama, Y; Shapiro, IM; Risbud, MV				Hirose, Yuichiro; Johnson, Zariel I.; Schoepflin, Zachary R.; Markova, Dessislava Z.; Chiba, Kazuhiro; Toyama, Yoshiaki; Shapiro, Irving M.; Risbud, Makarand V.			FIH-1-Mint3 Axis Does Not Control HIF-1 alpha Transcriptional Activity in Nucleus Pulposus Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; AMYLOID PRECURSOR PROTEIN; INTERVERTEBRAL DISC; ASPARAGINYL HYDROXYLASE; GENE-EXPRESSION; PROLYL 4-HYDROXYLASES; FIH; DEGENERATION; DEGRADATION; PATHWAY	The objective of this study was to determine the role of FIH-1 in regulating HIF-1 activity in the nucleus pulposus (NP) cells and the control of this regulation by binding and sequestration of FIH-1 by Mint3. FIH-1 and Mint3 were both expressed in the NP and were shown to strongly co-localize within the cell nucleus. Although both mRNA and protein expression of FIH-1 decreased in hypoxia, only Mint3 protein levels were hypoxia-sensitive. Overexpression of FIH-1 was able to reduce HIF-1 function, as seen by changes in activities of hypoxia response element-luciferase reporter and HIF-1 alpha-C-TAD and HIF-2 alpha-TAD. Moreover, co-transfection of either full-length Mint3 or the N terminus of Mint3 abrogated FIH-1-dependent reduction in HIF-1 activity under both normoxia and hypoxia. Nuclear levels of FIH-1 and Mint3 decreased in hypoxia, and the use of specific nuclear import and export inhibitors clearly showed that cellular compartmentalization of overexpressed FIH-1 was critical for its regulation of HIF-1 activity in NP cells. Interestingly, microarray results after stable silencing of FIH-1 showed no significant changes in transcripts of classical HIF-1 target genes. However, expression of several other transcripts, including those of the Notch pathway, changed in FIH-1-silenced cells. Moreover, co-transfection of Notch-ICD could restore suppression of HIF-1-TAD activity by exogenous FIH-1. Taken together, these results suggest that, possibly due to low endogenous levels and/or preferential association with substrates such as Notch, FIH-1 activity does not represent a major mechanism by which NP cells control HIF-1-dependent transcription, a testament to their adaptation to a unique hypoxic niche.	[Hirose, Yuichiro; Johnson, Zariel I.; Schoepflin, Zachary R.; Markova, Dessislava Z.; Shapiro, Irving M.; Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Hirose, Yuichiro; Toyama, Yoshiaki] Keio Univ, Sch Med, Dept Orthopaed Surg, Tokyo 1088345, Japan; [Chiba, Kazuhiro] Kitasato Univ, Kitasato Inst Hosp, Dept Orthopaed Surg, Tokyo 1088641, Japan	Jefferson University; Keio University; Kitasato University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, 1025 Walnut St,Suite 511 Coll Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu			National Institutes of Health [AR055655, AR064733, AR050087, T32 AR052273]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064733, R01AR055655, T32AR052273, R01AR050087] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR055655, AR064733, and AR050087 (to M. R.).; Supported by National Institutes of Health Grant T32 AR052273.	Agrawal A, 2007, AM J PHYSIOL-CELL PH, V293, pC621, DOI 10.1152/ajpcell.00538.2006; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Caster AH, 2013, J BIOL CHEM, V288, P28567, DOI 10.1074/jbc.M113.481101; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Couvelard A, 2008, CLIN CANCER RES, V14, P6634, DOI 10.1158/1078-0432.CCR-07-5258; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; Deng AH, 2010, AM J PHYSIOL-RENAL, V299, pF1365, DOI 10.1152/ajprenal.00153.2010; Feng HY, 2006, J BONE JOINT SURG AM, V88A, P25, DOI 10.2106/JBJS.E.01341; Fujita N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375964; Fujita N, 2012, J BIOL CHEM, V287, P16975, DOI 10.1074/jbc.M111.334466; Fujita N, 2012, J BONE MINER RES, V27, P401, DOI 10.1002/jbmr.538; Gogate SS, 2012, J BONE MINER RES, V27, P1106, DOI 10.1002/jbmr.1571; Gogate SS, 2011, ARTHRITIS RHEUM-US, V63, P1950, DOI 10.1002/art.30342; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hiyama A, 2011, ARTHRITIS RHEUM-US, V63, P1355, DOI 10.1002/art.30246; Hyseni A, 2011, CELL ONCOL, V34, P565, DOI 10.1007/s13402-011-0053-5; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; KAUPPILA LI, 1995, J BONE JOINT SURG AM, V77A, P26, DOI 10.2106/00004623-199501000-00004; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Kroeze SGC, 2010, EUR J CANCER, V46, P3375, DOI 10.1016/j.ejca.2010.07.018; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Li JP, 2007, MOL CELL BIOL, V27, P7345, DOI 10.1128/MCB.02201-06; Lu H, 2012, INT J NEPHROL RENOV, V5, P101, DOI 10.2147/IJNRD.S27332; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; Okamoto M, 1998, EUR J CELL BIOL, V77, P161, DOI 10.1016/S0171-9335(98)80103-9; Rajpurohit R, 2002, CELL TISSUE RES, V308, P401, DOI 10.1007/s00441-002-0563-6; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Sakamoto T, 2009, J BIOL CHEM, V284, P30350, DOI 10.1074/jbc.M109.019216; Schodel J, 2010, KIDNEY INT, V78, P857, DOI 10.1038/ki.2010.284; Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001; Short MD, 2006, MOL BIOL CELL, V17, P1995, DOI 10.1091/mbc.E05-09-0869; Singleton RS, 2011, J BIOL CHEM, V286, P33784, DOI 10.1074/jbc.M111.262808; Skubutyte R, 2010, ARTHRITIS RHEUM-US, V62, P2707, DOI 10.1002/art.27558; Tanahashi H, 1999, BIOCHEM BIOPH RES CO, V255, P663, DOI 10.1006/bbrc.1999.0265; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Wang EF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086102; Weidemann A, 2008, J AM SOC NEPHROL, V19, P486, DOI 10.1681/ASN.2007040419; Wilkins SE, 2009, INT J BIOCHEM CELL B, V41, P1563, DOI 10.1016/j.biocel.2009.01.005; Yan B, 2011, MOL CELL BIOCHEM, V348, P1, DOI 10.1007/s11010-010-0631-2; Zeng Y, 2007, J BONE MINER RES, V22, P1851, DOI 10.1359/JBMR.070620; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001	46	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20594	20605		10.1074/jbc.M114.565101	http://dx.doi.org/10.1074/jbc.M114.565101			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24867948	Green Published, hybrid			2022-12-25	WOS:000339396600019
J	Ul-Hussain, M; Olk, S; Schoenebeck, B; Wasielewski, B; Meier, C; Prochnow, N; May, C; Galozzi, S; Marcus, K; Zoidl, G; Dermietzel, R				Ul-Hussain, Mahboob; Olk, Stephan; Schoenebeck, Bodo; Wasielewski, Bianca; Meier, Carola; Prochnow, Nora; May, Caroline; Galozzi, Sara; Marcus, Katrin; Zoidl, Georg; Dermietzel, Rolf			Internal Ribosomal Entry Site (IRES) Activity Generates Endogenous Carboxyl-terminal Domains of Cx43 and Is Responsive to Hypoxic Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE-INDEPENDENT INITIATION; GAP-JUNCTION FORMATION; CELL-GROWTH; MESSENGER-RNA; MEDIATED TRANSLATION; POSSIBLE MECHANISM; GLIOMA-CELLS; CONNEXIN43; PROTEIN; ASTROCYTES	Connexin43 (Cx43) is the most abundant gap junction protein in higher vertebrate organisms and has been shown to be involved in junctional and non-junctional functions. In addition to the expression of full-length Cx43, endogenously produced carboxyl-terminal segments of Cx43 have been described and have been suggested to be involved in manifold biological functions, such as hypoxic preconditioning and neuronal migration. Molecular aspects, however, behind the separate generation of carboxyl-terminal segments of Cx43 have remained elusive. Here we report on a mechanism that may play a key role in the separate production of these domains. First, stringent evidence derived from siRNA treatment and specific knockouts revealed significant loss of the low molecular weight fragments of Cx43. By applying a dicistronic vector strategy on transfected cell lines, we were able to identify putative IRES activity (nucleotides 442-637) in the coding region of Cx43, which resides upstream from the nucleotide sequence encoding the carboxyl terminus (nucleotides 637-1149). Functional responsiveness of the endogenous expression of Cx43 fragments to hypoxic/ischemic treatment was evaluated in in vitro and in vivo models, which led to a significant increase of the fastest migrating form (20 kDa) under conditions of metabolic deprivation. By nano-MS spectrometry, we achieved stringent evidence of the identity of the 20-kDa segment as part of the carboxyl-terminal domain of full-length Cx43. Our data prove the existence of endogenously expressed carboxyl-terminal domains, which may serve as valuable tools for further translational application in ischemic disorders.	[Ul-Hussain, Mahboob; Olk, Stephan; Schoenebeck, Bodo; Wasielewski, Bianca; Prochnow, Nora; May, Caroline; Galozzi, Sara; Marcus, Katrin; Dermietzel, Rolf] Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, Med Proteome Ctr, D-44081 Bochum, Germany; [Ul-Hussain, Mahboob; Olk, Stephan; Schoenebeck, Bodo; Wasielewski, Bianca; Prochnow, Nora; May, Caroline; Galozzi, Sara; Marcus, Katrin; Dermietzel, Rolf] Ruhr Univ Bochum, Int Grad Sch Neurosci, D-44081 Bochum, Germany; [Ul-Hussain, Mahboob] Univ Kashmir, Dept Biotechnol, Srinaga, India; [Meier, Carola] Univ Saarland, Fac Med, Dept Anat & Cell Biol, D-66424 Saarland, Germany; [Zoidl, Georg] York Univ, Dept Psychol, Toronto, ON M3J 1P3, Canada	Ruhr University Bochum; Ruhr University Bochum; University of Kashmir; Saarland University; York University - Canada	Dermietzel, R (corresponding author), Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, Univ St 150, D-44081 Bochum, Germany.	rolf.dermietzel@rub.de			International Graduate School of Neuroscience of NRW/Germany; German Research Council (Deutsche Forschungsgemeinschaft (DFG); DFG [SFB 509]; Graduate College 736, Development and Plasticity of the Nervous System)	International Graduate School of Neuroscience of NRW/Germany; German Research Council (Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Graduate College 736, Development and Plasticity of the Nervous System)	This work was supported by the International Graduate School of Neuroscience of NRW/Germany (to M. H. and S. O.), German Research Council (Deutsche Forschungsgemeinschaft (DFG), Graduate College 736, Development and Plasticity of the Nervous System) (to B. W.), and DFG Grant SFB 509 (to R. D. and G. Z.).	Cina C, 2009, J NEUROSCI, V29, P2009, DOI 10.1523/JNEUROSCI.5025-08.2009; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Crespin S, 2010, J CELL BIOCHEM, V110, P589, DOI 10.1002/jcb.22554; Cusato K, 2003, J NEUROSCI, V23, P6413; Dang XT, 2003, MOL CELL BIOCHEM, V242, P35, DOI 10.1023/A:1021152709313; DERMIETZEL R, 1991, J NEUROSCI, V11, P1421; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839; Fernandez J, 2001, J BIOL CHEM, V276, P12285, DOI 10.1074/jbc.M009714200; Fu CT, 2004, J BIOL CHEM, V279, P36943, DOI 10.1074/jbc.M403952200; Gellhaus A, 2004, J BIOL CHEM, V279, P36931, DOI 10.1074/jbc.M404073200; Herbreteau CH, 2005, NAT STRUCT MOL BIOL, V12, P1001, DOI 10.1038/nsmb1011; Holcik M, 1999, NAT CELL BIOL, V1, P190, DOI 10.1038/11109; Hudder A, 2000, J BIOL CHEM, V275, P34586, DOI 10.1074/jbc.M005199200; Joshi-Mukherjee R, 2007, CELL COMMUN ADHES, V14, P75, DOI 10.1080/15419060701402320; Kanamori Y, 2001, RNA, V7, P266, DOI 10.1017/S1355838201001741; Kardami E, 2007, PROG BIOPHYS MOL BIO, V94, P245, DOI 10.1016/j.pbiomolbio.2007.03.009; King TJ, 2005, BBA-BIOMEMBRANES, V1719, P146, DOI 10.1016/j.bbamem.2005.08.012; Kozoriz MG, 2010, J NEUROPATH EXP NEUR, V69, P196, DOI 10.1097/NEN.0b013e3181cd44df; Lahlou H, 2005, MOL CELL BIOL, V25, P4034, DOI 10.1128/MCB.25.10.4034-4045.2005; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Lauring AS, 2000, MOL CELL, V6, P939, DOI 10.1016/S1097-2765(05)00084-5; LEVINE S, 1960, ARCH PATHOL, V69, P544; Li W, 2005, J BIOL CHEM, V280, P7941, DOI 10.1074/jbc.M410548200; Marquez-Rosado L, 2012, BBA-BIOMEMBRANES, V1818, P1985, DOI 10.1016/j.bbamem.2011.07.028; Meier C, 2006, PEDIATR RES, V59, P244, DOI 10.1203/01.pdr.0000197309.08852.f5; Mesnil M, 2005, BBA-BIOMEMBRANES, V1719, P125, DOI 10.1016/j.bbamem.2005.11.004; Moorby C, 2001, EXP CELL RES, V271, P238, DOI 10.1006/excr.2001.5357; Olbina G, 2003, MOL CANCER RES, V1, P690; Omori Y, 1998, INT J CANCER, V78, P446, DOI 10.1002/(SICI)1097-0215(19981109)78:4<446::AID-IJC10>3.3.CO;2-4; RajBhandary UL, 2000, P NATL ACAD SCI USA, V97, P1325, DOI 10.1073/pnas.040579197; Santiago MF, 2010, J BIOL CHEM, V285, P11836, DOI 10.1074/jbc.M109.058750; Sasaki J, 2000, P NATL ACAD SCI USA, V97, P1512, DOI 10.1073/pnas.010426997; Schiavi A, 1999, FEBS LETT, V464, P118, DOI 10.1016/S0014-5793(99)01699-3; Smyth JW, 2013, CELL REP, V5, P611, DOI 10.1016/j.celrep.2013.10.009; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Teubner B, 2003, HUM MOL GENET, V12, P13, DOI 10.1093/hmg/ddg001; Theis M, 2003, J NEUROSCI, V23, P766; Ul-Hussain M, 2012, BRAIN RES, V1487, P99, DOI 10.1016/j.brainres.2012.05.065; Ul-Hussain M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-92; Ul-Hussain M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-52; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; Van Eden ME, 2004, RNA, V10, P720, DOI 10.1261/rna.5225204; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Zhang YW, 2003, J BIOL CHEM, V278, P44852, DOI 10.1074/jbc.M305072200	46	43	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20979	20990		10.1074/jbc.M113.540187	http://dx.doi.org/10.1074/jbc.M113.540187			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24872408	hybrid, Green Published			2022-12-25	WOS:000339396600051
J	Birukawa, NK; Murase, K; Sato, Y; Kosaka, A; Yoneda, A; Nishita, H; Fujita, R; Nishimura, M; Ninomiya, T; Kajiwara, K; Miyazaki, M; Nakashima, Y; Ota, S; Murakami, Y; Tanaka, Y; Minomi, K; Tamura, Y; Niitsu, Y				Birukawa, Naoko Kubo; Murase, Kazuyuki; Sato, Yasushi; Kosaka, Akemi; Yoneda, Akihiro; Nishita, Hiroki; Fujita, Ryosuke; Nishimura, Miyuki; Ninomiya, Takafumi; Kajiwara, Keiko; Miyazaki, Miyono; Nakashima, Yusuke; Ota, Sigenori; Murakami, Yuya; Tanaka, Yasunobu; Minomi, Kenjiro; Tamura, Yasuaki; Niitsu, Yoshiro			Activated Hepatic Stellate Cells Are Dependent on Self-collagen, Cleaved by Membrane Type 1 Matrix Metalloproteinase for Their Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER FIBROSIS RESOLUTION; A-COUPLED LIPOSOMES; TISSUE INHIBITOR; APOPTOSIS; FIBRONECTIN; EXPRESSION; PROLIFERATION; MECHANISMS; STRATEGIES; CHAPERONE	Stellate cells are distributed throughout organs, where, upon chronic damage, they become activated and proliferate to secrete collagen, which results in organ fibrosis. An intriguing property of hepatic stellate cells (HSCs) is that they undergo apoptosis when collagen is resolved by stopping tissue damage or by treatment, even though the mechanisms are unknown. Here we disclose the fact that HSCs, normal diploid cells, acquired dependence on collagen for their growth during the transition from quiescent to active states. The intramolecular RGD motifs of collagen were exposed by cleavage with their own membrane type 1 matrix metalloproteinase (MT1-MMP). The following evidence supports this conclusion. When rat activated HSCs (aHSCs) were transduced with siRNA against the collagen-specific chaperone gp46 to inhibit collagen secretion, the cells underwent autophagy followed by apoptosis. Concomitantly, the growth of aHSCs was suppressed, whereas that of quiescent HSCs was not. These in vitro results are compatible with the in vivo observation that apoptosis of aHSCs was induced in cirrhotic livers of rats treated with siRNAgp46. siRNA against MT1-MMP and addition of tissue inhibitor of metalloproteinase 2 (TIMP-2), which mainly inhibits MT1-MMP, also significantly suppressed the growth of aHSCs in vitro. The RGD inhibitors echistatin and GRGDS peptide and siRNA against the RGD receptor alpha V beta 1 resulted in the inhibition of aHSCs growth. Transduction of siRNAs against gp46, alpha V beta 1, and MT1-MMP to aHSCs inhibited the survival signal of PI3K/AKT/I kappa B. These results could provide novel antifibrosis strategies.	[Birukawa, Naoko Kubo; Kosaka, Akemi; Yoneda, Akihiro; Nishita, Hiroki; Fujita, Ryosuke; Nishimura, Miyuki; Kajiwara, Keiko; Miyazaki, Miyono; Nakashima, Yusuke; Ota, Sigenori; Murakami, Yuya; Tanaka, Yasunobu; Minomi, Kenjiro; Niitsu, Yoshiro] Sapporo Med Univ, Sch Med, Dept Mol Target Explorat, Sapporo, Hokkaido 0608556, Japan; [Murase, Kazuyuki; Sato, Yasushi] Sapporo Med Univ, Sch Med, Dept Internal Med 4, Sapporo, Hokkaido 0608556, Japan; [Ninomiya, Takafumi] Sapporo Med Univ, Sch Med, Dept Basic Med Sci, Dept Anat 1, Sapporo, Hokkaido 0608556, Japan; [Kajiwara, Keiko; Miyazaki, Miyono; Tanaka, Yasunobu; Minomi, Kenjiro] Nitto Denko Corp, Translat Res Grp, Hokkaido Lab, Mol Therapeut Dept,Corp Business Dev Div, Sapporo, Hokkaido 0010021, Japan; [Tamura, Yasuaki] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0010021, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Nitto Denko Corporation; Hokkaido University	Niitsu, Y (corresponding author), Sapporo Med Univ, Sch Med, Dept Mol Target Explorat, Chuo Ku, South 1,West 17, Sapporo, Hokkaido 0608556, Japan.	niitsu@sapmed.ac.jp		Sato, Yasushi/0000-0002-6776-4609				Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Chiba H, 2006, J CELL BIOL, V175, P971, DOI 10.1083/jcb.200608012; Fowell AJ, 2011, BIOCHEM BIOPH RES CO, V407, P277, DOI 10.1016/j.bbrc.2011.02.009; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; Hartland SN, 2009, LIVER INT, V29, P966, DOI 10.1111/j.1478-3231.2009.02070.x; Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Ishiwatari H, 2013, GUT, V62, P1328, DOI 10.1136/gutjnl-2011-301746; Issa R, 2002, FASEB J, V16, P47, DOI 10.1096/fj.02-0494fje; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jiang QA, 2011, MOL BIOL CELL, V22, P1167, DOI 10.1091/mbc.E10-10-0860; Katoh D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.27; Manabe R, 1997, J CELL BIOL, V139, P295, DOI 10.1083/jcb.139.1.295; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; Oakley F, 2005, GASTROENTEROLOGY, V128, P108, DOI 10.1053/j.gastro.2004.10.003; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Roderfeld M, 2006, FASEB J, V20, P444, DOI 10.1096/fj.05-4828com; Rodriguez-Juan C, 2009, CELL PHYSIOL BIOCHEM, V24, P271, DOI 10.1159/000233252; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Sheu JR, 1997, J PHARM PHARMACOL, V49, P78, DOI 10.1111/j.2042-7158.1997.tb06756.x; To WS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-21; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Xu GX, 1997, J PATHOL, V183, P90, DOI 10.1002/(SICI)1096-9896(199709)183:1<90::AID-PATH1105>3.0.CO;2-J; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Yoshiji H, 2002, HEPATOLOGY, V36, P850, DOI 10.1053/jhep.2002.35625; Zhao LN, 2007, J MOL HISTOL, V38, P53, DOI 10.1007/s10735-007-9078-5; Zhou XY, 2006, J BIOL CHEM, V281, P39757, DOI 10.1074/jbc.M605621200; Zhou XY, 2004, J BIOL CHEM, V279, P23996, DOI 10.1074/jbc.M311668200	29	21	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20209	20221		10.1074/jbc.M113.544494	http://dx.doi.org/10.1074/jbc.M113.544494			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24867951	Green Published, hybrid			2022-12-25	WOS:000339395200034
J	Lee, GH; Chhangawala, Z; von Daake, S; Savas, JN; Yates, JR; Comoletti, D; D'Arcangelo, G				Lee, Gum Hwa; Chhangawala, Zinal; von Daake, Sventja; Savas, Jeffrey N.; Yates, John R., III; Comoletti, Davide; D'Arcangelo, Gabriella			Reelin Induces Erk1/2 Signaling in Cortical Neurons Through a Non-canonical Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; ACTIVATED PROTEIN-KINASE; CAJAL-RETZIUS CELLS; SYNAPTIC PLASTICITY; TYROSINE KINASE; HIPPOCAMPAL CONNECTIONS; DENDRITE DEVELOPMENT; DISABLED-1; PHOSPHORYLATION; MIGRATION	Reelin is an extracellular protein that controls many aspects of pre- and postnatal brain development and function. The molecular mechanisms that mediate postnatal activities of Reelin are not well understood. Here, we first set out to express and purify the full length Reelin protein and a biologically active central fragment. Second, we investigated in detail the signal transduction mechanisms elicited by these purified Reelin proteins in cortical neurons. Unexpectedly, we discovered that the full-length Reelin moiety, but not the central fragment, is capable of activating Erk1/2 signaling, leading to increased p90RSK phosphorylation and the induction of immediate-early gene expression. Remarkably, Erk1/2 activation is not mediated by the canonical signal transduction pathway, involving ApoER2/VLDLR and Dab1, that mediates other functions of Reelin in early brain development. The activation of Erk1/2 signaling likely contributes to the modulation of neuronal maturation and synaptic plasticity by Reelin in the postnatal and adult brain.	[Lee, Gum Hwa; D'Arcangelo, Gabriella] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Chhangawala, Zinal; von Daake, Sventja; Comoletti, Davide] Rutgers Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; [Savas, Jeffrey N.; Yates, John R., III] Scripps Res Inst, Dept Chem Physiol & Mol & Cellular Neurobiol, La Jolla, CA 92037 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Scripps Research Institute	D'Arcangelo, G (corresponding author), Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA.	darcangelo@biology.rutgers.edu		D'Arcangelo, Gabriella/0000-0003-1575-1010	National Institutes of Health [R01-MH092906]; New Jersey Governor's Council for Medical Research and Treatment of Autism [10-409-SCH-E-O]; NIH [K99DC013805-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC013805] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Governor's Council for Medical Research and Treatment of Autism; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported in part by National Institutes of Health Grant R01-MH092906 (to D. C.) and by Research Grant 10-409-SCH-E-O from the New Jersey Governor's Council for Medical Research and Treatment of Autism (to G. D.).; Supported by NIH Pathway to Independence Award K99DC013805-01.	Alcantara S, 1998, J NEUROSCI, V18, P7779; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Ballif BA, 2003, MOL BRAIN RES, V117, P152, DOI 10.1016/S0169-328X(03)00295-X; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Belvindrah R, 2007, J NEUROSCI, V27, P13854, DOI 10.1523/JNEUROSCI.4494-07.2007; Bock HH, 2003, J BIOL CHEM, V278, P38772, DOI 10.1074/jbc.M306416200; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Borrell V, 1999, J NEUROSCI, V19, P1345; Bouche E, 2013, CELL RES, V23, P473, DOI 10.1038/cr.2013.7; Catchpole T, 2011, J NEUROSCI, V31, P11472, DOI 10.1523/JNEUROSCI.6349-10.2011; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Chen Y, 2005, J NEUROSCI, V25, P8209, DOI 10.1523/JNEUROSCI.1951-05.2005; Comoletti D, 2010, STRUCTURE, V18, P1044, DOI 10.1016/j.str.2010.06.005; Curtis J, 1999, J NEUROSCI RES, V58, P88, DOI 10.1002/(SICI)1097-4547(19991001)58:1<88::AID-JNR9>3.3.CO;2-I; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; D'Arcangelo G., 2014, ADV NEUROSCI; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Forster E, 2002, P NATL ACAD SCI USA, V99, P13178, DOI 10.1073/pnas.202035899; Gil-Sanz C, 2013, NEURON, V79, P461, DOI 10.1016/j.neuron.2013.06.040; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; HERZ J, 1991, J BIOL CHEM, V266, P21232; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Iafrati J, 2014, MOL PSYCHIATR, V19, P417, DOI 10.1038/mp.2013.66; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816; Keshvara L, 2001, J BIOL CHEM, V276, P16008, DOI 10.1074/jbc.M101422200; Koie M, 2014, J BIOL CHEM, V289, P12922, DOI 10.1074/jbc.M113.536326; Krueger DD, 2006, PSYCHOPHARMACOLOGY, V189, P95, DOI 10.1007/s00213-006-0530-0; Kubo K, 2002, NEUROSCI RES, V43, P381, DOI 10.1016/S0168-0102(02)00068-8; Larson J, 2003, BRAIN RES, V971, P40, DOI 10.1016/S0006-8993(03)02353-9; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Nakano Y, 2007, J BIOL CHEM, V282, P20544, DOI 10.1074/jbc.M702300200; Niu S, 2004, NEURON, V41, P71, DOI 10.1016/S0896-6273(03)00819-5; Niu SY, 2008, J NEUROSCI, V28, P10339, DOI 10.1523/JNEUROSCI.1917-08.2008; O'Donnell A, 2012, BIOCHEM SOC T, V40, P58, DOI 10.1042/BST20110636; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Orban PC, 1999, TRENDS NEUROSCI, V22, P38, DOI 10.1016/S0166-2236(98)01306-X; Park TJ, 2008, J NEUROSCI, V28, P13551, DOI 10.1523/JNEUROSCI.4323-08.2008; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Qiu SF, 2007, J NEUROPHYSIOL, V97, P2312, DOI 10.1152/jn.00869.2006; Qui SF, 2006, NEUROBIOL LEARN MEM, V85, P228, DOI 10.1016/j.nlm.2005.11.001; Rodriguez JJ, 2005, EUR J NEUROSCI, V21, P2384, DOI 10.1111/j.1460-9568.2005.04068.x; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Senturk A, 2011, NATURE, V472, P356, DOI 10.1038/nature09874; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Simo S, 2007, CEREB CORTEX, V17, P294, DOI 10.1093/cercor/bhj147; Sinagra M, 2005, J NEUROSCI, V25, P6127, DOI 10.1523/JNEUROSCI.1757-05.2005; Stritt C, 2010, MOL CELL BIOL, V30, P1828, DOI 10.1128/MCB.01434-09; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Trotter J, 2013, J NEUROSCI, V33, P15652, DOI 10.1523/JNEUROSCI.2010-13.2013; Utsunomiya-Tate N, 2000, P NATL ACAD SCI USA, V97, P9729, DOI 10.1073/pnas.160272497; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Yasui N, 2007, P NATL ACAD SCI USA, V104, P9988, DOI 10.1073/pnas.0700438104	66	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20307	20317		10.1074/jbc.M114.576249	http://dx.doi.org/10.1074/jbc.M114.576249			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24876378	Green Published, hybrid			2022-12-25	WOS:000339395200042
J	Su, WM; Han, GS; Carman, GM				Su, Wen-Min; Han, Gil-Soo; Carman, George M.			Cross-talk Phosphorylations by Protein Kinase C and Pho85p-Pho80p Protein Kinase Regulate Pah1p Phosphatidate Phosphatase Abundance in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MEMBRANE GROWTH; PHOSPHOLIPID-SYNTHESIS; CTP SYNTHETASE; LIPID-METABOLISM; PHOSPHATIDYLCHOLINE SYNTHESIS; MULTISITE PHOSPHORYLATION; MEDIATED REGULATION; ORTHOLOGUE PAH1P; MAJOR SITES; CELL-CYCLE	Yeast Pah1p is the phosphatidate phosphatase that catalyzes the penultimate step in triacylglycerol synthesis and plays a role in the transcriptional regulation of phospholipid synthesis genes. The enzyme is multiply phosphorylated, some of which is mediated by Pho85p-Pho80p, Cdc28p-cyclin B, and protein kinase A. Here, we showed that Pah1p is a bona fide substrate of protein kinase C; the phosphorylation reaction was time-and dose-dependent and dependent on the concentrations of ATP (K-m = 4.5 mu M) and Pah1p (K-m = 0.75 mu M). The stoichiometry of the reaction was 0.8 mol of phosphate/mol of Pah1p. By combining mass spectrometry, truncation analysis, site-directed mutagenesis, and phosphopeptide mapping, we identified Ser-677, Ser-769, Ser-773, and Ser-788 as major sites of phosphorylation. Analysis of Pah1p phosphorylations by different protein kinases showed that prephosphorylation with protein kinase C reduces its subsequent phosphorylation with protein kinase A and vice versa. Prephosphorylation with Pho85p-Pho80p had an inhibitory effect on its subsequent phosphorylation with protein kinase C; however, prephosphorylation with protein kinase C had no effect on the subsequent phosphorylation with Pho85p-Pho80p. Unlike its phosphorylations by Pho85p-Pho80p and protein kinase A, which cause a significant reduction in phosphatidate phosphatase activity, the phosphorylation of Pah1p by protein kinase C had a small stimulatory effect on the enzyme activity. Analysis of phosphorylation-deficient forms of Pah1p indicated that protein kinase C does not have a major effect on its location or its function in triacylglycerol synthesis, but instead, the phosphorylation favors loss of Pah1p abundance when it is not phosphorylated with Pho85p-Pho80p.	Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu		Su, Wen-Min/0000-0002-1861-6335	National Institutes of Health Grant [NS046593]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS046593] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Symeon Siniossoglou for supplying the pah1 Delta and pah1 Delta nem1 Delta mutants and Erin O'Shea for the plasmids to express Pho85p-Pho80p. Mass spectrometry data were obtained from an Orbitrap instrument funded in part by National Institutes of Health Grant NS046593 for the support of the Rutgers Biomedical and Health Sciences-New Jersey Medical School Neuroproteomics Core Facility.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2006, TRENDS BIOCHEM SCI, V31, P694, DOI 10.1016/j.tibs.2006.10.003; Carman George M, 2011, Front Biol (Beijing), V6, P172; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carman GM, 2004, BIOCHEM CELL BIOL, V82, P62, DOI 10.1139/o03-064; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Choi HS, 2010, J BIOL CHEM, V285, P11526, DOI 10.1074/jbc.M110.100727; Choi MG, 2005, J BIOL CHEM, V280, P26105, DOI 10.1074/jbc.M503551200; Choi MG, 2003, J BIOL CHEM, V278, P23610, DOI 10.1074/jbc.M303337200; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; De Virgilio C, 2012, FEMS MICROBIOL REV, V36, P306, DOI 10.1111/j.1574-6976.2011.00287.x; Dephoure N, 2005, P NATL ACAD SCI USA, V102, P17940, DOI 10.1073/pnas.0509080102; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Grkovich A, 2009, ADV ENZYME REGUL, V49, P114, DOI 10.1016/j.advenzreg.2009.01.005; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2005, J BIOL CHEM, V280, P38328, DOI 10.1074/jbc.M509622200; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jeffery DA, 2001, J MOL BIOL, V306, P997, DOI 10.1006/jmbi.2000.4417; Kamada Y, 1996, J BIOL CHEM, V271, P9193, DOI 10.1074/jbc.271.16.9193; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; KENNEDY EP, 1961, FED PROC, V20, P934; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE KS, 1992, MOL CELL BIOL, V12, P172, DOI 10.1128/MCB.12.1.172; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; LEVIN DE, 1990, CELL, V62, P213, DOI 10.1016/0092-8674(90)90360-Q; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Lindegaard B, 2007, INT J OBESITY, V31, P449, DOI 10.1038/sj.ijo.0803434; LUTTERBACH B, 1994, MOL CELL BIOL, V14, P5510, DOI 10.1128/MCB.14.8.5510; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Michot C, 2013, BBA-MOL BASIS DIS, V1832, P2103, DOI 10.1016/j.bbadis.2013.07.021; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Mul JD, 2011, J BIOL CHEM, V286, P26781, DOI 10.1074/jbc.M110.197947; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nadra K, 2012, MOL CELL BIOL, V32, P4794, DOI 10.1128/MCB.00512-12; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Nunez LR, 2008, J BIOL CHEM, V283, P34204, DOI 10.1074/jbc.M806391200; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; OGITA K, 1990, P NATL ACAD SCI USA, V87, P5011, DOI 10.1073/pnas.87.13.5011; Park TS, 2003, J BIOL CHEM, V278, P20785, DOI 10.1074/jbc.M301394200; Pascual F, 2014, J BIOL CHEM, V289, P9811, DOI 10.1074/jbc.M114.550103; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Pearlman SM, 2011, CELL, V147, P934, DOI 10.1016/j.cell.2011.08.052; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Reue K, 2009, J LIPID RES, V50, pS109, DOI 10.1194/jlr.R800052-JLR200; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Rose MD., 1990, METHODS YEAST GENETI; Saleem RA, 2010, MOL CELL PROTEOMICS, V9, P2076, DOI 10.1074/mcp.M000116-MCP201; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; SIKORSKI RS, 1989, GENETICS, V122, P19; SIMON AJ, 1991, P ROY SOC B-BIOL SCI, V243, P165, DOI 10.1098/rspb.1991.0027; SMITH SW, 1957, J BIOL CHEM, V228, P915; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Sreenivas A, 2001, J BIOL CHEM, V276, P29915, DOI 10.1074/jbc.M105147200; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; WATANABE M, 1994, J BIOL CHEM, V269, P16829; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798; Yang WL, 1996, J BIOL CHEM, V271, P11113, DOI 10.1074/jbc.271.19.11113; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002	100	32	35	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18818	18830		10.1074/jbc.M114.581462	http://dx.doi.org/10.1074/jbc.M114.581462			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24876385	Green Published, hybrid			2022-12-25	WOS:000339062900017
J	de Vries, EA; Caljouw, SR; Coppens, MJM; Postema, K; Verkerke, GJ; Lamoth, CJC				de Vries, Elisabeth A.; Caljouw, Simone R.; Coppens, Milou J. M.; Postema, Klaas; Verkerke, Gijsbertus J.; Lamoth, Claudine J. C.			Differences between Young and Older Adults in the Control of Weight Shifting within the Surface of Support	PLOS ONE			English	Article							ANTICIPATORY POSTURAL ADJUSTMENTS; AGE; BALANCE; STABILITY; FALLS; SPEED; INFORMATION; MOVEMENTS; COMMUNITY; ACCURACY	An important reason for falling in elderly is incorrect weight-shifting. In many daily life activities quick and accurate weight-shifting is needed to maintain balance and to prevent from falling. The present study aims to gain more insight in age-related differences in the control of weight-shifting. Nine healthy older adults (70.3 +/- 6.9 years) and twelve young adults (20.9 +/- 0.5 years) participated in the study. They performed a weight shifting task by moving the body's center of pressure, represented by a red dot on a screen, in different directions, towards targets of different sizes and at different distances projected on a screen. Movement time, fluency and accuracy of the movement were determined. Accuracy was quantified by the number of times the cursor hit the goal target before a target switch was realized (counts on goal) and by the time required to realize a target switch after the goal target was hit by the cursor for the first time (dwelling time). Fluency was expressed by the maximal deviation of the performed path with respect to the ideal path and the number of peaks, or inflections in the performed path. Significant main effects of target size, target distance and age on all outcome measures were found. With decreasing target size, increasing target distance and increasing age, movement time significantly increased and fluency and accuracy significantly decreased (i.e. increased number of peaks, maximal deviation, number of times on the goal target and longer dwelling time around the goal target). In addition, significant interaction effects of size*age and distance*age were found. Older adults needed more time to perform the weight-shifting task and their movements were less fluent and accurate compared to younger adults, especially with increasing task difficulty. This indicates that elderly might have difficulties with executing an adequate adaptation to a perturbation in daily life.	[de Vries, Elisabeth A.; Caljouw, Simone R.; Coppens, Milou J. M.; Lamoth, Claudine J. C.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Postema, Klaas; Verkerke, Gijsbertus J.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Dept Rehabil Med, Groningen, Netherlands; [Verkerke, Gijsbertus J.] Univ Twente, Dept Biomech Engn, NL-7500 AE Enschede, Netherlands	University of Groningen; University of Groningen; University of Twente	de Vries, EA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	e.a.de.vries@umcg.nl	Coppens, Milou JM/F-7810-2016; Lamoth, Claudine JC/N-4325-2013	Coppens, Milou JM/0000-0002-6115-5271; Lamoth, Claudine JC/0000-0002-6495-2823; Caljouw, Simone R./0000-0002-3004-9900; Verkerke, Bart/0000-0003-3533-2446	Center of Research Excellence SPRINT	Center of Research Excellence SPRINT	Center of Research Excellence SPRINT (www.imdi-sprint.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleuse S, 2006, GAIT POSTURE, V24, P203, DOI 10.1016/j.gaitpost.2005.09.001; Bouisset S, 2008, NEUROPHYSIOL CLIN, V38, P345, DOI 10.1016/j.neucli.2008.10.001; Chapman GJ, 2010, EXP BRAIN RES, V201, P467, DOI 10.1007/s00221-009-2058-0; Cheng KC, 2012, J GERONTOL A-BIOL, V67, P1238, DOI 10.1093/gerona/gls116; Danion F, 1999, NEUROSCI LETT, V277, P131, DOI 10.1016/S0304-3940(99)00842-3; Duarte M, 2005, MOTOR CONTROL, V9, P180, DOI 10.1123/mcj.9.2.180; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Hernandez ME, 2012, HUM MOVEMENT SCI, V31, P1213, DOI 10.1016/j.humov.2011.11.002; Hernandez ME, 2012, CLIN BIOMECH, V27, P910, DOI 10.1016/j.clinbiomech.2012.06.007; HORAK FB, 1989, NEUROBIOL AGING, V10, P727, DOI 10.1016/0197-4580(89)90010-9; Huang MH, 2013, GAIT POSTURE, V38, P837, DOI 10.1016/j.gaitpost.2013.04.004; Jongman V, 2012, STUD HEALTH TECHNOL, V181, P93, DOI 10.3233/978-1-61499-121-2-93; Kanekar N, 2014, AGE, V36, P1067, DOI 10.1007/s11357-014-9621-8; Kanekar N, 2014, EXP BRAIN RES, V232, P1127, DOI 10.1007/s00221-014-3822-3; Ketcham CJ, 2002, J GERONTOL B-PSYCHOL, V57, pP54, DOI 10.1093/geronb/57.1.P54; Kosse NM., 2011, J CYBER THERAPY REHA, V4, P399; Lamoth CJC, 2011, STUD HEALTH TECHNOL, V167, P159, DOI 10.3233/978-1-60750-766-6-159; Laughton CA, 2003, GAIT POSTURE, V18, P101, DOI 10.1016/S0966-6362(02)00200-X; Prado JM, 2011, GAIT POSTURE, V33, P93, DOI 10.1016/j.gaitpost.2010.10.003; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; Sihvonen SE, 2004, GERONTOLOGY, V50, P87, DOI 10.1159/000075559; Spreitzer L, 2013, AM J PHYS MED REHAB, V92, P36, DOI 10.1097/PHM.0b013e318269d8f9; Stalenhoef PA, 1997, EUR J PUBLIC HEALTH, V7, P328, DOI 10.1093/eurpub/7.3.328; Stapley P, 1998, NEUROREPORT, V9, P395, DOI 10.1097/00001756-199802160-00007; Thelen DG, 1996, J GERONTOL A-BIOL, V51, pM226, DOI 10.1093/gerona/51A.5.M226; Toledo DR, 2010, BRAZ J PHYS THER, V14, P267, DOI 10.1590/S1413-35552010000300004; Tucker MG, 2010, ARCH PHYS MED REHAB, V91, P750, DOI 10.1016/j.apmr.2010.01.004; Tucker MG, 2009, CLIN BIOMECH, V24, P597, DOI 10.1016/j.clinbiomech.2009.06.002; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Young WR, 2012, GAIT POSTURE, V36, P477, DOI 10.1016/j.gaitpost.2012.04.009	30	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98494	10.1371/journal.pone.0098494	http://dx.doi.org/10.1371/journal.pone.0098494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24892646	Green Submitted, Green Published, gold			2022-12-25	WOS:000336911400058
J	Luo, YB; Mitrpant, C; Adams, AM; Johnsen, RD; Fletcher, S; Mastaglia, FL; Wilton, SD				Luo, Yue-Bei; Mitrpant, Chalermchai; Adams, Abbie M.; Johnsen, Russell D.; Fletcher, Sue; Mastaglia, Frank L.; Wilton, Steve D.			Antisense Oligonucleotide Induction of Progerin in Human Myogenic Cells	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; LAMIN-A; NUCLEAR-ENVELOPE; RESTRICTIVE DERMOPATHY; OXIDATIVE STRESS; PREMESSENGER RNA; MDX MOUSE; GENE; MUTATIONS; MUSCLE	We sought to use splice-switching antisense oligonucleotides to produce a model of accelerated ageing by enhancing expression of progerin, translated from a mis-spliced lamin A gene (LMNA) transcript in human myogenic cells. The progerin transcript (LMNA Delta 150) lacks the last 150 bases of exon 11, and is translated into a truncated protein associated with the severe premature ageing disease, Hutchinson-Gilford progeria syndrome (HGPS). HGPS arises from de novo mutations that activate a cryptic splice site in exon 11 of LMNA and result in progerin accumulation in tissues of mesodermal origin. Progerin has also been proposed to play a role in the 'natural' ageing process in tissues. We sought to test this hypothesis by producing a model of accelerated muscle ageing in human myogenic cells. A panel of splice-switching antisense oligonucleotides were designed to anneal across exon 11 of the LMNA pre-mRNA, and these compounds were transfected into primary human myogenic cells. RT-PCR showed that the majority of oligonucleotides were able to modify LMNA transcript processing. Oligonucleotides that annealed within the 150 base region of exon 11 that is missing in the progerin transcript, as well as those that targeted the normal exon 11 donor site induced the LMNA Delta 150 transcript, but most oligonucleotides also generated variable levels of LMNA transcript missing the entire exon 11. Upon evaluation of different oligomer chemistries, the morpholino phosphorodiamidate oligonucleotides were found to be more efficient than the equivalent sequences prepared as oligonucleotides with 2'-O-methyl modified bases on a phosphorothioate backbone. The morpholino oligonucleotides induced nuclear localised progerin, demonstrated by immunostaining, and morphological nuclear changes typical of HGPS cells. We show that it is possible to induce progerin expression in myogenic cells using splice-switching oligonucleotides to redirect splicing of LMNA. This may offer a model to investigate the role of progerin in premature muscle ageing.	[Luo, Yue-Bei; Mitrpant, Chalermchai; Adams, Abbie M.; Johnsen, Russell D.; Fletcher, Sue; Mastaglia, Frank L.; Wilton, Steve D.] Univ Western Australia, Australian Neuromuscular Res Inst, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia; [Luo, Yue-Bei] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Mitrpant, Chalermchai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Biochem, Bangkok 10700, Thailand; [Adams, Abbie M.; Johnsen, Russell D.; Fletcher, Sue; Wilton, Steve D.] Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia; [Mastaglia, Frank L.] Murdoch Univ, Inst Immunol & Infect Dis, Perth, WA, Australia	University of Western Australia; Central South University; Mahidol University; Murdoch University; Murdoch University	Wilton, SD (corresponding author), Univ Western Australia, Australian Neuromuscular Res Inst, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia.	swilton@ccg.murdoch.edu.au	Mitrpant, Chalermchai/HDN-9842-2022; Mitrpant, Chalermchai/AAX-6699-2021; L, YB/AAF-9728-2021	Mitrpant, Chalermchai/0000-0001-9311-7977; Wilton, Steve/0000-0002-9400-893X; Fletcher, Sue/0000-0002-8632-641X; Adams, Abbie/0000-0003-3445-7052	Neuromuscular Foundation of Western Australia; China Scholarship Council-University of Western Australia; Chalermphrakiat grant, Faculty of Medicine, Siriraj Hospital, Mahidol University	Neuromuscular Foundation of Western Australia; China Scholarship Council-University of Western Australia; Chalermphrakiat grant, Faculty of Medicine, Siriraj Hospital, Mahidol University	This work was supported by the Neuromuscular Foundation of Western Australia. Yue-Bei Luo was supported by a China Scholarship Council-University of Western Australia joint PhD scholarship. Chalermchai Mitrpant was partly supported by a Chalermphrakiat grant, Faculty of Medicine, Siriraj Hospital, Mahidol University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Carmeli E, 2002, EXP GERONTOL, V37, P477, DOI 10.1016/S0531-5565(01)00220-0; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Clark DJ, 2012, J GERONTOL A-BIOL, V67, P41, DOI 10.1093/gerona/glr041; Cooper ST, 2003, NEUROLOGY, V61, P93, DOI 10.1212/01.WNL.0000069460.53438.38; Crooke RM, 2005, J LIPID RES, V46, P872, DOI 10.1194/jlr.M400492-JLR200; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; DOMINSKI Z, 1993, P NATL ACAD SCI USA, V90, P8673, DOI 10.1073/pnas.90.18.8673; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; Fletcher S, 2006, J GENE MED, V8, P207, DOI 10.1002/jgm.838; Fletcher S, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.40; Fong LG, 2009, HUM MOL GENET, V18, P2462, DOI 10.1093/hmg/ddp184; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Genschel J, 2000, HUM MUTAT, V16, P451, DOI 10.1002/1098-1004(200012)16:6<451::AID-HUMU1>3.0.CO;2-9; Gleave M, 2005, ANN NY ACAD SCI, V1058, P1, DOI 10.1196/annals.1359.001; Guo SL, 2013, J CLIN INVEST, V123, P1531, DOI 10.1172/JCI66969; Harding PL, 2007, MOL THER, V15, P157, DOI 10.1038/sj.mt.6300006; Heemskerk HA, 2009, J GENE MED, V11, P257, DOI 10.1002/jgm.1288; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Kumaran RI, 2002, J CELL BIOL, V159, P783, DOI 10.1083/jcb.200204149; Lahoute C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003910; Lee HC, 2001, BIOGERONTOLOGY, V2, P231, DOI 10.1023/A:1013270512172; Liu YY, 2006, J CELL SCI, V119, P4644, DOI 10.1242/jcs.03263; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Lopez-Mejia IC, 2011, HUM MOL GENET, V20, P4540, DOI 10.1093/hmg/ddr385; Luo YB, 2011, NEUROMUSCULAR DISORD, V21, P734, DOI 10.1016/j.nmd.2011.06.1063; Luo YB, 2013, INT J CLIN EXP PATHO, V6, P1723; Machiels BM, 1996, J BIOL CHEM, V271, P9249, DOI 10.1074/jbc.271.16.9249; Mann CJ, 2002, J GENE MED, V4, P644, DOI 10.1002/jgm.295; Mattioli E, 2011, CELL DEATH DIFFER, V18, P1305, DOI 10.1038/cdd.2010.183; McClintock D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001269; McClorey G, 2006, GENE THER, V13, P1373, DOI 10.1038/sj.gt.3302800; Mendell JR, 2013, ANN NEUROL, V74, P637, DOI 10.1002/ana.23982; Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; Navarro CL, 2004, HUM MOL GENET, V13, P2493, DOI 10.1093/hmg/ddh265; Navarro CL, 2005, HUM MOL GENET, V14, P1503, DOI 10.1093/hmg/ddi159; Olins AL, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-30; Pereira S, 2008, MECH AGEING DEV, V129, P449, DOI 10.1016/j.mad.2008.04.003; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Sazani P, 2003, J CLIN INVEST, V112, P481, DOI 10.1172/JCI200319547; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Serdaroglu P, 2007, HDB CLIN NEUROLOGY, P357; Shimi T, 2012, CURR OPIN CELL BIOL, V24, P71, DOI 10.1016/j.ceb.2011.11.007; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102; Wilton SD, 2005, CURR GENE THER, V5, P467, DOI 10.2174/156652305774329249; Wilton SD, 2007, MOL THER, V15, P1288, DOI 10.1038/sj.mt.6300095; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642	57	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98306	10.1371/journal.pone.0098306	http://dx.doi.org/10.1371/journal.pone.0098306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892300	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400045
J	Picard-Meyer, E; Robardet, E; Arthur, L; Larcher, G; Harbusch, C; Servat, A; Cliquet, F				Picard-Meyer, Evelyne; Robardet, Emmanuelle; Arthur, Laurent; Larcher, Gerald; Harbusch, Christine; Servat, Alexandre; Cliquet, Florence			Bat Rabies in France: A 24-Year Retrospective Epidemiological Study	PLOS ONE			English	Article							SEROTINE BATS; VIRUS-INFECTION; NATTERERS BAT; LYSSAVIRUS; SURVEILLANCE; ECOLOGY; SEASONALITY; DYNAMICS; HOST	Since bat rabies surveillance was first implemented in France in 1989, 48 autochthonous rabies cases without human contamination have been reported using routine diagnosis methods. In this retrospective study, data on bats submitted for rabies testing were analysed in order to better understand the epidemiology of EBLV-1 in bats in France and to investigate some epidemiological trends. Of the 3176 bats submitted for rabies diagnosis from 1989 to 2013, 1.96% (48/2447 analysed) were diagnosed positive. Among the twelve recognised virus species within the Lyssavirus genus, two species were isolated in France. 47 positive bats were morphologically identified as Eptesicus serotinus and were shown to be infected by both the EBLV-1a and the EBLV-1b lineages. Isolation of BBLV in Myotis nattereri was reported once in the north-east of France in 2012. The phylogenetic characterisation of all 47 French EBLV-1 isolates sampled between 1989 and 2013 and the French BBLV sample against 21 referenced partial nucleoprotein sequences confirmed the low genetic diversity of EBLV-1 despite its extensive geographical range. Statistical analysis performed on the serotine bat data collected from 1989 to 2013 showed seasonal variation of rabies occurrence with a significantly higher proportion of positive samples detected during the autumn compared to the spring and the summer period (34% of positive bats detected in autumn, 15% in summer, 13% in spring and 12% in winter). In this study, we have provided the details of the geographical distribution of EBLV-1a in the south-west of France and the north-south division of EBLV-1b with its subdivisions into three phylogenetic groups: group B1 in the north-west, group B2 in the centre and group B3 in the north-east of France.	[Picard-Meyer, Evelyne; Robardet, Emmanuelle; Servat, Alexandre; Cliquet, Florence] French Agcy Food Environm & Occupat Hlth & Safety, Nancy Lab Rabies & Wildlife, European Union Reference Lab Rabies Serol, European Union Reference Lab Rabies,OIE Reference, Malzeville, France; [Arthur, Laurent] Museum Hist Nat Bourges, Bourges, France; [Larcher, Gerald] Museum Hist Nat Bourges, SFEPM Chiroptera Grp, Bourges, France; [Harbusch, Christine] Nat & Biodivers Conservat Union, Perl Kesslingen, Germany	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Technopole Agricole et Veterinaire	Picard-Meyer, E (corresponding author), French Agcy Food Environm & Occupat Hlth & Safety, Nancy Lab Rabies & Wildlife, European Union Reference Lab Rabies Serol, European Union Reference Lab Rabies,OIE Reference, Malzeville, France.	evelyne.picard-meyer@anses.fr	Servat, Alexandre/J-1804-2019	Servat, Alexandre/0000-0003-4753-6614; Picard-Meyer, Evelyne/0000-0001-9122-9027; CLIQUET, Florence/0000-0003-2237-1243				Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Ceballos NA, 2013, EMERG INFECT DIS, V19, P793, DOI 10.3201/eid1905.121071; Arthur Laurent, 2012, Symbioses, V28, P23; Baker ML, 2013, ZOONOSES PUBLIC HLTH, V60, P104, DOI 10.1111/j.1863-2378.2012.01528.x; Banyard AC, 2011, ADV VIRUS RES, V79, P239, DOI 10.1016/B978-0-12-387040-7.00012-3; Bourhy H, 2011, EPIDEMIOLOGIE RAGE H; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Cliquet F, 2010, DEV HARMONISED SCHEM; Dacheux L, 2009, EMERG INFECT DIS, V15, P280, DOI 10.3201/eid1502.080637; Davis PL, 2005, J VIROL, V79, P10487, DOI 10.1128/JVI.79.16.10487-10497.2005; Dean D. J., 1996, LAB TECHNIQUES RABIE; Dietz C, 2004, ILLUSTRATED IDENTIFI; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fenton MB, 2010, CURR ZOOL, V56, P454, DOI 10.1093/czoolo/56.4.454; Franka R, 2008, J GEN VIROL, V89, P1998, DOI 10.1099/vir.0.83688-0; Freuling C, 2009, J GEN VIROL, V90, P2493, DOI 10.1099/vir.0.011510-0; Freuling CM, 2011, EMERG INFECT DIS, V17, P1519, DOI 10.3201/eid1708.110201; Georgea DB, 2011, P NATL ACAD SCI USA, V108, P10208, DOI 10.1073/pnas.1010875108; Godineau F, 2007, PLAN RESTAURATION CH; Harbusch C, 2002, ASPECTS ECOLOGY SERO; Hayman DTS, 2013, ZOONOSES PUBLIC HLTH, V60, P2, DOI 10.1111/zph.12000; Hayman DTS, 2011, J VIROL METHODS, V177, P87, DOI 10.1016/j.jviromet.2011.07.002; ICTV, 2012, VERT; Jackson FR, 2008, J WILDLIFE DIS, V44, P612, DOI 10.7589/0090-3558-44.3.612; KAPLAN MM, 1969, NATURE, V221, P421, DOI 10.1038/221421a0; Kappeler A., 1989, Rabies Bulletin Europe, V13, P12; King A. A., 2004, Historical perspective of rabies in Europe and the Mediterranean Basin: a testament to rabies by Dr Arthur A. King, P221; Marston DA, 2012, EMERG INFECT DIS, V18, P664, DOI 10.3201/eid1804.111553; McElhinney LM, 2013, ZOONOSES PUBLIC HLTH, V60, P35, DOI 10.1111/zph.12003; Meslin FX, 1996, LAB TECHNIQUES RABIE; Muller T, 2007, ARCH VIROL, V152, P273, DOI 10.1007/s00705-006-0853-5; Patyk K, 2012, VECTOR-BORNE ZOONOT, V12, P666, DOI 10.1089/vbz.2011.0839; Picard-Meyer E, 2004, VET REC, V155, P774; Picard-Meyer E, 2004, VACCINE, V22, P1921, DOI 10.1016/j.vaccine.2003.11.015; Picard-Meyer E, 2013, B EPIDEMIOLOGIQUE SA, V60, P12; Picard-Meyer E, 2013, ARCH VIROL, V158, P2333, DOI 10.1007/s00705-013-1747-y; Picard-Meyer E, 2011, VET MICROBIOL, V151, P390, DOI 10.1016/j.vetmic.2011.03.034; Salicini I, 2011, MOL PHYLOGENET EVOL, V61, P888, DOI 10.1016/j.ympev.2011.08.010; Schatz J, 2013, ZOONOSES PUBLIC HLTH, V60, P22, DOI 10.1111/zph.12002; Scherrer B, 1984, BIOSTATISTIQUE; Serra-Cobo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064467; Servat A, 2012, BIOLOGICALS, V40, P61, DOI 10.1016/j.biologicals.2011.12.011; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turmelle AS, 2010, J GEN VIROL, V91, P2360, DOI 10.1099/vir.0.020073-0; Turmelle AS, 2010, VECTOR-BORNE ZOONOT, V10, P165, DOI 10.1089/vbz.2008.0163; Van der Poel WHM, 2005, EMERG INFECT DIS, V11, P1854, DOI 10.3201/eid1112.041200; Vazquez-Moron S, 2008, DEV BIOLOGICALS, V131, P311; Vazquez-Moron S, 2008, EMERG INFECT DIS, V14, P1263, DOI [10.3201/eid1408.080068, 10.3201/1408.080068]	49	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98622	10.1371/journal.pone.0098622	http://dx.doi.org/10.1371/journal.pone.0098622			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892287	Green Published, gold			2022-12-25	WOS:000336911400075
J	Rodrigues, ASB; Silva, SE; Marabuto, E; Silva, DN; Wilson, MR; Thompson, V; Yurtsever, S; Halkka, A; Borges, PAV; Quartau, JA; Paulo, OS; Seabra, SG				Rodrigues, Ana S. B.; Silva, Sara E.; Marabuto, Eduardo; Silva, Diogo N.; Wilson, Mike R.; Thompson, Vinton; Yurtsever, Selcuk; Halkka, Antti; Borges, Paulo A. V.; Quartau, Jose A.; Paulo, Octavio S.; Seabra, Sofia G.			New Mitochondrial and Nuclear Evidences Support Recent Demographic Expansion and an Atypical Phylogeographic Pattern in the Spittlebug Philaenus spumarius (Hemiptera, Aphrophoridae)	PLOS ONE			English	Article							POPULATION-STRUCTURE; PHYLOGENETIC ANALYSIS; GENETIC-VARIATION; DNA-SEQUENCES; REFUGIA; COLONIZATION; EVOLUTION; SOFTWARE; GROWTH; POLYMORPHISM	Philaenus spumarius is a widespread insect species in the Holarctic region. Here, by focusing on the mtDNA gene COI but also using the COII and Cyt b genes and the nuclear gene EF-1 alpha, we tried to explain how and when its current biogeographic pattern evolved by providing time estimates of the main demographic and evolutionary events and investigating its colonization patterns in and out of Eurasia. Evidence of recent divergence and expansion events at less than 0.5 Ma ago indicate that climate fluctuations in the Mid-Late Pleistocene were important in shaping the current phylogeographic pattern of the species. Data support a first split and differentiation of P. spumarius into two main mitochondrial lineages: the "western", in the Mediterranean region and the "eastern", in Anatolia/Caucasus. It also supports a following differentiation of the "western" lineage into two sub-lineages: the "western-Mediterranean", in Iberia and the "eastern-Mediterranean" in the Balkans. The recent pattern seems to result from postglacial range expansion from Iberia and Caucasus/Anatolia, thus not following one of the four common paradigms. Unexpected patterns of recent gene-flow events between Mediterranean peninsulas, a close relationship between Iberia and North Africa, as well as high levels of genetic diversity being maintained in northern Europe were found. The mitochondrial pattern does not exactly match to the nuclear pattern suggesting that the current biogeographic pattern of P. spumarius may be the result of both secondary admixture and incomplete lineage sorting. The hypothesis of recent colonization of North America from both western and northern Europe is corroborated by our data and probably resulted from accidental human translocations. A probable British origin for the populations of the Azores and New Zealand was revealed, however, for the Azores the distribution of populations in high altitude native forests is somewhat puzzling and may imply a natural colonization of the archipelago.	[Rodrigues, Ana S. B.; Silva, Sara E.; Marabuto, Eduardo; Silva, Diogo N.; Quartau, Jose A.; Paulo, Octavio S.; Seabra, Sofia G.] Univ Lisbon, Fac Ciencias, Dept Biol Anim Platform Enhancing Ecol Res & Sust, Computat Biol & Populat Genom Grp,Ctr Biol Ambien, Lisbon, Portugal; [Wilson, Mike R.] Natl Museum Wales, Dept Nat Sci, Cardiff CF1 3NP, S Glam, Wales; [Thompson, Vinton] Metropolitan Coll New York, New York, NY USA; [Yurtsever, Selcuk] Trakya Univ, Fac Sci, Dept Biol, Edirne, Turkey; [Halkka, Antti] Univ Helsinki, Dept Biol & Environm Sci, Helsinki, Finland; [Borges, Paulo A. V.] Univ Acores, Dept Ciencias Agr, Ctr Invest & Tecnol Agr Acores, Azorean Biodivers Grp, Angra Do Heroismo, Terceira, Portugal; [Borges, Paulo A. V.] Univ Acores, Dept Ciencias Agr, Angra Do Heroismo, Terceira, Portugal	Universidade de Lisboa; Trakya University; University of Helsinki; Universidade dos Acores; Universidade dos Acores	Rodrigues, ASB (corresponding author), Univ Lisbon, Fac Ciencias, Dept Biol Anim Platform Enhancing Ecol Res & Sust, Computat Biol & Populat Genom Grp,Ctr Biol Ambien, Lisbon, Portugal.	asorodrigues@fc.ul.pt	Borges, Paulo/H-5153-2019; Silva, Sara Ema/M-9608-2013; Paulo, Octávio/D-9921-2011; Seabra, Sofia G/B-3808-2013; Borges, Paulo/B-2780-2008; Marabuto, Eduardo/B-7284-2013	Borges, Paulo/0000-0002-8448-7623; Silva, Sara Ema/0000-0001-8766-8131; Paulo, Octávio/0000-0001-5408-5212; Seabra, Sofia G/0000-0003-1413-2349; Borges, Paulo/0000-0002-8448-7623; Marabuto, Eduardo/0000-0001-7017-8451; Silva, Diogo/0000-0002-6827-2673; Rodrigues, Ana Sofia/0000-0003-4887-3823	FCT, Portugal [SFRH/BPD/26365/2006, SFRH/BD/73879/2010, PTDC/BIA-BEC/098783/2008]	FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	Financial support: FCT, Portugal (Grant SFRH/BPD/26365/2006; Grant SFRH/BD/73879/2010; Project PTDC/BIA-BEC/098783/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arensburger P, 2004, J BIOGEOGR, V31, P557, DOI 10.1046/j.1365-2699.2003.01012.x; Assing V, 2010, LIST TERRESTRIAL MAR; Besold J, 2008, J BIOGEOGR, V35, P2090, DOI 10.1111/j.1365-2699.2008.01939.x; Bhagwat SA, 2008, J BIOGEOGR, V35, P464, DOI 10.1111/j.1365-2699.2007.01861.x; Downie DA, 2004, SYST ENTOMOL, V29, P238, DOI 10.1111/j.0307-6970.2004.00241.x; DROSOPOULOS S, 2002, ZOOTAXA, V68, P1, DOI DOI 10.11646/ZOOTAXA.68.1.1; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flot JF, 2007, MOL ECOL NOTES, V7, P974, DOI 10.1111/j.1471-8286.2007.01857.x; Franck P, 2001, HEREDITY, V86, P420, DOI 10.1046/j.1365-2540.2001.00842.x; Fu YX, 1997, GENETICS, V147, P915; Gibbard PL, 2010, J QUATERNARY SCI, V25, P96, DOI 10.1002/jqs.1338; Graur D, 2004, TRENDS GENET, V20, P80, DOI 10.1016/j.tig.2003.12.003; Habel JC, 2005, J BIOGEOGR, V32, P1489, DOI 10.1111/j.1365-2699.2005.01273.x; HALKKA O, 1990, EVOL BIOL, V24, P149; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HAMILTON KGA, 1979, CAN ENTOMOL, V111, P127, DOI 10.4039/Ent111127-2; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HARPENDING HC, 1994, HUM BIOL, V66, P591; Heads M, 2005, CLADISTICS, V21, P62, DOI 10.1111/j.1096-0031.2005.00052.x; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hewitt Godfrey M., 2011, P123; Hewitt GM, 2011, GENETICA, V139, P617, DOI 10.1007/s10709-011-9547-3; Horn A, 2006, MOL ECOL, V15, P1603, DOI 10.1111/j.1365-294X.2006.02872.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; Karban R, 2004, ECOL ENTOMOL, V29, P251, DOI 10.1111/j.1365-2311.2004.00576.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maryanska-Nadachowska A, 2012, SYST ENTOMOL, V37, P55, DOI 10.1111/j.1365-3113.2011.00592.x; Nardi F, 2005, MOL ECOL, V14, P2729, DOI 10.1111/j.1365-294X.2005.02610.x; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Pina-Martins F, 2008, MOL ECOL RESOUR, V8, P1254, DOI 10.1111/j.1755-0998.2008.02164.x; Pinto-Juma GA, 2008, B ENTOMOL RES, V98, P15, DOI 10.1017/S0007485307005573; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Quartau J, 1992, ACTAS C IBERICO ENTO, V1, P129; Quartau J. A., 1997, Miscellania Zoologica (Barcelona), V20, P19; Rambaut A., 2007, TRACER V1 4; Ribera I, 2004, MOL ECOL, V13, P179, DOI 10.1046/j.1365-294X.2003.02035.x; Rodriguez-Sanchez F, 2008, QUATERNARY SCI REV, V27, P2100, DOI 10.1016/j.quascirev.2008.08.006; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Schmitt T, 2005, BIOL J LINN SOC, V85, P419, DOI 10.1111/j.1095-8312.2005.00504.x; Schmitt T, 2001, J BIOGEOGR, V28, P1129, DOI 10.1046/j.1365-2699.2001.00621.x; Schmitt T, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-22; Schneider S, 1999, GENETICS, V152, P1079; Seabra SG, 2010, MOL PHYLOGENET EVOL, V56, P462, DOI 10.1016/j.ympev.2010.03.023; Seabra SG, 2009, BIOL J LINN SOC, V96, P249, DOI 10.1111/j.1095-8312.2008.01116.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON V, 1984, NEW ZEAL ENTOMOL, V8, P86, DOI 10.1080/00779962.1984.9722475; Weaver C., 1954, RES B, V741, P1; Yurtsever Selcuk, 2000, Turkish Journal of Zoology, V24, P447; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	62	14	15	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98375	10.1371/journal.pone.0098375	http://dx.doi.org/10.1371/journal.pone.0098375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892429	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400046
J	Zhen, XE; Zong, M; Gao, SN; Cao, YG; Jiang, L; Chen, SX; Wang, K; Sun, SQ; Peng, HS; Bai, YH; Li, S				Zhen, Xi-E; Zong, Ming; Gao, Sai-Nan; Cao, Yong-Gang; Jiang, Lei; Chen, Shu-Xin; Wang, Kuan; Sun, Shi-Qin; Peng, Hai-Sheng; Bai, Yu-Hua; Li, Sen			Preparation and Characterization of a Novel Aspirin Derivative with Anti-Thrombotic and Gastric Mucosal Protection Properties	PLOS ONE			English	Article							NITRIC-OXIDE; PROSTAGLANDINS	The use of acetylsalicylic acid (ASP) is limited by its adverse effects, especially the effect on the gastric mucosa. To address this problem, we synthesized a derivative form of ASP, prepared by modification of ASP with nano-hydroxyapatite (a kind of inorganic particle containing Ca2+). The derivative was named Ca-ASP. Structural study showed that Ca-ASP was a kind of carboxylate containing intramolecular hydrogen bonds. Rats given a high dose of Ca-ASP (5 mmol per kg body weight) showed similar anti-thrombotic activity as those given the same dose of ASP, but had much lower gastric mucosal damage than ASP (UI: 2 versus UI: 12.5). These rats also showed reduced expression of COX-2, but their COX-1 expression was similar to that of control rats, but significantly higher than that of ASP-administered rats. Furthermore, the level of prostaglandin E2 (PGE2) was up-regulated in Ca-ASP-administered rats compared to ASP-administered rats. Taken together, the results showed that Ca-ASP possessed similar antithrombotic activity as ASP but without the side effect associated with ASP, and the underlying mechanism may center on inhibiting COX-2 without inhibiting COX-1, and thus favouring the production of PGE2, the prostaglandin that plays a vital role in the suppression of platelet aggregation and thrombosis, as well as in the repair of gastric damage.	[Zhen, Xi-E; Zong, Ming; Gao, Sai-Nan; Cao, Yong-Gang; Jiang, Lei; Chen, Shu-Xin; Wang, Kuan; Sun, Shi-Qin; Peng, Hai-Sheng; Bai, Yu-Hua; Li, Sen] Harbin Med Univ, Dept Pharmaceut, Daqing Branch, Daqing, Peoples R China	Harbin Medical University	Li, S (corresponding author), Harbin Med Univ, Dept Pharmaceut, Daqing Branch, Daqing, Peoples R China.	tiande0405@sina.com			Heilongjiang Young Scientists Fund of Natural Science Foundation [QC2011C099]; Post-Doctoral Scientific Research Startup Fund [LBH-Q13131]; Postgraduate Innovation Scientific Research Fund [YJSCX2012-212HLJ]	Heilongjiang Young Scientists Fund of Natural Science Foundation; Post-Doctoral Scientific Research Startup Fund; Postgraduate Innovation Scientific Research Fund	This work was financially supported by the Heilongjiang Young Scientists Fund of Natural Science Foundation (QC2011C099), Post-Doctoral Scientific Research Startup Fund (LBH-Q13131), and Postgraduate Innovation Scientific Research Fund YJSCX2012-212HLJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amagase K, 2013, J PHYSIOL PHARMACOL, V64, P65; Bai BL, 2007, NEW J CHEM, V31, P401, DOI 10.1039/b614444f; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Ballhausen CJ, 1996, INORG CHEM, V111; Etcheverry SB, 2002, BIOMETALS, V15, P37, DOI 10.1023/A:1013183910203; GUTH PH, 1979, GASTROENTEROLOGY, V76, P88; Harrison P, 2008, PLATELETS, V19, P119, DOI 10.1080/09537100701771736; Have LWJ, 2013, PEDIATR BLOOD CANCER, V60, P1198, DOI 10.1002/pbc.24484; Jian Cheng H, 1989, POLYCRYSTAL STRUCTUR, P153; Jonsson F, 2013, BRIT J CANCER, V109, P1921, DOI 10.1038/bjc.2013.411; Lin-Vien D., 1991, HDB INFRARED RAMAN C; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Luo T, 2012, BREAST CANCER RES TR, V131, P581, DOI 10.1007/s10549-011-1747-0; Matsuura K, 2009, HEART VESSELS, V24, P169, DOI 10.1007/s00380-008-1105-2; Morais TC, 2010, CHEM-BIOL INTERACT, V183, P264, DOI 10.1016/j.cbi.2009.10.008; Morgan MP, 2001, MOL CARCINOGEN, V32, P111, DOI 10.1002/mc.1070; Nakamoto K., 1997, INFRARED RAMAN SPE B; Pathi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048208; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rolando B, 2013, CHEMMEDCHEM, V8, P1199, DOI 10.1002/cmdc.201300105; Rubner G, 2011, ARCH PHARM, V344, P684, DOI 10.1002/ardp.201000382; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Tarnawski A, 2013, CURR PHARM DESIGN, V19, P126; Do TNT, 2012, THER DELIV, V3, P623, DOI 10.4155/TDE.12.39; Wallace JL, 2000, GASTROENTEROLOGY, V119, P512, DOI 10.1053/gast.2000.9304; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang Xiao, 2000, The ways of making medicines with no or low gastrointestinal system poisonous side effect, Patent No. [CN99107973.6, 991079736]; Wang XY, 2011, CHINESE J PHARM, V7, P266; Zhang P, 2010, LANGMUIR, V26, P10183, DOI 10.1021/la100325c	29	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98513	10.1371/journal.pone.0098513	http://dx.doi.org/10.1371/journal.pone.0098513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892779	Green Published, gold			2022-12-25	WOS:000336911400060
J	Catone, MV; Ruiz, JA; Castellanos, M; Segura, D; Espin, G; Lopez, NI				Catone, Mariela V.; Ruiz, Jimena A.; Castellanos, Mildred; Segura, Daniel; Espin, Guadalupe; Lopez, Nancy I.			High Polyhydroxybutyrate Production in Pseudomonas extremaustralis Is Associated with Differential Expression of Horizontally Acquired and Core Genome Polyhydroxyalkanoate Synthase Genes	PLOS ONE			English	Article							CHAIN-LENGTH POLYHYDROXYALKANOATES; GRANULE-ASSOCIATED PROTEIN; POLY-BETA-HYDROXYBUTYRATE; PUTIDA KT2442; ANTARCTIC BACTERIUM; RALSTONIA-EUTROPHA; ESCHERICHIA-COLI; PHA GENES; POLY(3-HYDROXYBUTYRATE); IDENTIFICATION	Pseudomonas extremaustralis produces mainly polyhydroxybutyrate (PHB), a short chain length polyhydroxyalkanoate (sclPHA) infrequently found in Pseudomonas species. Previous studies with this strain demonstrated that PHB genes are located in a genomic island. In this work, the analysis of the genome of P. extremaustralis revealed the presence of another PHB cluster phbFPX, with high similarity to genes belonging to Burkholderiales, and also a cluster, phaC1ZC2D, coding for medium chain length PHA production (mclPHA). All mclPHA genes showed high similarity to genes from Pseudomonas species and interestingly, this cluster also showed a natural insertion of seven ORFs not related to mclPHA metabolism. Besides PHB, P. extremaustralis is able to produce mclPHA although in minor amounts. Complementation analysis demonstrated that both mclPHA synthases, PhaC1 and PhaC2, were functional. RT-qPCR analysis showed different levels of expression for the PHB synthase, phbC, and the mclPHA synthases. The expression level of phbC, was significantly higher than the obtained for phaC1 and phaC2, in late exponential phase cultures. The analysis of the proteins bound to the PHA granules showed the presence of PhbC and PhaC1, whilst PhaC2 could not be detected. In addition, two phasin like proteins (PhbP and PhaI) associated with the production of scl and mcl PHAs, respectively, were detected. The results of this work show the high efficiency of a foreign gene (phbC) in comparison with the mclPHA core genome genes (phaC1 and phaC2) indicating that the ability of P. extremaustralis to produce high amounts of PHB could be explained by the different expression levels of the genes encoding the scl and mcl PHA synthases.	[Catone, Mariela V.; Ruiz, Jimena A.; Lopez, Nancy I.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Ruiz, Jimena A.] Consejo Nacl Invest Cient & Tecn, Inst Invest Biociencias Agr & Ambientales, RA-1033 Buenos Aires, DF, Argentina; [Castellanos, Mildred; Segura, Daniel; Espin, Guadalupe] Univ Nacl Autonoma Mexico, Dept Mol Microbiol, Inst Biol, Cuernavaca 62191, Morelos, Mexico; [Lopez, Nancy I.] Consejo Nacl Invest Cient & Tecn, IQUIBICEN, RA-1033 Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional Autonoma de Mexico; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Lopez, NI (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina.	nan@qb.fcen.uba.ar		Lopez, Nancy/0000-0002-2966-3014	Universidad de Buenos Aires (UBACyT) [20020100100854]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP) [0338]; Agencia Nacional de Promocion Cientifica (ANPCyT: PICT), Argentina [0639]; Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico [127979]; ANPCyT; program Ciencia y Tecnologia para el Desarrollo (CYTED)	Universidad de Buenos Aires (UBACyT)(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica (ANPCyT: PICT), Argentina; Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ANPCyT(ANPCyT); program Ciencia y Tecnologia para el Desarrollo (CYTED)	This work was supported by grants from Universidad de Buenos Aires (UBACyT 2011-2014, No 20020100100854), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP 2011, No 0338) and Agencia Nacional de Promocion Cientifica (ANPCyT: PICT 2007, No 0639), Argentina and from Consejo Nacional de Ciencia y Tecnologia (CONACyT, grant 127979), Mexico. J.A.R. and N.I.L. are career investigators from CONICET, and M.V.C. has received a graduate student fellowship from ANPCyT and financial support from the program Ciencia y Tecnologia para el Desarrollo (CYTED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayub ND, 2007, PLASMID, V58, P240, DOI 10.1016/j.plasmid.2007.05.003; Ayub ND, 2006, FEMS MICROBIOL LETT, V264, P125, DOI 10.1111/j.1574-6968.2006.00446.x; Ayub ND, 2009, EXTREMOPHILES, V13, P59, DOI 10.1007/s00792-008-0197-z; BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854; Conte E, 2006, APPL MICROBIOL BIOT, V72, P1054, DOI 10.1007/s00253-006-0373-y; de Almeida A, 2011, APPL ENVIRON MICROB, V77, P6622, DOI 10.1128/AEM.05469-11; de Roo G, 2000, J MICROBIOL METH, V41, P1, DOI 10.1016/S0167-7012(00)00129-9; Diard S, 2002, SYST APPL MICROBIOL, V25, P183, DOI 10.1078/0723-2020-00114; FRIEDRICH B, 1981, J BACTERIOL, V147, P198, DOI 10.1128/JB.147.1.198-205.1981; Galan B, 2011, MOL MICROBIOL, V79, P402, DOI 10.1111/j.1365-2958.2010.07450.x; Han MJ, 2006, J MICROBIOL BIOTECHN, V16, P901; Hazer B, 2007, APPL MICROBIOL BIOT, V74, P1, DOI 10.1007/s00253-006-0732-8; Hoffmann N, 2004, FEMS MICROBIOL LETT, V237, P1, DOI 10.1111/j.1574-6968.2004.tb09671.x; Hu FQ, 2007, J IND MICROBIOL BIOT, V34, P255, DOI 10.1007/s10295-006-0180-6; HUIJBERTS GNM, 1994, J BACTERIOL, V176, P1661, DOI 10.1128/jb.176.6.1661-1666.1994; HUISMAN GW, 1991, J BIOL CHEM, V266, P2191; de Eugenio LI, 2010, ENVIRON MICROBIOL, V12, P207, DOI [10.1111/j.1462-2920.2009.02061.x, 10.1111/j.1462-2920.2010.02199.x]; Jaenecke S, 1999, Int Microbiol, V2, P29; Jendrossek D, 2007, APPL MICROBIOL BIOT, V74, P1186, DOI 10.1007/s00253-007-0860-9; Jendrossek D, 2014, ENVIRON MICROBIOL, V16, P2357, DOI 10.1111/1462-2920.12356; Kessler B, 2000, INT J SYST EVOL MICR, V50, P711, DOI 10.1099/00207713-50-2-711; Knoll M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-89; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Langille MGI, 2009, BIOINFORMATICS, V25, P664, DOI 10.1093/bioinformatics/btp030; Lopez NI, 2009, CURR MICROBIOL, V59, P514, DOI 10.1007/s00284-009-9469-9; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsusaki H, 1998, J BACTERIOL, V180, P6459, DOI 10.1128/JB.180.24.6459-6467.1998; MESELSON M, 1968, NATURE, V217, P1110, DOI 10.1038/2171110a0; OSTLE AG, 1982, APPL ENVIRON MICROB, V44, P238, DOI 10.1128/AEM.44.1.238-241.1982; Pettinari MJ, 2003, PLASMID, V50, P36, DOI 10.1016/S0147-619X(03)00009-X; Pfeiffer D, 2011, MOL MICROBIOL, V82, P936, DOI 10.1111/j.1365-2958.2011.07869.x; Potter M, 2004, MICROBIOL-SGM, V150, P2301, DOI 10.1099/mic.0.26970-0; Prieto MA, 1999, J BACTERIOL, V181, P858, DOI 10.1128/JB.181.3.858-868.1999; Rehm BHA, 2003, BIOCHEM J, V376, P15, DOI 10.1042/BJ20031254; Ren Q, 2009, BIOMACROMOLECULES, V10, P916, DOI 10.1021/bm801431c; Setubal JC, 2009, J BACTERIOL, V191, P4534, DOI 10.1128/JB.00504-09; SHAGGER H, 1987, ANAL BIOCHEM, V166, P386; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Solaiman DKY, 2008, J IND MICROBIOL BIOT, V35, P111, DOI 10.1007/s10295-007-0272-y; TIMM A, 1992, EUR J BIOCHEM, V209, P15, DOI 10.1111/j.1432-1033.1992.tb17256.x; Tirapelle EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075066; Tortajada M, 2013, INT MICROBIOL, V16, P1, DOI 10.2436/20.1501.01.175; Tribelli PM, 2012, J BACTERIOL, V194, P2381, DOI 10.1128/JB.00172-12; Tribelli PM, 2011, EXTREMOPHILES, V15, P541, DOI 10.1007/s00792-011-0384-1; WEBER K, 1969, J BIOL CHEM, V244, P4406; Yan YL, 2008, P NATL ACAD SCI USA, V105, P7564, DOI 10.1073/pnas.0801093105	47	21	21	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98873	10.1371/journal.pone.0098873	http://dx.doi.org/10.1371/journal.pone.0098873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887088	Green Submitted, Green Published, gold			2022-12-25	WOS:000336956300115
J	Wang, B; Yang, Q; Bai, WW; Xing, YF; Lu, XT; Sun, YY; Zhao, YX				Wang, Bo; Yang, Qing; Bai, Wen-wu; Xing, Yi-fan; Lu, Xiao-ting; Sun, Yuan-yuan; Zhao, Yu-xia			Tongxinluo Protects against Pressure Overload-Induced Heart Failure in Mice Involving VEGF/Akt/eNOS Pathway Activation	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE SYNTHASE; ISCHEMIA-REPERFUSION INJURY; CARDIOMYOCYTE-SPECIFIC OVEREXPRESSION; INDUCED CARDIAC-HYPERTROPHY; MYOCARDIAL-INFARCTION; CELL MOBILIZATION; OXIDATIVE STRESS; KNOCKOUT MICE; FAILING HEART	Background: It has been demonstrated that Tongxinluo (TXL), a traditional Chinese medicine compound, improves ischemic heart disease in animal models via vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (eNOS). The present study aimed to investigate whether TXL protects against pressure overload-induced heart failure in mice and explore the possible mechanism of action. Methods and Results: Transverse aortic constriction (TAC) surgery was performed in mice to induce heart failure. Cardiac function was evaluated by echocardiography. Myocardial pathology was detected using hematoxylin and eosin or Masson trichrome staining. We investigated cardiomyocyte ultrastructure using transmission electron microscopy. Angiogenesis and oxidative stress levels were determined using CD31 and 8-hydroxydeoxyguanosine immunostaining and malondialdehyde assay, respectively. Fetal gene expression was measured using real-time PCR. Protein expression of VEGF, phosphorylated (p)-VEGF receptor 2 (VEGFR2), p-phosphatidylinositol 3-kinase (PI3K), p-Akt, p-eNOS, heme oxygenase-1 (HO-1), and NADPH oxidase 4 (Nox4) were measured with western blotting. Twelve-week low-and high-dose TXL treatment following TAC improved cardiac systolic and diastolic function and ameliorated left ventricular hypertrophy, fibrosis, and myocardial ultrastructure derangement. Importantly, TXL increased myocardial capillary density significantly and attenuated oxidative stress injury in failing hearts. Moreover, TXL upregulated cardiac nitrite content and the protein expression of VEGF, p-VEGFR2, p-PI3K, p-Akt, p-eNOS, and HO-1, but decreased Nox4 expression in mouse heart following TAC. Conclusion: Our findings indicate that TXL protects against pressure overload-induced heart failure in mice. Activation of the VEGF/Akt/eNOS signaling pathway might be involved in TXL improvement of the failing heart.	[Wang, Bo; Xing, Yi-fan; Zhao, Yu-xia] Shandong Univ, Qilu Hosp, Dept Tradit Chinese Med, Jinan 250100, Peoples R China; [Yang, Qing] Shandong Univ, Inst Pathogen Biol, Jinan 250100, Peoples R China; [Bai, Wen-wu; Lu, Xiao-ting; Sun, Yuan-yuan] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Zhao, YX (corresponding author), Shandong Univ, Qilu Hosp, Dept Tradit Chinese Med, Jinan 250100, Peoples R China.	yu_xia_zhao@163.com			National 973 Basic Research Program of China [2012CB518603]; National Natural Science Foundation of China [81100103, 30873325, 81173251]; Natural Science Foundation of Shandong Province [ZR2011HQ020]	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by grants from the National 973 Basic Research Program of China (2012CB518603), the National Natural Science Foundation of China (81100103, 30873325, and 81173251), and the Natural Science Foundation of Shandong Province (ZR2011HQ020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov A, 2013, CIRCULATION, V127, P424, DOI 10.1161/CIRCULATIONAHA.112.127472; Bai Wen-Wu, 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/813247; Bugger H, 2010, CARDIOVASC RES, V85, P376, DOI 10.1093/cvr/cvp344; Chaanine AH, 2011, EUR J HEART FAIL, V13, P825, DOI 10.1093/eurjhf/hfr080; *CHIN PHARM COMM, 2005, PHARM PEOPL REP CHIN, V1; Di Napoli P, 2005, CARDIOVASC RES, V66, P462, DOI 10.1016/j.cardiores.2005.02.008; Elrod JW, 2006, ARTERIOSCL THROM VAS, V26, P1517, DOI 10.1161/01.ATV.0000224324.52466.e6; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Hafstad AD, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0359-8; Higashikuni Y, 2012, ARTERIOSCL THROM VAS, V32, P654, DOI 10.1161/ATVBAHA.111.240341; Janssens S, 2004, CIRC RES, V94, P1256, DOI 10.1161/01.RES.0000126497.38281.23; Khoo NKH, 2010, FREE RADICAL BIO MED, V48, P230, DOI 10.1016/j.freeradbiomed.2009.10.046; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Kuroda J, 2010, P NATL ACAD SCI USA, V107, P15565, DOI 10.1073/pnas.1002178107; Landmesser U, 2004, CIRCULATION, V110, P1933, DOI 10.1161/01.CIR.0000143232.67642.7A; Li XD, 2010, AM J PHYSIOL-HEART C, V299, pH1255, DOI 10.1152/ajpheart.00459.2010; Liang JQ, 2011, J ETHNOPHARMACOL, V133, P517, DOI 10.1016/j.jep.2010.10.031; Liao YL, 2004, CIRCULATION, V110, P692, DOI 10.1161/01.CIR.0000137831.08683.E1; Liu YH, 2002, HYPERTENSION, V39, P375, DOI 10.1161/hy02t2.102796; Matsushima S, 2013, CIRC RES, V112, P651, DOI 10.1161/CIRCRESAHA.112.279760; Murohara T, 1998, CIRCULATION, V97, P99, DOI 10.1161/01.CIR.97.1.99; Nako H, 2012, HYPERTENS RES, V35, P194, DOI 10.1038/hr.2011.175; Patel VB, 2013, CIRC RES, V112, P1542, DOI 10.1161/CIRCRESAHA.111.300299; PEARLMAN JD, 1995, NAT MED, V1, P1085, DOI 10.1038/nm1095-1085; Ruetten H, 2005, CARDIOVASC RES, V66, P444, DOI 10.1016/j.cardiores.2005.01.021; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Scherrer-Crosbie M, 2001, CIRCULATION, V104, P1286, DOI 10.1161/hc3601.094298; Serpi R, 2011, CARDIOVASC RES, V89, P204, DOI 10.1093/cvr/cvq267; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiojima I, 2012, AM J PATHOL, V181, P1969, DOI 10.1016/j.ajpath.2012.08.020; Shyu KG, 2005, J BIOMED SCI, V12, P409, DOI 10.1007/s11373-005-3008-x; Souders CA, 2012, AM J PATHOL, V181, P1226, DOI 10.1016/j.ajpath.2012.06.015; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053; Verma SK, 2012, CIRCULATION, V126, P418, DOI 10.1161/CIRCULATIONAHA.112.112185; Wang GW, 2010, CIRCULATION, V121, P1912, DOI 10.1161/CIRCULATIONAHA.109.905471; Xu XH, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-54; Zhang L, 2009, AM J PHYSIOL-HEART C, V297, pH2004, DOI 10.1152/ajpheart.00208.2009	39	34	40	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98047	10.1371/journal.pone.0098047	http://dx.doi.org/10.1371/journal.pone.0098047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887083	gold, Green Published			2022-12-25	WOS:000336956300035
J	Yagi, M; Bang, G; Tougan, T; Palacpac, NMQ; Arisue, N; Aoshi, T; Matsumoto, Y; Ishii, KJ; Egwang, TG; Druilhe, P; Horii, T				Yagi, Masanori; Bang, Gilles; Tougan, Takahiro; Palacpac, Nirianne M. Q.; Arisue, Nobuko; Aoshi, Taiki; Matsumoto, Yoshitsugu; Ishii, Ken J.; Egwang, Thomas G.; Druilhe, Pierre; Horii, Toshihiro			Protective Epitopes of the Plasmodium falciparum SERA5 Malaria Vaccine Reside in Intrinsically Unstructured N-Terminal Repetitive Sequences	PLOS ONE			English	Article							SERINE REPEAT ANTIGEN; ANTIBODY-MEDIATED INHIBITION; DISORDERED PROTEINS; PARASITE GROWTH; TARGET; DYNAMICS; HUMANS; DOMAIN	The malaria vaccine candidate antigen, SE36, is based on the N-terminal 47 kDa domain of Plasmodium falciparum serine repeat antigen 5 (SERA5). In epidemiological studies, we have previously shown the inhibitory effects of SE36 specific antibodies on in vitro parasite growth and the negative correlation between antibody level and malaria symptoms. A phase 1 b trial of the BK-SE36 vaccine in Uganda elicited 72% protective efficacy against symptomatic malaria in children aged 620 years during the follow-up period 130-365 days post-second vaccination. Here, we performed epitope mapping with synthetic peptides covering the whole sequence of SE36 to identify and map dominant epitopes in Ugandan adult serum presumed to have clinical immunity to P. falciparum malaria. High titer sera from the Ugandan adults predominantly reacted with peptides corresponding to two successive N-terminal regions of SERA5 containing octamer repeats and serine rich sequences, regions of SERA5 that were previously reported to have limited polymorphism. Affinity purified antibodies specifically recognizing the octamer repeats and serine rich sequences exhibited a high antibody-dependent cellular inhibition (ADCI) activity that inhibited parasite growth. Furthermore, protein structure predictions and structural analysis of SE36 using spectroscopic methods indicated that N-terminal regions possessing inhibitory epitopes are intrinsically unstructured. Collectively, these results suggest that strict tertiary structure of SE36 epitopes is not required to elicit protective antibodies in naturally immune Ugandan adults.	[Yagi, Masanori; Tougan, Takahiro; Palacpac, Nirianne M. Q.; Arisue, Nobuko; Horii, Toshihiro] Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Suita, Osaka 565, Japan; [Bang, Gilles; Druilhe, Pierre] Inst Pasteur, Biochem Parasitol Lab, Paris, France; [Aoshi, Taiki; Ishii, Ken J.] Natl Inst Biomed Innovat, Lab Adjuvant Innovat, Osaka, Japan; [Aoshi, Taiki; Ishii, Ken J.] Osaka Univ, Immunol Frontier Res Ctr, Lab Vaccine Sci, Suita, Osaka, Japan; [Matsumoto, Yoshitsugu] Univ Tokyo, Lab Mol Immunol, Sch Agr & Life Sci, Tokyo, Japan; [Egwang, Thomas G.] Med Biotech Labs, Kampala, Uganda	Osaka University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institute of Health Sciences - Japan; Osaka University; University of Tokyo	Horii, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Suita, Osaka 565, Japan.	horii@biken.osaka-u.ac.jp	Ishii, Ken J/B-1685-2012; Tougan, Takahiro/AAP-5129-2020	Ishii, Ken J/0000-0002-6728-3872; Palacpac, Nirianne Marie/0000-0003-4098-3972; Horii, Toshihiro/0000-0002-3000-2045	Japanese Ministry of Education, Science, Sports, Culture and Technology [22770151, 24249024]; Global Health Innovative Technology Fund [GHIT RFP 2013-001]	Japanese Ministry of Education, Science, Sports, Culture and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Health Innovative Technology Fund	This work was supported by Grant-in-Aid for Young Scientists (B) (22770151) and Grant-in-Aid for Global COE (Centers of Excellence) Program to MY; Grant-in-Aid for Scientific Research (A) (24249024), Program for the Promotion of International Policy Dialogues Contributing to the Development of Science and Technology Diplomacy to TH from the Japanese Ministry of Education, Science, Sports, Culture and Technology. The authors would like to acknowledge the funding support of Global Health Innovative Technology Fund (GHIT RFP 2013-001) to TH under the project Clinical development of BK-SE36/CpG malaria vaccine. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adda CG, 2012, INFECT IMMUN, V80, P4177, DOI 10.1128/IAI.00665-12; [Anonymous], 2012, WHO WORLD MALARIA RE; Aoki S, 2002, J BIOL CHEM, V277, P47533, DOI 10.1074/jbc.M207145200; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Bueno LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021289; Chauhan VS, 2010, HUM VACCINES, V6, P757, DOI 10.4161.hv.6.9.12468; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fox BA, 2002, EXP PARASITOL, V101, P69, DOI 10.1016/S0014-4894(02)00034-6; Fox BA, 1997, EXP PARASITOL, V85, P121, DOI 10.1006/expr.1996.4118; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Healer J, 2004, MOL MICROBIOL, V52, P159, DOI 10.1111/j.1365-2958.2003.03974.x; Hilser VJ, 2011, J BIOL CHEM, V286, P39675, DOI 10.1074/jbc.R111.278929; Horii T, 2010, PARASITOL INT, V59, P380, DOI 10.1016/j.parint.2010.05.002; Igarashi Y, 2009, NUCLEIC ACIDS RES, V37, pD611, DOI 10.1093/nar/gkn683; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Kim OTP, 2006, NUCLEIC ACIDS RES, V34, P6450, DOI 10.1093/nar/gkl819; Kulangara C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046112; Levy Y, 2007, J AM CHEM SOC, V129, P738, DOI 10.1021/ja065531n; Li H, 2002, PARASITOL INT, V51, P343, DOI 10.1016/S1383-5769(02)00042-9; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Mohan A, 2008, MOL BIOSYST, V4, P328, DOI 10.1039/b719168e; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Okech BA, 2001, AM J TROP MED HYG, V65, P912, DOI 10.4269/ajtmh.2001.65.912; Okech RN, 2006, AM J TROP MED HYG, V74, P191, DOI 10.4269/ajtmh.2006.74.191; Olugbile S, 2009, INFECT IMMUN, V77, P5701, DOI 10.1128/IAI.00652-09; Palacpac NMQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064073; Palacpac NMQ, 2011, VACCINE, V29, P5837, DOI 10.1016/j.vaccine.2011.06.052; Pan WQ, 2004, J IMMUNOL, V172, P6167, DOI 10.4049/jimmunol.172.10.6167; Pang XL, 1999, INFECT IMMUN, V67, P1821; Pang XL, 1998, VACCINE, V16, P1299, DOI 10.1016/S0264-410X(98)00057-7; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Soe S, 2002, INFECT IMMUN, V70, P7182, DOI 10.1128/IAI.70.12.7182-7184.2002; Tanabe K, 2012, VACCINE, V30, P1583, DOI 10.1016/j.vaccine.2011.12.124; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Uversky VN, 2011, INT J BIOCHEM CELL B, V43, P1090, DOI 10.1016/j.biocel.2011.04.001; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049; Zhang XC, 2008, J MOL BIOL, V379, P105, DOI 10.1016/j.jmb.2008.03.039; Zilversmit MM, 2010, MOL BIOL EVOL, V27, P2198, DOI 10.1093/molbev/msq108	43	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98460	10.1371/journal.pone.0098460	http://dx.doi.org/10.1371/journal.pone.0098460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886718	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300068
J	Llopis, S; Hernandez-Haro, C; Monteoliva, L; Querol, A; Molina, M; Fernandez-Espinar, MT				Llopis, Silvia; Hernandez-Haro, Carolina; Monteoliva, Lucia; Querol, Amparo; Molina, Maria; Fernandez-Espinar, Maria T.			Pathogenic Potential of Saccharomyces Strains Isolated from Dietary Supplements	PLOS ONE			English	Article							CANDIDA-ALBICANS; CEREVISIAE FUNGEMIA; BREWERS-YEAST; NATURAL HYBRIDS; GASTROINTESTINAL COLONIZATION; MOLECULAR CHARACTERIZATION; SPECIES IDENTIFICATION; GLUCOSE-TOLERANCE; SERUM-LIPIDS; VIRULENCE	Saccharomyces cerevisiae plays a beneficial role in health because of its intrinsic nutritional value and bio-functional properties, which is why it is also used as a dietary supplement. However, the perception that S. cerevisiae is harmless has changed due to an increasing number of infections caused by this yeast. Given this scenario, we have tested whether viable strains contained in dietary supplements displayed virulence-associated phenotypic traits that could contribute to virulence in humans. We have also performed an in vivo study of the pathogenic potential of these strains using a murine model of systemic infection by intravenous inoculation. A total of 5 strains were isolated from 22 commercial products and tested. Results highlight one strain (D14) in terms of burden levels in brains and kidneys and ability to cause death, whereas the other two strains (D2 and D4) were considered of low virulence. Our results suggest a strong relationship between some of the virulence-associated phenotypic traits (ability to grow at 39 degrees C and pseudohyphal growth) and the in vivo virulence in a mouse model of intravenous inoculation for isolates under study. The isolate displaying greatest virulence (D14) was evaluated in an experimental murine model of gastrointestinal infection with immunosuppression and disruption of mucosal integrity, which are common risk factors for developing infection in humans, and results were compared with an avirulent strain (D23). We showed that D14 was able to spread to mesenteric nodes and distant organs under these conditions. Given the widespread consumption of dietary supplements, we recommend only safe strains be used.	[Llopis, Silvia; Querol, Amparo; Fernandez-Espinar, Maria T.] CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol Alimentos, E-46010 Valencia, Spain; [Hernandez-Haro, Carolina; Monteoliva, Lucia; Molina, Maria] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain; [Hernandez-Haro, Carolina; Monteoliva, Lucia; Molina, Maria] Inst Ramon & Cajal Invest Sanitaria IRYCIS, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Complutense University of Madrid	Fernandez-Espinar, MT (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol Alimentos, Jaime Roig 11, E-46010 Valencia, Spain.	tfer@iata.csic.es	Monteoliva, Lucia/G-8720-2015; Fernández-Espinar, M Teresa/H-4547-2012; Querol, Amparo/H-3782-2012; Querol, Amparo/AAW-7469-2020; Molina, Maria/ABE-7186-2021	Monteoliva, Lucia/0000-0003-4949-0664; Fernández-Espinar, M Teresa/0000-0001-6285-8174; Querol, Amparo/0000-0002-6478-6845; Querol, Amparo/0000-0002-6478-6845; Molina, Maria/0000-0003-0074-3309	CICYT grant from the Ministerio de Ciencia y Tecnologia, Spain [AGL2006-12710-C02-01, AGL2006-12710-C02-02]; Comunidad Autonoma de Madrid (Spain) [PROMPT S2010/BMD-2414]; Ministerio de Ciencia y Tecnologia (Spain)	CICYT grant from the Ministerio de Ciencia y Tecnologia, Spain; Comunidad Autonoma de Madrid (Spain)(Comunidad de Madrid); Ministerio de Ciencia y Tecnologia (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was financially supported by a CICYT grant (Grant Nos AGL2006-12710-C02-01 and AGL2006-12710-C02-02) from the Ministerio de Ciencia y Tecnologia, Spain, to M. T. F.-E. and M. M., and by PROMPT S2010/BMD-2414 from Comunidad Autonoma de Madrid (Spain), to M. M. S. L. and C.H.-H. wish to thank the Ministerio de Ciencia y Tecnologia (Spain) for their FPU and an FPI predoctoral fellowships respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrutis KA, 2000, J CLIN MICROBIOL, V38, P2317; AOKI S, 1994, MYCOPATHOLOGIA, V128, P143, DOI 10.1007/BF01138475; Bahijiri SM, 2000, SAUDI MED J, V21, P831; Belloch C, 2009, APPL ENVIRON MICROB, V75, P2534, DOI 10.1128/AEM.02282-08; BYRON JK, 1995, INFECT IMMUN, V63, P478, DOI 10.1128/IAI.63.2.478-485.1995; CartwrightShamoon J, 1996, GUT, V39, P204, DOI 10.1136/gut.39.2.204; CARTWRIGHTSHAMOON J, 1995, J DRUG TARGET, V3, P61, DOI 10.3109/10611869509015935; Cesaro S, 2000, SUPPORT CARE CANCER, V8, P504, DOI 10.1007/s005200000123; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; CLEMONS KV, 1994, J INFECT DIS, V169, P859, DOI 10.1093/infdis/169.4.859; Clemons KV, 1996, J MED VET MYCOL, V34, P259; de Llanos R, 2004, SYST APPL MICROBIOL, V27, P427, DOI 10.1078/0723202041438473; de Llanos R, 2011, INT J FOOD MICROBIOL, V144, P393, DOI 10.1016/j.ijfoodmicro.2010.10.025; de Llanos R, 2006, ANTON LEEUW INT J G, V90, P221, DOI 10.1007/s10482-006-9077-7; de Llanos R, 2006, INT J FOOD MICROBIOL, V110, P286, DOI 10.1016/j.ijfoodmicro.2006.04.023; de Llanos R, 2010, YEAST, V27, P549, DOI 10.1002/yea.1799; Debelian GJ, 1997, INT ENDOD J, V30, P313, DOI 10.1046/j.1365-2591.1997.00101.x; El-Azizi Mohamed, 1999, Indian Journal of Experimental Biology, V37, P941; Enache-Angoulvant A, 2005, CLIN INFECT DIS, V41, P1559, DOI 10.1086/497832; Fernandez-Espinar MT, 2000, ANTON LEEUW INT J G, V78, P87; Fernandez-Espinar MT, 2001, INT J FOOD MICROBIOL, V70, P1, DOI 10.1016/S0168-1605(01)00502-5; Fung KSC, 1996, SCAND J INFECT DIS, V28, P83, DOI 10.3109/00365549609027155; Gancedo JM, 2001, FEMS MICROBIOL REV, V25, P107, DOI 10.1016/S0168-6445(00)00056-5; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Gonzalez SS, 2008, APPL ENVIRON MICROB, V74, P2314, DOI 10.1128/AEM.01867-07; Gonzalez SS, 2006, FEMS YEAST RES, V6, P1221, DOI 10.1111/j.1567-1364.2006.00126.x; Hennequin C, 2000, EUR J CLIN MICROBIOL, V19, P16, DOI 10.1007/s100960050003; Herbrecht R, 2005, CLIN INFECT DIS, V40, P1635, DOI 10.1086/429926; Jain N, 2006, INFECT IMMUN, V74, P896, DOI 10.1128/IAI.74.2.896-903.2006; JENSEN DP, 1976, ARCH INTERN MED, V136, P332, DOI 10.1001/archinte.136.3.332; Klingberg TD, 2008, FEMS YEAST RES, V8, P631, DOI 10.1111/j.1567-1364.2008.00365.x; Lherm T, 2002, INTENS CARE MED, V28, P797, DOI 10.1007/s00134-002-1267-9; LI YC, 1994, BIOL TRACE ELEM RES, V41, P341, DOI 10.1007/BF02917434; Lopes CA, 2010, FEMS YEAST RES, V10, P412, DOI 10.1111/j.1567-1364.2010.00614.x; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Martin H, 1993, MOL GEN GENET, V241, P177; Martins FS, 2007, J MED MICROBIOL, V56, P352, DOI 10.1099/jmm.0.46525-0; McCullough MJ, 1998, J CLIN MICROBIOL, V36, P2613, DOI 10.1128/JCM.36.9.2613-2617.1998; MCCUSKER JH, 1994, INFECT IMMUN, V62, P5447, DOI 10.1128/IAI.62.12.5447-5455.1994; MCCUSKER JH, 1994, GENETICS, V136, P1261; Mellado E, 2000, DIAGN MICR INFEC DIS, V38, P21, DOI 10.1016/S0732-8893(00)00165-6; Moyad Mark A, 2007, Urol Nurs, V27, P560; Munoz P, 2005, CLIN INFECT DIS, V40, P1625, DOI 10.1086/429916; Murphy AR, 2001, MED MYCOL, V39, P123, DOI 10.1080/mmy.39.1.123.127; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nakamura T, 2001, BIOSCI BIOTECH BIOCH, V65, P774, DOI 10.1271/bbb.65.774; NESS F, 1993, J SCI FOOD AGR, V62, P89, DOI 10.1002/jsfa.2740620113; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Peret LA, 1998, J MED MICROBIOL, V47, P111, DOI 10.1099/00222615-47-2-111; Perez-Torrado R, 2012, INT J FOOD MICROBIOL, V157, P59, DOI 10.1016/j.ijfoodmicro.2012.04.012; POPE LM, 1982, SCAN ELECTRON MICROS, P1667; PRICE MF, 1982, SABOURAUDIA, V20, P7; QUEROL A, 1992, SYST APPL MICROBIOL, V15, P439, DOI 10.1016/S0723-2020(11)80219-5; Querol A, 2009, FEMS MICROBIOL LETT, V293, P1, DOI 10.1111/j.1574-6968.2008.01480.x; Reddy BS, 2000, INT J MOL MED, V5, P327; Riquelme AJ, 2003, J CLIN GASTROENTEROL, V36, P41, DOI 10.1097/00004836-200301000-00013; Rodrigues ACP, 2000, J APPL MICROBIOL, V89, P404, DOI 10.1046/j.1365-2672.2000.01128.x; Roman E, 2007, TRENDS MICROBIOL, V15, P181, DOI 10.1016/j.tim.2007.02.001; ROTROSEN D, 1986, REV INFECT DIS, V8, P73; Samonis G, 2011, MED MYCOL, V49, P395, DOI 10.3109/13693786.2010.533203; Smith D, 2002, J CLIN MICROBIOL, V40, P2691, DOI 10.1128/JCM.40.7.2691-2692.2002; SOLL DR, 1988, J CLIN MICROBIOL, V26, P1448, DOI 10.1128/JCM.26.8.1448-1459.1988; SOLL DR, 1992, CLIN MICROBIOL REV, V5, P183, DOI 10.1128/CMR.5.2.183-203.1992; Takahashi K, 2003, MICROB PATHOGENESIS, V35, P179, DOI 10.1016/j.micpath.2003.06.001; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; van Burik JAH, 2001, ANNU REV MICROBIOL, V55, P743, DOI 10.1146/annurev.micro.55.1.743; Wells CL, 2007, J MED MICROBIOL, V56, P688, DOI 10.1099/jmm.0.47049-0; Wheeler RT, 2003, P NATL ACAD SCI USA, V100, P2766, DOI 10.1073/pnas.0437995100; Whelan K, 2010, AM J CLIN NUTR, V91, P687, DOI 10.3945/ajcn.2009.28759; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Yanez A., 2009, Open Mycology Journal, V3, P37, DOI 10.2174/1874437000903010037; Zupan J, 2008, J MICROBIOL METH, V73, P100, DOI 10.1016/j.mimet.2008.02.009	75	21	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98094	10.1371/journal.pone.0098094	http://dx.doi.org/10.1371/journal.pone.0098094			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879417	Green Accepted, gold, Green Published			2022-12-25	WOS:000338101500030
J	Nedosyko, AM; Young, JE; Edwards, JW; da Silva, KB				Nedosyko, Anita M.; Young, Jeanne E.; Edwards, John W.; da Silva, Karen Burke			Searching for a Toxic Key to Unlock the Mystery of Anemonefish and Anemone Symbiosis	PLOS ONE			English	Article							SEA-ANEMONE; FINDING NEMO; HOST; FISH; STOICHACTIS; SELECTION; ANTHOZOA; PATTERNS; STUNG	Twenty-six species of anemonefish of the genera Amphiprion and monospecific Premnas, use only 10 species of anemones as hosts in the wild (Families: Actiniidae, Stichodactylidae and Thalassianthidae). Of these 10 anemone species some are used by multiple species of anemonefish while others have only a single anemonefish symbiont. Past studies have explored the different patterns of usage between anemonefish species and anemone species; however the evolution of this relationship remains unknown and has been little studied over the past decade. Here we reopen the case, comparing the toxicity of crude venoms obtained from anemones that host anemonefish as a way to investigate why some anemone species are used as a host more than others. Specifically, for each anemone species we investigated acute toxicity using Artemia francisca (LC50), haemolytic toxicity using ovine erythrocytes (EC50) and neurotoxicity using shore crabs (Ozius truncatus). We found that haemolytic and neurotoxic activity varied among host anemone species. Generally anemone species that displayed greater haemolytic activity also displayed high neurotoxic activity and tend to be more toxic on average as indicated by acute lethality analysis. An overall venom toxicity ranking for each anemone species was compared with the number of anemonefish species that are known to associate with each anemone species in the wild. Interestingly, anemones with intermediate toxicity had the highest number of anemonefish associates, whereas anemones with either very low or very high toxicity had the fewest anemonefish associates. These data demonstrate that variation in toxicity among host anemone species may be important in the establishment and maintenance of anemonefish anemone symbiosis.	[Nedosyko, Anita M.; Young, Jeanne E.; Edwards, John W.; da Silva, Karen Burke] Flinders Univ South Australia, Fac Sci & Engn, Adelaide, SA, Australia	Flinders University South Australia	da Silva, KB (corresponding author), Flinders Univ South Australia, Fac Sci & Engn, Adelaide, SA, Australia.	karen.burkedasilva@flinders.edu.au		, Karen/0000-0002-0294-6583	School of Biological Sciences, Flinders University of SA	School of Biological Sciences, Flinders University of SA	Funding for this project was from The School of Biological Sciences, Flinders University of SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 1975, ANEMONEFISHES CLASSI; Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X; Arvedlund M., 2000, Naga, V23, P18; Astakhov DA, 2002, P 1 C ICHTH RUSS VNI, P9; Bailey PM, 2005, TOXICON, V45, P233, DOI 10.1016/j.toxicon.2004.10.013; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Buston PM, 2007, J FISH BIOL, V70, P1710, DOI 10.1111/j.1095-8649.2007.01445.x; Castellan NJ, 1988, NONPARAMETRIC STAT B; Chadwick NE, 2005, J MAR BIOL ASSOC UK, V85, P1287, DOI 10.1017/S0025315405012440; Daly M, 2008, MOL PHYLOGENET EVOL, V48, P292, DOI 10.1016/j.ympev.2008.02.022; DAVENPORT D, 1958, BIOL BULL, V115, P397, DOI 10.2307/1539105; DUNN DF, 1981, T AM PHILOS SOC, V71, P3, DOI 10.2307/1006382; Elliot J.K., 1996, J EXP MAR BIOL ECOL, V208, P57; Elliott JK, 2001, MAR BIOL, V138, P23, DOI 10.1007/s002270000441; ELLIOTT JK, 1994, J EXP MAR BIOL ECOL, V179, P99, DOI 10.1016/0022-0981(94)90019-1; FAUTIN DG, 1991, SYMBIOSIS, V10, P23; FAUTIN DG, 1986, ENVIRON BIOL FISH, V15, P171, DOI 10.1007/BF00002992; Fautin DG, 1997, ANEMONEFISHES THEIR; Fautin DG, 1985, P 5 INT COR REEF C, V5, P373; Huerta V, 2001, TOXICON, V39, P1253, DOI 10.1016/S0041-0101(00)00247-6; Ishida M, 1997, TOXICON, V35, P537, DOI 10.1016/S0041-0101(96)00143-2; JANSSEN A, 1989, FUNCT ECOL, V3, P469, DOI 10.2307/2389621; Jones AM, 2008, J FISH BIOL, V73, P753, DOI 10.1111/j.1095-8649.2008.01969.x; LUBBOCK R, 1979, J EXP BIOL, V83, P283; LUBBOCK R, 1980, PROC R SOC SER B-BIO, V207, P35, DOI 10.1098/rspb.1980.0013; LUBBOCK R, 1981, PARASITOLOGY, V82, P159, DOI 10.1017/S0031182000041962; MARISCAL R N, 1970, Journal of Experimental Marine Biology and Ecology, V4, P134, DOI 10.1016/0022-0981(70)90020-1; MARISCAL RN, 1969, EXPERIENTIA, V25, P1114, DOI 10.1007/BF01901467; MEBS D, 1994, TOXICON, V32, P1059, DOI 10.1016/0041-0101(94)90390-5; Mebs D, 2009, TOXICON, V54, P1071, DOI 10.1016/j.toxicon.2009.02.027; MIYAGAWA K, 1989, ETHOLOGY, V80, P19; MOYER J T, 1976, Japanese Journal of Ichthyology, V23, P23; MURATA M, 1986, SCIENCE, V234, P585, DOI 10.1126/science.234.4776.585; Ollerton J, 2007, P ROY SOC B-BIOL SCI, V274, P591, DOI 10.1098/rspb.2006.3758; PAWLIK JR, 1993, CHEM REV, V93, P1911, DOI 10.1021/cr00021a012; Pohnert G, 2004, TOP CURR CHEM, V239, P179, DOI 10.1007/b95453; Ricciardi F, 2010, ENVIRON BIOL FISH, V87, P333, DOI 10.1007/s10641-010-9606-0; Rivero A, 2000, ECOL ENTOMOL, V25, P467, DOI 10.1046/j.1365-2311.2000.00276.x; Santini S, 2006, GENE, V385, P19, DOI 10.1016/j.gene.2006.03.028; Schlichter D., 1976, P433; Schulz S., TOPICS CURRENT CHEM, V239; SENCIC L, 1990, COMP BIOCHEM PHYS B, V97, P687, DOI 10.1016/0305-0491(90)90108-6; Srinivasan M, 1999, MAR ECOL PROG SER, V186, P283, DOI 10.3354/meps186283; Standker L, 2006, TOXICON, V48, P211, DOI 10.1016/j.toxicon.2006.05.001; Vanhaecke P, 1984, ECOTOXICOLOGICAL TES, V2, P143	45	20	20	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98449	10.1371/journal.pone.0098449	http://dx.doi.org/10.1371/journal.pone.0098449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878777	gold, Green Published, Green Submitted			2022-12-25	WOS:000338101500060
J	Zhou, P; Kannan, R; Spee, C; Sreekumar, PG; Dou, GR; Hinton, DR				Zhou, Peng; Kannan, Ram; Spee, Christine; Sreekumar, Parameswaran G.; Dou, Guorui; Hinton, David R.			Protection of Retina by alpha B Crystallin in Sodium Iodate Induced Retinal Degeneration	PLOS ONE			English	Article							PIGMENT EPITHELIAL-CELLS; MACULAR DEGENERATION; PHOTORECEPTOR DEGENERATION; GEOGRAPHIC ATROPHY; NLRP3 INFLAMMASOME; OXIDATIVE STRESS; AGE; MODEL; EXPRESSION; DISEASE	Age-related macular degeneration (AMD) is a leading cause of blindness in the developed world. The retinal pigment epithelium (RPE) is a critical site of pathology in AMD and alpha B crystallin expression is increased in RPE and associated drusen in AMD. The purpose of this study was to investigate the role of alpha B crystallin in sodium iodate (NaIO3)-induced retinal degeneration, a model of AMD in which the primary site of pathology is the RPE. Dose dependent effects of intravenous NaIO3 (20-70 mg/kg) on development of retinal degeneration (fundus photography) and RPE and retinal neuronal loss (histology) were determined in wild type and alpha B crystallin knockout mice. Absence of alpha B crystallin augmented retinal degeneration in low dose (20 mg/kg) NaIO3-treated mice and increased retinal cell apoptosis which was mainly localized to the RPE layer. Generation of reactive oxygen species (ROS) was observed with NaIO3 in mouse and human RPE which increased further after alpha B crystallin knockout or siRNA knockdown, respectively. NaIO3 upregulated AKT phosphorylation and peroxisome proliferator-activator receptor-gamma (PPAR(gamma)) which was suppressed after alpha B crystallin siRNA knockdown. Further, PPAR(gamma) ligand inhibited NaIO3-induced ROS generation. Our data suggest that alpha B crystallin plays a critical role in protection of NaIO3-induced oxidative stress and retinal degeneration in part through upregulation of AKT phosphorylation and PPAR(gamma) expression.	[Zhou, Peng; Kannan, Ram; Sreekumar, Parameswaran G.; Dou, Guorui] Doheny Eye Inst, Los Angeles, CA 90033 USA; [Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Spee, Christine; Hinton, David R.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA	Doheny Eye Institute; University of Southern California; University of Southern California	Hinton, DR (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA.	dhinton@usc.edu	kannan, ram/ABB-7154-2020	kannan, ram/0000-0002-1583-3414; /0000-0002-9425-3986	Arnold and Mabel Beckman Foundation; Research to Prevent Blindness Inc., New York, NY;  [EY01545];  [EY03040]; NATIONAL EYE INSTITUTE [P30EY003040, R01EY001545] Funding Source: NIH RePORTER	Arnold and Mabel Beckman Foundation; Research to Prevent Blindness Inc., New York, NY(Research to Prevent Blindness (RPB)); ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported in part by grants EY01545 (DRH) and by core grant EY03040, the Arnold and Mabel Beckman Foundation, and an unrestricted grant to the Department of Ophthalmology from Research to Prevent Blindness Inc., New York, NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Bird AC, 2010, J CLIN INVEST, V120, P3033, DOI 10.1172/JCI42437; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Brownell SE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00074; Cheng HC, 2008, MOL VIS, V14, P95; Chung SS, 2011, AM J PHYSIOL-ENDOC M, V301, pE912, DOI 10.1152/ajpendo.00120.2011; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; De S, 2007, ARCH OPHTHALMOL-CHIC, V125, P641, DOI 10.1001/archopht.125.5.641; Ding JD, 2011, P NATL ACAD SCI USA, V108, pE279, DOI 10.1073/pnas.1100901108; Dou GR, 2012, FREE RADICAL BIO MED, V53, P1111, DOI 10.1016/j.freeradbiomed.2012.06.042; Enzmann V, 2006, EXP EYE RES, V82, P441, DOI 10.1016/j.exer.2005.08.002; Fort PE, 2011, EXP EYE RES, V92, P98, DOI 10.1016/j.exer.2010.11.008; Franco LM, 2009, INVEST OPHTH VIS SCI, V50, P4004, DOI 10.1167/iovs.08-2898; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kannan R, 2012, PROG RETIN EYE RES, V31, P576, DOI 10.1016/j.preteyeres.2012.06.001; Karan G, 2005, P NATL ACAD SCI USA, V102, P4164, DOI 10.1073/pnas.0407698102; Kase S, 2010, BLOOD, V115, P3398, DOI 10.1182/blood-2009-01-197095; Kerur N, 2013, INVEST OPHTH VIS SCI, V54, P7395, DOI 10.1167/iovs.13-12500; Kim JW, 2008, GENE DEV, V22, P3147, DOI 10.1101/gad.1700108; Kiuchi K, 2002, CURR EYE RES, V25, P373, DOI 10.1076/ceyr.25.6.373.14227; Klein ML, 2008, OPHTHALMOLOGY, V115, P1026, DOI 10.1016/j.ophtha.2007.08.030; Kleinman ME, 2012, MOL THER, V20, P101, DOI 10.1038/mt.2011.212; Kolosova NG, 2012, AM J PATHOL, V181, P472, DOI 10.1016/j.ajpath.2012.04.018; Liu B, 2011, BIOCHEM BIOPH RES CO, V321, P254; Longbottom R, 2009, P NATL ACAD SCI USA, V106, P18728, DOI 10.1073/pnas.0902593106; Malek G, 2005, P NATL ACAD SCI USA, V102, P11900, DOI 10.1073/pnas.0503015102; Markovets AM, 2011, AGING-US, V3, P44; Martin HL, 2012, EXP NEUROL, V235, P528, DOI 10.1016/j.expneurol.2012.02.017; Murata T, 2000, INVEST OPHTH VIS SCI, V41, P2309; Nakata K, 2005, EXP EYE RES, V80, P821, DOI 10.1016/j.exer.2004.12.011; Organisciak D, 2006, PHOTOCHEM PHOTOBIOL, V82, P1088, DOI 10.1562/2005-06-30-RA-599; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Pasupuleti N, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.3; Ramkumar HL, 2010, PROG RETIN EYE RES, V29, P169, DOI 10.1016/j.preteyeres.2010.02.002; Redfern WS, 2011, J PHARMACOL TOXICOL, V63, P102, DOI 10.1016/j.vascn.2010.06.008; RINGVOLD A, 1981, EXP EYE RES, V33, P361, DOI 10.1016/S0014-4835(81)80088-7; Rothbard JB, 2012, J BIOL CHEM, V287, P9708, DOI 10.1074/jbc.M111.337691; Sakaguchi H, 2003, EXP EYE RES, V76, P131, DOI 10.1016/S0014-4835(02)00249-X; Sonoda S, 2010, AGING-US, V2, P28, DOI 10.18632/aging.100111; Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33; Sreekumar PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033420; Sreekumar PG, 2012, OXID STRESS APPL BAS, P181, DOI 10.1007/978-1-61779-606-7_9; Sreekumar PG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012578; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Whiteside C, 2009, EXP DIABETES RES, DOI 10.1155/2009/910783; Xi JH, 2003, MOL VIS, V9, P410; Yang P, 2006, INVEST OPHTH VIS SCI, V47, P4598, DOI 10.1167/iovs.06-0140; Yaung J, 2008, EXP EYE RES, V86, P355, DOI 10.1016/j.exer.2007.11.007; Yaung J, 2007, MOL VIS, V13, P566; Zhao C, 2011, J CLIN INVEST, V121, P369, DOI 10.1172/JCI44303; Zhou P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043173; Zhu C, 2011, AGING, V3, P346; Zhu DH, 2009, AGING-US, V1, P740, DOI 10.18632/aging.100078; Zhu DH, 2009, J BIOL CHEM, V284, P9529, DOI 10.1074/jbc.M809393200; Zhu XM, 2005, J NEUROCHEM, V95, P1351, DOI 10.1111/j.1471-4159.2005.03460.x	56	48	52	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98275	10.1371/journal.pone.0098275	http://dx.doi.org/10.1371/journal.pone.0098275			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874187	Green Submitted, Green Published, gold			2022-12-25	WOS:000336790800030
J	Coman, A; Maftei, DN; Krueger, WS; Heil, GL; Chereches, RM; Sirlincan, E; Bria, P; Dragnea, C; Kasler, I; Valentine, MA; Gray, GC				Coman, Alexandru; Maftei, Daniel N.; Krueger, Whitney S.; Heil, Gary L.; Chereches, Razvan M.; Sirlincan, Emanuela; Bria, Paul; Dragnea, Claudiu; Kasler, Iosif; Valentine, Marissa A.; Gray, Gregory C.			A Prospective Study of Romanian Agriculture Workers for Zoonotic Influenza Infections	PLOS ONE			English	Article							AVIAN INFLUENZA; SWINE INFLUENZA; VIRUSES	Background: In this prospective study we sought to examine seroepidemiological evidence for acute zoonotic influenza virus infection among Romanian agricultural workers. Methods: Sera were drawn upon enrollment (2009) and again at 12 and 24 months from 312 adult agriculture workers and 51 age-group matched controls. Participants were contacted monthly for 24 months and queried regarding episodes of acute influenza-like illnesses (ILI). Cohort members meeting ILI criteria permitted respiratory swab collections as well as acute and convalescent serum collection. Serologic assays were performed against 9 avian, 3 swine, and 3 human influenza viruses. Results: During the two-year follow-up, a total of 23 ILI events were reported. Two subjects' specimens were identified as influenza A by rRT-PCR. During the follow-up period, three individuals experienced elevated microneutralization antibody titers >= 1:80 against three (one each) avian influenza viruses: A/Teal/Hong Kong/w312/97(H6N1), A/Hong Kong/1073/ 1999(H9N2), or A/Duck/Alberta/60/1976(H12N5). However, none of these participants met the criteria for poultry exposure. A number of subjects demonstrated four-fold increases over time in hemagglutination inhibition (HI) assay titers for at least one of the three swine influenza viruses (SIVs); however, it seems likely that two of these three responses were due to crossreacting antibody against human influenza. Only elevated antibody titers against A/Swine/Flanders/1/1998(H3N2) lacked evidence for such confounding. In examining risk factors for elevated antibody against this SIV with multiple logistic regression, swine exposure (adjusted OR = 1.8, 95% CI 1.1-2.8) and tobacco use (adjusted OR = 1.8; 95% CI 1.1-2.9) were important predictors. Conclusions: While Romania has recently experienced multiple incursions of highly pathogenic avian influenza among domestic poultry, this cohort of Romanian agriculture workers had sparse evidence of avian influenza virus infections. In contrast, there was evidence, especially among the swine exposed participants, of infections with human and one swine H3N2 influenza virus.	[Coman, Alexandru; Maftei, Daniel N.; Chereches, Razvan M.; Sirlincan, Emanuela; Bria, Paul; Dragnea, Claudiu; Kasler, Iosif] Univ Babes Bolyai, Ctr Hlth Policy & Publ Hlth, Inst Social Res, Fac Polit Adm & Commun Sci, R-3400 Cluj Napoca, Romania; [Krueger, Whitney S.; Heil, Gary L.; Valentine, Marissa A.; Gray, Gregory C.] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA; [Krueger, Whitney S.; Heil, Gary L.; Valentine, Marissa A.; Gray, Gregory C.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	Babes Bolyai University from Cluj; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Gray, GC (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL 32611 USA.	gcgray@phhp.ufl.edu	Gray, Gregory C./ABF-1298-2020; Maftei, Daniel/GLT-6228-2022	Gray, Gregory/0000-0002-4628-5908; Coman, Alexandru/0000-0002-9417-5033	US Department of Defense Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response Program; ARRA supplement grant from the National Institute of Allergy and Infectious Diseases [R01 AI068803]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068803] Funding Source: NIH RePORTER	US Department of Defense Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response Program; ARRA supplement grant from the National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by multiple grants from the US Department of Defense Armed Forces Health Surveillance Center's Global Emerging Infections Surveillance and Response Program (Dr. Gray, principal investigator) and an ARRA supplement grant from the National Institute of Allergy and Infectious Diseases (R01 AI068803-Dr. Gray). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, INF ROM CLASS SWIN F, P1; Coman A, 2013, J INFECT PUBLIC HLTH; Gill JS, 2006, EMERG INFECT DIS, V12, P1284, DOI 10.3201/eid1708.060492; Gray GC, 2007, EMERG INFECT DIS, V13, P1871, DOI 10.3201/eid1312.061323; Jernigan DB, 2011, CLIN INFECT DIS, V52, pS36, DOI 10.1093/cid/ciq020; Kayali G, 2008, J CLIN VIROL, V43, P73, DOI 10.1016/j.jcv.2008.04.013; Kendal AP, 1982, CONCEPTS PROCEDURES; Khuntirat BP, 2011, CLIN INFECT DIS, V53, pE107, DOI 10.1093/cid/cir525; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Myers KP, 2006, CLIN INFECT DIS, V42, P14, DOI 10.1086/498977; Nicoll A, 2005, EUROSURVEILLANCE, V10; Oprisan G, 2006, Roum Arch Microbiol Immunol, V65, P79; Ramirez A, 2006, EMERG INFECT DIS, V12, P997, DOI 10.3201/eid1206.051576; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reid SM, 2011, TRANSBOUND EMERG DIS, V58, P76, DOI 10.1111/j.1865-1682.2010.01175.x; ROWE WP, 1958, P SOC EXP BIOL MED, V97, P465, DOI 10.3181/00379727-97-23776	16	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98248	10.1371/journal.pone.0098248	http://dx.doi.org/10.1371/journal.pone.0098248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24869796	Green Published, gold			2022-12-25	WOS:000336858300029
J	Graudenzi, A; Caravagna, G; De Matteis, G; Antoniotti, M				Graudenzi, Alex; Caravagna, Giulio; De Matteis, Giovanni; Antoniotti, Marco			Investigating the Relation between Stochastic Differentiation, Homeostasis and Clonal Expansion in Intestinal Crypts via Multiscale Modeling	PLOS ONE			English	Article							STEM-CELLS; GENE-EXPRESSION; MIGRATION; NETWORK; CANCER; NOISE; MECHANISMS; EQUILIBRIUM; POPULATIONS; ACTIVATION	Colorectal tumors originate and develop within intestinal crypts. Even though some of the essential phenomena that characterize crypt structure and dynamics have been effectively described in the past, the relation between the differentiation process and the overall crypt homeostasis is still only partially understood. We here investigate this relation and other important biological phenomena by introducing a novel multiscale model that combines a morphological description of the crypt with a gene regulation model: the emergent dynamical behavior of the underlying gene regulatory network drives cell growth and differentiation processes, linking the two distinct spatio-temporal levels. The model relies on a few a priori assumptions, yet accounting for several key processes related to crypt functioning, such as: dynamic gene activation patterns, stochastic differentiation, signaling pathways ruling cell adhesion properties, cell displacement, cell growth, mitosis, apoptosis and the presence of biological noise. We show that this modeling approach captures the major dynamical phenomena that characterize the regular physiology of crypts, such as cell sorting, coordinate migration, dynamic turnover, stem cell niche correct positioning and clonal expansion. All in all, the model suggests that the process of stochastic differentiation might be sufficient to drive the crypt to homeostasis, under certain crypt configurations. Besides, our approach allows to make precise quantitative inferences that, when possible, were matched to the current biological knowledge and it permits to investigate the role of gene-level perturbations, with reference to cancer development. We also remark the theoretical framework is general and may be applied to different tissues, organs or organisms.	[Graudenzi, Alex; Caravagna, Giulio; Antoniotti, Marco] Univ Milano Bicocca, Dept Informat Syst & Commun, Milan, Italy; [De Matteis, Giovanni] Northumbria Univ, Dept Math & Informat, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England	University of Milano-Bicocca; Northumbria University	Graudenzi, A (corresponding author), Univ Milano Bicocca, Dept Informat Syst & Commun, Milan, Italy.	alex.graudenzi@unimib.it	Graudenzi, Alex/AAY-5241-2020; Caravagna, Giulio/F-5011-2015	Graudenzi, Alex/0000-0001-5452-1918; Caravagna, Giulio/0000-0003-4240-3265	ASTIL program project RetroNet" [12-4-5148000-40]; U.A [053]; NEDD Project Fondo Accordi Istituzionali 2009 [ID14546A Rif SAL-7]	ASTIL program project RetroNet"; U.A; NEDD Project Fondo Accordi Istituzionali 2009	This work was partially supported by the ASTIL program, project RetroNet '', grant n. 12-4-5148000-40; U.A 053 and NEDD Project [ID14546A Rif SAL-7] Fondo Accordi Istituzionali 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Alberts B., 2010, MOL BIOL CELL; Andreu P, 2008, DEV BIOL, V324, P288, DOI 10.1016/j.ydbio.2008.09.027; Antoniotti M, 2013, BIOINFORMATICS, V29, P513, DOI 10.1093/bioinformatics/bts726; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BarabuYSi A., 2003, LINKED EVERYTHING IS; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; Bjerknes M, 1996, J THEOR BIOL, V178, P381, DOI 10.1006/jtbi.1996.0034; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Boman BM, 2001, CANCER RES, V61, P8408; Brittan M, 2002, J PATHOL, V197, P492, DOI 10.1002/path.1155; Buske P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001045; Caravagna G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051174; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Creixell P, 2012, NAT BIOTECHNOL, V30, P842, DOI 10.1038/nbt.2345; Damiani C, 2011, IET SYST BIOL, V5, P137, DOI 10.1049/iet-syb.2010.0039; De Matteis G, 2013, J MATH BIOL, V66, P1409, DOI 10.1007/s00285-012-0539-4; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Frank S, 2007, DYNAMICS CANCER; Furusawa C, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-17; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Graudenzi A, 2012, P WIV 2012 IT WORKSH; Graudenzi A, 2011, J COMPUT BIOL, V18, P1291, DOI 10.1089/cmb.2010.0069; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grefenstette J, 2006, BIOSYSTEMS, V84, P81, DOI 10.1016/j.biosystems.2005.09.009; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Haga H, 2005, BIOPHYS J, V88, P2250, DOI 10.1529/biophysj.104.047654; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hocker M, 1998, ANN NY ACAD SCI, V859, P160, DOI 10.1111/j.1749-6632.1998.tb11120.x; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Huang S, 2009, SEMIN CELL DEV BIOL, V20, P869, DOI 10.1016/j.semcdb.2009.07.003; Huang S, 2009, BIOESSAYS, V31, P546, DOI 10.1002/bies.200800189; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Huynh-Do U, 1999, EMBO J, V18, P2165, DOI 10.1093/emboj/18.8.2165; Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kaneko K, 2006, LIFE INTRO COMPLEX S; Kashiwagi A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000049; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Kauffman S, 2003, P NATL ACAD SCI USA, V100, P14796, DOI 10.1073/pnas.2036429100; Kauffman S, 2004, P NATL ACAD SCI USA, V101, P17102, DOI 10.1073/pnas.0407783101; Kauffman S., 1995, HOME UNIVERSE SEARCH; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; KAUR P, 1986, CELL TISSUE KINET, V19, P591, DOI 10.1111/j.1365-2184.1986.tb00760.x; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lestas I, 2008, IEEE T AUTOMAT CONTR, V53, P189, DOI 10.1109/TAC.2007.911347; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; Miao H, 2005, J BIOL CHEM, V280, P923, DOI 10.1074/jbc.M411383200; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.2307/2332142; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Murray PJ, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/2/026011; Nachman MW, 2000, GENETICS, V156, P297; Noble D, 2002, SCIENCE, V295, P1678, DOI 10.1126/science.1069881; Peixoto TP, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.036108; Pitt-Francis J, 2009, COMPUT PHYS COMMUN, V180, P2452, DOI 10.1016/j.cpc.2009.07.019; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Potten CS, 2009, CELL PROLIFERAT, V42, P731, DOI 10.1111/j.1365-2184.2009.00642.x; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; POTTEN CS, 1987, J THEOR BIOL, V127, P381, DOI 10.1016/S0022-5193(87)80136-4; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Ramo P, 2006, J THEOR BIOL, V242, P164, DOI 10.1016/j.jtbi.2006.02.011; Ristma L, 2014, NATURE, V507, P362; Robertson C, 2008, ATLAS CANC MORTALITY, P91; Ryu Seongho, 2008, Syst Synth Biol, V2, P49, DOI 10.1007/s11693-009-9022-y; Sanchez L, 1997, J THEOR BIOL, V189, P377, DOI 10.1006/jtbi.1997.0523; Sanchez L, 2001, J THEOR BIOL, V211, P115, DOI 10.1006/jtbi.2001.2335; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Schroeder T, 2007, CELL STEM CELL, V1, P479, DOI 10.1016/j.stem.2007.10.016; Scianna M, 2013, CH CRC MATH COMP BIO, P1, DOI 10.1201/b14075; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Serra R, 2007, J THEOR BIOL, V246, P449, DOI 10.1016/j.jtbi.2007.01.012; Serra R, 2004, J THEOR BIOL, V227, P149, DOI 10.1016/j.jtbi.2003.10.018; Serra R, 2010, J THEOR BIOL, V265, P185, DOI 10.1016/j.jtbi.2010.04.012; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; Shmulevich I, 2005, P NATL ACAD SCI USA, V102, P13439, DOI 10.1073/pnas.0506771102; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Southern J, 2008, PROGR BIOPHYSICS MOL, V96; STEINBERG MS, 1962, P NATL ACAD SCI USA, V48, P1577, DOI 10.1073/pnas.48.9.1577; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Tamborero D, 2013, NATURE SCI REPORTS, V3; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; van Leeuwen IMM, 2006, CELL PROLIFERAT, V39, P157, DOI 10.1111/j.1365-2184.2006.00378.x; Villani M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017703; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; Wong SY, 2010, J R SOC INTERFACE, V7, pS351, DOI 10.1098/rsif.2010.0018.focus; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180	106	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97272	10.1371/journal.pone.0097272	http://dx.doi.org/10.1371/journal.pone.0097272			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24869488	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000336858300007
J	Kitano, YF; Benzoni, F; Arrigoni, R; Shirayama, Y; Wallace, CC; Fukami, H				Kitano, Yuko F.; Benzoni, Francesca; Arrigoni, Roberto; Shirayama, Yoshihisa; Wallace, Carden C.; Fukami, Hironobu			A Phylogeny of the Family Poritidae (Cnidaria, Scleractinia) Based on Molecular and Morphological Analyses	PLOS ONE			English	Article							SPECIES BOUNDARIES; CORAL; GENUS; ANTHOZOA; REEF; MITOCHONDRIAL; ACROPORIDAE; ATLANTIC; PACIFIC; GROWTH	The family Poritidae formerly included 6 genera: Alveopora, Goniopora, Machadoporites, Porites, Poritipora, and Stylaraea. Morphologically, the genera can be differentiated based on the number of tentacles, the number of septa and their arrangement, the length of the polyp column, and the diameter of the corallites. However, the phylogenetic relationships within and between the genera are unknown or contentious. On the one hand, Alveopora has been transferred to the Acroporidae recently because it was shown to be more closely related to this family than to the Poritidae by previous molecular studies. On the other hand, Goniopora is morphologically similar to 2 recently described genera, Machadoporites and Poritipora, particularly with regard to the number of septa (approximately 24), but they have not yet been investigated at the molecular level. In this study, we analyzed 93 samples from all 5 poritid genera and Alveopora using 2 genetic markers (the barcoding region of the mitochondrial COI and the ITS region of the nuclear rDNA) to investigate their phylogenetic relationships and to revise their taxonomy. The reconstructed molecular trees confirmed that Alveopora is genetically distant from all poritid genera but closely related to the family Acroporidae, whereas the other genera are genetically closely related. The molecular trees also revealed that Machadoporites and Poritipora were indistinguishable from Goniopora. However, Goniopora stutchburyi was genetically isolated from the other congeneric species and formed a sister group to Goniopora together with Porites and Stylaraea, thus suggesting that 24 septa could be an ancestral feature in the Poritidae. Based on these data, we move G. stutchburyi into a new genus, Bernardpora gen. nov., whereas Machadoporites and Poritipora are merged with Goniopora.	[Kitano, Yuko F.; Shirayama, Yoshihisa] Kyoto Univ, Field Sci & Educ Ctr, Seto Marine Biol Lab, Wakayama, Japan; [Kitano, Yuko F.; Fukami, Hironobu] Miyazaki Univ, Fac Agr, Dept Marine Biol & Environm Sci, Miyazaki 88921, Japan; [Benzoni, Francesca; Arrigoni, Roberto] Univ Milano Bicocca, Deptartment Biotechnol & Biosci, Milan, Italy; [Shirayama, Yoshihisa] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Wallace, Carden C.] Museum Trop Queensland, Townsville, Qld, Australia	Kyoto University; University of Miyazaki; University of Milano-Bicocca; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Fukami, H (corresponding author), Miyazaki Univ, Fac Agr, Dept Marine Biol & Environm Sci, Miyazaki 88921, Japan.	hirofukami@cc.miyazaki-u.ac.jp	Benzoni, Francesca/G-1304-2010	Benzoni, Francesca/0000-0001-8906-1309; Arrigoni, Roberto/0000-0002-6825-6331; Kitano, Yuko/0000-0001-6118-4884	Japan science society [23-515];  [223070033]	Japan science society; 	Financial support was provided by a grant to H. F. from Grant-in-Aid for Scientific Research (B) (No. 223070033) and by Sasagawa Science Research grant from the Japan science society (23-515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2011, Bulletin of Zoological Nomenclature, V68, P162; Arrigoni R, 2012, MOL PHYLOGENET EVOL, V65, P183, DOI 10.1016/j.ympev.2012.06.001; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; Basett-Smith PW, 1890, ANN MAG NAT HIST SER, V6, P353; Bedot M., 1907, Revue Suisse de Zoologie, V15; Benzoni F, 2007, CONTRIB ZOOL, V76, P35, DOI 10.1163/18759866-07601004; Benzoni F, 2012, SYST BIODIVERS, V10, P417, DOI 10.1080/14772000.2012.744369; Benzoni Francesca, 2012, Zootaxa, V3447, P56; Benzoni F, 2010, ZOOL J LINN SOC-LOND, V160, P421, DOI 10.1111/j.1096-3642.2010.00622.x; Bernard H. M., 1903, CATALOGUE MADREPORAR, V4, P1; Bernard HM, 1905, CATALOGUE MADREPORAR, V5, P1; Bernard HM, 1906, CATALOG MADREPORARIA, V6, P1; Bernard HN, 1906, CAT MADREPORARIAN CO, V6, P145; Bessat F, 2001, PALAEOGEOGR PALAEOCL, V175, P381, DOI 10.1016/S0031-0182(01)00381-9; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Budd AF, 2011, J MORPHOL, V272, P66, DOI 10.1002/jmor.10899; Budd AF, 2009, ACTA ZOOL-STOCKHOLM, V90, P142, DOI 10.1111/j.1463-6395.2008.00345.x; Claereboudt MR, 2004, ZOOTAXA, P1; Crossland C., 1952, Scientific Reports Great Barrier Reef Expedition, V6, P85; Dai C. F., 2009, SCLERACTINIA FAUNA T; Dana J. D., 1846, ZOOPHYTES US EXPLORI, V7; Eguchi M, 1965, NEW ILLUSTRATED ENCY, V1, P270; Eguchi M., 1968, HYDROCORALS SCLERACT; FAUSTINO LEOPOLDO A., 1927, BUR SCI MANILA P I MONOGR NO, V22, P1; Forsman ZH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-45; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; Golbuu Y, 2007, MAR BIOL, V152, P639, DOI 10.1007/s00227-007-0717-x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; HEYWARD AJ, 1985, HEREDITY, V55, P269, DOI 10.1038/hdy.1985.101; Hoffmeister J. E., 1925, PAPERS DEP MARINE BI, VXXII, P1; Hunter Cynthia L., 1997, P1599; Jameson SC, 2012, P BIOL SOC WASH, V125, P189, DOI 10.2988/11-07.1; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keshavmurthy S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01520; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kitahara MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011490; Kitano YF, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-25; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; McClanahan TR, 2009, GLOBAL CHANGE BIOL, V15, P1804, DOI 10.1111/j.1365-2486.2008.01799.x; Milne-Edwards H., 1851, ARCH MUSEUM HIST NAT, V5, P1; Nemenzo F, 1955, NATURAL APPL SCI B, V15, P3; Nishihira M., 1995, HERMATYPIC CORALS JA; Nylander J.A.A., 2004, MR MODELTEST V2; Ortmann A., 1888, Zoologische Jahrbuecher, Viii, P143; Peach MB, 1999, INVERTEBR BIOL, V118, P1, DOI 10.2307/3226906; Quelch JJ, 1886, REP SCI RESULTS VOYA, V16, P1, DOI DOI 10.5962/BHL.TITLE.11615; Reijnen BT, 2014, MOL PHYLOGENET EVOL, V70, P383, DOI 10.1016/j.ympev.2013.09.028; Romano SL, 2000, B MAR SCI, V67, P1043; ROSEN BR, 1969, SCIENCE, V166, P119, DOI 10.1126/science.166.3901.119; Saville-Kent W, 1891, REC AUST MUS, V1, P123; Saville-Kent William, 1893, GREAT BARRIER REEF A; Shearer TL, 2008, MOL ECOL RESOUR, V8, P247, DOI 10.1111/j.1471-8286.2007.01996.x; Stimson J, 2011, CORAL REEFS, V30, P133, DOI 10.1007/s00338-010-0672-8; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tseng CC, 2005, CORAL REEFS, V24, P502, DOI 10.1007/s00338-005-0499-x; van Oppen MJH, 2002, J MOL EVOL, V55, P1, DOI 10.1007/s00239-001-0075-0; Vaughan T.W., 1943, GEOLOGICAL SOC AM SP, V44, P1, DOI DOI 10.1130/SPE44-P1; Vaughan T. Wayland, 1907, Proceedings of the United States National Museum Smithsonian Institution Washington, V32; VAUGHAN TW, 1918, PAPERS DEP MARINE BI, V9, P51; Veron J.E.N., 1982, Australian Institute of Marine Science Monograph Series, V5, P1; VERON J E N, 1990, Galaxea, V9, P95; VERON J E N, 1985, Records of the Western Australian Museum, V12, P147; Veron JEN, 2002, AUSTR I MARINE SCI M, V11, P1; Veron JEN, 2000, CORALS WORLD, V3; Verrill AE., 1864, B MUS COMP ZO L HARV, V1, P29; Wallace CC, 2012, GEOL BELG, V15, P388; Wallace CC, 2011, J NAT HIST, V45, P1905, DOI 10.1080/00222933.2011.573098; Wallace Carden C., 2009, Memoirs of the Queensland Museum, V54, P1; Wei NWV, 2006, ZOOL STUD, V45, P404; Wells J. W., 1956, pf328; WELLS JW, 1968, PAC SCI, V22, P274; Wells JW, 1955, U QUEENSL PAP DEP GE, V4, P1; WoRMS Editorial Board, 2013, WORLD REGISTER MARIN; ZWICKL D.J., 2006, THESIS U TEXAS AUSTI	78	40	41	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98406	10.1371/journal.pone.0098406	http://dx.doi.org/10.1371/journal.pone.0098406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871224	Green Published, gold			2022-12-25	WOS:000336858300041
J	Lancha, A; Rodriguez, A; Catalan, V; Becerril, S; Sainz, N; Ramirez, B; Burrell, MA; Salvador, J; Fruhbeck, G; Gomez-Ambrosi, J				Lancha, Andoni; Rodriguez, Amaia; Catalan, Victoria; Becerril, Sara; Sainz, Neira; Ramirez, Beatriz; Burrell, Maria A.; Salvador, Javier; Fruehbeck, Gema; Gomez-Ambrosi, Javier			Osteopontin Deletion Prevents the Development of Obesity and Hepatic Steatosis via Impaired Adipose Tissue Matrix Remodeling and Reduced Inflammation and Fibrosis in Adipose Tissue and Liver in Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; OXIDATIVE STRESS; NONALCOHOLIC STEATOHEPATITIS; DEFICIENCY PROTECTS; PLASMA OSTEOPONTIN; ANGIOTENSIN-II; UP-REGULATION; EXPRESSION; LEPTIN; ACCUMULATION	Osteopontin (OPN) is a multifunctional extracellular matrix (ECM) protein involved in multiple physiological processes. OPN expression is dramatically increased in visceral adipose tissue in obesity and the lack of OPN protects against the development of insulin resistance and inflammation in mice. We sought to unravel the potential mechanisms involved in the beneficial effects of the absence of OPN. We analyzed the effect of the lack of OPN in the development of obesity and hepatic steatosis induced by a high-fat diet (HFD) using OPN-KO mice. OPN expression was upregulated in epididymal white adipose tissue (EWAT) and liver in wild type (WT) mice with HFD. OPN-KO mice had higher insulin sensitivity, lower body weight and fat mass with reduced adipose tissue ECM remodeling and reduced adipocyte size than WT mice under a HFD. Reduced MMP2 and MMP9 activity was involved in the decreased ECM remodeling. Crown-like structure number in EWAT as well as F4/80-positive cells and Emr1 expression in EWAT and liver increased with HFD, while OPN-deficiency blunted the increase. Moreover, our data show for the first time that OPN-KO under a HFD mice display reduced fibrosis in adipose tissue and liver, as well as reduced oxidative stress in adipose tissue. Gene expression of collagens Col1a1, Col6a1 and Col6a3 in EWAT and liver, as well as the profibrotic cytokine Tgfb1 in EWAT were increased with HFD, while OPN-deficiency prevented this increase. OPN deficiency prevented hepatic steatosis via reduction in the expression of molecules involved in the onset of fat accumulation such as Pparg, Srebf1, Fasn, Mogat1, Dgat2 and Cidec. Furthermore, OPN-KO mice exhibited higher body temperature and improved BAT function. The present data reveal novel mechanisms of OPN in the development of obesity, pointing out the inhibition of OPN as a promising target for the treatment of obesity and fatty liver.	[Lancha, Andoni; Rodriguez, Amaia; Catalan, Victoria; Becerril, Sara; Sainz, Neira; Ramirez, Beatriz; Fruehbeck, Gema; Gomez-Ambrosi, Javier] Univ Navarra Clin, Metab Res Lab, Pamplona, Spain; [Lancha, Andoni; Rodriguez, Amaia; Catalan, Victoria; Becerril, Sara; Ramirez, Beatriz; Burrell, Maria A.; Salvador, Javier; Fruehbeck, Gema; Gomez-Ambrosi, Javier] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Madrid, Spain; [Burrell, Maria A.] Univ Navarra, Dept Histol & Pathol, E-31080 Pamplona, Spain; [Salvador, Javier; Fruehbeck, Gema] Univ Navarra Clin, Dept Endocrinol & Nutr, Pamplona, Spain	University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Navarra; University of Navarra	Gomez-Ambrosi, J (corresponding author), Univ Navarra Clin, Metab Res Lab, Pamplona, Spain.	jagomez@unav.es	Burrell, María A/J-2570-2012; Gómez-Ambrosi, Javier/D-2984-2017; Sáinz, Neira/AAA-4624-2019; Burrell, María Ángela/AAB-5465-2022; Ramírez, Beatriz/I-1922-2017; Catalan, Victoria/H-3566-2017; Rodriguez, Amaia/D-3044-2019	Burrell, María A/0000-0002-8018-764X; Gómez-Ambrosi, Javier/0000-0001-5601-1604; Burrell, María Ángela/0000-0002-8018-764X; Ramírez, Beatriz/0000-0003-3381-7220; Catalan, Victoria/0000-0002-7513-7509; Becerril, Sara/0000-0002-3441-1970; Rodriguez, Amaia/0000-0002-2180-461X	Fondo de Investigacion Sanitaria-FEDER; Instituto de Salud Carlos III (ISCIII) [PI081146, PI11/02681, PI12/00515]; Departments of Health and Education of the Gobierno de Navarra of Spain [58/2011, res228/2008]	Fondo de Investigacion Sanitaria-FEDER(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Departments of Health and Education of the Gobierno de Navarra of Spain	This work was supported by grants from the Fondo de Investigacion Sanitaria-FEDER, Instituto de Salud Carlos III (ISCIII), (PI081146, PI11/02681, and PI12/00515); and from the Departments of Health (58/2011) and Education (res228/2008) of the Gobierno de Navarra of Spain. CIBERobn is an initiative of the ISCIII, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouadi M, 2013, P NATL ACAD SCI USA, V110, P8278, DOI 10.1073/pnas.1300492110; Becerril S, 2012, PHYSIOL GENOMICS, V44, P678, DOI 10.1152/physiolgenomics.00039.2012; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Borkham-Kamphorst E, 2011, LIVER INT, V31, P656, DOI 10.1111/j.1478-3231.2011.02495.x; Bouloumie A, 2001, DIABETES, V50, P2080, DOI 10.2337/diabetes.50.9.2080; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Catalan V, 2007, HORM METAB RES, V39, P495, DOI 10.1055/s-2007-982502; Catalan V, 2009, J MOL MED, V87, P803, DOI 10.1007/s00109-009-0486-8; Chapman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013959; CONTI M, 1991, CLIN CHEM, V37, P1273; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Divoux A, 2010, DIABETES, V59, P2817, DOI 10.2337/db10-0585; Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224; Fruhbeck G, 2009, TRENDS PHARMACOL SCI, V30, P387, DOI 10.1016/j.tips.2009.05.003; Fruhbeck G, 2005, NATURE, V438, P436, DOI 10.1038/438436b; FRUHBECK G, 1995, ANAL BIOCHEM, V225, P206, DOI 10.1006/abio.1995.1145; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Georgiadou P, 2008, EXPERT OPIN THER TAR, V12, P917, DOI 10.1517/14728222.12.8.917 ; Gerstenfeld LC, 1999, J BONE MINER RES, V14, P850, DOI 10.1359/jbmr.1999.14.6.850; Gomez-Ambrosi J, 2008, OBES SURG, V18, P1134, DOI 10.1007/s11695-008-9548-1; Gomez-Ambrosi J, 2007, J CLIN ENDOCR METAB, V92, P3719, DOI 10.1210/jc.2007-0349; Hadler-Olsen E, 2011, FEBS J, V278, P28, DOI 10.1111/j.1742-4658.2010.07920.x; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Hopps E, 2012, EUR J INTERN MED, V23, P99, DOI 10.1016/j.ejim.2011.09.012; Irita J, 2011, AM J PHYSIOL-RENAL, V301, pF833, DOI 10.1152/ajprenal.00557.2010; Kang HH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058417, 10.1371/journal.pone.0084097]; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kiefer FW, 2011, DIABETOLOGIA, V54, P2132, DOI 10.1007/s00125-011-2170-0; Kiefer FW, 2008, ENDOCRINOLOGY, V149, P1350, DOI 10.1210/en.2007-1312; Kiefer FW, 2010, DIABETES, V59, P935, DOI 10.2337/db09-0404; Kodama K, 2012, P NATL ACAD SCI USA, V109, P7049, DOI 10.1073/pnas.1114513109; Lai CF, 2006, CIRC RES, V98, P1479, DOI 10.1161/01.RES.0000227550.00426.60; Lancha A, 2012, NUTR RES REV, V25, P223, DOI 10.1017/S0954422412000145; Law IKM, 2010, DIABETES, V59, P872, DOI 10.2337/db09-1541; Lee YH, 2013, CELL METAB, V18, P355, DOI 10.1016/j.cmet.2013.08.003; Lima-Cabello E, 2011, CLIN SCI, V120, P239, DOI 10.1042/CS20100387; Liu H, 2010, CANCER LETT, V295, P27, DOI 10.1016/j.canlet.2010.02.012; Lo L, 2011, J HEPATOL, V55, P435, DOI 10.1016/j.jhep.2010.10.039; Matsui Y, 2004, HYPERTENSION, V43, P1195, DOI 10.1161/01.HYP.0000128621.68160.dd; Miao B, 2004, J LIPID RES, V45, P1410, DOI 10.1194/jlr.M300450-JLR200; Morales-Ibanez O, 2013, HEPATOLOGY, V58, P1742, DOI 10.1002/hep.26521; Muruzabal FJ, 2002, GEN COMP ENDOCR, V128, P149, DOI 10.1016/S0016-6480(02)00072-2; Nau K, 2008, J COMP PHYSIOL B, V178, P269, DOI 10.1007/s00360-007-0219-7; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Rittling SR, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001839; Rodriguez A, 2009, INT J OBESITY, V33, P541, DOI 10.1038/ijo.2009.40; Rodriguez A, 2011, J CLIN ENDOCR METAB, V96, pE586, DOI 10.1210/jc.2010-1408; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG264, DOI 10.1152/ajpgi.00002.2004; Sainz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029389; Sainz N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006808; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Syn WK, 2012, GUT, V61, P1323, DOI 10.1136/gutjnl-2011-301857; Zeyda M, 2011, ENDOCRINOLOGY, V152, P2219, DOI 10.1210/en.2010-1328; Zhang LJ, 2010, J CELL BIOCHEM, V110, P219, DOI 10.1002/jcb.22529	59	54	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98398	10.1371/journal.pone.0098398	http://dx.doi.org/10.1371/journal.pone.0098398			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871103	gold, Green Submitted, Green Published			2022-12-25	WOS:000336858300040
J	Chavez, O; Godinez, FA; Beltran, A; Garcia, A; Zenit, R				Chavez, Oscar; Godinez, Francisco A.; Beltran, Alberto; Garcia, Armando; Zenit, Roberto			A Conjugate Thermo-Electric Model for a Composite Medium	PLOS ONE			English	Article								Electrical transmission signals have been used for decades to characterize the internal structure of composite materials. We theoretically analyze the transmission of an electrical signal through a composite material which consists of two phases with different chemical compositions. We assume that the temperature of the biphasic system increases as a result of Joule heating and its electrical resistivity varies linearly with temperature; this last consideration leads to simultaneously study the electrical and thermal effects. We propose a nonlinear conjugate thermo-electric model, which is solved numerically to obtain the current density and temperature profiles for each phase. We study the effect of frequency, resistivities and thermal conductivities on the current density and temperature. We validate the prediction of the model with comparisons with experimental data obtained from rock characterization tests.	[Chavez, Oscar; Beltran, Alberto; Zenit, Roberto] Univ Nacl Autonoma Mexico, Inst Invest Mat, Ciudad Univ, Mexico City 04510, DF, Mexico; [Godinez, Francisco A.] Univ Nacl Autonoma Mexico, Inst Ingn, Mexico City 04510, DF, Mexico; [Garcia, Armando] Tecnol Aplicada Explorac & Prod Petrolera Inc, Polanco, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Zenit, R (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Mat, Ciudad Univ, Mexico City 04510, DF, Mexico.	zenit@unam.mx	Godínez, Francisco/GPS-5022-2022	Beltran, Alberto/0000-0003-3920-5217; Zenit, Roberto/0000-0002-2717-4954	CONACyT-Mexico through its SENER-HIDROCARBUROS program [143927]	CONACyT-Mexico through its SENER-HIDROCARBUROS program	This research was funded by CONACyT-Mexico through its SENER-HIDROCARBUROS program (grant number: 143927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal K. C., 2001, NEWNES POWER ENG SER, pxvi; Ahrens TJ., 1995, ROCK PHYS PHASE RELA, DOI 10.1029/RF003; Archie G. E., 1942, T AIME, V146; Borai AM, 1985, 60 ANN TECHN C EXH S; Brovelli A, 2010, GEOPHYS J INT, V180, P225, DOI [10.1111/j.1365-246X.2009.04415.x, 10.1111/J.1365-246X.2009.04415.X]; Chavez O, 2011, APPL THERMAL ENG, V31; Chui ST, 2013, ELECTROMAGNETIC BEHA, P105; Dongqing L., 2004, ELECTROKINETICS MICR; Endres AL, 2000, EXPLORATION GEOPHYS, V31; GHANDAKLY AA, 1990, IEEE T IND APPL, V26, P1043, DOI 10.1109/28.62385; Hunt, 2005, PERCOLATION THEORY F; Hussain S, 2003, JORNAL EUROPEAN CERA, V23; Jackson J., 1975, CLASSICAL ELECTRODYN; Kagawa Y, 2007, J MAT SCI, V42; Kakati BK, 2011, INT J HYDROGEN ENERG, V36, P14851, DOI 10.1016/j.ijhydene.2011.02.136; Katsube TJ, 2000, TECHNICAL REPORT; Laukaitis A, 2008, ACTA PHYS POLONICA A, V113; M'Peko JC, 2003, SOLID STATE IONICS, V156, P59, DOI 10.1016/S0167-2738(02)00611-2; Maciej M, 2012, AIP C P, P1453; Makoviny I, 2011, EUROPEAN J WOOD WOOD, V59; Ozisik M.N., 1993, HEAT CONDUCTION; Ozisik M. N, 1994, FINITE DIFFERENCE ME; Palacky G.J., 1987, ELECTROMAGNETIC METH, V1; Sahimi M., 2011, FLOW TRANSPORT POROU, V2nd rev. enlarged ed., DOI DOI 10.1002/9783527636693; Salem HS, 2001, ENERGY SOURCES, V23; Schwartz LM, 1994, PHYSICA A; Singh BP, 2011, J NANOPARTICLE RES, V13; Sung YK, 2002, MACROMOLECULAR RES, V10; Timofte C, 2013, COMPUT MATH APPL, V66, P1573, DOI 10.1016/j.camwa.2012.12.003; Wang M, 2009, APPL THERMAL ENG, V29; Wang Z, 1991, TECHNICAL REPORT; Yue WZ, 2013, GEOPHYS J INT, V195, P282, DOI 10.1093/gji/ggt231	32	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97895	10.1371/journal.pone.0097895	http://dx.doi.org/10.1371/journal.pone.0097895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867618	Green Published, Green Submitted, gold			2022-12-25	WOS:000336914100026
J	Kalpakci, KN; Brown, WE; Hu, JC; Athanasiou, KA				Kalpakci, Kerem N.; Brown, Wendy E.; Hu, Jerry C.; Athanasiou, Kyriacos A.			Cartilage Tissue Engineering Using Dermis Isolated Adult Stem Cells: The Use of Hypoxia during Expansion versus Chondrogenic Differentiation	PLOS ONE			English	Article							LOW-OXYGEN TENSION; INFRAPATELLAR FAT PAD; HUMAN MENISCUS CELLS; IN-VITRO; ARTICULAR-CARTILAGE; HYDROSTATIC-PRESSURE; STROMAL CELLS; COLLAGEN; CHONDROINDUCTION; PROLIFERATION	Dermis isolated adult stem (DIAS) cells, a subpopulation of dermis cells capable of chondrogenic differentiation in the presence of cartilage extracellular matrix, are a promising source of autologous cells for tissue engineering. Hypoxia, through known mechanisms, has profound effects on in vitro chondrogenesis of mesenchymal stem cells and could be used to improve the expansion and differentiation processes for DIAS cells. The objective of this study was to build upon the mechanistic knowledge of hypoxia and translate it to tissue engineering applications to enhance chondrogenic differentiation of DIAS cells through exposure to hypoxic conditions (5% O-2) during expansion and/or differentiation. DIAS cells were isolated and expanded in hypoxic (5% O2) or normoxic (20% O-2) conditions, then differentiated for 2 weeks in micromass culture on chondroitin sulfate-coated surfaces in both environments. Monolayer cells were examined for proliferation rate and colony forming efficiency. Micromasses were assessed for cellular, biochemical, and histological properties. Differentiation in hypoxic conditions following normoxic expansion increased per cell production of collagen type II 2.3 fold and glycosaminoglycans 1.2 fold relative to continuous normoxic culture (p<0.0001). Groups expanded in hypoxia produced 51% more collagen and 23% more GAGs than those expanded in normoxia (p<0.0001). Hypoxia also limited cell proliferation in monolayer and in 3D culture. Collectively, these data show hypoxic differentiation following normoxic expansion significantly enhances chondrogenic differentiation of DIAS cells, improving the potential utility of these cells for cartilage engineering.	[Kalpakci, Kerem N.] Medtron Spine & Biol, Memphis, TN USA; [Brown, Wendy E.; Hu, Jerry C.; Athanasiou, Kyriacos A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	University of California System; University of California Davis	Athanasiou, KA (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	athanasiou@ucdavis.edu			California Institute for Regenerative Medicine (CIRM) [TR3-05709]	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine)	This work was supported by California Institute for Regenerative Medicine (CIRM) grant #TR3-05709 (http://www.cirm.ca.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesida AB, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1929; Adesida AB, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt100; Adesida AB, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2267; AHRENS PB, 1977, DEV BIOL, V60, P69, DOI 10.1016/0012-1606(77)90110-5; Allen CB, 2001, AM J PHYSIOL-LUNG C, V281, pL1021, DOI 10.1152/ajplung.2001.281.4.L1021; Almarza AJ, 2004, ANN BIOMED ENG, V32, P2, DOI 10.1023/B:ABME.0000007786.37957.65; Aufderheide AC, 2007, TISSUE ENG, V13, P2195, DOI 10.1089/ten.2006.0291; Boraldi F, 2007, BBA-PROTEINS PROTEOM, V1774, P1402, DOI 10.1016/j.bbapap.2007.08.011; BRIGHTON CT, 1971, J BONE JOINT SURG AM, VA 53, P719, DOI 10.2106/00004623-197153040-00011; Buckley CT, 2010, OSTEOARTHR CARTILAGE, V18, P1345, DOI 10.1016/j.joca.2010.07.004; Chung HM, 2009, EXPERT OPIN BIOL TH, V9, P1499, DOI 10.1517/14712590903307362; Clewes O, 2011, STEM CELL REV REP, V7, P799, DOI 10.1007/s12015-011-9255-5; D'Ippolito G, 2006, BONE, V39, P513, DOI 10.1016/j.bone.2006.02.061; Deng Y, 2007, ARTHRITIS RHEUM-US, V56, P168, DOI 10.1002/art.22300; Diekman BO, 2009, TISSUE ENG A; Duval E, 2009, ARTHRITIS RHEUM-US, V60, P3038, DOI 10.1002/art.24851; Elder BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002341; Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270; FALANGA V, 1991, J INVEST DERMATOL, V97, P634, DOI 10.1111/1523-1747.ep12483126; Falanga V, 2002, J CELL PHYSIOL, V191, P42, DOI 10.1002/jcp.10065; FALANGA V, 1993, J CELL PHYSIOL, V157, P408, DOI 10.1002/jcp.1041570225; French MM, 2004, ANN BIOMED ENG, V32, P50, DOI 10.1023/B:ABME.0000007790.65773.e0; Fu WL, 2011, CHINESE MED J-PEKING, V124, P3959, DOI 10.3760/cma.j.issn.0366-6999.2011.23.022; Glowacki J, 2005, Orthod Craniofac Res, V8, P200, DOI 10.1111/j.1601-6343.2005.00333.x; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Hansen U, 2001, J BIOMECH, V34, P941, DOI 10.1016/S0021-9290(01)00050-1; HASELGROVE JC, 1993, AM J PHYSIOL, V265, pC497, DOI 10.1152/ajpcell.1993.265.2.C497; Hoben GA, 2008, BIOTECHNOL BIOENG, V100, P587, DOI 10.1002/bit.21768; Hoben GM, 2008, STEM CELLS, V26, P422, DOI 10.1634/stemcells.2007-0641; Hoben GM, 2009, STEM CELLS DEV, V18, P283, DOI 10.1089/scd.2008.0024; Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969; Kanichai M, 2008, J CELL PHYSIOL, V216, P708, DOI 10.1002/jcp.21446; Khan WS, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2211; Koay EJ, 2008, OSTEOARTHR CARTILAGE, V16, P1450, DOI 10.1016/j.joca.2008.04.007; Koay EJ, 2007, STEM CELLS, V25, P2183, DOI 10.1634/stemcells.2007-0105; Lavoie JF, 2009, STEM CELLS DEV, V18, P893, DOI 10.1089/scd.2008.0260; Lennon DP, 2001, J CELL PHYSIOL, V187, P345, DOI 10.1002/jcp.1081; Ma T, 2009, BIOTECHNOL PROGR, V25, P32, DOI 10.1002/btpr.128; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Mahmoudifar N, 2010, BIOMATERIALS, V31, P3858, DOI 10.1016/j.biomaterials.2010.01.090; Makris EA, 2013, OSTEOARTHR CARTILAGE, V21, P634, DOI 10.1016/j.joca.2013.01.007; Malladi P, 2007, TISSUE ENG, V13, P1159, DOI 10.1089/ten.2006.0265; Martin-Rendon E, 2007, STEM CELLS, V25, P1003, DOI 10.1634/stemcells.2006-0398; Mizuno S, 2005, CELLS TISSUES ORGANS, V180, P151, DOI 10.1159/000088243; Mizuno S, 1996, BIOMATERIALS, V17, P1819, DOI 10.1016/0142-9612(96)00041-5; Nicoll SB, 2001, CONNECT TISSUE RES, V42, P59, DOI 10.3109/03008200109014249; Oberringer M, 2005, HISTOCHEM CELL BIOL, V123, P595, DOI 10.1007/s00418-005-0782-5; Pacifici M, 2000, CONNECT TISSUE RES, V41, P175, DOI 10.3109/03008200009005288; Provot S, 2007, ANN NY ACAD SCI, V1117, P26, DOI 10.1196/annals.1402.076; Qu CJ, 2012, CELL TISSUE RES, V348, P109, DOI 10.1007/s00441-012-1366-z; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; Robins JC, 2005, BONE, V37, P313, DOI 10.1016/j.bone.2005.04.040; Sanchez-Adams J, 2012, BIOMATERIALS, V33, P109, DOI 10.1016/j.biomaterials.2011.09.038; Schipani E, 2005, SEMIN CELL DEV BIOL, V16, P539, DOI 10.1016/j.semcdb.2005.03.003; Siddiqui Aamir, 1996, Wound Repair and Regeneration, V4, P211, DOI 10.1046/j.1524-475X.1996.40207.x; Steinbrech DS, 1999, J SURG RES, V84, P127, DOI 10.1006/jsre.1999.5627; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; Vaculik C, 2012, J INVEST DERMATOL, V132, P563, DOI 10.1038/jid.2011.355; Wang DW, 2005, J CELL PHYSIOL, V204, P184, DOI 10.1002/jcp.20324; Xu Y, 2007, TISSUE ENG, V13, P2981, DOI 10.1089/ten.2007.0050	60	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98570	10.1371/journal.pone.0098570	http://dx.doi.org/10.1371/journal.pone.0098570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867063	Green Published, gold			2022-12-25	WOS:000336914100063
J	Matta-Camacho, E; Banerjee, S; Hughes, TS; Solt, LA; Wang, YJ; Burris, TP; Kojetin, DJ				Matta-Camacho, Edna; Banerjee, Subhashis; Hughes, Travis S.; Solt, Laura A.; Wang, Yongjun; Burris, Thomas P.; Kojetin, Douglas J.			Structure of REV-ERB beta Ligand-binding Domain Bound to a Porphyrin Antagonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COBALT-PROTOPORPHYRIN; TRANSCRIPTION FACTOR; ZINC-PROTOPORPHYRIN; SYNTHASE ACTIVITY; HEME OXYGENASE; CO-BINDING; ALPHA; DYNAMICS; MODULATION; EXPRESSION	REV-ERB alpha and REV-ERB beta are members of the nuclear receptor (NR) superfamily of ligand-regulated transcription factors that play important roles in the regulation of circadian physiology, metabolism, and immune function. Although the REV-ERBs were originally characterized as orphan receptors, recent studies have demonstrated that they function as receptors for heme. Here, we demonstrate that cobalt protoporphyrin IX (CoPP) and zinc protoporphyrin IX (ZnPP) are ligands that bind directly to the REV-ERBs. However, instead of mimicking the agonist action of heme, CoPP and ZnPP function as antagonists of REV-ERB function. This was unexpected because the only distinction between these ligands is the metal ion that is coordinated. To understand the structural basis by which REV-ERB beta can differentiate between a porphyrin agonist and antagonist, we characterized the interaction between REV-ERB beta with heme, CoPP, and ZnPP using biochemical and structural approaches, including x-ray crystallography and NMR. The crystal structure of CoPP-bound REV-ERB beta indicates only minor conformational changes induced byCoPPcompared with heme, including the porphyrin ring of CoPP, which adopts a planar conformation as opposed to the puckered conformation observed in the heme-bound REV-ERB beta crystal structure. Thus, subtle changes in the porphyrin metal center and ring conformation may influence the agonist versus antagonist action of porphyrins and when considered with other studies suggest that gas binding to the iron metal center heme may drive alterations in REV-ERB activity.	[Matta-Camacho, Edna; Banerjee, Subhashis; Hughes, Travis S.; Solt, Laura A.; Wang, Yongjun; Burris, Thomas P.; Kojetin, Douglas J.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33418 USA; [Wang, Yongjun; Burris, Thomas P.] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63103 USA	Scripps Research Institute; Saint Louis University	Burris, TP (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 South Grand Blvd, St Louis, MO 63104 USA.	burristp@slu.edu; dkojetin@scripps.edu	Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449; Hughes, Travis/0000-0002-5764-5884	National Institutes of Health [DK080201, DK101871]; James and Esther King Biomedical Research Program from the Florida Department of Health Grant [1KN-09]; Scripps Research Institute; National Institutes of Health National Research Service Award [DK097890, DK088499]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101871, F32DK097890, R01DK080201, F32DK088499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James and Esther King Biomedical Research Program from the Florida Department of Health Grant; Scripps Research Institute; National Institutes of Health National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants DK080201 (to T. P. B.) and DK101871 (to D. J. K.). This work was also supported by the James and Esther King Biomedical Research Program from the Florida Department of Health Grant 1KN-09 (to D. J. K.) and start-up funds provided by The Scripps Research Institute (to D. J. K.).; Recipient of National Institutes of Health National Research Service Award DK097890.; Recipient of National Institutes of Health National Research Service Award DK088499.	Afonine PV, 2010, ACTA CRYSTALLOGR D, V66, P1153, DOI 10.1107/S0907444910026582; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BLOUGH NV, 1980, J AM CHEM SOC, V102, P5683, DOI 10.1021/ja00537a050; Brucker EA, 1996, J BIOL CHEM, V271, P25419, DOI 10.1074/jbc.271.41.25419; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; Csongradi E, 2012, INT J OBESITY, V36, P244, DOI 10.1038/ijo.2011.78; Degtyarenko I, 2006, BIOPHYS J, V91, P2024, DOI 10.1529/biophysj.106.083048; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; DUMAS B, 1994, MOL ENDOCRINOL, V8, P996, DOI 10.1210/me.8.8.996; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GALBRAITH RA, 1990, PHARMACOLOGY, V41, P292, DOI 10.1159/000138738; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Gupta N, 2011, J BIOL CHEM, V286, P4392, DOI 10.1074/jbc.M110.193466; Hao B, 2002, BIOCHEMISTRY-US, V41, P12952, DOI 10.1021/bi020144l; HOFFMAN BM, 1970, COBOGLOBINS OXYGEN C; Hughes TS, 2012, STRUCTURE, V20, P139, DOI 10.1016/j.str.2011.10.018; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kojetin D, 2011, ACS CHEM BIOL, V6, P131, DOI 10.1021/cb1002575; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; Labbe RF, 1999, CLIN CHEM, V45, P2060; LAZAR MA, 1989, MOL CELL BIOL, V9, P1128, DOI 10.1128/MCB.9.3.1128; Lu JY, 2006, BIOCHEMISTRY-US, V45, P1629, DOI 10.1021/bi051474j; MAINES MD, 1981, BIOCHIM BIOPHYS ACTA, V673, P339, DOI 10.1016/0304-4165(81)90465-7; Marden MC, 2000, FEBS LETT, V472, P221, DOI 10.1016/S0014-5793(00)01423-X; Marvin KA, 2009, BIOCHEMISTRY-US, V48, P7056, DOI 10.1021/bi900697c; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meng QJ, 2008, J CELL SCI, V121, P3629, DOI 10.1242/jcs.035048; Olea C, 2008, ACS CHEM BIOL, V3, P703, DOI 10.1021/cb800185h; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phelan CA, 2010, NAT STRUCT MOL BIOL, V17, P808, DOI 10.1038/nsmb.1860; Puranik M, 2004, J BIOL CHEM, V279, P21096, DOI 10.1074/jbc.M400613200; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Renaud JP, 2000, MOL ENDOCRINOL, V14, P700, DOI 10.1210/me.14.5.700; Rodgers KR, 2005, J INORG BIOCHEM, V99, P963, DOI 10.1016/j.jinorgbio.2005.02.016; Savkur RS, 2004, VITAM HORM, V68, P145; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Shelver D, 1997, P NATL ACAD SCI USA, V94, P11216, DOI 10.1073/pnas.94.21.11216; Singh S, 2009, J INORG BIOCHEM, V103, P689, DOI 10.1016/j.jinorgbio.2009.01.009; SMITH A, 1993, J BIOL CHEM, V268, P7365; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Solt LA, 2011, FUTURE MED CHEM, V3, P623, DOI [10.4155/FMC.11.9, 10.4155/fmc.11.9]; Tsai AL, 2011, J BIOL CHEM, V286, P43182, DOI 10.1074/jbc.M111.290304; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; Weeks CL, 2009, J AM CHEM SOC, V131, P12809, DOI 10.1021/ja904468w; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yin Lei, 2010, Nucl Recept Signal, V8, pe001, DOI 10.1621/nrs.08001; YONETANI T, 1972, J BIOL CHEM, V247, P2447; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06	52	19	20	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20054	20066		10.1074/jbc.M113.545111	http://dx.doi.org/10.1074/jbc.M113.545111			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24872411	Green Published, hybrid			2022-12-25	WOS:000339395200020
J	Shenkin, SD; Watson, R; Laidlaw, K; Starr, JM; Deary, IJ				Shenkin, Susan D.; Watson, Roger; Laidlaw, Ken; Starr, John M.; Deary, Ian J.			The Attitudes to Ageing Questionnaire: Mokken Scaling Analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; OLDER-ADULTS; RELIABILITY; VALIDITY; PEOPLE; SAMPLE; AAQ; IRT	Background: Hierarchical scales are useful in understanding the structure of underlying latent traits in many questionnaires. The Attitudes to Ageing Questionnaire (AAQ) explored the attitudes to ageing of older people themselves, and originally described three distinct subscales: (1) Psychosocial Loss (2) Physical Change and (3) Psychological Growth. This study aimed to use Mokken analysis, a method of Item Response Theory, to test for hierarchies within the AAQ and to explore how these relate to underlying latent traits. Methods: Participants in a longitudinal cohort study, the Lothian Birth Cohort 1936, completed a cross-sectional postal survey. Data from 802 participants were analysed using Mokken Scaling analysis. These results were compared with factor analysis using exploratory structural equation modelling. Results: Participants were 51.6% male, mean age 74.0 years (SD 0.28). Three scales were identified from 18 of the 24 items: two weak Mokken scales and one moderate Mokken scale. (1) 'Vitality' contained a combination of items from all three previously determined factors of the AAQ, with a hierarchy from physical to psychosocial; (2) 'Legacy' contained items exclusively from the Psychological Growth scale, with a hierarchy from individual contributions to passing things on; (3) 'Exclusion' contained items from the Psychosocial Loss scale, with a hierarchy from general to specific instances. All of the scales were reliable and statistically significant with 'Legacy' showing invariant item ordering. The scales correlate as expected with personality, anxiety and depression. Exploratory SEM mostly confirmed the original factor structure. Conclusions: The concurrent use of factor analysis and Mokken scaling provides additional information about the AAQ. The previously-described factor structure is mostly confirmed. Mokken scaling identifies a new factor relating to vitality, and a hierarchy of responses within three separate scales, referring to vitality, legacy and exclusion. This shows what older people themselves consider important regarding their own ageing.	[Shenkin, Susan D.; Starr, John M.] Univ Edinburgh, Dept Geriatr Med, Edinburgh, Midlothian, Scotland; [Shenkin, Susan D.; Starr, John M.; Deary, Ian J.] Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Watson, Roger] Univ Hull, Fac Hlth & Social Care, Kingston Upon Hull HU6 7RX, N Humberside, England; [Laidlaw, Ken] Univ E Anglia, Dept Clin Psychol, Norwich NR4 7TJ, Norfolk, England; [Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Hull; University of East Anglia; University of Edinburgh	Shenkin, SD (corresponding author), Univ Edinburgh, Dept Geriatr Med, Edinburgh, Midlothian, Scotland.	susan.shenkin@ed.ac.uk	Deary, Ian J/C-6297-2009; Shenkin, Susan/GWZ-3174-2022; Watson, Roger/A-2969-2009	Deary, Ian J/0000-0002-1733-263X; Watson, Roger/0000-0001-8040-7625; Shenkin, Susan/0000-0001-7375-4776	British Geriatrics Society Scottish Branch; BBSRC; EPSRC; MRC; MRC [G0700704] Funding Source: UKRI; Medical Research Council [G0700704, MR/K026992/1] Funding Source: researchfish	British Geriatrics Society Scottish Branch; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a start up grant from the British Geriatrics Society Scottish Branch. The University of Edinburgh Centre for Cognitive Aging and Cognitive Epidemiology is part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698). Funding from the BBSRC, EPSRC, ESRC and MRC is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedford A, 2011, PERS INDIV DIFFER, V50, P38, DOI 10.1016/j.paid.2010.08.017; Bryant C, 2012, INT PSYCHOGERIATR, V24, P1674, DOI 10.1017/S1041610212000774; Byrne B. M., 2001, STRUCTURAL EQUATION; Chachamovich E, 2008, GERONTOLOGIST, V48, P593, DOI 10.1093/geront/48.5.593; Deary IJ, 2012, INT J EPIDEMIOL, V41, P1576, DOI 10.1093/ije/dyr197; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; DEGRUIJTER DNM, 1994, APPL PSYCH MEAS, V18, P27, DOI 10.1177/014662169401800103; Diehl MK, 2010, J GERONTOL B, V65B, DOI 10.1093/geronb/gbp110; Fry PS, 2000, INT J AGING HUM DEV, V50, P361, DOI 10.2190/DD41-W8F4-W6LK-FY8Q; H.M.S.O, 1956, CENSUS 1951 CLASSIFI; Hempker BT, 1995, APPL PSYCH MEAS, V19, P337; House of Lords Select Committee on Public Service and Demographic Change, 2013, 140 HL; Kalfoss MH, 2010, SCAND J CARING SCI, V24, P75, DOI 10.1111/j.1471-6712.2010.00786.x; KOGAN N, 1961, J ABNORM SOC PSYCH, V62, P616, DOI 10.1037/h0048356; Kuijpers RE, 2013, SOCIOL METHODOL, V43, P42, DOI 10.1177/0081175013481958; Laidlaw K, 2007, INT J GERIATR PSYCH, V22, P367, DOI 10.1002/gps.1683; LAWTON MP, 1975, J GERONTOL, V30, P85, DOI 10.1093/geronj/30.1.85; Levy BR, 2003, J GERONTOL B-PSYCHOL, V58, pP203, DOI 10.1093/geronb/58.4.P203; Lucas-Carrasco R, 2013, INT PSYCHOGERIATR, V25, P490, DOI 10.1017/S1041610212001809; Meijer RR, 2012, EDUC PSYCHOL MEAS, V72, P589, DOI 10.1177/0013164411429344; MEIJER RR, 1990, APPL PSYCH MEAS, V14, P283, DOI 10.1177/014662169001400306; Meijer RR, 2001, PSYCHOL METHODS, V9, P351; Molenaar I. W., 2000, MSP5 WINDOWS PROGRAM; Mooij T, 2012, J PSYCHOEDUC ASSESS, V30, P496, DOI 10.1177/0734282912439387; Nader IW, 2012, ARCH SUICIDE RES, V16, P226, DOI 10.1080/13811118.2012.695271; Office for National Statistics, 2011, NAT POP PROJ 2010 BA; R Foundation for Statistical Computing, 2012, LANG ENV STAT COMP; Scheibe S, 2010, J GERONTOL B-PSYCHOL, V65, P135, DOI 10.1093/geronb/gbp132; Shenkin SD, 2014, INT PSYCHOGERIATR, V26, P1417, DOI 10.1017/S1041610214000301; Sijtsma K, 1996, BRIT J MATH STAT PSY, V49, P79, DOI 10.1111/j.2044-8317.1996.tb01076.x; Sijtsma K, 2011, PERS INDIV DIFFER, V50, P31, DOI 10.1016/j.paid.2010.08.016; Stuart-Hamilton I, 2000, EDUC GERONTOL, V26, P37, DOI 10.1080/036012700267385; United Nations Department of Economic and Social Affairs Population Division, 2011, WORLD POP PROSP 2010, VII; van der Ark L. A., 2007, J STAT SOFTW, V20, P1, DOI DOI 10.18637/JSS.V020.I11; van Schuur WH, 2003, POLIT ANAL, V11, P139, DOI 10.1093/pan/mpg002; Watson R, 2008, PSYCHOL MED, V38, P575, DOI 10.1017/S003329170800281X; Watson R, 2014, PERS INDIV DIFFER, V66, P74, DOI 10.1016/j.paid.2014.03.017; Watson R, 2012, J CLIN NURS, V21, P2736, DOI 10.1111/j.1365-2702.2011.03893.x	39	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e99100	10.1371/journal.pone.0099100	http://dx.doi.org/10.1371/journal.pone.0099100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24892302	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400125
J	Hamilton, ST; Milbradt, J; Marschall, M; Rawlinson, WD				Hamilton, Stuart T.; Milbradt, Jens; Marschall, Manfred; Rawlinson, William D.			Human Cytomegalovirus Replication Is Strictly Inhibited by siRNAs Targeting UL54, UL97 or UL122/123 Gene Transcripts	PLOS ONE			English	Article							COMPOUND AIC246 LETERMOVIR; IMMEDIATE-EARLY PROMOTER; EFFICIENT INHIBITION; DNA-REPLICATION; IN-VITRO; EXPRESSION; CELL; INTERFERENCE; INFECTION; PROTEINS	Human cytomegalovirus (HCMV) causes severe sequelae in immunocompromised hosts. Current antiviral therapies have serious adverse effects, with treatment in many clinical settings problematic, making new therapeutic approaches necessary. We examined the in vitro efficacy of small interfering RNAs (siRNAs) targeting the HCMV gene transcripts UL54 (DNA polymerase), UL97 (protein kinase) and UL122/123 (immediate-early proteins) as inhibitors of viral protein expression and virus replication in cell cultures. Two siRNAs for each HCMV target (designated A and B) were assessed for inhibition efficacy using western blot and standard plaque assays. Continuous human embryonic kidney 293T cells were treated with HCMV or non-specific scrambled (siSc) siRNA followed by transfection with plasmids expressing the target transcripts. Human MRC-5 fibroblasts were HCMV-siRNA or siSc treated, infected with HCMV strain AD169 (1 pfu/cell) and HCMV immediate-early (IE1p72 and IE2p86), early (pp65), early-late (pUL97) and true late (MCP) protein and virus progeny production measured during a single round of replication. Concordant results showed siUL54B, siUL97A and siUL122B displayed the most potent inhibitory effects with a reduction of 92.7%, 99.6% and 93.7% in plasmid protein expression, 65.9%, 58.1% and 64.8% in total HCMV protein expression and 97.2%, 96.2% and 94.3% (p < 0.0001) in viral progeny production respectively. Analysing the siRNA inhibitory effects during multiple rounds of HCMV replication at a multiplicity of infection of 0.001 pfu/cell, siUL54B, siUL97A and siUL122B treatment resulted in a reduction of 80.0%, 59.6% and 84.5% in total HCMV protein expression, 52.9%, 49.2% and 58.3% in number of cells infected and 98.5%, 91.4% and 99.1%(p < 0.0001) in viral progeny production at 7 dpi respectively. These results suggest potential in vivo siRNA therapies targeting the HCMV gene transcripts UL54, UL97 and UL122/123 would be highly effective, however, the antiviral efficacy of siRNAs targeting UL97 may be more highly dependent on viral load and methods of administration.	[Hamilton, Stuart T.; Rawlinson, William D.] Prince Wales Hosp, SEALS Microbiol, Div Virol, Sydney, NSW, Australia; [Hamilton, Stuart T.; Rawlinson, William D.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Rawlinson, William D.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Milbradt, Jens; Marschall, Manfred] Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany	University of New South Wales Sydney; University of New South Wales Sydney; University of Erlangen Nuremberg	Rawlinson, WD (corresponding author), Prince Wales Hosp, SEALS Microbiol, Div Virol, Sydney, NSW, Australia.	w.rawlinson@unsw.edu.au		Rawlinson, William/0000-0003-0988-7827; Hamilton, Stuart/0000-0002-2170-4889; Milbradt, Jens/0000-0003-2172-7471	Stillbirth Foundation Australia; NHMRC [APP1045989]; Deutsche Forschungsgemeinschaft [SFB796, C3]; DAAD/Go8 [54390135]	Stillbirth Foundation Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DAAD/Go8(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by grants from the Stillbirth Foundation Australia (http://www.stillbirthfoundation.org.au), the NHMRC (APP1045989), the Deutsche Forschungsgemeinschaft SFB796 (grant C3) and DAAD/Go8 (grant 54390135), support which is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 1999, J VIROL, V73, P10458, DOI 10.1128/JVI.73.12.10458-10471.1999; Bai ZQ, 2010, BIOSCI BIOTECH BIOCH, V74, P1368, DOI 10.1271/bbb.90966; Bigley TM, 2013, J VIROL, V87, P7393, DOI 10.1128/JVI.02825-12; Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894; Chou SW, 2006, ANTIMICROB AGENTS CH, V50, P2557, DOI 10.1128/AAC.00207-06; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315; Devi GR, 2006, CANCER GENE THER, V13, P819, DOI 10.1038/sj.cgt.7700931; Duan QJ, 2009, J BASIC MICROB, V49, P531, DOI 10.1002/jobm.200800364; E XF, 2012, J VIROL, V86, P5660, DOI 10.1128/JVI.06338-11; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873; Goldner T, 2011, J VIROL, V85, P10884, DOI 10.1128/JVI.05265-11; Graf L, 2013, VIRUSES-BASEL, V5, P3213, DOI 10.3390/v5123213; Hamilton ST, 2013, J GEN VIROL, V94, P2495, DOI 10.1099/vir.0.052878-0; Hamilton ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052899; Hertel L, 2007, PLOS PATHOG, V3, P14, DOI 10.1371/journal.ppat.0030006; Isomura H, 2004, J VIROL, V78, P12788, DOI 10.1128/JVI.78.23.12788-12799.2004; Isomura H, 2008, J VIROL, V82, P1638, DOI 10.1128/JVI.01917-07; Kapadia SB, 2003, P NATL ACAD SCI USA, V100, P2014, DOI 10.1073/pnas.252783999; Kerry JA, 1996, J VIROL, V70, P373, DOI 10.1128/JVI.70.1.373-382.1996; Lischka P, 2010, ANTIMICROB AGENTS CH, V54, P1290, DOI 10.1128/AAC.01596-09; Marchini A, 2001, J VIROL, V75, P1870, DOI 10.1128/JVI.75.4.1870-1878.2001; Marschall M, 2012, ANTIMICROB AGENTS CH, V56, P1135, DOI 10.1128/AAC.05908-11; Marschall M, 2011, ADV VIRUS RES, V80, P69, DOI 10.1016/B978-0-12-385987-7.00004-X; Nekhai S, 2006, CURR OPIN MOL THER, V8, P52; Renzette N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003735; Renzette N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001344; Sadanari H, 2005, ARCH VIROL, V150, P1763, DOI 10.1007/s00705-005-0559-0; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Shin MC, 2006, ACTA VIROL, V50, P263; Sinclair J, 2006, J GEN VIROL, V87, P1763, DOI 10.1099/vir.0.81891-0; Tao R, 2008, CURR MICROBIOL, V57, P395, DOI 10.1007/s00284-008-9210-0; Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085; Wang KZ, 2013, ACTA BIOCH BIOPH SIN, V45, P401, DOI 10.1093/abbs/gmt025; Wiebusch L, 2004, J GEN VIROL, V85, P179, DOI 10.1099/vir.0.19453-0; Wu J, 2004, EXPERT OPIN BIOL TH, V4, P1649, DOI 10.1517/14712598.4.10.1649; Zheng ZM, 2005, ANN NY ACAD SCI, V1058, P105, DOI 10.1196/annals.1359.019	38	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97231	10.1371/journal.pone.0097231	http://dx.doi.org/10.1371/journal.pone.0097231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887060	gold, Green Published, Green Submitted			2022-12-25	WOS:000336956300014
J	Rosa-Ribeiro, R; Nishan, U; Vidal, RO; Barbosa, GO; Reis, LO; Cesar, CL; Carvalho, HF				Rosa-Ribeiro, Rafaela; Nishan, Umar; Vidal, Ramon Oliveira; Barbosa, Guilherme Oliveira; Reis, Leonardo Oliveira; Cesar, Carlos Lenz; Carvalho, Hernandes F.			Transcription Factors Involved in Prostate Gland Adaptation to Androgen Deprivation	PLOS ONE			English	Article							VENTRAL PROSTATE; B-MYB; PROGRAMMED DEATH; CELL-CYCLE; KAPPA-B; RECEPTOR; CANCER; EXPRESSION; APOPTOSIS; PROLIFERATION	Androgens regulate prostate physiology, and exert their effects through the androgen receptor. We hypothesized that androgen deprivation needs additional transcription factors to orchestrate the changes taking place in the gland after castration and for the adaptation of the epithelial cells to the androgen-deprived environment, ultimately contributing to the origin of castration-resistant prostate cancer. This study was undertaken to identify transcription factors that regulate gene expression after androgen deprivation by castration (Cas). For the sake of comparison, we extended the analysis to the effects of administration of a high dose of 17 beta-estradiol (E2) and a combination of both (Cas+ E2). We approached this by (i) identifying gene expression profiles and enrichment terms, and by searching for transcription factors in the derived regulatory pathways; and (ii) by determining the density of putative transcription factor binding sites in the proximal promoter of the 10 most up- or down-regulated genes in each experimental group in comparison to the controls Gapdh and Tbp7. Filtering and validation confirmed the expression and localized EVI1 (Mecom), NFY, ELK1, GATA2, MYBL1, MYBL2, and NFkB family members (NFkB1, NFkB2, REL, RELA and RELB) in the epithelial and/or stromal cells. These transcription factors represent major regulators of epithelial cell survival and immaturity as well as an adaptation of the gland as an immune barrier in the absence of functional stimulation by androgens. Elk1 was expressed in smooth muscle cells and was up-regulated after day 4. Evi1 and Nfy genes are expressed in both epithelium and stroma, but were apparently not affected by androgen deprivation.	[Rosa-Ribeiro, Rafaela; Nishan, Umar; Barbosa, Guilherme Oliveira; Carvalho, Hernandes F.] Univ Estadual Campinas, Dept Struct & Funct Biol, Sao Paulo, Brazil; [Vidal, Ramon Oliveira] Natl Ctr Res Energy & Mat, Lab Bioinformat, Sao Paulo, Brazil; [Reis, Leonardo Oliveira] Univ Estadual Campinas, Div Urol, Sao Paulo, Brazil; [Cesar, Carlos Lenz] Univ Estadual Campinas, Dept Quantum Phys, Sao Paulo, Brazil; [Cesar, Carlos Lenz; Carvalho, Hernandes F.] Univ Estadual Campinas, Natl Inst Photon Appl Cell Biol INFABiC, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas	Carvalho, HF (corresponding author), Univ Estadual Campinas, Dept Struct & Funct Biol, Sao Paulo, Brazil.	hern@unicamp.br	Lenz Cesar, Carlos/F-2442-2018; Barbosa, Guilherme Oliveira/AAB-6855-2019; MSc, Leonardo O. Reis MD/B-3652-2011	Lenz Cesar, Carlos/0000-0001-5573-9636; Barbosa, Guilherme Oliveira/0000-0002-5881-0896; MSc, Leonardo O. Reis MD/0000-0003-2092-414X; da Rosa Ribeiro, Rafaela/0000-0003-1297-2205	FAPESP [2009/16150-6]; CNPq	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by grants from FAPESP (Grant nr 2009/16150-6) and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonioli E, 2004, J ANDROL, V25, P50; Asirvatham AJ, 2006, ENDOCRINOLOGY, V147, P257, DOI 10.1210/en.2005-0942; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Bard-Chapeau EA, 2012, P NATL ACAD SCI USA, V109, P2168, DOI 10.1073/pnas.1119229109; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; BERGES RR, 1993, P NATL ACAD SCI USA, V90, P8910, DOI 10.1073/pnas.90.19.8910; Bohm M, 2009, ONCOGENE, V28, P3847, DOI 10.1038/onc.2009.243; Ceribelli M, 2006, CELL CYCLE, V5, P1102, DOI 10.4161/cc.5.10.2777; Culig Z, 2012, WORLD J UROL, V30, P297, DOI 10.1007/s00345-011-0797-6; Desai KV, 2004, MOL ENDOCRINOL, V18, P2895, DOI 10.1210/me.2004-0033; Duan RQ, 2001, J BIOL CHEM, V276, P11590, DOI 10.1074/jbc.M005492200; Edwards J, 2003, CLIN CANCER RES, V9, P5271; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fridmann-Sirkis Y, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-18; FURUYA Y, 1993, ENDOCRINOLOGY, V133, P2660, DOI 10.1210/en.133.6.2660; GARCIA JA, 1992, P NATL ACAD SCI USA, V89, P9372, DOI 10.1073/pnas.89.20.9372; Garcia-Florez M, 2005, BRAZ J MED BIOL RES, V38, P487, DOI 10.1590/S0100-879X2005000400002; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; GONDA TJ, 1984, NATURE, V310, P249, DOI 10.1038/310249a0; Grassilli E, 1999, CANCER RES, V59, P2451; Griekspoor A, 2007, NUCL RECEPT SIGNAL, V5, P1; Hasan RN, 2008, CIRC RES, V102, P42, DOI 10.1161/CIRCRESAHA.107.155143; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Hsiao PW, 1999, J BIOL CHEM, V274, P22373, DOI 10.1074/jbc.274.32.22373; JANKNECHT R, 1992, NUCLEIC ACIDS RES, V20, P3317, DOI 10.1093/nar/20.13.3317; Jia L, 2004, CANCER RES, V64, P2619, DOI 10.1158/0008-5472.CAN-03-3486; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; LEAV I, 1989, PROSTATE, V15, P23, DOI 10.1002/pros.2990150104; Leimgruber C, 2013, J CELL PHYSIOL, V228, P1551, DOI 10.1002/jcp.24314; Leimgruber C, 2011, PROSTATE, V71, P1097, DOI 10.1002/pros.21322; Lim KC, 2012, J CLIN INVEST, V122, P3705, DOI 10.1172/JCI61619; Louie MC, 2003, P NATL ACAD SCI USA, V100, P2226, DOI 10.1073/pnas.0437824100; Matsui T, 2004, J BIOL CHEM, V279, P25093, DOI 10.1074/jbc.M403232200; Miao RY, 2011, CANCER RES, V71, P7029, DOI 10.1158/0008-5472.CAN-11-1015; Mirosevich J, 1999, J ENDOCRINOL, V162, P341, DOI 10.1677/joe.0.1620341; Miyamoto H, 2004, PROSTATE, V61, P332, DOI 10.1002/pros.20115; Mori K, 2002, FEBS LETT, V520, P127, DOI 10.1016/S0014-5793(02)02803-X; Nantermet PV, 2004, J BIOL CHEM, V279, P1310, DOI 10.1074/jbc.M310206200; NEUMANN F, 1986, J STEROID BIOCHEM, V25, P885, DOI 10.1016/0022-4731(86)90320-1; Otto-Duessel M, 2012, ENDOCR RES, V37, P203, DOI 10.3109/07435800.2012.668254; Pang ST, 2002, ENDOCRINOLOGY, V143, P4897, DOI 10.1210/en.2002-220327; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Peterziel H, 1999, ONCOGENE, V18, P6322, DOI 10.1038/sj.onc.1203032; PRINS GS, 1991, ENDOCRINOLOGY, V129, P3187, DOI 10.1210/endo-129-6-3187; Quintar AA, 2012, INT J ANDROL, V35, P845, DOI 10.1111/j.1365-2605.2012.01288.x; Robinson C, 1996, ONCOGENE, V12, P1855; Sala A, 1997, P NATL ACAD SCI USA, V94, P532, DOI 10.1073/pnas.94.2.532; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Sharma NL, 2013, CANCER CELL, V23, P35, DOI 10.1016/j.ccr.2012.11.010; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; Srivastava SK, 2012, CARCINOGENESIS, V33, P1149, DOI 10.1093/carcin/bgs134; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Uramoto H, 2004, J CELL SCI, V117, P5323, DOI 10.1242/jcs.01384; Vilamaior PSL, 2000, PROSTATE, V45, P253; Wang QB, 2002, J BIOL CHEM, V277, P42852, DOI 10.1074/jbc.M206061200; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang Z, 1997, P NATL ACAD SCI USA, V94, P12999, DOI 10.1073/pnas.94.24.12999; Yeh HY, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-70; Zhang GJ, 1998, ONCOL REP, V5, P1211	61	17	17	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97080	10.1371/journal.pone.0097080	http://dx.doi.org/10.1371/journal.pone.0097080			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886974	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300012
J	Takebayashi, H; Yamamoto, N; Umino, A; Nishikawa, T				Takebayashi, Hironao; Yamamoto, Naoki; Umino, Asami; Nishikawa, Toru			Identification of Developmentally Regulated PCP-Responsive Non-Coding RNA, prt6, in the Rat Thalamus	PLOS ONE			English	Article							INDUCED C-FOS; MICRORNA EXPRESSION; PREFRONTAL CORTEX; NMDA RECEPTOR; SAP97 GENE; SCHIZOPHRENIA; PHENCYCLIDINE; PROTEIN; PATTERNS; ABNORMALITIES	Schizophrenia and similar psychoses induced by NMDA-type glutamate receptor antagonists, such as phencyclidine (PCP) and ketamine, usually develop after adolescence. Moreover, adult-type behavioral disturbance following NMDA receptor antagonist application in rodents is observed after a critical period at around 3 postnatal weeks. These observations suggest that the schizophrenic symptoms caused by and psychotomimetic effects of NMDA antagonists require the maturation of certain brain neuron circuits and molecular networks, which differentially respond to NMDA receptor antagonists across adolescence and the critical period. From this viewpoint, we have identified a novel developmentally regulated phencyclidine-responsive transcript from the rat thalamus, designated as prt6, as a candidate molecule involved in the above schizophrenia-related systems using a DNA microarray technique. The transcript is a non-coding RNA that includes sequences of at least two microRNAs, miR132 and miR212, and is expressed strongly in the brain and testis, with trace or non-detectable levels in the spleen, heart, liver, kidney, lung and skeletal muscle, as revealed by Northern blot analysis. The systemic administration of PCP (7.5 mg/kg, subcutaneously (s.c.)) significantly elevated the expression of prt6 mRNA in the thalamus at postnatal days (PD) 32 and 50, but not at PD 8, 13, 20, or 24 as compared to saline-treated controls. At PD 50, another NMDA receptor antagonist, dizocilpine (0.5 mg/kg, s.c.), and a schizophrenomimetic dopamine agonist, methamphetamine (4.8 mg/kg, s.c.), mimicked a significant increase in the levels of thalamic prt6 mRNAs, while a D2 dopmamine receptor antagonist, haloperidol, partly inhibited the increasing influence of PCP on thalamic prt6 expression without its own effects. These data indicate that prt6 may be involved in the pathophysiology of the onset of drug-induced schizophrenia-like symptoms and schizophrenia through the possible dysregulation of target genes of the long non-coding RNA or microRNAs in the transcript.	[Takebayashi, Hironao; Yamamoto, Naoki; Umino, Asami; Nishikawa, Toru] Tokyo Med & Dent Univ, Dept Psychiat & Behav Sci, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Nishikawa, T (corresponding author), Tokyo Med & Dent Univ, Dept Psychiat & Behav Sci, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan.	tnis.psyc@tmd.ac.jp			Tokyo Medical and Dental University Funds; Ministry of Education, Culture, Sports, Science and Technology of Japan	Tokyo Medical and Dental University Funds; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Tokyo Medical and Dental University Funds. In addition, a part of this study is the result of "Development of biomarker candidates for social behavior" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. These institutions had no further role in study design, in the collection, analysis and interpretation of data, in the writing of the report, and in the decision to submit the paper for publication.	Andreasen NC, 1997, LANCET, V349, P1730, DOI 10.1016/S0140-6736(96)08258-X; Brugger S, 2011, BIOL PSYCHIAT, V69, P495, DOI 10.1016/j.biopsych.2010.10.004; Celada P, 2013, INT J NEUROPSYCHOPH, V16, P2145, DOI 10.1017/S1461145713000643; Clinton SM, 2004, NEUROPSYCHOPHARMACOL, V29, P1353, DOI 10.1038/sj.npp.1300451; Clinton SM, 2004, SCHIZOPHR RES, V69, P237, DOI 10.1016/j.schres.2003.09.017; DRAGUNOW M, 1990, NEUROSCI LETT, V111, P39, DOI 10.1016/0304-3940(90)90341-6; Duncan GE, 1999, BRAIN RES, V843, P171, DOI 10.1016/S0006-8993(99)01776-X; Fujiwara Y, 1987, BEHAVIORAL; GREIFENSTEIN F E, 1958, Anesth Analg, V37, P283; Hiraoka S, 2010, EUR NEUROPSYCHOPHARM, V20, P176, DOI 10.1016/j.euroneuro.2009.08.007; Ito T, 2007, INT J NEUROPSYCHOPH, V10, P717, DOI 10.1017/S1461145707007882; Javitt DC, 2004, MOL PSYCHIATR, V9, P984, DOI 10.1038/sj.mp.4001551; Kajii Y, 2003, MOL PSYCHIATR, V8, P434, DOI 10.1038/sj.mp.4001258; Kim AH, 2010, SCHIZOPHR RES, V124, P183, DOI 10.1016/j.schres.2010.07.002; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Krishnan J, 2014, FEBS J, V281, P34, DOI 10.1111/febs.12578; Lewis DA, 2009, J CLIN INVEST, V119, P706, DOI 10.1172/JCI37335; Lidow MS, 1998, TRENDS PHARMACOL SCI, V19, P136, DOI 10.1016/S0165-6147(98)01186-9; Matsuo R, 2000, J NEUROCHEM, V74, P2239, DOI 10.1046/j.1471-4159.2000.0742239.x; Miller BH, 2012, P NATL ACAD SCI USA, V109, P3125, DOI 10.1073/pnas.1113793109; MIYASAKA M, 1968, INT J NEUROPHARMACOL, V7, P557; Murata M, 2001, NEUROSCI LETT, V303, P99, DOI 10.1016/S0304-3940(01)01710-4; NISHIKAWA T, 1991, TANIG SYMP BRAIN SCI, V14, P65; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; PETERSEN R C, 1978, National Institute on Drug Abuse Research Monograph, P1; Remenyi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062509; Sakurai S, 2004, J NEUROCHEM, V90, P1378, DOI 10.1111/j.1471-4159.2004.02592.x; Santana N, 2011, BIOL PSYCHIAT, V69, P918, DOI 10.1016/j.biopsych.2010.10.030; Sato D, 1997, NEUROSCI LETT, V239, P21, DOI 10.1016/S0304-3940(97)00879-3; Sato J, 2008, J NEURAL TRANSM, V115, P1355, DOI 10.1007/s00702-008-0085-9; Shepherd AM, 2012, NEUROSCI BIOBEHAV R, V36, P1342, DOI 10.1016/j.neubiorev.2011.12.015; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; SHINTOMI K, 1975, EUR J PHARMACOL, V31, P195, DOI 10.1016/0014-2999(75)90040-0; Shirayama Y, 2000, SYNAPSE, V35, P292, DOI 10.1002/(SICI)1098-2396(20000315)35:4<292::AID-SYN7>3.3.CO;2-V; Sim K, 2006, J NEURAL TRANSM, V113, P907, DOI 10.1007/s00702-005-0363-8; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Takebayashi H, 2009, INT J NEUROPSYCHOPH, V12, P1111, DOI 10.1017/S1461145709009997; TANII Y, 1994, J PHARMACOL EXP THER, V269, P1040; Tsuchida K, 1994, ONTOGENY ENHANCED ST; Uezato A, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-2; Umino A, 1998, BRIT J PHARMACOL, V124, P377, DOI 10.1038/sj.bjp.0701830; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Vollenweider FX, 1997, EUR NEUROPSYCHOPHARM, V7, P25, DOI 10.1016/S0924-977X(96)00042-9; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Watis L, 2008, J NEURAL TRANSM, V115, P493, DOI 10.1007/s00702-007-0859-5	45	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97955	10.1371/journal.pone.0097955	http://dx.doi.org/10.1371/journal.pone.0097955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886782	gold, Green Published, Green Submitted			2022-12-25	WOS:000336956300029
J	Wang, JF; Wu, XZ; Xiao, R; Dong, PT; Wang, CG				Wang, Jun Feng; Wu, Xue Zhong; Xiao, Rui; Dong, Pei Tao; Wang, Chao Guang			Performance-Enhancing Methods for Au Film over Nanosphere Surface-Enhanced Raman Scattering Substrate and Melamine Detection Application	PLOS ONE			English	Article							COLLOIDAL SILVER; DNA DETECTION; SPECTROSCOPY; SERS; NANOPARTICLES; LITHOGRAPHY; LABEL	A new high-performance surface-enhanced Raman scattering (SERS) substrate with extremely high SERS activity was produced. This SERS substrate combines the advantages of Au film over nanosphere (AuFON) substrate and Ag nanoparticles (AgNPs). A three order enhancement of SERS was observed when Rhodamine 6G (R6G) was used as a probe molecule to compare the SERS effects of the new substrate and commonly used AuFON substrate. These new SERS substrates can detect R6G down to 1 nM. The new substrate was also utilized to detect melamine, and the limit of detection (LOD) is 1 ppb. A linear relationship was also observed between the SERS intensity at Raman peak 682 cm(-1) and the logarithm of melamine concentrations ranging from 10 ppm to 1 ppb. This ultrasensitive SERS substrate is a promising tool for detecting trace chemical molecules because of its simple and effective fabrication procedure, high sensitivity and high reproducibility of the SERS effect.	[Wang, Jun Feng; Wu, Xue Zhong; Dong, Pei Tao; Wang, Chao Guang] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China; [Xiao, Rui] Beijing Inst Radiat Med, Beijing, Peoples R China; [Wang, Jun Feng; Dong, Pei Tao] Chinese Acad Sci, State Key Lab Transducer Technol, Shanghai, Peoples R China	National University of Defense Technology - China; Academy of Military Medical Sciences - China; Chinese Academy of Sciences	Xiao, R (corresponding author), Beijing Inst Radiat Med, Beijing, Peoples R China.	ruixiao203@sina.com; ptdong@nudt.edu.cn			National University of Defense Technology [kxk130302]; Foundation of State Key Laboratories of Transducer Technology [SKT1201]	National University of Defense Technology; Foundation of State Key Laboratories of Transducer Technology	This work was funded by the Research Project of National University of Defense Technology under Grant No. kxk130302 and the Foundation of State Key Laboratories of Transducer Technology under Grant No. SKT1201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2013, APPL SURF SCI, V270, P6, DOI 10.1016/j.apsusc.2012.11.165; Chen J, 2008, MATER CHEM PHYS, V108, P421, DOI 10.1016/j.matchemphys.2007.10.019; Dasary SSR, 2009, J AM CHEM SOC, V131, P13806, DOI 10.1021/ja905134d; Dick LA, 2002, J PHYS CHEM B, V106, P853, DOI 10.1021/jp013638l; Du XB, 2010, APPL SPECTROSC, V64, P781, DOI 10.1366/000370210791666426; Fan MK, 2011, ANAL CHIM ACTA, V693, P7, DOI 10.1016/j.aca.2011.03.002; Fang C, 2008, BIOSENS BIOELECTRON, V24, P216, DOI 10.1016/j.bios.2008.03.032; Harpster MH, 2009, BIOSENS BIOELECTRON, V25, P674, DOI 10.1016/j.bios.2009.05.020; Haynes CL, 2001, J PHYS CHEM B, V105, P5599, DOI 10.1021/jp010657m; HILDEBRANDT P, 1984, J PHYS CHEM-US, V88, P5935, DOI 10.1021/j150668a038; Kang T, 2010, NANO LETT, V10, P1189, DOI 10.1021/nl1000086; LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025; Lin M, 2008, J FOOD SCI, V73, pT129, DOI 10.1111/j.1750-3841.2008.00901.x; Liu BH, 2012, ANAL CHEM, V84, P255, DOI 10.1021/ac202452t; MOODY RL, 1987, APPL SPECTROSC, V41, P966, DOI 10.1366/0003702874447761; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Raveendran P, 2006, GREEN CHEM, V8, P34, DOI 10.1039/b512540e; RUNDQUIST PA, 1989, J CHEM PHYS, V91, P4932, DOI 10.1063/1.456734; Shende Chetan, 2010, Sensing and Instrumentation for Food Quality and Safety, V4, P101, DOI 10.1007/s11694-010-9100-6; Tsoutsi D, 2013, NANOSCALE, V5, P5841, DOI 10.1039/c3nr01518a; Velikov KP, 2003, LANGMUIR, V19, P1384, DOI 10.1021/la026610p; Vo-Dinh T, 1998, TRAC-TREND ANAL CHEM, V17, P557, DOI 10.1016/S0165-9936(98)00069-7; Wang YQ, 2013, CHEM REV, V113, P1391, DOI 10.1021/cr300120g; Yang SM, 2006, SMALL, V2, P458, DOI 10.1002/smll.200500390; Zhao YH, 2013, TALANTA, V113, P7, DOI 10.1016/j.talanta.2013.03.075	25	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97976	10.1371/journal.pone.0097976	http://dx.doi.org/10.1371/journal.pone.0097976			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886913	Green Submitted, gold, Green Published			2022-12-25	WOS:000336956300031
J	Yaung, SJ; Esvelt, KM; Church, GM				Yaung, Stephanie J.; Esvelt, Kevin M.; Church, George M.			CRISPR/Cas9-Mediated Phage Resistance Is Not Impeded by the DNA Modifications of Phage T4	PLOS ONE			English	Article							ESCHERICHIA-COLI; CRISPR RNA; BACTERIOPHAGE; GENE; TRANSCRIPTION; INTERFERENCE; RESTRICTION; GENOME	Bacteria rely on two known DNA-level defenses against their bacteriophage predators: restriction-modification and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-CRISPR-associated (Cas) systems. Certain phages have evolved countermeasures that are known to block endonucleases. For example, phage T4 not only adds hydroxymethyl groups to all of its cytosines, but also glucosylates them, a strategy that defeats almost all restriction enzymes. We sought to determine whether these DNA modifications can similarly impede CRISPR-based defenses. In a bioinformatics search, we found naturally occurring CRISPR spacers that potentially target phages known to modify their DNA. Experimentally, we show that the Cas9 nuclease from the Type II CRISPR system of Streptococcus pyogenes can overcome a variety of DNA modifications in Escherichia coli. The levels of Cas9-mediated phage resistance to bacteriophage T4 and the mutant phage T4 gt, which contains hydroxymethylated but not glucosylated cytosines, were comparable to phages with unmodified cytosines, T7 and the T4-like phage RB49. Our results demonstrate that Cas9 is not impeded by N-6-methyladenine, 5-methylcytosine, 5-hydroxymethylated cytosine, or glucosylated 5-hydroxymethylated cytosine.	[Yaung, Stephanie J.; Esvelt, Kevin M.; Church, George M.] Harvard Univ, Sch Med, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Yaung, Stephanie J.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Yaung, Stephanie J.] MIT, Harvard Mit Div Hlth Sci & Technol, Program Med Engn & Med Phys, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT)	Church, GM (corresponding author), Harvard Univ, Sch Med, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	gchurch@genetics.med.harvard.edu		church, george/0000-0001-6232-9969; Esvelt, Kevin/0000-0001-8797-3945; Yaung, Stephanie/0000-0003-4203-2505	US Department of Energy [DE-FG02-02ER63445]; Wyss Institute for Biologically Inspired Engineering; National Science Foundation; Wyss Technology Development Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK102669, R00DK102669] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); Wyss Institute for Biologically Inspired Engineering; National Science Foundation(National Science Foundation (NSF)); Wyss Technology Development Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US Department of Energy grant DE-FG02-02ER63445 (to GMC) and the Wyss Institute for Biologically Inspired Engineering. SJY was supported by a National Science Foundation Graduate Research Fellowship and KME by the Wyss Technology Development Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Choo Y, 1998, NAT STRUCT BIOL, V5, P264, DOI 10.1038/nsb0498-264; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dupuis ME, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3087; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fineran PC, 2014, P NATL ACAD SCI US; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; GEORGOPOULOS CP, 1967, BIOCHEM BIOPH RES CO, V28, P179, DOI 10.1016/0006-291X(67)90426-3; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KELLEHER JE, 1991, J BACTERIOL, V173, P5220, DOI 10.1128/jb.173.16.5220-5223.1991; KORNBERG S, 1961, J BIOL CHEM, V236, P1487; LEHMAN IR, 1960, J BIOL CHEM, V235, P3254; Levin BR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003312; Magadan AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040913; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Monod C, 1997, J MOL BIOL, V267, P237, DOI 10.1006/jmbi.1996.0867; Petrov VM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-292; Seed KD, 2013, NATURE, V494, P489, DOI 10.1038/nature11927; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sheludchenko MS, 2010, APPL ENVIRON MICROB, V76, P4337, DOI 10.1128/AEM.00128-10; SNYDER L, 1976, P NATL ACAD SCI USA, V73, P3098, DOI 10.1073/pnas.73.9.3098; Toro M, 2014, APPL ENVIRON MICROB, V80, P1411, DOI 10.1128/AEM.03018-13; Touchon M, 2011, J BACTERIOL, V193, P2460, DOI 10.1128/JB.01307-10; Valton J, 2012, J BIOL CHEM, V287, P38427, DOI 10.1074/jbc.C112.408864; WARREN RAJ, 1980, ANNU REV MICROBIOL, V34, P137, DOI 10.1146/annurev.mi.34.100180.001033	33	24	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98811	10.1371/journal.pone.0098811	http://dx.doi.org/10.1371/journal.pone.0098811			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886988	gold, Green Submitted, Green Published			2022-12-25	WOS:000336956300112
J	Zhu, B; Ellis, MS; Fancher, KL; Rudstam, LG				Zhu, Bin; Ellis, Michael S.; Fancher, Kelly L.; Rudstam, Lars G.			Shading as a Control Method for Invasive European Frogbit (Hydrocharis morsus-ranae L.)	PLOS ONE			English	Article							LAKE; MACROPHYTES; GROWTH; DEPTH	Invasive European frogbit (Hydrocharis morsus-ranae L.) has negative environmental and economic impacts in North American water bodies. It is therefore important to develop effective management tools to control this invasive species. This study investigated shading as a control method for European frogbit in both greenhouse and lake mesocosm experiments. A series of shade treatments (0%, 50%, 60%, 70%, 80%, and 100%) were tested in the greenhouse for three weeks. Results showed that the 100% shade was most effective at controlling European frogbit, and other shade treatments greater than 50% were less effective, reducing frogbit biomass up to 38.2%. There were no differences found in temperature between treatments, but dissolved oxygen decreased as shading increased. A lake mesocosm experiment utilizing 0% shade, 70% shade, and 100% shade treatments was performed in a sheltered inlet of Oneida Lake in New York State for over one month. Resulting European frogbit biomass was significantly (25 times) less in areas treated with the 70% shade and nearly zero with the 100% shade. Shading did not affect temperature but improved DO conditions. Results on the shading effects on submerged macrophytes were not conclusive: no significant differences in changes in species richness and abundance between the three groups at the end of studied period suggested no shading effects; significant differences between the beginning and end communities in the 70% shade and the 100% shade but not in the control group indicated significant impacts of shading. This study is the first one to investigate shading as a control method for European frogbit and it is concluded that a moderately high density shade can effective remove European frogbit likely with minor impacts on the environment. More experiments with larger scales and longer time periods are recommended for further investigation.	[Zhu, Bin; Fancher, Kelly L.] Univ Hartford, Dept Biol, Hartford, CT 06117 USA; [Ellis, Michael S.] Hobart & William Smith Coll, Dept Biol, Geneva, NY 14456 USA; [Rudstam, Lars G.] Cornell Univ, Dept Nat Resources, Ithaca, NY 14853 USA	University of Hartford; Cornell University	Zhu, B (corresponding author), Univ Hartford, Dept Biol, Hartford, CT 06117 USA.	zhu@hartford.edu		Rudstam, Lars/0000-0002-3732-6368	New York Great Lakes Protection Fund; Vincent B. Coffin Grant; A&S Dean's Research Fund at the University of Hartford	New York Great Lakes Protection Fund; Vincent B. Coffin Grant; A&S Dean's Research Fund at the University of Hartford	This project was supported by the New York Great Lakes Protection Fund and the Vincent B. Coffin Grant and the A&S Dean's Research Fund at the University of Hartford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CATLING P M, 1988, Naturaliste Canadien (Quebec), V115, P131; Catling PM, 2003, CAN J PLANT SCI, V83, P1001, DOI 10.4141/P02-033; Chiariello NR, 1991, RESPONSE PLANTS MULT, P161, DOI DOI 10.1016/B978-0-08-092483-0.50013-X; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; COOK CDK, 1982, AQUAT BOT, V14, P177, DOI 10.1016/0304-3770(82)90097-3; DORE W G, 1968, Canadian Field-Naturalist, V82, P76; FROEMMING E., 1954, PHARMAZIE, V9, P766; Holz W, 1963, 5 DTSCH ARB FRAG UNK; Hudon C, 2000, CAN J FISH AQUAT SCI, V57, P31, DOI 10.1139/f99-232; Karatayev AY, 2002, INVASIVE AQUATIC SPECIES OF EUROPE: DISTRIBUTION, IMPACTS AND MANAGEMENT, P433; Kuehl R, 2000, DESIGN EXPT STAT PRI; LANGDON S., 2007, ERADICATION EUROPEAN; Madsen JD, 1997, ASSESSMENT MANAGEMEN, P145, DOI [10.1007/978-1-4612-1926-2_13, DOI 10.1007/978-1-4612-1926-2_13]; Magomaev F. M., 1973, Sbornik Nauchnykh Trudov, Vsesoyuznyi Nauchno-Issledovatel'skii Institut Prudovogo Rybnogo Khozyaistva, P192; MILLER JD, 1993, J AQUAT PLANT MANAGE, V31, P101; MINSHALL W. HAROLD, 1959, CANADIAN JOUR BOT, V37, P1134, DOI 10.1139/b59-090; New York State Department of Environmental Conservation, 2005, PRIM AQ PLANT MAN NE; Panetta FD, 2009, INVAS PLANT SCI MANA, V2, P360, DOI 10.1614/IPSM-09-003.1; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; REED DC, 1984, ECOLOGY, V65, P937, DOI 10.2307/1938066; Renard C, 1963, COMPT REND C COM FRA; RICHARDS A J, 1975, Watsonia, V10, P273; ROBERTS ML, 1981, RHODORA, V83, P147; SANDJENSEN K, 1991, AQUAT BOT, V41, P137, DOI 10.1016/0304-3770(91)90042-4; Schindler DE, 2002, OIKOS, V98, P177, DOI 10.1034/j.1600-0706.2002.980201.x; Schooler SS, 2008, J AQUAT PLANT MANAGE, V46, P168; Skubinna JP, 1995, J GREAT LAKES RES, V21, P476, DOI 10.1016/S0380-1330(95)71060-7; SPENCE DHN, 1982, ADV ECOL RES, V12, P37, DOI 10.1016/S0065-2504(08)60077-X; Vaananen Veli-Matti, 2003, Suomen Riista, V49, P7; Wade P. M., 1990, AQUATIC WEEDS ECOLOG, P93; Zhu B, 2006, ECOSYSTEMS, V9, P1017, DOI 10.1007/s10021-005-0049-y; Zhu B, 2008, J AQUAT PLANT MANAGE, V46, P186; Zhu B, 2007, J GREAT LAKES RES, V33, P122, DOI 10.3394/0380-1330(2007)33[122:QOHCOS]2.0.CO;2	33	8	8	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98488	10.1371/journal.pone.0098488	http://dx.doi.org/10.1371/journal.pone.0098488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886916	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300071
J	Freeman, CM; Quillin, RC; Wilson, GC; Nojima, H; Johnson, BL; Sutton, JM; Schuster, RM; Blanchard, J; Edwards, MJ; Caldwell, CC; Lentsch, AB				Freeman, Christopher M.; Quillin, Ralph C., III; Wilson, Gregory C.; Nojima, Hiroyuki; Johnson, Bobby L., III; Sutton, Jeffrey M.; Schuster, Rebecca M.; Blanchard, John; Edwards, Michael J.; Caldwell, Charles C.; Lentsch, Alex B.			Characterization of Microparticles after Hepatic Ischemia-Reperfusion Injury	PLOS ONE			English	Article							CIRCULATING MICROPARTICLES; ENDOTHELIAL MICROPARTICLES; PLATELET MICROPARTICLES; RAT-LIVER; ISCHEMIA/REPERFUSION INJURY; NEUTROPHIL; MECHANISMS; SEPSIS; MICROVESICLES; MODULATION	Background: Hepatic ischemia-reperfusion (I/R) is a well-studied model of liver injury and has demonstrated a biphasic followed by recovery and regeneration. Microparticles (MPs) are a developing field of study and these small membrane bound vesicles have been shown to have effector function in other physiologic and pathologic states. This study was designed to quantify the levels of MPs from various cell origins-platelets, neutrophils, and endolethial cells-following hepatic ischemia-reperfusion injury. Methods: A murine model was used with mice undergoing 90 minutes of partial hepatic ischemia followed by various times of reperfusion. Following reperfusion, plasma samples were taken and MPs of various cell origins were labeled and levels were measured using flow cytometry. Additionally, cell specific MPs were further assessed by Annexin V, which stains for the presence of phosphatidylserine, a cell surface marker linked to apoptosis. Statistical analysis was performed using one-way analysis of variance with subsequent Student-Newman-Keuls test with data presented as the mean and standard error of the mean. Results: MPs from varying sources show an increase in circulating levels following hepatic I/R injury. However, the timing of the appearance of different MP subtypes differs for each cell type. Platelet and neutrophil-derived MP levels demonstrated an acute elevation following injury whereas endothelial-derived MP levels demonstrated a delayed elevation. Conclusion: This is the first study to characterize circulating levels of cell-specific MPs after hepatic I/R injury and suggests that MPs derived from platelets and neutrophils serve as markers of inflammatory injury and may be active participants in this process. In contrast, MPs derived from endothelial cells increase after the injury response during the reparative phase and may be important in angiogenesis that occurs in the regenerating liver.	[Freeman, Christopher M.; Quillin, Ralph C., III; Wilson, Gregory C.; Nojima, Hiroyuki; Johnson, Bobby L., III; Sutton, Jeffrey M.; Schuster, Rebecca M.; Blanchard, John; Edwards, Michael J.; Caldwell, Charles C.; Lentsch, Alex B.] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Lentsch, AB (corresponding author), Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45221 USA.	alex.lentsch@uc.edu	NOJIMA, HIROYUKI/E-3782-2017	Caldwell, Charles/0000-0003-1692-4550; Wilson, Gregory/0000-0001-6237-0136; NOJIMA, HIROYUKI/0000-0003-3983-2501	National Institutes Health [DK56029, GM08478]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392, R01DK056029] Funding Source: NIH RePORTER	National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes Health grants DK56029 and GM08478. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo Luciano C P, 2007, Recent Pat Cardiovasc Drug Discov, V2, P41, DOI 10.2174/157489007779606121; Barry OP, 1998, J CLIN INVEST, V102, P136, DOI 10.1172/JCI2592; Brown GT, 2011, J IMMUNOL, V186, P5489, DOI 10.4049/jimmunol.1001623; Dalli J, 2012, FASEB J, V26, P387, DOI 10.1096/fj.11-182089; Densmore JC, 2006, SHOCK, V26, P464, DOI 10.1097/01.shk.0000228791.10550.36; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Faure V, 2006, J THROMB HAEMOST, V4, P566, DOI 10.1111/j.1538-7836.2005.01780.x; Forlow SB, 2000, BLOOD, V95, P1317, DOI 10.1182/blood.V95.4.1317.004k30_1317_1323; Gasser O, 2005, EXP CELL RES, V307, P381, DOI 10.1016/j.yexcr.2005.03.011; GEORGE JN, 1982, BLOOD, V60, P834; HUGUET C, 1994, J AM COLL SURGEONS, V178, P454; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Husted TL, 2006, CURR PHARM DESIGN, V12, P2867, DOI 10.2174/138161206777947597; JAESCHKE H, 1992, J LEUKOCYTE BIOL, V52, P377, DOI 10.1002/jlb.52.4.377; JAESCHKE H, 1991, AM J PHYSIOL, V260, pG355, DOI 10.1152/ajpgi.1991.260.3.G355; JAESCHKE H, 1990, FASEB J, V4, P3355, DOI 10.1096/fasebj.4.15.2253850; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Janiszewski M, 2004, CRIT CARE MED, V32, P818, DOI 10.1097/01.CCM.0000114829.17746.19; Jy WC, 1995, BLOOD CELL MOL DIS, V21, P217, DOI 10.1006/bcmd.1995.0025; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Lemasters JJ, 1997, ANNU REV PHARMACOL, V37, P327, DOI 10.1146/annurev.pharmtox.37.1.327; Lentsch AB, 1998, HEPATOLOGY, V27, P1172; Lentsch AB, 2000, HEPATOLOGY, V32, P169, DOI 10.1053/jhep.2000.9323; Leroyer AS, 2008, J AM COLL CARDIOL, V52, P1302, DOI 10.1016/j.jacc.2008.07.032; Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058; Liu DL, 1996, ARCH SURG-CHICAGO, V131, P442; Mesri C, 1998, J IMMUNOL, V161, P4382; Mesri M, 1999, J BIOL CHEM, V274, P23111, DOI 10.1074/jbc.274.33.23111; Meziani F, 2010, CRIT CARE, V14, DOI 10.1186/cc9231; Morel O, 2011, SEMIN IMMUNOPATHOL, V33, P469, DOI 10.1007/s00281-010-0239-3; Morel O, 2011, ARTERIOSCL THROM VAS, V31, P15, DOI 10.1161/ATVBAHA.109.200956; Mostefai HA, 2008, AM J RESP CRIT CARE, V178, P1148, DOI 10.1164/rccm.200712-1835OC; Nagendra S, 2004, CYTOM PART A, V58A, P195, DOI 10.1002/cyto.a.20007; Ogura H, 2004, J TRAUMA, V56, P823, DOI 10.1097/01.TA.0000084517.39244.46; Ogura H, 2001, J TRAUMA, V50, P801, DOI 10.1097/00005373-200105000-00005; Prakash PS, 2012, J TRAUMA ACUTE CARE, V73, P401, DOI 10.1097/TA.0b013e31825a776d; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; Sindram D, 2000, GASTROENTEROLOGY, V118, P183, DOI 10.1016/S0016-5085(00)70427-6; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P112, DOI 10.1161/01.ATV.0000191634.13057.15; Yadav SS, 1999, HEPATOLOGY, V29, P1494, DOI 10.1002/hep.510290505	40	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97945	10.1371/journal.pone.0097945	http://dx.doi.org/10.1371/journal.pone.0097945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879335	Green Published, Green Submitted, gold			2022-12-25	WOS:000338101500027
J	Muller, HK; Kragballe, M; Fjorback, AW; Wiborg, O				Muller, Heidi Kaastrup; Kragballe, Marie; Fjorback, Anja Winther; Wiborg, Ove			Differential Regulation of the Serotonin Transporter by Vesicle-Associated Membrane Protein 2 in Cells of Neuronal versus Non-Neuronal Origin	PLOS ONE			English	Article							CALMODULIN-DEPENDENT REGULATION; NEUROTRANSMITTER TRANSPORTERS; PLASMA-MEMBRANE; TETANUS-TOXIN; RN46A CELLS; SYNAPTOBREVIN; TRAFFICKING; NEUROTOXINS; ENDOCYTOSIS; EXPRESSION	The serotonin transporter (SERT) is a key regulator of serotonergic signalling as it mediates the re-uptake of synaptic serotonin into nerve terminals, thereby terminating or modulating its signal. It is well-known that SERT regulation is a dynamic process orchestrated by a wide array of proteins and mechanisms. However, molecular details on possible coordinated regulation of SERT activity and 5-HT release are incomplete. Here, we report that vesicle-associated membrane protein 2 (VAMP2), a SNARE protein that mediates vesicle fusion with the plasma membrane, interacts with SERT. This was documented in vitro, through GST pull-down assays, by co-immunoprecipitation experiments on heterologous cells and rat hippocampal synaptosomes, and with FRET analysis in live transfected HEK-293 MSR cells. The related isoforms VAMP1 and VAMP3 also physically interact with SERT. However, comparison of the three VAMP isoforms shows that only VAMP2 possesses a functionally distinct role in relation to SERT. VAMP2 influences 5-HT uptake, cell surface expression and the delivery rate of SERT to the plasma membrane differentially in HEK-293 MSR and PC12 cells. Moreover, siRNA-mediated knock-down of endogenous VAMP2 reduces 5-HT uptake in CAD cells stably expressing low levels of heterologous SERT. Deletion and mutant analysis suggest a role for the isoform specific C-terminal domain of VAMP2 in regulating SERT function. Our data identify a novel interaction between SERT and a synaptic vesicle protein and support a link between 5-HT release and re-uptake.	[Muller, Heidi Kaastrup; Kragballe, Marie; Wiborg, Ove] Aarhus Univ Hosp, Dept Clin Med, Translat Neuropsychiat Unit, Risskov, Denmark; [Fjorback, Anja Winther] Univ Aarhus, Dept Clin Med, Ctr Stochast Geometry & Adv Bioimaging, Stereol & Electron Microscopy Lab, Aarhus, Denmark	Aarhus University; Aarhus University	Muller, HK (corresponding author), Aarhus Univ Hosp, Dept Clin Med, Translat Neuropsychiat Unit, Risskov, Denmark.	heidmull@rm.dk		Kaastrup Muller, Heidi/0000-0002-9842-8114	Lundbeck Foundation; Augustinus Foundation; Aase and Ejnar Danielsens Foundation; Else and Mogens Wedell-Wedellsborgs Foundation; Direktor Jacob Madsen and Hustru Olga Madsens Foundation; Kong Christian den Tiendes Foundation	Lundbeck Foundation(Lundbeckfonden); Augustinus Foundation; Aase and Ejnar Danielsens Foundation; Else and Mogens Wedell-Wedellsborgs Foundation; Direktor Jacob Madsen and Hustru Olga Madsens Foundation; Kong Christian den Tiendes Foundation	This study was supported by Grants from the Lundbeck Foundation, Augustinus Foundation, Aase and Ejnar Danielsens Foundation, Else and Mogens Wedell-Wedellsborgs Foundation, Direktor Jacob Madsen and Hustru Olga Madsens Foundation, and Kong Christian den Tiendes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen J, 2009, CHEM COMMUN, P3677, DOI 10.1039/b903035m; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Ciccone MA, 2008, NEUROPHARMACOLOGY, V55, P763, DOI 10.1016/j.neuropharm.2008.06.018; De Haro L, 2003, BIOL CELL, V95, P459, DOI 10.1016/S0248-4900(03)00076-5; Dittman JS, 2006, P NATL ACAD SCI USA, V103, P11399, DOI 10.1073/pnas.0600784103; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; Fjorback AW, 2009, BIOCHEM BIOPH RES CO, V380, P724, DOI 10.1016/j.bbrc.2009.01.128; Grote E, 1996, J CELL BIOL, V132, P537, DOI 10.1083/jcb.132.4.537; Haase J, 2001, BIOCHEM SOC T, V29, P722, DOI 10.1042/BST0290722; Han Dawn D., 2006, BMC Pharmacology, V6, P6, DOI 10.1186/1471-2210-6-6; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Inserte J, 1999, BIOCHEM PHARMACOL, V57, P111, DOI 10.1016/S0006-2952(98)00281-0; JAYANTHI LD, 1994, J BIOL CHEM, V269, P14424; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; Koo Seong Joo, 2011, Cell Logist, V1, P168; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Li YL, 2007, J NEUROSCI RES, V85, P2601, DOI 10.1002/jnr.21216; Lvov A, 2008, PFLUG ARCH EUR J PHY, V456, P1121, DOI 10.1007/s00424-008-0468-7; Magnani F, 2004, J BIOL CHEM, V279, P38770, DOI 10.1074/jbc.M400831200; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006; Muller HK, 2006, J BIOL CHEM, V281, P28901, DOI 10.1074/jbc.M602848200; Muller HK, 2011, BRAIN RES, V1385, P26, DOI 10.1016/j.brainres.2011.02.048; Qi YP, 1997, J NEUROSCI, V17, P1217; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; Quick MW, 2002, INT J DEV NEUROSCI, V20, P219, DOI 10.1016/S0736-5748(02)00021-7; Samuvel DJ, 2005, J NEUROSCI, V25, P29, DOI 10.1523/JNEUROSCI.3754-04.2005; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Steiner JA, 2008, TRAFFIC, V9, P1393, DOI 10.1111/j.1600-0854.2008.00757.x; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; SURI C, 1993, J NEUROSCI, V13, P1280; Taubenblatt P, 1999, J CELL SCI, V112, P3559; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Yammamoto H, 2013, J PHARMACOL SCI, V121, P25, DOI 10.1254/jphs.12229FP; YOFFE JR, 1982, MOL PHARMACOL, V21, P368; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9; Zhou FC, 1998, BRAIN RES, V805, P241, DOI 10.1016/S0006-8993(98)00691-X	42	10	10	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97540	10.1371/journal.pone.0097540	http://dx.doi.org/10.1371/journal.pone.0097540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878716	gold, Green Published, Green Submitted			2022-12-25	WOS:000338101500017
J	Nakanishi, T; Kato, Y; Matsuura, T; Watanabe, H				Nakanishi, Takashi; Kato, Yasuhiko; Matsuura, Tomoaki; Watanabe, Hajime			CRISPR/Cas-Mediated Targeted Mutagenesis in Daphnia magna	PLOS ONE			English	Article							HOMEOBOX-CONTAINING GENE; XENOPUS-TROPICALIS; WATER FLEA; C. ELEGANS; GENOME; DROSOPHILA; SYSTEM; PAX6; CAS9; EYE	The water flea Daphnia magna has been used as an animal model in ecology, evolution, and environmental sciences. Thanks to the recent progress in Daphnia genomics, genetic information such as the draft genome sequence and expressed sequence tags (ESTs) is now available. To investigate the relationship between phenotypes and the available genetic information about Daphnia, some gene manipulation methods have been developed. However, a technique to induce targeted mutagenesis into Daphnia genome remains elusive. To overcome this problem, we focused on an emerging genome editing technique mediated by the clustered regularly interspaced short palindromic repeats/CRISPR-associated (CRISPR/Cas) system to introduce genomic mutations. In this study, we targeted a functionally conserved regulator of eye development, the eyeless gene in D. magna. When we injected Cas9 mRNAs and eyeless-targeting guide RNAs into eggs, 1847% of the survived juveniles exhibited abnormal eye morphology. After maturation, up to 8.2% of the adults produced progenies with deformed eyes, which carried mutations in the eyeless loci. These results showed that CRISPR/Cas system could introduce heritable mutations into the endogenous eyeless gene in D. magna. This is the first report of a targeted gene knockout technique in Daphnia and will be useful in uncovering Daphnia gene functions.	[Nakanishi, Takashi; Kato, Yasuhiko; Matsuura, Tomoaki; Watanabe, Hajime] Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan	Osaka University	Watanabe, H (corresponding author), Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan.	watanabe@bio.eng.osaka-u.ac.jp	WATANABE, Hajime/AAJ-8904-2021; Kato, Yasuhiko/AES-3929-2022; Matsuura, Tomoaki/W-6086-2019; matsuura, tomoaki/O-7368-2018; Watanabe, Hajime/S-8957-2019	Kato, Yasuhiko/0000-0002-1041-1044; Matsuura, Tomoaki/0000-0003-1015-6781; matsuura, tomoaki/0000-0003-1015-6781; Watanabe, Hajime/0000-0001-9657-6554	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Asahi Glass Foundation; Osaka University, MEXT	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Asahi Glass Foundation; Osaka University, MEXT	This study was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and partially supported by the Asahi Glass Foundation. One of the authors (Y.K.) would like to acknowledge the Frontier Research Base for Global Young Researchers, Osaka University, based on the Program of MEXT, for providing financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Blitz IL, 2013, GENESIS, V51, P827, DOI 10.1002/dvg.22719; Callaerts P, 2006, ARTHROPOD STRUCT DEV, V35, P379, DOI 10.1016/j.asd.2006.09.002; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chen CC, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt805; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Ebert D., 2005, ECOLOGY EPIDEMIOLOGY; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; HEBERT PDN, 1978, BIOL REV, V53, P387, DOI 10.1111/j.1469-185X.1978.tb00860.x; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kato Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045318; Kato Y, 2011, DEV GENES EVOL, V220, P337, DOI 10.1007/s00427-011-0353-9; Kim EA, 2006, J BIOL CHEM, V281, P7489, DOI 10.1074/jbc.M507227200; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; Kronhamn J, 2002, DEVELOPMENT, V129, P1015; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mikkola I, 1999, J BIOL CHEM, V274, P15115, DOI 10.1074/jbc.274.21.15115; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Sagawa K, 2005, GENE EXPR PATTERNS, V5, P669, DOI 10.1016/j.modgep.2005.02.007; Suzuki KT, 2013, BIOL OPEN, V2, P448, DOI 10.1242/bio.20133855; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Watanabe H, 2005, GENOME, V48, P606, DOI 10.1139/G05-038; Yan Q, 2010, P NATL ACAD SCI USA, V107, P21034, DOI 10.1073/pnas.1007866107; Yu ZS, 2013, GENETICS, V195, P289, DOI 10.1534/genetics.113.153825; Zhao P, 2014, CELL RES, V24, P247, DOI 10.1038/cr.2014.9; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	42	64	69	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98363	10.1371/journal.pone.0098363	http://dx.doi.org/10.1371/journal.pone.0098363			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878568	Green Submitted, Green Published, gold			2022-12-25	WOS:000338101500053
J	Parkkari, T; Haavikko, R; Laitinen, T; Navia-Paldanius, D; Rytilahti, R; Vaara, M; Lehtonen, M; Alakurtti, S; Yli-Kauhaluoma, J; Nevalainen, T; Savinainen, JR; Laitinen, JT				Parkkari, Teija; Haavikko, Raisa; Laitinen, Tuomo; Navia-Paldanius, Dina; Rytilahti, Roosa; Vaara, Miia; Lehtonen, Marko; Alakurtti, Sami; Yli-Kauhaluoma, Jari; Nevalainen, Tapio; Savinainen, Juha R.; Laitinen, Jarmo T.			Discovery of Triterpenoids as Reversible Inhibitors of alpha/beta-hydrolase Domain Containing 12 (ABHD12)	PLOS ONE			English	Article							OLEANOLIC ACID; BETULINIC ACID; HYDROLYSIS; PATHWAYS; POTENT	Background: alpha/beta-hydrolase domain containing (ABHD) 12 is a recently discovered serine hydrolase that acts in vivo as a lysophospholipase for lysophosphatidylserine. Dysfunctional ABHD12 has been linked to the rare neurodegenerative disorder called PHARC (polyneuropathy, hearing loss, ataxia, retinosis pigmentosa, cataract). In vitro, ABHD12 has been implicated in the metabolism of the endocannabinoid 2-arachidonoylglycerol (2-AG). Further studies on ABHD12 function are hampered as no selective inhibitor have been identified to date. In contrast to the situation with the other endocannabinoid hydrolases, ABHD12 has remained a challenging target for inhibitor development as no crystal structures are available to facilitate drug design. Methodology/Principal Findings: Here we report the unexpected discovery that certain triterpene-based structures inhibit human ABHD12 hydrolase activity in a reversible manner, the best compounds showing submicromolar potency. Based on structure activity relationship (SAR) data collected for 68 natural and synthetic triterpenoid structures, a pharmacophore model has been constructed. A pentacyclic triterpene backbone with carboxyl group at position 17, small hydrophobic substituent at the position 4, hydrogen bond donor or acceptor at position 3 accompanied with four axial methyl substituents was found crucial for ABHD12 inhibitor activity. Although the triterpenoids typically may have multiple protein targets, we witnessed unprecedented selectivity for ABHD12 among the metabolic serine hydrolases, as activity-based protein profiling of mouse brain membrane proteome indicated that the representative ABHD12 inhibitors did not inhibit other serine hydrolases, nor did they target cannabinoid receptors. Conclusions/Significance: We have identified reversibly-acting triterpene-based inhibitors that show remarkable selectivity for ABHD12 over other metabolic serine hydrolases. Based on SAR data, we have constructed the first pharmacophore model of ABHD12 inhibitors. This model should pave the way for further discovery of novel lead structures for ABHD12 selective inhibitors.	[Parkkari, Teija; Navia-Paldanius, Dina; Rytilahti, Roosa; Vaara, Miia; Savinainen, Juha R.; Laitinen, Jarmo T.] Univ Eastern Finland, Inst Biomed, Sch Med, Kuopio, Finland; [Parkkari, Teija; Laitinen, Tuomo; Lehtonen, Marko; Nevalainen, Tapio] Univ Eastern Finland, Fac Hlth Sci, Sch Pharm, Kuopio, Finland; [Haavikko, Raisa; Alakurtti, Sami; Yli-Kauhaluoma, Jari] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem & Technol, Helsinki, Finland; [Alakurtti, Sami] VTT Tech Res Ctr Finland, Helsinki, Finland	University of Eastern Finland; University of Eastern Finland; University of Helsinki; VTT Technical Research Center Finland	Laitinen, JT (corresponding author), Univ Eastern Finland, Inst Biomed, Sch Med, Kuopio, Finland.	jarmo.laitinen@uef.fi		Laitinen, Tuomo/0000-0003-1539-2142; Savinainen, Juha/0000-0002-1301-9064; Haavikko, Raisa/0000-0002-2445-503X; Yli-Kauhaluoma, Jari/0000-0003-0370-7653; Laitinen, Jarmo T/0000-0002-9490-3686; Lehtonen, Marko/0000-0002-5611-0466	Academy of Finland [139620, 139140, 256515, 264020]; European Commission [EU-KBBE-227239-ForestSpeCs]; Finnish Cultural Foundation; Biocenter Finland/DDCB	Academy of Finland(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Biocenter Finland/DDCB	This research was supported by the Academy of Finland (grant 139620 to JTL, grant 139140 to TN, grants 256515 and 264020 to JYK), the European Commission (Contract no EU-KBBE-227239-ForestSpeCs to JYK), and the Finnish Cultural Foundation (RH). TL was supported by Biocenter Finland/DDCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen N, 2013, CHEM BIOL, V20, P379, DOI 10.1016/j.chembiol.2013.01.012; Alakurtti S, 2006, EUR J PHARM SCI, V29, P1, DOI 10.1016/j.ejps.2006.04.006; Alakurtti S, 2010, BIOORGAN MED CHEM, V18, P1573, DOI 10.1016/j.bmc.2010.01.003; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Blankman JL, 2013, P NATL ACAD SCI USA, V110, P1500, DOI 10.1073/pnas.1217121110; Castellano JM, 2013, DIABETES, V62, P1791, DOI 10.2337/db12-1215; Chicca A, 2012, BRIT J PHARMACOL, V167, P1596, DOI 10.1111/j.1476-5381.2012.02059.x; Fiskerstrand T, 2010, AM J HUM GENET, V87, P410, DOI 10.1016/j.ajhg.2010.08.002; Fulda S, 2008, INT J MOL SCI, V9, P1096, DOI 10.3390/ijms9061096; Gao HY, 2003, CHEM PHARM BULL, V51, P1318, DOI 10.1248/cpb.51.1318; Genet C, 2010, J MED CHEM, V53, P178, DOI 10.1021/jm900872z; Haavikko R, 2014, MEDCHEMCOMM, V5, P445, DOI 10.1039/c3md00282a; Hao J, 2009, TETRAHEDRON, V65, P7975, DOI 10.1016/j.tet.2009.07.047; He XJ, 2007, J AGR FOOD CHEM, V55, P4366, DOI 10.1021/jf063563o; Hoover HS, 2008, BIOORG MED CHEM LETT, V18, P5838, DOI 10.1016/j.bmcl.2008.06.091; Jager S, 2009, MOLECULES, V14, P2016, DOI 10.3390/molecules14062016; King AR, 2009, CHEM BIOL, V16, P1045, DOI 10.1016/j.chembiol.2009.09.012; KUMAR NS, 1985, PHYTOCHEMISTRY, V24, P1337, DOI 10.1016/S0031-9422(00)81128-0; Laitinen T, 2014, MOL PHARMACOL, V85, P510, DOI 10.1124/mol.113.090795; Li LT, 2013, BRAIN RES, V1497, P32, DOI 10.1016/j.brainres.2012.12.032; Liu QC, 2013, EUR J MED CHEM, V64, P1, DOI 10.1016/j.ejmech.2013.04.016; Moura-Letts G, 2006, J NAT PROD, V69, P978, DOI 10.1021/np0601152; Navia-Paldanius D, 2012, J LIPID RES, V53, P2413, DOI 10.1194/jlr.M030411; Patel JZ, 2013, J MED CHEM, V56, P8484, DOI 10.1021/jm400923s; Pohjala L, 2009, J NAT PROD, V72, P1917, DOI 10.1021/np9003245; Pollier J, 2012, PHYTOCHEMISTRY, V77, P10, DOI 10.1016/j.phytochem.2011.12.022; Saario SM, 2006, J MED CHEM, V49, P4650, DOI 10.1021/jm060394q; Safe SH, 2012, ANTI-CANCER AGENT ME, V12, P1211; Salminen A, 2008, CELL MOL LIFE SCI, V65, P2979, DOI 10.1007/s00018-008-8103-5; Santos RC, 2010, BIOORGAN MED CHEM, V18, P4385, DOI 10.1016/j.bmc.2010.04.085; Savinainen JR, 2005, BRIT J PHARMACOL, V145, P636, DOI 10.1038/sj.bjp.0706230; Savinainen JR, 2003, BRIT J PHARMACOL, V140, P1451, DOI 10.1038/sj.bjp.0705577; Siewert B, 2014, EUR J MED CHEM, V72, P84, DOI 10.1016/j.ejmech.2013.11.025; da Silva KABS, 2011, PAIN, V152, P1872, DOI 10.1016/j.pain.2011.04.005; Yadav VR, 2010, TOXINS, V2, P2428, DOI 10.3390/toxins2102428	35	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98286	10.1371/journal.pone.0098286	http://dx.doi.org/10.1371/journal.pone.0098286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879289	Green Published, Green Submitted, gold			2022-12-25	WOS:000338101500044
J	Roeder, E; Henrionnet, C; Goebel, JC; Gambier, N; Beuf, O; Grenier, D; Chen, BL; Vuissoz, PA; Gillet, P; Pinzano, A				Roeder, Emilie; Henrionnet, Christel; Goebel, Jean Christophe; Gambier, Nicolas; Beuf, Olivier; Grenier, Denis; Chen, Bailiang; Vuissoz, Pierre-Andre; Gillet, Pierre; Pinzano, Astrid			Dose-Response of Superparamagnetic Iron Oxide Labeling on Mesenchymal Stem Cells Chondrogenic Differentiation: A Multi-Scale In Vitro Study	PLOS ONE			English	Article							COLLAGEN SCAFFOLDS; VIVO TRACKING; NANOPARTICLES; CHONDROCYTES; EXPRESSION; PARTICLES; RELEVANCE; CAPACITY; DELIVERY; REPAIR	Aim: The aim of this work was the development of successful cell therapy techniques for cartilage engineering. This will depend on the ability to monitor non-invasively transplanted cells, especially mesenchymal stem cells (MSCs) that are promising candidates to regenerate damaged tissues. Methods: MSCs were labeled with superparamagnetic iron oxide particles (SPIO). We examined the effects of long-term labeling, possible toxicological consequences and the possible influence of progressive concentrations of SPIO on chondrogenic differentiation capacity. Results: No influence of various SPIO concentrations was noted on human bone marow MSC viability or proliferation. We demonstrated long-term (4 weeks) in vitro retention of SPIO by human bone marrow MSCs seeded in collagenic sponges under TGF-beta 1 chondrogenic conditions, detectable by Magnetic Resonance Imaging (MRI) and histology. Chondrogenic differentiation was demonstrated by molecular and histological analysis of labeled and unlabeled cells. Chondrogenic gene expression (COL2A2, ACAN, SOX9, COL10, COMP) was significantly altered in a dose-dependent manner in labeled cells, as were GAG and type II collagen staining. As expected, SPIO induced a dramatic decrease of MRI T2 values of sponges at 7T and 3T, even at low concentrations. Conclusions: This study clearly demonstrates (1) long-term in vitro MSC traceability using SPIO and MRI and (2) a deleterious dose-dependence of SPIO on TGF-beta 1 driven chondrogenesis in collagen sponges. Low concentrations (12.5-25 mu g Fe/mL) seem the best compromise to optimize both chondrogenesis and MRI labeling.	[Roeder, Emilie; Henrionnet, Christel; Gambier, Nicolas; Gillet, Pierre; Pinzano, Astrid] Univ Lorraine, CNRS, Unite Mixte Recherches 7365, Vandoeuvre Les Nancy, France; [Goebel, Jean Christophe; Beuf, Olivier; Grenier, Denis] Univ Lyon, CNRS, Ctr Rech Acquisit & Traitement Image Sante, Inst Natl Sci Appl Lyon,Inst Natl Sante & Rech Me, Villeurbanne, France; [Chen, Bailiang; Vuissoz, Pierre-Andre] Inst Natl Sante & Rech Med, U947, Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gillet, P (corresponding author), Univ Lorraine, CNRS, Unite Mixte Recherches 7365, Vandoeuvre Les Nancy, France.	Pierre.Gillet@univ-lorraine.fr	PINZANO, Astrid/ABD-5162-2020; BEUF, Olivier/H-6966-2014; Grenier, Denis/H-7904-2014; Vuissoz, Pierre-André/Y-8259-2019; CHEN, Bailiang/U-9572-2019	PINZANO, Astrid/0000-0002-3867-2676; BEUF, Olivier/0000-0002-4516-4565; Vuissoz, Pierre-André/0000-0003-3519-1743; CHEN, Bailiang/0000-0003-1038-7846; GILLET, Pierre/0000-0002-0598-7508; Roeder, Emilie/0000-0001-5992-6623; Christel, HENRIONNET/0000-0001-7484-0377	Agence Nationale de la Recherche-programme ANR Blanc 2009: Cartilage Engineering and MRI: Assessment of Biointegration and Biofunctionality in the Rat (CEMABIR) [ANR-09-BLANC-0150-01]; Region Lorraine Communaute Urbaine du Grand Nancy; Conseil General de Meurthe et Moselle	Agence Nationale de la Recherche-programme ANR Blanc 2009: Cartilage Engineering and MRI: Assessment of Biointegration and Biofunctionality in the Rat (CEMABIR)(French National Research Agency (ANR)); Region Lorraine Communaute Urbaine du Grand Nancy(Region Grand-Est); Conseil General de Meurthe et Moselle	This work was supported by grants from Agence Nationale de la Recherche -programme ANR Blanc 2009: Cartilage Engineering and MRI: Assessment of Biointegration and Biofunctionality in the Rat (CEMABIR, ANR-09-BLANC-0150-01) and grants from the Region Lorraine Communaute Urbaine du Grand Nancy, and Conseil General de Meurthe et Moselle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbab AS, 2005, NMR BIOMED, V18, P553, DOI 10.1002/nbm.991; Arbab AS, 2004, HUM GENE THER, V15, P351, DOI 10.1089/104303404322959506; Babic M, 2008, BIOCONJUGATE CHEM, V19, P740, DOI 10.1021/bc700410z; Boddington SE, 2011, MOL IMAGING BIOL, V13, P3, DOI 10.1007/s11307-010-0322-0; Boutry S, 2008, CONTRAST MEDIA MOL I, V3, P223, DOI 10.1002/cmmi.256; Bulte JWM, 2004, BLOOD, V104, P3410, DOI 10.1182/blood-2004-06-2117; Chajra H, 2008, BIO-MED MATER ENG, V18, pS33; Chen JR, 2012, ANN BIOMED ENG, V40, P2568, DOI 10.1007/s10439-012-0621-5; Daldrup-Link HE, 2003, RADIOLOGY, V228, P760, DOI 10.1148/radiol.2283020322; Farrell E, 2009, OSTEOARTHR CARTILAGE, V17, P961, DOI 10.1016/j.joca.2008.11.016; Farrell E, 2008, BIOCHEM BIOPH RES CO, V369, P1076, DOI 10.1016/j.bbrc.2008.02.159; Feng Y, 2011, J HUAZHONG U SCI-MED, V31, P204, DOI 10.1007/s11596-011-0253-2; Foldager CB, 2011, J MAGN RESON IMAGING, V33, P724, DOI 10.1002/jmri.22470; Frank JA, 2003, RADIOLOGY, V228, P480, DOI 10.1148/radiol.2281020638; Freyria AM, 2012, INJURY, V43, P259, DOI 10.1016/j.injury.2011.05.035; Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871; Henrionnet C, 2010, BIO-MED MATER ENG, V20, P175, DOI 10.3233/BME-2010-0629; Heymer A, 2008, BIOMATERIALS, V29, P1473, DOI 10.1016/j.biomaterials.2007.12.003; Hong H, 2010, CURR PHARM BIOTECHNO, V11, P685, DOI 10.2174/138920110792246500; Jing XH, 2008, JOINT BONE SPINE, V75, P432, DOI 10.1016/j.jbspin.2007.09.013; Khan WS, 2010, KNEE, V17, P369, DOI 10.1016/j.knee.2009.12.003; Kostura L, 2004, NMR BIOMED, V17, P513, DOI 10.1002/nbm.925; Markides H, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt337; Mueller MB, 2010, CELLS TISSUES ORGANS, V192, P158, DOI 10.1159/000313399; Neri M, 2008, STEM CELLS, V26, P505, DOI 10.1634/stemcells.2007-0251; Nieminen MT, 2012, J MAGN RESON IMAGING, V36, P1287, DOI 10.1002/jmri.23644; Pelttari K, 2008, INJURY, V39, pS58, DOI 10.1016/j.injury.2008.01.038; Perrier E, 2011, BIOTECHNOL LETT, V33, P2091, DOI 10.1007/s10529-011-0653-1; Qi Y, 2013, MOL BIOL REP; Ramaswamy S, 2009, TISSUE ENG PT A, V15, P3899, DOI 10.1089/ten.tea.2008.0677; Reddy AM, 2010, J KOREAN MED SCI, V25, P211, DOI 10.3346/jkms.2010.25.2.211; Saha S, 2013, J TISSUE ENG REGEN M, V7, P461, DOI 10.1002/term.544; Schafer R, 2009, CYTOTHERAPY, V11, P68, DOI 10.1080/14653240802666043; Shintani N, 2011, Eur Cell Mater, V22, P302; Shintani N, 2011, EUR CELLS MATER, V22, P319; Studer D, 2012, EUR CELLS MATER, V24, P118, DOI 10.22203/eCM.v024a09; Sykova E, 2011, METHODS MOL BIOL, V750, P79, DOI 10.1007/978-1-61779-145-1_5; Terrovitis JV, 2006, TISSUE ENG, V12, P2765, DOI 10.1089/ten.2006.12.2765; van Buul GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017001; Yang CY, 2011, MOL IMAGING BIOL, V13, P443, DOI 10.1007/s11307-010-0360-7; Zhu WZ, 2007, J HUAZHONG U SCI-MED, V27, P107, DOI 10.1007/s11596-007-0130-1	41	40	41	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98451	10.1371/journal.pone.0098451	http://dx.doi.org/10.1371/journal.pone.0098451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878844	gold, Green Submitted, Green Published			2022-12-25	WOS:000338101500061
J	Takeda, Y; Yamanaka, K; Yamagishi, N; Sato, M				Takeda, Yusuke; Yamanaka, Kentaro; Yamagishi, Noriko; Sato, Masa-aki			Revealing Time-Unlocked Brain Activity from MEG Measurements by Common Waveform Estimation	PLOS ONE			English	Article							DENOISING SOURCE SEPARATION; EVENT-RELATED POTENTIALS; HUMAN AUDITORY-CORTEX; ALPHA OSCILLATIONS; ATTENTIONAL MODULATION; SELECTIVE ATTENTION; CORTICAL CURRENTS; VISUAL-CORTEX; 10-HZ RHYTHM; MINDS EYE	Brain activities related to cognitive functions, such as attention, occur with unknown and variable delays after stimulus onsets. Recently, we proposed a method (Common Waveform Estimation, CWE) that could extract such brain activities from magnetoencephalography (MEG) or electroencephalography (EEG) measurements. CWE estimates spatiotemporal MEG/EEG patterns occurring with unknown and variable delays, referred to here as unlocked waveforms, without hypotheses about their shapes. The purpose of this study is to demonstrate the usefulness of CWE for cognitive neuroscience. For this purpose, we show procedures to estimate unlocked waveforms using CWE and to examine their role. We applied CWE to the MEG epochs during Go trials of a visual Go/NoGo task. This revealed unlocked waveforms with interesting properties, specifically large alpha oscillations around the temporal areas. To examine the role of the unlocked waveform, we attempted to estimate the strength of the brain activity of the unlocked waveform in various conditions. We made a spatial filter to extract the component reflecting the brain activity of the unlocked waveform, applied this spatial filter to MEG data under different conditions (a passive viewing, a simple reaction time, and Go/NoGo tasks), and calculated the powers of the extracted components. Comparing the powers across these conditions suggests that the unlocked waveforms may reflect the inhibition of the task-irrelevant activities in the temporal regions while the subject attends to the visual stimulus. Our results demonstrate that CWE is a potential tool for revealing new findings of cognitive brain functions without any hypothesis in advance.	[Takeda, Yusuke; Sato, Masa-aki] ATR Neural Informat Anal Labs, Dept Computat Brain Imaging, Kyoto, Japan; [Yamanaka, Kentaro] Showa Womens Univ, Grad Sch Human Life Sci, Tokyo, Japan; [Yamagishi, Noriko] ATR Cognit Mech Labs, Dept Cognit Neurosci, Kyoto, Japan; [Yamagishi, Noriko] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Brain Networks & Commun Lab, Osaka, Japan; [Yamagishi, Noriko] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	National Institute of Information & Communications Technology (NICT) - Japan; Japan Science & Technology Agency (JST)	Takeda, Y (corresponding author), ATR Neural Informat Anal Labs, Dept Computat Brain Imaging, Kyoto, Japan.	takeda@atr.jp	Yamanaka, Kentaro/HII-3291-2022	Yamanaka, Kentaro/0000-0002-5578-440X	National Institute of Information and Communications Technology; JSPS KAKENHI Grant [23700499]; Grants-in-Aid for Scientific Research [26540075] Funding Source: KAKEN	National Institute of Information and Communications Technology; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by contracts with the National Institute of Information and Communications Technology entitled, "Multimodal integration for brain imaging measurements'' and "Development of network dynamics modeling methods for human brain data simulation systems'', and JSPS KAKENHI Grant Number 23700499. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara T, 2012, NEUROIMAGE, V59, P4006, DOI 10.1016/j.neuroimage.2011.09.087; Anderson KL, 2011, NEUROSCIENCE, V180, P165, DOI 10.1016/j.neuroscience.2011.02.004; [Anonymous], 2000, EEGLAB ICA TOOLBOX P; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Callan D, 2010, NEUROIMAGE, V51, P844, DOI 10.1016/j.neuroimage.2010.02.027; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; David O, 2006, NEUROIMAGE, V31, P1580, DOI 10.1016/j.neuroimage.2006.02.034; de Cheveigne A, 2007, J NEUROSCI METH, V165, P297, DOI 10.1016/j.jneumeth.2007.06.003; de Cheveigne A, 2010, J NEUROSCI METH, V189, P113, DOI 10.1016/j.jneumeth.2010.03.002; Foxe JJ, 1998, NEUROREPORT, V9, P3929, DOI 10.1097/00001756-199812010-00030; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Fu KMG, 2001, COGNITIVE BRAIN RES, V12, P145, DOI 10.1016/S0926-6410(01)00034-9; Haegens S, 2010, HUM BRAIN MAPP, V31, P26, DOI 10.1002/hbm.20842; Hairston WD, 2008, NEUROREPORT, V19, P151, DOI 10.1097/WNR.0b013e3282f42509; Jensen O, 2002, CEREB CORTEX, V12, P877, DOI 10.1093/cercor/12.8.877; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; KAWASHIMA R, 1995, P NATL ACAD SCI USA, V92, P5969, DOI 10.1073/pnas.92.13.5969; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; KOK A, 1988, BIOL PSYCHOL, V27, P51, DOI 10.1016/0301-0511(88)90005-1; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Laurienti PJ, 2002, J COGNITIVE NEUROSCI, V14, P420, DOI 10.1162/089892902317361930; Lehtela L, 1997, NEUROSCI LETT, V222, P111, DOI 10.1016/S0304-3940(97)13361-4; Mo J, 2011, J NEUROSCI, V31, P878, DOI 10.1523/JNEUROSCI.5295-10.2011; Morioka H, 2014, NEUROIMAGE, V90, P128, DOI 10.1016/j.neuroimage.2013.12.035; Mozolic JL, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-35; PFURTSCHELLER G, 1992, ELECTROEN CLIN NEURO, V83, P62, DOI 10.1016/0013-4694(92)90133-3; PHAM D T, 1987, Biometrika, V74, P525; RIERADIAZ JJ, 1995, INT J BIOMED COMPUT, V38, P109, DOI 10.1016/0020-7101(94)01030-5; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Rinne Teemu, 2010, Open Neuroimag J, V4, P187, DOI 10.2174/1874440001004010187; Sato M, 2004, NEUROIMAGE, V23, P806, DOI 10.1016/j.neuroimage.2004.06.037; Shibata K, 2008, CEREB CORTEX, V18, P1664, DOI 10.1093/cercor/bhm194; Takeda Y, 2008, NEUROIMAGE, V41, P777, DOI 10.1016/j.neuroimage.2008.03.012; Takeda Y, 2008, NEUROIMAGE, V39, P742, DOI 10.1016/j.neuroimage.2007.09.003; Takeda Y, 2010, NEUROIMAGE, V51, P629, DOI 10.1016/j.neuroimage.2010.02.002; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; TallonBaudry C, 1996, J NEUROSCI, V16, P4240; TIIHONEN J, 1991, NEUROSCI LETT, V129, P303, DOI 10.1016/0304-3940(91)90486-D; Toda A, 2011, NEUROIMAGE, V54, P892, DOI 10.1016/j.neuroimage.2010.09.057; VERLEGER R, 1988, BIOL PSYCHOL, V27, P45, DOI 10.1016/0301-0511(88)90004-X; WOODY CD, 1967, MED BIOL ENG, V5, P539, DOI 10.1007/BF02474247; Yamagishi N, 2003, NEUROIMAGE, V20, P98, DOI 10.1016/S1053-8119(03)00341-0; Yamagishi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074962; Yin G, 2011, IEEE T BIO-MED ENG, V58, P1534, DOI 10.1109/TBME.2010.2090152; Yin G, 2009, J NEUROSCI METH, V178, P219, DOI 10.1016/j.jneumeth.2008.11.022; Yoshimura N, 2012, NEUROIMAGE, V59, P1324, DOI 10.1016/j.neuroimage.2011.08.029; Yoshioka T, 2008, NEUROIMAGE, V42, P1397, DOI 10.1016/j.neuroimage.2008.06.013; Zhang J, 1998, J NEUROSCI METH, V80, P49, DOI 10.1016/S0165-0270(97)00194-5	50	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98014	10.1371/journal.pone.0098014	http://dx.doi.org/10.1371/journal.pone.0098014			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879410	Green Published, Green Submitted, gold			2022-12-25	WOS:000338101500029
J	Yi, GS; Wang, J; Wei, XL; Tsang, KM; Chan, WL; Deng, B				Yi, Guo-Sheng; Wang, Jiang; Wei, Xi-Le; Tsang, Kai-Ming; Chan, Wai-Lok; Deng, Bin			Neuronal Spike Initiation Modulated by Extracellular Electric Fields	PLOS ONE			English	Article							RAT HIPPOCAMPAL SLICES; MAGNETIC STIMULATION; IN-VITRO; EPILEPTIFORM ACTIVITY; SYNCHRONIZATION; EXCITABILITY; MODEL; POLARIZATION; OSCILLATIONS; BIFURCATION	Based on a reduced two-compartment model, the dynamical and biophysical mechanism underlying the spike initiation of the neuron to extracellular electric fields is investigated in this paper. With stability and phase plane analysis, we first investigate in detail the dynamical properties of neuronal spike initiation induced by geometric parameter and internal coupling conductance. The geometric parameter is the ratio between soma area and total membrane area, which describes the proportion of area occupied by somatic chamber. It is found that varying it could qualitatively alter the bifurcation structures of equilibrium as well as neuronal phase portraits, which remain unchanged when varying internal coupling conductance. By analyzing the activating properties of somatic membrane currents at subthreshold potentials, we explore the relevant biophysical basis of spike initiation dynamics induced by these two parameters. It is observed that increasing geometric parameter could greatly decrease the intensity of the internal current flowing from soma to dendrite, which switches spike initiation dynamics from Hopf bifurcation to SNIC bifurcation; increasing internal coupling conductance could lead to the increase of this outward internal current, whereas the increasing range is so small that it could not qualitatively alter the spike initiation dynamics. These results highlight that neuronal geometric parameter is a crucial factor in determining the spike initiation dynamics to electric fields. The finding is useful to interpret the functional significance of neuronal biophysical properties in their encoding dynamics, which could contribute to uncovering how neuron encodes electric field signals.	[Yi, Guo-Sheng; Wang, Jiang; Wei, Xi-Le; Deng, Bin] Tianjin Univ, Sch Elect Engn & Automat, Tianjin 300072, Peoples R China; [Tsang, Kai-Ming; Chan, Wai-Lok] Hong Kong Polytech Univ, Dept Elect Engn, Hong Kong, Hong Kong, Peoples R China	Tianjin University; Hong Kong Polytechnic University	Wei, XL (corresponding author), Tianjin Univ, Sch Elect Engn & Automat, Tianjin 300072, Peoples R China.	xilewei@tju.edu.cn		TSANG, Kai Ming/0000-0002-1516-3174; CHAN, Wai Lok/0000-0002-4637-0344	National Natural Science Foundation of China [61072012, 61172009, 61372010]; Tianjin Municipal Natural Science Foundation [12JCZDJC21100, 13JCZDJC27900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Natural Science Foundation(Natural Science Foundation of Tianjin)	This work is supported by the National Natural Science Foundation of China under Grants 61072012 (URL:http://www.nsfc.gov.cn/publish/portal0/default.htm), 61172009 (URL: http://www.nsfc.gov.cn/publish/portal0/default.htm) and 61372010 (URL: http://www.nsfc.gov.cn/publish/portal0/default.htm), and Tianjin Municipal Natural Science Foundation under Grants 12JCZDJC21100 (URL: http://www.tstc.gov.cn/) and 13JCZDJC27900 (URL: http://www.tstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAWIN SM, 1984, BRAIN RES, V323, P227, DOI 10.1016/0006-8993(84)90293-2; Berzhanskaya J, 2013, J COMPUT NEUROSCI, V34, P369, DOI 10.1007/s10827-012-0426-4; Bikson M, 2004, J PHYSIOL-LONDON, V557, P175, DOI 10.1113/jphysiol.2003.055772; CHAN CY, 1986, J PHYSIOL-LONDON, V371, P89, DOI 10.1113/jphysiol.1986.sp015963; CHAN CY, 1988, J PHYSIOL-LONDON, V402, P751, DOI 10.1113/jphysiol.1988.sp017232; Colwell LJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000265; Deans JK, 2007, J PHYSIOL-LONDON, V583, P555, DOI 10.1113/jphysiol.2007.137711; Durand DM, 2003, RADIAT PROT DOSIM, V106, P325, DOI 10.1093/oxfordjournals.rpd.a006368; Ghai RS, 2000, J NEUROPHYSIOL, V84, P274, DOI 10.1152/jn.2000.84.1.274; Gluckman BJ, 1996, J NEUROPHYSIOL, V76, P4202, DOI 10.1152/jn.1996.76.6.4202; Gluckman BJ, 2001, J NEUROSCI, V21, P590, DOI 10.1523/JNEUROSCI.21-02-00590.2001; Izhikevich E M, 2005, DYNAMICAL SYSTEMS NE; JEFFERYS JGR, 1981, J PHYSIOL-LONDON, V319, P143, DOI 10.1113/jphysiol.1981.sp013897; Lazutkin D, 2010, IEEE ENG MED BIO, P581, DOI 10.1109/IEMBS.2010.5626402; Nguyen LH, 2012, BIOL CYBERN, V106, P587, DOI 10.1007/s00422-012-0508-4; Lundstrom BN, 2009, J COMPUT NEUROSCI, V27, P277, DOI 10.1007/s10827-009-0142-x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Park EH, 2005, J COMPUT NEUROSCI, V19, P53, DOI 10.1007/s10827-005-0214-5; Park EH, 2003, NEUROCOMPUTING, V52-4, P169, DOI 10.1016/S0925-2312(02)00820-2; Pashut T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002022; Peterchev AV, 2012, BRAIN STIMUL, V5, P435, DOI 10.1016/j.brs.2011.10.001; Peterchev AV, 2010, J ECT, V26, P159, DOI 10.1097/YCT.0b013e3181e48165; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; Prescott SA, 2006, J NEUROSCI, V26, P9084, DOI 10.1523/JNEUROSCI.1388-06.2006; Prescott SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000198; Prescott SA, 2008, J NEUROPHYSIOL, V100, P3030, DOI 10.1152/jn.90634.2008; Prescott SA, 2008, J NEUROSCI, V28, P13649, DOI 10.1523/JNEUROSCI.1792-08.2008; Radman T, 2009, BRAIN STIMUL, V2, P215, DOI 10.1016/j.brs.2009.03.007; Reato D, 2010, J NEUROSCI, V30, P15067, DOI 10.1523/JNEUROSCI.2059-10.2010; Richardson KA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.028103; Rotem A, 2006, IEEE T BIO-MED ENG, V53, P414, DOI 10.1109/TBME.2005.869770; Rotem A, 2008, BIOPHYS J, V94, P5065, DOI 10.1529/biophysj.107.125708; Sunderam S, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046009; Svirskis G, 1997, BIOPHYS J, V73, P3004, DOI 10.1016/S0006-3495(97)78329-2; Thomas AW, 2007, PAIN RES MANAG, V12, P249, DOI 10.1155/2007/626072; TRANCHINA D, 1986, BIOPHYS J, V50, P1139, DOI 10.1016/S0006-3495(86)83558-5; Wagner T, 2007, ANNU REV BIOMED ENG, V9, P527, DOI 10.1146/annurev.bioeng.9.061206.133100; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; Wang HX, 2013, COGN NEURODYNAMICS, V7, P121, DOI 10.1007/s11571-012-9222-0; Wang HX, 2011, CHAOS SOLITON FRACT, V44, P667, DOI 10.1016/j.chaos.2011.06.003; Wei XL, 2014, COGN NEURODYNAMICS, V8, P177, DOI 10.1007/s11571-013-9269-6; Wester JC, 2013, J COMPUT NEUROSCI, V35, P1, DOI 10.1007/s10827-012-0436-2; Yi GS, 2014, J COMPUT NEUROSCI, V36, P383, DOI 10.1007/s10827-013-0479-z	43	26	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97481	10.1371/journal.pone.0097481	http://dx.doi.org/10.1371/journal.pone.0097481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24873827	gold, Green Published, Green Submitted			2022-12-25	WOS:000336790800007
J	Carlson, BE; McGinley, S; Rowe, MP				Carlson, Bradley E.; McGinley, Shannen; Rowe, Matthew P.			Meek Males and Fighting Females: Sexually-Dimorphic Antipredator Behavior and Locomotor Performance Is Explained by Morphology in Bark Scorpions (Centruroides vittatus)	PLOS ONE			English	Article							SIZE DIMORPHISM; SPRINT SPEED; TROPHIC MORPHOLOGY; TRAIT COMPENSATION; ECOLOGICAL CAUSES; GRAVID LIZARDS; LIFE-HISTORY; BUTHIDAE; EVOLUTION; ALLOMETRY	Sexual dimorphism can result from sexual or ecological selective pressures, but the importance of alternative reproductive roles and trait compensation in generating phenotypic differences between the sexes is poorly understood. We evaluated morphological and behavioral sexual dimorphism in striped bark scorpions (Centruroides vittatus). We propose that reproductive roles have driven sexually dimorphic body mass in this species which produces sex differences in locomotor performance. Poor locomotor performance in the females (due to the burden of being gravid) favors compensatory aggression as part of an alternative defensive strategy, while male morphology is coadapted to support a sprinting-based defensive strategy. We tested the effects of sex and morphology on stinging and sprinting performance and characterized overall differences between the sexes in aggressiveness towards simulated threats. Greater body mass was associated with higher sting rates and slower sprinting within sexes, which explained the greater aggression of females (the heavier sex) and, along with longer legs in males, the improved sprint performance in males. These findings suggest females are aggressive to compensate for locomotor costs of reproduction while males possess longer legs to enhance sprinting for predator evasion and mate finding. Sexual dimorphism in the metasoma ("tail'') was unrelated to stinging and sprinting performance and may best be explained by sexual selection.	[Carlson, Bradley E.; McGinley, Shannen] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Carlson, Bradley E.] Penn State Univ, Intercoll Grad Degree Program Ecol, University Pk, PA 16802 USA; [Rowe, Matthew P.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Texas State University System; Sam Houston State University	Carlson, BE (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	bec169@psu.edu	Carlson, Bradley E/A-8766-2012	Carlson, Bradley E/0000-0001-8667-0416	National Science Foundation grant (IOS) [1122115]; Department of Biological Sciences at Sam Houston State University	National Science Foundation grant (IOS); Department of Biological Sciences at Sam Houston State University	This research was partially supported by a National Science Foundation grant (IOS # 1122115) to A. Rowe, H. Zakon, and M. Rowe, as well as by the Department of Biological Sciences at Sam Houston State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander A. J., 1959, Proceedings of the Zoological Society of London, V133, P145; BALLINGER RE, 1979, HERPETOLOGICA, V35, P114; BAUWENS D, 1995, EVOLUTION, V49, P848, DOI 10.1111/j.1558-5646.1995.tb02321.x; Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x; Bonduriansky R, 2007, EVOLUTION, V61, P838, DOI 10.1111/j.1558-5646.2007.00081.x; Booncham U, 2007, NU SCI J, V4, P42; Brandt Y, 2007, FUNCT ECOL, V21, P379, DOI 10.1111/j.1365-2435.2007.01243.x; Brown CA, 2000, AM MIDL NAT, V144, P406, DOI 10.1674/0003-0031(2000)144[0406:PCBITS]2.0.CO;2; Bulte G, 2008, FUNCT ECOL, V22, P824, DOI 10.1111/j.1365-2435.2008.01422.x; CAMILLERI C, 1990, COPEIA, P649, DOI 10.2307/1446430; Carlson BE, 2009, J ARACHNOL, V37, P321, DOI 10.1636/Hi09-06.1; Carrier DR, 2001, J EXP BIOL, V204, P3917; COOPER WE, 1990, BEHAV ECOL SOCIOBIOL, V27, P153; Cotton PA, 2004, ECOLOGY, V85, P1581, DOI 10.1890/03-3104; DeWitt TJ, 1999, ANIM BEHAV, V58, P397, DOI 10.1006/anbe.1999.1158; Foellmer MW, 2005, OECOLOGIA, V142, P653, DOI 10.1007/s00442-004-1756-3; Framenau VW, 2005, J ARACHNOL, V33, P334, DOI 10.1636/04-57.1; FRANCKE OF, 1979, J ARACHNOL, V7, P223; FRANCKE OF, 1982, J ARACHNOL, V10, P223; HARINGTON A, 1977, J ARACHNOL, V5, P243; HEDRICK AV, 1989, TRENDS ECOL EVOL, V4, P136, DOI 10.1016/0169-5347(89)90212-7; Husak JF, 2008, EVOL ECOL RES, V10, P213; Husak JF, 2011, FUNCT ECOL, V25, P608, DOI 10.1111/j.1365-2435.2010.01827.x; Husak JF, 2011, BEHAVIOUR, V148, P1, DOI 10.1163/000579510X541265; Kaltsas D, 2010, J NAT HIST, V44, P1445, DOI 10.1080/00222931003632732; Koch L.E., 1977, Records W Aust Mus, V5, P83; Kodric-Brown A, 2006, P NATL ACAD SCI USA, V103, P8733, DOI 10.1073/pnas.0602994103; Martin J, 1998, FUNCT ECOL, V12, P794, DOI 10.1046/j.1365-2435.1998.00247.x; MCDANIEL M M, 1968, Entomological News, V79, P278; McReynolds CN, 2008, J ARACHNOL, V36, P557, DOI 10.1636/T07-07.1; Newlands G., 1972, Koedoe, V15, P37; Nisani Z, 2007, COMP BIOCHEM PHYS A, V147, P509, DOI 10.1016/j.cbpa.2007.01.027; Nisani Z, 2012, TOXICON, V60, P315, DOI 10.1016/j.toxicon.2012.04.343; O'Connell DJ, 1998, J HERPETOL, V32, P75, DOI 10.2307/1565482; Olsson M, 2000, J EVOLUTION BIOL, V13, P263; Oufiero CE, 2007, FUNCT ECOL, V21, P676, DOI 10.1111/j.1365-2435.2007.01259.x; POLIS GA, 1979, J ARACHNOL, V7, P33; Polis GA, 1990, BIOL SCORPIONS, P224; Prendini L, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)502[0001:NSAFRS]2.0.CO;2; Prenter J, 2010, FUNCT ECOL, V24, P400, DOI 10.1111/j.1365-2435.2009.01633.x; Pruitt JN, 2010, J ZOOL, V281, P39, DOI 10.1111/j.1469-7998.2009.00677.x; Pruitt JN, 2010, FUNCT ECOL, V24, P392, DOI 10.1111/j.1365-2435.2009.01655.x; Pullin AO, 2012, IEEE INT CONF ROBOT, P5086, DOI 10.1109/ICRA.2012.6225261; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2012, R LANG ENV STAT COMP; Rowe AH, 2006, ANIM BEHAV, V71, P725, DOI 10.1016/j.anbehav.2005.08.003; Sanchez-Quiros C, 2012, J ARACHNOL, V40, P338, DOI 10.1636/B12-14.1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaffer LR, 1996, ANIM BEHAV, V51, P1017, DOI 10.1006/anbe.1996.0104; SHELLEY RM, 1995, J ARACHNOL, V23, P100; Shine R, 2000, BEHAV ECOL, V11, P239, DOI 10.1093/beheco/11.3.239; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; Shine R, 2003, OECOLOGIA, V136, P450, DOI 10.1007/s00442-003-1281-9; Shine R, 1998, J ZOOL, V246, P203; SLATKIN M, 1984, EVOLUTION, V38, P622, DOI 10.1111/j.1558-5646.1984.tb00327.x; Smith DG, 1997, BEHAV ECOL, V8, P622, DOI 10.1093/beheco/8.6.622; Stahnke HL, 1957, AM BIOL TEACH, V19, P75; van der Meijden A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078955; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Willey JS, 2004, J EXP BIOL, V207, P553, DOI 10.1242/jeb.00774; WILLIAMS SC, 1987, ANNU REV ENTOMOL, V32, P275, DOI 10.1146/annurev.en.32.010187.001423; YAMASHITA T, 2004, EUSCORPIUS, V17, P25	62	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97648	10.1371/journal.pone.0097648	http://dx.doi.org/10.1371/journal.pone.0097648			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870611	gold, Green Submitted, Green Published			2022-12-25	WOS:000336858300017
J	Chaiyachati, KH; Gordon, K; Long, T; Levin, W; Khan, A; Meyer, E; Justice, A; Brienza, R				Chaiyachati, Krisda H.; Gordon, Kirsha; Long, Theodore; Levin, Woody; Khan, Ali; Meyer, Emily; Justice, Amy; Brienza, Rebecca			Continuity in a VA Patient-Centered Medical Home Reduces Emergency Department Visits	PLOS ONE			English	Article							CONTROLLED-TRIAL; HEALTH SYSTEM; PRIMARY-CARE; VETERANS; LESSONS; DISEASE	Background: One major goal of the Patient-Centered Medical Home (PCMH) is to improve continuity of care between patients and providers and reduce the utilization of non-primary care services like the emergency department (ED). Objective: To characterize continuity under the Veterans Health Administration's PCMH model - the Patient Aligned Care Team (PACT), at one large Veterans Affair's (VA's) primary care clinic, determine the characteristics associated with high levels of continuity, and assess the association between continuity and ED visits. Design: Retrospective, observational cohort study of patients at the West Haven VA (WHVA) Primary Care Clinic from March 2011 to February 2012. Patients: The 13,495 patients with established care at the Clinic, having at least one visit, one year before March 2011. Main Measures: Our exposure variable was continuity of care -a patient seeing their assigned primary care provider (PCP) at each clinic visit. The outcome of interest was having an ED visit. Results: The patients encompassed 42,969 total clinic visits, and 3185 (24%) of them had 15,458 ED visits. In a multivariable logistic regression analysis, patients with continuity of care - at least one visit with their assigned PCP - had lower ED utilization compared to individuals without continuity (adjusted odds ratio [AOR] 0.54; 95% CI: 0.41, 0.71), controlling for frequency of primary care visits, comorbidities, insurance, distance from the ED, and having a trainee PCP assigned. Likewise, the adjusted rate of ED visits was 544/1000 person-year (PY) for patients with continuity vs. 784/1000 PY for patients without continuity (p = 0.001). Compared to patients with low continuity (<33% of visits), individuals with medium (33-50%) and high (>50%) continuity were less likely to utilize the ED. Conclusions: Strong continuity of care is associated with decreased ED utilization in a PCMH model and improving continuity may help reduce the utilization of non-primary care services.	[Chaiyachati, Krisda H.; Long, Theodore; Khan, Ali; Meyer, Emily; Justice, Amy; Brienza, Rebecca] VA Connecticut Healthcare Syst, Ctr Excellence Primary Care Educ, West Haven, CT 06516 USA; [Chaiyachati, Krisda H.; Long, Theodore; Khan, Ali; Justice, Amy; Brienza, Rebecca] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Gordon, Kirsha; Levin, Woody; Justice, Amy; Brienza, Rebecca] VA Connecticut Healthcare Syst, West Haven, CT USA; [Long, Theodore] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT USA; [Levin, Woody] Evergreen Design, Guilford, CT USA; [Khan, Ali] Iora Hlth, Collect Primary Care, Brooklyn, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Chaiyachati, KH (corresponding author), VA Connecticut Healthcare Syst, Ctr Excellence Primary Care Educ, West Haven, CT 06516 USA.	Krisda.Chaiyachati@yale.edu		Chaiyachati, Krisda/0000-0003-3326-6641	Office of Academic Affiliations; VA Connecticut Health System Center of Excellence in Primary Care Education; Evergreen Design; Iora Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA020790] Funding Source: NIH RePORTER	Office of Academic Affiliations(US Department of Veterans Affairs); VA Connecticut Health System Center of Excellence in Primary Care Education; Evergreen Design; Iora Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This publication was supported by the Office of Academic Affiliations and the VA Connecticut Health System Center of Excellence in Primary Care Education. Neither funding source had any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation or review of the manuscript. The Office of Academic Affiliation did approve the manuscript for publication, but no modifications were made to the manuscript. Evergreen Design provided support in the form of a salary for author WL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Iora Health provided support in the form of a salary for author AK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2007, JOINT PRINC PAT CTR; BICE TW, 1977, MED CARE, V15, P347, DOI 10.1097/00005650-197704000-00010; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; Burge F, 2003, MED CARE, V41, P992, DOI 10.1097/00005650-200308000-00012; Chang A, 2012, J GEN INTERN MED; Dewan NA, 2011, COPD, V8, P153, DOI 10.3109/15412555.2011.560129; Dewing S, 2012, AIDS BEHAV, V16, P1286, DOI 10.1007/s10461-011-0059-z; Duncan LG, 2012, J PAIN SYMPTOM MANAG, V43, P161, DOI 10.1016/j.jpainsymman.2011.04.007; Fields D, 2010, HEALTH AFFAIR, V29, P819, DOI 10.1377/hlthaff.2010.0009; Flores-Mateo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035903; Gill JM, 2000, ARCH FAM MED, V9, P333, DOI 10.1001/archfami.9.4.333; Grafstein E, 2013, ACAD EMERG MED, V20, P63, DOI 10.1111/acem.12063; Grumbach K., 2010, OUTCOMES IMPLEMENTIN; Harbrecht MG, 2012, HEALTH AFFAIR, V31, P2010, DOI 10.1377/hlthaff.2012.0359; Henschen BL, 2013, J GEN INTERN MED; Hochman ME, 2013, JAMA INTERN MED; Ionescu-Ittu R, 2007, CAN MED ASSOC J, V177, P1362, DOI 10.1503/cmaj.061615; Ishani A, 2011, DIABETES CARE, V34, P1689, DOI 10.2337/dc10-2121; Justice AC, 2006, MED CARE, V44, pS52, DOI 10.1097/01.mlr.0000228003.08925.8c; Kuehn BM, 2012, JAMA-J AM MED ASSOC, V307, P442, DOI 10.1001/jama.2012.47; Lee TA, 2007, J GEN INTERN MED, V22, P403, DOI 10.1007/s11606-007-0277-2; MAGILL MK, 1987, J FAM PRACTICE, V24, P165; Markova T, 2012, J AM BOARD FAM MED, V25, P224, DOI 10.3122/jabfm.2012.02.110181; McCusker J, 2012, CAN MED ASSOC J, V184, pE307, DOI 10.1503/cmaj.111069; Nutting PA, 2011, HEALTH AFFAIR, V30, P439, DOI 10.1377/hlthaff.2010.0159; Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381; Reid RJ, 2009, AM J MANAG CARE, V15, pE71; Rice KL, 2010, AM J RESP CRIT CARE, V182, P890, DOI 10.1164/rccm.200910-1579OC; Roby DH, 2010, MED CARE RES REV, V67, P412, DOI 10.1177/1077558710368682; Rosland AM, 2013, AM J MANAG CARE, V19, pE263; Sia C, 2004, PEDIATRICS, V113, P1473; Sidorov JE, 2008, HEALTH AFFAIR, V27, P1231, DOI 10.1377/hlthaff.27.5.1231; Westover AN, 2007, ARCH GEN PSYCHIAT, V64, P495, DOI 10.1001/archpsyc.64.4.495; Wharam JF, 2013, HEALTH AFFAIR, V32, P1398, DOI 10.1377/hlthaff.2012.1426	34	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e96356	10.1371/journal.pone.0096356	http://dx.doi.org/10.1371/journal.pone.0096356			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5NG	24867300	Green Submitted, gold, Green Published			2022-12-25	WOS:000336914100004
J	Greco, M; Saez, CA; Brown, MT; Bitonti, MB				Greco, Maria; Saez, Claudio A.; Brown, Murray T.; Bitonti, Maria Beatrice			A Simple and Effective Method for High Quality Co-Extraction of Genomic DNA and Total RNA from Low Biomass Ectocarpus siliculosus, the Model Brown Alga	PLOS ONE			English	Article							MARINE FOULING ALGA; PHENOLIC-COMPOUNDS; COPPER TOLERANCE; LARGE-SCALE; EXTRACTION; POLYSACCHARIDES; PHAEOPHYCEAE; PROTOCOL; NORMALIZATION; LAMINARIALES	The brown seaweed Ectocarpus siliculosus is an emerging model species distributed worldwide in temperate coastal ecosystems. Over 1500 strains of E. siliculosus are available in culture from a broad range of geographic locations and ecological niches. To elucidate the molecular mechanisms underlying its capacity to cope with different environmental and biotic stressors, genomic and transcriptomic studies are necessary; this requires the co-isolation of genomic DNA and total RNA. In brown algae, extraction of nucleic acids is hindered by high concentrations of secondary metabolites that co-precipitate with nucleic acids. Here, we propose a reliable, rapid and cost-effective procedure for the co-isolation of high-quality nucleic acids using small quantities of biomass (25-, 50- and 100 mg) from strains of E. siliculosus (RHO12; LIA4A; EC524 and REP10-11) isolated from sites with different environmental conditions. The procedure employs a high pH extraction buffer (pH 9.5) which contains 100 mM Tris-HCl and 150 mM NaCl, with the addition of 5 mM DTT and 1% sarkosyl to ensure maximum solubility of nucleic acids, effective inhibition of nuclease activity and removal of interfering contaminants (e. g. polysaccharides, polyphenols). The use of sodium acetate together with isopropanol shortened precipitation time and enhanced the yields of DNA/RNA. A phenol: chlorophorm:isoamyl alcohol step was subsequently used to purify the nucleic acids. The present protocol produces high yields of nucleic acids from only 25 mg of fresh algal biomass (0.195 and 0.284 mu g mg(-1) fresh weigh of RNA and DNA, respectively) and the high quality of the extracted nucleic acids was confirmed through spectrophotometric and electrophoretic analyses. The isolated RNA can be used directly in downstream applications such as RT-PCR and the genomic DNA was suitable for PCR, producing reliable restriction enzyme digestion patterns. Co-isolation of DNA/RNA from different strains indicates that this method is likely to have wider applications for intra-and inter-specific studies on other brown algae.	[Greco, Maria; Bitonti, Maria Beatrice] Univ Calabria, Dept Biol Ecol & Earth Sci, Lab Plant Cytophysiol, I-87036 Cosenza, Italy; [Saez, Claudio A.; Brown, Murray T.] Univ Plymouth, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England; [Saez, Claudio A.] Univ Santiago Chile, Fac Quim & Biol, Dept Biol, Santiago, Chile	University of Calabria; University of Plymouth; Universidad de Santiago de Chile	Greco, M (corresponding author), Univ Calabria, Dept Biol Ecol & Earth Sci, Lab Plant Cytophysiol, I-87036 Cosenza, Italy.	maria.greco@unical.it	Sáez, Claudio/AAP-6923-2021; Saez, Claudio/F-5978-2015; Bitonti, Maria/AAO-7345-2020; Brown, Murray/K-5291-2014	Sáez, Claudio/0000-0002-5037-3484; Saez, Claudio/0000-0002-5037-3484; Greco, Maria/0000-0002-1404-6937; Brown, Murray/0000-0003-2655-8611	CONICYT Becas Chile Scholarship [72110557]	CONICYT Becas Chile Scholarship	This study was funded by CONICYT Becas Chile Scholarship (72110557) awarded to Claudio A. Saez for doctoral studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth C., 1994, Plant Molecular Biology Reporter, V12, P198, DOI 10.1007/BF02668741; ARAKI S, 1992, NIPPON SUISAN GAKK, V58, P477; Asif MH, 2000, PLANT MOL BIOL REP, V18, P109, DOI 10.1007/BF02824018; Azevedo H, 2003, PLANT MOL BIOL REP, V21, P333, DOI 10.1007/BF02772582; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Birtic S, 2006, PHYTOCHEM ANALYSIS, V17, P144, DOI 10.1002/pca.903; Boehringer Mannheim, 1990, REAG MOL BIOL CAT, P255; Box MS, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-7; Brooks G., 1998, BIOTECHNOLOGY HEALTH; Buckingham L, 2007, MOL DIAGNOSTICS FUND; Charrier B, 2008, NEW PHYTOL, V177, P319, DOI 10.1111/j.1469-8137.2007.02304.x; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cock JM, 2010, NATURE, V465, P617, DOI 10.1038/nature09016; Coelho Susana M, 2012, Cold Spring Harb Protoc, V2012, P365, DOI 10.1101/pdb.prot067967; COYER JA, 1995, J PHYCOL, V31, P177, DOI 10.1111/j.0022-3646.1995.00177.x; CRONSHAW J, 1958, BIOCHIM BIOPHYS ACTA, V27, P89, DOI 10.1016/0006-3002(58)90295-6; Cseke L.J., 2004, HDB MOL CELLULAR MET; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Davis RH, 2004, NAT REV GENET, V5, p69A, DOI 10.1038/nrg1250; Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8; Deville C, 2004, J SCI FOOD AGR, V84, P1030, DOI 10.1002/jsfa.1754; Dittami SM, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-2; Dittami SM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r66; Dolferus R, 1991, LAB GUIDE CELLULAR M, P133; Doyle K., 1996, SOURCE DISCOVERY PRO; Eggermont K, 1996, PLANT MOL BIOL REP, V14, P273, DOI 10.1007/BF02671663; FANG G, 1992, BIOTECHNIQUES, V13, P52; Gao JianWei, 2001, Plant Molecular Biology Reporter, V19, P185, DOI 10.1007/BF02772163; HALL A, 1981, BOT MAR, V24, P223, DOI 10.1515/botm.1981.24.4.223; HALL A, 1979, MAR BIOL, V54, P195, DOI 10.1007/BF00395780; HALL A, 1980, NEW PHYTOL, V85, P73, DOI 10.1111/j.1469-8137.1980.tb04449.x; Hoarau G, 2007, MOL ECOL NOTES, V7, P191, DOI 10.1111/j.1471-8286.2006.01587.x; Holdt SL, 2011, J APPL PHYCOL, V23, P543, DOI 10.1007/s10811-010-9632-5; HONG YK, 1995, J APPL PHYCOL, V7, P101, DOI 10.1007/BF00693055; Hughes DW, 1988, PLANT MOL BIOL REP, V6, P253, DOI DOI 10.1007/BF02670385; Jaakola L, 2001, PLANT MOL BIOL REP, V19, P125, DOI 10.1007/BF02772901; Jin HJ, 1997, J APPL PHYCOL, V9, P383, DOI 10.1023/A:1007925202219; KENDALL TL, 1991, ANAL BIOCHEM, V195, P74, DOI 10.1016/0003-2697(91)90297-7; KIRBY KS, 1956, BIOCHEM J, V64, P405, DOI 10.1042/bj0640405; KLOAREG B, 1988, OCEANOGR MAR BIOL, V26, P259; Kojima K, 2002, US Patent No, Patent No. [20,020,192,667, 20020192667]; LaClaire JW, 1997, PLANT MOL BIOL REP, V15, P263, DOI 10.1023/A:1007486419576; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Le Bail A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-75; Li ZW, 2005, BIOTECHNIQUES, V38, P872, DOI 10.2144/05386BM05; Liu JJ, 1998, PLANT MOL BIOL REP, V16, P87, DOI 10.1023/A:1007492421119; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; MABEAU S, 1990, PHYTOCHEMISTRY, V29, P2441, DOI 10.1016/0031-9422(90)85163-A; Manickavelu A, 2007, COLLOID SURFACE B, V54, P254, DOI 10.1016/j.colsurfb.2006.10.024; MANNING K, 1991, ANAL BIOCHEM, V195, P45, DOI 10.1016/0003-2697(91)90292-2; Matthews CK, 2000, BIOCHEMISTRY-US, p[48, 209]; MAYES C, 1992, J PHYCOL, V28, P712, DOI 10.1111/j.0022-3646.1992.00712.x; Michel G, 2010, NEW PHYTOL, V188, P82, DOI 10.1111/j.1469-8137.2010.03374.x; MOREL FMM, 1979, J PHYCOL, V15, P135, DOI 10.1111/j.0022-3646.1979.00135.x; Muller DG, 1998, ADV VIRUS RES, V50, P49, DOI 10.1016/S0065-3527(08)60805-2; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Pearson G, 2006, EUR J PHYCOL, V41, P97, DOI 10.1080/09670260500505011; Peng J, 2011, MAR DRUGS, V9, P1806, DOI 10.3390/md9101806; Peters AF, 2004, J PHYCOL, V40, P1079, DOI 10.1111/j.1529-8817.2004.04058.x; Peters AF, 2008, DEVELOPMENT, V135, P1503, DOI 10.1242/dev.016303; Phillips Naomi, 2001, Phycological Research, V49, P97, DOI 10.1111/j.1440-1835.2001.tb00239.x; Provasoli L, 1974, ALGAL PHYSL BIOCH, P741; QUATRANO RS, 1976, PLANT PHYSIOL, V58, P224, DOI 10.1104/pp.58.2.224; Rioux LE, 2007, CARBOHYD POLYM, V69, P530, DOI 10.1016/j.carbpol.2007.01.009; RUSSELL G, 1970, NATURE, V228, P288, DOI 10.1038/228288a0; Saez CA, 2012, CHEM ECOL, V28, P1, DOI 10.1080/02757540.2011.619529; Salzman RA, 1999, PLANT MOL BIOL REP, V17, P11, DOI 10.1023/A:1007520314478; Sambrook J, 2001, MOL CLONING LAB MANU; Schoenwaelder MEA, 2000, PLANT BIOLOGY, V2, P24, DOI 10.1055/s-2000-9178; Schultz D. J., 1994, Plant Molecular Biology Reporter, V12, P310, DOI 10.1007/BF02669273; Singh G., 2003, PLANT MOL BIOL REP, V21, P93, DOI DOI 10.1007/BF02773401; Smith SDA, 1996, MAR POLLUT BULL, V33, P309, DOI 10.1016/S0025-326X(96)00124-5; Smith SDA, 1996, AUST J ECOL, V21, P144, DOI 10.1111/j.1442-9993.1996.tb00595.x; Stone BA, 1992, CHEM BIOL 1 3 BETA G; SU X, 1988, ANAL BIOCHEM, V174, P650, DOI 10.1016/0003-2697(88)90068-1; THOMAS DN, 1991, BOT ACTA, V104, P26, DOI 10.1111/j.1438-8677.1991.tb00190.x; THOMAS DN, 1991, PHYSIOL PLANTARUM, V83, P281, DOI 10.1111/j.1399-3054.1991.tb02154.x; Vicient CM, 1999, ANAL BIOCHEM, V268, P412, DOI 10.1006/abio.1998.3045; Villegas MJ, 2008, HELGOLAND MAR RES, V62, pS33, DOI 10.1007/s10152-007-0096-1; Vreeland V, 1998, J PHYCOL, V34, P1, DOI 10.1046/j.1529-8817.1998.340001.x; WALLACE DM, 1987, METHOD ENZYMOL, V152, P33; Wang GG, 2005, J APPL PHYCOL, V17, P75, DOI 10.1007/s10811-005-5557-9; Wang TY, 2011, GENET MOL RES, V10, P519, DOI 10.4238/vol10-1gmr1055; Wilkins Thea A., 1996, P21; Wink M, 2006, METHODS APPL MODERN; Yao JT, 2009, J APPL PHYCOL, V21, P233, DOI 10.1007/s10811-008-9354-0	86	33	35	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e96470	10.1371/journal.pone.0096470	http://dx.doi.org/10.1371/journal.pone.0096470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867404	Green Published, gold, Green Submitted			2022-12-25	WOS:000336914100005
J	Bais, MV; Ozdener, GB; Sonenshein, GE; Trackman, PC				Bais, M. V.; Ozdener, G. B.; Sonenshein, G. E.; Trackman, P. C.			Effects of tumor-suppressor lysyl oxidase propeptide on prostate cancer xenograft growth and its direct interactions with DNA repair pathways	ONCOGENE			English	Article							ATM PROTEIN-KINASE; TRANSFORMED PHENOTYPE; MRE11 NUCLEASE; EXPRESSION; LUNG; ACTIVATION; RESISTANCE; RADIATION; BINDING; CELLS	Lysyl oxidase (LOX) is a multifunctional protein required for normal collagen and elastin biosynthesis and maturation. In addition, LOX has complex roles in cancer in which the lysyl oxidase propeptide (LOX-PP) domain of secreted pro-LOX has tumor-suppressor activity, while the active enzyme promotes metastasis. In prostate cancer cell lines, recombinant LOX-PP (rLOX-PP) inhibits the growth of PC3 cells in vitro by mechanisms that were not characterized, while in DU145 cells rLOX-PP targeted fibroblast growth factor signaling. Because rLOX-PP can enhance effects of a genotoxic chemotherapeutic on breast cancer cell apoptosis, we reasoned that rLOX-PP could target DNA repair pathways typically elevated in cancer. Here we demonstrate for the first time that rLOX-PP inhibits prostate xenograft growth in vivo and that activating phosphorylations of the key DNA repair molecules ataxia-telangiectasia mutated (ATM) and checkpoint kinase 2 (CHK2) are inhibited by rLOX-PP expression in vivo. In addition, in vitro studies showed that rLOX-PP inhibits radiation-induced activating phosphorylations of ATM and CHK2 and that exogenously added rLOX-PP protein can localize to the nucleus in both DU145 and PC3 cells. rLOX-PP pull-down studies resulted in detection of a protein complex with the nuclear DNA repair regulator MRE11 in both cell lines, and rLOX-PP localized to radiation-induced nuclear DNA repair foci. Finally, rLOX-PP was shown to sensitize both DU145 and PC3 cells to radiation-induced cell death determined in colony-formation assays. These data provide evidence that rLOX-PP has a nuclear mechanism of action in which it directly interacts with DNA repair proteins to sensitize prostate cancer cells to the effects of ionizing radiation.	[Bais, M. V.; Ozdener, G. B.; Trackman, P. C.] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Sonenshein, G. E.] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA	Boston University; Tufts University	Trackman, PC (corresponding author), Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, 700 Albany St,W-201, Boston, MA 02118 USA.	trackman@bu.edu	Trackman, Philip C/AAX-9280-2021	Trackman, Philip C/0000-0001-5064-614X; Bais, Manish/0000-0003-4198-7377	NIH [DE R01014066, DOD W81XWH-08-1-0349 PC073646, R01 CA143108]; NATIONAL CANCER INSTITUTE [R01CA143108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014066] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the NIH grants DE R01014066, DOD W81XWH-08-1-0349 PC073646 and R01 CA143108.	Agra N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066281; [Anonymous], 2003, METH MOL B; Bais MV, 2009, BONE, V45, P254, DOI 10.1016/j.bone.2009.04.239; Bais MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031188; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Berlier JE, 2003, J HISTOCHEM CYTOCHEM, V51, P1699, DOI 10.1177/002215540305101214; Bhatti S, 2011, CELL MOL LIFE SCI, V68, P2977, DOI 10.1007/s00018-011-0683-9; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Buscemi G, 2006, MOL CELL BIOL, V26, P7832, DOI 10.1128/MCB.00534-06; Carlessi L, 2007, MOL CANCER THER, V6, P935, DOI 10.1158/1535-7163.MCT-06-0567; Choudhury A, 2006, SEMIN RADIAT ONCOL, V16, P51, DOI 10.1016/j.semradonc.2005.08.007; CONTENTE S, 1990, SCIENCE, V249, P796, DOI 10.1126/science.1697103; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; de Jager M, 2001, NUCLEIC ACIDS RES, V29, P1317, DOI 10.1093/nar/29.6.1317; Delia D, 2003, ONCOGENE, V22, P7866, DOI 10.1038/sj.onc.1207086; Eastman A, 2004, J CELL BIOCHEM, V91, P223, DOI 10.1002/jcb.10699; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Hurtado PA, 2008, BIOCHEM BIOPH RES CO, V366, P156, DOI 10.1016/j.bbrc.2007.11.116; Jobson AG, 2007, MOL PHARMACOL, V72, P876, DOI 10.1124/mol.107.035832; Kauffmann A, 2008, ONCOGENE, V27, P565, DOI 10.1038/sj.onc.1210700; KENYON K, 1991, SCIENCE, V253, P802, DOI 10.1126/science.1678898; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lee JH, 2003, J BIOL CHEM, V278, P45171, DOI 10.1074/jbc.M308705200; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Martinez-Marignac VL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016394; Matos CS, 2012, CURR MED CHEM, V19, P4678; Min CY, 2007, CANCER RES, V67, P1105, DOI 10.1158/0008-5472.CAN-06-3867; Min CY, 2010, J CELL BIOCHEM, V111, P1160, DOI 10.1002/jcb.22828; Mok MTS, 2012, RADIOTHER ONCOL, V103, P415, DOI 10.1016/j.radonc.2012.04.009; Munshi A, 2005, METH MOLEC MED, V110, P21; Nakano D, 2012, J AM SOC NEPHROL, V23, P1847, DOI 10.1681/ASN.2012010078; Neel DS, 2013, CLIN CANCER RES, V19, P3, DOI 10.1158/1078-0432.CCR-12-3232; Olson E, 2007, MOL CELL BIOL, V27, P6053, DOI 10.1128/MCB.00532-07; Oxnard GR, 2012, ARCH PATHOL LAB MED, V136, P1205, DOI 10.5858/arpa.2012-0254-RA; Palamakumbura AH, 2009, ONCOGENE, V28, P3390, DOI 10.1038/onc.2009.203; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; Palamakumbura AH, 2003, J BIOL CHEM, V278, P30781, DOI 10.1074/jbc.M305238200; Pallis A, 2011, CURR MED CHEM, V18, P1613, DOI 10.2174/092986711795471383; Panchenko MV, 1996, J BIOL CHEM, V271, P7113, DOI 10.1074/jbc.271.12.7113; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Rainey MD, 2008, CANCER RES, V68, P7466, DOI 10.1158/0008-5472.CAN-08-0763; Ritter M, 2008, SEMIN RADIAT ONCOL, V18, P249, DOI 10.1016/j.semradonc.2008.04.007; Sanchez-Morgan N, 2011, MOL CELL BIOL, V31, P3286, DOI 10.1128/MCB.01426-10; Sarasin A, 2008, MUTAT RES-REV MUTAT, V659, P49, DOI 10.1016/j.mrrev.2007.12.002; Sato S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077288; Sato S, 2011, MOL CELL BIOL, V31, P2683, DOI 10.1128/MCB.01148-10; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Spalding AC, 2002, ONCOGENE, V21, P260, DOI 10.1038/sj.onc.1205048; Stolz A, 2011, CLIN CANCER RES, V17, P401, DOI 10.1158/1078-0432.CCR-10-1215; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Vora SR, 2010, BIOCHEMISTRY-US, V49, P2962, DOI 10.1021/bi902218p; Wang LM, 2008, AM J PHYSIOL-HEART C, V295, pH237, DOI 10.1152/ajpheart.01366.2007; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Wu M, 2007, CANCER RES, V67, P6278, DOI 10.1158/0008-5472.CAN-07-0776; Yu ZB, 2012, CELL RES, V22, P305, DOI 10.1038/cr.2011.128; Zaorsky NG, 2013, CANCER TREAT REV, V39, P728, DOI 10.1016/j.ctrv.2013.01.008; Zhao YS, 2009, J BIOL CHEM, V284, P1385, DOI 10.1074/jbc.M802612200; Zheng Y, 2014, ONCOL REP, V31, P1669, DOI 10.3892/or.2014.3044	64	27	29	3	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 9	2015	34	15					1928	1937		10.1038/onc.2014.147	http://dx.doi.org/10.1038/onc.2014.147			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CF7GY	24882580	Green Accepted			2022-12-25	WOS:000352725600007
J	Elias, D; Vever, H; Laenkholm, AV; Gjerstorff, MF; Yde, CW; Lykkesfeldt, AE; Ditzel, HJ				Elias, D.; Vever, H.; Laenkholm, A-V; Gjerstorff, M. F.; Yde, C. W.; Lykkesfeldt, A. E.; Ditzel, H. J.			Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy	ONCOGENE			English	Article							BREAST-CANCER CELLS; ESTROGEN-RECEPTOR; ANTIESTROGEN RESISTANCE; POSTMENOPAUSAL WOMEN; POOR-PROGNOSIS; C-SRC; GROWTH; LETROZOLE; ER; ACTIVATION	To elucidate the molecular mechanisms of tamoxifen resistance in breast cancer, we performed gene array analyses and identified 366 genes with altered expression in four unique tamoxifen-resistant (TamR) cell lines vs the parental tamoxifen-sensitive MCF-7/S0.5 cell line. Most of these genes were functionally linked to cell proliferation, death and control of gene expression, and include FYN, PRKCA, ITPR1, DPYD, DACH1, LYN, GBP1 and PRLR. Treatment with FYN-specific small interfering RNA or a SRC family kinase inhibitor reduced cell growth of TamR cell lines while exerting no significant effect on MCF-7/S0.5 cells. Moreover, overexpression of FYN in parental tamoxifen-sensitive MCF-7/S0.5 cells resulted in reduced sensitivity to tamoxifen treatment, whereas knockdown of FYN in the FYN-overexpressing MCF-7/S0.5 cells restored sensitivity to tamoxifen, demonstrating growth-and survival-promoting function of FYN in MCF-7 cells. FYN knockdown in TamR cells led to reduced phosphorylation of 14-3-3 and Cdc25A, suggesting that FYN, by activation of important cell cycle-associated proteins, may overcome the anti-proliferative effects of tamoxifen. Evaluation of the subcellular localization of FYN in primary breast tumors from two cohorts of endocrine-treated ER+ breast cancer patients, one with advanced disease (N = 47) and the other with early disease (N = 76), showed that in the former, plasma membrane-associated FYN expression strongly correlated with longer progression-free survival (P < 0.0002). Similarly, in early breast cancer patients, membrane-associated expression of FYN in the primary breast tumor was significantly associated with increased metastasis-free (P < 0.04) and overall (P < 0.004) survival independent of tumor size, grade or lymph node status. Our results indicate that FYN has an important role in tamoxifen resistance, and its subcellular localization in breast tumor cells may be an important novel biomarker of response to endocrine therapy in breast cancer.	[Elias, D.; Vever, H.; Gjerstorff, M. F.; Ditzel, H. J.] Univ Southern Denmark, Inst Mol Med, Dept Canc & Inflammat Res, DK-5000 Odense C, Denmark; [Laenkholm, A-V] Slagelse Hosp, Dept Pathol, Slagelse, Denmark; [Yde, C. W.; Lykkesfeldt, A. E.] Danish Canc Soc Res Ctr, Breast Canc Grp, Cell Death & Metab, Copenhagen, Denmark; [Ditzel, H. J.] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark	University of Southern Denmark; Danish Cancer Society; University of Southern Denmark; Odense University Hospital	Elias, D (corresponding author), Univ Southern Denmark, Inst Mol Med, Dept Canc & Inflammat Res, JB Winsloewsvej 25, DK-5000 Odense C, Denmark.	delias@health.sdu.dk; hditzel@health.sdu.dk		Ditzel, Henrik J./0000-0003-3927-5135; gjerstorff, morten/0000-0002-0845-1952; Laenkholm, Anne-Vibeke/0000-0003-2166-8686	Danish Cancer Society; Danish Cancer Research Foundation; Danish Research Council; Danish Strategic Research Council; A Race Against Breast Cancer; Sino-Danish Breast Cancer Research Centre; NanoCAN Lundbeck Center of Excellence; Region of Southern Denmark Research Foundation; Odense University Hospital Research Council; Danish Center for Translational Breast Cancer research	Danish Cancer Society(Danish Cancer Society); Danish Cancer Research Foundation; Danish Research Council(Det Frie Forskningsrad (DFF)); Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); A Race Against Breast Cancer; Sino-Danish Breast Cancer Research Centre; NanoCAN Lundbeck Center of Excellence; Region of Southern Denmark Research Foundation; Odense University Hospital Research Council; Danish Center for Translational Breast Cancer research	We thank Lisbet Mortensen and Ole Nielsen at the Department of Pathology, Odense University Hospital, for excellent technical assistance and MK Occhipinti-Bender for editorial assistance. This work was supported in part by the Danish Cancer Society, the Danish Cancer Research Foundation, the Danish Research Council, the Danish Strategic Research Council, A Race Against Breast Cancer, Sino-Danish Breast Cancer Research Centre, NanoCAN Lundbeck Center of Excellence, Region of Southern Denmark Research Foundation, Odense University Hospital Research Council and Danish Center for Translational Breast Cancer research.	Ali HR, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3061; Assender JW, 2007, J CLIN PATHOL, V60, P1216, DOI 10.1136/jcp.2006.041616; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Bertero T, 2013, CELL DEATH DIFFER, V20, P800, DOI 10.1038/cdd.2013.5; Bilal Erhan, 2010, Genes Cancer, V1, P1063, DOI 10.1177/1947601910395583; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; BRIAND P, 1984, CANCER RES, V44, P1114; Browne BC, 2013, FEBS J, V280, P5237, DOI 10.1111/febs.12441; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; BUSS JE, 1986, J VIROL, V58, P468, DOI 10.1128/JVI.58.2.468-474.1986; Campbell EJ, 2008, BRIT J CANCER, V99, P1769, DOI 10.1038/sj.bjc.6604768; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Elsberger B, 2012, J CANCER RES CLIN, V138, P327, DOI 10.1007/s00432-011-1096-8; Fox EM, 2011, CANCER RES, V71, P6773, DOI 10.1158/0008-5472.CAN-11-1295; Frankel LB, 2007, BREAST CANCER RES TR, V104, P165, DOI 10.1007/s10549-006-9399-1; Frasor J, 2006, CANCER RES, V66, P7334, DOI 10.1158/0008-5472.CAN-05-4269; Frogne T, 2005, ENDOCR-RELAT CANCER, V12, P599, DOI 10.1677/erc.1.00946; Frogne T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2230; Gallardo A, 2012, BRIT J CANCER, V106, P1367, DOI 10.1038/bjc.2012.85; Giuliano M, 2011, BREAST, V20, pS42, DOI 10.1016/S0960-9776(11)70293-4; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Henriksen K, 2009, ACTA ONCOL, V48, P522, DOI 10.1080/02841860802676383; Hiscox S, 2006, BREAST CANCER RES TR, V97, P263, DOI 10.1007/s10549-005-9120-9; Ito Y, 2002, BREAST CANCER RES TR, V76, P261, DOI 10.1023/A:1020860221099; JOHNSTON SRD, 1995, CANCER RES, V55, P3331; Jordan NJ, 2004, BREAST CANCER RES TR, V87, P167, DOI 10.1023/B:BREA.0000041623.21338.47; Leth-Larsen R, 2009, MOL CELL PROTEOMICS, V8, P1436, DOI 10.1074/mcp.M800061-MCP200; Lundholt BK, 2001, BREAST CANCER RES TR, V67, P199, DOI 10.1023/A:1017977406429; LYKKESFELDT AE, 1994, CANCER RES, V54, P1587; LYKKESFELDT AE, 1986, BRIT J CANCER, V53, P29, DOI 10.1038/bjc.1986.5; Madsen MW, 1997, CANCER RES, V57, P585; Masri S, 2008, CANCER RES, V68, P4910, DOI 10.1158/0008-5472.CAN-08-0303; Mayer EL, 2010, CLIN CANCER RES, V16, P3526, DOI 10.1158/1078-0432.CCR-09-1834; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Morgan L, 2009, CANCER BIOL THER, V8, P1550, DOI 10.4161/cbt.8.16.8954; Mouridsen H, 2001, J CLIN ONCOL, V19, P2596, DOI 10.1200/JCO.2001.19.10.2596; Mouridsen H, 2007, J CLIN ONCOL, V25, P5715, DOI 10.1200/JCO.2007.12.1665; Mouridsen Henning T, 2005, MedGenMed, V7, P20; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nehra R, 2010, FASEB J, V24, P2040, DOI 10.1096/fj.09-138305; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Osborne CK, 1998, NEW ENGL J MED, V339, P1609, DOI 10.1056/NEJM199811263392207; Pancholi S, 2008, ENDOCR-RELAT CANCER, V15, P985, DOI 10.1677/ERC-07-0240; Rasmussen BB, 2008, LANCET ONCOL, V9, P23, DOI 10.1016/S1470-2045(07)70386-8; Saito YD, 2010, CANCER-AM CANCER SOC, V116, P1629, DOI 10.1002/cncr.24879; Schiff R, 2004, CLIN CANCER RES, V10, p331S, DOI 10.1158/1078-0432.CCR-031212; Schrecengost RS, 2007, CANCER RES, V67, P6174, DOI 10.1158/0008-5472.CAN-06-3455; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Sun M, 2001, CANCER RES, V61, P5985; Tang SH, 2004, NUCLEIC ACIDS RES, V32, pD533, DOI 10.1093/nar/gkh083; Thrane S, 2013, BREAST CANCER RES TR, V139, P71, DOI 10.1007/s10549-013-2485-2; VANAGTHOVEN T, 1992, CANCER RES, V52, P5082; Xu XD, 2003, CLIN CANCER RES, V9, P1764; Yde CW, 2012, BREAST CANCER RES TR, V135, P67, DOI 10.1007/s10549-012-2053-1	54	56	57	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 9	2015	34	15					1919	1927		10.1038/onc.2014.138	http://dx.doi.org/10.1038/onc.2014.138			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CF7GY	24882577				2022-12-25	WOS:000352725600006
J	Chhabra, S; Chang, SC; Nguyen, HM; Huq, R; Tanner, MR; Londono, LM; Estrada, R; Dhawan, V; Chauhan, S; Upadhyay, SK; Gindin, M; Hotez, PJ; Valenzuela, JG; Mohanty, B; Swarbrick, JD; Wulff, H; Iadonato, SP; Gutman, GA; Beeton, C; Pennington, MW; Norton, RS; Chandy, KG				Chhabra, Sandeep; Chang, Shih Chieh; Nguyen, Hai M.; Huq, Redwan; Tanner, Mark R.; Londono, Luz M.; Estrada, Rosendo; Dhawan, Vikas; Chauhan, Satendra; Upadhyay, Sanjeev K.; Gindin, Mariel; Hotez, Peter J.; Valenzuela, Jesus G.; Mohanty, Biswaranjan; Swarbrick, James D.; Wulff, Heike; Iadonato, Shawn P.; Gutman, George A.; Beeton, Christine; Pennington, Michael W.; Norton, Raymond S.; Chandy, K. George			Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases	FASEB JOURNAL			English	Article						ShK; probiotic worm therapy; T lymphocytes; ion channel modulator; hookworm	MEMORY T-CELLS; REMITTING MULTIPLE-SCLEROSIS; TRICHURIS-SUIS THERAPY; POTASSIUM-CHANNEL; INHIBITORY FACTOR; NECATOR-AMERICANUS; SELECTIVE BLOCKADE; PROTEIN STRUCTURES; INDUCED COLITIS; K+ CHANNEL	The voltage-gated potassium (Kv) 1.3 channel is widely regarded as a therapeutic target for immunomodulation in autoimmune diseases. ShK-186, a selective inhibitor of Kv1.3 channels, ameliorates autoimmune diseases in rodent models, and human phase 1 trials of this agent in healthy volunteers have been completed. In this study, we identified and characterized a large family of Stichodactyla helianthus toxin (ShK)-related peptides in parasitic worms. Based on phylogenetic analysis, 2 worm peptides were selected for study: AcK1, a 51-residue peptide expressed in the anterior secretory glands of the dog-infecting hookworm Ancylostoma caninum and the human-infecting hookworm Ancylostoma ceylanicum, and BmK1, the C-terminal domain of a metalloprotease from the filarial worm Brugia malayi. These peptides in solution adopt helical structures closely resembling that of ShK. At doses in the nanomolar-micromolar range, they block native Kv1.3 in human T cells and cloned Kv1.3 stably expressed in L929 mouse fibroblasts. They preferentially suppress the proliferation of rat CCR7-effector memory T cells without affecting naive and central memory subsets and inhibit the delayed-type hypersensitivity (DTH) response caused by skin-homing effector memory T cells in rats. Further, they suppress IFN gamma production by human T lymphocytes. ShK-related peptides in parasitic worms may contribute to the potential beneficial effects of probiotic parasitic worm therapy in human autoimmune diseases.	[Chhabra, Sandeep; Chang, Shih Chieh; Mohanty, Biswaranjan; Swarbrick, James D.; Norton, Raymond S.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Nguyen, Hai M.; Upadhyay, Sanjeev K.; Gutman, George A.; Chandy, K. George] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Nguyen, Hai M.; Wulff, Heike] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Huq, Redwan; Tanner, Mark R.; Beeton, Christine] Baylor Coll Med, Natl Sch Trop Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Huq, Redwan] Baylor Coll Med, Natl Sch Trop Med, Grad Program Mol Physiol & Biophys, Houston, TX 77030 USA; [Tanner, Mark R.] Baylor Coll Med, Natl Sch Trop Med, Interdepartmental Grad Program Translat Biol & Mo, Houston, TX 77030 USA; [Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Sabin Vaccine Inst, Houston, TX 77030 USA; [Hotez, Peter J.] Texas Childrens Hosp, Baylor Coll Med, Ctr Vaccine Dev, Natl Sch Trop Med, Houston, TX 77030 USA; [Londono, Luz M.; Iadonato, Shawn P.] Kineta Inc, Seattle, WA USA; [Estrada, Rosendo; Dhawan, Vikas; Chauhan, Satendra; Pennington, Michael W.] Peptides Int, Louisville, KY USA; [Gindin, Mariel] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Gindin, Mariel; Valenzuela, Jesus G.] NIAID, Vector Mol Biol Sect, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA	Monash University; University of California System; University of California Irvine; University of California System; University of California Davis; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; George Washington University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Norton, RS (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia.	ray.norton@monash.edu; gchandy@uci.edu	Chhabra, Sandeep/T-5468-2018; Mohanty, Biswaranjan/E-2080-2018; chhabra, sandeep/R-9942-2017; wulff, Heike/Z-2056-2019	Chhabra, Sandeep/0000-0002-5225-1333; Mohanty, Biswaranjan/0000-0002-6921-343X; Norton, Raymond/0000-0001-8893-0584; Beeton, Christine/0000-0002-2500-5874; Tanner, Mark/0000-0002-6516-0166; pennington, michael/0000-0001-5446-3447; Hotez, Peter/0000-0001-8770-1042	U.S. National Institutes of Health (NIH) [R01 NS48252, NS073712, GM076063]; Howard Hughes Medical Institutes Med into Grad Initiative; NIH T32 award [GM088129]; Human Hookworm Initiative of the Gates Foundation; National Institute of Allergy and Infectious Diseases (NIAID) at NIH; University of California, Irvine; National Health and Medical Research Council of Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000932] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institutes Med into Grad Initiative; NIH T32 award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Hookworm Initiative of the Gates Foundation; National Institute of Allergy and Infectious Diseases (NIAID) at NIH; University of California, Irvine(University of California System); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for this work was provided by U.S. National Institutes of Health (NIH) grants R01 NS48252 (to K.G.C.), NS073712 (to C.B., M.W.P., and R.S.N.); GM076063 (to H.W.); Howard Hughes Medical Institutes Med into Grad Initiative and NIH T32 award GM088129 (to M.R.T.); the Human Hookworm Initiative of the Gates Foundation (to P.J.H.); the intramural program of the National Institute of Allergy and Infectious Diseases (NIAID) at NIH (to J.G.V.); a bridge fund from the University of California, Irvine (to K.G.C); and fellowship support by the National Health and Medical Research Council of Australia (to R.S.N.).	Anbu KA, 2008, PARASITE IMMUNOL, V30, P23, DOI 10.1111/j.1365-3024.2007.00995.x; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P133; Azam P, 2007, J INVEST DERMATOL, V127, P1419, DOI 10.1038/sj.jid.5700717; Beeton C, 2005, MOL PHARMACOL, V67, P1369, DOI 10.1124/mol.104.008193; Beeton C, 2001, P NATL ACAD SCI USA, V98, P13942, DOI 10.1073/pnas.241497298; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boitelle A, 2003, J IMMUNOL, V171, P447, DOI 10.4049/jimmunol.171.1.447; Broadhurst MJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001500; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Chu KM, 2013, INFLAMM BOWEL DIS, V19, P614, DOI 10.1097/MIB.0b013e31827f27f4; Correale J, 2007, ANN NEUROL, V61, P97, DOI 10.1002/ana.21067; Cotton J, 1997, EUR J BIOCHEM, V244, P192, DOI 10.1111/j.1432-1033.1997.00192.x; Cox GM, 2013, J IMMUNOL, V191, P1043, DOI 10.4049/jimmunol.1200485; Dauplais M, 1997, J BIOL CHEM, V272, P4302, DOI 10.1074/jbc.272.7.4302; Dunne DW, 2005, NAT REV IMMUNOL, V5, P420, DOI 10.1038/nri1601; Elliott DE, 2012, CURR OPIN GASTROEN, V28, P551, DOI 10.1097/MOG.0b013e3283572f73; Ferreira I, 2013, INFECT IMMUN, V81, P2104, DOI 10.1128/IAI.00563-12; Fleming JO, 2011, MULT SCLER J, V17, P743, DOI 10.1177/1352458511398054; Flugel A, 1999, NAT MED, V5, P843, DOI 10.1038/10567; Gaze S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002520; Ghanshani S, 2000, J BIOL CHEM, V275, P37137, DOI 10.1074/jbc.M003941200; Gocke AR, 2012, J IMMUNOL, V188, P5877, DOI 10.4049/jimmunol.1103095; Goodridge HS, 2001, J IMMUNOL, V167, P940, DOI 10.4049/jimmunol.167.2.940; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Harnett MM, 2010, CLIN EXP IMMUNOL, V159, P256, DOI 10.1111/j.1365-2249.2009.04064.x; Harnett W, 2010, NAT REV IMMUNOL, V10, P278, DOI 10.1038/nri2730; Hartmann S, 1997, EUR J IMMUNOL, V27, P2253, DOI 10.1002/eji.1830270920; Hernandez JLR, 2013, INT J PARASITOL, V43, P233, DOI 10.1016/j.ijpara.2012.09.005; Hu L, 2007, J IMMUNOL, V179, P4563, DOI 10.4049/jimmunol.179.7.4563; Huys I, 2004, J BIOL CHEM, V279, P2781, DOI 10.1074/jbc.M311029200; Johnston MJG, 2010, INFECT IMMUN, V78, P1364, DOI 10.1128/IAI.01349-08; Kalman K, 1998, J BIOL CHEM, V273, P32697, DOI 10.1074/jbc.273.49.32697; Kawakami N, 2005, J IMMUNOL, V175, P69, DOI 10.4049/jimmunol.175.1.69; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koshy S, 2014, J BIOL CHEM, V289, P12623, DOI 10.1074/jbc.M113.517037; Kuszewski J, 1996, PROTEIN SCI, V5, P1067; La Flamme AC, 2003, INFECT IMMUN, V71, P4996, DOI 10.1128/IAI.71.9.4996-5004.2003; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Leung JM, 2013, INT J PARASITOL, V43, P253, DOI 10.1016/j.ijpara.2012.10.015; Llamas-Covarrubias MA, 2013, CYTOKINE, V61, P759, DOI 10.1016/j.cyto.2012.12.032; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Mortimer K, 2006, AM J TROP MED HYG, V75, P914, DOI 10.4269/ajtmh.2006.75.914; MOYLE M, 1994, J BIOL CHEM, V269, P10008; MUCHOWSKI PJ, 1994, J BIOL CHEM, V269, P26419; Ovchinnikova TV, 2006, BIOCHEM BIOPH RES CO, V348, P514, DOI 10.1016/j.bbrc.2006.07.078; Pennington MW, 2009, MOL PHARMACOL, V75, P762, DOI 10.1124/mol.108.052704; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rangaraju S, 2010, J BIOL CHEM, V285, P9124, DOI 10.1074/jbc.M109.071266; Rauer H, 1999, J BIOL CHEM, V274, P21885, DOI 10.1074/jbc.274.31.21885; Ren YZR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004009; Rosche B, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-112; Rus H, 2005, P NATL ACAD SCI USA, V102, P11094, DOI 10.1073/pnas.0501770102; Ruyssers NE, 2009, INFLAMM BOWEL DIS, V15, P491, DOI 10.1002/ibd.20787; Sandborn WJ, 2013, ALIMENT PHARM THER, V38, P255, DOI 10.1111/apt.12366; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sewell D, 2003, INT IMMUNOL, V15, P59, DOI 10.1093/intimm/dxg012; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tarcha EJ, 2012, J PHARMACOL EXP THER, V342, P642, DOI 10.1124/jpet.112.191890; Teixeira-Carvalho A, 2008, INFECT IMMUN, V76, P5810, DOI 10.1128/IAI.00419-08; Tudor JE, 1996, NAT STRUCT BIOL, V3, P317, DOI 10.1038/nsb0496-317; Tudor JE, 1998, EUR J BIOCHEM, V251, P133, DOI 10.1046/j.1432-1327.1998.2510133.x; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Upadhyay SK, 2013, P NATL ACAD SCI USA, V110, pE2239, DOI 10.1073/pnas.1221206110; Valverde P, 2004, J BONE MINER RES, V19, P155, DOI 10.1359/JBMR.0301213; Vicente R, 2008, J BIOL CHEM, V283, P8756, DOI 10.1074/jbc.M708223200; Wammes LJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001655; Weinstock JV, 2012, NATURE, V491, P183, DOI 10.1038/491183a; Wu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035470; Wulff H, 2004, J IMMUNOL, V173, P776, DOI 10.4049/jimmunol.173.2.776; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Zaccone P, 2013, CURR OPIN IMMUNOL, V25, P418, DOI 10.1016/j.coi.2013.02.006	76	55	55	0	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					3952	3964		10.1096/fj.14-251967	http://dx.doi.org/10.1096/fj.14-251967			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24891519	Green Published, Green Submitted			2022-12-25	WOS:000340845900013
J	Lan, WJ; Yamaguchi, S; Yamamoto, T; Yamahira, S; Tan, MD; Murakami, N; Zhang, JY; Nakamura, M; Nagamune, T				Lan, Wanjun; Yamaguchi, Satoshi; Yamamoto, Teruyasu; Yamahira, Shinya; Tan, Modong; Murakami, Naoka; Zhang, Jingyan; Nakamura, Motonao; Nagamune, Teruyuki			Visualization of the pH-dependent dynamic distribution of G2A in living cells	FASEB JOURNAL			English	Article						GPCR; internalization; pH dependence; pulse labeling	PROTEIN-COUPLED RECEPTOR; RETRACTED ARTICLE. SEE; SURFACE-PROTEINS; EXTRACELLULAR PH; SMOOTH-MUSCLE; LYSOPHOSPHATIDYLCHOLINE; SORTASE; LIGAND; CANCER; TUMOR	G2A (from G2 accumulation) receptor is a member of the proton-sensing G-protein coupled receptor (GPCR) family and induces signal transduction events that regulate the cell cycle, proliferation, oncogenesis, and immunity. The mechanism by which G2A-mediated signal transduction is regulated by the extracellular pH remains unresolved. Here, we first visualize the pH-dependent G2A distribution change in living cells by a sortase A-mediated pulse labeling technology: the short-peptide tag-fused human G2A on human embryo kidney HEK293T cell surfaces was labeled with a small fluorescent dye in the presence of lysophosphatidylcholine, and the labeled G2A was chased at acidic and neutral pHs in real time by microscope time course observations. G2A internalization from cell surfaces into intracellular compartments was observed to be inhibited under acidic pH conditions, and this inhibition was relieved at neutral pH. Additionally, the internalized G2A was redistributed onto cell surfaces by jumping from a neutral to an acidic pH. From quantitative image analysis data, we conclude the amount of G2A on the cell surface was controlled by suppressing the G2A internalization rate by one-tenth in response to the extracellular acidic pH, and this acidic pH-induced G2A accumulation on cell surfaces may be explained by proton-induced dissociation of G2A from endocytic machinery.	[Lan, Wanjun; Yamaguchi, Satoshi; Yamamoto, Teruyasu; Tan, Modong; Nagamune, Teruyuki] Univ Tokyo, Dept Chem & Biotechnol, Tokyo 1138656, Japan; [Yamahira, Shinya; Nagamune, Teruyuki] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Tokyo 1138656, Japan; [Murakami, Naoka; Nakamura, Motonao] Univ Tokyo, Grad Sch Med, Dept Biochem & Mol Biol, Tokyo 1138656, Japan; [Lan, Wanjun; Zhang, Jingyan] E China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, State Key Lab Bioreactor Engn, Shanghai, Peoples R China	University of Tokyo; University of Tokyo; University of Tokyo; East China University of Science & Technology	Nagamune, T (corresponding author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	nagamune@bioeng.t.u-tokyo.ac.jp	Nagamune, Teruyuki/R-7708-2017; Yamaguchi, Satoshi/V-3211-2017; Zhang, Jing/HII-4294-2022	Nagamune, Teruyuki/0000-0002-2435-0270; Yamaguchi, Satoshi/0000-0003-4822-7469; Yamahira, Shinya/0000-0002-8402-4514	Ministry of Education, Culture, Sports, Science and Technology, Japan [246564498]; China Scholarship Council (CSC); National Science Foundation of China [31070742]; grant for the Center for NanoBio Integration (CNBI)	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); China Scholarship Council (CSC)(China Scholarship Council); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); grant for the Center for NanoBio Integration (CNBI)	This work was supported by a Ministry of Education, Culture, Sports, Science and Technology, Japan, Grant-in-Aid for Challenging Exploratory Research 246564498 and a grant for the Center for NanoBio Integration (CNBI). W. L. was supported by the China Scholarship Council (CSC) and the National Science Foundation of China (No. 31070742).	Bidani A, 1998, LUNG, V176, P111, DOI 10.1007/PL00007593; Chen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027586; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Choi JW, 1996, CELL IMMUNOL, V168, P78, DOI 10.1006/cimm.1996.0051; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Gerweck LE, 1996, CANCER RES, V56, P1194; Ghanouni P, 2000, J BIOL CHEM, V275, P3121, DOI 10.1074/jbc.275.5.3121; Graler MH, 2002, BBA-MOL CELL BIOL L, V1582, P168, DOI 10.1016/S1388-1981(02)00152-X; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; GRINSTEIN S, 1991, CLIN BIOCHEM, V24, P241, DOI 10.1016/0009-9120(91)80014-T; Hirota N, 2010, J BIOL CHEM, V285, P5931, DOI 10.1074/jbc.M109.066282; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Kabarowski JHS, 2000, P NATL ACAD SCI USA, V97, P12109, DOI 10.1073/pnas.97.22.12109; Kabarowski JHS, 2001, SCIENCE, V293, P702, DOI 10.1126/science.1061781; Kraus M, 1996, TUMOR BIOL, V17, P133, DOI 10.1159/000217977; Lin P, 2003, J BIOL CHEM, V278, P14379, DOI 10.1074/jbc.M209101200; Lippincott-Schwartz J, 2003, SCIENCE, V300, P87, DOI 10.1126/science.1082520; Lombardi MS, 2002, CRIT REV IMMUNOL, V22, P141; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Matsumoto T, 2012, BIOTECHNOL J, V7, P642, DOI 10.1002/biot.201100213; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Radu CG, 2005, P NATL ACAD SCI USA, V102, P1632, DOI 10.1073/pnas.0409415102; Radu CG, 2004, P NATL ACAD SCI USA, V101, P245, DOI 10.1073/pnas.2536801100; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; ROTIN D, 1986, CANCER RES, V46, P2821; Saxena H, 2012, BRIT J PHARMACOL, V166, P981, DOI 10.1111/j.1476-5381.2011.01807.x; SPIEGEL S, 1995, J MEMBRANE BIOL, V146, P225; Tanaka T, 2008, CHEMBIOCHEM, V9, P802, DOI 10.1002/cbic.200700614; TANNOCK IF, 1989, CANCER RES, V49, P4373; Tobo M, 2007, CELL SIGNAL, V19, P1745, DOI 10.1016/j.cellsig.2007.03.009; Tomura H, 2005, J BIOL CHEM, V280, P34458, DOI 10.1074/jbc.M505287200; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; VAUPEL PW, 1981, CANCER RES, V41, P2008; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Wang JQ, 2004, J BIOL CHEM, V279, P45626, DOI 10.1074/jbc.M406966200; Wang L, 2005, MOL BIOL CELL, V16, P2234, DOI 10.1091/mbc.E04-12-1044; Weng Z., 2000, P NATL ACAD SCI USA, V95, P12334; Xu Y, 2000, NAT CELL BIOL, V2, P261, DOI 10.1038/35010529; Yamamoto T, 2009, CHEM COMMUN, P1022, DOI 10.1039/b818792d; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	44	10	10	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					3965	3974		10.1096/fj.14-252999	http://dx.doi.org/10.1096/fj.14-252999			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24891524	Green Published			2022-12-25	WOS:000340845900014
J	Pang, A; Frank, S; Brown, I; Warren, MJ; Pickersgill, RW				Pang, Allan; Frank, Stefanie; Brown, Ian; Warren, Martin J.; Pickersgill, Richard W.			Structural Insights into Higher Order Assembly and Function of the Bacterial Microcompartment Protein PduA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALMONELLA-ENTERICA; 1,2-PROPANEDIOL; ORGANELLES; TYPHIMURIUM; CARBOXYSOMES; ETHANOLAMINE; SEQUENCE; OPERON; SHELL; FORM	Bacterial microcompartments are large proteinaceous assemblies that are found in the cytoplasm of some bacteria. These structures consist of proteins constituting a shell that houses a number of enzymes involved in specific metabolic processes. The 1,2-propanediol-utilizing microcompartment is assembled from seven different types of shell proteins, one of which is PduA. It is one of the more abundant components of the shell and intriguingly can form nanotubule-like structures when expressed on its own in the cytoplasm of Escherichia coli. We propose a model that accounts for the size and appearance of these PduA structures and underpin our model using a combinatorial approach. Making strategic mutations at Lys-26, Val51, and Arg-79, we targeted residues predicted to be important for PduA assembly. We present the effect of the amino acid residue substitution on the phenotype of the PduA higher order assemblies (transmission electron microscopy) and the crystal structure of the K26D mutant with one glycerol molecule bound to the central pore. Our results support the view that the hexamer-hexamer interactions seen in PduA crystals persist in the cytoplasmic structures and reveal the profound influence of the two key amino acids, Lys-26 and Arg-79, on tiling, not only in the crystal lattice but also in the bacterial cytoplasm. Understanding and controlling PduA assemblies is valuable in order to inform manipulation for synthetic biology and biotechnological applications.	[Pang, Allan; Pickersgill, Richard W.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Frank, Stefanie; Brown, Ian; Warren, Martin J.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England	University of London; Queen Mary University London; University of Kent	Warren, MJ (corresponding author), Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England.	m.j.warren@kent.ac.uk; r.w.pickersgill@qmul.ac.uk	Pang, Allan/AAU-3701-2021	Warren, Martin/0000-0002-6028-6456; Frank, Stefanie/0000-0003-3153-6417	Biotechnology and Biological Sciences Research Council [BB/H013180/1, BB/I013334/1]; Higher Education Council of England; Queen Mary University of London; BBSRC [BB/I013334/1, BB/H013180/1, BB/M002969/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M002969/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Higher Education Council of England; Queen Mary University of London; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/H013180/1 and BB/I013334/1 and the Higher Education Council of England.; Recipient of studentship funding from Queen Mary University of London.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; BOCK E, 1974, ARCH MICROBIOL, V97, P115, DOI 10.1007/BF00403051; Brinsmade SR, 2005, J BACTERIOL, V187, P8039, DOI 10.1128/JB.187.23.8039-8046.2005; Cheng SQ, 2011, J BACTERIOL, V193, P1385, DOI 10.1128/JB.01473-10; Crowley CS, 2010, J BIOL CHEM, V285, P37838, DOI 10.1074/jbc.M110.160580; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frank S, 2013, J BIOTECHNOL, V163, P273, DOI 10.1016/j.jbiotec.2012.09.002; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Heldt D, 2009, BIOCHEM J, V423, P199, DOI 10.1042/BJ20090780; Jorda J, 2013, PROTEIN SCI, V22, P179, DOI 10.1002/pro.2196; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Kerfeld CA, 2010, ANNU REV MICROBIOL, V64, P391, DOI 10.1146/annurev.micro.112408.134211; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pang A, 2012, ACTA CRYSTALLOGR D, V68, P1642, DOI 10.1107/S0907444912039315; Pang A, 2011, ACTA CRYSTALLOGR D, V67, P91, DOI 10.1107/S0907444910050201; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; Parsons JB, 2010, MOL CELL, V38, P305, DOI 10.1016/j.molcel.2010.04.008; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schneidman-Duhovny D, 2005, PROTEINS, V60, P224, DOI 10.1002/prot.20562; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; Shively JM, 1998, CAN J BOT, V76, P906, DOI 10.1139/b98-088; Sriramulu DD, 2008, J BACTERIOL, V190, P4559, DOI 10.1128/JB.01535-07; STOJILJKOVIC I, 1995, J BACTERIOL, V177, P1357, DOI 10.1128/jb.177.5.1357-1366.1995; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walter D, 1997, J BACTERIOL, V179, P1013, DOI 10.1128/jb.179.4.1013-1022.1997; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913	32	47	49	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22377	22384		10.1074/jbc.M114.569285	http://dx.doi.org/10.1074/jbc.M114.569285			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24873823	Green Published, hybrid			2022-12-25	WOS:000340593500048
J	Adams, EJ; Chen, XW; O'Shea, KS; Ginsburg, D				Adams, Elizabeth J.; Chen, Xiao-Wei; O'Shea, K. Sue; Ginsburg, David			Mammalian COPII Coat Component SEC24C Is Required for Embryonic Development in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEROTONIN TRANSPORTER; MEMBRANE-PROTEINS; CARGO SELECTION; EXPRESSION; MUTATIONS; MECHANISMS; DATABASE; HOMEOSTASIS; DISRUPTION; VESICLES	COPII-coated vesicles mediate the transport of newly synthesized proteins from the endoplasmic reticulum to the Golgi. SEC24 is the COPII component primarily responsible for recruitment of protein cargoes into nascent vesicles. There are four Sec24 paralogs in mammals, with mice deficient in SEC24A, -B, and -D exhibiting a wide range of phenotypes. We now report the characterization of mice with deficiency in the fourth Sec24 paralog, SEC24C. Although mice haploinsufficient for Sec24c exhibit no apparent abnormalities, homozygous deficiency results in embryonic lethality at approximately embryonic day 7. Tissue-specific deletion of Sec24c in hepatocytes, pancreatic cells, smooth muscle cells, and intestinal epithelial cells results in phenotypically normal mice. Thus, SEC24C is required in early mammalian development but is dispensable in a number of tissues, likely as a result of compensation by other Sec24 paralogs. The embryonic lethality resulting from loss of SEC24C occurs considerably later than the lethality previously observed in SEC24D deficiency; it is clearly distinct from the restricted neural tube phenotype of Sec24b null embryos and the mild hypocholesterolemic phenotype of adult Sec24a null mice. Taken together, these results demonstrate that the four Sec24 paralogs have developed unique functions over the course of vertebrate evolution.	[Adams, Elizabeth J.; Chen, Xiao-Wei; Ginsburg, David] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Adams, Elizabeth J.; Ginsburg, David] Univ Michigan, Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [O'Shea, K. Sue] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Internal Med Human Genet & Pediat, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Ginsburg, D (corresponding author), Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Inst Life Sci, 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	ginsburg@umich.edu		Chen, Xiao-Wei/0000-0001-6466-6248; Ginsburg, David/0000-0002-6436-8942	University of Michigan Multipurpose Arthritis Center; National Institutes of Health [AR20557, CA46592]; University of Michigan Cancer Center; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL039693, P01HL057346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	University of Michigan Multipurpose Arthritis Center(University of Michigan System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Cancer Center(University of Michigan System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Jonathan Goldberg for helpful discussions regarding the Sec24c splice forms, Marta Dzaman for help with E7.5 histology, and Anya Kiseleva and Gengeng Yu for their technical support. We acknowledge Elizabeth Hughes, Keith Childs, Galina Gavrilina, and Debora VanHeyningen for preparation of ES cell mouse chimeras from gene-trapped ES clone EPD0241-2-A11 and the Transgenic Animal Model Core of the University of Michigan's Biomedical Research Core Facilities (core support was provided by the University of Michigan Multipurpose Arthritis Center, National Institutes of Health Grant AR20557, University of Michigan Cancer Center, and National Institutes of Health Grant CA46592). All histology work was performed in the Microscopy and Image Analysis Laboratory at the University of Michigan, Biomedical Research Core Facilities, with the assistance of Judy Poore. The Microscopy and Image Analysis Laboratory is a multiuser imaging facility supported by NCI, National Institutes of Health, O'Brien Renal Center, University of Michigan Medical School, and Endowment for the Basic Sciences, Department of Cell and Developmental Biology, and the University of Michigan.	Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; BAHOU WF, 1988, BLOOD, V72, P308; Baines AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061114; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Budnik A, 2009, FEBS LETT, V583, P3796, DOI 10.1016/j.febslet.2009.10.038; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen XW, 2013, ELIFE, V2, DOI 10.7554/eLife.00444; Driever W, 1996, DEVELOPMENT, V123, P37; Fahim AT, 2009, THROMB RES, V123, P785, DOI 10.1016/j.thromres.2008.07.004; Frutkin AD, 2006, J MOL CELL CARDIOL, V41, P724, DOI 10.1016/j.yjmcc.2006.06.067; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; KENDALL SK, 1995, GENE DEV, V9, P2007, DOI 10.1101/gad.9.16.2007; Krupp M, 2012, BIOINFORMATICS, V28, P1184, DOI 10.1093/bioinformatics/bts084; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Lee MCS, 2007, SEMIN CELL DEV BIOL, V18, P424, DOI 10.1016/j.semcdb.2007.06.007; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Nagy A., 2003, MANIPULATING MOUSE E, P237; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pagano A, 1999, J BIOL CHEM, V274, P7833, DOI 10.1074/jbc.274.12.7833; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Peng RW, 2000, J BIOL CHEM, V275, P11521, DOI 10.1074/jbc.275.15.11521; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Richardson L, 2010, NUCLEIC ACIDS RES, V38, pD703, DOI 10.1093/nar/gkp763; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Schwarz K, 2009, NAT GENET, V41, P936, DOI 10.1038/ng.405; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Sucic S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230037; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Tang BL, 1999, BIOCHEM BIOPH RES CO, V258, P679, DOI 10.1006/bbrc.1999.0574; Tao JY, 2012, P NATL ACAD SCI USA, V109, pE2001, DOI 10.1073/pnas.1209207109; Van Keuren ML, 2009, TRANSGENIC RES, V18, P769, DOI 10.1007/s11248-009-9271-2; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Westrick RJ, 2010, P NATL ACAD SCI USA, V107, P16904, DOI 10.1073/pnas.1012050107; Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492; Yang XW., 2005, CURR PROTOC NEUROSCI, V20; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153	54	19	19	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20858	20870		10.1074/jbc.M114.566687	http://dx.doi.org/10.1074/jbc.M114.566687			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24876386	Green Published, hybrid			2022-12-25	WOS:000339396600040
J	Zhuo, Y; Vishnivetskiy, SA; Zhan, XZ; Gurevich, VV; Klug, CS				Zhuo, Ya; Vishnivetskiy, Sergey A.; Zhan, Xuanzhi; Gurevich, Vsevolod V.; Klug, Candice S.			Identification of Receptor Binding-induced Conformational Changes in Non-visual Arrestins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CLATHRIN ADAPTER AP-2; BETA-ARRESTIN; CRYSTAL-STRUCTURE; RHODOPSIN PHOSPHORYLATION; VISUAL ARRESTIN; SPECIFICITY; ACTIVATION; EXPRESSION; ELEMENTS	The non-visual arrestins, arrestin-2 and arrestin-3, belong to a small family of multifunctional cytosolic proteins. Non-visual arrestins interact with hundreds of G protein-coupled receptors (GPCRs) and regulate GPCR desensitization by binding active phosphorylated GPCRs and uncoupling them from heterotrimeric G proteins. Recently, non-visual arrestins have been shown to mediate G protein-independent signaling by serving as adaptors and scaffolds that assemble multiprotein complexes. By recruiting various partners, including trafficking and signaling proteins, directly to GPCRs, non-visual arrestins connect activated receptors to diverse signaling pathways. To investigate arrestin-mediated signaling, a structural understanding of arrestin activation and interaction with GPCRs is essential. Here we identified global and local conformational changes in the non-visual arrestins upon binding to the model GPCR rhodopsin. To detect conformational changes, pairs of spin labels were introduced into arrestin-2 and arrestin-3, and the interspin distances in the absence and presence of the receptor were measured by double electron electron resonance spectroscopy. Our data indicate that both non-visual arrestins undergo several conformational changes similar to arrestin-1, including the finger loop moving toward the predicted location of the receptor in the complex as well as the C-tail release upon receptor binding. The arrestin-2 results also suggest that there is no clam shell-like closure of the N- and C-domains and that the loop containing residue 136 (homolog of 139 in arrestin-1) has high flexibility in both free and receptor-bound states.	[Zhuo, Ya; Klug, Candice S.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Vishnivetskiy, Sergey A.; Zhan, Xuanzhi; Gurevich, Vsevolod V.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA	Medical College of Wisconsin; Vanderbilt University	Klug, CS (corresponding author), Med Coll Wisconsin, Dept Biophys, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	candice@mcw.edu	Vishnivetskiy, Sergey/AAJ-8661-2020; Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351	National Institutes of Health (NIH) [GM077561, EY011500, GM081756]; NIH [S10RR022422, S10OD011937, P41EB001980]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022422] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081756, R01GM077561] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD011937] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants GM077561, EY011500, and GM081756 (to V. V. G.). The DEER instrumentation was supported by NIH Grants S10RR022422 and S10OD011937, and data were collected at the National Biomedical EPR Center (supported by NIH Grant P41EB001980).	ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Breitman M, 2012, J BIOL CHEM, V287, P19653, DOI 10.1074/jbc.M112.358192; Carter JM, 2005, J MOL BIOL, V351, P865, DOI 10.1016/j.jmb.2005.06.048; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Coffa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028723; DeFea KA, 2007, ANNU REV PHYSIOL, V69, P535, DOI 10.1146/annurev.physiol.69.022405.154804; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Feuerstein SE, 2009, BIOCHEMISTRY-US, V48, P10733, DOI 10.1021/bi900544p; Gimenez LE, 2012, J BIOL CHEM, V287, P29495, DOI 10.1074/jbc.M112.366674; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich EV, 2012, PHARMACOL THERAPEUT, V133, P40, DOI 10.1016/j.pharmthera.2011.08.001; Gurevich EV, 2004, J NEUROCHEM, V91, P1404, DOI 10.1111/j.1471-4159.2004.02830.x; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Gurevich VV, 2003, STRUCTURE, V11, P1037, DOI 10.1016/S0969-2126(03)00184-9; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; GUREVICH VV, 1995, J BIOL CHEM, V270, P720, DOI 10.1074/jbc.270.2.720; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Hatmal MM, 2012, BIOPOLYMERS, V97, P35, DOI 10.1002/bip.21699; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Kovoor A, 1999, J BIOL CHEM, V274, P6831, DOI 10.1074/jbc.274.11.6831; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Milano SK, 2002, BIOCHEMISTRY-US, V41, P3321, DOI 10.1021/bi015905j; Moaven H, 2013, P NATL ACAD SCI USA, V110, P9463, DOI 10.1073/pnas.1301126110; Modzelewska A, 2006, CELL BIOCHEM BIOPHYS, V46, P1, DOI 10.1385/CBB:46:1:1; OHGURO H, 1994, PROTEIN SCI, V3, P2428, DOI 10.1002/pro.5560031226; PALCZEWSKI K, 1992, BIOCHEMISTRY-US, V31, P3902, DOI 10.1021/bi00131a003; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rapp CS, 2005, PROTEINS, V60, P103, DOI 10.1002/prot.20492; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Skegro D, 2007, PHOTOCHEM PHOTOBIOL, V83, P385, DOI 10.1562/2006-08-25-RA-1014; Sommer ME, 2007, J BIOL CHEM, V282, P25560, DOI 10.1074/jbc.M702155200; Song X, 2011, NEUROSCIENCE, V174, P37, DOI 10.1016/j.neuroscience.2010.11.009; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Vishnivetskiy SA, 2004, J BIOL CHEM, V279, P1262, DOI 10.1074/jbc.M308834200; Vishnivetskiy SA, 2002, J BIOL CHEM, V277, P43961, DOI 10.1074/jbc.M206951200; Vishnivetskiy SA, 2000, J BIOL CHEM, V275, P41049, DOI 10.1074/jbc.M007159200; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vishnivetskiy SA, 2013, J BIOL CHEM, V288, P11741, DOI 10.1074/jbc.M113.450031; Vishnivetskiy SA, 2011, J BIOL CHEM, V286, P24288, DOI 10.1074/jbc.M110.213835; Vishnivetskiy SA, 2010, J MOL BIOL, V395, P42, DOI 10.1016/j.jmb.2009.10.058; Vishnivetskiy SK, 1999, J BIOL CHEM, V274, P11451, DOI 10.1074/jbc.274.17.11451; Warshaviak DT, 2013, J MAGN RESON, V232, P53, DOI 10.1016/j.jmr.2013.04.013; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Xiao KH, 2010, P NATL ACAD SCI USA, V107, P15299, DOI 10.1073/pnas.1008461107; Zhan XZ, 2011, J MOL BIOL, V406, P467, DOI 10.1016/j.jmb.2010.12.034; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110; Zhuang TD, 2010, BIOCHEMISTRY-US, V49, P10473, DOI 10.1021/bi101596g	68	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20991	21002		10.1074/jbc.M114.560680	http://dx.doi.org/10.1074/jbc.M114.560680			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24867953	hybrid, Green Published			2022-12-25	WOS:000339396600052
J	Zhuang, XL; Stahl, SJ; Watts, NR; DiMattia, MA; Steven, AC; Wingfield, PT				Zhuang, Xiaolei; Stahl, Stephen J.; Watts, Norman R.; DiMattia, Michael A.; Steven, Alasdair C.; Wingfield, Paul T.			A Cell-penetrating Antibody Fragment against HIV-1 Rev Has High Antiviral Activity CHARACTERIZATION OF THE PARATOPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-CD4 MONOCLONAL-ANTIBODY; NUCLEAR-LOCALIZATION; PEPTIDE; BINDING; TAT; RRE; MINIANTIBODY; REPLICATION; ANTAGONISM; CORECEPTOR	The HIV-1 protein Rev oligomerizes on viral transcripts and directs their nuclear export. Previously, a Fab against Rev generated by phage display was used to crystallize and solve the structure of the Rev oligomerization domain. Here we have investigated the capability of this Fab to block Rev oligomerization and inhibit HIV-1 replication. The Fab itself did not have antiviral activity, but when a Tat-derived cell-penetrating peptide was appended, the resulting molecule (FabRev1-Tat) was strongly inhibitory of three different CCR5-tropic HIV-1 isolates (IC50 = 0.09-0.44 mu g/ml), as assessed by suppression of reverse transcriptase activity in infected peripheral blood mononuclear cells, and had low cell toxicity (TC50 > 100 mu g/ml). FabRev1-Tat was taken up by both peripheral blood mononuclear and HEK293T cells, appearing in both the cytoplasm and nucleus, as shown by immunofluorescence confocal laser scanning microscopy. Computational alanine scanning was used to identify key residues in the complementarity-determining regions to guide mutagenesis experiments. Residues in the light chain CDR3 (LCDR3) were assessed to be important. Residues in LCDR3 were mutated, and LCDR3-Tyr(92) was found to be critical for binding to Rev, as judged by surface plasmon resonance and electron microscopy. Peptides corresponding to all six CDR regions were synthesized and tested for Rev binding. None of the linear peptides had significant affinity for Rev, but four of the amide-cyclic forms did. Especially cyclic-LCDR3 (LGGYPAASYRTA) had high affinity for Rev and was able to effectively depolymerize Rev filaments, as shown by both surface plasmon resonance and electron microscopy.	NIAMSD, Prot Express Lab, NIH, Bethesda, MD 20892 USA; [DiMattia, Michael A.; Steven, Alasdair C.] NIAMSD, Struct Biol Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Wingfield, PT (corresponding author), NIH, Bldg 6B,Rm 1B130, Bethesda, MD 20892 USA.	pelpw@helix.nih.gov		Wingfield, Paul/0000-0002-9515-4752	Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health [HHSN272200700041C]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041115, ZIAAR041166] Funding Source: NIH RePORTER	Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Drs. Marc Nicklaus and Megan Peach (NCI/National Institutes of Health) for performing the computational alanine scanning, and Drs. Steven Turk (NIAID/National Institutes of Health) and Christoph Rader (Scripps) for much appreciated discussions. Drs. Evelyn Ralston and Kristina Zaal (NIAMS/National Institutes of Health) provided advice on the immunofluorescence microscopy. We also thank Joshua Kaufman and Ira Palmer (NIAMS/National Institutes of Health) for expert technical assistance. The anti-HIV testing was conducted by the Southern Research Institute using federal funds from the Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, under contract HHSN272200700041C entitled "Confirmatory In Vitro Evaluations of HIV Therapeutics."	Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Bes C, 2001, FEBS LETT, V508, P67, DOI 10.1016/S0014-5793(01)03036-8; Casset F, 2003, BIOCHEM BIOPH RES CO, V307, P198, DOI 10.1016/S0006-291X(03)01131-8; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Daugherty MD, 2010, NAT STRUCT MOL BIOL, V17, P1337, DOI 10.1038/nsmb.1902; DiMattia MA, 2010, P NATL ACAD SCI USA, V107, P5810, DOI 10.1073/pnas.0914946107; Dupont E, 2011, METHODS MOL BIOL, V683, P21, DOI 10.1007/978-1-60761-919-2_2; Fang XY, 2013, CELL, V155, P594, DOI 10.1016/j.cell.2013.10.008; Fleta-Soriano E, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-17; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Guo QG, 2012, CHEM BIOL DRUG DES, V79, P683, DOI 10.1111/j.1747-0285.2011.01315.x; Heap CJ, 2005, J GEN VIROL, V86, P1791, DOI 10.1099/vir.0.80812-0; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Jain C, 2001, MOL CELL, V7, P603, DOI 10.1016/S1097-2765(01)00207-6; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Kruger DM, 2010, NUCLEIC ACIDS RES, V38, pW480, DOI 10.1093/nar/gkq471; Laune D, 2002, J IMMUNOL METHODS, V267, P53, DOI 10.1016/S0022-1759(02)00140-0; LEVI M, 1993, P NATL ACAD SCI USA, V90, P4374, DOI 10.1073/pnas.90.10.4374; Levi M, 2000, AIDS RES HUM RETROV, V16, P59, DOI 10.1089/088922200309601; Lewis HD, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-79; Lo SL, 2008, BIOMATERIALS, V29, P2408, DOI 10.1016/j.biomaterials.2008.01.031; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9; McManus H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048839; Meireles LMC, 2010, NUCLEIC ACIDS RES, V38, pW407, DOI 10.1093/nar/gkq502; Monnet C, 1999, J BIOL CHEM, V274, P3789, DOI 10.1074/jbc.274.6.3789; Mora JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012352; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Pond SJK, 2009, P NATL ACAD SCI USA, V106, P1404, DOI 10.1073/pnas.0807388106; Shimane K, 2010, INT J BIOCHEM CELL B, V42, P1482, DOI 10.1016/j.biocel.2010.05.005; Sloan EA, 2013, J VIROL, V87, P11173, DOI 10.1128/JVI.01392-13; Stahl SJ, 2010, J MOL BIOL, V397, P697, DOI 10.1016/j.jmb.2010.01.061; Tuncbag N, 2010, NUCLEIC ACIDS RES, V38, pW402, DOI 10.1093/nar/gkq323; Varkouhi AK, 2011, J CONTROL RELEASE, V151, P220, DOI 10.1016/j.jconrel.2010.11.004; Vercruysse T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060259; Watts NR, 1998, J STRUCT BIOL, V121, P41, DOI 10.1006/jsbi.1998.3964; WINGFIELD PT, 1991, BIOCHEMISTRY-US, V30, P7527, DOI 10.1021/bi00244a023; Wong RW, 2013, NUCLEIC ACIDS RES, V41, P9471, DOI 10.1093/nar/gkt727; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Zaro JL, 2009, MOL PHARMACEUT, V6, P337, DOI 10.1021/mp800239p; Zhu XL, 2011, PROTEINS, V79, P2671, DOI 10.1002/prot.23094	41	17	20	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20222	20233		10.1074/jbc.M114.581090	http://dx.doi.org/10.1074/jbc.M114.581090			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24878961	Green Published, hybrid			2022-12-25	WOS:000339395200035
J	Mattijssen, F; Georgiadi, A; Andasarie, T; Szalowska, E; Zota, A; Krones-Herzig, A; Heier, C; Ratman, D; De Bosscher, K; Qi, L; Zechner, R; Herzig, S; Kersten, S				Mattijssen, Frits; Georgiadi, Anastasia; Andasarie, Tresty; Szalowska, Ewa; Zota, Annika; Krones-Herzig, Anja; Heier, Christoph; Ratman, Dariusz; De Bosscher, Karolien; Qi, Ling; Zechner, Rudolf; Herzig, Stephan; Kersten, Sander			Hypoxia-inducible Lipid Droplet-associated (HILPDA) Is a Novel Peroxisome Proliferator-activated Receptor (PPAR) Target Involved in Hepatic Triglyceride Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-RELATED PROTEIN; LOW-DENSITY LIPOPROTEINS; FATTY-ACID OXIDATION; NUCLEAR RECEPTORS; GENE-EXPRESSION; ENDOPLASMIC-RETICULUM; ADIPOSE LIPOLYSIS; MICE LACKING; ALPHA; STEATOHEPATITIS	Peroxisome proliferator-activated receptors (PPARs) play major roles in the regulation of hepatic lipid metabolism through the control of numerous genes involved in processes such as lipid uptake and fatty acid oxidation. Here we identify hypoxia-inducible lipid droplet-associated (Hilpda/Hig2) as a novel PPAR target gene and demonstrate its involvement in hepatic lipid metabolism. Microarray analysis revealed that Hilpda is one of the most highly induced genes by the PPAR alpha agonist Wy14643 in mouse precision cut liver slices. Induction of Hilpda mRNA by Wy14643 was confirmed in mouse and human hepatocytes. Oral dosing with Wy14643 similarly induced Hilpda mRNA levels in livers of wild-type mice but not Ppara(-/-) mice. Transactivation studies and chromatin immunoprecipitation showed that Hilpda is a direct PPAR alpha target gene via a conserved PPAR response element located 1200 base pairs upstream of the transcription start site. Hepatic overexpression of HILPDA in mice via adeno-associated virus led to a 4-fold increase in liver triglyceride storage, without any changes in key genes involved in de novo lipogenesis, beta-oxidation, or lipolysis. Moreover, intracellular lipase activity was not affected by HILPDA overexpression. Strikingly, HILPDA overexpression significantly impaired hepatic triglyceride secretion. Taken together, our data uncover HILPDA as a novel PPAR target that raises hepatic triglyceride storage via regulation of triglyceride secretion.	[Mattijssen, Frits; Georgiadi, Anastasia; Andasarie, Tresty; Kersten, Sander] Wageningen Univ, Nutr Metab & Genom Grp, Div Human Nutr, NL-6700 EV Wageningen, Netherlands; [Szalowska, Ewa] Univ Wageningen & Res Ctr, RIKILT Inst Food Safety, NL-6700 AE Wageningen, Netherlands; [Zota, Annika; Krones-Herzig, Anja; Herzig, Stephan] Heidelberg Univ, Joint Div Mol Metab Control, DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ Heidelberg,Ctr Mol Biol, D-69120 Heidelberg, Germany; [Zota, Annika; Krones-Herzig, Anja; Herzig, Stephan] Heidelberg Univ, Univ Hosp, D-69120 Heidelberg, Germany; [Heier, Christoph; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, Graz, Austria; [Ratman, Dariusz; De Bosscher, Karolien] Univ Ghent, Flanders Inst Biotechnol, Dept Med Prot Res, Nucl Receptor Signaling Unit,Cytokine Receptor La, B-9000 Ghent, Belgium; [Qi, Ling; Kersten, Sander] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Wageningen University & Research; Wageningen University & Research; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Graz; Flanders Institute for Biotechnology (VIB); Ghent University; Cornell University	Kersten, S (corresponding author), Wageningen Univ, Nutr Metab & Genom Grp, Bomenweg 2, NL-6703 HD Wageningen, Netherlands.	sander.kersten@wur.nl	Kersten, Sander/A-1116-2011	Kersten, Sander/0000-0003-4488-7734; Heier, Christoph/0000-0001-6858-408X; Qi, Ling/0000-0001-8229-0184; Herzig, Stephan/0000-0003-3950-3652; Zechner, Rudolf/0000-0001-5483-1182; De Bosscher, Karolien/0000-0001-5059-9718	Fondation Leducq Grant [12CVD04]; Netherlands Organization for Health Research and Development Grant, NWO ZonMW [40-00812-98-08030]; Austrian Science Fund (FWF) [Z 136, F 3002] Funding Source: researchfish	Fondation Leducq Grant(Leducq Foundation); Netherlands Organization for Health Research and Development Grant, NWO ZonMW; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Fondation Leducq Grant 12CVD04 and by Netherlands Organization for Health Research and Development Grant 40-00812-98-08030, NWO ZonMW.	Ahrens M, 2013, CELL METAB, V18, P296, DOI 10.1016/j.cmet.2013.07.004; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; Edvardsson U, 2006, J LIPID RES, V47, P329, DOI 10.1194/jlr.M500203-JLR200; Gimm T, 2010, FASEB J, V24, P4443, DOI 10.1096/fj.10-159806; Gordon DA, 2000, BBA-MOL CELL BIOL L, V1486, P72, DOI 10.1016/S1388-1981(00)00049-4; GORDON GB, 1977, AM J PATHOL, V88, P663; Gusarova V, 2003, J BIOL CHEM, V278, P48051, DOI 10.1074/jbc.M306898200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Ip E, 2004, HEPATOLOGY, V39, P1286, DOI 10.1002/hep.20170; Ip E, 2003, HEPATOLOGY, V38, P123, DOI 10.1053/jhep.2003.50307; Kashireddy PV, 2004, HEPATOL RES, V30, P104, DOI 10.1016/j.hepres.2004.06.004; Kenny PA, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-3; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kleiner S, 2009, J BIOL CHEM, V284, P18624, DOI 10.1074/jbc.M109.008797; Kong LB, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-246; Lalloyer F, 2010, ARTERIOSCL THROM VAS, V30, P894, DOI 10.1161/ATVBAHA.108.179689; Li XH, 2012, J LIPID RES, V53, P1877, DOI 10.1194/jlr.M026591; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Linden D, 2002, J BIOL CHEM, V277, P23044, DOI 10.1074/jbc.M110416200; Linden D, 2001, J LIPID RES, V42, P1831; Magnusson B, 2006, ARTERIOSCL THROM VAS, V26, P1566, DOI 10.1161/01.ATV.0000223345.11820.da; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; McPherson PAC, 2012, J PHYSIOL BIOCHEM, V68, P141, DOI 10.1007/s13105-011-0112-4; Nakamura MT, 2004, LIPIDS, V39, P1077, DOI 10.1007/s11745-004-1333-0; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Pawlak M, 2012, CURR TOP MED CHEM, V12, P486, DOI 10.2174/156802612799436641; Peters JM, 1997, J BIOL CHEM, V272, P27307, DOI 10.1074/jbc.272.43.27307; Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269; Poulsen LL, 2012, SEMIN CELL DEV BIOL, V23, P631, DOI 10.1016/j.semcdb.2012.01.003; Qin W, 2011, J BIOL CHEM, V286, P27769, DOI 10.1074/jbc.M110.203679; Rakhshandehroo M, 2007, PPAR RES, V2007, DOI 10.1155/2007/26839; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Roberts LD, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r75; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; Schupp M, 2010, J BIOL CHEM, V285, P40409, DOI 10.1074/jbc.R110.182451; Semenza GL, 2011, COLD SH Q B, V76, P347, DOI 10.1101/sqb.2011.76.010678; Shah A, 2010, ATHEROSCLEROSIS, V210, P35, DOI 10.1016/j.atherosclerosis.2009.11.010; Shiri-Sverdlov R, 2006, J HEPATOL, V44, P732, DOI 10.1016/j.jhep.2005.10.033; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Strong A, 2012, J CLIN INVEST, V122, P2807, DOI 10.1172/JCI63563; Sun Z, 2013, TRENDS ENDOCRIN MET, V24, P4, DOI 10.1016/j.tem.2012.09.005; Tiwari S, 2012, ARTERIOSCL THROM VAS, V32, P1079, DOI 10.1161/ATVBAHA.111.241471; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tordjman K, 2001, J CLIN INVEST, V107, P1025, DOI 10.1172/JCI11497; Wang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072315; Webster KA, 2003, J EXP BIOL, V206, P2911, DOI 10.1242/jeb.00516; Yamaguchi J, 2003, J BIOL CHEM, V278, P42643, DOI 10.1074/jbc.M306920200; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zandbergen F, 2005, BIOCHEM J, V392, P313, DOI 10.1042/BJ20050636; Zhang XD, 2014, DIABETES, V63, P934, DOI 10.2337/db13-1422	55	47	48	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19279	19293		10.1074/jbc.M114.570044	http://dx.doi.org/10.1074/jbc.M114.570044			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24876382	Green Published, hybrid			2022-12-25	WOS:000339326800006
J	Clausen, MP; Arnspang, EC; Ballou, B; Bear, JE; Lagerholm, BC				Clausen, Mathias P.; Arnspang, Eva C.; Ballou, Byron; Bear, James E.; Lagerholm, B. Christoffer			Simultaneous Multi-Species Tracking in Live Cells with Quantum Dot Conjugates	PLOS ONE			English	Article							UNDERGO HOP DIFFUSION; PLASMA-MEMBRANE; RECEPTOR CLUSTERS; SURFACE-PROTEINS; PARTICLE; CHOLESTEROL; CONFINEMENT; MONOVALENT; MOLECULES; TRANSPORT	Quantum dots are available in a range of spectrally separated emission colors and with a range of water-stabilizing surface coatings that offers great flexibility for enabling bio-specificity. In this study, we have taken advantage of this flexibility to demonstrate that it is possible to perform a simultaneous investigation of the lateral dynamics in the plasma membrane of i) the transmembrane epidermal growth factor receptor, ii) the glucosylphospatidylinositol-anchored protein CD59, and iii) ganglioside G(M1)-cholera toxin subunit B clusters in a single cell. We show that a large number of the trajectories are longer than 50 steps, which we by simulations show to be sufficient for robust single trajectory analysis. This analysis shows that the populations of the diffusion coefficients are heterogeneously distributed for all three species, but differ between the different species. We further show that the heterogeneity is decreased upon treating the cells with methyl-beta-cyclodextrin.	[Clausen, Mathias P.; Arnspang, Eva C.; Lagerholm, B. Christoffer] Univ Southern Denmark, MEMPHYS Ctr Biomembrane Phys, Odense M, Denmark; [Clausen, Mathias P.; Arnspang, Eva C.; Lagerholm, B. Christoffer] Univ Southern Denmark, Danish Mol Biomed Imaging Ctr DaMBIC, Odense M, Denmark; [Ballou, Byron] Carnegie Mellon Univ, MBIC, Mellon Inst, Pittsburgh, PA 15213 USA; [Bear, James E.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Bear, James E.] Univ N Carolina, Dept Cell & Dev Biol, Howard Hughes Med Inst, Chapel Hill, NC USA	University of Southern Denmark; University of Southern Denmark; Carnegie Mellon University; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Lagerholm, BC (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Oxford, England.	christoffer.lagerholm@imm.ox.ac.uk	Clausen, Mathias P./AAE-6487-2020; Arnspang, Eva C/Y-1132-2018	Clausen, Mathias P./0000-0003-1196-6241; Arnspang, Eva C/0000-0002-3095-4070; Lagerholm, Christoffer/0000-0003-4678-5168	VillumKann Rasmussen Foundation; Leo PharmaForskningsfond; Lundbeck Foundation; Novo Nordisk Foundation; Danish Natural Research Foundation; DaMBIC (Danish Molecular Biomedical Imaging Center); National Institutes of Health (NIH) [GM083035]; NIH [R01 EB000364]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083035] Funding Source: NIH RePORTER	VillumKann Rasmussen Foundation; Leo PharmaForskningsfond(LEO Pharma); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Natural Research Foundation(Danish Natural Science Research Council); DaMBIC (Danish Molecular Biomedical Imaging Center); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the VillumKann Rasmussen Foundation (to BioNET), Leo PharmaForskningsfond, the Lundbeck Foundation, the Novo Nordisk Foundation, and the Danish Natural Research Foundation (to MEMPHYS - Center for Biomembrane Physics) and DaMBIC (Danish Molecular Biomedical Imaging Center). J.E.B. was supported by National Institutes of Health (NIH) grant GM083035. B. B. was supported by NIH grant R01 EB000364. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Andrews NL, 2009, IMMUNITY, V31, P469, DOI 10.1016/j.immuni.2009.06.026; Arnspang EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048521; Bannai H, 2006, NAT PROTOC, V1, P2628, DOI 10.1038/nprot.2006.429; Bauer R, 1997, BBA-GEN SUBJECTS, V1334, P98, DOI 10.1016/S0304-4165(96)00078-5; Boggara M, 2013, BBA-BIOMEMBRANES, V1828, P419, DOI 10.1016/j.bbamem.2012.08.022; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Chakraborty SK, 2007, NANO LETT, V7, P2618, DOI 10.1021/nl0709930; Chen I, 2005, NAT METHODS, V2, P99, DOI 10.1038/NMETH735; Christensen EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044355; Clausen MP, 2013, NANO LETT, V13, P2332, DOI 10.1021/nl303151f; Clausen MP, 2011, CURR PROTEIN PEPT SC, V12, P699; Cutler PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064320; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Day CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034923; Day CA, 2009, BBA-BIOMEMBRANES, V1788, P245, DOI 10.1016/j.bbamem.2008.10.024; Durisic N, 2007, BIOPHYS J, V93, P1338, DOI 10.1529/biophysj.107.106864; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Howarth M, 2008, NAT PROTOC, V3, P534, DOI 10.1038/nprot.2008.20; Howarth M, 2008, NAT METHODS, V5, P397, DOI [10.1038/nmeth.1206, 10.1038/NMETH.1206]; Kopriva-Altfahrt G, 2009, PERITON DIALYSIS INT, V29, P330; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Mahammad S, 2008, BBA-BIOMEMBRANES, V1778, P1251, DOI 10.1016/j.bbamem.2008.02.010; Mascalchi P, 2012, SOFT MATTER, V8, P4462, DOI 10.1039/c2sm07018a; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Mittal R, 2011, BIOCONJUGATE CHEM, V22, P362, DOI 10.1021/bc100321c; Orr G, 2005, BIOPHYS J, V89, P1362, DOI 10.1529/biophysj.104.056192; Petershans A, 2011, CHEM COMMUN, V47, P10671, DOI 10.1039/c1cc12874d; Pinaud F, 2010, NAT METHODS, V7, P275, DOI [10.1038/nmeth.1444, 10.1038/NMETH.1444]; Pinaud F, 2009, TRAFFIC, V10, P691, DOI 10.1111/j.1600-0854.2009.00902.x; Rosenthal SJ, 2011, CHEM BIOL, V18, P10, DOI 10.1016/j.chembiol.2010.11.013; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; SIMSON R, 1995, BIOPHYS J, V69, P989, DOI 10.1016/S0006-3495(95)79972-6; Sunbul M, 2008, CHEM COMMUN, P5927, DOI 10.1039/b812162a; Suzuki K, 2005, BIOPHYS J, V88, P3659, DOI 10.1529/biophysj.104.048538; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Thompson AR, 2013, BIOPHYS J, V104, P2651, DOI 10.1016/j.bpj.2013.05.022; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tu RS, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041914; Umemura YM, 2008, BIOPHYS J, V95, P435, DOI 10.1529/biophysj.107.123018; Wang S, 2013, B MATH BIOL; Wieser S, 2007, BIOPHYS J, V92, P3719, DOI 10.1529/biophysj.106.095398; Wieser S, 2008, METHODS, V46, P131, DOI 10.1016/j.ymeth.2008.06.010; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; You CJ, 2010, ANGEW CHEM INT EDIT, V49, P4108, DOI 10.1002/anie.200907032	52	20	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97671	10.1371/journal.pone.0097671	http://dx.doi.org/10.1371/journal.pone.0097671			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892555	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400017
J	Ladner-Keay, CL; Griffith, BJ; Wishart, DS				Ladner-Keay, Carol L.; Griffith, Bethany J.; Wishart, David S.			Shaking Alone Induces De Novo Conversion of Recombinant Prion Proteins to beta-Sheet Rich Oligomers and Fibrils	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; IN-VITRO; CONFORMATION; STRAINS; STATE	The formation of beta-sheet rich prion oligomers and fibrils from native prion protein (PrP) is thought to be a key step in the development of prion diseases. Many methods are available to convert recombinant prion protein into beta-sheet rich fibrils using various chemical denaturants (urea, SDS, GdnHCl), high temperature, phospholipids, or mildly acidic conditions (pH 4). Many of these methods also require shaking or another form of agitation to complete the conversion process. We have identified that shaking alone causes the conversion of recombinant PrP to beta-sheet rich oligomers and fibrils at near physiological pH (pH 5.5 to pH 6.2) and temperature. This conversion does not require any denaturant, detergent, or any other chemical cofactor. Interestingly, this conversion does not occur when the water-air interface is eliminated in the shaken sample. We have analyzed shaking-induced conversion using circular dichroism, resolution enhanced native acidic gel electrophoresis (RENAGE), electron microscopy, Fourier transform infrared spectroscopy, thioflavin T fluorescence and proteinase K resistance. Our results show that shaking causes the formation of beta-sheet rich oligomers with a population distribution ranging from octamers to dodecamers and that further shaking causes a transition to beta-sheet fibrils. In addition, we show that shaking-induced conversion occurs for a wide range of full-length and truncated constructs of mouse, hamster and cervid prion proteins. We propose that this method of conversion provides a robust, reproducible and easily accessible model for scrapie-like amyloid formation, allowing the generation of milligram quantities of physiologically stable beta-sheet rich oligomers and fibrils. These results may also have interesting implications regarding our understanding of prion conversion and propagation both within the brain and via techniques such as protein misfolding cyclic amplification (PMCA) and quaking induced conversion (QuIC).	[Ladner-Keay, Carol L.; Griffith, Bethany J.; Wishart, David S.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Ladner-Keay, Carol L.; Wishart, David S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Ladner-Keay, Carol L.; Griffith, Bethany J.; Wishart, David S.] Natl Inst Nanotechnol, Edmonton, AB, Canada	University of Alberta; University of Alberta; National Research Council Canada	Wishart, DS (corresponding author), Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada.	david.wishart@ualberta.ca	Wishart, David Scott/ABI-3181-2020	Wishart, David S/0000-0002-3207-2434; Ladner-Keay, Carol/0000-0003-0273-713X	Alberta Prion Research Institute (APRI); Alberta Meat and Livestock Agency (ALMA)	Alberta Prion Research Institute (APRI); Alberta Meat and Livestock Agency (ALMA)	This work was supported by grants awarded to DSW from the Alberta Prion Research Institute (APRI) and Alberta Meat and Livestock Agency (ALMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bjorndahl TC, 2011, BIOCHEMISTRY-US, V50, P1162, DOI 10.1021/bi101435c; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Breydo L, 2005, ANAL BIOCHEM, V339, P165, DOI 10.1016/j.ab.2005.01.003; Caughey B, 2003, J VIROL, V77, P5499, DOI 10.1128/JVI.77.9.5499-5502.2003; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Cobb NJ, 2008, J BIOL CHEM, V283, P34704, DOI 10.1074/jbc.M806701200; Colby DW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000736; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2012, P NATL ACAD SCI USA, V109, P8546, DOI 10.1073/pnas.1204498109; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Di Stasio E, 2010, BIOPHYS CHEM, V153, P1, DOI 10.1016/j.bpc.2010.07.002; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Gomes MPB, 2008, J BIOL CHEM, V283, P19616, DOI 10.1074/jbc.M802102200; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Ladner CL, 2012, ANAL BIOCHEM, V426, P54, DOI 10.1016/j.ab.2012.04.005; Loksztejn A, 2010, J MOL BIOL, V395, P643, DOI 10.1016/j.jmb.2009.10.065; McGuire LI, 2012, ANN NEUROL, V72, P278, DOI 10.1002/ana.23589; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; Murray AN, 2013, PROTEIN SCI, V22, P1531, DOI 10.1002/pro.2339; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; Ostapchenko VG, 2010, J MOL BIOL, V400, P908, DOI 10.1016/j.jmb.2010.05.051; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Saleem F, PRION IN PRESS; Sankaranarayanan K, 2012, J PHYS CHEM B, V116, P895, DOI 10.1021/jp2100733; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; SLUZKY V, 1991, P NATL ACAD SCI USA, V88, P9377, DOI 10.1073/pnas.88.21.9377; Spassov S, 2006, BBA-GEN SUBJECTS, V1760, P1138, DOI 10.1016/j.bbagen.2006.02.018; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Wong E, 2004, BIOCHEM J, V380, P273, DOI 10.1042/BJ20031767	45	23	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98753	10.1371/journal.pone.0098753	http://dx.doi.org/10.1371/journal.pone.0098753			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892647	Green Submitted, Green Published, gold			2022-12-25	WOS:000336911400088
J	Puenpa, J; Mauleekoonphairoj, J; Linsuwanon, P; Suwannakarn, K; Chieochansin, T; Korkong, S; Theamboonlers, A; Poovorawan, Y				Puenpa, Jiratchaya; Mauleekoonphairoj, John; Linsuwanon, Piyada; Suwannakarn, Kamol; Chieochansin, Thaweesak; Korkong, Sumeth; Theamboonlers, Apiradee; Poovorawan, Yong			Prevalence and Characterization of Enterovirus Infections among Pediatric Patients with Hand Foot Mouth Disease, Herpangina and Influenza Like Illness in Thailand, 2012	PLOS ONE			English	Article							COXSACKIEVIRUS A6; BC LOOP; OUTBREAK; TAIWAN; EPIDEMIOLOGY; CIRCULATION; VP1; A10; SEROTYPES; EVOLUTION	Hand, foot, and mouth disease (HFMD) and herpangina are common infectious diseases caused by several genotypes of human enterovirus species A and frequently occurring in young children. This study was aimed at analyzing enteroviruses from patients with these diseases in Thailand in 2012. Detection and genotype determination of enteroviruses were accomplished by reverse transcription-polymerase chain reaction and sequencing of the VP1 region. Enterovirus-positive samples were differentiated into 17 genotypes (coxsackievirus A4 (CAV4), A5, A6, A8, A9, A10, A12, A16, A21, B1, B2, B4, B5, echovirus 7, 16, 25 and Enterovirus 71). The result showed CAV6 (33.5%), followed by CAV16 (9.4%) and EV71 (8.8%) as the most frequent genotypes in HFMD, CAV8 (19.3%) in herpangina and CAV6 (1.5%) in influenza like illness. Enterovirus infections were most prevalent during July with 34.4% in HFMD, 39.8% in herpangina and 1.6% in ILI. The higher enterovirus infection associated with HFMD and herpangina occurred in infants over one year-old. This represents the first report describing the circulation of multiple enteroviruses in Thailand.	[Puenpa, Jiratchaya; Mauleekoonphairoj, John; Linsuwanon, Piyada; Suwannakarn, Kamol; Chieochansin, Thaweesak; Korkong, Sumeth; Theamboonlers, Apiradee; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Dept Pediat, Ctr Excellence Clin Virol, Bangkok 10330, Thailand	Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Dept Pediat, Ctr Excellence Clin Virol, Bangkok 10330, Thailand.	Yong.P@chula.ac.th	Linsuwanon, Piyada/AAS-7642-2020; ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Mauleekoonphairoj, John/0000-0001-7644-0940; Poovorawan, Yong/0000-0002-2337-6807	National Research Council of Thailand; Higher Education Research Promotion and National Research University Project of Thailand Office of the Higher Education Commission [HR1155A]; Center of Excellence in Clinical Virology, Chulalongkorn University, Centenary Academic Development Project, Integrated Innovation Academic Center; Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093]; Outstanding Professor of the Thailand Research Fund [DPG5480002]; King Chulalongkorn Memorial Hospital Thai Red Cross Society; RGJ PhD program [PHD/0087/2554, PHD/0083/2552]	National Research Council of Thailand(National Research Council of Thailand (NRCT)); Higher Education Research Promotion and National Research University Project of Thailand Office of the Higher Education Commission; Center of Excellence in Clinical Virology, Chulalongkorn University, Centenary Academic Development Project, Integrated Innovation Academic Center; Chulalongkorn University Centenary Academic Development Project; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); Outstanding Professor of the Thailand Research Fund; King Chulalongkorn Memorial Hospital Thai Red Cross Society; RGJ PhD program	This study was supported by the National Research Council of Thailand; The Higher Education Research Promotion and National Research University Project of Thailand Office of the Higher Education Commission (HR1155A); the Center of Excellence in Clinical Virology, Chulalongkorn University, Centenary Academic Development Project, Integrated Innovation Academic Center; Chulalongkorn University Centenary Academic Development Project (CU56-HR01); the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530093); the Outstanding Professor of the Thailand Research Fund (DPG5480002); King Chulalongkorn Memorial Hospital Thai Red Cross Society; and the RGJ PhD program (PHD/0087/2554) and (PHD/0083/2552). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-297; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Chatproedprai S, 2010, JPN J INFECT DIS, V63, P229; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; Flett K, 2012, EMERG INFECT DIS, V18, P1702, DOI 10.3201/eid1810.120813; Fujimoto T, 2012, EMERG INFECT DIS, V18, P337, DOI 10.3201/eid1802.111147; Gopalkrishna V, 2012, J MED MICROBIOL, V61, P420, DOI 10.1099/jmm.0.036400-0; He Y, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/481580; Herrero LJ, 2003, ARCH VIROL, V148, P1369, DOI 10.1007/s00705-003-0100-2; Hu YF, 2011, J CLIN MICROBIOL, V49, P2426, DOI 10.1128/JCM.00007-11; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang YP, 2008, VIRUS RES, V137, P206, DOI 10.1016/j.virusres.2008.07.015; Kapusinszky B, 2010, VIRUS GENES, V40, P163, DOI 10.1007/s11262-009-0440-4; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Laxmivandana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061650; Thoa LPK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069895; Lee MH, 2011, J MICROBIOL IMMUNOL, V44, P178, DOI 10.1016/j.jmii.2011.01.018; Lin JY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-103; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Liu MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025287; Lu QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052073; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; Mirand A, 2012, CLIN MICROBIOL INFEC, V18, pE110, DOI 10.1111/j.1469-0691.2012.03789.x; Mizuta K, 2005, J CLIN MICROBIOL, V43, P6171, DOI 10.1128/JCM.43.12.6171-6175.2005; Montes M, 2013, EMERG INFECT DIS, V19, P676, DOI 10.3201/eid1904.121589; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Norder H, 2003, J GEN VIROL, V84, P827, DOI 10.1099/vir.0.18647-0; Osterback R, 2009, EMERG INFECT DIS, V15, P1485, DOI 10.3201/eid1509.090438; Park K, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-205; Puenpa J, 2013, EMERG INFECT DIS, V19, P641, DOI 10.3201/eid1904.121666; Puenpa J, 2011, ARCH VIROL, V156, P2007, DOI 10.1007/s00705-011-1098-5; Ryu WS, 2010, J CLIN MICROBIOL, V48, P2490, DOI 10.1128/JCM.02369-09; Shah VA, 2003, ANN ACAD MED SINGAP, V32, P381; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; STIRK HJ, 1994, PROTEIN ENG, V7, P47, DOI 10.1093/protein/7.1.47; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Khanh TH, 2012, EMERG INFECT DIS, V18, P2002, DOI 10.3201/eid1812.120929; Tryfonos C, 2011, J MED MICROBIOL, V60, P1433, DOI 10.1099/jmm.0.029892-0; Tseng FC, 2007, J MED VIROL, V79, P1850, DOI 10.1002/jmv.21006; Wang XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048069, 10.1371/journal.pone.0051667, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0032405, 10.1371/journal.pone.0036274]; Wei SH, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-346; Wong SSY, 2010, EPIDEMIOL INFECT, V138, P1071, DOI 10.1017/S0950268809991555; World Health Organization, 2006, COLL PRES SHIPP SPEC, P42; Wu Y, 2010, INT J INFECT DIS, V14, pE1076, DOI 10.1016/j.ijid.2010.07.006; Xiang ZC, 2012, EMERG INFECT DIS, V18, P821, DOI 10.3201/eid1805.111376; Zeng M, 2012, J CLIN VIROL, V53, P285, DOI 10.1016/j.jcv.2011.12.025; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhao K, 2011, EMERG INFECT DIS, V17, P1537, DOI 10.3201/eid1708.101719	51	47	63	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98888	10.1371/journal.pone.0098888	http://dx.doi.org/10.1371/journal.pone.0098888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887237	Green Submitted, Green Published, gold			2022-12-25	WOS:000336956300119
J	Shaffer, SA; Clatterbuck, CA; Kelsey, EC; Naiman, AD; Young, LC; VanderWerf, EA; Warzybok, P; Bradley, R; Jahncke, J; Bower, GC				Shaffer, Scott A.; Clatterbuck, Corey A.; Kelsey, Emma C.; Naiman, Alex D.; Young, Lindsay C.; VanderWerf, Eric A.; Warzybok, Pete; Bradley, Russell; Jahncke, Jaime; Bower, Geoff C.			As the Egg Turns: Monitoring Egg Attendance Behavior in Wild Birds Using Novel Data Logging Technology	PLOS ONE			English	Article							HUMAN DISTURBANCE; HEART-RATE; INCUBATION; PENGUINS; EMBRYOS; CONSEQUENCES; TEMPERATURES; FREQUENCY; FAILURE; SUCCESS	Egg turning is unique to birds and critical for embryonic development in most avian species. Technology that can measure changes in egg orientation and temperature at fine temporal scales (1 Hz) was neither readily available nor small enough to fit into artificial eggs until recently. Here we show the utility of novel miniature data loggers equipped with 3-axis (i.e., triaxial) accelerometers, magnetometers, and a temperature thermistor to study egg turning behavior in free-ranging birds. Artificial eggs containing egg loggers were deployed in the nests of three seabird species for 1-7 days of continuous monitoring. These species (1) turned their eggs more frequently (up to 6.5 turns h(-1)) than previously reported for other species, but angular changes were often small (1-10 degrees most common), (2) displayed similar mean turning rates (ca. 2 turns h(-1)) despite major differences in reproductive ecology, and (3) demonstrated distinct diurnal cycling in egg temperatures that varied between 1.4 and 2.4 degrees C. These novel egg loggers revealed high-resolution, three-dimensional egg turning behavior heretofore never measured in wild birds. This new form of biotechnology has broad applicability for addressing fundamental questions in avian breeding ecology, life history, and development, and can be used as a tool to monitor birds that are sensitive to disturbance while breeding.	[Shaffer, Scott A.; Clatterbuck, Corey A.; Kelsey, Emma C.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA; [Naiman, Alex D.; Bower, Geoff C.] Stanford Univ, Dept Aeronaut & Astronaut, Stanford, CA 94305 USA; [Young, Lindsay C.; VanderWerf, Eric A.] Pacif Rim Conservat, Honolulu, HI USA; [Warzybok, Pete; Bradley, Russell; Jahncke, Jaime] Point Blue Conservat Sci, Petaluma, CA USA	California State University System; San Jose State University; Stanford University	Shaffer, SA (corresponding author), San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA.	scott.shaffer@sjsu.edu	Shaffer, Scott A/D-5015-2009	Shaffer, Scott A/0000-0002-7751-5059; , Corey/0000-0003-1351-8565; Kelsey, Emma/0000-0002-0107-3530	California State University Program for Education and Research in Biotechnology (CSUPERB); California State University Council on Ocean Affairs, Science and Technology (CSU COAST); Dr. Earl H. Myers and Ethel M. Myers Oceanographic and Marine Biology Trust; Frank M. Chapman Memorial Fund; San Jose State University Research, Scholarship and Activity (RSCA) grants; Pacific Rim Conservation	California State University Program for Education and Research in Biotechnology (CSUPERB); California State University Council on Ocean Affairs, Science and Technology (CSU COAST); Dr. Earl H. Myers and Ethel M. Myers Oceanographic and Marine Biology Trust; Frank M. Chapman Memorial Fund; San Jose State University Research, Scholarship and Activity (RSCA) grants; Pacific Rim Conservation	This research was supported by grants from the California State University Program for Education and Research in Biotechnology (CSUPERB); California State University Council on Ocean Affairs, Science and Technology (CSU COAST); Dr. Earl H. Myers and Ethel M. Myers Oceanographic and Marine Biology Trust; Frank M. Chapman Memorial Fund; and San Jose State University Research, Scholarship and Activity (RSCA) grants. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Pacific Rim Conservation provided support in the form of salaries for authors LCY and EAVW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaulieu M, 2010, POLAR BIOL, V33, P485, DOI 10.1007/s00300-009-0725-z; BEER CG, 1965, AUK, V82, P1; BOONE RB, 1989, J FIELD ORNITHOL, V60, P315; CALDWELL PJ, 1975, AUK, V92, P706, DOI 10.2307/4084783; De Villiers M, 2006, POLAR BIOL, V29, P717, DOI 10.1007/s00300-006-0137-2; Deeming D.C., 2002, AVIAN INCUBATION BEH; DEEMING DC, 1989, BRIT POULTRY SCI, V30, P591, DOI 10.1080/00071668908417182; DEEMING DC, 1989, J MORPHOL, V201, P179, DOI 10.1002/jmor.1052010207; Drent R. H., 1970, P1; Drent R. H, 1970, pUnpaginated; DuRant SE, 2012, FUNCT ECOL, V26, P416, DOI 10.1111/j.1365-2435.2011.01945.x; Elibol O, 2006, POULTRY SCI, V85, P1433, DOI 10.1093/ps/85.8.1433; Ellenberg U, 2006, BIOL CONSERV, V133, P95, DOI 10.1016/j.biocon.2006.05.019; Eycleshymer AC, 1907, BIOL BULL-US, V12, P360, DOI 10.2307/1535688; Fernandez MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061030; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; GEE GF, 1995, ZOO BIOL, V14, P159, DOI 10.1002/zoo.1430140209; Giese M, 1999, J FIELD ORNITHOL, V70, P49; Groscolas R, 2000, AM J PHYSIOL-REG I, V279, pR2104, DOI 10.1152/ajpregu.2000.279.6.R2104; Hepp GR, 2006, FUNCT ECOL, V20, P307, DOI 10.1111/j.1365-2435.2006.01108.x; Holmes N, 2005, BIOL CONSERV, V126, P339, DOI 10.1016/j.biocon.2005.06.009; HOWEY P, 1984, IBIS, V126, P16, DOI 10.1111/j.1474-919X.1984.tb03660.x; Mitani Y, 2010, BIOL LETTERS, V6, P163, DOI 10.1098/rsbl.2009.0719; Naito Y, 2013, FUNCT ECOL, V27, P710, DOI 10.1111/1365-2435.12083; NEW DAT, 1957, J EMBRYOL EXP MORPH, V5, P293; Nimon AJ, 1996, PHYSIOL BEHAV, V60, P1019; PRINCE PA, 1994, IBIS, V136, P50, DOI 10.1111/j.1474-919X.1994.tb08131.x; Reid JM, 2000, FUNCT ECOL, V14, P560, DOI 10.1046/j.1365-2435.2000.00446.x; Reneerkens J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016834; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Thierry AM, 2013, HORM BEHAV, V64, P737, DOI 10.1016/j.yhbeh.2013.06.003; Thierry AM, 2013, HORM BEHAV, V63, P475, DOI 10.1016/j.yhbeh.2012.12.011; Thomson DL, 1998, BIOL REV, V73, P293, DOI 10.1017/S0006323198005180; Tona K, 2005, POULTRY SCI, V84, P315, DOI 10.1093/ps/84.2.315; TULLETT SG, 1987, BRIT POULTRY SCI, V28, P239, DOI 10.1080/00071668708416958; Walsh PT, 2007, BIRD STUDY, V54, P133, DOI 10.1080/00063650709461466; Weathers Wesley W., 2010, Western Birds, V41, P2; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; WEIMERSKIRCH H, 1995, OECOLOGIA, V102, P37, DOI 10.1007/BF00333308; Yoda K, 2001, J EXP BIOL, V204, P685	40	20	25	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97898	10.1371/journal.pone.0097898	http://dx.doi.org/10.1371/journal.pone.0097898			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887441	gold, Green Published			2022-12-25	WOS:000336956300025
J	Govindan, S; Shapiro, L; Langa, KM; Iwashyna, TJ				Govindan, Sushant; Shapiro, Letitia; Langa, Kenneth M.; Iwashyna, Theodore J.			Death Certificates Underestimate Infections as Proximal Causes of Death in the US	PLOS ONE			English	Article							SEVERE SEPSIS; CANCER-MORTALITY; ACCURACY; AUTOPSY; TRENDS; STATISTICS	Background: Death certificates are a primary data source for assessing the population burden of diseases; however, there are concerns regarding their accuracy. Diagnosis-Related Group (DRG) coding of a terminal hospitalization may provide an alternative view. We analyzed the rate and patterns of disagreement between death certificate data and hospital claims for patients who died during an inpatient hospitalization. Methods: We studied respondents from the Health and Retirement Study (a nationally representative sample of older Americans who had an inpatient death documented in the linked Medicare claims from 1993-2007). Causes of death abstracted from death certificates were aggregated to the standard National Center for Health Statistics List of 50 Rankable Causes of Death. Centers for Medicare and Medicaid Services (CMS)-DRGs were manually aggregated into a parallel classification. We then compared the two systems via 2x2, focusing on concordance. Our primary analysis was agreement between the two data sources, assessed with percentages and Cohen's kappa statistic. Results: 2074 inpatient deaths were included in our analysis. 36.6% of death certificate cause-of-death codes agreed with the reason for the terminal hospitalization in the Medicare claims at the broad category level; when re-classifying DRGs without clear alignment as agreements, the concordance only increased to 61%. Overall Kappa was 0.21, or "fair.'' Death certificates in this cohort redemonstrated the conventional top 3 causes of death as diseases of the heart, malignancy, and cerebrovascular disease. However, hospitalization claims data showed infections, diseases of the heart, and cerebrovascular disease as the most common diagnoses for the same terminal hospitalizations. Conclusion: There are significant differences between Medicare claims and death certificate data in assigning cause of death for inpatients. The importance of infections as proximal causes of death is underestimated by current death certificate-based strategies.	[Govindan, Sushant; Shapiro, Letitia; Langa, Kenneth M.; Iwashyna, Theodore J.] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.; Iwashyna, Theodore J.] HSR&D Ctr Excellence, VA Ctr Clin Management Res, Ann Arbor, MI USA; [Langa, Kenneth M.; Iwashyna, Theodore J.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Iwashyna, TJ (corresponding author), Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA.	tiwashyn@umich.edu		Iwashyna, Theodore/0000-0002-4226-9310; Langa, Kenneth/0000-0002-2798-1836	National Institutes of Health [K08 HL091249, R01 AG030155, U01 AG09740]; Department of Veterans Affairs Health Services Research & Development Service [IIR 11-109]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL091249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG009740, R01AG030155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Health Services Research & Development Service(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants K08 HL091249, R01 AG030155, and U01 AG09740 from the National Institutes of Health, and IIR 11-109 from the Department of Veterans Affairs Health Services Research & Development Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], 2011, STAT ABSTR US 2012; [Anonymous], 2013, CAUSES DEATH ST 0302; Armstrong GL, 1999, JAMA-J AM MED ASSOC, V281, P61, DOI 10.1001/jama.281.1.61; Burger EH, 2012, J CLIN EPIDEMIOL, V65, P309, DOI 10.1016/j.jclinepi.2011.08.007; Campbell SE, 2001, J PUBLIC HEALTH MED, V23, P205, DOI 10.1093/pubmed/23.3.205; Combes A, 2004, ARCH INTERN MED, V164, P389, DOI 10.1001/archinte.164.4.389; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Doria-Rose VP, 2009, LUNG CANCER, V63, P295, DOI 10.1016/j.lungcan.2008.05.019; Farmer SA, 2013, JAMA-J AM MED ASSOC, V309, P349, DOI 10.1001/jama.2012.191276; Fauci AS, 2005, EMERG INFECT DIS, V11, P519, DOI 10.3201/eid1104.041167; Flory J, 2004, HEALTH AFFAIR, V23, P194, DOI 10.1377/hlthaff.23.3.194; German RR, 2011, CANCER EPIDEMIOL, V35, P126, DOI 10.1016/j.canep.2010.09.005; HASUO Y, 1989, J CLIN EPIDEMIOL, V42, P577, DOI 10.1016/0895-4356(89)90154-6; Haut ER, 2012, JAMA-J AM MED ASSOC, V307, P2589, DOI 10.1001/jama.2012.6626; Heron Melonie, 2013, Natl Vital Stat Rep, V62, P1; Heron Melonie, 2011, Natl Vital Stat Rep, V59, P1; Iwashyna TJ, 2012, J AM GERIATR SOC, V60, P1070, DOI 10.1111/j.1532-5415.2012.03989.x; Iwashyna TJ, 2012, AM J RESP CRIT CARE, V185, P835, DOI 10.1164/rccm.201109-1660OC; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Johansson LA, 2002, J EPIDEMIOL COMMUN H, V56, P301, DOI 10.1136/jech.56.4.301; Karlsson S, 2009, CRIT CARE MED, V37, P1268, DOI 10.1097/CCM.0b013e31819c13ac; KIRCHER T, 1985, NEW ENGL J MED, V313, P1263, DOI 10.1056/NEJM198511143132005; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lund JL, 2010, CANCER INVEST, V28, P758, DOI 10.3109/07357901003630959; Mlangeni DA, 2011, J HOSP INFECT, V77, P370, DOI 10.1016/j.jhin.2010.12.016; MODELMOG D, 1992, CANCER CAUSE CONTROL, V3, P541, DOI 10.1007/BF00052751; Morrow DA, 2012, CIRCULATION, V126, P1408, DOI 10.1161/CIR.0b013e31826890b0; MOUSSA MAA, 1990, J CLIN EPIDEMIOL, V43, P1285, DOI 10.1016/0895-4356(90)90094-6; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Sarrazin MSV, 2012, JAMA-J AM MED ASSOC, V307, P1433, DOI 10.1001/jama.2012.404; Sehdev AES, 2001, ARCH INTERN MED, V161, P277, DOI 10.1001/archinte.161.2.277; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d	34	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97714	10.1371/journal.pone.0097714	http://dx.doi.org/10.1371/journal.pone.0097714			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK0KM	24878897	gold, Green Submitted, Green Published			2022-12-25	WOS:000338101500022
J	Cava, C; Bertoli, G; Ripamonti, M; Mauri, G; Zoppis, I; Della Rosa, PA; Gilardi, MC; Castiglioni, I				Cava, Claudia; Bertoli, Gloria; Ripamonti, Marilena; Mauri, Giancarlo; Zoppis, Italo; Della Rosa, Pasquale Anthony; Gilardi, Maria Carla; Castiglioni, Isabella			Integration of mRNA Expression Profile, Copy Number Alterations, and microRNA Expression Levels in Breast Cancer to Improve Grade Definition	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXM1; HISTONE VARIANT H2A.Z; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; CLINICOPATHOLOGICAL FEATURES; HEPATOCELLULAR-CARCINOMA; CHROMOSOMAL IMBALANCES; CIRCULATING MICRORNAS; POTENTIAL BIOMARKERS; MOLECULAR PORTRAITS	Defining the aggressiveness and growth rate of a malignant cell population is a key step in the clinical approach to treating tumor disease. The correct grading of breast cancer (BC) is a fundamental part in determining the appropriate treatment. Biological variables can make it difficult to elucidate the mechanisms underlying BC development. To identify potential markers that can be used for BC classification, we analyzed mRNAs expression profiles, gene copy numbers, microRNAs expression and their association with tumor grade in BC microarray-derived datasets. From mRNA expression results, we found that grade 2 BC is most likely a mixture of grade 1 and grade 3 that have been misclassified, being described by the gene signature of either grade 1 or grade 3. We assessed the potential of the new approach of integrating mRNA expression profile, copy number alterations, and microRNA expression levels to select a limited number of genomic BC biomarkers. The combination of mRNA profile analysis and copy number data with microRNA expression levels led to the identification of two gene signatures of 42 and 4 altered genes (FOXM1, KPNA4, H2AFV and DDX19A) respectively, the latter obtained through a meta-analytical procedure. The 42-based gene signature identifies 4 classes of up-or down-regulated microRNAs (17 microRNAs) and of their 17 target mRNA, and the 4-based genes signature identified 4 microRNAs (Hsa-miR-320d, Hsa-miR-139-5p, Hsa-miR-567 and Hsa-let-7c). These results are discussed from a biological point of view with respect to pathological features of BC. Our identified mRNAs and microRNAs were validated as prognostic factors of BC disease progression, and could potentially facilitate the implementation of assays for laboratory validation, due to their reduced number.	[Cava, Claudia; Bertoli, Gloria; Ripamonti, Marilena; Della Rosa, Pasquale Anthony; Gilardi, Maria Carla; Castiglioni, Isabella] CNR, Inst Mol Bioimaging & Physiol IBFM, I-20133 Milan, Italy; [Mauri, Giancarlo; Zoppis, Italo] Univ Milano Bicocca, Dept Informat Syst & Commun, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); University of Milano-Bicocca	Castiglioni, I (corresponding author), CNR, Inst Mol Bioimaging & Physiol IBFM, I-20133 Milan, Italy.	isabella.castiglioni@ibfm.cnr.it	Ripamonti, Marilena/AAY-4013-2020; Castiglioni, Isabella/AAC-4949-2022; Mauri, Giancarlo/M-3258-2013; Cava, Claudia/P-2257-2018; Rosa, Pasquale Anthony Della/AAC-3459-2019; Bertoli, Gloria/J-6559-2016	Mauri, Giancarlo/0000-0003-3520-4022; Cava, Claudia/0000-0002-5540-4104; Rosa, Pasquale Anthony Della/0000-0002-3137-1731; Bertoli, Gloria/0000-0002-5901-4269; ZOPPIS, ITALO FRANCESCO/0000-0001-7312-7123; Castiglioni, Isabella/0000-0001-7191-5417; GILARDI, MARIA CARLA/0000-0002-5472-3509; RIPAMONTI, MARILENA/0000-0001-9403-9915	INTEROMICS flagship project; National Research Council CUP [B91J12000190001]	INTEROMICS flagship project; National Research Council CUP	This study was partially supported by INTEROMICS flagship project (url: http://www.interomics.eu/it/home), National Research Council CUP grant B91J12000190001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abdelhaleem M, 2004, ANTICANCER RES, V24, P3951; Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Alexandrov Peter N, 2012, Int J Biochem Mol Biol, V3, P365; Altintas DM, 2012, MOL ENDOCRINOL, V26, P1531, DOI 10.1210/me.2012-1016; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andre F, 2009, CLIN CANCER RES, V15, P441, DOI 10.1158/1078-0432.CCR-08-1791; Andrews J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008665; Angeloni Debora, 2007, Briefings in Functional Genomics & Proteomics, V6, P19, DOI 10.1093/bfgp/elm007; Arigami T, 2012, ONCOLOGY-BASEL, V83, P158, DOI 10.1159/000341390; Ayaz L, 2013, J CANCER RES CLIN, V139, P1499, DOI 10.1007/s00432-013-1469-2; Balsara BR, 2002, ONCOGENE, V21, P6877, DOI 10.1038/sj.onc.1205836; Bambang IF, 2013, ONCOGENE, V32, P1240, DOI 10.1038/onc.2012.149; Banigan MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048814; Barrio-Real L, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003543; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bektas N, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-42; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bergamaschi A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2913; Bevilacqua V, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S7-S9; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Bock-Axelsen J, 2007, P NATL ACAD SCI USA, V104, P13122, DOI 10.1073/pnas.0705824104; Borel C, 2008, MAMM GENOME, V19, P503, DOI 10.1007/s00335-008-9137-6; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Callagy G, 2005, J PATHOL, V205, P388, DOI 10.1002/path.1694; Carlson Robert W, 2007, J Natl Compr Canc Netw, V5, P246; Caron C, 2010, ONCOGENE, V29, P5171, DOI 10.1038/onc.2010.259; Carr JR, 2012, CELL REP, V1, P715, DOI 10.1016/j.celrep.2012.05.005; Cava C, 2013, IEEE ENG MED BIO, P608, DOI 10.1109/EMBC.2013.6609573; Cava Claudia, 2013, Artificial Intelligence in Medicine. 14th Conference on Artificial Intelligence in Medicine, AIME 2013. Proceedings, P104, DOI 10.1007/978-3-642-38326-7_16; Cava Claudia, 2014, J Clin Bioinforma, V4, P2, DOI 10.1186/2043-9113-4-2; Cazzoli R, 2013, J THORAC ONCOL, V8, P1156, DOI 10.1097/JTO.0b013e318299ac32; Chan E, 2011, CELL CYCLE, V10, P1845, DOI 10.4161/cc.10.11.15777; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen ZH, 2012, PROSTATE, V72, P1443, DOI 10.1002/pros.22495; Cheng I, 2012, GENE CHROMOSOME CANC, V51, P66, DOI 10.1002/gcc.20932; Chi B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-243; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin SF, 2007, ONCOGENE, V26, P1959, DOI 10.1038/sj.onc.1209985; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Chiu L Y, 2013, J GASTROENTEROL, P1; Choschzick M, 2010, MODERN PATHOL, V23, P603, DOI 10.1038/modpathol.2010.5; Colak D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063204; Corpet A, 2011, EMBO J, V30, P480, DOI 10.1038/emboj.2010.335; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Cuk K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076729; Debnath R, 2010, BIOSYSTEMS, V100, P39, DOI 10.1016/j.biosystems.2009.12.006; Duan ZJ, 2013, PROSTATE, V73, P455, DOI 10.1002/pros.22587; Duttagupta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031241; El-Murr N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031862; Eo HS, 2012, MOL CELLS, V34, P393, DOI 10.1007/s10059-012-0177-0; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Ferretti E, 2009, INT J CANCER, V124, P568, DOI 10.1002/ijc.23948; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Gao F, 2014, ONCOL REP, V31, P351, DOI 10.3892/or.2013.2830; Garcia-Tunon I, 2005, HISTOPATHOLOGY, V47, P82, DOI 10.1111/j.1365-2559.2005.02178.x; Gilam A, 2013, BREAST CANCER RES TR, V138, P753, DOI 10.1007/s10549-013-2502-5; Goh XY, 2011, GUT, V60, P1317, DOI 10.1136/gut.2010.234179; Guo X, 2009, RNA BIOL, V6, P575, DOI 10.4161/rna.6.5.10079; Hayes DF, 2001, J MAMMARY GLAND BIOL, V6, P375, DOI 10.1023/A:1014778713034; Hedges L.V., 1985, STAT METHODS META AN; Hiroki E, 2010, CANCER SCI, V101, P241, DOI 10.1111/j.1349-7006.2009.01385.x; Horlings HM, 2010, CLIN CANCER RES, V16, P651, DOI 10.1158/1078-0432.CCR-09-0709; Hsu W C, 2003, PRACTICAL GUIDE SUPP; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Huang NJ, 2012, J CELL BIOL, V197, P361, DOI [10.1083/jcb.201111141, 10.1083/jcb.201108062]; Hyman E, 2002, CANCER RES, V62, P6240; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Janssen EAM, 2010, MODERN PATHOL, V23, P1567, DOI 10.1038/modpathol.2010.177; Johnson CE, 2012, BREAST CANCER RES TR, V133, P889, DOI 10.1007/s10549-011-1835-1; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Juric Dejan, 2007, Methods Mol Biol, V377, P187; Kanaan Z, 2013, ANN SURG, V258, P400, DOI 10.1097/SLA.0b013e3182a15bcc; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Katayama Y, 2012, ONCOL LETT, V4, P817, DOI 10.3892/ol.2012.810; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kim JH, 2009, COMPUT STAT DATA AN, V53, P3735, DOI 10.1016/j.csda.2009.04.009; Kim K, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-34; Kitago M, 2009, CLIN CANCER RES, V15, P2988, DOI 10.1158/1078-0432.CCR-08-3172; Klokov D, 2004, MUTAT RES-FUND MOL M, V568, P97, DOI 10.1016/j.mrfmmm.2004.06.049; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Korn EL, 2004, J STAT PLAN INFER, V124, P379, DOI 10.1016/S0378-3758(03)00211-8; Kosaka Nobuyoshi, 2013, Frontiers in Genetics, V4, P173, DOI 10.3389/fgene.2013.00173; Krishnan K, 2013, RNA, V19, P1767, DOI 10.1261/rna.042143.113; Kristensen VN, 2012, P NATL ACAD SCI USA, V109, P2802, DOI 10.1073/pnas.1108781108; Krohn A, 2013, J PATHOL, V231, P130, DOI 10.1002/path.4223; Kumar D, 2013, 2013 IEEE CONFERENCE ON INFORMATION AND COMMUNICATION TECHNOLOGIES (ICT 2013), P594; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kurubanjerdjit N, 2013, COMPUT BIOL MED, V43, P1645, DOI 10.1016/j.compbiomed.2013.08.010; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Lahti L, 2013, BRIEF BIOINFORM, V14, P27, DOI 10.1093/bib/bbs005; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Leite KRM, 2011, UROL ONCOL-SEMIN ORI, V29, P265, DOI 10.1016/j.urolonc.2009.02.002; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li W, 2009, J MED GENET, V46, P358, DOI 10.1136/jmg.2008.063123; Li X, 2012, PLOS ONE, V7; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Li Y, 2013, ANAL CHEM, V85, P11174, DOI 10.1021/ac403462f; Liu C. Y., 2012, TYROSINE PHOSPHORYLA; Liu JJ, 2013, CHINESE J CANCER RES, V25, P46, DOI 10.3978/j.issn.1000-9604.2012.11.04; Liu R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077068; Liu X, 2013, MED ONCOL, V30, P1, DOI DOI 10.1007/S12032-013-0735-0; Liu XL, 2004, WORLD J GASTROENTERO, V10, P2340; Liu YF, 2007, ONCOL REP, V18, P943; Long Q, 2011, AM J PATHOL, V179, P46, DOI 10.1016/j.ajpath.2011.03.008; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Manuylov NL, 2007, ONCOGENE, V26, P5204, DOI 10.1038/sj.onc.1210333; Marchenko ND, 2010, CELL DEATH DIFFER, V17, P255, DOI 10.1038/cdd.2009.173; Martin RW, 2007, CANCER RES, V67, P9658, DOI 10.1158/0008-5472.CAN-07-0290; Martins VR, 2013, CURR OPIN ONCOL, V25, P66, DOI 10.1097/CCO.0b013e32835b7c81; McAvoy S, 2007, CYTOGENET GENOME RES, V118, P260, DOI 10.1159/000108309; Metzger O, 2011, CRIT REV ONCOL HEMAT, V77, P21, DOI 10.1016/j.critrevonc.2010.01.011; Meyer D, 2003, NEUROCOMPUTING, V55, P169, DOI 10.1016/S0925-2312(03)00431-4; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Monni O, 2001, P NATL ACAD SCI USA, V98, P5711, DOI 10.1073/pnas.091582298; Morello LG, 2011, NUCLEIC ACIDS RES, V39, P648, DOI 10.1093/nar/gkq758; Muniategui A, 2013, BRIEF BIOINFORM, V14, P263, DOI 10.1093/bib/bbs028; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Ngan E, 2013, J CELL SCI, V126, P1981, DOI 10.1242/jcs.118315; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Orsetti B, 2006, BRIT J CANCER, V95, P1439, DOI 10.1038/sj.bjc.6603433; Orsetti B, 2004, CANCER RES, V64, P6453, DOI 10.1158/0008-5472.CAN-04-0756; Padi SKR, 2013, GASTROENTEROLOGY, V145, P437, DOI 10.1053/j.gastro.2013.04.012; Page DL, 1998, J NATL CANCER I, V90, P88, DOI 10.1093/jnci/90.2.88; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pan YZ, 2009, MOL PHARMACOL, V75, P1374, DOI 10.1124/mol.108.054163; Parikesit A A, 2013, MALAYSIAN J FUNDAMEN, V10; Parris TZ, 2014, INT J CANCER, V134, P1617, DOI 10.1002/ijc.28497; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pennanen PI, 2009, STEROIDS, V74, P404, DOI 10.1016/j.steroids.2008.12.005; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Pinho FG, 2013, CANCER RES, V73, P5936, DOI 10.1158/0008-5472.CAN-13-0158; Polanowska J, 2000, GENE CHROMOSOME CANC, V28, P126, DOI 10.1002/(SICI)1098-2264(200005)28:1<126::AID-GCC15>3.0.CO;2-G; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Rachidi SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057911; Raeder MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054873; Rakha EA, 2008, BREAST CANCER RES TR, V111, P121, DOI 10.1007/s10549-007-9768-4; Rakha EA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2607; Ravdin PM, 2001, J CLIN ONCOL, V19, P980, DOI 10.1200/JCO.2001.19.4.980; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Reid JF, 2009, GENE CHROMOSOME CANC, V48, P953, DOI 10.1002/gcc.20697; Rennstam K, 2003, CANCER RES, V63, P8861; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Roa W, 2010, CLIN INVEST MED, V33, pE124; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sadakata T, 2013, FEBS LETT, V587, P54, DOI 10.1016/j.febslet.2012.10.047; Sadikovic B, 2008, CURR GENOMICS, V9, P394, DOI 10.2174/138920208785699580; Sadikovic B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002834; Saito K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071480; Sakurai M, 2012, J STEROID BIOCHEM, V131, P101, DOI 10.1016/j.jsbmb.2011.10.007; Salhab M, 2012, BREAST CANCER-TOKYO, V19, P153, DOI 10.1007/s12282-010-0228-3; Sand M, 2012, BRIT J DERMATOL, V167, P847, DOI 10.1111/j.1365-2133.2012.11022.x; Scarpati GD, 2012, INT J RADIAT ONCOL, V83, P1113, DOI 10.1016/j.ijrobp.2011.09.030; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schlomm T, 2007, CLIN CANCER RES, V13, P6579, DOI 10.1158/1078-0432.CCR-07-1257; Scholz M., 2006, P 12 ACM SIGKDD INT, P935, DOI [10.1145/1150402.1150531, DOI 10.1145/1150402.1150531]; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Singletary SE, 2002, J CLIN ONCOL, V20, P3628, DOI 10.1200/JCO.2002.02.026; Siveen KS, 2014, BBA-REV CANCER, V1845, P136, DOI 10.1016/j.bbcan.2013.12.005; Smith MA, 2013, NUCLEIC ACIDS RES, V41, P8220, DOI 10.1093/nar/gkt596; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Su CH, 2014, NUCLEIC ACIDS RES, V42, P3073, DOI 10.1093/nar/gkt1341; Tang J, 2012, INT J MOL SCI, V13, P13414, DOI 10.3390/ijms131013414; Therneau TM, 2014, PACKAGE SURVIVAL ANA; Therneau TM, 2000, MODELING SURVIVAL DA; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Umemura S, 2009, BRIT J CANCER, V100, P764, DOI 10.1038/sj.bjc.6604900; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang GF, 2009, FEBS J, V276, P5571, DOI 10.1111/j.1742-4658.2009.07238.x; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang PY, 2013, FEBS LETT, V587, P2675, DOI 10.1016/j.febslet.2013.07.004; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wells WA, 1998, J NATL CANCER I, V90, P142, DOI 10.1093/jnci/90.2.142; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Wu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035661; Xiao M, 2013, J CANCER RES CLIN, V139, P661, DOI 10.1007/s00432-012-1368-y; Xu XE, 2010, PROTEOMICS, V10, P1374, DOI 10.1002/pmic.200900380; Xu Y, 2012, J BIOMED RES, V26, P125, DOI 10.1016/S1674-8301(12)60022-0; Xue JF, 2014, J CLIN INVEST, V124, P564, DOI 10.1172/JCI71104; Yang C, 2013, CANCER GENE THER, V20, P117, DOI 10.1038/cgt.2012.94; Yang LQ, 2012, FUTURE ONCOL, V8, P431, DOI [10.2217/FON.12.27, 10.2217/fon.12.27]; Yang M, 2013, ONCOL REP, V29, P169, DOI 10.3892/or.2012.2105; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yuan E, 2006, CANCER RES, V66, P3443, DOI 10.1158/0008-5472.CAN-05-3739; Zhang HL, 2011, BIOCHEM BIOPH RES CO, V404, P273, DOI 10.1016/j.bbrc.2010.11.106; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhao BT, 2014, CANCER LETT, V342, P43, DOI 10.1016/j.canlet.2013.08.030; Zhao J, 2013, MED ONCOL, V30, P1; Zhi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056718	209	56	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97681	10.1371/journal.pone.0097681	http://dx.doi.org/10.1371/journal.pone.0097681			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866763	Green Published, Green Submitted, gold			2022-12-25	WOS:000336914100020
J	Erickson, ME; Found-Jackson, C; Boyce, MS				Erickson, Mara E.; Found-Jackson, Christine; Boyce, Mark S.			Using Latent Selection Difference to Model Persistence in a Declining Population	PLOS ONE			English	Article							CLIMATE-CHANGE; WOODLAND CARIBOU; NESTING ECOLOGY; WESTERN GREBES; CONSERVATION; LAKE; ABUNDANCE; BEARS	Population persistence is a direct measure of the viability of a population. Monitoring the distribution of declining populations or subpopulations over time can yield estimates of persistence, which we show can be modeled as a latent selection difference (LSD) contrasting attributes of sites where populations have persisted versus those that have not. Predicted persistence can be modeled with predictor covariates to identify factors correlated with species persistence. We demonstrate how to model persistence based on changes in occupancy that can include adjustments for detection probability. Using a known historical distribution of the western grebe (Aechmophorus occidentalis), we adapted methods originally developed for occupancy modeling to evaluate how environmental covariates including emergent vegetation and human developments have affected western grebe persistence in Alberta. The relative probability of persistence was correlated with the extent of shoreline bulrush (Scirpus lacustris), which is important vegetation for nesting cover. We also documented that western grebe populations were less likely to persist on lakes in the boreal forest, primarily located on the northern boundary of the species' range. Factors influencing occupancy were different than those determining persistence by western grebes; persistence and occupancy were not correlated. Persistence was more likely on lakes with recreational development, reflecting reliance by grebes on the larger, fish-bearing waterbodies that also are attractive for lakeshore development. Unfortunately, the correlation with recreational development on Alberta's lakes puts grebes at risk for loss of brood-rearing habitats-primary threats to altricial birds-if steps are not taken to prevent disturbance to bulrush stands. Identifying factors related to the persistence of a species-especially one in decline-is a fundamental step in conservation management.	[Erickson, Mara E.; Boyce, Mark S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Found-Jackson, Christine] Alberta Environm & Sustainable Resource Dev, Edmonton, AB, Canada	University of Alberta	Erickson, ME (corresponding author), Alberta Fish & Game Assoc, Operat Grassland Commun, Edmonton, AB, Canada.	m.erickson@ualberta.ca	Boyce, Mark S/A-2620-2014	Boyce, Mark S/0000-0001-5811-325X	Alberta Conservation Association [030-00-90-146]; Natural Sciences and Engineering Research Council of Canada [227081-09]; North American Waterfowl Management Plan [520811]; Alberta Sport, Recreation, Parks & Wildlife Foundation (SPR) [SPR09/0332]	Alberta Conservation Association; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); North American Waterfowl Management Plan; Alberta Sport, Recreation, Parks & Wildlife Foundation (SPR)	Funding was received from the following sources: Alberta Conservation Association (Grant Eligible Conservation Fund #030-00-90-146; http://www.ab-conservation.com/; MEE,MSB), the Natural Sciences and Engineering Research Council of Canada (#227081-09; http://www.nserc-crsng.gc.ca/index_eng.asp, MSB), the North American Waterfowl Management Plan (#520811; http://nawmp.wetlandnetwork.ca/; MEE,CF,MSB), and Alberta Sport, Recreation, Parks & Wildlife Foundation (SPR#: SPR09/0332; http://www.albertasport.ca/; MEE, MSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agri-Environment Services Branch (AESB) Agriculture and Agri-Food Canada, 2008, LAND COV AGR REG CAN; Alberta Environment and Sustainable Resource Development and Alberta Conservation Association, 2013, 60 ALB ENV SUST RES; Allen JH, 2008, WATERBIRDS, V31, P402, DOI 10.1675/1524-4695-31.3.402; Allen JH, 2008, WATERBIRDS, V31, P411, DOI 10.1675/1524-4695-31.3.411; B.C. Resources Inventory Committee, 1998, INV METH COL NEST FR; Berg G, 2004, 94 ALB SUST RES DEV; Bower John L., 2009, Marine Ornithology, V37, P9; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Burger AE, 1997, WR87 BC ENV WILDL BR; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; Cross PC, 2001, CONSERV BIOL, V15, P1335, DOI 10.1046/j.1523-1739.2001.00031.x; Drever MC, 2012, GLOBAL CHANGE BIOL, V18, P480, DOI 10.1111/j.1365-2486.2011.02541.x; *ENV SYST RES I, 2008, ARCGIS REL 9 3; Epps CW, 2004, CONSERV BIOL, V18, P102, DOI 10.1111/j.1523-1739.2004.00023.x; Feerer J.L., 1977, Cal-Neva Wildlife, V1977, P80; Fischer LA, 2005, CAN J ZOOL, V83, P1162, DOI 10.1139/Z05-117; Fjeldsa J., 1993, Bird Conservation International, V3, P221; Forbes L. C., 1984, NESTING ECOLOGY W GR; Found C, 2008, CAN J ZOOL, V86, P277, DOI 10.1139/Z07-137; Found C, 2004, 88 ALB SUST RES DEV; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hines, 2017, OCCUPANCY ESTIMATION; Hines JE, 2006, PRESENCE 2 4 SOFTWAR; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Humple D. L., 2009, THESIS SONOMA STATE; Johnson CJ, 2004, J WILDLIFE MANAGE, V68, P966, DOI 10.2193/0022-541X(2004)068[0966:MSAOTA]2.0.CO;2; Kemper C, 2008, 121 ALB SUST RES DEV; LaBastille A, 1984, ENVIRON CONSERV, V11, P346; LaPorte N, 1992, BIRDS N AM ONLINE; Latham ADM, 2011, CAN J ZOOL, V89, P267, DOI [10.1139/z10-115, 10.1139/Z10-115]; Lele SR, 2013, J ANIM ECOL, V82, P1183, DOI 10.1111/1365-2656.12141; LINDVALL ML, 1982, CONDOR, V84, P66, DOI 10.2307/1367823; Lutolf M, 2009, ENVIRON MANAGE, V43, P436, DOI 10.1007/s00267-008-9256-6; MacArthur R.H., 1972, pvii; Mace GM, 2010, PHILOS T R SOC B, V365, P3743, DOI 10.1098/rstb.2010.0264; Morita K, 2002, CONSERV BIOL, V16, P1318, DOI 10.1046/j.1523-1739.2002.01476.x; Mueller C, 2004, URSUS, V15, P35, DOI 10.2192/1537-6176(2004)015<0035:DOSGBI>2.0.CO;2; Newbrey JL, 2012, HYDROBIOLOGIA, V697, P73, DOI 10.1007/s10750-012-1171-4; Newbrey JL, 2005, WATERBIRDS, V28, P478, DOI 10.1675/1524-4695(2005)28[478:EOLCAH]2.0.CO;2; Nuechterlein G, 1975, THESIS COLORADO STAT; Nuechterlein G.L., 1982, National Geographic Magazine, V161, P624; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; PIERSMA T, 1988, ARDEA, V76, P96; Radomski P, 2001, N AM J FISH MANAGE, V21, P46, DOI 10.1577/1548-8675(2001)021<0046:COHLDO>2.0.CO;2; RAHEL FJ, 1990, AM NAT, V136, P328, DOI 10.1086/285101; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Riske M.E., 1976, THESIS U CALGARY CAL; SEBER GAF, 1984, MULTIVARIATE OBSERVA; Semenchuk G. P, 2007, ATLAS BREEDING BIRDS; Short H. L., 1984, HABITAT SUITABILITY; StataCorp L, 2007, STAT DAT AN STAT SOF; Stattersfield AJ, 2000, THREAT BIRDS WORLD; Stout BE, 2003, WATERBIRDS, V26, P88, DOI 10.1675/1524-4695(2003)026[0088:TALOWM]2.0.CO;2; Traylor JJ, 2004, AUK, V121, P950, DOI 10.1642/0004-8038(2004)121[0950:NEOWSM]2.0.CO;2; Venter O, 2006, BIOSCIENCE, V56, P903, DOI 10.1641/0006-3568(2006)56[903:TTESIC]2.0.CO;2; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Wilson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065408	59	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98126	10.1371/journal.pone.0098126	http://dx.doi.org/10.1371/journal.pone.0098126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866172	Green Published, gold, Green Submitted			2022-12-25	WOS:000336914100035
J	Jain, S; Rana, V; Shrinet, J; Sharma, A; Tridibes, A; Sunil, S; Bhatnagar, RK				Jain, Shanu; Rana, Vandita; Shrinet, Jatin; Sharma, Anil; Tridibes, Adak; Sunil, Sujatha; Bhatnagar, Raj K.			Blood Feeding and Plasmodium Infection Alters the miRNome of Anopheles stephensi	PLOS ONE			English	Article							RNA-INTERFERENCE; GENE-EXPRESSION; NUCLEAR EXPORT; WEB SERVER; MICRORNA; MOSQUITO; MALARIA; TARGET; GAMBIAE; VECTOR	Blood feeding is an integral process required for physiological functions and propagation of the malaria vector Anopheles. During blood feeding, presence of the malaria parasite, Plasmodium in the blood induces several host effector molecules including microRNAs which play important roles in the development and maturation of the parasite within the mosquito. The present study was undertaken to elucidate the dynamic expression of miRNAs during gonotrophic cycle and parasite development in Anopheles stephensi. Using next generation sequencing technology, we identified 126 miRNAs of which 17 were novel miRNAs. The miRNAs were further validated by northern hybridization and cloning. Blood feeding and parasitized blood feeding in the mosquitoes revealed regulation of 13 and 16 miRNAs respectively. Expression profiling of these miRNAs revealed that significant miRNAs were down-regulated upon parasitized blood feeding with a repertoire of miRNAs showing stage specific up-regulation. Expression profiles of significantly modulated miRNAs were further validated by real time PCR. Target prediction of regulated miRNAs revealed overlapping targeting by different miRNAs. These targets included several metabolic pathways including metabolic, redox homeostasis and protein processing machinery components. Our analysis revealed tight regulation of specific miRNAs post blood feeding and parasite infection in An. stephensi. Such regulated expression suggests possible role of these miRNAs during gonotrophic cycle in mosquito. Another set of miRNAs were also significantly regulated at 42 h and 5 days post infection indicating parasite stage-specific role of host miRNAs. This study will result in better understanding of the role of miRNAs during gonotrophic cycle and parasite development in mosquito and can probably facilitate in devising novel malaria control strategies at vector level.	[Jain, Shanu; Rana, Vandita; Shrinet, Jatin; Sharma, Anil; Sunil, Sujatha; Bhatnagar, Raj K.] Int Ctr Genet Engn & Biotechnol, New Delhi, India; [Tridibes, Adak] Natl Inst Malaria Res, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Sunil, S (corresponding author), Int Ctr Genet Engn & Biotechnol, New Delhi, India.	sujatha@icgeb.res.in; raj@icgeb.res.in	SHRINET, JATIN/P-9088-2014; Bhatnagar, Raj/AAP-2311-2021	Sunil, Sujatha/0000-0002-6531-7768; SHRINET, JATIN/0000-0002-4274-613X; Jain, Shanu/0000-0003-3110-1990	Science and Engineering Research Board (SERB) [SR/FT/LS-109/2011]; ICGEB; Department of Science and Technology, Government of India; Council of Scientific and Industrial Research, India	Science and Engineering Research Board (SERB); ICGEB; Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	The study was funded through Science and Engineering Research Board (SERB) Young Scientist grant (SR/FT/LS-109/2011) awarded to SS and through ICGEB internal funds. SS is a recipient of Ramanujan Fellowship, Department of Science and Technology, Government of India and their support is duly acknowledged. SJ and VR are recipients of senior research fellowships from the Council of Scientific and Industrial Research, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ AMM, 1991, REV I MED TROP, V33, P421, DOI [10.1590/S0036-46651991000600001, 10.1590/S0036-46651991000600013]; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bahia Ana C, 2014, Environ Microbiol, V16, P2980, DOI 10.1111/1462-2920.12381; Bejarano F, 2010, DEV BIOL, V338, P63, DOI 10.1016/j.ydbio.2009.11.025; Biron DG, 2013, J EXP BIOL, V216, P148, DOI 10.1242/jeb.073825; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107; Bushati N, 2008, CURR BIOL, V18, P501, DOI 10.1016/j.cub.2008.02.081; Dana AN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-119; Dash AP, 2008, J BIOSCIENCES, V33, P583, DOI 10.1007/s12038-008-0076-x; Felix RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-312; Fullaondo A, 2012, DEV COMP IMMUNOL, V36, P267, DOI 10.1016/j.dci.2011.03.034; Goltsev Y, 2009, DEV BIOL, V330, P462, DOI 10.1016/j.ydbio.2009.02.038; Goncalves RLS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041083; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hussain M, 2013, INSECT BIOCHEM MOLEC, V43, P146, DOI 10.1016/j.ibmb.2012.11.005; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kin T, 2007, NUCLEIC ACIDS RES, V35, pD145, DOI 10.1093/nar/gkl837; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lefevre T, 2007, PROTEOMICS, V7, P1908, DOI 10.1002/pmic.200601021; Li J, 2014, NUCLEIC ACIDS RES, V42, P458, DOI 10.1093/nar/gkt839; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Marinotti O, 2006, INSECT MOL BIOL, V15, P1, DOI 10.1111/j.1365-2583.2006.00610.x; Mathias DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003757; Mead EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-244; Megy K, 2012, NUCLEIC ACIDS RES, V40, pD729, DOI 10.1093/nar/gkr1089; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Nagpal, 1995, INDIAN ANOPHELINES, P1; Navarro L, 2008, SCIENCE, V321, P964, DOI 10.1126/science.1159505; Okada C, 2009, SCIENCE, V326, P1275, DOI 10.1126/science.1178705; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Puthiyakunnon S, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-230; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Shrinet J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002616; Singh CP, 2012, J VIROL, V86, P7867, DOI 10.1128/JVI.00064-12; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Surachetpong W, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000366; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Winter F, 2007, NUCLEIC ACIDS RES, V35, P6953, DOI 10.1093/nar/gkm686; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	55	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98402	10.1371/journal.pone.0098402	http://dx.doi.org/10.1371/journal.pone.0098402			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866389	gold, Green Submitted, Green Published			2022-12-25	WOS:000336914100059
J	Wang, HW; Lo, HH; Chiu, YL; Chang, SJ; Huang, PH; Liao, KH; Tasi, CF; Wu, CH; Tsai, TN; Cheng, CC; Cheng, SM				Wang, Hsei-Wei; Lo, Hung-Hao; Chiu, Ya-Lin; Chang, Shing-Jyh; Huang, Po-Hsun; Liao, Ko-Hsun; Tasi, Cheng-Fong; Wu, Chun-Hsien; Tsai, Tsung-Neng; Cheng, Cheng-Chung; Cheng, Shu-Meng			Dysregulated miR-361-5p/VEGF Axis in the Plasma and Endothelial Progenitor Cells of Patients with Coronary Artery Disease	PLOS ONE			English	Article							BONE-MARROW; CIRCULATING MICRORNAS; CARDIOVASCULAR-DISEASE; ANGIOGENESIS; EXPRESSION; VEGF; INFLAMMATION; RECRUITMENT; GROWTH; BLOOD	Dysfunction and reduction of circulating endothelial progenitor cell (EPC) is correlated with the onset of cardiovascular disorders including coronary artery disease (CAD). VEGF is a known mitogen for EPC to migrate out of bone marrow to possess angiogenic activities, and the plasma levels of VEGF are inversely correlated to the progression of CAD. Circulating microRNAs (miRNAs) in patient body fluids have recently been considered to hold the potential of being novel disease biomarkers and drug targets. However, how miRNAs and VEGF cooperate to regulate CAD progression is still unclear. Through the small RNA sequencing (smRNA-seq), we deciphered the miRNome patterns of EPCs with different angiogenic activities, hypothesizing that miRNAs targeting VEGF must be more abundant in EPCs with lower angiogenic activities. Candidates of anti-VEGF miRNAs, including miR-361-5p and miR-484, were enriched in not only diseased EPCs but also the plasma of CAD patients. However, we found out only miR-361-5p, but not miR-484, was able to suppress VEGF expression and EPC activities. Reporter assays confirmed the direct binding and repression of miR-361-5p to the 3'-UTR of VEGF mRNA. Knock down of miR-361-5p not only restored VEGF levels and angiogenic activities of diseased EPCs in vitro, but further promoted blood flow recovery in ischemic limbs of mice. Collectively, we discovered a miR-361-5p/VEGF-dependent regulation that could help to develop new therapeutic modalities not only for ischemia-related diseases but also for tumor angiogenesis.	[Wang, Hsei-Wei; Lo, Hung-Hao; Chiu, Ya-Lin; Liao, Ko-Hsun] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Wang, Hsei-Wei] Natl Yang Ming Univ, Genome Res Ctr, Taipei 112, Taiwan; [Wang, Hsei-Wei] Natl Yang Ming Univ, Canc Res Ctr, Taipei 112, Taiwan; [Wang, Hsei-Wei; Tasi, Cheng-Fong] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Wang, Hsei-Wei] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Chang, Shing-Jyh] Hsin Chu Mackay Mem Hosp, Dept Obstet & Gynecol, Hsinchu, Taiwan; [Huang, Po-Hsun] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Huang, Po-Hsun] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Huang, Po-Hsun] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan; [Wu, Chun-Hsien; Tsai, Tsung-Neng; Cheng, Cheng-Chung; Cheng, Shu-Meng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Cardiol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; Mackay Memorial Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Defense Medical Center; Tri-Service General Hospital	Cheng, SM (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Cardiol, Taipei, Taiwan.	chengsm@cm1.hinet.net	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	National Science Council [NSC] [NSC101-2320-B-010-059-MY3, NSC101-2627-B-010-003, NSC101-2321-B-010-011]; Tri-Service General Hospital [TSGH-C102-027]; Veterans General Hospitals University System of Taiwan (VGHUST); Tsou's Foundation [VGHUST103-G7-2-3]; National Health Research Institutes [NHRI-EX102-10254SI]; Taipei City Hospital [10201-62-070]; National Yang-Ming University [Ministry of Education, Aim for the Top University Plan]; UST-UCSD International Center for Excellence in Advanced Bioengineering - Taiwan NSC I-RiCE Program [NSC102-2911-I-009-101]	National Science Council [NSC](Ministry of Science and Technology, Taiwan); Tri-Service General Hospital; Veterans General Hospitals University System of Taiwan (VGHUST); Tsou's Foundation; National Health Research Institutes(National Health Research Institutes, Japan); Taipei City Hospital; National Yang-Ming University [Ministry of Education, Aim for the Top University Plan](Ministry of Education, Taiwan); UST-UCSD International Center for Excellence in Advanced Bioengineering - Taiwan NSC I-RiCE Program	This work was supported by National Science Council [NSC; NSC101-2320-B-010-059-MY3, NSC101-2627-B-010-003 and NSC101-2321-B-010-011], Tri-Service General Hospital [TSGH-C102-027], Veterans General Hospitals University System of Taiwan (VGHUST) Joint Research Program, Tsou's Foundation [VGHUST103-G7-2-3], National Health Research Institutes [NHRI-EX102-10254SI], Taipei City Hospital [10201-62-070], and National Yang-Ming University [Ministry of Education, Aim for the Top University Plan]. This work was also support in part by the UST-UCSD International Center for Excellence in Advanced Bioengineering sponsored by the Taiwan NSC I-RiCE Program [NSC102-2911-I-009-101]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Badran A, 2004, BIOCHEM BIOPH RES CO, V314, P902, DOI 10.1016/j.bbrc.2003.12.178; Briasoulis A, 2010, CARDIOVASC THER; Briguori C, 2010, FASEB J, V24, P1981, DOI 10.1096/fj.09-138198; Caporali A, 2011, CIRCULATION, V123, P282, DOI 10.1161/CIRCULATIONAHA.110.952325; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen YH, 2007, DIABETES, V56, P1559, DOI 10.2337/db06-1103; Cheng CC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-447; Cheng WC, 2013, NUCLEIC ACIDS RES, V41, pD285, DOI 10.1093/nar/gks1238; Cho HJ, 2003, CIRCULATION, V108, P2918, DOI 10.1161/01.CIR.0000097001.79750.78; Dang LTH, 2013, ARTERIOSCL THROM VAS, V33, P193, DOI 10.1161/ATVBAHA.112.300142; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Grisar JC, 2011, BIOMARK MED, V5, P731, DOI [10.2217/BMM.11.92, 10.2217/bmm.11.92]; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Heissig B, 2003, THROMB HAEMOSTASIS, V90, P570, DOI 10.1160/TH03-03-0188; Hsu JBK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-300; Huang PH, 2013, ARTERIOSCL THROM VAS, V33, P709, DOI 10.1161/ATVBAHA.112.300318; Hulsmans M, 2013, CARDIOVASC RES, V100, P7, DOI 10.1093/cvr/cvt161; Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673; Kumar B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037601; Lia D, 2010, J HYPERTENS, V28, P1646, DOI 10.1097/HJH.0b013e32833a4922; Liu H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-476; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Minami Y, 2009, EUR J CLIN INVEST, V39, P359, DOI 10.1111/j.1365-2362.2009.02110.x; Mocharla P, 2013, BLOOD, V121, P226, DOI 10.1182/blood-2012-01-407106; Mobius-Winkler S, 2009, CYTOM PART A, V75A, P25, DOI 10.1002/cyto.a.20669; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Real Carla, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P185, DOI 10.2174/187152908785849071; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Smythe J, 2008, TISSUE ENG PT C-METH, V14, P59, DOI 10.1089/tec.2007.0251; Szczyrba J, 2013, INT J CANCER, V132, P775, DOI 10.1002/ijc.27731; Tabuchi T, 2012, CLIN SCI, V123, P161, DOI 10.1042/CS20110563; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vecchione A, 2013, P NATL ACAD SCI USA, V110, P9845, DOI 10.1073/pnas.1305472110; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Wang RZ, 2013, HEPATOLOGY, V58, P642, DOI 10.1002/hep.26373; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yin KJ, 2012, J BIOL CHEM, V287, P27055, DOI 10.1074/jbc.M112.364414; Yu J, 2012, BIOMATERIALS, V33, P8062, DOI 10.1016/j.biomaterials.2012.07.042; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang QW, 2011, BIOCHEM BIOPH RES CO, V405, P42, DOI 10.1016/j.bbrc.2010.12.119; Zhou BS, 2013, CANCER LETT, V333, P159, DOI 10.1016/j.canlet.2013.01.028	50	58	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98070	10.1371/journal.pone.0098070	http://dx.doi.org/10.1371/journal.pone.0098070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865854	Green Published, Green Submitted, gold			2022-12-25	WOS:000336914100032
J	Ma, RJ; Hou, XJ; Zhang, L; Sun, SC; Schedl, T; Moley, K; Wang, Q				Ma, Rujun; Hou, Xiaojing; Zhang, Liang; Sun, Shao-Chen; Schedl, Tim; Moley, Kelle; Wang, Qiang			Rab5a is required for spindle length control and kinetochore-microtubule attachment during meiosis in oocytes	FASEB JOURNAL			English	Article						CENPF; vesicles; chromosome	CENP-F; CHROMOSOME ALIGNMENT; EFFECTOR EEA1; MEMBRANE; PROTEIN; GTPASES; NUMA; LOCALIZATION; RECRUITMENT; CAPTURE	Rab GTPases are highly conserved components of vesicle trafficking pathways. Rab5, as a master regulator of endocytic trafficking, has been shown to function in membrane tethering and docking. However, the function of Rab5 in meiosis has not been addressed. Here, we report elongated spindles and misaligned chromosomes, with kinetochore-microtubule misattachments, on specific depletion of Rab5a in mouse oocytes. Moreover, the localization and levels of centromere protein F (CENPF), a component of the nuclear matrix, are severely reduced at kinetochores in metaphase oocytes following Rab5a knockdown. Consistent with this finding, nuclear lamina disassembly in the transition from prophase arrest to meiosis I is also impaired in Rab5a-depleted oocytes. Notably, oocyte-specific ablation of CENPF phenocopies the meiotic defects resulting from Rab5a knockdown. In summary, our data support a model where Rab5a-positive vesicles, likely through interaction with nuclear lamina, modulate CENPF localization and levels at centromeres, consequently ensuring proper spindle length and kinetochore-microtubule attachment in meiotic oocytes.	[Ma, Rujun] Nanjing Agr Univ, Coll Vet Med, Nanjing 210029, Jiangsu, Peoples R China; [Zhang, Liang; Sun, Shao-Chen] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210029, Jiangsu, Peoples R China; [Ma, Rujun; Hou, Xiaojing; Zhang, Liang; Wang, Qiang] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Schedl, Tim; Moley, Kelle] Washington Univ, Sch Med, St Louis, MO USA	Nanjing Agricultural University; Nanjing Agricultural University; Nanjing Medical University; Washington University (WUSTL)	Wang, Q (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, 140 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China.	qwang2012@njmu.edu.cn			National Key Scientific Research Projects [2014CB943200]; National Natural Science Foundation [31301181]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [13KJA310001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100756] Funding Source: NIH RePORTER	National Key Scientific Research Projects; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dong Zhang (Nanjing Medical University) for technical assistance. This work was supported by National Key Scientific Research Projects (2014CB943200), National Natural Science Foundation (31301181), and Natural Science Foundation of the Jiangsu Higher Education Institutions (13KJA310001) of China. The authors declare no conflicts of interest.	Audhya A, 2007, J CELL BIOL, V178, P1309, DOI 10.1083/jcb.20070113920070911c; Barr FA, 2013, J CELL BIOL, V202, P191, DOI 10.1083/jcb.201306010; Bomont P, 2005, EMBO J, V24, P3927, DOI 10.1038/sj.emboj.7600848; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Capalbo L, 2011, P NATL ACAD SCI USA, V108, P17343, DOI 10.1073/pnas.1103720108; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Fu WX, 2013, P NATL ACAD SCI USA, V110, P15295, DOI 10.1073/pnas.1312382110; Galvez T, 2012, CELL, V151, P234, DOI 10.1016/j.cell.2012.09.013; Gregan J, 2011, TRENDS CELL BIOL, V21, P374, DOI 10.1016/j.tcb.2011.01.003; Haren Laurence, 2009, BMC Res Notes, V2, P64, DOI 10.1186/1756-0500-2-64; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Holt SV, 2005, J CELL SCI, V118, P4889, DOI 10.1242/jcs.02614; Holubcova Z, 2013, NAT CELL BIOL, V15, P937, DOI 10.1038/ncb2802; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Howe K, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.112151; Hunt PA, 2003, CURR BIOL, V13, P546, DOI 10.1016/S0960-9822(03)00189-1; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kawasaki M, 2005, CURR OPIN STRUC BIOL, V15, P681, DOI 10.1016/j.sbi.2005.10.015; Kolano A, 2012, P NATL ACAD SCI USA, V109, pE1858, DOI 10.1073/pnas.1204686109; Krisher R.L., 2004, J ANIM SCI, V82, pE14, DOI 10.2527/2004.8213_supplE14x; LIAO H, 1995, J CELL BIOL, V130, P507, DOI 10.1083/jcb.130.3.507; Liu ZH, 2009, J CELL BIOL, V186, P473, DOI 10.1083/jcb.200902071; Miserey-Lenkei S, 2006, EMBO J, V25, P278, DOI 10.1038/sj.emboj.7600929; Radulescu AE, 2010, TRENDS CELL BIOL, V20, P214, DOI 10.1016/j.tcb.2010.01.003; Serio G, 2011, P NATL ACAD SCI USA, V108, P17337, DOI 10.1073/pnas.1103516108; Silk AD, 2009, J CELL BIOL, V184, P677, DOI 10.1083/jcb.200810091; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tanaka K, 2013, CELL MOL LIFE SCI, V70, P559, DOI 10.1007/s00018-012-1057-7; Tanaka TU, 2013, EMBO REP, V14, P1073, DOI 10.1038/embor.2013.181; Wang Q, 2012, ENDOCRINOLOGY, V153, P1984, DOI 10.1210/en.2011-1815; Yang ZY, 2005, MOL CELL BIOL, V25, P4062, DOI 10.1128/MCB.25.10.4062-4074.2005; Yu LZ, 2007, CELL CYCLE, V6, P330, DOI 10.4161/cc.6.3.3805; Zhang D, 2004, BIOL REPROD, V71, P740, DOI 10.1095/biolreprod.104.028282	36	28	28	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					4026	4035		10.1096/fj.14-250886	http://dx.doi.org/10.1096/fj.14-250886			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24876181	Green Published, Bronze			2022-12-25	WOS:000340845900020
J	Alvarado, DM; Coulombe, PA				Alvarado, David M.; Coulombe, Pierre A.			Directed Expression of a Chimeric Type II Keratin Partially Rescues Keratin 5-null Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMOLYSIS-BULLOSA SIMPLEX; CORNIFIED CELL-ENVELOPE; TRANSGENIC MOUSE SKIN; HUMAN EPIDERMAL-CELLS; INTERMEDIATE-FILAMENTS; MECHANICAL-PROPERTIES; SELF-ORGANIZATION; EPITHELIAL-CELLS; GENE; NETWORKS	The crucial role of structural support fulfilled by keratin intermediate filaments (IFs) in surface epithelia likely requires that they be organized into cross-linked networks. For IFs comprised of keratins 5 and 14 (K5 and K14), which occur in basal keratinocytes of the epidermis, formation of cross-linked bundles is, in part, self-driven through cis-acting determinants. Here, we targeted the expression of a bundling-competent KRT5/KRT8 chimeric cDNA (KRT8bc) or bundling-deficient wild type KRT8 as a control to the epidermal basal layer of Krt5-null mice to assess the functional importance of keratin IF self-organization in vivo. Such targeted expression of K8bc rescued Krt5-null mice with a 47% frequency, whereas K8 completely failed to do so. This outcome correlated with lower than expected levels of K8bc and especially K8 mRNA and protein in the epidermis of E18.5 replacement embryos. Ex vivo culture of embryonic skin keratinocytes confirmed the ability of K8bc to form IFs in the absence of K5. Additionally, electron microscopy analysis of E18.5 embryonic skin revealed that the striking defects observed in keratin IF bundling, cytoarchitecture, and mitochondria are partially restored by K8bc expression. As young adults, viable KRT8bc replacement mice develop alopecia and chronic skin lesions, indicating that the skin epithelia are not completely normal. These findings are consistent with a contribution of self-mediated organization of keratin IFs to structural support and cytoarchitecture in basal layer keratinocytes of the epidermis and underscore the importance of context-dependent regulation for keratin genes and proteins in vivo.	[Alvarado, David M.; Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Training Program Cellular & Mol Med, Baltimore, MD 21205 USA; [Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; [Alvarado, David M.; Coulombe, Pierre A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Coulombe, PA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St, Baltimore, MD 21205 USA.	coulombe@jhu.edu		Alvarado, David/0000-0001-8748-0761	National Institutes of Health [AR042047]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R55AR042047, R01AR042047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR042047.	Bernot KM, 2005, J CELL BIOL, V168, P965, DOI 10.1083/jcb.200408116; Betz RC, 2006, AM J HUM GENET, V78, P510, DOI 10.1086/500850; BONIFAS JM, 1991, SCIENCE, V254, P1202, DOI 10.1126/science.1720261; Bousquet O, 2001, J CELL BIOL, V155, P747, DOI 10.1083/jcb.200104063; Casanova ML, 2004, FASEB J, V18, P1556, DOI 10.1096/fj.04-1683fje; COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y; Coulombe PA, 2012, J INVEST DERMATOL, V132, P763, DOI 10.1038/jid.2011.450; Coulombe PA, 2009, J CLIN INVEST, V119, P1784, DOI 10.1172/JCI38177; Feng X, 2013, J INVEST DERMATOL, V133, P850, DOI 10.1038/jid.2012.397; FRANKE WW, 1981, J MOL BIOL, V153, P933, DOI 10.1016/0022-2836(81)90460-5; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Green KJ, 2005, ADV PROTEIN CHEM, V70, P143, DOI 10.1016/S0065-3233(04)70006-6; HANUKOGLU I, 1983, CELL, V33, P915, DOI 10.1016/0092-8674(83)90034-X; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Jang SI, 2005, J CELL SCI, V118, P781, DOI 10.1242/jcs.01647; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Kerns ML, 2007, P NATL ACAD SCI USA, V104, P14460, DOI 10.1073/pnas.0706486104; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; Kirfel J, 2002, DIFFERENTIATION, V70, P56, DOI 10.1046/j.1432-0436.2002.700106.x; Kroger C, 2013, J CELL BIOL, V201, P681, DOI 10.1083/jcb.201208162; KULESH DA, 1989, MOL CELL BIOL, V9, P1553, DOI 10.1128/MCB.9.4.1553; Kumemura H, 2008, BIOCHEM BIOPH RES CO, V367, P33, DOI 10.1016/j.bbrc.2007.12.116; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; Lee CH, 2012, NAT STRUCT MOL BIOL, V19, P707, DOI 10.1038/nsmb.2330; Lee CH, 2009, J CELL BIOL, V186, P409, DOI 10.1083/jcb.200810196; LEE SC, 1993, J BIOL CHEM, V268, P12164; LERSCH R, 1988, MOL CELL BIOL, V8, P486, DOI 10.1128/MCB.8.1.486; LERSCH R, 1989, MOL CELL BIOL, V9, P3685, DOI 10.1128/MCB.9.9.3685; Lessard JC, 2013, P NATL ACAD SCI USA, V110, P19537, DOI 10.1073/pnas.1309576110; LEUBE RE, 1986, DIFFERENTIATION, V33, P69, DOI 10.1111/j.1432-0436.1986.tb00412.x; Liao J, 1997, J BIOL CHEM, V272, P17565, DOI 10.1074/jbc.272.28.17565; Liovic M, 2009, EXP CELL RES, V315, P2995, DOI 10.1016/j.yexcr.2009.07.013; LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329; Lu H, 2007, J INVEST DERMATOL, V127, P2781, DOI 10.1038/sj.jid.5700918; Ma LL, 2001, NAT CELL BIOL, V3, P503, DOI 10.1038/35074576; McGowan K, 1998, Subcell Biochem, V31, P173; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; McLean WHI, 2011, HUM MOL GENET, V20, pR189, DOI 10.1093/hmg/ddr379; MOLL R, 1984, DIFFERENTIATION, V28, P136, DOI 10.1111/j.1432-0436.1984.tb00277.x; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Paladini RD, 1998, J CELL BIOL, V142, P1035, DOI 10.1083/jcb.142.4.1035; Peters B, 2001, MOL BIOL CELL, V12, P1775, DOI 10.1091/mbc.12.6.1775; Reichelt J, 2010, METHODS MOL BIOL, V585, P59, DOI 10.1007/978-1-60761-380-0_5; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Roth W, 2009, HUM MUTAT, V30, P832, DOI 10.1002/humu.20981; SAITOU M, 1995, NATURE, V374, P159, DOI 10.1038/374159a0; Seltmann K, 2013, P NATL ACAD SCI USA, V110, P18507, DOI 10.1073/pnas.1310493110; Seltmann K, 2013, J INVEST DERMATOL, V133, P181, DOI 10.1038/jid.2012.256; Simpson CL, 2011, NAT REV MOL CELL BIO, V12, P565, DOI 10.1038/nrm3175; STAPPENBECK TS, 1993, J CELL BIOL, V123, P691, DOI 10.1083/jcb.123.3.691; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; StoneO MR, 2007, J CELL SCI, V120, P3999, DOI 10.1242/jcs.009241; SUN TT, 1978, J BIOL CHEM, V253, P2053; Suozzi KC, 2012, J CELL BIOL, V197, P465, DOI 10.1083/jcb.201112034; Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652; TAKAHASHI K, 1994, J CELL BIOL, V127, P505, DOI 10.1083/jcb.127.2.505; Tao GZ, 2009, J CELL SCI, V122, P3851, DOI 10.1242/jcs.051862; Thornell LE, 1997, J MOL CELL CARDIOL, V29, P2107, DOI 10.1006/jmcc.1997.0446; WEISS RA, 1984, J CELL BIOL, V98, P1397, DOI 10.1083/jcb.98.4.1397; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; WILSON AK, 1992, J CELL BIOL, V119, P401, DOI 10.1083/jcb.119.2.401; Yamada S, 2002, MOL BIOL CELL, V13, P382, DOI 10.1091/mbc.01-10-0522	64	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19435	19447		10.1074/jbc.M114.553867	http://dx.doi.org/10.1074/jbc.M114.553867			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24867950	Green Published, hybrid			2022-12-25	WOS:000339326800019
J	Brady, OA; Zhou, XL; Hu, FH				Brady, Owen A.; Zhou, Xiaolai; Hu, Fenghua			Regulated Intramembrane Proteolysis of the Frontotemporal Lobar Degeneration Risk Factor, TMEM106B, by Signal Peptide Peptidase-like 2a (SPPL2a)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE; B-CELL; ASPARTIC PROTEASE; INVARIANT CHAIN; DENDRITIC CELLS; TNF-ALPHA; CLEAVAGE; MEMBRANE; PRESENILIN	The sequential processing of single pass transmembrane proteins via ectodomain shedding followed by intramembrane proteolysis is involved in a wide variety of signaling processes, as well as maintenance of membrane protein homeostasis. Here we report that the recently identified frontotemporal lobar degeneration risk factor TMEM106B undergoes regulated intramembrane proteolysis. We demonstrate that TMEM106B is readily processed to an N-terminal fragment containing the transmembrane and intracellular domains, and this processing is dependent on the activities of lysosomal proteases. The N-terminal fragment is further processed into a small, rapidly degraded intracellular domain. The GxGD aspartyl proteases SPPL2a and, to a lesser extent, SPPL2b are responsible for this intramembrane cleavage event. Additionally, the TMEM106B paralog TMEM106A is also lysosomally localized; however, it is not a specific substrate of SPPL2a or SPPL2b. Our data add to the growing list of proteins that undergo intramembrane proteolysis and may shed light on the regulation of the frontotemporal lobar degeneration risk factor TMEM106B.	[Brady, Owen A.; Zhou, Xiaolai; Hu, Fenghua] Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Hu, FH (corresponding author), 345 Weill Hall, Ithaca, NY 14853 USA.	fh87@cornell.edu	Zhou, Xiaolai/AAF-7227-2020		National Institutes of Health [R21 NS081357-01]; Weill Institute for Cell and Molecular Biology; Association of Frontotemporal Dementia, Alzheimer's Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081357, R01NS088448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weill Institute for Cell and Molecular Biology; Association of Frontotemporal Dementia, Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 NS081357-01 (to F. H.). This work was also supported by funding from the Weill Institute for Cell and Molecular Biology and from the Association of Frontotemporal Dementia, Alzheimer's Association (to F. H.).	Behnke J, 2011, FEBS LETT, V585, P2951, DOI 10.1016/j.febslet.2011.08.043; Beisner DR, 2013, J EXP MED, V210, P23, DOI 10.1084/jem.20121072; Bergmann H, 2013, J EXP MED, V210, P31, DOI 10.1084/jem.20121076; Brady OA, 2013, HUM MOL GENET, V22, P685, DOI 10.1093/hmg/dds475; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chen-Plotkin AS, 2012, J NEUROSCI, V32, P11213, DOI 10.1523/JNEUROSCI.0521-12.2012; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Fluhrer R, 2012, J BIOL CHEM, V287, P5156, DOI 10.1074/jbc.M111.328104; Fluhrer R, 2009, J BIOL CHEM, V284, P13975, DOI 10.1074/jbc.R800040200; Friedmann E, 2004, J BIOL CHEM, V279, P50790, DOI 10.1074/jbc.M407898200; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Gallagher MD, 2014, ACTA NEUROPATHOL, V127, P407, DOI 10.1007/s00401-013-1239-x; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Lang CM, 2012, J BIOL CHEM, V287, P19355, DOI 10.1074/jbc.M112.365098; Lemberg MK, 2011, TRAFFIC, V12, P1109, DOI 10.1111/j.1600-0854.2011.01219.x; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Lu RC, 2014, J NEURAL TRANSM, V121, P283, DOI 10.1007/s00702-013-1106-x; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Martin L, 2009, J BIOL CHEM, V284, P5662, DOI 10.1074/jbc.M807485200; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nicholson AM, 2013, J NEUROCHEM, V126, P781, DOI 10.1111/jnc.12329; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Rutherford NJ, 2012, NEUROLOGY, V79, P717, DOI 10.1212/WNL.0b013e318264e3ac; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schneppenheim J, 2014, MOL CELL BIOL, V34, P1398, DOI 10.1128/MCB.00038-14; Schneppenheim J, 2013, J EXP MED, V210, P41, DOI 10.1084/jem.20121069; Schwenk BM, 2014, EMBO J, V33, P450, DOI 10.1002/embj.201385857; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; TANAKA RD, 1986, J LIPID RES, V27, P261; van Blitterswijk M, 2014, ACTA NEUROPATHOL, V127, P397, DOI 10.1007/s00401-013-1240-4; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; van der Zee J, 2011, BRAIN, V134, P808, DOI 10.1093/brain/awr007; Vancha AR, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-23; Vass R, 2011, ACTA NEUROPATHOL, V121, P373, DOI 10.1007/s00401-010-0782-y; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Verspurten J, 2009, TRENDS BIOCHEM SCI, V34, P319, DOI 10.1016/j.tibs.2009.04.001; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yu Q, 2000, GENE DEV, V14, P163; Zahn C, 2013, FEBS J, V280, P1653, DOI 10.1111/febs.12176	52	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19670	19680		10.1074/jbc.M113.515700	http://dx.doi.org/10.1074/jbc.M113.515700			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24872421	Green Published, hybrid			2022-12-25	WOS:000339326800039
J	Gifford, SM; Liu, WZ; Mader, CC; Halo, TL; Machida, K; Boggon, TJ; Koleske, AJ				Gifford, Stacey M.; Liu, Weizhi; Mader, Christopher C.; Halo, Tiffany L.; Machida, Kazuya; Boggon, Titus J.; Koleske, Anthony J.			Two Amino Acid Residues Confer Different Binding Affinities of Abelson Family Kinase Src Homology 2 Domains for Phosphorylated Cortactin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABL TYROSINE KINASE; 3-DIMENSIONAL SOLUTION STRUCTURE; SH2 DOMAIN; C-ABL; ACTIN POLYMERIZATION; MOLECULAR-GRAPHICS; CELL-MIGRATION; F-ACTIN; ADHESION; PEPTIDE	The closely related Abl family kinases, Arg and Abl, play important non-redundant roles in the regulation of cell morphogenesis and motility. Despite similar N-terminal sequences, Arg and Abl interact with different substrates and binding partners with varying affinities. This selectivity may be due to slight differences in amino acid sequence leading to differential interactions with target proteins. We report that the Arg Src homology (SH) 2 domain binds two specific phosphotyrosines on cortactin, a known Abl/Arg substrate, with over 10-fold higher affinity than the Abl SH2 domain. We show that this significant affinity difference is due to the substitution of arginine 161 and serine 187 in Abl to leucine 207 and threonine 233 in Arg, respectively. We constructed Abl SH2 domains with R161L and S187T mutations alone and in combination and find that these substitutions are sufficient to convert the low affinity Abl SH2 domain to a higher affinity "Arg-like" SH2 domain in binding to a phospho-cortactin peptide. We crystallized the Arg SH2 domain for structural comparison to existing crystal structures of the Abl SH2 domain. We show that these two residues are important determinants of Arg and Abl SH2 domain binding specificity. Finally, we expressed Arg containing an "Abl-like" low affinity mutant Arg SH2 domain (L207R/T233S) and find that this mutant, although properly localized to the cell periphery, does not support wild type levels of cell edge protrusion. Together, these observations indicate that these two amino acid positions confer different binding affinities and cellular functions on the distinct Abl family kinases.	[Gifford, Stacey M.; Koleske, Anthony J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Liu, Weizhi; Boggon, Titus J.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; [Mader, Christopher C.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [Halo, Tiffany L.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Boggon, Titus J.; Koleske, Anthony J.] Yale Univ, Yale Canc Ctr, New Haven, CT 06520 USA; [Koleske, Anthony J.] Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA; [Koleske, Anthony J.] Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA; [Machida, Kazuya] Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Raymond & Beverly Sackler Lab Genet & Mol Med, Farmington, CT 06030 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; University of Connecticut	Boggon, TJ (corresponding author), Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	titus.boggon@yale.edu; anthony.koleske@yale.edu			National Institutes of Health [GM100411, AI075133, NS39475, CA133346, R01 CA82258]; Connecticut Breast Health Initiative; American Heart Association [11PRE7450039]; Women's Health Research at Yale; NATIONAL CANCER INSTITUTE [R01CA082258, R01CA133346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039475] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut Breast Health Initiative; American Heart Association(American Heart Association); Women's Health Research at Yale; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM100411 and AI075133 (to T. J. B.), NS39475, GM100411, and CA133346 (to A. J. K.), and pilot grants from the Connecticut Breast Health Initiative and Women's Health Research at Yale (to T. J. B. and A. J. K.).; Supported by American Heart Association Founders Affiliate Predoctoral Fellowship 11PRE7450039.; Supported by National Institutes of Health Grant R01 CA82258.	Arold ST, 2001, J BIOL CHEM, V276, P17199, DOI 10.1074/jbc.M011185200; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Butler B, 2008, NAT IMMUNOL, V9, P887, DOI 10.1038/ni.1630; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GILMER T, 1994, J BIOL CHEM, V269, P31711; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; KRUH GD, 1990, P NATL ACAD SCI USA, V87, P5802, DOI 10.1073/pnas.87.15.5802; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu BA, 2010, MOL CELL PROTEOMICS, V9, P2391, DOI 10.1074/mcp.M110.001586; Liu WZ, 2012, ACTA CRYSTALLOGR F, V68, P154, DOI 10.1107/S1744309111056132; MacGrath SM, 2012, J CELL SCI, V125, P1621, DOI 10.1242/jcs.093781; Mader CC, 2011, CANCER RES, V71, P1730, DOI 10.1158/0008-5472.CAN-10-1432; Martin KH, 2006, J CELL SCI, V119, P2851, DOI 10.1242/jcs03034; MAYER BJ, 1994, MOL CELL BIOL, V14, P2883, DOI 10.1128/MCB.14.5.2883; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Metzler WJ, 1996, BIOCHEMISTRY-US, V35, P6201, DOI 10.1021/bi960157x; Miller AL, 2004, J CELL BIOL, V165, P407, DOI 10.1083/jcb.200308055; Miller MM, 2010, BIOCHEMISTRY-US, V49, P2227, DOI 10.1021/bi901721u; Moresco EMY, 2005, J NEUROSCI, V25, P6105, DOI 10.1523/JNEUROSCI.1432-05.2005; MULLER R, 1982, NATURE, V299, P640, DOI 10.1038/299640a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nam HJ, 1996, STRUCTURE, V4, P1105, DOI 10.1016/S0969-2126(96)00116-5; Oser M, 2010, J CELL SCI, V123, P3662, DOI 10.1242/jcs.068163; OVERDUIN M, 1992, CELL, V70, P697, DOI 10.1016/0092-8674(92)90437-H; Peacock JG, 2010, CYTOSKELETON, V67, P666, DOI 10.1002/cm.20479; Pellicena P, 1998, J BIOL CHEM, V273, P15325, DOI 10.1074/jbc.273.25.15325; PEREGO R, 1991, ONCOGENE, V6, P1899; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; RENSHAW MW, 1988, MOL CELL BIOL, V8, P4547, DOI 10.1128/MCB.8.10.4547; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Tong L, 1996, J MOL BIOL, V256, P601, DOI 10.1006/jmbi.1996.0112; Wang YX, 2001, P NATL ACAD SCI USA, V98, P14865, DOI 10.1073/pnas.251249298; Wojcik J, 2010, NAT STRUCT MOL BIOL, V17, P519, DOI 10.1038/nsmb.1793; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	45	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19704	19713		10.1074/jbc.M114.556480	http://dx.doi.org/10.1074/jbc.M114.556480			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24891505	hybrid, Green Published			2022-12-25	WOS:000339326800042
J	Kwa, MQ; Nguyen, T; Huynh, J; Ramnath, D; De Nardo, D; Lam, PY; Reynolds, EC; Hamilton, JA; Sweet, MJ; Scholz, GM				Kwa, Mei Qi; Thao Nguyen; Jennifer Huynh; Ramnath, Divya; De Nardo, Dominic; Lam, Pui Yeng; Reynolds, Eric C.; Hamilton, John A.; Sweet, Matthew J.; Scholz, Glen M.			Interferon Regulatory Factor 6 Differentially Regulates Toll-like Receptor 2-dependent Chemokine Gene Expression in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; RESPIRATORY SYNCYTIAL VIRUS; TRANSCRIPTION FACTORS; NUCLEAR TRANSLOCATION; DENDRITIC CELLS; DNA-BINDING; IRF FAMILY; IN-VIVO; ACTIVATION	Epidermal and mucosal epithelial cells are integral to host defense. They not only act as a physical barrier but also utilize pattern recognition receptors, such as the Toll-like receptors (TLRs), to detect and respond to pathogens. Members of the interferon regulatory factor (IRF) family of transcription factors are key components of TLR signaling as they impart specificity to downstream responses. Although IRF6 is a critical regulator of epithelial cell proliferation and differentiation, its role in TLR signaling has not previously been addressed. We show here that IRF6 is activated by IRAK1 as well as by MyD88 but not by TRIF or TBK1. Co-immunoprecipitation experiments further demonstrated that IRF6 can interact with IRAK1. Gene silencing in epithelial cells along with gene promoter reporter assays showed that IRAK1 mediates TLR2-inducible CCL5 gene expression at least in part by promoting IRF6 activation. Conversely, IRAK1 regulated CXCL8 gene expression independently of IRF6, thus identifying a molecular mechanism by which TLR2 signaling differentially regulates the expression of specific chemokines in epithelial cells. Bioinformatics analysis and mutagenesis-based experiments identified Ser-413 and Ser-424 as key regulatory sites in IRF6. Phosphomimetic mutation of these residues resulted in greatly enhanced IRF6 dimerization and trans-activator function. Collectively, our findings suggest that, in addition to its importance for epithelial barrier function, IRF6 also contributes to host defense by providing specificity to the regulation of inflammatory chemokine expression by TLR2 in epithelial cells.	[Kwa, Mei Qi; Jennifer Huynh; Reynolds, Eric C.; Scholz, Glen M.] Univ Melbourne, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Royal Melbourne Hosp, Melbourne, Vic 3010, Australia; [Kwa, Mei Qi; Jennifer Huynh; Reynolds, Eric C.; Scholz, Glen M.] Univ Melbourne, Royal Melbourne Hosp, Inst Bio21, Melbourne, Vic 3010, Australia; [Kwa, Mei Qi; Thao Nguyen; Jennifer Huynh; De Nardo, Dominic; Lam, Pui Yeng; Hamilton, John A.; Scholz, Glen M.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic 3010, Australia; [Ramnath, Divya; Sweet, Matthew J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Ramnath, Divya; Sweet, Matthew J.] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia	Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; University of Queensland; University of Queensland	Scholz, GM (corresponding author), Univ Melbourne, Melbourne Dent Sch, Melbourne, Vic 3010, Australia.	glenms@unimelb.edu.au	Ramnath, Divya/C-2735-2015; Sweet, Matthew J/F-2229-2011; Kwa, Mei/I-6802-2018; Nguyen, Thao/GWN-0419-2022	Ramnath, Divya/0000-0002-1935-9043; Sweet, Matthew J/0000-0002-0406-8139; Kwa, Mei/0000-0001-8890-3391; Scholz, Glen/0000-0003-2722-6344; Reynolds, Eric/0000-0002-6618-4856; De Nardo, Dominic/0000-0002-7045-4695; Hamilton, John A/0000-0002-9493-9224; Lam, Pui Yeng/0000-0003-4031-367X	National Health and Medical Research Council [628769]; Oral Health CRC	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Oral Health CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by National Health and Medical Research Council Project Grant 628769 and the Oral Health CRC.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Bailey CM, 2008, MOL CELL BIOL, V28, P2235, DOI 10.1128/MCB.01866-07; Bailey CM, 2005, J BIOL CHEM, V280, P34210, DOI 10.1074/jbc.M503523200; Barnes BJ, 2003, J BIOL CHEM, V278, P16630, DOI 10.1074/jbc.M212609200; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Biggs LC, 2012, J INVEST DERMATOL, V132, P50, DOI 10.1038/jid.2011.272; Burns E, 2010, J IMMUNOL, V184, P1455, DOI 10.4049/jimmunol.0900378; Casola A, 2001, J VIROL, V75, P6428, DOI 10.1128/JVI.75.14.6428-6439.2001; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; De Nardo D, 2005, J BIOL CHEM, V280, P9813, DOI 10.1074/jbc.M409745200; De Nardo D, 2009, CELL SIGNAL, V21, P246, DOI 10.1016/j.cellsig.2008.10.009; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Fukata M, 2009, CURR OPIN PHARMACOL, V9, P680, DOI 10.1016/j.coph.2009.09.006; Garofalo R, 1996, J VIROL, V70, P8773, DOI 10.1128/JVI.70.12.8773-8781.1996; Genin P, 2000, J IMMUNOL, V164, P5352, DOI 10.4049/jimmunol.164.10.5352; Goto Y, 2012, IMMUNOL REV, V245, P147, DOI 10.1111/j.1600-065X.2011.01078.x; Gribar SC, 2008, J LEUKOCYTE BIOL, V83, P493, DOI 10.1189/jlb.0607358; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Knight AS, 2006, DEV DYNAM, V235, P1441, DOI 10.1002/dvdy.20598; Kobayashi Y, 2006, CRIT REV IMMUNOL, V26, P307, DOI 10.1615/CritRevImmunol.v26.i4.20; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Krausgruber T, 2010, BLOOD, V115, P4421, DOI 10.1182/blood-2010-01-263020; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lin RT, 1999, MOL CELL BIOL, V19, P959; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Mancuso G, 2004, J IMMUNOL, V172, P6324, DOI 10.4049/jimmunol.172.10.6324; Marie I, 2000, MOL CELL BIOL, V20, P8803, DOI 10.1128/MCB.20.23.8803-8814.2000; Matsukura S, 2006, CLIN EXP ALLERGY, V36, P1049, DOI 10.1111/j.1365-2222.2006.02530.x; Miller Lloyd S, 2008, Adv Dermatol, V24, P71; Nguyen T, 2009, CELL SIGNAL, V21, P719, DOI 10.1016/j.cellsig.2009.01.010; Nickoloff BJ, 2007, CLIN DERMATOL, V25, P568, DOI 10.1016/j.clindermatol.2007.08.011; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Ullman KS, 1997, CELL, V90, P967, DOI 10.1016/S0092-8674(00)80361-X; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Way KJ, 2009, J LEUKOCYTE BIOL, V85, P766, DOI 10.1189/jlb.1108689	59	27	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19758	19768		10.1074/jbc.M114.584540	http://dx.doi.org/10.1074/jbc.M114.584540			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24872416	Green Published, hybrid			2022-12-25	WOS:000339326800047
J	Ong, ST; Freeley, M; Skubis-Zegadlo, J; Fazil, MHUT; Kelleher, D; Fresser, F; Baier, G; Verma, NK; Long, A				Ong, Seow Theng; Freeley, Michael; Skubis-Zegadlo, Joanna; Fazil, Mobashar Hussain Urf Turabe; Kelleher, Dermot; Fresser, Friedrich; Baier, Gottfried; Verma, Navin Kumar; Long, Aideen			Phosphorylation of Rab5a Protein by Protein Kinase C epsilon Is Crucial for T-cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; PKC-EPSILON; MEDIATED PHOSPHORYLATION; MEMBRANE TRAFFICKING; GROWTH-FACTOR; RHO-GTPASES; INTEGRIN; LFA-1; ADHESION; ACTIVATION	Rab GTPases control membrane traffic and receptor-mediated endocytosis. Within this context, Rab5a plays an important role in the spatial regulation of intracellular transport and signal transduction processes. Here, we report a previously uncharacterized role for Rab5a in the regulation of T-cell motility. We show that Rab5a physically associates with protein kinase C epsilon (PKC epsilon) in migrating T-cells. After stimulation of T-cells through the integrin LFA-1 or the chemokine receptor CXCR4, Rab5a is phosphorylated on an N-terminal Thr-7 site by PKC epsilon. Both Rab5a and PKC epsilon dynamically interact at the centrosomal region of migrating cells, and PKC epsilon-mediated phosphorylation on Thr-7 regulates Rab5a trafficking to the cell leading edge. Furthermore, we demonstrate that Rab5a Thr-7 phosphorylation is functionally necessary for Rac1 activation, actin rearrangement, and T-cell motility. We present a novel mechanism by which a PKC epsilon-Rab5a-Rac1 axis regulates cytoskeleton remodeling and T-cell migration, both of which are central for the adaptive immune response.	[Ong, Seow Theng; Freeley, Michael; Skubis-Zegadlo, Joanna; Long, Aideen] Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin 8, Ireland; [Skubis-Zegadlo, Joanna] Med Univ Warsaw, Dept Appl Pharm & Bioengn, PL-02091 Warsaw, Poland; [Fazil, Mobashar Hussain Urf Turabe; Kelleher, Dermot; Verma, Navin Kumar] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 637553, Singapore; [Kelleher, Dermot] Univ London Imperial Coll Sci Technol & Med, Fac Med, London SW7 2AZ, England; [Fresser, Friedrich; Baier, Gottfried] Med Univ Innsbruck, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria	Trinity College Dublin; Medical University of Warsaw; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Imperial College London; Medical University of Innsbruck	Verma, NK (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 637553, Singapore.	nkverma@ntu.edu.sg; longai@tcd.ie	Verma, Navin Kumar/B-7641-2008; Fazil, M H U Turabe/C-9373-2016; Long, Aideen/HGB-4149-2022; Fazil, M H U Turabe/AAA-1329-2020	Verma, Navin Kumar/0000-0002-5940-6633; Fazil, M H U Turabe/0000-0002-4621-8625; Fazil, M H U Turabe/0000-0002-4621-8625; Freeley, Michael/0000-0002-5763-6582	Science Foundation Ireland; Higher Education Authority of Ireland under PRTLI cycle 3; Health Research Board of Ireland; Marie Curie [MTKDCT-2005-029798]; NTU-MOE start-up grant; FWF Austrian Science Fund [P19505-B05]; European Community Program SYBILLA [HEALTH-F4-2008-201106]; Austrian Science Fund (FWF) [P 25044] Funding Source: researchfish	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Higher Education Authority of Ireland under PRTLI cycle 3; Health Research Board of Ireland; Marie Curie(European Commission); NTU-MOE start-up grant; FWF Austrian Science Fund(Austrian Science Fund (FWF)); European Community Program SYBILLA; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from Science Foundation Ireland (to A. L.), Higher Education Authority of Ireland under PRTLI cycle 3 (to D. K.), Health Research Board of Ireland (to A. L.), Marie Curie MTKDCT-2005-029798 (to J. S.-Z.), NTU-MOE start-up grant (to N. K. V.), FWF Austrian Science Fund (P19505-B05) (to F. F. and G. B.), and the European Community Program SYBILLA under Grant HEALTH-F4-2008-201106 (to F. F. and G. B.).	Akita Y, 2008, FEBS J, V275, P3995, DOI 10.1111/j.1742-4658.2008.06557.x; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Besson A, 2002, J BIOL CHEM, V277, P22073, DOI 10.1074/jbc.M111644200; Besson A, 2001, ONCOGENE, V20, P7398, DOI 10.1038/sj.onc.1204899; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bretscher MS, 1996, CELL, V85, P465, DOI 10.1016/S0092-8674(00)81246-5; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chae YC, 2010, MOL CELL BIOL, V30, P5086, DOI 10.1128/MCB.00443-10; Chun JS, 1996, J BIOL CHEM, V271, P13008, DOI 10.1074/jbc.271.22.13008; Fabbri M, 2005, MOL BIOL CELL, V16, P5793, DOI 10.1091/mbc.E05-05-0413; Fan GH, 2003, BLOOD, V101, P2115, DOI 10.1182/blood-2002-07-1965; Fanning A, 2005, INT IMMUNOL, V17, P449, DOI 10.1093/intimm/dxh225; Freeley M, 2012, J IMMUNOL, V188, P6357, DOI 10.4049/jimmunol.1103242; Freeley M, 2010, J BIOMOL SCREEN, V15, P541, DOI 10.1177/1087057110369703; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hernandez RM, 2001, J CELL BIOCHEM, V83, P532, DOI 10.1002/jcb.1246; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Ivaska J, 2002, EMBO J, V21, P3608, DOI 10.1093/emboj/cdf371; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; LI GP, 1993, J BIOL CHEM, V268, P24475; Long A, 2004, ANN NY ACAD SCI, V1028, P313, DOI 10.1193/annals.1322.035; Magee Tony, 1992, Trends in Cell Biology, V2, P318, DOI 10.1016/0962-8924(92)90172-J; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Onodera Y, 2012, J CELL BIOL, V197, P983, DOI 10.1083/jcb.201201065; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Pan Q, 2006, CANCER RES, V66, P9379, DOI 10.1158/0008-5472.CAN-06-2646; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Prekeris R, 1996, J CELL BIOL, V132, P77, DOI 10.1083/jcb.132.1.77; Radhakrishna H, 1999, J CELL SCI, V112, P855; Ramel D, 2013, NAT CELL BIOL, V15, P317, DOI 10.1038/ncb2681; Rappoport JZ, 2003, J CELL SCI, V116, P847, DOI 10.1242/jcs.00289; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Sanchez-Martin L, 2004, J BIOL CHEM, V279, P16194, DOI 10.1074/jbc.M400905200; SANFORD JC, 1995, MOL BIOL CELL, V6, P71, DOI 10.1091/mbc.6.1.71; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; Serio G, 2011, P NATL ACAD SCI USA, V108, P17337, DOI 10.1073/pnas.1103516108; Smith A, 2005, J CELL BIOL, V170, P141, DOI 10.1083/jcb.200412032; SOLDATI T, 1993, MOL BIOL CELL, V4, P425, DOI 10.1091/mbc.4.4.425; Spaargaren M, 1999, MOL BIOL CELL, V10, P3239, DOI 10.1091/mbc.10.10.3239; Stanley P, 2008, EMBO J, V27, P62, DOI 10.1038/sj.emboj.7601959; Stanley P, 2012, BIOL OPEN, V1, P1161, DOI 10.1242/bio.20122824; Stawowy P, 2005, CARDIOVASC RES, V67, P50, DOI 10.1016/j.cardiores.2005.03.002; STEELEMORTIMER O, 1994, EMBO J, V13, P34, DOI 10.1002/j.1460-2075.1994.tb06232.x; Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084; STENMARK H, 1994, EMBO J, V13, P575, DOI 10.1002/j.1460-2075.1994.tb06295.x; Stenmark H, 2001, GENOME BIOL, V2; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Svensson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038517; Tachado SD, 2002, J CELL BIOCHEM, V85, P785, DOI 10.1002/jcb.10164; TAKAI Y, 1992, INT REV CYTOL, V133, P187, DOI 10.1016/S0074-7696(08)61861-6; Torres VA, 2010, MOL BIOL CELL, V21, P369, DOI 10.1091/mbc.E09-09-0769; ULLRICH O, 1994, NATURE, V368, P157, DOI 10.1038/368157a0; VALENCIA A, 1991, BIOCHEMISTRY-US, V30, P4637, DOI 10.1021/bi00233a001; Verma NK, 2008, J MOL MED-JMM, V86, P457, DOI 10.1007/s00109-008-0312-8; Verma NK, 2012, J BIOL CHEM, V287, P27204, DOI 10.1074/jbc.M112.376616; Verma NK, 2011, J CELL PHYSIOL, V226, P1489, DOI 10.1002/jcp.22478; Verma NK, 2010, CELL MOL BIOL LETT, V15, P342, DOI 10.2478/s11658-010-0008-2; Verma NK, 2004, BRIT J PHARMACOL, V143, P1006, DOI 10.1038/sj.bjp.0706002; Volkov Y, 2001, NAT IMMUNOL, V2, P508, DOI 10.1038/88700; Wu SK, 1996, TRENDS BIOCHEM SCI, V21, P472, DOI 10.1016/S0968-0004(96)10062-1; Zeng LL, 2012, ADV EXP MED BIOL, V740, P639, DOI 10.1007/978-94-007-2888-2_28; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu GY, 2003, J BIOL CHEM, V278, P2452, DOI 10.1074/jbc.M211042200	76	41	42	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19420	19434		10.1074/jbc.M113.545863	http://dx.doi.org/10.1074/jbc.M113.545863			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24872409	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000339326800018
J	Rahman, SU; Arenas, J; Ozturk, H; Dekker, N; van Ulsen, P				Rahman, Sadeeq Ur; Arenas, Jesus; Ozturk, Hulya; Dekker, Nicole; van Ulsen, Peter			The Polypeptide Transport-associated (POTRA) Domains of TpsB Transporters Determine the System Specificity of Two-partner Secretion Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEISSERIA-MENINGITIDIS; PROTEIN SECRETION; ARCHITECTURE; SIGNAL; OMP85; HRPA	The two-partner secretion (TPS) systems of Gram-negative bacteria secrete large TpsA exoproteins by a dedicated TpsB transporter in the outer membrane. TpsBs contain an N-terminal module located in the periplasm that includes two polypeptide transport-associated (POTRA) domains. These are thought to initiate secretion of a TpsA by binding its N-terminal secretion signal, called the TPS domain. Neisseria meningitidis encodes up to five TpsA proteins that are secreted via only two TpsB transporters: TpsB1 and TpsB2. Of these two, the TpsB2 recognizes the TPS domains of all TpsAs, despite their sequence diversity. By contrast, the TpsB1 shows a limited recognition of a TPS domain that is shared by two TpsAs. The difference in substrate specificity of the TpsBs enabled us to investigate the role of the POTRA domains in the selection of TPS domains. We tested secretion of TPS domains or full-length TpsAs by TpsB mutants with deleted, duplicated, and exchanged POTRA domains. Exchanging the two POTRA domains of a TpsB resulted in a switch in specificity. Furthermore, exchanging a single POTRA domain showed that each of the two domains contributed to the cargo selection. Remarkably, the order of the POTRA domains could be reversed without affecting substrate selection, but this aberrant order did result in an alternatively processed secretion product. Our results suggest that secretion of a TpsA is initiated by engaging both POTRA domains of a TpsB transporter and that these select the cognate TpsAs for secretion.	[Rahman, Sadeeq Ur; Ozturk, Hulya; Dekker, Nicole; van Ulsen, Peter] Vrije Univ Amsterdam, Dept Mol Cell Biol, Sect Mol Microbiol, NL-1081 HV Amsterdam, Netherlands; [Arenas, Jesus] Univ Utrecht, Dept Biol, Sect Mol Microbiol, NL-3584 CH Utrecht, Netherlands	Vrije Universiteit Amsterdam; Utrecht University	van Ulsen, P (corresponding author), Vrije Univ Amsterdam, Dept Mol Cell Biol, Sect Mol Microbiol, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	j.p.van.ulsen@vu.nl	Arenas, Jesús/A-5420-2017	Arenas, Jesús/0000-0002-8134-0693; van Ulsen, Peter/0000-0002-2164-1611; ur Rahman, Sadeeq/0000-0002-9314-6257	Higher Education Commission of Pakistan; Netherlands Organization for Health Research and Development (ZonMw)	Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	Supported by the Higher Education Commission of Pakistan.; Supported by the Netherlands Organization for Health Research and Development (ZonMw).	Arenas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-622; Arnold T, 2010, J BIOL CHEM, V285, P18003, DOI 10.1074/jbc.M110.112516; Bos MP, 2007, EMBO REP, V8, P1149, DOI 10.1038/sj.embor.7401092; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; D'Ulisse V, 2007, MICROBIOL-SGM, V153, P124, DOI 10.1099/mic.0.2006/000265-0; Delattre AS, 2011, MOL MICROBIOL, V81, P99, DOI 10.1111/j.1365-2958.2011.07680.x; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Grass S, 2000, MOL MICROBIOL, V36, P55, DOI 10.1046/j.1365-2958.2000.01812.x; Hodak H, 2006, MOL MICROBIOL, V61, P368, DOI 10.1111/j.1365-2958.2006.05242.x; Jacob-Dubuisson F, 2013, RES MICROBIOL, V164, P583, DOI 10.1016/j.resmic.2013.03.009; Jacob-Dubuisson F, 2009, BIOL CHEM, V390, P675, DOI 10.1515/BC.2009.099; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Koenig P, 2010, J BIOL CHEM, V285, P18016, DOI 10.1074/jbc.M110.112649; NAKAMURA K, 1976, J BIOCHEM, V80, P1411, DOI 10.1093/oxfordjournals.jbchem.a131414; Neil RB, 2009, INFECT IMMUN, V77, P2285, DOI 10.1128/IAI.01502-08; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rahman SU, 2013, J BACTERIOL, V195, P788, DOI 10.1128/JB.01355-12; Robson SA, 2006, P NATL ACAD SCI USA, V103, P6700, DOI 10.1073/pnas.0601397103; Ruer S, 2008, EMBO J, V27, P2669, DOI 10.1038/emboj.2008.197; Sanchez-Pulido L, 2003, TRENDS BIOCHEM SCI, V28, P523, DOI 10.1016/j.tibs.2003.08.003; Sauri A, 2011, J MOL BIOL, V412, P553, DOI 10.1016/j.jmb.2011.07.035; Schmitt C, 2007, J BACTERIOL, V189, P7968, DOI 10.1128/JB.00851-07; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Surana NK, 2004, P NATL ACAD SCI USA, V101, P14497, DOI 10.1073/pnas.0404679101; Tala A, 2008, CELL MICROBIOL, V10, P2461, DOI 10.1111/j.1462-5822.2008.01222.x; van Ulsen P, 2006, FEMS MICROBIOL REV, V30, P292, DOI 10.1111/j.1574-6976.2006.00013.x; van Ulsen P, 2003, MOL MICROBIOL, V50, P1017, DOI 10.1046/j.1365-2958.2003.03773.x; van Ulsen P, 2001, FEMS IMMUNOL MED MIC, V32, P53, DOI 10.1016/S0928-8244(01)00271-1; van Ulsen P, 2008, INFECT IMMUN, V76, P4649, DOI 10.1128/IAI.00393-08; van Ulsen P, 2006, MICROBES INFECT, V8, P2088, DOI 10.1016/j.micinf.2006.03.007; van Ulsen P, 2014, BBA-MOL CELL RES, V1843, P1592, DOI 10.1016/j.bbamcr.2013.11.006; Walker G, 2004, INFECT IMMUN, V72, P611, DOI 10.1128/IAI.72.1.611-614.2004; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	37	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19799	19809		10.1074/jbc.M113.544627	http://dx.doi.org/10.1074/jbc.M113.544627			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24872418	hybrid, Green Published			2022-12-25	WOS:000339326800051
J	Horsley, A; Macleod, K; Gupta, R; Goddard, N; Bell, N				Horsley, Alex; Macleod, Kenneth; Gupta, Ruchi; Goddard, Nick; Bell, Nicholas			Enhanced Photoacoustic Gas Analyser Response Time and Impact on Accuracy at Fast Ventilation Rates during Multiple Breath Washout	PLOS ONE			English	Article							LUNG CLEARANCE INDEX; RISE-TIME; DISEASE; INDICATOR; CHILDREN; DELAY	Background: The Innocor device contains a highly sensitive photoacoustic gas analyser that has been used to perform multiple breath washout (MBW) measurements using very low concentrations of the tracer gas SF6. Use in smaller subjects has been restricted by the requirement for a gas analyser response time of <100 ms, in order to ensure accurate estimation of lung volumes at rapid ventilation rates. Methods: A series of previously reported and novel enhancements were made to the gas analyser to produce a clinically practical system with a reduced response time. An enhanced lung model system, capable of delivering highly accurate ventilation rates and volumes, was used to assess in vitro accuracy of functional residual capacity (FRC) volume calculation and the effects of flow and gas signal alignment on this. Results: 10-90% rise time was reduced from 154 to 88 ms. In an adult/child lung model, accuracy of volume calculation was -0.9 to 2.9% for all measurements, including those with ventilation rate of 30/min and FRC of 0.5 L; for the un-enhanced system, accuracy deteriorated at higher ventilation rates and smaller FRC. In a separate smaller lung model (ventilation rate 60/min, FRC 250 ml, tidal volume 100 ml), mean accuracy of FRC measurement for the enhanced system was minus 0.95% (range -3.8 to 2.0%). Error sensitivity to flow and gas signal alignment was increased by ventilation rate, smaller FRC and slower analyser response time. Conclusion: The Innocor analyser can be enhanced to reliably generate highly accurate FRC measurements down at volumes as low as those simulating infant lung settings. Signal alignment is a critical factor. With these enhancements, the Innocor analyser exceeds key technical component recommendations for MBW apparatus.	[Horsley, Alex] Univ Manchester, Inst Inflammat & Repair, Manchester, Lancs, England; [Horsley, Alex] Univ S Manchester Hosp, Manchester Adult Cyst Fibrosis Ctr, Manchester M20 8LR, Lancs, England; [Macleod, Kenneth] Great Ormond St Hosp Sick Children, Dept Resp Med, London, England; [Gupta, Ruchi; Goddard, Nick] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester, Lancs, England; [Bell, Nicholas] Univ Hosp Bristol NHS Fdn Trust, Dept Resp Med, Bristol Royal Infirm, Bristol, Avon, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Manchester; Bristol Royal Infirmary; University of Bristol	Horsley, A (corresponding author), Univ Manchester, Inst Inflammat & Repair, Manchester, Lancs, England.	alexander.horsley@manchester.ac.uk	Gupta, Ruchi/B-5321-2018; MacLeod, Kenneth/GWU-8940-2022; Gupta, Ruchi/Q-7542-2019	Gupta, Ruchi/0000-0001-6456-8007; Gupta, Ruchi/0000-0001-6456-8007; Horsley, Alex/0000-0003-1828-0058	National Institute for Health Research Clinician Scientist award; National Institute for Health Research (NIHR); North West Lung Centre (Manchester, UK); National Institute for Health Research [NIHR-CS-012-013] Funding Source: researchfish	National Institute for Health Research Clinician Scientist award; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); North West Lung Centre (Manchester, UK); National Institute for Health Research(National Institute for Health Research (NIHR))	Dr Horsley is funded by a National Institute for Health Research Clinician Scientist award. This report presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Part of this work was supported by an additional grant from the North West Lung Centre (Manchester, UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2011, EUR RESPIR J, V37, P806, DOI 10.1183/09031936.00072510; Arieli R, 2010, RESP PHYSIOL NEUROBI, V170, P183, DOI 10.1016/j.resp.2009.12.013; Aurora P, 2005, AM J RESP CRIT CARE, V171, P249, DOI 10.1164/rccm.200407-895OC; BECKLAKE MR, 1952, THORAX, V7, P111, DOI 10.1136/thx.7.1.111; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; BRUNNER JX, 1985, J APPL PHYSIOL, V59, P1008, DOI 10.1152/jappl.1985.59.3.1008; BRUNNER JX, 1988, BRIT J ANAESTH, V61, P628, DOI 10.1093/bja/61.5.628; Cunningham S, 2012, THORAX, V67, P849, DOI 10.1136/thoraxjnl-2012-202465; Farmery AD, 2000, J APPL PHYSIOL, V89, P581, DOI 10.1152/jappl.2000.89.2.581; Frey U, 2000, EUR RESPIR J, V16, P731, DOI 10.1034/j.1399-3003.2000.16d28.x; Fuchs SI, 2006, PEDIATR PULM, V41, P1218, DOI 10.1002/ppul.20524; Gonem S, 2014, RESPIRATION; Gustafsson PM, 2003, EUR RESPIR J, V22, P972, DOI 10.1183/09031936.03.00049502; Hoo AF, 2012, THORAX, V67, P874, DOI 10.1136/thoraxjnl-2012-201747; Horsley AR, 2008, THORAX, V63, P135, DOI 10.1136/thx.2007.082628; Jensen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056868; Kent L, 2013, J CYST FIBROS; Latzin P, 2008, THORAX, V63, P98, DOI 10.1136/thx.2007.085332; MACLEOD K, 2008, EUR RESP J S52, V32, pS691; Macleod KA, 2008, THORAX; Pittman JE, 2012, PEDIATR PULM, V47, P1242, DOI 10.1002/ppul.22531; Robinson P, 2013, EUROPEAN RESP J; Rowan SA, 2014, AM J RESP CRIT CARE, V189, P586, DOI 10.1164/rccm.201310-1747OC; SCHENA J, 1984, CRIT CARE MED, V12, P672, DOI 10.1097/00003246-198408000-00015; Schmidt A, 2014, PEDIAT PULMONOL; Singer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036083; Tang YQ, 2005, PHYSIOL MEAS, V26, P1103, DOI 10.1088/0967-3334/26/6/019; Thompson EB, 2013, AM J RESP CRIT CARE, V187	28	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98487	10.1371/journal.pone.0098487	http://dx.doi.org/10.1371/journal.pone.0098487			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892522	Green Submitted, Green Published, gold			2022-12-25	WOS:000336911400057
J	Leu, HB; Chung, CM; Lin, SJ; Lu, TM; Yang, HC; Ho, HY; Ting, CT; Lin, TH; Sheu, SH; Tsai, WC; Chen, JH; Yin, WH; Chiu, TY; Chen, CL; Pan, WH; Chen, JW				Leu, Hsin-Bang; Chung, Chia-Min; Lin, Shing-Jong; Lu, Tse-Min; Yang, Hsin-Chou; Ho, Hung-Yun; Ting, Chih-Tai; Lin, Tsung-Hsien; Sheu, Sheng-Hsiung; Tsai, Wei-Chuan; Chen, Jyh-Hong; Yin, Wei-Hsian; Chiu, Ting-Yu; Chen, Chin-luan; Pan, Wen-Harn; Chen, Jaw-Wen			A Novel SNP Associated with Nighttime Pulse Pressure in Young-Onset Hypertension Patients Could Be a Genetic Prognostic Factor for Cardiovascular Events in a General Cohort in Taiwan	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AMBULATORY BLOOD-PRESSURE; ISCHEMIC-STROKE; HEART-DISEASE; RISK-FACTORS; POPULATION; LINKAGE; HERITABILITY; PREDICTOR; NUTRITION	Background: Pulse pressure (PP) is a risk factor for cardiovascular disease. It has been reported that ambulatory blood pressure (BP) and nighttime BP parameters are heritable traits. However, the genetic association of pulse pressure and its clinical impact remain undetermined. Method and Results: We conducted a genome-wide association study of PP using ambulatory BP monitoring in young-onset hypertensive patients and found a significant association between nighttime PP and SNP rs897876 (p = 0.009) at chromosome 2p14, which contains the predicted gene FLJ16124. Young-onset hypertension patients carrying TT genotypes at rs897876 had higher nighttime PP than those with CT and CC genotypes (TT, 41.6+/-7.3 mm Hg; CT, 39.1+/-6.0 mm Hg; CC, 38.9+/-6.3 mm Hg; p<0.05,). The T risk allele resulted in a cumulative increase in nighttime PP (beta = 1.036 mm Hg, se. = 0.298, p<0.001 per T allele). An independent community-based cohort containing 3325 Taiwanese individuals (mean age, 50.2 years) was studied to investigate the genetic impact of rs897876 polymorphisms in determining future cardiovascular events. After an average 7.79+/-0.28 years of follow-up, the TT genotype of rs897876 was independently associated with an increased risk (in a recessive model) of coronary artery disease (HR, 2.20; 95% CI, 1.20-4.03; p = 0.01) and total cardiovascular events (HR, 1.99; 95% CI, 1.29-3.06; p = 0.002), suggesting that the TT genotype of rs897876C, which is associated with nighttime pulse pressure in young-onset hypertension patients, could be a genetic prognostic factor of cardiovascular events in the general cohort. Conclusion: The TT genotype of rs897876C at 2p14 identified in young-onset hypertensive had higher nighttime PP and could be a genetic prognostic factor of cardiovascular events in the general cohort in Taiwan.	[Leu, Hsin-Bang; Lin, Shing-Jong; Lu, Tse-Min; Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Leu, Hsin-Bang; Lin, Shing-Jong; Lu, Tse-Min; Chen, Jaw-Wen] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Leu, Hsin-Bang] Taipei Vet Gen Hosp, Heath Care & Management Ctr, Taipei, Taiwan; [Leu, Hsin-Bang; Lin, Shing-Jong; Lu, Tse-Min; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Chung, Chia-Min; Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Yang, Hsin-Chou] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Ho, Hung-Yun; Ting, Chih-Tai] Taichung Vet Gen Hosp, Taichung, Taiwan; [Lin, Tsung-Hsien; Sheu, Sheng-Hsiung] Kaohsiung Med Univ, Chung Ho Mem Hosp, Kaohsiung, Taiwan; [Tsai, Wei-Chuan; Chen, Jyh-Hong] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan; [Yin, Wei-Hsian] Cheng Hsin Rehabil Med Ctr, Taipei, Taiwan; [Chiu, Ting-Yu; Chen, Chin-luan] Min Sheng Gen Hosp, Taoyuan, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Taichung Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Cheng Kung University; National Cheng Kung University Hospital	Pan, WH (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	pan@ibms.sinica.edu.tw; jwchen@vghtpe.gov.tw	Yang, Hsin-Chou/AAP-2547-2021; Pan, Wen-Harn/F-9972-2010	Yang, Hsin-Chou/0000-0001-6853-7881; Pan, Wen-Harn/0000-0001-9136-0658; Lin, Tsung-Hsien/0000-0002-7226-8730	Taipei Veterans General Hospital [V98B1-010, V99B1-023, V100B-004]; National Science Council [101-2314-B-075-071, 99-2628-B-010-015-MY3, 99-2314-B-075-042-MY2]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by project grants from the Taipei Veterans General Hospital (Grant No. V98B1-010, V99B1-023, V100B-004) and National Science Council (Grant No. 101-2314-B-075-071, 99-2628-B-010-015-MY3, 99-2314-B-075-042-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bochud M, 2005, HYPERTENSION, V45, P445, DOI 10.1161/01.HYP.0000156538.59873.86; Brautbar A, 2009, CIRC-CARDIOVASC GENE, V2, P279, DOI 10.1161/CIRCGENETICS.108.817338; Chae CU, 1999, JAMA-J AM MED ASSOC, V281, P634, DOI 10.1001/jama.281.7.634; Chen HJ, 2006, STROKE, V37, P1060, DOI 10.1161/01.STR.0000206458.58142.f3; Chen JW, 2004, INT J CARDIOL, V96, P65, DOI 10.1016/j.ijcard.2003.07.010; Chuang SY, 2009, STROKE, V40, P1578, DOI 10.1161/STROKEAHA.108.540492; Domanski M, 2001, HYPERTENSION, V38, P793, DOI 10.1161/hy1001.092966; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Fagard RH, 2004, J HYPERTENS, V22, P1663, DOI 10.1097/00004872-200409000-00005; Fava C, 2005, AM J HYPERTENS, V18, P1402, DOI 10.1016/j.amjhyper.2005.05.011; Franklin SS, 1997, J HYPERTENS, V15, P1143, DOI 10.1097/00004872-199715100-00012; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Huang CC, 2008, J HUM HYPERTENS, V22, P329, DOI 10.1038/sj.jhh.1002330; HUNT SC, 1986, J CHRON DIS, V39, P809, DOI 10.1016/0021-9681(86)90083-4; Jiang WJ, 2012, TWIN RES HUM GENET, V15, P759, DOI 10.1017/thg.2012.58; Kao YT, 2011, J HUM HYPERTENS, V25, P444, DOI 10.1038/jhh.2010.80; Kikuya M, 2005, HYPERTENSION, V45, P240, DOI 10.1161/01.HYP.0000152079.04553.2c; Kobayashi S, 1996, CIRCULATION, V94, P3362, DOI 10.1161/01.CIR.94.12.3362; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mitchell GF, 1997, CIRCULATION, V96, P4254; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; O'Keefe JH, 2009, MAYO CLIN PROC, V84, P741, DOI 10.1016/S0025-6196(11)60525-9; Palomaki GE, 2010, JAMA-J AM MED ASSOC, V303, P648, DOI 10.1001/jama.2010.118; Pan WH, 2001, J HUM HYPERTENS, V15, P793, DOI 10.1038/sj.jhh.1001268; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rice T, 2006, AM J HYPERTENS, V19, P270, DOI 10.1016/j.amjhyper.2005.09.006; Rice T, 2002, HYPERTENSION, V39, P1037, DOI 10.1161/01.HYP.0000018911.46067.6E; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Ullrich M, 2011, J BIOL CHEM, V286, P9477, DOI 10.1074/jbc.M110.171306; Vaccarino V, 2001, AM J CARDIOL, V88, P980, DOI 10.1016/S0002-9149(01)01974-9; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Wang XL, 2009, J HYPERTENS, V27, P2358, DOI 10.1097/HJH.0b013e328330e84d; Weng LC, 2008, STROKE, V39, P3152, DOI 10.1161/STROKEAHA.108.524934; Wu GY, 2001, CIRC RES, V89, P1130, DOI 10.1161/hh2401.100427; Yang HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005459	38	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97919	10.1371/journal.pone.0097919	http://dx.doi.org/10.1371/journal.pone.0097919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892410	gold, Green Submitted, Green Published			2022-12-25	WOS:000336911400026
J	Lin, WC; Chen, PC; Wang, HC; Tsai, NW; Chou, KH; Chen, HL; Su, YJ; Lin, CP; Li, SH; Chang, WN; Lu, CH				Lin, Wei-Che; Chen, Pei-Chin; Wang, Hung-Chen; Tsai, Nai-Wen; Chou, Kun-Hsien; Chen, Hsiu-Ling; Su, Yu-Jih; Lin, Ching-Po; Li, Shau-Hsuan; Chang, Wen-Neng; Lu, Cheng-Hsien			Diffusion Tensor Imaging Study of White Matter Damage in Chronic Meningitis	PLOS ONE			English	Article							CRYPTOCOCCAL MENINGITIS; TUBERCULOUS MENINGITIS; PROGNOSTIC-FACTORS; WATER DIFFUSION; NERVOUS-SYSTEM; BASAL GANGLIA; MENINGOENCEPHALITIS; SCHIZOPHRENIA; HYDROCEPHALUS; DEGENERATION	Tuberculous meningitis (TBM) and cryptococcal meningitis (CM) are two of the most common types of chronic meningitis. This study aimed to assess whether chronic neuro-psychological sequelae are associated with micro-structure white matter (WM) damage in HIV-negative chronic meningitis. Nineteen HIV-negative TBM patients, 13 HIV-negative CM patients, and 32 sex-and age-matched healthy volunteers were evaluated and compared. The clinical relevance of WM integrity was studied using voxel-based diffusion tensor imaging (DTI) magnetic resonance imaging. All of the participants underwent complete medical and neurologic examinations, and neuro-psychological testing. Differences in DTI indices correlated with the presence of neuro-psychological rating scores and cerebrospinal fluid (CSF) analysis during the initial hospitalization. Patients with CM had more severe cognitive deficits than healthy subjects, especially in TBM. There were changes in WM integrity in several limbic regions, including the para-hippocampal gyrus and cingulate gyrus, and in the WM close to the globus pallidus. A decline in WM integrity close to the globus pallidus and anterior cingulate gyrus was associated with worse CSF analysis profiles. Poorer DTI parameters directly correlated with worse cognitive performance on follow-up. These correlations suggest that WM alterations may be involved in the psychopathology and pathophysiology of co-morbidities. Abnormalities in the limbic system and globus pallidus, with their close relationship to the CSF space, may be specific biomarkers for disease evaluation.	[Lin, Wei-Che; Chen, Pei-Chin; Chen, Hsiu-Ling] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Radiol, Kaohsiung, Taiwan; [Wang, Hung-Chen] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Tsai, Nai-Wen; Chang, Wen-Neng; Lu, Cheng-Hsien] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan; [Chou, Kun-Hsien; Lin, Ching-Po] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan; [Su, Yu-Jih; Li, Shau-Hsuan] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Lu, Cheng-Hsien] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 80424, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University; National Sun Yat Sen University	Lu, CH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Neurol, Kaohsiung, Taiwan.	chlu99@adm.cgmh.org.tw	Su, Yu-Jih/AGJ-4763-2022	Su, Yu-Jih/0000-0002-7274-3458	Chang Gung Memorial Hospital [CMRPG 870482, CMRPG 870991, CMRPG 890801]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This study was supported by Chang Gung Memorial Hospital (Chang Gung Medical Research Project Grant/CMRPG 870482 to WC Lin, CMRPG 870991 to CH Lu, and CMRPG 890801 to HL Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Bai YM, 2009, SCHIZOPHR RES, V109, P167, DOI 10.1016/j.schres.2009.02.003; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; Carter CS, 1997, AM J PSYCHIAT, V154, P1670, DOI 10.1176/ajp.154.12.1670; Catani M, 2006, CURR OPIN NEUROL, V19, P599, DOI 10.1097/01.wco.0000247610.44106.3f; Chang CC, 2008, EUR J NEUROL, V15, pE66, DOI 10.1111/j.1468-1331.2008.02151.x; Vieira MADES, 2013, REV SOC BRAS MED TRO, V46, P658, DOI 10.1590/0037-8682-0142-2013; Dammann O, 2000, J PEDIATR-US, V136, P433, DOI 10.1016/S0022-3476(00)90004-0; Del Bigio MR, 2003, ANN NEUROL, V53, P337, DOI 10.1002/ana.10453; DELBIGIO MR, 1993, ACTA NEUROPATHOL, V85, P573, DOI 10.1007/BF00334666; DIAMOND RD, 1974, ANN INTERN MED, V80, P176, DOI 10.7326/0003-4819-80-2-176; Girgis NI, 1998, AM J TROP MED HYG, V58, P28, DOI 10.4269/ajtmh.1998.58.28; Glass HC, 2008, PEDIATRICS, V122, P299, DOI 10.1542/peds.2007-2184; Gumbo T, 2002, PEDIATR INFECT DIS J, V21, P54, DOI 10.1097/00006454-200201000-00012; Hoffmann M, 2009, J ALZHEIMERS DIS, V16, P517, DOI 10.3233/JAD-2009-0985; Kuwahara H, 2014, NEUROPATHOLOGY, V34, P45, DOI 10.1111/neup.12046; Lan SH, 2001, QJM-MON J ASSOC PHYS, V94, P247, DOI 10.1093/qjmed/94.5.247; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee SC, 1996, HUM PATHOL, V27, P839, DOI 10.1016/S0046-8177(96)90459-1; Liliang PC, 2003, CLIN INFECT DIS, V37, P673, DOI 10.1086/377208; Lim KO, 2002, NMR BIOMED, V15, P587, DOI 10.1002/nbm.789; Lin WC, 2009, AM J NEURORADIOL, V30, P1248, DOI 10.3174/ajnr.A1517; Lin WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033809; Lu CH, 2007, INFECTION, V35, P359, DOI 10.1007/s15010-007-6263-0; Lu CH, 2011, AM J NEURORADIOL, V32, P1333, DOI 10.3174/ajnr.A2489; Lu CH, 1999, J HOSP INFECT, V42, P313, DOI 10.1053/jhin.1998.0610; Malik GK, 2008, BRAIN DEV-JPN, V30, P334, DOI 10.1016/j.braindev.2007.10.002; Misra UK, 1996, J NEUROL SCI, V137, P57, DOI 10.1016/0022-510X(95)00334-X; Moseley M, 2002, NMR BIOMED, V15, P553, DOI 10.1002/nbm.785; MS G, 1997, HYDROCEPHALUS; Mukherjee P, 2000, RADIOLOGY, V215, P211, DOI 10.1148/radiology.215.1.r00ap29211; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; Rock RB, 2008, CLIN MICROBIOL REV, V21, P243, DOI 10.1128/CMR.00042-07; SAADAH MA, 1995, TROP GEOGR MED, V47, P224; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Szeszko PR, 2000, SCHIZOPHR RES, V43, P97, DOI 10.1016/S0920-9964(99)00155-3; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites GE, 2003, J INFECT DIS, V188, P1105, DOI 10.1086/378642; Trivedi R, 2007, NEURORADIOLOGY, V49, P767, DOI 10.1007/s00234-007-0246-9; Trivedi Richa, 2009, Indian J Radiol Imaging, V19, P256, DOI 10.4103/0971-3026.57205; Tung GA, 2003, AM J NEURORADIOL, V24, P1110; Volpe JJ., 2001, NEUROLOGY NEWBORN, V4; Wechsler D, 1981, WECHSLER ADAPT INTEL; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7	48	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98210	10.1371/journal.pone.0098210	http://dx.doi.org/10.1371/journal.pone.0098210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892826	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400040
J	Neuber, C; Uebeler, J; Schulze, T; Sotoud, H; El-Armouche, A; Eschenhagen, T				Neuber, Christiane; Uebeler, June; Schulze, Thomas; Sotoud, Hannieh; El-Armouche, Ali; Eschenhagen, Thomas			Guanabenz Interferes with ER Stress and Exerts Protective Effects in Cardiac Myocytes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; INITIATION-FACTOR 2-ALPHA; CELL-DEATH; EIF2-ALPHA DEPHOSPHORYLATION; CARDIOVASCULAR-DISEASE; SELECTIVE-INHIBITION; BINDING-SITES; IN-VIVO; TRANSLATION	Endoplasmic reticulum (ER) stress has been implicated in a variety of cardiovascular diseases. During ER stress, disruption of the complex of protein phosphatase 1 regulatory subunit 15A and catalytic subunit of protein phosphatase 1 by the small molecule guanabenz (antihypertensive, alpha(2)-adrenoceptor agonist) and subsequent inhibition of stress-induced dephosphorylation of eukaryotic translation initiation factor 2 alpha (eIF2 alpha) results in prolonged eIF2 alpha phosphorylation, inhibition of protein synthesis and protection from ER stress. In this study we assessed whether guanabenz protects against ER stress in cardiac myocytes and affects the function of 3 dimensional engineered heart tissue (EHT). We utilized neonatal rat cardiac myocytes for the assessment of cell viability and activation of ER stress-signalling pathways and EHT for functional analysis. (i) Tunicamycin induced ER stress as measured by increased mRNA and protein levels of glucose-regulated protein 78 kDa, P-eIF2 alpha, activating transcription factor 4, C/EBP homologous protein, and cell death. (ii) Guanabenz had no measurable effect alone, but antagonized the effects of tunicamycin on ER stress markers. (iii) Tunicamycin and other known inducers of ER stress (hydrogen peroxide, doxorubicin, thapsigargin) induced cardiac myocyte death, and this was antagonized by guanabenz in a concentration-and time-dependent manner. (iv) ER stressors also induced acute or delayed contractile dysfunction in spontaneously beating EHTs and this was, with the notable exception of relaxation deficits under thapsigargin, not significantly affected by guanabenz. The data confirm that guanabenz interferes with ER stress-signalling and has protective effects on cell survival. Data show for the first time that this concept extends to cardiac myocytes. The modest protection in EHTs points to more complex mechanisms of force regulation in intact functional heart muscle.	[Neuber, Christiane; Uebeler, June; Schulze, Thomas; Sotoud, Hannieh; Eschenhagen, Thomas] Univ Med Ctr Hamburg Eppendorf, Dept Expt Pharmacol & Toxicol, Hamburg, Germany; [Neuber, Christiane; Uebeler, June; Schulze, Thomas; Sotoud, Hannieh; Eschenhagen, Thomas] DZHK German Ctr Cardiovasc Res, Hamburg, Germany; [El-Armouche, Ali] Univ Med Ctr Goettingen, Dept Pharmacol, Gottingen, Germany; [El-Armouche, Ali] DZHK German Ctr Cardiovasc Res, Gottingen, Germany; [El-Armouche, Ali] Tech Univ Dresden, Dept Pharmacol, Dresden, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; German Centre for Cardiovascular Research; University of Gottingen; German Centre for Cardiovascular Research; Technische Universitat Dresden	Eschenhagen, T (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Expt Pharmacol & Toxicol, Hamburg, Germany.	t.eschenhagen@uke.de	El-Armouche, Ali/H-3161-2018	El-Armouche, Ali/0000-0003-2514-9429	European Union	European Union(European Commission)	The study was supported by the European Union (FP7 Angioscaff). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbezier N, 2011, EMBO MOL MED, V3, P35, DOI 10.1002/emmm.201000109; BOGNAR IT, 1984, EUR J PHARMACOL, V103, P173, DOI 10.1016/0014-2999(84)90207-3; Boyce M, 2008, CELL DEATH DIFFER, V15, P589, DOI 10.1038/sj.cdd.4402296; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chiellini G, 2007, FASEB J, V21, P1597, DOI 10.1096/fj.06-7474com; Cnop M, 2007, J BIOL CHEM, V282, P3989, DOI 10.1074/jbc.M607627200; Dan H, 2008, BIOCHEM BIOPH RES CO, V365, P777, DOI 10.1016/j.bbrc.2007.11.040; DeGracia DJ, 1997, J CEREBR BLOOD F MET, V17, P1291, DOI 10.1097/00004647-199712000-00004; El-Armouche A, 2003, FASEB J, V17, P437, DOI 10.1096/fj.02-0057fje; El-Armouche A, 2008, CARDIOVASC RES, V80, P396, DOI 10.1093/cvr/cvn208; ERNSBERGER P, 1987, EUR J PHARMACOL, V134, P1, DOI 10.1016/0014-2999(87)90125-7; Frascarelli S, 2008, EUR J PHARMACOL, V587, P231, DOI 10.1016/j.ejphar.2008.03.055; Frascarelli S, 2011, CARDIOVASC DRUG THER, V25, P307, DOI 10.1007/s10557-011-6320-x; Fu HY, 2010, CIRCULATION, V122, P361, DOI 10.1161/CIRCULATIONAHA.109.917914; Ghelardoni S, 2009, J CELL MOL MED, V13, P3082, DOI 10.1111/j.1582-4934.2009.00728.x; Hansen A, 2010, CIRC RES, V107, P35, DOI 10.1161/CIRCRESAHA.109.211458; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; HOLMES B, 1983, DRUGS, V26, P212, DOI 10.2165/00003495-198326030-00003; Hu LYA, 2009, BIOCHEM J, V424, P39, DOI 10.1042/BJ20090998; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kim I, 2009, J BIOL CHEM, V284, P1593, DOI 10.1074/jbc.M807308200; Kitakaze M, 2010, CIRC RES, V107, P15, DOI 10.1161/CIRCRESAHA.110.222919; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; LACHAUDPETTITI V, 1991, EUR J PHARM-MOLEC PH, V206, P23, DOI 10.1016/0922-4106(91)90142-5; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu LP, 2008, J BIOL CHEM, V283, P31153, DOI 10.1074/jbc.M805056200; Ma YJ, 2003, J BIOL CHEM, V278, P34864, DOI 10.1074/jbc.M301107200; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Minamino T, 2010, J MOL CELL CARDIOL, V48, P1105, DOI 10.1016/j.yjmcc.2009.10.026; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Norez C, 2008, EUR J PHARMACOL, V592, P33, DOI 10.1016/j.ejphar.2008.06.103; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Ozaita A, 1997, BRIT J PHARMACOL, V121, P901, DOI 10.1038/sj.bjp.0701214; Ron D, 2008, CELL, V132, P24, DOI 10.1016/j.cell.2007.12.017; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Srivastava SP, 1998, J BIOL CHEM, V273, P2416, DOI 10.1074/jbc.273.4.2416; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001981; Tsaytler P, 2013, FEBS J, V280, P766, DOI 10.1111/j.1742-4658.2012.08535.x; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Yamaguchi O, 2003, P NATL ACAD SCI USA, V100, P15883, DOI 10.1073/pnas.2136717100; Zhang YW, 2009, ARCH IMMUNOL THER EX, V57, P435, DOI 10.1007/s00005-009-0051-8; Zhang YM, 2011, FREE RADICAL BIO MED, V51, P2172, DOI 10.1016/j.freeradbiomed.2011.09.005	51	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98893	10.1371/journal.pone.0098893	http://dx.doi.org/10.1371/journal.pone.0098893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892553	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400107
J	Ruano-Fajardo, G; Rovito, SM; Ladle, RJ				Ruano-Fajardo, Gustavo; Rovito, Sean M.; Ladle, Richard J.			Bromeliad Selection by Two Salamander Species in a Harsh Environment	PLOS ONE			English	Article							ADAPTIVE RADIATION; PLETHODONTIDAE; ANURA; DIVERSIFICATION; MICROHABITAT; EVOLUTIONARY; AMPHIBIA; ECOLOGY; GENUS; PH	Bromeliad phytotelmata are frequently used by several Neotropical amphibian taxa, possibly due to their high humidity, microclimatic stability, and role as a refuge from predators. Indeed, the ability of phytotelmata to buffer against adverse environmental conditions may be instrumental in allowing some amphibian species to survive during periods of environmental change or to colonize sub-optimal habitats. Association between bromeliad traits and salamanders has not been studied at a fine scale, despite the intimate association of many salamander species with bromeliads. Here, we identify microhabitat characteristics of epiphytic bromeliads used by two species of the Bolitoglossa morio group (B. morio and B. pacaya) in forest disturbed by volcanic activity in Guatemala. Specifically, we measured multiple variables for bromeliads (height and position in tree, phytotelma water temperature and pH, canopy cover, phytotelma size, leaf size, and tree diameter at breast height), as well as salamander size. We employed a DNA barcoding approach to identify salamanders. We found that B. morio and B. pacaya occurred in microsympatry in bromeliads and that phytotelmata size and temperature of bromeliad microhabitat were the most important factors associated with the presence of salamanders. Moreover, phytotelmata with higher pH contained larger salamanders, suggesting that larger salamanders or aggregated individuals might modify pH. These results show that bromeliad selection is nonrandom with respect to microhabitat characteristics, and provide insight into the relationship between salamanders and this unique arboreal environment.	[Ruano-Fajardo, Gustavo] Univ San Carlos, Fac Ciencias Quim & Farm, Escuela Biol, Museo Hist Nat, Ciudad De Guatemala, Guatemala; [Rovito, Sean M.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Ruano-Fajardo, Gustavo; Ladle, Richard J.] Univ Fed Alagoas, Inst Ciencias Biol & Saude, Sect Diversidade Biol & Conservacao Trop, Maceio, Alagoas, Brazil; [Ladle, Richard J.] Univ Oxford, Sch Geog & Environm, Oxford, England	Universidad de San Carlos de Guatemala; University of California System; University of California Berkeley; Universidade Federal de Alagoas; University of Oxford	Ruano-Fajardo, G (corresponding author), Univ San Carlos, Fac Ciencias Quim & Farm, Escuela Biol, Museo Hist Nat, Ciudad De Guatemala, Guatemala.	ruano.gustavo@yahoo.com	Rovito, Sean/AAG-1143-2019; Ladle, Richard/E-4228-2014	Rovito, Sean/0000-0002-4713-9654; Ladle, Richard/0000-0003-3200-3946	Direccion General de Docencia (DIGED), Universidad San Carlos de Guatemala (USAC); U.S. National Science Foundation [DEB 1026396]; UC MEXUS-CONACyT postdoctoral fellowship	Direccion General de Docencia (DIGED), Universidad San Carlos de Guatemala (USAC); U.S. National Science Foundation(National Science Foundation (NSF)); UC MEXUS-CONACyT postdoctoral fellowship	G. Ruano-Fajardo was funded by the Direccion General de Docencia (DIGED), Universidad San Carlos de Guatemala (USAC) and S. Rovito was supported by a Biodiversity Survey and Inventory grant from the U.S. National Science Foundation (DEB 1026396) and a UC MEXUS-CONACyT postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AmphibiaWeb, 2013, AMPHIBIAWEB INF AMPH; Bandoni F, 2004, J HERPETOL, V38, P331; BENZING DH, 2000, BROMELIACEAE PROFILE; Blankers T, 2012, J EVOLUTION BIOL, V25, P634, DOI 10.1111/j.1420-9101.2012.02458.x; Buosi PRB, 2014, J EUKARYOT MICROBIOL, V61, P2, DOI 10.1111/jeu.12071; Campbell Jonathan A., 2010, MISCELLANEOUS PUBLICATIONS MUSEUM OF ZOOLOGY UNIVERSITY OF MICHIGAN, P1; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; FEDER ME, 1982, ECOLOGY, V63, P1665, DOI 10.2307/1940108; FRISBIE MP, 1992, ARCH ENVIRON CON TOX, V23, P64; Goncalves-Souza T, 2010, J ARACHNOL, V38, P270, DOI 10.1636/P09-58.1; Grinnell J., 1904, Auk, Vxxi, P364; Grippa CR, 2007, MYCORRHIZA, V17, P235, DOI 10.1007/s00572-006-0090-5; Heyer W. R., 1994, MEASURING MONITORING, P364; Kitching R. L., 2000, FOOD WEBS CONTAINER, P431; Lehtinen Richard M., 2004, Miscellaneous Publications Museum of Zoology University of Michigan, V193, P1; Leroy C, 2013, ANN BOT-LONDON, V112, P919, DOI 10.1093/aob/mct147; LYNCH JF, 1985, J HERPETOL, V19, P328, DOI 10.2307/1564262; Maguire Jr B, 1971, ANNU REV ECOL SYST, V2, P439, DOI [DOI 10.1146/ANNUREV.ES.02.110171.002255, 10.1146/annurev.es.02.110171.002255]; McLachlan A, 2001, BIOL REV, V76, P377, DOI 10.1017/S1464793101005723; MORITZ C, 1992, SYST BIOL, V41, P273, DOI 10.2307/2992567; Palumbi S. R., 1996, MOL SYSTEMATICS, V2, P205, DOI DOI 10.1080/17451000.2014.902536; Parra-Olea G, 2004, BIOL J LINN SOC, V81, P325, DOI 10.1111/j.1095-8312.2003.00303.x; Pederassi J, 2012, BRAZ J BIOL, V72, P229, DOI 10.1590/S1519-69842012000200001; Peixoto OL, 2003, HERPETOLOGICA, V59, P235, DOI 10.1655/0018-0831(2003)059[0235:TNSOPA]2.0.CO;2; Peixoto Oswaldo Luiz, 1995, Revista Universidade Rural Serie Ciencias da Vida, V17, P75; Peng CYJ, 2002, J EDUC RES, V96, P3, DOI 10.1080/00220670209598786; Poelman EH, 2013, EVOL ECOL, V27, P661, DOI 10.1007/s10682-013-9633-3; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Romero GQ, 2010, OECOLOGIA, V162, P941, DOI 10.1007/s00442-009-1533-4; Rovito SM, 2013, BIOL J LINN SOC, V109, P622, DOI 10.1111/bij.12083; Rovito SM, 2012, J BIOGEOGR, V39, P1251, DOI 10.1111/j.1365-2699.2012.02696.x; Sherman E, 2012, NORTHEAST NAT, V19, P111, DOI 10.1656/045.019.0109; Stuckert Adam M. M., 2009, Phyllomedusa, V8, P125; Wake D.B., 1976, NAT HIST MUS LOS ANG, V25, P1; Wake DB, 2009, ANNU REV ECOL EVOL S, V40, P333, DOI 10.1146/annurev.ecolsys.39.110707.173552; WAKE DB, 1987, ANN MO BOT GARD, V74, P242, DOI 10.2307/2399397; Woodley SK, 2014, GEN COMP ENDOCR, V201, P8, DOI 10.1016/j.ygcen.2014.03.019	37	8	10	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98474	10.1371/journal.pone.0098474	http://dx.doi.org/10.1371/journal.pone.0098474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892414	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400056
J	Wang, SL; Wu, B; Zhu, LA; Leng, L; Bucala, R; Lu, LJ				Wang, Su-li; Wu, Bin; Zhu, Li-an; Leng, Lin; Bucala, Richard; Lu, Liang-jing			Construct and Criterion Validity of the Euro Qol-5D in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							QUALITY-OF-LIFE; THE-LITERATURE; INDEX; COHORT	Objective: To investigate the construct and criterion validity of the Euro Qol-5D (EQ-5D), which allows quality-adjusted life-years to be calculated, in patients with systemic lupus erythematosus (SLE). Methods: Consecutive SLE patients who had been followed at the Renji Hospital, School of Medicine, Shanghai Jiao Tong University were recruited. Cross-sectional correlations of the EQ-5D with equivalent domains in disease-specific health-related quality of life (HRQoL), LupusQol, Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) measures, the Systemic Lupus International Collaborating Clinics Damage Index (SDI), and patient characteristics were tested. Discriminant validity to assess the ability to distinguish between patients of different disease severity was assessed. There also were evaluations of ceiling and floor effects. Results: 240 patients were recruited in total. The EQ-5D correlated moderately to strongly with all domains of the LupusQoL (r : 0.44-0.7) apart from intimate relationships (r = 0.25) and body image (r = 0.18). There was moderate negative correlation between EQ-5D and clinical assessment of disease, SLEDAI (r = -0.589) and SDI (r = -0.509). When compared with equivalent domains on LupusQoL, there was good construct validity in EQ-5D (r: 0.631-0.812). EQ-5D could also discriminate patients with varied disease severity (according SLEDAI and SDI). There was no floor effect in EQ-5D but the ceiling effect remains strong (34%). Conclusion: Our results provide sufficient evidence that the EQ-5D displays construct and criterion validity for use in SLE patients. Disease-specific measures of HRQoL used alongside may be a better choice.	[Wang, Su-li; Lu, Liang-jing] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Rheumatol, Shanghai 200030, Peoples R China; [Wu, Bin] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Clin Outcomes & Econ Grp,Dept Pharm, Shanghai 200030, Peoples R China; [Zhu, Li-an; Leng, Lin; Bucala, Richard] Yale Univ, Sch Med, Dept Med, Sect Rheumatol,Anlyan Ctr, New Haven, CT 06510 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Yale University	Lu, LJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Rheumatol, Shanghai 200030, Peoples R China.	lu_liangjing@medmail.com.cn		Leng, Lin/0000-0002-0605-358X; Lu, Liangjing/0000-0001-9116-6038	National Natural Sciences Foundation of China [81373209, 81072469, 30671946]; Shanghai Natural Sciences Foundation [09ZR1417600]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Sciences Foundation(Natural Science Foundation of Shanghai)	This work was supported by grants from the National Natural Sciences Foundation of China (No. 81373209; No. 81072469; No. 30671946) and Shanghai Natural Sciences Foundation (No. 09ZR1417600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aday LA, 1996, DESIGNING CONDUCTING; Alarcon GS, 2004, ARTHRIT RHEUM-ARTHR, V51, P465, DOI 10.1002/art.20409; [Anonymous], 2011, FDA APPROVES BENLYST; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Dua AB, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0380-9; Gladman DD, 1997, ARTHRITIS RHEUM-US, V40, P809, DOI 10.1002/art.1780400506; Gladman DD, 2002, J RHEUMATOL, V29, P288; Grech P, 2013, LUPUS, V22, P978, DOI 10.1177/0961203313499417; Group EQ, 1990, HLTH POLICY, V16, P199, DOI DOI 10.1016/0168-8510(90)90421-9; Harrison MJ, 2012, J RHEUMATOL, V39, P735, DOI 10.3899/jrheum.110648; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jolly M, 2005, J RHEUMATOL, V32, P1706; Jolly M, 2010, ANN RHEUM DIS, V69, P29, DOI 10.1136/ard.2008.094763; Kularatna S, 2013, VALUE HEALTH, V16, P1091, DOI 10.1016/j.jval.2013.05.006; Kuriya B, 2008, ARTHRIT RHEUM-ARTHR, V59, P181, DOI 10.1002/art.23339; McElhone K, 2007, ARTHRIT RHEUM-ARTHR, V57, P972, DOI 10.1002/art.22881; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Mok CC, 2005, MEDICINE, V84, P218, DOI 10.1097/01.md.0000170022.44998.d1; Rudmik L, 2013, LARYNGOSCOPE, V123, P1341, DOI 10.1002/lary.23943; Sullivan PW, 2006, MED DECIS MAKING, V26, P410, DOI 10.1177/0272989X06290495; Veenhof C, 2006, ARTHRIT RHEUM-ARTHR, V55, P480, DOI 10.1002/art.22001; Waldheim E, 2013, LUPUS, V22, P1118, DOI 10.1177/0961203313502109; Wang SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063795; Whitehurst DGT, 2011, MED DECIS MAKING, V31, pE34, DOI 10.1177/0272989X11421529	24	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98883	10.1371/journal.pone.0098883	http://dx.doi.org/10.1371/journal.pone.0098883			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892282	Green Submitted, gold, Green Published			2022-12-25	WOS:000336911400105
J	Chen, YQ; Lu, ZX; Li, Q; Hoffmann, BD; Zhang, W				Chen, Youqing; Lu, Zhixing; Li, Qiao; Hoffmann, Benjamin D.; Zhang, Wei			Multiple Ant Species Tending Lac Insect Kerria yunnanensis (Hemiptera: Kerriidae) Provide Asymmetric Protection against Parasitoids	PLOS ONE			English	Article							COMPETITION; FORMICIDAE; MUTUALISM; ASSOCIATION; HYMENOPTERA; ATTENDANCE; HOMOPTERA; OUTCOMES; DEFENSE	This study investigated the effects of ant attendance on the parasitoid community and parasitism of lac insect Kerria yunnanensis aggregations in Yunnan province, China. We manipulated ant attendance to establish three treatments: (1) ant exclusion; (2) low ant attendance by several ant species; and (3) high ant attendance by Crematogaster macaoensis. Five parasitoid species were collected, with two species contributing 82.7 and 13.2% of total abundance respectively. Total parasitoid abundance was lowest in the February sample when K. yunnanensis was in its younger life stage, being significantly lower in the ant exclusion treatment. In April, all three treatments had significantly different parasitoid abundances, being highest in the ant exclusion treatment and the lowest in the high ant attendance treatment. When ants were present, there were strong negative relationships between total parasitoid abundance and ant abundance, with the relationships being dependent upon the ant species composition and abundance. The patterns of total parasitoid abundance were driven by the two most abundant parasitoid species. Parasitoid species richness did not differ among treatments or between sample times, however, multivariate analysis confirmed that overall parasitoid community structure differed significantly among treatments and between sample times, with the high ant attendance treatment differing most from the other two treatments. Interestingly the absence of ants did not result in increased parasitism from four of the five parasitoids. Ants in lac insect farming systems have a clear role for agricultural pest management. A full understanding of the asymmetric abilities of ants to influence parasitoid communities, and affect parasitism of hosts will require further experimental manipulation to assess the relative roles of 1) the abundance of each individual ant species on parasitoid access to hosts, 2) competition among parasitoids, and 3) the interaction between the first two factors.	[Chen, Youqing; Lu, Zhixing] Chinese Acad Forestry, Res Inst Resources Insects, Kunming, Yunnan, Peoples R China; [Li, Qiao; Zhang, Wei] Southwest Forestry Univ, Sch Forestry, Kunming, Yunnan, Peoples R China; [Hoffmann, Benjamin D.] CSIRO Ecosyst Sci, Trop Ecosyst Res Ctr, Darwin, NT, Australia	Chinese Academy of Forestry; Research Institute of Resources Insects, CAF; Southwest Forestry University - China; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Chen, YQ (corresponding author), Chinese Acad Forestry, Res Inst Resources Insects, Kunming, Yunnan, Peoples R China.	cyqcaf@126.com	Hoffmann, Ben D/A-2746-2011; LU, ZHIXING/AAL-7700-2021	Hoffmann, Ben D/0000-0002-4010-4723; LU, ZHIXING/0000-0002-1329-7929	Special Fund for Forestry Research in the Public Interest [201204602]; National Natural Science Foundation (NSF) [31270561]	Special Fund for Forestry Research in the Public Interest; National Natural Science Foundation (NSF)(National Natural Science Foundation of China (NSFC))	This research was partly supported from grant 201204602 provided by Special Fund for Forestry Research in the Public Interest and National Natural Science Foundation (NSF) grant 31270561. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICOTT JF, 1978, CAN J ZOOL, V56, P2093, DOI 10.1139/z78-283; ADDICOTT JF, 1979, CAN J ZOOL, V57, P558, DOI 10.1139/z79-066; Agarwal V. M., 2005, Entomon, V30, P263; Bannerman JA, 2014, OIKOS, V123, P89, DOI 10.1111/j.1600-0706.2013.00686.x; BHAGAT M L, 1985, Journal of Entomological Research (New Delhi), V9, P240; BRETON LM, 1992, ECOLOGY, V73, P2175, DOI 10.2307/1941465; BRISTOW CM, 1984, J ANIM ECOL, V53, P715, DOI 10.2307/4654; BUCKLEY R, 1987, ADV ECOL RES, V16, P53; BUCKLEY R, 1991, BIOTROPICA, V23, P282, DOI 10.2307/2388205; Cerda X, 1998, OECOLOGIA, V117, P404, DOI 10.1007/s004420050674; Chen XM, 2008, LAC INSECT CULTIVATI; Chen YQ, 2013, TROP ECOL, V54, P301; Chen YouQing, 2007, World Forestry Research, V20, P61; CUSHMAN JH, 1991, OIKOS, V61, P138, DOI 10.2307/3545416; CUSHMAN JH, 1991, ANT - PLANT INTERACTIONS, P92; CUSHMAN JH, 1989, ECOLOGY, V70, P1040, DOI 10.2307/1941372; Davidson DW, 2004, OECOLOGIA, V139, P255, DOI 10.1007/s00442-004-1508-4; Del-Claro K, 2000, OECOLOGIA, V124, P156, DOI 10.1007/s004420050002; Eastwood R, 2004, AUST J ENTOMOL, V43, P1, DOI 10.1111/j.1440-6055.2003.00371.x; Gibernau M, 2001, OECOLOGIA, V126, P53, DOI 10.1007/s004420000479; Gullan PJ, 1997, ANNU REV ENTOMOL, V42, P23, DOI 10.1146/annurev.ento.42.1.23; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Inouye BD, 2004, ECOL ENTOMOL, V29, P692, DOI 10.1111/j.0307-6946.2004.00652.x; Itioka T, 1996, OECOLOGIA, V106, P448, DOI 10.1007/BF00329700; Jaiswal A. K., 1995, Journal of Entomological Research (New Delhi), V19, P27; Janzen D.H., 1985, P40; Liao DX, 1987, EC INSECT FAUNA CHIN, V34, P1; MAHDIHASSAN S, 1981, Pakistan Journal of Scientific and Industrial Research, V24, P148; MESSINA FJ, 1981, ECOLOGY, V62, P1433, DOI 10.2307/1941499; MILLER DR, 1979, ANNU REV ENTOMOL, V24, P1, DOI 10.1146/annurev.en.24.010179.000245; Morales MA, 2000, OIKOS, V90, P469, DOI 10.1034/j.1600-0706.2000.900305.x; Ness JH, 2009, ECOLOGY, V90, P2823, DOI 10.1890/08-1580.1; Peng R, 2013, J APPL ENTOMOL, V137, P711, DOI 10.1111/jen.12058; Peng RK, 2004, INT J PEST MANAGE, V50, P107, DOI 10.1080/09670870410001658125; Santini G, 2007, ECOL ENTOMOL, V32, P319, DOI 10.1111/j.1365-2311.2007.00882.x; Sharma K. K., 2001, Indian Journal of Entomology, V63, P456; Sharma KK, 1999, BEE WORLD, V80, P115, DOI 10.1080/0005772X.1999.11099439; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; SRIVASTAVA D C, 1984, Indian Journal of Ecology, V11, P37; Srivastava DC, 1984, INDIAN J ECOL, V11, P96; Srivastava DC, 1984, INDIAN SHELLAC, P24; Stadler B, 2005, ANNU REV ECOL EVOL S, V36, P345, DOI 10.1146/annurev.ecolsys.36.091704.175531; Wang Si-ming, 2011, Yingyong Shengtai Xuebao, V22, P229; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515	44	1	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98975	10.1371/journal.pone.0098975	http://dx.doi.org/10.1371/journal.pone.0098975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887398	gold, Green Published, Green Submitted			2022-12-25	WOS:000336956300122
J	Green, A; de Azevedo, V; Patten, G; Davies, MA; Ibeto, M; Cox, V				Green, Ann; de Azevedo, Virginia; Patten, Gabriela; Davies, Mary-Ann; Ibeto, Mary; Cox, Vivian			Clinical Mentorship of Nurse Initiated Antiretroviral Therapy in Khayelitsha, South Africa: A Quality of Care Assessment	PLOS ONE			English	Article							SUSTAINABILITY	Introduction: To combat the AIDS epidemic and increase HIV treatment access, the South African government implemented a nurse-based, doctor-supported model of care that decentralizes administration of antiretroviral treatment (ART) for HIV positive patients through nurse initiated and managed ART. Medecins Sans Frontieres (MSF) implemented a mentorship programme to ensure successful task-shifting, subsequently assessing the quality of clinical care provided by nurses. Methods: A before-after cross-sectional study was conducted on nurses completing the mentorship programme in Khayelitsha, South Africa, from February 2011-September 2012. Routine clinical data from 229 patient folders and 21 self-assessment questionnaires was collected to determine the number of patients initiated on ART by nurses; quality of ART management before-after mentorship; patient characteristics for doctor and nurse ART initiations; and nurse self-assessments after mentorship. Results: Twenty one nurses were authorized by one nurse mentor with one part-time medical officer's support, resulting in nurses initiating 77% of ART eligible patients. Improvements in ART management were found for drawing required bloods (91% vs 99%, p = 0.03), assessing adherence (50% vs 78%, p < 0.001) and WHO staging (63% vs 91%, p < 0.001). Nurse ART initiation indicators were successfully completed at 95-100% for 11 of 16 indicators: clinical presentation; patient weight; baseline blood work (CD4, creatinine, haemoglobin); STI screening; WHO stage, correlating medical history; medications prescribed appropriately; ART start date; and documented return date. Doctors initiated more patients with TB/HIV co-infection and WHO Stage 3 and 4 disease than nurses. Nurse confidence improved for managing HIV-infected children and pregnant women, blood result interpretation and long-term side effects. Conclusions: Implementation of a clinical mentorship programme in Khayelitsha led to nurse initiation of a majority of eligible patients, enabling medical officers to manage complex cases. As mentorship can increase clinical confidence and enhance professional development, it should be considered essential for universal ART access in resource limited settings.	[Green, Ann; Davies, Mary-Ann] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, South Africa; [de Azevedo, Virginia] City Cape Town, Dept Hlth, Cape Town, South Africa; [Patten, Gabriela; Ibeto, Mary; Cox, Vivian] Med Sans Frontieres Khayelitsha, Khayelitsha, South Korea	University of Cape Town	Green, A (corresponding author), Vanderbilt Inst Global Hlth, Nashville, TN 37203 USA.	annfordgreen@gmail.com	Patten, Gabriela/J-3461-2019	Patten, Gabriela/0000-0003-2511-1367; Green, Ann/0000-0002-9248-2216				Bachmann MO, 2012, LANCET, V380, P1908, DOI 10.1016/S0140-6736(12)62111-4; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Bingham A, 2003, SALUD PUBLICA MEXICO, V45, pS408; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Cameron D, 2012, SAMJ S AFR MED J, V102, P98, DOI 10.7196/SAMJ.5195; Chung J, 2008, HIV AIDS IMPL M 3 7; Department of Social Services and Poverty Alleviation, 2006, POP REG UPD KHAYEL 2; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; International Agency for Research on Cancer, 2010, GLOBOCAN 2008 FAST S; Kiweewa FM, 2013, J ACQUIRED IMMUNE DE, V63; Kredo T, 2012, TASK SHIFTING DOCTOR; Long L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001055; Medecins Sans Frontieres, 2012, CLIN MENT TOOLK; Medecins Sans Frontieres, 2011, KHAYEL 2001 2011 ACT; Naranbhai V, 2012, LANCET, V380, P1907, DOI 10.1016/S0140-6736(12)62110-2; Penazzato M, 2014, JAIDS-J ACQ IMM DEF, V65, P414, DOI 10.1097/QAI.0000000000000024; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; South African National Department of Health, 2011, CLIN MENT MAN INT SE; South African National Department of Health, 2011, NAT STRAT PLAN HIV A; StataCorp, 2011, STAT STAT SOFTW REL; Stinson K, 2014, S AFR J HIV MED, V15, P30, DOI [10.7196/sajhivmed.1025, 10.7196/SAJHIVMED.1025]; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Western Cape's HIV&AIDS STI TB Directorate, 2012, FRAM NURS IN MAN ANT; Workneh G, 2013, AIDS CARE, V25, P11, DOI 10.1080/09540121.2012.674096; World Health Organization, 2008, TASK SHIFT RAT RED T	26	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98389	10.1371/journal.pone.0098389	http://dx.doi.org/10.1371/journal.pone.0098389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887260	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300060
J	Lim, SI; Mizuta, Y; Takasu, A; Kim, YH; Kwon, I				Lim, Sung In; Mizuta, Yukina; Takasu, Akinori; Kim, Yong Hwan; Kwon, Inchan			Site-Specific Bioconjugation of a Murine Dihydrofolate Reductase Enzyme by Copper(I)-Catalyzed Azide-Alkyne Cycloaddition with Retained Activity	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; DIMETHYL-SULFOXIDE; GENETIC-CODE; PROTEIN; ACID; IMMOBILIZATION; CONJUGATION; MUTAGENESIS; TRAFFICKING; EFFICACY	Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) is an efficient reaction linking an azido and an alkynyl group in the presence of copper catalyst. Incorporation of a non-natural amino acid (NAA) containing either an azido or an alkynyl group into a protein allows site-specific bioconjugation in mild conditions via CuAAC. Despite its great potential, bioconjugation of an enzyme has been hampered by several issues including low yield, poor solubility of a ligand, and protein structural/functional perturbation by CuAAC components. In the present study, we incorporated an alkyne-bearing NAA into an enzyme, murine dihydrofolate reductase (mDHFR), in high cell density cultivation of Escherichia coli, and performed CuAAC conjugation with fluorescent azide dyes to evaluate enzyme compatibility of various CuAAC conditions comprising combination of commercially available Cu(I)-chelating ligands and reductants. The condensed culture improves the protein yield 19-fold based on the same amount of non-natural amino acid, and the enzyme incubation under the optimized reaction condition did not lead to any activity loss but allowed a fast and high-yield bioconjugation. Using the established conditions, a biotin-azide spacer was efficiently conjugated to mDHFR with retained activity leading to the site-specific immobilization of the biotin-conjugated mDHFR on a streptavidin-coated plate. These results demonstrate that the combination of reactive non-natural amino acid incorporation and the optimized CuAAC can be used to bioconjugate enzymes with retained enzymatic activity.	[Lim, Sung In; Kwon, Inchan] Univ Virginia, Dept Chem Engn, Charlottesville, VA 22904 USA; [Mizuta, Yukina; Takasu, Akinori] Nagoya Inst Technol, Dept Frontier Mat, Nagoya, Aichi, Japan; [Kim, Yong Hwan] Kwangwoon Univ, Dept Chem Engn, Seoul, South Korea; [Kwon, Inchan] GIST, Sch Mat Sci & Engn, Kwangju, South Korea	University of Virginia; Nagoya Institute of Technology; Kwangwoon University; Gwangju Institute of Science & Technology (GIST)	Kwon, I (corresponding author), Univ Virginia, Dept Chem Engn, Charlottesville, VA 22904 USA.	ik4t@virginia.edu		Kwon, Inchan/0000-0003-0806-4116	Korea CCS RD Center (KCRC) [2013M1A8A1038187]; University of Virginia	Korea CCS RD Center (KCRC); University of Virginia	This work was supported by the Korea CCS R&D Center (KCRC) grant (2013M1A8A1038187). This article was published in part thanks to funds provided by the University of Virginia Library Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agard NJ, 2006, ACS CHEM BIOL, V1, P644, DOI 10.1021/cb6003228; Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Aissaoui N, 2013, ENZYME MICROB TECH, V52, P336, DOI 10.1016/j.enzmictec.2013.02.018; Albayrak C, 2013, NUCLEIC ACIDS RES, V41, P5949, DOI 10.1093/nar/gkt226; Anderson JC, 2003, BIOCHEMISTRY-US, V42, P9598, DOI 10.1021/bi034550w; Averick SE, 2012, LANGMUIR, V28, P1954, DOI 10.1021/la204077v; Banerjee D, 2010, CHEMBIOCHEM, V11, P1273, DOI 10.1002/cbic.201000125; Basle E, 2010, CHEM BIOL, V17, P213, DOI 10.1016/j.chembiol.2010.02.008; Beatty KE, 2005, J AM CHEM SOC, V127, P14150, DOI 10.1021/ja054643W; Besanceney-Webler C, 2011, ANGEW CHEM INT EDIT, V50, P8051, DOI 10.1002/anie.201101817; Brennan JL, 2006, BIOCONJUGATE CHEM, V17, P1373, DOI 10.1021/bc0601018; Budisa N, 2013, CURR OPIN BIOTECH, V24, P591, DOI 10.1016/j.copbio.2013.02.026; Bundy BC, 2010, BIOCONJUGATE CHEM, V21, P255, DOI 10.1021/bc9002844; Busby WF, 1999, DRUG METAB DISPOS, V27, P246; Chan TR, 2004, ORG LETT, V6, P2853, DOI 10.1021/ol0493094; Christen EH, 2012, ORG BIOMOL CHEM, V10, P6629, DOI 10.1039/c2ob25556a; Cody V, 2008, ACTA CRYSTALLOGR D, V64, P977, DOI 10.1107/S0907444908022348; Cody V, 2006, PROTEINS, V65, P959, DOI 10.1002/prot.21131; Easterbrook J, 2001, DRUG METAB DISPOS, V29, P141; Gillmeister MP, 2011, BIOCONJUGATE CHEM, V22, P556, DOI 10.1021/bc900445g; Goerke AR, 2009, BIOTECHNOL BIOENG, V102, P400, DOI 10.1002/bit.22070; Hernandez K, 2011, ENZYME MICROB TECH, V48, P107, DOI 10.1016/j.enzmictec.2010.10.003; Hershfield MS, 2010, P NATL ACAD SCI USA, V107, P14351, DOI 10.1073/pnas.1001072107; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087; Johnson DBF, 2011, NAT CHEM BIOL, V7, P779, DOI 10.1038/nchembio.657; Kim CH, 2013, CURR OPIN CHEM BIOL, V17, P412, DOI 10.1016/j.cbpa.2013.04.017; Kislukhin AA, 2013, BIOCONJUGATE CHEM, V24, P684, DOI 10.1021/bc300672b; Kwon I, 2003, J AM CHEM SOC, V125, P7512, DOI 10.1021/ja0350076; Kwon I, 2006, J AM CHEM SOC, V128, P11778, DOI 10.1021/ja0626281; Lallana E, 2011, ANGEW CHEM INT EDIT, V50, P8794, DOI 10.1002/anie.201101019; Levengood MR, 2009, CHEMBIOCHEM, V10, P911, DOI 10.1002/cbic.200800752; Lim SI, 2013, J CONTROL RELEASE, V170, P219, DOI 10.1016/j.jconrel.2013.05.023; Liu J, 2010, BIOORG MED CHEM LETT, V20, P5613, DOI 10.1016/j.bmcl.2010.08.049; McLoughlin SY, 2013, P NATL ACAD SCI USA, V110, P19396, DOI 10.1073/pnas.1311761110; Nairn NW, 2012, BIOCONJUGATE CHEM, V23, P2087, DOI 10.1021/bc300295x; Patel KG, 2011, BIOCONJUGATE CHEM, V22, P376, DOI 10.1021/bc100367u; Presolski Stanislav I, 2011, Curr Protoc Chem Biol, V3, P153; Redeker ES, 2013, BIOCONJUGATE CHEM, V24, P1761, DOI 10.1021/bc4002823; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Rusmini F, 2007, BIOMACROMOLECULES, V8, P1775, DOI 10.1021/bm061197b; Santoro SW, 2003, NUCLEIC ACIDS RES, V31, P6700, DOI 10.1093/nar/gkg903; Schneider D, 2013, BIOORGAN MED CHEM, V21, P3430, DOI 10.1016/j.bmc.2013.03.063; Schoffelen S, 2008, BIOCONJUGATE CHEM, V19, P1127, DOI 10.1021/bc800019v; Schoffelen S, 2013, BIOCONJUGATE CHEM, V24, P987, DOI 10.1021/bc400021j; Seo MH, 2011, ANAL CHEM, V83, P2841, DOI 10.1021/ac103334b; Shah V, 2006, BIOTECHNOL LETT, V28, P651, DOI 10.1007/s10529-006-0031-6; Sisido M, 2005, METHODS, V36, P270, DOI 10.1016/j.ymeth.2005.04.009; Sivakumar K, 2004, ORG LETT, V6, P4603, DOI 10.1021/ol047955x; Soundrarajan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046741; Steinmetz NF, 2009, J AM CHEM SOC, V131, P17093, DOI 10.1021/ja902293w; Takasu A, 2011, BIOMACROMOLECULES, V12, P3444, DOI 10.1021/bm200522d; Thornalley PJ, 1998, CHEM-BIOL INTERACT, V112, P137, DOI 10.1016/S0009-2797(97)00157-9; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Young DD, 2011, BIOCHEMISTRY-US, V50, P1894, DOI 10.1021/bi101929e; Zheng S, 2012, BIOTECHNOL J, V7, P47, DOI 10.1002/biot.201100267; Zheng XT, 2013, ACS NANO, V7, P6278, DOI 10.1021/nn4023137	59	31	32	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98403	10.1371/journal.pone.0098403	http://dx.doi.org/10.1371/journal.pone.0098403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887377	gold, Green Published, Green Submitted			2022-12-25	WOS:000336956300062
J	Prompetchara, E; Ketloy, C; Keelapang, P; Sittisombut, N; Ruxrungtham, K				Prompetchara, Eakachai; Ketloy, Chutitorn; Keelapang, Poonsook; Sittisombut, Nopporn; Ruxrungtham, Kiat			Induction of Neutralizing Antibody Response against Four Dengue Viruses in Mice by Intramuscular Electroporation of Tetravalent DNA Vaccines	PLOS ONE			English	Article							IMMUNE-RESPONSES; PROTECTIVE EFFICACY; IMMUNOGENICITY; SEROTYPES; SAFETY; FORMULATIONS; INTERFERENCE; MUCOSAL; TRIAL; PRNT	DNA vaccine against dengue is an interesting strategy for a prime/boost approach. This study evaluated neutralizing antibody (NAb) induction of a dengue tetravalent DNA (TDNA) vaccine candidate administered by intramuscular-electroporation (IM-EP) and the benefit of homologous TDNA boosting in mice. Consensus humanized pre-membrane (prM) and envelope (E) of each serotypes, based on isolates from year 1962-2003, were separately cloned into a pCMVkan expression vector. ICR mice, five-six per group were immunized for three times (2-week interval) with TDNA at 100 mu g (group I; 25 mu g/monovalent) or 10 mu g (group II; 2.5 mu g/monovalent). In group I, mice received an addtional TDNA boosting 13 weeks later. Plaque reduction neutralization tests (PRNT) were performed at 4 weeks post-last immunization. Both 100 mu g and 10 mu g doses of TDNA induced high NAb levels against all DENV serotypes. The median PRNT50 titers were comparable among four serotypes of DENV after TDNA immunization. Median PRNT50 titers ranged 240-320 in 100 mu g and 160-240 in 10 mu g groups (p = ns). A time course study of the 100 mu g dose of TDNA showed detectable NAb at 2 weeks after the second injection. The NAb peaked at 4 weeks after the third injection then declined over time but remained detectable up to 13 weeks. An additional homologous TDNA boosting significantly enhanced the level of NAb from the nadir for at least ten-fold (p < 0.05). Of interest, we have found that the use of more recent dengue viral strain for both vaccine immunogen design and neutralization assays is critical to avoid a mismatching outcome. In summary, this TDNA vaccine candidate induced good neutralizing antibody responses in mice; and the DNA/DNA prime/boost strategy is promising and warranted further evaluation in non-human primates.	[Prompetchara, Eakachai; Ketloy, Chutitorn; Ruxrungtham, Kiat] Chulalongkorn Univ, Fac Med, Chula Vaccine Res Ctr ChulaVRC, Dengue Vaccine Res Unit, Bangkok 10330, Thailand; [Ketloy, Chutitorn] Chulalongkorn Univ, Fac Med, Dept Lab Med, Bangkok 10330, Thailand; [Keelapang, Poonsook; Sittisombut, Nopporn] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand; [Sittisombut, Nopporn] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Med Biotechnol Unit, Bangkok, Thailand; [Ruxrungtham, Kiat] Chulalongkorn Univ, Fac Med, Dept Med, Vaccine & Cellular Immunol Lab, Bangkok 10330, Thailand	Chulalongkorn University; Chulalongkorn University; Chiang Mai University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University	Sittisombut, N (corresponding author), Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand.	nsittiso@mail.med.cmu.ac.th; rkiatchula@gmail.com	Ketloy, Chutitorn/ACW-3484-2022	Keelapang, Poonsook/0000-0003-2036-4437; Ruxrungtham, Kiat/0000-0001-7348-2352	National Science and Technology Development Agency (NSTDA), Thailand [P-00-10146]; Senior Researcher Scholar, Thailand Research Fund (TRF); Royal Golden Jubilee Ph.D. Program [Ph.D. 0035/2551]; Thailand Research Fund MRG [5480150]	National Science and Technology Development Agency (NSTDA), Thailand; Senior Researcher Scholar, Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); Thailand Research Fund MRG	This research project was fully sponsored by National Science and Technology Development Agency (NSTDA), Thailand (P-00-10146); and KR was partially supported by the Senior Researcher Scholar, Thailand Research Fund (TRF); EP and KR were also supported by The Royal Golden Jubilee Ph.D. Program (Ph.D. 0035/2551). CK was supported by Thailand Research Fund MRG (5480150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KB, 2011, J INFECT DIS, V204, P442, DOI 10.1093/infdis/jir279; Apt D, 2006, VACCINE, V24, P335, DOI 10.1016/j.vaccine.2005.07.100; Beckett CG, 2011, VACCINE, V29, P960, DOI 10.1016/j.vaccine.2010.11.050; Brave A, 2009, VACCINE, V27, P3692, DOI 10.1016/j.vaccine.2009.04.013; Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Durbin AP, 2013, J INFECT DIS, V207, P957, DOI 10.1093/infdis/jis936; Eick-Cost AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041435; Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004; Guy B, 2009, AM J TROP MED HYG, V80, P302, DOI 10.4269/ajtmh.2009.80.302; Halstead SB, 2013, VACCINE, V31, P4501, DOI 10.1016/j.vaccine.2013.06.079; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; Holman DH, 2007, CLIN VACCINE IMMUNOL, V14, P182, DOI 10.1128/CVI.00330-06; Johns MC, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010722, 10.1371/journal.pone.0015801]; Kitchener S, 2006, VACCINE, V24, P1238, DOI 10.1016/j.vaccine.2005.09.029; Konishi E, 2006, VACCINE, V24, P2200, DOI 10.1016/j.vaccine.2005.11.002; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Lima DM, 2011, VACCINE, V29, P831, DOI 10.1016/j.vaccine.2010.10.078; Mattapallil JJ, 2006, J EXP MED, V203, P1533, DOI 10.1084/jem.20060657; Morrison D, 2010, J INFECT DIS, V201, P370, DOI 10.1086/649916; Pasetti MF, 2009, J VIROL, V83, P2789, DOI 10.1128/JVI.02191-08; Patel V, 2010, VACCINE, V28, P4827, DOI 10.1016/j.vaccine.2010.04.064; Porter KR, 2012, VACCINE, V30, P336, DOI 10.1016/j.vaccine.2011.10.085; Pulsawat P, 2013, IMMUNOL LETT, V151, P23, DOI 10.1016/j.imlet.2013.01.013; Ramanathan MP, 2009, VACCINE, V27, P6444, DOI 10.1016/j.vaccine.2009.06.061; Raviprakash K, 2000, J GEN VIROL, V81, P1659, DOI 10.1099/0022-1317-81-7-1659; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Simasathien S, 2008, AM J TROP MED HYG, V78, P426, DOI 10.4269/ajtmh.2008.78.426; Simmons M, 2010, VIROLOGY, V396, P280, DOI 10.1016/j.virol.2009.10.023; Sun W, 2009, HUM VACCINES, V5, P33, DOI 10.4161/hv.5.1.6348; Swaminathan S, 2013, LANCET INFECT DIS, V13, P191, DOI 10.1016/S1473-3099(13)70028-8; Thaisomboonsuk B, 2012, INT J INFECT DIS, V16, pE113, DOI 10.1016/j.ijid.2012.05.261; Thomas SJ, 2013, AM J TROP MED HYG, V88, P73, DOI 10.4269/ajtmh.2012.12-0361; Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625; Vesikari T, 2009, PEDIATR INFECT DIS J, V28, P563, DOI 10.1097/INF.0b013e31819d6394; World Health Organization, 2009, DENGUE GUIDELINES DI	36	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e92643	10.1371/journal.pone.0092643	http://dx.doi.org/10.1371/journal.pone.0092643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887426	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300003
J	van der Zwan, YG; Rijlaarsdam, MA; Rossello, FJ; Notini, AJ; de Boer, S; Watkins, DN; Gillis, AJM; Dorssers, LCJ; White, SJ; Looijenga, LHJ				van der Zwan, Yvonne G.; Rijlaarsdam, Martin A.; Rossello, Fernando J.; Notini, Amanda J.; de Boer, Suzan; Watkins, D. Neil; Gillis, Ad J. M.; Dorssers, Lambert C. J.; White, Stefan J.; Looijenga, Leendert H. J.			Seminoma and Embryonal Carcinoma Footprints Identified by Analysis of Integrated Genome-Wide Epigenetic and Expression Profiles of Germ Cell Cancer Cell Lines	PLOS ONE			English	Article							DNA METHYLATION; STEM-CELLS; MICRORNAS MIR-371-3; ESTROGEN-RECEPTOR; SERUM BIOMARKERS; IN-SITU; TUMORS; DMRT1; INITIATION; BINDING	Background: Originating from Primordial Germ Cells/gonocytes and developing via a precursor lesion called Carcinoma In Situ (CIS), Germ Cell Cancers (GCC) are the most common cancer in young men, subdivided in seminoma (SE) and non-seminoma (NS). During physiological germ cell formation/maturation, epigenetic processes guard homeostasis by regulating the accessibility of the DNA to facilitate transcription. Epigenetic deregulation through genetic and environmental parameters (i.e. genvironment) could disrupt embryonic germ cell development, resulting in delayed or blocked maturation. This potentially facilitates the formation of CIS and progression to invasive GCC. Therefore, determining the epigenetic and functional genomic landscape in GCC cell lines could provide insight into the pathophysiology and etiology of GCC and provide guidance for targeted functional experiments. Results: This study aims at identifying epigenetic footprints in SE and EC cell lines in genome-wide profiles by studying the interaction between gene expression, DNA CpG methylation and histone modifications, and their function in the pathophysiology and etiology of GCC. Two well characterized GCC-derived cell lines were compared, one representative for SE (TCam-2) and the other for EC (NCCIT). Data were acquired using the Illumina HumanHT-12-v4 (gene expression) and HumanMethylation450 BeadChip (methylation) microarrays as well as ChIP-sequencing (activating histone modifications (H3K4me3, H3K27ac)). Results indicate known germ cell markers not only to be differentiating between SE and NS at the expression level, but also in the epigenetic landscape. Conclusion: The overall similarity between TCam-2/NCCIT support an erased embryonic germ cell arrested in early gonadal development as common cell of origin although the exact developmental stage from which the tumor cells are derived might differ. Indeed, subtle difference in the (integrated) epigenetic and expression profiles indicate TCam-2 to exhibit a more germ cell-like profile, whereas NCCIT shows a more pluripotent phenotype. The results provide insight into the functional genome in GCC cell lines.	[van der Zwan, Yvonne G.; Rijlaarsdam, Martin A.; Gillis, Ad J. M.; Dorssers, Lambert C. J.; Looijenga, Leendert H. J.] Erasmus MC Univ Med Ctr Rotterdam, Dept Pathol, Rotterdam, Netherlands; [Rossello, Fernando J.; Watkins, D. Neil] Monash Univ, MIMR PHI Inst Med Res, Ctr Canc Res, Clayton, Vic, Australia; [Notini, Amanda J.; de Boer, Suzan; White, Stefan J.] Monash Univ, MIMR PHI Inst Med Res, Ctr Genet Dis, Clayton, Vic, Australia	Erasmus University Rotterdam; Erasmus MC; Monash University; Prince Henry's Institute of Medical Research; Monash University; Prince Henry's Institute of Medical Research	Looijenga, LHJ (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Pathol, Rotterdam, Netherlands.	l.looijenga@erasmusmc.nl	Rossello, Fernando/B-1208-2015; Looijenga, Leendert/B-8145-2019	Rossello, Fernando/0000-0003-3885-8777; Looijenga, Leendert/0000-0002-8146-1911; Rijlaarsdam, Martin/0000-0002-2528-8077	European Society for Pediatric Endocrinology Research Fellowship; Translational Grant, Erasmus MC; Monash University; Victorian Government's Operational Infrastructure Support Program	European Society for Pediatric Endocrinology Research Fellowship; Translational Grant, Erasmus MC; Monash University(Monash University); Victorian Government's Operational Infrastructure Support Program	This work is supported by funding from the European Society for Pediatric Endocrinology Research Fellowship (YZ). MR is supported by a Translational Grant, Erasmus MC. SB is supported by APA and IPRS scholarships from Monash University. This work was supported by funding from Monash University (SW). MIMR receives support from the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatruda JF, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-313; Ammerpohl O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073288; Andreassen KE, 2013, HUM REPROD, V28, P1995, DOI 10.1093/humrep/det127; Banks Kimberly, 2012, Front Endocrinol (Lausanne), V3, P182, DOI 10.3389/fendo.2012.00182; Belge G, 2012, EUR UROL, V61, P1068, DOI 10.1016/j.eururo.2012.02.037; Bhat GK, 2006, J ANDROL, V27, P302, DOI 10.2164/jandrol.05133; Bignell G, 2006, GENE CHROMOSOME CANC, V45, P42, DOI 10.1002/gcc.20265; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; Clark SJ, 2002, ONCOGENE, V21, P5380, DOI 10.1038/sj.onc.1205598; Clouaire T, 2012, GENE DEV, V26, P1714, DOI 10.1101/gad.194209.112; Cools M, 2006, ENDOCR REV, V27, P468, DOI 10.1210/er.2006-0005; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; de Jong J, 2008, J PATHOL, V215, P21, DOI 10.1002/path.2332; de Jong J, 2005, J PATHOL, V206, P242, DOI 10.1002/path.1766; de Jong J, 2008, GENE CHROMOSOME CANC, V47, P185, DOI 10.1002/gcc.20520; Del Mazo J, 2013, INT J DEV BIOL, V57, P225, DOI 10.1387/ijdb.130042jd; Demichelis F, 2013, NAT MED, V19, P966, DOI 10.1038/nm.3285; Dieckmann KP, 2012, BRIT J CANCER, V107, P1754, DOI 10.1038/bjc.2012.469; Dieckmann KP, 2004, WORLD J UROL, V22, P2, DOI 10.1007/s00345-004-0398-8; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eckert D, 2008, CELL TISSUE RES, V331, P529, DOI 10.1007/s00441-007-0527-y; Elzinga-Tinke JE, 2010, INT J ANDROL, V33, P597, DOI 10.1111/j.1365-2605.2009.00997.x; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Gillis AJM, 2007, J PATHOL, V213, P319, DOI 10.1002/path.2230; Gillis AJM, 2013, MOL ONCOL, V7, P1083, DOI 10.1016/j.molonc.2013.08.002; Godmann M, 2009, MICROSC RES TECHNIQ, V72, P603, DOI 10.1002/jemt.20715; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hawkins RD, 2011, CELL RES, V21, P1393, DOI 10.1038/cr.2011.146; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoei-Hansen CE, 2004, CLIN CANCER RES, V10, P8521, DOI 10.1158/1078-0432.CCR-04-1285; Horwich A, 2006, LANCET, V367, P754, DOI 10.1016/S0140-6736(06)68305-0; Huang YH, 2009, FASEB J, V23, P2076, DOI 10.1096/fj.08-121939; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kanetsky PA, 2011, HUM MOL GENET, V20, P3109, DOI 10.1093/hmg/ddr207; Kanetsky PA, 2009, NAT GENET, V41, P811, DOI 10.1038/ng.393; Kratz CP, 2010, BEST PRACT RES CL EN, V24, P503, DOI 10.1016/j.beem.2010.01.005; Krentz AD, 2009, P NATL ACAD SCI USA, V106, P22323, DOI 10.1073/pnas.0905431106; Looijenga LHJ, 2011, INT J ANDROL, V34, pE234, DOI 10.1111/j.1365-2605.2011.01157.x; Looijenga LHJ, 2013, INT J DEV BIOL, V57, P241, DOI 10.1387/ijdb.130026ll; Looijenga LHJ, 2009, J PATHOL, V218, P146, DOI 10.1002/path.2522; MacDonald WA, 2014, MOL REPROD DEV, V81, P126, DOI 10.1002/mrd.22220; Marabita F, 2013, EPIGENETICS-US, V8, P333, DOI 10.4161/epi.24008; Matson CK, 2011, NATURE, V476, P101, DOI 10.1038/nature10239; Mirbahai L, 2014, MUTAT RES-GEN TOX EN, V764, P10, DOI 10.1016/j.mrgentox.2013.10.003; Mizuno Y, 1993, Nihon Hinyokika Gakkai Zasshi, V84, P1211; Murphy MW, 2010, P NATL ACAD SCI USA, V107, P13360, DOI 10.1073/pnas.1006243107; Murray MJ, 2012, NAT REV UROL, V9, P298, DOI 10.1038/nrurol.2012.86; Murray MJ, 2011, AM J CLIN PATHOL, V135, P119, DOI 10.1309/AJCPOE11KEYZCJHT; Nettersheim D, 2012, GENE CHROMOSOME CANC, V51, P717, DOI 10.1002/gcc.21958; Nettersheim D, 2011, GENE CHROMOSOME CANC, V50, P1033, DOI 10.1002/gcc.20918; Nettersheim D, 2011, EPIGENETICS-US, V6, P114, DOI 10.4161/epi.6.1.13433; Netto GJ, 2008, MODERN PATHOL, V21, P1337, DOI 10.1038/modpathol.2008.127; Ohnesorg T, 2012, METHODS MOL BIOL, V786, P201, DOI 10.1007/978-1-61779-292-2_12; Ohnesorg T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-412; Oosterhuis JW, 2005, NAT REV CANCER, V5, P210, DOI 10.1038/nrc1568; Orso F, 2004, BIOCHEM J, V377, P429, DOI 10.1042/BJ20031133; Rada-Iglesias A, 2011, GENOME MED, V3, DOI 10.1186/gm252; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Rijlaarsdam MA, 2011, BRIT J CANCER, V105, P854, DOI 10.1038/bjc.2011.270; Rijlaarsdam MA, 2014, BMC BIOINFO IN PRESS; Schemmer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071113; Schmid R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-349; Schuur ER, 2001, J BIOL CHEM, V276, P15519, DOI 10.1074/jbc.M009001200; Seisenberger S, 2013, CURR OPIN CELL BIOL, V25, P281, DOI 10.1016/j.ceb.2013.02.013; Shu WJ, 2011, NUCLEIC ACIDS RES, V39, P7428, DOI 10.1093/nar/gkr443; Skinner MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066318; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; TESHIMA S, 1988, LAB INVEST, V59, P328; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Van der Zwan YG, 2013, INT J DEV BIOL, V57, P299, DOI 10.1387/ijdb.130017ll; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Weber S, 2010, BIOL REPROD, V82, P214, DOI 10.1095/biolreprod.109.078717; Wermann H, 2010, J PATHOL, V221, P433, DOI 10.1002/path.2725; White SJ, 2004, METHOD CELL BIOL, V75, P751; WOODWARD PJ, 2004, WHO CLASSIFICATION T, P217	81	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98330	10.1371/journal.pone.0098330	http://dx.doi.org/10.1371/journal.pone.0098330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887064	gold, Green Published			2022-12-25	WOS:000336956300054
J	Ye, Q; Shao, WX; Xu, XJ; Yang, YZ				Ye, Qing; Shao, Wen-Xia; Xu, Xiao-Jun; Yang, Ying-zhi			The Clinical Application Value of Cytokines in Treating Infectious Diseases	PLOS ONE			English	Article							RECOMBINANT HUMAN INTERLEUKIN-6; SEVERE SEPSIS; CELL; INFLAMMATION; CHILDREN; IL-10	We performed a prospective study to evaluate the abilities of inflammatory cytokines to rule out the potential risk of sepsis and intracranial infection and to estimate the function of inflammatory cytokines in discriminating Gram-negative bacteria from Gram-positive ones through ROC analysis. During the course of the study, Levels of serum inflammatory cytokines were measured by flow cytometry at the onset of diseases of patients who suffered from sepsis or intracranial infection. A total of 299 cases of sepsis and 43 cases of intracranial infection were observed during the study. It is noticed that there is no difference of inflammatory cytokine levels between sepsis group and intracranial infection group. The area under ROC curve (AUC) of cytokines, such as IL-2, IL-6 and IL-10 were 0.901, 0.86, 0.888, respectively, which was employed to rule out the diseases of sepsis and intracranial infection. Through comparisons with the patients who were infected by Gram-positive bacteria or Gram-negative ones, it is estimated that IL-6 and IL-10 sharply elevated in patients with Gram-negative bacteria infection (median levels, pg/mL: IL-6: 116.6 vs. 25.4, P = 0.000; IL-10: 13.7 vs. 6.3, P = 0.000). Additionally, IL-2 significantly decreased when patients suffered from Gram-negative bacteria infection (median levels, pg/mL: IL-2: 2.2 vs. 2.7, P = 0.031). The AUCs for detecting cytokines, including IL-2, IL-10 and LOGREGR. Pred_IL-2+IL-10 were 0.581 (95% CI, 0.526 to 0.634), 0.661 (95% CI, 0.608 to 0.712) and 0.735 (95% CI, 0.685 to 0.782), respectively, which was used to evaluate the function of inflammatory cytokines in discriminating Gram-negative bacteria from Gram-positive ones infection. This paper indicates that IL-2, IL-6 and IL-10 are effective biomarkers to rule out sepsis and intracranial infection. Additionally, the combination of IL-2 and IL-10 is an effective biomarkers to diagnose whether patients afflicted by Gram-negative bacteria.	[Ye, Qing] Zhejiang Univ, Sch Med, Childrens Hosp, Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Shao, Wen-Xia] Hangzhou First Peoples Hosp, Clin Lab, Hangzhou, Zhejiang, Peoples R China; [Xu, Xiao-Jun] Zhejiang Univ, Sch Med, Childrens Hosp, Dept Hematol Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Ying-zhi] Zhejiang Univ City Coll, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University City College	Ye, Q (corresponding author), Zhejiang Univ, Sch Med, Childrens Hosp, Clin Lab, Hangzhou 310003, Zhejiang, Peoples R China.	yeqingkaoyan@163.com		Xu, Xiaojun/0000-0003-1388-2535				Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; CASTELL JV, 1988, FEBS LETT, V232, P347, DOI 10.1016/0014-5793(88)80766-X; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; DeClue AE, 2012, VET J, V192, P455, DOI 10.1016/j.tvjl.2011.09.001; Finney SJ, 2012, INTENS CARE MED, V38, P324, DOI 10.1007/s00134-011-2444-5; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Foerster BR, 2007, ACTA RADIOL, V48, P875, DOI 10.1080/02841850701477728; Fonseca JE, 2009, AUTOIMMUN REV, V8, P538, DOI 10.1016/j.autrev.2009.01.012; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; Hartman ME, 2013, PEDIATR CRIT CARE ME, P1; HIRANO T, 1992, CLIN IMMUNOL IMMUNOP, V62, pS60, DOI 10.1016/0090-1229(92)90042-M; Jenabian MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003319; Jinquan T, 2000, IMMUNOLOGY, V99, P402, DOI 10.1046/j.1365-2567.2000.00954.x; Leng SX, 2008, J GERONTOL A-BIOL, V63, P879, DOI 10.1093/gerona/63.8.879; MALEFYT RD, 1991, J EXP MED, V174, P1209; MALEFYT RD, 1993, J IMMUNOL, V150, P4754; MARKHAM JL, 1975, INFECT IMMUN, V12, P378, DOI 10.1128/IAI.12.2.378-386.1975; Richens JL, 2010, J BIOMOL SCREEN, V15, P562, DOI 10.1177/1087057110362099; Salinas N, 2013, J IMMUNOL, V190; Sciuca S, 2013, ALLERGY, V68, P347; Sharma R, 2011, J AUTOIMMUN, V36, P91, DOI 10.1016/j.jaut.2011.01.001; Sharma R, 2011, J IMMUNOL, V186, P1268, DOI 10.4049/jimmunol.1002677; VELDHUIS GJ, 1995, J CLIN ONCOL, V13, P2585, DOI 10.1200/JCO.1995.13.10.2585; Watson R Scott, 2005, Pediatr Crit Care Med, V6, pS3; Watson RS, 2003, AM J RESP CRIT CARE, V167, P695, DOI 10.1164/rccm.200207-682OC; Wolfler A, 2008, INTENS CARE MED, V34, P1690, DOI 10.1007/s00134-008-1148-y; Xu XJ, 2013, INTENS CARE MED, V39, P319, DOI 10.1007/s00134-012-2752-4; Ye Q, 2011, J PEDIAT HEMATOL ONC, V33, pE186, DOI 10.1097/MPH.0b013e31821ba92c	30	15	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98745	10.1371/journal.pone.0098745	http://dx.doi.org/10.1371/journal.pone.0098745			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887408	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300103
J	Yeh, WL; Lin, HY; Wu, HM; Chen, DR				Yeh, Wei-Lan; Lin, Hui-Yi; Wu, Hung-Ming; Chen, Dar-Ren			Combination Treatment of Tamoxifen with Risperidone in Breast Cancer	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CASPASE-MEDIATED APOPTOSIS; CELL-CYCLE PROGRESSION; QUALITY-OF-LIFE; HOT FLASHES; GLIOMA CANCER; WOMEN; ESTROGEN; THERAPY; METABOLISM	Tamoxifen has long been used and still is the most commonly used endocrine therapy for treatment of both early and advanced estrogen receptor-positive breast cancer in pre- and post-menopause women. Tamoxifen exerts its cytotoxic effect primarily through cytostasis which is associated with the accumulation of cells in the G(0)/G(1) phase of the cell cycle. Apoptotic activity can also be exerted by tamoxifen which involves cleavage of caspase 9, caspase 7, caspase 3, and poly-ADP-ribose polymerase (PARP). Down-regulation of anti-apoptotic proteins Bcl-2 and Bcl-xL and up-regulation of proapoptotic proteins Bax and Bak have also been observed. In addition, stress response protein of GRP 94 and GRP 78 have also been induced by tamoxifen in our study. However, side effects occur during tamoxifen treatment in breast cancer patients. Researching into combination regimen of tamoxifen and drug(s) that relieves tamoxifen-induced hot flushes is important, because drug interactions may decrease tamoxifen efficacy. Risperidone has been shown to be effective in reducing or eliminating hot flushes on women with hormonal variations. In this present study, we demonstrated that combination of tamoxifen with risperidone did not interfered tamoxifen-induced cytotoxic effects in both in vitro and in vivo models, while fluoxetine abrogated the effects of tamoxifen. This is the first paper suggesting the possibility of combination treatment of tamoxifen with risperidone in breast cancer patients, providing a conceivable resolution of tamoxifen-induced side effects without interfering the efficacy of tamoxifen against breast cancer.	[Yeh, Wei-Lan] Changhua Christian Hosp, Dept Cell & Tissue Engn, Changhua, Taiwan; [Lin, Hui-Yi] China Med Univ, Sch Pharm, Taichung, Taiwan; [Wu, Hung-Ming] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Chen, Dar-Ren] Changhua Christian Hosp, Comprehens Breast Canc Ctr, Changhua, Taiwan	Changhua Christian Hospital; China Medical University Taiwan; Changhua Christian Hospital; Changhua Christian Hospital	Yeh, WL (corresponding author), Changhua Christian Hosp, Dept Cell & Tissue Engn, Changhua, Taiwan.	blue_lan0816@yahoo.com.tw; darren_chen@cch.org.tw			Ministry of Science and Technology [NSC 100-2314-B-371-001-MY3, NSC 102-2320-B-371-002]; Changhua Christian Hospital [101-CCH-PRJ-07, 102-CCH-IRP-096]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Changhua Christian Hospital	This work was supported by grants from the Ministry of Science and Technology (NSC 100-2314-B-371-001-MY3 and NSC 102-2320-B-371-002) and Changhua Christian Hospital (101-CCH-PRJ-07 and 102-CCH-IRP-096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; [Anonymous], 1998, LANCET, V351, P1451; Appiani F, 2011, ANN CLIN PSYCHIATRY, V23, P152; Aubert EJS, 2009, AM SOC CLIN ONC ANN; Avis NE, 2008, J CLIN ONCOL, V26, P5008, DOI 10.1200/JCO.2008.18.2170; Avis NE, 2003, MED CARE, V41, P1262, DOI 10.1097/01.MLR.0000093479.39115.AF; Berecz R, 2004, CURR DRUG TARGETS, V5, P573, DOI 10.2174/1389450043345263; Berendsen HHG, 2000, MATURITAS, V36, P155, DOI 10.1016/S0378-5122(00)00151-1; Butt AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1779; Carpenter Janet S, 2002, Oncol Nurs Forum, V29, pE16, DOI 10.1188/02.ONF.E16-E25; Carpenter JS, 1998, CANCER-AM CANCER SOC, V82, P1682, DOI 10.1002/(SICI)1097-0142(19980501)82:9<1682::AID-CNCR14>3.3.CO;2-8; Charalambous C, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-238; COLE MP, 1971, BRIT J CANCER, V25, P270, DOI 10.1038/bjc.1971.33; COUZI RJ, 1995, J CLIN ONCOL, V13, P2737, DOI 10.1200/JCO.1995.13.11.2737; Dekkers OM, 2010, PITUITARY, V13, P195, DOI 10.1007/s11102-009-0214-y; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; GINSBURG J, 1981, BRIT J OBSTET GYNAEC, V88, P925, DOI 10.1111/j.1471-0528.1981.tb02230.x; Goetz MP, 2007, BREAST CANCER RES TR, V101, P113, DOI 10.1007/s10549-006-9428-0; Graf Maria C, 2003, Clin J Oncol Nurs, V7, P637, DOI 10.1188/03.CJON.637-640; Haddad PM, 2004, DRUGS, V64, P2291, DOI 10.2165/00003495-200464200-00003; Harrington EA, 1998, P NATL ACAD SCI USA, V95, P11945, DOI 10.1073/pnas.95.20.11945; Henry NL, 2008, AM J PSYCHIAT, V165, P1251, DOI 10.1176/appi.ajp.2008.08040482; Huang SM, 2011, J CELL BIOCHEM, V112, P643, DOI 10.1002/jcb.22966; Jin Y, 2005, JNCI-J NATL CANCER I, V97, P30, DOI 10.1093/jnci/dji005; Joffe H, 2007, J CLIN PSYCHIAT, V68, P10; Jordan VC, 2006, EUR J CANCER, V42, P2909, DOI 10.1016/j.ejca.2006.09.012; Jordan VC, 2006, BRIT J PHARMACOL, V147, pS269, DOI 10.1038/sj.bjp.0706399; Kelly CM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c693; KIANG DT, 1977, ANN INTERN MED, V87, P687, DOI 10.7326/0003-4819-87-6-687; Kim R, 2005, CANCER-AM CANCER SOC, V103, P2199, DOI 10.1002/cncr.21029; Kotoh T, 1999, SURGERY, V125, P536, DOI 10.1016/S0039-6060(99)70206-0; KRONENBERG F, 1994, EXP GERONTOL, V29, P319, DOI 10.1016/0531-5565(94)90012-4; Kumari M, 2005, J CLIN EPIDEMIOL, V58, P719, DOI 10.1016/j.jclinepi.2004.09.016; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Li CB, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007474.pub2; Li ZS, 2008, MOL CANCER THER, V7, P3056, DOI 10.1158/1535-7163.MCT-07-2142; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; LOPRINZI CL, 2002, J CLIN ONCOL, V20, P1578; Lu DY, 2013, J CELL PHYSIOL, V228, P563, DOI 10.1002/jcp.24163; Lu DY, 2012, PHYTOMEDICINE, V19, P1093, DOI 10.1016/j.phymed.2012.06.010; MacDowell KS, 2013, INT J NEUROPSYCHOPH, V16, P121, DOI 10.1017/S1461145711001775; Mas S, 2012, PHARMACOGENOMICS J, V12, P255, DOI 10.1038/tpj.2010.91; Masamha CP, 2009, CANCER RES, V69, P6565, DOI 10.1158/0008-5472.CAN-09-0913; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Mom CH, 2006, CRIT REV ONCOL HEMAT, V57, P63, DOI 10.1016/j.critrevonc.2005.04.009; Mooney LM, 2002, BRIT J CANCER, V87, P909, DOI 10.1038/sj.bjc.6600541; Muly EC, 2012, J PHARMACOL EXP THER, V341, P81, DOI 10.1124/jpet.111.189076; Myong NH, 2009, KOREAN J PATHOL, V43, P56, DOI 10.4132/KoreanJPathol.2009.43.1.56; OSBORNE CK, 1985, CANCER RES, V45, P584; Pritchard KI, 2001, ONCOLOGIST, V6, P353, DOI 10.1634/theoncologist.6-4-353; Ray A, 1996, BRIT MED J, V313, P1484, DOI 10.1136/bmj.313.7070.1484b; Rixe O, 2007, CLIN CANCER RES, V13, P7280, DOI 10.1158/1078-0432.CCR-07-2141; Ruddy Jean Marie B., 2002, Journal of Biomedicine and Biotechnology, V2, P7, DOI 10.1155/S1110724302000359; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Schotte A, 1996, PSYCHOPHARMACOLOGY, V124, P57, DOI 10.1007/BF02245606; Singh MS, 2011, BREAST, V20, P111, DOI 10.1016/j.breast.2010.11.003; Sloan JA, 2001, J CLIN ONCOL, V19, P4280, DOI 10.1200/JCO.2001.19.23.4280; Stathopoulos GP, 2013, J BUON, V18, P532; Stearns V, 2003, JNCI-J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Stearns V, 2002, J CLIN ONCOL, V20, P1436, DOI 10.1200/JCO.2002.20.6.1436; TAYLOR IW, 1983, CANCER RES, V43, P4007; Travis MJ, 1998, BRIT J PSYCHIAT, V173, P236, DOI 10.1192/bjp.173.3.236; Tsai CF, 2014, INT J MOL SCI, V15, P3889, DOI 10.3390/ijms15033889; Tsai CF, 2012, INT J MOL SCI, V13, P9877, DOI 10.3390/ijms13089877; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Wang X, 2011, CELL DEATH DIFFER, V18, P38, DOI 10.1038/cdd.2010.68; Weston RT, 2010, ADV EXP MED BIOL, V687, P65; Williams C, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.370; Wu H-M, 2010, TREATMENT HOT FLASHE; Wu H-M, 2010, METHOD TREATING SYMP; Yamaguchi I, 2009, J PHARMACOL EXP THER, V328, P256, DOI 10.1124/jpet.108.141895; Yeh WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060889; Yeh WL, 2012, J CELL PHYSIOL, V227, P558, DOI 10.1002/jcp.22746	73	20	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98805	10.1371/journal.pone.0098805	http://dx.doi.org/10.1371/journal.pone.0098805			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886861	Green Submitted, gold, Green Published			2022-12-25	WOS:000336956300110
J	Kuo, MW; Lou, SW; Chung, BC				Kuo, Ming-Wei; Lou, Show-Wan; Chung, Bon-chu			Hedgehog-PKA Signaling and gnrh3 Regulate the Development of Zebrafish gnrh3 Neurons	PLOS ONE			English	Article							ONTOGENIC DEVELOPMENT; HORMONE NEURONS; EMBRYONIC-DEVELOPMENT; KALLMANN-SYNDROME; NEURAL CREST; DANIO-RERIO; EXPRESSION; BRAIN; GENE; INDUCTION	GnRH neurons secrete GnRH that controls the development of the reproduction system. Despite many studies, the signals controlling the development of GnRH neurons from its progenitors have not been fully established. To understand the development of GnRH neurons, we examined the development of gnrh3-expressing cells using a transgenic zebrafish line that expresses green fluorescent protein (GFP) and LacZ driven by the gnrh3 promoter. GFP and LacZ expression recapitulated that of gnrh3 in the olfactory region, olfactory bulb and telencephalon. Depletion of gnrh3 by morpholinos led to a reduction of GFP- and gnrh3-expressing cells, while over-expression of gnrh3 mRNA increased the number of these cells. This result indicates a positive feed-forward regulation of gnrh3 cells by gnrh3. The gnrh3 cells were absent in embryos that lack Hedgehog signaling, but their numbers were increased in embryos overexpressing shhb. We manipulated the amounts of kinase that antagonizes the Hedgehog signaling pathway, protein kinase A (PKA), by treating embryos with PKA activator forskolin or by injecting mRNAs encoding its constitutively active catalytic subunit (PKA*) and dominant negative regulatory subunit (PKI) into zebrafish embryos. PKA* misexpression or forskolin treatment decreased GFP cell numbers, while PKI misexpression led to ectopic production of GFP cells. Our data indicate that the Hedgehog-PKA pathway participates in the development of gnrh3-expressing neurons during embryogenesis.	[Kuo, Ming-Wei; Chung, Bon-chu] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Kuo, Ming-Wei; Lou, Show-Wan] Natl Taiwan Univ, Inst Fisheries Sci, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Chung, BC (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	mbchung@sinica.edu.tw		Chung, Bon-chu/0000-0002-8612-0219	National Science Council [NSC 102-2923-B-001-003-MY3]; NHRI [NHRI- EX102-10210SI]; Academia Sinica, Republic of China [AS-101-TP-B05]	National Science Council(Ministry of Science and Technology, Taiwan); NHRI(National Health Research Institutes - Taiwan); Academia Sinica, Republic of China(Academia Sinica - Taiwan)	This work was supported by grants NSC 102-2923-B-001-003-MY3 from the National Science Council, NHRI- EX102-10210SI from NHRI, and AS-101-TP-B05 from Academia Sinica, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2008, J NEUROENDOCRINOL, V20, P394, DOI 10.1111/j.1365-2826.2008.01654.x; Abraham E, 2010, ENDOCRINOLOGY, V151, P332, DOI 10.1210/en.2009-0548; AGUZZI A, 1994, HISTOCHEMISTRY, V102, P477, DOI 10.1007/BF00269579; Ahlgren SC, 1999, CURR BIOL, V9, P1304, DOI 10.1016/S0960-9822(00)80052-4; Amano M, 2004, ZOOL SCI, V21, P311, DOI 10.2108/zsj.21.311; Amano M, 1998, CELL TISSUE RES, V293, P427, DOI 10.1007/s004410051134; Balmer CW, 2004, J COMP NEUROL, V472, P292, DOI 10.1002/cne.20053; Barnett DK, 2006, ENDOCRINOLOGY, V147, P615, DOI 10.1210/en.2005-0662; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Berghard A, 2012, FASEB J, V26, P3464, DOI 10.1096/fj.12-206193; CHIBA A, 1994, NEUROSCI LETT, V178, P51, DOI 10.1016/0304-3940(94)90287-9; Cornesse Y, 2005, DEV BIOL, V277, P296, DOI 10.1016/j.ydbio.2004.09.016; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Gill JC, 2004, ENDOCRINOLOGY, V145, P3830, DOI 10.1210/en.2004-0214; Gonzalez-Martinez D, 2002, J CHEM NEUROANAT, V23, P255, DOI 10.1016/S0891-0618(02)00004-2; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; Kramer PR, 2000, DEV BIOL, V227, P343, DOI 10.1006/dbio.2000.9896; Kuo MW, 2005, J BIOMED SCI, V12, P629, DOI 10.1007/s11373-005-7457-z; LaMantia AS, 2000, NEURON, V28, P411, DOI 10.1016/S0896-6273(00)00121-5; Litsiou A, 2005, DEVELOPMENT, V132, P4051, DOI 10.1242/dev.01964; MASON AJ, 1986, SCIENCE, V234, P1366, DOI 10.1126/science.3024317; Meng AM, 1999, DEVELOPMENT, V126, P1259; Ogawa S, 2006, NEUROSCI LETT, V403, P201, DOI 10.1016/j.neulet.2006.02.041; Okubo K, 2006, ENDOCRINOLOGY, V147, P1076, DOI 10.1210/en.2005-0468; Palevitch O, 2010, GEN COMP ENDOCR, V165, P262, DOI 10.1016/j.ygcen.2009.07.001; PARHAR IS, 1995, J COMP NEUROL, V362, P256, DOI 10.1002/cne.903620208; Ramakrishnan S, 2010, GEN COMP ENDOCR, V168, P401, DOI 10.1016/j.ygcen.2010.05.009; Romanelli RG, 2004, J BIOL CHEM, V279, P117, DOI 10.1074/jbc.M307955200; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; Schier AF, 1997, DEVELOPMENT, V124, P327; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; Streit A, 2004, DEV BIOL, V276, P1, DOI 10.1016/j.ydbio.2004.08.037; Tong SK, 2001, J STEROID BIOCHEM, V79, P299, DOI 10.1016/S0960-0760(01)00146-7; Toro S, 2007, SEMIN CELL DEV BIOL, V18, P534, DOI 10.1016/j.semcdb.2007.04.003; Tsai PS, 2005, MOL ENDOCRINOL, V19, P225, DOI 10.1210/me.2004-0330; Uchida H, 2005, J NEUROBIOL, V65, P1, DOI 10.1002/neu.20156; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Whitlock KE, 2003, DEV BIOL, V257, P140, DOI 10.1016/S0012-1606(03)00039-3; Whitlock KE, 2005, TRENDS ENDOCRIN MET, V16, P145, DOI 10.1016/j.tem.2005.03.005; Zhang WS, 2005, DEV CELL, V8, P267, DOI 10.1016/j.devcel.2005.01.001	41	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e95545	10.1371/journal.pone.0095545	http://dx.doi.org/10.1371/journal.pone.0095545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879419	Green Submitted, Green Published, gold			2022-12-25	WOS:000338101500003
J	Lund, AM; Kildegaard, HF; Petersen, MBK; Rank, J; Hansen, BG; Andersen, MR; Mortensen, UH				Lund, Anne Mathilde; Kildegaard, Helene Faustrup; Petersen, Maja Borup Kjaer; Rank, Julie; Hansen, Bjarne Gram; Andersen, Mikael Rordam; Mortensen, Uffe Hasbro			A Versatile System for USER Cloning-Based Assembly of Expression Vectors for Mammalian Cell Engineering	PLOS ONE			English	Article							GENE; TRANSMEMBRANE; SUFFICIENT; SEQUENCES; FUSION; MUSCLE; SIGNAL	A new versatile mammalian vector system for protein production, cell biology analyses, and cell factory engineering was developed. The vector system applies the ligation-free uracil-excision based technique - USER cloning - to rapidly construct mammalian expression vectors of multiple DNA fragments and with maximum flexibility, both for choice of vector backbone and cargo. The vector system includes a set of basic vectors and a toolbox containing a multitude of DNA building blocks including promoters, terminators, selectable marker- and reporter genes, and sequences encoding an internal ribosome entry site, cellular localization signals and epitope-and purification tags. Building blocks in the toolbox can be easily combined as they contain defined and tested Flexible Assembly Sequence Tags, FASTs. USER cloning with FASTs allows rapid swaps of gene, promoter or selection marker in existing plasmids and simple construction of vectors encoding proteins, which are fused to fluorescence-, purification-, localization-, or epitope tags. The mammalian expression vector assembly platform currently allows for the assembly of up to seven fragments in a single cloning step with correct directionality and with a cloning efficiency above 90%. The functionality of basic vectors for FAST assembly was tested and validated by transient expression of fluorescent model proteins in CHO, U-2-OS and HEK293 cell lines. In this test, we included many of the most common vector elements for heterologous gene expression in mammalian cells, in addition the system is fully extendable by other users. The vector system is designed to facilitate high-throughput genome-scale studies of mammalian cells, such as the newly sequenced CHO cell lines, through the ability to rapidly generate high-fidelity assembly of customizable gene expression vectors.	[Lund, Anne Mathilde; Petersen, Maja Borup Kjaer; Rank, Julie; Hansen, Bjarne Gram; Andersen, Mikael Rordam; Mortensen, Uffe Hasbro] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Kildegaard, Helene Faustrup] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Horsholm, Denmark	Technical University of Denmark; Technical University of Denmark	Andersen, MR (corresponding author), Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark.	mr@bio.dtu.dk	Andersen, Mikael R/F-9377-2013; Mortensen, Uffe/AAQ-1150-2021; Andersen, Mikael Rørdam/P-6743-2019	Andersen, Mikael R/0000-0003-4794-6808; Andersen, Mikael Rørdam/0000-0003-4794-6808; Nyman Kjaer, Maja/0000-0003-0944-6175; Kildegaard, Helene Faustrup/0000-0003-3727-5721	Lundbeck foundation; Novo Nordisk Foundation; Lundbeck Foundation [R34-2009-3625] Funding Source: researchfish; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [CHO Cell Line Engineering & Design] Funding Source: researchfish	Lundbeck foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability	H. F. K. thanks the Lundbeck foundation and the Novo Nordisk Foundation for financial support. J.R. and A. M. L. thank Novozymes, Bavarian Nordic, ALK-Abello, DNA Technology, Integrated DNA Technologies, Pharma Denmark and the Lundbeck Foundation for financial support during the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bitinaite J, 2007, NUCLEIC ACIDS RES, V35, P1992, DOI 10.1093/nar/gkm041; BURKE J, 1992, J BIOL CHEM, V267, P24433; Durocher Y, 2000, ANAL BIOCHEM, V284, P316, DOI 10.1006/abio.2000.4698; Ellis T, 2011, INTEGR BIOL-UK, V3, P109, DOI 10.1039/c0ib00070a; FLIEGEL L, 1989, J BIOL CHEM, V264, P21522; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; GRAY PW, 1982, NATURE, V295, P503, DOI 10.1038/295503a0; GRAY PW, 1982, NATURE, V298, P859, DOI 10.1038/298859a0; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; Hansen BG, 2011, APPL ENVIRON MICROB, V77, P3044, DOI 10.1128/AEM.01768-10; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Lewis NE, 2013, NAT BIOTECHNOL, V31, P759, DOI 10.1038/nbt.2624; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; MUNRO S, 1991, EMBO J, V10, P3577, DOI 10.1002/j.1460-2075.1991.tb04924.x; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Nour-Eldin HH, 2010, METHODS MOL BIOL, V643, P185, DOI 10.1007/978-1-60761-723-5_13; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; ROTH J, 1982, J CELL BIOL, V93, P223, DOI 10.1083/jcb.93.1.223; Smith T, 2000, ARCH BIOCHEM BIOPHYS, V375, P195, DOI 10.1006/abbi.1999.1659; TATE SS, 1990, FASEB J, V4, P227, DOI 10.1096/fasebj.4.2.2298343; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917; Wurm FM, 2011, NAT BIOTECHNOL, V29, P718, DOI 10.1038/nbt.1943; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; ZHOU MY, 1995, BIOTECHNIQUES, V19, P34	30	20	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e96693	10.1371/journal.pone.0096693	http://dx.doi.org/10.1371/journal.pone.0096693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879460	Green Published, Green Submitted, gold			2022-12-25	WOS:000338101500008
J	Maiwald, S; Sivapalaratnam, S; Motazacker, MM; van Capelleveen, JC; Bot, I; de Jager, SC; van Eck, M; Jolley, J; Kuiper, J; Stephens, J; Albers, CA; Vosmeer, CR; Kruize, H; Geerke, DP; van der Wal, AC; van der Loos, CM; Kastelein, JJP; Trip, MD; Ouwehand, WH; Dallinga-Thie, GM; Hovingh, GK				Maiwald, Stephanie; Sivapalaratnam, Suthesh; Motazacker, Mahdi M.; van Capelleveen, Julian C.; Bot, Ilze; de Jager, Saskia C.; van Eck, Miranda; Jolley, Jennifer; Kuiper, Johan; Stephens, Jonathon; Albers, Cornelius A.; Vosmeer, C. Ruben; Kruize, Heleen; Geerke, Daan P.; van der Wal, Allard C.; van der Loos, Chris M.; Kastelein, John J. P.; Trip, Mieke D.; Ouwehand, Willem H.; Dallinga-Thie, Geesje M.; Hovingh, G. Kees			Mutation in KERA Identified by Linkage Analysis and Targeted Resequencing in a Pedigree with Premature Atherosclerosis	PLOS ONE			English	Article							RECEPTOR-DEFICIENT MICE; CORONARY-ARTERY-DISEASE; RECESSIVE CORNEA PLANA; MYOCARDIAL-INFARCTION; RISK-FACTORS; SUSCEPTIBILITY; LOCUS; MEF2A; ACCUMULATION; ASSOCIATION	Aims: Genetic factors explain a proportion of the inter-individual variation in the risk for atherosclerotic events, but the genetic basis of atherosclerosis and atherothrombosis in families with Mendelian forms of premature atherosclerosis is incompletely understood. We set out to unravel the molecular pathology in a large kindred with an autosomal dominant inherited form of premature atherosclerosis. Methods and Results: Parametric linkage analysis was performed in a pedigree comprising 4 generations, of which a total of 11 members suffered from premature vascular events. A parametric LOD-score of 3.31 was observed for a 4.4 Mb interval on chromosome 12. Upon sequencing, a non-synonymous variant in KERA (c. 920C. G; p. Ser307Cys) was identified. The variant was absent from nearly 28,000 individuals, including 2,571 patients with premature atherosclerosis. KERA, a proteoglycan protein, was expressed in lipid-rich areas of human atherosclerotic lesions, but not in healthy arterial specimens. Moreover, KERA expression in plaques was significantly associated with plaque size in a carotid-collar Apoe 2/2 mice (r(2) = 0.69; p, 0.0001). Conclusion: A rare variant in KERA was identified in a large kindred with premature atherosclerosis. The identification of KERA in atherosclerotic plaque specimen in humans and mice lends support to its potential role in atherosclerosis.	[Maiwald, Stephanie; Sivapalaratnam, Suthesh; van Capelleveen, Julian C.; Kastelein, John J. P.; Trip, Mieke D.; Dallinga-Thie, Geesje M.; Hovingh, G. Kees] Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Maiwald, Stephanie; Motazacker, Mahdi M.; Dallinga-Thie, Geesje M.] Acad Med Ctr, Dept Expt Vasc Med, Amsterdam, Netherlands; [Bot, Ilze; de Jager, Saskia C.; van Eck, Miranda; Kuiper, Johan] Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, Leiden, Netherlands; [Jolley, Jennifer; Stephens, Jonathon; Albers, Cornelius A.; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England; [Jolley, Jennifer; Stephens, Jonathon; Albers, Cornelius A.; Ouwehand, Willem H.] Natl Hlth Serv Blood & Transplant, Cambridge, England; [Vosmeer, C. Ruben; Kruize, Heleen; Geerke, Daan P.] Vrije Univ Amsterdam, Dept Chem & Pharmaceut Sci, Div Mol & Computat Toxicol, Amsterdam Inst Mol Med & Syst, Amsterdam, Netherlands; [van der Wal, Allard C.; van der Loos, Chris M.] Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Bot, Ilze; de Jager, Saskia C.; van Eck, Miranda; Kuiper, Johan] Wellcome Trust Sanger Inst, Dept Human Genet, Hinxton, Cambs, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC; University of Cambridge; NHS Blood & Transplant (NHSBT); Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Wellcome Trust Sanger Institute	Dallinga-Thie, GM (corresponding author), Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands.	g.m.dallinga@amc.nl; g.k.hovingh@amc.nl	Kastelein, John/AAF-7950-2020; Vosmeer, Ruben/H-2025-2014; de+Jager, Saskia/AAE-1132-2022; de+Jager, Saskia/ABC-4264-2020; Geerke, Daan/A-1839-2015	Geerke, Daan/0000-0002-5262-6166; van Eck, Miranda/0000-0003-3936-3194; de Jager, Saskia/0000-0002-5233-0066; Ouwehand, Willem/0000-0002-7744-1790; Bot, Ilze/0000-0002-1242-1959; van der Wal, Allard/0000-0001-5590-3758; dallinga-thie, geesje/0000-0001-5412-5923; Stephens, Jonathan/0000-0003-2020-9330	Marie-Curie NetSim ITN grant from the European Commission 7th Framework Programme [EC-215820]; Ipse Movet; ATHEROS; Fondation LeDucq; Dutch Heart Foundation [2010T082]; National Institute for Health Research (NIHR) [RP-PG-0310-1002]; British Heart Foundation [RG/09/12/28096]; European Commission and the Medical Research Council; Netherlands Organisation for Scientific Research (NWO) [91612122]; CardioVascular Research Initiative [CVON2011-19]; European Union; British Heart Foundation [RG/09/012/28096] Funding Source: researchfish; National Institute for Health Research [RP-PG-0310-1002, NF-SI-0513-10151, NF-SI-0510-10214] Funding Source: researchfish	Marie-Curie NetSim ITN grant from the European Commission 7th Framework Programme; Ipse Movet; ATHEROS; Fondation LeDucq(Leducq Foundation); Dutch Heart Foundation(Netherlands Heart Foundation); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); European Commission and the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); CardioVascular Research Initiative; European Union(European Commission); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	SM has been supported by the Marie-Curie NetSim ITN grant [grant number EC-215820] from the European Commission 7th Framework Programme and Ipse Movet. SS is supported by a grant from ATHEROS. MMM is supported by Fondation LeDucq (Transatlantic Network, 2009-2014). MvE is an Established Investigator [2007T056] of the Dutch Heart Foundation. JJPK is a recipient of the Lifetime Achievement Award of the Dutch Heart Foundation [2010T082]. Research in WHO group is supported by programme grants from the National Institute for Health Research (NIHR) (RP-PG-0310-1002), from the British Heart Foundation [RG/09/12/28096], from the European Commission and the Medical Research Council. The project made use of NHS Blood and Transplant donors from the Cambridge BioResource (http://www.cambridgebioresource.org.uk/). This local resource for genotype-phenotype association studies is supported by a grant from the NIHR to the Cambridge Biomedical Research Centre. GKH is holder of a Veni grant [91612122] from the Netherlands Organisation for Scientific Research (NWO). This work is supported by CardioVascular Research Initiative [CVON2011-19; Genius] and the European Union [Resolve: FP7-305707' TransCard: FP7603091- 2]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldave AJ, 2007, OPHTHALMIC GENET, V28, P57, DOI 10.1080/13816810701351321; [Anonymous], 2010, NATURE, V467, P1061, DOI DOI 10.1038/NATURE09534; Boisvert WA, 2006, AM J PATHOL, V168, P1385, DOI 10.2353/ajpath.2006.040748; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Carlson EC, 2007, J BIOL CHEM, V282, P35502, DOI 10.1074/jbc.M705823200; Carlson EC, 2010, J LEUKOCYTE BIOL, V88, P517, DOI 10.1189/jlb.0310134; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Dudakova L, 2014, OPHTHALMIC GENET, V35, P252, DOI 10.3109/13816810.2013.811272; Erdmann J, 2013, NATURE, V504, P432, DOI 10.1038/nature12722; Forsius H, 1998, ACTA OPHTHALMOL SCAN, V76, P196, DOI 10.1034/j.1600-0420.1998.760215.x; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Guella I, 2009, CIRC-CARDIOVASC GENE, V2, P165, DOI 10.1161/CIRCGENETICS.108.819326; Hauser ER, 2003, AM HEART J, V145, P602, DOI 10.1067/mhj.2003.13; Huijgen Roeland, 2008, Expert Rev Cardiovasc Ther, V6, P567, DOI 10.1586/14779072.6.4.567; Keramati AR, 2011, P NATL ACAD SCI USA, V108, P1914, DOI 10.1073/pnas.1019443108; Khan Arif, 2004, Ophthalmic Genet, V25, P147, DOI 10.1080/13816810490514397; Khan AO, 2006, OPHTHALMOLOGY, V113, P1773, DOI 10.1016/j.ophtha.2006.04.026; Lee K, 2012, EUR J PREV CARDIOL, V19, P1161, DOI 10.1177/1741826711422763; Lieb W, 2008, CIRCULATION, V117, P185, DOI 10.1161/CIRCULATIONAHA.107.728485; Liskova P, 2007, MOL VIS, V13, P1339; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031406, 10.1371/journal.pone.0048083]; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Scott PG, 2004, P NATL ACAD SCI USA, V101, P15633, DOI 10.1073/pnas.0402976101; Sivapalaratnam S, 2010, HEART, V96, P1985, DOI 10.1136/hrt.2010.210740; Surendran RP, 2012, J INTERN MED, V272, P185, DOI 10.1111/j.1365-2796.2012.02516.x; Vergeer M, 2010, CIRCULATION, V122, P470, DOI 10.1161/CIRCULATIONAHA.109.912519; von der Thusen JH, 2001, CIRCULATION, V103, P1164, DOI 10.1161/01.CIR.103.8.1164; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; Wang Q, 2004, AM J HUM GENET, V74, P262, DOI 10.1086/381560; Wentz-Hunter K, 2001, MOL MED, V7, P470, DOI 10.1007/BF03401852; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174; Zhou Z, 2011, CELL METAB, V13, P592, DOI 10.1016/j.cmet.2011.02.016	35	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98289	10.1371/journal.pone.0098289	http://dx.doi.org/10.1371/journal.pone.0098289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879339	Green Published, gold, Green Submitted			2022-12-25	WOS:000338101500046
J	Pan, HT; Zhu, CL; Zhang, F; Yuan, Y; Zhang, SM; Zhang, WH; Li, CJ; Wang, L; Xia, JL				Pan, Haitao; Zhu, Cailin; Zhang, Feng; Yuan, Ying; Zhang, Shemin; Zhang, Wenhong; Li, Chanjuan; Wang, Ling; Xia, Jielai			The Continual Reassessment Method for Multiple Toxicity Grades: A Bayesian Model Selection Approach	PLOS ONE			English	Article								Grade information has been considered in Yuan et al. (2007) wherein they proposed a Quasi-CRM method to incorporate the grade toxicity information in phase I trials. A potential problem with the Quasi-CRM model is that the choice of skeleton may dramatically vary the performance of the CRM model, which results in similar consequences for the Quasi-CRM model. In this paper, we propose a new model by utilizing bayesian model selection approach - Robust Quasi-CRM model - to tackle the above-mentioned pitfall with the Quasi-CRM model. The Robust Quasi-CRM model literally inherits the BMA-CRM model proposed by Yin and Yuan (2009) to consider a parallel of skeletons for Quasi-CRM. The superior performance of Robust Quasi-CRM model was demonstrated by extensive simulation studies. We conclude that the proposed method can be freely used in real practice.	[Pan, Haitao; Zhang, Shemin; Zhang, Wenhong] Xian Univ Finance & Econ, Sch Stat, Xian, Peoples R China; [Zhu, Cailin] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Dept Gastrointestinal Surg, Xian 710032, Peoples R China; [Zhang, Feng] Shandong Univ, Shandong Prov Hosp, Dept Hematol, Jinan 250100, Peoples R China; [Yuan, Ying] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Li, Chanjuan; Wang, Ling; Xia, Jielai] Fourth Mil Med Univ, Dept Hlth Stat, Xian 710032, Peoples R China	Xi'an University of Finance & Economics; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of Texas System; UTMD Anderson Cancer Center; Air Force Military Medical University	Li, CJ (corresponding author), Fourth Mil Med Univ, Dept Hlth Stat, Xian 710032, Peoples R China.	chanjuanli@sohu.com; medstat@gmail.com; jielaixia@yahoo.com	Pan, Haitao/N-2529-2018	Pan, Haitao/0000-0003-4457-7349	National Science Foundation of China [81302513, 81273176, 81001290, 81302509, 11XTJ003]; Teaching Research Project of Xi'an University of Finance and Economics [13xcj41]; Research Project of Xi'an University of Finance and Economics [13JD01]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Teaching Research Project of Xi'an University of Finance and Economics; Research Project of Xi'an University of Finance and Economics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Haitao Pan's work was partially supported by Research Grant 81302513 from National Science Foundation of China, Teaching Research Project of Xi'an University of Finance and Economics (13xcj41), and Research Project of Xi'an University of Finance and Economics (13JD01). Dr. Jielai Xia's work was partially supported by Research Grant 81273176 and 81001290 from National Science Foundation of China. Dr. Ling Wang's work was partially supported by Research Grant 81302509 from National Science Foundation of China. Dr. Wenhong Zhang's work was partially supported by National Social Science Foundation of China 11XTJ003. No other additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekele BN, 2004, J AM STAT ASSOC, V99, P26, DOI 10.1198/016214504000000043; GOURIEROUX C, 1984, ECONOMETRICA, V52, P681, DOI 10.2307/1913471; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Ji YA, 2010, CLIN TRIALS, V7, P653, DOI 10.1177/1740774510382799; McCullagh P, 1989, GEN LINEAR MODELS; OQUIGLEY J, 1990, BIOMETRICS, V46, P33, DOI 10.2307/2531628; Pan HT, 2014, CLIN TRIALS, V11, P49, DOI 10.1177/1740774513500081; Papke LE, 1996, J APPL ECONOM, V11, P619, DOI 10.1002/(SICI)1099-1255(199611)11:6<619::AID-JAE418>3.0.CO;2-1; Raftery AE, 1997, J AM STAT ASSOC, V92, P179, DOI 10.2307/2291462; Van Meter EM, 2012, CLIN TRIALS, V9, P303, DOI 10.1177/1740774512443593; Yin GS, 2009, J AM STAT ASSOC, V104, P954, DOI 10.1198/jasa.2009.ap08425; Yuan Z, 2007, BIOMETRICS, V63, P173, DOI 10.1111/j.1541-0420.2006.00666.x	12	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98147	10.1371/journal.pone.0098147	http://dx.doi.org/10.1371/journal.pone.0098147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875783	gold, Green Published, Green Submitted			2022-12-25	WOS:000336790800025
J	Pearcey, GEP; Power, KE; Button, DC				Pearcey, Gregory E. P.; Power, Kevin E.; Button, Duane C.			Differences in Supraspinal and Spinal Excitability during Various Force Outputs of the Biceps Brachii in Chronic- and Non-Resistance Trained Individuals	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CROSS-SECTIONAL AREA; MOTONEURONS IN-VIVO; MOTOR UNIT BEHAVIOR; LOWER-LIMB MUSCLES; VOLUNTARY CONTRACTIONS; NEURAL ADAPTATIONS; CORTICOSPINAL STIMULATION; FATIGUING CONTRACTION; SYSTEMATIC VARIATIONS	Motor evoked potentials (MEP) and cervicomedullary evoked potentials (CMEP) may help determine the corticospinal adaptations underlying chronic resistance training-induced increases in voluntary force production. The purpose of the study was to determine the effect of chronic resistance training on corticospinal excitability (CE) of the biceps brachii during elbow flexion contractions at various intensities and the CNS site (i.e. supraspinal or spinal) predominantly responsible for any training-induced differences in CE. Fifteen male subjects were divided into two groups: 1) chronic resistance-trained (RT), (n = 8) and 2) non-RT, (n = 7). Each group performed four sets of,5 s elbow flexion contractions of the dominant arm at 10 target forces (from 10%-100% MVC). During each contraction, subjects received 1) transcranial magnetic stimulation, 2) transmastoid electrical stimulation and 3) brachial plexus electrical stimulation, to determine MEP, CMEP and compound muscle action potential (M-max) amplitudes, respectively, of the biceps brachii. All MEP and CMEP amplitudes were normalized to M-max. MEP amplitudes were similar in both groups up to 50% MVC, however, beyond 50% MVC, MEP amplitudes were lower in the chronic RT group (p<0.05). CMEP amplitudes recorded from 10-100% MVC were similar for both groups. The ratio of MEP amplitude/absolute force and CMEP amplitude/absolute force were reduced (p<0.012) at all contraction intensities from 10-100% MVC in the chronic-RT compared to the non-RT group. In conclusion, chronic resistance training alters supraspinal and spinal excitability. However, adaptations in the spinal cord (i.e. motoneurone) seem to have a greater influence on the altered CE.	[Pearcey, Gregory E. P.; Power, Kevin E.; Button, Duane C.] Mem Univ Newfoundland, Sch Human Kinet & Recreat, St John, NF, Canada; [Button, Duane C.] Mem Univ Newfoundland, Fac Med, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Button, DC (corresponding author), Mem Univ Newfoundland, Sch Human Kinet & Recreat, St John, NF, Canada.	dbutton@mun.ca	Behm, David George/I-6509-2019	Behm, David George/0000-0002-9406-6056; Pearcey, Gregory/0000-0002-6751-4351; Power, Kevin/0000-0001-5958-0271	Memorial University start-up grant [208604]	Memorial University start-up grant	This research was supported by a Memorial University start-up grant 208604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2002, J APPL PHYSIOL, V92, P2309, DOI 10.1152/japplphysiol.01185.2001; Beaumont E, 2003, MUSCLE NERVE, V27, P228, DOI 10.1002/mus.10308; Beaumont E, 2002, J PHYSIOL-LONDON, V540, P129, DOI 10.1113/jphysiol.2001.013084; Beck S, 2007, BRAIN RES, V1179, P51, DOI 10.1016/j.brainres.2007.08.048; Button DC, 2006, J PHYSIOL-LONDON, V573, P663, DOI 10.1113/jphysiol.2006.107292; CAROLAN B, 1992, J APPL PHYSIOL, V73, P911, DOI 10.1152/jappl.1992.73.3.911; CARP JS, 1994, J NEUROPHYSIOL, V72, P431, DOI 10.1152/jn.1994.72.1.431; Carroll TJ, 2011, ACTA PHYSIOL, V202, P119, DOI 10.1111/j.1748-1716.2011.02271.x; Carroll TJ, 2009, ACTA PHYSIOL, V197, P161, DOI 10.1111/j.1748-1716.2009.01992.x; Carroll TJ, 2002, J PHYSIOL-LONDON, V544, P641, DOI 10.1113/jphysiol.2002.024463; Carroll TJ, 2001, SPORTS MED, V31, P829, DOI 10.2165/00007256-200131120-00001; Davidson AW, 2010, MUSCLE NERVE, V42, P514, DOI 10.1002/mus.21717; DE LUCA CJ, 1982, J PHYSIOL-LONDON, V329, P113, DOI 10.1113/jphysiol.1982.sp014293; De Luca CJ, 1996, J NEUROPHYSIOL, V76, P1503, DOI 10.1152/jn.1996.76.3.1503; Del Balso C, 2007, J APPL PHYSIOL, V103, P402, DOI 10.1152/japplphysiol.00477.2006; del Olmo MF, 2006, EUR J APPL PHYSIOL, V96, P722, DOI 10.1007/s00421-006-0153-5; Di Lazzaro V, 1998, J PHYSIOL-LONDON, V508, P625; Dragert K, 2013, EXP BRAIN RES, V225, P93, DOI 10.1007/s00221-012-3351-x; Enoka RM, 1997, J BIOMECH, V30, P447, DOI 10.1016/S0021-9290(96)00170-4; Falvo MJ, 2010, EUR J APPL PHYSIOL, V109, P923, DOI 10.1007/s00421-010-1432-8; Folland JP, 2007, SPORTS MED, V37, P145, DOI 10.2165/00007256-200737020-00004; Gandevia SC, 1999, J PHYSIOL-LONDON, V521, P749, DOI 10.1111/j.1469-7793.1999.00749.x; Gardiner P, 2006, J APPL PHYSIOL, V101, P1228, DOI 10.1152/japplphysiol.00482.2006; GARFINKEL S, 1992, MED SCI SPORT EXER, V24, P1220; Gelli F, 2007, EUR J NEUROSCI, V25, P3469, DOI 10.1111/j.1460-9568.2007.05590.x; Goodwill AM, 2012, MUSCLE NERVE, V46, P384, DOI 10.1002/mus.23316; Griffin L, 2007, J ELECTROMYOGR KINES, V17, P446, DOI 10.1016/j.jelekin.2006.05.001; HAKKINEN K, 1983, MED SCI SPORT EXER, V15, P455; Heckman CJ, 2003, EXERC SPORT SCI REV, V31, P96, DOI 10.1097/00003677-200304000-00008; Heckman CJ, 2008, NEUROSCIENTIST; Jensen JL, 2005, J APPL PHYSIOL, V99, P1558, DOI 10.1152/japplphysiol.01408.2004; Jones KE, 1997, J NEUROPHYSIOL, V77, P405, DOI 10.1152/jn.1997.77.1.405; Khan SI, 2012, J PHYSIOL-LONDON, V590, P4957, DOI 10.1113/jphysiol.2012.235697; Kidgell DJ, 2010, J STRENGTH COND RES, V24, P3123, DOI 10.1519/JSC.0b013e3181f56794; Kidgell DJ, 2010, HUM MOVEMENT SCI, V29, P631, DOI 10.1016/j.humov.2010.01.004; Lee RH, 1998, J NEUROPHYSIOL, V80, P572, DOI 10.1152/jn.1998.80.2.572; Lee RH, 1998, J NEUROPHYSIOL, V80, P583, DOI 10.1152/jn.1998.80.2.583; Levenez M, 2008, J NEUROPHYSIOL, V99, P554, DOI 10.1152/jn.00963.2007; MacDonell CW, 2012, J NEUROPHYSIOL, V107, P265, DOI 10.1152/jn.00122.2011; Martin PG, 2008, J PHYSIOL-LONDON, V586, P1277, DOI 10.1113/jphysiol.2007.140426; Martin PG, 2006, J NEUROPHYSIOL, V95, P3512, DOI 10.1152/jn.01230.2005; Martin PG, 2009, J NEUROPHYSIOL, V102, P606, DOI 10.1152/jn.91348.2008; Matthews PBC, 1999, J PHYSIOL-LONDON, V518, P867, DOI 10.1111/j.1469-7793.1999.0867p.x; MAZZOCCHIO R, 1994, J PHYSIOL-LONDON, V474, P261, DOI 10.1113/jphysiol.1994.sp020018; McNeil CJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00152; McNeil CJ, 2011, J PHYSIOL-LONDON, V589, P3533, DOI 10.1113/jphysiol.2011.207191; Narici MV, 1996, ACTA PHYSIOL SCAND, V157, P175, DOI 10.1046/j.1365-201X.1996.483230000.x; OLIVIER E, 1995, J PHYSIOL-LONDON, V485, P257, DOI 10.1113/jphysiol.1995.sp020728; Oya T, 2008, J APPL PHYSIOL, V105, P1527, DOI 10.1152/japplphysiol.90586.2008; Pearcey GEP, 2013, APPL PHYSIOL NUTR ME, V38, P1069; Rossi A, 2012, J NEUROPHYSIOL, V108, P2473, DOI 10.1152/jn.00477.2012; Rossi S, 2011, CLIN NEUROPHYSIOL, V122, P1686, DOI 10.1016/j.clinph.2010.12.037; Tallent J, 2013, J ELECTROMYOGR KINES, V23, P1075, DOI 10.1016/j.jelekin.2013.04.014; Taylor JL, 2006, J ELECTROMYOGR KINES, V16, P215, DOI 10.1016/j.jelekin.2005.07.001; Taylor JL, 2002, J PHYSIOL-LONDON, V541, P949, DOI 10.1113/jphysiol.2002.016782; Tillin NA, 2011, MUSCLE NERVE, V43, P375, DOI 10.1002/mus.21885; Ugawa Y, 1995, ELECTROMYOGR MOTOR C, V97, P451, DOI 10.1016/0924-980X(95)00214-6; UGAWA Y, 1991, ANN NEUROL, V29, P418, DOI 10.1002/ana.410290413; Van Cutsem M, 1998, J PHYSIOL-LONDON, V513, P295, DOI 10.1111/j.1469-7793.1998.295by.x; Vila-Cha C, 2010, J APPL PHYSIOL, V109, P1455, DOI 10.1152/japplphysiol.01213.2009; Weier AT, 2012, ACTA PHYSIOL, V206, P109, DOI 10.1111/j.1748-1716.2012.02454.x	61	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98468	10.1371/journal.pone.0098468	http://dx.doi.org/10.1371/journal.pone.0098468			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875495	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000336790800042
J	Pearson, T; Kabayo, T; Ng, R; Chamberlain, J; McArdle, A; Jackson, MJ				Pearson, Timothy; Kabayo, Tabitha; Ng, Rainer; Chamberlain, Jeffrey; McArdle, Anne; Jackson, Malcolm J.			Skeletal Muscle Contractions Induce Acute Changes in Cytosolic Superoxide, but Slower Responses in Mitochondrial Superoxide and Cellular Hydrogen Peroxide	PLOS ONE			English	Article							NITRIC-OXIDE; INTRACELLULAR SUPEROXIDE; OXIDATIVE STRESS; RELEASE; PRODUCT; DIHYDROETHIDIUM; HYDROETHIDINE; FLUORESCENCE; GENERATION; ETHIDIUM	Skeletal muscle generation of reactive oxygen species (ROS) is increased following contractile activity and these species interact with multiple signaling pathways to mediate adaptations to contractions. The sources and time course of the increase in ROS during contractions remain undefined. Confocal microscopy with specific fluorescent probes was used to compare the activities of superoxide in mitochondria and cytosol and the hydrogen peroxide content of the cytosol in isolated single mature skeletal muscle (flexor digitorum brevis) fibers prior to, during, and after electrically stimulated contractions. Superoxide in mitochondria and cytoplasm were assessed using MitoSox red and dihydroethidium (DHE) respectively. The product of superoxide with DHE, 2-hydroxyethidium (2-HE) was acutely increased in the fiber cytosol by contractions, whereas hydroxy-MitoSox showed a slow cumulative increase. Inhibition of nitric oxide synthases increased the contraction-induced formation of hydroxy-MitoSox only with no effect on 2-HE formation. These data indicate that the acute increases in cytosolic superoxide induced by contractions are not derived from mitochondria. Data also indicate that, in muscle mitochondria, nitric oxide (NO) reduces the availability of superoxide, but no effect of NO on cytosolic superoxide availability was detected. To determine the relationship of changes in superoxide to hydrogen peroxide, an alternative specific approach was used where fibers were transduced using an adeno-associated viral vector to express the hydrogen peroxide probe, HyPer within the cytoplasmic compartment. HyPer fluorescence was significantly increased in fibers following contractions, but surprisingly followed a relatively slow time course that did not appear directly related to cytosolic superoxide. These data demonstrate for the first time temporal and site specific differences in specific ROS that occur in skeletal muscle fibers during and after contractile activity.	[Pearson, Timothy; Kabayo, Tabitha; McArdle, Anne; Jackson, Malcolm J.] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England; [Ng, Rainer; Chamberlain, Jeffrey] Univ Washington, Dept Neurol, Seattle, WA 98195 USA	University of Liverpool; University of Washington; University of Washington Seattle	Jackson, MJ (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England.	m.j.jackson@liverpool.ac.uk		Jackson, Malcolm/0000-0003-3683-8297; Pearson, Tim/0000-0002-3653-4421; Chamberlain, Jeffrey/0000-0001-5299-0059	Medical Research Council [G1002120]; National Institutes of Health (NIA) [AG033610]; National Research Services Award from the National Institutes of Health (NINDS) [1F32AR057651]; MRC [MR/K006312/1, G0700919, G1002120] Funding Source: UKRI; Medical Research Council [G0700919, MR/K006312/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057651, R01AR044533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033610] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Research Services Award from the National Institutes of Health (NINDS); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The project was suuported by the Medical Research Council (grant #G1002120). JSC was supported by grant #AG033610 from the National Institutes of Health (NIA). RN was supported by a National Research Services Award from the National Institutes of Health (NINDS, #1F32AR057651). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbogast S, 2004, AM J PHYSIOL-REG I, V287, pR698, DOI 10.1152/ajpregu.00072.2004; Aydin J, 2009, HUM MOL GENET, V18, P278, DOI 10.1093/hmg/ddn355; BALON TW, 1994, J APPL PHYSIOL, V77, P2519, DOI 10.1152/jappl.1994.77.6.2519; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Blankinship MJ, 2004, MOL THER, V10, P671, DOI 10.1016/j.ymthe.2004.07.016; Close GL, 2005, COMP BIOCHEM PHYS A, V142, P257, DOI 10.1016/j.cbpa.2005.08.005; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; Halliwell B, 1989, FREE RADICAL BIOL ME; Hidalgo C, 2006, J BIOL CHEM, V281, P26473, DOI 10.1074/jbc.M600451200; Jackson MJ, 2011, ANTIOXID REDOX SIGN, V15, P2477, DOI 10.1089/ars.2011.3976; Markvicheva KN, 2011, BIOORGAN MED CHEM, V19, P1079, DOI 10.1016/j.bmc.2010.07.014; McArdle A, 2001, AM J PHYSIOL-CELL PH, V280, pC621, DOI 10.1152/ajpcell.2001.280.3.C621; Michaelson LP, 2010, MUSCLE NERVE, V42, P522, DOI 10.1002/mus.21724; Mukhopadhyay P, 2007, BIOCHEM BIOPH RES CO, V358, P203, DOI 10.1016/j.bbrc.2007.04.106; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; Murrant CL, 1999, ACTA PHYSIOL SCAND, V166, P111; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Palomero J, 2008, ANTIOXID REDOX SIGN, V10, P1463, DOI 10.1089/ars.2007.2009; Peshavariya HM, 2007, FREE RADICAL RES, V41, P699, DOI 10.1080/10715760701297354; Pfeiffer S, 1996, BRIT J PHARMACOL, V118, P1433, DOI 10.1111/j.1476-5381.1996.tb15557.x; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Pye D, 2007, J PHYSIOL-LONDON, V581, P309, DOI 10.1113/jphysiol.2006.125930; Rabinowitz JE, 1998, CURR OPIN BIOTECH, V9, P470, DOI 10.1016/S0958-1669(98)80031-1; Robinson KM, 2008, NAT PROTOC, V3, P941, DOI 10.1038/nprot.2008.56; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Sakellanou G-K, 2013, PLOS ONE, V8; Sakellariou GK, 2011, AGING CELL, V10, P749, DOI 10.1111/j.1474-9726.2011.00709.x; Sakellariou GK, 2013, ANTIOXID REDOX SIGN, V18, P603, DOI 10.1089/ars.2012.4623; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; Stamler JS, 2001, PHYSIOL REV, V81, P209, DOI 10.1152/physrev.2001.81.1.209; Sun QA, 2011, P NATL ACAD SCI USA, V108, P16098, DOI 10.1073/pnas.1109546108; Vasilaki A, 2006, MECH AGEING DEV, V127, P830, DOI 10.1016/j.mad.2006.08.004; Vasilaki A, 2006, AGING CELL, V5, P109, DOI 10.1111/j.1474-9726.2006.00198.x; Vasilaki A, 2007, PROTEOM CLIN APPL, V1, P362, DOI 10.1002/prca.200600702; Whiteman M, 2009, METHOD MOL BIOL, V476, P28; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473	38	69	69	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e96378	10.1371/journal.pone.0096378	http://dx.doi.org/10.1371/journal.pone.0096378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875639	Green Published, Green Submitted, gold			2022-12-25	WOS:000336790800002
J	Prabhu, V; Rao, SBS; Fernandes, EM; Rao, ACK; Prasad, K; Mahato, KK				Prabhu, Vijendra; Rao, Satish B. S.; Fernandes, Edward Mark; Rao, Anuradha C. K.; Prasad, Keerthana; Mahato, Krishna K.			Objective Assessment of Endogenous Collagen In Vivo during Tissue Repair by Laser Induced Fluorescence	PLOS ONE			English	Article							SKIN; THERAPY; PROTEOGLYCAN; SPECTROSCOPY; MORPHOLOGY	Collagen, a triple helical protein with the primary role of mechanical function, provides tensile strength to the skin, and plays a pivotal task in tissue repair. During tissue regeneration, collagen level increases gradually and therefore, monitoring of such changes in vivo by laser induced fluorescence was the main objective behind the present study. In order to accomplish this, 15 mm diameter excisional wounds were created on six to eight week old Swiss albino mice. The collagen deposition accelerated upon irradiation of single exposure of 2 J/cm(2) He-Ne laser dose immediately after wounding was recorded by laser induced autofluorescence in vivo along with un-illuminated and un-wounded controls. Autofluorescence spectra were recorded for each animal of the experimental groups on 0, 5, 10, 30, 45 and 60 days post-wounding, by exciting the granulation tissue/skin with 325 nm He-Cd laser. The variations in the average collagen intensities from the granulation tissue/skin of mice were inspected as a function of age and gender. Further, the spectral findings of the collagen synthesis in wound granulation tissue/un-wounded skin tissues were validated by Picro-Sirius red-polarized light microscopy in a blinded manner through image analysis of the respective collagen birefringence. The in vivo autofluorescence studies have shown a significant increase in collagen synthesis in laser treated animals as compared to the un-illuminated controls. Image analysis of the collagen birefringence further authenticated the ability of autofluorescence in the objective monitoring of collagen in vivo. Our results clearly demonstrate the potential of laser induced autofluorescence in the monitoring of collegen synthesis during tissue regeneration, which may have clinical implications.	[Prabhu, Vijendra; Fernandes, Edward Mark; Mahato, Krishna K.] Manipal Univ, Sch Life Sci, Biophys Unit, Manipal, India; [Rao, Satish B. S.] Manipal Univ, Sch Life Sci, Div Radiobiol & Toxicol, Manipal, India; [Fernandes, Edward Mark] Manipal Univ, Sch Life Sci, Div Biotechnol, Manipal, India; [Rao, Anuradha C. K.] Manipal Univ, Dept Pathol, Kasturba Med Coll, Manipal, India; [Prasad, Keerthana] Manipal Univ, Sch Informat Sci, Manipal, India	Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE)	Mahato, KK (corresponding author), Manipal Univ, Sch Life Sci, Biophys Unit, Manipal, India.	kkmahato@gmail.com	Prabhu, Vijendra/F-7469-2014; Fernandes, Edward/GXW-1837-2022; MAHATO, KRISHNA K./H-8205-2015	Prabhu, Vijendra/0000-0001-5927-2180; MAHATO, KRISHNA K./0000-0001-9873-3445; Prasad, Keerthana/0000-0002-4138-6814; Rao Bola Sadashiva, Satish/0000-0002-9631-9731	patronage of DRDO - GOI [DLS/81/48222/LSRB-164/BDB/2008]	patronage of DRDO - GOI	The patronage of DRDO - GOI (Grant No. DLS/81/48222/LSRB-164/BDB/2008, 2008-2011) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimova A, 2009, J PHOTOCH PHOTOBIO B, V96, P178, DOI 10.1016/j.jphotobiol.2009.06.004; American National Standard for Safe Use of Lasers, 1993, Z13611993 ANSI LAS I; Avci P, 2013, SEMIN CUTAN MED SURG, V32, P41; Cavanagh HD, 2000, CORNEA, V19, P712, DOI 10.1097/00003226-200009000-00016; Curtis A, 2011, MOL IMAGING BIOL, V13, P1114, DOI 10.1007/s11307-010-0440-8; Cuttle L, 2005, WOUND REPAIR REGEN, V13, P198, DOI 10.1111/j.1067-1927.2005.130211.x; da Silva Dde F, 2006, J BIOMED OPT, V11; Deka G, 2014, PROC SPIE, V8948, DOI 10.1117/12.2038472; Deka G, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.061222; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Hegde VN, 2011, PHOTOCHEM PHOTOBIOL, V87, P1433, DOI 10.1111/j.1751-1097.2011.00991.x; JUNQUEIRA LCU, 1978, ARCH HISTOL JAPON, V41, P267, DOI 10.1679/aohc1950.41.267; Kamath SD, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2437738; Kiernan JA., 2015, HISTOLOGICAL HISTOCH, P184; Kollias N, 1998, J INVEST DERMATOL, V111, P776, DOI 10.1046/j.1523-1747.1998.00377.x; Korol RM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2714055; KRIEG T, 1985, ARCH DERMATOL RES, V277, P373, DOI 10.1007/BF00509236; Luo T, 2009, LASER PHYS, V19, P478, DOI 10.1134/S1054660X09030219; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Monstrey S, 2008, BURNS, V34, P761, DOI 10.1016/j.burns.2008.01.009; MONTES GS, 1991, MEM I OSWALDO CRUZ, V86, P1; Mostaco-Guidolin LB, 2013, SCI REP-UK, V3, DOI 10.1038/srep02190; Nissi MJ, 2004, J ORTHOP RES, V22, P557, DOI 10.1016/j.orthres.2003.09.008; OLERUD JE, 1995, J SURG RES, V59, P349, DOI 10.1006/jsre.1995.1175; Ooi GJ, 2008, MED PHYS, V35, P2151, DOI 10.1118/1.2890391; PASSARELLA S, 1984, FEBS LETT, V175, P95, DOI 10.1016/0014-5793(84)80577-3; Prabhu V, 2010, PHOTOCHEM PHOTOBIOL, V86, P1364, DOI 10.1111/j.1751-1097.2010.00791.x; Prasad K, 2012, COMPUT METH PROG BIO, V106, P27, DOI 10.1016/j.cmpb.2011.08.004; Razzaque MS, 2003, PATHOL INT, V53, P133, DOI 10.1046/j.1440-1827.2003.01446.x; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; RichardsKortum R, 1996, ANNU REV PHYS CHEM, V47, P555, DOI 10.1146/annurev.physchem.47.1.555; Robles DT, 2007, CLIN DERMATOL, V25, P26, DOI 10.1016/j.clindermatol.2006.09.009; Schaffer CJ, 1996, INT REV CYTOL, V169, P151, DOI 10.1016/S0074-7696(08)61986-5; Schulz R, 2005, BASIC RES CARDIOL, V100, P48, DOI 10.1007/s00395-004-0497-5; SHUSTER S, 1975, BRIT J DERMATOL, V93, P639, DOI 10.1111/j.1365-2133.1975.tb05113.x; Singer AJ, 2007, ACAD EMERG MED, V14, P387, DOI 10.1197/j.aem.2006.11.022; Takeda U, 2002, J INVEST DERMATOL, V119, P678, DOI 10.1046/j.1523-1747.2002.01863.x; UITTO J, 1980, J AM ACAD DERMATOL, V3, P441, DOI 10.1016/S0190-9622(80)80106-X; van Zuijlen PPM, 2003, BURNS, V29, P423, DOI 10.1016/S0305-4179(03)00052-4; Wagnieres GA, 1998, PHOTOCHEM PHOTOBIOL, V68, P603; Walsh AJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116015; Woodruff LD, 2004, PHOTOMED LASER SURG, V22, P241, DOI 10.1089/1549541041438623; Wysocki AB, 1996, INT J DERMATOL, V35, P82, DOI 10.1111/j.1365-4362.1996.tb03266.x	44	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98609	10.1371/journal.pone.0098609	http://dx.doi.org/10.1371/journal.pone.0098609			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874229	Green Published, gold, Green Submitted			2022-12-25	WOS:000336790800050
J	Schramm, AE; Marinazzo, D; Gener, T; Graham, LJ				Schramm, Adrien E.; Marinazzo, Daniele; Gener, Thomas; Graham, Lyle J.			The Touch and Zap Method for In Vivo Whole-Cell Patch Recording of Intrinsic and Visual Responses of Cortical Neurons and Glial Cells	PLOS ONE			English	Article							AUDITORY-CORTEX; CLAMP RECORDINGS; SYNAPTIC INPUTS; MAMMALIAN BRAIN; DIRECTION SELECTIVITY; INTRACRANIAL-PRESSURE; SPREADING DEPRESSION; INFERIOR COLLICULUS; SLEEP OSCILLATIONS; CEREBRAL-CORTEX	Whole-cell patch recording is an essential tool for quantitatively establishing the biophysics of brain function, particularly in vivo. This method is of particular interest for studying the functional roles of cortical glial cells in the intact brain, which cannot be assessed with extracellular recordings. Nevertheless, a reasonable success rate remains a challenge because of stability, recording duration and electrical quality constraints, particularly for voltage clamp, dynamic clamp or conductance measurements. To address this, we describe "Touch and Zap", an alternative method for whole-cell patch clamp recordings, with the goal of being simpler, quicker and more gentle to brain tissue than previous approaches. Under current clamp mode with a continuous train of hyperpolarizing current pulses, seal formation is initiated immediately upon cell contact, thus the "Touch". By maintaining the current injection, whole-cell access is spontaneously achieved within seconds from the cell-attached configuration by a self-limited membrane electroporation, or "Zap", as seal resistance increases. We present examples of intrinsic and visual responses of neurons and putative glial cells obtained with the revised method from cat and rat cortices in vivo. Recording parameters and biophysical properties obtained with the Touch and Zap method compare favourably with those obtained with the traditional blind patch approach, demonstrating that the revised approach does not compromise the recorded cell. We find that the method is particularly well-suited for whole-cell patch recordings of cortical glial cells in vivo, targeting a wider population of this cell type than the standard method, with better access resistance. Overall, the gentler Touch and Zap method is promising for studying quantitative functional properties in the intact brain with minimal perturbation of the cell's intrinsic properties and local network. Because the Touch and Zap method is performed semi-automatically, this approach is more reproducible and less dependent on experimenter technique.	[Schramm, Adrien E.; Marinazzo, Daniele; Gener, Thomas; Graham, Lyle J.] Univ Paris 05, CNRS UMR 8154, INSERM U603, Neurophysiol & New Microscopies Lab, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Graham, LJ (corresponding author), Univ Paris 05, CNRS UMR 8154, INSERM U603, Neurophysiol & New Microscopies Lab, Paris, France.	lyle@biomedicale.univ-paris5.fr	Marinazzo, Daniele/H-4793-2019	Marinazzo, Daniele/0000-0002-9803-0122; gener, thomas/0000-0001-9209-9228	Agence Nationale de Recherche grant (FUNVISYNIN); HFSP grant [RGP0049/2002]; Marie Curie grant	Agence Nationale de Recherche grant (FUNVISYNIN)(French National Research Agency (ANR)); HFSP grant; Marie Curie grant(European Commission)	This work was supported by an Agence Nationale de Recherche grant (FUNVISYNIN) and an HFSP grant (RGP0049/2002) to LJG. AES was also supported in part by a Marie Curie grant to Sophie Deneve and Boris Gutkin (Ecole Normale Superieure Paris). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amzica F, 2002, J NEUROSCI, V22, P1042, DOI 10.1523/JNEUROSCI.22-03-01042.2002; Amzica F, 1999, J NEUROPHYSIOL, V82, P2731, DOI 10.1152/jn.1999.82.5.2731; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; BARTH KNM, 1992, NEUROSURGERY, V30, P138, DOI 10.1227/00006123-199201000-00028; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Cauli Bruno, 2010, Front Neuroenergetics, V2, P9, DOI 10.3389/fnene.2010.00009; COLEMAN PA, 1989, J NEUROPHYSIOL, V61, P218, DOI 10.1152/jn.1989.61.1.218; de Sa VR, 2001, NEUROCOMPUTING, V38, P1651, DOI 10.1016/S0925-2312(01)00525-2; Deweese MR, 2004, J NEUROPHYSIOL, V92, P1840, DOI 10.1152/jn.00197.2004; DeWeese MR, 2007, CURRENT PROTOCOLS NE; EDWARDS FA, 1992, METHOD ENZYMOL, V207, P208; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FERSTER D, 1992, J NEUROSCI, V12, P1262; Furue Hidemasa, 2007, V38, P229; Graham L. J., 2009, DYNAMIC CLAMP PRINCI; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Helmchen F, 2002, EUR J PHARMACOL, V447, P119, DOI 10.1016/S0014-2999(02)01836-8; HUGUENARD JR, 1986, J NEUROPHYSIOL, V56, P1; JAGADEESH B, 1993, SCIENCE, V262, P1901, DOI 10.1126/science.8266083; Jia HB, 2011, NAT PROTOC, V6, P28, DOI 10.1038/nprot.2010.169; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; KARAHASHI Y, 1966, ELECTROEN CLIN NEURO, V20, P600, DOI 10.1016/0013-4694(66)90024-1; KELLY JP, 1974, J PHYSIOL-LONDON, V238, P515, DOI 10.1113/jphysiol.1974.sp010541; Kitamura K, 2008, NAT METHODS, V5, P61, DOI 10.1038/NMETH1150; Kodandaramaiah SB, 2012, NAT METHODS, V9, P585, DOI [10.1038/NMETH.1993, 10.1038/nmeth.1993]; Komai S, 2006, NAT PROTOC, V1, P648, DOI 10.1038/nprot.2006.100; Kramar P, 2007, BIOELECTROCHEMISTRY, V70, P23, DOI 10.1016/j.bioelechem.2006.03.022; Kudo C, 2008, EXP NEUROL, V212, P201, DOI 10.1016/j.expneurol.2008.03.026; LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9; Levy M, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00101; MAEDA M, 1988, J AUTONOM NERV SYST, V25, P155, DOI 10.1016/0165-1838(88)90020-3; Margrie TW, 2003, NEURON, V39, P911, DOI 10.1016/j.neuron.2003.08.012; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Mishima T, 2007, J NEUROSCI METH, V166, P32, DOI 10.1016/j.jneumeth.2007.06.021; Monier C, 2008, J NEUROSCI METH, V169, P323, DOI 10.1016/j.jneumeth.2007.11.008; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Nagtegaal AP, 2010, J NEUROPHYSIOL, V104, P940, DOI 10.1152/jn.00264.2010; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; Penner R, 2009, SINGLE CHANNEL RECOR, P3; Rae JL, 2002, PFLUG ARCH EUR J PHY, V443, P664, DOI 10.1007/s00424-001-0753-1; Rancz EA, 2011, NAT NEUROSCI, V14, P527, DOI 10.1038/nn.2765; REN JQ, 1992, EXP BRAIN RES, V92, P1; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Smith JM, 2006, BIOL REV, V81, P457, DOI 10.1017/S1464793106007081; Straw Andrew D, 2008, Front Neuroinform, V2, P4, DOI 10.3389/neuro.11.004.2008; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Takahashi N, 2012, SCIENCE, V335, P353, DOI 10.1126/science.1210362; Tan AYY, 2011, J NEUROSCI, V31, P12339, DOI 10.1523/JNEUROSCI.2039-11.2011; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Tan ML, 2007, J NEUROPHYSIOL, V98, P443, DOI 10.1152/jn.01273.2006; Varga Z, 2011, P NATL ACAD SCI USA, V108, P15420, DOI 10.1073/pnas.1112355108; Walz W, 2007, PATCH CLAMP ANAL; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; XING P, 1991, NEUROREPORT, V2, P485	62	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97310	10.1371/journal.pone.0097310	http://dx.doi.org/10.1371/journal.pone.0097310			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875855	Green Published, gold, Green Submitted			2022-12-25	WOS:000336790800005
J	Chen, X; Long, H; Gao, P; Deng, GB; Pan, ZF; Liang, JJ; Tang, YW; Tashi, N; Yu, MQ				Chen, Xin; Long, Hai; Gao, Ping; Deng, Guangbing; Pan, Zhifen; Liang, Junjun; Tang, Yawei; Tashi, Nyima; Yu, Maoqun			Transcriptome Assembly and Analysis of Tibetan Hulless Barley (Hordeum vulgare L. var. nudum) Developing Grains, with Emphasis on Quality Properties	PLOS ONE			English	Article							BOUND STARCH SYNTHASE; FULL-LENGTH CDNAS; GENE-EXPRESSION; CEREAL GENOMICS; BETA-GLUCAN; IN-VITRO; RNA-SEQ; IDENTIFICATION; (1,3/1,4)-BETA-D-GLUCAN; ANNOTATION	Background: Hulless barley is attracting increasing attention due to its unique nutritional value and potential health benefits. However, the molecular biology of the barley grain development and nutrient storage are not well understood. Furthermore, the genetic potential of hulless barley has not been fully tapped for breeding. Methodology/Principal Findings: In the present study, we investigated the transcriptome features during hulless barley grain development. Using Illumina paired-end RNA-Sequencing, we generated two data sets of the developing grain transcriptomes from two hulless barley landraces. A total of 13.1 and 12.9 million paired-end reads with lengths of 90 bp were generated from the two varieties and were assembled to 48,863 and 45,788 unigenes, respectively. A combined dataset of 46,485 All-Unigenes were generated from two transcriptomes with an average length of 542 bp, and 36,278 among were annotated with gene descriptions, conserved protein domains or gene ontology terms. Furthermore, sequences and expression levels of genes related to the biosynthesis of storage reserve compounds (starch, protein, and beta-glucan) were analyzed, and their temporal and spatial patterns were deduced from the transcriptome data of cultivated barley Morex. Conclusions/Significance: We established a sequences and functional annotation integrated database and examined the expression profiles of the developing grains of Tibetan hulless barley. The characterization of genes encoding storage proteins and enzymes of starch synthesis and (1-3; 1-4)-beta-D-glucan synthesis provided an overview of changes in gene expression associated with grain nutrition and health properties. Furthermore, the characterization of these genes provides a gene reservoir, which helps in quality improvement of hulless barley.	[Chen, Xin; Long, Hai; Deng, Guangbing; Pan, Zhifen; Liang, Junjun; Yu, Maoqun] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Chen, Xin; Gao, Ping] Sichuan Univ, Coll Life Sci, Chengdu 610064, Sichuan, Peoples R China; [Chen, Xin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Tang, Yawei; Tashi, Nyima] Tibet Acad Agr & Anim Husb Sci, Lhasa, Tibet, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Sichuan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, MQ (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China.	yumaoqun@cib.ac.cn			National Natural Foundation of China [31101150]; West Light Foundation of the Chinese Academy of Sciences; National Science and Technology Supporting Programs [2012BAD03B01]	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); West Light Foundation of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Science and Technology Supporting Programs	This study is supported by National Natural Foundation of China (31101150), the West Light Foundation of the Chinese Academy of Sciences and the National Science and Technology Supporting Programs (2012BAD03B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. National Natural Foundation of China: www.nsfc.gov.cn; Chinese Academy of Sciences: english.cas.cn/; Ministry of National Science and Technology of China: www.most.gov.cn/eng/.	Abdel-Aal E. S. M., 2005, SPECIALTY GRAINS FOO; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asare EK, 2011, J AGR FOOD CHEM, V59, P4743, DOI 10.1021/jf200054e; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Baik BK, 2008, J CEREAL SCI, V48, P233, DOI 10.1016/j.jcs.2008.02.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BHATTY RS, 1993, CEREAL CHEM, V70, P397; BUNCE NAC, 1986, SEED SCI TECHNOL, V14, P419; Burton RA, 2006, SCIENCE, V311, P1940, DOI 10.1126/science.1122975; Burton RA, 2008, PLANT PHYSIOL, V146, P1821, DOI 10.1104/pp.107.114694; Cao HP, 1999, PLANT PHYSIOL, V120, P205, DOI 10.1104/pp.120.1.205; Close TJ, 2004, PLANT PHYSIOL, V134, P960, DOI 10.1104/pp.103.034462; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dickin E, 2012, EUPHYTICA, V184, P85, DOI 10.1007/s10681-011-0567-y; Doblin MS, 2009, P NATL ACAD SCI USA, V106, P5996, DOI 10.1073/pnas.0902019106; Druka Arnis, 2006, Functional & Integrative Genomics, V6, P202, DOI 10.1007/s10142-006-0025-4; EDNEY MJ, 1992, J SCI FOOD AGR, V60, P451, DOI 10.1002/jsfa.2740600408; Eggert K, 2011, PROTEOMICS, V11, P972, DOI 10.1002/pmic.201000322; FINCHER GB, 1976, J I BREWING, V82, P347, DOI 10.1002/j.2050-0416.1975.tb06961.x; FINCHER GB, 1975, J I BREWING, V81, P116, DOI 10.1002/j.2050-0416.1975.tb03672.x; Fischbeck G, 2003, DEV PL GEN, V7, P29, DOI 10.1016/S0168-7972(03)80005-1; Fujita N, 2006, PLANT PHYSIOL, V140, P1070, DOI 10.1104/pp.105.071845; Fulton DC, 2002, J BIOL CHEM, V277, P10834, DOI 10.1074/jbc.M111579200; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu YQ, 2003, GENOME, V46, P1084, DOI [10.1139/g03-071, 10.1139/G03-071]; Gutierrez-Gonzalez JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-471; HECK GR, 1993, MOL GEN GENET, V239, P209, DOI 10.1007/BF00281620; Hecker KD, 1998, J SCI FOOD AGR, V77, P179, DOI 10.1002/(SICI)1097-0010(199806)77:2&lt;179::AID-JSFA23&gt;3.0.CO;2-0; Hirose T, 2004, PLANTA, V220, P9, DOI 10.1007/s00425-004-1314-6; Ibrahim Adel F. M., 2005, Functional & Integrative Genomics, V5, P163, DOI 10.1007/s10142-005-0135-4; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jadhav SJ, 1998, CRIT REV FOOD SCI, V38, P123, DOI 10.1080/10408699891274183; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Konzak C F, 1977, Adv Genet, V19, P407, DOI 10.1016/S0065-2660(08)60249-7; Kriz AL, 1999, 7S GLOBULINS CEREALS, P477; Leymarie J, 2007, J EXP BOT, V58, P425, DOI 10.1093/jxb/erl211; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li ZY, 2000, PLANT PHYSIOL, V123, P613, DOI 10.1104/pp.123.2.613; Liu C. T., 1996, HULLESS BARLEY NEW L; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Marshall J, 1996, PLANT CELL, V8, P1121, DOI 10.1105/tpc.8.7.1121; Matsumoto T, 2011, PLANT PHYSIOL, V156, P20, DOI 10.1104/pp.110.171579; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Morell MK, 2003, PLANT J, V34, P172, DOI 10.1046/j.1365-313X.2003.01712.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nemeth C, 2010, PLANT PHYSIOL, V152, P1209, DOI 10.1104/pp.109.151712; Newman RK, 2008, BARLEY TAXONOMY MORP, P18; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; Ozturk ZN, 2002, PLANT MOL BIOL, V48, P551, DOI 10.1023/A:1014875215580; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Piston F, 2004, THEOR APPL GENET, V108, P1359, DOI 10.1007/s00122-003-1548-x; Radchuk VV, 2009, PLANT PHYSIOL, V150, P190, DOI 10.1104/pp.108.133520; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Roldan I, 2007, PLANT J, V49, P492, DOI 10.1111/j.1365-313X.2006.02968.x; SAASTAMOINEN M, 1989, J CEREAL SCI, V10, P199, DOI 10.1016/S0733-5210(89)80049-9; Sato K, 2009, DNA RES, V16, P81, DOI 10.1093/dnares/dsn034; Sharma P, 2010, J FOOD ENG, V97, P329, DOI 10.1016/j.jfoodeng.2009.10.025; Shewry P, 1983, HEREDITY, V50; SHEWRY PR, 1985, FEBS LETT, V190, P61, DOI 10.1016/0014-5793(85)80427-0; SHEWRY PR, 1985, BIOCHEM GENET, V23, P391, DOI 10.1007/BF00499082; Sreenivasulu N, 2004, PLANT J, V37, P539, DOI 10.1046/j.1365-313X.2003.01981.x; Sreenivasulu N, 2006, PLANT J, V47, P310, DOI 10.1111/j.1365-313X.2006.02789.x; Sun LJ, 1999, GENET RESOUR CROP EV, V46, P361, DOI 10.1023/A:1008606613602; Taketa S, 2012, J EXP BOT, V63, P381, DOI 10.1093/jxb/err285; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Tomlinson K, 1998, PLANTA, V204, P86, DOI 10.1007/s004250050233; van de Wal M, 1998, J BIOL CHEM, V273, P22232, DOI 10.1074/jbc.273.35.22232; Vrinten PL, 2000, PLANT PHYSIOL, V122, P255, DOI 10.1104/pp.122.1.255; Wei KeSu, 2009, Acta Agronomica Sinica, V35, P18, DOI 10.3724/SP.J.1006.2009.00018; White J, 2006, PLANT BIOTECHNOL J, V4, P289, DOI 10.1111/j.1467-7652.2006.00181.x; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin YQ, 2003, THEOR APPL GENET, V107, P837, DOI 10.1007/s00122-003-1328-7; Zhang XQ, 2008, MOL BREEDING, V22, P227, DOI 10.1007/s11032-008-9169-3; Zhao N-C, 2009, ACTA AGRONOMICA SINI, V34, P1977; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	78	14	16	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98144	10.1371/journal.pone.0098144	http://dx.doi.org/10.1371/journal.pone.0098144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871534	Green Published, gold, Green Submitted			2022-12-25	WOS:000336858300026
J	Keeping, D; Pelletier, R				Keeping, Derek; Pelletier, Rick			Animal Density and Track Counts: Understanding the Nature of Observations Based on Animal Movements	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; PRESENCE-ABSENCE DATA; PHOTOGRAPHIC RATES; POPULATION-DENSITY; MAMMALIAN CARNIVORES; BEHAVIORAL-RESPONSES; RELATIVE ABUNDANCE; TIGER POPULATIONS; INDIVIDUAL TIGERS; CRYPTIC MAMMALS	Counting animals to estimate their population sizes is often essential for their management and conservation. Since practitioners frequently rely on indirect observations of animals, it is important to better understand the relationship between such indirect indices and animal abundance. The Formozov-Malyshev-Pereleshin (FMP) formula provides a theoretical foundation for understanding the relationship between animal track counts and the true density of species. Although this analytical method potentially has universal applicability wherever animals are readily detectable by their tracks, it has long been unique to Russia and remains widely underappreciated. In this paper, we provide a test of the FMP formula by isolating the influence of animal travel path tortuosity (i.e., convolutedness) on track counts. We employed simulations using virtual and empirical data, in addition to a field test comparing FMP estimates with independent estimates from line transect distance sampling. We verify that track counts (total intersections between animals and transects) are determined entirely by density and daily movement distances. Hence, the FMP estimator is theoretically robust against potential biases from specific shapes or patterns of animal movement paths if transects are randomly situated with respect to those movements (i.e., the transects do not influence animals' movements). However, detectability (the detection probability of individual animals) is not determined simply by daily travel distance but also by tortuosity, so ensuring that all intersections with transects are counted regardless of the number of individual animals that made them becomes critical for an accurate density estimate. Additionally, although tortuosity has no bearing on mean track encounter rates, it does affect encounter rate variance and therefore estimate precision. We discuss how these fundamental principles made explicit by the FMP formula have widespread implications for methods of assessing animal abundance that rely on indirect observations.	[Keeping, Derek; Pelletier, Rick] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	University of Alberta	Keeping, D (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	dkeeping@ualberta.ca		Pelletier, Rick/0000-0002-1900-4963	Comanis Foundation; Kanabo Conservation Link; Natural Sciences and Engineering Research Council of Canada; Safari Club International Foundation and Conservation Force	Comanis Foundation; Kanabo Conservation Link; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Safari Club International Foundation and Conservation Force	This work was supported by Comanis Foundation, Kanabo Conservation Link, Natural Sciences and Engineering Research Council of Canada, Safari Club International Foundation and Conservation Force. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberta Biodiversity Monitoring Institute, 2012, TERR FIELD DAT COLL; Alibhai SK, 1992, SYSTEMATIC GROUND SU; Allen L, 1996, WILDLIFE RES, V23, P197, DOI 10.1071/WR9960197; Anderson DR, 2001, WILDLIFE SOC B, V29, P1294; Ballard Warren B., 1995, Canadian Circumpolar Institute Occasional Publication, V35, P469; Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; BECKER EF, 1991, J WILDLIFE MANAGE, V55, P730, DOI 10.2307/3809525; Beier P, 1996, WILDLIFE SOC B, V24, P540; Blaum N, 2008, WILDLIFE RES, V35, P72, DOI 10.1071/WR07023; Boast LK, 2012, S AFR J WILDL RES, V42, P138, DOI 10.3957/056.042.0202; Buckland S.T., 2001, pi; Carbone C, 2005, AM NAT, V165, P290, DOI 10.1086/426790; Carbone C, 2002, ANIM CONSERV, V5, P121, DOI 10.1017/S1367943002002172; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; Carrillo E, 2000, CONSERV BIOL, V14, P1580, DOI 10.1046/j.1523-1739.2000.99103.x; Caughley GJ, 1994, WILDLIFE ECOLOGY MAN; Chiarello AG, 2000, CONSERV BIOL, V14, P1649, DOI 10.1046/j.1523-1739.2000.99071.x; Clevenger AP, 1996, WILDLIFE BIOL, V2, P275, DOI 10.2981/wlb.1996.031; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Danilov Pjotr, 1996, Finnish Game Research, V49, P18; Duckworth JW, 1998, J ZOOL, V246, P466, DOI 10.1111/j.1469-7998.1998.tb00183.x; DZIECIOLOWSKI R, 1976, Acta Theriologica, V21, P217; Edelmann F, 1999, NORTHWEST SCI, V73, P295; Edwards GP, 2000, WILDLIFE RES, V27, P143, DOI 10.1071/WR98067; Efron B., 1994, INTRO BOOTSTRAP; Engeman RM, 2007, AFR J ECOL, V45, P184, DOI 10.1111/j.1365-2028.2006.00695.x; Engeman RM, 2002, WILDLIFE RES, V29, P85, DOI 10.1071/WR01046; Engeman RM, 2003, WILDLIFE SOC B, V31, P286; Engeman RM, 2001, ENVIRON CONSERV, V28, P235, DOI 10.1017/S0376892901000248; Evans JW, 2009, J WILDLIFE MANAGE, V73, P426, DOI 10.2193/2007-514; Forsey ES, 2001, FOREST ECOL MANAG, V145, P163, DOI 10.1016/S0378-1127(00)00404-7; Fritz H, 2003, LANDSCAPE ECOL, V18, P293, DOI 10.1023/A:1024411711670; Funston PJ, 2010, J ZOOL, V281, P56, DOI 10.1111/j.1469-7998.2009.00682.x; FUNSTON PJ, 2001, KALAHARI TRANSFRONTI; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Gurarie E, 2013, THEOR ECOL-NETH, V6, P189, DOI 10.1007/s12080-012-0170-4; Gusset M, 2005, AFR J ECOL, V43, P320, DOI 10.1111/j.1365-2028.2005.00581.x; Halfpenny James C., 1995, U S Forest Service General Technical Report PSW, V157, P91; Hayward GD, 2002, WILDLIFE SOC B, V30, P1150; Hines JE, 2010, ECOL APPL, V20, P1456, DOI 10.1890/09-0321.1; Houser AM, 2009, J ZOOL, V278, P108, DOI 10.1111/j.1469-7998.2009.00554.x; Hutchinson JMC, 2007, BIOL REV, V82, P335, DOI 10.1111/j.1469-185X.2007.00014.x; Jachmann H., 1984, Nyala, V10, P77; Jachmann H., 2001, ESTIMATING ABUNDANCE, DOI 10.1007/978-1-4615-1381-0; Jennelle CS, 2002, ANIM CONSERV, V5, P119, DOI 10.1017/S1367943002002160; Jewell ZC, 2001, J ZOOL, V254, P1, DOI 10.1017/S0952836901000516; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Karanth KU, 2003, ANIM CONSERV, V6, P141, DOI 10.1017/S1367943003003184; Keeping D, 2014, ANIM CONSERV, V17, P486, DOI 10.1111/acv.12113; KENDALL KC, 1992, ECOL APPL, V2, P422, DOI 10.2307/1941877; Keswick T, 2012, THESIS U W CAPE; Kurki S, 1998, J ANIM ECOL, V67, P874, DOI 10.1046/j.1365-2656.1998.6760874.x; Liebenberg L., 1990, ART TRACKING ORIGIN; Linden Harto, 1996, Finnish Game Research, V49, P4; Linnell JDC, 2007, WILDLIFE BIOL, V13, P456, DOI 10.2981/0909-6396(2007)13[456:AEOSSS]2.0.CO;2; Lizcano DJ, 2000, BIOTROPICA, V32, P165; Lopes MA, 2000, CONSERV BIOL, V14, P1658, DOI [10.1046/j.1523-1739.2000.98402.x, 10.1111/j.1523-1739.2000.98402.x]; MacKenzie D. I., 2004, Animal Biodiversity and Conservation, V27, P461; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2005, J WILDLIFE MANAGE, V69, P849, DOI 10.2193/0022-541X(2005)069[0849:WATIWP]2.0.CO;2; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mahon PS, 1998, WILDLIFE RES, V25, P11, DOI 10.1071/WR97007; McBride RT, 2008, SOUTHEAST NAT, V7, P381, DOI 10.1656/1528-7092-7.3.381; Mills MGL, 1990, KALAHARI HYAENAS COM; Nielsen SE, 2005, ECOGRAPHY, V28, P197, DOI 10.1111/j.0906-7590.2005.04002.x; Norbury GL, 1998, J WILDLIFE MANAGE, V62, P45, DOI 10.2307/3802263; Norris D, 2008, MAMMALIA, V72, P15, DOI 10.1515/MAMM.2008.002; O'Connell AF, 2006, J WILDLIFE MANAGE, V70, P1625, DOI 10.2193/0022-541X(2006)70[1625:ESOADP]2.0.CO;2; ODonoghue M, 1997, OIKOS, V80, P150, DOI 10.2307/3546526; RAINE RM, 1983, CAN J ZOOL, V61, P25, DOI 10.1139/z83-002; REID DG, 1987, CAN FIELD NAT, V101, P576; Riordan P, 1998, ANIM CONSERV, V1, P253, DOI 10.1111/j.1469-1795.1998.tb00036.x; Roshier DA, 2008, OECOLOGIA, V156, P465, DOI 10.1007/s00442-008-0987-0; Rovero F, 2009, J APPL ECOL, V46, P1011, DOI 10.1111/j.1365-2664.2009.01705.x; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Rowcliffe JM, 2013, J WILDLIFE MANAGE, V77, P876, DOI 10.1002/jwmg.533; Rowcliffe JM, 2012, METHODS ECOL EVOL, V3, P653, DOI 10.1111/j.2041-210X.2012.00197.x; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; SARRAZIN JP, 1973, J MAMMAL, V54, P369, DOI 10.2307/1379124; SERVIN JI, 1987, ACTA THERIOL, V32, P489; Sharma S, 2005, J ZOOL, V267, P9, DOI 10.1017/S0952836905007119; Silveira L, 2003, BIOL CONSERV, V114, P351, DOI 10.1016/S0006-3207(03)00063-6; SKARPE C, 1986, VEGETATIO, V68, P3; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; SMALLWOOD KS, 1993, BIOL CONSERV, V65, P51, DOI 10.1016/0006-3207(93)90196-8; SMALLWOOD KS, 1995, BIOL CONSERV, V71, P251, DOI 10.1016/0006-3207(94)00034-N; Southgate R, 2007, J ARID ENVIRON, V68, P438, DOI 10.1016/j.jaridenv.2006.06.006; Southgate R, 2008, TRACK BASED MONITORI; SOUTIERE EC, 1979, J WILDLIFE MANAGE, V43, P850, DOI 10.2307/3808268; Squires JR, 2004, CAN FIELD NAT, V118, P583, DOI 10.22621/cfn.v118i4.60; Stander PE, 1997, J ZOOL, V242, P329; Stander PE, 1998, J APPL ECOL, V35, P378, DOI 10.1046/j.1365-2664.1998.00313.x; Stanley TR, 2005, J WILDLIFE MANAGE, V69, P874, DOI 10.2193/0022-541X(2005)069[0874:ESOAAU]2.0.CO;2; Stephens PA, 2006, ANIM CONSERV, V9, P339, DOI 10.1111/j.1469-1795.2006.00044.x; Stephens P. A., 2006, ANAL LONG TERM DYNAM; Strayer DL, 1999, CONSERV BIOL, V13, P1034, DOI 10.1046/j.1523-1739.1999.98143.x; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; THOMPSON ID, 1989, CAN J ZOOL, V67, P1816, DOI 10.1139/z89-258; Thorn M, 2011, BIOL CONSERV, V144, P1799, DOI 10.1016/j.biocon.2011.03.009; Vojta CD, 2005, J WILDLIFE MANAGE, V69, P845, DOI 10.2193/0022-541X(2005)069[0845:ODNTIW]2.0.CO;2; WARD RMP, 1985, CAN J ZOOL, V63, P2817, DOI 10.1139/z85-421; Wearn OR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077598; Wharton CA, 2006, THESIS TEXAS A M U; Wilson GJ, 2001, WILDLIFE RES, V28, P151, DOI 10.1071/WR00033; Wong PBY, 2011, CAN FIELD NAT, V125, P140, DOI 10.22621/cfn.v125i2.1197; WRANGHAM RW, 1993, BEHAV ECOL SOCIOBIOL, V32, P199; Zielinski WJ, 1996, ECOL APPL, V6, P1254, DOI 10.2307/2269605	107	29	30	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e96598	10.1371/journal.pone.0096598	http://dx.doi.org/10.1371/journal.pone.0096598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871490	Green Submitted, Green Published, gold			2022-12-25	WOS:000336858300004
J	Cole, MH; van den Hoorn, W; Kavanagh, JK; Morrison, S; Hodges, PW; Smeathers, JE; Kerr, GK				Cole, Michael H.; van den Hoorn, Wolbert; Kavanagh, Justin K.; Morrison, Steven; Hodges, Paul W.; Smeathers, James E.; Kerr, Graham K.			Concurrent Validity of Accelerations Measured Using a Tri-Axial Inertial Measurement Unit while Walking on Firm, Compliant and Uneven Surfaces	PLOS ONE			English	Article							MOBILITY-RELATED ACTIVITIES; TEST-RETEST RELIABILITY; AGE-RELATED DIFFERENCES; TRUNK ACCELEROMETRY; WEARABLE SYSTEMS; HEAD STABILITY; GAIT; PATTERNS; PELVIS; COORDINATION	Although accelerometers are extensively used for assessing gait, limited research has evaluated the concurrent validity of these devices on less predictable walking surfaces or the comparability of different methods used for gravitational acceleration compensation. This study evaluated the concurrent validity of trunk accelerations derived from a tri-axial inertial measurement unit while walking on firm, compliant and uneven surfaces and contrasted two methods used to remove gravitational accelerations; i) subtraction of the best linear fit from the data (detrending); and ii) use of orientation information (quaternions) from the inertial measurement unit. Twelve older and twelve younger adults walked at their preferred speed along firm, compliant and uneven walkways. Accelerations were evaluated for the thoracic spine (T12) using a tri-axial inertial measurement unit and an eleven-camera Vicon system. The findings demonstrated excellent agreement between accelerations derived from the inertial measurement unit and motion analysis system, including while walking on uneven surfaces that better approximate a real-world setting (all differences <0.16 m.s(-2)). Detrending produced slightly better agreement between the inertial measurement unit and Vicon system on firm surfaces (delta range: -0.05 to 0.06 vs. 0.00 to 0.14 m.s(-2)), whereas the quaternion method performed better when walking on compliant and uneven walkways (delta range: -0.16 to -0.02 vs. -0.07 to 0.07 m.s(-2)). The technique used to compensate for gravitational accelerations requires consideration in future research, particularly when walking on compliant and uneven surfaces. These findings demonstrate trunk accelerations can be accurately measured using a wireless inertial measurement unit and are appropriate for research that evaluates healthy populations in complex environments.	[Cole, Michael H.] Australian Catholic Univ, Sch Exercise Sci, Brisbane, Qld, Australia; [Cole, Michael H.; Kerr, Graham K.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Movement Neurosci Program, Brisbane, Qld 4001, Australia; [van den Hoorn, Wolbert; Hodges, Paul W.] Univ Queensland, Ctr Clin Res Excellence Spinal Pain Injury & Hlth, Brisbane, Qld, Australia; [Kavanagh, Justin K.] Griffith Univ, Ctr Musculoskeletal Res, Gold Coast, Qld, Australia; [Morrison, Steven] Old Dominion Univ, Sch Phys Therapy & Athlet Training, Norfolk, VA USA; [Smeathers, James E.; Kerr, Graham K.] Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia	Australian Catholic University; Queensland University of Technology (QUT); University of Queensland; Griffith University; Old Dominion University; Queensland University of Technology (QUT)	Cole, MH (corresponding author), Australian Catholic Univ, Sch Exercise Sci, Brisbane, Qld, Australia.	michael.cole@acu.edu.au; g.kerr@qut.edu.au	van den Hoorn, Wolbert/F-6894-2010; Cole, Michael H/O-6816-2018; Hodges, Paul W/B-6578-2008	van den Hoorn, Wolbert/0000-0002-9658-2388; Hodges, Paul W/0000-0002-1206-9107; Kavanagh, Justin/0000-0002-1046-260X; Cole, Michael/0000-0003-1817-7528; Kerr, Graham/0000-0002-1008-256X	National Health and Medical Research Council of Australia; Institute of Health and Biomedical Innovation, Queensland University of Technology	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Institute of Health and Biomedical Innovation, Queensland University of Technology	This research was supported by a project grant and Research Fellowship (PWH) from the National Health and Medical Research Council of Australia and grants from the Institute of Health and Biomedical Innovation, Queensland University of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allet L, 2010, SENSORS-BASEL, V10, P9026, DOI 10.3390/s101009026; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonnet V, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-29; Cole MH, 2011, PARKINSONISM RELAT D, V17, P610, DOI 10.1016/j.parkreldis.2011.05.019; de Bruin Eling D, 2012, J Aging Res, V2012, P954378, DOI 10.1155/2012/954378; de Bruin ED, 2008, CLIN REHABIL, V22, P878, DOI 10.1177/0269215508090675; Grimpampi E, 2013, GAIT POSTURE, V38, P523, DOI 10.1016/j.gaitpost.2013.01.031; Hartmann A, 2009, GAIT POSTURE, V30, P351, DOI 10.1016/j.gaitpost.2009.06.008; Hartmann A, 2009, GAIT POSTURE, V29, P444, DOI 10.1016/j.gaitpost.2008.11.003; Hendrick P, 2010, J REHABIL RES DEV, V47, P157, DOI 10.1682/JRRD.2009.04.0047; Henriksen M, 2004, GAIT POSTURE, V19, P288, DOI 10.1016/S0966-6362(03)00069-9; Jurman D, 2007, SENSOR ACTUAT A-PHYS, V138, P411, DOI 10.1016/j.sna.2007.05.008; Kavanagh J, 2005, EUR J APPL PHYSIOL, V94, P468, DOI 10.1007/s00421-005-1328-1; Kavanagh JJ, 2005, HUM MOVEMENT SCI, V24, P574, DOI 10.1016/j.humov.2005.07.003; Kavanagh JJ, 2004, GAIT POSTURE, V20, P291, DOI 10.1016/j.gaitpost.2003.10.004; Kavanagh J, 2006, EXP BRAIN RES, V172, P454, DOI 10.1007/s00221-006-0353-6; Kavanagh JJ, 2008, GAIT POSTURE, V28, P1, DOI 10.1016/j.gaitpost.2007.10.010; Kavanagh JJ, 2006, J BIOMECH, V39, P2863, DOI 10.1016/j.jbiomech.2005.09.012; Kavanagh JJ, 2006, J APPL PHYSIOL, V101, P1118, DOI 10.1152/japplphysiol.00165.2006; Latt MD, 2008, EXP BRAIN RES, V184, P201, DOI 10.1007/s00221-007-1094-x; Luinge H J, 1999, Technol Health Care, V7, P455; Mayagoitia RE, 2002, J BIOMECH, V35, P537, DOI 10.1016/S0021-9290(01)00231-7; Mazza C, 2012, GAIT POSTURE, V35, P138, DOI 10.1016/j.gaitpost.2011.08.024; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Menz HB, 2003, GAIT POSTURE, V18, P35, DOI 10.1016/S0966-6362(02)00159-5; Menz HB, 2003, J GERONTOL A-BIOL, V58, P446, DOI 10.1093/gerona/58.5.M446; Menz HB, 2003, AGE AGEING, V32, P137, DOI 10.1093/ageing/32.2.137; Moe-Nilssen R, 2002, GAIT POSTURE, V16, P60, DOI 10.1016/S0966-6362(01)00200-4; Moe-Nilssen R, 1998, CLIN BIOMECH, V13, P320, DOI 10.1016/S0268-0033(98)00089-8; Moe-Nilssen R, 1998, ARCH PHYS MED REHAB, V79, P1377, DOI 10.1016/S0003-9993(98)90231-3; Patel S, 2009, SIXTH INTERNATIONAL WORKSHOP ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS, PROCEEDINGS, P234, DOI 10.1109/P3644.52; Portney LG, 2000, FDN CLIN RES APPL PR, V2; Sabatini AM, 2005, MED BIOL ENG COMPUT, V43, P94, DOI 10.1007/BF02345128; Schepers HM, 2010, MED BIOL ENG COMPUT, V48, P27, DOI 10.1007/s11517-009-0562-9; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Toebes MJP, 2012, GAIT POSTURE, V36, P527, DOI 10.1016/j.gaitpost.2012.05.016; Wilson J.S., 2004, SENSOR TECHNOLOGY HD	37	21	21	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98395	10.1371/journal.pone.0098395	http://dx.doi.org/10.1371/journal.pone.0098395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866262	Green Published, Green Submitted, gold			2022-12-25	WOS:000336914100058
J	Lim, JKH; Nguyen, CTO; He, Z; Vingrys, AJ; Bui, BV				Lim, Jeremiah K. H.; Nguyen, Christine T. O.; He, Zheng; Vingrys, Algis J.; Bui, Bang V.			The Effect of Ageing on Ocular Blood Flow, Oxygen Tension and Retinal Function during and after Intraocular Pressure Elevation	PLOS ONE			English	Article							OPTIC-NERVE HEAD; POSTISCHEMIC REPERFUSION; HYPERBARIC OXYGENATION; GANGLION-CELLS; RABBIT RETINA; TRANSIT-TIME; B-WAVE; AGE; METABOLISM; RAT	Purpose: To investigate the effect of ageing on the recovery of ocular blood flow, intravitreal oxygen tension and retinal function during and after intraocular pressure (IOP) elevation. Methods: Long Evans rats (3- and 14-month-old) underwent acute stepwise IOP elevation from 10 to 120 mmHg (5 mmHg steps each 3 minutes). IOP was then returned to baseline and recovery was monitored for 2 hours. Photopic electroretinograms (ERG) were recorded at each IOP step during stress and at each minute during recovery. Ocular blood flow and vitreal oxygen tension (pO(2)) were assayed continuously and simultaneously using a combined laser Doppler flow meter (LDF) and an oxygen sensitive fibre-optic probe, respectively. The combined sensor was placed in the vitreous chamber, proximal to the retina. Data were binned into 3 minute intervals during stress and 1 min intervals during recovery. Recovery data was described using a bi-logistic function. Results: Rats of both ages showed similar susceptibility to IOP elevation, with pO(2) showing a closer relationship to ERG than LDF. During recovery, both ages showed a distinctive two-phased recovery for all three measures with the exception of the LDF in 3-month-old rats, which showed only 1 phase. In all animals, LDF recovered fastest (<1 minute), followed by pO2 (<10 minute) and ERG (>1 hour). 14-month-old rats showed surprisingly faster and greater LDF recovery compared to the younger group, with similar levels of pO(2) recovery. However, the ERG in these middle-aged animals did not fully recover after two hours, despite showing no difference in susceptibility to IOP during stress compared to the young group. Conclusions: Young and middle-aged eyes showed similar susceptibility to IOP elevation in terms of pO(2), LDF and ERG. Despite this lack of difference during stress, older eyes did not completely recover function, suggesting a more subtle age-related susceptibility to IOP.	[Lim, Jeremiah K. H.; Nguyen, Christine T. O.; He, Zheng; Vingrys, Algis J.; Bui, Bang V.] Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic 3010, Australia	University of Melbourne	Bui, BV (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic 3010, Australia.	bvb@unimelb.edu.au	Bui, Bang/AAD-2679-2021; Lim, Jeremiah Kah Heng/AAC-4260-2019	Bui, Bang/0000-0001-7298-1352; Lim, Jeremiah Kah Heng/0000-0002-4694-9479; Nguyen, Christine/0000-0002-3298-3086; He, Zheng/0000-0001-6496-3971; Vingrys, Algis/0000-0001-5920-4604	National Health and Medical Research Council [566570]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the National Health and Medical Research Council Project Grant 566570. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah W, 2011, INVEST OPHTH VIS SCI, V52, P1035, DOI 10.1167/iovs.09-4516; ALDER VA, 1989, AM J PHYSIOL, V256, pH1627, DOI 10.1152/ajpheart.1989.256.6.H1627; ALDER VA, 1985, CURR EYE RES, V4, P121, DOI 10.3109/02713688508999977; ALDER VA, 1991, EXP EYE RES, V52, P293, DOI 10.1016/0014-4835(91)90093-T; ALDER VA, 1986, CURR EYE RES, V5, P249, DOI 10.3109/02713688609020050; ALM A, 1970, ACTA PHYSIOL SCAND, V80, P19, DOI 10.1111/j.1748-1716.1970.tb04765.x; ALM A, 1972, ACTA PHYSIOL SCAND, V84, P306, DOI 10.1111/j.1748-1716.1972.tb05182.x; AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992; AMES A, 1963, J NEUROPHYSIOL, V26, P617, DOI 10.1152/jn.1963.26.4.617; AMES A, 1992, CAN J PHYSIOL PHARM, V70, pS158, DOI 10.1139/y92-257; ANDERSON B, 1965, ARCH OPHTHALMOL-CHIC, V73, P315; ANDERSON B, 1965, SOUTHERN MED J, V58, P1047, DOI 10.1097/00007611-196508000-00023; BENNUN J, 1988, INVEST OPHTH VIS SCI, V29, P298; BRAUN RD, 1995, INVEST OPHTH VIS SCI, V36, P523; Bui BV, 2003, INVEST OPHTH VIS SCI, V44, P2708, DOI 10.1167/iovs.02-1054; Bui BV, 2005, INVEST OPHTH VIS SCI, V46, P202, DOI 10.1167/iovs.04-0421; BUNAG RD, 1982, HYPERTENSION, V4, P898, DOI 10.1161/01.HYP.4.6.898; BUNAG RD, 1973, J APPL PHYSIOL, V34, P279, DOI 10.1152/jappl.1973.34.2.279; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Cantini C, 2001, HYPERTENSION, V38, P943, DOI 10.1161/hy1001.096211; Casson RJ, 2004, ARCH OPHTHALMOL-CHIC, V122, P361, DOI 10.1001/archopht.122.3.361; Charng J, 2011, INVEST OPHTH VIS SCI, V52, P8891, DOI 10.1167/iovs.11-7602; Chrysostomou V, 2010, OPHTHALMIC RES, V44, P173, DOI 10.1159/000316478; Chu CS, 2011, PHOTONIC SENS, V1, P234, DOI 10.1007/s13320-011-0025-4; CRINGLE SJ, 1988, INVEST OPHTH VIS SCI, V29, P1044; DOBREE J H, 1956, Br J Ophthalmol, V40, P1, DOI 10.1136/bjo.40.1.1; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; Ehrlich R, 2009, GRAEF ARCH CLIN EXP, V247, P583, DOI 10.1007/s00417-008-1018-x; Embleton SJ, 2002, EYE, V16, P156; ENROTHCUGELL C, 1980, J PHYSIOL-LONDON, V304, P59, DOI 10.1113/jphysiol.1980.sp013310; ERNEST JT, 1973, INVEST OPHTH VISUAL, V12, P927; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Fredriksson I., 2007, LASER DOPPLER FLOWME; Fredriksson I, 2009, MICROVASC RES, V78, P4, DOI 10.1016/j.mvr.2009.02.008; GRAYMORE CN, 1970, BRIT MED BULL, V26, P130, DOI 10.1093/oxfordjournals.bmb.a070763; Groh MJM, 1996, OPHTHALMOLOGY, V103, P529; GUTIERREZ G, 1986, RESP PHYSIOL, V63, P79, DOI 10.1016/0034-5687(86)90032-0; Harwerth RS, 2008, INVEST OPHTH VIS SCI, V49, P4437, DOI 10.1167/iovs.08-1753; Hatta Shiro, 1993, Nippon Ganka Gakkai Zasshi, V97, P181; HAYREH SS, 1994, GRAEF ARCH CLIN EXP, V232, P745, DOI 10.1007/BF00184278; He Z, 2006, INVEST OPHTH VIS SCI, V47, P4872, DOI 10.1167/iovs.06-0590; He Z, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.55; He Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031104; Hughes S, 2006, NEUROBIOL AGING, V27, P1838, DOI 10.1016/j.neurobiolaging.2005.10.021; Ishihara M, 2000, JPN J PHYSIOL, V50, P125, DOI 10.2170/jjphysiol.50.125; Kalliokoski KK, 2004, MICROVASC RES, V67, P125, DOI 10.1016/j.mvr.2003.11.004; Katano H, 2001, JPN J PHYSIOL, V51, P89, DOI 10.2170/jjphysiol.51.89; KIEL JW, 1992, INVEST OPHTH VIS SCI, V33, P2399; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; Kong YXG, 2011, AGING CELL, V10, P572, DOI 10.1111/j.1474-9726.2011.00690.x; Kong YXG, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.026; Kurtz TW, 2005, ARTERIOSCL THROM VAS, V25, pE22, DOI 10.1161/01.ATV.0000158419.98675.d7; la Cour M, 2000, BRIT J OPHTHALMOL, V84, P1045; Landers M B 3rd, 1978, Trans Am Ophthalmol Soc, V76, P528; Liao DP, 2004, STROKE, V35, P837, DOI 10.1161/01.STR.0000120310.43457.AD; Linsenmeier RA, 1998, INVEST OPHTH VIS SCI, V39, P1647; LINSENMEIER RA, 1990, GRAEF ARCH CLIN EXP, V228, P143, DOI 10.1007/BF02764309; LINSENMEIER RA, 1981, EXP EYE RES, V32, P369, DOI 10.1016/S0014-4835(81)80016-4; Lu HZ, 2011, CEREB CORTEX, V21, P1426, DOI 10.1093/cercor/bhq224; Matsuura K, 1998, JPN J PHYSIOL, V48, P9, DOI 10.2170/jjphysiol.48.9; McFarland RA, 1940, J GEN PHYSIOL, V24, P69, DOI 10.1085/jgp.24.1.69; MEYER P, 1994, TECHNOL FORECAST SOC, V47, P89, DOI 10.1016/0040-1625(94)90042-6; MILDENBERGER RR, 1977, CAN J PHYSIOL PHARM, V55, P478, DOI 10.1139/y77-068; Mojumder DK, 2008, J PHYSIOL-LONDON, V586, P2551, DOI 10.1113/jphysiol.2008.150755; Mozaffarieh M, 2008, MOL VIS, V14, P224; Park YH, 2011, BRIT J OPHTHALMOL, V95, P118, DOI 10.1136/bjo.2010.186064; PETERSON JI, 1984, SCIENCE, V224, P123, DOI 10.1126/science.6422554; PETERSON JI, 1984, ANAL CHEM, V56, P62, DOI 10.1021/ac00265a017; Pittman RN, 2011, ACTA PHYSIOL, V202, P311, DOI 10.1111/j.1748-1716.2010.02232.x; Pittman RN, 2005, MICROCIRCULATION, V12, P59, DOI 10.1080/10739680590895064; POURNARAS CJ, 1989, EXP EYE RES, V49, P347, DOI 10.1016/0014-4835(89)90045-6; Quinones-Hinojosa A, 1999, J NEUROSCI METH, V90, P107, DOI 10.1016/S0165-0270(99)00068-0; Riva CE, 1997, GRAEF ARCH CLIN EXP, V235, P618, DOI 10.1007/BF00946937; RIVA CE, 1981, INVEST OPHTH VIS SCI, V21, P34; RIVA CE, 1986, J APPL PHYSIOL, V61, P592, DOI 10.1152/jappl.1986.61.2.592; RIZZO JF, 1991, INVEST OPHTH VIS SCI, V32, P3263; Rochtchina E, 2002, CLIN EXP OPHTHALMOL, V30, P173, DOI 10.1046/j.1442-9071.2002.00519.x; RUSSELL RWR, 1973, LANCET, V2, P1048; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; Schulte K, 1996, GER J OPHTHALMOL, V5, P1; Smith LM, 2004, AM J PHYSIOL-HEART C, V287, pH401, DOI 10.1152/ajpheart.00980.2002; TORNQUIST P, 1979, ACTA PHYSIOL SCAND, V106, P351, DOI 10.1111/j.1748-1716.1979.tb06409.x; WILSON CA, 1995, INVEST OPHTH VIS SCI, V36, P131; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; Wong TY, 2003, INVEST OPHTH VIS SCI, V44, P4644, DOI 10.1167/iovs.03-0079; Xuan B, 1999, J OCUL PHARMACOL TH, V15, P135, DOI 10.1089/jop.1999.15.135; YANCEY CM, 1988, INVEST OPHTH VIS SCI, V29, P700; Yu DY, 1999, INVEST OPHTH VIS SCI, V40, P2082; Zhi ZW, 2012, BIOMED OPT EXPRESS, V3, P2220, DOI 10.1364/BOE.3.002220	90	41	41	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98393	10.1371/journal.pone.0098393	http://dx.doi.org/10.1371/journal.pone.0098393			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866182	Green Submitted, Green Published, gold			2022-12-25	WOS:000336914100057
J	Soares, RJ; Cagnin, S; Chemello, F; Silvestrin, M; Musaro, A; De Pitta, C; Lanfranchi, G; Sandri, M				Soares, Ricardo Jose; Cagnin, Stefano; Chemello, Francesco; Silvestrin, Matteo; Musaro, Antonio; De Pitta, Cristiano; Lanfranchi, Gerolamo; Sandri, Marco			Involvement of MicroRNAs in the Regulation of Muscle Wasting during Catabolic Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YIN YANG 1; SKELETAL-MUSCLE; IN-VIVO; UBIQUITIN-PROTEASOME; ATROPHY INVOLVE; GENE-EXPRESSION; AUTOPHAGY; TRANSCRIPTION; DENERVATION; MICE	Loss of muscle proteins and the consequent weakness has important clinical consequences in diseases such as cancer, diabetes, chronic heart failure, and in aging. In fact, excessive proteolysis causes cachexia, accelerates disease progression, and worsens life expectancy. Muscle atrophy involves a common pattern of transcriptional changes in a small subset of genes named atrophy-related genes or atrogenes. Whether microRNAs play a role in the atrophy program and muscle loss is debated. To understand the involvement of miRNAs in atrophy we performed miRNA expression profiling of mouse muscles under wasting conditions such as fasting, denervation, diabetes, and cancer cachexia. We found that the miRNA signature is peculiar of each catabolic condition. We then focused on denervation and we revealed that changes in transcripts and microRNAs expression did not occur simultaneously but were shifted. Indeed, whereas transcriptional control of the atrophy-related genes peaks at 3 days, changes of miRNA expression maximized at 7 days after denervation. Among the different miRNAs, microRNA-206 and -21 were the most induced in denervated muscles. We characterized their pattern of expression and defined their role in muscle homeostasis. Indeed, in vivo gain and loss of function experiments revealed that miRNA-206 and miRNA-21 were sufficient and required for atrophy program. In silico and in vivo approaches identified transcription factor YY1 and the translational initiator factor eIF4E3 as downstream targets of these miRNAs. Thus miRNAs are important for finetuning the atrophy program and their modulation can be a novel potential therapeutic approach to counteract muscle loss and weakness in catabolic conditions.	[Soares, Ricardo Jose; Sandri, Marco] Venetian Inst Mol Med, Dulbecco Telethon Inst, I-35129 Padua, Italy; [Sandri, Marco] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Cagnin, Stefano; Chemello, Francesco; Silvestrin, Matteo; De Pitta, Cristiano; Lanfranchi, Gerolamo] Univ Padua, Dept Biol, I-35121 Padua, Italy; [Cagnin, Stefano; Chemello, Francesco; Silvestrin, Matteo; De Pitta, Cristiano; Lanfranchi, Gerolamo] Univ Padua, CRIBI Biotechnol Ctr, I-35121 Padua, Italy; [Soares, Ricardo Jose] Univ Coimbra, PhD Programme Expt Biol & Biomedicine, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Sandri, Marco] CNR, Inst Neurosci, I-35121 Padua, Italy; [Musaro, Antonio] Univ Roma La Sapienza, DAHFMO Unit Histol & Med Embryol, I-00161 Rome, Italy; [Sandri, Marco] Telethon Inst Genet & Med TIGEM, I-80131 Naples, Italy	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; University of Padua; University of Padua; University of Padua; Universidade de Coimbra; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	De Pitta, C (corresponding author), Univ Padua, Dept Biol, Via Trieste 75, I-35121 Padua, Italy.	cristiano.depitta@unipd.it; gerolamo.lanfranchi@unipd.it; marco.sandri@unipd.it	Musarò, Antonio/K-9598-2016; cagnin, stefano/E-9095-2011; Chemello, Francesco/ABB-3801-2020; De Pitta, Cristiano/AAY-7302-2020; Ribeiro Soares, Ricardo Jose/M-9706-2015; Musaro, Antonio/P-2953-2019	Musarò, Antonio/0000-0002-2944-9739; cagnin, stefano/0000-0001-7271-4625; De Pitta, Cristiano/0000-0001-8013-8162; Ribeiro Soares, Ricardo Jose/0000-0002-0457-6862; Musaro, Antonio/0000-0002-2944-9739; Chemello, Francesco/0000-0002-3877-527X	Telethon-Italy [TCP04009]; European Research Council (ERC) [282310-MyoPHAGY]; Progetti di Ricerca di Ateneo of University of Padova; Foundation Leducq; CARIPARO; "Bolsa de Doutoramento" of the "Fundacao para a Ciencia e Tecnologia" [SFRH/BD/15890/2005]; Association Francaise contre les Myopathies [14724]	Telethon-Italy(Fondazione Telethon); European Research Council (ERC)(European Research Council (ERC)); Progetti di Ricerca di Ateneo of University of Padova; Foundation Leducq(Leducq Foundation); CARIPARO(Fondazione Cariparo); "Bolsa de Doutoramento" of the "Fundacao para a Ciencia e Tecnologia"; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported in part by Telethon-Italy Grant TCP04009, European Research Council (ERC) Grant 282310-MyoPHAGY, Progetti di Ricerca di Ateneo of University of Padova, Foundation Leducq, and CARIPARO (to M. S.).; Recipient of a "Bolsa de Doutoramento" of the "Fundacao para a Ciencia e Tecnologia" Grant SFRH/BD/15890/2005 and a fellow from the Association Francaise contre les Myopathies (Grant 14724).	Adams GR, 2007, J APPL PHYSIOL, V103, P1644, DOI 10.1152/japplphysiol.00669.2007; Agarwal P, 2013, BBA-MOL BASIS DIS, V1832, P1294, DOI 10.1016/j.bbadis.2013.03.021; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Blattler SM, 2012, MOL CELL BIOL, V32, P3333, DOI 10.1128/MCB.00337-12; Blattler SM, 2012, CELL METAB, V15, P505, DOI 10.1016/j.cmet.2012.03.008; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Chemello F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016807; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dona M, 2003, BIOCHEM BIOPH RES CO, V312, P1132, DOI 10.1016/j.bbrc.2003.11.032; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Gibbings D, 2012, NAT CELL BIOL, V14, P1314, DOI 10.1038/ncb2611; Girardi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031293; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hsieh CH, 2011, J TRAUMA, V70, P472, DOI 10.1097/TA.0b013e3181e634ce; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeng SF, 2009, J NEUROTRAUM, V26, P2345, DOI 10.1089/neu.2009.0960; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Koning M, 2012, DIFFERENTIATION, V84, P314, DOI 10.1016/j.diff.2012.08.002; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Luo W, 2013, J GENET GENOMICS, V40, P107, DOI 10.1016/j.jgg.2013.02.002; Lynch GS, 2007, PHARMACOL THERAPEUT, V113, P461, DOI 10.1016/j.pharmthera.2006.11.004; Magnusson C, 2005, EUR J NEUROSCI, V21, P577, DOI 10.1111/j.1460-9568.2005.03855.x; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Melov S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000465; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Raffaello A, 2006, PHYSIOL GENOMICS, V25, P60, DOI 10.1152/physiolgenomics.00051.2005; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Romualdi C, 2005, NUCLEIC ACIDS RES, V33, pW644, DOI 10.1093/nar/gki497; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; SCHIAFFINO S, 1972, J ULTRA MOL STRUCT R, V39, P1, DOI 10.1016/S0022-5320(72)80002-9; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shen H, 2013, MOL CELL BIOCHEM, V381, P105, DOI 10.1007/s11010-013-1692-9; Shingara J, 2005, RNA, V11, P1461, DOI 10.1261/rna.2610405; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vaccaro MI, 2008, AUTOPHAGY, V4, P388, DOI 10.4161/auto.5656; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Winbanks CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073589; Winbanks CE, 2012, J CELL BIOL, V197, P997, DOI 10.1083/jcb.201109091; Zacharewicz E, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00266	64	107	112	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					21909	21925		10.1074/jbc.M114.561845	http://dx.doi.org/10.1074/jbc.M114.561845			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24891504	hybrid, Green Published			2022-12-25	WOS:000340593500009
J	Morales, JF; Morin, TJ; Yu, B; Tatsuno, GP; O'Rourke, SM; Theolis, R; Mesa, KA; Berman, PW				Morales, Javier F.; Morin, Trevor J.; Yu, Bin; Tatsuno, Gwen P.; O'Rourke, Sara M.; Theolis, Richard, Jr.; Mesa, Kathryn A.; Berman, Phillip W.			HIV-1 Envelope Proteins and V1/V2 Domain Scaffolds with Mannose-5 to Improve the Magnitude and Quality of Protective Antibody Responses to HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BROADLY NEUTRALIZING ANTIBODIES; VACCINE EFFICACY TRIAL; MONOCLONAL-ANTIBODIES; RECOMBINANT GLYCOPROTEIN-120; POTENT NEUTRALIZATION; SYNTHETIC GLYCOPEPTIDES; TYPE-1 INFECTION; CD4-BINDING SITE; STRUCTURAL BASIS	Two lines of investigation have highlighted the importance of antibodies to the V1/V2 domain of gp120 in providing protection from HIV-1 infection. First, the recent RV144 HIV-1 vaccine trial documented a correlation between non-neutralizing antibodies to the V2 domain and protection. Second, multiple broadly neutralizing monoclonal antibodies to the V1/V2 domain (e. g. PG9) have been isolated from rare infected individuals, termed elite neutralizers. Interestingly, the binding of both types of antibodies appears to depend on the same cluster of amino acids (positions 167-171) adjacent to the junction of the B and C strands of the four-stranded V1/V2 domain beta-sheet structure. However, the broadly neutralizing mAb, PG9, additionally depends on mannose-5 glycans at positions 156 and 160 for binding. Because the gp120 vaccine immunogens used in previous HIV-1 vaccine trials were enriched for complex sialic acid-containing glycans, and lacked the high mannose structures required for the binding of PG9-like mAbs, we wondered if these immunogens could be improved by limiting glycosylation to mannose-5 glycans. Here, we describe the PG9 binding activity of monomeric gp120s from multiple strains of HIV-1 produced with mannose-5 glycans. We also describe the properties of glycopeptide scaffolds from the V1/V2 domain also expressed with mannose-5 glycans. The V1/V2 scaffold from the A244 isolate was able to bind the PG9, CH01, and CH03 mAbs with high affinity provided that the proper glycans were present. We further show that immunization with A244 V1/V2 fragments alone, or in a prime/boost regimen with gp120, enhanced the antibody response to sequences in the V1/V2 domain associated with protection in the RV144 trial.	[Morales, Javier F.; Morin, Trevor J.; Yu, Bin; Tatsuno, Gwen P.; O'Rourke, Sara M.; Theolis, Richard, Jr.; Mesa, Kathryn A.; Berman, Phillip W.] Univ Calif Santa Cruz, Baskin Sch Engn, Dept Biomol Engn, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Berman, PW (corresponding author), Univ Calif Santa Cruz, Baskin Sch Engn, Dept Biomol Engn, 1156 High St,MS SOE2, Santa Cruz, CA 95064 USA.	pwb@soe.ucsc.edu			National Institutes of Health from NIAID [R01 AI 089378-01]; National Institute on Drug Abuse [R01 DA 26801-01A1]; Henry Jackson Foundation [683948]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026801] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Henry Jackson Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI 089378-01 from NIAID and R01 DA 26801-01A1 from National Institute on Drug Abuse. This work was also supported by Grant 683948 from the Henry Jackson Foundation.	Alam SM, 2013, P NATL ACAD SCI USA, V110, P18214, DOI 10.1073/pnas.1317855110; Alam SM, 2013, J VIROL, V87, P1554, DOI 10.1128/JVI.00718-12; Amin MN, 2013, NAT CHEM BIOL, V9, P521, DOI 10.1038/nchembio.1288; ANDERSON KP, 1989, J INFECT DIS, V160, P960, DOI 10.1093/infdis/160.6.960; Andersson KM, 2011, VACCINE, V29, P6092, DOI 10.1016/j.vaccine.2011.06.060; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Aussedat B, 2013, J AM CHEM SOC, V135, P13113, DOI 10.1021/ja405990z; Beddows S, 1998, J GEN VIROL, V79, P77, DOI 10.1099/0022-1317-79-1-77; Beddows S, 2005, VIROLOGY, V337, P136, DOI 10.1016/j.virol.2005.03.033; BELSHE RB, 1994, JAMA-J AM MED ASSOC, V272, P475, DOI 10.1001/jama.272.6.475; Berman PW, 1999, VIROLOGY, V265, P1, DOI 10.1006/viro.1999.0031; Berman PW, 1998, AIDS RES HUM RETROV, V14, pS277; Berman PW, 1997, J INFECT DIS, V176, P384, DOI 10.1086/514055; BERMAN PW, 1990, NATURE, V345, P622, DOI 10.1038/345622a0; Bonomelli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023521; Bonsignori M, 2012, J VIROL, V86, P11521, DOI 10.1128/JVI.01023-12; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; BOUHABIB DC, 1994, J VIROL, V68, P6006, DOI 10.1128/JVI.68.9.6006-6013.1994; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Davenport TM, 2011, J VIROL, V85, P7095, DOI 10.1128/JVI.00411-11; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Doria-Rose NA, 2012, J VIROL, V86, P8319, DOI 10.1128/JVI.00696-12; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Euler Z, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00215; Evans TG, 2001, VACCINE, V19, P2080, DOI 10.1016/S0264-410X(00)00415-1; Excler JL, 2013, CURR OPIN HIV AIDS, V8, P421, DOI 10.1097/COH.0b013e3283632c26; FISCHINGER PJ, 1985, CANCER RES, V45, P4694; Forthal DN, 2007, J IMMUNOL, V178, P6596, DOI 10.4049/jimmunol.178.10.6596; Forthal DN, 2009, CURR OPIN HIV AIDS, V4, P388, DOI 10.1097/COH.0b013e32832f0a89; FRANCIS DP, 1985, NEW ENGL J MED, V313, P1586, DOI 10.1056/NEJM198512193132506; Gilbert PB, 1998, BIOMETRICS, V54, P799, DOI 10.2307/2533835; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Go EP, 2011, INT J MASS SPECTROM, V305, P209, DOI 10.1016/j.ijms.2010.11.009; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; GORNY MK, 1994, J VIROL, V68, P8312, DOI 10.1128/JVI.68.12.8312-8320.1994; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; Haas J, 1996, CURR BIOL, V6, P315, DOI 10.1016/S0960-9822(02)00482-7; Haynes BF, 2013, CURR OPIN HIV AIDS, V8, P326, DOI 10.1097/COH.0b013e328361d178; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hoffenberg S, 2013, J VIROL, V87, P5372, DOI 10.1128/JVI.02827-12; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; Karnasuta C, 2005, VACCINE, V23, P2522, DOI 10.1016/j.vaccine.2004.10.028; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Koff WC, 2012, VACCINE, V30, P4310, DOI 10.1016/j.vaccine.2011.11.014; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; LASKY LA, 1986, SCIENCE, V233, P209, DOI 10.1126/science.3014647; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Long EF, 2011, VACCINE, V29, P6113, DOI 10.1016/j.vaccine.2011.04.013; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; Mascola JR, 1996, J INFECT DIS, V173, P340, DOI 10.1093/infdis/173.2.340; McCoy LE, 2013, J EXP MED, V210, P209, DOI 10.1084/jem.20121827; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; McMichael AJ, 1997, ANNU REV IMMUNOL, V15, P271, DOI 10.1146/annurev.immunol.15.1.271; Migasena S, 2000, AIDS RES HUM RETROV, V16, P655, DOI 10.1089/088922200308882; Montefiori DC, 2012, J INFECT DIS, V206, P431, DOI 10.1093/infdis/jis367; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; MORIKAWA Y, 1990, AIDS RES HUM RETROV, V6, P765, DOI 10.1089/aid.1990.6.765; Nakamura GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039045; NAKAMURA GR, 1993, J VIROL, V67, P6179, DOI 10.1128/JVI.67.10.6179-6191.1993; Nature Publishing Group, 1985, NATURE, V313, P254; Nitayaphan S, 2004, J INFECT DIS, V190, P702, DOI 10.1086/422258; O'Rourke SM, 2009, J VIROL, V83, P7728, DOI 10.1128/JVI.00688-09; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pinter A, 1998, VACCINE, V16, P1803, DOI 10.1016/S0264-410X(98)00182-0; Pitisuttithum P, 2004, JAIDS-J ACQ IMM DEF, V37, P1160, DOI 10.1097/01.qai.0000136091.72955.4b; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WANG YH, 1995, VIROLOGY, V208, P142, DOI 10.1006/viro.1995.1137; Wu LY, 2012, J IMMUNOL, V188, P322, DOI 10.4049/jimmunol.1102466; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Yu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043903; Yu B, 2010, J VIROL, V84, P1513, DOI 10.1128/JVI.01765-09; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053629	98	17	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20526	20542		10.1074/jbc.M114.554089	http://dx.doi.org/10.1074/jbc.M114.554089			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24872420	hybrid, Green Published			2022-12-25	WOS:000339396600014
J	Barucker, C; Harmeier, A; Weiske, J; Fauler, B; Albring, KF; Prokop, S; Hildebrand, P; Lurz, R; Heppner, FL; Huber, O; Multhaup, G				Barucker, Christian; Harmeier, Anja; Weiske, Joerg; Fauler, Beatrix; Albring, Kai Frederik; Prokop, Stefan; Hildebrand, Peter; Lurz, Rudi; Heppner, Frank L.; Huber, Otmar; Multhaup, Gerhard			Nuclear Translocation Uncovers the Amyloid Peptide A beta 42 as a Regulator of Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; APOLIPOPROTEIN-E; DIFFERENTIAL REGULATION; ENDOPLASMIC-RETICULUM; SYNAPTIC PLASTICITY; TRANSGENIC MICE; HUMAN BRAIN; CELL-DEATH	Although soluble species of the amyloid-beta peptide A beta 42 correlate with disease symptoms in Alzheimer disease, little is known about the biological activities of amyloid-beta (A beta). Here, we show that A beta peptides varying in lengths from 38 to 43 amino acids are internalized by cultured neuroblastoma cells and can be found in the nucleus. By three independent methods, we demonstrate direct detection of nuclear A beta 42 as follows: (i) biochemical analysis of nuclear fractions; (ii) detection of biotin-labeled A beta in living cells by confocal laser scanning microscopy; and (iii) transmission electron microscopy of A beta in cultured cells, as well as brain tissue of wild-type and transgenic APPPS1 mice (overexpression of amyloid precursor protein and presenilin 1 with Swedish and L166P mutations, respectively). Also, this study details a novel role for A beta 42 in nuclear signaling, distinct from the amyloid precursor protein intracellular domain. Chromatin immunoprecipitation showed that A beta 42 specifically interacts as a repressor of gene transcription with LRP1 and KAI1 promoters. By quantitative RT-PCR, we confirmed that mRNA levels of the examined candidate genes were exclusively decreased by the potentially neurotoxic A beta 42 wild-type peptide. Shorter peptides (A beta 38 or A beta 40) and other longer peptides (nontoxic A beta 42 G33A substitution or A beta 43) did not affect mRNA levels. Overall, our data indicate that the nuclear translocation of A beta 42 impacts gene regulation, and deleterious effects of A beta 42 in Alzheimer disease pathogenesis may be influenced by altering the expression profiles of disease-modifying genes.	[Barucker, Christian; Harmeier, Anja; Multhaup, Gerhard] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Barucker, Christian; Multhaup, Gerhard] McGill Univ, Dept Pharmacol & Therapeut, Fac Med, Montreal, PQ H3G 0B1, Canada; [Weiske, Joerg; Albring, Kai Frederik; Huber, Otmar] Charite Campus Benjamin Franklin, Inst Clin Chem & Pathobiochem, D-12203 Berlin, Germany; [Fauler, Beatrix; Lurz, Rudi] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Albring, Kai Frederik; Huber, Otmar] Univ Jena, Inst Biochem 2, Jena Univ Hosp, D-07743 Jena, Germany; [Prokop, Stefan; Heppner, Frank L.] Charite, Dept Neuropathol, D-10117 Berlin, Germany; [Hildebrand, Peter] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany	Free University of Berlin; McGill University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Friedrich Schiller University of Jena; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Multhaup, G (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Fac Med, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	gerhard.multhaup@mcgill.ca	Heppner, Frank/ABH-8393-2020; Huber, Otmar/AAA-4548-2021; Prokop, Stefan/Y-1257-2019	Heppner, Frank/0000-0001-9816-8917; Huber, Otmar/0000-0003-4359-1747; Prokop, Stefan/0000-0002-5633-2149; Albring, Kai Frederik/0000-0003-3761-7533	Deutsche Forschungsgemeinschaft [SFB740, GRK1123, SFBTRR 43, NeuroCure Exc 257]; Kompetenznetz Degenerative Demenzen Forderkennzeichen Grant [01 GI 0723]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Kompetenznetz Degenerative Demenzen Forderkennzeichen Grant	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB740 and GRK1123 (to G. M.), Kompetenznetz Degenerative Demenzen Forderkennzeichen Grant 01 GI 0723 (to G. M.), Deutsche Forschungsgemeinschaft grants (to F. L. H. and S. P.), and Deutsche Forschungsgemeinschaft Grant SFBTRR 43 and NeuroCure Exc 257 (to F. L. H.).	Aho L, 2010, J ALZHEIMERS DIS, V20, P1015, DOI 10.3233/JAD-2010-091681; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bailey JA, 2011, GENE, V488, P13, DOI 10.1016/j.gene.2011.06.017; Barrantes A, 2007, J ALZHEIMERS DIS, V12, P345; Bayer TA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00008; Benilova I, 2013, SCIENCE, V341, P1354, DOI 10.1126/science.1244166; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; FRASER PE, 1991, J NEUROSCI RES, V28, P474, DOI 10.1002/jnr.490280404; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Gersbacher MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069363; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harmeier A, 2009, J NEUROSCI, V29, P7582, DOI 10.1523/JNEUROSCI.1336-09.2009; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Ida N, 1996, FEBS LETT, V394, P174, DOI 10.1016/0014-5793(96)00948-9; Kaden D, 2012, EMBO MOL MED, V4, P647, DOI 10.1002/emmm.201200239; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Kagan BL, 2002, PEPTIDES, V23, P1311, DOI 10.1016/S0196-9781(02)00067-0; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; LAFERLA FM, 1995, NAT GENET, V9, P21, DOI 10.1038/ng0195-21; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li J, 2012, J BIOL CHEM, V287, P44593, DOI 10.1074/jbc.M112.420224; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Maloney B, 2011, GENE, V488, P1, DOI 10.1016/j.gene.2011.06.004; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Mohr D, 2009, EMBO J, V28, P2541, DOI 10.1038/emboj.2009.200; Munter LM, 2010, J BIOL CHEM, V285, P21636, DOI 10.1074/jbc.M109.088005; Nielsen HM, 2010, GLIA, V58, P1235, DOI 10.1002/glia.21004; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Ohyagi Y, 2005, FASEB J, V19, P255, DOI 10.1096/fj.04-2637fje; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Riese F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076094; Rowe A, 2008, NEOPLASIA, V10, P1421, DOI 10.1593/neo.08850; Saavedra L, 2007, J BIOL CHEM, V282, P35722, DOI 10.1074/jbc.M701823200; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Stephan A, 2001, J NEUROSCI, V21, P5703, DOI 10.1523/JNEUROSCI.21-15-05703.2001; STICHT H, 1995, EUR J BIOCHEM, V233, P293, DOI 10.1111/j.1432-1033.1995.293_1.x; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Sultan A, 2011, J BIOL CHEM, V286, P4566, DOI 10.1074/jbc.M110.199976; Uchida Y, 2007, J BIOL CHEM, V282, P19700, DOI 10.1074/jbc.M703099200; Umeda T, 2011, J NEUROSCI RES, V89, P1031, DOI 10.1002/jnr.22640; Verdier Y, 2004, J PEPT SCI, V10, P229, DOI 10.1002/psc.573; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wegiel J, 2007, ACTA NEUROPATHOL, V113, P389, DOI 10.1007/s00401-006-0191-4; Welander H, 2009, J NEUROCHEM, V110, P697, DOI 10.1111/j.1471-4159.2009.06170.x; Yoshiike Y, 2007, NEUROMOL MED, V9, P270, DOI 10.1007/s12017-007-0003-6; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	64	54	54	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20182	20191		10.1074/jbc.M114.564690	http://dx.doi.org/10.1074/jbc.M114.564690			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24878959	Green Published, hybrid			2022-12-25	WOS:000339395200031
J	Yang, J; Singh, V; Chen, TE; Sarker, R; Xiong, L; Cha, B; Jin, S; Li, X; Tse, CM; Zachos, NC; Donowitz, M				Yang, Jianbo; Singh, Varsha; Chen, Tian-E; Sarker, Rafiquel; Xiong, Lishou; Cha, Boyoung; Jin, Shi; Li, Xuhang; Tse, C. Ming; Zachos, Nicholas C.; Donowitz, Mark			NHERF2/NHERF3 Protein Heterodimerization and Macrocomplex Formation Are Required for the Inhibition of NHE3 Activity by Carbachol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; NA+/H+ EXCHANGER NHE3; ILEAL BRUSH-BORDER; PDZ DOMAINS; SCAFFOLDING PROTEINS; CLASS-B; STIMULATION; TRAFFICKING; ASSOCIATION; COMPLEX	NHERF1, NHERF2, and NHERF3 belong to the NHERF (Na+/H+ exchanger regulatory factor) family of PSD-95/Discs-large/ZO-1 (PDZ) scaffolding proteins. Individually, each NHERF protein has been shown to be involved in the regulation of multiple receptors or transporters including Na+/H+ exchanger 3 (NHE3). Although NHERF dimerizations have been reported, results have been inconsistent, and the physiological function of NHERF dimerizations is still unknown. The current study semiquantitatively compared the interaction strength among all possible homodimerizations and heterodimerizations of these three NHERF proteins by pulldown and co-immunoprecipitation assays. Both methods showed that NHERF2 and NHERF3 heterodimerize as the strongest interaction among all NHERF dimerizations. In vivo NHERF2/NHERF3 heterodimerization was confirmed by FRET and FRAP (fluorescence recovery after photobleach). NHERF2/NHERF3 heterodimerization is mediated by PDZ domains of NHERF2 and the C-terminal PDZ domain recognition motif of NHERF3. The NHERF3-4A mutant is defective in heterodimerization with NHERF2 and does not support the inhibition of NHE3 by carbachol. This suggests a role for NHERF2/NHERF3 heterodimerization in the regulation of NHE3 activity. In addition, both PDZ domains of NHERF2 could be simultaneously occupied by NHERF3 and another ligand such as NHE3, alpha-actinin-4, and PKC alpha, promoting formation of NHE3 macrocomplexes. This study suggests that NHERF2/NHERF3 heterodimerization mediates the formation of NHE3 macrocomplexes, which are required for the inhibition of NHE3 activity by carbachol.	[Yang, Jianbo; Singh, Varsha; Chen, Tian-E; Sarker, Rafiquel; Xiong, Lishou; Cha, Boyoung; Jin, Shi; Li, Xuhang; Tse, C. Ming; Zachos, Nicholas C.; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21205 USA; [Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Donowitz, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, 925 Ross Res Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.	mdonowit@jhmi.edu	Yang, Jianbo/G-1254-2013; Zachos, Nicholas/GWC-7914-2022	Jin, Shi/0000-0003-0177-5716	National Institutes of Health [P30DK089502]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072084, R01DK061765, R01DK026523, K08DK088950, P30DK089502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Mr. John Gibas (Johns Hopkins University) for technical assistance in performance of the FRET and FRAP studies. We thank Dr. Chris Yun (Emory University) for providing rabbit polyclonal antibody against NHERF2. We acknowledge use of the Kudsi Imaging Core Facility (National Institutes of Health Grant P30DK089502).	Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Blaine J, 2011, ADV CHRONIC KIDNEY D, V18, P77, DOI 10.1053/j.ackd.2011.01.005; Cha BY, 2010, J CELL SCI, V123, P2434, DOI 10.1242/jcs.056713; Chang BH, 2011, CHEM BIOL, V18, P1143, DOI 10.1016/j.chembiol.2011.06.013; Chen MM, 2010, J PHYSIOL-LONDON, V588, P5049, DOI 10.1113/jphysiol.2010.198721; CHOUGH SP, 1993, YALE J BIOL MED, V66, P525; Cinar A, 2007, J PHYSIOL-LONDON, V581, P1235, DOI 10.1113/jphysiol.2007.131722; Cotton LM, 2010, MOL REPROD DEV, V77, P114, DOI 10.1002/mrd.21122; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; DONOWITZ M, 1989, J CLIN INVEST, V83, P1953, DOI 10.1172/JCI114104; DONOWITZ M, 1982, LIFE SCI, V31, P1929, DOI 10.1016/0024-3205(82)90031-5; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Fenske SA, 2009, J BIOL CHEM, V284, P5797, DOI 10.1074/jbc.M808211200; Fouassier L, 2000, J BIOL CHEM, V275, P25039, DOI 10.1074/jbc.C000092200; Garbett D, 2010, J CELL BIOL, V191, P397, DOI 10.1083/jcb.201004115; Gisler SM, 2003, KIDNEY INT, V64, P1733, DOI 10.1046/j.1523-1755.2003.00266.x; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Kim JH, 2002, J BIOL CHEM, V277, P23714, DOI 10.1074/jbc.M200835200; LaLonde DP, 2010, MOL BIOL CELL, V21, P1519, DOI 10.1091/mbc.E10-01-0008; LaLonde DP, 2009, BIOCHEMISTRY-US, V48, P2261, DOI 10.1021/bi802089k; Lamprecht G, 2002, BIOCHEMISTRY-US, V41, P12336, DOI 10.1021/bi0259103; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Lee-Kwon W, 2003, AM J PHYSIOL-CELL PH, V285, pC1527, DOI 10.1152/ajpcell.00017.2003; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Li XH, 2004, J PHYSIOL-LONDON, V556, P791, DOI 10.1113/jphysiol.2004.060921; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Maudsley S, 2000, MOL CELL BIOL, V20, P8352, DOI 10.1128/MCB.20.22.8352-8363.2000; Murtazina R, 2007, J BIOL CHEM, V282, P25141, DOI 10.1074/jbc.M701910200; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Murtazina R, 2011, AM J PHYSIOL-CELL PH, V301, pC126, DOI 10.1152/ajpcell.00311.2010; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; Sarker R, 2011, AM J PHYSIOL-CELL PH, V300, pC771, DOI 10.1152/ajpcell.00119.2010; Schultheis PJ, 1998, NAT GENET, V19, P282, DOI 10.1038/969; Seidler U, 2009, ANN NY ACAD SCI, V1165, P249, DOI 10.1111/j.1749-6632.2009.04046.x; Seidler U, 2009, EXP PHYSIOL, V94, P175, DOI 10.1113/expphysiol.2008.043018; Singh V, 2014, CLIN GASTROENTEROL H, V12, P27, DOI 10.1016/j.cgh.2013.10.020; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Tsukamoto K, 2013, J BIOL CHEM, V288, P19845, DOI 10.1074/jbc.M113.460170; Wade JB, 2003, AM J PHYSIOL-CELL PH, V285, pC1494, DOI 10.1152/ajpcell.00092.2003; Weinman EJ, 2003, BIOCHEMISTRY-US, V42, P12662, DOI 10.1021/bi035244l; WEINMAN EJ, 1995, J CLIN INVEST, V95, P2143, DOI 10.1172/JCI117903; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Yang JB, 2013, J BIOL CHEM, V288, P16960, DOI 10.1074/jbc.M113.470799; Yun CC, 2002, J BIOL CHEM, V277, P7676, DOI 10.1074/jbc.M107768200; Yun CHC, 1998, J BIOL CHEM, V273, P25856, DOI 10.1074/jbc.273.40.25856; Zachos NC, 2009, J BIOL CHEM, V284, P23708, DOI 10.1074/jbc.M109.012641	50	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20039	20053		10.1074/jbc.M114.562413	http://dx.doi.org/10.1074/jbc.M114.562413			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24867958	hybrid, Green Published			2022-12-25	WOS:000339395200019
J	Kuntner, M; Naparus, M; Li, DQ; Coddington, JA				Kuntner, Matjaz; Naparus, Magdalena; Li, Daiqin; Coddington, Jonathan A.			Phylogeny Predicts Future Habitat Shifts Due to Climate Change	PLOS ONE			English	Article							RANGE EXPANSION; IMPACTS; DRIVEN; DISTRIBUTIONS; BIODIVERSITY; EXTINCTIONS; EVOLUTION; PATTERNS; ARANEAE	Background: Taxa may respond differently to climatic changes, depending on phylogenetic or ecological effects, but studies that discern among these alternatives are scarce. Here, we use two species pairs from globally distributed spider clades, each pair representing two lifestyles (generalist, specialist) to test the relative importance of phylogeny versus ecology in predicted responses to climate change. Methodology: We used a recent phylogenetic hypothesis for nephilid spiders to select four species from two genera (Nephilingis and Nephilengys) that match the above criteria, are fully allopatric but combined occupy all subtropical-tropical regions. Based on their records, we modeled each species niche spaces and predicted their ecological shifts 20, 40, 60, and 80 years into the future using customized GIS tools and projected climatic changes. Conclusions: Phylogeny better predicts the species current ecological preferences than do lifestyles. By 2080 all species face dramatic reductions in suitable habitat (54.8-77.1%) and adapt by moving towards higher altitudes and latitudes, although at different tempos. Phylogeny and life style explain simulated habitat shifts in altitude, but phylogeny is the sole best predictor of latitudinal shifts. Models incorporating phylogenetic relatedness are an important additional tool to predict accurately biotic responses to global change.	[Kuntner, Matjaz] Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Ljubljana, Slovenia; [Kuntner, Matjaz; Li, Daiqin] Hubei Univ, Coll Life Sci, Ctr Behav Ecol & Evolut, Wuhan, Hubei, Peoples R China; [Kuntner, Matjaz; Coddington, Jonathan A.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Naparus, Magdalena] Univ Bucharest, Ctr Landscape Terr Informat Syst CeLTIS, Bucharest, Romania; [Naparus, Magdalena] Tular Cave Lab, Kranj, Slovenia; [Li, Daiqin] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National Institute of Biology - Slovenia; Slovenian Academy of Sciences & Arts (SASA); Hubei University; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Bucharest; National University of Singapore	Kuntner, M (corresponding author), Slovenian Acad Sci & Arts, Inst Biol, Ctr Sci Res, Ljubljana, Slovenia.	kuntner@gmail.com	Li, Daiqin/CAH-3746-2022; Kuntner, Matjaz/AAE-2195-2020; Aljancic, Magdalena/O-4801-2014; Li, Daiqin/D-6922-2013	Li, Daiqin/0000-0001-8269-7734; Li, Daiqin/0000-0001-8269-7734; Coddington, Jonathan A./0000-0001-6004-7730	Raffles Museum for Biodiversity Research (RMBR); Slovenian Research Agency [P10236, BI-US/09-12-016, MU-PROM/12-001]; NSFC [31272324]; Singapore Ministry of Education (MOE) AcRF [R-154-000-476-112]	Raffles Museum for Biodiversity Research (RMBR); Slovenian Research Agency(Slovenian Research Agency - Slovenia); NSFC(National Natural Science Foundation of China (NSFC)); Singapore Ministry of Education (MOE) AcRF(Ministry of Education, Singapore)	This research was supported in part by a Raffles Museum for Biodiversity Research (RMBR) Short-term Fellowship and the grants P10236, BI-US/09-12-016 and MU-PROM/12-001 from the Slovenian Research Agency to M. K. and by the NSFC grant (31272324) and Singapore Ministry of Education (MOE) AcRF grant (R-154-000-476-112) to D. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angert AL, 2011, ECOL LETT, V14, P677, DOI 10.1111/j.1461-0248.2011.01620.x; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Banfai DS, 2006, BIOL CONSERV, V131, P553, DOI 10.1016/j.biocon.2006.03.002; Barton BT, 2009, ECOL LETT, V12, P1317, DOI 10.1111/j.1461-0248.2009.01386.x; Beale CM, 2013, ECOL LETT, V16, P1061, DOI 10.1111/ele.12139; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bennie J, 2013, ECOL LETT, V16, P921, DOI 10.1111/ele.12129; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Brierley AS, 2009, CURR BIOL, V19, pR602, DOI 10.1016/j.cub.2009.05.046; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Diamond SE, 2012, GLOBAL CHANGE BIOL, V18, P448, DOI 10.1111/j.1365-2486.2011.02542.x; Erwin DH, 2009, CURR BIOL, V19, pR575, DOI 10.1016/j.cub.2009.05.047; ESRI, 2010, ARCGIS 9 3 1; Flato GM, 2001, GEOPHYS RES LETT, V28, P195, DOI 10.1029/2000GL012121; Forster P., 2007, CLIMATE CHANGE 2007; Franco AMA, 2006, GLOBAL CHANGE BIOL, V12, P1545, DOI 10.1111/j.1365-2486.2006.01180.x; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/NCLIMATE1329, 10.1038/nclimate1329]; Habel JC, 2011, GLOBAL CHANGE BIOL, V17, P194, DOI 10.1111/j.1365-2486.2010.02233.x; Hegland SJ, 2009, ECOL LETT, V12, P184, DOI 10.1111/j.1461-0248.2008.01269.x; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; Heubes J, 2011, J BIOGEOGR, V38, P2248, DOI 10.1111/j.1365-2699.2011.02560.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hillebrand H, 2010, GLOBAL CHANGE BIOL, V16, P1181, DOI 10.1111/j.1365-2486.2009.02045.x; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hof C, 2011, GLOBAL CHANGE BIOL, V17, P2987, DOI 10.1111/j.1365-2486.2011.02418.x; Intergovernmental Panel on Climate Change (IPCC), 2000, SPEC REP EM SCEN SUM; IPCC, 2007, REP WORK GROUP 1 INT; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Kearney MR, 2013, ECOL LETT, V16, P1470, DOI 10.1111/ele.12192; Kuntner M, 2007, SYST ENTOMOL, V32, P95, DOI 10.1111/j.1365-3113.2006.00348.x; Kuntner M, 2013, MOL PHYLOGENET EVOL, V69, P961, DOI 10.1016/j.ympev.2013.06.008; Kuntner M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-119; Kuntner M, 2011, MOL PHYLOGENET EVOL, V59, P477, DOI 10.1016/j.ympev.2011.02.002; Lawler JJ, 2013, ECOL LETT, V16, P1014, DOI 10.1111/ele.12132; Munday PL, 2013, ECOL LETT, V16, P1488, DOI 10.1111/ele.12185; Naparus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030047; Pau S, 2011, GLOBAL CHANGE BIOL, V17, P3633, DOI 10.1111/j.1365-2486.2011.02515.x; Pigot AL, 2013, ECOL LETT, V16, P330, DOI 10.1111/ele.12043; Post E, 2013, P ROYAL SOC B, V280; Quintero I, 2013, ECOL LETT, V16, P1095, DOI 10.1111/ele.12144; Ramirez-Villegas J, 2010, 1 CIAT; Razgour O, 2013, ECOL LETT, V16, P1258, DOI 10.1111/ele.12158; Saikkonen K, 2012, NAT CLIM CHANGE, V2, P239, DOI [10.1038/NCLIMATE1430, 10.1038/nclimate1430]; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Sandel B, 2012, GLOBAL CHANGE BIOL, V18, P277, DOI 10.1111/j.1365-2486.2011.02480.x; Scinocca JF, 2008, ATMOS CHEM PHYS, V8, P7055, DOI 10.5194/acp-8-7055-2008; Slatyer RA, 2013, ECOL LETT, V16, P1104, DOI 10.1111/ele.12140; Teixeira J, 2002, BIODIVERS CONSERV, V11, P2167, DOI 10.1023/A:1021342611769; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; Vink CJ, 2011, BIOL INVASIONS, V13, P1003, DOI 10.1007/s10530-010-9885-6; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105	52	11	11	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98907	10.1371/journal.pone.0098907	http://dx.doi.org/10.1371/journal.pone.0098907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892737	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400109
J	Monnahan, CC; Branch, TA; Stafford, KM; Ivashchenko, YV; Oleson, EM				Monnahan, Cole C.; Branch, Trevor A.; Stafford, Kathleen M.; Ivashchenko, Yulia V.; Oleson, Erin M.			Estimating Historical Eastern North Pacific Blue Whale Catches Using Spatial Calling Patterns	PLOS ONE			English	Article							BALAENOPTERA-MUSCULUS; TROPICAL PACIFIC; CALIFORNIA; WATERS	Blue whales (Balaenoptera musculus) were exploited extensively around the world and remain endangered. In the North Pacific their population structure is unclear and current status unknown, with the exception of a well-studied eastern North Pacific (ENP) population. Despite existing abundance estimates for the ENP population, it is difficult to estimate pre-exploitation abundance levels and gauge their recovery because historical catches of the ENP population are difficult to separate from catches of other populations in the North Pacific. We collated previously unreported Soviet catches and combined these with known catches to form the most current estimates of North Pacific blue whale catches. We split these conflated catches using recorded acoustic calls from throughout the North Pacific, the knowledge that the ENP population produces a different call than blue whales in the western North Pacific (WNP). The catches were split by estimating spatiotemporal occurrence of blue whales with generalized additive models fitted to acoustic call patterns, which predict the probability a catch belonged to the ENP population based on the proportion of calls of each population recorded by latitude, longitude, and month. When applied to the conflated historical catches, which totaled 9,773, we estimate that ENP blue whale catches totaled 3,411 (95% range 2,593 to 4,114) from 1905-1971, and amounted to 35% (95% range 27% to 42%) of all catches in the North Pacific. Thus most catches in the North Pacific were for WNP blue whales, totaling 6,362 (95% range 5,659 to 7,180). The uncertainty in the acoustic data influence the results substantially more than uncertainty in catch locations and dates, but the results are fairly insensitive to the ecological assumptions made in the analysis. The results of this study provide information for future studies investigating the recovery of these populations and the impact of continuing and future sources of anthropogenic mortality.	[Monnahan, Cole C.] Univ Washington, Seattle, WA 98195 USA; [Branch, Trevor A.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Stafford, Kathleen M.] Univ Washington, Appl Phys Lab, Seattle, WA 98195 USA; [Ivashchenko, Yulia V.] Alaska Fisheries Sci Ctr, Natl Marine Mammal Lab, Seattle, WA USA; [Ivashchenko, Yulia V.] So Cross Univ, Sch Environm Sci & Management, Lismore, NSW 2480, Australia; [Oleson, Erin M.] Pacific Isl Fisheries Sci Ctr, Protected Species Div, Honolulu, HI USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; Southern Cross University	Monnahan, CC (corresponding author), Univ Washington, Seattle, WA 98195 USA.	colemonnahan@gmail.com	Oleson, Erin/AAA-9681-2019	Oleson, Erin/0000-0002-4889-6059; Stafford, Kathleen/0000-0003-0039-5025	Joint Institute for the Study of the Atmosphere and Ocean (JISAO) under NOAA [NA10OAR4320148, 2151]	Joint Institute for the Study of the Atmosphere and Ocean (JISAO) under NOAA	This publication is funded by the Joint Institute for the Study of the Atmosphere and Ocean (JISAO) under NOAA Cooperative Agreement NA10OAR4320148, Contribution No. 2151. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison C, 2011, IWC SUMMARY CATCH DA; Allison C, 2011, IWC INDIVIDUAL CATCH; Bailey Helen, 2010, Endangered Species Research, V10, P93, DOI 10.3354/esr00239; Baker CS, 2004, TRENDS ECOL EVOL, V19, P365, DOI 10.1016/j.tree.2004.05.005; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Calambokidis J, 2004, MAR MAMMAL SCI, V20, P63, DOI 10.1111/j.1748-7692.2004.tb01141.x; Calambokidis J., 2009, PHOTOGRAPHIC IDENTIF; Calambokidis J, 2009, MAR MAMMAL SCI, V25, P816, DOI 10.1111/j.1748-7692.2009.00298.x; Carretta JV, 2012, NOAATMNMFSSWFSC504; Costa-Urrutia P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058315; Efron B., 1994, INTRO BOOTSTRAP; Gilpatrick James W. Jr., 2008, Journal of Cetacean Research and Management, V10, P9; Goldbogen JA, 2011, J EXP BIOL, V214, P698, DOI 10.1242/jeb.054726; Gregr EJ, 2001, CAN J FISH AQUAT SCI, V58, P1265, DOI 10.1139/cjfas-58-7-1265; Ivashchenko Y. V., 2013, Journal of Cetacean Research and Management, V13, P59; McDonald MA, 1999, J ACOUST SOC AM, V105, P2643, DOI 10.1121/1.426880; McDonald Mark A., 2006, Journal of Cetacean Research and Management, V8, P55; Melcon ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032681; Oleson EM, 2007, ANIM BEHAV, V74, P881, DOI 10.1016/j.anbehav.2007.01.022; Oleson EM, 2007, MAR MAMMAL SCI, V23, P574, DOI 10.1111/j.1748-7692.2007.02303.x; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; R Core Team, 2012, R LANG ENV STAT COMP; Reeves RR, 1998, PUBLICATIONS AGENCES; Reilly SB, 2008, IUCN 2012 IUCN RED L; RICE DW, 1998, MARINE MAMMALS WORLD; Rigby RA, 2005, J R STAT SOC C-APPL, V54, P507, DOI 10.1111/j.1467-9876.2005.00510.x; Rivers JA, 1997, MAR MAMMAL SCI, V13, P186, DOI 10.1111/j.1748-7692.1997.tb00626.x; Stafford Kathleen M., 2001, Journal of Cetacean Research and Management, V3, P65; Stafford KM, 2003, MAR MAMMAL SCI, V19, P682, DOI 10.1111/j.1748-7692.2003.tb01124.x; Stafford KM, 1999, MAR MAMMAL SCI, V15, P1258, DOI 10.1111/j.1748-7692.1999.tb00889.x; Stafford KM, 1999, J ACOUST SOC AM, V106, P3687, DOI 10.1121/1.428220; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; YABLOKOV AV, 1994, NATURE, V367, P108, DOI 10.1038/367108a0	33	17	19	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98974	10.1371/journal.pone.0098974	http://dx.doi.org/10.1371/journal.pone.0098974			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892427	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400116
J	Hao, XP; Xing, YZ; Moore, MW; Zhang, JN; Han, DM; Schulte, BA; Dubno, JR; Lang, HN				Hao, Xinping; Xing, Yazhi; Moore, Michael W.; Zhang, Jianning; Han, Demin; Schulte, Bradley A.; Dubno, Judy R.; Lang, Hainan			Sox10 Expressing Cells in the Lateral Wall of the Aged Mouse and Human Cochlea	PLOS ONE			English	Article							SPIRAL LIGAMENT PATHOLOGY; STRIA VASCULARIS; INNER-EAR; CARBONIC-ANHYDRASE; MARGINAL CELLS; FINE-STRUCTURE; K+ CHANNEL; FIBROCYTES; LOCALIZATION; MECHANISMS	Age-related hearing loss (presbycusis) is a common human disorder, affecting one in three Americans aged 60 and over. Previous studies have shown that presbyacusis is associated with a loss of non-sensory cells in the cochlear lateral wall. Sox10 is a transcription factor crucial to the development and maintenance of neural crest-derived cells including some non-sensory cell types in the cochlea. Mutations of the Sox10 gene are known to cause various combinations of hearing loss and pigmentation defects in humans. This study investigated the potential relationship between Sox10 gene expression and pathological changes in the cochlear lateral wall of aged CBA/CaJ mice and human temporal bones from older donors. Cochlear tissues prepared from young adult (1-3 month-old) and aged (2-2.5 year-old) mice, and human temporal bone donors were examined using quantitative immunohistochemical analysis and transmission electron microscopy. Cells expressing Sox10 were present in the stria vascularis, outer sulcus and spiral prominence in mouse and human cochleas. The Sox10(+) cell types included marginal and intermediate cells and outer sulcus cells, including those that border the scala media and those extending into root processes (root cells) in the spiral ligament. Quantitative analysis of immunostaining revealed a significant decrease in the number of Sox10(+) marginal cells and outer sulcus cells in aged mice. Electron microscopic evaluation revealed degenerative alterations in the surviving Sox10(+) cells in aged mice. Strial marginal cells in human cochleas from donors aged 87 and older showed only weak immunostaining for Sox10. Decreases in Sox10 expression levels and a loss of Sox10(+) cells in both mouse and human aged ears suggests an important role of Sox10 in the maintenance of structural and functional integrity of the lateral wall. A loss of Sox10(+) cells may also be associated with a decline in the repair capabilities of non-sensory cells in the aged ear.	[Hao, Xinping; Han, Demin] Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Hao, Xinping; Xing, Yazhi; Zhang, Jianning; Schulte, Bradley A.; Dubno, Judy R.; Lang, Hainan] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Moore, Michael W.; Schulte, Bradley A.; Dubno, Judy R.] Med Univ S Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA; [Zhang, Jianning] Shanghai Yueyang Integrated Med Hosp, Dept Otolaryngol, Shanghai, Peoples R China	Capital Medical University; Medical University of South Carolina; Medical University of South Carolina	Han, DM (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	handm@trhos.com; langh@musc.edu	Xing, Yazhi/HDO-1842-2022; Xing, Yazhi/GVU-8191-2022	Xing, Yazhi/0000-0001-8975-7242; Lang, Hainan/0000-0003-2210-7856	National Institutes of Health (NIH) [NIH DC12058, NIH DC00422]; South Carolina Clinical and Translational Research Institute (SCTR) Clinical and Translational Science Award [NIH/NCRR UL1RR029882]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P50DC000422, P01DC000422, R01DC012058] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Clinical and Translational Research Institute (SCTR) Clinical and Translational Science Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH), Grant number: NIH DC12058 (HL), Grant number: NIH DC00422 (HL, JRD). This work also benefited from the South Carolina Clinical and Translational Research Institute (SCTR) Clinical and Translational Science Award (NIH/NCRR UL1RR029882). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando M, 1999, CELL TISSUE RES, V298, P179, DOI 10.1007/s004419900066; ANNIKO M, 1980, ARCH OTO-RHINO-LARYN, V229, P281, DOI 10.1007/BF02565531; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Cheung M, 2005, DEV CELL, V8, P179, DOI 10.1016/j.devcel.2004.12.010; Crouch JJ, 1997, J HISTOCHEM CYTOCHEM, V45, P773, DOI 10.1177/002215549704500601; Cunningham CD, 2001, LARYNGOSCOPE, V111, P278, DOI 10.1097/00005537-200102000-00017; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; FORGE A, 1993, SCIENCE, V259, P1616, DOI 10.1126/science.8456284; GATES GA, 1990, EAR HEARING, V11, P247, DOI 10.1097/00003446-199008000-00001; Haldin CE, 2010, INT J BIOCHEM CELL B, V42, P441, DOI 10.1016/j.biocel.2009.11.014; Hequembourg S, 2001, JARO-J ASSOC RES OTO, V2, P118, DOI 10.1007/s101620010075; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Hibino H, 1997, J NEUROSCI, V17, P4711; Hibino H, 2004, EUR J NEUROSCI, V19, P76, DOI 10.1111/j.1460-9568.2004.03092.x; Hibino H, 2006, PHYSIOLOGY, V21, P336, DOI 10.1152/physiol.00023.2006; HIEBER V, 1989, J NEUROSCI RES, V23, P9, DOI 10.1002/jnr.490230103; HILDING DA, 1977, ACTA OTO-LARYNGOL, V84, P24, DOI 10.3109/00016487709123939; HINOJOSA R, 1966, AM J ANAT, V118, P631, DOI 10.1002/aja.1001180218; Jagger DJ, 2010, J ASS RES OTOLARYNGO; Jagger DJ, 2012, HEARING RES, V303, P1; JAHNKE K, 1975, ANAT EMBRYOL, V147, P189, DOI 10.1007/BF00306733; Kelsh RN, 2002, RES PRO CEL, V40, P216; Kim HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017949; Kusunoki T, 2004, OTOLARYNG HEAD NECK, V131, P897, DOI 10.1016/j.otohns.2004.05.022; Lang H, 2003, JARO-J ASSOC RES OTO, V4, P164, DOI 10.1007/s10162-002-2056-4; Lang H, 2013, ASS RES OT ABSTR, V35, P905; Lang HN, 2011, JARO-J ASSOC RES OTO, V12, P151, DOI 10.1007/s10162-010-0244-1; Lang HN, 2010, JARO-J ASSOC RES OTO, V11, P419, DOI 10.1007/s10162-010-0214-7; Lang HN, 2006, J NEUROSCI, V26, P3541, DOI 10.1523/JNEUROSCI.2488-05.2006; LIM DJ, 1983, AM J OTOLARYNG, V4, P33, DOI 10.1016/S0196-0709(83)80005-2; LOWE N, 1991, GENOMICS, V10, P882, DOI 10.1016/0888-7543(91)90176-F; Minowa O, 1999, SCIENCE, V285, P1408, DOI 10.1126/science.285.5432.1408; Mistrik P, 2009, J R SOC INTERFACE, V6, P279, DOI 10.1098/rsif.2008.0201; Neng LL, 2013, JARO-J ASSOC RES OTO, V14, P175, DOI 10.1007/s10162-012-0365-9; Ohlemiller KK, 2006, HEARING RES, V220, P10, DOI 10.1016/j.heares.2006.06.012; Ohlemiller KK, 2010, JARO-J ASSOC RES OTO, V11, P605, DOI 10.1007/s10162-010-0228-1; Ohlemiller KK, 2009, BRAIN RES, V1277, P70, DOI 10.1016/j.brainres.2009.02.079; Patuzzi R, 2011, HEARING RES, V277, P4, DOI 10.1016/j.heares.2011.01.010; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; Ruben RJ, 1967, ACTA OTO LARYNGOLOGI, V220, P221; SALT AN, 1987, LARYNGOSCOPE, V97, P984; Santi PA, 2005, OTOLARYNGOLOGY HEAD; SANTOS-SACCHI J, 1982, HEARING RES, V6, P7, DOI 10.1016/0378-5955(82)90003-X; Schlierf B, 2006, J MOL BIOL, V361, P11, DOI 10.1016/j.jmb.2006.05.072; Schmiedt RA, 1996, J NEUROPHYSIOL, V76, P2799, DOI 10.1152/jn.1996.76.4.2799; Schmiedt RA, 2010, SPRINGER HANDB AUDIT, V34, P9, DOI 10.1007/978-1-4419-0993-0_2; SCHUKNECHT HF, 1993, ANN OTO RHINOL LARYN, V102, P1; SCHULNECHT H, 1968, Archives of Otolaryngology, V87, P129; SCHULTE BA, 1992, HEARING RES, V61, P35, DOI 10.1016/0378-5955(92)90034-K; SCHULTE BA, 1994, HEARING RES, V78, P65, DOI 10.1016/0378-5955(94)90045-0; SCHULTE BA, 1989, J HISTOCHEM CYTOCHEM, V37, P127, DOI 10.1177/37.2.2536055; Sha SH, 2008, HEARING RES, V243, P87, DOI 10.1016/j.heares.2008.06.001; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Spicer SS, 1996, HEARING RES, V100, P80, DOI 10.1016/0378-5955(96)00106-2; SPICER SS, 1990, AM J ANAT, V187, P55, DOI 10.1002/aja.1001870107; Spicer SS, 2005, HEARING RES, V205, P225, DOI 10.1016/j.heares.2005.03.022; Spicer SS, 1998, HEARING RES, V118, P1, DOI 10.1016/S0378-5955(98)00006-9; Spicer SS, 2002, HEARING RES, V172, P172, DOI 10.1016/S0378-5955(02)00581-6; SPICER SS, 1991, HEARING RES, V56, P53, DOI 10.1016/0378-5955(91)90153-Z; Spicer SS, 1997, HEARING RES, V111, P93, DOI 10.1016/S0378-5955(97)00097-X; Steel KP, 1999, SCIENCE, V285, P1363, DOI 10.1126/science.285.5432.1363; Stolt CC, 2010, INT J BIOCHEM CELL B, V42, P437, DOI 10.1016/j.biocel.2009.07.014; Thomopoulos GN, 1997, HEARING RES, V111, P31, DOI 10.1016/S0378-5955(97)00080-4; Wakaoka T, 2013, HEARING RES, V302, P17, DOI 10.1016/j.heares.2013.05.003; WANGEMANN P, 1995, HEARING RES, V84, P19, DOI 10.1016/0378-5955(95)00009-S; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Watanabe K, 2000, MOL BRAIN RES, V84, P141, DOI 10.1016/S0169-328X(00)00236-9; Weber PC, 2001, LARYNGOSCOPE, V111, P1156, DOI 10.1097/00005537-200107000-00006; Wu T, 2003, JARO-J ASSOC RES OTO, V4, P353, DOI 10.1007/s10162-002-3026-6; Xing YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034500	72	15	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97389	10.1371/journal.pone.0097389	http://dx.doi.org/10.1371/journal.pone.0097389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887110	Green Submitted, Green Published, gold			2022-12-25	WOS:000336956300017
J	Bassaganas, S; Carvalho, S; Dias, AM; Perez-Garay, M; Ortiz, MR; Figueras, J; Reis, CA; Pinho, SS; Peracaula, R				Bassaganas, Sonia; Carvalho, Sandra; Dias, Ana M.; Perez-Garay, Marta; Ortiz, M. Rosa; Figueras, Joan; Reis, Celso A.; Pinho, Salome S.; Peracaula, Rosa			Pancreatic Cancer Cell Glycosylation Regulates Cell Adhesion and Invasion through the Modulation of alpha 2 beta 1 Integrin and E-Cadherin Function	PLOS ONE			English	Article							N-GLYCOSYLATION; MALIGNANT PHENOTYPE; ACID RESIDUES; I COLLAGEN; EXPRESSION; MIGRATION; ADENOCARCINOMA; SURFACE; METASTASIS; PROMOTES	In our previous studies we have described that ST3Gal III transfected pancreatic adenocarcinoma Capan-1 and MDAPanc-28 cells show increased membrane expression levels of sialyl-Lewis x (SLe(x)) along with a concomitant decrease in alpha 2,6-sialic acid compared to control cells. Here we have addressed the role of this glycosylation pattern in the functional properties of two glycoproteins involved in the processes of cancer cell invasion and migration, alpha 2 beta 1 integrin, the main receptor for type 1 collagen, and E-cadherin, responsible for cell-cell contacts and whose deregulation determines cell invasive capabilities. Our results demonstrate that ST3Gal III transfectants showed reduced cell-cell aggregation and increased invasive capacities. ST3Gal III transfected Capan-1 cells exhibited higher SLe(x) and lower alpha 2,6-sialic acid content on the glycans of their alpha 2 beta 1 integrin molecules. As a consequence, higher phosphorylation of focal adhesion kinase tyrosine 397, which is recognized as one of the first steps of integrin-derived signaling pathways, was observed in these cells upon adhesion to type 1 collagen. This molecular mechanism underlies the increased migration through collagen of these cells. In addition, the pancreatic adenocarcinoma cell lines as well as human pancreatic tumor tissues showed colocalization of SLe(x) and Ecadherin, which was higher in the ST3Gal III transfectants. In conclusion, changes in the sialylation pattern of alpha 2 beta 1 integrin and E-cadherin appear to influence the functional role of these two glycoproteins supporting the role of these glycans as an underlying mechanism regulating pancreatic cancer cell adhesion and invasion.	[Bassaganas, Sonia; Perez-Garay, Marta; Peracaula, Rosa] Univ Girona, Dept Biol, Biochem & Mol Biol Unit, Girona, Spain; [Carvalho, Sandra; Dias, Ana M.; Reis, Celso A.; Pinho, Salome S.] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Ortiz, M. Rosa] Dr Josep Trueta Univ Hosp, Dept Pathol, Girona, Spain; [Figueras, Joan] Dr Josep Trueta Univ Hosp, Dept Surg, IdIBGi, Girona, Spain; [Carvalho, Sandra; Dias, Ana M.; Reis, Celso A.; Pinho, Salome S.] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, Oporto, Portugal; [Reis, Celso A.] Univ Porto, Fac Med, Oporto, Portugal	Universitat de Girona; Universidade do Porto; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universidade do Porto; Universidade do Porto	Pinho, SS (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal.	salomep@ipatimup.pt; rosa.peracaula@udg.edu	Dias, Ana/AAE-8828-2020; Carvalho, Sandra/ABA-8715-2020; Carvalho, Sandra S/K-1724-2016; REIS, Celso A/B-9969-2008; Pinho, Salome/F-1764-2011	Carvalho, Sandra/0000-0003-3647-3582; Carvalho, Sandra S/0000-0003-3647-3582; REIS, Celso A/0000-0002-0286-6639; Peracaula, Rosa/0000-0003-3513-524X; Dias, Ana/0000-0003-0060-2872; Pinho, Salome/0000-0002-3484-5162; Ortiz, Rosa/0000-0002-8973-0493	Spanish Ministery of Science and Innovation [BIO 2010-16922]; La Marato de TV3 Foundation [050932]; Portuguese Foundation for Science and Technology (FCT) [PTDC/CVT/111358/2009, PTDC/BBB-EBI/0786/2012, EXPL/BIM-MEC/0149/ 2012]; "financiados no ambito do Programa Operacional Tematico Factores de Competitividade (COMPETE) e comparticipado pelo fundo Comunitario Europeu FEDER'; e do Quadro de Referencia Estrategia Nacional QREN; FCT; Government of Catalonia for a pre-doctoral fellowship; University of Girona for a mobility grant; SSP [SFRH/BPD/63094/2009]; SC [SFRH/BD/77386/2011]	Spanish Ministery of Science and Innovation(European Commission); La Marato de TV3 Foundation; Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); "financiados no ambito do Programa Operacional Tematico Factores de Competitividade (COMPETE) e comparticipado pelo fundo Comunitario Europeu FEDER'; e do Quadro de Referencia Estrategia Nacional QREN; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Government of Catalonia for a pre-doctoral fellowship; University of Girona for a mobility grant; SSP; SC	This work was supported by grants from the Spanish Ministery of Science and Innovation [grant BIO 2010-16922], La Marato de TV3 Foundation [grant 050932], the Portuguese Foundation for Science and Technology (FCT), project grants [PTDC/CVT/111358/2009; PTDC/BBB-EBI/0786/2012; EXPL/BIM-MEC/0149/ 2012], "financiados no ambito do Programa Operacional Tematico Factores de Competitividade (COMPETE) e comparticipado pelo fundo Comunitario Europeu FEDER'', e do Quadro de Referencia Estrategia Nacional QREN. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education, and is partially supported by FCT. SB acknowledges the Government of Catalonia for a pre-doctoral fellowship and the University of Girona for a mobility grant. SSP [SFRH/BPD/63094/2009] and SC [SFRH/BD/77386/2011] also acknowledge FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong T, 2004, CLIN CANCER RES, V10, P7427, DOI 10.1158/1078-0432.CCR-03-0825; Bassaganas S, 2014, PANCREAS, V43, P109, DOI 10.1097/MPA.0b013e31829d9090; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Benton G, 2011, INT J CANCER, V128, P1751, DOI 10.1002/ijc.25781; Boterberg T, 2004, METHODS MOL MED, V58, P33; Camper L, 1998, J BIOL CHEM, V273, P20383, DOI 10.1074/jbc.273.32.20383; Cavallaro U, 2004, ANN NY ACAD SCI, V1014, P58, DOI 10.1196/annals.1294.006; Chen JY, 2011, CANCER RES, V71, P473, DOI 10.1158/0008-5472.CAN-10-1303; Chen R, 2009, J PROTEOME RES, V8, P651, DOI 10.1021/pr8008012; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Cui HX, 2011, ONCOL REP, V25, P1365, DOI 10.3892/or.2011.1192; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Geisler C, 2011, GLYCOBIOLOGY, V21, P988, DOI 10.1093/glycob/cwr080; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; Gomes C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066737; Grzesiak JJ, 2006, BRIT J CANCER, V94, P1311, DOI 10.1038/sj.bjc.6603088; Grzesiak JJ, 2007, PANCREAS, V35, P293, DOI 10.1097/mpa.0b013e31811f4526; Gu JG, 2004, GLYCOCONJUGATE J, V21, P9, DOI 10.1023/B:GLYC.0000043741.47559.30; Guo HB, 2002, CANCER RES, V62, P6837; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Hall D, 2004, METHODS MOL MED, V58, P61; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Janik ME, 2010, BBA-GEN SUBJECTS, V1800, P545, DOI 10.1016/j.bbagen.2010.03.013; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kariya Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027084; Keleg Shereen, 2003, Mol Cancer, V2, P14, DOI 10.1186/1476-4598-2-14; Kishimoto T, 1996, INT J CANCER, V69, P290, DOI 10.1002/(SICI)1097-0215(19960822)69:4<290::AID-IJC9>3.0.CO;2-S; Kleeff J, 2007, INT J CANCER, V121, P699, DOI 10.1002/ijc.22871; Lee CY, 2011, J ONCOL, V2011, DOI 10.1155/2011/365651; Liu T, 2005, J PROTEOME RES, V4, P2070, DOI 10.1021/pr0502065; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mousa SA, 2008, MOL BIOTECHNOL, V38, P33, DOI 10.1007/s12033-007-0072-7; Nadanaka S, 2001, J BIOL CHEM, V276, P33657, DOI 10.1074/jbc.M011100200; Nagathihalli NS, 2012, FRONT BIOSCI-LANDMRK, V17, P2059, DOI 10.2741/4037; Ohlund D, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-154; Oliveira MJ, 2006, J BIOL CHEM, V281, P34888, DOI 10.1074/jbc.M607067200; Park Hee-Ug, 2003, Pancreas, V26, pe48, DOI 10.1097/00006676-200304000-00022; Peracaula R, 2005, GLYCOCONJUGATE J, V22, P135, DOI 10.1007/s10719-005-0734-2; Perez-Garay M, 2013, INT J BIOCHEM CELL B, V45, P1748, DOI 10.1016/j.biocel.2013.05.015; Perez-Garay M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012524; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Pinho SS, 2013, TRENDS MOL MED, V19, P664, DOI [10.1016/j.molmed.2013, 10.1016/j.molmed.2013.07.003]; Pinho SS, 2013, BBA-GEN SUBJECTS, V1830, P2690, DOI 10.1016/j.bbagen.2012.10.021; Pinho SS, 2011, CELL MOL LIFE SCI, V68, P1011, DOI 10.1007/s00018-010-0595-0; Pinho SS, 2009, BIOCHEM BIOPH RES CO, V379, P1091, DOI 10.1016/j.bbrc.2009.01.024; Pinho S, 2007, CANCER LETT, V249, P157, DOI 10.1016/j.canlet.2006.08.010; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sobin LH., 2010, TNM CLASSIFICATION M; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Varki A, 2009, ESSENTIALS GLYCOBIOL, P617; Wang FL, 2009, CANCER DETECT PREV, V32, P437, DOI 10.1016/j.cdp.2009.01.001; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Zhao HB, 2008, J CELL BIOCHEM, V104, P162, DOI 10.1002/jcb.21608; Zhao YY, 2008, FEBS J, V275, P1939, DOI 10.1111/j.1742-4658.2008.06346.x; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200	71	46	47	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98595	10.1371/journal.pone.0098595	http://dx.doi.org/10.1371/journal.pone.0098595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878505	Green Submitted, gold, Green Published			2022-12-25	WOS:000338101500071
J	Bifano, TD; Ueti, MW; Esteves, E; Reif, KE; Braz, GRC; Scoles, GA; Bastos, RG; White, SN; Daffre, S				Bifano, Thais D.; Ueti, Massaro W.; Esteves, Eliane; Reif, Kathryn E.; Braz, Gloria R. C.; Scoles, Glen A.; Bastos, Reginaldo G.; White, Stephen N.; Daffre, Sirlei			Knockdown of the Rhipicephalus microplus Cytochrome c Oxidase Subunit III Gene Is Associated with a Failure of Anaplasma marginale Transmission	PLOS ONE			English	Article							PROTECTIVE ANTIGEN SUBOLESIN; GLUTATHIONE-S-TRANSFERASE; IXODES-SCAPULARIS ACARI; CELL-LINE BME26; BOOPHILUS-MICROPLUS; DIFFERENTIAL EXPRESSION; SALIVARY-GLANDS; A-PHAGOCYTOPHILUM; OXIDATIVE STRESS; BABESIA-BOVIS	Rhipicephalus microplus is an obligate hematophagous ectoparasite of cattle and an important biological vector of Anaplasma marginale in tropical and subtropical regions. The primary determinants for A. marginale transmission are infection of the tick gut, followed by infection of salivary glands. Transmission of A. marginale to cattle occurs via infected saliva delivered during tick feeding. Interference in colonization of either the tick gut or salivary glands can affect transmission of A. marginale to naive animals. In this study, we used the tick embryonic cell line BME26 to identify genes that are modulated in response to A. marginale infection. Suppression-subtractive hybridization libraries (SSH) were constructed, and five up-regulated genes {glutathione S-transferase (GST), cytochrome c oxidase sub III (COXIII), dynein (DYN), synaptobrevin (SYN) and phosphatidylinositol-3,4,5-triphosphate 3-phosphatase (PHOS)} were selected as targets for functional in vivo genomic analysis. RNA interference (RNAi) was used to determine the effect of tick gene knockdown on A. marginale acquisition and transmission. Although RNAi consistently knocked down all individually examined tick genes in infected tick guts and salivary glands, only the group of ticks injected with dsCOXIII failed to transmit A. marginale to naive calves. To our knowledge, this is the first report demonstrating that RNAi of a tick gene is associated with a failure of A. marginale transmission.	[Bifano, Thais D.; Esteves, Eliane; Daffre, Sirlei] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil; [Bifano, Thais D.; Reif, Kathryn E.; Bastos, Reginaldo G.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Ueti, Massaro W.; Scoles, Glen A.; White, Stephen N.] Washington State Univ, USDA ARS, Anim Dis Res Unit, Pullman, WA 99164 USA; [Braz, Gloria R. C.] Univ Fed Rio de Janeiro, Inst Quim, Dept Biochem, Rio De Janeiro, RJ, Brazil; [Braz, Gloria R. C.; Daffre, Sirlei] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, RJ, Brazil	Universidade de Sao Paulo; Washington State University; United States Department of Agriculture (USDA); Washington State University; Universidade Federal do Rio de Janeiro	Bifano, TD (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508 Sao Paulo, Brazil.	thaisbifano@usp.br	Esteves, Eliane/H-9508-2013; Esteves, Eliane/H-1037-2015; Bifano, Thaís D/F-8411-2013; Daffre, Sirlei/M-4233-2013	Daffre, Sirlei/0000-0002-9966-0433; Esteves, Eliane/0000-0002-4347-798X; White, Stephen N./0000-0001-9255-6054	Sao Paulo Research Foundation (FAPESP) [2008/56408-0, 2010/50940-1, 2011/22124-8]; CNPq; CAPES; U.S. Department of Agriculture [ARS 5348-32000-033-00D]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007025] Funding Source: NIH RePORTER	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Sao Paulo Research Foundation (FAPESP) grants 2008/56408-0, 2010/50940-1, 2011/22124-8, CNPq, CAPES and U.S. Department of Agriculture grant ARS 5348-32000-033-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastos RG, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-111; Bastos RG, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-57; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; Blouin EF, 1998, J MED ENTOMOL, V35, P788, DOI 10.1093/jmedent/35.5.788; Bode M, 2013, ANTIOXID REDOX SIGN, V18, P1597, DOI 10.1089/ars.2012.4685; Brown CGD, 1997, TROP ANIM HEALTH PRO, V29, p1S, DOI 10.1007/BF02632905; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; CONNELL M, 1972, AUST VET J, V48, P477, DOI 10.1111/j.1751-0813.1972.tb02298.x; Dana AN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-119; de la Fuente J, 2007, GENOMICS, V90, P712, DOI 10.1016/j.ygeno.2007.08.009; de la Fuente J, 2006, PARASITOL RES, V100, P85, DOI 10.1007/s00436-006-0244-6; de la Fuente J, 2008, ANN NY ACAD SCI, V1149, P27, DOI 10.1196/annals.1428.056; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Esteves E, 2009, VET PARASITOL, V161, P150, DOI 10.1016/j.vetpar.2008.12.006; Esteves E, 2008, INSECT BIOCHEM MOLEC, V38, P568, DOI 10.1016/j.ibmb.2008.01.006; Lasmar PVF, 2012, REV BRAS PARASITOL V, V21, P112, DOI 10.1590/S1984-29612012000200008; Freitas DRJ, 2007, COMP BIOCHEM PHYS A, V146, P688, DOI 10.1016/j.cbpa.2006.04.032; Futse JE, 2003, J CLIN MICROBIOL, V41, P3829, DOI 10.1128/JCM.41.8.3829-3834.2003; Galletti MFBM, 2009, INFECT IMMUN, V77, P1459, DOI 10.1128/IAI.01518-08; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Harada T, 2012, BIOL PHARM BULL, V35, P1460, DOI 10.1248/bpb.b11-00011; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Karim S, 2005, BIOCHEM BIOPH RES CO, V334, P1336, DOI 10.1016/j.bbrc.2005.07.036; Karim S, 2004, INSECT BIOCHEM MOLEC, V34, P407, DOI 10.1016/j.ibmb.2004.01.005; Karim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028525; Knowles D, 1996, J CLIN MICROBIOL, V34, P2225, DOI 10.1128/JCM.34.9.2225-2230.1996; Kocan KM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-42; Kocan KM, 2008, EXP APPL ACAROL, V46, P17, DOI 10.1007/s10493-008-9159-5; Kocan KM, 2003, CLIN MICROBIOL REV, V16, P698, DOI 10.1128/CMR.16.4.698-712.2003; KOCAN KM, 1992, AM J VET RES, V53, P499; Kocan KM, 2000, ANN NY ACAD SCI, V916, P501, DOI 10.1111/j.1749-6632.2000.tb05329.x; Lewis S, 2000, CURR OPIN STRUC BIOL, V10, P349, DOI 10.1016/S0959-440X(00)00095-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; MASON CA, 1981, VET PARASITOL, V8, P185, DOI 10.1016/0304-4017(81)90046-7; Mercado-Curiel RF, 2011, INT J PARASITOL, V41, P851, DOI 10.1016/j.ijpara.2011.03.003; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nijhof AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-112; Ramabu SS, 2010, INFECT IMMUN, V78, P3047, DOI 10.1128/IAI.00300-10; Reddy BPN, 2011, COMPUT BIOL CHEM, V35, P114, DOI 10.1016/j.compbiolchem.2011.03.004; Rozen S, 2000, Methods Mol Biol, V132, P365; Rudenko N, 2005, J MED ENTOMOL, V42, P36, DOI 10.1603/0022-2585(2005)042[0036:DEOIRT]2.0.CO;2; SAMISH M, 1993, AM J VET RES, V54, P411; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Scoles GA, 2005, J MED ENTOMOL, V42, P668, DOI 10.1603/0022-2585(2005)042[0668:REOBTO]2.0.CO;2; Scoles GA, 2007, J MED ENTOMOL, V44, P484, DOI 10.1603/0022-2585(2007)44[484:COTPOA]2.0.CO;2; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Ueti MW, 2007, INFECT IMMUN, V75, P2959, DOI 10.1128/IAI.00284-07; Ulienberg G, 1968, REV ELEV MED VET PAY, V21, P467; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065; Zivkovic Z, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-186; Zivkovic Z, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-7; Zivkovic Z, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/705034	56	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98614	10.1371/journal.pone.0098614	http://dx.doi.org/10.1371/journal.pone.0098614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878588	gold, Green Published, Green Submitted			2022-12-25	WOS:000338101500074
J	Impullitti, AE; Malvick, DK				Impullitti, Ann E.; Malvick, Dean K.			Anatomical Response and Infection of Soybean during Latent and Pathogenic Infection by Type A and B of Phialophora gregata	PLOS ONE			English	Article							STEM ROT RESISTANCE; CEPHALOSPORIUM-GREGATUM; GENOTYPE-A; MAIZE; TRANSFORMATION; COLONIZATION; CULTIVARS; HISTOPATHOLOGY; REGISTRATION; CADOPHORA	Growth and anatomical responses of plants during latent and pathogenic infection by fungal pathogens are not well understood. The interactions between soybean (Glycine max) and two types of the pathogen Phialophora gregata were investigated to determine how plants respond during latent and pathogenic infection. Stems of soybean cultivars with different or no genes for resistance to infection by P. gregata were inoculated with wildtype or GFP and RFP-labeled strains of types A or B of P. gregata. Plants were sectioned during latent and pathogenic infection, examined with transmitted light or fluorescent microscopy, and quantitative differences in vessels and qualitative differences in infection were assessed using captured images. During latent infection, the number of vessels was similar in resistant and susceptible plants infected with type A or B compared to the control, and fungal infection was rarely observed in vessels. During pathogenic infection, the resistant cultivars had 20 to 25% more vessels than the uninfected plants, and fungal hyphae were readily observed in the vessels. Furthermore, during the pathogenic phase in a resistant cultivar, P. gregata type A-GFP was limited to outside of the primary xylem, while P. gregata type B-RFP was observed in the primary xylem. The opposite occurred with the susceptible cultivar, where PgA-GFP was observed in the primary xylem and PgB-RFP was limited to the interfascicular region. In summary, soybean cultivars with resistance to BSR produced more vessels and can restrict or exclude P. gregata from the vascular system compared to susceptible cultivars. Structural resistance mechanisms potentially compensate for loss of vessel function and disrupted water movement.	[Impullitti, Ann E.; Malvick, Dean K.] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Impullitti, AE (corresponding author), Univ Minnesota, Dept Plant Pathol, St Paul, MN 55455 USA.	impullit@augsburg.edu		Malvick, Dean/0000-0002-0131-8411	University of Minnesota Graduate School; Minnesota Soybean Research and Promotion Council	University of Minnesota Graduate School(University of Minnesota System); Minnesota Soybean Research and Promotion Council	This research was supported by the Doctoral Dissertation Fellowship and Thesis Research Grant program at the University of Minnesota Graduate School and the Minnesota Soybean Research and Promotion Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLINGTON WB, 1948, PHYTOPATHOLOGY, V38, P793; Andrie RM, 2005, MYCOLOGIA, V97, P1152, DOI 10.3852/mycologia.97.5.1152; BAAYEN RP, 1985, NETH J PLANT PATHOL, V91, P119, DOI 10.1007/BF01976386; Bacon CW, 1996, CAN J BOT, V74, P1195, DOI 10.1139/b96-144; Chen WD, 2000, PHYTOPATHOLOGY, V90, P875, DOI 10.1094/PHYTO.2000.90.8.875; De Cal A, 2000, PHYTOPATHOLOGY, V90, P260, DOI 10.1094/PHYTO.2000.90.3.260; Denison RF, 2004, FEMS MICROBIOL LETT, V237, P187, DOI 10.1016/j.femsle.2004.07.013; Dodd J. L., 1980, Plant Disease, V64, P533, DOI 10.1094/PD-64-533; Eckert M, 2005, FEMS MICROBIOL LETT, V253, P67, DOI 10.1016/j.femsle.2005.09.041; GRAY LE, 1971, PHYTOPATHOLOGY, V61, P1410, DOI 10.1094/Phyto-61-1410; HANSON PM, 1988, CROP SCI, V28, P41, DOI 10.2135/cropsci1988.0011183X002800010010x; Harrington TC, 2003, MYCOTAXON, V87, P141; Horowitz S, 2002, PHYTOPATHOLOGY, V92, P743, DOI 10.1094/PHYTO.2002.92.7.743; Hughes TJ, 2002, PLANT DIS, V86, P729, DOI 10.1094/PDIS.2002.86.7.729; Impullitti AE, 2009, PLANT DIS, V93, P734, DOI 10.1094/PDIS-93-7-0734; KEDERA CJ, 1994, PHYTOPATHOLOGY, V84, P603, DOI 10.1094/Phyto-84-603; Lersten N.R., 2004, SOYBEANS IMPROVEMENT, V3 ed, P15; Lewers KS, 1999, MOL BREEDING, V5, P33, DOI 10.1023/A:1009634710039; Malvick DK, 2007, PLANT DIS, V91, P736, DOI 10.1094/PDIS-91-6-0736; Malvick DK, 2008, CAN J PLANT PATHOL, V30, P581, DOI 10.1080/07060660809507558; Malvick DK, 2003, PLANT DIS, V87, P1250, DOI 10.1094/PDIS.2003.87.10.1250; McCully ME, 2001, AUST J PLANT PHYSIOL, V28, P983, DOI 10.1071/PP01101; MENGISTU A, 1986, PLANT DIS, V70, P1005, DOI 10.1094/PD-70-1005; Nickell CD, 1997, CROP SCI, V37, P1987, DOI 10.2135/cropsci1997.0011183X003700060067x; Oren L, 2003, APPL ENVIRON MICROB, V69, P1695, DOI 10.1128/AEM.69.3.1695-1701.2003; Patzoldt ME, 2005, CROP SCI, V45, P1241, DOI 10.2135/cropsci2003.0615; PENNYPACKER BW, 1993, PHYTOPATHOLOGY, V83, P80, DOI 10.1094/Phyto-83-80; PETRINI O, 1991, MICROBIAL ECOLOGY LE, P179, DOI DOI 10.1007/978-1-4612-3168-4_9; Rasband W.S., 1997, IMAGE J; SCHNEIDER RW, 1972, PHYTOPATHOLOGY, V62, P345, DOI 10.1094/Phyto-62-345; SINCLAIR JB, 1991, PLANT DIS, V75, P220, DOI 10.1094/PD-75-0220; Sinclair JB, 1996, LATENT INFECT VS END; Stanosz GR, 2001, NEW PHYTOL, V149, P531, DOI 10.1046/j.1469-8137.2001.00052.x; Tabor GM, 2007, PLANT DIS, V91, P574, DOI 10.1094/PDIS-91-5-0574; Tabor GM, 2006, PLANT DIS, V90, P1186, DOI 10.1094/PD-90-1186; TACHIBANA H, 1987, CROP SCI, V27, P612, DOI 10.2135/cropsci1987.0011183X002700030045x; TESSIER BJ, 1990, PHYTOPATHOLOGY, V80, P756, DOI 10.1094/Phyto-80-756; TURGEON BG, 1993, MOL GEN GENET, V238, P270; TURGEON BG, 1987, MOL CELL BIOL, V7, P3297, DOI 10.1128/MCB.7.9.3297; TURGEON BG, 1985, MOL GEN GENET, V201, P450, DOI 10.1007/BF00331338; USDA, 2009, NAT PLANT GERMPL SYS; Vallad GE, 2008, PHYTOPATHOLOGY, V98, P871, DOI 10.1094/PHYTO-98-8-0871; Yates IE, 1997, PLANT DIS, V81, P723, DOI 10.1094/PDIS.1997.81.7.723	43	7	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98311	10.1371/journal.pone.0098311	http://dx.doi.org/10.1371/journal.pone.0098311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879418	Green Submitted, Green Published, gold			2022-12-25	WOS:000338101500049
J	Lofvendahl, S; Theander, E; Svensson, A; Carlsson, KS; Englund, M; Petersson, IF				Lofvendahl, Sofia; Theander, Elke; Svensson, Ake; Carlsson, Katarina Steen; Englund, Martin; Petersson, Ingemar F.			Validity of Diagnostic Codes and Prevalence of Physician-Diagnosed Psoriasis and Psoriatic Arthritis in Southern Sweden - A Population-Based Register Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; PLAQUE PSORIASIS; ECONOMIC BURDEN; EPIDEMIOLOGY; DATABASES; CARE	Objective: To validate diagnostic codes for psoriasis and psoriatic arthritis (PsA) and estimate physician-diagnosed prevalence of psoriasis and PsA in the Skane region, Sweden. Methods: In the Skane Healthcare Register (SHR), all healthcare consultations are continuously collected for all inhabitants in the Skane region (population 1.2 million). During 2005-2010 we identified individuals with >= 1 physician-consultations consistent with psoriasis (ICD-10). Within this group we also identified those diagnosed with PsA. We performed a validation by reviewing medical records in 100 randomly selected cases for psoriasis and psoriasis with PsA, respectively. Further, we estimated the pre- and post-validation point prevalence by December 31, 2010. Results: We identified 16 171 individuals (psoriasis alone: n = 13 185, psoriasis with PsA n = 2 986). The proportion of ICD-10 codes that could be confirmed by review of medical records was 81% for psoriasis and 63% for psoriasis with PsA with highest percentage of confirmed codes for cases diagnosed >= 2 occasions in specialized care. For 19% and 29% of the cases respectively it was not possible to determine diagnosis due to insufficient information. Thus, the positive predicted value (PPV) of one ICD-10 code for psoriasis and psoriasis with PsA ranged between 81-100% and 63-92%, respectively. Assuming the most conservative PPV, the post-validation prevalence was 1.23% (95% CI: 1.21-1.25) for psoriasis (with or without PsA), 1.02% (95% CI: 1.00-1.03) for psoriasis alone and 0.21% (95% CI: 0.20-0.22) for psoriasis with PsA. The post-validation prevalence of PsA in the psoriasis cohort was 17.3% (95% CI: 16.65-17.96). Conclusions: The proportion of diagnostic codes in SHR that could be verified varied with frequency of diagnostic codes and level of care highlighting the importance of sensitivity analyses using different case ascertainment criteria. The prevalence of physician-diagnosed psoriasis and PsA confirm other population-based studies, also after adjustment due to misclassification of disease.	[Lofvendahl, Sofia; Englund, Martin; Petersson, Ingemar F.] Lund Univ, Dept Orthoped, Lund, Sweden; [Lofvendahl, Sofia; Englund, Martin; Petersson, Ingemar F.] Skane Univ Hosp, Epidemiol & Register Ctr South, Lund, Sweden; [Theander, Elke] Lund Univ, Skane Univ Hosp Malmo, Dept Rheumatol, Malmo, Sweden; [Svensson, Ake] Lund Univ, Skane Univ Hosp Malmo, Dept Dermatol, Malmo, Sweden; [Carlsson, Katarina Steen] Lund Univ, Skane Univ Hosp Malmo, Dept Clin Sci, Malmo, Sweden; [Englund, Martin] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA; [Petersson, Ingemar F.] Keele Univ, Arthrit Res UK Primary Care Ctr, Keele, Staffs, England	Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Boston University; Keele University	Lofvendahl, S (corresponding author), Lund Univ, Dept Orthoped, Lund, Sweden.	Hsofia.lofvendahl@med.lu.se	Englund, Martin/J-7245-2012	Englund, Martin/0000-0003-3320-2437; Steen Carlsson, Katarina/0000-0002-2325-5634; Petersson, Ingemar/0000-0001-9139-1892	Region Skane; Swedish Social Insurance Agency; Swedish Research Council, Faculty of Medicine, Lund University; Osterlund and Kock Foundations; King Gustav V 80 Year Fund; Swedish Rheumatism Associa-tion	Region Skane; Swedish Social Insurance Agency; Swedish Research Council, Faculty of Medicine, Lund University(Swedish Research Council); Osterlund and Kock Foundations; King Gustav V 80 Year Fund; Swedish Rheumatism Associa-tion	This study was supported by grants from the Region Skane, the Swedish Social Insurance Agency, the Swedish Research Council, Faculty of Medicine, Lund University, the Osterlund and Kock Foundations, King Gustav V 80 Year Fund and the Swedish Rheumatism Associa-tion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgari MM, 2013, PHARMACOEPIDEM DR S, V22, P842, DOI 10.1002/pds.3447; Bhutani T, 2013, JAMA DERMATOL, V149, P717, DOI 10.1001/jamadermatol.2013.133; Biondi Oriente C, 1989, Acta Derm Venereol Suppl (Stockh), V146, P69; Boehncke WH, 2013, AM J CLIN DERMATOL, V14, P377, DOI 10.1007/s40257-013-0032-x; Chandran V, 2010, J AUTOIMMUN, V34, pJ314, DOI 10.1016/j.jaut.2009.12.001; Cortesi PA, 2012, CLIN EXP RHEUMATOL, V30, pS126; Englund M, 2010, RHEUMATOLOGY, V49, P1563, DOI 10.1093/rheumatology/keq127; Gelfand JM, 2005, J AM ACAD DERMATOL, V53, P573, DOI 10.1016/j.jaad.2005.03.046; Gelfand JM, 2005, ARCH DERMATOL, V141, P1537, DOI 10.1001/archderm.141.12.1537; Ghatnekar O, 2012, EUR J DERMATOL, V22, P238, DOI 10.1684/ejd.2011.1635; Haglund E, 2011, ANN RHEUM DIS; Hellgren L, 1967, PSORIASIS PREVALENCE; Helmick CG, 2013, AM J PREV MED, V44, P424, DOI 10.1016/j.amepre.2013.01.004; Ibrahim G, 2009, ARTHRIT CARE RES, V61, P1373, DOI 10.1002/art.24608; Icen M, 2008, J AM ACAD DERMATOL, V59, P981, DOI 10.1016/j.jaad.2008.08.034; Joud A, 2012, ARTHRIT CARE RES, V64, P1084, DOI 10.1002/acr.21642; Kimball AB, 2011, J EUR ACAD DERMATOL, V25, P157, DOI 10.1111/j.1468-3083.2010.03730.x; Levy AR, 2012, INT J DERMATOL, V51, P1432, DOI 10.1111/j.1365-4632.2011.05359.x; Love TJ, 2011, SEMIN ARTHRITIS RHEU, V40, P413, DOI 10.1016/j.semarthrit.2010.05.002; Mease PJ, 2013, J AM ACAD DERMATOL; Nossent JC, 2009, SCAND J RHEUMATOL, V38, P251, DOI 10.1080/03009740802609558; Ogdie A, 2013, RHEUMATOLOGY, V52, P568, DOI 10.1093/rheumatology/kes324; Olivieri I, 2008, J RHEUMATOL, V35, P3; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Pedersen OBV, 2008, ANN RHEUM DIS, V67, P1422, DOI 10.1136/ard.2007.082172; Prey S, 2010, J EUR ACAD DERMATOL, V24, P31, DOI 10.1111/j.1468-3083.2009.03565.x; Radtke MA, 2009, J EUR ACAD DERMATOL, V23, P683, DOI 10.1111/j.1468-3083.2009.03159.x; Richardson Stephen K, 2008, Adv Dermatol, V24, P171, DOI 10.1016/j.yadr.2008.09.006; SALVARANI C, 1995, J RHEUMATOL, V22, P1499; SCARPA R, 1984, BRIT J RHEUMATOL, V23, P246; Seminara NM, 2011, BRIT J DERMATOL, V164, P602, DOI 10.1111/j.1365-2133.2010.10134.x; Shbeeb M, 2000, J RHEUMATOL, V27, P1247; Singh JA, 2007, ARTHRIT RHEUM-ARTHR, V57, P648, DOI 10.1002/art.22682; Strombeck B, 2010, J RHEUMATOL; SWANBECK G, 1994, BRIT J DERMATOL, V131, P32, DOI 10.1111/j.1365-2133.1994.tb08454.x; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Wilson FC, 2009, J RHEUMATOL, V36, P361, DOI 10.3899/jrheum.080691; Zachariae H, 2002, ACTA DERM-VENEREOL, V82, P108, DOI 10.1080/00015550252948130	38	83	84	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98024	10.1371/journal.pone.0098024	http://dx.doi.org/10.1371/journal.pone.0098024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875275	Green Published, gold, Green Submitted			2022-12-25	WOS:000336790800020
J	Di Pace, E; Saracini, C				Di Pace, Enrico; Saracini, Chiara			Action Imitation Changes Perceptual Alternations in Binocular Rivalry	PLOS ONE			English	Article							BIOLOGICAL MOTION PERCEPTION; FACIAL EXPRESSIONS; VISUAL AWARENESS; ATTENTION; DOMINANCE; RESPONSES; MECHANISMS; SIMULATION; PLASTICITY; LANGUAGE	Binocular rivalry is a visual phenomenon in which perception alternates between two different monocular images presented to each of the two eyes. Here, we propose using this phenomenon as a method to study the relation between action execution and action perception. In our experiment, a simple background (a checkerboard) was contrasted with a video representing a hand continuously grasping and releasing a ball. In Experiment 1, our subjects were asked to reproduce the perceived movement with their right hand whenever they became aware of it and to stop doing this when the checkerboard dominated. Our results revealed that motor imitation of the perceived action significantly increased the time spent perceiving the hand. Three control experiments showed that these effects were not due to a generic involvement of focused attention (Experiment 2 and 3), to a verbal description of the performed action (Experiment 3) or to the execution of an unrelated movement of the hand (Experiment 4). Although an intrinsic connection between action execution and attention cannot be excluded with certainty, and the boundary between action imitation and unrelated action execution may vary along various degrees of similarity, on the whole, the present results seem to suggest, at least on a preliminary basis, that action imitation do play a relevant role in the perception of action. We discuss these findings in the frame of current theories concerning the relation between perception and action.	[Di Pace, Enrico] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy; [Di Pace, Enrico; Saracini, Chiara] Fdn Santa Lucia, IRCCS, Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia	Di Pace, E (corresponding author), Univ Roma La Sapienza, Dept Psychol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	enrico.dipace@uniroma1.it	Saracini, Chiara/AAP-9256-2020	Saracini, Chiara/0000-0002-1594-7382	Italian Ministry of Health [RC13.D]	Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by Italian Ministry of Health (grant RC13.D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Alpers GW, 2007, EMOTION, V7, P495, DOI 10.1037/1528-3542.7.3.495; Alpers GW, 2005, INT J PSYCHOPHYSIOL, V57, P25, DOI 10.1016/j.ijpsycho.2005.01.008; Anderson E, 2011, SCIENCE, V332, P1446, DOI 10.1126/science.1201574; Anderson E, 2011, J EXP SOC PSYCHOL, V47, P856, DOI 10.1016/j.jesp.2011.02.009; Avenanti A, 2013, CEREB CORTEX, V23, P570, DOI 10.1093/cercor/bhs040; Bahrami B, 2008, PERCEPTION, V37, P1520, DOI 10.1068/p5999; Bannerman RL, 2008, OPHTHAL PHYSL OPT, V28, P317, DOI 10.1111/j.1475-1313.2008.00568.x; Beets IAM, 2010, VISION RES, V50, P2633, DOI 10.1016/j.visres.2010.10.004; Bekkering H, 2004, Q J EXP PSYCHOL-A, V57, P1345, DOI 10.1080/02724980343000765; BLAKE R, 1980, PERCEPTION, V9, P223, DOI 10.1068/p090223; Blake R, 2006, P NATL ACAD SCI USA, V103, P4783, DOI 10.1073/pnas.0509634103; Blake R, 2004, PSYCHOL SCI, V15, P397, DOI 10.1111/j.0956-7976.2004.00691.x; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Buccino G, 2004, BRAIN LANG, V89, P370, DOI 10.1016/S0093-934X(03)00356-0; Carlson TA, 2000, CURR BIOL, V10, P1055, DOI 10.1016/S0960-9822(00)00672-2; CARNEY T, 1987, NATURE, V328, P647, DOI 10.1038/328647a0; Casile A, 2006, CURR BIOL, V16, P69, DOI 10.1016/j.cub.2005.10.071; Cattaneo L, 2011, SOC COGN AFFECT NEUR, V6, P301, DOI 10.1093/scan/nsq099; Chong SC, 2005, J VISION, V5, P1004, DOI 10.1167/5.11.6; Chong SC, 2006, VISION RES, V46, P1794, DOI 10.1016/j.visres.2005.10.031; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; Christensen A, 2011, J NEUROSCI, V31, P3493, DOI 10.1523/JNEUROSCI.4277-10.2011; COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111; Craighero L, 1999, J EXP PSYCHOL HUMAN, V25, P1673, DOI 10.1037/0096-1523.25.6.1673; Craighero L, 1996, NEUROREPORT, V8, P347, DOI 10.1097/00001756-199612200-00068; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; Craighero L, 1998, VIS COGN, V5, P109, DOI 10.1080/713756780; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Fagioli S, 2007, PSYCHOL RES-PSYCH FO, V71, P22, DOI 10.1007/s00426-005-0033-3; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gibson J. J., 1979, ECOLOGICAL APPROACH; Glenberg AM, 2008, Q J EXP PSYCHOL, V61, P905, DOI 10.1080/17470210701625550; Glenberg AM, 2008, CURR BIOL, V18, pR290, DOI 10.1016/j.cub.2008.02.036; Grafton ST, 2009, ANN NY ACAD SCI, V1156, P97, DOI 10.1111/j.1749-6632.2009.04425.x; GREENWAL.AG, 1970, J EXP PSYCHOL, V86, P20, DOI 10.1037/h0029960; GREENWALD AG, 1970, PSYCHOL REV, V77, P73, DOI 10.1037/h0028689; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Heiser M, 2003, EUR J NEUROSCI, V17, P1123, DOI 10.1046/j.1460-9568.2003.02530.x; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 2004, TRENDS COGN SCI, V8, P494, DOI 10.1016/j.tics.2004.08.007; Hugrass L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035963; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; Kanai R, 2006, CURR BIOL, V16, P2332, DOI 10.1016/j.cub.2006.10.001; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Laubrock J, 2008, J VISION, V8, DOI 10.1167/8.14.13; Lee SH, 2004, VISION RES, V44, P983, DOI 10.1016/j.visres.2003.12.007; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Lindemann O, 2009, J EXP PSYCHOL HUMAN, V35, P1062, DOI 10.1037/a0015023; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; LOGOTHETIS NK, 1990, VISION RES, V30, P1409, DOI 10.1016/0042-6989(90)90022-D; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Lunghi C, 2010, CURR BIOL, V20, pR143, DOI 10.1016/j.cub.2009.12.015; Maruya K, 2007, PSYCHOL SCI, V18, P1090, DOI 10.1111/j.1467-9280.2007.02030.x; Meng M, 2004, J VISION, V4, P539, DOI 10.1167/4.7.2; Mitchell JF, 2004, NATURE, V429, P410, DOI 10.1038/nature02584; Mitsumatsu H, 2009, PERCEPTION, V38, P1522, DOI 10.1068/p6298; Musseler J, 1997, J EXP PSYCHOL HUMAN, V23, P861, DOI 10.1037/0096-1523.23.3.861; Nagamine M, 2007, PHYSIOL BEHAV, V91, P161, DOI 10.1016/j.physbeh.2007.02.016; Necker L.A, 1832, LONDON EDINBURGH PHI, V1, P329, DOI 10.1080/14786443208647909; Ooi TL, 1999, PERCEPTION, V28, P551, DOI 10.1068/p2923; Paffen CLE, 2006, PSYCHOL SCI, V17, P752, DOI 10.1111/j.1467-9280.2006.01777.x; Pearson J, 2005, CURR BIOL, V15, P2142, DOI 10.1016/j.cub.2005.10.066; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Salomon R, 2013, J VISION, V13, DOI 10.1167/13.7.2; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Smith DT, 2012, NEUROPSYCHOLOGIA, V50, P1104, DOI 10.1016/j.neuropsychologia.2012.01.025; Sun FC, 2002, BRAIN RES, V944, P56, DOI 10.1016/S0006-8993(02)02706-3; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Tucker M, 1998, J EXP PSYCHOL HUMAN, V24, P830, DOI 10.1037/0096-1523.24.3.830; van Ee R, 2005, VISION RES, V45, P41, DOI 10.1016/j.visres.2004.07.030; van Ee R, 2009, J NEUROSCI, V29, P11641, DOI 10.1523/JNEUROSCI.0873-09.2009; Vogt S, 2003, NEUROPSYCHOLOGIA, V41, P941, DOI 10.1016/S0028-3932(02)00319-6; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004; Wohlschlager A, 2000, VISION RES, V40, P925, DOI 10.1016/S0042-6989(99)00239-4; Yoon KL, 2009, EMOTION, V9, P172, DOI 10.1037/a0014714; Zhang P, 2011, NEURON, V71, P362, DOI 10.1016/j.neuron.2011.05.035; Zhou W, 2010, CURR BIOL, V20, P1356, DOI 10.1016/j.cub.2010.05.059	89	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98305	10.1371/journal.pone.0098305	http://dx.doi.org/10.1371/journal.pone.0098305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TS	24870450	Green Submitted, Green Published, gold			2022-12-25	WOS:000336858300035
J	Albi, E; Curcio, F; Lazzarini, A; Floridi, A; Cataldi, S; Lazzarini, R; Loreti, E; Ferri, I; Ambesi-Impiombato, FS				Albi, Elisabetta; Curcio, Francesco; Lazzarini, Andrea; Floridi, Alessandro; Cataldi, Samuela; Lazzarini, Remo; Loreti, Elisabetta; Ferri, Ivana; Ambesi-Impiombato, Francesco Saverio			A Firmer Understanding of the Effect of Hypergravity on Thyroid Tissue: Cholesterol and Thyrotropin Receptor	PLOS ONE			English	Article							LIPID RAFTS; ALTERED GRAVITY; CYTOSKELETON; CELLS; LOCALIZATION; MICRODOMAINS; CAVEOLAE; MISSION; ACTIN	Maintaining a good health requires the maintenance of a body homeostasis which largely depends on correct functioning of thyroid gland. The cells of the thyroid tissue are strongly sensitive to hypogravity, as already proven in mice after returning to the earth from long-term space missions. Here we studied whether hypergravity may be used to counteract the physiological deconditioning of long-duration spaceflight. We investigated the influence of hypergravity on key lipids and proteins involved in thyroid tissue function. We quantified cholesterol (CHO) and different species of sphingomyelin (SM) and ceramide, analysed thyrotropin (TSH) related molecules such as thyrotropin-receptor (TSHR), cAMP, Caveolin-1 and molecule signalling such as Signal transducer and activator of transcription-3 (STAT3). The hypergravity treatment resulted in the upregulation of the TSHR and Caveolin-1 and downregulation of STAT3 without changes of cAMP. TSHR lost its specific localization and spread throughout the cell membrane; TSH treatment facilitated the shedding of a subunit of TSHR and its releasing into the extracellular space. No specific variations were observed for each species of SM and ceramide. Importantly, the level of CHO was strongly reduced. In conclusion, hypergravity conditions induce change in CHO and TSHR of thyroid gland. The possibility that lipid rafts are strongly perturbed by hypergravity-induced CHO depletion by influencing TSH-TSHR interaction was discussed.	[Albi, Elisabetta; Lazzarini, Andrea; Floridi, Alessandro; Cataldi, Samuela; Lazzarini, Remo] CRABioN, Lab Nucl Lipid BioPathol, Perugia, Italy; [Curcio, Francesco; Lazzarini, Andrea; Ambesi-Impiombato, Francesco Saverio] Univ Udine, Dept Clin & Biol Sci, I-33100 Udine, Italy; [Loreti, Elisabetta; Ferri, Ivana] Univ Perugia, Inst Pathol Anat & Histol, Osped Santa Maria Misericordia, I-06100 Perugia, Italy	University of Udine; Hospital Santa Maria della Misericordia; University of Perugia	Albi, E (corresponding author), CRABioN, Lab Nucl Lipid BioPathol, Perugia, Italy.	elisabetta.albi@yahoo.com	Curcio, Francesco/K-4669-2014; Albi, Elisabetta/K-3369-2016	Albi, Elisabetta/0000-0002-5745-5343; Migliaccio, Antimo/0000-0002-4197-2055; CURCIO, Francesco/0000-0002-9070-4807	Agenzia Spaziale Italiana (ASI)	Agenzia Spaziale Italiana (ASI)(Agenzia Spaziale Italiana (ASI))	This work has been supported by Agenzia Spaziale Italiana (ASI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albi E, 2012, ASTROBIOLOGY, V12, P1035, DOI 10.1089/ast.2012.0881; Albi E, 2011, ASTROBIOLOGY, V11, P57, DOI 10.1089/ast.2010.0519; Albi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048518; Barnett-Norris J, 2005, LIFE SCI, V77, P1625, DOI 10.1016/j.lfs.2005.05.040; Cascianelli G, 2008, MOL BIOL CELL, V19, P5289, DOI 10.1091/mbc.E08-05-0517; Chubinskiy-Nadezhdin VI, 2013, CELL BIOL INT, V37, P617, DOI 10.1002/cbin.10079; Ciofani G, 2012, J BIOSCI BIOENG, V113, P258, DOI 10.1016/j.jbiosc.2011.09.025; Costa MJ, 2004, ENDOCRINOLOGY, V145, P1464, DOI 10.1210/en.2003-1432; Couto JP, 2012, P NATL ACAD SCI USA, V109, pE2361, DOI 10.1073/pnas.1201232109; Dai KS, 2009, THROMB HAEMOSTASIS, V101, P902, DOI 10.1160/TH08-11-0750; Fallahi-Sichani M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006604; Graves PN, 1996, ENDOCRINOLOGY, V137, P3915, DOI 10.1210/en.137.9.3915; Hughes-Fulford M, 2003, ADV SPACE RES-SERIES, V32, P1585, DOI 10.1016/S0273-1177(03)90399-1; Klappe K, 2010, BIOCHEM J, V430, P519, DOI 10.1042/BJ20091882; Latif R, 2003, ENDOCRINOLOGY, V144, P4725, DOI 10.1210/en.2003-0932; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; LOOSFELT H, 1992, P NATL ACAD SCI USA, V89, P3765, DOI 10.1073/pnas.89.9.3765; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068140; Masini MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035418; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Misrahi M, 1997, EUR J ENDOCRINOL, V137, P599, DOI 10.1530/eje.0.1370599; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Rabagny Y, 2011, ANAL BIOANAL CHEM, V401, P891, DOI 10.1007/s00216-011-5154-5; Rosner H, 2006, PROTOPLASMA, V229, P225, DOI 10.1007/s00709-006-0202-2; Schmidt W, 2004, MICROGRAVITY SCI TEC, V15, P42, DOI 10.1007/BF02870951; Soga K, 2013, J PLANT RES, V126, P589, DOI 10.1007/s10265-013-0572-4; Tauber S, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-32; Ulbrich C, 2011, CELL PHYSIOL BIOCHEM, V28, P185, DOI 10.1159/000331730	29	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98250	10.1371/journal.pone.0098250	http://dx.doi.org/10.1371/journal.pone.0098250			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866829	Green Published, Green Submitted, gold			2022-12-25	WOS:000336914100040
J	Blum, CA; Mirza, U; Christ-Crain, M; Mueller, B; Schindler, C; Puder, JJ				Blum, Claudine A.; Mirza, Uzma; Christ-Crain, Mirjam; Mueller, Beat; Schindler, Christian; Puder, Jardena J.			Copeptin Levels Remain Unchanged during the Menstrual Cycle	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; LOW-GRADE INFLAMMATION; BODY-FLUID; VASOPRESSIN; WOMEN; SECRETION; RELIABILITY; PLASMA; IMPEDANCE; PRECURSOR	Background: Copeptin, a surrogate marker for arginin vasopressin production, is evaluated as an osmo-dependent stress and inflammatory biomarker in different diseases. We investigated copeptin during the menstrual cycle and its relationship to sex hormones, markers of subclinical inflammation and estimates of body fluid. Methods: In 15 healthy women with regular menstrual cycles, blood was drawn on fifteen defined days of their menstrual cycle and was assayed for copeptin, progesterone, estradiol, luteinizing hormone, high-sensitive C-reactive protein, tumor necrosis factor-alpha and procalcitonin. Symptoms of fluid retention were assessed on each visit, and bio impedance analysis was measured thrice to estimate body fluid changes. Mixed linear model analysis was performed to assess the changes of copeptin across the menstrual cycle and the relationship of sex hormones, markers of subclinical inflammation and estimates of body fluid with copeptin. Results: Copeptin levels did not significantly change during the menstrual cycle (p = 0.16). Throughout the menstrual cycle, changes in estradiol (p = 0.002) and in the physical premenstrual symptom score (p = 0.01) were positively related to copeptin, but changes in other sex hormones, in markers of subclinical inflammation or in bio impedance analysis-estimated body fluid were not (all p = ns). Conclusion: Although changes in estradiol and the physical premenstrual symptom score appear to be related to copeptin changes, copeptin does not significantly change during the menstrual cycle.	[Blum, Claudine A.; Mirza, Uzma; Mueller, Beat] Kantonsspital Aarau, Med Univ Clin, Aarau, Switzerland; [Blum, Claudine A.; Christ-Crain, Mirjam] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Puder, Jardena J.] Univ Lausanne Hosp, Serv Endocrinol Diabet & Metab, Lausanne, Switzerland; [Schindler, Christian] Swiss Trop & Publ Hlth Inst, Basel, Switzerland	Kantonsspital Aarau AG (KSA); University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel; Swiss Tropical & Public Health Institute	Blum, CA (corresponding author), Kantonsspital Aarau, Med Univ Clin, Aarau, Switzerland.	claudineblum@yahoo.com	Schindler, Christian/D-3472-2015; Mueller, Beat/G-2662-2012; Blum, Claudine Angela A/G-8467-2016	Blum, Claudine Angela A/0000-0003-0487-5587; Puder, Jardena/0000-0002-0460-7614; Christ-Crain, Mirjam/0000-0002-6336-0965	Gottfried and Julia Bangerter-Rhyner-Stiftung, Bern, Switzerland; University of Basel, Switzerland (Nachwuchsfoerderung); W&W-Fonds of the Kantonsspital Aarau AG, Switzerland; Swiss National Science Foundation [PP00P3-12346]	Gottfried and Julia Bangerter-Rhyner-Stiftung, Bern, Switzerland; University of Basel, Switzerland (Nachwuchsfoerderung); W&W-Fonds of the Kantonsspital Aarau AG, Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Gottfried and Julia Bangerter-Rhyner-Stiftung, 3011 Bern, Switzerland (to CAB), by the University of Basel, Switzerland (Nachwuchsfoerderung) (to CAB), by the W&W-Fonds of the Kantonsspital Aarau AG, Switzerland (to CAB), and Grant PP00P3-12346 from the Swiss National Science Foundation (to MCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altemus M, 2001, J CLIN ENDOCR METAB, V86, P2525, DOI 10.1210/jc.86.6.2525; Blum CA, 2005, J CLIN ENDOCR METAB, V90, P3230, DOI 10.1210/jc.2005-0231; Darzy KH, 2010, CLIN CHEM, V56, P1190, DOI 10.1373/clinchem.2009.141689; FORSLING ML, 1982, J ENDOCRINOL, V95, P147, DOI 10.1677/joe.0.0950147; Freeman EW, 1996, PSYCHIAT RES, V65, P97, DOI 10.1016/S0165-1781(96)02929-0; GLEICHAUF CN, 1989, AM J CLIN NUTR, V50, P903, DOI 10.1093/ajcn/50.5.903; Jaffrin MY, 2008, MED ENG PHYS, V30, P1257, DOI 10.1016/j.medengphy.2008.06.009; Katan M, 2010, EUR J MED SERVICES, V140, P13101; Kostoglou-Athanassiou I, 1998, CLIN ENDOCRINOL, V49, P209, DOI 10.1046/j.1365-2265.1998.00504.x; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; PREIBISZ JJ, 1983, HYPERTENSION, V5, pI129, DOI 10.1161/01.HYP.5.2_Pt_2.I129; Puder JJ, 2006, EUR J CLIN INVEST, V36, P58, DOI 10.1111/j.1365-2362.2006.01591.x; PUNNONEN R, 1983, HORM RES, V17, P90, DOI 10.1159/000179681; ROBERTSON GL, 1973, J CLIN INVEST, V52, P2340, DOI 10.1172/JCI107423; Russell JA, 2009, CRIT CARE MED, V37, P749, DOI 10.1097/CCM.0b013e318194d117; Schuetz P, 2007, CURR OPIN CRIT CARE, V13, P578, DOI 10.1097/MCC.0b013e3282c9ac2a; Sergi G, 2006, SCAND J CLIN LAB INV, V66, P19, DOI 10.1080/00365510500402158; Stachenfeld NS, 2009, J APPL PHYSIOL, V107, P864, DOI 10.1152/japplphysiol.91211.2008; Steinwall M, 1998, ACTA OBSTET GYN SCAN, V77, P983, DOI 10.1034/j.1600-0412.1998.771007.x; WILLIAMS TDM, 1985, CLIN ENDOCRINOL, V22, P589, DOI 10.1111/j.1365-2265.1985.tb02994.x	20	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98240	10.1371/journal.pone.0098240	http://dx.doi.org/10.1371/journal.pone.0098240			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866705	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000336914100039
J	Fraser, SDS; Roderick, PJ; McIntyre, NJ; Harris, S; McIntyre, C; Fluck, R; Taal, MW				Fraser, Simon D. S.; Roderick, Paul J.; McIntyre, Natasha J.; Harris, Scott; McIntyre, Christopher; Fluck, Richard; Taal, Maarten W.			Assessment of Proteinuria in Patients with Chronic Kidney Disease Stage 3: Albuminuria and Non-Albumin Proteinuria	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; RENAL-DISEASE; CARDIOVASCULAR MORTALITY; ALL-CAUSE; NONDIABETIC INDIVIDUALS; URINARY ALBUMIN; METAANALYSIS; ASSOCIATION; RISK; PROGRESSION	Background and Objective: Proteinuria assessment is key in investigating chronic kidney disease (CKD) but uncertainty exists regarding optimal methods. Albuminuria, reflecting glomerular damage, is usually measured, but non-albumin proteinuria (NAP), reflecting tubular damage, may be important. This study investigated the prevalence and associations of albuminuria and NAP, and the optimum number of urine specimens required. Methods: 1,741 patients with CKD stage 3, recruited from primary care, underwent medical history, clinical assessment, blood sampling, and submitted three early morning urine samples for albumin to creatinine ratio (uACR) and protein to creatinine ratios (uPCR). Albuminuria was defined as uACR >= 3 mg/mmol in at least two of three samples. Isolated NAP was defined as uPCR >= 17 mg/mmol in two of three samples and uACR<3 mg/mmol in all three. Prevalence and associations of albuminuria and NAP, degree of agreement between single uACR and average of three uACRs, and urine albumin to protein ratio (uAPR = uACR/uPCR) were identified. Results: Albuminuria prevalence was 16% and NAP 6%. Using a <1 mg/mmol threshold for uACR reduced NAP prevalence to 3.6%. Independent associations of albuminuria were: males (OR 3.06 (95% CI, 2.23-4.19)), diabetes (OR 2.14 (1.53-3.00)), lower estimated glomerular filtration rate ((OR 2.06 (1.48-2.85) 30-44 vs 45-59), and high sensitivity CRP ((OR 1.70 (1.25-2.32)). NAP was independently associated with females (OR 6.79 (3.48-13.26)), age (OR 1.62 (1.02-2.56) 80 s vs 70-79) and high sensitivity CRP ((OR 1.74 (1.14-2.66)). Of those with uPCR >= 17 mg/mmol, 62% had uAPR<0.4. Sensitivity of single uACR was 95%, specificity 98%, PPV 90%. Bland Altman plot one vs average of three uACRs showed: mean difference 0.0064 mg/mmol (SD 4.69, limits of agreement -9.19 to +9.20, absolute mean difference 0.837). Conclusions: In CKD stage 3, albuminuria has associations distinct from those of isolated NAP (except for inflammatory markers). Single uACR categorised albuminuria but average of three performed better for quantification.	[Fraser, Simon D. S.; Roderick, Paul J.; Harris, Scott] Univ Southampton, Acad Unit Primary Care & Populat Sci, Southampton, Hants, England; [McIntyre, Natasha J.; Fluck, Richard; Taal, Maarten W.] Royal Derby Hosp NHS Fdn Trust, Dept Renal Med, Derby, England; [McIntyre, Christopher] Univ Nottingham, Div Med Sci & Grad Entry Med, Nottingham NG7 2RD, England	University of Southampton; University of Nottingham	Fraser, SDS (corresponding author), Univ Southampton, Acad Unit Primary Care & Populat Sci, Southampton, Hants, England.	s.fraser@soton.ac.uk	Fraser, Simon DS/HCH-3208-2022; McIntyre, Christopher W/O-8927-2014	Taal, Maarten/0000-0002-9065-212X; Fraser, Simon D/0000-0002-4172-4406	Kidney Research UK; British Renal Society; Roche Products plc	Kidney Research UK(Kidney Research UK (KRUK)); British Renal Society; Roche Products plc	This study was supported by a fellowship grant from Kidney Research UK (http://www.kidneyresearchuk.org/) and the British Renal Society (http://www.britishrenal.org/), as well as an unrestricted educational grant from Roche Products plc (http://www.roche.co.uk/portal/uk). The authors declare that they have no financial or non-financial conflicts of interest to declare. No individuals employed or contracted by the funders (other than the named authors) played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; de Lusignana S, 2013, KIDNEY INT, V84, P609, DOI 10.1038/ki.2013.96; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grundy E, 2001, J EPIDEMIOL COMMUN H, V55, P895, DOI 10.1136/jech.55.12.895; Gupta J, 2012, CLIN J AM SOC NEPHRO, V7, P1938, DOI 10.2215/CJN.03500412; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Jafar TH, 2001, KIDNEY INT, V60, P1131, DOI 10.1046/j.1523-1755.2001.0600031131.x; Jordan H, 2004, J EPIDEMIOL COMMUN H, V58, P250, DOI 10.1136/jech.2003.013011; Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, 2013, KIDNEY INT S, P1; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McIntyre NJ, 2011, CLIN J AM SOC NEPHRO, V6, P2356, DOI 10.2215/CJN.02420311; McTaggart MP, 2013, CLIN CHEM LAB MED, V51, P1961, DOI 10.1515/cclm-2013-0225; Menon V, 2005, KIDNEY INT, V68, P766, DOI 10.1111/j.1523-1755.2005.00455.x; Methven S, 2011, QJM-INT J MED, V104, P663, DOI 10.1093/qjmed/hcr026; Methven S, 2011, AM J KIDNEY DIS, V57, P21, DOI 10.1053/j.ajkd.2010.08.009; Methven S, 2010, NEPHROL DIAL TRANSPL, V25, P2991, DOI 10.1093/ndt/gfq140; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f324; Pinto-Sietsma SJ, 2003, AM J KIDNEY DIS, V41, P733, DOI 10.1016/S0272-6386(03)00020-9; SHAW AB, 1983, BRIT MED J, V287, P929, DOI 10.1136/bmj.287.6397.929; Smith ER, 2012, NEPHROL DIAL TRANSPL, V27, P1534, DOI 10.1093/ndt/gfr708; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Tonelli M, 2005, KIDNEY INT, V68, P237, DOI 10.1111/j.1523-1755.2005.00398.x; Warnock DG, 2010, AM J KIDNEY DIS, V56, P861, DOI 10.1053/j.ajkd.2010.05.017; World Health Organization, 2006, DEF DIAGN DIAB MELL	32	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98261	10.1371/journal.pone.0098261	http://dx.doi.org/10.1371/journal.pone.0098261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867154	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000336914100042
J	Akimoto, M; Zhang, ZY; Boulton, S; Selvaratnam, R; VanSchouwen, B; Gloyd, M; Accili, EA; Lange, OF; Melacini, G				Akimoto, Madoka; Zhang, Zaiyong; Boulton, Stephen; Selvaratnam, Rajeevan; VanSchouwen, Bryan; Gloyd, Melanie; Accili, Eric A.; Lange, Oliver F.; Melacini, Giuseppe			A Mechanism for the Auto-inhibition of Hyperpolarization-activated Cyclic Nucleotide-gated (HCN) Channel Opening and Its Relief by cAMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; NMR CHEMICAL-SHIFTS; STRUCTURAL BASIS; BINDING DOMAIN; CONFORMATIONAL-CHANGES; DEPENDENT ALLOSTERY; STRUCTURE REVEALS; TERMINAL REGION; CS-ROSETTA; DYNAMICS	Hyperpolarization-activated cyclic nucleotide-gated (HCN) ion channels control neuronal and cardiac electrical rhythmicity. There are four homologous isoforms (HCN1-4) sharing a common multidomain architecture that includes an N-terminal transmembrane tetrameric ion channel followed by a cytoplasmic "C-linker," which connects a more distal cAMP-binding domain (CBD) to the inner pore. Channel opening is primarily stimulated by transmembrane elements that sense membrane hyperpolarization, although cAMP reduces the voltage required for HCN activation by promoting tetramerization of the intracellular C-linker, which in turn relieves auto-inhibition of the inner pore gate. Although binding of cAMP has been proposed to relieve auto-inhibition by affecting the structure of the C-linker and CBD, the nature and extent of these cAMP-dependent changes remain limitedly explored. Here, we used NMR to probe the changes caused by the binding of cAMP and of cCMP, a partial agonist, to the apo-CBD of HCN4. Our data indicate that the CBD exists in a dynamic two-state equilibrium, whose position as gauged by NMR chemical shifts correlates with the V-1/2 voltage measured through electrophysiology. In the absence of cAMP, the most populated CBD state leads to steric clashes with the activated or "tetrameric" C-linker, which becomes energetically unfavored. The steric clashes of the apo tetramer are eliminated either by cAMP binding, which selects for a CBD state devoid of steric clashes with the tetrameric C-linker and facilitates channel opening, or by a transition of apo-HCN to monomers or dimer of dimers, in which the C-linker becomes less structured, and channel opening is not facilitated.	[Akimoto, Madoka; Selvaratnam, Rajeevan; VanSchouwen, Bryan; Gloyd, Melanie; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada; [Boulton, Stephen; Gloyd, Melanie; Melacini, Giuseppe] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4M1, Canada; [Zhang, Zaiyong; Lange, Oliver F.] Tech Univ Munich, Biomol NMR, D-85747 Garching, Germany; [Zhang, Zaiyong; Lange, Oliver F.] Tech Univ Munich, Munich Ctr Integrated Prot Sci, Dept Chem, D-85747 Garching, Germany; [Accili, Eric A.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Lange, Oliver F.] Helmholtz Zentrum Munchen, Inst Biol Struct, D-85764 Neuherberg, Germany	McMaster University; McMaster University; Technical University of Munich; Technical University of Munich; University of British Columbia; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Melacini, G (corresponding author), McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada.	melacin@mcmaster.ca	Boulton, Stephen/AAM-3440-2021	Boulton, Stephen/0000-0002-2521-2240; Selvaratnam, Rajeevan/0000-0003-4457-616X	Canadian Institutes of Health Research [MOP-68897]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant MOP-68897 (to G. M.) from the Canadian Institutes of Health Research.	Abu-Abed M, 2007, PROTEINS, V69, P112, DOI 10.1002/prot.21446; Akimoto M, 2013, P NATL ACAD SCI USA, V110, P14231, DOI 10.1073/pnas.1312644110; Anand GS, 2010, MOL CELL PROTEOMICS, V9, P2225, DOI 10.1074/mcp.M900388-MCP200; Badireddy Suguna, 2011, Mol Cell Proteomics, V10, DOI 10.1074/mcp.M110.004390; Battiste JL, 2000, BIOCHEMISTRY-US, V39, P5355, DOI 10.1021/bi000060h; Boulton S, 2014, BIOCHEM SOC T, V42, P302, DOI 10.1042/BST20130282; Bouvignies G, 2011, NATURE, V477, P111, DOI 10.1038/nature10349; Bruystens JGH, 2014, STRUCTURE, V22, P59, DOI 10.1016/j.str.2013.10.012; Chow SS, 2012, J BIOL CHEM, V287, P600, DOI 10.1074/jbc.M111.269563; Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; Das R, 2008, J BIOL CHEM, V283, P19691, DOI 10.1074/jbc.M802164200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P219, DOI 10.1007/s10858-005-7944-6; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Flynn GE, 2001, NAT REV NEUROSCI, V2, P643, DOI 10.1038/35090015; Gavina JMA, 2009, BIOCHEMISTRY-US, V48, P223, DOI 10.1021/bi802121g; Goddard TD., SPARKY VERSION 3; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Hegle AP, 2010, AM J PHYSIOL-CELL PH, V298, pC1066, DOI 10.1152/ajpcell.00389.2009; Huang GY, 2014, STRUCTURE, V22, P116, DOI 10.1016/j.str.2013.09.021; Ilouz R, 2012, P NATL ACAD SCI USA, V109, P12443, DOI 10.1073/pnas.1209538109; Jackson HA, 2007, PHYSIOL GENOMICS, V29, P231, DOI 10.1152/physiolgenomics.00142.2006; Jackson HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047590; Johnson JP, 2005, P NATL ACAD SCI USA, V102, P2742, DOI 10.1073/pnas.0408323102; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kelkar DS, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011627, 10.1074/mcp.M111.011445]; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kim Jeong Joo, 2011, PLoS One, V6, pe18413, DOI 10.1371/journal.pone.0018413; Kusch J, 2012, NAT CHEM BIOL, V8, P162, DOI 10.1038/nchembio.747; Lange OF, 2012, P NATL ACAD SCI USA, V109, P10873, DOI 10.1073/pnas.1203013109; Lange OF, 2012, PROTEINS, V80, P884, DOI 10.1002/prot.23245; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Macri V, 2004, J BIOL CHEM, V279, P16832, DOI 10.1074/jbc.M400518200; Macri V, 2012, SCI REP-UK, V2, DOI 10.1038/srep00894; Macri V, 2009, J BIOL CHEM, V284, P15659, DOI 10.1074/jbc.M809164200; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; Mazhab-Jafari MT, 2007, J AM CHEM SOC, V129, P14482, DOI 10.1021/ja0753703; McNicholl ET, 2010, J BIOL CHEM, V285, P15523, DOI 10.1074/jbc.M110.105783; Ming DM, 2004, J BIOMOL NMR, V29, P363, DOI 10.1023/B:JNMR.0000032612.70767.35; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Nussinov R, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/4/045004; Nussinov R, 2013, ANNU REV BIOPHYS, V42, P169, DOI 10.1146/annurev-biophys-083012-130257; Nussinov R, 2011, TRENDS PHARMACOL SCI, V32, P686, DOI 10.1016/j.tips.2011.08.004; Pawley NH, 2002, J MOL BIOL, V324, P991, DOI 10.1016/S0022-2836(02)01146-4; Qu Y, 2008, J PHYSIOL-LONDON, V586, P701, DOI 10.1113/jphysiol.2007.144329; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schunke S, 2011, P NATL ACAD SCI USA, V108, P6121, DOI 10.1073/pnas.1015890108; Selvaratnam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048707; Selvaratnam R, 2012, BIOPHYS J, V102, P630, DOI 10.1016/j.bpj.2011.12.030; Selvaratnam R, 2012, BIOCHEM SOC T, V40, P219, DOI 10.1042/BST20110628; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; Sgourakis NG, 2011, J AM CHEM SOC, V133, P6288, DOI 10.1021/ja111318m; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi L, 2011, J AM CHEM SOC, V133, P2232, DOI 10.1021/ja109080t; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Thompson J, 2011, PROTEINS, V79, P2380, DOI 10.1002/prot.23046; Thompson JM, 2012, P NATL ACAD SCI USA, V109, P9875, DOI 10.1073/pnas.1202485109; Tonelli M, 2009, J AM CHEM SOC, V131, P14138, DOI 10.1021/ja904766g; Trudeau MC, 2003, J BIOL CHEM, V278, P18705, DOI 10.1074/jbc.R300001200; Tugarinov V, 2005, CHEMBIOCHEM, V6, P1567, DOI 10.1002/cbic.200500110; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; van der Schot G, 2013, J BIOMOL NMR, V57, P27, DOI 10.1007/s10858-013-9762-6; VanSchouwen B, 2011, J BIOL CHEM, V286, P42655, DOI 10.1074/jbc.M111.277723; Vernon R, 2013, J BIOMOL NMR, V57, P117, DOI 10.1007/s10858-013-9772-4; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Warner LR, 2011, J MOL BIOL, V411, P83, DOI 10.1016/j.jmb.2011.05.022; Whitaker GM, 2007, J BIOL CHEM, V282, P22900, DOI 10.1074/jbc.M610978200; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zhou L, 2004, NEURON, V44, P823, DOI 10.1016/j.neuron.2004.11.012; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012; Zong XG, 2012, J BIOL CHEM, V287, P26506, DOI 10.1074/jbc.M112.357129	82	57	59	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 8	2014	289	32					22205	22220		10.1074/jbc.M114.572164	http://dx.doi.org/10.1074/jbc.M114.572164			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AN4XQ	24878962	Green Published, hybrid			2022-12-25	WOS:000340593500035
J	Niu, JF; Feng, ZZ; Zhang, WW; Zhao, P; Wang, XK				Niu, Junfeng; Feng, Zhaozhong; Zhang, Weiwei; Zhao, Ping; Wang, Xiaoke			Non-Stomatal Limitation to Photosynthesis in Cinnamomum camphora Seedings Exposed to Elevated O-3	PLOS ONE			English	Article							GAS-EXCHANGE MEASUREMENTS; OZONE AIR-POLLUTION; CHLOROPHYLL FLUORESCENCE; PINUS-SYLVESTRIS; QUERCUS-ILEX; FOREST TREES; SCOTS PINE; HOLM OAK; RESPONSES; SEEDLINGS	Ozone (O-3) is the most phytotoxic air pollutant for global forests, with decreased photosynthesis widely regarded as one of its most common effects. However, controversy exists concerning the mechanism that underlies the depressing effects of O-3 on CO2 assimilation. In the present study, seedlings of Cinnamomum camphora, a subtropical evergreen tree species that has rarely been studied, were exposed to ambient air (AA), ambient air plus 60 [ppb] O-3 (AA+60), or ambient air plus 120 [ppb] O-3 (AA+120) in open-top chambers (OTCs) for 2 years. Photosynthetic CO2 exchange and chlorophyll a fluorescence were investigated in the second growing season (2010). We aim to determine whether stomatal or non-stomatal limitation is responsible for the photosynthesis reduction and to explore the potential implications for forest ecosystem functions. Results indicate that elevated O-3 (E-O-3) reduced the net photosynthetic rates (PN) by 6.0-32.2%, with significant differences between AA+60 and AA+120 and across the four measurement campaigns (MCs). The actual photochemical efficiency of photosystem II (PSII) in saturated light (F-v(')/F-m(')) was also significantly decreased by E-O-3, as was the effective quantum yield of PSII photochemistry (Phi(PSII)). Moreover, E-O-3 significantly and negatively impacted the maximum rates of carboxylation (V-cmax) and electron transport (J(max)). Although neither the stomatal conductance (g(s)) nor the intercellular CO2 concentration (C-i) was decreased by E-O-3, P-N/g(s) was significantly reduced. Therefore, the observed reduction in P-N in the present study should not be attributed to the unavailability of CO2 due to stomatal limitation, but rather to the O-3-induced damage to Ribulose-1,5-bisphosphate carboxylase/oxygenase and the photochemical apparatus. This suggests that the down-regulation of stomatal conductance could fail to occur, and the biochemical processes in protoplasts would become more susceptible to injuries under long-term O-3 exposure, which may have important consequences for forest carbon and water budget.	[Niu, Junfeng; Zhao, Ping] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Feng, Zhaozhong; Wang, Xiaoke] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China; [Zhang, Weiwei] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Black Soil Ecol, Harbin, Heilongjiang, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS	Wang, XK (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing, Peoples R China.	wangxk@rcees.ac.cn			National Natural Science Foundation of China [31170424, 71003092, 41030638, 41275169]; Tiantong National Station of Forest Ecosystems [XT200707]; South Botanical Garden, Chinese Academy of Sciences [201229]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tiantong National Station of Forest Ecosystems; South Botanical Garden, Chinese Academy of Sciences	Funding for this project was provided by the National Natural Science Foundation of China (No. 31170424, No. 71003092, No. 41030638 and No. 41275169), Tiantong National Station of Forest Ecosystems (No. XT200707) and South Botanical Garden, Chinese Academy of Sciences (No. 201229). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bortier K, 2000, NEW PHYTOL, V146, P271, DOI 10.1046/j.1469-8137.2000.00633.x; Bussotti F, 2007, J MEDITERRANEAN ECOL, V3, P23; Bussotti F, 2008, GLOBAL CHANGE BIOL, V14, P2727, DOI 10.1111/j.1365-2486.2008.01677.x; Bussotti F, 2007, ENVIRON POLLUT, V147, P430, DOI 10.1016/j.envpol.2006.08.036; Bussotti F, 2007, PHYSIOL PLANTARUM, V130, P122, DOI 10.1111/j.1399-3054.2007.00894.x; Bussotti F, 2011, ENVIRON EXP BOT, V73, P19, DOI 10.1016/j.envexpbot.2010.10.022; Calatayud A, 2006, PHOTOSYNTHETICA, V44, P548, DOI 10.1007/s11099-006-0070-1; Calatayud V, 2011, ENVIRON POLLUT, V159, P55, DOI 10.1016/j.envpol.2010.09.024; DANN MS, 1989, PLANT PHYSIOL, V91, P427, DOI 10.1104/pp.91.1.427; Darbah JNT, 2010, ENVIRON POLLUT, V158, P983, DOI 10.1016/j.envpol.2009.10.022; Degl'Innocenti E, 2003, PLANT PHYSIOL BIOCH, V41, P485, DOI 10.1016/S0981-9428(03)00057-3; Eichelmann H, 2004, PLANT CELL ENVIRON, V27, P479, DOI 10.1111/j.1365-3040.2003.01166.x; Feng ZZ, 2011, TREES-STRUCT FUNCT, V25, P617, DOI 10.1007/s00468-011-0538-x; Feng ZZ, 2011, GLOBAL CHANGE BIOL, V17, P580, DOI 10.1111/j.1365-2486.2010.02184.x; Fontaine V, 1999, PHYSIOL PLANTARUM, V105, P187, DOI 10.1034/j.1399-3054.1999.105201.x; Gerosa G, 2009, ENVIRON POLLUT, V157, P1737, DOI 10.1016/j.envpol.2007.11.025; Grulke NE, 2005, PHYTON-ANN REI BOT A, V45, P21; He XY, 2007, PHOTOSYNTHETICA, V45, P555, DOI 10.1007/s11099-007-0095-0; Karnosky DF, 2007, ENVIRON POLLUT, V147, P489, DOI 10.1016/j.envpol.2006.08.043; Karnosky DF, 2005, PLANT CELL ENVIRON, V28, P965, DOI 10.1111/j.1365-3040.2005.01362.x; Kets K, 2010, ENVIRON POLLUT, V158, P1000, DOI 10.1016/j.envpol.2009.09.001; Lombardozzi D, 2012, BIOGEOSCIENCES, V9, P3113, DOI 10.5194/bg-9-3113-2012; Long SP, 2003, J EXP BOT, V54, P2393, DOI 10.1093/jxb/erg262; Manes F, 2007, ENVIRON EXP BOT, V59, P235, DOI 10.1016/j.envexpbot.2005.12.001; MATYSSEK R, 1991, TREES-STRUCT FUNCT, V5, P5, DOI 10.1007/BF00225329; Matyssek R, 2008, ENVIRON POLLUT, V156, P567, DOI 10.1016/j.envpol.2008.04.017; Nali C, 2004, ATMOS ENVIRON, V38, P2247, DOI 10.1016/j.atmosenv.2003.11.043; Niu JF, 2011, J ENVIRON MONITOR, V13, P2873, DOI 10.1039/c1em10305a; Noormets A, 2001, PLANT CELL ENVIRON, V24, P327, DOI 10.1046/j.1365-3040.2001.00678.x; Noormets A, 2010, ENVIRON POLLUT, V158, P992, DOI 10.1016/j.envpol.2009.10.009; Novak K, 2007, TREE PHYSIOL, V27, P941, DOI 10.1093/treephys/27.7.941; Oksanen E, 2003, PLANT CELL ENVIRON, V26, P875, DOI 10.1046/j.1365-3040.2003.01020.x; Paoletti E, 2006, ENVIRON POLLUT, V144, P463, DOI 10.1016/j.envpol.2005.12.051; Ribas A, 2005, ATMOS ENVIRON, V39, P685, DOI 10.1016/j.atmosenv.2004.10.022; Ribas A, 2005, ENVIRON POLLUT, V134, P291, DOI 10.1016/j.envpol.2004.07.026; RICHARDSON CJ, 1992, FOREST ECOL MANAG, V51, P163, DOI 10.1016/0378-1127(92)90482-O; Rogers A, 2000, GLOBAL CHANGE BIOL, V6, P1005, DOI 10.1046/j.1365-2486.2000.00375.x; Samuelson L, 2001, NEW PHYTOL, V149, P21, DOI 10.1046/j.1469-8137.2001.00007.x; Soja G, 1998, PHYSIOL PLANTARUM, V104, P639, DOI 10.1034/j.1399-3054.1998.1040417.x; STRAND M, 1985, PHYSIOL PLANTARUM, V65, P117, DOI 10.1111/j.1399-3054.1985.tb02369.x; Sun G, 2012, GLOBAL CHANGE BIOL, V18, P3395, DOI 10.1111/j.1365-2486.2012.02787.x; Torsethaugen G, 1999, P NATL ACAD SCI USA, V96, P13577, DOI 10.1073/pnas.96.23.13577; Vitale M, 2008, WATER AIR SOIL POLL, V189, P113, DOI 10.1007/s11270-007-9560-4; Wang KY, 1997, NEW PHYTOL, V136, P277, DOI 10.1046/j.1469-8137.1997.00744.x; Warren CR, 2003, TREES-STRUCT FUNCT, V17, P359, DOI 10.1007/s00468-003-0246-2; Watanabe M, 2007, TREES-STRUCT FUNCT, V21, P421, DOI 10.1007/s00468-007-0134-2; Wittig VE, 2007, PLANT CELL ENVIRON, V30, P1150, DOI 10.1111/j.1365-3040.2007.01717.x; Yan K, 2010, ENVIRON EXP BOT, V69, P198, DOI 10.1016/j.envexpbot.2010.03.008; Zhang WW, 2011, PHOTOSYNTHETICA, V49, P29, DOI 10.1007/s11099-011-0003-5	49	6	11	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98572	10.1371/journal.pone.0098572	http://dx.doi.org/10.1371/journal.pone.0098572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892748	gold, Green Submitted, Green Published			2022-12-25	WOS:000336911400069
J	Viola, V; Tosoni, A; Kruglanski, AW; Galati, G; Mannetti, L				Viola, Vanda; Tosoni, Annalisa; Kruglanski, Arie W.; Galati, Gaspare; Mannetti, Lucia			Routes of Motivation: Stable Psychological Dispositions Are Associated with Dynamic Changes in Cortico-Cortical Functional Connectivity	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; COGNITIVE CONTROL; HUMAN BRAIN; PSYCHOPHYSIOLOGICAL INTERACTIONS; CONFLICT ADAPTATION; NEED; CLOSURE; ACTIVATION; INTERFERENCE	The present study provides a neurobiological framework to the theory of epistemic motivation that has been extensively studied for the last three decades in the domain of social cognition. Epistemic motivations affect the way people generate and validate hypotheses, and ultimately form and modify knowledge. Strong dispositional measures such as need for cognitive closure (NCC), the desire for a quick firm answer (any answer) to a question, show gross and stable inter-individual differences. The cognitive mechanisms and neural underpinnings of such differences, however, remain largely unexplored. Here we show that high (compared to low) levels of NCC, measured with need for cognitive closure scale, are associated with reduced online adjustment in cognitive control, as indexed by behavioral conflict adaptation. This behavioral effect is mediated by dynamic changes in cortico-cortical functional connectivity between prefrontal regions involved in conflict monitoring and implementation of cognitive control. In particular, these regions show increased functional connectivity after exposure to conflict in low but not high NCC individuals. These results demonstrate that the level of flexibility of functional cortico-cortical connections can mediate stable psychological dispositions.	[Viola, Vanda; Galati, Gaspare] Univ Roma La Sapienza, Dept Psychol, I-00185 Rome, Italy; [Viola, Vanda; Galati, Gaspare] Fdn Santa Lucia, Neuropsychol Lab, Rome, Italy; [Tosoni, Annalisa] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Tosoni, Annalisa] Fdn G DAnnunzio, Inst Adv Biomed Technol, Chieti, Italy; [Kruglanski, Arie W.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA; [Mannetti, Lucia] Univ Roma La Sapienza, Dept Dev & Social Psychol, I-00185 Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University System of Maryland; University of Maryland College Park; Sapienza University Rome	Mannetti, L (corresponding author), Univ Roma La Sapienza, Dept Dev & Social Psychol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	lucia.mannetti@uniroma1.it	Galati, Gaspare/F-3277-2011; Tosoni, Annalisa/J-7410-2016	Galati, Gaspare/0000-0002-0640-4247; Tosoni, Annalisa/0000-0001-9004-2623	Italian Ministry of Health; Sapienza University of Rome [C26A12Y33P]	Italian Ministry of Health(Ministry of Health, Italy); Sapienza University of Rome	This work was supported by: "RC block grants by the Italian Ministry of Health to Fondazione Santa Lucia" and by "C26A12Y33P grant by Sapienza University of Rome" to the last author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Caparos S, 2012, EMOTION, V12, P8, DOI 10.1037/a0026310; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Chirumbolo A, 2004, EUR J PERSONALITY, V18, P265, DOI 10.1002/per.518; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; Cohen JD, 2000, NAT NEUROSCI, V3, P421, DOI 10.1038/74783; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dijksterhuis A, 1996, J EXP SOC PSYCHOL, V32, P254, DOI 10.1006/jesp.1996.0012; Durston S, 2003, BIOL PSYCHIAT, V53, P871, DOI 10.1016/S0006-3223(02)01904-2; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Egner T, 2007, COGN AFFECT BEHAV NE, V7, P380, DOI 10.3758/CABN.7.4.380; Egner T, 2011, J COGNITIVE NEUROSCI, V23, P3903, DOI 10.1162/jocn_a_00064; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Hester RL, 2004, J COGNITIVE NEUROSCI, V16, P776, DOI 10.1162/089892904970726; Hommel B, 2004, TRENDS COGN SCI, V8, P494, DOI 10.1016/j.tics.2004.08.007; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Jost JT, 2007, PERS SOC PSYCHOL B, V33, P989, DOI 10.1177/0146167207301028; Jost JT, 2012, MOTIV EMOTION, V36, P55, DOI 10.1007/s11031-011-9260-7; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kerns JG, 2006, NEUROIMAGE, V33, P399, DOI 10.1016/j.neuroimage.2006.06.012; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Krug MK, 2010, COGN AFFECT BEHAV NE, V10, P357, DOI 10.3758/CABN.10.3.357; Kruglanski A, 2006, SHORTENED NEED UNPUB; Kruglanski A. W, 1989, LAY EPISTEMICS HUMAN; Kruglanski Arie W., 2004, PSYCHOL CLOSED MINDE; Kruglanski AW, 2006, PSYCHOL REV, V113, P84, DOI 10.1037/0033-295X.113.1.84; KRUGLANSKI AW, 1983, J EXP SOC PSYCHOL, V19, P448, DOI 10.1016/0022-1031(83)90022-7; KRUGLANSKI AW, 1993, J PERS SOC PSYCHOL, V65, P861, DOI 10.1037/0022-3514.65.5.861; Kruglanski AW, 1996, PSYCHOL REV, V103, P263, DOI 10.1037/0033-295X.103.2.263; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Leone L, 2008, J RES PERS, V42, P755, DOI 10.1016/j.jrp.2007.08.001; Luo QA, 2006, NEUROIMAGE, V30, P1449, DOI 10.1016/j.neuroimage.2005.11.005; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Mannetti L, 2007, J ECON PSYCHOL, V28, P186, DOI 10.1016/j.joep.2005.12.004; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; McLaren DG, 2012, NEUROIMAGE, V61, P1277, DOI 10.1016/j.neuroimage.2012.03.068; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Orehek E, 2010, BASIC APPL SOC PSYCH, V32, P279, DOI 10.1080/01973533.2010.519196; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Rocchi P., 1998, G ITAL PSICOL, V25, P153; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson-Schill SL, 2002, COGN AFFECT BEHAV NE, V2, P109, DOI 10.3758/CABN.2.2.109	57	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98010	10.1371/journal.pone.0098010	http://dx.doi.org/10.1371/journal.pone.0098010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24892718	Green Submitted, Green Published, gold			2022-12-25	WOS:000336911400029
J	Fausther, M; Lavoie, EG; Goree, JR; Baldini, G; Dranoff, JA				Fausther, Michel; Lavoie, Elise G.; Goree, Jessica R.; Baldini, Giulia; Dranoff, Jonathan A.			NT5E Mutations That Cause Human Disease Are Associated with Intracellular Mistrafficking of NT5E Protein	PLOS ONE			English	Article							HUMAN BREAST-CANCER; ALKALINE-PHOSPHATASE; ECTO-5'-NUCLEOTIDASE CD73; ADENOSINE PRODUCTION; B-CELLS; ADHESION; ECTO-5-NUCLEOTIDASE; IDENTIFICATION; SUBSTITUTION; GENERATION	Ecto-5'-nucleotidase/CD73/NT5E, the product of the NT5E gene, is the dominant enzyme in the generation of adenosine from degradation of AMP in the extracellular environment. Nonsense (c.662C -> A, p.S221X designated F1, c. 1609dupA, p.V537fsX7 designated F3) and missense (c.1073G -> A, p.C358Y designated F2) NT5E gene mutations in three distinct families have been shown recently to cause premature arterial calcification disease in human patients. However, the underlying mechanisms by which loss-of-function NT5E mutations cause human disease are unknown. We hypothesized that human NT5E gene mutations cause mistrafficking of the defective proteins within cells, ultimately blocking NT5E catalytic function. To test this hypothesis, plasmids encoding cDNAs of wild type and mutant human NT5E tagged with the fluorescent probe DsRed were generated and used for transfection and heterologous expression in immortalized monkey COS-7 kidney cells that lack native NT5E protein. Enzyme histochemistry and Malachite green assays were performed to assess the biochemical activities of wild type and mutant fusion NT5E proteins. Subcellular trafficking of fusion NT5E proteins was monitored by confocal microscopy and western blot analysis of fractionated cell constituents. All 3 F1, F2, and F3 mutations result in a protein with significantly reduced trafficking to the plasma membrane and reduced ER retention as compared to wild type protein. Confocal immunofluorescence demonstrates vesicles containing DsRed-tagged NT5E proteins (F1, F2 and F3) in the cell synthetic apparatus. All 3 mutations resulted in absent NT5E enzymatic activity at the cell surface. In conclusion, three familial NT5E mutations (F1, F2, F3) result in novel trafficking defects associated with human disease. These novel genetic causes of human disease suggest that the syndrome of premature arterial calcification due to NT5E mutations may also involve a novel "trafficking-opathy".	[Fausther, Michel; Lavoie, Elise G.; Goree, Jessica R.; Dranoff, Jonathan A.] Univ Arkansas Med Sci, Div Gastroenterol & Hepatol, Little Rock, AR 72205 USA; [Fausther, Michel; Lavoie, Elise G.; Goree, Jessica R.; Dranoff, Jonathan A.] Cent Arkansas VA Healthcare Syst, Res Serv, Little Rock, AR USA; [Baldini, Giulia] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Dranoff, JA (corresponding author), Univ Arkansas Med Sci, Div Gastroenterol & Hepatol, Little Rock, AR 72205 USA.	jadranoff@uams.edu		Fausther, Michel/0000-0002-5673-9360	NIH [UL1TR000039]; American Association for the Study of Liver Diseases; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070849] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Association for the Study of Liver Diseases; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors would like to acknowledge the UAMS Translational Research Institute's Digital Microscopy Core, supported by NIH grant UL1TR000039. Individual support to MF was provided by a Roger L. Jenkins MD, Postdoctoral Research Fellowship of the American Association for the Study of Liver Diseases. Individual support to JAD was provided by the National Institute of Diabetes and Digestive and Kidney Diseases in the form of NIH R01 DK070849. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airas L, 1998, LEUKEMIA LYMPHOMA, V29, P37, DOI 10.3109/10428199809058380; Airas L, 1996, BLOOD, V88, P1755, DOI 10.1182/blood.V88.5.1755.bloodjournal8851755; Airas L, 2000, J IMMUNOL, V165, P5411, DOI 10.4049/jimmunol.165.10.5411; Alam MS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04486; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Barry F, 2001, BIOCHEM BIOPH RES CO, V289, P519, DOI 10.1006/bbrc.2001.6013; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bonner F, 2013, CIRC RES, V113, P301, DOI 10.1161/CIRCRESAHA.113.300180; Catoire H, 2008, HUM MOL GENET, V17, P2108, DOI 10.1093/hmg/ddn109; CHENG SH, 1995, AM J PHYSIOL-LUNG C, V268, pL615, DOI 10.1152/ajplung.1995.268.4.L615; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Ernst PB, 2010, J IMMUNOL, V185, P1993, DOI 10.4049/jimmunol.1000108; Fankhauser N, 2005, BIOINFORMATICS, V21, P1846, DOI 10.1093/bioinformatics/bti299; Fausther Michel, 2013, Curr Pathobiol Rep, V1, P225; Fausther M, 2012, AM J PHYSIOL-GASTR L, V302, pG447, DOI [10.1152/ajpgi.00165.2011., 10.1152/ajpgi.00165.2011]; Fernandez P, 2013, AM J PATHOL, V183, P1740, DOI 10.1016/j.ajpath.2013.08.024; Fukushi-Irie M, 2000, BIOCHEM J, V348, P633, DOI 10.1042/0264-6021:3480633; Gahl WA, 2012, DIS MODEL MECH, V5, P3, DOI 10.1242/dmm.009258; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hausler SFM, 2014, AM J TRANSL RES, V6, P129; Hasko G, 2011, J IMMUNOL, V187, P4256, DOI 10.4049/jimmunol.1003379; Ito M, 2002, BIOCHEM J, V361, P473, DOI 10.1042/0264-6021:3610473; KLEMENS MR, 1990, BIOCHEM BIOPH RES CO, V172, P1371, DOI 10.1016/0006-291X(90)91601-N; Koso H, 2009, INVEST OPHTH VIS SCI, V50, P5411, DOI 10.1167/iovs.08-3246; Kukulski F, 2005, Purinergic Signal, V1, P193, DOI 10.1007/s11302-005-6217-x; Martin-Satue M, 2010, HISTOCHEM CELL BIOL, V133, P659, DOI 10.1007/s00418-010-0704-z; MISUMI Y, 1990, EUR J BIOCHEM, V191, P563, DOI 10.1111/j.1432-1033.1990.tb19158.x; Murakami Y, 2012, J BIOL CHEM, V287, P6318, DOI 10.1074/jbc.M111.331090; Peng Z, 2008, FASEB J, V22, P2263, DOI 10.1096/fj.07-100685; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrikovics I, 2012, AAPS PHARMSCITECH, V13, P112, DOI 10.1208/s12249-011-9728-5; Pfister S, 2012, CHEM SENSES, V37, P859, DOI 10.1093/chemse/bjs069; Resta R, 1998, IMMUNOL REV, V161, P95, DOI 10.1111/j.1600-065X.1998.tb01574.x; Rogan MP, 2011, CHEST, V139, P1480, DOI 10.1378/chest.10-2077; Rowe SM, 2009, BIODRUGS, V23, P165, DOI 10.2165/00063030-200923030-00003; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Sadej R, 2008, BBA-MOL BASIS DIS, V1782, P35, DOI 10.1016/j.bbadis.2007.11.001; Sadej R, 2012, ACTA BIOCHIM POL, V59, P647; Shibata H, 1998, J BIOCHEM-TOKYO, V123, P968; Snider NT, 2013, HEPATOLOGY, V58, P1790, DOI 10.1002/hep.26525; Sowa NA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-20; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; Stagg J, 2012, CANCER RES, V72, P2190, DOI 10.1158/0008-5472.CAN-12-0420; Stagg J, 2011, CANCER RES, V71, P2892, DOI 10.1158/0008-5472.CAN-10-4246; Terp MG, 2013, J IMMUNOL, V191, P4165, DOI 10.4049/jimmunol.1301274; Tkacz K, 2000, ADV EXP MED BIOL, V486, P355; Volmer JB, 2006, J IMMUNOL, V176, P4449, DOI 10.4049/jimmunol.176.7.4449; Wang L, 2008, J CANCER RES CLIN, V134, P365, DOI 10.1007/s00432-007-0292-z; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	51	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98568	10.1371/journal.pone.0098568	http://dx.doi.org/10.1371/journal.pone.0098568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887587	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300087
J	Kim, HS; Koh, JS; Choi, YB; Ro, J; Kim, HK; Kim, MK; Nam, BH; Kim, KT; Chandra, V; Seol, HS; Noh, WC; Kim, EK; Park, J; Bae, CD; Hong, KM				Kim, Han-Seong; Koh, Jae-Soo; Choi, Yong-Bock; Ro, Jungsil; Kim, Hyun-Kyoung; Kim, Mi-Kyung; Nam, Byung-Ho; Kim, Kyung-Tae; Chandra, Vishal; Seol, Hye-Sil; Noh, Woo-Chul; Kim, Eun-Kyu; Park, Joobae; Bae, Chang-Dae; Hong, Kyeong-Man			Chromatin CKAP2, a New Proliferation Marker, as Independent Prognostic Indicator in Breast Cancer	PLOS ONE			English	Article							SUBTYPES; KI-67; EXPRESSION; SURVIVAL; PROTEIN; RECOMMENDATIONS; CLASSIFICATION; IDENTIFICATION; DOCETAXEL; THERAPY	Background: The level of proliferation activity is a strong prognostic or predictive indicator in breast cancer, but its optimal measurement is still in debate, necessitating new proliferation markers. In the present study, the prognostic significance of the CKAP2-positive cell count (CPCC), a new proliferation marker, was evaluated, and the results were compared with those for the mitotic activity index (MAI). Methods: This study included 375 early-stage breast cancer samples collected from two institutions between 2000 and 2006. Immunohistochemical staining was performed using a CKAP2 monoclonal antibody. Cox proportional hazard regression models were fitted to determine the association between the CPCC and relapse-free survival (RFS) amongst three groups formed on the basis of the CPCC or MAI value: groups 2 and 3 showing the middle and highest values, respectively, and group 1 the lowest. Results: After adjustment for age, T stage, N stage, HER2 status, estrogen receptor status, progesterone receptor status, institution, and year of surgical resection, the CPCC was associated with a significantly worse RFS {hazard ratio [HR] = 4.10 (95% CI: 1.64-10.29) for group 2; HR = 4.35 (95% CI: 2.04-10.35) for group 3}. Moreover, its prognostic significance was similar to or higher than that based on the MAI {HR = 2.05 (95% CI: 0.94-4.65) for group 2; HR = 2.35 (95% CI: 1.09-5.10) for group 3}. In subgroup analyses, the CPCC showed a prognostic significance in the luminal A and triple-negative subgroups, but not in the HER2-positive subgroup. Conclusions: Chromatin CKAP2 is an independent prognostic marker for RFS in early-stage breast cancer, and could potentially replace the MAI in clinical evaluation of proliferation activity. Additionally, our study results suggest that the prognostic significance of proliferation activity differs among the various subgroups of breast cancer.	[Kim, Han-Seong] Inje Univ, Ilsan Paik Hosp, Dept Pathol, Goyang, South Korea; [Koh, Jae-Soo; Seol, Hye-Sil] Korea Canc Ctr Hosp, Dept Pathol, Seoul, South Korea; [Choi, Yong-Bock; Ro, Jungsil; Kim, Hyun-Kyoung; Kim, Mi-Kyung; Nam, Byung-Ho; Kim, Kyung-Tae; Chandra, Vishal; Hong, Kyeong-Man] Natl Canc Ctr, Res Inst, Goyang, South Korea; [Noh, Woo-Chul; Kim, Eun-Kyu] Korea Canc Ctr Hosp, Breast Canc Ctr, Dept Surg, Seoul, South Korea; [Park, Joobae; Bae, Chang-Dae] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea; [Park, Joobae; Bae, Chang-Dae] Samsung Biomed Res Inst, Suwon, South Korea	Inje University; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Sungkyunkwan University (SKKU)	Bae, CD (corresponding author), Inje Univ, Ilsan Paik Hosp, Dept Pathol, Goyang, South Korea.	cdbae@skku.edu; kmhong@ncc.re.kr	Chandra, Vishal/AAN-8756-2020		National Cancer Center, Korea [1410050]; Samsung Biomedical Research Institute, Korea [BB01022]; National Research Foundation, Korea [1230950]	National Cancer Center, Korea; Samsung Biomedical Research Institute, Korea; National Research Foundation, Korea(National Research Foundation of Korea)	This work was supported by a research grant to K.-M.H. from the National Cancer Center, Korea (1410050); by a grant to C.-D.B. from the Samsung Biomedical Research Institute, Korea (BB01022), and by a grant to J.R. from the National Research Foundation, Korea (1230950). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleskandarany MA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3084; Amadori D, 2000, J CLIN ONCOL, V18, P3125, DOI 10.1200/JCO.2000.18.17.3125; Baak JPA, 2009, BREAST CANCER RES TR, V115, P241, DOI 10.1007/s10549-008-0126-y; Baak JPA, 2005, J CLIN ONCOL, V23, P5993, DOI 10.1200/JCO.2005.05.511; Bossard C, 2006, J CLIN PATHOL, V59, P706, DOI 10.1136/jcp.2005.030452; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Colozza M, 2005, ANN ONCOL, V16, P1723, DOI 10.1093/annonc/mdi352; Dai HY, 2005, CANCER RES, V65, P4059, DOI 10.1158/0008-5472.CAN-04-3953; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Ferguson NL, 2013, BREAST J, V19, P22, DOI 10.1111/tbj.12059; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hong KU, 2008, EXP MOL MED, V40, P377, DOI 10.3858/emm.2008.40.4.377; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Jin Y, 2004, CANCER SCI, V95, P815, DOI 10.1111/j.1349-7006.2004.tb02187.x; Keam B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2834; Kim HS, 2012, J CANCER RES CLIN, V138, P95, DOI 10.1007/s00432-011-1053-6; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Maouche-Chretien L, 1998, ONCOGENE, V17, P1245, DOI 10.1038/sj.onc.1202048; Munzone E, 2012, BREAST CANCER RES TR, V134, P277, DOI 10.1007/s10549-012-2040-6; Nishimura R, 2010, EXP THER MED, V1, P747, DOI 10.3892/etm.2010.133; Nishimura R, 2010, BREAST CANCER-TOKYO, V17, P269, DOI 10.1007/s12282-009-0161-5; Oakman C, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2238; Penault-Llorca F, 2009, J CLIN ONCOL, V27, P2809, DOI 10.1200/JCO.2008.18.2808; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spyratos F, 2002, CANCER-AM CANCER SOC, V94, P2151, DOI 10.1002/cncr.10458; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Vallejos CS, 2010, CLIN BREAST CANCER, V10, P294, DOI 10.3816/CBC.2010.n.038; van Diest PJ, 2004, J CLIN PATHOL, V57, P675, DOI 10.1136/jcp.2003.010777; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1	31	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98160	10.1371/journal.pone.0098160	http://dx.doi.org/10.1371/journal.pone.0098160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887265	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300040
J	Richter, MKS; Voorham, JMD; Pedraza, ST; Hoornweg, TE; van de Pol, DPI; Rodenhuis-Zybert, IA; Wilschut, J; Smit, JM				Richter, Mareike K. S.; Voorham, Julia M. da Silva; Torres Pedraza, Silvia; Hoornweg, Tabitha E.; van de Pol, Denise P. I.; Rodenhuis-Zybert, Izabela A.; Wilschut, Jan; Smit, Jolanda M.			Immature Dengue Virus Is Infectious in Human Immature Dendritic Cells via Interaction with the Receptor Molecule DC-SIGN	PLOS ONE			English	Article							WEST-NILE-VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT; CELLULAR ATTACHMENT; HEMORRHAGIC-FEVER; CLEAVAGE; PRM; NEUTRALIZATION; FLAVIVIRUSES; PATHOGENESIS; NONINTEGRIN	Background: Dengue Virus (DENV) is the most common mosquito-borne viral infection worldwide. Important target cells during DENV infection are macrophages, monocytes, and immature dendritic cells (imDCs). DENV-infected cells are known to secrete a large number of partially immature and fully immature particles alongside mature virions. Fully immature DENV particles are considered non-infectious, but antibodies have been shown to rescue their infectious properties. This suggests that immature DENV particles only contribute to the viral load observed in patients with a heterologous DENV re-infection. Methodology/Principal findings: In this study, we re-evaluated the infectious properties of fully immature particles in absence and presence of anti-DENV human serum. We show that immature DENV is infectious in cells expressing DC-SIGN. Furthermore, we demonstrate that immature dendritic cells, in contrast to macrophage-like cells, do not support antibody-dependent enhancement of immature DENV. Conclusions/Significance: Our data shows that immature DENV can infect imDCs through interaction with DC-SIGN, suggesting that immature and partially immature DENV particles may contribute to dengue pathogenesis during primary infection. Furthermore, since antibodies do not further stimulate DENV infectivity on imDCs we propose that macrophages/monocytes rather than imDCs contribute to the increased viral load observed during severe heterotypic DENV re-infections.	[Richter, Mareike K. S.; Voorham, Julia M. da Silva; Torres Pedraza, Silvia; Hoornweg, Tabitha E.; van de Pol, Denise P. I.; Rodenhuis-Zybert, Izabela A.; Wilschut, Jan; Smit, Jolanda M.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Richter, Mareike K. S.; Voorham, Julia M. da Silva; Torres Pedraza, Silvia; Hoornweg, Tabitha E.; van de Pol, Denise P. I.; Rodenhuis-Zybert, Izabela A.; Wilschut, Jan; Smit, Jolanda M.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Torres Pedraza, Silvia] Univ Antioquia, Grp Immunovirol, Medellin, Colombia	University of Groningen; University of Groningen; Universidad de Antioquia	Smit, JM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.	jolanda.smit@umcg.nl	Rodenhuis-Zybert, Izabela A/N-7967-2017; Rodenhuis-Zybert, Izabela/AAD-3379-2021	Rodenhuis-Zybert, Izabela A/0000-0002-7820-8624; Rodenhuis-Zybert, Izabela/0000-0002-7820-8624	Dutch Organization for Scientific research (NWO- Earth and Life Sciences); Dutch Organization for Scientific research (NWO-ZonMW AGIKO); University Medical Center Groningen	Dutch Organization for Scientific research (NWO- Earth and Life Sciences)(Netherlands Organization for Scientific Research (NWO)); Dutch Organization for Scientific research (NWO-ZonMW AGIKO); University Medical Center Groningen	This work was supported by the Dutch Organization for Scientific research (NWO- Earth and Life Sciences (grant to JMS) and NWO-ZonMW AGIKO (grant to JW) and by the University Medical Center Groningen (grant to MKSR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Boonnak K, 2008, J VIROL, V82, P3939, DOI 10.1128/JVI.02484-07; Boonnak K, 2011, J VIROL, V85, P1671, DOI 10.1128/JVI.00220-10; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Colpitts TM, 2011, J GEN VIROL, V92, P2281, DOI 10.1099/vir.0.031427-0; da Silva Voorham J. M., 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE.0029957; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Elshuber S, 2005, J VIROL, V79, P11813, DOI 10.1128/JVI.79.18.11813-11823.2005; Elshuber S, 2003, J GEN VIROL, V84, P183, DOI 10.1099/vir.0.18723-0; Flipse J, 2012, MOL MECH INVOLVED AN; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08; Junjhon J, 2010, J VIROL, V84, P8353, DOI 10.1128/JVI.00696-10; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; Kwan WH, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000311; Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263; Lozach PY, 2005, J BIOL CHEM, V280, P23698, DOI 10.1074/jbc.M504337200; Marovich M, 2001, J INVEST DERM SYMP P, V6, P219, DOI 10.1046/j.0022-202x.2001.00037.x; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Midgey CM, 2012, J IMMUNOL, V188, P4971, DOI 10.4049/jimmunol.1200227; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Moesker B, 2010, J GEN VIROL, V91, P389, DOI 10.1099/vir.0.015255-0; Mukherjee S, 2011, J VIROL, V85, P12067, DOI 10.1128/JVI.05559-11; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011; Plevka P, 2011, EMBO REP, V12, P602, DOI 10.1038/embor.2011.75; Rodenhuis-Zybert IA, 2011, J VIROL, V85, P11800, DOI 10.1128/JVI.05237-11; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; Takhampunya R, 2009, VIRUS RES, V145, P31, DOI 10.1016/j.virusres.2009.05.016; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; World Health Organization, 2009, DENGUE GUIDELINES DI; Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553; Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09; Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264; Zheng A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001157; Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0	43	27	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98785	10.1371/journal.pone.0098785	http://dx.doi.org/10.1371/journal.pone.0098785			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886790	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300109
J	Yoon, S; Assimes, TL; Quertermous, T; Hsiao, CF; Chuang, LM; Hwu, CM; Rajaratnam, B; Olshen, RA				Yoon, Sangho; Assimes, Themistocles L.; Quertermous, Thomas; Hsiao, Chin-Fu; Chuang, Lee-Ming; Hwu, Chii-Min; Rajaratnam, Bala; Olshen, Richard A.			Insulin Resistance: Regression and Clustering	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; SUPPRESSION TEST; LOCI; TRIGLYCERIDES; ASSOCIATION; DISPOSAL; SEQUENCE; GENE	In this paper we try to define insulin resistance (IR) precisely for a group of Chinese women. Our definition deliberately does not depend upon body mass index (BMI) or age, although in other studies, with particular random effects models quite different from models used here, BMI accounts for a large part of the variability in IR. We accomplish our goal through application of Gauss mixture vector quantization (GMVQ), a technique for clustering that was developed for application to lossy data compression. Defining data come from measurements that play major roles in medical practice. A precise statement of what the data are is in Section 1. Their family structures are described in detail. They concern levels of lipids and the results of an oral glucose tolerance test (OGTT). We apply GMVQ to residuals obtained from regressions of outcomes of an OGTT and lipids on functions of age and BMI that are inferred from the data. A bootstrap procedure developed for our family data supplemented by insights from other approaches leads us to believe that two clusters are appropriate for defining IR precisely. One cluster consists of women who are IR, and the other of women who seem not to be. Genes and other features are used to predict cluster membership. We argue that prediction with "main effects'' is not satisfactory, but prediction that includes interactions may be.	[Yoon, Sangho] Google Inc, Mountain View, CA USA; [Assimes, Themistocles L.; Quertermous, Thomas] Falk Cardiovasc Res Ctr, Dept Med, Div Cardiovasc Med, Stanford, CA USA; [Hsiao, Chin-Fu] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Taipei, Miaoli County, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ, Grad Inst Clin Med, Taipei 10764, Taiwan; [Hwu, Chii-Min] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Yoon, Sangho; Olshen, Richard A.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Olshen, Richard A.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Rajaratnam, Bala; Olshen, Richard A.] Dept Environm Earth Syst Sci, Stanford, CA USA	Google Incorporated; National Health Research Institutes - Taiwan; National Taiwan University; National Yang Ming Chiao Tung University; Stanford University; Stanford University		olshen@stanford.edu	Chuang, Lee-Ming/AAF-3324-2019; Assimes, Themistocles Leonard/D-9696-2015; Hwu, Chii-Min/AAZ-7384-2021; Hsiao, Chin-Fu/E-3993-2010	Assimes, Themistocles Leonard/0000-0003-2349-0009; CHUANG, LEE-MING/0000-0003-0978-2662; Quertermous, Thomas/0000-0002-7645-9067; Hsiao, Chin-Fu/0000-0003-1284-7260	U.S. National Science Foundation (NSF) [DMS-1106642]; U.S. National Institutes of Health (NIH) MERIT Award [R37EB02784];  [NSA H98230-11-0194];  [SUWIEVP10-SMSCVISG0906]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB002784] Funding Source: NIH RePORTER	U.S. National Science Foundation (NSF)(National Science Foundation (NSF)); U.S. National Institutes of Health (NIH) MERIT Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	BR was supported in part by the U.S. National Science Foundation (NSF) under Grant DMS-1106642 and grants NSA H98230-11-0194 and SUWIEVP10-SMSCVISG0906. SY and RAO were supported in part by U.S. National Institutes of Health (NIH) MERIT Award R37EB02784. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyer A, 2005, SIGNAL PROCESS-IMAGE, V20, P459, DOI 10.1016/j.image.2005.03.003; Aiyer A, 2001, THESIS STANFORD U; Assimes TL, 2008, ASS MULTIPLE MARKERS; August P, 1999, J CLIN ENDOCR METAB, V84, P1862, DOI 10.1210/jc.84.6.1862; Bloch DA, 2002, J COMPUT GRAPH STAT, V11, P263, DOI 10.1198/106186002760180509; Boerwinkle E, 2002, HYPERTENSION, V39, P3; BOGARDUS C, 1985, AM J PHYSIOL, V248, pE286, DOI 10.1152/ajpendo.1985.248.3.E286; Brieman L, 1984, CLASSIFICATION REGRE; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; CHOU PA, 1989, IEEE T ACOUST SPEECH, V37, P31, DOI 10.1109/29.17498; COCHRAN WG, 1968, TECHNOMETRICS, V10, P637, DOI 10.2307/1267450; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cover TM, 1991, ELEMENTS INFORM THEO; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Einhorn Daniel, 2003, Endocr Pract, V9, P237; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Fuller W.A., 2009, MEASUREMENT ERROR MO; George L, 2011, J CLIN ENDOCR METAB, V96, P2136, DOI 10.1210/jc.2010-2813; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gray R.M., 1992, VECTOR QUANTIZATION; Gray RM, 2003, IEEE T INFORM THEORY, V49, P1204, DOI 10.1109/TIT.2003.810637; GREENFIELD MS, 1981, DIABETES, V30, P387, DOI 10.2337/diabetes.30.5.387; Hedelin P, 2000, IEEE T SPEECH AUDI P, V8, P385, DOI 10.1109/89.848220; HOLLENBECK CB, 1985, J AM GERIATR SOC, V33, P273, DOI 10.1111/j.1532-5415.1985.tb07116.x; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang J, 2004, P NATL ACAD SCI USA, V101, P10529, DOI 10.1073/pnas.0403794101; Huang W, 2006, P NATL ACAD SCI USA, V103, P1418, DOI 10.1073/pnas.0510360103; JARRETT RJ, 1978, INT J EPIDEMIOL, V7, P15, DOI 10.1093/ije/7.1.15; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Knowles JW, 2013, METABOLISM, V62, P548, DOI 10.1016/j.metabol.2012.10.002; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MILLER R, 1982, BIOMETRICS, V38, P1011, DOI 10.2307/2529881; Miyaoka K, 2001, LANCET, V357, P686, DOI 10.1016/S0140-6736(00)04138-6; Oparil S, 2003, ANN INTERN MED, V139, P761, DOI 10.7326/0003-4819-139-9-200311040-00011; Ozonat KM, 2004, IEEE IMAGE PROC, P1887; Park MY, 2008, BIOSTATISTICS, V9, P30, DOI 10.1093/biostatistics/kxm010; Park MY, 2007, J ROY STAT SOC B, V69, P659, DOI 10.1111/j.1467-9868.2007.00607.x; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Qu HQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021041; Reaven G, 2004, ENDOCRIN METAB CLIN, V33, P283, DOI 10.1016/j.ecl.2004.03.002; Reaven G, 2003, J CLIN ENDOCRINOLOGY, V88, P2239; RISCH N, 1995, SCIENCE, V268, P1584, DOI 10.1126/science.7777857; ROSENTHAL M, 1983, DIABETES, V32, P408, DOI 10.2337/diabetes.32.5.408; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schaap FG, 2004, J BIOL CHEM, V279, P27941, DOI 10.1074/jbc.M403240200; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sonquist J, 1964, I SOCIAL RES MONOGRA; STAMLER J, 1975, J CHRON DIS, V28, P527, DOI 10.1016/0021-9681(75)90060-0; Therneau TM, RPART PACKAGE R PORT; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Vapnik VN., 1996, COMPUTATIONAL LEARNI; Wang JG, 2012, DIABETES-METAB RES, V28, P67, DOI 10.1002/dmrr.2356; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Yan WL, 2004, OBES RES, V12, P1733, DOI 10.1038/oby.2004.214; Yeni-Komshian H, 2000, DIABETES CARE, V23, P171, DOI 10.2337/diacare.23.2.171; Yoon S, 2005, P INT C IM PROC, V2, P1198; Yoon S, 2007, INT CONF ACOUST SPEE, P1081	66	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e94129	10.1371/journal.pone.0094129	http://dx.doi.org/10.1371/journal.pone.0094129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887437	gold, Green Submitted, Green Published			2022-12-25	WOS:000336956300004
J	Chen, Y; Mcgee, J; Chen, XM; Doman, TN; Gong, XQ; Zhang, YY; Hamm, N; Ma, XW; Higgs, RE; Bhagwat, SV; Buchanan, S; Peng, SB; Staschke, KA; Yadav, V; Yue, Y; Kouros-Mehr, H				Chen, Ying; McGee, Jeremy; Chen, Xianming; Doman, Thompson N.; Gong, Xueqian; Zhang, Youyan; Hamm, Nicole; Ma, Xiwen; Higgs, Richard E.; Bhagwat, Shripad V.; Buchanan, Sean; Peng, Sheng-Bin; Staschke, Kirk A.; Yadav, Vipin; Yue, Yong; Kouros-Mehr, Hosein			Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets	PLOS ONE			English	Article							BREAST-CANCER; GROWTH-FACTOR; AMPLIFICATION; EPIGENETICS; INHIBITORS; EXPRESSION; RECEPTOR; PROTEIN; GRB7; AMPK	The Cancer Genome Atlas (TCGA) projects have advanced our understanding of the driver mutations, genetic backgrounds, and key pathways activated across cancer types. Analysis of TCGA datasets have mostly focused on somatic mutations and translocations, with less emphasis placed on gene amplifications. Here we describe a bioinformatics screening strategy to identify putative cancer driver genes amplified across TCGA datasets. We carried out GISTIC2 analysis of TCGA datasets spanning 16 cancer subtypes and identified 486 genes that were amplified in two or more datasets. The list was narrowed to 75 cancer-associated genes with potential "druggable'' properties. The majority of the genes were localized to 14 amplicons spread across the genome. To identify potential cancer driver genes, we analyzed gene copy number and mRNA expression data from individual patient samples and identified 42 putative cancer driver genes linked to diverse oncogenic processes. Oncogenic activity was further validated by siRNA/shRNA knockdown and by referencing the Project Achilles datasets. The amplified genes represented a number of gene families, including epigenetic regulators, cell cycle-associated genes, DNA damage response/repair genes, metabolic regulators, and genes linked to the Wnt, Notch, Hedgehog, JAK/STAT, NF-KB and MAPK signaling pathways. Among the 42 putative driver genes were known driver genes, such as EGFR, ERBB2 and PIK3CA. Wild-type KRAS was amplified in several cancer types, and KRAS-amplified cancer cell lines were most sensitive to KRAS shRNA, suggesting that KRAS amplification was an independent oncogenic event. A number of MAP kinase adapters were co-amplified with their receptor tyrosine kinases, such as the FGFR adapter FRS2 and the EGFR family adapters GRB2 and GRB7. The ubiquitin-like ligase DCUN1D1 and the histone methyltransferase NSD3 were also identified as novel putative cancer driver genes. We discuss the patient tailoring implications for existing cancer drug targets and we further discuss potential novel opportunities for drug discovery efforts.	[Chen, Ying; McGee, Jeremy; Chen, Xianming; Doman, Thompson N.; Gong, Xueqian; Zhang, Youyan; Hamm, Nicole; Ma, Xiwen; Higgs, Richard E.; Bhagwat, Shripad V.; Buchanan, Sean; Peng, Sheng-Bin; Staschke, Kirk A.; Yadav, Vipin; Yue, Yong; Kouros-Mehr, Hosein] Eli Lilly & Co, Dept Oncol, Indianapolis, IN 46285 USA	Eli Lilly	Kouros-Mehr, H (corresponding author), Eli Lilly & Co, Dept Oncol, Indianapolis, IN 46285 USA.	kouros.mehr@gmail.com	gong, xue/GYQ-8649-2022; Staschke, Kirk/HGC-5664-2022	Staschke, Kirk/0000-0001-8722-9585	Eli Lilly and Company	Eli Lilly and Company(Eli Lilly)	This study was funded by Eli Lilly and Company. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Agochiya M, 1999, ONCOGENE, V18, P5646, DOI 10.1038/sj.onc.1202957; Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bhargava R, 2005, MODERN PATHOL, V18, P1027, DOI 10.1038/modpathol.3800438; Birkeland E, 2012, BRIT J CANCER, V107, P1997, DOI 10.1038/bjc.2012.477; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Cepero V, 2010, CANCER RES, V70, P7580, DOI 10.1158/0008-5472.CAN-10-0436; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dabir S, 2014, INT J CANCER, V134, P1045, DOI 10.1002/ijc.28448; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Franci C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058183; Gembarska A, 2012, NAT MED, V18, P1239, DOI 10.1038/nm.2863; Gibcus JH, 2007, CLIN CANCER RES, V13, P6257, DOI 10.1158/1078-0432.CCR-07-1247; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herrmann H, 2012, ONCOTARGET, V3, P1588, DOI 10.18632/oncotarget.733; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kang D, 2013, GENE CHROMOSOME CANC, V52, P126, DOI 10.1002/gcc.22012; Kim KI, 2009, INT REV CEL MOL BIO, V273, P265, DOI 10.1016/S1937-6448(08)01807-8; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kranenburg O, 2005, BBA-REV CANCER, V1756, P81, DOI 10.1016/j.bbcan.2005.10.001; Li CL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-357; Liang JY, 2013, CANCER RES, V73, P2929, DOI 10.1158/0008-5472.CAN-12-3876; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Lucio-Eterovic AK, 2011, TRANSCR-AUSTIN, V2, P158, DOI 10.4161/trns.2.4.16217; McIntyre A, 2005, CANCER RES, V65, P8085, DOI 10.1158/0008-5472.CAN-05-0471; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morishita M, 2011, BBA-REV CANCER, V1816, P158, DOI 10.1016/j.bbcan.2011.05.004; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nencioni A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009024; Nobusawa S, 2011, NEUROPATHOLOGY, V31, P583, DOI 10.1111/j.1440-1789.2011.01204.x; Qin CH, 2001, CLIN CANCER RES, V7, P818; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Rodriguez-Paredes M., 2013, ONCOGENE, DOI 10.1038/onc.2013.239; Rytinki M, 2012, MOL CELL BIOL, V32, P4195, DOI 10.1128/MCB.00753-12; Saito M, 2012, FEBS LETT, V586, P1708, DOI 10.1016/j.febslet.2012.05.003; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sundvall M, 2012, J BIOL CHEM, V287, P23216, DOI 10.1074/jbc.M111.335927; Valtorta E, 2013, INT J CANCER, V133, P1259, DOI 10.1002/ijc.28106; Vidler LR, 2013, J MED CHEM, V56, P8073, DOI 10.1021/jm4011302; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Walch A, 2004, INT J CANCER, V112, P747, DOI 10.1002/ijc.20411; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Yang YL, 2008, GENE CHROMOSOME CANC, V47, P127, DOI 10.1002/gcc.20514; Zhao YJ, 2013, J MED CHEM, V56, P5553, DOI 10.1021/jm4005708	58	79	81	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98293	10.1371/journal.pone.0098293	http://dx.doi.org/10.1371/journal.pone.0098293			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874471	gold, Green Published, Green Submitted			2022-12-25	WOS:000336790800032
J	Zhang, GL; Ma, JY; Sun, Q; Hu, MW; Yang, XY; Gao, SH; Jiang, GJ				Zhang, Guang-Li; Ma, Jun-Yu; Sun, Quan; Hu, Meng-Wen; Yang, Xiu-yan; Gao, Si-Hua; Jiang, Guang-Jian			Effects of Postmortem Interval on Mouse Ovary Oocyte Survival and Maturation	PLOS ONE			English	Article							GERMINAL VESICLE STAGE; PORCINE OOCYTES; IN-VITRO; CRYOPRESERVATION; VITRIFICATION; EMBRYOS	To study the time-and temperature-dependent survival of ovarian oocytes collected from postmortem carcass, ICR mice were killed and placed for different periods (0, 1, 2, 4, 6, 8 and 10 h) at different temperatures (25 degrees C, 4 degrees C and 37 degrees C). After preservation, oocyte morphology, germinal vesicle (GV) oocyte number, oocyte meiotic maturation percentage, mitochondrial distribution and intracellular glutathione (GSH) level were evaluated. The results showed no surviving oocytes could be collected by 2h, 6h, and 12 h after carcass preservation at 37 degrees C, 25 degrees C and 4 degrees C, respectively. The number of collected GV oocytes in the ovary deceased as the preservation time lasted at the same temperature. Meanwhile at the same point in time, the ratio of germinal vesicle breakdown (GVBD) and the first polar body emission (PBE) gradually reduced as preservation temperature increased. In addition, the percentage of abnormal mitochondrial distribution in the preserved oocytes was obviously higher than that in the control oocytes, while GSH level was not altered in collected oocytes. Unexpectedly, neither chromosome arrangement nor spindle organization was affected as long as the oocytes from preserved carcasses could complete maturation. These data are helpful for proper use of ovary oocytes from postmortem carcass of valuable individuals.	[Zhang, Guang-Li; Sun, Quan; Yang, Xiu-yan; Gao, Si-Hua; Jiang, Guang-Jian] Beijing Univ Chinese Med, Diabet Res Ctr, Beijing, Peoples R China; [Zhang, Guang-Li; Sun, Quan; Jiang, Guang-Jian] Hebei United Univ, Dept Biochem & Mol Biol, Tangshan, Peoples R China; [Ma, Jun-Yu] Qingdao Agr Univ, Dept Anim Sci & Technol, Qingdao, Peoples R China; [Ma, Jun-Yu; Hu, Meng-Wen] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China	Beijing University of Chinese Medicine; North China University of Science & Technology; Qingdao Agricultural University; Chinese Academy of Sciences; Institute of Zoology, CAS	Jiang, GJ (corresponding author), Beijing Univ Chinese Med, Diabet Res Ctr, Beijing, Peoples R China.	jguangjian@yahoo.com		Hu, Mengwen/0000-0002-7480-6432	National Natural Science Foundation of China [NSFC81274041, NSFC81273995]; International Cooperation Projects of MOE [2011DFA30920]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Projects of MOE	This work was supported by Grants from the National Natural Science Foundation of China (NSFC81274041, NSFC81273995, http://isisn.nsfc.gov.cn) the International Cooperation Projects of MOE (2011DFA30920, http://www.istcp.org.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cleary M, 2001, CRYOBIOLOGY, V42, P121, DOI 10.1006/cryo.2001.2315; DIDION BA, 1990, J ANIM SCI, V68, P2803; FUNAHASHI H, 1994, BIOL REPROD, V51, P633, DOI 10.1095/biolreprod51.4.633; Ge L, 2008, FERTIL STERIL, V90, P2376, DOI 10.1016/j.fertnstert.2007.10.054; Gualtieri R, 2009, FERTIL STERIL, V91, P1023, DOI 10.1016/j.fertnstert.2008.01.076; Hinrichs K, 2005, BIOL REPROD, V72, P1142, DOI 10.1095/biolreprod.104.036012; Liu RH, 2003, ZYGOTE, V11, P299, DOI 10.1017/S0967199403002351; Miao DQ, 2007, MOL REPROD DEV, V74, P468, DOI 10.1002/mrd.20572; NAGASHIMA H, 1994, BIOL REPROD, V51, P618, DOI 10.1095/biolreprod51.4.618; SCHROEDER AC, 1991, J EXP ZOOL, V258, P240, DOI 10.1002/jez.1402580214; Shi LY, 2007, ANIM REPROD SCI, V100, P128, DOI 10.1016/j.anireprosci.2006.06.020; Snow M, 2001, REPROD FERT DEVELOP, V13, P389, DOI 10.1071/RD00130; Vajta G, 2006, REPROD BIOMED ONLINE, V12, P779, DOI 10.1016/S1472-6483(10)61091-7; Wang Q, 2009, MOL ENDOCRINOL, V23, P1603, DOI 10.1210/me.2009-0033; Yang CR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014242	15	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98384	10.1371/journal.pone.0098384	http://dx.doi.org/10.1371/journal.pone.0098384			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874949	Green Published, Green Submitted, gold			2022-12-25	WOS:000336790800037
J	Fouda, MA; El-Gowelli, HM; El-Gowilly, SM; Rashed, L; El-Mas, MM				Fouda, Mohamed A.; El-Gowelli, Hanan M.; El-Gowilly, Sahar M.; Rashed, Laila; El-Mas, Mahmoud M.			Impairment of Nitric Oxide Synthase but Not Heme Oxygenase Accounts for Baroreflex Dysfunction Caused by Chronic Nicotine in Female Rats	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; NUCLEUS-TRACTUS-SOLITARIUS; CARBON-MONOXIDE; SODIUM-NITROPRUSSIDE; BLOOD-PRESSURE; NERVE ACTIVITY; HEART-RATE; IN-VIVO; INDUCTION; SYSTEM	We recently reported that chronic nicotine impairs reflex chronotropic activity in female rats. Here, we sought evidence to implicate nitric oxide synthase (NOS) and/or heme oxygenase (HO) in the nicotine-baroreflex interaction. Baroreflex curves relating changes in heart rate to increases (phenylephrine) or decreases (sodium nitroprusside) in blood pressure were generated in conscious female rats treated with nicotine or saline in absence and presence of pharmacological modulators of NOS or HO activity. Compared with saline-treated rats, nicotine (2 mg/kg/day i.p., for 14 days) significantly reduced the slopes of baroreflex curves, a measure of baroreflex sensitivity (BRS). Findings that favor the involvement of NOS inhibition in the nicotine effect were (i) NOS inhibition (N-omega-Nitro-L-arginine methyl ester, L-NAME) reduced BRS in control rats but failed to do so in nicotine-treated rats, (ii) L-arginine, NO donor, reversed the BRS inhibitory effect of nicotine. Alternatively, HO inhibition (zinc protoporphyrin IX, ZnPP) had no effect on BRS in nicotine-or control rats and failed to reverse the beneficial effect of L-arginine on nicotine-BRS interaction. Similar to female rats, BRS was reduced by L-NAME, but not ZnPP, in male rats and the L-NAME effect was not accentuated after concomitant administration of nicotine. Baroreflex dysfunction caused by nicotine in female rats was blunted after supplementation with hemin (HO inducer) but not tricarbonyldichlororuthenium(II) dimer (CORM-2), a carbon monoxide (CO) releasing molecule, or bilirubin, the breakdown product of heme catabolism. The facilitatory effect of hemin was abolished upon simultaneous treatment with L-NAME or 1H-[1,2,4] oxadiazolo[4,3-a] quinoxalin-1-one (inhibitor of soluble guanylate cyclase, sGC). The activities of HO and NOS in brainstem tissues were also significantly increased by hemin. Thus, the inhibition of NOS, but not HO, accounts for the baroreflex depressant of chronic nicotine. Further, hemin alleviates the nicotine effect through a mechanism that is NOS/sGC but not CO or bilirubin-dependent.	[Fouda, Mohamed A.; El-Gowelli, Hanan M.; El-Gowilly, Sahar M.; Rashed, Laila; El-Mas, Mahmoud M.] Univ Alexandria, Fac Pharm, Dept Pharmacol & Toxicol, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University	El-Mas, MM (corresponding author), Univ Alexandria, Fac Pharm, Dept Pharmacol & Toxicol, Alexandria, Egypt.	mahelm@hotmail.com	El-Mas, Mahmoud M./B-9047-2009; Gowelli, Hanan M. El/F-9500-2010	El-Mas, Mahmoud M./0000-0001-8855-7070; Gowelli, Hanan M. El/0000-0001-8145-7608	Science and Technology Development Fund (STDF), Egypt [502]	Science and Technology Development Fund (STDF), Egypt(Science and Technology Development Fund (STDF))	This project was supported by the Science and Technology Development Fund (STDF), Egypt, Grant No. 502.(http://www.stdf.org.eg/ndex.php?option = com_contact&view = contact&id = 1&Itemid = 57). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELRAHMAN AA, 1992, CAN J PHYSIOL PHARM, V70, P1217, DOI 10.1139/y92-169; Achouh Paul E, 2008, Interact Cardiovasc Thorac Surg, V7, P959, DOI 10.1510/icvts.2008.180489; Ashworth-Preece M, 1998, NEUROSCIENCE, V83, P1113, DOI 10.1016/S0306-4522(97)00476-4; Aziz MTA, 2009, J SEX MED, V6, P3254, DOI 10.1111/j.1743-6109.2009.01517.x; Balakumar P, 2009, PHARMACOL RES, V60, P361, DOI 10.1016/j.phrs.2009.06.005; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Bullen Christopher, 2008, Expert Rev Cardiovasc Ther, V6, P883, DOI 10.1586/14779072.6.6.883; Chiu H, 2002, TOXICOL APPL PHARM, V181, P106, DOI 10.1006/taap.2002.9409; El-Gowelli HM, 2011, J CARDIOVASC PHARM, V58, P173, DOI 10.1097/FJC.0b013e31821ed803; El-Mas MA, 2001, BRAIN RES, V912, P79, DOI 10.1016/S0006-8993(01)02727-5; El-Mas MM, 2012, EUR J PHARMACOL, V694, P82, DOI 10.1016/j.ejphar.2012.08.021; El-Mas MM, 2012, J PHARMACOL EXP THER, V342, P568, DOI 10.1124/jpet.112.191940; El-Mas MM, 2012, NEUROPHARMACOLOGY, V62, P1890, DOI 10.1016/j.neuropharm.2011.12.017; ElMas MM, 1997, EUR J PHARMACOL, V322, P201, DOI 10.1016/S0014-2999(97)00010-1; ElMas MM, 1997, NEUROSCIENCE, V79, P581, DOI 10.1016/S0306-4522(96)00648-3; ELMAS MM, 1993, J PHARMACOL EXP THER, V264, P1198; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; GIANNATTASIO C, 1994, J HYPERTENS, V12, P691; Heaton DA, 2005, J MOL CELL CARDIOL, V39, P159, DOI 10.1016/j.yjmcc.2005.03.018; Hirooka Y, 2011, AM J PHYSIOL-REG I, V300, pR818, DOI 10.1152/ajpregu.00426.2010; Jansen T, 2010, J MOL CELL CARDIOL, V49, P186, DOI 10.1016/j.yjmcc.2010.04.011; Kinderlerer AR, 2009, BLOOD, V113, P1598, DOI 10.1182/blood-2008-04-152934; Kirkby K, 2007, AM J PHYSIOL-RENAL, V292, pF888, DOI 10.1152/ajprenal.00064.2006; KUMAGAI H, 1993, HYPERTENSION, V21, P476, DOI 10.1161/01.HYP.21.4.476; Lande RG, 2010, J AM OSTEOPATH ASSOC, V110, P127; Li L, 2009, PHARMACOL THERAPEUT, V123, P386, DOI 10.1016/j.pharmthera.2009.05.005; Lin CH, 2004, J PHARMACOL EXP THER, V308, P1213, DOI 10.1124/jpet.103.060186; Liu JL, 1996, AM J PHYSIOL-REG I, V270, pR1361, DOI 10.1152/ajpregu.1996.270.6.R1361; Lo W J, 1996, Chin J Physiol, V39, P57; Lo WC, 2006, J PHARMACOL EXP THER, V318, P8, DOI 10.1124/jpet.105.099051; Lo WC, 2000, HYPERTENSION, V35, P1253, DOI 10.1161/01.HYP.35.6.1253; Mancia G, 1997, AM J PHYSIOL-HEART C, V273, pH1555, DOI 10.1152/ajpheart.1997.273.3.H1555; Moreira TS, 2011, AUTON NEUROSCI-BASIC, V159, P62, DOI 10.1016/j.autneu.2010.08.003; Morin A, 2011, REGUL TOXICOL PHARM, V61, pS3, DOI 10.1016/j.yrtph.2010.09.020; Motterlini R, 2002, CIRC RES, V90, pE17, DOI 10.1161/hh0202.104530; Nakao A, 2003, SURGERY, V134, P285, DOI 10.1067/msy.2003.238; Ndisang JF, 2002, HYPERTENSION, V40, P315, DOI 10.1161/01.HYP.0000028488.71068.16; Ndisang JF, 2009, J CARD FAIL, V15, P616, DOI 10.1016/j.cardfail.2009.02.003; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Pae HO, 2010, NITRIC OXIDE-BIOL CH, V23, P251, DOI 10.1016/j.niox.2010.08.002; Roethig HJ, 2009, NICOTINE TOB RES, V11, P1216, DOI 10.1093/ntr/ntp126; Schubert R, 2004, HYPERTENSION, V43, P891, DOI 10.1161/01.HYP.0000121882.42731.6b; SMYTH HS, 1969, CIRC RES, V24, P109, DOI 10.1161/01.RES.24.1.109; SPYER KM, 1982, J EXP BIOL, V100, P109; Stern JE, 2005, J PHYSIOL-LONDON, V562, P725, DOI 10.1113/jphysiol.2004.077735; Tzeng E, 2009, VASCULAR, V17, pS55, DOI 10.2310/6670.2008.00090; Wang R, 2006, HYPERTENSION, V48, P685, DOI 10.1161/01.HYP.0000239673.80332.2f; WANG YX, 1993, BRIT J PHARMACOL, V108, P398, DOI 10.1111/j.1476-5381.1993.tb12816.x; Zhang F, 2001, AM J HYPERTENS, V14, p62S, DOI 10.1016/S0895-7061(01)02071-4	49	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98681	10.1371/journal.pone.0098681	http://dx.doi.org/10.1371/journal.pone.0098681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870610	Green Published, gold, Green Submitted			2022-12-25	WOS:000336858300056
J	Lam, CSC; Cheung, AHK; Wong, SKM; Wan, TMH; Ng, L; Chow, AKM; Cheng, NSM; Pak, RCH; Li, HS; Man, JHW; Yau, TCC; Lo, OSH; Poon, JTC; Pang, RWC; Law, WL				Lam, Colin Siu-Chi; Cheung, Alvin Ho-Kwan; Wong, Sunny Kit-Man; Wan, Timothy Ming-Hun; Ng, Lui; Chow, Ariel Ka-Man; Cheng, Nathan Shiu-Man; Pak, Ryan Chung-Hei; Li, Hung-Sing; Man, Johnny Hon-Wai; Yau, Thomas Chung-Cheung; Lo, Oswens Siu-Hung; Poon, Jensen Tung-Chung; Pang, Roberta Wen-Chi; Law, Wai Lun			Prognostic Significance of CD26 in Patients with Colorectal Cancer	PLOS ONE			English	Article							DIPEPTIDYL-PEPTIDASE-IV; CARCINOEMBRYONIC ANTIGEN CEA; FECAL-OCCULT-BLOOD; EXTRACELLULAR-MATRIX; SERUM CD26; CARCINOMA; DIAGNOSIS; BINDING; MORTALITY; SURFACE	Background: CD26, dipeptidyl peptidase IV, was discovered firstly as a membrane-associated peptidase on the surface of leukocyte. We previously demonstrated that a subpopulation of CD26(+) cells were associated with the development of distant metastasis, enhanced invasiveness and chemoresistance in colorectal cancer (CRC). In order to understand the clinical impact of CD26, the expression was investigated in CRC patient's specimens. This study investigated the prognostic significance of tumour CD26 expression in patients with CRC. Examination of CD26+ cells has significant clinical impact for the prediction of distant metastasis development in colorectal cancer, and could be used as a selection criterion for further therapy. Methods: Tumour CD26 expression levels were studied by immunohistochemistry using Formalin-fixed paraffin embedded (FFPE) tissues in 143 patients with CRC. Tumour CD26 expression levels were correlated with clinicopathological features of the CRC patients. The prognostic significance of tumour tissue CD26 expression levels was assessed by univariate and multivariate analyses. Result: CD26 expression levels in CRC patients with distant metastasis were significantly higher than those in non-metastatic. High expression levels of CD26 were significantly associated with advanced tumour staging. Patients with a high CD26 expression level had significantly worse overall survival than those with a lower level (p < 0.001). Conclusions: The expression of CD26 was positively associated with clinicopathological correlation such as TNM staging, degree of differentiation and development of metastasis. A high CD26 expression level is a predictor of poor outcome after resection of CRC. CD26 may be a useful prognostic marker in patients with CRC.	[Lam, Colin Siu-Chi; Cheung, Alvin Ho-Kwan; Wong, Sunny Kit-Man; Wan, Timothy Ming-Hun; Ng, Lui; Chow, Ariel Ka-Man; Cheng, Nathan Shiu-Man; Pak, Ryan Chung-Hei; Li, Hung-Sing; Man, Johnny Hon-Wai; Lo, Oswens Siu-Hung; Poon, Jensen Tung-Chung; Pang, Roberta Wen-Chi; Law, Wai Lun] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Yau, Thomas Chung-Cheung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Lam, Colin Siu-Chi; Wong, Sunny Kit-Man; Wan, Timothy Ming-Hun; Ng, Lui; Chow, Ariel Ka-Man; Cheng, Nathan Shiu-Man; Li, Hung-Sing; Man, Johnny Hon-Wai; Pang, Roberta Wen-Chi] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Canc Res, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Pang, RWC (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	robertap@hku.hk	Wan, Timothy/AAA-2432-2021; Ng, Lui/AAG-4397-2019; Chow, Ariel/HGF-2363-2022; Yau, Thomas Chung Cheung/B-3429-2011	Wan, Timothy/0000-0002-9235-2913; Ng, Lui/0000-0002-9010-2654; Chow, Ariel/0000-0002-5729-5415; Yau, Thomas Chung Cheung/0000-0002-7114-0305; /0000-0003-2801-5717; Li, Hung Sing/0000-0002-2156-8362; Cheung, Alvin Ho-Kwan/0000-0002-3913-8117				[Anonymous], 1972, Can Med Assoc J, V107, P25; Ayude D, 2003, DIS MARKERS, V19, P267; BAUVOIS B, 1988, BIOCHEM J, V252, P723, DOI 10.1042/bj2520723; Benoist S, 2006, J CLIN ONCOL, V24, P3939, DOI 10.1200/JCO.2006.05.8727; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Cordero OJ, 2000, BRIT J CANCER, V83, P1139, DOI 10.1054/bjoc.2000.1410; De La Haba-Rodriguez J, 2002, NEOPLASMA, V49, P307; DHAR P, 1972, J AMER MED ASSOC, V221, P31, DOI 10.1001/jama.221.1.31; GOLD P, 1965, J EXP MED, V121, P439, DOI 10.1084/jem.121.3.439; Gonzalez-Gronow M, 2008, FRONT BIOSCI-LANDMRK, V13, P1610, DOI 10.2741/2785; HAKOMORI SI, 1989, ADV CANCER RES, V52, P257; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; HERRERA MA, 1976, ANN SURG, V183, P5, DOI 10.1097/00000658-197601000-00002; Hundt S, 2007, CANCER EPIDEM BIOMAR, V16, P1935, DOI 10.1158/1055-9965.EPI-06-0994; Hunter Kent W, 2008, Breast Cancer Res, V10 Suppl 1, pS2, DOI 10.1186/bcr1988; Inamoto T, 2006, CLIN CANCER RES, V12, P3470, DOI 10.1158/1078-0432.CCR-06-0361; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kirkland SC, 2009, BRIT J CANCER, V101, P320, DOI 10.1038/sj.bjc.6605143; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; LOGERFO P, 1972, AM J SURG, V123, P127; LOSTER K, 1995, BIOCHEM BIOPH RES CO, V217, P341, DOI 10.1006/bbrc.1995.2782; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; PIAZZA GA, 1989, BIOCHEM J, V262, P327, DOI 10.1042/bj2620327; Sato T, 2005, CANCER RES, V65, P6950, DOI 10.1158/0008-5472.CAN-05-0647; Sedo Aleksi, 2008, Expert Opin Med Diagn, V2, P677, DOI 10.1517/17530059.2.6.677; Smith RA, 2002, CA-CANCER J CLIN, V52, P8, DOI 10.3322/canjclin.52.1.8; TANAKA T, 1992, J IMMUNOL, V149, P481; Vijan S, 2001, AM J MED, V111, P593, DOI 10.1016/S0002-9343(01)00977-9; Winawer Sidney J, 2005, Surg Oncol Clin N Am, V14, P699, DOI 10.1016/j.soc.2005.05.009; Wolf M, 2008, INT J BIOCHEM CELL B, V40, P1185, DOI 10.1016/j.biocel.2007.12.009; Yamada K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062304; ZAMCHECK N, 1972, NEW ENGL J MED, V286, P83, DOI 10.1056/NEJM197201132860207	34	58	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98582	10.1371/journal.pone.0098582	http://dx.doi.org/10.1371/journal.pone.0098582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870408	Green Published, gold, Green Submitted			2022-12-25	WOS:000336858300054
J	Lee, BS; Kim, SH; Oh, J; Jin, T; Choi, EY; Park, S; Lee, SH; Chung, JH; Kang, SM				Lee, Beom Seob; Kim, Soo Hyuk; Oh, Jaewon; Jin, Taewon; Choi, Eun Young; Park, Sungha; Lee, Sang-Hak; Chung, Ji Hyung; Kang, Seok-Min			C-Reactive Protein Inhibits Survivin Expression via Akt/mTOR Pathway Downregulation by PTEN Expression in Cardiac Myocytes	PLOS ONE			English	Article							APOPTOSIS	C-reactive protein (CRP) is one of the most important biomarkers for arteriosclerosis and cardiovascular disease. Recent studies have shown that CRP affects cell cycle and inflammatory process in cardiac myocytes. Survivin is also involved in cardiac myocytes replication and apoptosis. Reduction of survivin expression is associated with less favorable cardiac remodeling in animal models. However, the effect of CRP on survivin expression and its cellular mechanism has not yet been studied. We demonstrated that treatment of CRP resulted in a significant decrease of survivin protein expression in a concentration-dependent manner in cardiac myocytes. The upstream signaling proteins of survivin, such as Akt, mTOR and p70S6K, were also downregulated by CRP treatment. In addition, CRP increased the protein and mRNA levels of PTEN. The siRNA transfection or specific inhibitor treatment for PTEN restored the CRP-induced downregulation of Akt/mTOR/p70S6K pathway and survivin protein expression. Moreover, pretreatment with a specific p53 inhibitor decreased the CRP-induced PTEN expression. ERK-specific inhibitor also blocked the p53 phosphorylation and PTEN expression induced by CRP. Our study provides a novel insight into CRP-induced downregulation of survivin protein expression in cardiac myocytes through mechanisms that involved in downregulation of Akt/mTOR/p70S6K pathway by expression of PTEN.	[Lee, Beom Seob; Kim, Soo Hyuk; Jin, Taewon; Choi, Eun Young] Yonsei Univ, Grad Program Sci Aging, Seoul 120749, South Korea; [Lee, Beom Seob; Oh, Jaewon; Park, Sungha; Lee, Sang-Hak; Kang, Seok-Min] Yonsei Univ, Coll Med, Div Cardiol, Severance Cardiovasc Hosp, Seoul, South Korea; [Lee, Beom Seob; Oh, Jaewon; Park, Sungha; Lee, Sang-Hak; Kang, Seok-Min] Yonsei Univ, Coll Med, Cardiovasc Res Inst, Seoul, South Korea; [Lee, Beom Seob; Kang, Seok-Min] Yonsei Univ Hlth Syst, Severance Integrat Res Inst Cerebral & Cardiovasc, Seoul, South Korea; [Kim, Soo Hyuk; Jin, Taewon; Choi, Eun Young; Chung, Ji Hyung] CHA Univ, Coll Life Sci, Dept Appl Biosci, Gyeonggi Do, South Korea; [Kang, Seok-Min] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Pochon Cha University; Yonsei University; Yonsei University Health System	Chung, JH (corresponding author), CHA Univ, Coll Life Sci, Dept Appl Biosci, Gyeonggi Do, South Korea.	jhchung@cha.ac.kr; smkang@yuhs.ac		Oh, Jaewon/0000-0002-4585-1488; Kang, Seok-Min/0000-0001-9856-9227; Park, Sungha/0000-0001-5362-478X	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2012R1A1A2006347, NRF- 2012R1A1A2006779]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2012R1A1A2006347, NRF- 2012R1A1A2006779). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate A, 2006, INT J CARDIOL, V111, P371, DOI 10.1016/j.ijcard.2005.07.061; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Baldassarre D, 2008, ANN MED, V40, P21, DOI 10.1080/07853890701645399; Bisoendial RJ, 2010, EUR HEART J, V31, P2087, DOI 10.1093/eurheartj/ehq238; Castellino RC, 2007, NAT CLIN PRACT NEURO, V3, P682, DOI 10.1038/ncpneuro0661; Choi JW, 2011, BIOCHEM BIOPH RES CO, V410, P525, DOI 10.1016/j.bbrc.2011.06.016; Cui CJ, 2012, CELL SIGNAL, V24, P810, DOI 10.1016/j.cellsig.2011.11.019; Danenberg HD, 2003, CIRCULATION, V108, P512, DOI 10.1161/01.CIR.0000085568.13915.1E; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Johnson ME, 2004, VET PATHOL, V41, P599, DOI 10.1354/vp.41-6-599; Kawahara KI, 2008, CARDIOVASC PATHOL, V17, P129, DOI 10.1016/j.carpath.2007.08.006; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Keyes KT, 2010, AM J PHYSIOL-HEART C, V298, pH1198, DOI 10.1152/ajpheart.00915.2009; Lee BS, 2013, KOREAN CIRC J, V43, P400, DOI 10.4070/kcj.2013.43.6.400; Levkau B, 2008, CIRCULATION, V117, P1583, DOI 10.1161/CIRCULATIONAHA.107.734160; Levkau B, 2011, J MOL CELL CARDIOL, V50, P6, DOI 10.1016/j.yjmcc.2010.10.013; Li D, 2013, CANCER GENE THER, V20, P251, DOI 10.1038/cgt.2013.14; Liu JH, 2008, AM J PHYSIOL-HEART C, V295, pH1956, DOI 10.1152/ajpheart.00407.2008; Modgil A, 2012, AM J PHYSIOL-HEART C, V302, pH1116, DOI 10.1152/ajpheart.00832.2011; Nagai T, 2011, HYPERTENSION, V57, P208, DOI 10.1161/HYPERTENSIONAHA.110.158915; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Rosa J, 2006, MOL BIOL CELL, V17, P1483, DOI 10.1091/mbc.e05-08-0723; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Schneeweis C, 2010, J ATHEROSCLER THROMB, V17, P203, DOI 10.5551/jat.3004; Si R, 2011, J MOL CELL CARDIOL, V50, P16, DOI 10.1016/j.yjmcc.2010.08.017; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Suh W, 2004, BIOCHEM BIOPH RES CO, V321, P65, DOI 10.1016/j.bbrc.2004.06.107; Vaira V, 2007, ONCOGENE, V26, P2678, DOI 10.1038/sj.onc.1210094; Verma S, 2004, CIRCULATION, V109, P2058, DOI 10.1161/01.CIR.0000127577.63323.24; Zhao P, 2010, BIOCHEM BIOPH RES CO, V395, P219, DOI 10.1016/j.bbrc.2010.03.165	30	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98113	10.1371/journal.pone.0098113	http://dx.doi.org/10.1371/journal.pone.0098113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866016	Green Submitted, Green Published, gold			2022-12-25	WOS:000336914100033
J	Leitch, CC; Zaghloul, NA				Leitch, Carmen C.; Zaghloul, Norann A.			BBS4 Is Necessary for Ciliary Localization of TrkB Receptor and Activation by BDNF	PLOS ONE			English	Article							BARDET-BIEDL-SYNDROME; NEUROTROPHIC FACTOR; PRIMARY-CILIUM; LEPTIN RESISTANCE; SYNDROME PROTEINS; EPITHELIAL-CELLS; SITUS-INVERSUS; OBESITY; DIFFERENTIATION; CILIOPATHY	Primary cilia regulate an expanding list of signaling pathways in many different cell types. It is likely that identification of the full catalog of pathways associated with cilia will be necessary to fully understand their role in regulation of signaling and the implications for diseases associated with their dysfunction, ciliopathies. Bardet-Biedl Syndrome (BBS) is one such ciliopathy which is characterized by a spectrum of phenotypes. These include neural defects such as impaired cognitive development, centrally mediated hyperphagia and peripheral sensory defects. Here we investigate potential defects in a signaling pathway associated with neuronal function, brain derived neurotrophic factor (BDNF) signaling. Upon loss of BBS4 expression in cultured cells, we observed decreased phosphorylation and activation by BDNF of its target receptor, TrkB. Assessment of ciliary localization revealed that, TrkB localized to the axonemes or basal bodies of cilia only in the presence of BDNF. Axonemal localization, specifically, was abrogated with loss of BBS4. Finally, we present evidence that loss of the ciliary axoneme through depletion of KIF3A impedes activation of TrkB. Taken together, these data suggest the possibility of a previously uninvestigated pathway associated with perturbation of ciliary proteins.	[Leitch, Carmen C.; Zaghloul, Norann A.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Zaghloul, NA (corresponding author), Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA.	zaghloul@umaryland.edu			University of Maryland School of Medicine;  [K01DK092402]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, K01DK092402, P30DK072488, R01DK102001] Funding Source: NIH RePORTER	University of Maryland School of Medicine; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by University of Maryland School of Medicine seed funding as well as a K01DK092402 to Dr. Zaghloul. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajima R, 2011, NAT CELL BIOL, V13, P636, DOI 10.1038/ncb0611-636; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Beales PL, 1999, J MED GENET, V36, P437; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Berbari NF, 2013, P NATL ACAD SCI USA, V110, P7796, DOI 10.1073/pnas.1210192110; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Clement CA, 2013, CELL REP, V3, P1806, DOI 10.1016/j.celrep.2013.05.020; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Du J, 2003, J CELL BIOL, V163, P385, DOI 10.1083/jcb.200305134; Hackett SF, 1998, BRAIN RES, V789, P201, DOI 10.1016/S0006-8993(97)01440-6; Han JC, 2008, NEW ENGL J MED, V359, P918, DOI 10.1056/NEJMoa0801119; Janich P, 2007, FEBS LETT, V581, P1783, DOI 10.1016/j.febslet.2007.03.065; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; KAPLAN DR, 1993, NEURON, V11, P321, DOI 10.1016/0896-6273(93)90187-V; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kodani A, 2013, EMBO J, V32, P597, DOI 10.1038/emboj.2013.3; Loktev AV, 2013, CELL REP, V5, P1316, DOI 10.1016/j.celrep.2013.11.011; Marion V, 2012, J MED GENET, V49, P317, DOI 10.1136/jmedgenet-2012-100737; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; Rahmouni K, 2008, J CLIN INVEST, V118, P1458, DOI 10.1172/JCI32357; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Schaefer E, 2010, MOL SYNDROMOL, V1, P273, DOI 10.1159/000331268; Scheidecker S, 2013, J MED GENETICS; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Spalluto C, 2013, FEBS OPEN BIO, V3, P334, DOI 10.1016/j.fob.2013.08.002; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Vanesvki F, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00037; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276	34	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98687	10.1371/journal.pone.0098687	http://dx.doi.org/10.1371/journal.pone.0098687			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867303	Green Submitted, Green Published			2022-12-25	WOS:000336914100065
J	Simmonds, B; Fox, K; Davis, M; Ku, PW; Gray, S; Hillsdon, M; Sharp, D; Stathi, A; Thompson, J; Coulson, J; Trayers, T				Simmonds, Bethany; Fox, Kenneth; Davis, Mark; Ku, Po-Wen; Gray, Selena; Hillsdon, Melvyn; Sharp, Debbie; Stathi, Afroditi; Thompson, Janice; Coulson, Joanna; Trayers, Tanya			Objectively Assessed Physical Activity and Subsequent Health Service Use of UK Adults Aged 70 and Over: A Four to Five Year Follow Up Study	PLOS ONE			English	Article							LIFE-STYLE INTERVENTIONS; OLDER-ADULTS; CARE UTILIZATION; INDEPENDENCE; ELDERS; ASSOCIATION; DISABILITY; MORTALITY; MOBILITY; PEOPLE	Objectives: To examine the associations between volume and intensity of older peoples' physical activity, with their subsequent health service usage over the following four to five years. Study Design: A prospective cohort design using baseline participant characteristics, objectively assessed physical activity and lower limb function provided by Project OPAL (Older People and Active Living). OPAL-PLUS provided data on numbers of primary care consultations, prescriptions, unplanned hospital admissions, and secondary care referrals, extracted from medical records for up to five years following the baseline OPAL data collection. Participants and Data Collection: OPAL participants were a diverse sample of 240 older adults with a mean age of 78 years. They were recruited from 12 General Practitioner surgeries from low, middle, and high areas of deprivation in a city in the West of England. Primary care consultations, secondary care referrals, unplanned hospital admissions, number of prescriptions and new disease diagnoses were assessed for 213 (104 females) of the original 240 OPAL participants who had either consented to participate in OPAL-PLUS or already died during the follow-up period. Results: In regression modelling, adjusted for socio-economic variables, existing disease, weight status, minutes of moderate-to-vigorous physical activity (MVPA) per day predicted subsequent numbers of prescriptions. Steps taken per day and MVPA also predicted unplanned hospital admissions, although the strength of the effect was reduced when further adjustment was made for lower limb function. Conclusions: Community-based programs are needed which are successful in engaging older adults in their late 70s and 80s in more walking, MVPA and activity that helps them avoid loss of physical function. There is a potential for cost savings to health services through reduced reliance on prescriptions and fewer unplanned hospital admissions.	[Simmonds, Bethany; Fox, Kenneth; Davis, Mark; Coulson, Joanna] Univ Bristol, Sch Policy Studies, Ctr Exercise Nutr & Hlth Sci, Bristol, Avon, England; [Ku, Po-Wen] Natl Changhua Univ Educ, Grad Inst Sports & Hlth, Changua, Taiwan; [Gray, Selena] Univ W England, Dept Hlth & Appl Social Sci, Bristol BS16 1QY, Avon, England; [Hillsdon, Melvyn] Univ Exeter, Exeter, Devon, England; [Sharp, Debbie; Trayers, Tanya] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Stathi, Afroditi] Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England; [Fox, Kenneth; Thompson, Janice] Univ Birmingham, Sch Sport & Exercise Sci, Birmingham, W Midlands, England	University of Bristol; National Changhua University of Education; University of West England; University of Exeter; University of Bristol; University of Bath; University of Birmingham	Simmonds, B (corresponding author), Bristol Royal Infirm & Gen Hosp, Univ Hosp Bristol, Dept Rheumatol, Bristol, Avon, England.	bethany.simmonds@bristol.ac.uk	Ku, Po-Wen/S-7723-2019; STATHI, AFRODITI/AAM-4377-2020	STATHI, AFRODITI/0000-0003-2162-777X; Simmonds, Bethany Adela Joanna/0000-0003-2463-7623; Ku, Po-Wen/0000-0001-9724-018X; sharp, deborah/0000-0003-3071-9860; Thompson, Janice/0000-0002-7312-3226; Fox, Kenneth/0000-0003-2216-4287	Dunhill Medical Trust [R200/0511]; Avon Primary Care Research Collaborative; South West General Practitioners Trust; National Prevention Research Initiative - British Heart Foundation [G0501312]; Cancer Research UK; Department of Health; Diabetes UK; Economic and Social Research Council; Medical Research Council; Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office; Scottish Executive Health Department; Welsh Assembly Government; World Cancer Research Fund; MRC [MR/K00414X/1, G0501312] Funding Source: UKRI; Medical Research Council [MR/K00414X/1, G0501312] Funding Source: researchfish; The Dunhill Medical Trust [R200/0511] Funding Source: researchfish	Dunhill Medical Trust(Dunhill Medical Trust); Avon Primary Care Research Collaborative; South West General Practitioners Trust; National Prevention Research Initiative - British Heart Foundation; Cancer Research UK(Cancer Research UK); Department of Health; Diabetes UK(Diabetes UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research and Development Office for the Northern Ireland Health and Social Services; Chief Scientist Office; Scottish Executive Health Department; Welsh Assembly Government; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Dunhill Medical Trust(Dunhill Medical Trust)	This follow-up work (OPAL-PLUS) was supported by The Dunhill Medical Trust grant number R200/0511 with additional support from the Avon Primary Care Research Collaborative and the South West General Practitioners Trust. Project OPAL provided the baseline data and was funded by Phase 1 of the National Prevention Research Initiative (http://www.npri.org.uk; grant No. G0501312) that was supported by the British Heart Foundation, Cancer Research UK, Department of Health, Diabetes UK, Economic and Social Research Council, Medical Research Council, Research and Development Office for the Northern Ireland Health and Social Services, Chief Scientist Office, Scottish Executive Health Department, Welsh Assembly Government, and World Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; [Anonymous], 2010, WHO GLOB STAT REP NO; Bonnefoy M, 2001, J AM GERIATR SOC, V49, P28, DOI 10.1046/j.1532-5415.2001.49006.x; Breeze E, 2005, INT J EPIDEMIOL, V34, P276, DOI 10.1093/ije/dyh328; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Craig R, 2009, HLTH SURVEY ENGLAND; Davis MG, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-116; Davis MG, 2011, MED SCI SPORT EXER, V43, P647, DOI 10.1249/MSS.0b013e3181f36196; Department of Health, 2011, START ACT STAY ACT R; Fox KR, 2011, HEALTH PLACE, V17, P633, DOI 10.1016/j.healthplace.2011.01.002; Gine-Garriga M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066392; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; HAAN M, 1987, AM J EPIDEMIOL, V125, P989, DOI 10.1093/oxfordjournals.aje.a114637; House of Lords Select Committee on Public Service and Demographic Change, 2013, READ AG REP; Ip EH, 2013, J GERONTOL A-BIOL, V68, P426, DOI 10.1093/gerona/gls186; Lai JKC, 2013, J BONE MINER RES, V28, P2222, DOI 10.1002/jbmr.1963; MACINTYRE S, 1993, J SOC POLICY, V22, P213, DOI 10.1017/S0047279400019310; Marsh AP, 2011, J GERONTOL A-BIOL, V66, P1376, DOI 10.1093/gerona/glr158; Martin MY, 2006, J AGING PHYS ACTIV, V14, P392, DOI 10.1123/japa.14.4.392; Meltzer D, 2012, HLTH CARE QUALITY AC; Morina N, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-39; Nemet GF, 2000, SOC SCI MED, V50, P1197, DOI 10.1016/S0277-9536(99)00365-2; NICE, 2013, PHYS ACT BRIEF ADV A, V44, P44; Office for National Statistics, 2007, IND DEPR 2007 SUP OU; Perkins AJ, 2001, PREV MED, V32, P492, DOI 10.1006/pmed.2001.0832; Petrella RJ, 1999, PREV MED, V29, P571, DOI 10.1006/pmed.1999.0573; Prior MK, 2012, SOC WORK HEALTH CARE, V51, P345, DOI 10.1080/00981389.2011.644103; Rejeski WJ, 2013, CLIN INTERV AGING, V8, P1119, DOI 10.2147/CIA.S49737; Rejeski WJ, 2009, J GERONTOL A-BIOL, V64, P462, DOI 10.1093/gerona/gln041; Roberts RO, 1996, J CLIN EPIDEMIOL, V49, P989, DOI 10.1016/0895-4356(96)00143-6; Sari N, 2011, MATURITAS, V70, P285, DOI 10.1016/j.maturitas.2011.08.004; Sari N, 2010, CAN J PUBLIC HEALTH, V101, P385, DOI 10.1007/BF03404858; Cabrera MAS, 2012, CAN J AGING, V31, P357, DOI 10.1017/S0714980812000244; Smee D. J., 2012, CURRENT GERONTOLOGY; Tooth LR, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-179; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; Wang FF, 2005, OBES RES, V13, P1450, DOI 10.1038/oby.2005.175; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	38	26	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97676	10.1371/journal.pone.0097676	http://dx.doi.org/10.1371/journal.pone.0097676			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5NG	24866573	Green Published, gold			2022-12-25	WOS:000336914100019
J	Mellergaard, M; Skovbakke, SL; Schneider, CL; Lauridsen, F; Andresen, L; Jensen, H; Skov, S				Mellergaard, Maiken; Skovbakke, Sarah Line; Schneider, Christine L.; Lauridsen, Felicia; Andresen, Lars; Jensen, Helle; Skov, Soren			N-Glycosylation of Asparagine 8 Regulates Surface Expression of Major Histocompatibility Complex Class I Chain-related Protein A (MICA) Alleles Dependent on Threonine 24	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NKG2D LIGAND EXPRESSION; ACTIVATED T-LYMPHOCYTES; INTRACELLULAR RETENTION; LINKED OLIGOSACCHARIDES; GLYCOPROTEIN UL16; DOWN-REGULATION; MOLECULES; CELLS; HUMAN-HERPESVIRUS-7; SEQUESTRATION	NKG2Dis an activating receptor expressed on several types of human lymphocytes. NKG2D ligands can be induced upon cell stress and are frequently targeted post-translationally in infected or transformed cells to avoid immune recognition. Virus infection and inflammation alter protein N-glycosylation, and we have previously shown that changes in cellular N-glycosylation are involved in regulation of NKG2D ligand surface expression. The specific mode of regulation through N-glycosylation is, however, unknown. Here we investigated whether direct N-glycosylation of the NKG2D ligand MICA itself is critical for cell surface expression and sought to identify the essential residues. We found that a single N-glycosylation site (Asn(8)) was important for MICA018 surface expression. The frequently expressed MICA allele 008, with an altered transmembrane and intracellular domain, was not affected by mutation of this N-glycosylation site. Mutational analysis revealed that a single amino acid (Thr(24)) in the extracellular domain of MICA018 was essential for the N-glycosylation dependence, whereas the intracellular domain was not involved. The HHV7 immunoevasin, U21, was found to inhibit MICA018 surface expression by affecting N-glycosylation, and the retention was rescued by T24A substitution. Our study reveals N-glycosylation as an allele-specific regulatory mechanism important for regulation of surface expression of MICA018, and we pinpoint the residues essential for this N-glycosylation dependence. In addition, we show that this regulatory mechanism of MICA surface expression is likely targeted during different pathological conditions.	[Mellergaard, Maiken; Skovbakke, Sarah Line; Lauridsen, Felicia; Andresen, Lars; Jensen, Helle; Skov, Soren] Univ Copenhagen, Immunol Lab, Fac Hlth & Med Sci, Sect Expt Anim Models, DK-1870 Frederiksberg, Denmark; [Schneider, Christine L.] Carroll Univ, Dept Biol, Waukesha, WI 53186 USA	University of Copenhagen	Skov, S (corresponding author), Univ Copenhagen, Immunol Lab, Stigbojlen 7, DK-1870 Frederiksberg, Denmark.	sosk@sund.ku.dk	Andresen, Lars/O-2271-2019; Andresen, Lars/K-1287-2012	Andresen, Lars/0000-0002-6362-7973; Skovbakke, Sarah Line/0000-0002-4673-4419; Mellergaard, Maiken/0000-0001-5854-1086; Skov, Soren/0000-0003-0732-0026	Danish Council for Independent Research/Medical Sciences [DFF-1331-00169]	Danish Council for Independent Research/Medical Sciences(Det Frie Forskningsrad (DFF))	This work was supported by Project DFF-1331-00169 from the Danish Council for Independent Research/Medical Sciences.	Andresen L, 2007, J IMMUNOL, V179, P8235, DOI 10.4049/jimmunol.179.12.8235; Andresen L, 2012, J IMMUNOL, V188, P1847, DOI 10.4049/jimmunol.1004085; Andresen L, 2009, J IMMUNOL, V183, P897, DOI 10.4049/jimmunol.0803014; Ashiru O, 2009, J VIROL, V83, P12345, DOI 10.1128/JVI.01175-09; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Benjamin L., 2007, CELLS, P120; Blauvelt A, 2001, J INVEST DERM SYMP P, V6, P197, DOI 10.1046/j.0022-202x.2001.00040.x; Chalupny NJ, 2006, BIOCHEM BIOPH RES CO, V346, P175, DOI 10.1016/j.bbrc.2006.05.092; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(09)00098-3; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Dunn C, 2003, J EXP MED, V197, P1427, DOI 10.1084/jem.20022059; Eagle RA, 2009, EUR J IMMUNOL, V39, P3207, DOI 10.1002/eji.200939502; ELBEIN AD, 1990, J BIOL CHEM, V265, P15599; ELBEIN AD, 1991, TRENDS BIOTECHNOL, V9, P346, DOI 10.1016/0167-7799(91)90117-Z; Fares F, 2006, BBA-GEN SUBJECTS, V1760, P560, DOI 10.1016/j.bbagen.2005.12.022; FERNANDES B, 1991, CANCER RES, V51, P718; Fuertes MB, 2008, J IMMUNOL, V180, P4606, DOI 10.4049/jimmunol.180.7.4606; Glosson NL, 2010, J BIOL CHEM, V285, P37016, DOI 10.1074/jbc.M110.125849; Gonzalez S, 2006, CURR TOP MICROBIOL, V298, P121; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 2006, NAT IMMUNOL, V7, P755, DOI 10.1038/ni1350; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hudson AW, 2001, J VIROL, V75, P12347, DOI 10.1128/JVI.75.24.12347-12358.2001; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; Kobata A, 2005, IMMUNOL CELL BIOL, V83, P429, DOI 10.1111/j.1440-1711.2005.01351.x; Kroemer G, 2007, IMMUNOL REV, V220, P5; Kurtoglu M, 2007, ANTIOXID REDOX SIGN, V9, P1383, DOI 10.1089/ars.2007.1714; Lanteri M, 2003, GLYCOBIOLOGY, V13, P909, DOI 10.1093/glycob/cwg110; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Lopez-Larrea C, 2008, TRENDS MOL MED, V14, P179, DOI 10.1016/j.molmed.2008.02.004; Marcos NT, 2008, J CLIN INVEST, V118, P2325, DOI [10.1172/JC134324, 10.1172/JCI34324]; May NA, 2010, J VIROL, V84, P3738, DOI 10.1128/JVI.01782-09; McSharry BP, 2008, J VIROL, V82, P4585, DOI 10.1128/JVI.02251-07; Mizuki N, 1997, P NATL ACAD SCI USA, V94, P1298, DOI 10.1073/pnas.94.4.1298; Molinero LL, 2003, J LEUKOCYTE BIOL, V73, P815, DOI 10.1189/jlb.0602329; Nice TJ, 2010, J IMMUNOL, V185, P5369, DOI 10.4049/jimmunol.1000247; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Robinson J, 2001, IMMUNOGENETICS, V53, P150, DOI 10.1007/s002510100303; Satomaa T, 2009, CANCER RES, V69, P5811, DOI 10.1158/0008-5472.CAN-08-0289; Schneider CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002362; Skov S, 2005, CANCER RES, V65, P11136, DOI 10.1158/0008-5472.CAN-05-0599; Sousa CRE, 2004, SEMIN IMMUNOL, V16, P27, DOI 10.1016/j.smim.2003.10.004; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Stephens HAF, 2001, TRENDS IMMUNOL, V22, P378, DOI 10.1016/S1471-4906(01)01960-3; Suemizu H, 2002, P NATL ACAD SCI USA, V99, P2971, DOI 10.1073/pnas.052701099; Tesniere A, 2008, CELL DEATH DIFFER, V15, P3, DOI 10.1038/sj.cdd.4402269; Thomas M, 2008, P NATL ACAD SCI USA, V105, P1656, DOI 10.1073/pnas.0707883105; TULSIANI DRP, 1982, J BIOL CHEM, V257, P7936; Waldhauer I, 2008, CANCER RES, V68, P6368, DOI 10.1158/0008-5472.CAN-07-6768; Welte SA, 2003, EUR J IMMUNOL, V33, P194, DOI 10.1002/immu.200390022; Wu J, 2003, J IMMUNOL, V170, P4196, DOI 10.4049/jimmunol.170.8.4196; Zwirner NW, 2007, CYTOKINE GROWTH F R, V18, P159, DOI 10.1016/j.cytogfr.2007.01.013; Zwirner NW, 1998, IMMUNOGENETICS, V47, P139	58	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20078	20091		10.1074/jbc.M114.573238	http://dx.doi.org/10.1074/jbc.M114.573238			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24872415	Green Published, hybrid			2022-12-25	WOS:000339395200022
J	Hao, R; Hu, XX; Wu, CX; Li, N				Hao, Rui; Hu, Xiaoxiang; Wu, Changxin; Li, Ning			Hypoxia-Induced miR-15a Promotes Mesenchymal Ablation and Adaptation to Hypoxia during Lung Development in Chicken	PLOS ONE			English	Article							GAS-EXCHANGE; TIBET CHICKEN; BRANCHING MORPHOGENESIS; PULMONARY-HYPERTENSION; INDUCIBLE FACTOR-1; DOMESTIC-FOWL; TURKEY EGGS; AVIAN LUNG; MICRORNA; TARGET	The lungs undergo changes that are adaptive for high elevation in certain animal species. In chickens, animals bred at high elevations (e. g., Tibet chickens) are better able to hatch and survive under high-altitude conditions. In addition, lowland chicken breeds undergo physiological effects and suffer greater mortality when they are exposed to hypoxic conditions during embryonic development. Although these physiological effects have been noted, the mechanisms that are responsible for hypoxia-induced changes in lung development and function are not known. Here we have examined the role of a particular microRNA (miRNA) in the regulation of lung development under hypoxic conditions. When chicks were incubated in low oxygen (hypoxia), miR-15a was significantly increased in embryonic lung tissue. The expression level of miR-15a in hypoxic Tibet chicken embryos increased and remained relatively high at embryonic day (E) 16-20, whereas in normal chickens, expression increased and peaked at E19-20, at which time the cross-current gas exchange system (CCGS) is developing. Bcl-2 was a translationally repressed target of miR-15a in these chickens. miR-16, a cluster and family member of miR-15a, was detected but did not participate in the posttranscriptional regulation of bcl-2. Around E19, the hypoxia-induced decrease in Bcl-2 protein resulted in apoptosis in the mesenchyme around the migrating tubes, which led to an expansion and migration of the tubes that would become the air capillary network and the CCGS. Thus, interfering with miR-15a expression in lung tissue may be a novel therapeutic strategy for hypoxia insults and altitude adaptation.	[Hao, Rui; Hu, Xiaoxiang; Li, Ning] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Wu, Changxin] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China; [Li, Ning] Yunnan Agr Univ, Coll Anim Sci, Kunming, Peoples R China	China Agricultural University; China Agricultural University; Yunnan Agricultural University	Li, N (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	ninglcau@cau.edu.cn			High-Tech Research and Development Program of China [2011AA100301]; Yunnan Flexible Talents Development Program [2010C1118]	High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Yunnan Flexible Talents Development Program	This work was funded by The High-Tech Research and Development Program of China (2011AA100301) and Yunnan Flexible Talents Development Program (2010C1118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azzam MA, 2007, RESP PHYSIOL NEUROBI, V159, P155, DOI 10.1016/j.resp.2007.06.003; Bao HG, 2007, POULTRY SCI, V86, P2210, DOI 10.1093/ps/86.10.2210; Bao HG, 2011, POULTRY SCI, V90, P648, DOI 10.3382/ps.2010-00994; BARROSODELJESUS A, 2011, FASEB J; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bridges JP, 2012, DEV BIOL, V362, P24, DOI 10.1016/j.ydbio.2011.10.033; Calin GA, 2006, SEMIN ONCOL, V33, P167, DOI 10.1053/j.seminoncol.2006.01.010; Calin GA, 2008, P NATL ACAD SCI USA, V105, P5166, DOI 10.1073/pnas.0800121105; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; CHRISTENSEN VL, 1984, POULTRY SCI, V63, P1350, DOI 10.3382/ps.0631350; CHRISTENSEN VL, 1988, POULTRY SCI, V67, P956, DOI 10.3382/ps.0670956; CHRISTENSEN VL, 1989, POULTRY SCI, V68, P724, DOI 10.3382/ps.0680724; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cittelly DM, 2010, CARCINOGENESIS, V31, P2049, DOI 10.1093/carcin/bgq192; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Crosby ME, 2009, CANCER RES, V69, P1221, DOI 10.1158/0008-5472.CAN-08-2516; Darnell DK, 2006, DEV DYNAM, V235, P3156, DOI 10.1002/dvdy.20956; Dong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010854; Duncker H R, 1971, Ergeb Anat Entwicklungsgesch, V45, P7; DURMOWICZ AG, 1993, J APPL PHYSIOL, V74, P2276, DOI 10.1152/jappl.1993.74.5.2276; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Foshay Kara M, 2007, Curr Stem Cell Res Ther, V2, P264, DOI 10.2174/157488807782793781; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; GALLAGHER BC, 1986, J EMBRYOL EXP MORPH, V94, P173; GALLAGHER BC, 1986, J EMBRYOL EXP MORPH, V94, P189; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gunaratne PH, 2009, CURR STEM CELL RES T, V4, P168, DOI 10.2174/157488809789057400; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Jovanovic M, 2006, ONCOGENE, V25, P6176, DOI 10.1038/sj.onc.1209912; KALENGA M, 1995, PEDIATR RES, V37, P789, DOI 10.1203/00006450-199506000-00019; King AS, 1989, FORM FUNCTION BIRDS; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; LALTHANTLUANGA R, 1985, H-S Z PHYSIOL CHEM, V366, P63; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lin Q, 2009, FEBS J, V276, P2348, DOI 10.1111/j.1742-4658.2009.06967.x; Liu C, 2009, POULTRY SCI, V88, P2689, DOI 10.3382/ps.2009-00311; MAINA JN, 1989, PHILOS T R SOC B, V326, P1, DOI 10.1098/rstb.1989.0104; Maina JN, 2003, TISSUE CELL, V35, P375, DOI 10.1016/S0040-8166(03)00058-2; Maina JN, 2003, ANAT EMBRYOL, V207, P119, DOI 10.1007/s00429-003-0333-6; Makanya AN, 2011, MICROSC RES TECHNIQ, V74, P159, DOI 10.1002/jemt.20887; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Molina JN, 2004, TISSUE CELL, V36, P129, DOI 10.1016/j.tice.2003.11.002; Mortola J. P., 2001, RESP PHYSL NEWBORN M; Mujahid S, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-13; Obernosterer G, 2007, NAT PROTOC, V2, P1508, DOI 10.1038/nprot.2007.153; Ofir M, 2011, MOL CANCER RES, V9, P440, DOI 10.1158/1541-7786.MCR-10-0344; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Piret JP, 2002, BIOCHEM PHARMACOL, V64, P889, DOI 10.1016/S0006-2952(02)01155-3; Pocock R, 2011, PFLUG ARCH EUR J PHY, V461, P307, DOI 10.1007/s00424-010-0910-5; POWELL FL, 1982, FED PROC, V41, P2131; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Sangokoya C, 2010, BLOOD, V116, P4338, DOI 10.1182/blood-2009-04-214817; Scheinfeldt LB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-133; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Semenza GL, 2014, ANNU REV PHYSIOL, V76, P39, DOI 10.1146/annurev-physiol-021113-170322; Shan F, 2014, J CELL PHYSL; SHIMIZU S, 1995, NATURE, V374, P811, DOI 10.1038/374811a0; Tang JR, 2010, AM J PHYSIOL-LUNG C, V299, pL735, DOI 10.1152/ajplung.00153.2010; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Tuder RM, 2007, J MOL MED, V85, P1317, DOI 10.1007/s00109-007-0280-4; VISSCHEDIJK AHJ, 1985, J APPL PHYSIOL, V58, P416, DOI 10.1152/jappl.1985.58.2.416; VISSCHEDIJK AHJ, 1980, RESP PHYSIOL, V39, P33, DOI 10.1016/0034-5687(80)90012-2; VISSCHEDIJK AHJ, 1985, RESP PHYSIOL, V59, P339, DOI 10.1016/0034-5687(85)90137-9; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-199; Wang XY, 2013, ANIM GENET, V44, P472, DOI 10.1111/age.12020; Wu G, 2011, BRIT J CANCER, V105, P146, DOI 10.1038/bjc.2011.190; Xu HT, 2006, FEBS LETT, V580, P3610, DOI 10.1016/j.febslet.2006.05.044; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yang Y, 2012, INT J MOL MED, V29, P393, DOI 10.3892/ijmm.2011.855; Yin KJ, 2010, J NEUROSCI, V30, P6398, DOI 10.1523/JNEUROSCI.0780-10.2010; Yue JM, 2010, MAMM GENOME, V21, P88, DOI 10.1007/s00335-009-9240-3; Yue JQ, 2013, LAB INVEST, V93, P748, DOI 10.1038/labinvest.2013.63; Zhang H, 2012, POULTRY SCI, V91, P3191, DOI 10.3382/ps.2012-02449; [张浩 ZHANG Hao], 2006, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V37, P112; Zhang X, 2011, ONCOGENE	85	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98868	10.1371/journal.pone.0098868	http://dx.doi.org/10.1371/journal.pone.0098868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887070	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300114
J	Hohne, J; Tangermann, M				Hoehne, Johannes; Tangermann, Michael			Towards User-Friendly Spelling with an Auditory Brain-Computer Interface: The CharStreamer Paradigm	PLOS ONE			English	Article							CLASSIFICATION; PERFORMANCE; COMPONENTS; ATTENTION; DESIGN; SYSTEM; BCI	Realizing the decoding of brain signals into control commands, brain-computer interfaces (BCI) aim to establish an alternative communication pathway for locked-in patients. In contrast to most visual BCI approaches which use event-related potentials (ERP) of the electroencephalogram, auditory BCI systems are challenged with ERP responses, which are less class-discriminant between attended and unattended stimuli. Furthermore, these auditory approaches have more complex interfaces which imposes a substantial workload on their users. Aiming for a maximally user-friendly spelling interface, this study introduces a novel auditory paradigm: "CharStreamer". The speller can be used with an instruction as simple as "please attend to what you want to spell". The stimuli of CharStreamer comprise 30 spoken sounds of letters and actions. As each of them is represented by the sound of itself and not by an artificial substitute, it can be selected in a one-step procedure. The mental mapping effort (sound stimuli to actions) is thus minimized. Usability is further accounted for by an alphabetical stimulus presentation: contrary to random presentation orders, the user can foresee the presentation time of the target letter sound. Healthy, normal hearing users (n = 10) of the CharStreamer paradigm displayed ERP responses that systematically differed between target and non-target sounds. Class-discriminant features, however, varied individually from the typical N1-P2 complex and P3 ERP components found in control conditions with random sequences. To fully exploit the sequential presentation structure of CharStreamer, novel data analysis approaches and classification methods were introduced. The results of online spelling tests showed that a competitive spelling speed can be achieved with CharStreamer. With respect to user rating, it clearly outperforms a control setup with random presentation sequences.	[Hoehne, Johannes] Berlin Inst Technol, Machine Learning Lab, Berlin, Germany; [Hoehne, Johannes] Berlin Inst Technol, Neurotechnol Grp, Berlin, Germany; [Tangermann, Michael] Univ Freiburg, BrainLinks BrainTools Excellence Cluster, D-79106 Freiburg, Germany	Technical University of Berlin; Technical University of Berlin; University of Freiburg	Hohne, J (corresponding author), Berlin Inst Technol, Machine Learning Lab, Berlin, Germany.	j.hoehne@tu-berlin.de; michael.tangermann@blbt.uni-freiburg.de	Tangermann, Michael/ABE-4178-2020	Tangermann, Michael/0000-0001-6729-0290	European Information and Communication Technologies (ICT) Programme [FP7-224631]; Deutsche Forschungsgemeinschaft (DFG) [MU 987/3-2, EXC 1086]; Bundesministerium fur Bildung und Forschung [BMBF 01GQ0850]; Albert Ludwigs University Freiburg	European Information and Communication Technologies (ICT) Programme; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Albert Ludwigs University Freiburg	This work was partly supported by the European Information and Communication Technologies (ICT) Programme Project FP7-224631, by the Deutsche Forschungsgemeinschaft (DFG) (grants MU 987/3-2, EXC 1086) and Bundesministerium fur Bildung und Forschung (BMBF 01GQ0850). The article processing charge was funded by the open access publication fund of the Albert Ludwigs University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acqualagna L, 2013, CLIN NEUROPHYSIOL, V124, P901, DOI 10.1016/j.clinph.2012.12.050; Acqualagna L, 2010, IEEE ENG MED BIO, P2686, DOI 10.1109/IEMBS.2010.5626548; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Clemmensen L, 2011, TECHNOMETRICS, V53, P406, DOI 10.1198/TECH.2011.08118; De Massari D, 2013, BRAIN, V136, P1989, DOI 10.1093/brain/awt102; De Vos M, 2013, INT J PSYCHOPHYSIOLO; Dornhege G, 2003, ADV NEURAL INF P SYS, V15, P1115; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; Furdea A, 2009, PSYCHOPHYSIOLOGY, V46, P617, DOI 10.1111/j.1469-8986.2008.00783.x; Gao S, 2013, IEEE T BIOMEDICAL EN; Geuze J, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/1/016009; Hill NJ, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026011; Hill N. J., 2004, NEURAL INF PROCESS S, V17, P569; Hohne J, 2012, IEEE ENG MED BIO, P1802, DOI 10.1109/EMBC.2012.6346300; Hohne J, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045003; Hohne J, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00099; Hohne J, 2010, IEEE ENG MED BIO, P4185, DOI 10.1109/IEMBS.2010.5627379; Holz EM, 2013, ARTIF INTELL MED, V59, P111, DOI 10.1016/j.artmed.2013.08.001; Kathner I, 2013, CLIN NEUROPHYSIOL, V124, P327, DOI 10.1016/j.clinph.2012.08.006; Kaufmann T, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056016; Kaufmann T, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00129; Klobassa DS, 2009, CLIN NEUROPHYSIOL, V120, P1252, DOI 10.1016/j.clinph.2009.04.019; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; Kubler A, 2013, ARTIF INTELL MED, V59, P55, DOI 10.1016/j.artmed.2013.08.002; Leeb R, 2010, IEEE ENG MED BIO, P4343, DOI 10.1109/IEMBS.2010.5626233; Lopez-Gordo MA, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036013; Matsumoto Y., 2013, SIGN INF PROC ASS AN, P1, DOI 10.1109/APSIPA.2013.66943412-s2.0-84893246153; Quek M, 2012, PRACTICAL BRAIN COMP, P173, DOI [10.1007/978-3-642-29746-5, DOI 10.1007/978-3-642-29746-5]; Riccio A, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045001; Schreuder M., 2011, FRONTIERS NEUROSCIEN, V5; Schreuder M, 2013, ARTIF INTELL MED, V59, P71, DOI 10.1016/j.artmed.2013.07.005; Schreuder M, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036025; Schreuder M, 2012, IEEE ENG MED BIO, P6707, DOI 10.1109/EMBC.2012.6347533; Schreuder M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009813; Sellers EW, 2006, BIOL PSYCHOL, V73, P242, DOI 10.1016/j.biopsycho.2006.04.007; TANGERMANN M, 2012, ENG MED BIOL SOC EMB, P2501; Townsend G, 2012, NEUROSCIENCE LETT; Treder MS, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026009; Treder MS, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066003; Treder MS, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-28; van der Waal M, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045002; Wills SA, 2006, IEEE T NEUR SYS REH, V14, P244, DOI 10.1109/TNSRE.2006.875573; Winkler I, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-30; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Xu HL, 2013, CLIN NEUROPHYSIOL, V124, P83, DOI 10.1016/j.clinph.2012.06.004	46	29	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98322	10.1371/journal.pone.0098322	http://dx.doi.org/10.1371/journal.pone.0098322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI6CB	24886978	Green Published, gold			2022-12-25	WOS:000336956300052
J	Mommer, BC; Bell, AM				Mommer, Brett C.; Bell, Alison M.			Maternal Experience with Predation Risk Influences Genome-Wide Embryonic Gene Expression in Threespined Sticklebacks (Gasterosteus aculeatus)	PLOS ONE			English	Article							PRENATAL STRESS; OFFSPRING SURVIVAL; AXIS ACTIVITY; FETAL-GROWTH; RECEPTOR; SIZE; DNA; REPRODUCTION; MECHANISMS; RESPONSES	There is growing evidence for nongenetic effects of maternal experience on offspring. For example, previous studies have shown that female threespined stickleback fish (Gasterosteus aculeatus) exposed to predation risk produce offspring with altered behavior, metabolism and stress physiology. Here, we investigate the effect of maternal exposure to predation risk on the embryonic transcriptome in sticklebacks. Using RNA-sequencing we compared genome-wide transcription in three day post-fertilization embryos of predator-exposed and control mothers. There were hundreds of differentially expressed transcripts between embryos of predator-exposed mothers and embryos of control mothers including several non-coding RNAs. Gene Ontology analysis revealed biological pathways involved in metabolism, epigenetic inheritance, and neural proliferation and differentiation that differed between treatments. Interestingly, predation risk is associated with an accelerated life history in many vertebrates, and several of the genes and biological pathways that were identified in this study suggest that maternal exposure to predation risk accelerates the timing of embryonic development. Consistent with this hypothesis, embryos of predator-exposed mothers were larger than embryos of control mothers. These findings point to some of the molecular mechanisms that might underlie maternal effects.	[Mommer, Brett C.; Bell, Alison M.] Univ Illinois, Sch Integrat Biol, Dept Anim Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Mommer, BC (corresponding author), Univ Illinois, Sch Integrat Biol, Dept Anim Biol, Urbana, IL 61801 USA.	bmommer2@illinois.edu		Mommer, Brett/0000-0001-8721-7154	National Science Foundation [IOS 1121980]; National Institutes of Health R01 [GM082937]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082937] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [1121980] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (grant IOS 1121980), www.nsf.gov, and the National Institutes of Health R01 (GM082937), www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2002, ECOLOGY, V83, P3408, DOI 10.1890/0012-9658(2002)083[3408:HAMEMA]2.0.CO;2; Badyaev AV, 2003, EVOLUTION, V57, P384; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Bell AM, 2007, PHYSIOL BEHAV, V91, P15, DOI 10.1016/j.physbeh.2007.01.012; Blanchard RJ, 1998, PHYSIOL BEHAV, V63, P561, DOI 10.1016/S0031-9384(97)00508-8; Blow N, 2009, NATURE, V458, P239, DOI 10.1038/458239a; Canoine V, 2002, BEHAVIOUR, V139, P1303, DOI 10.1163/156853902321104172; Caserta MT, 2008, BRAIN BEHAV IMMUN, V22, P933, DOI 10.1016/j.bbi.2008.01.007; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Chivers DP, 2001, OIKOS, V92, P135, DOI 10.1034/j.1600-0706.2001.920116.x; CLARKE AS, 1994, DEV PSYCHOBIOL, V27, P257, DOI 10.1002/dev.420270502; CLARKE AS, 1993, DEV PSYCHOBIOL, V26, P293, DOI 10.1002/dev.420260506; Coe CL, 2007, PEDIATR RES, V61, P520, DOI 10.1203/pdr.0b013e318045be53; de Longh RU, 2001, DEVELOPMENT, V128, P3995; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; Fischer D, 2008, MOL CELL NEUROSCI, V37, P471, DOI 10.1016/j.mcn.2007.11.002; Fox CW, 1999, EVOLUTION, V53, P552, DOI [10.2307/2640791, 10.1111/j.1558-5646.1999.tb03790.x]; Gagliano M, 2009, OECOLOGIA, V160, P657, DOI 10.1007/s00442-009-1335-8; Giesing ER, 2011, P ROY SOC B-BIOL SCI, V278, P1753, DOI 10.1098/rspb.2010.1819; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Glezer I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000310; Gliwicz ZM, 1996, J PLANKTON RES, V18, P863, DOI 10.1093/plankt/18.6.863; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Graw J, 1997, BIOL CHEM, V378, P1331; Green MK, 2011, NEUROSCIENCE, V192, P438, DOI 10.1016/j.neuroscience.2011.06.041; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Hu F, 2008, ENDOCRINOLOGY, V149, P5470, DOI 10.1210/en.2008-0767; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jobe AH, 1998, AM J OBSTET GYNECOL, V178, P880, DOI 10.1016/S0002-9378(98)70518-6; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Joo JY, 2011, BIOCHEM BIOPH RES CO, V406, P627, DOI 10.1016/j.bbrc.2011.02.108; KAPLAN RH, 1992, ECOLOGY, V73, P280, DOI 10.2307/1938739; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kwon JY, 2001, BIOL REPROD, V65, P1701, DOI 10.1095/biolreprod65.6.1701; Lewis ZR, 2008, J MORPHOL, V269, P909, DOI 10.1002/jmor.10608; Li M, 2010, MOL REPROD DEV, V77, P922, DOI 10.1002/mrd.21239; MAGNHAGEN C, 1990, BEHAV ECOL SOCIOBIOL, V26, P331; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; Marasco V, 2012, J EXP BIOL, V215, P3955, DOI 10.1242/jeb.071423; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Matthews SG, 2010, ENDOCRINOLOGY, V151, P7, DOI 10.1210/en.2009-0916; McCormick MI, 2009, OIKOS, V118, P744, DOI 10.1111/j.1600-0706.2008.17410.x; McCormick MI, 2006, ECOLOGY, V87, P1104, DOI 10.1890/0012-9658(2006)87[1104:MMCLTS]2.0.CO;2; McGhee KE, 2012, FUNCT ECOL, V26, P932, DOI 10.1111/j.1365-2435.2012.02008.x; Millet S, 1996, DEVELOPMENT, V122, P3785; Mommer BC, 2013, PHYSIOL BEHAV, V122, P222, DOI 10.1016/j.physbeh.2013.04.004; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Mueller T., 2005, ATLAS EARLY ZEBRAFIS; Nishio H, 2001, INT J DEV NEUROSCI, V19, P37, DOI 10.1016/S0736-5748(00)00070-8; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; PRICE WA, 1992, ENDOCRINOLOGY, V130, P1424, DOI 10.1210/en.130.3.1424; Purves D., 2001, NEUROSCIENCE; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roche DP, 2012, BIOL LETTERS, V8, P932, DOI 10.1098/rsbl.2012.0685; Saino N, 2005, J EXP ZOOL PART A, V303A, P998, DOI 10.1002/jez.a.224; Sanogo YO, 2011, BRAIN BEHAV EVOLUT, V77, P270, DOI 10.1159/000328221; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; Shine R, 1999, OECOLOGIA, V119, P1, DOI 10.1007/s004420050754; Sie KKY, 2011, GUT, V60, P1687, DOI 10.1136/gut.2011.238782; STIBOR H, 1992, OECOLOGIA, V92, P162, DOI 10.1007/BF00317358; Storm JJ, 2010, AM NAT, V175, P382, DOI 10.1086/650443; SWARUP H, 1958, J EMBRYOL EXP MORPH, V6, P373; Szyf M, 2005, FRONT NEUROENDOCRIN, V26, P139, DOI 10.1016/j.yfrne.2005.10.002; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Triant DA, 2009, J HERED, V100, P246, DOI 10.1093/jhered/esn083; Van Buskirk J, 1998, OIKOS, V82, P20; von Hertzen LC, 2002, J ALLERGY CLIN IMMUN, V109, P923, DOI 10.1067/mai.2002.124776; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Weisser WW, 1999, P ROY SOC B-BIOL SCI, V266, P1175, DOI 10.1098/rspb.1999.0760; Wright RJ, 2010, AM J RESP CRIT CARE, V182, P25, DOI 10.1164/rccm.200904-0637OC	76	29	29	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98564	10.1371/journal.pone.0098564	http://dx.doi.org/10.1371/journal.pone.0098564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887438	Green Published, gold			2022-12-25	WOS:000336956300084
J	Novotna, A; Srovnalova, A; Svecarova, M; Korhonova, M; Bartonkova, I; Dvorak, Z				Novotna, Aneta; Srovnalova, Alzbeta; Svecarova, Michaela; Korhonova, Martina; Bartonkova, Iveta; Dvorak, Zdenek			Differential Effects of Omeprazole and Lansoprazole Enantiomers on Aryl Hydrocarbon Receptor in Human Hepatocytes and Cell Lines	PLOS ONE			English	Article							PROTON PUMP INHIBITORS; STEREOSELECTIVE METABOLISM; CYTOCHROME-P450 ENZYMES; AH RECEPTOR; CYP1A1; PHARMACOKINETICS; INDUCTION; ESOMEPRAZOLE; PANTOPRAZOLE; DISPOSITION	Proton pump inhibitors omeprazole and lansoprazole contain chiral sulfur atom and they are administered as a racemate, i.e. equimolar mixture of S- and R-enantiomers. The enantiopure drugs esomeprazole and dexlansoprazole have been developed and introduced to clinical practice due to their improved clinical and therapeutic properties. Since omeprazole and lansoprazole are activators of aryl hydrocarbon receptor (AhR) and inducers of CYP1A genes, we examined their enantiospecific effects on AhR-CYP1A pathway in human cancer cells and primary human hepatocytes. We performed gene reporter assays for transcriptional activity of AhR, RT-PCR analyses for CYP1A1/2 mRNAs, western blots for CYP1A1/2 proteins and EROD assay for CYP1A1/2 catalytic activity. Lansoprazole and omeprazole enantiomers displayed differential effects on AhR-CYP1A1/2 pathway. In general, S-enantiomers were stronger activators of AhR and inducers of CYP1A genes as compared to R-enantiomers in lower concentrations, i.e. 1-10 mu M for lansoprazole and 10-100 mu M for omeprazole. In contrast, R-enantiomers were stronger AhR activators and CYP1A inducers than S-enantiomers in higher concentrations, i.e. 100 mu M for lansoprazole and 250 mu M for omeprazole. In conclusion, we provide the first evidence of enantiospecific effects of omeprazole and lansoprazole on AhR signaling pathway.	[Novotna, Aneta; Srovnalova, Alzbeta; Svecarova, Michaela; Korhonova, Martina; Bartonkova, Iveta; Dvorak, Zdenek] Palacky Univ, Fac Sci, Dept Cell Biol & Genet, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc	Dvorak, Z (corresponding author), Palacky Univ, Fac Sci, Dept Cell Biol & Genet, CR-77147 Olomouc, Czech Republic.	moulin@email.cz	Grycova, Aneta/AGH-1515-2022	Grycova, Aneta/0000-0002-2134-1125; Dvorak, Zdenek/0000-0002-3938-3585	Czech Science Agency [GACR 13-01809S]; Palacky University [PrF-2014-004]	Czech Science Agency; Palacky University	This research was supported by the Czech Science Agency [Grant GACR 13-01809S] and by the student project from Palacky University [PrF-2014-004]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelo A, 2000, DRUG METAB DISPOS, V28, P966; Andersson T, 1996, CLIN PHARMACOKINET, V31, P9, DOI 10.2165/00003088-199631010-00002; Andersson T, 2001, ALIMENT PHARM THERAP, V15, P1563, DOI 10.1046/j.1365-2036.2001.01087.x; Andersson T, 2008, CLIN DRUG INVEST, V28, P263, DOI 10.2165/00044011-200828050-00001; CURIPEDROSA R, 1994, J PHARMACOL EXP THER, V269, P384; Katsuki H, 1996, PHARMACEUT RES, V13, P611, DOI 10.1023/A:1016062508580; Kendall MJ, 2003, ALIMENT PHARM THERAP, V17, P1, DOI 10.1046/j.1365-2036.17.s1.1.x; Kim KA, 2003, DRUG METAB DISPOS, V31, P1227, DOI 10.1124/dmd.31.10.1227; KOHL B, 1992, J MED CHEM, V35, P1049, DOI 10.1021/jm00084a010; Krusekopf S, 2003, XENOBIOTICA, V33, P107, DOI 10.1080/0049825021000023978; LESCA P, 1995, BIOCHEM BIOPH RES CO, V209, P474, DOI 10.1006/bbrc.1995.1526; LINDBERG P, 1986, J MED CHEM, V29, P1327, DOI 10.1021/jm00158a001; LUSSKA A, 1992, J BIOL CHEM, V267, P15146; Metz DC, 2009, ALIMENT PHARM THER, V29, P928, DOI 10.1111/j.1365-2036.2009.03984.x; Miura M, 2006, YAKUGAKU ZASSHI, V126, P395, DOI 10.1248/yakushi.126.395; NEUHOLD LA, 1989, MOL CELL BIOL, V9, P2378, DOI 10.1128/MCB.9.6.2378; Novotna A, 2011, ENVIRON SCI TECHNOL, V45, P10133, DOI 10.1021/es2029334; PICHARD L, 1995, MOL PHARMACOL, V47, P410; Sachs G, 1993, ALIMENT PHARM THER S, V7, P4; Sachs G, 1993, ALIMENT PHARM THE S1, V7, P29; Shih H, 1999, HUM EXP TOXICOL, V18, P95, DOI 10.1191/096032799678839699; Shin JM, 2004, BIOCHEM PHARMACOL, V68, P2117, DOI 10.1016/j.bcp.2004.07.035; Vrzal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074917; Vrzal R, 2009, CHEM-BIOL INTERACT, V179, P288, DOI 10.1016/j.cbi.2008.10.035	24	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98711	10.1371/journal.pone.0098711	http://dx.doi.org/10.1371/journal.pone.0098711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887303	Green Submitted, Green Published, gold			2022-12-25	WOS:000336956300100
J	Perez-Cidoncha, M; Killip, MJ; Asensio, VJ; Fernandez, Y; Bengoechea, JA; Randall, RE; Ortin, J				Perez-Cidoncha, Maite; Killip, Marian J.; Asensio, Victor J.; Fernandez, Yolanda; Bengoechea, Jose A.; Randall, Richard E.; Ortin, Juan			Generation of Replication-Proficient Influenza Virus NS1 Point Mutants with Interferon-Hyperinducer Phenotype	PLOS ONE			English	Article							A VIRUS; TRANSLATION INITIATION; MESSENGER-RNAS; ANTIVIRAL RESPONSES; POLYMERASE COMPLEX; CELLULAR-PROTEIN; INFECTED-CELLS; BINDING-SITE; IN-VITRO; RIG-I	The NS1 protein of influenza A viruses is the dedicated viral interferon (IFN)-antagonist. Viruses lacking NS1 protein expression cannot multiply in normal cells but are viable in cells deficient in their ability to produce or respond to IFN. Here we report an unbiased mutagenesis approach to identify positions in the influenza A NS1 protein that modulate the IFN response upon infection. A random library of virus ribonucleoproteins containing circa 40 000 point mutants in NS1 were transferred to infectious virus and amplified in MDCK cells unable to respond to interferon. Viruses that activated the interferon (IFN) response were subsequently selected by their ability to induce expression of green-fluorescent protein (GFP) following infection of A549 cells bearing an IFN promoter-dependent GFP gene. Using this approach we isolated individual mutant viruses that replicate to high titers in IFN-compromised cells but, compared to wild type viruses, induced higher levels of IFN in IFN-competent cells and had a reduced capacity to counteract exogenous IFN. Most of these viruses contained not previously reported NS1 mutations within either the RNA-binding domain, the effector domain or the linker region between them. These results indicate that subtle alterations in NS1 can reduce its effectiveness as an IFN antagonist without affecting the intrinsic capacity of the virus to multiply. The general approach reported here may facilitate the generation of replication-proficient, IFN-inducing virus mutants, that potentially could be developed as attenuated vaccines against a variety of viruses.	[Perez-Cidoncha, Maite; Fernandez, Yolanda; Ortin, Juan] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain; [Killip, Marian J.; Randall, Richard E.] Univ St Andrews, Ctr Biomol Sci, Sch Biol, St Andrews, Fife, Scotland; [Asensio, Victor J.] FISIB, Bunyola, Mallorca, Spain; [Bengoechea, Jose A.] FISIB, Lab Microbial Pathogenesis, Bunyola, Mallorca, Spain; [Perez-Cidoncha, Maite; Fernandez, Yolanda; Bengoechea, Jose A.; Ortin, Juan] Ciber Enfermedades Resp ISCIII, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of St Andrews; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Ortin, J (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain.	jortin@cnb.csic.es	Ortin, Juan/L-3622-2013	Bengoechea, Jose/0000-0002-9677-8751; Moron, Yolanda Fernandez/0000-0002-2256-163X; Ortin, Juan/0000-0002-6200-4678; Randall, Richard/0000-0002-9304-6678	Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) [BFU2010-17540/BMC]; Fundacion Marcelino Botin; Wellcome Trust [087751/A/08/Z]; Spanish Research Council (CSIC); Wellcome Trust [101788/Z/13/Z] Funding Source: researchfish	Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Marcelino Botin; Wellcome Trust(Wellcome Trust); Spanish Research Council (CSIC); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Spanish Ministry of Science and Innovation (Ministerio de Ciencia e Innovacion) (www.mineco.gob.es/portal/site/mineco/idi) (grant BFU2010-17540/BMC) (JO), by Fundacion Marcelino Botin (www.fundacionbotin.org/) (JO) and The Wellcome Trust (www.wellcome.ac.uk/) (grant 087751/A/08/Z) (RER). MP-C was a predoctoral fellow and awardee of a short-term travel fellowship from the Spanish Research Council (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; Arranz R, 2012, SCIENCE, V338, P1634, DOI 10.1126/science.1228172; Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; BOULOY M, 1978, P NATL ACAD SCI USA, V75, P4886, DOI 10.1073/pnas.75.10.4886; Bourmakina SV, 2005, J VIROL, V79, P7926, DOI 10.1128/JVI.79.12.7926-7932.2005; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; Chen S, 2010, VIROLOGY, V407, P247, DOI 10.1016/j.virol.2010.08.008; Coloma R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000491; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; de Lucas S, 2010, J VIROL, V84, P7603, DOI 10.1128/JVI.00504-10; DELALUNA S, 1995, J VIROL, V69, P2427, DOI 10.1128/JVI.69.4.2427-2433.1995; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Engelhardt OG, 2005, J VIROL, V79, P5812, DOI 10.1128/JVI.79.9.5812-5818.2005; Falcon AM, 2004, J VIROL, V78, P3880, DOI 10.1128/JVI.78.8.3880-3888.2004; FORTES P, 1994, EMBO J, V13, P704, DOI 10.1002/j.1460-2075.1994.tb06310.x; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Garaigorta U, 2005, J VIROL, V79, P15246, DOI 10.1128/JVI.79.24.15246-15257.2005; Garcia-Robles I, 2005, VIROLOGY, V332, P329, DOI 10.1016/j.virol.2004.09.036; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Graef KM, 2010, J VIROL; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hale BG, 2007, BIOCHEM SOC T, V35, P186, DOI 10.1042/BST0350186; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Hale BG, 2010, P NATL ACAD SCI USA, V107, P1954, DOI 10.1073/pnas.0910715107; Hatada E, 1999, J VIROL, V73, P2425, DOI 10.1128/JVI.73.3.2425-2433.1999; Hilton L, 2006, J VIROL, V80, P11723, DOI 10.1128/JVI.01145-06; Holler O, 2009, REV SCI TECH OIE, V28, P219, DOI 10.20506/rst.28.1.1867; Huarte M, 2001, J VIROL, V75, P8597, DOI 10.1128/JVI.75.18.8597-8604.2001; Iwai A, 2010, J BIOL CHEM; Jorba N, 2008, PROTEOMICS, V8, P2077, DOI 10.1002/pmic.200700508; Jorba N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000462; Killip MJ, 2011, VIROLOGY, V415, P39, DOI 10.1016/j.virol.2011.03.027; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Kochs G, 2007, J GEN VIROL, V88, P1403, DOI 10.1099/vir.0.82764-0; KRUG RM, 1979, CELL, V18, P329, DOI 10.1016/0092-8674(79)90052-7; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Li S.F., 2006, AQUAC RES, V2006, P1; Li YZ, 2001, RNA, V7, P920, DOI 10.1017/S1355838201010226; LUYTJES W, 1989, CELL, V59, P1107, DOI 10.1016/0092-8674(89)90766-6; Marazzi I, 2012, NATURE, V483, P428, DOI 10.1038/nature10892; Marion RM, 1997, NUCLEIC ACIDS RES, V25, P4271, DOI 10.1093/nar/25.21.4271; MARK GE, 1979, J VIROL, V29, P744, DOI 10.1128/JVI.29.2.744-752.1979; Martin-Benito J, 2013, ADV VIRUS RES, V87, P113, DOI 10.1016/B978-0-12-407698-3.00004-1; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Min JY, 2007, VIROLOGY, V363, P236, DOI 10.1016/j.virol.2007.01.038; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Moore TC, 2011, VIROLOGY, V418, P40, DOI 10.1016/j.virol.2011.06.028; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; ORTIN J, 1983, GENE, V23, P233, DOI 10.1016/0378-1119(83)90055-0; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Perez-Cidoncha M, 2014, J VIROL IN PRESS; Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034; Precious B, 2005, J GEN VIROL, V86, P151, DOI 10.1099/vir.0.80263-0; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Resa-Infante P, 2011, RNA BIOL, V8, P207, DOI 10.4161/rna.8.2.14513; Resa-Infante P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003904; Rodriguez A, 2007, J VIROL, V81, P5315, DOI 10.1128/JVI.02129-06; ROSE JK, 1991, BIOTECHNIQUES, V10, P520; Ruigrok RWH, 2010, CURR OPIN STRUC BIOL, V20, P104, DOI 10.1016/j.sbi.2009.12.007; SCHOLTISSEK C, 1970, VIROLOGY, V40, P989, DOI 10.1016/0042-6822(70)90145-5; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Takizawa N, 2006, MICROBES INFECT, V8, P823, DOI 10.1016/j.micinf.2005.10.005; Twu KY, 2006, J VIROL, V80, P3957, DOI 10.1128/JVI.80.8.3957-3965.2006; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; Wolff T, 2009, J INTERF CYTOK RES, V29, P549, DOI 10.1089/jir.2009.0066; Yanguez E, 2011, VIRUS RES, V156, P1, DOI 10.1016/j.virusres.2010.12.016; Yin CF, 2007, J BIOL CHEM, V282, P20584, DOI 10.1074/jbc.M611619200; Zhirnov OP, 2007, APOPTOSIS, V12, P1419, DOI 10.1007/s10495-007-0071-y	78	2	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98668	10.1371/journal.pone.0098668	http://dx.doi.org/10.1371/journal.pone.0098668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887174	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000336956300098
J	Tengroth, L; Millrud, CR; Kvarnhammar, AM; Georen, SK; Latif, L; Cardell, LO				Tengroth, Lotta; Millrud, Camilla Rydberg; Kvarnhammar, Anne Mansson; Georen, Susanna Kumlien; Latif, Leith; Cardell, Lars-Olaf			Functional Effects of Toll-Like Receptor (TLR)3, 7, 9, RIG-I and MDA-5 Stimulation in Nasal Epithelial Cells	PLOS ONE			English	Article							CHRONIC RHINOSINUSITIS; INNATE IMMUNITY; EXPRESSION; RNA; RECOGNITION; TLR3; NEUTROPHIL; INDUCTION; INFECTION; VIRUSES	Background: The human nasal epithelium is an important physical barrier, and a part of the innate immune defense that protect against pathogens. The epithelial cells recognize microbial components by pattern-recognition receptors (PRRs), and thereby trigger an immune response. Even though TLR3, TLR7, TLR9, RIG-I and MDA-5 are all known to respond to viral stimulation, their potential role in chronic airway inflammation triggered by local cytokine release remains to be established. Methods: mRNA and corresponding protein expression of TLR3, TLR7, TLR9, RIG-I and MDA-5 were analyzed in nasal biopsies and various upper airway epithelial cell lines using real-time reverse transcription PCR, immunohistochemistry and flow cytometry. Ligand induced, cytokine release, was evaluated with ELISA. Results: Nasal biopsies were found to express TLR3, TLR7, TLR9, RIG-I and MDA-5, with the most abundant expression in the surface epithelium. These receptors were verified in primary human nasal epithelial cell (HNEC) as well as in the airway epithelial cell lines Detroit-562 and FaDu. Poly(I: C) (TLR3) and R-837 (TLR7) stimulation increased secretion of IL-6 and GMCSF from the nasal mucosa and the epithelial cell lines. CpG (TLR9) stimulation caused release of IL-8 in the nasal mucosa and in FaDu. Poly(I: C)/LyoVec (RIG-I/MDA-5) stimulation activated the secretion of IFN-beta in the nasal mucosa. A corresponding release was also detected from HNEC and Detroit-562. Conclusion: The nasal epithelium has the ability to recognize viral intrusion through TLR and RLR receptors, and the subsequent response might have a role in exacerbation of inflammatory diseases like allergic rhinitis and chronic rhinosinusitis.	[Tengroth, Lotta; Millrud, Camilla Rydberg; Kvarnhammar, Anne Mansson; Georen, Susanna Kumlien; Cardell, Lars-Olaf] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div ENT Dis, Stockholm, Sweden; [Latif, Leith] Lund Univ, Dept Otorhinolaryngol, Skane Univ Hosp, Malmo, Sweden	Karolinska Institutet; Lund University; Skane University Hospital	Cardell, LO (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol, Div ENT Dis, Stockholm, Sweden.	lars-olaf.cardell@ki.se		Kumlien Georen, Susanna/0000-0001-7292-9255; Rydberg Millrud, Camilla/0000-0002-5873-2197	Swedish Medical Research Council [2011-3357]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	The authors would like to acknowledge the support from the Swedish Medical Research Council, Grant number: 2011-3357, http://www.vr.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2004, J PEDIATR-US, V144, P421, DOI 10.1016/j.jpeds.2004.01.057; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; AKIRA S, 1990, FASEB J, V4, P2860, DOI 10.1096/fasebj.4.11.2199284; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Bogefors J, 2011, AM J RHINOL ALLERGY, V25, pE262, DOI 10.2500/ajra.2011.25.3712; Broquet AH, 2011, J IMMUNOL, V186, P1618, DOI 10.4049/jimmunol.1002862; Cakebread JA, 2011, J ALLERGY CLIN IMMUN, V127, P1148, DOI 10.1016/j.jaci.2011.01.023; Canonica GW, 2009, CLIN EXP IMMUNOL, V158, P260, DOI 10.1111/j.1365-2249.2009.04017.x; Chehadeh W, 2013, VIRUS RES, V174, P88, DOI 10.1016/j.virusres.2013.03.006; Dassonville C, 2007, Acta Otorhinolaryngol Ital, V27, P78; Fleming HE, 1999, AM J RESP CRIT CARE, V160, P100, DOI 10.1164/ajrccm.160.1.9808074; Fransson M, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-100; Fransson M, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-17; Fu N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000216; Gaajetaan GR, 2013, J INFECTION, V66, P163, DOI 10.1016/j.jinf.2012.11.008; Gitlin L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000734; Golebski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087768; Gwaltney JM, 1996, CLIN INFECT DIS, V23, P1224; Hamilos DL, 2014, J ALLERGY CLIN IMMUN, V133, P640, DOI 10.1016/j.jaci.2013.06.049; Hartmann G, 2007, INFLAMM RES, V56, pS328; Holgate ST, 2007, J ALLERGY CLIN IMMUN, V120, P1233, DOI 10.1016/j.jaci.2007.10.025; Janssens S, 2003, CLIN MICROBIOLOGY RE, V16, P637; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kern RC, 2008, AM J RHINOL, V22, P549, DOI 10.2500/ajr.2008.22.3228; Laurent JM, 2010, PROTEOMICS, V10, P4209, DOI 10.1002/pmic.201000327; LEONARD EJ, 1990, AM J RESP CELL MOL, V2, P479, DOI 10.1165/ajrcmb/2.6.479; Lesmeister MJ, 2006, INT J PEDIATR OTORHI, V70, P987, DOI 10.1016/j.ijporl.2005.10.009; Li XJ, 2009, J BIOL CHEM, V284, P13881, DOI 10.1074/jbc.M900818200; Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06; LOPEZ AF, 1986, J CLIN INVEST, V78, P1220, DOI 10.1172/JCI112705; Matijevic T, 2009, SCAND J IMMUNOL, V70, P18, DOI 10.1111/j.1365-3083.2009.02262.x; Matijevic T, 2011, CLIN EXP METASTAS, V28, P701, DOI 10.1007/s10585-011-9402-z; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; O'Brien GJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-115; PATTEMORE PK, 1992, CLIN EXP ALLERGY, V22, P325, DOI 10.1111/j.1365-2222.1992.tb03094.x; PEDERSEN M, 1983, EUR J RESPIR DIS, V64, P355; Petterson T, 2011, IMMUNOLOGY, V133, P84, DOI 10.1111/j.1365-2567.2011.03414.x; Qian C, 2013, ANN NY ACAD SCI, V1283, P67, DOI 10.1111/j.1749-6632.2012.06786.x; Schleimer RP, 2007, J ALLERGY CLIN IMMUN, V120, P1279, DOI 10.1016/j.jaci.2007.08.046; SUBAUSTE MC, 1995, J CLIN INVEST, V96, P549, DOI 10.1172/JCI118067; Sukkar MB, 2006, J ALLERGY CLIN IMMUN, V118, P641, DOI 10.1016/j.jaci.2006.05.013; Takahasi K, 2009, J BIOL CHEM, V284, P17465, DOI 10.1074/jbc.M109.007179; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tieu DD, 2009, J ALLERGY CLIN IMMUN, V124, P37, DOI 10.1016/j.jaci.2009.04.045; Torres D, 2010, J IMMUNOL, V185, P451, DOI 10.4049/jimmunol.0902833; Uehara A, 2007, MOL IMMUNOL, V44, P3100, DOI 10.1016/j.molimm.2007.02.007; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Zhao CY, 2011, INT ARCH ALLERGY IMM, V156, P297, DOI 10.1159/000323767	51	43	45	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98239	10.1371/journal.pone.0098239	http://dx.doi.org/10.1371/journal.pone.0098239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886842	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300050
J	Hossain, MS; Ramachandiran, S; Gewirtz, AT; Waller, EK				Hossain, Mohammad S.; Ramachandiran, Sampath; Gewirtz, Andrew T.; Waller, Edmund K.			Recombinant TLR5 Agonist CBLB502 Promotes NK Cell-Mediated Anti-CMV Immunity in Mice	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; MURINE CYTOMEGALOVIRUS-INFECTION; BONE-MARROW TRANSPLANTATION; NATURAL-KILLER-CELLS; IFN-GAMMA PRODUCTION; VIRUS-INFECTION; ANTIVIRAL IMMUNITY; VIRAL-INFECTIONS; ACTIVATION; RESPONSES	Prior work using allogeneic bone marrow transplantation (allo-BMT) models showed that peritransplant administration of flagellin, a toll-like receptor 5 (TLR5) agonist protected murine allo-BMT recipients from CMV infection while limiting graft-vs- host disease (GvHD). However, the mechanism by which flagellin-TLR5 interaction promotes anti-CMV immunity was not defined. Here, we investigated the anti-CMV immunity of NK cells in C57BL/6 (B6) mice treated with a highly purified cGMP grade recombinant flagellin variant CBLB502 (rflagellin) followed by murine CMV (mCMV) infection. A single dose of rflagellin administered to mice between 48 to 72 hours prior to MCMV infection resulted in optimal protection from mCMV lethality. Anti-mCMV immunity in rflagellin-treated mice correlated with a significantly reduced liver viral load and increased numbers of Ly49H+ and Ly49D+ activated cytotoxic NK cells. Additionally, the increased anti-mCMV immunity of NK cells was directly correlated with increased numbers of IFN-gamma, granzyme B-and CD107a producing NK cells following mCMV infection. rFlagellin-induced anti-mCMV immunity was TLR5-dependent as rflagellin-treated TLR5 KO mice had,similar to 10-fold increased liver viral load compared with rflagellin-treated WT B6 mice. However, the increased anti-mCMV immunity of NK cells in rflagellin-treated mice is regulated indirectly as mouse NK cells do not express TLR5. Collectively, these data suggest that rflagellin treatment indirectly leads to activation of NK cells, which may be an important adjunct benefit of administering rflagellin in allo-BMT recipients.	[Hossain, Mohammad S.; Ramachandiran, Sampath; Waller, Edmund K.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst,Div Stem Cell & Bone Marrow Tra, Atlanta, GA 30322 USA; [Gewirtz, Andrew T.] Georgia State Univ, Dept Biol, Atlanta, GA USA	Emory University; University System of Georgia; Georgia State University	Waller, EK (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst,Div Stem Cell & Bone Marrow Tra, Atlanta, GA 30322 USA.	ewaller@emory.edu	Waller, Edmund K/AAP-3055-2020		National Institutes of Health [R01 CA-74364-03]; NATIONAL CANCER INSTITUTE [R01CA074364] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01 CA-74364-03 (to E. K. W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; ANTIN JH, 1992, BLOOD, V80, P2964; Babic M, 2011, TRENDS MOL MED, V17, P677, DOI 10.1016/j.molmed.2011.07.003; Biron CA, 1998, SEMIN IMMUNOL, V10, P383, DOI 10.1006/smim.1998.0138; Biron CA, 1997, CURR OPIN IMMUNOL, V9, P24, DOI 10.1016/S0952-7915(97)80155-0; Biron Christine A., 1996, Methods (Orlando), V9, P379, DOI 10.1006/meth.1996.0043; BRAUTIGAM AR, 1979, J GEN VIROL, V44, P349, DOI 10.1099/0022-1317-44-2-349; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; DAERON M, 1995, IMMUNITY, V3, P635, DOI 10.1016/1074-7613(95)90134-5; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; Ding XL, 2012, J IMMUNOL, V189, P4719, DOI 10.4049/jimmunol.1201206; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Fu BQ, 2011, IMMUNOLOGY, V133, P350, DOI 10.1111/j.1365-2567.2011.03446.x; Graubardt N, 2013, HEPATOLOGY, V57, P1969, DOI 10.1002/hep.26008; HOKLAND M, 1988, TRANSPLANTATION, V45, P1080, DOI 10.1097/00007890-198806000-00016; Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083; Hossain MS, 2011, J IMMUNOL, V187, P5130, DOI 10.4049/jimmunol.1101334; Hossain MS, 1999, IMMUNOPHARMACOLOGY, V41, P169, DOI 10.1016/S0162-3109(98)00066-6; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Kofoed EM, 2012, BIOESSAYS, V34, P589, DOI 10.1002/bies.201200013; Langston AA, 2002, BLOOD, V99, P1085, DOI 10.1182/blood.V99.3.1085; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lauzon NM, 2006, CELL IMMUNOL, V241, P102, DOI 10.1016/j.cellimm.2006.08.004; Lenac T, 2008, MED MICROBIOL IMMUN, V197, P159, DOI 10.1007/s00430-008-0080-7; Li JM, 2013, BLOOD, V121, P2347, DOI 10.1182/blood-2012-06-437640; Li JM, 2011, J IMMUNOL, V187, P1057, DOI 10.4049/jimmunol.1100686; NOMURA F, 1990, JPN J MED, V29, P595; Ohta M, 2005, EUR J IMMUNOL, V35, P2210, DOI 10.1002/eji.200425897; Orange JS, 1996, J IMMUNOL, V156, P1138; Orange JS, 1996, J IMMUNOL, V156, P4746; Paar DP, 1996, ADV EXP MED BIOL, V394, P145; Pyzik M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/641702; Salamone GV, 2010, LAB INVEST, V90, P1049, DOI 10.1038/labinvest.2010.77; Salem ML, 2000, INT J IMMUNOPHARMACO, V22, P729, DOI 10.1016/S0192-0561(00)00036-9; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; TANAKA J, 1995, LEUKEMIA LYMPHOMA, V19, P27, DOI 10.3109/10428199509059660; Tsujimoto H, 2005, J LEUKOCYTE BIOL, V78, P888, DOI 10.1189/jlb.0105051; Vahlne G, 2008, SCAND J IMMUNOL, V67, P1, DOI 10.1111/j.1365-3083.2007.02026.x; Wu X, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/759765; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584; Zeng H, 2006, AM J PHYSIOL-GASTR L, V290, pG96, DOI 10.1152/ajpgi.00273.2005; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326; Zhang Y, 2005, J IMMUNOL, V174, P3051, DOI 10.4049/jimmunol.174.5.3051	46	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e96165	10.1371/journal.pone.0096165	http://dx.doi.org/10.1371/journal.pone.0096165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879439	gold, Green Published, Green Submitted			2022-12-25	WOS:000338101500006
J	Ryan, MJ; Fuller, MM; Scott, NJ; Cook, JA; Poe, S; Willink, B; Chaves, G; Bolanos, F				Ryan, Mason J.; Fuller, Michael M.; Scott, Norman J.; Cook, Joseph A.; Poe, Steven; Willink, Beatriz; Chaves, Gerardo; Bolanos, Federico			Individualistic Population Responses of Five Frog Species in Two Changing Tropical Environments over Time	PLOS ONE			English	Article							AMPHIBIAN DECLINES; CLIMATE-CHANGE; DISEASE; BIODIVERSITY; TEMPERATURE; EXTINCTION; ECOLOGY; PRECIPITATION; CONSERVATION; DIVERSITY	Roughly 40% of amphibian species are in decline with habitat loss, disease, and climate change being the most cited threats. Heterogeneity of extrinsic (e. g. climate) and intrinsic (e. g. local adaptations) factors across a species' range should influence population response to climate change and other threats. Here we examine relative detectability changes for five direct-developing leaf litter frogs between 42-year sampling periods at one Lowland Tropical Forest site (51 m.a.s.l.) and one Premontane Wet Forest site (1100 m.a.s.l.) in southwest Costa Rica. We identify individualistic changes in relative detectability among populations between sampling periods at different elevations. Both common and rare species showed site-specific declines, and no species exhibited significant declines at both sites. Detection changes are correlated with changes in temperature, dry season rainfall, and leaf litter depth since1969. Our study species share Least Concern conservation status, life history traits, and close phylogenetic relationship, yet their populations changed individualistically both within and among species. These results counter current views of the uniformity or predictability of amphibian decline response and suggest additional complexity for conservation decisions.	[Ryan, Mason J.; Fuller, Michael M.; Scott, Norman J.; Cook, Joseph A.; Poe, Steven] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Ryan, Mason J.; Scott, Norman J.; Cook, Joseph A.; Poe, Steven] Univ New Mexico, Museum Southwestern Biol, Albuquerque, NM 87131 USA; [Willink, Beatriz; Chaves, Gerardo; Bolanos, Federico] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica	University of New Mexico; University of New Mexico; Universidad Costa Rica	Ryan, MJ (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	mjryan42@gmail.com	Willink, Beatriz/J-9931-2015; Willink, Beatriz/X-5198-2019	Willink, Beatriz/0000-0002-4579-6909; Willink, Beatriz/0000-0002-4579-6909; Chaves, Gerardo/0000-0002-4301-6569; Ryan, Mason/0000-0003-3713-649X	A UNM Grove Scholarship; LAII PhD Fellowship; IdeaWild grant; NSF [DEB 0844624]	A UNM Grove Scholarship; LAII PhD Fellowship; IdeaWild grant; NSF(National Science Foundation (NSF))	A UNM Grove Scholarship, LAII PhD Fellowship, and IdeaWild grant to MJ Ryan and NSF grant DEB 0844624 to S. Poe funded this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064347; Aguilar E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006119; Alford RA, 1999, ANNU REV ECOL SYST, V30, P133, DOI 10.1146/annurev.ecolsys.30.1.133; Angilleta MJ, 2010, THERMAL ADAPTATION; Balmford A, 2003, TRENDS ECOL EVOL, V18, P326, DOI 10.1016/S0169-5347(03)00067-3; Blaustein AR, 2011, ANN NY ACAD SCI, V1223, P108, DOI 10.1111/j.1749-6632.2010.05909.x; Boening C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053055; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Chalcraft DR, 1999, OECOLOGIA, V119, P285, DOI 10.1007/s004420050788; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Daily GC, 2003, CONSERV BIOL, V17, P1814, DOI 10.1111/j.1523-1739.2003.00298.x; Donnelly MA, 1998, CLIMATIC CHANGE, V39, P541, DOI 10.1023/A:1005315821841; Dorazio RM, 2013, ECOLOGY, V94, P1472, DOI 10.1890/0012-9658-94.7.1472; Dosch JJ, 2007, J TROP ECOL, V23, P151, DOI 10.1017/S0266467406003853; Gordo I, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0239; Green DM, 2003, BIOL CONSERV, V111, P331, DOI 10.1016/S0006-3207(02)00302-6; Hanski I, 2011, ECOL LETT, V14, P1025, DOI 10.1111/j.1461-0248.2011.01671.x; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Hines, 2017, OCCUPANCY ESTIMATION; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Hulme M., 1998, POTENTIAL IMPACTS CL, P5; Joyce A.T, 2006, LAND USE CHANGE COST; Kilburn VL, 2011, DIS AQUAT ORGAN, V97, P127, DOI 10.3354/dao02409; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; Lensing JR, 2006, P NATL ACAD SCI USA, V103, P15502, DOI 10.1073/pnas.0607064103; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Mac Nally R, 2014, GLOBAL ECOL BIOGEOGR, V23, P223, DOI 10.1111/geb.12104; MacArthur R.H., 1972, pvii; McCain CM, 2011, ECOL LETT, V14, P1236, DOI 10.1111/j.1461-0248.2011.01695.x; McDiarmid RW, 2005, Ecology & Evolution in the Tropics: A Herpetological Perspective, P366; McMenamin SK, 2008, P NATL ACAD SCI USA, V105, P16988, DOI 10.1073/pnas.0809090105; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Moritz C, 2012, PHILOS T R SOC B, V367, P1680, DOI 10.1098/rstb.2012.0018; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PECHMANN JHK, 1991, SCIENCE, V253, P892, DOI 10.1126/science.253.5022.892; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Picco AM, 2007, J HERPETOL, V41, P746, DOI 10.1670/07-033.1; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Pounds JA, 1997, CONSERV BIOL, V11, P1307, DOI 10.1046/j.1523-1739.1997.95485.x; Puschendorf R, 2011, CONSERV BIOL, V25, P956, DOI 10.1111/j.1523-1739.2011.01728.x; R Core Team, 2022, R LANG ENV STAT COMP; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Rouifed S, 2010, OECOLOGIA, V163, P247, DOI 10.1007/s00442-009-1528-1; Ryan MJ, 2008, BIOL CONSERV, V141, P1636, DOI 10.1016/j.biocon.2008.04.014; Santos-Barrera G, 2008, REV BIOL TROP, V56, P755; Savage J.M., 2002, AMPHIBIANS REPTILES; SCOTT N J JR, 1976, Biotropica, V8, P41, DOI 10.2307/2387818; Smith KG, 2009, ECOL LETT, V12, P1069, DOI 10.1111/j.1461-0248.2009.01363.x; Socci AM, 2005, HERPETOLOGICA, V61, P233, DOI 10.1655/04-67.1; Sodhi NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001636; Stewart Margaret M., 1996, P273; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Stuble KL, 2013, ECOL EVOL, V3, P482, DOI 10.1002/ece3.473; TAPER ML, 1995, OECOLOGIA, V101, P478, DOI 10.1007/BF00329427; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; TOFT CA, 1981, J HERPETOL, V15, P139, DOI 10.2307/1563372; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Whitfield SM, 2007, P NATL ACAD SCI USA, V104, P8352, DOI 10.1073/pnas.0611256104; Whitfield SM, 2012, BIOTROPICA, V44, P779, DOI 10.1111/j.1744-7429.2012.00872.x	64	7	9	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98351	10.1371/journal.pone.0098351	http://dx.doi.org/10.1371/journal.pone.0098351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878504	gold, Green Published, Green Submitted			2022-12-25	WOS:000338101500051
J	Tuteja, N; Banu, MSA; Huda, KMK; Gill, SS; Jain, P; Pham, XH; Tuteja, R				Tuteja, Narendra; Banu, Mst. Sufara Akhter; Huda, Kazi Md. Kamrul; Gill, Sarvajeet Singh; Jain, Parul; Xuan Hoi Pham; Tuteja, Renu			Pea p68, a DEAD-Box Helicase, Provides Salinity Stress Tolerance in Transgenic Tobacco by Reducing Oxidative Stress and Improving Photosynthesis Machinery	PLOS ONE			English	Article							RNA HELICASE; MESSENGER-RNA; SALT TOLERANCE; DNA HELICASE; PLASMODIUM-FALCIPARUM; ANTIOXIDANT MACHINERY; GENE; PROTEIN; RESPONSES; COLD	Background: The DEAD-box helicases are required mostly in all aspects of RNA and DNA metabolism and they play a significant role in various abiotic stresses, including salinity. The p68 is an important member of the DEAD-box proteins family and, in animal system, it is involved in RNA metabolism including pre-RNA processing and splicing. In plant system, it has not been well characterized. Here we report the cloning and characterization of p68 from pea (Pisum sativum) and its novel function in salinity stress tolerance in plant. Results: The pea p68 protein self-interacts and is localized in the cytosol as well as the surrounding of cell nucleus. The transcript of pea p68 is upregulated in response to high salinity stress in pea. Overexpression of p68 driven by constitutive cauliflower mosaic virus-35S promoter in tobacco transgenic plants confers enhanced tolerances to salinity stress by improving the growth, photosynthesis and antioxidant machinery. Under stress treatment, pea p68 overexpressing tobacco accumulated higher K+ and lower Na+ level than the wild-type plants. Reactive oxygen species (ROS) accumulation was remarkably regulated by the overexpression of pea p68 under salinity stress conditions, as shown from TBARS content, electrolyte leakage, hydrogen peroxide accumulation and 8-OHdG content and antioxidant enzyme activities. Conclusions: To the best of our knowledge this is the first direct report, which provides the novel function of pea p68 helicase in salinity stress tolerance. The results suggest that p68 can also be exploited for engineering abiotic stress tolerance in crop plants of economic importance.	[Tuteja, Narendra; Banu, Mst. Sufara Akhter; Huda, Kazi Md. Kamrul; Jain, Parul; Xuan Hoi Pham; Tuteja, Renu] Int Ctr Genet Engn & Biotechnol, New Delhi, India; [Gill, Sarvajeet Singh] Maharshi Dayanand Univ, Ctr Biotechnol, Stress Physiol & Mol Biol Lab, Rohtak, Haryana, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Maharshi Dayanand University	Tuteja, N (corresponding author), Int Ctr Genet Engn & Biotechnol, Aruna Asaf Ali Marg, New Delhi, India.	narendra@icgeb.res.in	Gill, Sarvajeet Singh/Q-4021-2017; Gill, Sarvajeet Singh/ABD-6031-2021	Gill, Sarvajeet Singh/0000-0002-8953-7714; Gill, Sarvajeet Singh/0000-0002-8953-7714; Pham, Xuan Hoi/0000-0002-9629-2970	Department of Biotechnology (DBT), Government of India; Department of Science and Technology (DST), Government of India; CSIR, New Delhi	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	Work on RNA/DNA metabolism and plant abiotic stress tolerance in N.T.'s laboratory is partially supported by Department of Biotechnology (DBT), Government of India and Department of Science and Technology (DST), Government of India. S.S.G. acknowledges the receipt of research grants from CSIR, New Delhi for helicase work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Cuin TA, 2008, J EXP BOT, V59, P2697, DOI 10.1093/jxb/ern128; Dang HQ, 2011, PLANT MOL BIOL, V76, P19, DOI 10.1007/s11103-011-9758-0; Ferraiuolo MA, 2004, P NATL ACAD SCI USA, V101, P4118, DOI 10.1073/pnas.0400933101; Fuller-Pace FV, 2006, NUCLEIC ACIDS RES, V34, P4206, DOI 10.1093/nar/gkl460; Gao ZX, 2010, PLANT CELL PHYSIOL, V51, P767, DOI 10.1093/pcp/pcq036; Gendra E, 2004, PLANT J, V38, P875, DOI 10.1111/j.1365-313X.2004.02095.x; Gill S. S., 2012, Improving crop resistance to abiotic stress, volume 1 & volume 2, P49; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gong ZZ, 2005, PLANT CELL, V17, P256, DOI 10.1105/tpc.104.027557; Guan QM, 2013, PLANT CELL, V25, P342, DOI 10.1105/tpc.112.108340; Hill CB, 2013, MOL PLANT, V6, P350, DOI 10.1093/mp/sss125; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Huda KMK, 2013, PLANT J, V76, P997, DOI 10.1111/tpj.12352; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Janknecht R, 2010, AM J TRANSL RES, V2, P223; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Kammel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060644; Kanai M, 2013, PLANT CELL PHYSIOL, V54, P1431, DOI 10.1093/pcp/pct091; Kant P, 2007, PLANT PHYSIOL, V145, P814, DOI 10.1104/pp.107.099895; Li DY, 2008, J EXP BOT, V59, P2133, DOI 10.1093/jxb/ern072; Lin CR, 2005, MOL CELL BIOL, V25, P7484, DOI 10.1128/MCB.25.17.7484-7493.2005; Liu HH, 2008, J EXP BOT, V59, P633, DOI 10.1093/jxb/erm355; Liu ZR, 2002, MOL CELL BIOL, V22, P5443, DOI 10.1128/MCB.22.15.5443-5450.2002; Luna CM, 2005, J EXP BOT, V56, P417, DOI 10.1093/jxb/eri039; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mhamdi A, 2010, J EXP BOT, V61, P4197, DOI 10.1093/jxb/erq282; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Munns R, 2010, METHODS MOL BIOL, V639, P371, DOI 10.1007/978-1-60761-702-0_23; Nakamura T, 2004, PLANT SCI, V167, P63, DOI 10.1016/j.plantsci.2004.03.001; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Ohtani M, 2013, PLANT CELL, V25, P2056, DOI 10.1105/tpc.113.111922; Okanami M, 1998, NUCLEIC ACIDS RES, V26, P2638, DOI 10.1093/nar/26.11.2638; Owttrim GW, 2006, NUCLEIC ACIDS RES, V34, P3220, DOI 10.1093/nar/gkl408; Pham XH, 2000, PLANT J, V24, P219, DOI 10.1046/j.1365-313x.2000.00869.x; Pradhan A, 2005, MOL BIOCHEM PARASIT, V144, P133, DOI 10.1016/j.molbiopara.2005.08.006; Pradhan A, 2005, MOL BIOCHEM PARASIT, V140, P55, DOI 10.1016/j.molbiopara.2004.12.004; Rajagopal D, 2007, MOL BREEDING, V19, P137, DOI 10.1007/s11032-006-9052-z; Sahoo RK, 2012, PLANT SIGNAL BEHAV, V7, P1042, DOI 10.4161/psb.20915; Sanan-Mishra N, 2005, P NATL ACAD SCI USA, V102, P509, DOI 10.1073/pnas.0406485102; Seki M, 2001, PLANT CELL, V13, P61, DOI 10.1105/tpc.13.1.61; Shabala S, 2009, J EXP BOT, V60, P709, DOI 10.1093/jxb/erp013; Shimizu KK, 2008, PLANT CELL PHYSIOL, V49, P1478, DOI 10.1093/pcp/pcn130; Soumen Bhattacharjee, 2012, Journal of Botany, V2012, P985298; Staiger D, 2013, PLANT CELL, V25, P3640, DOI 10.1105/tpc.113.113803; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Tuteja N, 2000, CRIT REV PLANT SCI, V19, P449; Tuteja N, 2012, IMPROVING CROP RESIS, P433; Tuteja N, 2013, PLANT J, V76, P115, DOI 10.1111/tpj.12277; Vashisht AA, 2005, PLANT J, V44, P76, DOI 10.1111/j.1365-313X.2005.02511.x; Vashisht AA, 2006, J PHOTOCH PHOTOBIO B, V84, P150, DOI 10.1016/j.jphotobiol.2006.02.010; WILLEKENS H, 1994, P NATL ACAD SCI USA, V91, P10450, DOI 10.1073/pnas.91.22.10450; Zhang ZhenHua, 2012, African Journal of Agricultural Research, V7, P19	55	45	50	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98287	10.1371/journal.pone.0098287	http://dx.doi.org/10.1371/journal.pone.0098287			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879307	Green Submitted, Green Published, gold			2022-12-25	WOS:000338101500045
J	Milani, D; Cabral-de-Mello, DC				Milani, Diogo; Cabral-de-Mello, Diogo Cavalcanti			Microsatellite Organization in the Grasshopper Abracris flavolineata (Orthoptera: Acrididae) Revealed by FISH Mapping: Remarkable Spreading in the A and B Chromosomes	PLOS ONE			English	Article							SEQUENCE REPEATS SSRS; REPETITIVE DNA; A-CHROMOSOME; EYPREPOCNEMIS-PLORANS; SEX-CHROMOSOMES; EVOLUTIONARY DYNAMICS; RIBOSOMAL DNA; ORIGIN; GENOME; HYMENOPTERA	With the aim of acquiring deeper knowledge about repetitive DNAs chromosomal organization in grasshoppers, we used fluorescent in situ hybridization (FISH) to map the distribution of 16 microsatellite repeats, including mono-, di-, tri- and tetra-nucleotides, in the chromosomes of the species Abracris flavolineata (Acrididae), which harbors B chromosome. FISH revealed two main patterns: (i) exclusively scattered signals, and (ii) scattered and specific signals, forming evident blocks. The enrichment was observed in both euchromatic and heterochromatic areas and only the motif (C)(30) was absent in heterochromatin. The A and B chromosomes were enriched with all the elements that were mapped, being observed in the B chromosome more distinctive blocks for (GA)(15) and (GAG)(10). For A complement distinctive blocks were noticed for (A)(30), (CA)(15), (CG)(15), (GA)(15), (CAC)(10), (CAA)(10), (CGG)(10), (GAA)(10), (GAC)(10) and (GATA)(8). These results revealed an intense spreading of microsatellites in the A. flavolineata genome that was independent of the A+T or G+C enrichment in the repeats. The data indicate that the microsatellites compose the B chromosome and could be involved in the evolution of this element in this species, although no specific relationship with any A chromosome was observed to discuss about its origin. The systematic analysis presented here contributes to the knowledge of repetitive DNA chromosomal organization among grasshoppers including the B chromosomes.	[Milani, Diogo; Cabral-de-Mello, Diogo Cavalcanti] UNESP Univ Estadual Paulista, Inst Biociencias IB, Dept Biol, Sao Paulo, Brazil	Universidade Estadual Paulista	Cabral-de-Mello, DC (corresponding author), UNESP Univ Estadual Paulista, Inst Biociencias IB, Dept Biol, Sao Paulo, Brazil.	mellodc@rc.unesp.br	Milani, Diogo/AAS-9977-2020; Cabral-de-Mello, Diogo Cavalcanti/E-7656-2012; Cabral-de-Mello, Diogo C/F-5328-2010	Cabral-de-Mello, Diogo Cavalcanti/0000-0002-4721-2655; Milani, Diogo/0000-0002-8886-5767	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP [2011/19481-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq [475308/2011-5]; PROPE-UNESP; PIBIC/CNPq program [27785]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PROPE-UNESP; PIBIC/CNPq program	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP (2011/19481-3), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq (475308/2011-5) and PROPE-UNESP. The scholarships of Milani D were granted by PIBIC/CNPq program (process number 27785). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelaziz M, 2007, CYTOGENET GENOME RES, V119, P143, DOI 10.1159/000109631; BEUKEBOOM LW, 1994, HEREDITY, V73, P328, DOI 10.1038/hdy.1994.140; Bidau CJ, 2004, CYTOGENET GENOME RES, V106, P295, DOI 10.1159/000079302; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Bueno D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066532; Bugrov AG, 2004, CYTOGENET GENOME RES, V106, P284, DOI 10.1159/000079300; Bugrov AG, 2007, CHROMOSOME RES, V15, P315, DOI 10.1007/s10577-007-1128-z; Butcher RDJ, 2000, INSECT MOL BIOL, V9, P375, DOI 10.1046/j.1365-2583.2000.00199.x; Cabral-de-Mello DC, 2010, HEREDITY, V104, P393, DOI 10.1038/hdy.2009.126; Cabrero J, 2007, CYTOGENET GENOME RES, V119, P135, DOI 10.1159/000109630; Cabrero J, 2003, CHROMOSOMA, V112, P207, DOI 10.1007/s00412-003-0264-2; Cabrero J, 2003, CHROMOSOME RES, V11, P375, DOI 10.1023/A:1024127525756; Cabrero J, 2008, CHROMOSOME RES, V16, P595, DOI 10.1007/s10577-008-1214-x; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; Camacho Juan Pedro M., 2005, P223, DOI 10.1016/B978-012301463-4/50006-1; Carmona A, 2013, ANN BOT-LONDON, V112, P1845, DOI 10.1093/aob/mct245; Chang SB, 2008, CHROMOSOME RES, V16, P919, DOI 10.1007/s10577-008-1249-z; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Comeron JM, 2001, CURR OPIN GENET DEV, V11, P652, DOI 10.1016/S0959-437X(00)00249-5; Cuadrado A, 2008, CYTOGENET GENOME RES, V120, P210, DOI 10.1159/000121069; Cuadrado A, 2007, CYTOGENET GENOME RES, V119, P91, DOI 10.1159/000109624; Cuadrado A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-205; Cuadrado A, 2010, CHROMOSOMA, V119, P495, DOI 10.1007/s00412-010-0273-x; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Grandi Fiorella C, 2013, Mob Genet Elements, V3, pe25674; Houben A, 2014, CELL MOL LIFE SCI, V71, P467, DOI 10.1007/s00018-013-1437-7; Munoz-Pajares A, 2011, GENETICS, V187, P853, DOI 10.1534/genetics.110.122713; Johnson PCD, 2006, MOL BIOCHEM PARASIT, V148, P210, DOI 10.1016/j.molbiopara.2006.04.011; Jones N, 2003, TRENDS PLANT SCI, V8, P417, DOI 10.1016/S1360-1385(03)00187-0; Jones RN, 2008, CYTOGENET GENOME RES, V120, P265, DOI 10.1159/000121076; Jones RN, 1995, NEW PHYTOL, V131, P411, DOI 10.1111/j.1469-8137.1995.tb03079.x; Kejnovsky E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045519; Kubat Z, 2008, GENOME, V51, P350, DOI 10.1139/G08-024; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Lopez-Flores I, 2012, GENOME DYNAM, V7, P1, DOI 10.1159/000337118; Lopez-Leon MD, 2008, CYTOGENET GENOME RES, V121, P260, DOI 10.1159/000138894; Lopez-Leon MD, 1994, CHROMOSOME RES, V2, P87, DOI 10.1007/BF01553487; Loreto V, 2008, CHROMOSOME RES, V16, P233, DOI 10.1007/s10577-007-1188-0; Marques A, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-34; Matsubara K, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-60; Messier W, 1996, NATURE, V381, P483, DOI 10.1038/381483a0; Montiel EE, 2012, GENETICA, V140, P365, DOI 10.1007/s10709-012-9686-1; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Nadir E, 1996, P NATL ACAD SCI USA, V93, P6470, DOI 10.1073/pnas.93.13.6470; NANDA I, 1990, J MOL EVOL, V30, P456, DOI 10.1007/BF02101117; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Oliveira NL, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-24; Palacios-Gimenez O, 2014, EUR J ENTOMOL, DOI 10.14411/eje.2014.000; Palestis BG, 2010, GENETICA, V138, P1181, DOI 10.1007/s10709-010-9509-1; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; Pokorna M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-90; Santos J, 2010, CHROMOSOME RES, V18, P213, DOI 10.1007/s10577-010-9112-4; Schlotterer C, 2000, CHROMOSOMA, V109, P365, DOI 10.1007/s004120000089; Shapiro JA, 2004, BIOL REV, V80, P1; Subramanian S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r13; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Terencio ML, 2013, SEX DEV, V7, P325, DOI 10.1159/000356691; Teruel M, 2009, CYTOGENET GENOME RES, V125, P286, DOI 10.1159/000235935; Teruel M, 2010, CHROMOSOMA, V119, P217, DOI 10.1007/s00412-009-0251-3; Teruel M, 2009, CHROMOSOME RES, V17, P11, DOI 10.1007/s10577-008-9001-2; THOREN PA, 1995, INSECT MOL BIOL, V4, P141, DOI 10.1111/j.1365-2583.1995.tb00019.x; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Ustinova J, 2006, J MOL EVOL, V62, P158, DOI 10.1007/s00239-005-0022-6; Vanzela Andre L. L., 2002, Cytologia (Tokyo), V67, P9, DOI 10.1508/cytologia.67.9; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; WEBB GC, 1978, CHROMOSOMA, V67, P309, DOI 10.1007/BF00285964; Wilder J, 2001, MOL BIOL EVOL, V18, P384, DOI 10.1093/oxfordjournals.molbev.a003814	68	30	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97956	10.1371/journal.pone.0097956	http://dx.doi.org/10.1371/journal.pone.0097956			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871300	Green Published, gold, Green Submitted			2022-12-25	WOS:000336858300022
J	Morton, CO; Fliesser, M; Dittrich, M; Mueller, T; Bauer, R; Kneitz, S; Hope, W; Rogers, TR; Einsele, H; Loeffler, J				Morton, Charles Oliver; Fliesser, Mirjam; Dittrich, Marcus; Mueller, Tobias; Bauer, Ruth; Kneitz, Susanne; Hope, William; Rogers, Thomas Richard; Einsele, Hermann; Loeffler, Juergen			Gene Expression Profiles of Human Dendritic Cells Interacting with Aspergillus fumigatus in a Bilayer Model of the Alveolar Epithelium/Endothelium Interface	PLOS ONE			English	Article							IN-VITRO MODEL; INNATE IMMUNE-RESPONSE; CANDIDA-ALBICANS; ANTIFUNGAL THERAPY; PULMONARY-DISEASE; HUMAN MONOCYTES; CONIDIA; LYMPHOCYTES; MOLECULES; INFECTION	The initial stages of the interaction between the host and Aspergillus fumigatus at the alveolar surface of the human lung are critical in the establishment of aspergillosis. Using an in vitro bilayer model of the alveolus, including both the epithelium (human lung adenocarcinoma epithelial cell line, A549) and endothelium (human pulmonary artery epithelial cells, HPAEC) on transwell membranes, it was possible to closely replicate the in vivo conditions. Two distinct sub-groups of dendritic cells (DC), monocyte-derived DC (moDC) and myeloid DC (mDC), were included in the model to examine immune responses to fungal infection at the alveolar surface. RNA in high quantity and quality was extracted from the cell layers on the transwell membrane to allow gene expression analysis using tailored custom-made microarrays, containing probes for 117 immunerelevant genes. This microarray data indicated minimal induction of immune gene expression in A549 alveolar epithelial cells in response to germ tubes of A. fumigatus. In contrast, the addition of DC to the system greatly increased the number of differentially expressed immune genes. moDC exhibited increased expression of genes including CLEC7A, CD209 and CCL18 in the absence of A. fumigatus compared to mDC. In the presence of A. fumigatus, both DC subgroups exhibited up-regulation of genes identified in previous studies as being associated with the exposure of DC to A. fumigatus and exhibiting chemotactic properties for neutrophils, including CXCL2, CXCL5, CCL20, and IL1B. This model closely approximated the human alveolus allowing for an analysis of the host pathogen interface that complements existing animal models of IA.	[Morton, Charles Oliver] Univ Western Sydney, Sch Sci & Hlth, Sydney, NSW, Australia; [Fliesser, Mirjam; Bauer, Ruth; Einsele, Hermann; Loeffler, Juergen] Univ Wurzburg, Med Klin & Poliklin 2, WU4i, D-97070 Wurzburg, Germany; [Dittrich, Marcus; Mueller, Tobias; Kneitz, Susanne] Univ Wurzburg, Dept Bioinformat, Bioctr, D-97070 Wurzburg, Germany; [Hope, William] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England; [Rogers, Thomas Richard] Univ Dublin Trinity Coll, Sir Patrick Res Lab, Dept Clin Microbiol, Dublin 2, Ireland	Western Sydney University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; University of Wurzburg; University of Liverpool; Trinity College Dublin	Loeffler, J (corresponding author), Univ Wurzburg, Med Klin & Poliklin 2, WU4i, D-97070 Wurzburg, Germany.	loeffler_j@ukw.de	Morton, Charles O/H-4000-2012	Morton, Charles Oliver/0000-0003-1702-0545; Rogers, Thomas/0000-0003-4336-7729; Hope, William/0000-0001-6187-878X	European Union; Development of Novel Management Strategies for Invasive Aspergillosis "MANASP'' from Sanderstiftung; Pathogenic fungi and their hosts - Networks of interaction - FungiNet [CRC/TR124]; National Institute for Health Research [CS/08/08/10] Funding Source: researchfish	European Union(European Commission); Development of Novel Management Strategies for Invasive Aspergillosis "MANASP'' from Sanderstiftung; Pathogenic fungi and their hosts - Networks of interaction - FungiNet; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by a European Union Framework 6 grant as part of a project entitled Development of Novel Management Strategies for Invasive Aspergillosis "MANASP,'' by a grant from the Sanderstiftung, and by the CRC/TR124, Pathogenic fungi and their hosts - Networks of interaction - FungiNet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Ballarin A, 2012, AM J RESP CRIT CARE, V186, P233, DOI 10.1164/rccm.201112-2142OC; Behnsen J, 2007, PLOS PATHOG, V3, P138, DOI 10.1371/journal.ppat.0030013; Bellanger AP, 2009, J MED MICROBIOL, V58, P174, DOI 10.1099/jmm.0.005488-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; CHANG MS, 1994, J BIOL CHEM, V269, P25277; Chiang LY, 2008, INFECT IMMUN, V76, P3429, DOI 10.1128/IAI.01510-07; Cortez KJ, 2006, INFECT IMMUN, V74, P2353, DOI 10.1128/IAI.74.4.2353-2365.2006; Cunha C, 2014, NEW ENGL J MED, V370, P421, DOI 10.1056/NEJMoa1211161; Gafa V, 2006, INFECT IMMUN, V74, P1480, DOI 10.1128/IAI.74.3.1480-1489.2006; Gaziano R, 2004, ANTIMICROB AGENTS CH, V48, P4414, DOI 10.1128/AAC.48.11.4414-4421.2004; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gugnani HC, 2003, FRONT BIOSCI-LANDMRK, V8, pS346, DOI 10.2741/1002; Hanley PJ, 2012, J BIOL CHEM, V287, P10650, DOI 10.1074/jbc.M111.332676; Hieshima K, 1997, J BIOL CHEM, V272, P5846, DOI 10.1074/jbc.272.9.5846; Hope WW, 2007, J INFECT DIS, V195, P455, DOI 10.1086/510535; Hope WW, 2009, MED MYCOL, V47, pS291, DOI 10.1080/13693780802510232; Hope WW, 2005, MED MYCOL, V43, pS207, DOI 10.1080/13693780400025179; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Loeffler J, 2009, J MED MICROBIOL, V58, P49, DOI 10.1099/jmm.0.003293-0; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; McDonagh A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000154; Mezger M, 2008, J INFECT DIS, V197, P924, DOI 10.1086/528694; Moalli F, 2011, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2011/830421; Morton CO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016016; Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846; Ok M, 2011, INT J MED MICROBIOL, V301, P445, DOI 10.1016/j.ijmm.2011.04.013; Oksanen J., 2016, R PACKAG; Oosthuizen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020527; Osugi Y, 2002, BLOOD, V100, P2858, DOI 10.1182/blood.V100.8.2858; Park SJ, 2010, J IMMUNOL, V185, P6190, DOI 10.4049/jimmunol.1002064; Park SJ, 2009, CLIN MICROBIOL REV, V22, P535, DOI 10.1128/CMR.00014-09; Romani L, 2008, MED MYCOL, V46, P515, DOI 10.1080/13693780801971450; Schaller M, 2005, INFECT IMMUN, V73, P2758, DOI 10.1128/IAI.73.5.2758-2765.2005; Schaller M, 2004, MICROBIOL-SGM, V150, P2807, DOI 10.1099/mic.0.27169-0; Schaller M, 2002, J MED MICROBIOL, V51, P672, DOI 10.1099/0022-1317-51-8-672; Shetron-Rama LM, 2010, MICROB PATHOGENESIS, V49, P38, DOI 10.1016/j.micpath.2010.02.004; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spinnler K, 2010, MED MYCOL, V48, P589, DOI 10.3109/13693780903420625; Sugui JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002655; Tournier JN, 2010, TRENDS MOL MED, V16, P303, DOI 10.1016/j.molmed.2010.04.006; Vermaelen K, 2005, AM J RESP CRIT CARE, V172, P530, DOI 10.1164/rccm.200410-1384SO; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942	45	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98279	10.1371/journal.pone.0098279	http://dx.doi.org/10.1371/journal.pone.0098279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870357	gold, Green Published, Green Submitted			2022-12-25	WOS:000336858300032
J	Zaal, FTJM; Bongers, RM				Zaal, Frank T. J. M.; Bongers, Raoul M.			Movements of Individual Digits in Bimanual Prehension Are Coupled into a Grasping Component	PLOS ONE			English	Article							CHANGING OBJECT SIZE; SELECTIVE PERTURBATION; VISUAL INPUT; VIEW; TRANSPORT; RESPONSES; POSITION; TASKS; THUMB; REACH	The classic understanding of prehension is that of coordinated reaching and grasping. An alternative view is that the grasping in prehension emerges from independently controlled individual digit movements (the double-pointing model). The current study tested this latter model in bimanual prehension: participants had to grasp an object between their two index fingers. Right after the start of the movement, the future end position of one of the digits was perturbed. The perturbations resulted in expected changes in the kinematics of the perturbed digit but also in adjusted kinematics in the unperturbed digit. The latter effects showed up when the end position of the right index finger was perturbed, but not when the end position of the left index finger was perturbed. Because the absence of a coupling between the digits is the core assumption of the double-pointing model, finding any perturbation effects challenges this account of prehension; the double-pointing model predicts that the unperturbed digit would be unaffected by the perturbation. The authors conclude that the movement of the digits in prehension is coupled into a grasping component.	[Zaal, Frank T. J. M.; Bongers, Raoul M.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands	University of Groningen	Zaal, FTJM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	f.t.j.m.zaal@umcg.nl	Zaal, Frank TJM/A-5578-2008; Bongers, Raoul/C-1094-2012	Zaal, Frank TJM/0000-0003-2697-3612; Bongers, Raoul/0000-0002-3518-7464				ABBS JH, 1984, J NEUROPHYSIOL, V51, P705, DOI 10.1152/jn.1984.51.4.705; Arbib M.A., 1985, EXP BRAIN RES S, V10, P111, DOI DOI 10.1007/978-3-642-70105-4_; Bongers RM, 2012, HUM MOVEMENT SCI, V31, P487, DOI 10.1016/j.humov.2011.07.014; BOOTSMA RJ, 1994, EXP BRAIN RES, V98, P535; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; CASTIELLO U, 1993, EXP BRAIN RES, V94, P163; COLE KJ, 1987, J NEUROPHYSIOL, V57, P1498, DOI 10.1152/jn.1987.57.5.1498; Diedrichsen J, 2004, EUR J NEUROSCI, V19, P1643, DOI 10.1111/j.1460-9568.2004.03242.x; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Galea MP, 2001, NEUROREPORT, V12, P2185, DOI 10.1097/00001756-200107200-00028; GENTILUCCI M, 1992, BEHAV BRAIN RES, V47, P71, DOI 10.1016/S0166-4328(05)80253-0; Haggard P, 1997, J MOTOR BEHAV, V29, P282, DOI 10.1080/00222899709600842; IBERALL T, 1986, EXPT BRAIN RES SERIE, V15, P158; Jeannerod M, 1999, HUM MOVEMENT SCI, V18, P201, DOI 10.1016/S0167-9457(99)00008-1; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; Jeannerod M., 1981, ATTENTION PERFORM, P153; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Johnson-Frey SH, 2004, VIS COGN, V11, P371, DOI 10.1080/13506280344000329; Kelso J.A., 1984, J EXPER PSYCH HUM PE, V6, P812; MARTENIUK RG, 1987, CAN J PSYCHOL, V41, P365, DOI 10.1037/h0084157; Marteniuk RG, 1999, MOTOR CONTROL, V3, P272, DOI 10.1123/mcj.3.3.272; Mon-Williams M, 2011, EXP BRAIN RES, V211, P145, DOI 10.1007/s00221-011-2659-2; Neilson PD, 1999, MOTOR CONTROL, V3, P280, DOI 10.1123/mcj.3.3.280; Newell KM, 1999, MOTOR CONTROL, V3, P285, DOI 10.1123/mcj.3.3.285; PAULIGNAN Y, 1991, EXP BRAIN RES, V87, P407; Paulignan Y, 1997, EXP BRAIN RES, V114, P226, DOI 10.1007/PL00005631; PAULIGNAN Y, 1991, EXP BRAIN RES, V83, P502; Rosenbaum DA, 2001, PSYCHOL REV, V108, P709, DOI 10.1037//0033-295X.108.4.709; Rosenbaum DA, 1999, MOTOR CONTROL, V3, P289, DOI 10.1123/mcj.3.3.289; Sartori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025203; Savelsbergh GJP, 1999, MOTOR CONTROL, V3, P298, DOI 10.1123/mcj.3.3.298; Schot WD, 2011, EXP BRAIN RES, V212, P487, DOI 10.1007/s00221-011-2756-2; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; Smeets JBJ, 1999, MOTOR CONTROL, V3, P316, DOI 10.1123/mcj.3.3.316; Smeets JBJ, 2001, EXP BRAIN RES, V139, P92, DOI 10.1007/s002210100748; Smeets JBJ, 2010, EXP BRAIN RES, V203, P339, DOI 10.1007/s00221-010-2236-0; Smeets JBJ, 2009, ADV EXP MED BIOL, V629, P499, DOI 10.1007/978-0-387-77064-2_27; Steenbergen B, 1999, MOTOR CONTROL, V3, P302, DOI 10.1123/mcj.3.3.302; Tresilian JR, 1997, EXP BRAIN RES, V115, P283, DOI 10.1007/PL00005697; van de Kamp C, 2007, EXP BRAIN RES, V182, P27, DOI 10.1007/s00221-007-0968-2; van de Kamp C, 2009, J MOTOR BEHAV, V41, P427, DOI 10.3200/35-08-033; Verheij R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033150; Wang JS, 1999, MOTOR CONTROL, V3, P307, DOI 10.1123/mcj.3.3.307; WING AM, 1983, Q J EXP PSYCHOL-A, V35, P297, DOI 10.1080/14640748308402135; ZAAL FTJM, 1995, J MOTOR BEHAV, V27, P193, DOI 10.1080/00222895.1995.9941710	45	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97790	10.1371/journal.pone.0097790	http://dx.doi.org/10.1371/journal.pone.0097790			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870948	Green Published, Green Submitted, gold			2022-12-25	WOS:000336858300019
J	Jiang, H; Stabler, SP; Allen, RH; Abman, SH; Maclean, KN				Jiang, Hua; Stabler, Sally P.; Allen, Robert H.; Abman, Steven H.; Maclean, Kenneth N.			Altered hepatic sulfur metabolism in cystathionine beta-synthase-deficient homocystinuria: regulatory role of taurine on competing cysteine oxidation pathways	FASEB JOURNAL			English	Article						glutamic-oxaloacetic transaminase; thiol metabolism; transsulfuration; cysteinesulfinate decarboxylase	IN-VITRO; DIOXYGENASE; HOMOCYSTEINE; CHLORAMINE; ENZYMES; MODEL; BIOSYNTHESIS; NEUTROPHILS; EXPRESSION; GENERATION	Cystathionine beta-synthase-deficient homocystinuria (HCU) is a serious life-threatening inborn error of sulfur metabolism with poorly understood pathogenic mechanisms. We investigated the effect of HCU on hepatic cysteine oxidation in a transgenic mouse model of the disease. Cysteine dioxygenase (CDO) protein levels were 90% repressed without any change in mRNA levels. Cysteinesulfinic acid decarboxylase (CSAD) was induced at both the mRNA (8-fold) and protein (15-fold) levels. Cysteine supplementation normalized CDO protein levels without reversing the induction of CSAD. Regulatory changes in CDO and CSAD expression were proportional to homocysteine elevation, indicating a possible threshold effect. Hepatic and blood taurine levels in HCU animals were decreased by 21 and 35%, respectively, and normalized by cysteine supplementation. Expression of the cytoplasmic (GOT1) and mitochondrial (GOT2) isoforms of glutamic-oxaloacetic transaminase were repressed in HCU animals by 86 and 30%, respectively. HCU induced regulatory changes in CSAD, CDO, and GOT1 expression were normalized by taurine supplementation, indicating that cysteine is not the only sulfur compound that regulates hepatic cysteine oxidation. Collectively, our results indicate that HCU induces significant alterations of sulfur metabolism with the potential to contribute to pathogenesis and that cysteine and taurine have the potential to serve as adjunctive treatments in this disease.	[Jiang, Hua; Abman, Steven H.; Maclean, Kenneth N.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Stabler, Sally P.; Allen, Robert H.] Univ Colorado, Hlth Sci Ctr, Dept Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Maclean, KN (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Mail Stop 8313, Aurora, CO 80045 USA.	ken.maclean@ucdenver.edu			William R. Hummel Homocystinuria Research Fund; Hayley's Heroes research fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068702] Funding Source: NIH RePORTER	William R. Hummel Homocystinuria Research Fund; Hayley's Heroes research fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	K.N.M. gratefully acknowledges financial support from the William R. Hummel Homocystinuria Research Fund and Hayley's Heroes research fund. The authors thank Professor Martha Stipanuk (Cornell University, Ithaca, NY, USA) for useful discussions and Dr. Joe Hurt (University of Colorado) for critical reading of the manuscript.	Adam S, 2013, MOL GENET METAB, V110, P454, DOI 10.1016/j.ymgme.2013.10.003; Bella DL, 1999, AM J PHYSIOL-ENDOC M, V276, pE326, DOI 10.1152/ajpendo.1999.276.2.E326; Bella DL, 1999, AM J PHYSIOL-ENDOC M, V277, pE144, DOI 10.1152/ajpendo.1999.277.1.E144; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Gupta S, 2014, FASEB J, V28, P781, DOI 10.1096/fj.13-240770; HIRAI T, 1987, ANAL BIOCHEM, V163, P339, DOI 10.1016/0003-2697(87)90233-8; HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101, DOI 10.1152/physrev.1992.72.1.101; Jerkins AA, 1998, J NUTR, V128, P1890, DOI 10.1093/jn/128.11.1890; Jiang H, 2012, MOL GENET METAB, V107, P55, DOI 10.1016/j.ymgme.2012.04.025; Keating AK, 2011, MOL GENET METAB, V103, P330, DOI 10.1016/j.ymgme.2011.04.012; Kerr TA, 2014, HEPATOL RES, V44, pE218, DOI 10.1111/hepr.12230; Lee JI, 2004, J NUTR BIOCHEM, V15, P112, DOI 10.1016/j.jnutbio.2003.10.005; Lee PJ, 2007, J INHERIT METAB DIS, V30, P35, DOI 10.1007/s10545-006-0452-3; Maclean KN, 2012, J BIOL CHEM, V287, P31994, DOI 10.1074/jbc.M112.355172; Maclean KN, 2012, MOL GENET METAB, V105, P395, DOI 10.1016/j.ymgme.2011.11.190; Maclean KN, 2010, MOL GENET METAB, V101, P153, DOI 10.1016/j.ymgme.2010.06.010; Maclean KN, 2010, MOL GENET METAB, V101, P163, DOI 10.1016/j.ymgme.2010.06.007; Maclean KN, 2002, HUM MUTAT, V19, P641, DOI 10.1002/humu.10089; Marcinkiewicz J, 1995, J LEUKOCYTE BIOL, V58, P667, DOI 10.1002/jlb.58.6.667; McCoy JG, 2006, P NATL ACAD SCI USA, V103, P3084, DOI 10.1073/pnas.0509262103; Mudd S., 2001, METABOLIC MOL BASES, P2007; PANTEGHINI M, 1990, CLIN BIOCHEM, V23, P311, DOI 10.1016/0009-9120(90)80062-N; Qusti S, 2000, CELL BIOL TOXICOL, V16, P243, DOI 10.1023/A:1007634110983; RENTSCHLER LA, 1986, COMP BIOCHEM PHYS B, V84, P319, DOI 10.1016/0305-0491(86)90084-2; Sadiq MA, 2013, SEMIN OPHTHALMOL, V28, P313, DOI 10.3109/08820538.2013.825276; Schiff M, 2012, NEUROPEDIATRICS, V43, P295, DOI 10.1055/s-0032-1329883; STABLER SP, 1993, BLOOD, V81, P3404; Stipanuk MH, 2011, J INHERIT METAB DIS, V34, P17, DOI 10.1007/s10545-009-9006-9; STURMAN JA, 1993, PHYSIOL REV, V73, P119, DOI 10.1152/physrev.1993.73.1.119; Tang XW, 1997, J NEUROSCI, V17, P6947; Tsuboyama-Kasaoka N, 2006, ENDOCRINOLOGY, V147, P3276, DOI 10.1210/en.2005-1007; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; Wojtecka-Lukasik E, 2006, INFLAMM RES, V55, pS17, DOI 10.1007/s00011-005-0021-5; Wojtecka-Lukasik E, 2005, INFLAMM RES, V54, pS21, DOI 10.1007/s00011-004-0409-3; Wu JY, 1998, ADV EXP MED BIOL, V442, P339; Ye S, 2007, J BIOL CHEM, V282, P3391, DOI 10.1074/jbc.M609337200	36	17	17	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					4044	4054		10.1096/fj.14-253633	http://dx.doi.org/10.1096/fj.14-253633			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24891521	Green Published			2022-12-25	WOS:000340845900022
J	Adams, VM; Pressey, RL; Stoeckl, N				Adams, Vanessa M.; Pressey, Robert L.; Stoeckl, Natalie			Estimating Landholders' Probability of Participating in a Stewardship Program, and the Implications for Spatial Conservation Priorities	PLOS ONE			English	Article							WILLINGNESS-TO-SELL; BIODIVERSITY CONSERVATION; DESIGN; COSTS; OPPORTUNITY; MANAGEMENT; PAYMENTS; AUCTIONS; SCALE	The need to integrate social and economic factors into conservation planning has become a focus of academic discussions and has important practical implications for the implementation of conservation areas, both private and public. We conducted a survey in the Daly Catchment, Northern Territory, to inform the design and implementation of a stewardship payment program. We used a choice model to estimate the likely level of participation in two legal arrangements conservation covenants and management agreements - based on payment level and proportion of properties required to be managed. We then spatially predicted landholders' probability of participating at the resolution of individual properties and incorporated these predictions into conservation planning software to examine the potential for the stewardship program to meet conservation objectives. We found that the properties that were least costly, per unit area, to manage were also the least likely to participate. This highlights a tension between planning for a cost-effective program and planning for a program that targets properties with the highest probability of participation.	[Adams, Vanessa M.; Pressey, Robert L.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Adams, Vanessa M.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Adams, Vanessa M.] Charles Darwin Univ, Northern Australia Natl Environm Res Program Hub, Darwin, NT 0909, Australia; [Stoeckl, Natalie] James Cook Univ, Sch Business, Townsville, Qld 4811, Australia; [Stoeckl, Natalie] James Cook Univ, Cairns Inst, Townsville, Qld 4811, Australia	James Cook University; Charles Darwin University; Charles Darwin University; James Cook University; James Cook University	Adams, VM (corresponding author), James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	vanessa.adams@cdu.edu.au	Stoeckl, Natalie/AAU-8562-2020; Adams, Vanessa M./A-3834-2012; Stoeckl, Natalie E/B-2000-2012	Stoeckl, Natalie/0000-0001-5899-4771; Adams, Vanessa M./0000-0002-3509-7901; Stoeckl, Natalie E/0000-0001-5899-4771	Nature Conservancy; Thomas Foundation; Australian Research Council	Nature Conservancy; Thomas Foundation; Australian Research Council(Australian Research Council)	VMA acknowledges funding for field work through The Nature Conservancy and The Thomas Foundation. RLP acknowledges support from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams VM, 2013, LAND USE POLICY, V30, P114, DOI 10.1016/j.landusepol.2012.03.009; Adams VM, 2012, BIOL CONSERV, V148, P44, DOI 10.1016/j.biocon.2012.01.064; Adams VM, 2013, ENVIRON RES LETT, V8, DOI [10.1088/1748-9326/1088/1082/025018, DOI 10.1088/1748-9326/1088/1082/025018.]; [Anonymous], [No title captured]; Armsworth PR, 2011, BIOL CONSERV, V144, P423, DOI 10.1016/j.biocon.2010.09.026; Armsworth PR, 2008, CONSERV LETT, V1, P182, DOI 10.1111/j.1755-263X.2008.00028.x; Armsworth PR, 2006, P NATL ACAD SCI USA, V103, P5403, DOI 10.1073/pnas.0505278103; Ban NC, 2013, FRONT ECOL ENVIRON, V11, P194, DOI 10.1890/110205; Ban NC, 2011, CONSERV LETT, V4, P241, DOI 10.1111/j.1755-263X.2011.00171.x; Broch SW, 2012, ENVIRON RESOUR ECON, V51, P561, DOI 10.1007/s10640-011-9512-8; Bruner AG, 2004, BIOSCIENCE, V54, P1119, DOI 10.1641/0006-3568(2004)054[1119:FCASOM]2.0.CO;2; Bryan BA, 2008, J ENVIRON MANAGE, V88, P1175, DOI 10.1016/j.jenvman.2007.06.003; Claassen R, 2008, ECOL ECON, V65, P737, DOI 10.1016/j.ecolecon.2007.07.032; Commonwealth of Australia, 2008, CAR OUR COUNTR OUTC; DERM, 2007, DELB AGR STAT RUR LE; Dillman D.A., 2008, INTERNET PHONE MAIL, V3rd ed.; Ferraro PJ, 2008, ECOL ECON, V65, P810, DOI 10.1016/j.ecolecon.2007.07.029; Fitzsimons JA, 2004, ENVIRON SCI POLICY, V7, P477, DOI 10.1016/j.envsci.2004.08.005; FITZSIMONS JA, 2006, ENV PLANNING LAW J, V23, P365; Game ET, 2011, CONSERV LETT, V4, P38, DOI 10.1111/j.1755-263X.2010.00140.x; Guerrero AM, 2010, CONSERV LETT, V3, P332, DOI 10.1111/j.1755-263X.2010.00116.x; Hajkowicz S, 2007, AUST J AGR RESOUR EC, V51, P39, DOI 10.1111/j.1467-8489.2007.00345.x; Hensher D.A, 2006, APPL CHOICE ANAL PRI; Horne P, 2006, SILVA FENN, V40, P169, DOI 10.14214/sf.359; Horne P, 2005, FOREST ECOL MANAG, V207, P189, DOI 10.1016/j.foreco.2004.10.026; Jack BK, 2009, CONSERV BIOL, V23, P359, DOI 10.1111/j.1523-1739.2008.01086.x; Jacobsen JB, 2010, ECOL ECON, V69, P1532, DOI 10.1016/j.ecolecon.2010.02.013; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Knight AT, 2011, BIOL CONSERV, V144, P2623, DOI 10.1016/j.biocon.2011.07.013; Lombard AT, 2010, ECOL SOC, V15; McCrea-Strub A, 2011, MAR POLICY, V35, P1, DOI 10.1016/j.marpol.2010.07.001; Moon K, 2011, J RURAL STUD, V27, P331, DOI 10.1016/j.jrurstud.2011.04.001; Moon K, 2011, CONSERV BIOL, V25, P493, DOI 10.1111/j.1523-1739.2010.01639.x; Nicholson E, 2006, ECOL LETT, V9, P1049, DOI 10.1111/j.1461-0248.2006.00956.x; NRETAS, 2009, REC SIT CONS SIGN BI; Orme B, 1998, SAMPLE SIZE ISSUES C; Polasky S, 2008, P NATL ACAD SCI USA, V105, P6505, DOI 10.1073/pnas.0802815105; Pressey RL, 2013, BIOL CONSERV, V166, P155, DOI 10.1016/j.biocon.2013.06.025; Rose JM, 2013, TRANSPORTATION, V40, P1021, DOI 10.1007/s11116-013-9451-z; Rouget M, 2006, CONSERV BIOL, V20, P549, DOI 10.1111/j.1523-1739.2006.00297.x; Seddon JA, 2010, CONSERV LETT, V3, P415, DOI 10.1111/j.1755-263X.2010.00135.x; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; Stoneham G, 2003, AUST J AGR RESOUR EC, V47, P477, DOI 10.1111/j.1467-8489.2003.t01-1-00224.x; UNEP, 2010, 10 M C PAR CONV BIOL; Watts M. E, 2009, ENVIRON MODELL SOFTW, DOI [10.1016/j.envsoft.2009.06.005, DOI 10.1016/J.ENVS0FT.2009.06.005, DOI 10.1016/J.ENVSOFT.2009.06.005]; Woinarski JCZ, 2013, LAND, V2, P20, DOI 10.3390/land2010020; Zander KK, 2010, ECOL ECON, V69, P2417, DOI 10.1016/j.ecolecon.2010.07.010; Zander KK, 2010, J ENVIRON MANAGE, V91, P2519, DOI 10.1016/j.jenvman.2010.07.012	49	31	31	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97941	10.1371/journal.pone.0097941	http://dx.doi.org/10.1371/journal.pone.0097941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24892520	Green Accepted, Green Published, gold			2022-12-25	WOS:000336911400027
J	Johnston-Cox, H; Eisenstein, AS; Koupenova, M; Carroll, S; Ravid, K				Johnston-Cox, Hillary; Eisenstein, Anna S.; Koupenova, Milka; Carroll, Shannon; Ravid, Katya			The Macrophage A2b Adenosine Receptor Regulates Tissue Insulin Sensitivity	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MOUSE PERITONEAL-MACROPHAGES; CORONARY-HEART-DISEASE; ADIPOSE-TISSUE; TNF-ALPHA; HEPATIC STEATOSIS; GENE-EXPRESSION; A(2B) RECEPTORS; HUMAN OBESITY; RESISTANCE	High fat diet (HFD)-induced type 2 diabetes continues to be an epidemic with significant risk for various pathologies. Previously, we identified the A2b adenosine receptor (A2bAR), an established regulator of inflammation, as a regulator of HFD-induced insulin resistance. In particular, HFD was associated with vast upregulation of liver A2bAR in control mice, and while mice lacking this receptor showed augmented liver inflammation and tissue insulin resistance. As the A2bAR is expressed in different tissues, here, we provide the first lead to cellular mechanism by demonstrating that the receptor's influence on tissue insulin sensitivity is mediated via its expression in macrophages. This was shown using a newly generated transgenic mouse model expressing the A2bAR gene in the macrophage lineage on an otherwise A2bAR null background. Reinstatement of macrophage A2bAR expression in A2bAR null mice fed HFD restored insulin tolerance and tissue insulin signaling to the level of control mice. The molecular mechanism for this effect involves A2bAR-mediated changes in cyclic adenosine monophosphate in macrophages, reducing the expression and release of inflammatory cytokines, which downregulate insulin receptor-2. Thus, our results illustrate that macrophage A2bAR signaling is needed and sufficient for relaying the protective effect of the A2bAR against HFD-induced tissue inflammation and insulin resistance in mice.	[Johnston-Cox, Hillary; Eisenstein, Anna S.; Koupenova, Milka; Ravid, Katya] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Koupenova, Milka; Carroll, Shannon; Ravid, Katya] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Johnston-Cox, Hillary; Eisenstein, Anna S.; Koupenova, Milka; Ravid, Katya] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Ravid, Katya] Boston Univ, Sch Med, Evans Ctr Interdisciplinary Biomed Res, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University	Ravid, K (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	kravid@bu.edu	Koupenova, Milka/L-3576-2019		National Heart, Lung and Blood Institute [HL93149]; Boston Nutrition Obesity Research Center [DK046200]; National Institutes of Health [HL007969, HL007224]; National Institutes of Diabetes and Digestive and Kidney Diseases NRSA F30 award [DK098834]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007224, R01HL093149, T32HL007969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK098834, P30DK046200] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston Nutrition Obesity Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Diabetes and Digestive and Kidney Diseases NRSA F30 award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Heart, Lung and Blood Institute Grant (HL93149) to KR, and by the Boston Nutrition Obesity Research Center (DK046200) to K. R., an established Investigator with the American Heart Association. H.J.C., A. E., were supported by Cardiovascular Training Grant from the National Institutes of Health (HL007969). A. E was supported by the National Institutes of Diabetes and Digestive and Kidney Diseases NRSA F30 award (DK098834). M. K. was supported by Cardiovascular Training Grant from the National Institutes of Health (HL007969 and HL007224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; Bouzakri K, 2009, J BIOL CHEM, V284, P27892, DOI 10.1074/jbc.M109.048058; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Chen HJ, 2009, EXP HEMATOL, V37, P533, DOI 10.1016/j.exphem.2009.02.001; Csoka B, 2014, DIABETES, V63, P850, DOI 10.2337/db13-0573; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; Donath MY, 2011, ENDOCRINOLOGY, V152, P4005, DOI 10.1210/en.2011-1691; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eigler A, 1998, J LEUKOCYTE BIOL, V63, P101, DOI 10.1002/jlb.63.1.101; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Endo M, 2007, EXP BIOL MED, V232, P614; ENDRES S, 1991, IMMUNOLOGY, V72, P56; Enjyoji K, 2008, DIABETES, V57, P2311, DOI 10.2337/db07-1265; Figler RA, 2011, DIABETES, V60, P669, DOI 10.2337/db10-1070; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Fukuda D, 2012, P NATL ACAD SCI USA, V109, pE1868, DOI 10.1073/pnas.1116889109; Gough PJ, 2001, IMMUNOLOGY, V103, P351, DOI 10.1046/j.1365-2567.2001.01256.x; Greaves DR, 1998, GENOMICS, V54, P165, DOI 10.1006/geno.1998.5546; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; HOTAMISLIGIL GS, 1994, DIABETES, V43, P1271, DOI 10.2337/diabetes.43.11.1271; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Johnston-Cox H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040584; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; KATAKAMI Y, 1988, IMMUNOLOGY, V64, P719; Koupenova M, 2012, CIRCULATION, V125, P354, DOI 10.1161/CIRCULATIONAHA.111.057596; Kreckler LM, 2006, J PHARMACOL EXP THER, V317, P172, DOI 10.1124/jpet.105.096016; Lawler JF, 1998, J BIOL CHEM, V273, P5053, DOI 10.1074/jbc.273.9.5053; Liang CP, 2007, CIRC RES, V100, P1546, DOI 10.1161/CIRCRESAHA.107.152165; Liang CP, 2004, J CLIN INVEST, V113, P764, DOI [10.1172/JCI200419528, 10.1172/JCI19528]; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; O'Reilly D, 2003, J BIOL CHEM, V278, P21909, DOI 10.1074/jbc.M212150200; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Orpana HM, 2010, OBESITY, V18, P214, DOI 10.1038/oby.2009.191; Papackova Z, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-22; Paz K, 1997, J BIOL CHEM, V272, P29911, DOI 10.1074/jbc.272.47.29911; Poulain-Godefroy O, 2008, AM J PHYSIOL-REG I, V295, pR1, DOI 10.1152/ajpregu.00926.2007; PULFORD KAF, 1990, INT IMMUNOL, V2, P973, DOI 10.1093/intimm/2.10.973; Qatanani M, 2009, J CLIN INVEST, V119, P531, DOI 10.1172/JCI37273; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shi C, 2008, BLOOD, V112, P4699, DOI 10.1182/blood-2008-01-137018; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Tanaka M, 2008, INFLAMM RES, V57, P593, DOI 10.1007/s00011-008-7171-1; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; VERGHESE MW, 1995, J PHARMACOL EXP THER, V272, P1313; WARNKE RA, 1989, AM J PATHOL, V135, P1089; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933	61	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98775	10.1371/journal.pone.0098775	http://dx.doi.org/10.1371/journal.pone.0098775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892847	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400091
J	Raza, SEA; Smith, HK; Clarkson, GJJ; Taylor, G; Thompson, AJ; Clarkson, J; Rajpoot, NM				Raza, Shan-e-Ahmed; Smith, Hazel K.; Clarkson, Graham J. J.; Taylor, Gail; Thompson, Andrew J.; Clarkson, John; Rajpoot, Nasir M.			Automatic Detection of Regions in Spinach Canopies Responding to Soil Moisture Deficit Using Combined Visible and Thermal Imagery	PLOS ONE			English	Article							STOMATAL CONDUCTANCE; STRESS; TEMPERATURE; THERMOGRAPHY; CLOSURE	Thermal imaging has been used in the past for remote detection of regions of canopy showing symptoms of stress, including water deficit stress. Stress indices derived from thermal images have been used as an indicator of canopy water status, but these depend on the choice of reference surfaces and environmental conditions and can be confounded by variations in complex canopy structure. Therefore, in this work, instead of using stress indices, information from thermal and visible light imagery was combined along with machine learning techniques to identify regions of canopy showing a response to soil water deficit. Thermal and visible light images of a spinach canopy with different levels of soil moisture were captured. Statistical measurements from these images were extracted and used to classify between canopies growing in well-watered soil or under soil moisture deficit using Support Vector Machines (SVM) and Gaussian Processes Classifier (GPC) and a combination of both the classifiers. The classification results show a high correlation with soil moisture. We demonstrate that regions of a spinach crop responding to soil water deficit can be identified by using machine learning techniques with a high accuracy of 97%. This method could, in principle, be applied to any crop at a range of scales.	[Raza, Shan-e-Ahmed; Rajpoot, Nasir M.] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England; [Smith, Hazel K.; Taylor, Gail] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England; [Clarkson, Graham J. J.] Vitacress Salads Ltd, Lower Link Farm, St Mary Bourne, Andover, England; [Thompson, Andrew J.] Cranfield Univ, Soil & Agri Food Inst, Sch Appl Sci, Bedford, England; [Clarkson, John] Univ Warwick, Sch Life Sci, Wellsbourne, Warwick, England; [Rajpoot, Nasir M.] Qatar Univ, Dept Comp Sci & Engn, Doha, Qatar	University of Warwick; University of Southampton; Cranfield University; University of Warwick; Qatar University	Raza, SEA (corresponding author), Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England.	s.e.a.raza@warwick.ac.uk; n.m.rajpoot@warwick.ac.uk	Thompson, Andrew J./AAF-3017-2020	Thompson, Andrew J./0000-0002-7419-3402; Taylor, Gail/0000-0001-8470-6390; Rajpoot, Nasir/0000-0002-4706-1308; Clarkson, John/0000-0001-5931-933X; Raza, Shan E Ahmed/0000-0002-1097-1738	Horticultural Development Company (HDC); Department of Computer Science, University of Warwick; Vitacress Salads Ltd.; Biotechnology and Biological Sciences Research Council (BBSRC)	Horticultural Development Company (HDC); Department of Computer Science, University of Warwick; Vitacress Salads Ltd.; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	S.E.A.R was funded by the Horticultural Development Company (HDC) and by the Department of Computer Science, University of Warwick. Work on sustainable water use in salad crops in the laboratory of GT is funded by Vitacress Salads Ltd. with the award of a PhD to H. K. S. Research on baby leaf salads in the lab of Gail Taylor is funded by Biotechnology and Biological Sciences Research Council (BBSRC). Field experiments were designed with the help of Vitacress Salads Ltd UK. All the other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alchanatis V, 2010, PRECIS AGRIC, V11, P27, DOI 10.1007/s11119-009-9111-7; Bazi Y, 2010, IEEE T GEOSCI REMOTE, V48, P186, DOI 10.1109/TGRS.2009.2023983; Cohen Y, 2012, PRECIS AGRIC, V13, P123, DOI 10.1007/s11119-011-9232-7; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Ebden M., 2008, GAUSSIAN PROCESSES R; Eberius M, 2011, 2 INT PLANT PHEN S; Eikvil L., 1993, OPTICAL CHARACTER RE; FUCHS M, 1990, THEOR APPL CLIMATOL, V42, P253, DOI 10.1007/BF00865986; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Grant OM, 2007, J EXP BOT, V58, P815, DOI 10.1093/jxb/erl153; Grant OM, 2006, PHYSIOL PLANTARUM, V127, P507, DOI 10.1111/j.1399-3054.2006.00686.x; Hackl H, 2012, J AGRON CROP SCI, V198, P415, DOI 10.1111/j.1439-037X.2012.00512.x; Haranadh G, 2008, IEEE IJCNN, P2195, DOI 10.1109/IJCNN.2008.4634101; IDSO SB, 1981, AGR METEOROL, V24, P45, DOI 10.1016/0002-1571(81)90032-7; Jackson R. D., 1982, Advances in Irrigation, V1, P43; JACKSON RD, 1981, WATER RESOUR RES, V17, P1133, DOI 10.1029/WR017i004p01133; Jones, 1992, PLANTS MICROCLIMATES; Jones HG, 1999, PLANT CELL ENVIRON, V22, P1043, DOI 10.1046/j.1365-3040.1999.00468.x; Jones HG, 1999, AGR FOREST METEOROL, V95, P139, DOI 10.1016/S0168-1923(99)00030-1; Jones HG, 2002, J EXP BOT, V53, P2249, DOI 10.1093/jxb/erf083; Leinonen I, 2006, PLANT CELL ENVIRON, V29, P1508, DOI 10.1111/j.1365-3040.2006.01528.x; Leinonen I, 2004, J EXP BOT, V55, P1423, DOI 10.1093/jxb/erh146; Lopez A, 2012, SCI HORTIC-AMSTERDAM, V137, P49, DOI 10.1016/j.scienta.2012.01.022; Moller M, 2007, J EXP BOT, V58, P827, DOI 10.1093/jxb/erl115; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; PIERCE LL, 1990, PHOTOGRAMM ENG REM S, V56, P579; Rasmussen CE, 2004, LECT NOTES ARTIF INT, V3176, P63, DOI 10.1007/978-3-540-28650-9_4; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Reinert S, 2012, TREE PHYSIOL, V32, P294, DOI 10.1093/treephys/tps017; Stoll M, 2007, J INT SCI VIGNE VIN, V41, P77	30	24	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97612	10.1371/journal.pone.0097612	http://dx.doi.org/10.1371/journal.pone.0097612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892284	Green Published, Green Accepted, gold			2022-12-25	WOS:000336911400015
J	Donat, U; Rother, J; Schafer, S; Hess, M; Hartl, B; Kober, C; Langbein-Laugwitz, J; Stritzker, J; Chen, NG; Aguilar, RJ; Weibel, S; Szalay, AA				Donat, Ulrike; Rother, Juliane; Schaefer, Simon; Hess, Michael; Haertl, Barbara; Kober, Christina; Langbein-Laugwitz, Johanna; Stritzker, Jochen; Chen, Nanhai G.; Aguilar, Richard J.; Weibel, Stephanie; Szalay, Aladar A.			Characterization of Metastasis Formation and Virotherapy in the Human C33A Cervical Cancer Model	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; HUMAN PROSTATE-CANCER; HUMAN BREAST-CANCER; NUDE-MOUSE MODEL; VACCINIA VIRUS; IN-VIVO; ORTHOTOPIC MODEL; CARCINOMA; TUMORS; MICE	More than 90% of cancer mortalities are due to cancer that has metastasized. Therefore, it is crucial to intensify research on metastasis formation and therapy. Here, we describe for the first time the metastasizing ability of the human cervical cancer cell line C33A in athymic nude mice after subcutaneous implantation of tumor cells. In this model, we demonstrated a steady progression of lumbar and renal lymph node metastases during tumor development. Besides predominantly occurring lymphatic metastases, we visualized the formation of hematogenous metastases utilizing red fluorescent protein (RFP) expressing C33A-RFP cells. RFP positive cancer cells were found migrating in blood vessels and forming micrometastases in lungs of tumor-bearing mice. Next, we set out to analyze the influence of oncolytic virotherapy in the C33A-RFP model and demonstrated an efficient virus-mediated reduction of tumor size and metastatic burden. These results suggest the C33A-RFP cervical cancer model as a new platform to analyze cancer metastases as well as to test novel treatment options to combat metastases.	[Donat, Ulrike; Rother, Juliane; Schaefer, Simon; Hess, Michael; Haertl, Barbara; Kober, Christina; Langbein-Laugwitz, Johanna; Stritzker, Jochen; Weibel, Stephanie; Szalay, Aladar A.] Univ Wurzburg, Inst Biochem, Wurzburg, Germany; [Stritzker, Jochen; Chen, Nanhai G.; Aguilar, Richard J.; Szalay, Aladar A.] Genelux Corp, San Diego Sci Ctr, San Diego, CA USA; [Chen, Nanhai G.; Szalay, Aladar A.] Univ Calif San Diego, Rebecca & John Moores Comprehens Canc Ctr, Dept Radiat Med & Appl Sci, San Diego, CA 92103 USA; [Haertl, Barbara; Szalay, Aladar A.] Genelux GmbH, Bernried, Germany; [Szalay, Aladar A.] Univ Wurzburg, Rudolph Virchow Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Szalay, Aladar A.] Univ Wurzburg, Inst Mol Infect Biol, D-97070 Wurzburg, Germany	University of Wurzburg; University of California System; University of California San Diego; University of Wurzburg; University of Wurzburg	Szalay, AA (corresponding author), Univ Wurzburg, Inst Biochem, Rontgenring 11, Wurzburg, Germany.	aaszalay@genelux.com			Research and Development Division of Genelux Corporation, San Diego, USA; Genelux Corp.; Genelux Corporation	Research and Development Division of Genelux Corporation, San Diego, USA; Genelux Corp.; Genelux Corporation	This work was supported by the Research and Development Division of Genelux Corporation, San Diego, USA, and a Service Grant to the University of Wuerzburg, Germany funded by Genelux Corp. UD and SW received postdoctoral fellowship. JR, CK, SS, and MH received a graduate fellowship from Genelux Corporation awarded to the University of Wuerzburg. AAS, JS, NGC, and RJA are salaried employees of Genelux Corporation and have financial interests in Genelux Corporation. BH is a salaried employee of Genelux GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZL, 1999, CLIN EXP METASTAS, V17, P265, DOI 10.1023/A:1006654600095; Bastide C, 2002, PROSTATE CANCER P D, V5, P311, DOI 10.1038/sj.pcan.4500606; Cairns RA, 2004, CLIN EXP METASTAS, V21, P275, DOI 10.1023/B:CLIN.0000037729.75981.9e; Cairns RA, 2004, CANCER RES, V64, P2054, DOI 10.1158/0008-5472.CAN-03-3196; Chen JM, 2002, NUTR CANCER, V43, P187, DOI 10.1207/S15327914NC432_9; CREDE R H, 1949, Cinci J Med, V30, P139; Donat U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045942; Duan P, 2012, EUR J GYNAECOL ONCOL, V33, P472; Fujihara T, 1998, CLIN EXP METASTAS, V16, P389; Gentschev I, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/489759; Gu J, 2003, DIS COLON RECTUM, V46, P1659, DOI 10.1007/BF02660772; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P745, DOI 10.1023/B:CLIN.0000006817.25962.87; Karkkainen MJ, 2002, NAT CELL BIOL, V4, pE2, DOI 10.1038/ncb0102-e2; Kelly KJ, 2008, HUM GENE THER, V19, P774, DOI 10.1089/hum.2008.036; Khanna C, 2005, CARCINOGENESIS, V26, P513, DOI 10.1093/carcin/bgh261; Kim JH, 2006, JNCI-J NATL CANCER I, V98, P1482, DOI 10.1093/jnci/djj397; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; Leong SPL, 2007, CANCER TREAT RES, P209; Li XM, 2002, CLIN EXP METASTAS, V19, P347, DOI 10.1023/A:1015510207431; Lin SF, 2008, J CLIN ENDOCR METAB, V93, P4403, DOI 10.1210/jc.2008-0316; Mountain CF, 1997, CHEST, V111, P1718, DOI 10.1378/chest.111.6.1718; Pearson HB, 2012, MODELING METASTASIS; Reinhardt MJ, 2001, RADIOLOGY, V218, P776, DOI 10.1148/radiology.218.3.r01mr19776; Sleeman JP, 2000, RECENT RESULTS CANC, V157, P55; SMITH JA, 1981, J UROLOGY, V126, P591, DOI 10.1016/S0022-5347(17)54638-8; Stubenrauch F, 2007, INT J CANCER, V121, P2284, DOI 10.1002/ijc.22907; Sugarbaker P H, 1981, Curr Probl Surg, V18, P753, DOI 10.1016/S0011-3840(81)80010-X; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Triest JA, 1998, CLIN CANCER RES, V4, P2009; Tsutsumi S, 2001, CANCER LETT, V169, P77, DOI 10.1016/S0304-3835(00)00622-4; Unno Y, 2005, CLIN CANCER RES, V11, P4553, DOI 10.1158/1078-0432.CCR-04-2610; Vaha-Koskela MJV, 2007, CANCER LETT, V254, P178, DOI 10.1016/j.canlet.2007.02.002; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Weibel S, 2008, CELL MICROBIOL, V10, P1235, DOI 10.1111/j.1462-5822.2008.01122.x; Weibel S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-68; Yamaguchi K, 2000, J EXP CLIN CANC RES, V19, P113; Yu YA, 2009, MOL CANCER THER, V8, P141, DOI 10.1158/1535-7163.MCT-08-0533; Zhang Q, 2007, CANCER RES, V67, P10038, DOI 10.1158/0008-5472.CAN-07-0146; Zhang Q, 2009, MOL GENET GENOMICS, V282, P417, DOI 10.1007/s00438-009-0475-1	39	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98533	10.1371/journal.pone.0098533	http://dx.doi.org/10.1371/journal.pone.0098533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887184	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300077
J	Dong, ZX; Xu, J; Zhang, HB; Dou, Z; Mi, GD; Ruan, YH; Shen, LM; Min, XD; Lan, GH; Li, F; Li, T; Ning, Z; Wu, GH; She, M; Wu, ZY				Dong, Zhenxin; Xu, Jie; Zhang, Hongbo; Dou, Zhi; Mi, Guodong; Ruan, Yuhua; Shen, Limei; Min, Xiangdong; Lan, Guanghua; Li, Fan; Li, Tian; Ning, Zhen; Wu, Guohui; She, Min; Wu, Zunyou		China Natl HIV Prevention Study Gr	HIV Incidence and Risk Factors in Chinese Young Men Who Have Sex with Men-A Prospective Cohort Study	PLOS ONE			English	Article							HEPATITIS-B; SYPHILIS; PREVALENCE; INFECTIONS; BEHAVIOR; VIRUS; EPIDEMIC; PROVINCE; SPREAD	Objectives: To assess HIV incidence and its associated risk factors among young men who have sex with men (YMSM) in urban areas, China. Design: The study used a prospective cohort study design and standard diagnostic tests. Methods: A twelve-month prospective cohort study was conducted among YMSM (18-25 years old) in 8 large cities in China. The participants were recruited via snowball sampling. A total of 1102 HIV-negative YMSM completed baseline assessment, 878 YMSM participants completed 6-month follow-up, and 902 completed 12-month follow-up. HIV was screened by an enzyme-linked immunosorbent assay and confirmed with Western Blot. Syphilis was screened via rapid plasma reagent and confirmed by treponema pallidum particle agglutination assay. Results: 78 HIV seroconversions were identified within 1168.4 person-year observations yielding an incidence rate of 6.7 per 100 person-years. HIV seroconversion was associated with non-student status (RR = 2.61, 90% CI = 1.3-5.26), low HIV transmission knowledge (RR = 8.87, 90% CI = 2.16-36.43), and syphilis infection (RR = 5.04, 90% CI = 2.57-9.90). Conclusions: Incidence of HIV among YMSM is high in urban areas of China. Interventions measures are required to contain the HIV epidemic within this population.	[Dong, Zhenxin; Zhang, Hongbo; She, Min] Anhui Med Univ, Sch Publ Hlth, Hefei, Anhui, Peoples R China; [Xu, Jie; Dou, Zhi; Mi, Guodong; Ruan, Yuhua; Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Shen, Limei] Guizhou Prov Ctr Dis Control & Prevent, Xingyi, Guizhou, Peoples R China; [Min, Xiangdong] Yunnan Prov Ctr Dis Control & Prevent, Beijing, Yunnan, Peoples R China; [Lan, Guanghua] Guangxi Prov Ctr Dis Control & Prevent, Nanning, Guangxi, Peoples R China; [Li, Fan] Xinjiang Ctr Dis Control & Prevent, Xinjiang, Peoples R China; [Li, Tian] Sichuan Prov Ctr Dis Control & Prevent, Chengdu, Sichuan, Peoples R China; [Ning, Zhen] Shanghai Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Wu, Guohui] Chongqing Ctr Dis Control & Prevent, Chongqing, Peoples R China	Anhui Medical University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Shanghai Center for Disease Control & Prevention	Zhang, HB (corresponding author), Anhui Med Univ, Sch Publ Hlth, Hefei, Anhui, Peoples R China.	zhhongbo62@163.com; wuzy@263.net		Liu, Enwu/0000-0003-2580-3523	National Science and Technology Major Project on Prevention and Treatment of Major Infectious Diseases including AIDS and Viral Hepatitis from the Chinese Ministry of Health [2008ZX10001-016]	National Science and Technology Major Project on Prevention and Treatment of Major Infectious Diseases including AIDS and Viral Hepatitis from the Chinese Ministry of Health	This study was supported by the National Science and Technology Major Project on Prevention and Treatment of Major Infectious Diseases including AIDS and Viral Hepatitis from the Chinese Ministry of Health (Grant No. 2008ZX10001-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyrer C, 2013, AIDS, V27, P2665, DOI 10.1097/01.aids.0000432449.30239.fe; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Buchacz K, 2005, SEX TRANSM DIS, V32, pS73, DOI 10.1097/01.olq.0000180466.62579.4b; Calzavara L, 2002, AIDS, V16, P1655, DOI 10.1097/00002030-200208160-00011; Chemnasiri T, 2010, AIDS EDUC PREV, V22, P100, DOI 10.1521/aeap.2010.22.2.100; Choi KH, 2007, JAIDS-J ACQ IMM DEF, V45, P77, DOI 10.1097/QAI.0b013e3180415dd7; Cong L, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-250; DEAN L, 1995, J ACQ IMMUN DEF SYND, V8, P208; Elkington KS, 2010, J YOUTH ADOLESCENCE, V39, P514, DOI 10.1007/s10964-010-9524-7; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Feng YJ, 2010, JAIDS-J ACQ IMM DEF, V53, pS74, DOI 10.1097/QAI.0b013e3181c7dd16; Hao C, 2011, SEX TRANSM INFECT, V87, P199, DOI 10.1136/sti.2010.042903; He Q, 2009, SEX TRANSM INFECT, V85, P383, DOI 10.1136/sti.2009.035808; Li DL, 2010, AIDS PATIENT CARE ST, V24, P595, DOI 10.1089/apc.2010.0083; Liu J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-356; Liu J, 2011, AIDS PATIENT CARE ST, V25, P423, DOI 10.1089/apc.2010.0333; Lyons T, 2013, J HIV-AIDS SOC SERV, V12, P368, DOI 10.1080/15381501.2013.816211; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; National Center for AIDS/STD Prevention and Control China CDC, 2010, 2009 UPD HIV AIDS EP; National Center for AIDS/STD Prevention and Control China CDC, 2011, 2011 UPD HIV AIDS EP; Pathela P, 2011, JAIDS-J ACQ IMM DEF, V58, P408, DOI 10.1097/QAI.0b013e318230e1ca; Reynolds SJ, 2006, SEX TRANSM INFECT, V82, P121, DOI 10.1136/sti.2005.015040; Ruan YH, 2007, SEX TRANSM DIS, V34, P592, DOI 10.1097/01.olq.0000253336.64324.ef; Ruan YH, 2009, JAIDS-J ACQ IMM DEF, V52, P604, DOI 10.1097/QAI.0b013e3181b31f5c; van Griensven F, 2013, AIDS, V27, P825, DOI 10.1097/QAD.0b013e32835c546e; Vian Taryn, 2012, Open AIDS J, V6, P259, DOI 10.2174/1874613601206010259; Wang L, 2012, CHINESE MED J-PEKING, V125, P1857, DOI 10.3760/cma.j.issn.0366-6999.2012.11.003; Wei S, 2013, AIDS BEHAV, V17, P1151, DOI 10.1007/s10461-011-0110-0; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; [许娟 XU Juan], 2007, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V16, P205; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Zhang L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033748, 10.1371/journal.pone.0037211]; Zou HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051919	33	25	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97527	10.1371/journal.pone.0097527	http://dx.doi.org/10.1371/journal.pone.0097527			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878586	Green Published, Green Submitted, gold			2022-12-25	WOS:000338101500015
J	Lalwani, A; Stokes, RA; Lau, SM; Gunton, JE				Lalwani, Amit; Stokes, Rebecca A.; Lau, Sue Mei; Gunton, Jenny E.			Deletion of ARNT (Aryl Hydrocarbon Receptor Nuclear Translocator) in beta-Cells Causes Islet Transplant Failure with Impaired beta-Cell Function	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; TYPE-1 DIABETES-MELLITUS; GENE-EXPRESSION; DEFICIENT MICE; ALPHA; PANCREAS; ARNT/HIF1-BETA; PANCREATECTOMY; TRANSCRIPTION; ACTIVATION	background: Replacing beta-cells by islet-transplantation can cure type 1 diabetes, but up to 70% of beta-cells die within 10 days of transplantation. ARNT (Aryl hydrocarbon Receptor Nuclear Translocator) regulates beta-cell function, and potentially survival. Lack of ARNT impairs the ability of beta-cells to respond to physiological stress and potentiates the onset of diabetes, but the exact role of ARNT in graft outcome is unknown. Aim: To investigate the effect of beta-cell deletion of ARNT on graft outcomes. Methods: Islets were isolated from donor mice which had beta-cell specific ARNT-deletion (beta-ARNT) or littermate floxed controls. The islets were transplanted into diabetic SCID recipients in ratios of (a) 3 donors:1 recipient, (b) 1 donor:1 recipient or (c) 1/2 of the islets from 1 donor:1 recipient. After 28 days, the kidney containing the graft was removed (nephrectomy) to exclude regeneration of the endogenous pancreas. Results: In the supra-physiological-mass model (3:1), both groups achieved reasonable glycaemia, with slightly higher levels in beta-ARNT-recipients. In adequate-mass model (1:1), beta-ARNT recipients had poor glucose control versus floxed-control recipients and versus the beta-ARNT donors. In the low-beta-cell-mass model (1/2:1) beta-ARNT transplants completely failed, whereas controls had good outcomes. Unexpectedly, there was no difference in the graft insulin content or beta-cell mass between groups indicating that the defect was not due to early altered beta-cell survival. Conclusion: Outcomes for islet transplants lacking beta-cell ARNT were poor, unless markedly supra-physiological masses of islets were transplanted. In the 1:1 transplant model, there was no difference in beta-cell volume. This is surprising because transplants of islets lacking one of the ARNT-partners HIF-1 alpha have increased apoptosis and decreased islet volume. ARNT also partners HIF-2 alpha and AhR (aryl hydrocarbon receptor) to form active transcriptional complexes, and further work to understand the roles of HIF-2 alpha and AhR in transplant outcomes is needed.	[Lalwani, Amit; Stokes, Rebecca A.; Lau, Sue Mei; Gunton, Jenny E.] Garvan Inst Med Res, Diabet & Transcript Factors Grp, Sydney, NSW, Australia; [Lalwani, Amit; Gunton, Jenny E.] Univ Sydney, Westmead Hosp, Fac Med, Sydney, NSW 2006, Australia; [Lau, Sue Mei; Gunton, Jenny E.] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW, Australia; [Gunton, Jenny E.] Westmead Hosp, Dept Endocrinol & Diabet, Sydney, NSW, Australia	Garvan Institute of Medical Research; University of Sydney; University of New South Wales Sydney; University of Sydney	Gunton, JE (corresponding author), Garvan Inst Med Res, Diabet & Transcript Factors Grp, Sydney, NSW, Australia.	j.gunton@garvan.org.au	Gunton, Jenny E/AAH-7719-2021		Juvenile Diabetes Research Foundation (JDRF); National Health and Medical Research Council of Australia (NHMRC); Diabetes Australia Research Trust (DART)	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust (DART)	Funding provided by Juvenile Diabetes Research Foundation (JDRF), National Health and Medical Research Council of Australia (NHMRC) and Diabetes Australia Research Trust (DART). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brunnberg S, 2003, P NATL ACAD SCI USA, V100, P6517, DOI 10.1073/pnas.1136688100; Cheng K, 2010, J CLIN INVEST, V120, P2171, DOI 10.1172/JCI35846; Czech MP, 2006, NAT MED, V12, P39, DOI 10.1038/nm0106-39; da Silva Xavier G, 2004, P NATL ACAD SCI USA, V101, P8319, DOI 10.1073/pnas.0307737101; Das SK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-16; De Sa JR, 2008, ARQ BRAS ENDOCRINOL, V52, P355, DOI 10.1590/S0004-27302008000200024; Deters NA, 2011, ARCH IMMUNOL THER EX, V59, P421, DOI 10.1007/s00005-011-0143-0; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; FernandezSalguero PM, 1997, VET PATHOL, V34, P605, DOI 10.1177/030098589703400609; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Huang JJ, 2000, ANN SURG, V231, P890, DOI 10.1097/00000658-200006000-00014; Kallio PJ, 1997, P NATL ACAD SCI USA, V94, P5667, DOI 10.1073/pnas.94.11.5667; Kin T, 2008, TRANSPL INT, V21, P1029, DOI 10.1111/j.1432-2277.2008.00719.x; Klinge CM, 1999, MOL CELL ENDOCRINOL, V157, P105, DOI 10.1016/S0303-7207(99)00165-3; Kozak KR, 1997, DEV BIOL, V191, P297, DOI 10.1006/dbio.1997.8758; LACY PE, 1987, CLIN INVEST MED, V10, P496; Lau SM, 2011, DIABETOLOGIA, V54, P910, DOI 10.1007/s00125-010-1998-z; Lau SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077419; Levisetti MG, 2005, CELL METAB, V2, P78, DOI 10.1016/j.cmet.2005.07.005; Litwin J, 2008, PANCREAS, V36, P26, DOI 10.1097/mpa.0b013e318137aa61; Menge BA, 2008, DIABETES, V57, P142, DOI 10.2337/db07-1294; Molina MG, 2005, TRANSPL P, V37, P1443, DOI 10.1016/j.transproceed.2005.02.049; PARR EL, 1980, TRANSPLANTATION, V30, P135, DOI 10.1097/00007890-198008000-00012; PIPELEERS D, 1994, DIABETOLOGIA, V37, pS57, DOI 10.1007/BF00400827; Ricordi C, 2004, NAT REV IMMUNOL, V4, P258, DOI 10.1038/nri1332; Robertson RP, 2000, DIABETES CARE, V23, P112, DOI 10.2337/diacare.23.1.112; Ruby CE, 2002, MOL PHARMACOL, V62, P722, DOI 10.1124/mol.62.3.722; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Stokes RA, 2013, CELL TRANSPLANT, V22, P253, DOI 10.3727/096368912X647180; Sutherland DER, 2004, TRANSPLANT P, V36, P1697, DOI 10.1016/j.transproceed.2004.06.069; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Wang XL, 2009, CELL METAB, V9, P428, DOI 10.1016/j.cmet.2009.04.001; Wong Mary S, 2010, Self Nonself, V1, P165, DOI 10.4161/self.1.3.12643; Yang JS, 2005, J BIOL CHEM, V280, P36047, DOI 10.1074/jbc.M501755200; Yim SH, 2006, HEPATOLOGY, V44, P550, DOI 10.1002/hep.21284	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98435	10.1371/journal.pone.0098435	http://dx.doi.org/10.1371/journal.pone.0098435			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878748	gold, Green Submitted, Green Published			2022-12-25	WOS:000338101500059
J	Amarasekera, M; Martino, D; Ashley, S; Harb, H; Kesper, D; Strickland, D; Saffery, R; Prescott, SL				Amarasekera, Manori; Martino, David; Ashley, Sarah; Harb, Hani; Kesper, Doerthe; Strickland, Deborah; Saffery, Richard; Prescott, Susan L.			Genome-wide DNA methylation profiling identifies a folate-sensitive region of differential methylation upstream of ZFP57-imprinting regulator in humans	FASEB JOURNAL			English	Article						epigenetics; developmental programming; neonate; antigen-presenting cells; T cells	EMBRYONIC STEM-CELLS; FOLIC-ACID USE; CORD BLOOD; PREGNANCY; GENE; SUPPLEMENTATION	Folate intake during pregnancy may affect the regulation of DNA methylation during fetal development. The genomic regions in the offspring that may be sensitive to folate exposure during in utero development have not been characterized. Using genome-scale profiling, we investigated DNA methylation in 2 immune cell types (CD4(+) and antigen-presenting cells) isolated from neonatal cord blood, selected on the basis of in utero folate exposure. High-folate (HF; n = 11) and low-folate (LF; n = 12) groups were selected from opposite extremes of maternal serum folate levels measured in the last trimester of pregnancy. A comparison of these groups revealed differential methylation at 7 regions across the genome. By far, the biggest effect observed was hypomethylation of a 923 bp region 3 kb upstream of the ZFP57 transcript, a regulator of DNA methylation during development, observed in both cell types. Levels of H3/H4 acetylation at ZFP57 promoter and ZFP57 mRNA expression were higher in CD4(+) cells in the HF group relative to the LF group. Hypomethylation at this region was replicated in an independent sample set. These data suggest that exposure to folate has effects on the regulation of DNA methylation during fetal development, and this may be important for health and disease.	[Amarasekera, Manori; Prescott, Susan L.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6001, Australia; [Martino, David; Ashley, Sarah; Saffery, Richard] Murdoch Childrens Res Inst, Canc & Dis Epigenet Grp, Melbourne, Vic, Australia; [Martino, David; Saffery, Richard] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Martino, David] Ctr Food & Allergy Res, Melbourne, Vic, Australia; [Ashley, Sarah] Monash Univ, Inst Med Res, Melbourne, Vic 3004, Australia; [Harb, Hani; Kesper, Doerthe] Philipps Univ, Inst Lab Med Pathobiochem & Mol Diagnost, Marburg, Germany; [Strickland, Deborah] Telethon Inst Child Hlth Res, Perth, WA, Australia	University of Western Australia; Murdoch Children's Research Institute; University of Melbourne; Monash University; University of Sydney; Westmead Institute for Medical Research; Philipps University Marburg; Telethon Kids Institute; University of Western Australia	Prescott, SL (corresponding author), Univ Western Australia, Princess Margaret Hosp, Sch Paediat & Child Hlth, POB D184, Perth, WA 6001, Australia.	susan.prescott@uwa.edu.au	Ashley, Sarah/P-1264-2017; Saffery, Richard/GLS-1976-2022; Harb, Hani/J-6517-2019; Martino, DJ/X-1753-2019; strickland, deborah/K-4597-2019; Strickland, Deborah/AGV-6937-2022; Harb, Hani/HGB-7333-2022; Prescott, Susan/H-5665-2014	Ashley, Sarah/0000-0001-9973-9742; Saffery, Richard/0000-0002-9510-4181; Harb, Hani/0000-0001-8218-2538; Martino, DJ/0000-0001-6823-4696; Strickland, Deborah/0000-0003-0114-4201; Harb, Hani/0000-0001-8218-2538; 	Australia National Health and Medical Research Council (NHMRC); NHMRC Early Career Fellowship; Victorian government	Australia National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Victorian government	R. S. is funded by an Australia National Health and Medical Research Council (NHMRC) Senior Research Fellowship and D. M. by an NHMRC Early Career Fellowship. Murdoch Children's Research Institute is supported by the Victorian government's Operational Infrastructure Scheme. All authors are members of the International Inflammation Network (inFLAME).	Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Binder AM, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-353; Chang HB, 2011, J NUTR BIOCHEM, V22, P1172, DOI 10.1016/j.jnutbio.2010.10.003; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Cho CE, 2013, EPIGENETICS-US, V8, P710, DOI 10.4161/epi.24948; Dunstan JA, 2012, ALLERGY, V67, P50, DOI 10.1111/j.1398-9995.2011.02714.x; Foley DL, 2009, AM J EPIDEMIOL, V169, P389, DOI 10.1093/aje/kwn380; Fryer AA, 2011, EPIGENETICS-US, V6, P86, DOI 10.4161/epi.6.1.13392; Girardot M, 2013, EPIGENOMICS-UK, V5, P715, DOI 10.2217/epi.13.66; Gueant JL, 2013, TRENDS ENDOCRIN MET, V24, P279, DOI 10.1016/j.tem.2013.01.010; Haberg SE, 2009, ARCH DIS CHILD, V94, P180, DOI 10.1136/adc.2008.142448; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Hoyo C, 2011, EPIGENETICS-US, V6, P928, DOI 10.4161/epi.6.7.16263; Jaffe AE, 2012, INT J EPIDEMIOL, V41, P200, DOI 10.1093/ije/dyr238; Kiefte-de Jong JC, 2012, J NUTR, V142, P731, DOI 10.3945/jn.111.154948; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; LUMLEY J, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001056.pub2, 10.1002/14651858.CD001056, DOI 10.1002/14651858.CD001056]; Martino DJ, 2011, EPIGENETICS-US, V6, P1085, DOI 10.4161/epi.6.9.16401; Plant K, 2014, EUR J HUM GENET, V22, P568, DOI 10.1038/ejhg.2013.244; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Sie KKY, 2013, MOL NUTR FOOD RES, V57, P677, DOI 10.1002/mnfr.201200186; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Tada Y, 2015, ONCOGENE, V34, P752, DOI 10.1038/onc.2013.599; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Whitrow MJ, 2009, AM J EPIDEMIOL, V170, P1486, DOI 10.1093/aje/kwp315; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002; Zuo XP, 2012, J BIOL CHEM, V287, P2107, DOI 10.1074/jbc.M111.322644	28	58	59	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					4068	4076		10.1096/fj.13-249029	http://dx.doi.org/10.1096/fj.13-249029			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24891518	Bronze, Green Published			2022-12-25	WOS:000340845900024
J	Covolan, L; de Almeida, ACG; Amorim, B; Cavarsan, C; Miranda, MF; Aarao, MC; Madureira, AP; Rodrigues, AM; Nobrega, JN; Mello, LE; Hamani, C				Covolan, Luciene; de Almeida, Antonio-Carlos G.; Amorim, Beatriz; Cavarsan, Clarissa; Miranda, Maisa Ferreira; Aarao, Mayra C.; Madureira, Ana Paula; Rodrigues, Antonio M.; Nobrega, Jose N.; Mello, Luiz E.; Hamani, Clement			Effects of Anterior Thalamic Nucleus Deep Brain Stimulation in Chronic Epileptic Rats	PLOS ONE			English	Article							FREQUENCY ELECTRICAL-STIMULATION; PILOCARPINE-INDUCED SEIZURES; KINDLED SEIZURES; ADENOSINE; PROJECTIONS; RELEASE	Deep brain stimulation (DBS) has been investigated for the treatment of epilepsy. In rodents, an increase in the latency for the development of seizures and status epilepticus (SE) has been reported in different animal models but the consequences of delivering stimulation to chronic epileptic animals have not been extensively addressed. We study the effects of anterior thalamic nucleus (AN) stimulation at different current intensities in rats rendered epileptic following pilocarpine (Pilo) administration. Four months after Pilo-induced SE, chronic epileptic rats were bilaterally implanted with AN electrodes or had sham-surgery. Stimulation was delivered for 6 h/day, 5 days/week at 130 Hz, 90 mu sec. and either 100 mu A or 500 mu A. The frequency of spontaneous recurrent seizures in animals receiving stimulation was compared to that recorded in the preoperative period and in rats given sham treatment. To investigate the effects of DBS on hippocampal excitability, brain slices from animals receiving AN DBS or sham surgery were studied with electrophysiology. We found that rats treated with AN DBS at 100 mu A had a 52% non-significant reduction in the frequency of seizures as compared to sham-treated controls and 61% less seizures than at baseline. Animals given DBS at 500 mu A had 5.1 times more seizures than controls and a 2.8 fold increase in seizure rate as compared to preoperative values. In non-stimulated controls, the average frequency of seizures before and after surgery remained unaltered. In vitro recordings have shown that slices from animals previously given DBS at 100 mu A had a longer latency for the development of epileptiform activity, shorter and smaller DC shifts, and a smaller spike amplitude compared to non-stimulated controls. In contrast, a higher spike amplitude was recorded in slices from animals given AN DBS at 500 mu A.	[Covolan, Luciene; Amorim, Beatriz; Cavarsan, Clarissa; Mello, Luiz E.; Hamani, Clement] Univ Fed Sao Paulo, Disciplina Neurofisiol, Sao Paulo, Brazil; [de Almeida, Antonio-Carlos G.; Miranda, Maisa Ferreira; Aarao, Mayra C.; Madureira, Ana Paula; Rodrigues, Antonio M.] Univ Fed Sao Joao del Rei, Lab Neurociencia Expt & Computac, Sao Joao Del Rei, Brazil; [Nobrega, Jose N.; Hamani, Clement] Ctr Addict & Mental Hlth, Behav Neurobiol Lab, Toronto, ON, Canada; [Hamani, Clement] Univ Toronto, Toronto Western Hosp, Div Neurosurg, Toronto, ON M5T 2S8, Canada	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Joao del-Rei; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Hamani, C (corresponding author), Univ Fed Sao Paulo, Disciplina Neurofisiol, Sao Paulo, Brazil.	Clement.Hamani@uhn.on.ca	Rodrigues, Antônio M/D-3953-2012; ALMEIDA, ANTÔNIO-CARLOS GUIMARÃES/B-8028-2008; Covolan, Luciene/C-5926-2012; Cavarsan, Clarissa F./J-9221-2013; Mello, Luiz/B-4177-2009	Rodrigues, Antônio M/0000-0002-2678-9180; ALMEIDA, ANTÔNIO-CARLOS GUIMARÃES/0000-0003-4893-338X; Covolan, Luciene/0000-0002-9751-6438; Cavarsan, Clarissa F./0000-0002-6687-2130; Mello, Luiz/0000-0002-6969-1108	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2011/50680-2, 2012/50950-2]; Fapemig (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fapemig (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Support to conduct this work was provided by FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; grants #2011/50680-2 and 2012/50950-2tel:2012%2F50950-2), Fapemig (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais), CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Otaibi FA, 2011, NEUROSURGERY, V69, P957, DOI 10.1227/NEU.0b013e31822b30cd; Andrade DM, 2006, NEUROLOGY, V66, P1571, DOI 10.1212/01.wnl.0000206364.19772.39; Arida RM, 1999, EPILEPSY RES, V34, P99, DOI 10.1016/S0920-1211(98)00092-8; Bekar L, 2008, NAT MED, V14, P75, DOI 10.1038/nm1693; Cooper I S, 1984, Int J Neurol, V18, P179; Cunha RA, 1996, J NEUROCHEM, V67, P2180; de Almeida ACG, 2008, EPILEPSIA, V49, P1908, DOI 10.1111/j.1528-1167.2008.01686.x; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Hamani C, 2004, NEUROSURGERY, V54, P191, DOI 10.1227/01.NEU.0000097552.31763.AE; Hamani C, 2010, CLIN PHARMACOL THER, V88, P559, DOI 10.1038/clpt.2010.133; Hamani C, 2012, SCI TRANSL MED, V4, DOI DOI 10.1126/SCITRANSLMED.3003722; Hamani C, 2008, EPILEPSY RES, V78, P117, DOI 10.1016/j.eplepsyres.2007.09.010; Hamani C, 2010, EXP NEUROL, V225, P154, DOI 10.1016/j.expneurol.2010.06.007; Hamani C, 2009, INT J NEURAL SYST, V19, P213, DOI 10.1142/S0129065709001975; Hodaie M, 2002, EPILEPSIA, V43, P603, DOI 10.1046/j.1528-1157.2002.26001.x; Kerrigan JF, 2004, EPILEPSIA, V45, P346, DOI 10.1111/j.0013-9580.2004.01304.x; Lado FA, 2006, EPILEPSIA, V47, P27, DOI 10.1111/j.1528-1167.2006.00366.x; Lee KJ, 2006, ACTA NEUROCHIR SUPPL, V99, P87, DOI 10.1007/978-3-211-35205-2_17; Lim SN, 2007, EPILEPSIA, V48, P342, DOI 10.1111/j.1528-1167.2006.00898.x; Mirski MA, 1997, EPILEPSY RES, V28, P89, DOI 10.1016/S0920-1211(97)00034-X; Mohammad-Zadeh M, 2009, NEUROSCIENCE, V158, P1632, DOI 10.1016/j.neuroscience.2008.11.008; Osorio I, 2005, ANN NEUROL, V57, P258, DOI 10.1002/ana.20377; Paxinos G, 1988, RAT BRAIN STEREOTAXI; SANDER JWAS, 1993, EPILEPSIA, V34, P1007, DOI 10.1111/j.1528-1157.1993.tb02126.x; SHIBATA H, 1993, J COMP NEUROL, V337, P431, DOI 10.1002/cne.903370307; SHIBATA H, 1992, J COMP NEUROL, V323, P117, DOI 10.1002/cne.903230110; Takebayashi S, 2007, EPILEPSY RES, V74, P163, DOI 10.1016/j.eplepsyres.2007.03.007; Takebayashi S, 2007, EPILEPSIA, V48, P348, DOI 10.1111/j.1528-1167.2006.00948.x; Tawfik VL, 2010, NEUROSURGERY, V67, P367, DOI 10.1227/01.NEU.0000371988.73620.4C; Theodore WH, 2004, LANCET NEUROL, V3, P111, DOI 10.1016/S1474-4422(03)00664-1; Upton A R, 1985, Int J Neurol, V19-20, P223; Zhang Q, 2012, BRAIN RES BULL, V87, P221, DOI 10.1016/j.brainresbull.2011.11.023; Zhong XL, 2011, BRAIN RES BULL, V86, P422, DOI 10.1016/j.brainresbull.2011.08.014	33	26	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97618	10.1371/journal.pone.0097618	http://dx.doi.org/10.1371/journal.pone.0097618			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892420	gold, Green Published, Green Submitted			2022-12-25	WOS:000336911400016
J	Szlachetko, DL; Gorniak, M; Kolanowska, M; Mytnik-Ejsmont, J; Kowalkowska, AK; Rutkowski, P; Kolinski, T				Szlachetko, Dariusz L.; Gorniak, Marcin; Kolanowska, Marta; Mytnik-Ejsmont, Joanna; Kowalkowska, Agnieszka K.; Rutkowski, Piotr; Kolinski, Tomasz			Taxonomic Position and Phylogeny of the Genus Vargasiella (Orchidaceae, Vandoideae) Based on Molecular and Morphological Evidence	PLOS ONE			English	Article							GENETIC CONSEQUENCES; EVOLUTION	Since the description of the Neotropical genus Vargasiella in 1952, its taxonomic position has remained unclear, mainly due to a lack of sufficient data. In this study, the taxonomic position of Vargasiella was revised based on the outcomes of macro- and micromorphological studies, analyses of selected molecular markers and ecological methods of niche distribution modeling. The phylogenetic relationships were inferred using three DNA markers: matK, trnL-F and ITS sequences. The morphological studies included the analysis of macromorphological features of herbarium specimens as well as micromorphological examination of preserved flowers. The ecological niche modeling was applied to identify the distribution of the suitable niches of the studied taxa. The relationships between Vargasiella and most similar taxa remain unresolved based on the molecular analysis. The outcomes from the morphological studies indicated significant differences between Vargasiella, Warrea and Warreopsis. Moreover, a niche shift in response to changing climate after the last glacial maximum is observed in Vargasiella, while no substantial changes in the occupied habitats were identified in the other related taxa. The clocktree of the Zygopetaleae estimated from the matK gene indicated that the most recent common ancestors of Vargasiella, Warrea and Warreopsis originated in the Miocene, while the divergence time for Vargasiella and Warrea was assessed at approximately 5.4 Ma ago. Vargasiella seems to be an outshoot of the main branch of evolution of the Zygopetaleae. It is noteworthy that the Vargasiella-Warrea dichotomy could have taken place later than the divergence of Warreopsis from the mutual lineage. The molecular analysis and morphological data suggest that Vargasiella and Warrea could have evolved from a common ancestor. Accumulation of morphological differences and acceleration of the evolution of Vargasiella were more intensive than in other Warreinae and this could probably be synchronized with adaptation to different climatic conditions.	[Szlachetko, Dariusz L.; Kolanowska, Marta; Mytnik-Ejsmont, Joanna; Rutkowski, Piotr] Univ Gdansk, Dept Plant Taxon & Nat Conservat, PL-80952 Gdansk, Poland; [Gorniak, Marcin] Univ Gdansk, Dept Mol Evolut, PL-80952 Gdansk, Poland; [Kowalkowska, Agnieszka K.] Univ Gdansk, Dept Plant Cytol & Embryol, PL-80952 Gdansk, Poland; [Kolinski, Tomasz] Med Univ Gdansk, Dept Immunol, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Kolanowska, M (corresponding author), Univ Gdansk, Dept Plant Taxon & Nat Conservat, PL-80952 Gdansk, Poland.	martakolanowska@wp.pl	Kolanowska, Marta/AAR-3107-2020; Górniak, Marcin/HGB-0473-2022; Kowalkowska, Agnieszka Kamila/AAB-2402-2019	Kolanowska, Marta/0000-0001-5347-5403; Górniak, Marcin/0000-0002-7568-7818; Kowalkowska, Agnieszka Kamila/0000-0001-9685-8156; Kolinski, Tomasz/0000-0001-7839-0609; Rutkowski, Piotr/0000-0002-7059-0902; Mytnik, Joanna/0000-0003-4921-4950	Polish Ministry of Science and Higher Education [N N303 343735]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Polish Ministry of Science and Higher Education grant (N N303 343735). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman RM, 1999, SYST ASSOC SPEC VOL, V57, P432; Braconnot P, 2007, CLIM PAST, V3, P279, DOI 10.5194/cp-3-279-2007; Ch Schweinfurth, 1952, HARV U BOT MUS LEAF, V15, P139; Ch Schweinfurth, 1958, HARV U BOT MUS LEAF, V18, P219; Chase M.W., 2009, GENERA ORCHIDACEARUM, V5, P362; CHASE MW, 1991, TAXON, V40, P215, DOI 10.2307/1222975; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; Davies KL, 2011, ANN BOT-LONDON, V108, P945, DOI 10.1093/aob/mcr202; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Dressler RL, 1981, ORCHIDS NATURAL HIST; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eldredge N., 1972, P82; ESRI, 2009, ARCGIS DESKT REL 10; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Garzione CN, 2006, EARTH PLANET SC LETT, V241, P543, DOI 10.1016/j.epsl.2005.11.026; Gustafsson ALS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-177; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Latrubesse EM, 2010, EARTH-SCI REV, V99, P99, DOI 10.1016/j.earscirev.2010.02.005; MOLVRAY M, 2000, MONOCOTS SYSTEMATICS, P441, DOI DOI 10.1002/ECE3.752; Urbina-Cardona JN, 2008, TROP CONSERV SCI, V1, P417, DOI 10.1177/194008290800100408; Olson JS, 1983, DOENBB0037 CARB DIOX; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pupulin F, 2009, GENERA ORCHIDACEAR 2, V5, P456; Rambaut A, 2007, TRACER V 1 5; Romero Gustavo A., 1993, Novon, V3, P79, DOI 10.2307/3391429; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Senghas K-H, 1996, ORCHIDEEN, P1862; Senghas K-H, 1983, ORCHIDEEN, P800; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Szlachetko D. L., 1995, FRAGMENTA FLORISTICA, V3, P1; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Whitten M.W., 2005, LANKESTERIANA, V5, P87; WRIGHT S, 1982, EVOLUTION, V36, P427, DOI 10.1111/j.1558-5646.1982.tb05065.x	45	3	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98472	10.1371/journal.pone.0098472	http://dx.doi.org/10.1371/journal.pone.0098472			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892289	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400055
J	Chen, GC; Yue, AH; Ruan, ZB; Yin, YG; Wang, RZ; Ren, Y; Zhu, L				Chen, Gecai; Yue, Aihuan; Ruan, Zhongbao; Yin, Yigang; Wang, RuZhu; Ren, Yin; Zhu, Li			Human Umbilical Cord-Derived Mesenchymal Stem Cells Do Not Undergo Malignant Transformation during Long-Term Culturing in Serum-Free Medium	PLOS ONE			English	Article							IN-VITRO CULTURE; BONE-MARROW; CROSS-CONTAMINATION; STROMAL CELLS; ISSUE	Background: Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) are in the foreground as a preferable application for treating diseases. However, the safety of hUC-MSCs after long-term culturing in vitro in serum-free medium remains unclear. Methods: hUC-MSCs were separated by adherent tissue culture. hUC-MSCs were cultured in serum-free MesenCult-XF medium and FBS-bases DMEM complete medium. At the 1st, 3rd, 5th, 8th, 10th, and 15th passage, the differentiation of MSCs into osteogenic, chondrogenic, and adipogenic cells was detected, and MTT, surface antigens were measured. Tumorigenicity was analyzed at the 15th passage. Conventional karyotyping was performed at passage 0, 8, and 15. The telomerase activity of hUC-MSCs at passage 1-15 was analyzed. Results: Flow cytometry analysis showed that very high expression was detected for CD105, CD73, and CD90 and very low expression for CD45, CD34, CD14, CD79a, and HLA-DR. MSCs could differentiate into osteocytes, chondrocytes, and adipocytes in vitro. There was no obvious chromosome elimination, displacement, or chromosomal imbalance as determined from the guidelines of the International System for Human Cytogenetic Nomenclature. Telomerase activity was down-regulated significantly when the culture time was prolonged. Further, no tumors formed in rats injected with hUC-MSCs (P-15) cultured in serum-free and in serum-containing conditions. Conclusion: Our data showed that hUC-MSCs met the International Society for Cellular Therapy standards for conditions of long-term in vitro culturing at P-15. Since hUC-MSCs can be safely expanded in vitro and are not susceptible to malignant transformation in serum-free medium, these cells are suitable for cell therapy.	[Chen, Gecai; Ruan, Zhongbao; Yin, Yigang; Wang, RuZhu; Ren, Yin; Zhu, Li] Taizhou Peoples Hosp, Dept Cardiol, Taizhou, Jiangsu, Peoples R China; [Yue, Aihuan] Jiangsu Beike Biotechnol Co Ltd, Taizhou, Jiangsu, Peoples R China		Zhu, L (corresponding author), Taizhou Peoples Hosp, Dept Cardiol, Taizhou, Jiangsu, Peoples R China.	yueaihuan@163.com	Wang, Ruzhu/A-6727-2012	Wang, Ruzhu/0000-0003-3586-5728				Aguilar S, 2007, STEM CELLS, V25, P1586, DOI 10.1634/stemcells.2006-0762; Ahrari Iman, 2013, Iran Red Crescent Med J, V15, P324, DOI 10.5812/ircmj.4506; Akiyama K, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt131; Al-Nbaheen M, 2013, STEM CELL REV REP, V9, P32, DOI 10.1007/s12015-012-9365-8; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Binato R, 2013, CELL PROLIFERAT, V46, P10, DOI 10.1111/cpr.12002; Arufe MC, 2011, WORLD J ORTHOP, V2, P43, DOI 10.5312/wjo.v2.i6.43; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Forostyak S, 2013, BIOCHIMIE, V95, P2257, DOI 10.1016/j.biochi.2013.08.004; Hartmann I, 2010, J IMMUNOL METHODS, V363, P80, DOI 10.1016/j.jim.2010.10.008; Herberts CA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-29; Lansdorp PM, 2008, BLOOD, V111, P1759, DOI 10.1182/blood-2007-09-084913; Li WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074478; Patel DM, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/496218; Patrikoski M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt175; Purandare B, 2014, REGEN MED, V9, P67, DOI [10.2217/RME.13.82, 10.2217/rme.13.82]; Redaelli S, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt138; Ren ZH, 2011, EXP CELL RES, V317, P2950, DOI 10.1016/j.yexcr.2011.09.008; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Sekulovic S, 2011, BLOOD, V118, P1766, DOI 10.1182/blood-2010-11-319632; Sensebe L, 2008, BIO-MED MATER ENG, V18, pS3; Tang QL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081844; Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620; Torsvik A, 2012, INT J BIOL SCI, V8, P1051, DOI 10.7150/ijbs.3665; Torsvik A, 2010, CANCER RES, V70, P6393, DOI 10.1158/0008-5472.CAN-10-1305; Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439; Wang LM, 2011, REGEN MED, V6, P95, DOI [10.2217/rme.10.98, 10.2217/RME.10.98]; Zhang Y, 2012, SCI WORLD J, DOI 10.1100/2012/793823; Zhou YF, 2006, CANCER RES, V66, P10849, DOI 10.1158/0008-5472.CAN-06-2146	30	40	45	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98565	10.1371/journal.pone.0098565	http://dx.doi.org/10.1371/journal.pone.0098565			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887492	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300085
J	Chu, YG; Huang, QJ; Zhang, BY; Ding, CJ; Su, XH				Chu, Yanguang; Huang, Qinjun; Zhang, Bingyu; Ding, Changjun; Su, Xiaohua			Expression and Molecular Evolution of Two DREB1 Genes in Black Poplar (Populus nigra)	PLOS ONE			English	Article							WATER-USE EFFICIENCY; LINKAGE DISEQUILIBRIUM; NUCLEOTIDE DIVERSITY; LOW-TEMPERATURE; TRANSCRIPTIONAL ACTIVATOR; NATURAL-POPULATIONS; STRESS TOLERANCE; CBF GENES; DNA; FAMILY	Environmental stresses such as low temperature, drought, and high salinity significantly affect plant growth and yield. As selective forces, these adverse factors play essential roles in shaping phenotypic variation in plant populations. Black poplar (Populus nigra) is an economically and ecologically important forest tree species with widely distributed populations and is thus suitable for experiments detecting evolutionary footprints left by stress. Here, we performed expression and evolutionary analysis of two duplicated DREB A1-subgroup (DREB1) genes, PnDREB68 and PnDREB69, encoding transcription factors that are involved in stress responses. The two genes showed partially overlapping but distinct expression patterns in response to stresses. These genes were strongly and rapidly induced by cold stress in leaves, stems, and roots. In leaf tissue, dehydration stress induced the expression of PnDREB68 but not PnDREB69. PnDREB69 displayed more rapid responses and longer expression durations than PnDREB68 under salt and ABA stress, respectively. Based on single nucleotide polymorphism (SNP) analysis, we found significant population genetic differentiation, with a greater FST value (0.09189) for PnDREB69 than for PnDREB68 (0.07743). Nucleotide diversity analysis revealed a two-fold higher pT for PnDREB68 than for PnDREB69 (0.00563 vs. 0.00243), reflecting strong purifying selection acting on the former. The results suggest that positive selection acted on PnDREB69, as evidenced by neutral testing using Tajima's D statistic. The distinct selective forces to which each of the genes was subjected may be associated with expression divergence. Linkage disequilibrium (LD) was low for the sequenced region, with a higher level for PnDREB68 than for PnDREB69. Additionally, analysis of the relationship among carbon isotope ratios, SNP classes and gene expression, together with motif and domain analysis, suggested that 14 polymorphisms within the two genes may be candidates for an association study of important traits such as water use efficiency/drought tolerance in black poplar.	[Chu, Yanguang; Huang, Qinjun; Zhang, Bingyu; Ding, Changjun; Su, Xiaohua] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat,State Forestry A, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF	Su, XH (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat,State Forestry A, Beijing, Peoples R China.	suxh@caf.ac.cn			National Natural Science Foundation of China [31000310]; National High-tech R&D Program of China [2011AA100201]; National Key Technology R&D Program for the Eleventh Five-Year-Plan of China [2006BAD01A15]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China(National High Technology Research and Development Program of China); National Key Technology R&D Program for the Eleventh Five-Year-Plan of China(National Key Technology R&D Program)	This work was financially supported by the National Natural Science Foundation of China (Grant No. 31000310), the National High-tech R&D Program of China (Grant No. 2011AA100201), and the National Key Technology R&D Program for the Eleventh Five-Year-Plan of China (Grant No. 2006BAD01A15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artlip TS, 2013, TREE PHYSIOL, V33, P866, DOI 10.1093/treephys/tpt056; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Benedict C, 2006, PLANT CELL ENVIRON, V29, P1259, DOI 10.1111/j.1365-3040.2006.01505.x; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breen AL, 2009, NEW PHYTOL, V182, P763, DOI 10.1111/j.1469-8137.2009.02779.x; Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; Chazen O, 2006, PLANT CELL ENVIRON, V18, P727; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Chu YG, 2009, GENETICA, V137, P141, DOI 10.1007/s10709-009-9371-1; Condon AG, 2004, J EXP BOT, V55, P2447, DOI 10.1093/jxb/erh277; Cong L, 2008, BIOCHEM BIOPH RES CO, V371, P702, DOI 10.1016/j.bbrc.2008.04.126; Eckenwalder James E., 1996, P7; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; FU YX, 1993, GENETICS, V133, P693; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Ingvarsson PK, 2008, GENETICS, V180, P329, DOI 10.1534/genetics.108.090431; Ingvarsson PK, 2005, GENETICS, V169, P945, DOI 10.1534/genetics.104.034959; Jansson S, 2007, ANNU REV PLANT BIOL, V58, P435, DOI 10.1146/annurev.arplant.58.032806.103956; Lan T, 2009, PLANT CELL, V21, P3749, DOI 10.1105/tpc.109.070219; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lata C, 2011, J EXP BOT, V62, P3387, DOI 10.1093/jxb/err016; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li YL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-146; Li YL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-6; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin YH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-111; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MacColl ADC, 2011, TRENDS ECOL EVOL, V26, P514, DOI 10.1016/j.tree.2011.06.009; Maestrini P, 2009, J PLANT PHYSIOL, V166, P1544, DOI 10.1016/j.jplph.2009.03.014; Magome H, 2004, PLANT J, V37, P720, DOI 10.1111/j.1365-313X.2003.01998.x; Magome H, 2008, PLANT J, V56, P613, DOI 10.1111/j.1365-313X.2008.03627.x; Mao DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047275; MARTIN B, 1988, PLANT PHYSIOL, V88, P213, DOI 10.1104/pp.88.1.213; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mboup M, 2012, MOL BIOL EVOL, V29, P3641, DOI 10.1093/molbev/mss176; Navarro M, 2009, J EXP BOT, V60, P2713, DOI 10.1093/jxb/erp129; Navarro M, 2011, PLANT BIOTECHNOL J, V9, P50, DOI 10.1111/j.1467-7652.2010.00530.x; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nei M., 1987, MOL EVOLUTIONARY GEN; Ohno S., 1970, P1; Olson MS, 2010, NEW PHYTOL, V186, P526, DOI 10.1111/j.1469-8137.2009.03174.x; ORR HA, 1992, AM NAT, V140, P725, DOI 10.1086/285437; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rozen S, 2000, Methods Mol Biol, V132, P365; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Smulders MJM, 2008, FOREST ECOL MANAG, V255, P1388, DOI 10.1016/j.foreco.2007.10.063; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang QY., 2002, DPS DATA PROCESSING; Tian JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053116; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vanden BA, 2003, EUFORGEN TECHNICAL G, P1; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Wisniewski M, 2011, PLANTA, V233, P971, DOI 10.1007/s00425-011-1358-3; Zhang DQ, 2011, TREE GENET GENOMES, V7, P443, DOI 10.1007/s11295-010-0346-2; Zhang DQ, 2010, TREE GENET GENOMES, V6, P331, DOI 10.1007/s11295-009-0252-7; Zhuang J, 2008, BIOCHEM BIOPH RES CO, V371, P468, DOI 10.1016/j.bbrc.2008.04.087	68	21	22	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98334	10.1371/journal.pone.0098334	http://dx.doi.org/10.1371/journal.pone.0098334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887081	gold, Green Submitted, Green Published			2022-12-25	WOS:000336956300055
J	Sargeant, DP; Deverasetty, S; Strong, CL; Alaniz, IJ; Bartlett, A; Brandon, NR; Brooks, SB; Brown, FA; Bufi, F; Chakarova, M; David, RP; Dobritch, KM; Guerra, HP; Hedden, MW; Kumra, R; Levitt, KS; Mathew, KR; Matti, R; Maza, DQ; Mistry, S; Novakovic, N; Pomerantz, A; Portillo, J; Rafalski, TF; Rathnayake, VR; Rezapour, N; Songao, S; Tuggle, SL; Yousif, S; Dorsky, DI; Schiller, MR				Sargeant, David P.; Deverasetty, Sandeep; Strong, Christy L.; Alaniz, Izua J.; Bartlett, Alexandria; Brandon, Nicholas R.; Brooks, Steven B.; Brown, Frederick A.; Bufi, Flaviona; Chakarova, Monika; David, Roxanne P.; Dobritch, Karlyn M.; Guerra, Horacio P.; Hedden, Michael W.; Kumra, Rma; Levitt, Kelvy S.; Mathew, Kiran R.; Matti, Ray; Maza, Dorothea Q.; Mistry, Sabyasachy; Novakovic, Nemanja; Pomerantz, Austin; Portillo, Josue; Rafalski, Timothy F.; Rathnayake, Viraj R.; Rezapour, Noura; Songao, Sarah; Tuggle, Sean L.; Yousif, Sandy; Dorsky, David I.; Schiller, Martin R.			The HIVToolbox 2 Web System Integrates Sequence, Structure, Function and Mutation Analysis	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1 REVERSE-TRANSCRIPTASE; VIROLOGICAL RESPONSE; HELICAL INTERACTIONS; INHIBITORY-ACTIVITY; PROTEIN DATA; TAT PROTEIN; TYPE-1 VPR; GP41 CORE; RNA	There is enormous interest in studying HIV pathogenesis for improving the treatment of patients with HIV infection. HIV infection has become one of the best-studied systems for understanding how a virus can hijack a cell. To help facilitate discovery, we previously built HIVToolbox, a web system for visual data mining. The original HIVToolbox integrated information for HIV protein sequence, structure, functional sites, and sequence conservation. This web system has been used for almost 40,000 searches. We report improvements to HIVToolbox including new functions and workflows, data updates, and updates for ease of use. HIVToolbox2, is an improvement over HIVToolbox with new functions. HIVToolbox2 has new functionalities focused on HIV pathogenesis including drug-binding sites, drug-resistance mutations, and immune epitopes. The integrated, interactive view enables visual mining to generate hypotheses that are not readily revealed by other approaches. Most HIV proteins form multimers, and there are posttranslational modification and protein-protein interaction sites at many of these multimerization interfaces. Analysis of protease drug binding sites reveals an anatomy of drug resistance with different types of drug-resistance mutations regionally localized on the surface of protease. Some of these drug-resistance mutations have a high prevalence in specific HIV-1 M subtypes. Finally, consolidation of Tat functional sites reveals a hotspot region where there appear to be 30 interactions or posttranslational modifications. A cursory analysis with HIVToolbox2 has helped to identify several global patterns for HIV proteins. An initial analysis with this tool identifies homomultimerization of almost all HIV proteins, functional sites that overlap with multimerization sites, a global drug resistance anatomy for HIV protease, and specific distributions of some DRMs in specific HIV M subtypes. HIVToolbox2 is an open-access web application available at [http://hivtoolbox2.bio-toolkit.com].	[Sargeant, David P.; Deverasetty, Sandeep; Strong, Christy L.; Alaniz, Izua J.; Bartlett, Alexandria; Brandon, Nicholas R.; Brooks, Steven B.; Brown, Frederick A.; Bufi, Flaviona; Chakarova, Monika; David, Roxanne P.; Dobritch, Karlyn M.; Guerra, Horacio P.; Hedden, Michael W.; Kumra, Rma; Levitt, Kelvy S.; Mathew, Kiran R.; Matti, Ray; Maza, Dorothea Q.; Mistry, Sabyasachy; Novakovic, Nemanja; Pomerantz, Austin; Portillo, Josue; Rafalski, Timothy F.; Rathnayake, Viraj R.; Rezapour, Noura; Songao, Sarah; Tuggle, Sean L.; Yousif, Sandy; Schiller, Martin R.] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Dorsky, David I.] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06032 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Connecticut	Schiller, MR (corresponding author), Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA.	martin.schiller@unlv.edu		Novakovic, Nemanja/0000-0002-1681-7715; Schiller, Martin R/0000-0003-1671-6823	National Institutes of Health [AI07870, AI078708-03S1, GM07689, RR016464]; National Science Foundation [1005223]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078708, F32AI007870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this project was provided by grants from the National Institutes of Health (AI07870, AI078708-03S1, GM07689, and RR016464) and the National Science Foundation (1005223). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfadhli A, 2007, J VIROL, V81, P1472, DOI 10.1128/JVI.02122-06; Andreola ML, 2009, CURR PHARM DESIGN, V15, P2508, DOI 10.2174/138161209788682244; Auclair JR, 2007, PROTEINS, V69, P270, DOI 10.1002/prot.21471; Bannwarth L, 2009, BIOCHEMISTRY-US, V48, P379, DOI 10.1021/bi801422u; Baxter JD, 2006, J VIROL, V80, P10794, DOI 10.1128/JVI.00712-06; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Borner K, 2010, BIOTECHNOL J, V5, P39, DOI 10.1002/biot.200900226; Bourbigot S, 2005, BIOCHEM J, V387, P333, DOI 10.1042/BJ20041759; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Briggs JAG, 2011, J MOL BIOL, V410, P491, DOI 10.1016/j.jmb.2011.04.021; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Buxton P, 2005, J VIROL, V79, P6338, DOI 10.1128/JVI.79.10.6338-6348.2005; Camarasa MJ, 2006, ANTIVIR RES, V71, P260, DOI 10.1016/j.antiviral.2006.05.021; Chen K, 2013, J BIOL CHEM, V288, P1511, DOI 10.1074/jbc.M112.425140; Colonno R, 2004, J INFECT DIS, V189, P1802, DOI 10.1086/386291; Colonno RJ, 2003, ANTIMICROB AGENTS CH, V47, P1324, DOI 10.1128/AAC.47.4.1324-1333.2003; Descamps D, 2009, J ANTIMICROB CHEMOTH, V63, P585, DOI 10.1093/jac/dkn544; DiMattia MA, 2010, P NATL ACAD SCI USA, V107, P5810, DOI 10.1073/pnas.0914946107; Doherty RS, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-18; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; FRANKEL AD, 1988, P NATL ACAD SCI USA, V85, P6297, DOI 10.1073/pnas.85.17.6297; Gautier VW, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-47; Hagan NA, 2007, J MOL BIOL, V365, P396, DOI 10.1016/j.jmb.2006.09.081; He JJ, 2009, RNA BIOL, V6, P384, DOI 10.4161/rna.6.4.8920; Horne WS, 2009, P NATL ACAD SCI USA, V106, P14751, DOI 10.1073/pnas.0902663106; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Jenkins Y, 2001, J VIROL, V75, P10537, DOI 10.1128/JVI.75.21.10537-10542.2001; Johnson Victoria A, 2006, Top HIV Med, V14, P125; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Johnson Victoria A, 2010, Top HIV Med, V18, P156; Johnson Victoria A, 2009, Top HIV Med, V17, P138; Kagan R, 2004, AIDS RES HUM RETROV, V20, P1, DOI 10.1089/088922204322749440; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kuiken Carla, 2003, AIDS Reviews, V5, P52; LEITNER T, 2005, HIV SEQUENCE COMPEND; Maes M, 2012, FEBS J, V279, P2795, DOI 10.1111/j.1742-4658.2012.08680.x; Malashkevich VN, 1998, P NATL ACAD SCI USA, V95, P9134, DOI 10.1073/pnas.95.16.9134; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; Meng X, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002886; Mulky A, 2005, ANTIMICROB AGENTS CH, V49, P3762, DOI 10.1128/AAC.49.9.3762-3769.2005; Nguyen DG, 2006, J VIROL, V80, P130, DOI 10.1128/JVI.80.1.130-137.2006; Pagans S, 2011, METHODS, V53, P91, DOI 10.1016/j.ymeth.2010.07.001; Prasanna MD, 2006, PROTEINS, V63, P907, DOI 10.1002/prot.20914; Rato S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009276; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Richter SN, 2006, CURR MED CHEM, V13, P1305, DOI 10.2174/092986706776872989; Robbins AH, 2010, ACTA CRYSTALLOGR D, V66, P233, DOI 10.1107/S0907444909054298; Root MJ, 2001, SCIENCE, V291, P884, DOI 10.1126/science.1057453; Sargeant D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020122; Sarmady M., 2011, PLOS ONE, V6; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Shafer RW, 2002, CLIN MICROBIOL REV, V15, P247, DOI 10.1128/CMR.15.2.247-277.2002; Sharpe S, 2006, BIOCHEMISTRY-US, V45, P918, DOI 10.1021/bi051766k; Shu W, 2000, BIOCHEMISTRY-US, V39, P1634, DOI 10.1021/bi9921687; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026629; Sluis-Cremer N, 2002, EUR J BIOCHEM, V269, P5103, DOI 10.1046/j.1432-1033.2002.03216.x; Solbak SMO, 2013, BBA-BIOMEMBRANES, V1828, P816, DOI 10.1016/j.bbamem.2012.11.010; Suhasini M, 2009, CURR HIV RES, V7, P91, DOI 10.2174/157016209787048474; Techtmann SM, 2012, BIOCHEMISTRY-US, V51, P2078, DOI 10.1021/bi201738a; Venkatachari NJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-119; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Waldmann I, 2012, J CELL SCI, V125, P144, DOI 10.1242/jcs.090316; Yang B, 2003, J BIOL CHEM, V278, P6596, DOI 10.1074/jbc.M210164200; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	66	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98810	10.1371/journal.pone.0098810	http://dx.doi.org/10.1371/journal.pone.0098810			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886930	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300111
J	Sun, YW; Skidmore, AK; Wang, TJ; van Gils, HAMJ; Wang, Q; Qing, BP; Ding, CQ				Sun, Yiwen; Skidmore, Andrew K.; Wang, Tiejun; van Gils, Hein A. M. J.; Wang, Qi; Qing, Baoping; Ding, Changqing			Reduced Dependence of Crested Ibis on Winter-Flooded Rice Fields: Implications for Their Conservation	PLOS ONE			English	Article							NEST-SITE SELECTION; HABITAT; POPULATION; CLASSIFICATION; PATTERNS; MODEL	The Crested Ibis Nipponia nippon was once thought to be extinct in the wild until seven birds were discovered in a remote mountain village in China in 1981. Studies suggested that winter-flooded rice fields play an essential role in nest site selection by the Crested Ibis and hence in their survival. Considerable efforts were therefore made to conserve the winter-flooded rice fields, but these have caused conflicts between the agricultural and conservation communities. The population and geographical range of the wild Crested Ibis has expanded greatly since 1981, but there is no spatial information on the winter-flooded rice fields, nor on the current association of nest sites and winter-flooded rice fields. We mapped winter-flooded rice fields across the entire current range of Crested Ibis using innovative remote sensing and geographical information systems (GIS) techniques. The spatial relationships between the nest site clusters and winter-flooded rice fields were quantified using Ward's hierarchical clustering method and Ripley's K-function. We show that both have significantly clumped distribution patterns and that they are positively associated. However, the dependence of Crested Ibis on the winter-flooded rice fields varied significantly among the nest site clusters and has decreased over the years, indicating the absence of winter-flooded rice fields is not constraining their recovery and population expansion. We therefore recommend that efforts should be made to protect the existing winter-flooded rice fields and to restore the functionality of natural and semi-natural wetlands, to encourage both in-situ conservation and the re-introduction of the Crested Ibis. In addition, we recommend that caution should be exercised when interpreting the habitat requirements of species with a narrow distribution, particularly when that interpretation is based only on their current habitat.	[Sun, Yiwen; Skidmore, Andrew K.; Wang, Tiejun; van Gils, Hein A. M. J.] Univ Twente, Fac Geoinformat Sci & Earth Observat, Dept Nat Resources, NL-7500 AE Enschede, Netherlands; [Wang, Tiejun] Bioresources Key Lab Shaanxi Prov, Hanzhong, Shaanxi Provinc, Peoples R China; [Wang, Qi] Shaanxi Univ Technol, Coll Biol Sci & Engn, Hanzhong, Shaanxi Provinc, Peoples R China; [Wang, Qi] Shaanxi Hanzhong Crested Ibis Natl Nat Reserve, Hanzhong, Shaanxi Provinc, Peoples R China; [Ding, Changqing] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China	University of Twente; Shaanxi University of Technology; Beijing Forestry University	Wang, TJ (corresponding author), Univ Twente, Fac Geoinformat Sci & Earth Observat, Dept Nat Resources, POB 217, NL-7500 AE Enschede, Netherlands.	t.wang@utwente.nl	Skidmore, Andrew K/C-7441-2011; Wang, Tiejun/A-4671-2010	Skidmore, Andrew K/0000-0002-7446-8429; Wang, Tiejun/0000-0002-1138-8464	China Scholarship Council [2011627018]; ITC Research Fund [93002773]; Shaanxi Provincial Education Department [13JS023]	China Scholarship Council(China Scholarship Council); ITC Research Fund; Shaanxi Provincial Education Department	This work was supported by the China Scholarship Council (No. 2011627018, www.csc.edu.cn) and co-funded by the ITC Research Fund (No. 93002773, www.itc.nl). This work was also part of the scientific research program funded by Shaanxi Provincial Education Department (Program No. 13JS023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barea LP, 2012, EMU, V112, P39, DOI 10.1071/MU10082; BESAG J, 1977, J ROYAL STAT SOC B, V39, P193, DOI DOI 10.1016/J.FORECO.2009.04.009; BirdLife International, 2012, IUCN 2013 IUCN RED L; BirdLife International, 2001, THREAT BIRDS AS BIRD; Boyle Terence P., 2004, Wetlands Ecology and Management, V12, P563, DOI 10.1007/s11273-005-1761-2; Brown M, 1999, ECOL MODEL, V120, P167, DOI 10.1016/S0304-3800(99)00100-3; Cody M.L., 1985, HABITATS SELECTION B; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cornulier T, 2006, ECOGRAPHY, V29, P240, DOI 10.1111/j.2006.0906-7590.04287.x; De Leeuw J, 2006, INT J REMOTE SENS, V27, P223, DOI 10.1080/01431160500275762; Dillner AM, 2005, ATMOS ENVIRON, V39, P1525, DOI 10.1016/j.atmosenv.2004.11.035; Ding C., 2004, RES CRESTED IBIS; Ding Changqing, 2010, Chinese Birds, V1, P156; Dixon P.M., 2002, ENCY ENV, VVolume 3, P1796, DOI DOI 10.1002/9780470057339.VAR046; Donald PF, 2004, CONSERV BIOL, V18, P17, DOI 10.1111/j.1523-1739.2004.01803.x; Dong J. P., 1992, Acta Universitatis Agriculturalis Borealis-Occidentalis, V20, P79; Elphick CS, 2003, AGR ECOSYST ENVIRON, V94, P17, DOI 10.1016/S0167-8809(02)00022-1; Elphick CS, 2000, CONSERV BIOL, V14, P181, DOI 10.1046/j.1523-1739.2000.98314.x; Foody GM, 2004, PHOTOGRAMM ENG REM S, V70, P627, DOI 10.14358/PERS.70.5.627; Fortin M.-J., 2002, ENCY ENV, V4, P2051, DOI [10.1002/9780470057339.vas039, DOI 10.1002/9780470057339]; Fritz LL, 2011, BIODIVERS CONSERV, V20, P2211, DOI 10.1007/s10531-011-0083-3; Gonzalez LM, 2008, BIRD CONSERV INT, V18, P242, DOI 10.1017/S0959270908000245; Goreaud F, 2003, J VEG SCI, V14, P681, DOI 10.1658/1100-9233(2003)014[0681:AMOBIW]2.0.CO;2; Guillen G, 2004, J MARINE SYST, V45, P221, DOI 10.1016/j.jmarsys.2003.11.006; Jia YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065843; Johnson Matthew, 2011, Zoological Research, V32, P128, DOI 10.3724/SP.J.1141.2011.02128; KIESTER AR, 1974, THEOR POPUL BIOL, V6, P1, DOI 10.1016/0040-5809(74)90028-8; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Li X., 2001, BIODIVERSITY SCI, V9, P352; Li XH, 2006, LANDSCAPE ECOL, V21, P1207, DOI 10.1007/s10980-006-0021-z; Li XH, 2009, BIODIVERS CONSERV, V18, P2165, DOI 10.1007/s10531-009-9580-z; LIN YZ, 1981, ACTA ZOOL SINICA, V27, P273; Liu Dong-Ping, 2003, Acta Zoologica Sinica, V49, P755; Lopez-Jamar J, 2011, BIRD CONSERV INT, V21, P328, DOI 10.1017/S0959270910000535; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Maltchik L, 2011, REV BIOL TROP, V59, P1895; Margalida A, 2008, IBIS, V150, P242, DOI 10.1111/j.1474-919X.2007.00768.x; Meissner Wlodzimierz, 2012, Wader Study Group Bulletin, V119, P89; Melles SJ, 2009, LANDSCAPE ECOL, V24, P519, DOI 10.1007/s10980-009-9329-9; Moreno-Opo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033469; Natuhara Y, 2013, ECOL ENG, V56, P97, DOI 10.1016/j.ecoleng.2012.04.026; Okolelov AY, 2003, ZOOL ZH, V82, P388; Pelissier R, 2010, ADS SPATIAL POINT PA; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Senapathi D, 2007, IBIS, V149, P328, DOI 10.1111/j.1474-919X.2006.00634.x; Skidmore A. K., 1990, International Journal of Geographical Information Systems, V4, P33, DOI 10.1080/02693799008941527; SKIDMORE AK, 1989, PHOTOGRAMM ENG REM S, V55, P1449; STAMPS JA, 1988, AM NAT, V131, P329, DOI 10.1086/284793; Toral GM, 2011, IBIS, V153, P684, DOI 10.1111/j.1474-919X.2011.01147.x; Treinys R, 2008, J ORNITHOL, V149, P75, DOI 10.1007/s10336-007-0220-7; Wang GM, 2008, WATERBIRDS, V31, P489, DOI 10.1675/1524-4695-31.3.489; Wang Zhong-yu, 2008, Sichuan Journal of Zoology, V27, P82; Wang Zhong-Yu, 2000, Chinese Journal of Zoology, V35, P28; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wood C, 2010, WATERBIRDS, V33, P30, DOI 10.1675/063.033.s103; Yu XP, 2010, WILSON J ORNITHOL, V122, P228; Yu XP, 2006, BIRD CONSERV INT, V16, P325, DOI 10.1017/S0959270906000499; Zhai Tian-Qing, 2001, Acta Zoologica Sinica, V47, P508	59	11	13	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98690	10.1371/journal.pone.0098690	http://dx.doi.org/10.1371/journal.pone.0098690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874870	Green Published, Green Submitted, gold			2022-12-25	WOS:000336790800055
J	Centanni, TM; Chen, FY; Booker, AM; Engineer, CT; Sloan, AM; Rennaker, RL; LoTurco, JJ; Kilgard, MP				Centanni, Tracy M.; Chen, Fuyi; Booker, Anne M.; Engineer, Crystal T.; Sloan, Andrew M.; Rennaker, Robert L.; LoTurco, Joseph J.; Kilgard, Michael P.			Speech Sound Processing Deficits and Training-Induced Neural Plasticity in Rats with Dyslexia Gene Knockdown	PLOS ONE			English	Article							IN-UTERO RNAI; DEVELOPMENTAL DYSLEXIA; SUSCEPTIBILITY GENE; BEHAVIORAL IMPAIRMENTS; GABAERGIC INHIBITION; READING DISABILITIES; RESPONSE PATTERNS; CORPUS-CALLOSUM; AUDITORY-CORTEX; CHILDREN	In utero RNAi of the dyslexia-associated gene Kiaa0319 in rats (KIA-) degrades cortical responses to speech sounds and increases trial-by-trial variability in onset latency. We tested the hypothesis that KIA- rats would be impaired at speech sound discrimination. KIA- rats needed twice as much training in quiet conditions to perform at control levels and remained impaired at several speech tasks. Focused training using truncated speech sounds was able to normalize speech discrimination in quiet and background noise conditions. Training also normalized trial-by-trial neural variability and temporal phase locking. Cortical activity from speech trained KIA-rats was sufficient to accurately discriminate between similar consonant sounds. These results provide the first direct evidence that assumed reduced expression of the dyslexia-associated gene KIAA0319 can cause phoneme processing impairments similar to those seen in dyslexia and that intensive behavioral therapy can eliminate these impairments.	[Centanni, Tracy M.; Engineer, Crystal T.; Sloan, Andrew M.; Rennaker, Robert L.; Kilgard, Michael P.] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA; [Chen, Fuyi; Booker, Anne M.; LoTurco, Joseph J.] Univ Connecticut, Storrs, CT USA	University of Texas System; University of Texas Dallas; University of Connecticut	Centanni, TM (corresponding author), Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA.	tmcentanni@gmail.com	Rennaker II, Robert/K-9049-2013	Rennaker II, Robert/0000-0003-1260-1973; Engineer, Crystal/0000-0002-2188-2335; Kilgard, Michael/0000-0002-6699-1818	National Institute for Deafness and Communication Disorders at the National Institutes of Health [R01DC010433]; National Institute of Child Health and Human Development at the National Institutes of Health [HD055655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010433] Funding Source: NIH RePORTER	National Institute for Deafness and Communication Disorders at the National Institutes of Health; National Institute of Child Health and Human Development at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute for Deafness and Communication Disorders at the National Institutes of Health (R01DC010433 to MPK) and the National Institute of Child Health and Human Development at the National Institutes of Health (HD055655 to JJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; Adler WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065179; Ahissar E, 2001, P NATL ACAD SCI USA, V98, P13367, DOI 10.1073/pnas.201400998; Bai J, 2008, DEV NEUROSCI-BASEL, V30, P144, DOI 10.1159/000109859; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bates TC, 2011, BEHAV GENET, V41, P50, DOI 10.1007/s10519-010-9402-9; Blondeau C, 2007, BIOL PSYCHIAT, V61, P1340, DOI 10.1016/j.biopsych.2006.06.030; Boscariol Mirela, 2010, Pró-Fono R. Atual. Cient., V22, P537, DOI 10.1590/S0104-56872010000400030; Brasselet R, 2012, J NEUROSCI, V32, P2998, DOI 10.1523/JNEUROSCI.5435-11.2012; BRYANT PE, 1989, J CHILD LANG, V16, P407, DOI 10.1017/S0305000900010485; Burbridge TJ, 2008, NEUROSCIENCE, V152, P723, DOI 10.1016/j.neuroscience.2008.01.020; Castles A, 1999, J EXP CHILD PSYCHOL, V72, P73, DOI 10.1006/jecp.1998.2482; Centanni TM, 2014, CEREB CORTEX, V24, P1753, DOI 10.1093/cercor/bht028; Centanni TM, 2013, J NEUROPHYSIOL, V110, P177, DOI 10.1152/jn.00092.2013; Chandrasekaran B, 2009, NEURON, V64, P311, DOI 10.1016/j.neuron.2009.10.006; Coffin JM, 2005, CORTEX, V41, P389, DOI 10.1016/S0010-9452(08)70275-2; Cope N, 2005, AM J HUM GENET, V76, P581, DOI 10.1086/429131; Couto JM, 2010, AM J MED GENET B, V153B, P447, DOI 10.1002/ajmg.b.30999; Currier TA, 2011, NEUROSCIENCE, V172, P535, DOI 10.1016/j.neuroscience.2010.11.002; Czamara D, 2011, BEHAV GENET, V41, P110, DOI 10.1007/s10519-010-9413-6; Deffenbacher KE, 2004, HUM GENET, V115, P128, DOI 10.1007/s00439-004-1126-6; Dennis MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000436; Dijkmans Thomas Frederik, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P32; Dong Y, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-25; Doron NN, 2002, J COMP NEUROL, V453, P345, DOI 10.1002/cne.10412; Eden GF, 2002, NAT NEUROSCI, V5, P1080, DOI 10.1038/nn946; Elbro C, 2004, J EDUC PSYCHOL, V96, P660, DOI 10.1037/0022-0663.96.4.660; Engineer CT, 2008, NAT NEUROSCI, V11, P603, DOI 10.1038/nn.2109; Engineer CT, 2008, SPEECH SOUND CODING; Engineer N, 2012, NEUROSCIENCE; Farmer ME, 1995, PSYCHON B REV, V2, P460, DOI 10.3758/BF03210983; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fisher SE, 2002, NAT REV NEUROSCI, V3, P767, DOI 10.1038/nrn936; FLOWERS DL, 1991, ARCH NEUROL-CHICAGO, V48, P637, DOI 10.1001/archneur.1991.00530180095023; Foffani G, 2005, I IEEE EMBS C NEUR E, P206; Foffani G, 2004, J NEUROSCI METH, V135, P107, DOI 10.1016/j.jneumeth.2003.12.011; Francks C, 2004, AM J HUM GENET, V75, P1046, DOI 10.1086/426404; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Galaburda AM, 2006, NAT NEUROSCI, V9, P1213, DOI 10.1038/nn1772; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Fine JG, 2007, NEUROPSYCHOLOGY, V21, P235, DOI 10.1037/0894-4105.21.2.235; Goswami U., 1990, PHONOLOGICAL SKILLS; Green DM, 1966, SIGNAL DETECTION THE; Habib M, 2002, INT J LANG COMM DIS, V37, P289, DOI 10.1080/13682820210136278; Hari R, 1996, NEUROSCI LETT, V205, P138, DOI 10.1016/0304-3940(96)12393-4; Harold D, 2006, MOL PSYCHIATR, V11, P1085, DOI 10.1038/sj.mp.4001904; Heim S, 2013, NEUROPSYCHOLOGIA, V51, P990, DOI 10.1016/j.neuropsychologia.2013.01.011; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Hornickel J, 2013, J NEUROSCI, V33, P3500, DOI 10.1523/JNEUROSCI.4205-12.2013; Hornickel J, 2012, P NATL ACAD SCI USA, V109, P16731, DOI 10.1073/pnas.1206628109; Jakkamsetti V, 2012, J NEUROPHYSIOL, V107, P1457, DOI 10.1152/jn.01057.2010; Kawahara H, 1997, INT CONF ACOUST SPEE, P1303, DOI 10.1109/ICASSP.1997.596185; Kovelman I, 2012, CEREB CORTEX, V22, P754, DOI 10.1093/cercor/bhr094; Kraus N, 2012, TRENDS COGN SCI, V16, P12, DOI 10.1016/j.tics.2011.12.001; Lind PA, 2010, EUR J HUM GENET, V18, P668, DOI 10.1038/ejhg.2009.237; Loos M, 2010, BEHAV BRAIN RES, V214, P216, DOI 10.1016/j.bbr.2010.05.027; LOVETT MW, 1989, BRAIN LANG, V37, P90, DOI 10.1016/0093-934X(89)90103-X; Lovio R, 2012, BRAIN RES, V1448, P42, DOI 10.1016/j.brainres.2012.01.071; Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2; Ma HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052942; Marino C, 2007, GENES BRAIN BEHAV, V6, P640, DOI 10.1111/j.1601-183X.2006.00291.x; Massinen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020580; McAnally KI, 1996, P ROY SOC B-BIOL SCI, V263, P961, DOI 10.1098/rspb.1996.0142; Nagarajan S, 1999, P NATL ACAD SCI USA, V96, P6483, DOI 10.1073/pnas.96.11.6483; Pandya PK, 2008, CEREB CORTEX, V18, P301, DOI 10.1093/cercor/bhm055; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Paracchini S, 2008, AM J PSYCHIAT, V165, P1576, DOI 10.1176/appi.ajp.2008.07121872; Paul LK, 2011, J NEURODEV DISORD, V3, P3, DOI 10.1007/s11689-010-9059-y; PENNINGTON BF, 1991, JAMA-J AM MED ASSOC, V266, P1527, DOI 10.1001/jama.266.11.1527; Penolazzi B, 2010, BEHAV BRAIN RES, V209, P179, DOI 10.1016/j.bbr.2010.01.029; Perez CA, 2013, CEREB CORTEX, V23, P670, DOI 10.1093/cercor/bhs045; Peschansky VJ, 2010, CEREB CORTEX, V20, P884, DOI 10.1093/cercor/bhp154; Peterson R. L, 2012, LANCET; Pinel P, 2012, J NEUROSCI, V32, P817, DOI 10.1523/JNEUROSCI.5996-10.2012; Polley DB, 2007, J NEUROPHYSIOL, V97, P3621, DOI 10.1152/jn.01298.2006; Poon M, 2011, J BIOCH MOL BIOL POS, V65; Porter BA, 2011, BEHAV BRAIN RES, V219, P68, DOI 10.1016/j.bbr.2010.12.015; Puckett AC, 2007, J NEUROPHYSIOL, V98, P253, DOI 10.1152/jn.01309.2006; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; Ranasinghe KG, 2012, HEARING RES, V289, P1, DOI 10.1016/j.heares.2012.04.020; Ranasinghe KG, 2012, JARO-J ASSOC RES OTO, P1; Raschle NM, 2012, P NATL ACAD SCI USA, V109, P2156, DOI 10.1073/pnas.1107721109; Rey V, 2002, BRAIN LANG, V80, P576, DOI 10.1006/brln.2001.2618; Rumsey JM, 1997, BRAIN, V120, P739, DOI 10.1093/brain/120.5.739; Russo NM, 2005, BEHAV BRAIN RES, V156, P95, DOI 10.1016/j.bbr.2004.05.012; Scerri TS, 2011, BIOL PSYCHIAT, V70, P237, DOI 10.1016/j.biopsych.2011.02.005; Schulte-Korne G, 2010, DTSCH ARZTEBL INT, V107, P718, DOI 10.3238/arztebl.2010.0718; Schulte-Korne G, 1998, NEUROREPORT, V9, P337, DOI 10.1097/00001756-199801260-00029; Schumacher J, 2006, AM J HUM GENET, V78, P52, DOI 10.1086/498992; Shaywitz SE, 1998, NEW ENGL J MED, V338, P307, DOI 10.1056/NEJM199801293380507; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; SHAYWITZ SE, 1992, NEW ENGL J MED, V326, P145, DOI 10.1056/NEJM199201163260301; Shetake JA, 2011, EUR J NEUROSCI, V34, P1823, DOI 10.1111/j.1460-9568.2011.07887.x; Sloan AM, 2009, HEARING RES, V251, P60, DOI 10.1016/j.heares.2009.02.009; SNOWLING MJ, 1980, J EXP CHILD PSYCHOL, V29, P294, DOI 10.1016/0022-0965(80)90021-1; STELZER A, 1987, NATURE, V326, P698, DOI 10.1038/326698a0; Szalkowski CE, 2012, INT J DEV NEUROSCI, V30, P293, DOI 10.1016/j.ijdevneu.2012.01.009; Szalkowski CE, 2012, INT J DEV NEUROSCI, V1, P116; Takahashi H, 2011, NEUROSCIENCE, V199, P243, DOI 10.1016/j.neuroscience.2011.09.046; TALLAL P, 1980, BRAIN LANG, V9, P182, DOI 10.1016/0093-934X(80)90139-X; TALLAL P, 1974, NEUROPSYCHOLOGIA, V12, P83, DOI 10.1016/0028-3932(74)90030-X; Tallal P, 1991, ANONYMOUS READING DI, P175; Temple E, 2001, NEUROREPORT, V12, P299, DOI 10.1097/00001756-200102120-00024; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; Threlkeld SW, 2007, BRAIN RES BULL, V71, P508, DOI 10.1016/j.brainresbull.2006.11.005; Tremblay KL, 2002, J SPEECH LANG HEAR R, V45, P564, DOI 10.1044/1092-4388(2002/045); Van Ingelghem M, 2001, NEUROREPORT, V12, P3603, DOI 10.1097/00001756-200111160-00046; Vandermosten M, 2010, P NATL ACAD SCI USA, V107, P10389, DOI 10.1073/pnas.0912858107; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3; Ziegler JC, 2009, DEVELOPMENTAL SCI, V12, P732, DOI 10.1111/j.1467-7687.2009.00817.x; Zou L, 2012, AM J MED GENET B, V159B, P970, DOI 10.1002/ajmg.b.32102	113	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98439	10.1371/journal.pone.0098439	http://dx.doi.org/10.1371/journal.pone.0098439			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871331	gold, Green Submitted, Green Published			2022-12-25	WOS:000336858300044
J	Pethybridge, HR; Parrish, CC; Bruce, BD; Young, JW; Nichols, PD				Pethybridge, Heidi R.; Parrish, Christopher C.; Bruce, Barry D.; Young, Jock W.; Nichols, Peter D.			Lipid, Fatty Acid and Energy Density Profiles of White Sharks: Insights into the Feeding Ecology and Ecophysiology of a Complex Top Predator	PLOS ONE			English	Article							CARCHARODON-CARCHARIAS; STOMACH CONTENT; NORTHERN GULF; TIGER SHARK; DIET; LIVER; FISHES; PREY; REQUIREMENTS; METABOLISM	Lipids are major sources of metabolic energy in sharks and are closely linked to environmental conditions and biological cycles, such as those related to diet, reproduction and migration. In this study, we report for the first time, the total lipid content, lipid class composition and fatty acid profiles of muscle and liver tissue of white sharks, Carcharodon carcharias, of various lengths (1.5-3.9 m), sampled at two geographically separate areas off southern and eastern Australia. Muscle tissue was low in total lipid content (<0.9% wet mass, wm) and was dominated by phospholipids (>90% of total lipid) and polyunsaturated fatty acids (34 +/- 12% of total fatty acids). In contrast, liver was high in total lipid which varied between 51-81% wm and was dominated by triacylglycerols (>93%) and monounsaturated fatty acids (36 +/- 12%). With knowledge of total lipid and dry tissue mass, we estimated the energy density of muscle (18.4 +/- 0.1 kJ g(-1) dm) and liver (34.1 +/- 3.2 kJ g(-1) dm), demonstrating that white sharks have very high energetic requirements. High among- individual variation in these biochemical parameters and related trophic markers were observed, but were not related to any one biological or environmental factor. Signature fatty acid profiles suggest that white sharks over the size range examined are generalist predators with fish, elasmobranchs and mammalian blubber all contributing to the diet. The ecological applications and physiological influences of lipids in white sharks are discussed along with recommendations for future research, including the use of non-lethal sampling to examine the nutritional condition, energetics and dietary relationships among and between individuals. Such knowledge is fundamental to better understand the implications of environmental perturbations on this iconic and threatened species.	[Pethybridge, Heidi R.; Bruce, Barry D.; Young, Jock W.; Nichols, Peter D.] CSIRO Wealth Ocean Flagship, Div Marine & Atmospher Res, Hobart, Tas, Australia; [Parrish, Christopher C.] Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Memorial University Newfoundland	Pethybridge, HR (corresponding author), CSIRO Wealth Ocean Flagship, Div Marine & Atmospher Res, Hobart, Tas, Australia.	Heidi.Pethybridge@csiro.au	Pethybridge, Heidi/AEO-8594-2022; Nichols, Peter D/C-5128-2011; Pethybridge, Heidi/AAI-9824-2021	Pethybridge, Heidi/0000-0002-7291-5766; 	Commonwealth Scientific and Industrial Research Organisation (CSIRO) Capability Development Fund Ernst Frohlich Fellowship; CSIRO Office of the Executive Chief Postdoctoral Award; Australia Governments' National Environmental Research Program; Marine Biodiversity Hub	Commonwealth Scientific and Industrial Research Organisation (CSIRO) Capability Development Fund Ernst Frohlich Fellowship; CSIRO Office of the Executive Chief Postdoctoral Award; Australia Governments' National Environmental Research Program; Marine Biodiversity Hub	Funding was provided by the Commonwealth Scientific and Industrial Research Organisation (CSIRO) Capability Development Fund Ernst Frohlich Fellowship. HP was supported by a CSIRO Office of the Executive Chief Postdoctoral Award. BDB's time on this paper was supported by the Australia Governments' National Environmental Research Program, Marine Biodiversity Hub. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony JA, 2000, J EXP MAR BIOL ECOL, V248, P53, DOI 10.1016/S0022-0981(00)00159-3; Ballantyne JS, 1997, COMP BIOCHEM PHYS B, V118, P703, DOI 10.1016/S0305-0491(97)00272-1; Barnett A, 2010, MAR ECOL PROG SER, V416, P189, DOI 10.3354/meps08778; Beckmann CL, 2013, J EXP MAR BIOL ECOL, V448, P10, DOI 10.1016/j.jembe.2013.06.009; Belicka LL, 2012, MAR ECOL PROG SER, V455, P245, DOI 10.3354/meps09674; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blower DC, 2012, MAR ECOL PROG SER, V455, P229, DOI 10.3354/meps09659; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Bruce Barry D., 2012, P225; BRUCE BD, 1992, AUST J MAR FRESH RES, V43, P1; Casey J.G., 1985, Memoirs of the Southern California Academy of Sciences, V9, P2; Chipps SR, 2008, T AM FISH SOC, V137, P298, DOI 10.1577/T05-236.1; CLIFF G, 1989, S AFR J MARINE SCI, V8, P131, DOI 10.2989/02577618909504556; Cooper MH, 2005, J COMP PHYSIOL B, V175, P133, DOI 10.1007/s00360-004-0469-6; CORTES E, 1990, COPEIA, P204; Couturier LIE, 2013, LIPIDS, V48, P1029, DOI 10.1007/s11745-013-3829-8; Davidson B, 2002, FISH PHYSIOL BIOCHEM, V26, P171, DOI 10.1023/A:1025447718625; Davidson BC, 2007, IN VIVO, V21, P333; Davidson B, 2011, FISH PHYSIOL BIOCHEM, V37, P105, DOI 10.1007/s10695-010-9421-8; Davidson B, 2011, FISH PHYSIOL BIOCHEM, V37, P613, DOI 10.1007/s10695-010-9463-y; Del Raye G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0836; Drazen JC, 2007, DEEP-SEA RES PT I, V54, P203, DOI 10.1016/j.dsr.2006.10.007; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; El-Sabaawi R, 2009, MAR BIOL, V156, P225, DOI 10.1007/s00227-008-1073-1; Fallows C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060797; GRAEVE M, 1994, J EXP MAR BIOL ECOL, V182, P97, DOI 10.1016/0022-0981(94)90213-5; Hammerschlag N, 2013, FUNCT ECOL, V27, P1273, DOI 10.1111/1365-2435.12157; Hoffmayer ER, 2006, J FISH BIOL, V68, P645, DOI 10.1111/j.0022-1112.2006.00942.x; Hussey Nigel E., 2012, P27; Iverson SJ, 2004, ECOL MONOGR, V74, P211, DOI 10.1890/02-4105; Jayasinghe C, 2003, FISHERIES SCI, V69, P644, DOI 10.1046/j.1444-2906.2003.00668.x; Kim SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030501, 10.1371/journal.pone.0045068]; Marshall CT, 1999, NATURE, V402, P288, DOI 10.1038/46272; McMeans BC, 2012, J EXP MAR BIOL ECOL, V429, P55, DOI 10.1016/j.jembe.2012.06.017; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Navarro-Garcia G., 2000, Journal of Food Composition and Analysis, V13, P791, DOI 10.1006/jfca.2000.0928; Nichols PD, 1998, MAR FRESHWATER RES, V49, P763, DOI 10.1071/MF97241; Nichols PD, 2001, 99369 FRDC CSIRO; Nordoy ES, 1995, DEV MAR BIO, V4, P307; Parrish CC, 2014, DEEP SEA 2 IN PRESS; Pethybridge H, 2011, MAR BIOL, V158, P2741, DOI 10.1007/s00227-011-1773-9; Pethybridge H, 2011, J EXP MAR BIOL ECOL, V409, P290, DOI 10.1016/j.jembe.2011.09.009; Pethybridge H, 2010, MAR BIOL, V157, P1367, DOI 10.1007/s00227-010-1416-6; Phleger CF, 1998, AM ZOOL, V38, P321; Powter DM, 2010, MAR FRESHWATER RES, V61, P74, DOI 10.1071/MF09021; Revill AT, 2009, MAR BIOL, V156, P1241, DOI 10.1007/s00227-009-1166-5; SARGENT JR, 1973, J MAR BIOL ASSOC UK, V53, P649, DOI 10.1017/S0025315400058847; Schindler DE, 2002, ECOL APPL, V12, P735, DOI 10.2307/3060985; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Semmens JM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01471; Simpfendorfer CA, 2001, ENVIRON BIOL FISH, V61, P37, DOI 10.1023/A:1011021710183; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Taylor JKD, 2013, MAR MAMMAL SCI, V29, P204, DOI 10.1111/j.1748-7692.2011.00542.x; Tierney M, 2008, J EXP MAR BIOL ECOL, V367, P65, DOI 10.1016/j.jembe.2008.07.046; Vanella FA, 2005, SCI MAR, V69, P305, DOI 10.3989/scimar.2005.69s2305; VANVLEET ES, 1984, COMP BIOCHEM PHYS B, V79, P549, DOI 10.1016/0305-0491(84)90364-X; Walker T, 1989, SO SHARK ASSESSMENT; Waugh CA, 2012, MAR ECOL PROG SER, V471, P271, DOI 10.3354/meps10059	59	47	49	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97877	10.1371/journal.pone.0097877	http://dx.doi.org/10.1371/journal.pone.0097877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871223	gold, Green Submitted, Green Published			2022-12-25	WOS:000336858300021
J	Suzuki, Y; Kitahara, T; Soma, K; Konno, S; Sato, K; Suzuki, S; Oka, H; Yamada, M; Fujii, K; Kitahara, Y; Yamamoto, Y; Otsuka, T; Sugiura, Y; Kanoh, Y; Tamai, Y; Ohto, H				Suzuki, Yuhko; Kitahara, Takao; Soma, Kazui; Konno, Shingo; Sato, Kimitoshi; Suzuki, Sachio; Oka, Hidehiro; Yamada, Masaru; Fujii, Kiyotaka; Kitahara, Yukio; Yamamoto, Yuji; Otsuka, Takashi; Sugiura, Yoshihiro; Kanoh, Yuhsaku; Tamai, Yoshiko; Ohto, Hitoshi			Impact of Platelet Transfusion on Survival of Patients with Intracerebral Hemorrhage after Administration of Anti-Platelet Agents at a Tertiary Emergency Center	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; CARDIOVASCULAR-DISEASE; HEMATOMA EXPANSION; CONTROLLED-TRIAL; HIGH-RISK; THERAPY; ASPIRIN; CLOPIDOGREL; STROKE; EVENTS	This study examined the impact of platelet transfusion (PLT) on the survival of intracerebral hemorrhage (ICH) patients who had been administered anti-platelet agents (APA). This retrospective cohort analysis investigated 432 patients (259 men, 60%) who were newly diagnosed with ICH between January 2006 and June 2011 at the tertiary emergency center of Kitasato University Hospital. Median age on arrival was 67.0 years (range, 40-95 years). ICH was subcortical in 72 patients (16.7%), supratentorial in 233 (53.9%), and infratentorial in 133 (30.8%). PLT was performed in 16 patients (3.7%). Within 90 days after admission to the center, 178 patients (41.2%) had died due to ICH. Before the onset of ICH, 66 patients had been prescribed APA because of atherosclerotic diseases. Multivariate regression analysis indicated APA administration was an independent risk factor for death within 7 days (odds ratio, 5.12; P = 0.006) and within 90 days (hazard ratio, 1.87; P = 0.006) after arrival. Regarding the effect of a PLT in ICH patients with APA, no patient with PLT died. PLT had a survival benefit on patients with ICH, according to our analysis. Further prospective analysis is necessary to confirm the effects of PLT on survival in ICH with APA.	[Suzuki, Yuhko; Ohto, Hitoshi] Fukushima Med Univ, Dept Blood Transfus, Fukushima, Japan; [Suzuki, Yuhko; Ohto, Hitoshi] Fukushima Med Univ, Dept Transplantat Immunol, Fukushima, Japan; [Kitahara, Takao; Soma, Kazui; Konno, Shingo] Kitasato Univ, Sch Med, Dept Emergency Med, Sagamihara, Kanagawa 228, Japan; [Kitahara, Takao; Soma, Kazui; Konno, Shingo] Kitasato Univ, Sch Med, Dept Crit Care Med, Sagamihara, Kanagawa 228, Japan; [Sato, Kimitoshi; Suzuki, Sachio; Oka, Hidehiro; Yamada, Masaru; Fujii, Kiyotaka] Kitasato Univ, Sch Med, Dept Neurosurg, Sagamihara, Kanagawa 228, Japan; [Kitahara, Yukio] Fuchinobe Gen Hosp, Dept Neurosurg, Sagamihara, Kanagawa, Japan; [Yamamoto, Yuji] Ashigarakami Hosp, Dept Neurosurg, Ashigarakami, Kanagawa, Japan; [Otsuka, Takashi] Sagamihara Chuo Hosp, Dept Neurosurg, Sagamihara, Kanagawa, Japan; [Sugiura, Yoshihiro] Fukushima Med Univ, Dept Neurol, Fukushima, Japan; [Kanoh, Yuhsaku] Kitasato Univ, Sch Med, Dept Clin Lab Med, Sagamihara, Kanagawa 228, Japan; [Tamai, Yoshiko] Hirosaki Univ, Sch Med, Dept Transfus, Hirosaki, Aomori 036, Japan	Fukushima Medical University; Fukushima Medical University; Kitasato University; Kitasato University; Kitasato University; Fukushima Medical University; Kitasato University; Hirosaki University	Suzuki, Y (corresponding author), Fukushima Med Univ, Dept Blood Transfus, Fukushima, Japan.	ysuzuki-hki@umin.ac.jp						Balami JS, 2012, LANCET NEUROL, V11, P101, DOI 10.1016/S1474-4422(11)70264-2; Batchelor JS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000588; Butler AC, 1998, BLOOD REV, V12, P35, DOI 10.1016/S0268-960X(98)90028-5; Creutzfeldt CJ, 2009, J STROKE CEREBROVASC, V18, P221, DOI 10.1016/j.jstrokecerebrovasdis.2008.10.007; De Schryver EL, 2010, COCHRANE DB SYST REV; Dearden NM, 1998, CLIN NEUROPATHOL, V17, P221; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Ducruet AF, 2010, NEUROL RES, V32, P706, DOI 10.1179/174313209X459129; Eikelboom JW, 2002, CIRCULATION, V105, P1650, DOI 10.1161/01.CIR.0000013777.21160.07; FitzGerald R, 2011, PHARMACOL THERAPEUT, V130, P213, DOI 10.1016/j.pharmthera.2011.01.011; Flaherty ML, 2010, SEMIN NEUROL, V30, P565, DOI 10.1055/s-0030-1268866; Flibotte JJ, 2004, NEUROLOGY, V63, P1059, DOI 10.1212/01.WNL.0000138428.40673.83; Florczak-Rzepka M, 2012, CEREBROVASC DIS, V34, P249, DOI 10.1159/000341686; FLORESRUNK P, 1993, ANN PHARMACOTHER, V27, P1090, DOI 10.1177/106002809302700915; Garg RK, 2012, STROKE, V43, P67, DOI 10.1161/STROKEAHA.111.629493; Hankey GJ, 2000, STROKE, V31, P1779, DOI 10.1161/01.STR.31.7.1779; Hennekens C, 2013, NONRESPONSE RESISTAN; Hennekens CH, 2013, SECONDARY PREVENTION; Hermosillo AJ, 2008, ANN PHARMACOTHER, V42, P790, DOI 10.1345/aph.1K591; Hoshino K, 2009, CIRC J, V73, P336, DOI 10.1253/circj.CJ-08-0559; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Jinnai T, 2009, CIRC J, V73, P1498, DOI 10.1253/circj.CJ-09-0019; Kiyohara Y, 2003, STROKE, V34, P2343, DOI 10.1161/01.STR.0000091845.14833.43; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Menon RS, 2012, ANN NEUROL, V71, P199, DOI 10.1002/ana.22668; Miyata Shigeki, 2008, Brain and Nerve (Tokyo), V60, P1357; Naidech AM, 2012, NEUROCRIT CARE, V16, P82, DOI 10.1007/s12028-011-9619-3; Naidech AM, 2009, STROKE, V40, P2398, DOI 10.1161/STROKEAHA.109.550939; Rincon F, 2013, NEUROCRIT CARE, V19, P95, DOI 10.1007/s12028-012-9793-y; Roquer J, 2005, J NEUROL, V252, P412, DOI 10.1007/s00415-005-0659-5; Sacco S, 2009, STROKE, V40, P394, DOI 10.1161/STROKEAHA.108.523209; Samama CM, 2005, CAN J ANAESTH, V52, P30, DOI 10.1007/BF03018577; Sarafoff N, 2012, CURR PHARM DESIGN, V18, P5224, DOI 10.2174/138161212803251853; Seizer P, 2013, THROMB HAEMOST, V110; Shinohara Y, 2008, STROKE, V39, P1827, DOI 10.1161/STROKEAHA.107.505131; Shinohara Y, 2010, LANCET NEUROL, V9, P959, DOI 10.1016/S1474-4422(10)70198-8; Steinhubl SR, 2009, ANN INTERN MED, V150, P379, DOI 10.7326/0003-4819-150-6-200903170-00006; TANAKA H, 1981, STROKE, V12, P460, DOI 10.1161/01.STR.12.4.460; Thompson BB, 2010, NEUROLOGY, V75, P1333, DOI 10.1212/WNL.0b013e3181f735e5; Toyoda K, 2005, NEUROLOGY, V65, P1000, DOI 10.1212/01.wnl.0000179178.37713.69; Toyoda K, 2008, STROKE, V39, P1740, DOI 10.1161/STROKEAHA.107.504993; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; Wijeyeratne YD, 2011, BRIT J CLIN PHARMACO, V72, P647, DOI 10.1111/j.1365-2125.2011.03999.x	45	19	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97328	10.1371/journal.pone.0097328	http://dx.doi.org/10.1371/journal.pone.0097328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24869669	Green Published, Green Submitted, gold			2022-12-25	WOS:000336858300008
J	Afanasyeva, MA; Britanova, LV; Korneev, KV; Mitkin, NA; Kuchmiy, AA; Kuprash, DV				Afanasyeva, Marina A.; Britanova, Liudmila V.; Korneev, Kirill V.; Mitkin, Nikita A.; Kuchmiy, Anna A.; Kuprash, Dmitry V.			Clusterin Is a Potential Lymphotoxin Beta Receptor Target That Is Upregulated and Accumulates in Germinal Centers of Mouse Spleen during Immune Response	PLOS ONE			English	Article							GENE-EXPRESSION; LYMPH-NODE; NUCLEAR CLUSTERIN; M-CELLS; MARKER; ORGANOGENESIS; MICE; LOCALIZATION; DEFICIENT; SURFACE	Clusterin is a multifunctional protein that participates in tissue remodeling, apoptosis, lipid transport, complement-mediated cell lysis and serves as an extracellular chaperone. The role of clusterin in cancer and neurodegeneration has been extensively studied, however little is known about its functions in the immune system. Using expression profiling we found that clusterin mRNA is considerably down-regulated in mouse spleen stroma upon knock-out of lymphotoxin beta receptor which plays pivotal role in secondary lymphoid organ development, maintenance and function. Using immunohistochemistry and western blot we studied clusterin protein level and distribution in mouse spleen and mesenteric lymph nodes in steady state and upon immunization with sheep red blood cells. We showed that clusterin protein, represented mainly by the secreted heterodimeric form, is present in all stromal compartments of secondary lymphoid organs except for marginal reticular cells. Clusterin protein level rose after immunization and accumulated in light zones of germinal centers in spleen the effect that was not observed in lymph nodes. Regulation of clusterin expression by the lymphotoxin beta signaling pathway and its protein dynamics during immune response suggest a specific role of this enigmatic protein in the immune system that needs further study.	[Afanasyeva, Marina A.; Britanova, Liudmila V.; Korneev, Kirill V.; Mitkin, Nikita A.; Kuchmiy, Anna A.; Kuprash, Dmitry V.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Korneev, Kirill V.; Kuprash, Dmitry V.] Moscow MV Lomonosov State Univ, Fac Biol, Dept Immunol, Moscow, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Lomonosov Moscow State University	Kuprash, DV (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia.	kuprash@eimb.ru	Britanova, Liudmila/AAC-3823-2022; Kuchmiy, Anna/N-7960-2019; Kuprash, Dmitry/O-4899-2015; Kuchmiy, Anna/S-2275-2016; Korneev, Kirill V/H-3644-2016; Mitkin, Nikita A/T-5892-2017	Kuchmiy, Anna/0000-0001-7277-736X; Kuprash, Dmitry/0000-0002-1488-4148; Kuchmiy, Anna/0000-0001-7277-736X; Korneev, Kirill V/0000-0003-3570-8327; Mitkin, Nikita A/0000-0002-1014-9250; Afanasyeva, Marina/0000-0001-5294-970X	Russian Foundation for Basic Research [11-04-01334a]; MCB grant from the Russian Academy of Sciences	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); MCB grant from the Russian Academy of Sciences	This project has been funded by the grant 11-04-01334a from the Russian Foundation for Basic Research (www.rfbr.ru) and by MCB grant from the Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLASCHUK O, 1983, J BIOL CHEM, V258, P7714; Browning JL, 1997, J IMMUNOL, V159, P3288; BROWNING JL, 1995, J IMMUNOL, V154, P33; BUTTYAN R, 1989, MOL CELL BIOL, V9, P3473, DOI 10.1128/MCB.9.8.3473; Chyou S, 2008, J IMMUNOL, V181, P3887, DOI 10.4049/jimmunol.181.6.3887; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; DESILVA HV, 1990, J BIOL CHEM, V265, P13240; DESILVA HV, 1990, BIOCHEMISTRY-US, V29, P5380, DOI 10.1021/bi00474a025; FRENCH LE, 1993, J CELL BIOL, V122, P1119, DOI 10.1083/jcb.122.5.1119; FRENCH LE, 1992, J CLIN INVEST, V90, P1919, DOI 10.1172/JCI116069; French LE, 1996, BIOL REPROD, V55, P1213, DOI 10.1095/biolreprod55.6.1213; FRENCH LE, 1994, IMMUNOLOGY, V82, P328; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Grogg KL, 2004, AM J SURG PATHOL, V28, P988, DOI 10.1097/01.pas.0000112536.76973.7f; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber C, 2005, J IMMUNOL, V174, P5526, DOI 10.4049/jimmunol.174.9.5526; JENNE DE, 1989, P NATL ACAD SCI USA, V86, P7123, DOI 10.1073/pnas.86.18.7123; Kim N, 2011, ANAT CELL BIOL, V44, P169, DOI 10.5115/acb.2011.44.3.169; Krautler NJ, 2012, CELL, V150, P194, DOI 10.1016/j.cell.2012.05.032; Leskov KS, 2003, J BIOL CHEM, V278, P11590, DOI 10.1074/jbc.M209233200; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lo JC, 2006, BLOOD, V107, P1048, DOI 10.1182/blood-2005-06-2452; Mackay F, 1997, EUR J IMMUNOL, V27, P2033, DOI 10.1002/eji.1830270830; MADDEN KS, 1995, PHYSIOL REV, V75, P77, DOI 10.1152/physrev.1995.75.1.77; Matsumoto M, 1999, J IMMUNOL, V163, P1584; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Ngo VN, 2001, J EXP MED, V194, P1649, DOI 10.1084/jem.194.11.1649; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Roozendaal R, 2011, ANNU REV IMMUNOL, V29, P23, DOI 10.1146/annurev-immunol-031210-101357; Schedin P, 2004, MOL CARCINOGEN, V41, P207, DOI 10.1002/mc.20058; Shakhov AN, 2000, J LEUKOCYTE BIOL, V68, P151; SHU HB, 1993, MOL CELL BIOL, V13, P6283, DOI 10.1128/MCB.13.10.6283; Stopfer P, 2004, CLIN EXP IMMUNOL, V136, P21, DOI 10.1111/j.1365-2249.2004.02402.x; Trougakos IP, 2009, CANCER RES, V69, P403, DOI 10.1158/0008-5472.CAN-08-2912; Trougakos IP, 2013, GERONTOLOGY; Verbrugghe P, 2006, J PATHOL, V209, P240, DOI 10.1002/path.1970; Verbrugghe P, 2008, HISTOCHEM CELL BIOL, V129, P311, DOI 10.1007/s00418-007-0369-4; Vondenhoff MF, 2009, J IMMUNOL, V182, P5439, DOI 10.4049/jimmunol.0801165; Vondenhoff MFR, 2007, EUR J IMMUNOL, V37, pS46, DOI 10.1002/eji.200737528; Wellmann A, 2000, BLOOD, V96, P398; WORKMAN C, 2002, GENOME BIOL, V0003; Wyatt A, 2009, ADV CANCER RES, V104, P89, DOI 10.1016/S0065-230X(09)04006-8; Zindl CL, 2009, IMMUNITY, V30, P408, DOI 10.1016/j.immuni.2009.01.010	43	11	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98349	10.1371/journal.pone.0098349	http://dx.doi.org/10.1371/journal.pone.0098349			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865838	Green Published, gold, Green Submitted			2022-12-25	WOS:000336914100052
J	Wang, WL; Han, RM; Wan, YJ; Liu, B; Tang, XY; Liang, B; Wang, GX				Wang Wenlin; Han Ruiming; Wan Yinjing; Liu Bo; Tang Xiaoyan; Liang Bin; Wang Guoxiang			Spatio-Temporal Patterns in Rhizosphere Oxygen Profiles in the Emergent Plant Species Acorus calamus	PLOS ONE			English	Article							ROOTS; DYNAMICS; TRANSPORT; GROWTH; RICE; PHOTOSYNTHESIS; EXCRETION; DISTANCE; FLOW; L.	Rhizosphere oxygen profiles are the key to understanding the role of wetland plants in ecological remediation. Though in situ determination of the rhizosphere oxygen profiles has been performed occasionally at certain growing stages within days, comprehensive study on individual roots during weeks is still missing. Seedlings of Acorus calamus, a wetland monocot, were cultivated in silty sediment and the rhizosphere oxygen profiles were characterized at regular intervals, using micro-optodes to examine the same root at four positions along the root axis. The rhizosphere oxygen saturation culminated at 42.9% around the middle part of the root and was at its lowest level, 3.3%, at the basal part of the root near the aboveground portion. As the plant grew, the oxygen saturation at the four positions remained nearly constant until shoot height reached 15 cm. When shoot height reached 60 cm, oxygen saturation was greatest at the point halfway along the root, followed by the point three-quarters of the way down the root, the tip of the root, and the point one-quarter of the way down. Both the internal and rhizosphere oxygen saturation steadily increased, as did the thickness of stably oxidized microzones, which ranged from 20 mu m in younger seedlings to a maximum of 320 mu m in older seedlings. The spatial patterns of rhizosphere oxygen profiles in sediment contrast with those from previous studies on radial oxygen loss in A. calamus that used conventional approaches. Rhizosphere oxygen saturation peaked around the middle part of roots and the thickness of stably oxidized zones increased as the roots grew.	[Wang Wenlin; Han Ruiming; Liu Bo; Wang Guoxiang] Nanjing Normal Univ, Coll Geog Sci, Jiangsu Key Lab Environm Change & Ecol Construct, Nanjing, Jiangsu, Peoples R China; [Wang Wenlin; Tang Xiaoyan; Liang Bin] Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China; [Wan Yinjing] Jiangsu Environm Engn Consulting Ctr, Nanjing, Jiangsu, Peoples R China; [Liu Bo] Nantong Univ, Sch Geog Sci, Nantong, Peoples R China	Nanjing Normal University; Nantong University	Wang, GX (corresponding author), Nanjing Normal Univ, Coll Geog Sci, Jiangsu Key Lab Environm Change & Ecol Construct, Nanjing, Jiangsu, Peoples R China.	wangguoxiang@njnu.edu.cn			National Natural Science Foundation of China [41173078]; International Science and Technology Cooperation of China [2010DFB33960]; National Water Pollution Control and Management Technology Major Projects [2012ZX07506-007]; National Forestry Commonweal Project [200904001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation of China; National Water Pollution Control and Management Technology Major Projects; National Forestry Commonweal Project	This study was supported by the National Natural Science Foundation of China (41173078), International Science and Technology Cooperation of China (2010DFB33960), National Water Pollution Control and Management Technology Major Projects (2012ZX07506-007) and National Forestry Commonweal Project (200904001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong J, 2001, AM J BOT, V88, P1359, DOI 10.2307/3558443; Armstrong W., 1979, Advances in Botanical Research, V7, P225, DOI 10.1016/S0065-2296(08)60089-0; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; Blossfeld S, 2007, PLANT CELL ENVIRON, V30, P176, DOI 10.1111/j.1365-3040.2006.01616.x; Blossfeld S, 2011, SOIL BIOL BIOCHEM, V43, P1186, DOI 10.1016/j.soilbio.2011.02.007; Blossfeld S, 2010, PLANT SOIL, V330, P173, DOI 10.1007/s11104-009-0190-z; BRIX H, 1992, LIMNOL OCEANOGR, V37, P1420, DOI 10.4319/lo.1992.37.7.1420; Chabbi A, 2001, ENVIRON EXP BOT, V46, P237, DOI 10.1016/S0098-8472(01)00101-0; Colmer TD, 2008, NEW PHYTOL, V178, P326, DOI 10.1111/j.1469-8137.2007.02364.x; Colmer TD, 2003, PLANT CELL ENVIRON, V26, P17, DOI 10.1046/j.1365-3040.2003.00846.x; Connell EL, 1999, AQUAT BOT, V63, P219, DOI 10.1016/S0304-3770(98)00126-0; Deng H, 2004, ENVIRON POLLUT, V132, P29, DOI 10.1016/j.envpol.2004.03.030; [邓泓 DENG Hong], 2007, [华东师范大学学报. 自然科学版, Journal of East China Normal University. Natural Science], P69; Frederiksen MS, 2006, LIMNOL OCEANOGR, V51, P1072, DOI 10.4319/lo.2006.51.2.1072; Gansert D, 2001, PLANT CELL ENVIRON, V24, P1055, DOI 10.1046/j.1365-3040.2001.00751.x; GROSSE W, 1991, AQUAT BOT, V39, P89, DOI 10.1016/0304-3770(91)90024-Y; Han RM, 2012, PLANT GROWTH REGUL, V68, P97, DOI 10.1007/s10725-012-9697-z; Huang Danping, 2012, Hupo Kexue, V24, P83; Inoue TM, 2008, LIMNOLOGY, V9, P207, DOI 10.1007/s10201-008-0253-5; Jacob DL, 2004, ENVIRON POLLUT, V130, P337, DOI 10.1016/j.envpol.2004.01.006; Jensen SI, 2005, MAR ECOL PROG SER, V293, P49, DOI 10.3354/meps293049; Lai WL, 2012, ECOL ENG, V39, P24, DOI 10.1016/j.ecoleng.2011.11.010; Laskov C, 2006, AQUAT BOT, V84, P333, DOI 10.1016/j.aquabot.2005.12.005; Li YL, 2013, PLANT SOIL, V365, P115, DOI 10.1007/s11104-012-1378-1; Lu MD, 2002, HYDROPHYTIC BIOL FRE, P46; Macek, 2006, PHYTOREMEDIATION RHI, P57; Mainiero R, 2005, PLANT SOIL, V270, P311, DOI 10.1007/s11104-004-1724-z; Pedersen O, 1998, MAR ECOL PROG SER, V169, P283, DOI 10.3354/meps169283; Peverill K., 1999, SOIL ANAL INTERPRETA; Pi N, 2010, ENVIRON POLLUT, V158, P381, DOI 10.1016/j.envpol.2009.09.004; Pi N, 2009, AQUAT BOT, V90, P222, DOI 10.1016/j.aquabot.2008.10.002; [曲久辉 QU Jiuhui], 2009, [环境科学学报, Acta Scientiae Circumstantiae], V29, P2; REDDY KR, 1990, J ENVIRON QUAL, V19, P261, DOI 10.2134/jeq1990.00472425001900020011x; Revsbech NP, 1998, LIMNOL OCEANOGR, V43, P986, DOI 10.4319/lo.1998.43.5.0986; Schreiber CM, 2012, J PLANT NUTR SOIL SC, V175, P761, DOI 10.1002/jpln.201000427; Visser EJW, 2000, PLANT CELL ENVIRON, V23, P1237, DOI 10.1046/j.1365-3040.2000.00628.x; Vojtiskova L, 2004, HYDROBIOLOGIA, V518, P9, DOI 10.1023/B:HYDR.0000025052.81373.f3; Weis JS, 2004, ENVIRON INT, V30, P685, DOI 10.1016/j.envint.2003.11.002; Wu ZB, 2000, ACTA PHYSL SIN, V26, P177; Xia Jin, 2012, Journal of Ecology and Rural Environment, V28, P422; Zhao YJ, 2011, ECOL ENG, V37, P1546, DOI 10.1016/j.ecoleng.2011.06.005	41	7	11	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98457	10.1371/journal.pone.0098457	http://dx.doi.org/10.1371/journal.pone.0098457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866504	Green Published, gold			2022-12-25	WOS:000336914100060
J	Janes, K; Little, JW; Li, C; Bryant, L; Chen, C; Chen, ZM; Kamocki, K; Doyle, T; Snider, A; Esposito, E; Cuzzocrea, S; Bieberich, E; Obeid, L; Petrache, I; Nicol, G; Neumann, WL; Salvemini, D				Janes, Kali; Little, Joshua W.; Li, Chao; Bryant, Leesa; Chen, Collin; Chen, Zhoumou; Kamocki, Krzysztof; Doyle, Timothy; Snider, Ashley; Esposito, Emanuela; Cuzzocrea, Salvatore; Bieberich, Erhard; Obeid, Lina; Petrache, Irina; Nicol, Grant; Neumann, William L.; Salvemini, Daniela			The Development and Maintenance of Paclitaxel-induced Neuropathic Pain Require Activation of the Sphingosine 1-Phosphate Receptor Subtype 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NERVE GROWTH-FACTOR; PERIPHERAL NEUROPATHY; S1P(1) RECEPTOR; PROTEIN-KINASE; LYMPHOCYTE EGRESS; SENSORY NEURONS; NITRIC-OXIDE; DORSAL-HORN; SPINAL-CORD	The ceramide-sphingosine 1-phosphate (S1P) rheostat is important in regulating cell fate. Several chemotherapeutic agents, including paclitaxel (Taxol), involve pro-apoptotic ceramide in their anticancer effects. The ceramide-to-S1P pathway is also implicated in the development of pain, raising the intriguing possibility that these sphingolipids may contribute to chemotherapy-induced painful peripheral neuropathy, which can be a critical dose-limiting side effect of many widely used chemotherapeutic agents. We demonstrate that the development of paclitaxel-induced neuropathic pain was associated with ceramide and S1P formation in the spinal dorsal horn that corresponded with the engagement of S1P receptor subtype 1 (S1PR(1))-dependent neuroinflammatory processes as follows: activation of redox-sensitive transcription factors (NF kappa B) and MAPKs (ERK and p38) as well as enhanced formation of pro-inflammatory and neuroexcitatory cytokines (TNF-alpha and IL-1 beta). Intrathecal delivery of the S1PR1 antagonist W146 reduced these neuroinflammatory processes but increased IL-10 and IL-4, potent anti-inflammatory/neuroprotective cytokines. Additionally, spinal W146 reversed established neuropathic pain. Noteworthy, systemic administration of the S1PR1 modulator FTY720 (Food and Drug Administration-approved for multiple sclerosis) attenuated the activation of these neuroinflammatory processes and abrogated neuropathic pain without altering anticancer properties of paclitaxel and with beneficial effects extended to oxaliplatin. Similar effects were observed with other structurally and chemically unrelated S1PR1 modulators (ponesimod and CYM-5442) and S1PR1 antagonists (NIBR-14/15) but not S1PR1 agonists (SEW2871). Our findings identify for the first time the S1P/S1PR(1) axis as a promising molecular and therapeutic target in chemotherapy-induced painful peripheral neuropathy, establish a mechanistic insight into the biomolecular signaling pathways, and provide the rationale for the clinical evaluation of FTY720 in chronic pain patients.	[Janes, Kali; Little, Joshua W.; Bryant, Leesa; Chen, Collin; Chen, Zhoumou; Doyle, Timothy; Salvemini, Daniela] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA; [Li, Chao; Nicol, Grant] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Kamocki, Krzysztof; Petrache, Irina] Indiana Univ Sch Med, Dept Biochem & Mol Biol & Med, Indianapolis, IN 46202 USA; [Snider, Ashley; Obeid, Lina] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Snider, Ashley; Obeid, Lina] Northport Vet Affairs Med Ctr, Northport, NY 11768 USA; [Esposito, Emanuela; Cuzzocrea, Salvatore] Univ Messina, Dept Clin & Expt Med & Pharmacol, I-98122 Messina, Italy; [Bieberich, Erhard] Georgia Regents Univ, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Neumann, William L.] So Illinois Univ, Sch Pharm, Dept Pharmaceut Sci, Edwardsville, IL 62026 USA	Saint Louis University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Messina; University System of Georgia; Augusta University; Southern Illinois University System; Southern Illinois University Edwardsville	Salvemini, D (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 South Grand Blvd, St Louis, MO 63104 USA.	salvemd@slu.edu	Petrache, Irina/AAZ-9648-2020	obeid, lina/0000-0002-0734-0847; Esposito, Emanuela/0000-0002-2663-6387; Cuzzocrea, Salvatore/0000-0001-6131-3690	Research Facilities Improvement Program from the National Center for Research Resources, National Institutes of Health [C06 RR015481-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015481] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077328] Funding Source: NIH RePORTER	Research Facilities Improvement Program from the National Center for Research Resources, National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr Gary J. Bennett (McGill University, Montreal, Canada) for pertinent insight, guidance, and helpful suggestions with the writing of this paper. The studies performed in GDN's laboratory were conducted in a facility constructed with support from Research Facilities Improvement Program Grant C06 RR015481-01 from the National Center for Research Resources, National Institutes of Health.	Adan-Gokbulut A, 2013, CURR MED CHEM, V20, P108; Angst D, 2012, J MED CHEM, V55, P9722, DOI 10.1021/jm3009508; Bennett GJ, 2010, ONCOLOGIST, V15, P9, DOI 10.1634/theoncologist.2009-S503; Bigaud M., 2013, BIOCHIM BIOPHYS ACTA, P745; Blondeau N, 2007, J NEUROCHEM, V103, P509, DOI 10.1111/j.1471-4159.2007.04755.x; Bolli MH, 2010, J MED CHEM, V53, P4198, DOI 10.1021/jm100181s; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Brossard P, 2013, BRIT J CLIN PHARMACO, V76, P888, DOI 10.1111/bcp.12129; Burgos E, 2012, EUR J PHARMACOL, V682, P62, DOI 10.1016/j.ejphar.2012.02.008; Cata JP, 2006, MINERVA ANESTESIOL, V72, P151; Cata JP, 2006, NEUROSCIENCE, V138, P329, DOI 10.1016/j.neuroscience.2005.11.009; Chen ZM, 2012, FASEB J, V26, P1855, DOI 10.1096/fj.11-201541; Chi XX, 2010, J NEUROPHYSIOL, V104, P2741, DOI 10.1152/jn.00709.2010; Choi JI, 2010, PAIN, V149, P243, DOI 10.1016/j.pain.2010.02.008; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Coste O, 2008, J BIOL CHEM, V283, P32442, DOI 10.1074/jbc.M806410200; Coste O, 2008, J CELL MOL MED, V12, P995, DOI 10.1111/j.1582-4934.2008.00160.x; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74; Dahan L, 2009, BRIT J PHARMACOL, V158, P610, DOI 10.1111/j.1476-5381.2009.00341.x; Daniel C, 2007, J IMMUNOL, V178, P2458, DOI 10.4049/jimmunol.178.4.2458; Daulhac L, 2006, MOL PHARMACOL, V70, P1246, DOI 10.1124/mol.106.025478; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Dobrowsky RT, 2001, METHOD CELL BIOL, V66, P135; Doyle T, 2011, FASEB J, V25, P2782, DOI 10.1096/fj.10-178095; Doyle T, 2011, NEUROSCI LETT, V499, P4, DOI 10.1016/j.neulet.2011.05.018; Doyle T, 2012, J NEUROSCI, V32, P6149, DOI 10.1523/JNEUROSCI.6343-11.2012; Durafourt BA, 2011, J NEUROIMMUNOL, V230, P10, DOI 10.1016/j.jneuroim.2010.08.006; Farquhar-Smith Paul, 2011, Curr Opin Support Palliat Care, V5, P1, DOI 10.1097/SPC.0b013e328342f9cc; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Ferrier J, 2013, CURR PAIN HEADACHE R, V17, DOI 10.1007/s11916-013-0364-5; Finley A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055255; Flatters SJL, 2006, PAIN, V122, P245, DOI 10.1016/j.pain.2006.01.037; Foster CA, 2007, J PHARMACOL EXP THER, V323, P469, DOI 10.1124/jpet.107.127183; Fryer RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052985; Gao M, 2013, NEUROSCIENCE, V254, P301, DOI 10.1016/j.neuroscience.2013.09.033; Gonzalez-Cabrera PJ, 2008, MOL PHARMACOL, V74, P1308, DOI 10.1124/mol.108.049783; Gonzalez-Cabrera PJ, 2012, MOL PHARMACOL, V81, P166, DOI 10.1124/mol.111.076109; Groves A, 2013, J NEUROL SCI, V328, P9, DOI 10.1016/j.jns.2013.02.011; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Huwiler A, 2003, BIOL CHEM, V384, P1379, DOI 10.1515/BC.2003.154; Itamochi H, 2011, CLIN CANCER RES, V17, P4742, DOI 10.1158/1078-0432.CCR-11-0190; Jackson SJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-76; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Jin SX, 2003, J NEUROSCI, V23, P4017; Joseph EK, 2004, EUR J NEUROSCI, V20, P2896, DOI 10.1111/j.1460-9568.2004.03750.x; Kriedt Christopher L, 2010, J Exp Ther Oncol, V8, P287; Krishnamurthy K, 2007, J LIPID RES, V48, P968, DOI 10.1194/jlr.D600043-JLR200; Lee MK, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-57; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Little JW, 2012, J NEUROSCI, V32, P10797, DOI 10.1523/JNEUROSCI.6345-11.2012; Mair N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017268; Marvizon JCG, 2009, J COMP NEUROL, V517, P51, DOI 10.1002/cne.22130; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Meno-Tetang GML, 2006, DRUG METAB DISPOS, V34, P1480, DOI 10.1124/dmd.105.009001; Muscoli C, 2010, J NEUROSCI, V30, P15400, DOI 10.1523/JNEUROSCI.2391-10.2010; Nayak D, 2010, NEUROSCIENCE, V166, P132, DOI 10.1016/j.neuroscience.2009.12.020; Ndengele MM, 2009, J PHARMACOL EXP THER, V329, P64, DOI 10.1124/jpet.108.146290; Nicol Grant D., 2008, Shengli Xuebao, V60, P603; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Paterniti I, 2012, SURGERY, V152, P90, DOI 10.1016/j.surg.2012.02.004; Patti GJ, 2012, NAT CHEM BIOL, V8, P232, DOI [10.1038/nchembio.767, 10.1038/NCHEMBIO.767]; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perrotta C, 2010, PHYSIOLOGY, V25, P64, DOI 10.1152/physiol.00048.2009; Peters CM, 2007, EXP NEUROL, V203, P42, DOI 10.1016/j.expneurol.2006.07.022; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Salvemini D, 2013, TRENDS PHARMACOL SCI, V34, P110, DOI 10.1016/j.tips.2012.12.001; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shah MR, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-84; Snider AJ, 2010, BIOCHIMIE, V92, P707, DOI 10.1016/j.biochi.2010.02.008; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Storkson RV, 1996, J NEUROSCI METH, V65, P167, DOI 10.1016/0165-0270(95)00164-6; Verzijl D, 2010, MOL CELLS, V29, P99, DOI 10.1007/s10059-010-0041-z; Wang XM, 2012, CYTOKINE, V59, P3, DOI 10.1016/j.cyto.2012.03.027; Warwick RA, 2013, EUR J PAIN, V17, P571, DOI 10.1002/j.1532-2149.2012.00219.x; Welch SP, 2012, BIOCHEM PHARMACOL, V84, P1551, DOI 10.1016/j.bcp.2012.08.010; Weng HR, 2005, NEUROSCI LETT, V386, P18, DOI 10.1016/j.neulet.2005.05.049; WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9; Won JS, 2006, FREE RADICAL BIO MED, V40, P1875, DOI 10.1016/j.freeradbiomed.2006.01.035; Xiao WH, 2012, NEUROSCIENCE, V203, P194, DOI 10.1016/j.neuroscience.2011.12.023; Yan XS, 2013, J BIOL CHEM, V288, P30544, DOI 10.1074/jbc.M113.495465; Youle M, 2007, HIV MED, V8, P241, DOI 10.1111/j.1468-1293.2007.00467.x; Zhang H., 2012, J PAIN, V3, P239; Zhang YH, 2006, J PHYSIOL-LONDON, V575, P101, DOI 10.1113/jphysiol.2006.111575; Zhang YH, 2004, NEUROSCI LETT, V366, P187, DOI 10.1016/j.neulet.2004.05.042; Zheng FY, 2011, NEUROSCIENCE, V176, P447, DOI 10.1016/j.neuroscience.2010.12.052	91	93	101	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					21082	21097		10.1074/jbc.M114.569574	http://dx.doi.org/10.1074/jbc.M114.569574			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24876379	hybrid, Green Published			2022-12-25	WOS:000339396600059
J	Watanabe, R; Matsukage, Y; Yukawa, A; Tabata, KV; Noji, H				Watanabe, Rikiya; Matsukage, Yuki; Yukawa, Ayako; Tabata, Kazuhito V.; Noji, Hiroyuki			Robustness of the Rotary Catalysis Mechanism of F-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP SYNTHASE; ESCHERICHIA-COLI; TORQUE GENERATION; F0F1-ATP SYNTHASE; PHOSPHATE RELEASE; MOLECULAR MOTOR; F-1 MOTOR; ROTATION; SUBUNIT; MYOSIN	F-1-ATPase (F-1) is the rotary motor protein fueled by ATP hydrolysis. Previous studies have suggested that three charged residues are indispensable for catalysis of F-1 as follows: the P-loop lysine in the phosphate-binding loop, GXXXXGK(T/S); a glutamic acid that activates water molecules for nucleophilic attack on the gamma-phosphate of ATP (general base); and an arginine directly contacting the gamma-phosphate (arginine finger). These residues are well conserved among P-loop NTPases. In this study, we investigated the role of these charged residues in catalysis and torque generation by analyzing alanine-substituted mutants in the single-molecule rotation assay. Surprisingly, all mutants continuously drove rotary motion, even though the rotational velocity was at least 100,000 times slower than that of wild type. Thus, although these charged residues contribute to highly efficient catalysis, they are not indispensable to chemo-mechanical energy coupling, and the rotary catalysis mechanism of F-1 is far more robust than previously thought.	[Watanabe, Rikiya; Yukawa, Ayako; Tabata, Kazuhito V.; Noji, Hiroyuki] Univ Tokyo, Dept Appl Chem, Tokyo 1138656, Japan; [Watanabe, Rikiya; Tabata, Kazuhito V.] Japan Sci & Technol Agcy, PRESTO, Bunkyo Ku, Tokyo 1138656, Japan; [Matsukage, Yuki] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Osaka University	Noji, H (corresponding author), Univ Tokyo, Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan.	hnoji@appchem.t.u-tokyo.ac.jp	Watanabe, Rikiya/AAO-1390-2021; 田端, 和仁/GON-3471-2022	Watanabe, Rikiya/0000-0001-7146-2745; 田端, 和仁/0000-0002-0463-1374	Ministry of Education, Culture, Sports, Science and Technology, Japan [18074005, 30540108]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research 18074005 (to H. N.) and 30540108 (to R. W.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; AMANO T, 1994, FEBS LETT, V348, P93, DOI 10.1016/0014-5793(94)00588-5; Bilyard T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0023; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cherepanov DA, 2001, BIOPHYS J, V81, P1234, DOI 10.1016/S0006-3495(01)75781-5; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Dittrich M, 2004, BIOPHYS J, V87, P2954, DOI 10.1529/biophysj.104.046128; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hayashi K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218103; Hayashi S, 2012, J AM CHEM SOC, V134, P8447, DOI 10.1021/ja211027m; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Iko Y, 2001, J BIOL CHEM, V276, P47508, DOI 10.1074/jbc.M108803200; Itoh H, 2004, NATURE, V427, P465, DOI 10.1038/nature02212; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; Kohori A, 2011, BIOPHYS J, V101, P188, DOI 10.1016/j.bpj.2011.05.008; Komoriya Y, 2012, J BIOL CHEM, V287, P15134, DOI 10.1074/jbc.M111.328153; Le NP, 2000, BIOCHEMISTRY-US, V39, P2778, DOI 10.1021/bi992530h; Li XD, 1998, J BIOL CHEM, V273, P27404, DOI 10.1074/jbc.273.42.27404; Lobau S, 1997, J BIOL CHEM, V272, P3648, DOI 10.1074/jbc.272.6.3648; Martin JL, 2014, P NATL ACAD SCI USA, V111, P3715, DOI 10.1073/pnas.1317784111; McGrath MJ, 2013, J AM CHEM SOC, V135, P8908, DOI 10.1021/ja401540g; Mukherjee S, 2011, P NATL ACAD SCI USA, V108, P20550, DOI 10.1073/pnas.1117024108; Muneyuki E, 2000, BBA-BIOENERGETICS, V1458, P467, DOI 10.1016/S0005-2728(00)00095-5; NAKAMOTO RK, 1992, ANN NY ACAD SCI, V671, P335, DOI 10.1111/j.1749-6632.1992.tb43807.x; Noji H, 2001, J BIOL CHEM, V276, P25480, DOI 10.1074/jbc.M102200200; Okuno D, 2010, EUR BIOPHYS J BIOPHY, V39, P1589, DOI 10.1007/s00249-010-0616-9; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SENIOR AE, 1992, J BIOL CHEM, V267, P21471; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Spetzler D, 2009, BIOCHEMISTRY-US, V48, P7979, DOI 10.1021/bi9008215; Sun Y, 2010, NAT STRUCT MOL BIOL, V17, P485, DOI 10.1038/nsmb.1785; Tanigawara M, 2012, BIOPHYS J, V103, P970, DOI 10.1016/j.bpj.2012.06.054; Usukura E, 2012, J BIOL CHEM, V287, P1884, DOI 10.1074/jbc.M111.305938; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Watanabe R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4486; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI 10.1038/NCHEMBIO.443; Weber J, 2010, NAT CHEM BIOL, V6, P794, DOI 10.1038/nchembio.458; Yagi H, 2009, J BIOL CHEM, V284, P2374, DOI 10.1074/jbc.M808212200; Yang W, 2003, P NATL ACAD SCI USA, V100, P874, DOI 10.1073/pnas.0337432100; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	48	7	7	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19331	19340		10.1074/jbc.M114.569905	http://dx.doi.org/10.1074/jbc.M114.569905			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24876384	Green Published, hybrid			2022-12-25	WOS:000339326800010
J	McQueen, CM; Doan, R; Dindot, SV; Bourquin, JR; Zlatev, ZZ; Chaffin, MK; Blodgett, GP; Ivanov, I; Cohen, ND				McQueen, Cole M.; Doan, Ryan; Dindot, Scott V.; Bourquin, Jessica R.; Zlatev, Zlatomir Z.; Chaffin, M. Keith; Blodgett, Glenn P.; Ivanov, Ivan; Cohen, Noah D.			Identification of Genomic Loci Associated with Rhodococcus equi Susceptibility in Foals	PLOS ONE			English	Article							COPY NUMBER VARIATION; SINGLE NUCLEOTIDE POLYMORPHISMS; WIDE ASSOCIATION; CYTOKINE EXPRESSION; VARIANT ANALYSIS; BREEDING FARMS; IN-VITRO; PNEUMONIA; NEUTROPHILS; INFECTION	Pneumonia caused by Rhodococcus equi is a common cause of disease and death in foals. Although agent and environmental factors contribute to the incidence of this disease, the genetic factors influencing the clinical outcomes of R. equi pneumonia are ill-defined. Here, we performed independent single nucleotide polymorphism (SNP)-and copy number variant (CNV)-based genome-wide association studies to identify genomic loci associated with R. equi pneumonia in foals. Foals at a large Quarter Horse breeding farm were categorized into 3 groups: 1) foals with R. equi pneumonia (clinical group [N = 43]); 2) foals with ultrasonographic evidence of pulmonary lesions that never developed clinical signs of pneumonia (subclinical group [N = 156]); and, 3) foals without clinical signs or ultrasonographic evidence of pneumonia (unaffected group [N = 49]). From each group, 24 foals were randomly selected and used for independent SNP-and CNV-based genome-wide association studies (GWAS). The SNP-based GWAS identified a region on chromosome 26 that had moderate evidence of association with R. equi pneumonia when comparing clinical and subclinical foals. A joint analysis including all study foals revealed a 3- to 4-fold increase in odds of disease for a homozygous SNP within the associated region when comparing the clinical group with either of the other 2 groups of foals or their combination. The region contains the transient receptor potential cation channel, subfamily M, member 2 (TRPM2) gene, which is involved in neutrophil function. No associations were identified in the CNV-based GWAS. Collectively, these data identify a region on chromosome 26 associated with R. equi pneumonia in foals, providing evidence that genetic factors may indeed contribute to this important disease of foals.	[McQueen, Cole M.; Bourquin, Jessica R.; Chaffin, M. Keith; Cohen, Noah D.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX 77843 USA; [Doan, Ryan; Dindot, Scott V.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX USA; [Dindot, Scott V.] Texas A&M Univ, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Zlatev, Zlatomir Z.] Texas A&M Univ, Dept Elect & Comp Engn, Dwight Look Coll Engn, College Stn, TX USA; [Blodgett, Glenn P.] 6666 Ranch, Guthrie, TX USA; [Ivanov, Ivan] Texas A&M Univ, Dept Vet Physiol & Pharmacol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Cohen, ND (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX 77843 USA.	ncohen@cvm.tamu.edu		Mcqueen, Cole/0000-0002-9557-3068	Morris Animal Foundation; Link Equine Research Endowment; American Quarter Horse Foundation; USDA-NIFA [2011-68004-30367]	Morris Animal Foundation; Link Equine Research Endowment; American Quarter Horse Foundation; USDA-NIFA(United States Department of Agriculture (USDA))	Supported by a grant from the Morris Animal Foundation. Additional funding was provided by the Link Equine Research Endowment. Blood sample collection was made possible by a grant from the American Quarter Horse Foundation. Cole McQueen (CMM) was supported by a grant from the USDA-NIFA #2011-68004-30367. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2007, PATHOLOGIC BASIS VET, P120; Ainsworth DM, 1998, J AM VET MED ASSOC, V213, P510; ARDANS AA, 1986, P AM ASS EQUINE PRAC, V32, P129; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bordin AI, 2012, VET IMMUNOL IMMUNOP, V145, P290, DOI 10.1016/j.vetimm.2011.11.012; Brosnahan MM, 2010, EQUINE VET J, V42, P658, DOI 10.1111/j.2042-3306.2010.00166.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Chaffin MK, 2004, VET IMMUNOL IMMUNOP, V100, P33, DOI 10.1016/j.vetimm.2004.02.010; Chaffin MK, 2003, J AM VET MED ASSOC, V222, P467, DOI 10.2460/javma.2003.222.467; Cohen ND, 2012, AM J VET RES, V73, P1603, DOI 10.2460/ajvr.73.10.1603; Corbin LJ, 2012, MAMM GENOME, V23, P294, DOI 10.1007/s00335-011-9363-1; Dawson TRMY, 2010, VET IMMUNOL IMMUNOP, V135, P1, DOI 10.1016/j.vetimm.2009.12.004; Doan R, 2012, GENOME RES, V22, P899, DOI 10.1101/gr.128991.111; Doan R, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-78; Dupuis MC, 2013, ANIM GENET, V44, P206, DOI 10.1111/j.1365-2052.2012.02373.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Giguere S, 2011, J VET INTERN MED, V25, P1221, DOI 10.1111/j.1939-1676.2011.00804.x; Giguere S, 2011, J VET INTERN MED, V25, P1209, DOI 10.1111/j.1939-1676.2011.00835.x; Gokcumen O, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r52; Graves KT, 2009, ANIM GENET, V40, P35, DOI 10.1111/j.1365-2052.2008.01795.x; Halbert ND, 2006, J VET INTERN MED, V20, P974, DOI 10.1892/0891-6640(2006)20[974:VIESNG]2.0.CO;2; Heller MC, 2010, VET IMMUNOL IMMUNOP, V136, P144, DOI 10.1016/j.vetimm.2010.02.016; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Horin P, 2010, INT J IMMUNOGENET, V37, P67, DOI 10.1111/j.1744-313X.2009.00890.x; Hou Y, 2012, FUNCT INTEGR GENOMIC, P1; Hou YL, 2012, FUNCT INTEGR GENOMIC, V12, P81, DOI 10.1007/s10142-011-0252-1; Kato M, 2010, HUM MOL GENET, V19, P761, DOI 10.1093/hmg/ddp541; Lee T, 2013, BMB REP, V46, P346, DOI 10.5483/BMBRep.2013.46.7.211; Liu GE, 2011, MAMM GENOME, V22, P111, DOI 10.1007/s00335-010-9308-0; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Liu M, 2009, CYTOKINE, V48, P280, DOI 10.1016/j.cyto.2009.08.012; Luo J, 2013, G3-GENES GENOM GENET, V3, P217, DOI 10.1534/g3.112.005132; Lykkjen S, 2013, ANIM GENET, V44, P766, DOI 10.1111/age.12064; Lykkjen S, 2010, ANIM GENET, V41, P111, DOI 10.1111/j.1365-2052.2010.02117.x; Lyons MJ, 2004, TUBERCULOSIS, V84, P283, DOI 10.1016/j.tube.2003.09.003; MARTENS RJ, 1989, EQUINE VET J, V21, P249, DOI 10.1111/j.2042-3306.1989.tb02161.x; Martens RJ, 2005, INFECT IMMUN, V73, P7040, DOI 10.1128/IAI.73.10.7040-7042.2005; Metzger J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-487; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Mousel MR, 2003, J VET DIAGN INVEST, V15, P470, DOI 10.1177/104063870301500512; Nerren JR, 2009, VET IMMUNOL IMMUNOP, V127, P212, DOI 10.1016/j.vetimm.2008.10.004; Nicholas TJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-414; Nicholas TJ, 2009, GENOME RES, V19, P491, DOI 10.1101/gr.084715.108; Petersen JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003211; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raudsepp T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003139; Signer-Hasler H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037282; Slovis N.M., 2005, P AM ASS EQUINE PRAC, V51; Tateda K, 2001, INFECT IMMUN, V69, P2017, DOI 10.1128/IAI.69.4.2017-2024.2001; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vazquez AI, 2010, J ANIM SCI, V88, P497, DOI 10.2527/jas.2009-1952; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Zhang W, 2003, J BIOL CHEM, V278, P16222, DOI 10.1074/jbc.M300298200	56	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98710	10.1371/journal.pone.0098710	http://dx.doi.org/10.1371/journal.pone.0098710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892408	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400086
J	Young, ME; Webb, TL; Rung, JM; McCoy, AW				Young, Michael E.; Webb, Tara L.; Rung, Jillian M.; McCoy, Anthony W.			Outcome Probability versus Magnitude: When Waiting Benefits One at the Cost of the Other	PLOS ONE			English	Article							RISK-TASK BART; ESCALATING INTEREST TASK; INNER-CITY ADOLESCENTS; BEHAVIORAL MEASURES; CONSTRUCT-VALIDITY; IMPULSIVITY; CHOICE; DELAY; UNCERTAINTY; REWARDS	Using a continuous impulsivity and risk platform (CIRP) that was constructed using a video game engine, choice was assessed under conditions in which waiting produced a continuously increasing probability of an outcome with a continuously decreasing magnitude (Experiment 1) or a continuously increasing magnitude of an outcome with a continuously decreasing probability (Experiment 2). Performance in both experiments reflected a greater desire for a higher probability even though the corresponding wait times produced substantive decreases in overall performance. These tendencies are considered to principally reflect hyperbolic discounting of probability, power discounting of magnitude, and the mathematical consequences of different response rates. Behavior in the CIRP is compared and contrasted with that in the Balloon Analogue Risk Task (BART).	[Young, Michael E.; McCoy, Anthony W.] Kansas State Univ, Manhattan, KS 66506 USA; [Webb, Tara L.] So Illinois Univ, Carbondale, IL 62901 USA; [Rung, Jillian M.] Utah State Univ, Logan, UT 84322 USA	Kansas State University; Southern Illinois University System; Southern Illinois University; Utah System of Higher Education; Utah State University	Young, ME (corresponding author), Kansas State Univ, Manhattan, KS 66506 USA.	michaelyoung@ksu.edu		Young, Michael/0000-0003-1493-9548	National Institute for Drug Abuse (NIDA) [1R15-D026290]	National Institute for Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	The study was funded by the National Institute for Drug Abuse (NIDA 1R15-D026290, www.drugabuse.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklin WM, 2005, BEHAV RES THER, V43, P215, DOI 10.1016/j.brat.2003.12.007; CHAPMAN GB, 1995, MED DECIS MAKING, V15, P373, DOI 10.1177/0272989X9501500408; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Dougherty DM, 2005, BEHAV RES METHODS, V37, P82, DOI 10.3758/BF03206401; Green L, 2004, PSYCHOL BULL, V130, P769, DOI 10.1037/0033-2909.130.5.769; Hopko DR, 2006, J PSYCHOPATHOL BEHAV, V28, P95, DOI 10.1007/s10862-006-7487-5; Hunt MK, 2005, ASSESSMENT, V12, P416, DOI 10.1177/1073191105278740; Kahneman D., 1979, ECONOMETRICA, V47, P313, DOI DOI 10.2307/1914185; Lakshminarayanan VR, 2011, J EXP SOC PSYCHOL, V47, P689, DOI 10.1016/j.jesp.2010.12.011; Lejuez CW, 2007, J CLIN CHILD ADOLESC, V36, P106, DOI 10.1207/s15374424jccp3601_11; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; LOEWENSTEIN GF, 1988, MANAGE SCI, V34, P200, DOI 10.1287/mnsc.34.2.200; Lynam D. R., 2006, UNPUB; Miller J, 2003, PERS INDIV DIFFER, V34, P1403, DOI 10.1016/S0191-8869(02)00122-8; Okasha S, 2007, J PHILOS, V104, P217, DOI 10.5840/jphil2007104523; Paglieri F, 2013, J EXPT ANAL BEHAV; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pinheiro JC, 2004, MIXED EFFECTS MODELS; Pleskac TJ, 2008, EXP CLIN PSYCHOPHARM, V16, P555, DOI 10.1037/a0014245; RACHLIN H, 1991, J EXP ANAL BEHAV, V55, P233, DOI 10.1901/jeab.1991.55-233; Reynolds B, 2006, PHARMACOL BIOCHEM BE, V83, P194, DOI 10.1016/j.pbb.2006.01.007; Shead NW, 2009, J EXP ANAL BEHAV, V92, P1, DOI 10.1901/jeab.2009.92-1; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Wallsten TS, 2005, PSYCHOL REV, V112, P862, DOI 10.1037/0033-295X.112.4.862; Weber BJ, 2005, ORGAN BEHAV HUM DEC, V96, P104, DOI 10.1016/j.obhdp.2005.01.001; Young ME, 2013, J EXP ANAL BEHAV, V99, P335, DOI 10.1002/jeab.24; Young ME, 2013, PSYCHON B REV, V20, P302, DOI 10.3758/s13423-012-0350-7; Young ME, 2012, BEHAV RES METHODS, V44, P176, DOI 10.3758/s13428-011-0133-5; Young ME, 2011, BEHAV PROCESS, V88, P101, DOI 10.1016/j.beproc.2011.08.003	30	7	7	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98996	10.1371/journal.pone.0098996	http://dx.doi.org/10.1371/journal.pone.0098996			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24892657	gold, Green Published, Green Submitted			2022-12-25	WOS:000336911400118
J	Zhang, W; Han, ZX; Guo, QL; Liu, Y; Zheng, YX; Wu, FL; Jin, WB				Zhang, Wei; Han, Zhaoxue; Guo, Qingli; Liu, Yu; Zheng, Yuxian; Wu, Fangli; Jin, Weibo			Identification of Maize Long Non-Coding RNAs Responsive to Drought Stress	PLOS ONE			English	Article							MESSENGER-RNA; PLANT DEVELOPMENT; GENOME-WIDE; MICRORNAS; ARABIDOPSIS; PROTEIN; ROLES; SEQ; TRANSCRIPTOMES; ENVIRONMENTS	Long non-coding RNAs (lncRNAs) represent a class of riboregulators that either directly act in long form or are processed to shorter miRNAs and siRNAs. Emerging evidence shows that lncRNAs participate in stress responsive regulation. In this study, to identify the putative maize lncRNAs responsive to drought stress, 8449 drought responsive transcripts were first uploaded to the Coding Potential Calculator website for classification as protein coding or non-coding RNAs, and 1724 RNAs were identified as potential non-coding RNAs. A Perl script was written to screen these 1724 ncRNAs and 664 transcripts were ultimately identified as drought-responsive lncRNAs. Of these 664 transcripts, 126 drought-responsive lncRNAs were highly similar to known maize lncRNAs; the remaining 538 transcripts were considered as novel lncRNAs. Among the 664 lncRNAs identified as drought responsive, 567 were upregulated and 97 were downregulated in drought-stressed leaves of maize. 8 lncRNAs were identified as miRNA precursor lncRNAs, 62 were classified as both shRNA and siRNA precursors, and 279 were classified as siRNA precursors. The remaining 315 lncRNAs were classified as other lncRNAs that are likely to function as longer molecules. Among these 315 lncRNAs, 10 are identified as antisense lncRNAs and 7 could pair with 17 CDS sequences with near-perfect matches. Finally, RT-qPCR results confirmed that all selected lncRNAs could respond to drought stress. These findings extend the current view on lncRNAs as ubiquitous regulators under stress conditions.	[Zhang, Wei; Han, Zhaoxue; Guo, Qingli; Liu, Yu; Zheng, Yuxian; Jin, Weibo] Northwest A&F Univ, Coll Life Sci, Yangling, Peoples R China; [Wu, Fangli; Jin, Weibo] Zhejiang Sci Tech Univ, Coll Life Sci, Inst Bioengn, Hangzhou, Zhejiang, Peoples R China	Northwest A&F University - China; Zhejiang Sci-Tech University	Jin, WB (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Peoples R China.	weibojin@gmail.com		Guo, Qingli/0000-0001-8467-8828; Han, Zhaoxue/0000-0002-6935-9535	Natural Science Foundation of China [31000913, 31372075, 31201268]; Fundamental Research Funds for the Central Universities [QN2011095]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Natural Science Foundation of China (grant No. 31000913, 31372075 and 31201268), and the website is http://isisn.nsfc.gov.cn/egrantweb/. This work was also supported by the Fundamental Research Funds for the Central Universities (grant No. QN2011095), the website is http://www.dost.moe.edu.cn/dostmoe/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, ANN STAT, V29, P1165; Boerner S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043047; Campalans A, 2004, PLANT CELL, V16, P1047, DOI 10.1105/tpc.019406; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; de Lima JC, 2012, GENET MOL BIOL, V35, P1069, DOI 10.1590/S1415-47572012000600023; Deikman J, 2012, CURR OPIN BIOTECH, V23, P243, DOI 10.1016/j.copbio.2011.11.003; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fu FengLing, 2008, Agricultural Sciences in China, V7, P280, DOI 10.1016/S1671-2927(08)60067-X; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; He HS, 2006, NUCLEIC ACIDS RES, V34, P2976, DOI 10.1093/nar/gkl371; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Hirsch J, 2006, PLANT PHYSIOL, V140, P1192, DOI 10.1104/pp.105.073817; Jiang TB, 2012, PLANT MOL BIOL REP, V30, P360, DOI 10.1007/s11105-011-0347-9; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Khraiwesh B, 2012, BBA-GENE REGUL MECH, V1819, P137, DOI 10.1016/j.bbagrm.2011.05.001; Kim ED, 2012, TRENDS PLANT SCI, V17, P16, DOI 10.1016/j.tplants.2011.10.008; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laporte P, 2007, BIOCHEM SOC T, V35, P1638, DOI 10.1042/BST0351638; Li JS, 2013, J INTEGR AGR, V12, P1414, DOI 10.1016/S2095-3119(13)60311-1; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Lu YL, 2011, FIELD CROP RES, V124, P37, DOI 10.1016/j.fcr.2011.06.003; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Mazzucotelli E, 2008, PLANT SCI, V174, P420, DOI 10.1016/j.plantsci.2008.02.005; MICHEL BE, 1973, PLANT PHYSIOL, V51, P914, DOI 10.1104/pp.51.5.914; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rymarquis LA, 2008, TRENDS PLANT SCI, V13, P329, DOI 10.1016/j.tplants.2008.02.009; Sasidharan R, 2008, NATURE, V453, P729, DOI 10.1038/453729a; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Soares LMM, 2006, EMBO J, V25, P923, DOI 10.1038/sj.emboj.7601023; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Tambo JA, 2012, MITIG ADAPT STRAT GL, V17, P277, DOI 10.1007/s11027-011-9325-7; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; Xin MM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-61; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237	42	119	126	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98958	10.1371/journal.pone.0098958	http://dx.doi.org/10.1371/journal.pone.0098958			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892290	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400115
J	Brandt, VC; Niessen, E; Ganos, C; Kahl, U; Baumer, T; Munchau, A				Brandt, Valerie Catherine; Niessen, Eva; Ganos, Christos; Kahl, Ursula; Baeumer, Tobias; Muenchau, Alexander			Altered Synaptic Plasticity in Tourette's Syndrome and Its Relationship to Motor Skill Learning	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PAIRED ASSOCIATIVE STIMULATION; CORTEX EXCITABILITY; CORTICAL PLASTICITY; NEURONAL NETWORKS; COGNITIVE CONTROL; NMDA RECEPTORS; TIC SEVERITY; MODULATION; INHIBITION	Gilles de la Tourette syndrome is a neuropsychiatric disorder characterized by motor and phonic tics that can be considered motor responses to preceding inner urges. It has been shown that Tourette patients have inferior performance in some motor learning tasks and reduced synaptic plasticity induced by transcranial magnetic stimulation. However, it has not been investigated whether altered synaptic plasticity is directly linked to impaired motor skill acquisition in Tourette patients. In this study, cortical plasticity was assessed by measuring motor-evoked potentials before and after paired associative stimulation in 14 Tourette patients (13 male; age 18-39) and 15 healthy controls (12 male; age 18-33). Tic and urge severity were assessed using the Yale Global Tic Severity Scale and the Premonitory Urges for Tics Scale. Motor learning was assessed 45 minutes after inducing synaptic plasticity and 9 months later, using the rotary pursuit task. On average, long-term potentiation-like effects in response to the paired associative stimulation were present in healthy controls but not in patients. In Tourette patients, long-term potentiation-like effects were associated with more and long-term depression-like effects with less severe urges and tics. While motor learning did not differ between patients and healthy controls 45 minutes after inducing synaptic plasticity, the learning curve of the healthy controls started at a significantly higher level than the Tourette patients' 9 months later. Induced synaptic plasticity correlated positively with motor skills in healthy controls 9 months later. The present study confirms previously found long-term improvement in motor performance after paired associative stimulation in healthy controls but not in Tourette patients. Tourette patients did not show long-term potentiation in response to PAS and also showed reduced levels of motor skill consolidation after 9 months compared to healthy controls. Moreover, synaptic plasticity appears to be related to symptom severity.	[Brandt, Valerie Catherine; Ganos, Christos; Baeumer, Tobias; Muenchau, Alexander] Univ Lubeck, Inst Neurogenet, Lubeck, Schleswig Holst, Germany; [Brandt, Valerie Catherine; Ganos, Christos; Kahl, Ursula] Univ Clin Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Niessen, Eva] Res Ctr Julich, Inst Neurosci & Med, Julich, Nordrhein Westf, Germany; [Ganos, Christos] UCL, Sobell Dept Motor Neurosci & Movement Disorders, London, England	University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Research Center Julich; University of London; University College London	Brandt, VC (corresponding author), Univ Lubeck, Inst Neurogenet, Lubeck, Schleswig Holst, Germany.	valerie.brandt@gmx.de	Niessen, Eva/H-8529-2017	Niessen, Eva/0000-0002-2801-0986; Kahl, Ursula/0000-0003-2096-9647; Ganos, Christos/0000-0001-8077-8530	"Else-Kroner-Stiftung'' [2011_A37]; Deutsche Forschungsgemeinschaft (DFG) [MU1692/2-1, MU 1692/3-1, SFB 936]; European Science Foundation; Actelion; Ipsen; Pharm Allergan; Merz Pharmaceuticals	"Else-Kroner-Stiftung''; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Science Foundation(European Science Foundation (ESF)European Commission); Actelion; Ipsen(Ipsen); Pharm Allergan(AbbVieAllergan); Merz Pharmaceuticals	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Disclosures for Brandt 20.1.2014: PhD grant from the "Else-Kroner-Stiftung'' Grant number: 2011_A37. Disclosures for Niessen 20.1.2014: None. Disclosures for Ganos 20.1.2014: Academic research support: Deutsche Forschungsgemeinschaft (DFG) Deutsche Forschungsgemeinschaft (MU1692/2-1) European Science Foundation. Commercial research support: Grants by Actelion, Ipsen, Pharm Allergan and Merz Pharmaceuticals. Disclosures for Kahl 20.1.2014: None. Disclosures for Baumer 20.1.2014: Commercial research support: Honoraria for lectures from Pharm Allergan, Ipsen, Merz Pharmaceuticals. Disclosures for Munchau 20.1.2014: Commercial research support: Grants by Pharm Allergan, Ipsen, Merz Pharmaceuticals. Honoraria for lectures from Pharm Allergan, Ipsen, Merz Pharmaceuticals, Actelion, GlaxoSmithKline and Desitin. Support from non-profit foundations or societies: Possehl-Stiftung, Lubeck; Dystonia Coalition (USA); Tourette Syndrome Association (Germany); European Huntington Disease Network; N.E.MO. Charity supporting the research of paediatric movement disorders. Academic research support not attributed in the manuscript: Deutsche Forschungsgemeinschaft (MU 1692/3-1; SFB 936). Else Kroner-Fresenius-Stiftung. A. Munchau is employed at the University of Lubeck.	Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bloch MH, 2006, ARCH PEDIAT ADOL MED, V160, P63; Bohlhalter S, 2006, BRAIN, V129, P2029, DOI 10.1093/brain/awl050; Bornstein R A, 1991, J Neuropsychiatry Clin Neurosci, V3, P157; Bornstein R A, 1990, J Neuropsychiatry Clin Neurosci, V2, P275; Citri A, 2008, NEUROPSYCHOPHARMACOL, V33, P18, DOI 10.1038/sj.npp.1301559; Como PG, 2005, HDB TOURETTES SYNDRO, P237; Crossley E, 2014, BRAIN DEV-JPN, V36, P45, DOI 10.1016/j.braindev.2012.12.010; Di Lazzaro V, 2011, J NEUROPHYSIOL, V105, P2150, DOI 10.1152/jn.00781.2010; DOYERE V, 1992, HIPPOCAMPUS, V2, P39, DOI 10.1002/hipo.450020106; Elahi B, 2012, J NEUROPHYSIOL, V107, P1935, DOI 10.1152/jn.00202.2011; FAHN S, 1993, ARCH NEUROL-CHICAGO, V50, P1013; Frantseva MV, 2008, CEREB CORTEX, V18, P990, DOI 10.1093/cercor/bhm151; GRAFTON ST, 1992, J NEUROSCI, V12, P2542; Heise KF, 2010, BRAIN, V133, P580, DOI 10.1093/brain/awp299; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Jackson GM, 2007, EXP BRAIN RES, V182, P357, DOI 10.1007/s00221-007-0999-8; Jackson SR, 2011, CURR BIOL, V21, P580, DOI 10.1016/j.cub.2011.02.047; Jung J, 2013, NEUROSCI BIOBEHAV R, V37, P1016, DOI 10.1016/j.neubiorev.2012.08.009; Krivanekova L, 2011, EUR J NEUROSCI, V34, P1292, DOI 10.1111/j.1460-9568.2011.07849.x; Leckman JF, 2002, LANCET, V360, P1577, DOI 10.1016/S0140-6736(02)11526-1; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Marsh R, 2005, NEUROPSYCHOLOGIA, V43, P1456, DOI 10.1016/j.neuropsychologia.2004.12.012; MORRIS RGM, 1990, PHILOS T ROY SOC B, V329, P187, DOI 10.1098/rstb.1990.0164; Mueller ST., 2012, PEBL PURSUIT ROTOR T; Muller-Dahlhaus JFM, 2008, EXP BRAIN RES, V187, P467, DOI 10.1007/s00221-008-1319-7; Muller-Dahlhaus F, 2010, FRONT SYNAPTIC NEURO, V2, P34, DOI DOI 10.3389/FNSYN.2010.00034; Munakata Y, 2011, TRENDS COGN SCI, V15, P453, DOI 10.1016/j.tics.2011.07.011; Neuner I, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-120; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Orth M, 2005, BRAIN, V128, P1292, DOI 10.1093/brain/awh473; Orth M, 2008, BIOL PSYCHIAT, V64, P248, DOI 10.1016/j.biopsych.2007.12.009; Orth M, 2013, BEHAV NEUROL, V27, P57, DOI [10.1155/2013/349137, 10.3233/BEN-120289]; Park P, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0131; Paszek J, 2010, MOVEMENT DISORD, V25, P1106, DOI 10.1002/mds.23053; Player MJ, 2012, CLIN NEUROPHYSIOL, V123, P2220, DOI 10.1016/j.clinph.2012.03.081; Potter-Nerger M, 2009, J NEUROPHYSIOL, V102, P3180, DOI 10.1152/jn.91046.2008; Rajji TK, 2011, BRAIN STIMUL, V4, P137, DOI 10.1016/j.brs.2010.09.007; Robertson MM, 2011, BRIT J HOSP MED, V72, P100, DOI 10.12968/hmed.2011.72.2.100; Robertson MM, 1999, NEUROLOGY, V53, P2108, DOI 10.1212/WNL.53.9.2108; Rosenkranz K, 2007, J NEUROSCI, V27, P12058, DOI 10.1523/JNEUROSCI.2663-07.2007; Rossner V., 2010, TOURETTE SYNDROM AND, P242; Russmann H, 2009, CLIN NEUROPHYSIOL, V120, P1204, DOI 10.1016/j.clinph.2009.04.005; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Serrien DJ, 2002, BRAIN, V125, P290, DOI 10.1093/brain/awf024; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Sumner P, 2007, NEURON, V54, P697, DOI 10.1016/j.neuron.2007.05.016; Suppa A, 2011, MOVEMENT DISORD, V26, P1703, DOI 10.1002/mds.23706; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Weise D, 2013, J PHYSIOL-LONDON, V591, P4903, DOI 10.1113/jphysiol.2013.253989; Weise D, 2011, NEUROBIOL DIS, V42, P171, DOI 10.1016/j.nbd.2010.11.009; Wolters A, 2003, J NEUROPHYSIOL, V89, P2339, DOI 10.1152/jn.00900.2002; Woods DW, 2005, J DEV BEHAV PEDIATR, V26, P397, DOI 10.1097/00004703-200512000-00001; Wu SW, 2012, BRAIN STIMUL, V5, P315, DOI 10.1016/j.brs.2011.04.001; Yeates KO, 1994, NEUROPSYCHOLOGY, V8, P65, DOI 10.1037/0894-4105.8.1.65; Ziemann U, 2004, J NEUROSCI, V24, P1666, DOI 10.1523/JNEUROSCI.5016-03.2004; Ziemann U, 1997, AM J PSYCHIAT, V154, P1277; Ziemann Ulf, 2004, Suppl Clin Neurophysiol, V57, P702; Ziemann U, 2008, BRAIN STIMUL, V1, P60, DOI 10.1016/j.brs.2007.08.003	66	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98417	10.1371/journal.pone.0098417	http://dx.doi.org/10.1371/journal.pone.0098417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878665	Green Submitted, Green Published, gold			2022-12-25	WOS:000338101500056
J	Endo, Y; Blinova, K; Romantseva, T; Golding, H; Zaitseva, M				Endo, Yukinori; Blinova, Ksenia; Romantseva, Tatiana; Golding, Hana; Zaitseva, Marina			Differences in PGE(2) Production between Primary Human Monocytes and Differentiated Macrophages: Role of IL-1 beta and TRIF/IRF3	PLOS ONE			English	Article							NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; FEBRILE RESPONSE; MOLECULAR-BIOLOGY; INTERFERON-BETA; GUINEA-PIGS; FEVER; ENDOTOXIN; CELLS; PROSTAGLANDIN	Prostaglandin E2 (PGE(2)) is induced in vivo by bacterial products including TLR agonists. To determine whether PGE(2) is induced directly or via IL-1 beta, human monocytes and macrophages were cultured with LPS or with Pam3CSK4 in presence of caspase-1 inhibitor, ZVAD, or IL-1R antagonist, Kineret. TLR agonists induced PGE(2) in macrophages exclusively via IL-1 beta-independent mechanisms. In contrast, ZVAD and Kineret reduced PGE2 production in LPS-treated (but not in Pam3CSK4-treated) monocytes, by 30-60%. Recombinant human IL-1 beta augmented COX-2 and mPGES-1 mRNA and PGE(2) production in LPS-pretreated monocytes but not in un-primed or Pam3CSK4-primed monocytes. This difference was explained by the finding that LPS but not Pam3CSK4 induced phosphorylation of IRF3 in monocytes suggesting activation of the TRIF signaling pathway. Knocking down TRIF, TRAM, or IRF3 genes by siRNA inhibited IL-1 beta-induced COX-2 and mPGES-1 mRNA. Blocking of TLR4 endocytosis during LPS priming prevented the increase in PGE(2) production by exogenous IL-1 beta. Our data showed that TLR2 agonists induce PGE(2) in monocytes independently from IL-1 beta. In the case of TLR4, IL-1 beta augments PGE(2) production in LPS-primed monocytes (but not in macrophages) through a mechanism that requires TLR4 internalization and activation of the TRIF/IRF3 pathway. These findings suggest a key role for blood monocytes in the rapid onset of fever in animals and humans exposed to bacterial products and some novel adjuvants.	[Endo, Yukinori; Blinova, Ksenia; Romantseva, Tatiana; Golding, Hana; Zaitseva, Marina] US FDA, CBER, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA)	Zaitseva, M (corresponding author), US FDA, CBER, Bethesda, MD 20014 USA.	marina.zaitseva@fda.hhs.gov		BLINOVA, KSENIA/0000-0003-1123-3152	Federal fund from the Critical Path Initiative at CBER; Federal fund from the Critical Path Initiative at FDA; Biomedical Advanced Research and Development Authority (BARDA), HHS	Federal fund from the Critical Path Initiative at CBER; Federal fund from the Critical Path Initiative at FDA; Biomedical Advanced Research and Development Authority (BARDA), HHS	This project has been funded in part with Federal funds from the Critical Path Initiative at CBER, FDA and from the Biomedical Advanced Research and Development Authority (BARDA), HHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbera-Cremades M, 2012, FASEB J, V26, P2951, DOI 10.1096/fj.12-205765; Bezugla Y, 2006, PROSTAG OTH LIPID M, V79, P93, DOI 10.1016/j.prostaglandins.2005.11.001; Blatteis CM, 2007, PROG BRAIN RES, V162, P3, DOI 10.1016/S0079-6123(06)62001-3; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Campisi J, 2003, J APPL PHYSIOL, V95, P1873, DOI 10.1152/japplphysiol.00371.2003; Carta S, 2011, J BIOL CHEM, V286, P27069, DOI 10.1074/jbc.M110.203398; Chen J, 2005, J BIOL CHEM, V280, P16354, DOI 10.1074/jbc.M411134200; Chi PL, 2011, ARTHRITIS RHEUM-US, V63, P2905, DOI 10.1002/art.30504; Davidson J, 2001, PFLUG ARCH EUR J PHY, V442, P526; Dinarello CA, 2004, J ENDOTOXIN RES, V10, P201, DOI 10.1179/096805104225006129; DINARELLO CA, 1984, REV INFECT DIS, V6, P51, DOI 10.1016/S1359-6101(97)00023-3; Fantuzzi G, 1996, J IMMUNOL, V157, P291; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gatti S, 2002, AM J PHYSIOL-REG I, V282, pR702, DOI 10.1152/ajpregu.00393.2001; Goehler LE, 2005, BRAIN BEHAV IMMUN, V19, P334, DOI 10.1016/j.bbi.2004.09.002; Greis A, 2007, AM J PHYSIOL-REG I, V293, pR152, DOI 10.1152/ajpregu.00182.2007; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hubschle T, 2006, AM J PHYSIOL-REG I, V290, pR180, DOI 10.1152/ajpregu.00579.2005; Ivanov AI, 2004, FRONT BIOSCI-LANDMRK, V9, P1977, DOI 10.2741/1383; JANSKY L, 1995, NEUROENDOCRINOLOGY, V62, P55, DOI 10.1159/000126988; Janssen E, 2014, J IMMUNOL, V192, P2651, DOI 10.4049/jimmunol.1300909; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kozak W, 2006, AM J PHYSIOL-REG I, V290, pR871, DOI 10.1152/ajpregu.00408.2005; Kuroda E, 2011, IMMUNITY, V34, P514, DOI 10.1016/j.immuni.2011.03.019; Lee JK, 2004, P NATL ACAD SCI USA, V101, P8815, DOI 10.1073/pnas.0402800101; Leon LR, 2002, J APPL PHYSIOL, V92, P2648, DOI 10.1152/japplphysiol.01005.2001; Lien E, 2001, J BIOL CHEM, V276, P1873, DOI 10.1074/jbc.M009040200; LONG NC, 1990, AM J PHYSIOL, V259, pR724, DOI 10.1152/ajpregu.1990.259.4.R724; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Murakami M, 2004, PROG LIPID RES, V43, P3, DOI 10.1016/S0163-7827(03)00037-7; Navarro L, 1999, J BIOL CHEM, V274, P35535, DOI 10.1074/jbc.274.50.35535; Netea MG, 1999, EUR J CLIN INVEST, V29, P351; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Perlik V, 2005, AM J PHYSIOL-REG I, V289, pR332, DOI 10.1152/ajpregu.00567.2004; RAZ A, 1988, J BIOL CHEM, V263, P3022; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sehic E, 1998, AM J PHYSIOL-REG I, V274, pR1594, DOI 10.1152/ajpregu.1998.274.6.R1594; Shimpo H, 2009, J ORTHOP SCI, V14, P611, DOI 10.1007/s00776-009-1370-7; Steiner AA, 2006, PLOS BIOL, V4, P1517, DOI 10.1371/journal.pbio.0040284; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tapping RI, 1999, J IMMUNOL, V162, P5483; Zaitseva M, 2012, VACCINE, V30, P4859, DOI 10.1016/j.vaccine.2012.05.002; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; ZHENG H, 1995, IMMUNITY, V3, P9, DOI 10.1016/1074-7613(95)90154-X	46	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98517	10.1371/journal.pone.0098517	http://dx.doi.org/10.1371/journal.pone.0098517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870145	Green Submitted, Green Published, gold			2022-12-25	WOS:000336858300051
J	Neo, WH; Yap, K; Lee, SH; Looi, LS; Khandelia, P; Neo, SX; Makeyev, EV; Su, IH				Neo, Wen Hao; Yap, Karen; Lee, Suet Hoay; Looi, Liang Sheng; Khandelia, Piyush; Neo, Sheng Xiong; Makeyev, Eugene V.; Su, I-hsin			MicroRNA miR-124 Controls the Choice between Neuronal and Astrocyte Differentiation by Fine-tuning Ezh2 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; DEVELOPMENTAL REGULATORS; MAMMALIAN MICRORNAS; GENE-EXPRESSION; SMALL RNAS; POLYCOMB; IDENTITY; NEUROGENESIS; MOUSE	Polycomb group protein Ezh2 is a histone H3 Lys-27 histone methyltransferase orchestrating an extensive epigenetic regulatory program. Several nervous system-specific genes are known to be repressed by Ezh2 in stem cells and derepressed during neuronal differentiation. However, the molecular mechanisms underlying this regulation remain poorly understood. Here we show that Ezh2 levels are dampened during neuronal differentiation by brain-enriched microRNA miR-124. Expression of miR-124 in a neuroblastoma cells line was sufficient to up-regulate a significant fraction of nervous system-specific Ezh2 target genes. On the other hand, naturally elevated expression of miR-124 in embryonic carcinoma cells undergoing neuronal differentiation correlated with down-regulation of Ezh2 levels. Importantly, overexpression of Ezh2 mRNA with a 3'-untranslated region (3'-UTR) lacking a functional miR-124 binding site, but not with the wild-type Ezh2 3'-UTR, hampered neuronal and promoted astrocyte-specific differentiation in P19 and embryonic mouse neural stem cells. Overall, our results uncover a molecular mechanism that allows miR-124 to balance the choice between alternative differentiation possibilities through fine-tuning the expression of a critical epigenetic regulator.	[Neo, Wen Hao; Yap, Karen; Lee, Suet Hoay; Looi, Liang Sheng; Khandelia, Piyush; Neo, Sheng Xiong; Makeyev, Eugene V.; Su, I-hsin] Nanyang Technol Univ, Sch Biol Sci, Div Mol Genet & Cell Biol, Coll Sci, Singapore 637551, Singapore; [Makeyev, Eugene V.] Kings Coll London, Med Res Council Ctr Dev Neurobiol, London SE1 1UL, England	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of London; King's College London	Su, IH (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Mol Genet & Cell Biol, Coll Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	ihsu@ntu.edu.sg	Su, I-hsin/A-2207-2011	Su, I-hsin/0000-0002-5894-9580; Yap, Karen/0000-0002-0182-4795; Makeyev, Eugene/0000-0001-6034-6896; Neo, Wen Hao/0000-0002-6827-3027	National Medical Research Council [NMRC/IRG/1269/2010, NMRC/CBRG/0028/2013]; National Research Foundation Singapore [NRF-RF2008-06]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation Singapore(National Research Foundation, Singapore)	This work was supported by research funding from National Medical Research Council Grants NMRC/IRG/1269/2010 (to W. H. N. and I. S.) and NMRC/CBRG/0028/2013 (to E. V. M.) and National Research Foundation Singapore Grant NRF-RF2008-06 (to E. V. M.).	Akerblom M, 2012, J NEUROSCI, V32, P8879, DOI 10.1523/JNEUROSCI.0558-12.2012; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berninger B, 2007, EUR J NEUROSCI, V25, P2581, DOI 10.1111/j.1460-9568.2007.05509.x; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Colin A, 2009, GLIA, V57, P667, DOI 10.1002/glia.20795; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Ender C, 2010, J CELL SCI, V123, P1819, DOI 10.1242/jcs.055210; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fode C, 2000, GENE DEV, V14, P67; Geoffroy CG, 2009, STEM CELLS, V27, P847, DOI 10.1002/stem.17; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Huang B, 2009, ACTA BIOCH BIOPH SIN, V41, P231, DOI 10.1093/abbs/gmp006; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Juvvuna PK, 2012, NUCLEIC ACIDS RES, V40, P6808, DOI 10.1093/nar/gks293; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kazama H, 1999, CELL GROWTH DIFFER, V10, P565; Khandelia P, 2011, P NATL ACAD SCI USA, V108, P12799, DOI 10.1073/pnas.1103532108; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Koshkin A. A., 2012, MOL THER, V20, P1590; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Sanuki R, 2011, NAT NEUROSCI, V14, P1125, DOI 10.1038/nn.2897; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Sparmann A, 2013, EMBO J, V32, P1598, DOI 10.1038/emboj.2013.93; Staines WA, 1996, NEUROSCIENCE, V71, P845, DOI 10.1016/0306-4522(95)00494-7; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Yap K, 2012, GENE DEV, V26, P1209, DOI 10.1101/gad.188037.112; Yeo M, 2005, SCIENCE, V307, P596, DOI 10.1126/science.1100801; Yoo AS, 2009, NATURE, V460, P642, DOI 10.1038/nature08139; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145	62	90	91	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20788	20801		10.1074/jbc.M113.525493	http://dx.doi.org/10.1074/jbc.M113.525493			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24878960	Green Published, hybrid			2022-12-25	WOS:000339396600034
J	Abidi, SH; Kalish, ML; Abbas, F; Rowland-Jones, S; Ali, S				Abidi, Syed Hani; Kalish, Marcia L.; Abbas, Farhat; Rowland-Jones, Sarah; Ali, Syed			HIV-1 Subtype A Gag Variability and Epitope Evolution	PLOS ONE			English	Article							DRUG-USERS; PHYLODYNAMICS; PREDICTION; INFECTION; SEQUENCES; COMMUNITY; NAIROBI; SINGLE; HBV; HCV	Objective: The aim of this study was to examine the course of time-dependent evolution of HIV-1 subtype A on a global level, especially with respect to the dynamics of immunogenic HIV gag epitopes. Methods: We used a total of 1,893 HIV-1 subtype A gag sequences representing a timeline from 1985 through 2010, and 19 different countries in Africa, Europe and Asia. The phylogenetic relationship of subtype A gag and its epidemic dynamics was analysed through a Maximum Likelihood tree and Bayesian Skyline plot, genomic variability was measured in terms of G -> A substitutions and Shannon entropy, and the time-dependent evolution of HIV subtype A gag epitopes was examined. Finally, to confirm observations on globally reported HIV subtype A sequences, we analysed the gag epitope data from our Kenyan, Pakistani, and Afghan cohorts, where both cohort-specific gene epitope variability and HLA restriction profiles of gag epitopes were examined. Results: The most recent common ancestor of the HIV subtype A epidemic was estimated to be 1956 +/- 1. A period of exponential growth began about 1980 and lasted for approximately 7 years, stabilized for 15 years, declined for 2-3 years, then stabilized again from about 2004. During the course of evolution, a gradual increase in genomic variability was observed that peaked in 2005-2010. We observed that the number of point mutations and novel epitopes in gag also peaked concurrently during 2005-2010. Conclusion: It appears that as the HIV subtype A epidemic spread globally, changing population immunogenetic pressures may have played a role in steering immune-evolution of this subtype in new directions. This trend is apparent in the genomic variability and epitope diversity of HIV-1 subtype A gag sequences.	[Abidi, Syed Hani; Ali, Syed] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan; [Kalish, Marcia L.] Vanderbilt Univ, Vanderbilt Inst Global Hlth, Nashville, TN 37235 USA; [Abbas, Farhat] Aga Khan Univ, Dept Surg, Karachi, Pakistan; [Rowland-Jones, Sarah] Univ Oxford, Nuffield Dept Med, Oxford, England	Aga Khan University; Vanderbilt University; Aga Khan University; University of Oxford	Ali, S (corresponding author), Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan.	syed.ali@aku.edu		Abidi, Syed Hani/0000-0001-9497-0902	HIV Research Trust [HIVRT 10-059]	HIV Research Trust	For this study, Syed Hani Abidi's training was funded by HIV Research Trust (scholarship no. HIVRT 10-059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi SH, 2013, INFECT GENET EVOL, V16, P78, DOI 10.1016/j.meegid.2013.02.003; Abidi SH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002926; Abidi SH, 2014, MED MICROBIOL IMMUN, V203, P57, DOI 10.1007/s00430-013-0314-1; Ansari AS, 2011, AIDS, V25, P1427, DOI 10.1097/QAD.0b013e32834800e7; Bettinotti MP, 1997, J IMMUNOTHER, V20, P425, DOI 10.1097/00002371-199711000-00001; Bhasin M, 2004, VACCINE, V22, P3195, DOI 10.1016/j.vaccine.2004.02.005; Bhasin M, 2007, J BIOSCIENCES, V32, P31, DOI 10.1007/s12038-007-0004-5; Brumme ZL, 2009, J EXP MED, V206, P1215, DOI 10.1084/jem.20091094; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Frost SDW, 2010, PHILOS T R SOC B, V365, P1879, DOI 10.1098/rstb.2010.0060; Hewitt EW, 2003, IMMUNOLOGY, V110, P163, DOI 10.1046/j.1365-2567.2003.01738.x; Jern P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000367; Khan S, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-164; Khanani MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022449; Khanani MR, 2010, J INFECTION, V61, P507, DOI 10.1016/j.jinf.2010.09.035; Khanani MR, 2010, J INFECTION, V61, P434, DOI 10.1016/j.jinf.2010.08.009; Khoja S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003191; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Novitsky V, 2010, VIRUSES-BASEL, V2, P33, DOI 10.3390/v2010033; Rai MA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-7; Robinson J, NUCL ACIDS RES, V39, pD1171; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Yang OO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007388; Zhang YH, 2011, J IMMUNOL, V187, P684, DOI 10.4049/jimmunol.1100316	29	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e93415	10.1371/journal.pone.0093415	http://dx.doi.org/10.1371/journal.pone.0093415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892852	Green Submitted, gold, Green Published			2022-12-25	WOS:000336911400001
J	Moustgaard, H; Joutsenniemi, K; Myrskyla, M; Martikainen, P				Moustgaard, Heta; Joutsenniemi, Kaisla; Myrskyla, Mikko; Martikainen, Pekka			Antidepressant Sales and the Risk for Alcohol-Related and Non-Alcohol-Related Suicide in Finland-An Individual-Level Population Study	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; RANDOMIZED CONTROLLED-TRIALS; NORDIC COUNTRIES; FOLLOW-UP; RATES; MORTALITY; REGISTER; NONALCOHOL; DISORDERS; TRENDS	Objectives: A marked decline in suicide rates has co-occurred with increased antidepressant sales in several countries but the causal connection between the trends remains debated. Most previous studies have focused on overall suicide rates and neglected differential effects in population subgroups. Our objective was to investigate whether increasing sales of non-tricyclic antidepressants have reduced alcohol-and non-alcohol-related suicide risk in different population subgroups. Methods: We followed a nationally representative sample of 950,158 Finnish adults in 1995-2007 for alcohol-related (n = 2,859) and non-alcohol-related (n = 8,632) suicides. We assessed suicide risk by gender and social group according to regional sales of non-tricyclic antidepressants, measured by sold doses per capita, prevalence of antidepressant users, and proportion of antidepressant users with doses reflecting minimally adequate treatment. Fixed-effects Poisson regression models controlled for regional differences and time trends that may influence suicide risk irrespective of antidepressant sales. Results: The number of sold antidepressant doses per capita and the prevalence of antidepressant users were unrelated to male suicide risk. However, one percentage point increase in the proportion of antidepressant users receiving minimally adequate treatment reduced non-alcohol-related male suicide risk by one percent (relative risk 0.987, 95% confidence interval 0.976-0.998). This beneficial effect only emerged among men with high education, high income, and employment, among men without a partner, and men not owning their home. Alcohol-related suicides and female suicides were unrelated to all measures of antidepressant sales. Conclusion: We found little evidence that increase in overall sales or in the prevalence of non-tricyclic antidepressant users would have caused the fall in suicide rates in Finland in 1995-2007. However, the rise in the proportion of antidepressant users receiving minimally adequate treatment, possibly due to enhanced treatment compliance, may have prevented non-alcohol-related suicides among men.	[Moustgaard, Heta; Martikainen, Pekka] Univ Helsinki, Populat Res Unit, Dept Social Res, FIN-00014 Helsinki, Finland; [Joutsenniemi, Kaisla] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland; [Myrskyla, Mikko] Univ London London Sch Econ & Polit Sci, Dept Social Policy, London WC2A 2AE, England	University of Helsinki; Finland National Institute for Health & Welfare; University of London; London School Economics & Political Science	Moustgaard, H (corresponding author), Univ Helsinki, Populat Res Unit, Dept Social Res, FIN-00014 Helsinki, Finland.	heta.moustgaard@helsinki.fi		Moustgaard, Heta/0000-0001-6632-4727; Martikainen, Pekka/0000-0001-9374-1438	Finnish Doctoral Programs in Public Health; Academy of Finland; Finnish National Institute for Health and Welfare; Max Planck Society	Finnish Doctoral Programs in Public Health; Academy of Finland(Academy of Finland); Finnish National Institute for Health and Welfare; Max Planck Society(Max Planck SocietyFoundation CELLEX)	The study was funded by the Finnish Doctoral Programs in Public Health (HM) and Academy of Finland (HM & PM). KJ was funded by the Finnish National Institute for Health and Welfare. MM was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P., 2009, FIXED EFFECTS REGRES, DOI [10.4135/9781412993869, DOI 10.4135/9781412993869]; Baldessarini RJ, 2007, HARVARD REV PSYCHIAT, V15, P133, DOI 10.1080/10673220701551102; Barbui C, 2009, CAN MED ASSOC J, V180, P291, DOI 10.1503/cmaj.081514; Beskow J, 1999, PSYCHIAT FENNICA, V30, P31; Bramness JG, 2007, J AFFECT DISORDERS, V102, P1, DOI 10.1016/j.jad.2006.12.002; Brook OH, 2006, J CLIN PSYCHOPHARM, V26, P643, DOI 10.1097/01.jcp.0000246217.34024.53; Chachamovich E, 2012, ALCOHOL, V46, P529, DOI 10.1016/j.alcohol.2012.03.007; Dahlberg M, 2005, ADV HEALTH ECON HEAL, V16, P121; Fergusson D, 2005, BMJ-BRIT MED J, V330, P396, DOI 10.1136/bmj.330.7488.396; Gardarsdottir H, 2007, J AFFECT DISORDERS, V98, P109, DOI 10.1016/j.jad.2006.07.003; Gibbons RD, 2005, ARCH GEN PSYCHIAT, V62, P165, DOI 10.1001/archpsyc.62.2.165; Grunebaum MF, 2004, J CLIN PSYCHIAT, V65, P1456, DOI 10.4088/JCP.v65n1103; Gunnell D, 2003, SOC SCI MED, V57, P595, DOI 10.1016/S0277-9536(02)00408-2; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Gusmao R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066455; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; Hirschfeld RMA, 2001, BRIT J PSYCHIAT, V179, pS4, DOI 10.1192/bjp.179.42.s4; Isacsson G, 2010, BRIT J PSYCHIAT, V196, P429, DOI 10.1192/bjp.bp.109.076166; Karlsson H, 2000, ACTA PSYCHIAT SCAND, V102, P354, DOI 10.1034/j.1600-0447.2000.102005354.x; Kelly CB, 2003, EUR PSYCHIAT, V18, P325, DOI 10.1016/j.eurpsy.2003.03.005; Kivimaki M, 2007, PSYCHOL MED, V37, P373, DOI 10.1017/S0033291706009457; Korkeila J, 2007, J CLIN PSYCHIAT, V68, P505, DOI 10.4088/JCP.v68n0403; Loomis D, 2005, OCCUP ENVIRON MED, V62, P325, DOI 10.1136/oem.2004.017459; Ludwig J, 2009, J HEALTH ECON, V28, P659, DOI 10.1016/j.jhealeco.2009.02.002; Maki N, 2009, SOC SCI MED, V68, P2161, DOI 10.1016/j.socscimed.2009.04.006; Maki N, 2008, EUR J POPUL, V24, P385, DOI 10.1007/s10680-007-9147-1; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Moustgaard H, 2013, J AFFECT DISORDERS, V148, P278, DOI 10.1016/j.jad.2012.12.008; National Agency for Medicines, 2008, FINN STAT MED 2007; National Agency for Medicines and Social Insurance Institution, 1996, FINN STAT MED 1995; Reseland S, 2006, BRIT J PSYCHIAT, V188, P354, DOI 10.1192/bjp.188.4.354; Safer DJ, 2007, PUBLIC HEALTH, V121, P274, DOI 10.1016/j.puhe.2006.09.024; Sihvo S, 2008, J AFFECT DISORDERS, V110, P94, DOI 10.1016/j.jad.2008.01.012; StataCorp, 2009, STAT STAT SOFTW REL; Statistics Finland, 2009, CAUS DEATH 2007; SUOKAS J, 1995, ACTA PSYCHIAT SCAND, V91, P36, DOI 10.1111/j.1600-0447.1995.tb09739.x; Suominen KH, 2002, SCHIZOPHRENIA BULL, V28, P637, DOI 10.1093/oxfordjournals.schbul.a006970; Zahl PH, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-62	38	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98405	10.1371/journal.pone.0098405	http://dx.doi.org/10.1371/journal.pone.0098405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5ML	24892560	Green Published, Green Accepted, gold			2022-12-25	WOS:000336911400047
J	von Versen-Hoynck, F; Brodowski, L; Dechend, R; Myerski, AC; Hubel, CA				von Versen-Hoeynck, Frauke; Brodowski, Lars; Dechend, Ralf; Myerski, Ashley C.; Hubel, Carl A.			Vitamin D Antagonizes Negative Effects of Preeclampsia on Fetal Endothelial Colony Forming Cell Number and Function	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; INTRAUTERINE GROWTH RESTRICTION; PROGENITOR CELLS; IN-VITRO; RISK; PREGNANCY; WOMEN; DISEASE; 1,25-DIHYDROXYVITAMIN-D; METAANALYSIS	Context: Endothelial dysfunction is a primary feature of preeclampsia, a pregnancy complication associated with an increased future cardiovascular risk for mother and offspring. Endothelial colony forming cells (ECFC) are endothelial progenitor cells that participate in vasculogenesis and endothelial repair. Objective: We hypothesized that the number and functional properties of fetal cord blood-derived ECFCs are reduced in preeclampsia compared to uncomplicated pregnancy (controls), and asked if adverse effects of preeclampsia on ECFC function are reversed by 1,25 (OH)(2) vitamin D-3. Design, Setting, Patients: This was a nested, case-control study. Forty women with uncomplicated pregnancy and 33 women with PE were recruited at Magee-Womens Hospital (USA) or at Hannover Medical School (Germany). Main Outcome Measures: Time to ECFC colony appearance in culture, and number of colonies formed, were determined. Functional abilities of ECFCs were assessed in vitro by tubule formation in Matrigel assay, migration, and proliferation. ECFC function was tested in the presence or absence of 1,25 (OH)(2) vitamin D-3, and after vitamin D receptor (VDR) or VEGF signaling blockade. Results: The number of cord ECFC colonies was lower (P = 0.04) in preeclampsia compared to controls. ECFCs from preeclampsia showed reduced proliferation (P < 0.0001), formed fewer tubules (P = 0.02), and migrated less (P = 0.049) than control. Vitamin D-3 significantly improved preeclampsia ECFC functional properties. VDR- or VEGF blockade reduced tubule formation, partially restorable by vitamin D-3. Conclusion: Fetal ECFCs from preeclamptic pregnancies are reduced in number and dysfunctional. Vitamin D-3 had rescuing effects. This may have implications for the increased cardiovascular risk associated with preeclampsia.	[von Versen-Hoeynck, Frauke; Brodowski, Lars] Hannover Med Sch, Gynecol Res Unit, Dept Obstet & Gynecol, Hannover, Germany; [Dechend, Ralf] Helios Klinikum Berlin Buch, Expt & Clin Res Ctr, Max Delbruck Ctr Mol Med, Berlin, Germany; [Dechend, Ralf] Helios Klinikum Berlin Buch, Fac Med, Charite, Berlin, Germany; [Dechend, Ralf] Helios Klinikum Berlin Buch, Franz Volhard Clin, Berlin, Germany; [Myerski, Ashley C.; Hubel, Carl A.] Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Pittsburgh, PA 15260 USA; [Myerski, Ashley C.; Hubel, Carl A.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA	Hannover Medical School; Helios Kliniken; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helios Kliniken; Franz-Volhard Clinical Research Center; Helios Kliniken; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hubel, CA (corresponding author), Univ Pittsburgh, Sch Med, Magee Womens Res Inst, Pittsburgh, PA 15260 USA.	chubel@mwri.magee.edu	von Versen-Höynck, Frauke/H-3719-2019	von Versen-Höynck, Frauke/0000-0002-1924-5695	National Institutes of Health [P01HD030367, UL1RR024153, UL1TR000005]; Hannover Medical School; Boehringer Ingelheim; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD030367] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hannover Medical School; Boehringer Ingelheim(Boehringer Ingelheim); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The study was supported by National Institutes of Health Grants P01HD030367 (CAH), UL1RR024153, and UL1TR000005 (University of Pittsburgh Clinical and Translational Science Institute), and a HiLF grant by Hannover Medical School. LB was supported by the Boehringer Ingelheim Funds travel grant program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUGUST P, 1992, AM J OBSTET GYNECOL, V166, P1295, DOI 10.1016/S0002-9378(11)90625-5; Bainbridge SA, 2009, AM J PHYSIOL-CELL PH, V297, pC440, DOI 10.1152/ajpcell.00593.2008; Brown MC, 2013, EUR J EPIDEMIOL, V28, P1, DOI 10.1007/s10654-013-9762-6; Chung I, 2009, CANCER RES, V69, P967, DOI 10.1158/0008-5472.CAN-08-2307; Davis EF, 2012, PEDIATRICS, V129, pE1552, DOI 10.1542/peds.2011-3093; Diaz L, 2009, J REPROD IMMUNOL, V81, P17, DOI 10.1016/j.jri.2009.02.005; Dignat-George F, 2003, PATHOPHYSIOL HAEMO T, V33, P495, DOI 10.1159/000083851; Egorova AD, 2012, IN VITRO CELL DEV-AN, V48, P21, DOI 10.1007/s11626-011-9470-z; FINA L, 1990, BLOOD, V75, P2417; Fraser A, 2013, HYPERTENSION, V62, P614, DOI 10.1161/HYPERTENSIONAHA.113.01513; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Grundmann M, 2012, AM J PHYSIOL-CELL PH, V303, pC954, DOI 10.1152/ajpcell.00030.2012; Halhali A, 2004, J STEROID BIOCHEM, V89-90, P553, DOI 10.1016/j.jsbmb.2004.03.069; Halhali A, 2014, J STEROID BIOCHEM, V144, P44, DOI 10.1016/j.jsbmb.2013.12.014; Haugen M, 2009, EPIDEMIOLOGY, V20, P720, DOI 10.1097/EDE.0b013e3181a70f08; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Hwang HS, 2012, J MATERN-FETAL NEO M, V25, P1769, DOI 10.3109/14767058.2012.663826; Hwang HS, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.060; Hypponen E, 2013, ANN NUTR METAB, V63, P331, DOI 10.1159/000358338; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Ingram DA, 2008, DIABETES, V57, P724, DOI 10.2337/db07-1507; Kajantie E, 2009, STROKE, V40, P1176, DOI 10.1161/STROKEAHA.108.538025; Kwon JY, 2007, GYNECOL OBSTET INVES, V64, P103, DOI 10.1159/000100081; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Lin C, 2009, AM J HYPERTENS, V22, P1014, DOI 10.1038/ajh.2009.101; Luppi P, 2010, REPROD SCI, V17, P643, DOI 10.1177/1933719110366164; Mantell DJ, 2000, CIRC RES, V87, P214, DOI 10.1161/01.RES.87.3.214; Monga R, 2012, J MATERN-FETAL NEO M, V25, P2385, DOI 10.3109/14767058.2012.697228; Povsic Thomas J, 2008, Ther Adv Cardiovasc Dis, V2, P199, DOI 10.1177/1753944708093412; Reynolds J, 2014, LANCET, V383, P89; Roberts JM, 2013, J REPROD IMMUNOL, V99, P1, DOI 10.1016/j.jri.2013.05.003; Roberts JM, 2000, SEMIN PERINATOL, V24, P24, DOI 10.1016/S0146-0005(00)80050-6; Sipos PI, 2010, PLACENTA, V31, P1, DOI 10.1016/j.placenta.2009.10.006; Sipos PI, 2013, J CLIN ENDOCR METAB, V98, P4953, DOI 10.1210/jc.2013-2580; Sipos PI, 2013, STEM CELLS, V31, P1363, DOI 10.1002/stem.1385; Sugawara J, 2005, J CLIN ENDOCR METAB, V90, P5329, DOI 10.1210/jc.2005-0532; Tabesh M, 2013, J CLIN ENDOCR METAB, V98, P3165, DOI 10.1210/jc.2013-1257; Wang YP, 2004, AM J OBSTET GYNECOL, V190, P817, DOI 10.1016/j.ajog.2003.09.049; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471	40	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98990	10.1371/journal.pone.0098990	http://dx.doi.org/10.1371/journal.pone.0098990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892558	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000336911400117
J	Boerkamp, KM; van Steenbeek, FG; Penning, LC; Koerkamp, MJAG; van Leenen, D; Vos-Loohuis, M; Grinwis, GCM; Rutteman, GR				Boerkamp, Kim M.; van Steenbeek, Frank G.; Penning, Louis C.; Koerkamp, Marian J. A. Groot; van Leenen, Dik; Vos-Loohuis, Manon; Grinwis, Guy C. M.; Rutteman, Gerard R.			The Two Main Forms of Histiocytic Sarcoma in the Predisposed Flatcoated Retriever Dog Display Variation in Gene Expression	PLOS ONE			English	Article							REAL-TIME PCR; GUIDELINES MINIMUM INFORMATION; FLAT-COATED RETRIEVERS; BREAST-CANCER; DENDRITIC CELLS; IDENTIFICATION; CLASSIFICATION; PUBLICATION; CHEMOKINES; LEUKEMIA	Examination of gene functions in specific tumor types improves insight in tumorigenesis and helps design better treatments. Due to the rarity of histiocytic/dendritic cell sarcoma in humans, it is difficult to accrue such knowledge. Therefore, comparative research of these cancers in predisposed dog breeds, such as the Flatcoated retriever, can be of value. Histiocytic sarcoma in the dog can be grouped into a soft tissue-and visceral form. The soft tissue form at first is localized, while the visceral form progresses more quickly to a terminal state, which might be related to variations in gene expression. Microarray analyses were performed on fresh-frozen tissue from Flatcoated retrievers with either soft tissue-or visceral histiocytic sarcoma. Expression differences of ten most significantly differentially expressed genes were validated with quantitative real-time PCR (q PCR) analyses. Q PCR analyses confirmed the significantly aberrant expression of three of the selected genes: C6 was up-regulated; CLEC12A and CCL5 were down-regulated in the visceral histiocytic sarcoma compared to the soft tissue form. The findings of our study indicate that these two forms of histiocytic sarcoma in the dog display a variation in gene expression and warrant analysis of functional changes in the expression of those genes in these rare sarcomas in man.	[Boerkamp, Kim M.; van Steenbeek, Frank G.; Penning, Louis C.; Vos-Loohuis, Manon; Rutteman, Gerard R.] Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Koerkamp, Marian J. A. Groot; van Leenen, Dik] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Grinwis, Guy C. M.] Univ Utrecht, Dept Pathobiol, Fac Vet Med, Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University	Boerkamp, KM (corresponding author), Univ Utrecht, Fac Vet Med, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	K.M.Boerkamp@uu.nl	van Steenbeek, F.G./AFL-0046-2022; Penning, Louis/AAC-7524-2019	van Steenbeek, F.G./0000-0001-5460-6540; Grinwis, Guy/0000-0002-1583-9648; Groot Koerkamp, Marian JA/0000-0002-0867-0821	European Commission [LUPA-GA-201370]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was partly funded by the European Commission (LUPA-GA-201370). No external financers contributed to this experiment. Intervet International BV, that in later stage became part of Merck Sharp Dohme, provided a gift to this study in order to help finance the purchase of micro-arrays. The donation was provided without any obligation by authors to this company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie J, 2009, J HERED, V100, pS19, DOI 10.1093/jhered/esp039; Affolter VK, 2002, VET PATHOL, V39, P74, DOI 10.1354/vp.39-1-74; Baier PK, 2005, ANTICANCER RES, V25, P3581; Beverley PCL, 2005, NAT REV CANCER, V5, P488, DOI 10.1038/nrc1632; Bieche I, 2004, CLIN CANCER RES, V10, P6789, DOI 10.1158/1078-0432.CCR-04-0306; Boerkamp KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071094; Breen M, 2008, CHROMOSOME RES, V16, P145, DOI 10.1007/s10577-007-1212-4; Brinkhof B, 2006, ANAL BIOCHEM, V356, P36, DOI 10.1016/j.ab.2006.06.001; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cambien B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028842; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Constantino-Casas F, 2011, VET PATHOL, V48, P764, DOI 10.1177/0300985810385153; de la Rosa G, 2003, J LEUKOCYTE BIOL, V73, P639, DOI 10.1189/jlb.1002516; Dobson J, 2009, VET COMP ONCOL, V7, P115, DOI 10.1111/j.1476-5829.2009.00181.x; Fidel J, 2006, VET COMP ONCOL, V4, P63, DOI 10.1111/j.1476-5810.2006.00090.x; Fulmer AK, 2007, CAN VET J, V48, P1041; GYAPAY G, 1991, COMPLEMENT INFLAMMAT, V8, P370, DOI 10.1159/000463208; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Hedan B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-201; Hoffman MM, 2007, MOL BIOL EVOL, V24, P522, DOI 10.1093/molbev/msl179; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kischel P, 2012, ANTICANCER RES, V32, P5211; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; Marshall ASJ, 2006, EUR J IMMUNOL, V36, P2159, DOI 10.1002/eji.200535628; Marshall ASJ, 2004, J BIOL CHEM, V279, P14792, DOI 10.1074/jbc.M313127200; MEUTEN DJ, 2002, TUMORS DOMESTIC ANIM, DOI DOI 10.1002/9780470376928.FMATTER; Mimori K, 2005, CLIN EXP METASTAS, V22, P59, DOI 10.1007/s10585-005-4417-y; Moore PF, 2006, VET PATHOL, V43, P632, DOI 10.1354/vp.43-5-632; Moore PF, 2014, VET PATHOL, V51, P167, DOI 10.1177/0300985813510413; Mori M, 1998, CLIN CANCER RES, V4, P1507; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Pileri SA, 2002, HISTOPATHOLOGY, V41, P1, DOI 10.1046/j.1365-2559.2002.01418.x; Qian XS, 2011, J BIOL CHEM, V286, P2111, DOI 10.1074/jbc.M110.154971; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Rust R, 2006, J PATHOL, V209, P474, DOI 10.1002/path.2003; Schlotter YM, 2009, VET IMMUNOL IMMUNOP, V129, P115, DOI 10.1016/j.vetimm.2008.12.004; SHEARIN AL, 2012, CANCER EPIDEM BIOMAR, DOI DOI 10.1158/1055-9965; Skorupski KA, 2009, VET COMP ONCOL, V7, P139, DOI 10.1111/j.1476-5829.2009.00186.x; Swamydas M, 2013, CELL ADHES MIGR, V7, P315, DOI 10.4161/cam.25138; Swerdlow E., 2008, WHO CLASSIFICATION T; Tamburini BA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-619; Tamburini BA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005549; van de Peppel J, 2003, EMBO REP, V4, P387, DOI 10.1038/sj.embor.embor798; van Steenbeek FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057662; van Steenbeek FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057973; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velasco-Velazquez M, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23660; Wang SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035101; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	53	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98258	10.1371/journal.pone.0098258	http://dx.doi.org/10.1371/journal.pone.0098258			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886914	gold, Green Submitted, Green Published			2022-12-25	WOS:000336956300051
J	Guerrini, M; Gennai, C; Panayides, P; Crabtree, A; Zuberogoitia, I; Copland, AS; Babushkina, O; Politi, PM; Giunchi, D; Barbanera, F				Guerrini, Monica; Gennai, Clizia; Panayides, Panicos; Crabtree, Alan; Zuberogoitia, Inigo; Copland, Alex S.; Babushkina, Olga; Politi, Paolo M.; Giunchi, Dimitri; Barbanera, Filippo			Large-Scale Patterns of Genetic Variation in a Female-Biased Dispersing Passerine: The Importance of Sex-Based Analyses	PLOS ONE			English	Article							POPULATION-STRUCTURE; MITOCHONDRIAL-DNA; BARN SWALLOWS; MICROSATELLITE MARKERS; BREEDING DISPERSAL; MIGRATION PATTERNS; NEUTRALITY TESTS; HIRUNDO-RUSTICA; FLOW; EVOLUTION	Dispersal affects the distribution, dynamics and genetic structure of natural populations, and can be significantly different between sexes. However, literature records dealing with the dispersal of migratory birds are scarce, as migratory behaviour can notably complicate the study of dispersal. We used the barn swallow Hirundo rustica as model taxon to investigate patterns of genetic variability in males and in females of a migratory species showing sex-biased dispersal. We collected blood samples (n = 186) over the period 2006 to 2011 from adults (H. r. rustica subspecies) nesting in the same breeding site at either high (Ireland, Germany and Russia) or low (Spain, Italy and Cyprus) latitude across Europe. We amplified the Chromo Helicase DNA gene in all birds in order to warrant a sex-balanced sample size (92 males, 94 females). We investigated both uniparental (mitochondrial ND2 gene) and biparental (microsatellite DNA: 10 loci) genetic systems. The mtDNA provided evidence for demographic expansion yet no significant partition of the genetic variability was disclosed. Nevertheless, a comparatively distant Russian population investigated in another study, whose sequences were included in the present dataset, significantly diverged from all other ones. Different to previous studies, microsatellites highlighted remarkable genetic structure among the studied populations, and pointed to the occurrence of differences between male and female barn swallows. We produced evidence for non-random patterns of gene flow among barn swallow populations probably mediated by female natal dispersal, and we found significant variability in the philopatry of males of different populations. Our data emphasize the importance of taking into account the sex of sampled individuals in order to obtain reliable inferences on species characterized by different patterns of dispersal between males and females.	[Guerrini, Monica; Gennai, Clizia; Barbanera, Filippo] Univ Pisa, Zool & Anthropol Unit, Dept Biol, Pisa, Italy; [Panayides, Panicos] Minist Interior, Game & Fauna Serv, Nicosia, Cyprus; [Crabtree, Alan] BirdLife Cyprus, Nicosia, Cyprus; [Zuberogoitia, Inigo] Icarus Environm Studies, Logrono, Spain; [Copland, Alex S.] BirdWatch Ireland, Banagher, Ireland; [Babushkina, Olga] St Petersburg State Univ, Lab Avian Ecol & Bird Protect, St Petersburg 199034, Russia; [Politi, Paolo M.] World Wildlife Fund, Orti Bottagone Nat Reserve, Piombino, Italy; [Giunchi, Dimitri] Univ Pisa, Dept Biol, Ethol Unit, Pisa, Italy	University of Pisa; Saint Petersburg State University; University of Pisa	Barbanera, F (corresponding author), Univ Pisa, Zool & Anthropol Unit, Dept Biol, Pisa, Italy.	filippo.barbanera@unipi.it	Barbanera, Filippo/L-3109-2015; Babushkina, Olga/I-6326-2013; Giunchi, Dimitri/B-9642-2008; Iñigo, Zuberogoitia/H-5062-2019	Barbanera, Filippo/0000-0003-4225-1919; Babushkina, Olga/0000-0002-2277-2285; Giunchi, Dimitri/0000-0003-2753-8997; Zuberogoitia, Inigo/0000-0002-8945-7386	Anastasios G. Leventis Foundation (Nicosia, Cyprus)	Anastasios G. Leventis Foundation (Nicosia, Cyprus)	The Anastasios G. Leventis Foundation (Nicosia, Cyprus) funded this research with two grants (2008-2010, 2010-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini R, 2002, J APPL ECOL, V39, P524, DOI 10.1046/j.1365-2664.2002.00721.x; Ambrosini R, 2009, J THEOR BIOL, V257, P203, DOI 10.1016/j.jtbi.2008.11.019; Arguedas N, 2000, CONDOR, V102, P517, DOI 10.1650/0010-5422(2000)102[0517:SMAGPS]2.0.CO;2; Balbontin J, 2009, BEHAV ECOL SOCIOBIOL, V63, P1197, DOI 10.1007/s00265-009-0752-3; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barbanera F, 2005, BIOL CONSERV, V122, P275, DOI 10.1016/j.biocon.2004.07.017; Barbanera F, 2009, MOL PHYLOGENET EVOL, V52, P103, DOI 10.1016/j.ympev.2009.02.006; Barbanera F, 2009, NATURWISSENSCHAFTEN, V96, P1203, DOI 10.1007/s00114-009-0586-x; Belliure J, 2000, J EVOLUTION BIOL, V13, P480; Blair ME, 2012, AM J PRIMATOL, V74, P37, DOI 10.1002/ajp.21007; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Borden WC, 2006, J GREAT LAKES RES, V32, P242, DOI 10.3394/0380-1330(2006)32[242:DPGSOS]2.0.CO;2; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Davis LA, 2006, MOL ECOL, V15, P2141, DOI 10.1111/j.1365-294X.2006.02914.x; Dor R, 2012, J HERED, V103, P55, DOI 10.1093/jhered/esr114; Dor R, 2010, MOL PHYLOGENET EVOL, V56, P409, DOI 10.1016/j.ympev.2010.02.008; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fu YX, 1997, GENETICS, V147, P915; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Itonaga N, 2010, J ETHOL, V28, P393, DOI 10.1007/s10164-010-0204-6; Johnson JA, 2003, MOL ECOL, V12, P3335, DOI 10.1046/j.1365-294X.2003.02013.x; Jones KL, 2005, MOL ECOL, V14, P2645, DOI 10.1111/j.1365-294X.2005.02622.x; Kahn NW, 1998, AUK, V115, P1074; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; Lampert KP, 2003, MOL ECOL, V12, P3325, DOI 10.1046/j.1365-294X.2003.02016.x; Le Galliard JF, 2012, MOL ECOL, V21, P505, DOI 10.1111/j.1365-294X.2011.05410.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Moller AP, 2011, J EVOLUTION BIOL, V24, P1744, DOI 10.1111/j.1420-9101.2011.02302.x; Moller AP., 1994, SEXUAL SELECTION BAR; Newton I., 2003, SPECIATION BIOGEOGRA; Nichols J., 2001, DISPERSAL; Ortego J, 2011, ANIM BEHAV, V82, P131, DOI 10.1016/j.anbehav.2011.04.007; Paetkau D, 1998, CONSERV BIOL, V12, P418, DOI 10.1046/j.1523-1739.1998.96457.x; Palo JU, 2004, MOL ECOL, V13, P2865, DOI 10.1111/j.1365-294X.2004.02286.x; Paquette SR, 2010, J HERED, V101, P403, DOI 10.1093/jhered/esq020; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; Perez-Tris J, 2004, EVOLUTION, V58, P1819, DOI 10.1554/03-731; Perrin N, 2000, AM NAT, V155, P116, DOI 10.1086/303296; Piertney SB, 2000, EVOLUTION, V54, P279, DOI 10.1111/j.0014-3820.2000.tb00028.x; Pilkington MM, 2008, MOL BIOL EVOL, V25, P517, DOI 10.1093/molbev/msm279; PRIMMER CR, 1995, MOL ECOL, V4, P493, DOI 10.1111/j.1365-294X.1995.tb00243.x; Pritchard JK, 2000, GENETICS, V155, P945; Prochazka P, 2011, J AVIAN BIOL, V42, P103, DOI 10.1111/j.1600-048X.2010.05161.x; Prugnolle F, 2002, HEREDITY, V88, P161, DOI 10.1038/sj.hdy.6800060; Ptak SE, 2002, TRENDS GENET, V18, P559, DOI 10.1016/S0168-9525(02)02781-6; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Randi E, 2003, MOL ECOL, V12, P2201, DOI 10.1046/j.1365-294X.2003.01899.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rockwell R.F., 1987, P223; Rodriguez-Ramilo ST, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-49; Roff DA, 2004, HEREDITY, V93, P8, DOI 10.1038/sj.hdy.6800404; Santure AW, 2010, BIOL J LINN SOC, V99, P306, DOI 10.1111/j.1095-8312.2009.01366.x; Schneider S, 1999, GENETICS, V152, P1079; Scribner KT, 2001, EVOLUTION, V55, P2105; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Spina F., 2008, ATLANTE MIGRAZIONE U; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsyusko OV, 2007, MOL ECOL NOTES, V7, P833, DOI 10.1111/j.1471-8286.2007.01719.x; Turner A., 2006, BARN SWALLOW; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Zink RM, 2006, P ROY SOC B-BIOL SCI, V273, P1245, DOI 10.1098/rspb.2005.3414; [No title captured]	81	7	8	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98574	10.1371/journal.pone.0098574	http://dx.doi.org/10.1371/journal.pone.0098574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886720	gold, Green Published, Green Submitted			2022-12-25	WOS:000336956300088
J	Mammari, N; Vignoles, P; Halabi, MA; Darde, ML; Courtioux, B				Mammari, Nour; Vignoles, Philippe; Halabi, Mohamad Adnan; Darde, Marie Laure; Courtioux, Bertrand			In Vitro Infection of Human Nervous Cells by Two Strains of Toxoplasma gondii: A Kinetic Analysis of Immune Mediators and Parasite Multiplication	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INTERCELLULAR-ADHESION MOLECULE-1; CHEMOTACTIC PROTEIN-1 SECRETION; MICROGLIAL CELLS; GENETIC DIVERSITY; DENDRITIC CELLS; HOST-RESISTANCE; CHEMOKINE; EXPRESSION; ASTROCYTES	The severity of toxoplasmic infection depends mainly on the immune status of the host, but also on the Toxoplasma gondii strains, which differ by their virulence profile. The relationship between the human host and T. gondii has not yet been elucidated because few studies have been conducted on human models. The immune mechanisms involved in the persistence of T. gondii in the brains of immunocompetent subjects and during the reactivation of latent infections are still unclear. In this study, we analyzed the kinetics of immune mediators in human nervous cells in vitro, infected with two strains of T. gondii. Human neuroblast cell line (SH SY5Y), microglial (CMH5) and endothelial cells (Hbmec) were infected separately by RH (type I) or PRU (type II) strains for 8 h, 14 h, 24 h and 48 h (ratio 1 cell: 2 tachyzoites). Pro-inflammatory protein expression was different between the two strains and among different human nervous cells. The cytokines IL-6, IL-8 and the chemokines MCP-1 and GRO alpha, and SERPIN E1 were significantly increased in CMH5 and SH SY5Y at 24 h pi. At this point of infection, the parasite burden declined in microglial cells and neurons, but remained high in endothelial cells. This differential effect on the early parasite multiplication may be correlated with a higher production of immune mediators by neurons and microglial cells compared to endothelial cells. Regarding strain differences, PRU strain, but not RH strain, stimulates all cells to produce pro-inflammatory growth factors, G-CSF and GM-CSF. These proteins could increase the inflammatory effect of this type II strain. These results suggest that the different protein expression profiles depend on the parasitic strain and on the human nervous cell type, and that this could be at the origin of diverse brain lesions caused by T. gondii.	[Mammari, Nour; Vignoles, Philippe; Darde, Marie Laure; Courtioux, Bertrand] Natl Inst Hlth & Med Res 1094, Trop Neuroepidemiol Inst, Limoges, France; [Mammari, Nour; Vignoles, Philippe; Darde, Marie Laure; Courtioux, Bertrand] Univ Limoges, Natl Ctr Sci Res, France 3503 Inst Genom Environm Immun Hlth & Ther, Limoges, France; [Halabi, Mohamad Adnan] Univ Limoges, Fac Pharm, France 3503 Inst Genom Environm Immun Hlth & Ther, Natl Ctr Sci Res France 7276, Limoges, France; [Darde, Marie Laure] Univ Hosp, Dept Parasitol, Biol Resource Ctr Toxoplasma, Limoges, France	Universite de Limoges; Universite de Limoges; CHU Limoges	Mammari, N (corresponding author), INSERM UMR1094, Trop Neuroepidemiol Inst, Limoges, France.	nour.mammari@unilim.fr	HALABI, Mohamad adnan/AAY-6996-2021; Mammari, Nour/AAY-7000-2021	HALABI, Mohamad adnan/0000-0001-8869-5385; Mammari, Nour/0000-0002-3075-110X	"3IS, infection et immunite sous immunosuppression'' from FR 3503 GEIST, Limoges, France; INSERM 1094 Tropical Neuroepidemiology Institute	"3IS, infection et immunite sous immunosuppression'' from FR 3503 GEIST, Limoges, France; INSERM 1094 Tropical Neuroepidemiology Institute	This work was supported by grants from "3IS, infection et immunite" sous immunosuppression'' from FR 3503 GEIST, Limoges, France, and INSERM 1094 Tropical Neuroepidemiology Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agholme L, 2013, MOL CELL NEUROSCI; Ajzenberg D, 2004, INT J PARASITOL, V34, P1185, DOI 10.1016/j.ijpara.2004.06.007; Ajzenberg D, 2002, INT J PARASITOL, V32, P27, DOI 10.1016/S0020-7519(01)00301-0; Ajzenberg D, 2009, J INFECT DIS, V199, P1155, DOI 10.1086/597477; Aviles H, 2008, J PARASITOL, V94, P1282, DOI 10.1645/GE-1309.1; Barragan A, 2005, CELL MICROBIOL, V7, P561, DOI 10.1111/j.1462-5822.2005.00486.x; BLEWETT DA, 1983, VET REC, V112, P98, DOI 10.1136/vr.112.5.98; BOHNE W, 1995, MOL MICROBIOL, V16, P1221, DOI 10.1111/j.1365-2958.1995.tb02344.x; BRACH MA, 1992, BLOOD, V80, P2920; Brenier-Pinchart MP, 2002, FEMS MICROBIOL LETT, V214, P45, DOI 10.1111/j.1574-6968.2002.tb11323.x; Brenier-Pinchart MP, 2004, ACTA NEUROPATHOL, V107, P245, DOI 10.1007/s00401-003-0804-0; Cassaing S, 2006, J CLIN MICROBIOL, V44, P720, DOI 10.1128/JCM.44.3.720-724.2006; Channon JY, 2002, INFECT IMMUN, V70, P6048, DOI 10.1128/IAI.70.11.6048-6057.2002; Clahsen T, 2008, J LEUKOCYTE BIOL, V84, P1521, DOI 10.1189/jlb.0308178; COLEMAN DL, 1988, BLOOD, V72, P573; de Gannes FMP, 1998, NEUROCHEM INT, V33, P61, DOI 10.1016/S0197-0186(05)80010-5; Del Rio L, 2001, J IMMUNOL, V167, P6503, DOI 10.4049/jimmunol.167.11.6503; Denkers EY, 2004, INT J PARASITOL, V34, P411, DOI 10.1016/j.ijpara.2003.11.001; Denney CF, 1999, INFECT IMMUN, V67, P1547; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Edvinsson B, 2006, CLIN MICROBIOL INFEC, V12, P131, DOI 10.1111/j.1469-0691.2005.01332.x; ERBE DV, 1991, J IMMUNOL, V146, P3145; Fagard R, 1999, PARASITOL TODAY, V15, P504, DOI 10.1016/S0169-4758(99)01568-9; Fischer HG, 1997, EUR J IMMUNOL, V27, P1539, DOI 10.1002/eji.1830270633; Flores M, 2008, FASEB J, V22, P3661, DOI 10.1096/fj.08-111666; Freund YR, 2001, INFECT IMMUN, V69, P765, DOI 10.1128/IAI.69.2.765-772.2001; Halonen SK, 1996, J NEUROPATH EXP NEUR, V55, P1150, DOI 10.1097/00005072-199611000-00006; Halonen SK, 1998, INT J PARASITOL, V28, P815, DOI 10.1016/S0020-7519(98)00035-6; Haroon F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035516; Herrmann DC, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-39; HULINSKA D, 1990, FOLIA PARASIT, V37, P207; JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H; Jebbari H, 1998, PARASITE IMMUNOL, V20, P231, DOI 10.1046/j.1365-3024.1998.00152.x; Kikumura A, 2012, BRIT J OPHTHALMOL, V96, P1259, DOI 10.1136/bjophthalmol-2012-301490; Knight BC, 2006, J NEUROIMMUNOL, V179, P126, DOI 10.1016/j.jneuroim.2006.06.002; Lachenmaier SM, 2011, J NEUROIMMUNOL, V232, P119, DOI 10.1016/j.jneuroim.2010.10.029; Lambert H, 2009, INFECT IMMUN, V77, P1679, DOI 10.1128/IAI.01289-08; Lieberman Linda A, 2002, Int Rev Immunol, V21, P373, DOI 10.1080/08830180213281; Liu ZY, 1997, BLOOD, V90, P2253, DOI 10.1182/blood.V90.6.2253.2253_2253_2259; Luder CGK, 1999, EXP PARASITOL, V93, P23, DOI 10.1006/expr.1999.4421; Goncalves RM, 2007, ACTA OPHTHALMOL SCAN, V85, P871, DOI 10.1111/j.1600-0420.2007.00943.x; Mercier A, 2011, INFECT GENET EVOL, V11, P1378, DOI 10.1016/j.meegid.2011.05.003; Mercier A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000876; Nagineni CN, 2000, INFECT IMMUN, V68, P407, DOI 10.1128/IAI.68.1.407-410.2000; Petersen E, 2012, OCUL IMMUNOL INFLAMM, V20, P68, DOI 10.3109/09273948.2012.661115; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Rahman A, 2009, ANTIOXID REDOX SIGN, V11, P823, DOI [10.1089/ars.2008.2204, 10.1089/ARS.2008.2204]; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; ROSS RA, 1983, J NATL CANCER I, V71, P741; Schuindt SHS, 2012, VET PARASITOL, V186, P207, DOI 10.1016/j.vetpar.2011.11.035; Schluter D, 2001, INFECT IMMUN, V69, P7889, DOI 10.1128/IAI.69.12.7889-7893.2001; SCHWEITZER CM, 1995, EXP HEMATOL, V23, P41; Schweitzer KM, 1997, LAB INVEST, V76, P25; Skariah S, 2010, PARASITOL RES, V107, P253, DOI 10.1007/s00436-010-1899-6; Su CL, 2012, P NATL ACAD SCI USA, V109, P5844, DOI 10.1073/pnas.1203190109; Suzuki Y, 1997, INFECT IMMUN, V65, P2339, DOI 10.1128/IAI.65.6.2339-2345.1997; Venturi GM, 2003, IMMUNITY, V19, P713, DOI 10.1016/S1074-7613(03)00295-4; Xiao JC, 2011, INFECT IMMUN, V79, P1363, DOI 10.1128/IAI.00947-10; Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598	60	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98491	10.1371/journal.pone.0098491	http://dx.doi.org/10.1371/journal.pone.0098491			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886982	gold, Green Published, Green Submitted			2022-12-25	WOS:000336956300072
J	Paulus-Hock, V; Cheung, EC; Roxburgh, P; Vousden, KH; Hock, AK				Paulus-Hock, Viola; Cheung, Eric C.; Roxburgh, Patricia; Vousden, Karen H.; Hock, Andreas K.			iRFP Is a Real Time Marker for Transformation Based Assays in High Content Screening	PLOS ONE			English	Article							GROWTH; CELLS	Anchorage independent growth is one of the hallmarks of oncogenic transformation. Here we show that infrared fluorescent protein (iRFP) based assays allow accurate and unbiased determination of colony formation and anchorage independent growth over time. This protocol is particularly compatible with high throughput systems, in contrast to traditional methods which are often labor-intensive, subjective to bias and do not allow further analysis using the same cells. Transformation in a single layer soft agar assay could be documented as early as 2 to 3 days in a 96 well format, which can be easily combined with standard transfection, infection and compound screening setups to allow for high throughput screening to identify therapeutic targets.	[Paulus-Hock, Viola; Cheung, Eric C.; Roxburgh, Patricia; Vousden, Karen H.; Hock, Andreas K.] Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland; [Roxburgh, Patricia] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland	Beatson Institute; University of Glasgow	Vousden, KH (corresponding author), Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland.	k.vousden@beatson.gla.ac.uk; a.hock@beatson.gla.ac.uk		Paulus-Hock, Viola/0000-0002-2891-5419	Cancer Research UK; Cancer Research UK [18274] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	The authors would like to acknowledge funding from Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY MC, 1991, CANCER RES, V51, P1247; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Hock AK, 2014, CELL CYCLE, V13, P220, DOI 10.4161/cc.26985; Ke N, 2004, BIOTECHNIQUES, V36, P826, DOI 10.2144/04365ST07; MACPHERSON I, 1964, VIROLOGY, V23, P291, DOI 10.1016/0042-6822(64)90301-0; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Shcherbakova DM, 2013, NAT METHODS, V10, P751, DOI 10.1038/nmeth.2521; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; SIMONS PJ, 1967, NATURE, V214, P897, DOI 10.1038/214897a0; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299	10	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98399	10.1371/journal.pone.0098399	http://dx.doi.org/10.1371/journal.pone.0098399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887316	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000336956300061
J	Schmidt, BL; Kuczynski, J; Bhattacharya, A; Huey, B; Corby, PM; Queiroz, ELS; Nightingale, K; Kerr, AR; DeLacure, MD; Veeramachaneni, R; Olshen, AB; Albertson, DG				Schmidt, Brian L.; Kuczynski, Justin; Bhattacharya, Aditi; Huey, Bing; Corby, Patricia M.; Queiroz, Erica L. S.; Nightingale, Kira; Kerr, A. Ross; DeLacure, Mark D.; Veeramachaneni, Ratna; Olshen, Adam B.; Albertson, Donna G.			Changes in Abundance of Oral Microbiota Associated with Oral Cancer	PLOS ONE			English	Article							FUSOBACTERIUM-NUCLEATUM; BACTERIA PRESENT; NECK-CANCER; DIVERSITY; HEAD; PERIODONTITIS; MICROFLORA; EXPRESSION; CARCINOMA; SEQUENCES	Individual bacteria and shifts in the composition of the microbiome have been associated with human diseases including cancer. To investigate changes in the microbiome associated with oral cancers, we profiled cancers and anatomically matched contralateral normal tissue from the same patient by sequencing 16S rDNA hypervariable region amplicons. In cancer samples from both a discovery and a subsequent confirmation cohort, abundance of Firmicutes (especially Streptococcus) and Actinobacteria (especially Rothia) was significantly decreased relative to contralateral normal samples from the same patient. Significant decreases in abundance of these phyla were observed for pre-cancers, but not when comparing samples from contralateral sites (tongue and floor of mouth) from healthy individuals. Weighted UniFrac principal coordinates analysis based on 12 taxa separated most cancers from other samples with greatest separation of node positive cases. These studies begin to develop a framework for exploiting the oral microbiome for monitoring oral cancer development, progression and recurrence.	[Schmidt, Brian L.; Corby, Patricia M.; Queiroz, Erica L. S.; Nightingale, Kira] NYU, Coll Dent, Bluestone Ctr Clin Res, New York, NY 10012 USA; [Schmidt, Brian L.] NYU, Coll Dent, Dept Oral & Maxillofacial Surg, New York, NY USA; [Kuczynski, Justin] Second Genome, Bioinformat Dept, San Bruno, CA USA; [Bhattacharya, Aditi; Huey, Bing; Veeramachaneni, Ratna; Olshen, Adam B.; Albertson, Donna G.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Kerr, A. Ross] NYU, Coll Dent, Dept Oral & Maxillofacial Pathol Radiol & Med, New York, NY USA; [DeLacure, Mark D.] NYU, Dept Otolaryngol, New York, NY 10016 USA; [DeLacure, Mark D.] NYU, Dept Plast Surg, New York, NY USA	New York University; New York University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; New York University; New York University; New York University	Albertson, DG (corresponding author), NYU, Coll Dent, Bluestone Ctr Clin Res, New York, NY 10012 USA.	da66@nyu.edu	Veeramachaneni, Ratna/N-1810-2015; Teh, Muy-Teck/B-9284-2016	Veeramachaneni, Ratna/0000-0003-2515-0120; Schmidt, Brian/0000-0002-2409-8984; Teh, Muy-Teck/0000-0002-7725-8355	Roche; National Center for Research Resources; National Center for Advancing Translational Sciences; Office of the Director, National Institutes of Health, through University of San Francisco (UCSF)-CTSI [UL1 RR024129]; National Cancer Institute [R01 CA131286, R21 CA 941186215]; National Institute of Dental and Craniofacial Research [R01 DE019796]; NATIONAL CANCER INSTITUTE [R01CA131286] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019796] Funding Source: NIH RePORTER	Roche(Roche Holding); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Office of the Director, National Institutes of Health, through University of San Francisco (UCSF)-CTSI; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by an award of a GS Junior 454 Sequencing run from Roche, the National Center for Research Resources, the National Center for Advancing Translational Sciences, and the Office of the Director, National Institutes of Health, through University of San Francisco (UCSF)-CTSI grant number UL1 RR024129, and individual investigator awards from the National Cancer Institute grant (R01 CA131286, R21 CA 941186215) and the National Institute of Dental and Craniofacial Research (R01 DE019796). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bebek G, 2012, HUM MOL GENET, V21, P1557, DOI 10.1093/hmg/ddr593; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Bizzarro S, 2013, J CLIN PERIODONTOL, V40, P483, DOI 10.1111/jcpe.12087; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chang AH, 2010, CLIN MICROBIOL REV, V23, P837, DOI 10.1128/CMR.00012-10; Charlson ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015216; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Cheng Allen, 2008, Oral Maxillofac Surg Clin North Am, V20, P477, DOI 10.1016/j.coms.2008.02.002; Contreras M, 2010, MICROBIOL-SGM, V156, P3282, DOI 10.1099/mic.0.043174-0; CORREA P, 1975, LANCET, V2, P58; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Gillison ML, 2004, SEMIN ONCOL, V31, P744, DOI 10.1053/j.seminoncol.2004.09.011; Guan SM, 2011, FEMS IMMUNOL MED MIC, V62, P91, DOI 10.1111/j.1574-695X.2011.00789.x; Gursoy UK, 2010, J PERIODONTOL, V81, P1084, DOI 10.1902/jop.2010.090664; Hooper SJ, 2007, J MED MICROBIOL, V56, P1651, DOI 10.1099/jmm.0.46918-0; Hooper SJ, 2006, J CLIN MICROBIOL, V44, P1719, DOI 10.1128/JCM.44.5.1719-1725.2006; Hooper SJ, 2009, HEAD NECK-J SCI SPEC, V31, P1228, DOI 10.1002/hed.21140; Jenkinson HF, 2005, TRENDS MICROBIOL, V13, P589, DOI 10.1016/j.tim.2005.09.006; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Kumar PS, 2011, INFECT IMMUN, V79, P4730, DOI 10.1128/IAI.05371-11; Lax AJ, 2002, TRENDS MICROBIOL, V10, P293, DOI 10.1016/S0966-842X(02)02360-0; Lazarevic V, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-523; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Mager DL, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-14; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Markopoulos AK, 2010, OPEN DENT J, V4, P172, DOI 10.2174/1874210601004010172; Matthews AM, 2012, BRIT J ORAL MAXILLOF; Nagy KN, 1998, ORAL ONCOL, V34, P304, DOI 10.1016/S1368-8375(98)80012-2; Nasidze I, 2009, ANAL BIOCHEM, V391, P64, DOI 10.1016/j.ab.2009.04.034; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Nobbs AH, 2011, J DENT RES, V90, P1271, DOI 10.1177/0022034511399096; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Parkin DM, 1999, CA-CANCER J CLIN, V49, P33, DOI 10.3322/canjclin.49.1.33; Pushalkar S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-144; Pushalkar S, 2011, FEMS IMMUNOL MED MIC, V61, P269, DOI 10.1111/j.1574-695X.2010.00773.x; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Schmidt BL, 2004, J ORAL MAXIL SURG, V62, P1055, DOI 10.1016/j.joms.2004.03.010; Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998; Stahringer SS, 2012, GENOME RES; Tabor MP, 2001, CLIN CANCER RES, V7, P1523; Tezal M, 2009, CANCER EPIDEM BIOMAR, V18, P2406, DOI 10.1158/1055-9965.EPI-09-0334; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wei JE, 2011, INT J CANCER, V129, P2207, DOI 10.1002/ijc.25881; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhang G, 2011, J PERIODONTAL RES, V46, P558, DOI 10.1111/j.1600-0765.2011.01373.x; Zhang G, 2011, MOL ORAL MICROBIOL, V26, P150, DOI 10.1111/j.2041-1014.2010.00600.x	57	192	199	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98741	10.1371/journal.pone.0098741	http://dx.doi.org/10.1371/journal.pone.0098741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887397	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300102
J	Leal, MF; Cirilo, PDR; Mazzotti, TKF; Calcagno, DQ; Wisnieski, F; Demachki, S; Martinez, MC; Assumpcao, PP; Chammas, R; Burbano, RR; Smith, MC				Leal, Mariana Ferreira; Ramos Cirilo, Priscila Daniele; Furuya Mazzotti, Tatiane Katsue; Calcagno, Danielle Queiroz; Wisnieski, Fernanda; Demachki, Samia; Martinez, Margarita Cortes; Assumpcao, Paulo Pimentel; Chammas, Roger; Burbano, Rommel Rodriguez; Smith, Marilia Cardoso			Prohibitin Expression Deregulation in Gastric Cancer Is Associated with the 3 ' Untranslated Region 1630 C > T Polymorphism and Copy Number Variation	PLOS ONE			English	Article							CLINICOPATHOLOGICAL CHARACTERISTICS; NUMERICAL ABERRATIONS; YOUNG; IDENTIFICATION; CHROMOSOME-17; PROGNOSIS; CARCINOMA; BIOMARKER; DIFFUSE; PROTEIN	PHB is a reported oncogene and tumor suppressor in gastric cancer. Here, we evaluated whether the PHB copy number and the rs6917 polymorphism affect its expression in gastric cancer. Down-regulation and up-regulation of PHB were observed in the evaluated tumors. Reduced expression was associated with tumor dedifferentiation and cancer initiation. The T allele of the rs6917 polymorphism was associated with reduced PHB mRNA levels. Moreover, the up-regulation of PHB appeared to be regulated by the gain of additional gene copies. Thus, PHB copy number variation and differential expression of the rs6917 polymorphism may play a role in PHB transcriptional regulation.	[Leal, Mariana Ferreira; Calcagno, Danielle Queiroz; Wisnieski, Fernanda; Smith, Marilia Cardoso] Univ Fed Sao Paulo, Disciplina Genet, Dept Morfol & Genet, Sao Paulo, Brazil; [Leal, Mariana Ferreira] Univ Fed Sao Paulo, Dept Ortopedia & Traumatol, Sao Paulo, Brazil; [Ramos Cirilo, Priscila Daniele; Furuya Mazzotti, Tatiane Katsue; Martinez, Margarita Cortes; Chammas, Roger] Univ Fed Sao Paulo, Fac Med, Dept Radiol, Lab Oncol Expt, Sao Paulo, Brazil; [Ramos Cirilo, Priscila Daniele; Furuya Mazzotti, Tatiane Katsue; Martinez, Margarita Cortes; Chammas, Roger] Inst Canc Estado Sao Paulo, Ctr Invest Translat Oncol, Sao Paulo, Brazil; [Calcagno, Danielle Queiroz; Demachki, Samia; Assumpcao, Paulo Pimentel] Fed Univ Para, Hosp Univ Joao Barros Barreto, BR-66059 Belem, Para, Brazil; [Burbano, Rommel Rodriguez] Fed Univ Para, Inst Ciencias Biol, Lab Citogenet Humana, BR-66059 Belem, Para, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Para; Universidade Federal do Para	Leal, MF (corresponding author), Univ Fed Sao Paulo, Disciplina Genet, Dept Morfol & Genet, Sao Paulo, Brazil.	mariana.morf@epm.br	Chammas, Roger/A-8004-2011; Burbano, Rommel R/C-4149-2012; Furuya, Tatiane K/E-5543-2013; Leal, Mariana/C-4010-2012; Cirillo, Priscila Daniele Ramos/AAH-4246-2020; de A. C. Smith, Marilia/C-4397-2012; Furuya, Tatiane Katsue/B-5842-2015	Chammas, Roger/0000-0003-0342-8726; Burbano, Rommel R/0000-0002-4872-234X; Leal, Mariana/0000-0003-4375-2563; Cirillo, Priscila Daniele Ramos/0000-0001-5453-3978; de A. C. Smith, Marilia/0000-0002-1441-1033; Wisnieski, Fernanda/0000-0003-4963-3194	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPESP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPESP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; RC, MACS and RRB) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; MFL, PDRC and DQC) as grants and fellowship awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Assumpcao PP, 2006, CANCER GENET CYTOGEN, V169, P45, DOI 10.1016/j.cancergencyto.2006.03.019; Buffart TE, 2007, J PATHOL, V211, P45, DOI 10.1002/path.2085; Burbano RR, 2006, ANTICANCER RES, V26, P2909; Francisco G, 2013, MELANOMA RES, V23, P231, DOI 10.1097/CMR.0b013e3283612483; Ge B, 2005, GENOME RES, V15, P1584, DOI 10.1101/gr.4023805; He QY, 2004, PROTEOMICS, V4, P3276, DOI 10.1002/pmic.200300916; Jang JS, 2004, ONCOL RES, V14, P491, DOI 10.3727/0965040042380441; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jia J, 2013, CURR OPIN GENET DEV, V23, P29, DOI 10.1016/j.gde.2012.12.004; Jupe ER, 1996, EXP CELL RES, V224, P128, DOI 10.1006/excr.1996.0120; Jupe ER, 1996, CELL GROWTH DIFFER, V7, P871; Kang XD, 2008, J GASTROENTEROL, V43, P618, DOI 10.1007/s00535-008-2208-3; Khayat AS, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-55; Kitamura K, 1996, BRIT J CANCER, V73, P798, DOI 10.1038/bjc.1996.139; Kitayama Y, 2003, LAB INVEST, V83, P1311, DOI 10.1097/01.LAB.0000087622.80751.C5; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Leal MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042255; Leal MF, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/631268; Leal MF, 2009, CANCER GENET CYTOGEN, V195, P85, DOI 10.1016/j.cancergencyto.2009.04.020; Li J, 2013, CANCER LETT, V337, P22, DOI 10.1016/j.canlet.2013.05.034; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Maehara Y, 1996, CANCER-AM CANCER SOC, V77, P1774, DOI 10.1002/(SICI)1097-0142(19960501)77:9<1774::AID-CNCR3>3.0.CO;2-C; Manjeshwar S, 2004, J MOL HISTOL, V35, P639; Manjeshwar S, 2003, CANCER RES, V63, P5251; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; NUELL MJ, 1991, MOL CELL BIOL, V11, P1372, DOI 10.1128/MCB.11.3.1372; Panani AD, 2008, CANCER LETT, V266, P99, DOI 10.1016/j.canlet.2008.02.053; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rajalingam K, 2005, CELL CYCLE, V4, P1503, DOI 10.4161/cc.4.11.2142; Ren H, 2006, WORLD J GASTROENTERO, V12, P2789, DOI 10.3748/wjg.v12.i17.2789; Ryu JW, 2003, J KOREAN MED SCI, V18, P505, DOI 10.3346/jkms.2003.18.4.505; Takeno SS, 2009, CANCER GENET CYTOGEN, V190, P1, DOI 10.1016/j.cancergencyto.2008.09.007; Tang L, 2013, ONCOTARGETS THER, V6, P177, DOI 10.2147/OTT.S40997; Tavares A, 2013, PATHOL ONCOL RES, V19, P111, DOI 10.1007/s12253-012-9530-z; Terada R, 1999, J GASTROENTEROL, V34, P11, DOI 10.1007/s005350050210; Theiss AL, 2011, BBA-MOL CELL RES, V1813, P1137, DOI 10.1016/j.bbamcr.2011.01.033; Wang KJ, 2004, WORLD J GASTROENTERO, V10, P2179; WARBURG O, 1956, SCIENCE, V124, P269; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Zhou TB, 2012, ASIAN PAC J CANCER P, V13, P3319, DOI 10.7314/APJCP.2012.13.7.3319	43	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98583	10.1371/journal.pone.0098583	http://dx.doi.org/10.1371/journal.pone.0098583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879411	Green Published, Green Submitted, gold			2022-12-25	WOS:000338101500069
J	Trauth, S; Bischofs, IB				Trauth, Stephanie; Bischofs, Ilka B.			Ectopic Integration Vectors for Generating Fluorescent Promoter Fusions in Bacillus subtilis with Minimal Dark Noise	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEIN; TRANSCRIPTOME; VARIANTS; DNA	Fluorescent protein promoter reporters are important tools that are widely used for diverse purposes in microbiology, systems biology and synthetic biology and considerable engineering efforts are still geared at improving the sensitivity of the reporter systems. Here we focus on dark noise, i.e. the signal that is generated by the empty vector control. We quantitatively characterize the dark noise of a few common bacterial reporter systems by single cell microscopy. All benchmarked reporter systems generated significant amounts of dark noise that exceed the cellular autofluorescence to different extents. We then reengineered a multicolor set of fluorescent ectopic integration vectors for Bacillus subtilis by introducing a terminator immediately upstream of the promoter insertion site, resulting in an up to 2.7-fold reduction of noise levels. The sensitivity and dynamic range of the new high-performance pXFP_Star reporter system is only limited by cellular autofluorescence. Moreover, based on studies of the rapE promoter of B. subtilis we show that the new pXFP_Star reporter system reliably reports on the weak activity of the rapE promoter whereas the original reporter system fails because of transcriptional interference. Since the pXFP_Star reporter system properly isolates the promoter from spurious transcripts, it is a particularly suitable tool for quantitative characterization of weak promoters in B. subtilis.	[Trauth, Stephanie; Bischofs, Ilka B.] Univ Heidelberg ZMBH, Zentrum Mol Biol, Heidelberg, Germany; [Trauth, Stephanie; Bischofs, Ilka B.] Heidelberg Univ, Ctr Quantitat Anal Mol & Cellular Biosyst BioQuan, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Bischofs, IB (corresponding author), Univ Heidelberg ZMBH, Zentrum Mol Biol, Heidelberg, Germany.	i.bischofs@zmbh.uni-heidelberg.de		Bischofs, Ilka/0000-0001-5905-7106	European Research Council [ERC-StG ComMots-260860]; Deutsche Forschungsgemeinschaft [BI 1213/3-1,2, SPP1617 BE 5098/1-1]	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the European Research Council by ERC-StG ComMots-260860 and the Deutsche Forschungsgemeinschaft [Emmy Noether Program, BI 1213/3-1,2 SPP1617 BE 5098/1-1, CellNetworks]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADHYA S, 1982, CELL, V29, P939, DOI 10.1016/0092-8674(82)90456-1; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Belitsky BR, 2013, P NATL ACAD SCI USA, V110, P7026, DOI 10.1073/pnas.1300428110; Bischofs IB, 2009, P NATL ACAD SCI USA, V106, P6459, DOI 10.1073/pnas.0810878106; Bisicchia P, 2010, PLASMID, V64, P143, DOI 10.1016/j.plasmid.2010.06.002; Blom EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027160; BOSHART M, 1992, GENE, V110, P129, DOI 10.1016/0378-1119(92)90456-Y; de Hoon MJL, 2005, PLOS COMPUT BIOL, V1, P212, DOI 10.1371/journal.pcbi.0010025; Doan T, 2005, MOL MICROBIOL, V55, P1767, DOI 10.1111/j.1365-2958.2005.04501.x; Ferguson ML, 2012, P NATL ACAD SCI USA, V109, P155, DOI 10.1073/pnas.1110541108; Ferguson ML, 2011, ANAL BIOCHEM, V419, P250, DOI 10.1016/j.ab.2011.08.017; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Green MR, 2012, MOL CLONING 4 EDI CO; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hentschel E, 2013, MICROB BIOTECHNOL, V6, P196, DOI 10.1111/j.1751-7915.2012.00360.x; Jiang M, 2000, J BACTERIOL, V182, P303, DOI 10.1128/JB.182.2.303-310.2000; KUSHNER PJ, 1994, MOL ENDOCRINOL, V8, P405, DOI 10.1210/me.8.4.405; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Molle V, 2003, J BACTERIOL, V185, P1911, DOI 10.1128/JB.185.6.1911-1922.2003; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Overkamp W, 2013, APPL ENVIRON MICROB, V79, P6481, DOI 10.1128/AEM.02033-13; Palmer AC, 2009, MOL CELL, V34, P545, DOI 10.1016/j.molcel.2009.04.018; Sastalla I, 2009, APPL ENVIRON MICROB, V75, P2099, DOI 10.1128/AEM.02066-08; Schenborn E, 1999, MOL BIOTECHNOL, V13, P29, DOI 10.1385/MB:13:1:29; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Uliczka F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020425; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; van der Meer JR, 2010, NAT REV MICROBIOL, V8, P511, DOI 10.1038/nrmicro2392; Veening JW, 2004, APPL ENVIRON MICROB, V70, P6809, DOI 10.1128/AEM.70.11.6809-6815.2004; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895	35	8	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98360	10.1371/journal.pone.0098360	http://dx.doi.org/10.1371/journal.pone.0098360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874808	gold, Green Published, Green Submitted			2022-12-25	WOS:000336790800035
J	Dettmann, HM; Zhang, Y; Wronna, N; Kraushaar, U; Guenther, E; Mohr, R; Neckel, PH; Mack, A; Fuchs, J; Just, L; Obermayr, F				Dettmann, Heike Monika; Zhang, Ying; Wronna, Nadine; Kraushaar, Udo; Guenther, Elke; Mohr, Roland; Neckel, Peter Helmut; Mack, Andreas; Fuchs, Joerg; Just, Lothar; Obermayr, Florian			Isolation, Expansion and Transplantation of Postnatal Murine Progenitor Cells of the Enteric Nervous System	PLOS ONE			English	Article							NEURAL STEM-CELLS; DEVELOPMENTAL DISTURBANCES; NITRIC-OXIDE; GUT; NEURONS; MOTILITY; FETAL; BOWEL; DIFFERENTIATE; THERAPY	Neural stem or progenitor cells have been proposed to restore gastrointestinal function in patients suffering from congenital or acquired defects of the enteric nervous system. Various, mainly embryonic cell sources have been identified for this purpose. However, immunological and ethical issues make a postnatal cell based therapy desirable. We therefore evaluated and quantified the potential of progenitor cells of the postnatal murine enteric nervous system to give rise to neurons and glial cells in vitro. Electrophysiological analysis and BrdU uptake studies provided direct evidence that generated neurons derive from expanded cells in vitro. Transplantation of isolated and expanded postnatal progenitor cells into the distal colon of adult mice demonstrated cell survival for 12 weeks (end of study). Implanted cells migrated within the gut wall and differentiated into neurons and glial cells, both of which were shown to derive from proliferated cells by BrdU uptake. This study indicates that progenitor cells isolated from the postnatal enteric nervous system might have the potential to serve as a source for a cell based therapy for neurogastrointestinal motility disorders. However, further studies are necessary to provide evidence that the generated cells are capable to positively influence the motility of the diseased gastrointestinal tract.	[Dettmann, Heike Monika; Fuchs, Joerg; Obermayr, Florian] Univ Childrens Hosp Tuebingen, Dept Pediat Surg & Pediat Urol, Tubingen, Germany; [Zhang, Ying; Mohr, Roland; Neckel, Peter Helmut; Mack, Andreas; Just, Lothar] Univ Tubingen, Inst Anat, Ctr Regenerat Biol & Med, Tubingen, Germany; [Wronna, Nadine; Kraushaar, Udo; Guenther, Elke] Univ Tubingen, Deptartment Electrophysiol, Nat & Med Sci Inst, Reutlingen, Germany	Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Obermayr, F (corresponding author), Univ Childrens Hosp Tuebingen, Dept Pediat Surg & Pediat Urol, Tubingen, Germany.	florian.obermayr@med.uni-tuebingen.de		Mack, Andreas/0000-0001-7591-4374; Neckel, Peter/0000-0003-1976-0512; Dr. Guenther, Elke/0000-0002-8758-1607; Kraushaar, Udo/0000-0002-4660-1093	German Federal Ministry for Education and Research (BMBF) [01GN0967]; Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University	German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University	The project was supported by a grant from the German Federal Ministry for Education and Research (BMBF, Grant Number: 01GN0967). The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Almond S, 2007, GUT, V56, P489, DOI 10.1136/gut.2006.094565; Anitha M, 2008, GASTROENTEROLOGY, V134, P1424, DOI 10.1053/j.gastro.2008.02.018; Bondurand N, 2003, DEVELOPMENT, V130, P6387, DOI 10.1242/dev.00857; BREHMER A, 2006, ADV ANAT EMBRYOL CEL, V186, P1; Burns AJ, 2004, NEUROGASTROENT MOTIL, V16, P3, DOI 10.1111/j.1743-3150.2004.00466.x; Dong YL, 2008, TRANSPL P, V40, P3646, DOI 10.1016/j.transproceed.2008.06.107; Furness JB, 2000, J AUTONOM NERV SYST, V81, P87, DOI 10.1016/S0165-1838(00)00127-2; Gariepy CE, 2004, J PEDIATR GASTR NUTR, V39, P5, DOI 10.1097/00005176-200407000-00003; Geisbauer CL, 2012, J SURG RES, V176, P20, DOI 10.1016/j.jss.2011.05.014; Geisbauer CL, 2012, J SURG RES, V174, P257, DOI 10.1016/j.jss.2010.12.016; Gershon MD, 1999, HOSP PRACT, V34, P31, DOI 10.3810/hp.1999.07.153; Gershon MD, 2007, GUT, V56, P459, DOI 10.1136/gut.2006.107748; Hanani M, 2000, AM J PHYSIOL-GASTR L, V278, pG644, DOI 10.1152/ajpgi.2000.278.4.G644; Hao MM, 2011, J NEUROSCI, V31, P15352, DOI 10.1523/JNEUROSCI.3053-11.2011; Harberson J, 2010, DIGEST DIS SCI, V55, P359, DOI 10.1007/s10620-009-1071-2; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Hotta R, 2013, J CLIN INVEST, V123, P1182, DOI 10.1172/JCI65963; Hotta R, 2009, SEMIN PEDIATR SURG, V18, P263, DOI 10.1053/j.sempedsurg.2009.07.008; Jarvi K, 2010, ANN SURG, V252, P977, DOI 10.1097/SLA.0b013e3182018542; Kruger GM, 2002, NEURON, V35, P657, DOI 10.1016/S0896-6273(02)00827-9; Lindley RM, 2008, GASTROENTEROLOGY, V135, P205, DOI 10.1053/j.gastro.2008.03.035; Liu W, 2007, NEUROGASTROENT MOTIL, V19, P1001, DOI 10.1111/j.1365-2982.2007.00981.x; Martucciello G, 2007, EUR J PEDIATR SURG, V17, P34, DOI 10.1055/s-2007-964952; Metzger M, 2007, DEV DYNAM, V236, P128, DOI 10.1002/dvdy.20920; Metzger M, 2009, GASTROENTEROLOGY, V137, P2063, DOI 10.1053/j.gastro.2009.06.038; Metzger M, 2009, GASTROENTEROLOGY, V136, P2214, DOI 10.1053/j.gastro.2009.02.048; Micci MA, 2005, GASTROENTEROLOGY, V129, P1817, DOI 10.1053/j.gastro.2005.08.055; Micci MA, 2001, GASTROENTEROLOGY, V121, P757, DOI 10.1053/gast.2001.28633; Natarajan D, 1999, DEVELOPMENT, V126, P157; Newgreen D, 2002, PEDIATR DEVEL PATHOL, V5, P224, DOI 10.1007/s10024-001-0142-y; Newgreen D, 2002, PEDIATR DEVEL PATHOL, V5, P329, DOI 10.1007/s10024-002-0002-4; Pan H, 2000, J NEUROSCI, V20, P3295, DOI 10.1523/JNEUROSCI.20-09-03295.2000; Pan WK, 2011, J SURG RES, V167, pE221, DOI 10.1016/j.jss.2011.01.016; Pfeiffer RF, 2011, PARKINSONISM RELAT D, V17, P10, DOI 10.1016/j.parkreldis.2010.08.003; Rauch U, 2006, INT J COLORECTAL DIS, V21, P554, DOI 10.1007/s00384-005-0051-z; Sasselli V, 2012, DEV BIOL, V366, P64, DOI 10.1016/j.ydbio.2012.01.012; Schafer KH, 2009, NEUROGASTROENT MOTIL, V21, P103, DOI 10.1111/j.1365-2982.2008.01257.x; Schemann M, 2005, J PEDIATR GASTR NUTR, V41, pS4, DOI 10.1097/01.scs.0000180285.51365.55; Suarez-Rodriguez R, 2004, STEM CELLS, V22, P1373, DOI 10.1634/stemcells.2003-0049; Tsai YH, 2011, NEUROGASTROENT MOTIL, V23, P362, DOI 10.1111/j.1365-2982.2010.01656.x; Vogalis F, 2000, J NEUROPHYSIOL, V83, P1253, DOI 10.1152/jn.2000.83.3.1253; Wade PR, 2004, NEUROGASTROENT MOTIL, V16, P19, DOI 10.1111/j.1743-3150.2004.00469.x; Wood JD, 2004, GASTROENTEROLOGY, V127, P635, DOI 10.1053/j.gastro.2004.02.017; YNTEMA CL, 1954, J COMP NEUROL, V101, P515, DOI 10.1002/cne.901010212	44	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97792	10.1371/journal.pone.0097792	http://dx.doi.org/10.1371/journal.pone.0097792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871092	Green Submitted, Green Published, gold			2022-12-25	WOS:000336858300020
J	Huang, YMM; Chang, CEA				Huang, Yu-ming M.; Chang, Chia-en A.			Achieving Peptide Binding Specificity and Promiscuity by Loops: Case of the Forkhead-Associated Domain	PLOS ONE			English	Article							FHA DOMAIN; STRUCTURAL BASIS; SIGNAL-TRANSDUCTION; FORCE-FIELD; PHOSPHOPEPTIDE RECOGNITION; MECHANISTIC INSIGHTS; MOLECULAR-DYNAMICS; SQ/TQ CLUSTER; BRCT REPEATS; PROTEIN	The regulation of a series of cellular events requires specific protein-protein interactions, which are usually mediated by modular domains to precisely select a particular sequence from diverse partners. However, most signaling domains can bind to more than one peptide sequence. How do proteins create promiscuity from precision ? Moreover, these complex interactions typically occur at the interface of a well-defined secondary structure, alpha helix and beta sheet. However, the molecular recognition primarily controlled by loop architecture is not fully understood. To gain a deep understanding of binding selectivity and promiscuity by the conformation of loops, we chose the forkhead-associated (FHA) domain as our model system. The domain can bind to diverse peptides via various loops but only interact with sequences containing phosphothreonine (pThr). We applied molecular dynamics (MD) simulations for multiple free and bound FHA domains to study the changes in conformations and dynamics. Generally, FHA domains share a similar folding structure whereby the backbone holds the overall geometry and the variety of sidechain atoms of multiple loops creates a binding surface to target a specific partner. FHA domains determine the specificity of pThr by well-organized binding loops, which are rigid to define a phospho recognition site. The broad range of peptide recognition can be attributed to different arrangements of the loop interaction network. The moderate flexibility of the loop conformation can help access or exclude binding partners. Our work provides insights into molecular recognition in terms of binding specificity and promiscuity and helpful clues for further peptide design.	[Huang, Yu-ming M.; Chang, Chia-en A.] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Huang, YMM (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	yhuan022@ucr.edu; chiaenc@ucr.edu			US National Science Foundation (NSF) [MCB-0919586]; NSF supercomputer centers	US National Science Foundation (NSF)(National Science Foundation (NSF)); NSF supercomputer centers(National Science Foundation (NSF))	This research was supported by the US National Science Foundation (NSF; MCB-0919586) and the NSF supercomputer centers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai R, 2010, J COMPUT AID MOL DES, V24, P819, DOI 10.1007/s10822-010-9376-y; Basdevant N, 2006, J AM CHEM SOC, V128, P12766, DOI 10.1021/ja060830y; Birrane G, 2007, BIOCHEMISTRY-US, V46, P7706, DOI 10.1021/bi700323t; Byeon IJL, 2005, NAT STRUCT MOL BIOL, V12, P987, DOI 10.1038/nsmb1008; Campbell SJ, 2010, STRUCTURE, V18, P167, DOI 10.1016/j.str.2009.12.008; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castagnoli L, 2004, FEBS LETT, V567, P74, DOI 10.1016/j.febslet.2004.03.116; Cumberworth A, 2013, BIOCHEM J, V454, P361, DOI 10.1042/BJ20130545; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Ding ZF, 2005, BIOCHEMISTRY-US, V44, P10119, DOI 10.1021/bi050414a; Ding Z, 2007, BIOCHEMISTRY-US, V46, P2684, DOI 10.1021/bi061763n; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fossett N, 2013, BBA-GEN SUBJECTS, V1830, P2375, DOI 10.1016/j.bbagen.2012.06.005; Gan WX, 2009, PROTEINS, V74, P996, DOI 10.1002/prot.22209; Gerek ZN, 2009, PROTEINS, V77, P796, DOI 10.1002/prot.22492; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang YMM, 2012, J PHYS CHEM B, V116, P10247, DOI 10.1021/jp305028d; Huang YMM, 2011, BMC BIOPHYS, V4, DOI 10.1186/2046-1682-4-12; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Huggins DJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000880; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joughin BA, 2005, PROTEIN SCI, V14, P131, DOI 10.1110/ps.04964705; Kaneko T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000796; Kupfer Gary M., 2013, Yale Journal of Biology and Medicine, V86, P491; Lee H, 2008, MOL CELL, V30, P767, DOI 10.1016/j.molcel.2008.05.013; Li HY, 2004, J MOL BIOL, V335, P371, DOI 10.1016/j.jmb.2003.10.032; Liang XY, 2008, ACCOUNTS CHEM RES, V41, P991, DOI 10.1021/ar700148u; Liao H, 2000, J MOL BIOL, V304, P941, DOI 10.1006/jmbi.2000.4291; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu BA, 2010, MOL CELL PROTEOMICS, V9, P2391, DOI 10.1074/mcp.M110.001586; Lokesh GL, 2007, J AM CHEM SOC, V129, P10658, DOI 10.1021/ja0739178; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Mahajan A, 2005, J AM CHEM SOC, V127, P14572, DOI 10.1021/ja054538m; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; McClendon CL, 2009, J CHEM THEORY COMPUT, V5, P2486, DOI 10.1021/ct9001812; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Mohammad DH, 2009, DNA REPAIR, V8, P1009, DOI 10.1016/j.dnarep.2009.04.004; Munz M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002749; Nachman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011215; Nobeli I, 2009, NAT BIOTECHNOL, V27, P157, DOI 10.1038/nbt1519; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Pennell S, 2010, STRUCTURE, V18, P1587, DOI 10.1016/j.str.2010.09.014; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Song YF, 2009, J COMPUT CHEM, V30, P2231, DOI 10.1002/jcc.21222; Song YF, 2009, J MOL BIOL, V387, P840, DOI 10.1016/j.jmb.2009.01.038; Sudol Marius, 2005, V3, P185, DOI 10.1007/0-387-24532-4_9; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wickstrom L, 2009, BIOPHYS J, V97, P853, DOI 10.1016/j.bpj.2009.04.063; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Yaffe MB, 2004, ANNU REV BIOPH BIOM, V33, P225, DOI 10.1146/annurev.biophys.33.110502.133346; Yaffe MB, 2002, NAT REV MOL CELL BIO, V3, P177, DOI 10.1038/nrm759; Yaffe MB, 1999, NATURE, V402, P30; Yaffe MB, 2001, STRUCTURE, V9, pR33, DOI 10.1016/S0969-2126(01)00580-9; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Yongkiettrakul S, 2004, BIOCHEMISTRY-US, V43, P3862, DOI 10.1021/bi036195f; Yuan CH, 2001, J MOL BIOL, V314, P563, DOI 10.1006/jmbi.2001.5140	74	3	3	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98291	10.1371/journal.pone.0098291	http://dx.doi.org/10.1371/journal.pone.0098291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870410	Green Submitted, Green Published, gold			2022-12-25	WOS:000336858300034
J	Jitkova, Y; Gronda, M; Hurren, R; Wang, XM; Goard, CA; Jhas, B; Schimmer, AD				Jitkova, Yulia; Gronda, Marcela; Hurren, Rose; Wang, Xiaoming; Goard, Carolyn A.; Jhas, Bozhena; Schimmer, Aaron D.			A Novel Formulation of Tigecycline Has Enhanced Stability and Sustained Antibacterial and Antileukemic Activity	PLOS ONE			English	Article							REDUCING REAGENT OXYRASE; ACUTE MYELOID-LEUKEMIA; MITOCHONDRIAL TRANSLATION; IN-VITRO; INHIBITION; CELLS; GLYCYLCYCLINE; GAR-936; FRESH; ACID	Tigecycline is a broad-spectrum, first-in-class glycylcycline antibiotic currently used to treat complicated skin and intra-abdominal infections, as well as community-acquired pneumonia. In addition, we have demonstrated that tigecycline also has in vitro and in vivo activity against acute myeloid leukemia (AML) due to its ability to inhibit mitochondrial translation. Tigecycline is relatively unstable after reconstitution, and this instability may limit the use of the drug in ambulatory infusions for the treatment of infection and may prevent the development of optimal dosing schedules for the treatment of AML. This study sought to identify a formulation that improved the stability of the drug after reconstitution and maintained its antimicrobial and antileukemic activity. A panel of chemical additives was tested to identify excipients that enhanced the stability of tigecycline in solution at room temperature for up to one week. We identified a novel formulation containing the oxygen-reducing agents ascorbic acid (3 mg/mL) and pyruvate (60 mg/mL), in saline solution, pH 7.0, in which tigecycline (1 mg/mL) remained intact when protected from light for at least 7 days. This formulation also preserved the drug's antibacterial and antileukemic activity in vitro. Moreover, the novel formulation retained tigecycline's antileukemic activity in vivo. Thus, we identified and characterized a novel formulation for tigecycline that preserves its stability and efficacy after reconstitution.	[Jitkova, Yulia; Gronda, Marcela; Hurren, Rose; Wang, Xiaoming; Goard, Carolyn A.; Jhas, Bozhena; Schimmer, Aaron D.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Schimmer, AD (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.	aaron.schimmer@utoronto.ca		Schimmer, Aaron/0000-0003-4023-3899	Canadian Stem Cell Network; Leukemia and Lymphoma Society; National Institutes of Health (NCI) [1R01CA157456]; Princess Margaret Hospital Foundation; Ministry of Long Term Health and Planning in the Province of Ontario; NATIONAL CANCER INSTITUTE [R01CA157456] Funding Source: NIH RePORTER	Canadian Stem Cell Network; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Princess Margaret Hospital Foundation; Ministry of Long Term Health and Planning in the Province of Ontario; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Canadian Stem Cell Network, the Leukemia and Lymphoma Society, the National Institutes of Health (NCI 1R01CA157456), the Princess Margaret Hospital Foundation, and the Ministry of Long Term Health and Planning in the Province of Ontario. A. D. S. is a Leukemia and Lymphoma Society Scholar in clinical research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer G, 2004, J ANTIMICROB CHEMOTH, V53, P592, DOI 10.1093/jac/dkh125; Bradford PA, 2005, ANTIMICROB AGENTS CH, V49, P3903, DOI 10.1128/AAC.49.9.3903-3909.2005; CHEN W, 1989, LEUKEMIA, V3, P264; Fawzi MB, 2011, US patent, Patent No. 7879828; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Giamarellou H, 2011, EXPERT OPIN DRUG MET, V7, P1459, DOI 10.1517/17425255.2011.623126; Hope R, 2005, J ANTIMICROB CHEMOTH, V56, P1042, DOI 10.1093/jac/dki386; Jenner L, 2013, P NATL ACAD SCI USA, V110, P3812, DOI 10.1073/pnas.1216691110; Kehrein K, 2013, ANTIOXID REDOX SIGNA; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Li CH, 2004, J CHROMATOGR B, V811, P225, DOI 10.1016/j.jchromb.2004.09.011; Olson MW, 2006, ANTIMICROB AGENTS CH, V50, P2156, DOI 10.1128/AAC.01499-05; Petersen PJ, 1999, ANTIMICROB AGENTS CH, V43, P738, DOI 10.1128/AAC.43.4.738; Petersen PJ, 2005, ANTIMICROB AGENTS CH, V49, P3910, DOI 10.1128/AAC.49.9.3910-3918.2005; Pohanka M, 2012, MINI-REV MED CHEM, V12, P35, DOI 10.2174/138955712798868986; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Schimmer AD, 2012, EXPERT REV HEMATOL, V5, P117, DOI [10.1586/ehm.12.8, 10.1586/EHM.12.8]; Schimmer AD, 2006, CANCER RES, V66, P2367, DOI 10.1158/0008-5472.CAN-05-1061; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Sum PE, 1999, BIOORG MED CHEM LETT, V9, P1459, DOI 10.1016/S0960-894X(99)00216-4; Warner JK, 2005, LEUKEMIA, V19, P1794, DOI 10.1038/sj.leu.2403917; Wenzel R, 2005, NAT REV DRUG DISCOV, V4, P809, DOI 10.1038/nrd1857; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wyeth Pharmaceuticals Inc, 2012, TYG FULL PRESCR INF	24	21	22	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e95281	10.1371/journal.pone.0095281	http://dx.doi.org/10.1371/journal.pone.0095281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871339	gold, Green Submitted, Green Published			2022-12-25	WOS:000336858300002
J	McCormick, AW; Abuelezam, NN; Rhode, ER; Hou, TG; Walensky, RP; Pei, PP; Becker, JE; DiLorenzo, MA; Losina, E; Freedberg, KA; Lipsitch, M; Seage, GR				McCormick, Alethea W.; Abuelezam, Nadia N.; Rhode, Erin R.; Hou, Taige; Walensky, Rochelle P.; Pei, Pamela P.; Becker, Jessica E.; DiLorenzo, Madeline A.; Losina, Elena; Freedberg, Kenneth A.; Lipsitch, Marc; Seage, George R., III			Development, Calibration and Performance of an HIV Transmission Model Incorporating Natural History and Behavioral Patterns: Application in South Africa	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SEXUAL RISK BEHAVIOR; COST-EFFECTIVENESS; POTENTIAL IMPACT; MALE CIRCUMCISION; DIFFERENT REGIONS; REFERENCE RANGES; CLINICAL IMPACT; INFECTED ADULTS; UNITED-STATES	Understanding HIV transmission dynamics is critical to estimating the potential population-wide impact of HIV prevention and treatment interventions. We developed an individual-based simulation model of the heterosexual HIV epidemic in South Africa and linked it to the previously published Cost-Effectiveness of Preventing AIDS Complications (CEPAC) International Model, which simulates the natural history and treatment of HIV. In this new model, the CEPAC Dynamic Model (CDM), the probability of HIV transmission per sexual encounter between short-term, long-term and commercial sex worker partners depends upon the HIV RNA and disease stage of the infected partner, condom use, and the circumcision status of the uninfected male partner. We included behavioral, demographic and biological values in the CDM and calibrated to HIV prevalence in South Africa pre-antiretroviral therapy. Using a multi-step fitting procedure based on Bayesian melding methodology, we performed 264,225 simulations of the HIV epidemic in South Africa and identified 3,750 parameter sets that created an epidemic and had behavioral characteristics representative of a South African population pre-ART. Of these parameter sets, 564 contributed 90% of the likelihood weight to the fit, and closely reproduced the UNAIDS HIV prevalence curve in South Africa from 1990-2002. The calibration was sensitive to changes in the rate of formation of short-duration partnerships and to the partnership acquisition rate among high-risk individuals, both of which impacted concurrency. Runs that closely fit to historical HIV prevalence reflect diverse ranges for individual parameter values and predict a wide range of possible steady-state prevalence in the absence of interventions, illustrating the value of the calibration procedure and utility of the model for evaluating interventions. This model, which includes detailed behavioral patterns and HIV natural history, closely fits HIV prevalence estimates.	[McCormick, Alethea W.; Abuelezam, Nadia N.; Lipsitch, Marc; Seage, George R., III] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Rhode, Erin R.; Hou, Taige; Walensky, Rochelle P.; Pei, Pamela P.; Becker, Jessica E.; DiLorenzo, Madeline A.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Rhode, Erin R.; Hou, Taige; Walensky, Rochelle P.; Pei, Pamela P.; Becker, Jessica E.; DiLorenzo, Madeline A.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Rhode, Erin R.; Hou, Taige; Walensky, Rochelle P.; Pei, Pamela P.; Becker, Jessica E.; DiLorenzo, Madeline A.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.] Harvard Univ, Ctr AIDS Res, Boston, MA 02115 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston University; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	McCormick, AW (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	amccormi@hsph.harvard.edu	Abuelezam, Nadia/AAO-1952-2021	Abuelezam, Nadia/0000-0002-5459-8592; Walensky, Rochelle P./0000-0002-8795-379X; Becker, Jessica/0000-0003-0522-2836; Losina, ELENA/0000-0002-3424-0892	 [RO1-AI-058736];  [RO1-MH-087326];  [T32-AI-007535];  [T32-AI-007433]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007535, R01AI058736, R37AI042006, T32AI007433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087328] Funding Source: NIH RePORTER	; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the following grants: RO1-AI-058736, RO1-MH-087326, T32-AI-007535 and T32-AI-007433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; Abuelezam NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075624; Alkema L, 2008, SEX TRANSM INFECT, V84, pI11, DOI 10.1136/sti.2008.029991; Alkema L, 2007, ANN APPL STAT, V1, P229, DOI 10.1214/07-AOAS111; [Anonymous], 2002, WORLD MORTALITY 2000; Auvert B, 2000, COMPUT BIOMED RES, V33, P84, DOI 10.1006/cbmr.1999.1533; Baggaley RF, 2006, PLOS MED, V3, P493, DOI 10.1371/journal.pmed.0030124; Barlow D, 1997, AIDS, V11, P1039, DOI 10.1097/00002030-199708000-00013; Baxter JD, 2000, AIDS, V14, pF83, DOI 10.1097/00002030-200006160-00001; Bendavid E, 2010, ARCH INTERN MED, V170, P1347, DOI 10.1001/archinternmed.2010.249; Bershteyn A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0613; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Blower SM, 2001, NAT MED, V7, P1016, DOI 10.1038/nm0901-1016; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Cambiano V, 2013, J INFECT DIS, V207, pS57, DOI 10.1093/infdis/jit111; Carael M, 2006, SEX TRANSM INFECT, V82, pIII26, DOI 10.1136/sti.2006.021196; Chopra M, 2009, JAIDS-J ACQ IMM DEF, V51, P72, DOI 10.1097/QAI.0b013e31819907de; Chou R, 2007, SCREENING HIV FOCUSE; Detsky A S, 1993, Pharmacoeconomics, V3, P354, DOI 10.2165/00019053-199303050-00003; Doherty IA, 2009, JAIDS-J ACQ IMM DEF, V52, P114, DOI 10.1097/QAI.0b013e3181ab5e10; Dunkle KL, 2005, INT J STD AIDS, V16, P256, DOI 10.1258/0956462053420220; Eaton JW, 2014, LANCET GLOB HEALTH, V2, pE23, DOI 10.1016/S2214-109X(13)70172-4; Eaton JW, 2011, AIDS BEHAV, V15, P687, DOI 10.1007/s10461-010-9787-8; Edmonds A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001044; Eisenberg JNS, 2002, ENVIRON HEALTH PERSP, V110, P783, DOI 10.1289/ehp.02110783; GARNETT GP, 1993, PHILOS T R SOC B, V342, P137, DOI 10.1098/rstb.1993.0143; Garnett GP, 1996, J INFECT DIS, V174, pS150, DOI 10.1093/infdis/174.Supplement_2.S150; GARNETT GP, 1994, IMA J MATH APPL MED, V11, P161; Gibson GJ, 2004, P NATL ACAD SCI USA, V101, P12120, DOI 10.1073/pnas.0400829101; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gray RH, 2003, AIDS, V17, P1941, DOI 10.1097/00002030-200309050-00013; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Hallett TB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001123; Harrison A, 2008, STUD FAMILY PLANN, V39, P295, DOI 10.1111/j.1728-4465.2008.00176.x; Hoare A, 2012, SEX HEALTH, V9, P144, DOI 10.1071/SH10145; Holmes CB, 2006, JAIDS-J ACQ IMM DEF, V42, P464, DOI 10.1097/01.qai.0000225729.79610.b7; Hontelez JAC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001534; Hontelez JAC, 2011, VACCINE, V29, P6100, DOI 10.1016/j.vaccine.2011.06.059; Introcaso CE, 2013, SEX TRANSM DIS, V40, P521, DOI 10.1097/01.OLQ.0000430797.56499.0d; JACQUEZ JA, 1994, J ACQ IMMUN DEF SYND, V7, P1169; Jewkes R, 2006, TROP MED INT HEALTH, V11, P3, DOI 10.1111/j.1365-3156.2005.01530.x; Johnson LF, 2010, SEX TRANSM INFECT, V86, P169, DOI 10.1136/sti.2009.037341; Johnson LF, 2009, DEMOGR RES, V21, P289, DOI 10.4054/DemRes.2009.21.11; Kelly R, 1999, AIDS, V13, P399, DOI 10.1097/00002030-199902250-00013; Korenromp EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005950; Lara AM, 2008, AIDS, V22, pS123, DOI 10.1097/01.aids.0000327633.85221.9a; Lawrie D, 2009, SAMJ S AFR MED J, V99, P243; Levin BR, 1996, MATH BIOSCI, V132, P69, DOI 10.1016/0025-5564(95)00053-4; Losina E, 2006, SAMJ S AFR MED J, V96, P526; Losina E, 2007, ANTIVIR THER, V12, P543; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Maini MK, 1996, GENITOURIN MED, V72, P27; McCormick AW, 2007, CLIN INFECT DIS, V44, P1115, DOI 10.1086/512816; McCreesh N, 2012, SEX TRANSM DIS, V39, P407, DOI 10.1097/OLQ.0b013e318254c84a; Meekers D, 2000, INT J STD AIDS, V11, P21, DOI 10.1258/0956462001914850; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; MORRIS M, 1995, SOC NETWORKS, V17, P299, DOI 10.1016/0378-8733(95)00268-S; National Department of Health ICF, 2019, S AFR DEM HLTH SURV; Ndase P, 2012, JAIDS-J ACQ IMM DEF, V59, P65, DOI 10.1097/QAI.0b013e318237b864; Padian NS, 2007, LANCET, V370, P251, DOI 10.1016/S0140-6736(07)60950-7; Patel K, 2008, CLIN INFECT DIS, V46, P507, DOI 10.1086/526524; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Phair JP, 1997, J INFECT DIS, V175, P959, DOI 10.1086/514000; Poole D, 2000, J AM STAT ASSOC, V95, P1244, DOI 10.2307/2669764; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Raftery AE, 2010, BIOMETRICS, V66, P1162, DOI 10.1111/j.1541-0420.2010.01399.x; RAFTERY AE, 1995, J AM STAT ASSOC, V90, P402, DOI 10.2307/2291048; RICARD D, 1994, AIDS, V8, P977, DOI 10.1097/00002030-199407000-00016; Schneider E., 2006, Morbidity and Mortality Weekly Report, V55, P589; Sevcikova H, 2007, TRANSPORTATION RES B, V41, P652; Sevcikova H, 2007, TRANSPORT RES B-METH, V41, P652, DOI 10.1016/j.trb.2006.11.001; SHISANA O, 2005, S AFRICAN NATL HIV P; Shisana O., 2002, N MANDELA HSRC STUDY; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X; Stover J, 2003, GOALS MODEL ESTIMATI; Tassiopoulos K, 2013, CLIN INFECT DIS, V56, P283, DOI 10.1093/cid/cis816; U.S Census Bureau, 2012, INT DAT BAS DEM OV S; UNAIDS, 2021, PREV HIV INF TIM NEW; UNAIDS, 2010, REP GLOB AIDS EP; UNAIDS/WHO, 2009, AIDS EP UPD NOV 2009; Urassa W, 2004, AIDS, V18, P433, DOI 10.1097/00002030-200402200-00009; US Preventive Serv Task Force, 2005, ANN INTERN MED, V143, P32, DOI 10.7326/0003-4819-143-1-200507050-00008; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; Vieira IT, 2010, ANN OPER RES, V178, P173, DOI 10.1007/s10479-009-0571-y; Walensky RP, 2012, CLIN INFECT DIS, V54, P1504, DOI 10.1093/cid/cis225; Walensky RP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000382; Walensky RP, 2011, JAIDS-J ACQ IMM DEF, V56, P26, DOI 10.1097/QAI.0b013e3181fb8f24; Walensky RP, 2010, CLIN INFECT DIS, V51, P392, DOI 10.1086/655130; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Williams BG, 2006, J INFECT DIS, V194, P1450, DOI 10.1086/508206; World Health Organization, 2006, ANT THER HIV INF AD; Wu JT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000085; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6; Zuma K, 2005, EPIDEMIOL INFECT, V133, P421, DOI 10.1017/S0950268804003607	102	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98272	10.1371/journal.pone.0098272	http://dx.doi.org/10.1371/journal.pone.0098272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867402	Green Published, gold, Green Submitted			2022-12-25	WOS:000336914100044
J	Nandi, B; Pai, C; Huang, Q; Prabhala, RH; Munshi, NC; Gold, JS				Nandi, Bisweswar; Pai, Christine; Huang, Qin; Prabhala, Rao H.; Munshi, Nikhil C.; Gold, Jason S.			CCR6, the Sole Receptor for the Chemokine CCL20, Promotes Spontaneous Intestinal Tumorigenesis	PLOS ONE			English	Article							INFLAMMATORY PROTEIN 3-ALPHA; EXPRESSION LEVEL; CELLS; TH17; PROLIFERATION; MACROPHAGES; HOMEOSTASIS; NEOPLASIA; MIGRATION; MUTATION	Interactions between the inflammatory chemokine CCL20 and its receptor CCR6 have been associated with colorectal cancer growth and metastasis, however, a causal role for CCL20 signaling through CCR6 in promoting intestinal carcinogenesis has not been demonstrated in vivo. In this study, we aimed to determine the role of CCL20-CCR6 interactions in spontaneous intestinal tumorigenesis. CCR6-deficient mice were crossed with mice heterozygous for a mutation in the adenomatous polyposis coli (APC) gene (APC(MIN/+) mice) to generate APC(MIN/+) mice with CCR6 knocked out (CCR6KO-APC(MIN/+) mice). CCR6KO-APC(MIN/+) mice had diminished spontaneous intestinal tumorigenesis. CCR6KO-APC(MIN/+) also had normal sized spleens as compared to the enlarged spleens found in APC(MIN/+) mice. Decreased macrophage infiltration into intestinal adenomas and non-tumor epithelium was observed in CCR6KO-APC(MIN/+) as compared to APC(MIN/+) mice. CCL20 signaling through CCR6 caused increased production of CCL20 by colorectal cancer cell lines. Furthermore, CCL20 had a direct mitogenic effect on colorectal cancer cells. Thus, interactions between CCL20 and CCR6 promote intestinal carcinogenesis. Our results suggest that the intestinal tumorigenesis driven by CCL20-CCR6 interactions may be driven by macrophage recruitment into the intestine as well as proliferation of neoplastic epithelial cells. This interaction could be targeted for the treatment or prevention of malignancy.	[Nandi, Bisweswar; Pai, Christine; Prabhala, Rao H.] VA Boston Healthcare Syst, Res Serv, West Roxbury, MA USA; [Nandi, Bisweswar; Huang, Qin; Prabhala, Rao H.; Munshi, Nikhil C.; Gold, Jason S.] Harvard Univ, Sch Med, Boston, MA 02138 USA; [Huang, Qin] VA Boston Healthcare Syst, Serv, Pathol, West Roxbury, MA USA; [Prabhala, Rao H.; Munshi, Nikhil C.] Dana Farber Canc Ctr, Boston, MA USA; [Munshi, Nikhil C.] VA Boston Healthcare Syst, Med Serv, West Roxbury, MA USA; [Gold, Jason S.] VA Boston Healthcare Syst, Surg Serv, West Roxbury, MA USA; [Gold, Jason S.] Brigham & Womens Hosp, Boston, MA 02115 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Dana-Farber Cancer Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital	Gold, JS (corresponding author), Harvard Univ, Sch Med, Boston, MA 02138 USA.	jgold4@partners.org	Nandi, Bisweswar/N-5815-2019; Gold, Jason S./O-5112-2014; Munshi, Nikhil/ABE-2338-2021	Gold, Jason S./0000-0002-2925-4755; 	Department of Veterans Affairs Office of Research and Development	Department of Veterans Affairs Office of Research and Development(US Department of Veterans Affairs)	This work is supported by the Department of Veterans Affairs Office of Research and Development through a Career Development Award-2 to JSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 1997, J BIOL CHEM, V272, P14893, DOI 10.1074/jbc.272.23.14893; Balkwill FR, 2012, J PATHOL, V226, P148, DOI 10.1002/path.3029; Baltgalvis KA, 2008, AM J PHYSIOL-REG I, V294, pR393, DOI 10.1152/ajpregu.00716.2007; Beider K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005125; Blanchet X, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00175; Brand S, 2006, J CELL BIOCHEM, V97, P709, DOI 10.1002/jcb.20672; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Cook DN, 2000, IMMUNITY, V12, P495, DOI 10.1016/S1074-7613(00)80201-0; Dellacasagrande J, 2003, SCAND J IMMUNOL, V57, P534, DOI 10.1046/j.1365-3083.2003.01263.x; Dieu-Nosjean MC, 2000, J EXP MED, V192, P705, DOI 10.1084/jem.192.5.705; Fenton JI, 2010, MOL CARCINOGEN, V49, P700, DOI 10.1002/mc.20644; Frick VO, 2013, SCAND J IMMUNOL, V78, P298, DOI 10.1111/sji.12087; Ghadjar P, 2006, J CLIN ONCOL, V24, P1910, DOI 10.1200/JCO.2005.04.1822; Ghadjar P, 2008, J CANCER RES CLIN, V134, P1181, DOI 10.1007/s00432-008-0403-5; Greaves DR, 1997, J EXP MED, V186, P837, DOI 10.1084/jem.186.6.837; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Hausmann M, 2005, J IMMUNOL, V175, P1389, DOI 10.4049/jimmunol.175.3.1389; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Iwata T, 2013, J SURG ONCOL, V107, P160, DOI 10.1002/jso.23247; Kakinuma T, 2006, J LEUKOCYTE BIOL, V79, P639, DOI 10.1189/jlb.1105633; Kaser A, 2004, J CLIN IMMUNOL, V24, P74, DOI 10.1023/B:JOCI.0000018066.46279.6b; Keates S, 2007, J IMMUNOL, V178, P8013, DOI 10.4049/jimmunol.178.12.8013; Kimsey TF, 2004, CANCER J, V10, P374, DOI 10.1097/00130404-200411000-00007; Kirshberg S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024856; Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6; Liu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019495; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; McClellan JL, 2012, AM J PHYSIOL-GASTR L, V303, pG1087, DOI 10.1152/ajpgi.00252.2012; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Rao VP, 2006, CANCER RES, V66, P57, DOI 10.1158/0008-5472.CAN-05-3445; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; ROSENBERG SA, 1986, SCIENCE, V233, P1318, DOI 10.1126/science.3489291; Rubie C, 2006, TUMOR BIOL, V27, P166, DOI 10.1159/000092777; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Wang C, 2009, MUCOSAL IMMUNOL, V2, P173, DOI 10.1038/mi.2008.84; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; You SJ, 2006, INT J EXP PATHOL, V87, P227, DOI 10.1111/j.1365-2613.2006.00477.x	41	35	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97566	10.1371/journal.pone.0097566	http://dx.doi.org/10.1371/journal.pone.0097566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866282	gold, Green Published, Green Submitted			2022-12-25	WOS:000336914100017
J	Mu, LX; Tang, J; Liu, H; Shen, CB; Rong, MQ; Zhang, ZY; Lai, R				Mu, Lixian; Tang, Jing; Liu, Han; Shen, Chuanbin; Rong, Mingqiang; Zhang, Zhiye; Lai, Ren			A potential wound-healing-promoting peptide from salamander skin	FASEB JOURNAL			English	Article						TGF-beta; urodele amphibians; full-thickness incision; reepithelialization	GROWTH-FACTORS; LL-37; ANGIOGENESIS; REGENERATION; EXPRESSION; CYTOKINES; MOUSE	Although it is well known that wound healing proceeds incredibly quickly in urodele amphibians, such as newts and salamanders, little is known about skin-wound healing, and no bioactive/effector substance that contributes to wound healing has been identified from these animals. As a step toward understanding salamander wound healing and skin regeneration, a potential wound-healing-promoting peptide (tylotoin; KCVRQNNKRVCK) was identified from salamander skin of Tylototriton verrucosus. It shows comparable wound-healing-promoting ability (EC50 = 11.14 mu g/ml) with epidermal growth factor (EGF; NSDSECPLSHDGYCLHDGVCMYIEALDKYACNCVVGYIGERCQYRDL-KWWELR) in a murine model of full-thickness dermal wound. Tylotoin directly enhances the motility and proliferation of keratinocytes, vascular endothelial cells, and fibroblasts, resulting in accelerated reepithelialization and granulation tissue formation in the wound site. Tylotoin also promotes the release of transforming growth factor beta 1 (TGF-beta 1) and interleukin 6 (IL-6), which are essential in the wound healing response. Gene-encoded tylotoin secreted in salamander skin is possibly an effector molecule for skin wound healing. This study may facilitate understanding of the cellular and molecular events that underlie quick wound healing in salamanders.	[Mu, Lixian; Tang, Jing; Liu, Han; Shen, Chuanbin; Rong, Mingqiang; Zhang, Zhiye; Lai, Ren] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Mu, Lixian; Tang, Jing; Liu, Han; Shen, Chuanbin; Zhang, Zhiye] Univ Chinese Acad Sci, Kunming Coll Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Lai, R (corresponding author), Key Lab Anim Models & Human Dis Mech, 32 Jiaochangdonglu, Kunming 650223, Yunnan, Peoples R China.	rlai@mail.kiz.ac.cn		Shen, Chuanbin/0000-0002-4635-5160	Ministry of Science and Technology [2010CB529800, 2013CB911300]; National Natural Science Foundation [31025025, U1132601, U1302221, 31200590, 31260208]; Jiangsu Province [BK2012365, BE2012748]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Jiangsu Province	The authors thank all staff of the Animal Center at Kunming Institute of Zoology for taking good care of the animals; and members of the Cell Banks at Kunming Institute of Zoology for providing cells and culture instruction. This work was supported by the Ministry of Science and Technology (2010CB529800, 2013CB911300), the National Natural Science Foundation (31025025, U1132601, U1302221, 31200590, 31260208), and Jiangsu Province (BK2012365, BE2012748). The authors declare no conflicts of interest.	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Cotran R. S., 1999, ROBBINS PATHOLOGIC B, P107; Davidson DJ, 2004, J IMMUNOL, V172, P1146, DOI 10.4049/jimmunol.172.2.1146; Ferris DR, 2010, DEV GROWTH DIFFER, V52, P715, DOI 10.1111/j.1440-169X.2010.01208.x; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Galeano M, 2003, DIABETOLOGIA, V46, P546, DOI 10.1007/s00125-003-1064-1; HOPKINSONWOOLLEY J, 1994, J CELL SCI, V107, P1159; KANE CJM, 1991, J CELL PHYSIOL, V148, P157, DOI 10.1002/jcp.1041480119; KIRSNER RS, 1993, DERMATOL CLIN, V11, P629, DOI 10.1016/S0733-8635(18)30216-X; Kondo T, 2010, FORENSIC SCI INT, V203, P93, DOI 10.1016/j.forsciint.2010.07.004; Kopecki Z, 2007, J PATHOL, V211, P351, DOI 10.1002/path.2113; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Muthusamy V, 2010, ARCH DERMATOL RES, V302, P5, DOI 10.1007/s00403-009-0994-y; Niyonsaba F, 2002, IMMUNOLOGY, V106, P20, DOI 10.1046/j.1365-2567.2002.01398.x; Rodero MP, 2010, INT J CLIN EXP PATHO, V3, P643; Schett G, 2008, ANN RHEUM DIS, V67, P909, DOI 10.1136/ard.2007.074278; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Valluru M, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00089; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yokoyama H, 2011, J INVEST DERMATOL, V131, P2477, DOI 10.1038/jid.2011.223	25	61	67	1	40	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					3919	3929		10.1096/fj.13-248476	http://dx.doi.org/10.1096/fj.13-248476			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24868009	Green Published			2022-12-25	WOS:000340845900010
J	Kobayashi, H; Saito, T; Sato, K; Furusawa, K; Hosokawa, T; Tsutsumi, K; Asada, A; Kamada, S; Ohshima, T; Hisanaga, S				Kobayashi, Hiroyuki; Saito, Taro; Sato, Ko; Furusawa, Kotaro; Hosokawa, Tomohisa; Tsutsumi, Koji; Asada, Akiko; Kamada, Shinji; Ohshima, Toshio; Hisanaga, Shin-ichi			Phosphorylation of Cyclin-dependent Kinase 5 (Cdk5) at Tyr-15 Is Inhibited by Cdk5 Activators and Does Not Contribute to the Activation of Cdk5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P35; COMPLEXES; SUBUNIT; PROTEIN; BRAIN; LOCALIZATION; SUPPRESSION; STABILITY; MECHANISM; DENDRITE	Cdk5 is a member of the cyclin-dependent kinase (Cdk) family. In contrast to other Cdks that promote cell proliferation, Cdk5 plays a role in regulating various neuronal functions, including neuronal migration, synaptic activity, and neuron death. Cdks responsible for cell proliferation need phosphorylation in the activation loop for activation in addition to binding a regulatory subunit cyclin. Cdk5, however, is activated only by binding to its activator, p35 or p39. Furthermore, in contrast to Cdk1 and Cdk2, which are inhibited by phosphorylation at Tyr-15, the kinase activity of Cdk5 is reported to be stimulated when phosphorylated at Tyr-15 by Src family kinases or receptor-type tyrosine kinases. We investigated the activation mechanism of Cdk5 by phosphorylation at Tyr-15. Unexpectedly, however, it was found that Tyr-15 phosphorylation occurred only on monomeric Cdk5, and the coexpression of activators, p35/p25, p39, or Cyclin I, inhibited the phosphorylation. In neuron cultures, too, the activation of Fyn tyrosine kinase did not increase Tyr-15 phosphorylation of Cdk5. Further, phospho-Cdk5 at Tyr-15 was not detected in the p35-bound Cdk5. In contrast, expression of active Fyn increased p35 in neurons. These results indicate that phosphorylation at Tyr-15 is not an activation mechanism of Cdk5 but, rather, indicate that tyrosine kinases could activate Cdk5 by increasing the protein amount of p35. These results call for reinvestigation of how Cdk5 is regulated downstream of Src family kinases or receptor tyrosine kinases in neurons, which is an important signaling cascade in a variety of neuronal activities.	[Kobayashi, Hiroyuki; Saito, Taro; Sato, Ko; Furusawa, Kotaro; Hosokawa, Tomohisa; Tsutsumi, Koji; Asada, Akiko; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan; [Kamada, Shinji] Kobe Univ, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo 6578501, Japan; [Ohshima, Toshio] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo 1628480, Japan	Tokyo Metropolitan University; Kobe University; Waseda University	Hisanaga, S (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo 1920397, Japan.	hisanaga-shinichi@tmu.ac.jp		Hosokawa, Tomohisa/0000-0001-7522-6141; Suzuki, Ko/0000-0003-0045-7919	MEXT of Japan	MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research on a priority area from MEXT of Japan (to S. H.).	Asada A, 2008, J NEUROCHEM, V106, P1325, DOI 10.1111/j.1471-4159.2008.05500.x; ATHERTONFESSLER S, 1994, MOL BIOL CELL, V5, P989, DOI 10.1091/mbc.5.9.989; Barnett DGS, 2011, BRAIN RES BULL, V85, P9, DOI 10.1016/j.brainresbull.2010.11.016; Brinkkoetter PT, 2009, J CLIN INVEST, V119, P3089, DOI 10.1172/JCI37978; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Cheung ZH, 2007, PLOS BIOL, V5, P865, DOI 10.1371/journal.pbio.0050063; Cheung Zelda H., 2007, Biotechnology Journal, V2, P949, DOI 10.1002/biot.200700056; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; DUCOMMUN B, 1991, EMBO J, V10, P3311, DOI 10.1002/j.1460-2075.1991.tb04895.x; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Hisanaga S, 2010, J NEUROCHEM, V115, P1309, DOI 10.1111/j.1471-4159.2010.07050.x; Hisatsune C, 1999, GENES CELLS, V4, P657, DOI 10.1046/j.1365-2443.1999.00287.x; Hosokawa T, 2010, MOL CELL PROTEOMICS, V9, P1133, DOI 10.1074/mcp.M900578-MCP200; Kamei H, 2007, J BIOL CHEM, V282, P1687, DOI 10.1074/jbc.M610541200; Kaminosono S, 2008, J NEUROSCI, V28, P8747, DOI 10.1523/JNEUROSCI.0973-08.2008; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Lee KY, 1996, J BIOL CHEM, V271, P1538, DOI 10.1074/jbc.271.3.1538; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Lin H, 2007, CELL DEATH DIFFER, V14, P607, DOI 10.1038/sj.cdd.4402033; Mapelli M, 2005, J MED CHEM, V48, P671, DOI 10.1021/jm049323m; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Minegishi S, 2010, BIOCHEMISTRY-US, V49, P5482, DOI 10.1021/bi100631f; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nagano T, 2013, CELL CYCLE, V12, P2617, DOI 10.4161/cc.25623; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1998, J BIOL CHEM, V273, P24057, DOI 10.1074/jbc.273.37.24057; Saito T, 2003, J NEUROSCI, V23, P1189, DOI 10.1523/JNEUROSCI.23-04-01189.2003; Saito T, 2013, J BIOL CHEM, V288, P32433, DOI 10.1074/jbc.M113.512293; Sasaki Y, 2002, NEURON, V35, P907, DOI 10.1016/S0896-6273(02)00857-7; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; Tanabe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092291; Tarricone C, 2001, MOL CELL, V8, P657, DOI 10.1016/S1097-2765(01)00343-4; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; UCHIDA T, 1994, FEBS LETT, V355, P35, DOI 10.1016/0014-5793(94)01163-X; Yamada M, 2007, J NEUROCHEM, V102, P1477, DOI 10.1111/j.1471-4159.2007.04505.x; Zhu YS, 2005, J NEUROCHEM, V94, P1535, DOI 10.1111/j.1471-4159.2005.03301.x; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	40	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19627	19636		10.1074/jbc.M113.501148	http://dx.doi.org/10.1074/jbc.M113.501148			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24872417	hybrid, Green Published			2022-12-25	WOS:000339326800035
J	Li, PY; Ji, P; Li, CY; Zhang, Y; Wang, GL; Zhang, XY; Xie, BB; Qin, QL; Chen, XL; Zhou, BC; Zhang, YZ				Li, Ping-Yi; Ji, Peng; Li, Chun-Yang; Zhang, Yi; Wang, Guang-Long; Zhang, Xi-Ying; Xie, Bin-Bin; Qin, Qi-Long; Chen, Xiu-Lan; Zhou, Bai-Cheng; Zhang, Yu-Zhong			Structural Basis for Dimerization and Catalysis of a Novel Esterase from the GTSAG Motif Subfamily of the Bacterial Hormone-sensitive Lipase Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; METAGENOMIC LIBRARY; FUNCTIONAL-ANALYSIS; CARBOXYLESTERASE; STABILITY; SOFTWARE; HOMOLOG; GENES; TOOLS; ESTE1	Hormone-sensitive lipases (HSLs) are widely distributed in microorganisms, plants, and animals. Microbial HSLs are classified into two subfamilies, an unnamed new subfamily and the GDSAG motif subfamily. Due to the lack of structural information, the detailed catalytic mechanism of the new subfamily is not yet clarified. Based on sequence analysis, we propose to name the new subfamily as the GTSAG motif subfamily. We identified a novel HSL esterase E25, a member of the GTSAG motif subfamily, by functional metagenomic screening, and resolved its structure at 2.05 angstrom. E25 is mesophilic (optimum temperature at 50 degrees C), salt-tolerant, slightly alkaline (optimum pH at 8.5) for its activity, and capable of hydrolyzing short chain monoesters (C2-C10). E25 tends to form dimers both in the crystal and in solution. An E25 monomer contains an N-terminal CAP domain, and a classical alpha/beta hydrolase-fold domain. Residues Ser(186), Asp(282), and His(312) comprise the catalytic triad. Structural and mutational analyses indicated that E25 adopts a dimerization pattern distinct from other HSLs. E25 dimer is mainly stabilized by an N-terminal loop intersection from the CAP domains and hydrogen bonds and salt bridges involving seven highly conserved hydrophilic residues from the catalytic domains. Further analysis indicated that E25 also has some catalytic profiles different from other HSLs. Dimerization is essential for E25 to exert its catalytic activity by keeping the accurate orientation of the catalytic Asp282 within the catalytic triad. Our results reveal the structural basis for dimerization and catalysis of an esterase from the GTSAG motif subfamily of the HSL family.	[Li, Ping-Yi; Ji, Peng; Li, Chun-Yang; Zhang, Yi; Wang, Guang-Long; Zhang, Xi-Ying; Xie, Bin-Bin; Qin, Qi-Long; Chen, Xiu-Lan; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Li, Ping-Yi; Ji, Peng; Li, Chun-Yang; Zhang, Yi; Wang, Guang-Long; Zhang, Xi-Ying; Xie, Bin-Bin; Qin, Qi-Long; Chen, Xiu-Lan; Zhou, Bai-Cheng; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, Jinan 250100, Peoples R China; [Zhang, Xi-Ying; Xie, Bin-Bin; Qin, Qi-Long; Chen, Xiu-Lan; Zhang, Yu-Zhong] Shandong Univ, Collaborat Innovat Ctr Deep Sea Biol, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Zhang, YZ (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn		Li, Chun-Yang/0000-0002-1151-4897; Zhang, Yu-Zhong/0000-0002-2017-1005	National Natural Science Foundation of China [91228210, 31290230, 31290231, 31025001]; Hi-Tech Research and Development Program of China [2012AA092105, 2012AA092103]; China Ocean Mineral Resources R & D Association (COMRA) Special Foundation [DY125-15-T-05]; Program of Shandong for Taishan Scholars [2008BS02019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); China Ocean Mineral Resources R & D Association (COMRA) Special Foundation; Program of Shandong for Taishan Scholars	This work was supported by National Natural Science Foundation of China Grants 91228210, 31290230, 31290231, and 31025001, Hi-Tech Research and Development Program of China Grants 2012AA092105 and 2012AA092103, China Ocean Mineral Resources R & D Association (COMRA) Special Foundation Grant DY125-15-T-05, and Program of Shandong for Taishan Scholars Grant 2008BS02019.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Angkawidjaja C, 2012, FEBS J, V279, P3071, DOI 10.1111/j.1742-4658.2012.08687.x; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Benavente R, 2013, FEBS J, V280, P6658, DOI 10.1111/febs.12569; Bornscheuer UT, 2002, CURR OPIN BIOTECH, V13, P543, DOI 10.1016/S0958-1669(02)00350-6; Byun JS, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-47; De Simone G, 2001, J MOL BIOL, V314, P507, DOI 10.1006/jmbi.2001.5152; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; Hu YF, 2010, FEMS MICROBIOL ECOL, V72, P228, DOI 10.1111/j.1574-6941.2010.00851.x; Jaeger KE, 1999, ANNU REV MICROBIOL, V53, P315, DOI 10.1146/annurev.micro.53.1.315; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Jensen LH, 1997, METHOD ENZYMOL, V277, P353, DOI 10.1016/S0076-6879(97)77020-4; Jeon JH, 2012, APPL MICROBIOL BIOT, V93, P623, DOI 10.1007/s00253-011-3433-x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lenfant N, 2013, NUCLEIC ACIDS RES, V41, pD423, DOI 10.1093/nar/gks1154; Li PY, 2012, ENVIRON MICROBIOL, V14, P467, DOI 10.1111/j.1462-2920.2011.02637.x; Mandrich L, 2005, J MOL BIOL, V345, P501, DOI 10.1016/j.jmb.2004.10.035; Nam KH, 2009, PROTEINS, V74, P1036, DOI 10.1002/prot.22313; Nam KH, 2009, BIOCHEM BIOPH RES CO, V379, P553, DOI 10.1016/j.bbrc.2008.12.085; Ngo TD, 2013, ACTA CRYSTALLOGR D, V69, P1726, DOI 10.1107/S0907444913013425; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Palm GJ, 2011, APPL MICROBIOL BIOT, V91, P1061, DOI 10.1007/s00253-011-3337-9; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfeffer JM, 2013, J BIOL CHEM, V288, P2605, DOI 10.1074/jbc.M112.436352; Rhee JK, 2006, APPL ENVIRON MICROB, V72, P3021, DOI 10.1128/AEM.72.4.3021-3025.2006; Schiefner A, 2014, PROTEINS, V82, P268, DOI 10.1002/prot.24383; Singleton MR, 1999, STRUCT FOLD DES, V7, P237, DOI 10.1016/S0969-2126(99)80034-3; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vonrhein C, 1998, J MOL BIOL, V282, P167, DOI 10.1006/jmbi.1998.2003; Wei YY, 1999, NAT STRUCT BIOL, V6, P340; Zhu XY, 2003, J BIOL CHEM, V278, P2008, DOI 10.1074/jbc.M210103200	33	46	49	0	21	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					19031	19041		10.1074/jbc.M114.574913	http://dx.doi.org/10.1074/jbc.M114.574913			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24867954	hybrid, Green Published			2022-12-25	WOS:000339062900034
J	Chujo, T; Miyamoto, K; Ogawa, S; Masuda, Y; Shimizu, T; Kishi-Kaboshi, M; Takahashi, A; Nishizawa, Y; Minami, E; Nojiri, H; Yamane, H; Okada, K				Chujo, Tetsuya; Miyamoto, Koji; Ogawa, Satoshi; Masuda, Yuka; Shimizu, Takafumi; Kishi-Kaboshi, Mitsuko; Takahashi, Akira; Nishizawa, Yoko; Minami, Eiichi; Nojiri, Hideaki; Yamane, Hisakazu; Okada, Kazunori			Overexpression of Phosphomimic Mutated OsWRKY53 Leads to Enhanced Blast Resistance in Rice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; WRKY TRANSCRIPTION FACTORS; MAP KINASE; DEFENSE RESPONSES; PLANT DEFENSE; PHYTOALEXIN BIOSYNTHESIS; BINDING-PROTEINS; CELL-DEATH; GENE; ARABIDOPSIS	WRKY transcription factors and mitogen-activated protein kinase (MAPK) cascades have been shown to play pivotal roles in the regulation of plant defense responses. We previously reported that OsWRKY53-overexpressing rice plants showed enhanced resistance to the rice blast fungus. In this study, we identified OsWRKY53 as a substrate of OsMPK3/OsMPK6, components of a fungal PAMP-responsive MAPK cascade in rice, and analyzed the effect of OsWRKY53 phosphorylation on the regulation of basal defense responses to a virulence race of rice blast fungus Magnaporthe oryzae strain Ina86-137. An in vitro phosphorylation assay revealed that the OsMPK3/OsMPK6 activated by OsMKK4 phosphorylated OsWRKY53 recombinant protein at its multiple clustered serine-proline residues (SP cluster). When OsWRKY53 was coexpressed with a constitutively active mutant of OsMKK4 in a transient reporter gene assay, the enhanced transactivation activity of OsWRKY53 was found to be dependent on phosphorylation of the SP cluster. Transgenic rice plants overexpressing a phospho-mimic mutant of OsWRKY53 (OsWRKY53SD) showed further-enhanced disease resistance to the blast fungus compared to native OsWRKY53-overexpressing rice plants, and a substantial number of defense-related genes, including pathogenesis-related protein genes, were more upregulated in the OsWRKY53SD-overexpressing plants compared to the OsWRKY53-overexpressing plants. These results strongly suggest that the OsMKK4-OsMPK3/OsMPK6 cascade regulates transactivation activity of OsWRKY53, and overexpression of the phospho-mimic mutant of OsWRKY53 results in a major change to the rice transcriptome at steady state that leads to activation of a defense response against the blast fungus in rice plants.	[Chujo, Tetsuya; Miyamoto, Koji; Ogawa, Satoshi; Masuda, Yuka; Shimizu, Takafumi; Nojiri, Hideaki; Yamane, Hisakazu; Okada, Kazunori] Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo, Japan; [Kishi-Kaboshi, Mitsuko; Takahashi, Akira; Nishizawa, Yoko; Minami, Eiichi] Natl Inst Agrobiol Sci, Genetically Modified Organism Res Ctr, Tsukuba, Ibaraki, Japan; [Miyamoto, Koji; Yamane, Hisakazu] Teikyo Univ, Dept Biosci, Utsunomiya, Tochigi, Japan	University of Tokyo; National Institute of Agrobiological Sciences - Japan; Teikyo University	Okada, K (corresponding author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo, Japan.	ukokada@mail.ecc.u-tokyo.ac.jp	Ogawa, Satoshi/F-2719-2017; Shimizu, Takafumi/C-4123-2017; Kishi-Kaboshi, Mitsuko/ABE-6455-2020; Miyamoto, Koji/N-1504-2014; Kishi-Kaboshi, Mitsuko/AAE-2828-2022	Ogawa, Satoshi/0000-0002-4790-546X; Shimizu, Takafumi/0000-0003-4372-1337; Kishi-Kaboshi, Mitsuko/0000-0002-1552-2608; Miyamoto, Koji/0000-0002-9862-7412; 	JSPS KAKENHI [22380066]; Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	This work was supported by JSPS KAKENHI (grant no. 22380066) and by the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S, 2011, MOL PLANT MICROBE IN, V24, P519, DOI 10.1094/MPMI-07-10-0172; Ando S, 2009, J PHYTOPATHOL, V157, P420, DOI 10.1111/j.1439-0434.2008.01515.x; Andreasson E, 2005, EMBO J, V24, P2579, DOI 10.1038/sj.emboj.7600737; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Cheng Y, 2012, PLANT PHYSIOL, V159, P810, DOI 10.1104/pp.112.196816; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Chuio T, 2007, BBA-GENE STRUCT EXPR, V1769, P497, DOI 10.1016/j.bbaexp.2007.04.006; Chujo T, 2013, PLANT MOL BIOL, V82, P23, DOI 10.1007/s11103-013-0032-5; Chujo T, 2009, BIOSCI BIOTECH BIOCH, V73, P1901, DOI 10.1271/bbb.90262; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Eulgem T, 1999, EMBO J, V18, P4689, DOI 10.1093/emboj/18.17.4689; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Hiratsu K, 2004, BIOCHEM BIOPH RES CO, V321, P172, DOI 10.1016/j.bbrc.2004.06.115; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ishihama N, 2012, CURR OPIN PLANT BIOL, V15, P431, DOI 10.1016/j.pbi.2012.02.003; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; Jin HL, 2003, PLANT J, V33, P719, DOI 10.1046/j.1365-313X.2003.01664.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kim CY, 2004, PLANT J, V38, P142, DOI 10.1111/j.1365-313X.2004.02033.x; Kishi-Kaboshi M, 2010, PLANT SIGNAL BEHAV, V5, P1653, DOI 10.4161/psb.5.12.13982; Kishi-Kaboshi M, 2010, PLANT J, V63, P599, DOI 10.1111/j.1365-313X.2010.04264.x; Kitagawa K, 2010, PLANT CELL PHYSIOL, V51, P1315, DOI 10.1093/pcp/pcq092; Koo SC, 2009, BIOCHEM BIOPH RES CO, V387, P365, DOI 10.1016/j.bbrc.2009.07.026; Lai ZB, 2011, PLANT CELL, V23, P3824, DOI 10.1105/tpc.111.090571; Liu YD, 2007, PLANT J, V51, P941, DOI 10.1111/j.1365-313X.2007.03191.x; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Menke FLH, 2005, MOL PLANT MICROBE IN, V18, P1027, DOI 10.1094/MPMI-18-1027; Okada A, 2009, J BIOL CHEM, V284, P26510, DOI 10.1074/jbc.M109.036871; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Ross CA, 2007, J INTEGR PLANT BIOL, V49, P827, DOI 10.1111/j.1744-7909.2007.00504.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Rushton PJ, 1996, EMBO J, V15, P5690, DOI 10.1002/j.1460-2075.1996.tb00953.x; SEO S, 1995, SCIENCE, V270, P1988, DOI 10.1126/science.270.5244.1988; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Shimizu T, 2008, PHYTOCHEMISTRY, V69, P973, DOI 10.1016/j.phytochem.2007.10.005; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Shimura K, 2007, J BIOL CHEM, V282, P34013, DOI 10.1074/jbc.M703344200; Tanaka S, 2009, PLANT CELL, V21, P2517, DOI 10.1105/tpc.109.068023; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Toyomasu T, 2014, PHYSIOL PLANTARUM, V150, P55, DOI 10.1111/ppl.12066; Wang QA, 2011, PLANT J, V65, P87, DOI 10.1111/j.1365-313X.2010.04408.x; Yang PZ, 1999, PLANT J, V18, P141, DOI 10.1046/j.1365-313X.1999.00437.x; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3; Yokotani N, 2013, J EXP BOT, V64, P5085, DOI 10.1093/jxb/ert298; Zhang SQ, 1998, P NATL ACAD SCI USA, V95, P7225, DOI 10.1073/pnas.95.12.7225; Zhang SQ, 1997, PLANT CELL, V9, P809, DOI 10.1105/tpc.9.5.809; Zipfel C, 2010, PLANT PHYSIOL, V154, P551, DOI 10.1104/pp.110.161547	52	72	76	7	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98737	10.1371/journal.pone.0098737	http://dx.doi.org/10.1371/journal.pone.0098737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892523	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400087
J	Wang, J; Jia, LH; Kuang, ZR; Wu, T; Hong, Y; Chen, XB; Leung, WK; Xia, J; Cheng, B				Wang, Juan; Jia, Lihua; Kuang, Zirong; Wu, Tong; Hong, Yun; Chen, Xiaobing; Leung, W. Keung; Xia, Juan; Cheng, Bin			The In Vitro and In Vivo Antitumor Effects of Clotrimazole on Oral Squamous Cell Carcinoma (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							HUMAN BREAST-CANCER; GLIOBLASTOMA CELLS; VIABILITY; GROWTH; CARCINOGENESIS; ADENOCARCINOMA; CYTOSKELETON; INHIBITION; BLOCKAGE; THERAPY	Background: Clotrimazole is an antifungal imidazole derivative showing anti-neoplastic effect in some tumors, but its anticancer potential is still unclear in oral squamous cell carcinoma (OSCC). The aim of this study was to evaluate the antitumor effect of clotrimazole, and to investigate the possible mechanism of clotrimazole-mediated antitumor activity in OSCC. Methodology: In vitro experiments, the cell viability and clonogenic ability of three human OSCC cell lines CAL27, SCC25 and UM1 were detected after clotrimazole treatment by CCK8 assay and colony formation assay. Cell cycle progression and apoptosis were assessed by flow cytometry, and the involvement of several mediators of apoptosis was examined by western blot analysis. Then, the in vivo antitumor effect of clotrimazole was investigated in CAL27 xenograft model. Immunohistochemistry and western blot analysis were performed to determine the presence of apoptotic cells and the expression of Bcl-2 and Bax in tumors from mice treated with or without clotrimazole. Results: Clotrimazole inhibited proliferation in all three OSCC cell lines in a dose-and time-dependent manner, and significantly reduced the colony formation of OSCC cells in vitro. Clotrimazole caused cell cycle arrest at the G(0)/G(1) phase. In addition, clotrimazole induced apoptosis in OSCC cells, and significantly down-regulated the anti-apoptotic protein Bcl-2 and up-regulated the pro-apoptotic protein Bax. Notably, clotrimazole treatment inhibited OSCC tumor growth and cell proliferation in CAL27 xenograft model. Clotrimazole also markedly reduced Bcl-2 expression and increased the protein level of Bax in tumor tissues of xenograft model. Conclusion: Our findings demonstrated a potent anticancer effect of clotrimazole by inducing cell cycle arrest and cellular apoptosis in OSCC.	[Wang, Juan; Jia, Lihua; Kuang, Zirong; Wu, Tong; Hong, Yun; Chen, Xiaobing; Xia, Juan; Cheng, Bin] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guanghua Sch Stomatol, Dept Oral Med, Guangzhou 510275, Guangdong, Peoples R China; [Leung, W. Keung] Univ Hong Kong, Fac Dent, Prince Philip Dent Hosp, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; University of Hong Kong	Xia, J (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guanghua Sch Stomatol, Dept Oral Med, Guangzhou 510275, Guangdong, Peoples R China.	xiajuan@mail.sysu.edu.cn; chengbin@mail.sysu.edu.cn	LEUNG, Wai Keung/B-2159-2009; li, jia/GVT-7587-2022; Jia, li/GPW-8015-2022	LEUNG, Wai Keung/0000-0003-1979-910X; 	National Natural Science Foundation of China [91029712, 81272948, 81371148]; Guangdong Translation Medicine Public Platform	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Translation Medicine Public Platform	This work was supported by the National Natural Science Foundation of China (Nos. 91029712, 81272948, and 81371148), Guangdong Translation Medicine Public Platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas H, 1998, P NATL ACAD SCI USA, V95, P8280, DOI 10.1073/pnas.95.14.8280; Argiris A, 2008, LANCET, V371, P1695, DOI 10.1016/S0140-6736(08)60728-X; Burmeister BH, 2013, LANCET ONCOL, V14, P569, DOI 10.1016/S1470-2045(13)70157-8; Cao MY, 2004, J PHARMACOL EXP THER, V308, P538, DOI 10.1124/jpet.103.059618; Coelho RG, 2011, MOL GENET METAB, V103, P394, DOI 10.1016/j.ymgme.2011.04.003; Czerninski R, 2010, CLIN ORAL INVEST, V14, P71, DOI 10.1007/s00784-009-0275-3; DEFRANCESCHI L, 1994, J CLIN INVEST, V93, P1670, DOI 10.1172/JCI117149; Furtado CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030462; Goncalves P, 2012, ANTI-CANCER DRUG, V23, P220, DOI 10.1097/CAD.0b013e32834d9ad2; Horng CT, 2013, J RECEPT SIG TRANSD, V33, P89, DOI 10.3109/10799893.2013.764321; Ito C, 2002, LEUKEMIA, V16, P1344, DOI 10.1038/sj.leu.2402510; Jager H, 2004, MOL PHARMACOL, V65, P630, DOI 10.1124/mol.65.3.630; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Johnson NW, 2011, PERIODONTOL 2000, V57, P19, DOI 10.1111/j.1600-0757.2011.00401.x; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Katanyoo K, 2012, GYNECOL ONCOL, V125, P292, DOI 10.1016/j.ygyno.2012.01.034; Khalid MH, 2005, J NEUROSURG, V103, P79, DOI 10.3171/jns.2005.103.1.0079; Khalid MH, 1999, J NEUROSURG, V90, P918, DOI 10.3171/jns.1999.90.5.0918; Liu H, 2010, ANTI-CANCER DRUG, V21, P841, DOI 10.1097/CAD.0b013e32833e8022; Marcondes MC, 2010, ARCH BIOCHEM BIOPHYS, V497, P62, DOI 10.1016/j.abb.2010.03.013; Meira DD, 2005, MOL GENET METAB, V84, P354, DOI 10.1016/j.ymgme.2004.11.012; Mhawech-Fauceglia P, 2011, HISTOPATHOLOGY, V59, P1015, DOI 10.1111/j.1365-2559.2011.03944.x; Penso J, 2002, MOL GENET METAB, V76, P181, DOI 10.1016/S1096-7192(02)00046-X; Pienaar ED, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003940.pub3; Rufo PA, 1997, J CLIN INVEST, V100, P3111, DOI 10.1172/JCI119866; Tait SWG, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008706; Takei S, 2003, INT J UROL, V10, P78, DOI 10.1046/j.1442-2042.2003.00575.x; Vitale-Cross L, 2009, CANCER PREV RES, V2, P419, DOI 10.1158/1940-6207.CAPR-09-0058; Wang ZH, 2007, ONCOGENE, V26, P5107, DOI 10.1038/sj.onc.1210308	29	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98885	10.1371/journal.pone.0098885	http://dx.doi.org/10.1371/journal.pone.0098885			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892421	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400106
J	Lechenet, M; Bretagnolle, V; Bockstaller, C; Boissinot, F; Petit, MS; Petit, S; Munier-Jolain, NM				Lechenet, Martin; Bretagnolle, Vincent; Bockstaller, Christian; Boissinot, Francois; Petit, Marie-Sophie; Petit, Sandrine; Munier-Jolain, Nicolas M.			Reconciling Pesticide Reduction with Economic and Environmental Sustainability in Arable Farming	PLOS ONE			English	Article							BIODIVERSITY; MANAGEMENT; IMPACTS; RISK	Reducing pesticide use is one of the high-priority targets in the quest for a sustainable agriculture. Until now, most studies dealing with pesticide use reduction have compared a limited number of experimental prototypes. Here we assessed the sustainability of 48 arable cropping systems from two major agricultural regions of France, including conventional, integrated and organic systems, with a wide range of pesticide use intensities and management (crop rotation, soil tillage, cultivars, fertilization, etc.). We assessed cropping system sustainability using a set of economic, environmental and social indicators. We failed to detect any positive correlation between pesticide use intensity and both productivity (when organic farms were excluded) and profitability. In addition, there was no relationship between pesticide use and workload. We found that crop rotation diversity was higher in cropping systems with low pesticide use, which would support the important role of crop rotation diversity in integrated and organic strategies. In comparison to conventional systems, integrated strategies showed a decrease in the use of both pesticides and nitrogen fertilizers, they consumed less energy and were frequently more energy efficient. Integrated systems therefore appeared as the best compromise in sustainability trade-offs. Our results could be used to re-design current cropping systems, by promoting diversified crop rotations and the combination of a wide range of available techniques contributing to pest management.	[Lechenet, Martin; Petit, Sandrine; Munier-Jolain, Nicolas M.] INRA, Unite Mixte Rech Agroecol 1347, Dijon, Cote Dor, France; [Bretagnolle, Vincent] Ctr Natl Rech Sci, Ctr Etud Biol Chize, Beauvoir Sur Niort, Deux Sevres, France; [Bockstaller, Christian] INRA, Unite Rech Agron & Environm 1121, Colmar, Haut Rhin, France; [Bockstaller, Christian] Univ Lorraine, Vandoeuvre Les Nancy, Meurthe Et Mose, France; [Boissinot, Francois] Chambre Agr Pays Loire, Angers, Maine Et Loire, France; [Petit, Marie-Sophie] Chambre Reg Agr Bourgogne, Quetigny, Cote Dor, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); INRAE; Universite de Lorraine	Munier-Jolain, NM (corresponding author), INRA, Unite Mixte Rech Agroecol 1347, Dijon, Cote Dor, France.	nicolas.munier-jolain@dijon.inra.fr	Petit, Sandrine/C-3310-2013	Petit, Sandrine/0000-0001-8781-8873; Shang, Rachel/0000-0002-2296-608X	French National Research Agency ANR (STRA-08-02 Advherb project); Region Bourgogne; European Network of Excellence ENDURE	French National Research Agency ANR (STRA-08-02 Advherb project)(French National Research Agency (ANR)); Region Bourgogne(Region Bourgogne-Franche-Comte); European Network of Excellence ENDURE	Funding for the study was provided by the French National Research Agency ANR (STRA-08-02 Advherb project) and from Region Bourgogne. The Burgundy farms network was developed in the framework of the Reseau Mixte Technologique "Systemes de Culture Innovants" and the project "Plus d'Agronomie, Moins d'intrants" initiated by Region Bourgogne. The long term experiment at Dijon-Epoisses was partly funded by the European Network of Excellence ENDURE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aavik T, 2010, AGR ECOSYST ENVIRON, V135, P178, DOI 10.1016/j.agee.2009.09.005; ADEME (Agence de l'Environment et de la Maitrise de l'Energie), 2011, GUID VAL DIAT VERS R; ALTIERI MA, 2009, CROP DIVERSIFICATION, P116; Andersson GKS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031599; [Anonymous], 2011, PEST IND SAL US 2006; Ascherio A, 2006, ANN NEUROL, V60, P197, DOI 10.1002/ana.20904; Aubertot JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073202; Bastiaans L, 2008, WEED RES, V48, P481, DOI 10.1111/j.1365-3180.2008.00662.x; BCMA, 2012, SIMC ONL DEC TOOL; Beckie HJ, 2009, PRAIRIE SOILS CROPS, V2, P3; Beketov MA, 2013, P NATL ACAD SCI USA, V110, P11039, DOI 10.1073/pnas.1305618110; Bockstaller C, 2000, 3 INT CROP SCI C 200, P195; Bukowski R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0033047, 10.1371/journal.pone.0047149]; Centre d'Etudes Biologiques de Chize, 2009, ZON AT PLAIN VAL SER; Chikowo R, 2009, AGR ECOSYST ENVIRON, V132, P237, DOI 10.1016/j.agee.2009.04.009; Deike S, 2008, EUR J AGRON, V28, P461, DOI 10.1016/j.eja.2007.11.009; Di Falco S, 2008, LAND ECON, V84, P83, DOI 10.3368/le.84.1.83; European commission, 2010, EUR AGR ONL DAT; Ferron P, 2005, AGRON SUSTAIN DEV, V25, P17, DOI 10.1051/agro:2004050; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Food and Agriculture Organization of the United Nations (FAO), 2013, FAOSTAT RES PEST US; Halberg N, 2005, LIVEST PROD SCI, V96, P33, DOI 10.1016/j.livprodsci.2005.05.013; HOLLAND JM, 1994, ANN APPL BIOL, V125, P399, DOI 10.1111/j.1744-7348.1994.tb04980.x; Hulme MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054597; Hulsbergen KJ, 2001, AGR ECOSYST ENVIRON, V86, P303, DOI 10.1016/S0167-8809(00)00286-3; Krupinsky JM, 2002, AGRON J, V94, P198, DOI 10.2134/agronj2002.0198; Li R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051897; Mader P, 2002, SCIENCE, V296, P1694, DOI 10.1126/science.1071148; Meiss H, 2010, WEED RES, V50, P331, DOI 10.1111/j.1365-3180.2010.00784.x; Meynard J.M., 2013, FREINS LEVIERS DIVER, P1; Ministere de l'Agriculture de l'Agro-alimentaire et de la Foret, 2012, NOT SUIV PLAN EC 201; Munier-Jolain N, 2010, INNOVATIONS AGRONOMI, V8, P57; Nemecek T, 2008, EUR J AGRON, V28, P380, DOI 10.1016/j.eja.2007.11.004; OECD, 2001, ENV IND AGR METH RES, V3; Pardo G, 2010, EUR J AGRON, V33, P24, DOI 10.1016/j.eja.2010.02.003; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Pimentel D, 2005, BIOSCIENCE, V55, P573, DOI 10.1641/0006-3568(2005)055[0573:EEAECO]2.0.CO;2; Pimentel D, 2003, AM J CLIN NUTR, V78, p660S, DOI 10.1093/ajcn/78.3.660S; PIMENTEL D, 1995, J AGR ENVIRON ETHIC, V8, P17, DOI 10.1007/BF02286399; R Development Core Team, 2012, R LANG ENV STAT COMP; Reganold JP, 2001, NATURE, V410, P926, DOI 10.1038/35073574; Reidsma P, 2010, EUR J AGRON, V32, P91, DOI 10.1016/j.eja.2009.06.003; Seufert V, 2012, NATURE, V485, P229, DOI 10.1038/nature11069; Theobald DM, 2001, GEOGR REV, V91, P544, DOI 10.2307/3594740; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Trewavas A, 2001, NATURE, V410, P409, DOI 10.1038/35068639; USDA Economic Research Service, 2010, US CERT ORG FARML AC; van der Werf HMG, 1998, CHEMOSPHERE, V36, P2225, DOI 10.1016/S0045-6535(97)10194-1	49	94	97	1	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97922	10.1371/journal.pone.0097922	http://dx.doi.org/10.1371/journal.pone.0097922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887494	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300026
J	Liu, W; Li, W; He, QL; Daud, MK; Chen, JH; Zhu, SJ				Liu, Wei; Li, Wei; He, Qiuling; Daud, Muhammad Khan; Chen, Jinhong; Zhu, Shuijin			Genome-Wide Survey and Expression Analysis of Calcium-Dependent Protein Kinase in Gossypium raimondii	PLOS ONE			English	Article							ABIOTIC STRESS CONDITIONS; CALMODULIN-LIKE DOMAIN; GENE FAMILY; FUNCTIONAL-CHARACTERIZATION; COMPREHENSIVE ANALYSIS; REGULATORY NETWORKS; LOW-TEMPERATURE; ARABIDOPSIS; RICE; CDPK	Calcium-dependent protein kinases (CDPKs) are one of the largest protein kinases in plants and participate in different physiological processes through regulating downstream components of calcium signaling pathways. In this study, 41 CDPK genes, from GrCPK1 to GrCPK41, were identified in the genome of the diploid cotton, Gossypium raimondii. The phylogenetic analysis indicated that all these genes were divided into four subgroups and members within the same subgroup shared conserved exon-intron structures. The expansion of GrCPKs family in G. raimondii was due to the segmental duplication events, and the analysis of Ka/Ks ratios implied that the duplicated GrCPKs had mainly undergone strong purifying selection pressure with limited functional divergence. The cold-responsive elements in promoter regions were detected in the majority of GrCPKs. The expression analysis of 11 selected genes showed that GrCPKs exhibited tissue-specific expression patterns and the expression of GrCPKs were induced or repressed by cold treatment. These observations would lay an important foundation for functional and evolutionary analysis of CDPK gene family in Gossypium species.	[Liu, Wei; Li, Wei; He, Qiuling; Chen, Jinhong; Zhu, Shuijin] Zhejiang Univ, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China; [Daud, Muhammad Khan] Kohat Univ Sci & Technol, Dept Biotechnol & Genet Engn, Kohat, Pakistan	Zhejiang University; Kohat University of Science & Technology	Chen, JH (corresponding author), Zhejiang Univ, Dept Agron, Hangzhou 310003, Zhejiang, Peoples R China.	jinhongchen@zju.edu.cn; shjzhu@zju.edu.cn	Khan, Muhammad Daud/AAF-1011-2021		National Basic Research Program (973 program) [2010CB126006]; National High Technology Research and Development Program of China [2011AA10A102, 2013AA102601]	National Basic Research Program (973 program)(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The works are support by the National Basic Research Program (973 program, No: 2010CB126006) and the National High Technology Research and Development Program of China (2011AA10A102, 2013AA102601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2005, PLANT CELL PHYSIOL, V46, P356, DOI 10.1093/pcp/pci035; Asano T, 2012, PLANT J, V69, P26, DOI 10.1111/j.1365-313X.2011.04766.x; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berberich T, 1997, MOL GEN GENET, V254, P275, DOI 10.1007/s004380050416; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Bologna G, 2004, PROTEOMICS, V4, P1626, DOI 10.1002/pmic.200300783; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chang WJ, 2009, BIOSCI BIOTECH BIOCH, V73, P2427, DOI 10.1271/bbb.90385; Chen F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080818; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Christodoulou J, 2004, J BIOL CHEM, V279, P29092, DOI 10.1074/jbc.M401297200; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dubrovina AS, 2013, J PLANT PHYSIOL, V170, P1491, DOI 10.1016/j.jplph.2013.06.014; ESTRUCH JJ, 1994, P NATL ACAD SCI USA, V91, P8837, DOI 10.1073/pnas.91.19.8837; Evans NH, 2001, CURR OPIN PLANT BIOL, V4, P415, DOI 10.1016/S1369-5266(00)00194-1; Franz S, 2011, MOL PLANT, V4, P83, DOI 10.1093/mp/ssq064; Giammaria V, 2011, PLANTA, V233, P593, DOI 10.1007/s00425-010-1319-2; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Harmon AC, 2001, NEW PHYTOL, V151, P175, DOI 10.1046/j.1469-8137.2001.00171.x; HARPER JF, 1991, SCIENCE, V252, P951, DOI 10.1126/science.1852075; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hong Y, 1996, PLANT MOL BIOL, V30, P1259, DOI 10.1007/BF00019557; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hrabak EM, 1996, PLANT MOL BIOL, V31, P405, DOI 10.1007/BF00021802; Huang QS, 2008, PLANT CELL REP, V27, P1869, DOI 10.1007/s00299-008-0603-0; Ivashuta S, 2005, PLANT CELL, V17, P2911, DOI 10.1105/tpc.105.035394; JOHNSON DR, 1994, ANNU REV BIOCHEM, V63, P869, DOI 10.1146/annurev.bi.63.070194.004253; Kargiotidou A, 2008, J EXP BOT, V59, P2043, DOI 10.1093/jxb/ern065; Klimecka M, 2007, ACTA BIOCHIM POL, V54, P219, DOI 10.18388/abp.2007_3242; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; Kong XP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-433; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SS, 2003, PLANT J, V33, P825, DOI 10.1046/j.1365-313X.2003.01672.x; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li AL, 2008, PLANT MOL BIOL, V66, P429, DOI 10.1007/s11103-007-9281-5; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SX, 2013, PLANT MOL BIOL, V82, P267, DOI 10.1007/s11103-013-0061-0; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Ma PD, 2013, APPL BIOCHEM BIOTECH, V169, P2111, DOI 10.1007/s12010-013-0125-2; Ma SY, 2007, PLANT MOL BIOL, V65, P511, DOI 10.1007/s11103-007-9187-2; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Martin ML, 2000, PLANT J, V24, P429, DOI 10.1046/j.1365-313x.2000.00889.x; McCormack E, 2003, NEW PHYTOL, V159, P585, DOI 10.1046/j.1469-8137.2003.00845.x; Mehlmer N, 2010, PLANT J; Mori IC, 2006, PLOS BIOL, V4, P1749, DOI 10.1371/journal.pbio.0040327; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Ray S, 2007, MOL GENET GENOMICS, V278, P493, DOI 10.1007/s00438-007-0267-4; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Gargantini P, 2009, PLANT MOL BIOL, V70, P153, DOI 10.1007/s11103-009-9462-5; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; Saijo Y, 2001, PLANT CELL PHYSIOL, V42, P1228, DOI 10.1093/pcp/pce158; Szczegielniak J, 2012, PHYSIOL PLANTARUM, V146, P1, DOI 10.1111/j.1399-3054.2012.01587.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tran LSP, 2007, METHOD ENZYMOL, V428, P109, DOI 10.1016/S0076-6879(07)28006-1; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P79, DOI 10.4161/psb.2.2.4176; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; Wan BL, 2007, FEBS LETT, V581, P1179, DOI 10.1016/j.febslet.2007.02.030; Wang CT, 2013, PLANT MOL BIOL REP, V31, P222, DOI 10.1007/s11105-012-0496-5; Wang H, 2011, ACTA BIOCH BIOPH SIN, V43, P654, DOI 10.1093/abbs/gmr056; Wei HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068435; Witte CP, 2010, J BIOL CHEM, V285, P9740, DOI 10.1074/jbc.M109.052126; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang DH, 2012, PLANT PHYSIOL, V159, P1591, DOI 10.1104/pp.112.199018; Yoon GM, 1999, PLANT MOL BIOL, V39, P991, DOI 10.1023/A:1006170512542; Zhang M, 2005, BBA-GENE STRUCT EXPR, V1729, P174, DOI 10.1016/j.bbaexp.2005.04.006; ZHAO Y, 1994, BIOCHEMISTRY-US, V33, P3714, DOI 10.1021/bi00178a031; Zhao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028488; Zou JJ, 2010, PLANT PHYSIOL, V154, P1232, DOI 10.1104/pp.110.157545; Zuo R, 2013, MOL BIOL REP, V40, P2645, DOI 10.1007/s11033-012-2351-z	74	52	57	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98189	10.1371/journal.pone.0098189	http://dx.doi.org/10.1371/journal.pone.0098189			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887436	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300044
J	Mou, B; Beltran, CJ; Park, SS; Olivier, KR; Furutani, KM				Mou, Benjamin; Beltran, Chris J.; Park, Sean S.; Olivier, Kenneth R.; Furutani, Keith M.			Feasibility of Proton Transmission-Beam Stereotactic Ablative Radiotherapy versus Photon Stereotactic Ablative Radiotherapy for Lung Tumors: A Dosimetric and Feasibility Study	PLOS ONE			English	Article							BODY RADIATION-THERAPY; SBRT; CANCER	Stereotactic ablative radiotherapy is being increasingly adopted in the treatment of lung tumors. The use of proton beam therapy can further reduce dose to normal structures. However, uncertainty exists in proton-based treatment plans, including range uncertainties, large sensitivity to position uncertainty, and calculation of dose deposition in heterogeneous areas. This study investigated the feasibility of proton transmission beams, i.e. without the Bragg peak, to treat lung tumors with stereotactic ablative radiotherapy. We compared three representative treatment plans using proton transmission beams versus conformal static-gantry photon beams. It was found that proton treatment plans using transmission beams passing through the patient were feasible and demonstrated lower dose to normal structures and markedly reduced treatment times than photon plans. This is the first study to demonstrate the feasibility of proton-based stereotactic ablative radiotherapy planning for lung tumors using proton transmission beams alone. Further research using this novel approach for proton-based planning is warranted.	[Mou, Benjamin; Beltran, Chris J.; Park, Sean S.; Olivier, Kenneth R.; Furutani, Keith M.] Mayo Clin, Dept Radiat Oncol, Rochester, MN 55905 USA	Mayo Clinic	Beltran, CJ (corresponding author), Mayo Clin, Dept Radiat Oncol, Rochester, MN 55905 USA.	Beltran.Chris@mayo.edu		Mou, Benjamin/0000-0002-5636-604X; Park, Sean/0000-0003-3814-853X				Bradley J, 2013, J CLIN ONCOL, V31, P7501; Georg D, 2008, RADIOTHER ONCOL, V88, P368, DOI 10.1016/j.radonc.2008.03.007; Hoppe BS, 2010, RADIOTHER ONCOL, V97, P425, DOI 10.1016/j.radonc.2010.09.006; Keall PJ, 2006, MED PHYS, V33, P3874, DOI 10.1118/1.2349696; Macdonald OK, 2009, INT J RADIAT ONCOL, V75, P950, DOI 10.1016/j.ijrobp.2009.04.023; Paganetti H, 2012, PHYS MED BIOL, V57, pR99, DOI 10.1088/0031-9155/57/11/R99; Register SP, 2011, INT J RADIAT ONCOL, V80, P1015, DOI 10.1016/j.ijrobp.2010.03.012; Seco J, 2012, INT J RADIAT ONCOL, V83, P354, DOI 10.1016/j.ijrobp.2011.05.062; Videtic GM, 2013, INT J RADIAT ONCOL, V87, pS3, DOI 10.1016/j.ijrobp.2013.06.016; Westover KD, 2012, J THORAC ONCOL, V7, P1021, DOI 10.1097/JTO.0b013e31824de0bf	10	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98621	10.1371/journal.pone.0098621	http://dx.doi.org/10.1371/journal.pone.0098621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887068	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300094
J	Streicher, W; Luedeke, M; Azoitei, A; Zengerling, F; Herweg, A; Genze, F; Schrader, MG; Schrader, AJ; Cronauer, MV				Streicher, Wolfgang; Luedeke, Manuel; Azoitei, Anca; Zengerling, Friedemann; Herweg, Alexander; Genze, Felicitas; Schrader, Mark G.; Schrader, Andres J.; Cronauer, Marcus V.			Stilbene Induced Inhibition of Androgen Receptor Dimerization: Implications for AR and ARDLBD-Signalling in Human Prostate Cancer Cells	PLOS ONE			English	Article							SPLICE VARIANTS; FULL-LENGTH; ABIRATERONE ACETATE; ANTITUMOR-ACTIVITY; RESVERATROL; GROWTH; ENZALUTAMIDE; EXPRESSION; DOCETAXEL; MECHANISM	Background: Advanced castration resistant prostate cancer (CRPC) is often characterized by an increase of C-terminally truncated, constitutively active androgen receptor (AR) variants. Due to the absence of a ligand binding domain located in the AR-C-terminus, these receptor variants (also termed AR Delta LBD) are unable to respond to all classical forms of endocrine treatments like surgical/chemical castration and/or application of anti-androgens. Methodology: In this study we tested the effects of the naturally occurring stilbene resveratrol (RSV) and (E)-4-(2, 6-Difluorostyryl)-N, N-dimethylaniline, a fluorinated dialkylaminostilbene (FIDAS) on AR-and AR Delta LBD in prostate cancer cells. The ability of the compounds to modulate transcriptional activity of AR and the AR Delta LBD-variant Q640X was shown by reporter gene assays. Expression of endogenous AR and AR Delta LBD mRNA and protein levels were determined by qRT-PCR and Western Blot. Nuclear translocation of AR-molecules was analyzed by fluorescence microscopy. AR and AR Delta LBD/Q640X homo-/heterodimer formation was assessed by mammalian two hybrid assays. Biological activity of both compounds in vivo was demonstrated using a chick chorioallantoic membrane xenograft assay. Results: The stilbenes RSV and FIDAS were able to significantly diminish AR and Q640X-signalling. Successful inhibition of the Q640X suggests that RSV and FIDAS are not interfering with the AR-ligand binding domain like all currently available anti-hormonal drugs. Repression of AR and Q640X-signalling by RSV and FIDAS in prostate cancer cells was caused by an inhibition of the AR and/or Q640X-dimerization. Although systemic bioavailability of both stilbenes is very low, both compounds were also able to downregulate tumor growth and AR-signalling in vivo. Conclusion: RSV and FIDAS are able to inhibit the dimerization of AR and AR Delta LBD molecules suggesting that stilbenes might serve as lead compounds for a novel generation of AR-inhibitors.	[Streicher, Wolfgang; Luedeke, Manuel; Azoitei, Anca; Zengerling, Friedemann; Herweg, Alexander; Genze, Felicitas; Schrader, Mark G.; Schrader, Andres J.; Cronauer, Marcus V.] Univ Ulm, Dept Urol, D-89069 Ulm, Germany	Ulm University	Cronauer, MV (corresponding author), Univ Ulm, Dept Urol, D-89069 Ulm, Germany.	marcus.cronauer@uni-ulm.de	Cronauer, Marcus/AAG-7457-2021		Anneliese Pohl Stiftung; Ferdinand Eisenberger Grant of the German Society of Urology [ZeF1/FE-11]	Anneliese Pohl Stiftung; Ferdinand Eisenberger Grant of the German Society of Urology	This work was supported by the Anneliese Pohl Stiftung (AJS, MVC), and a Ferdinand Eisenberger Grant of the German Society of Urology - grant ID ZeF1/FE-11 (FZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amri A, 2012, J CONTROL RELEASE, V158, P182, DOI 10.1016/j.jconrel.2011.09.083; Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bianchini D, 2014, EUR J CANCER, V50, P78, DOI 10.1016/j.ejca.2013.08.020; Cai CM, 2011, ENDOCR-RELAT CANCER, V18, pR175, DOI 10.1530/ERC-10-0339; Ceraline J, 2004, INT J CANCER, V108, P152, DOI 10.1002/ijc.11404; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Chen HL, 2010, ENDOCR-RELAT CANCER, V17, P857, DOI 10.1677/ERC-10-0081; Cronauer MV, 2007, ONCOGENE, V26, P1875, DOI 10.1038/sj.onc.1209984; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Dias SJ, 2013, PROSTATE, V73, P1135, DOI 10.1002/pros.22657; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Haile S, 2011, CELL MOL LIFE SCI, V68, P3971, DOI 10.1007/s00018-011-0766-7; Harada N, 2007, J NUTR SCI VITAMINOL, V53, P556, DOI 10.3177/jnsv.53.556; Harada N, 2011, J STEROID BIOCHEM, V123, P65, DOI 10.1016/j.jsbmb.2010.11.002; Hornberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019059; Hsieh TC, 2000, ANTICANCER RES, V20, P225; Hsieh TC, 1999, EXP CELL RES, V249, P109, DOI 10.1006/excr.1999.4471; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Iguchi K, 2012, J ANDROL, V33, P1208, DOI 10.2164/jandrol.112.016782; JENSTER G, 1991, MOL ENDOCRINOL, V5, P1396, DOI 10.1210/mend-5-10-1396; Jernberg E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077407; Jones SB, 2005, CANCER EPIDEM BIOMAR, V14, P596, DOI 10.1158/1055-9965.EPI-04-0398; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Kuefer R, 2004, BRIT J CANCER, V90, P535, DOI 10.1038/sj.bjc.6601510; Laschak M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-130; Li XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031213; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Libertini SJ, 2007, CANCER RES, V67, P9001, DOI 10.1158/0008-5472.CAN-07-1072; Loriot Y, 2013, ANN ONCOL, V24, P1807, DOI 10.1093/annonc/mdt136; Meimetis LG, 2012, J MED CHEM, V55, P503, DOI 10.1021/jm2014056; Mitchell SH, 1999, CANCER RES, V59, P5892; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Mudryj M, 2013, HORM CANCER-US, V4, P259, DOI 10.1007/s12672-013-0152-z; Noonan KL, 2013, ANN ONCOL, V24, P1802, DOI 10.1093/annonc/mdt138; Reid J, 2002, J BIOL CHEM, V277, P20079, DOI 10.1074/jbc.M201003200; Rinnab L, 2008, NEOPLASIA, V10, P624, DOI 10.1593/neo.08248; Sadar MD, 2008, ORG LETT, V10, P4947, DOI 10.1021/ol802021w; Sadar MD, 2012, WORLD J UROL, V30, P311, DOI 10.1007/s00345-011-0745-5; Schrader AJ, 2014, EUR UROL, V65, P30, DOI 10.1016/j.eururo.2013.06.042; Schutz SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025341; Schutz SV, 2010, J CELL BIOCHEM, V109, P1192, DOI 10.1002/jcb.22500; Shi WF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007398; Streicher W, 2012, WORLD J UROL, V30, P333, DOI 10.1007/s00345-012-0842-0; Sun SH, 2010, J CLIN INVEST, V120, P2715, DOI 10.1172/JCI41824; Tepper CG, 2002, CANCER RES, V62, P6606; van Royen ME, 2012, J CELL SCI, V125, P1970, DOI 10.1242/jcs.096792; Vang O, 2013, ANN NY ACAD SCI, V1290, P1, DOI 10.1111/nyas.12173; Wang TTY, 2008, CARCINOGENESIS, V29, P2001, DOI 10.1093/carcin/bgn131; Watson PA, 2010, P NATL ACAD SCI USA, V107, P16759, DOI 10.1073/pnas.1012443107; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Yamashita S, 2012, NEOPLASIA, V14, P74, DOI 10.1593/neo.111436; Zhang W, 2013, ACS CHEM BIOL, V8, P796, DOI 10.1021/cb3005353; Zhang W, 2011, J MED CHEM, V54, P1288, DOI 10.1021/jm101248v; Zhang XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027970	56	23	25	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98566	10.1371/journal.pone.0098566	http://dx.doi.org/10.1371/journal.pone.0098566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887556	gold, Green Published, Green Submitted			2022-12-25	WOS:000336956300086
J	Chen, W; DelProposto, Z; Liu, W; Kassir, M; Wang, ZY; Zhao, J; Xie, B; Wen, YM; Wang, J; Hu, JN				Chen, Wei; DelProposto, Zachary; Liu, Wei; Kassir, Mohammad; Wang, Zhiyuan; Zhao, Jun; Xie, Bing; Wen, Yaming; Wang, Jian; Hu, Jiani			Susceptibility-Weighted Imaging for the Noncontrast Evaluation of Hepatocellular Carcinoma: A Prospective Study with Histopathologic Correlation	PLOS ONE			English	Article							INTRATUMORAL HEMORRHAGE; MRI; DIAGNOSIS; PATHOLOGY; LIVER; CT; NODULES; LESIONS	Background: Specific morphologic features of hepatocellular carcinoma (HCC) on imaging have identifiable pathologic correlates as well as implications for altering surgical management and defining prognosis. In this study, we compared susceptibility-weighted imaging (SWI) to conventional techniques and correlated our findings with histopathology to determine the role of SWI in assessing morphologic features of HCC without using a contrast agent. Methods: 86 consecutive patients with suspected HCC were imaged with MRI (including T1, T2, T2*, and SWI) and subsequently CT. 59 histologically-proven HCC lesions were identified in 53 patients. Each lesion on each imaging sequence was evaluated by two radiologists, and classified with respect to lesion morphology, signal intensity relative to surrounding hepatic parenchyma, presence of a pseudocapsule, presence of venous invasion, and internal homogeneity. Results: Histopathology confirmed pseudocapsules in 41/59 lesions. SWI was able to detect a pseudocapsule in 34/41 lesions; compared to conventional T1/T2 imaging (12/41) and T2* (27/41). Mosaic pattern was identified in 25/59 lesions by histopathology; SWI confirmed this in all 25 lesions, compared to T1/T2 imaging (13/25) or T2* (18/25). Hemorrhage was confirmed by histopathology in 43/59 lesions, and visible on SWI in 41/43 lesions, compared to T1/T2 (7/43) and T2* (38/43). Venous invasion was confirmed by histopathology in 31/59 patients; SWI demonstrated invasion in 28/31 patients, compared to T1/T2 (7/31) and T2* (24/31). Conclusions: SWI is better at identifying certain morphologic features such as pseudocapsule and hemorrhage than conventional MRI without using a contrast agent in HCC patients.	[Chen, Wei; Zhao, Jun; Xie, Bing; Wen, Yaming; Wang, Jian] Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China; [DelProposto, Zachary] Henry Ford Hosp, Dept Radiol, Detroit, MI 48202 USA; [Liu, Wei] Third Mil Med Univ, Southwest Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China; [Kassir, Mohammad; Hu, Jiani] Wayne State Univ, Dept Radiol, Detroit, MI USA; [Wang, Zhiyuan] Cent S Univ, Xiangya Med Sch, Hunan Prov Tumor Hosp, Canc Biotherapy Ctr, Changsha, Hunan, Peoples R China	Army Medical University; Henry Ford Health System; Henry Ford Hospital; Army Medical University; Wayne State University; Central South University	Wang, J (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Radiol, Chongqing, Peoples R China.	wangjian811@gmail.com; jhu@med.wayne.edu			National Natural Science Foundation of China [81272442/H1608]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Natural Science Foundation of China (Project No: 81272442/H1608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Chen W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036454; CHOI BI, 1993, AM J ROENTGENOL, V160, P1177, DOI 10.2214/ajr.160.6.8388618; Choi JH, 2004, J KOREAN MED SCI, V19, P895, DOI 10.3346/jkms.2004.19.6.895; Dai YM, 2011, J MAGN RESON IMAGING, V34, P318, DOI 10.1002/jmri.22607; Earls JP, 1996, RADIOLOGY, V201, P207, DOI 10.1148/radiology.201.1.8816545; EBARA M, 1986, RADIOLOGY, V159, P371, DOI 10.1148/radiology.159.2.3008213; Grazioli L, 1999, EUR RADIOL, V9, P62, DOI 10.1007/s003300050629; Hardie AD, 2010, MAGN RESON IMAGING, V28, P281, DOI 10.1016/j.mri.2009.12.010; HONDA H, 1992, GASTROINTEST RADIOL, V17, P245, DOI 10.1007/BF01888559; Ito K, 2006, EUR J RADIOL, V58, P186, DOI 10.1016/j.ejrad.2005.11.039; KADOYA M, 1992, RADIOLOGY, V183, P819, DOI 10.1148/radiology.183.3.1316622; Lee JM, 2012, SEMIN ONCOL, V39, P399, DOI 10.1053/j.seminoncol.2012.05.010; Li RK, 2012, J MAGN RESON IMAGING, V36, P900, DOI 10.1002/jmri.23734; Mie MB, 2010, Z MED PHYS, V20, P143, DOI 10.1016/j.zemedi.2010.02.004; Miller G, 2007, SURG ONCOL CLIN N AM, V16, P343, DOI 10.1016/j.soc.2007.04.001; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; NAKASHIMA T, 1986, SEMIN LIVER DIS, V6, P259, DOI 10.1055/s-2008-1040608; Onaya H, 2000, Magn Reson Imaging Clin N Am, V8, P757; Perazella MA, 2008, CURR DRUG SAF, V3, P67, DOI 10.2174/157488608783333989; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Stevens WR, 1996, J COMPUT ASSIST TOMO, V20, P337, DOI 10.1097/00004728-199605000-00001; Sumie S, 2008, ANN SURG ONCOL, V15, P1375, DOI 10.1245/s10434-008-9846-9; Tan MGK, 2009, EXP BIOL MED, V234, P693, DOI 10.3181/0807-RM-227; Tao R, 2012, CLIN RADIOL, V67, pE91, DOI 10.1016/j.crad.2012.08.015	25	13	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98303	10.1371/journal.pone.0098303	http://dx.doi.org/10.1371/journal.pone.0098303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879409	Green Published, Green Submitted, gold			2022-12-25	WOS:000338101500048
J	Ferrero, R; Lima, M; Gonzalez-Andujar, JL				Ferrero, Rosana; Lima, Mauricio; Luis Gonzalez-Andujar, Jose			Spatio-Temporal Dynamics of Maize Yield Water Constraints under Climate Change in Spain	PLOS ONE			English	Article							TEMPERATURE; CROP; VARIABILITY; IRRIGATION; MINIMUM; MODELS; HEAT; GAPS; US	Many studies have analyzed the impact of climate change on crop productivity, but comparing the performance of water management systems has rarely been explored. Because water supply and crop demand in agro-systems may be affected by global climate change in shaping the spatial patterns of agricultural production, we should evaluate how and where irrigation practices are effective in mitigating climate change effects. Here we have constructed simple, general models, based on biological mechanisms and a theoretical framework, which could be useful in explaining and predicting crop productivity dynamics. We have studied maize in irrigated and rain-fed systems at a provincial scale, from 1996 to 2009 in Spain, one of the most prominent "hot-spots'' in future climate change projections. Our new approach allowed us to: (1) evaluate new structural properties such as the stability of crop yield dynamics, (2) detect nonlinear responses to climate change (thresholds and discontinuities), challenging the usual linear way of thinking, and (3) examine spatial patterns of yield losses due to water constraints and identify clusters of provinces that have been negatively affected by warming. We have reduced the uncertainty associated with climate change impacts on maize productivity by improving the understanding of the relative contributions of individual factors and providing a better spatial comprehension of the key processes. We have identified water stress and water management systems as being key causes of the yield gap, and detected vulnerable regions where efforts in research and policy should be prioritized in order to increase maize productivity.	[Ferrero, Rosana; Luis Gonzalez-Andujar, Jose] CSIC, Inst Agr Sostenible, Dept Protecc Cult, Cordoba, Spain; [Lima, Mauricio] Pontificia Univ Catolica Chile, Dept Ecol, Santiago, Chile; [Lima, Mauricio; Luis Gonzalez-Andujar, Jose] LINCG CSIC PUC, Lab Int Cambio Global, Santiago, Chile; [Ferrero, Rosana; Lima, Mauricio] Ctr Appl Ecol & Sustainabil CAPES, Santiago, Chile	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Pontificia Universidad Catolica de Chile	Ferrero, R (corresponding author), CSIC, Inst Agr Sostenible, Dept Protecc Cult, Cordoba, Spain.	rferrero@ias.csic.es	GONZALEZ-ANDUJAR, JOSE L./G-5671-2013; Lima, Mauricio/F-2722-2013; Ferrero, Rosana/G-6435-2014	GONZALEZ-ANDUJAR, JOSE L./0000-0003-2356-4098; Lima, Mauricio/0000-0002-3700-2945; Ferrero, Rosana/0000-0002-2520-0231	Fundacion Carolina; FEDER (Fondo Europeo de Desarrollo Regional); Spanish Ministry of Economy and Competitiveness funds [AGL2012-33736]; Fondo Basal-CONICYT [FB-0002]; LINCGlobal (Laboratorio Internacional en Cambio Global)	Fundacion Carolina; FEDER (Fondo Europeo de Desarrollo Regional)(European Commission); Spanish Ministry of Economy and Competitiveness funds(Spanish Government); Fondo Basal-CONICYT; LINCGlobal (Laboratorio Internacional en Cambio Global)	R. Ferrero gratefully acknowledges receipt of a grant from the Fundacion Carolina. J. L. Gonzalez-Andujar and R. Ferrero were supported by FEDER (Fondo Europeo de Desarrollo Regional) and the Spanish Ministry of Economy and Competitiveness funds (AGL2012-33736). R. Ferrero and M. Lima acknowledge financial support from Fondo Basal-CONICYT grant FB-0002. We are grateful to LINCGlobal (Laboratorio Internacional en Cambio Global) for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alward RD, 1999, SCIENCE, V283, P229, DOI 10.1126/science.283.5399.229; Bates D.M., 1991, STAT MODELS S; Berryman A, 2001, OIKOS, V92, P265, DOI 10.1034/j.1600-0706.2001.920208.x; Berryman A., 1999, PRINCIPLES POPULATIO; Bivand R, 2013, SPEED SPATIAL DEPEND; Bivand RS, 2008, USE R, P1; Bosello F, 2009, SSRN ELECT J; Butler EE, 2013, NAT CLIM CHANGE, V3, P68, DOI [10.1038/NCLIMATE1585, 10.1038/nclimate1585]; Cameron AC, 1996, J BUS ECON STAT, V14, P209, DOI 10.2307/1392433; Chen CQ, 2011, AGR FOREST METEOROL, V151, P1580, DOI 10.1016/j.agrformet.2011.06.013; De La Maza M, 2009, GLOBAL CHANGE BIOL, V15, P1116, DOI 10.1111/j.1365-2486.2008.01796.x; Doll P, 2002, CLIMATIC CHANGE, V54, P269, DOI 10.1023/A:1016124032231; Easterling W, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P273; IGLESIAS A, 1995, ASA SPEC P, P259; Iglesias A, 2012, CLIMATIC CHANGE, V112, P29, DOI 10.1007/s10584-011-0338-8; Iglesias A, 2011, REG ENVIRON CHANGE, V11, pS159, DOI 10.1007/s10113-010-0187-4; KATZ RW, 1992, CLIMATIC CHANGE, V21, P289, DOI 10.1007/BF00139728; Lawrence JF, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007836; Licker R, 2010, GLOBAL ECOL BIOGEOGR, V19, P769, DOI 10.1111/j.1466-8238.2010.00563.x; Liu Z, 2012, GLOB CHANG BIOL, V86; Lobell D, 2009, J CLIMATE, V22, P2248, DOI 10.1175/2008JCLI2703.1; Lobell DB, 2007, AGR FOREST METEOROL, V145, P229, DOI 10.1016/j.agrformet.2007.05.002; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Lobell DB, 2013, NAT CLIM CHANGE, V3, P497, DOI [10.1038/nclimate1832, 10.1038/NCLIMATE1832]; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lobell DB, 2011, NAT CLIM CHANGE, V1, P42, DOI [10.1038/nclimate1043, 10.1038/NCLIMATE1043]; Lobell DB, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034145; Lobell DB, 2006, ECOL MODEL, V196, P173, DOI 10.1016/j.ecolmodel.2005.11.030; Long SP, 2006, SCIENCE, V312, P1918, DOI 10.1126/science.1114722; MAGRAMA, 2012, MAGRAMA STAT DAT; Medici LO, 2014, ENVIRON EXP BOT, V99, P38, DOI 10.1016/j.envexpbot.2013.10.019; Meng QF, 2013, FIELD CROP RES, V143, P91, DOI 10.1016/j.fcr.2012.09.023; Mohammed AR, 2011, GLOBAL WARMING IMPACTS - CASE STUDIES ON THE ECONOMY, HUMAN HEALTH, AND ON URBAN AND NATURAL ENVIRONMENTS, P153; MUCHOW RC, 1990, AGRON J, V82, P338, DOI 10.2134/agronj1990.00021962008200020033x; MUCHOW RC, 1990, FIELD CROP RES, V23, P145, DOI 10.1016/0378-4290(90)90109-O; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Neumann K, 2010, AGR SYST, V103, P316, DOI 10.1016/j.agsy.2010.02.004; Olesen JE, 2007, CLIMATIC CHANGE, V81, P123, DOI 10.1007/s10584-006-9216-1; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reidsma P, 2009, AGR SYST, V100, P51, DOI 10.1016/j.agsy.2008.12.009; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Rodriguez-Puebla C, 2007, CLIM RES, V34, P223, DOI 10.3354/cr00700; Rosenzweig C, 1996, AGR FOREST METEOROL, V80, P215, DOI 10.1016/0168-1923(95)02299-6; Royama T., 1992, ANAL POPULATION ECOL; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Sun BJ, 2013, J AGR SCI, P1; Tokatlidis IS, 2013, AGRON SUSTAIN DEV, V33, P63, DOI 10.1007/s13593-012-0108-7; Turral H., 2011, CLIMATE CHANGE WATER, P204; WOLF J, 1995, CLIMATIC CHANGE, V29, P299, DOI 10.1007/BF01091866; Zou XX, 2012, MITIG ADAPT STRAT GL, V17, P111, DOI 10.1007/s11027-011-9316-8	51	9	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98220	10.1371/journal.pone.0098220	http://dx.doi.org/10.1371/journal.pone.0098220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878747	Green Submitted, Green Published, gold			2022-12-25	WOS:000338101500038
J	Han, JM; Kim, HG; Lee, JS; Choi, MK; Kim, YA; Son, CG				Han, Jong-Min; Kim, Hyeong-Geug; Lee, Jin-Seok; Choi, Min-Kyung; Kim, Young-Ae; Son, Chang-Gue			Repeated Sense of Hunger Leads to the Development of Visceral Obesity and Metabolic Syndrome in a Mouse Model	PLOS ONE			English	Article							MESSENGER-RNA; INSULIN-RESISTANCE; GLUCOSE-TRANSPORTER; EATING PATTERNS; ENERGY-BALANCE; LEPTIN LEVELS; ADIPOSITY; FAT; ADIPONECTIN; EXPRESSION	Obesity-related disorders, especially metabolic syndrome, contribute to 2.8 million deaths each year worldwide, with significantly increasing morbidity. Eating at regular times and proper food quantity are crucial for maintaining a healthy status. However, many people in developed countries do not follow a regular eating schedule due to a busy lifestyle. Herein, we show that a repeated sense of hunger leads to a high risk of developing visceral obesity and metabolic syndrome in a mouse model (both 3-week and 6-week-old age, 10 mice in each group). The ad libitum (AL) group (normal eating pattern) and the food restriction (FR) group (alternate-day partially food restriction by given only 1/3 of average amount) were compared after 8-week experimental period. The total food consumption in the FR group was lower than in the AL group, however, the FR group showed a metabolic syndrome-like condition with significant fat accumulation in adipose tissues. Consequently, the repeated sense of hunger induced the typical characteristics of metabolic syndrome in an animal model; a distinct visceral obesity, hyperlipidemia, hyperglycemia and hepatic steatosis. Furthermore, we found that specifically leptin, a major metabolic hormone, played a major role in the development of these pathological disorders. Our study indicated the importance of regular eating habits besides controlling calorie intake.	[Han, Jong-Min; Kim, Hyeong-Geug; Lee, Jin-Seok; Choi, Min-Kyung; Kim, Young-Ae; Son, Chang-Gue] Daejeon Univ, Inst Tradit Med & Biosci, Liver & Immunol Res Ctr, Taejon, South Korea	Daejeon University	Son, CG (corresponding author), Daejeon Univ, Inst Tradit Med & Biosci, Liver & Immunol Res Ctr, 22-5 Daeheung Dong, Taejon, South Korea.	ckson@dju.ac.kr	son, chang gue/ABC-2215-2021		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A2001519]; Oriental Medicine Research and Development Project, Ministry of Health and Welfare [B120047]; Korea Institute of Oriental Medicine, Republic of Korea [K12101]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Oriental Medicine Research and Development Project, Ministry of Health and Welfare; Korea Institute of Oriental Medicine, Republic of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) founded by the Ministry of Education, Science and Technology (2012R1A1A2001519), the Oriental Medicine Research and Development Project, Ministry of Health and Welfare (B120047), and the "Study of aging-control by energy metabolism based on oriental medicine'' of Korea Institute of Oriental Medicine, Republic of Korea (K12101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait Saada D., 2008, ADV BIOL RES, V2, P111; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Berg C, 2009, APPETITE, V52, P21, DOI 10.1016/j.appet.2008.07.008; Berg CM, 2008, AM J CLIN NUTR, V88, P289; Bouguerra R, 2006, ANN ENDOCRINOL-PARIS, V67, P54, DOI 10.1016/S0003-4266(06)72541-0; Brietzke SA, 2007, MED CLIN N AM, V91, P1041, DOI 10.1016/j.mcna.2007.06.005; CARR TP, 1993, CLIN BIOCHEM, V26, P39, DOI 10.1016/0009-9120(93)90015-X; Chitturi S, 2002, HEPATOLOGY, V36, P403, DOI 10.1053/jhep.2002.34738; Devlin MJ, 2000, AM J PSYCHIAT, V157, P854, DOI 10.1176/appi.ajp.157.6.854; FREDERICH RC, 1995, J CLIN INVEST, V96, P1658, DOI 10.1172/JCI118206; GARVEY WT, 1989, SCIENCE, V245, P60, DOI 10.1126/science.2662408; Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Habegger KM, 2012, ENDOCRINOLOGY, V153, P2130, DOI 10.1210/en.2011-2099; Harsch IA, 2007, J PHYSIOL PHARMACOL, V58, P65; Havel PJ, 1998, AM J CLIN NUTR, V67, P355, DOI 10.1093/ajcn/67.3.355; Hayashi T, 2008, DIABETES, V57, P1269, DOI 10.2337/db07-1378; Inui A, 2004, FASEB J, V18, P439, DOI 10.1096/fj.03-0641rev; Jaakkola J, 2013, NUTRITION, V29, P1209, DOI 10.1016/j.nut.2013.03.008; Johnson JB, 2006, MED HYPOTHESES, V67, P209, DOI 10.1016/j.mehy.2006.01.030; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; Klempel MC, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-98; Korner J, 2001, J NEUROENDOCRINOL, V13, P959, DOI 10.1046/j.1365-2826.2001.00716.x; Kusminski CM, 2005, CLIN SCI, V109, P243, DOI 10.1042/CS20050078; Li LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066069; Liu Q, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-42; Ma YS, 2003, AM J EPIDEMIOL, V158, P85, DOI 10.1093/aje/kwg117; Martins MD, 2012, REV PORT CARDIOL, V31, P711, DOI 10.1016/j.repc.2012.08.002; Mason RJ, 2003, J CLIN INVEST, V112, P244, DOI 10.1172/JCI200316793; Monroe MB, 2000, INT J OBESITY, V24, P1183, DOI 10.1038/sj.ijo.0801364; Mozzanega B, 2004, ANN NY ACAD SCI, V1034, P364, DOI 10.1196/annals.1335.038; Olson AL, 1996, ANNU REV NUTR, V16, P235, DOI 10.1146/annurev.nu.16.070196.001315; Savino F, 2011, INT J PEDIAT, V2011, DOI 10.1155/2011/803985; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Segal KR, 1996, DIABETES, V45, P988, DOI 10.2337/diabetes.45.7.988; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Silha JV, 2003, EUR J ENDOCRINOL, V149, P331, DOI 10.1530/eje.0.1490331; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Swart I, 2002, AM J PHYSIOL-REG I, V283, pR1020, DOI 10.1152/ajpregu.00501.2001; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Unger RH, 2010, TRENDS ENDOCRIN MET, V21, P345, DOI 10.1016/j.tem.2010.01.009; Varela L, 2012, EMBO REP, V13, P1079, DOI 10.1038/embor.2012.174; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; Weissman C, 1999, CRIT CARE, V3, pR67, DOI 10.1186/cc360; Wilding JPH, 2002, DIABETIC MED, V19, P619, DOI 10.1046/j.1464-5491.2002.00790.x; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Ye JP, 2010, AGING-US, V2, P361, DOI 10.18632/aging.100155; Yun JE, 2010, METABOLISM, V59, P424, DOI 10.1016/j.metabol.2009.08.012	50	4	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98276	10.1371/journal.pone.0098276	http://dx.doi.org/10.1371/journal.pone.0098276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879081	gold, Green Submitted, Green Published			2022-12-25	WOS:000338101500043
J	Levesque, C; Provost, C; Labrie, J; Reyes, YH; Nava, JAB; Gagnon, CA; Jacques, M				Levesque, Cynthia; Provost, Chantale; Labrie, Josee; Reyes, Yenney Hernandez; Burciaga Nava, Jorge A.; Gagnon, Carl A.; Jacques, Mario			Actinobacillus pleuropneumoniae Possesses an Antiviral Activity against Porcine Reproductive and Respiratory Syndrome Virus	PLOS ONE			English	Article							SWINE INFLUENZA-VIRUS; CELL-LINE; STREPTOCOCCUS-PNEUMONIAE; MYCOPLASMA-HYOPNEUMONIAE; EPITHELIAL-CELLS; SYNDROME PRRS; IN-VITRO; INFECTION; PIGS; REPLICATION	Pigs are often colonized by more than one bacterial and/or viral species during respiratory tract infections. This phenomenon is known as the porcine respiratory disease complex (PRDC). Actinobacillus pleuropneumoniae (App) and porcine reproductive and respiratory syndrome virus (PRRSV) are pathogens that are frequently involved in PRDC. The main objective of this project was to study the in vitro interactions between these two pathogens and the host cells in the context of mixed infections. To fulfill this objective, PRRSV permissive cell lines such as MARC-145, SJPL, and porcine alveolar macrophages (PAM) were used. A pre-infection with PRRSV was performed at 0.5 multiplicity of infection (MOI) followed by an infection with App at 10 MOI. Bacterial adherence and cell death were compared. Results showed that PRRSV pre-infection did not affect bacterial adherence to the cells. PRRSV and App co-infection produced an additive cytotoxicity effect. Interestingly, a pre-infection of SJPL and PAM cells with App blocked completely PRRSV infection. Incubation of SJPL and PAM cells with an App cell-free culture supernatant is also sufficient to significantly block PRRSV infection. This antiviral activity is not due to LPS but rather by small molecular weight, heat-resistant App metabolites(<1 kDa). The antiviral activity was also observed in SJPL cells infected with swine influenza virus but to a much lower extent compared to PRRSV. More importantly, the PRRSV antiviral activity of App was also seen with PAM, the cells targeted by the virus in vivo during infection in pigs. The antiviral activity might be due, at least in part, to the production of interferon c. The use of in vitro experimental models to study viral and bacterial co-infections will lead to a better understanding of the interactions between pathogens and their host cells, and could allow the development of novel prophylactic and therapeutic tools.	[Levesque, Cynthia; Provost, Chantale; Labrie, Josee; Reyes, Yenney Hernandez; Gagnon, Carl A.; Jacques, Mario] Univ Montreal, Fac Med Vet, CRIPA, St Hyacinthe, PQ J2S 7C6, Canada; [Levesque, Cynthia; Provost, Chantale; Labrie, Josee; Reyes, Yenney Hernandez; Gagnon, Carl A.; Jacques, Mario] Univ Montreal, Fac Med Vet, GREMIP, St Hyacinthe, PQ J2S 7C6, Canada; [Burciaga Nava, Jorge A.] Univ Juarez Estado Durango, Fac Med, Dept Bioquim, Durango, Mexico	Universite de Montreal; Universite de Montreal; Universidad Juarez del Estado de Durango	Jacques, M (corresponding author), Univ Montreal, Fac Med Vet, CRIPA, St Hyacinthe, PQ J2S 7C6, Canada.	mario.jacques@umontreal.ca	Jacques, Mario/D-4901-2015; Gagnon, Carl A/A-9239-2015	Provost, Chantale/0000-0002-6674-1157; Gagnon, Carl A./0000-0003-4528-541X	Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds de recherche du Quebec nature et technologies (FRQNT); Canadian Swine Health Board (CSHB); NSERC-Alexander Graham Bell Canada Graduate Scholarship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche du Quebec nature et technologies (FRQNT); Canadian Swine Health Board (CSHB); NSERC-Alexander Graham Bell Canada Graduate Scholarship	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grants (to CAG and MJ) and Fonds de recherche du Quebec nature et technologies (FRQNT) team research project program (to CAG and MJ). C. Provost was a recipient of a postdoctoral fellowship grant from the Canadian Swine Health Board (CSHB). Y. Hernandez Reyes was a recipient of a NSERC-Alexander Graham Bell Canada Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albina E, 1997, VET RES, V28, P305; Allende R, 2000, J VIROL, V74, P10834, DOI 10.1128/JVI.74.22.10834-10837.2000; Auger E, 2009, INFECT IMMUN, V77, P1426, DOI 10.1128/IAI.00297-08; Avadhanula V, 2007, J MED MICROBIOL, V56, P1133, DOI 10.1099/jmm.0.47086-0; Bautista EM, 1999, ARCH VIROL, V144, P1191, DOI 10.1007/s007050050578; BIKOUR MH, 1995, J GEN VIROL, V76, P2539, DOI 10.1099/0022-1317-76-10-2539; Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004; Blackall PJ, 2002, VET MICROBIOL, V84, P47, DOI 10.1016/S0378-1135(01)00428-X; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Cafruny WA, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-90; Chen Z, 2010, VIROLOGY, V398, P87, DOI 10.1016/j.virol.2009.11.033; Chiers K, 2010, VET RES, V41, DOI 10.1051/vetres/2010037; de Wilde AH, 2013, J VIROL, V87, P1454, DOI 10.1128/JVI.02078-12; Dubreuil J. Daniel, 2000, Animal Health Research Reviews, V1, P73, DOI 10.1017/S1466252300000074; Firth AE, 2011, J GEN VIROL, V92, P1097, DOI 10.1099/vir.0.029264-0; Gagnon CA, 2003, ARCH VIROL, V148, P951, DOI 10.1007/s00705-002-0943-y; Gagnon CA, 2009, J CLIN MICROBIOL, V47, P796, DOI 10.1128/JCM.01228-08; Gagnon CA, 2008, J VET DIAGN INVEST, V20, P545, DOI 10.1177/104063870802000503; Gao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063767; Golda A, 2011, J GEN VIROL, V92, P1358, DOI 10.1099/vir.0.028381-0; Ishizuka S, 2003, J INFECT DIS, V188, P1928, DOI 10.1086/379833; Jacques M, 2004, CAN J VET RES, V68, P81; Jiang YB, 2010, VET RES COMMUN, V34, P607, DOI 10.1007/s11259-010-9435-9; Johnson CR, 2011, J GEN VIROL, V92, P1107, DOI 10.1099/vir.0.030213-0; Karuppannan AK, 2012, ANTIVIR RES, V94, P188, DOI 10.1016/j.antiviral.2012.03.008; Keffaber K., 1989, AM ASS SWINE PRACT N, V1, P1; Kheyar A, 2005, VACCINE, V23, P4016, DOI 10.1016/j.vaccine.2005.03.012; Kim Y, 2013, VIRUS RES, V171, P44, DOI 10.1016/j.virusres.2012.10.018; Liu CM, 2013, INT J BIOL MACROMOL, V52, P21, DOI 10.1016/j.ijbiomac.2012.09.020; Luo R, 2011, ANTIVIR RES, V91, P99, DOI 10.1016/j.antiviral.2011.04.017; Murtaugh MP, 2011, VACCINE, V29, P8192, DOI 10.1016/j.vaccine.2011.09.013; Music Nedzad, 2010, Animal Health Research Reviews, V11, P135, DOI 10.1017/S1466252310000034; Opriessnig T., 2011, Animal Health Research Reviews, V12, P133, DOI 10.1017/S1466252311000120; Opriessnig T, 2011, ANTIVIR RES, V91, P36, DOI 10.1016/j.antiviral.2011.04.012; Patel D, 2010, J VIROL, V84, P11045, DOI 10.1128/JVI.00655-10; PAYMENT P, 1989, MANUEL TECHNIQUES VI; Provost C, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-267; Qiao SL, 2011, VET MICROBIOL, V149, P213, DOI 10.1016/j.vetmic.2010.11.006; Ramjeet M, 2005, J BIOL CHEM, V280, P39104, DOI 10.1074/jbc.M502852200; Rimar J M, 1986, MCN Am J Matern Child Nurs, V11, P413, DOI 10.1097/00005721-198611000-00013; ROSSOW KD, 1994, J VET DIAGN INVEST, V6, P3, DOI 10.1177/104063879400600102; Sang Yongming, 2011, BMC Proc, V5 Suppl 4, pS8, DOI 10.1186/1753-6561-5-S4-S8; Seo SH, 2001, J VIROL, V75, P9517, DOI 10.1128/JVI.75.19.9517-9525.2001; SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705; Silversides DW, 2010, J VIROL, V84, P5454, DOI 10.1128/JVI.00042-10; SNELL NJC, 1990, LUNG, V168, P422, DOI 10.1007/BF02718160; Storgaard T, 1999, ARCH VIROL, V144, P2389, DOI 10.1007/s007050050652; Sun N, 2012, J ASIAN NAT PROD RES, V14, P721, DOI 10.1080/10286020.2012.685727; Sun Z, 2010, J VIROL, V84, P7832, DOI 10.1128/JVI.00217-10; Thacker EL, 1999, J CLIN MICROBIOL, V37, P620, DOI 10.1128/JCM.37.3.620-627.1999; Thacker EL, 2001, J CLIN MICROBIOL, V39, P2525, DOI 10.1128/JCM.39.7.2525-2530.2001; Thanawongnuwech R, 2000, VET PATHOL, V37, P143, DOI 10.1354/vp.37-2-143; Thanawongnuwech R, 2010, VIRUS RES, V154, P133, DOI 10.1016/j.virusres.2010.09.003; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Wang R, 2013, J VIROL, V87, P5219, DOI 10.1128/JVI.02643-12; Wills RW, 2003, J CLIN MICROBIOL, V41, P58, DOI 10.1128/JCM.41.1.58-62.2003; Xu M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-184; Yang Q, 2013, ANTIVIR RES, V97, P66, DOI 10.1016/j.antiviral.2012.11.004; Yu J, 2012, VET MICROBIOL, V158, P316, DOI 10.1016/j.vetmic.2012.03.001	60	20	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98434	10.1371/journal.pone.0098434	http://dx.doi.org/10.1371/journal.pone.0098434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878741	Green Submitted, Green Published, gold			2022-12-25	WOS:000338101500058
J	Yadav, A; Desai, RS; Bhuta, BA; Singh, JS; Mehta, R; Nehete, AP				Yadav, Archana; Desai, Rajiv S.; Bhuta, Bansari A.; Singh, Jatinder S.; Mehta, Reema; Nehete, Akash P.			Altered Immunohistochemical Expression of Mast Cell Tryptase and Chymase in the Pathogenesis of Oral Submucous Fibrosis and Malignant Transformation of the Overlying Epithelium	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR ANGIOGENESIS; FIBROBLAST PROLIFERATION; COLLAGEN; DENSITY; MYOFIBROBLASTS; INFLAMMATION; RELEVANCE; CLEAVAGE; CANCER	Mast cells (MCs) expressing serine proteases; tryptase and chymase, are associated with fibrosis in various diseases. However, little is known about their involvement in oral submucous fibrosis (OSF). Our goal was to evaluate the role of MC tryptase and chymase in the pathogenesis of OSF and its malignant transformation. Immunohistochemical expression of MC tryptase and chymase was evaluated in 20 cases of OSF, 10 cases of oral squamous cell carcinoma (OSCC) and 10 cases of healthy controls. Subepithelial zone of Stage 1 and 2 while deep zone of Stage 3 and 4 OSF demonstrated increased tryptase positive MCs. OSCC revealed a proportionate increase in tryptase and chymase positive MCs irrespective of areas of distribution. An altered balance in the subepithelial and deep distribution of tryptase and chymase positive MCs play an important role in the pathogenesis of OSF and its malignant transformation.	[Yadav, Archana; Desai, Rajiv S.; Bhuta, Bansari A.; Singh, Jatinder S.; Mehta, Reema; Nehete, Akash P.] Nair Hosp, Coll Dent, Dept Oral Pathol, Bombay, Maharashtra, India		Desai, RS (corresponding author), Nair Hosp, Coll Dent, Dept Oral Pathol, Bombay, Maharashtra, India.	nansrd@hotmail.com	MEHTA, REEMA V./AAS-5718-2021	singh, Jatinder/0000-0003-4869-1210				Akers IA, 2000, AM J PHYSIOL-LUNG C, V278, pL193, DOI 10.1152/ajplung.2000.278.1.L193; Akimoto S, 1998, BRIT J DERMATOL, V138, P399; Algermissen B, 1994, Exp Dermatol, V3, P290, DOI 10.1111/j.1600-0625.1994.tb00291.x; Angadi PV, 2011, J ORAL PATHOL MED, V40, P208, DOI 10.1111/j.1600-0714.2010.00995.x; Ankle M. R., 2007, J ORAL MAXILLOFACIAL, V11, P18, DOI [10.4103/0973-029X.33959, DOI 10.4103/0973-029X.33959]; Artuc M, 2002, J INVEST DERMATOL, V118, P391, DOI 10.1046/j.0022-202x.2001.01705.x; Benitez-Bribiesca L, 2001, J HISTOCHEM CYTOCHEM, V49, P1061, DOI 10.1177/002215540104900816; Bhatt AP, 1997, J IND DENT ASS, V49, P187; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bishen KA, 2008, J ORAL PATHOL MED, V37, P402, DOI 10.1111/j.1600-0714.2008.00649.x; Cairns JA, 1997, J CLIN INVEST, V99, P1313, DOI 10.1172/JCI119290; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Chen Ching-Charng, 1995, Kaohsiung Journal of Medical Sciences, V11, P604; CHOI KL, 1987, IMMUNOL RES, V6, P145, DOI 10.1007/BF02918088; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Desai RS, 2010, ORAL ONCOL, V46, P553, DOI 10.1016/j.oraloncology.2010.04.004; Desai RS, 2012, CURRENT ANGIOGENESIS, V1, P347; Elpek GO, 2001, J CLIN PATHOL, V54, P940, DOI 10.1136/jcp.54.12.940; FARRELL DJ, 1995, HEPATOLOGY, V22, P1175, DOI 10.1016/0270-9139(95)90627-4; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Folkman J, 1985, ADV CANCER RES, V43, P203; Folkman J., 2000, CANC MED, V5, P13; Frungieri MB, 2002, P NATL ACAD SCI USA, V99, P15072, DOI 10.1073/pnas.232422999; Fukushima H, 2006, HISTOPATHOLOGY, V49, P498, DOI 10.1111/j.1365-2559.2006.02534.x; Gruber BL, 1997, J IMMUNOL, V158, P2310; Haque MF, 1997, J ORAL PATHOL MED, V26, P75, DOI 10.1111/j.1600-0714.1997.tb00025.x; Haque MF, 1998, CYTOKINE, V10, P713, DOI 10.1006/cyto.1997.0342; Iamaroon A, 2003, J ORAL PATHOL MED, V32, P195, DOI 10.1034/j.1600-0714.2003.00128.x; IRANI AA, 1986, P NATL ACAD SCI USA, V83, P4464, DOI 10.1073/pnas.83.12.4464; Kale AD, 2013, MED ORAL PATOL ORAL, V18, pE12, DOI 10.4317/medoral.18226; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Khan I, 2011, GROWTH FACTORS, V29, P119, DOI 10.3109/08977194.2011.582839; Khatri MJ, 2013, ISRN PATHOLOGY; Kofford MW, 1997, J BIOL CHEM, V272, P7127, DOI 10.1074/jbc.272.11.7127; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kumar KK, 2007, INDIAN J DENT RES, V18, P106, DOI DOI 10.4103/0970-9290.33785; Kyzas PA, 2005, J CANCER RES CLIN, V131, P624, DOI 10.1007/s00432-005-0003-6; Lingstedt KA, 2001, FASEB J, V15, P1377; Longley BJ, 1997, P NATL ACAD SCI USA, V94, P9017, DOI 10.1073/pnas.94.17.9017; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Pujari R, 2013, INT J HEALTH SCI-IJH, V7, P23, DOI 10.12816/0006017; Punnya V, 2011, ORAL MAXILLOFAC SURG, V15, P1; Rajalalitha P, 2005, J ORAL PATHOL MED, V34, P321, DOI 10.1111/j.1600-0714.2005.00325.x; Roberts ISD, 2000, J CLIN PATHOL, V53, P858, DOI 10.1136/jcp.53.11.858; Rojas IG, 2005, J ORAL PATHOL MED, V34, P268, DOI 10.1111/j.1600-0714.2004.00297.x; Rojas IG, 2012, J ORAL PATHOL MED, V41, P27, DOI 10.1111/j.1600-0714.2011.01057.x; RUOKONEN H, 1993, J ORAL PATHOL MED, V22, P30, DOI 10.1111/j.1600-0714.1993.tb00116.x; RUOSS SJ, 1991, J CLIN INVEST, V88, P493, DOI 10.1172/JCI115330; Sabarinath B, 2011, Indian J Dent Res, V22, P116, DOI 10.4103/0970-9290.80009; Sorrell JM, 2004, J CELL SCI, V117, P667, DOI 10.1242/jcs.01005; Surekha Chavan, 2013, Al Ameen Journal of Medical Sciences, V6, P144; Tanigawa N, 1997, J CLIN ONCOL, V15, P826, DOI 10.1200/JCO.1997.15.2.826; Thode C, 2011, J ORAL PATHOL MED, V40, P201, DOI 10.1111/j.1600-0714.2010.00999.x; Trautmann A, 1998, J IMMUNOL, V160, P5053; Tsai Chi-Cheng, 1999, Kaohsiung Journal of Medical Sciences, V15, P513; TUAN TL, 1994, J CELL SCI, V107, P2285; WALSH LJ, 1995, J ORAL PATHOL MED, V24, P266, DOI 10.1111/j.1600-0714.1995.tb01180.x; Walsh LJ, 2003, CRIT REV ORAL BIOL M, V14, P188, DOI 10.1177/154411130301400304; Wang HW, 2005, EXP DERMATOL, V14, P295, DOI 10.1111/j.0906-6705.2005.00315.x; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yoshiji H, 1996, CANCER RES, V56, P2013	64	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98719	10.1371/journal.pone.0098719	http://dx.doi.org/10.1371/journal.pone.0098719			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874976	Green Published, Green Submitted, gold			2022-12-25	WOS:000336790800056
J	Han, XL; Zhang, W; Gu, J; Zhao, H; Ni, L; Han, JJ; Zhou, Y; Gu, YN; Zhu, XS; Sun, J; Hou, XL; Yang, HL; Dai, JW; Shi, Q				Han, Xinglong; Zhang, Wen; Gu, Jun; Zhao, Huan; Ni, Li; Han, Jiajun; Zhou, Yun; Gu, Yannan; Zhu, Xuesong; Sun, Jie; Hou, Xianglin; Yang, Huilin; Dai, Jianwu; Shi, Qin			Accelerated Postero-Lateral Spinal Fusion by Collagen Scaffolds Modified with Engineered Collagen-Binding Human Bone Morphogenetic Protein-2 in Rats	PLOS ONE			English	Article							LONG-TERM DELIVERY; RABBIT MODEL; RHBMP-2; MATRIX; REGENERATION; BMP-2; CARRIER; GRAFT; OSTEOGENESIS; ARTHRODESIS	Bone morphogenetic protein-2 (BMP-2) is a potent osteoinductive cytokine that plays a critical role in bone regeneration and repair. However, its distribution and side effects are major barriers to its success as therapeutic treatment. The improvement of therapy using collagen delivery matrices has been reported. To investigate a delivery system on posterolateral spinal fusion, both engineered human BMP-2 with a collagen binding domain (CBD-BMP-2) and collagen scaffolds were developed and their combination was implanted into Sprague-Dawley (SD) rats to study Lumbar 4-5 (L4-L5) posterolateral spine fusion. We divided SD rats into three groups, the sham group (G1, n = 20), the collagen scaffold-treated group (G2, n = 20) and the BMP-2-loaded collagen scaffolds group (G3, n = 20). 16 weeks after surgery, the spines of the rats were evaluated by X-radiographs, high-resolution micro-computed tomography (micro-CT), manual palpation and hematoxylin and eosin (H&E) staining. The results showed that spine L4-L5 fusions occurred in G2(40%) and G3(100%) group, while results from the sham group were inconsistent. Moreover, G3 had better results than G2, including higher fusion efficiency (X score, G2 = 2.4 +/- 0.163, G3 = 3.0 +/- 0, p<0.05), higher bone mineral density (BMD, G2: 0.3337 +/- 0.0025g/cm3, G3: 0.4353 +/- 0.0234g/cm3, p<0.05) and more bone trabecular formation. The results demonstrated that with site-specific collagen binding domain, a dose of BMP-2 as low as 0.02mg CBD-BMP-2/cm(3) collagen scaffold could enhance the posterolateral intertransverse process fusion in rats. It suggested that combination delivery could be an alternative in spine fusion with dramatically decreased side effects caused by high dose of BMP-2.	[Han, Xinglong; Zhao, Huan; Ni, Li; Han, Jiajun; Zhou, Yun; Gu, Yannan; Zhu, Xuesong; Yang, Huilin; Shi, Qin] Soochow Univ, Affiliated Hosp 1, Dept Orthoped, Suzhou, Peoples R China; [Zhang, Wen] Soochow Univ, Inst Orthoped, Suzhou, Peoples R China; [Gu, Jun] Soochow Univ, Affiliated Hosp 2, Dept Orthoped, Suzhou, Peoples R China; [Sun, Jie] Chinese Acad Sci, Suzhou Inst Nanotech & Nanob, Div Nanobiomed, Suzhou, Peoples R China; [Hou, Xianglin; Dai, Jianwu] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Dai, JW (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China.	jwdai@genetics.ac.cn; shiqin@suda.edu.cn	ZHU, XUESONG/AAI-1933-2020	Zhu, Xuesong/0000-0003-3579-2741	National Nature Science Foundation of China [81101369]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01030000]; SRF for ROCS of SEM; Jiangsu Provincial Special Program of Medical Science [BL2012004, BK2011264]; State Key Laboratory Cultivation Base of Stem Cell and Bio-medical Materials; Program Foundation of SEM [20113201110013]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); SRF for ROCS of SEM; Jiangsu Provincial Special Program of Medical Science; State Key Laboratory Cultivation Base of Stem Cell and Bio-medical Materials; Program Foundation of SEM	This work was supported by National Nature Science Foundation of China (81101369), the "Strategic Priority Research Program of the Chinese Academy of Sciences'' (Grant No. XDA01030000), SRF for ROCS of SEM (QS), PH.D. Program Foundation of SEM (20113201110013), Jiangsu Provincial Special Program of Medical Science (BL2012004, BK2011264), and the State Key Laboratory Cultivation Base of Stem Cell and Bio-medical Materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaleh KA, 2012, SPINE, V37, P993; Bae HW, 2012, J BONE JOINT SURG AM, V94A, P1845, DOI 10.2106/JBJS.K.00469; Ben-David D, 2013, BIOMATERIALS, V34, P2902, DOI 10.1016/j.biomaterials.2013.01.035; Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063; Carragee EJ, 2013, J BONE JOINT SURG AM, V95A, P1537, DOI 10.2106/JBJS.L.01483; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Chen B, 2007, J BIOMED MATER RES A, V80A, P428, DOI 10.1002/jbm.a.30900; Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013; Crandall DG, 2013, SPINE, V38, P1137, DOI 10.1097/BRS.0b013e3182880298; Devine John G, 2012, Evid Based Spine Care J, V3, P35, DOI 10.1055/s-0031-1298616; Dewan AK, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-58; Dmitriev AE, 2010, SPINE J, V10, P16, DOI 10.1016/j.spinee.2009.10.003; Drespe Inneke H, 2005, Spine J, V5, p209S, DOI 10.1016/j.spinee.2005.02.013; Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010; Glassman SD, 2008, SPINE J, V8, P443, DOI 10.1016/j.spinee.2007.03.004; Glassman SD, 2007, SPINE J, V7, P44, DOI 10.1016/j.spinee.2006.06.381; Gupta MC, 2005, CYTOKINE GROWTH F R, V16, P347, DOI 10.1016/j.cytogfr.2005.02.004; Hannink G, 2013, J MATER SCI-MATER M, V24, P325, DOI 10.1007/s10856-012-4802-4; Hsieh CY, 2006, DENT MATER, V22, P622, DOI 10.1016/j.dental.2005.05.012; Hsu HP, 2006, J ORTHOP RES, V24, P1660, DOI 10.1002/jor.20204; Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031; Kettler A, 2011, EUR SPINE J, V20, P578, DOI 10.1007/s00586-010-1635-z; Koo KH, 2013, ARTIF ORGANS, V37, P487, DOI 10.1111/j.1525-1594.2012.01578.x; Lee JW, 2011, ACTA ORTHOP, V82, P756, DOI 10.3109/17453674.2011.636675; Lee SS, 2013, BIOMATERIALS, V34, P452, DOI 10.1016/j.biomaterials.2012.10.005; Liao SS, 2003, SPINE, V28, P1954, DOI 10.1097/01.BRS.0000083240.13332.F6; Lin H, 2006, J BIOMED MATER RES A, V79A, P591, DOI 10.1002/jbm.a.30862; Lopez MJ, 2009, J ORTHOP RES, V27, P366, DOI 10.1002/jor.20735; Lu J, 2008, SPINE, V33, P242, DOI 10.1097/BRS.0b013e318162451b; Miyazaki M, 2009, SPINE J, V9, P22, DOI 10.1016/j.spinee.2008.08.009; Park BH, 2011, BONE, V49, P447, DOI 10.1016/j.bone.2011.05.020; Park DK, 2013, SPINE, V38, pE738, DOI 10.1097/BRS.0b013e31828fd23c; Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/00007632-200208151-00010; Rao RD, 2008, SPINE J, V8, P563, DOI 10.1016/j.spinee.2007.04.017; Reid JJ, 2011, J BIOMECH, V44, P213, DOI 10.1016/j.jbiomech.2010.10.021; SCHIMANDLE JH, 1994, SPINE, V19, P1998, DOI 10.1097/00007632-199409000-00023; Shi Q, 2012, BIOMATERIALS, V33, P6644, DOI 10.1016/j.biomaterials.2012.05.071; Zhao H, 2013, CHINESE MED J-PEKING, V126, P729, DOI 10.3760/cma.j.issn.0366-6999.20122566; Zhu W, 2004, J BONE MINER RES, V19, P2021, DOI 10.1359/JBMR.040821	39	16	18	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98480	10.1371/journal.pone.0098480	http://dx.doi.org/10.1371/journal.pone.0098480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24869484	gold, Green Published, Green Submitted			2022-12-25	WOS:000336858300047
J	Li, Q; Li, CY; Mahtani, HK; Du, J; Patel, AR; Lancaster, JR				Li, Qian; Li, Chuanyu; Mahtani, Harry K.; Du, Jian; Patel, Aashka R.; Lancaster, Jack R., Jr.			Nitrosothiol Formation and Protection against Fenton Chemistry by Nitric Oxide-induced Dinitrosyliron Complex Formation from Anoxia-initiated Cellular Chelatable Iron Increase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; MITOCHONDRIAL PERMEABILITY TRANSITION; INTRACELLULAR FREE IRON; REPERFUSION INJURY; REACTIVE OXYGEN; ISCHEMIA-REPERFUSION; OXIDATIVE STRESS; RAT HEPATOCYTES; LIVER ISCHEMIA; SPIN-RESONANCE	Dinitrosyliron complexes (DNIC) have been found in a variety of pathological settings associated with (NO)-N-center dot. However, the iron source of cellular DNIC is unknown. Previous studies on this question using prolonged (NO)-N-center dot exposure could be misleading due to the movement of intracellular iron among different sources. We here report that brief (NO)-N-center dot exposure results in only barely detectable DNIC, but levels increase dramatically after 1-2 h of anoxia. This increase is similar quantitatively and temporally with increases in the chelatable iron, and brief (NO)-N-center dot-treatment prevents detection of this anoxia-induced increased chelatable iron by deferoxamine. DNIC formation is so rapid that it is limited by the availability of (NO)-N-center dot and chelatable iron. We utilize this ability to selectively manipulate cellular chelatable iron levels and provide evidence for two cellular functions of endogenous DNIC formation, protection against anoxia-induced reactive oxygen chemistry from the Fenton reaction and formation by transnitrosation of protein nitrosothiols (RSNO). The levels of RSNO under these high chelatable iron levels are comparable with DNIC levels and suggest that under these conditions, both DNIC and RSNO are the most abundant cellular adducts of (NO)-N-center dot.	[Li, Qian; Li, Chuanyu; Mahtani, Harry K.; Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL 35294 USA; [Li, Qian; Li, Chuanyu; Mahtani, Harry K.; Lancaster, Jack R., Jr.] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Du, Jian] Anhui Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Hefei 230032, Peoples R China; [Patel, Aashka R.] Vestavia Hills High Sch, Vestavia Hills, AL 35216 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Anhui Medical University	Li, Q (corresponding author), Univ Alabama Birmingham, Dept Anesthesiol, 901 19th St S, Birmingham, AL 35294 USA.	qianli@uab.edu			National Institutes of Health [RO1 CA-131653]; NATIONAL CANCER INSTITUTE [R01CA131653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA-131653 (to J. R. L.).	Aggarwal Rajiv, 2001, Indian Journal of Pediatrics, V68, P1149, DOI 10.1007/BF02722933; Aldinucci C, 2007, FREE RADICAL BIO MED, V42, P1749, DOI 10.1016/j.freeradbiomed.2007.03.010; Aldinucci C, 2010, NEUROCHEM RES, V35, P1691, DOI 10.1007/s11064-010-0231-2; Aldinucci C, 2010, NEUROCHEM RES, V35, P42, DOI 10.1007/s11064-009-0028-3; Anand P, 2012, J MOL MED, V90, P233, DOI 10.1007/s00109-012-0878-z; Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Arkadopoulos N, 2010, HEMOGLOBIN, V34, P265, DOI 10.3109/03630269.2010.484766; AVRAMOVICIGRISARU S, 1983, J MED CHEM, V26, P298, DOI 10.1021/jm00356a037; BERTON G, 1983, IMMUNOLOGY, V49, P693; Bosworth CA, 2009, P NATL ACAD SCI USA, V106, P4671, DOI 10.1073/pnas.0710416106; Ciccoli L, 2004, BBA-GEN SUBJECTS, V1672, P203, DOI 10.1016/j.bbagen.2004.04.003; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; FERREIRARAJABI L, 1989, BIOCHEMISTRY-US, V28, P8028, DOI 10.1021/bi00446a009; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; HEALING G, 1990, BIOCHEM PHARMACOL, V39, P1239, DOI 10.1016/0006-2952(90)90269-Q; Hickok JR, 2012, ANTIOXID REDOX SIGN, V17, P962, DOI 10.1089/ars.2012.4543; Hickok JR, 2011, FREE RADICAL BIO MED, V51, P1558, DOI 10.1016/j.freeradbiomed.2011.06.030; Hines IN, 2011, J CLIN BIOCHEM NUTR, V48, P50, DOI 10.3164/jcbn.11-016FR; Hines IN, 2002, MOL CELL BIOCHEM, V234, P229, DOI 10.1023/A:1015952926016; JACOBS A, 1977, BLOOD, V50, P433; Jacobs A, 1976, Ciba Found Symp, P91; Kagan VE, 2001, ANTIOXID REDOX SIGN, V3, P189, DOI 10.1089/152308601300185160; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; KANNER J, 1991, ARCH BIOCHEM BIOPHYS, V289, P130, DOI 10.1016/0003-9861(91)90452-O; Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208; Kharitonov V. G., 1996, METHODS NITRIC OXIDE, P44; Kim JS, 2012, AM J PHYSIOL-GASTR L, V302, pG723, DOI 10.1152/ajpgi.00082.2011; Kim JS, 2006, AM J PHYSIOL-HEART C, V290, pH2024, DOI 10.1152/ajpheart.00683.2005; KOSAKA H, 1989, CARCINOGENESIS, V10, P563, DOI 10.1093/carcin/10.3.563; KOZLOV AV, 1992, FREE RADICAL BIO MED, V13, P9, DOI 10.1016/0891-5849(92)90159-E; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Lancaster JR, 2004, AM J PHYSIOL-LUNG C, V287, pL465, DOI 10.1152/ajplung.00151.2004; LANGREHR JM, 1993, TRANSPLANTATION, V55, P1205, DOI 10.1097/00007890-199306000-00001; LEAF CD, 1989, CANCER SURV, V8, P323; Lewandowska H, 2011, DALTON T, V40, P8273, DOI 10.1039/c0dt01244k; Li Q, 2009, NITRIC OXIDE-BIOL CH, V21, P69, DOI 10.1016/j.niox.2009.04.001; MALLARD JR, 1964, NATURE, V204, P1192, DOI 10.1038/2041192a0; Marzocchi B, 2005, PEDIATR RES, V58, P660, DOI 10.1203/01.PDR.0000180545.24457.AC; MCDONALD CC, 1965, J AM CHEM SOC, V87, P3319, DOI 10.1021/ja01093a007; MIWA M, 1987, CARCINOGENESIS, V8, P955, DOI 10.1093/carcin/8.7.955; Moller MN, 2007, CHEM RES TOXICOL, V20, P709, DOI 10.1021/tx700010h; Muller B, 1996, BRIT J PHARMACOL, V119, P1281, DOI 10.1111/j.1476-5381.1996.tb16034.x; O'Hayer KM, 2006, METHOD ENZYMOL, V407, P637, DOI 10.1016/S0076-6879(05)07050-3; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Phillips L, 2009, J INVEST SURG, V22, P46, DOI 10.1080/08941930802709470; Postl A, 2011, SHOCK, V36, P501, DOI 10.1097/SHK.0b013e318231822d; Rana MW, 2002, SHOCK, V17, P339, DOI 10.1097/00024382-200204000-00018; Sergent O, 2005, BIOMETALS, V18, P567, DOI 10.1007/s10534-005-8488-7; Shupik MA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1197, DOI 10.1134/S0006297911110010; Signorini C, 2009, J PINEAL RES, V46, P148, DOI 10.1111/j.1600-079X.2008.00639.x; STADLER J, 1993, ARCH BIOCHEM BIOPHYS, V302, P4, DOI 10.1006/abbi.1993.1173; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Toledo JC, 2008, J BIOL CHEM, V283, P28926, DOI 10.1074/jbc.M707862200; VANEIJK HG, 1992, BIOL TRACE ELEM RES, V35, P13, DOI 10.1007/BF02786234; Vanin A. F., 2011, J BIOPHYS, V2011; VANIN AF, 1992, BIOCHIM BIOPHYS ACTA, V1135, P275, DOI 10.1016/0167-4889(92)90231-Y; Vanin AF, 2007, NITRIC OXIDE-BIOL CH, V16, P82, DOI 10.1016/j.niox.2006.07.005; VITHAYATHIL AJ, 1965, NATURE, V207, P1246, DOI 10.1038/2071246a0; VOOGD A, 1992, J CLIN INVEST, V90, P2050, DOI 10.1172/JCI116086; Wang J, 2005, MOL CELL BIOL, V25, P1347, DOI 10.1128/MCB.25.4.1347-1353.2005; Watts RN, 2006, P NATL ACAD SCI USA, V103, P7670, DOI 10.1073/pnas.0602515103; Wink DA, 1996, ARCH BIOCHEM BIOPHYS, V331, P241, DOI 10.1006/abbi.1996.0304; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Woodmansee AN, 2002, METHOD ENZYMOL, V349, P3, DOI 10.1016/S0076-6879(02)49316-0; WOOLUM JC, 1970, BIOCHIM BIOPHYS ACTA, V201, P131, DOI 10.1016/0304-4165(70)90018-8	67	31	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19917	19927		10.1074/jbc.M114.569764	http://dx.doi.org/10.1074/jbc.M114.569764			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24891512	Green Published, hybrid			2022-12-25	WOS:000339395200010
J	Kim, DS; Song, HN; Nam, HJ; Kim, SG; Park, YS; Park, JC; Woo, EJ; Lim, HK				Kim, Dong-Sik; Song, Hyung-Nam; Nam, Hyo Jung; Kim, Sung-Geun; Park, Young-Seoub; Park, Jae-Chan; Woo, Eui-Jeon; Lim, Hyung-Kwon			Directed Evolution of Human Heavy Chain Variable Domain (V-H) Using In Vivo Protein Fitness Filter	PLOS ONE			English	Article							ARGININE TRANSLOCATION PATHWAY; FOLDING QUALITY-CONTROL; ESCHERICHIA-COLI; SINGLE-DOMAIN; GENETIC SELECTION; ANTIBODY; SOLUBILITY; IMMUNOGENICITY; RESISTANCE; STABILITY	Human immunoglobulin heavy chain variable domains (V-H) are promising scaffolds for antigen binding. However, V-H is an unstable and aggregation-prone protein, hindering its use for therapeutic purposes. To evolve the V-H domain, we performed in vivo protein solubility selection that linked antibiotic resistance to the protein folding quality control mechanism of the twin-arginine translocation pathway of E. coli. After screening a human germ-line V-H library, 95% of the V-H proteins obtained were identified as V(H)3 family members; one V-H protein, MG2x1, stood out among separate clones expressing individual V-H variants. With further screening of combinatorial framework mutation library of MG2x1, we found a consistent bias toward substitution with tryptophan at the position of 50 and 58 in V-H. Comparison of the crystal structures of the V-H variants revealed that those substitutions with bulky side chain amino acids filled the cavity in the V-H interface between heavy and light chains of the Fab arrangement along with the increased number of hydrogen bonds, decreased solvation energy, and increased negative charge. Accordingly, the engineered V-H acquires an increased level of thermodynamic stability, reversible folding, and soluble expression. The library built with the V-H variant as a scaffold was qualified as most of V-H clones selected randomly were expressed as soluble form in E. coli regardless length of the combinatorial CDR. Furthermore, a non-aggregation feature of the selected V-H conferred a free of humoral response in mice, even when administered together with adjuvant. As a result, this selection provides an alternative directed evolution pathway for unstable proteins, which are distinct from conventional methods based on the phage display.	[Kim, Dong-Sik; Nam, Hyo Jung; Kim, Sung-Geun; Park, Young-Seoub; Park, Jae-Chan; Lim, Hyung-Kwon] Mogam Biotechnol Res Inst, Yongin, South Korea; [Song, Hyung-Nam; Woo, Eui-Jeon] Korea Res Inst Biosci & Biotechnol, BioMed Prote Res Ctr, Taejon, South Korea; [Song, Hyung-Nam] Korea Univ, Dept Biotechnol & Bioinformat, Sejong, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea University	Lim, HK (corresponding author), Mogam Biotechnol Res Inst, Yongin, South Korea.	lhk@mogam.re.kr		Woo, Eui-Jeon/0000-0001-6983-0270	Green Cross Corporation	Green Cross Corporation	The authors are grateful to Green Cross Corporation (http://www.greencross.com) for funding this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Bleicher L, 2011, J PHYS CHEM B, V115, P7940, DOI 10.1021/jp200330z; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Christ D, 2007, PROTEIN ENG DES SEL, V20, P413, DOI 10.1093/protein/gzm037; Conrath KE, 2001, J BIOL CHEM, V276, P7346, DOI 10.1074/jbc.M007734200; da Silva FA, 2004, J MOL BIOL, V340, P525, DOI 10.1016/j.jmb.2004.04.062; DAVIES J, 1994, FEBS LETT, V339, P285, DOI 10.1016/0014-5793(94)80432-X; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Dolk E, 2005, PROTEINS, V59, P555, DOI 10.1002/prot.20378; Dudgeon K, 2012, P NATL ACAD SCI USA, V109, P10879, DOI 10.1073/pnas.1202866109; Enever C, 2009, CURR OPIN BIOTECH, V20, P405, DOI 10.1016/j.copbio.2009.07.002; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Fisher AC, 2006, PROTEIN SCI, V15, P449, DOI 10.1110/ps.051902606; Fisher AC, 2009, J MOL BIOL, V385, P299, DOI 10.1016/j.jmb.2008.10.051; Foit L, 2009, MOL CELL, V36, P861, DOI 10.1016/j.molcel.2009.11.022; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Hermeling S, 2004, PHARM RES-DORDR, V21, P897, DOI 10.1023/B:PHAM.0000029275.41323.a6; Hudson PJ, 2003, NAT MED, V9, P129, DOI 10.1038/nm0103-129; Jespers L, 2004, NAT BIOTECHNOL, V22, P1161, DOI 10.1038/nbt1000; Jespers L, 2004, J MOL BIOL, V337, P893, DOI 10.1016/j.jmb.2004.02.013; Joubert MK, 2011, J BIOL CHEM, V286, P25118, DOI 10.1074/jbc.M110.160457; Jung TY, 2012, J BIOL CHEM, V287, P7979, DOI 10.1074/jbc.M111.304774; Karlsson AJ, 2012, J MOL BIOL, V416, P94, DOI 10.1016/j.jmb.2011.12.021; KORTT AA, 1995, J PROTEIN CHEM, V14, P167, DOI 10.1007/BF01980329; Lee PA, 2006, ANNU REV MICROBIOL, V60, P373, DOI 10.1146/annurev.micro.60.080805.142212; Lim HK, 2009, PROTEIN SCI, V18, P2537, DOI 10.1002/pro.262; Oates J, 2003, J MOL BIOL, V330, P277, DOI 10.1016/S0022-2836(03)00621-1; Ribnicky B, 2007, J MOL BIOL, V369, P631, DOI 10.1016/j.jmb.2007.03.068; Riechmann L, 1996, J MOL BIOL, V259, P957, DOI 10.1006/jmbi.1996.0373; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Schellekens H, 2002, NAT REV DRUG DISCOV, V1, P457, DOI 10.1038/nrd818; Shaw BF, 2008, PROTEIN SCI, V17, P1446, DOI 10.1110/ps.035154.108; Silence K, 2011, Single domain antibodies directed against tumor necrosis factor-alpha and uses therefor, Patent No. [EP2390268A1, 2390268]; Tijink BM, 2008, MOL CANCER THER, V7, P2288, DOI 10.1158/1535-7163.MCT-07-2384; To R, 2005, J BIOL CHEM, V280, P41395, DOI 10.1074/jbc.M509900200; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389	40	11	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98178	10.1371/journal.pone.0098178	http://dx.doi.org/10.1371/journal.pone.0098178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892548	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400037
J	Bertin, Y; Deval, C; de la Foye, A; Masson, L; Gannon, V; Harel, J; Martin, C; Desvaux, M; Forano, E				Bertin, Yolande; Deval, Christiane; de la Foye, Anne; Masson, Luke; Gannon, Victor; Harel, Josee; Martin, Christine; Desvaux, Mickael; Forano, Evelyne			The Gluconeogenesis Pathway Is Involved in Maintenance of Enterohaemorrhagic Escherichia coli O157:H7 in Bovine Intestinal Content	PLOS ONE			English	Article							STATIONARY-PHASE; GROWTH ADVANTAGE; AMINO-ACIDS; O157-H7; BACTERIA; COLONIZATION; UREASE; GENES; NORMALIZATION; GLYCEROL	Enterohaemorrhagic Escherichia coli (EHEC) are responsible for outbreaks of food- and water-borne illness. The bovine gastrointestinal tract (GIT) is thought to be the principle reservoir of EHEC. Knowledge of the nutrients essential for EHEC growth and survival in the bovine intestine may help in developing strategies to limit their shedding in bovine faeces thus reducing the risk of human illnesses. To identify specific metabolic pathways induced in the animal GIT, the transcriptome profiles of EHEC O157:H7 EDL933 during incubation in bovine small intestine contents (BSIC) and minimal medium supplemented with glucose were compared. The transcriptome analysis revealed that genes responsible for the assimilation of ethanolamine, urea, agmatine and amino acids (Asp, Thr, Gly, Ser and Trp) were strongly up-regulated suggesting that these compounds are the main nitrogen sources for EHEC in BSIC. A central role for the gluconeogenesis pathway and assimilation of gluconeogenic substrates was also pinpointed in EHEC incubated in BSIC. Our results suggested that three amino acids (Asp, Ser and Trp), glycerol, glycerol 3-phosphate, L-lactate and C4-dicarboxylates are important carbon sources for EHEC in BSIC. The ability to use gluconeogenic substrates as nitrogen sources (amino acids) and/or carbon sources (amino acids, glycerol and lactate) may provide a growth advantage to the bacteria in intestinal fluids. Accordingly, aspartate (2.4 mM), serine (1.9 mM), glycerol (5.8 mM) and lactate (3.6 mM) were present in BSIC and may represent the main gluconeogenic substrates potentially used by EHEC. A double mutant of E. coli EDL933 defective for phosphoenolpyruvate synthase (PpsA) and phosphoenolpyruvate carboxykinase (PckA), unable to utilize tricarboxylic acid (TCA) intermediates was constructed. Growth competition experiments between EHEC EDL933 and the isogenic mutant strain in BSIC clearly showed a significant competitive growth advantage of the wild-type strain further illustrating the importance of the gluconeogenesis pathway in maintaining EHEC in the bovine GIT.	[Bertin, Yolande; Martin, Christine; Desvaux, Mickael; Forano, Evelyne] INRA, Microbiol UR454, St Genes Champanelle, France; [Deval, Christiane] INRA, UMR 1019, Unite Nutr Humaine, Ctr Rech Nutr Humaine Auvergne, Clermont Ferrand, France; [Deval, Christiane] Clermont Univ, Univ Auvergne, Unite Nutr Humaine, Clermont Ferrand, France; [de la Foye, Anne] INRA, Herbivores UMR1213, St Genes Champanelle, France; [Masson, Luke] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Gannon, Victor] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Lethbridge, AB, Canada; [Harel, Josee] Univ Montreal, Fac Med Vet, Grp Rech Malad Infect Porc, St Hyacinthe, PQ J2S 7C6, Canada	INRAE; INRAE; Universite Clermont Auvergne (UCA); INRAE; VetAgro Sup; National Research Council Canada; Public Health Agency of Canada; Universite de Montreal	Bertin, Y (corresponding author), INRA, Microbiol UR454, St Genes Champanelle, France.	yolande.bertin@clermont.inra.fr	DESVAUX, Mickael/A-8333-2008; Harel, Josée/H-1933-2011; FORANO, Evelyne/C-9976-2009	DESVAUX, Mickael/0000-0003-2986-6417; Harel, Josée/0000-0002-7822-3795; FORANO, Evelyne/0000-0002-7450-3466	EU [Food-CT-2006-32241]	EU(European Commission)	Funding provided by EU project ProsafeBeef within the 6th Framework Programme (Food-CT-2006-32241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Amer AE, 2004, J BACTERIOL, V186, P1879, DOI 10.1128/JB.186.6.1879-1889.2004; AbuGhazaleh AA, 2011, J ANIM PHYSIOL AN N, V95, P313, DOI 10.1111/j.1439-0396.2010.01056.x; Alteri CJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000448; Bacun-Druzina V, 2011, FOOD TECHNOL BIOTECH, V49, P13; Baev MV, 2006, APPL MICROBIOL BIOT, V71, P310, DOI 10.1007/s00253-006-0317-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergholz TM, 2009, APPL ENVIRON MICROB, V75, P3542, DOI 10.1128/AEM.02841-08; Bertin Y, 2013, ENVIRON MICROBIOL, V15, P610, DOI 10.1111/1462-2920.12019; Bertin Y, 2011, ENVIRON MICROBIOL, V13, P365, DOI 10.1111/j.1462-2920.2010.02334.x; Caprioli A, 2005, VET RES, V36, P289, DOI 10.1051/vetres:2005002; Chagnot C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00303; Chagnot C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059386; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; CHAO YP, 1993, J BACTERIOL, V175, P6939, DOI 10.1128/jb.175.21.6939-6944.1993; Chaucheyras-Durand F, 2006, APPL ENVIRON MICROB, V72, P4136, DOI 10.1128/AEM.02600-05; Chaucheyras-Durand F, 2010, APPL ENVIRON MICROB, V76, P640, DOI 10.1128/AEM.02054-09; Christophe G, 2009, BIOPROC BIOSYST ENG, V32, P123, DOI 10.1007/s00449-008-0230-8; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Vaux A, 2002, APPL ENVIRON MICROB, V68, P519, DOI 10.1128/AEM.68.2.519-524.2002; DeFrain JM, 2004, J DAIRY SCI, V87, P4195, DOI 10.3168/jds.S0022-0302(04)73564-X; Delmar P, 2005, BIOINFORMATICS, V21, P502, DOI 10.1093/bioinformatics/bti023; DONG JM, 1993, J BACTERIOL, V175, P6671, DOI 10.1128/jb.175.20.6671-6678.1993; Dougherty MJ, 2006, J BIOL CHEM, V281, P33892, DOI 10.1074/jbc.M604429200; Dziva F, 2004, MICROBIOL-SGM, V150, P3631, DOI 10.1099/mic.0.27448-0; ENGEL P, 1992, J BACTERIOL, V174, P5533, DOI 10.1128/JB.174.17.5533-5539.1992; Farrell MJ, 2003, J BACTERIOL, V185, P7044, DOI 10.1128/JB.185.24.7044-7052.2003; Ferenci T, 2001, ENVIRON MICROBIOL, V3, P605, DOI 10.1046/j.1462-2920.2001.00238.x; FRETER R, 1983, INFECT IMMUN, V39, P676, DOI 10.1128/IAI.39.2.676-685.1983; Friedrich AW, 2005, J CLIN MICROBIOL, V43, P546, DOI 10.1128/JCM.43.2.546-550.2005; Heimer SR, 2002, INFECT IMMUN, V70, P1027, DOI 10.1128/IAI.70.2.1027-1031.2002; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Janausch IG, 2002, BBA-BIOENERGETICS, V1553, P39, DOI 10.1016/S0005-2728(01)00233-X; Jandu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004889; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; Ljungh Asa, 2006, Current Issues in Intestinal Microbiology, V7, P73; Matulova M, 2008, FEBS J, V275, P3503, DOI 10.1111/j.1742-4658.2008.06497.x; McEvoy JM, 2003, J APPL MICROBIOL, V95, P256, DOI 10.1046/j.1365-2672.2003.01981.x; Miranda RL, 2004, INFECT IMMUN, V72, P1666, DOI 10.1128/IAI.72.3.1666-1676.2004; Molderings GJ, 2003, ANN NY ACAD SCI, V1009, P44, DOI 10.1196/annals.1304.005; MONDINO A, 1972, J CHROMATOGR, V74, P255, DOI 10.1016/S0021-9673(01)86154-9; Montagne L, 2000, J DAIRY SCI, V83, P507, DOI 10.3168/jds.S0022-0302(00)74910-1; OLUKOYA DK, 1986, J GEN MICROBIOL, V132, P3231; Palchevskiy V, 2006, J BACTERIOL, V188, P3902, DOI 10.1128/JB.01974-05; PANAGIOTIDIS CA, 1987, P NATL ACAD SCI USA, V84, P4423, DOI 10.1073/pnas.84.13.4423; Poirier K, 2008, INFECT IMMUN, V76, P4814, DOI 10.1128/IAI.00446-08; Pradhan S, 2010, J BACTERIOL, V192, P955, DOI 10.1128/JB.01180-09; Pruimboom-Brees IM, 2000, P NATL ACAD SCI USA, V97, P10325, DOI 10.1073/pnas.190329997; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Snider TA, 2009, VET MICROBIOL, V136, P150, DOI 10.1016/j.vetmic.2008.10.033; Steyert SR, 2012, INFECT IMMUN, V80, P2589, DOI 10.1128/IAI.00210-12; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Trabue S, 2007, J AGR FOOD CHEM, V55, P7043, DOI 10.1021/jf071076i; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yimga MT, 2006, INFECT IMMUN, V74, P1130, DOI 10.1128/IAI.74.2.1130-1140.2006	58	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98367	10.1371/journal.pone.0098367	http://dx.doi.org/10.1371/journal.pone.0098367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887187	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300059
J	Dias, CB; Milanski, M; Portovedo, M; Horita, V; Ayrizono, MDS; Planell, N; Coy, CSR; Velloso, LA; Meirelles, LR; Leal, RF				Dias, Cilene Bicca; Milanski, Marciane; Portovedo, Mariana; Horita, Vivian; Setsuko Ayrizono, Maria de Lourdes; Planell, Nuria; Rodrigues Coy, Claudio Saddy; Velloso, Licio Augusto; Meirelles, Luciana Rodrigues; Leal, Raquel Franco			Defective Apoptosis in Intestinal and Mesenteric Adipose Tissue of Crohn's Disease Patients	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; FACTOR-KAPPA-B; CREEPING FAT; EXPRESSION; ADIPONECTIN; MACROPHAGES; ADIPOCYTES; PROTEIN; LEPTIN; PATHOGENESIS	Background: Crohn's disease (CD) is associated with complex pathogenic pathways involving defects in apoptosis mechanisms. Recently, mesenteric adipose tissue (MAT) has been associated with CD ethiopathology, since adipose thickening is detected close to the affected intestinal area. However, the potential role of altered apoptosis in MAT of CD has not been addressed. Aims: To evaluate apoptosis in the intestinal mucosa and MAT of patients with CD. Methods: Samples of intestinal mucosa and MAT from patients with ileocecal CD and from non-inflammatory bowel diseases patients (controls) were studied. Apoptosis was assessed by TUNEL assay and correlated with the adipocytes histological morphometric analysis. The transcriptional and protein analysis of selected genes and proteins related to apoptosis were determined. Results: TUNEL assay showed fewer apoptotic cells in CD, when compared to the control groups, both in the intestinal mucosa and in MAT. In addition, the number of apoptotic cells (TUNEL) correlated significantly with the area and perimeter of the adipose cells in MAT. Transcriptomic and proteomic analysis reveal a significantly lower transcript and protein levels of Bax in the intestinal mucosa of CD, compared to the controls; low protein levels of Bax were found localized in the lamina propria and not in the epithelium of this tissue. Furthermore, higher level of Bcl-2 and low level of Caspase 3 were seen in the MAT of CD patients. Conclusion: The defective apoptosis in MAT may explain the singular morphological characteristics of this tissue in CD, which may be implicated in the pathophysiology of the disease.	[Dias, Cilene Bicca; Setsuko Ayrizono, Maria de Lourdes; Rodrigues Coy, Claudio Saddy; Leal, Raquel Franco] Univ Campinas UNICAMP, Dept Surg, Coloproctol Unit, Sch Med, Sao Paulo, Brazil; [Dias, Cilene Bicca; Milanski, Marciane; Portovedo, Mariana; Velloso, Licio Augusto; Leal, Raquel Franco] Univ Campinas UNICAMP, Sch Med, Dept Internal Med, Lab Cell Signaling, Sao Paulo, Brazil; [Dias, Cilene Bicca] Univ Estadual Campinas, Fac Med Sch, Post Grad Program Surg Sci, Sao Paulo, Brazil; [Horita, Vivian; Meirelles, Luciana Rodrigues] Univ Campinas UNICAMP, Sch Med, Dept Pathol, Sao Paulo, Brazil; [Planell, Nuria] CIBERehd, Dept Gastroenterol & Bioinformat Platform, Barcelona, Spain	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Leal, RF (corresponding author), Univ Campinas UNICAMP, Dept Surg, Coloproctol Unit, Sch Med, Sao Paulo, Brazil.	rafranco.unicamp@gmail.com	Velloso, Licio/AAJ-3778-2020; Milanski, Marciane/F-5410-2012; Leal, Raquel/W-7997-2019; Planell, Núria/H-6807-2015	Milanski, Marciane/0000-0002-6322-5368; Leal, Raquel/0000-0003-4285-4402; Planell, Núria/0000-0001-7550-2433; Portovedo, Mariana/0000-0001-6417-8252	FAPESP (Foundation for Research Support of the Sao Paulo State); CAPES-Brazil	FAPESP (Foundation for Research Support of the Sao Paulo State)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	FAPESP (Foundation for Research Support of the Sao Paulo State) for financial support and CAPES-Brazil for research fellowship (C.B. Dias). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner P, 2010, BIOCHEM BIOPH RES CO, V396, P101, DOI 10.1016/j.bbrc.2010.02.165; Barbier M, 2005, GASTROENTEROL CLIN B, V27, P1; Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Batra A, 2009, INFLAMM BOWEL DIS, V15, P1897, DOI 10.1002/ibd.20937; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazil JC, 2013, INFLAMM BOWEL DIS, V19, P1556, DOI 10.1097/MIB.0b013e318281f54e; Bullen TF, 2006, LAB INVEST, V86, P1052, DOI 10.1038/labinvest.3700464; Catarzi S, 2008, INFLAMM BOWEL DIS, V14, P819, DOI 10.1002/ibd.20397; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Coffey JC, 2001, J SURG RES, V98, P27, DOI 10.1006/jsre.2001.6129; Curat CA, 2004, DIABETES, V53, P1285, DOI 10.2337/diabetes.53.5.1285; Deveraux Quinn L., 2001, Cardiology Clinics, V19, P57; Di Sabatino A, 2003, DIS COLON RECTUM, V46, P1498, DOI 10.1007/s10350-004-6802-z; Drouet M, 2012, NUTRITION, V28, P113, DOI 10.1016/j.nut.2011.09.009; Hisamatsu T, 2013, PHARMACOL THERAPEUT, V137, P283, DOI 10.1016/j.pharmthera.2012.10.008; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Huerta S, 2007, J SURG RES, V139, P143, DOI 10.1016/j.jss.2006.07.034; Itoh J, 2001, GUT, V49, P35, DOI 10.1136/gut.49.1.35; Jung SH, 2013, CYTOKINE, V61, P459, DOI 10.1016/j.cyto.2012.11.021; Karmiris K, 2005, INFLAMM BOWEL DIS, V11, P847, DOI 10.1097/01.mib.0000178915.54264.8f; Karmiris K, 2008, MOL NUTR FOOD RES, V52, P855, DOI 10.1002/mnfr.200700050; Leal RF, 2012, CELL TISSUE RES, V350, P549, DOI 10.1007/s00441-012-1491-8; Lin J, 2013, BIOCHEM BIOPH RES CO, V433, P368, DOI 10.1016/j.bbrc.2012.12.040; Marchiando AM, 2011, GASTROENTEROLOGY, V140, P1208, DOI 10.1053/j.gastro.2011.01.004; Olivier I, 2011, INFLAMM BOWEL DIS, V17, P747, DOI 10.1002/ibd.21413; Palmer CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007787; Paul G, 2006, INFLAMM BOWEL DIS, V12, P471, DOI 10.1097/00054725-200606000-00005; Peyrin-Biroulet L, 2007, GUT, V56, P577, DOI 10.1136/gut.2005.082925; Peyrin-Biroulet L, 2012, GUT, V61, P78, DOI 10.1136/gutjnl-2011-300370; Pietsch J, 2006, ANN NY ACAD SCI, V1072, P407, DOI 10.1196/annals.1326.021; Rodrigues VS, 2012, CLIN EXP IMMUNOL, V170, P358, DOI 10.1111/j.1365-2249.2012.04660.x; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Sanders EJ, 1996, HISTOCHEM J, V28, P275, DOI 10.1007/BF02409015; Santaolalla R, 2011, INFLAMM BOWEL DIS, V17, P1490, DOI 10.1002/ibd.21507; Schaffler A, 2009, GUT, V58, P317, DOI 10.1136/gut.2008.159210; Schaffler A, 2005, GUT, V54, P742, DOI 10.1136/gut.2004.061531; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; SHEEHAN AL, 1992, BRIT J SURG, V79, P955, DOI 10.1002/bjs.1800790934; Sitaraman S, 2004, FASEB J, V18, P696, DOI 10.1096/fj.03-0422fje; Sun XF, 2007, HISTOL HISTOPATHOL, V22, P1387, DOI 10.14670/HH-22.1387; Ueyama H, 1998, GUT, V43, P48, DOI 10.1136/gut.43.1.48; Velloso LA, 1996, P NATL ACAD SCI USA, V93, P12490, DOI 10.1073/pnas.93.22.12490; Vermeulen K, 2005, ANN HEMATOL, V84, P627, DOI 10.1007/s00277-005-1065-x; Wang C.H., 1999, FLORA REIPUBLICAE PO, V6, P1; Yamamoto K, 2005, GUT, V54, P789, DOI 10.1136/gut.2004.046516; Ziegler U, 2004, NEWS PHYSIOL SCI, V19, P124, DOI 10.1152/nips.01519.2004; Zulian A, 2012, GUT, V61, P86, DOI 10.1136/gutjnl-2011-300391	49	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98547	10.1371/journal.pone.0098547	http://dx.doi.org/10.1371/journal.pone.0098547			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887376	Green Submitted, Green Published, gold			2022-12-25	WOS:000336956300080
J	Eftekhar, A; Juffali, W; El-Imad, J; Constandinou, TG; Toumazou, C				Eftekhar, Amir; Juffali, Walid; El-Imad, Jamil; Constandinou, Timothy G.; Toumazou, Christofer			Ngram-Derived Pattern Recognition for the Detection and Prediction of Epileptic Seizures	PLOS ONE			English	Article							TIME; LONG; TERM	This work presents a new method that combines symbol dynamics methodologies with an Ngram algorithm for the detection and prediction of epileptic seizures. The presented approach specifically applies Ngram-based pattern recognition, after data pre-processing, with similarity metrics, including the Hamming distance and Needlman-Wunsch algorithm, for identifying unique patterns within epochs of time. Pattern counts within each epoch are used as measures to determine seizure detection and prediction markers. Using 623 hours of intracranial electrocorticogram recordings from 21 patients containing a total of 87 seizures, the sensitivity and false prediction/detection rates of this method are quantified. Results are quantified using individual seizures within each case for training of thresholds and prediction time windows. The statistical significance of the predictive power is further investigated. We show that the method presented herein, has significant predictive power in up to 100% of temporal lobe cases, with sensitivities of up to 70-100% and low false predictions (dependant on training procedure). The cases of highest false predictions are found in the frontal origin with 0.31-0.61 false predictions per hour and with significance in 18 out of 21 cases. On average, a prediction sensitivity of 93.81% and false prediction rate of approximately 0.06 false predictions per hour are achieved in the best case scenario. This compares to previous work utilising the same data set that has shown sensitivities of up to 40-50% for a false prediction rate of less than 0.15/hour.	[Eftekhar, Amir; Juffali, Walid; El-Imad, Jamil; Constandinou, Timothy G.; Toumazou, Christofer] Univ London Imperial Coll Sci Technol & Med, Ctr Bioinspired Technol, London, England	Imperial College London	Eftekhar, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Bioinspired Technol, South Kensington Campus, London, England.	a.eftekhar@imperial.ac.uk		Constandinou, Timothy/0000-0001-9778-1162	Engineering and Physical Sciences Research Council [EP/K009842/1]; EPSRC [EP/I000569/1, EP/K009842/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I000569/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors acknowledge the support received from Engineering and Physical Sciences Research Council grant number EP/K009842/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarabi A, 2006, CLIN NEUROPHYSIOLOGY, V117; Aarabi A, 2012, CLIN NEUROPHYSIOL, V123, P1111, DOI 10.1016/j.clinph.2012.01.014; al Naqeeb N, 1999, PEDIATRICS, V103, P1263, DOI 10.1542/peds.103.6.1263; [Anonymous], 2007, TRENT NEON SURV REP; ASCHENBRENNERSC.R, 2003, BRAIN, V126, P1; Badawi N, 1998, BMJ-BRIT MED J, V317, P1549, DOI 10.1136/bmj.317.7172.1549; Banerjee S, 2003, P INT TEXT PROC COMP; Bengio Y., 2003, J MACHINE LEARNING R; Cohen P, 2002, ESF EXPL WORKSH PATT, P99; Cook MJ, 2013, LANCET NEUROL, V12, P563, DOI 10.1016/S1474-4422(13)70075-9; Daw CS, 2003, REV SCI INSTRUMENTS, V74; Eftaxias K, 2011, PHYS GEOPHYS, V1; Eftekhar A, 2013, J SIGNAL PROCESSING; Faul S, 2005, CLIN NEUROPHYSIOLOGY, V116; Feldwisch-Drentrup H, 2011, EPILEPSY BEHAV, V22, pS119, DOI 10.1016/j.yebeh.2011.08.023; Feldwisch-Drentrup H, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066704; Gadhoumi K, 2013, CLIN NEUROPHISIOLOGY; Gailey PC, 1999, P EXP CHAOS; Gupta S, 2006, ISA T, V45, P477, DOI 10.1016/S0019-0578(07)60226-2; Hill WM, 2000, EPILEPSIA, V41; Hively LM, 2005, J CLIN NEUROPHYSIOL, V22, P402; Jain A, 2000, IEEE T PATTERN ANAL, P22; Juffali W, 2010, BIOMED CIRC SYST C, P45, DOI 10.1109/BIOCAS.2010.5709567; Keller K., 2007, CHAOS COMPLEXITY LET, V2, P247; Klatt J, 2012, EPILEPSIA, V53, P1669, DOI 10.1111/j.1528-1167.2012.03564.x; Logesparan L, 2012, MED BIOL ENG COMPUT, V50, P659, DOI 10.1007/s11517-012-0904-x; Maiwald T, 2004, PHYSICA D, V194, P357, DOI 10.1016/j.physd.2004.02.013; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Osorio I, 2000, ANN NEUROLOGY, V57; Paraskevopoulou SE, 2013, J NEUROSCI METH, V215, P29, DOI 10.1016/j.jneumeth.2013.01.012; PETROSIAN A, 1995, COMP MED SY, P212, DOI 10.1109/CBMS.1995.465426; Rennie JM, 2004, ARCH DIS CHILD FETAL; Schelter B, 2006, CHAOS, V16, DOI 10.1063/1.2137623; Schelter B, 2006, EPILEPSIA, V47, P2058, DOI 10.1111/j.1528-1167.2006.00848.x; Schindler K, 2011, EPILEPSIA, V52, P1771, DOI 10.1111/j.1528-1167.2011.03202.x; Schulze-Bonhage A, 2011, EPILEPSY BEHAV, V22, pS88, DOI 10.1016/j.yebeh.2011.08.030; Stein GA, 2000, EPILEPSY RES, V39; Takens F., 1981, LECT NOTES MATH, V898, DOI [10.1007/BF02368233, 10.1007/bfb0091924]; Toet MC, 1999, ARCH DIS CHILD-FETAL, V81, pF19, DOI 10.1136/fn.81.1.F19; Williamson JR, 2012, EPILEPSY BEHAV, V25, P230, DOI 10.1016/j.yebeh.2012.07.007; Winterhalder M, 2003, EPILEPSY BEHAV, V4, P318, DOI 10.1016/S1525-5050(03)00105-7; Yadav R, 2012, IEEE T BIO-MED ENG, V59, P1871, DOI 10.1109/TBME.2012.2190601; Zandi AS, 2013, IEEE T BIO-MED ENG, V60, P1401, DOI 10.1109/TBME.2012.2237399; Zhou W, 2013, IEEE T BIOMEDICAL EN	46	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e96235	10.1371/journal.pone.0096235	http://dx.doi.org/10.1371/journal.pone.0096235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886714	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300008
J	Ruan, Z; Liu, SQ; Zhou, Y; Mi, SM; Liu, G; Wu, X; Yao, K; Assaad, H; Deng, ZY; Hou, YQ; Wu, GY; Yin, YL				Ruan, Zheng; Liu, Shiqiang; Zhou, Yan; Mi, Shumei; Liu, Gang; Wu, Xin; Yao, Kang; Assaad, Houssein; Deng, Zeyuan; Hou, Yongqing; Wu, Guoyao; Yin, Yulong			Chlorogenic Acid Decreases Intestinal Permeability and Increases Expression of Intestinal Tight Junction Proteins in Weaned Rats Challenged with LPS	PLOS ONE			English	Article							MUCOSAL BARRIER FUNCTION; AMINO-ACIDS; OCCLUDIN; SUPPLEMENTATION; PIGS; INFLAMMATION; ANTIOXIDANT; POLYPHENOLS; DISRUPTION; MODULATION	Chlorogenic acid, a natural phenolic acid present in fruits and plants, provides beneficial effects for human health. The objectives of this study were to investigate whether chlorogenic acid (CHA) could improve the intestinal barrier integrity for weaned rats with lipopolysaccharide (LPS) challenge. Thirty-two weaned male Sprague Dawley rats (21 +/- 1 d of age; 62.26 +/- 2.73 g) were selected and randomly allotted to four treatments, including weaned rat control, LPS-challenged and chlorogenic acid (CHA) supplemented group (orally 20 mg/kg and 50 mg/kg body). Dietary supplementation with CHA decreased (P < 0.05) the concentrations of urea and albumin in the serum, compared to the LPS-challenged group. The levels of IFN-gamma and TNF-alpha were lower (P < 0.05) in the jejunal and colon of weaned rats receiving CHA supplementation, in comparison with the control group. CHA supplementation increased (P < 0.05) villus height and the ratio of villus height to crypt depth in the jejunal and ileal mucosae under condictions of LPS challenge. CHA supplementation decreased (P < 0.05) intestinal permeability, which was indicated by the ratio of lactulose to mannitol and serum DAO activity, when compared to weaned rats with LPS challenge. Immunohistochemical analysis of tight junction proteins revealed that ZO-1 and occludin protein abundances in the jejunum and colon were increased (P < 0.05) by CHA supplementation. Additionally, results of immunoblot analysis revealed that the amount of occludin in the colon was also increased (P < 0.05) in CHA-supplemented rats. In conclusion, CHA decreases intestinal permeability and increases intestinal expression of tight junction proteins in weaned rats challenged with LPS.	[Ruan, Zheng; Liu, Shiqiang; Zhou, Yan; Mi, Shumei; Deng, Zeyuan; Yin, Yulong] Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang, Jiangxi, Peoples R China; [Liu, Gang; Wu, Xin; Yao, Kang; Yin, Yulong] Chinese Acad Sci, Inst Subtrop Agr, Changsha, Hunan, Peoples R China; [Assaad, Houssein] Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA; [Hou, Yongqing] Wuhan Polytech Univ, Hubei Key Lab Anim Nutr & Feed Sci, Wuhan, Hubei, Peoples R China; [Hou, Yongqing; Wu, Guoyao] Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA	Nanchang University; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Texas A&M University System; Texas A&M University College Station; Wuhan Polytechnic University; Texas A&M University System; Texas A&M University College Station	Wu, GY (corresponding author), Texas A&M Univ, Dept Anim Sci, College Stn, TX 77843 USA.	g-wu@tamu.edu; yinyulong@isa.ac.cn	Deng, zeyuan/P-1933-2014; Liu, Gang/G-5283-2017	Deng, zeyuan/0000-0001-5650-1507; Liu, Gang/0000-0002-9475-5134; Ruan, Zheng/0000-0001-9638-1466	National Basic Research Program of China [2013CB12730]; National Natural Science Foundation of China [31001014, 530901040, 31110103909, 30928018, 31101729]; Dr. Li Jieshou (Academician of CAS) Research Fund for Intestinal Barrier [LJS_201006]; Research Foundation [SKLF-TS-201108, SKLF-TS-200817]; Open Project Program of State Key Laboratory of Food Science and Technology, Nanchang University [SKLF-KF-201005, SKLF-KF-201216]; Texas A&M AgriLife Research [H-8200]; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists Grant [2011T2S15]; National Cancer Institute [R25T-CA090301]; NATIONAL CANCER INSTITUTE [R25CA090301] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Dr. Li Jieshou (Academician of CAS) Research Fund for Intestinal Barrier; Research Foundation; Open Project Program of State Key Laboratory of Food Science and Technology, Nanchang University; Texas A&M AgriLife Research; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was jointly supported by the National Basic Research Program of China (2013CB12730), the National Natural Science Foundation of China (31001014, 530901040, 31110103909, 30928018, and 31101729), the Dr. Li Jieshou (Academician of CAS) Research Fund for Intestinal Barrier (LJS_201006), the Research Foundation (SKLF-TS-201108 and SKLF-TS-200817) and the Open Project Program (SKLF-KF-201005 and SKLF-KF-201216) of State Key Laboratory of Food Science and Technology, Nanchang University, and Texas A&M AgriLife Research (H-8200). GW was funded by the Chinese Academy of Sciences Visiting Professorship for Senior International Scientists Grant (No. 2011T2S15). HA was supported by a postdoctoral training grant (R25T-CA090301) from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JM, 1995, AM J PHYSIOL-GASTR L, V269, pG467, DOI 10.1152/ajpgi.1995.269.4.G467; Bergmann H, 2009, MOL NUTR FOOD RES, V53, P1211, DOI 10.1002/mnfr.200800498; Blachier F, 2007, AMINO ACIDS, V33, P547, DOI 10.1007/s00726-006-0477-9; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Chiang LC, 2003, PLANTA MED, V69, P600, DOI 10.1055/s-2003-41113; Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI [10.1002/(SICI)1097-0010(19990301)79:3&lt;362::AID-JSFA256&gt;3.0.CO;2-D, 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D]; dos Santos MD, 2006, BIOL PHARM BULL, V29, P2236, DOI 10.1248/bpb.29.2236; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Forster C, 2008, HISTOCHEM CELL BIOL, V130, P55, DOI 10.1007/s00418-008-0424-9; Gong J, 2004, IMMUNOL INVEST, V33, P295, DOI 10.1081/IMM-120037603; Han J, 2009, AMINO ACIDS, V37, P643, DOI 10.1007/s00726-008-0184-9; Hou YQ, 2013, AMINO ACIDS, V45, P513, DOI 10.1007/s00726-012-1295-x; Hou YQ, 2011, AMINO ACIDS, V41, pS57, DOI 10.1007/s00726-011-1191-9; Hou YQ, 2011, FRONT BIOSCI-LANDMRK, V16, P1186, DOI 10.2741/3783; Hou YQ, 2010, AMINO ACIDS, V39, P555, DOI 10.1007/s00726-010-0473-y; Liu Y, 2008, BRIT J NUTR, V100, P552, DOI 10.1017/S0007114508911612; Ma L, 2008, HERALD MED, V10, P1168; Marsilio R, 1998, CLIN CHEM, V44, P1685; Martel F, 2010, NUTR RES REV, V23, P47, DOI 10.1017/S0954422410000053; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V293, pG413, DOI 10.1152/ajpgi.00304.2006; Montagne L, 2003, ANIM FEED SCI TECH, V108, P95, DOI 10.1016/S0377-8401(03)00163-9; NABUURS MJA, 1993, RES VET SCI, V55, P78, DOI 10.1016/0034-5288(93)90038-H; Noth R, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-109; Oswald IP, 2001, PARASITOLOGY, V122, P299, DOI 10.1017/S0031182001007399; Peace RM, 2011, J NUTR, V141, P1312, DOI 10.3945/jn.110.136796; Peng X, 2004, BURNS, V30, P135, DOI 10.1016/j.burns.2003.09.032; Pie S, 2004, J NUTR, V134, P641, DOI 10.1093/jn/134.3.641; Qin HL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-63; Rezaei R, 2013, AMINO ACIDS, V44, P911, DOI 10.1007/s00726-012-1420-x; Rogoll D, 2010, J APPL BOT FOOD QUAL, V83, P110; Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Shi HT, 2013, TOXICOLOGY, V303, P107, DOI 10.1016/j.tox.2012.10.025; Smith F, 2010, AM J PHYSIOL-GASTR L, V298, pG352, DOI 10.1152/ajpgi.00081.2009; Suzuki A, 2006, J HYPERTENS, V24, P1065, DOI 10.1097/01.hjh.0000226196.67052.c0; Suzuki T, 2009, J NUTR, V139, P965, DOI 10.3945/jn.108.100867; Tatefuji T, 1996, BIOL PHARM BULL, V19, P966, DOI 10.1248/bpb.19.966; THOMPSON JS, 1987, JPEN-PARENTER ENTER, V11, P28, DOI 10.1177/014860718701100128; Wang HF, 2011, ANIM FEED SCI TECH, V170, P141, DOI 10.1016/j.anifeedsci.2011.08.004; Wang JJ, 2008, J NUTR, V138, P1025, DOI 10.1093/jn/138.6.1025; Wang WW, 2013, AMINO ACIDS, V45, P463, DOI 10.1007/s00726-013-1493-1; Wu GY, 2013, AMINO ACIDS, V45, P241, DOI 10.1007/s00726-013-1515-z; Wu GY, 2013, AMINO ACIDS, V44, P1107, DOI 10.1007/s00726-012-1444-2; Xu XD, 2013, FOOD CONTROL, V32, P678, DOI 10.1016/j.foodcont.2013.02.007; Yang CM, 2012, J ANIM SCI, V90, P2671, DOI 10.2527/jas.2011-4699; Yang Y, 2011, NUTRITION, V27, P227, DOI 10.1016/j.nut.2009.11.024; Yao K, 2012, AMINO ACIDS, V42, P2491, DOI 10.1007/s00726-011-1060-6; Yu ASL, 2005, AM J PHYSIOL-CELL PH, V288, pC1231, DOI 10.1152/ajpcell.00581.2004; Yun N, 2012, J NUTR BIOCHEM, V23, P1249, DOI 10.1016/j.jnutbio.2011.06.018; Zhang BK, 2009, BRIT J NUTR, V102, P687, DOI 10.1017/S0007114509289033; Zhang Y, 2011, WORLD J GASTROENTERO, V17, P254, DOI 10.3748/wjg.v17.i2.254; Zhao JH, 2011, EUR J PHARMACOL, V654, P289, DOI 10.1016/j.ejphar.2010.12.032; Zhao Y, 2011, INT J MOL SCI, V12, P8502, DOI 10.3390/ijms12128502; Zhou QQ, 2009, PAIN, V146, P41, DOI 10.1016/j.pain.2009.06.017	54	71	78	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97815	10.1371/journal.pone.0097815	http://dx.doi.org/10.1371/journal.pone.0097815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887396	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300022
J	Suh, HS; Lo, YT; Choi, N; Letendre, S; Lee, SC				Suh, Hyeon-Sook; Lo, Yungtai; Choi, Namjong; Letendre, Scott; Lee, Sunhee C.			Evidence of the Innate Antiviral and Neuroprotective Properties of Progranulin	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVATED MICROGLIA; UP-REGULATION; EXPRESSION; INFECTION; INDUCTION; BRAIN; GAMMA; MUTATIONS; RECEPTORS	Background: Compelling data exist that show that normal levels of progranulin (PGRN) are required for successful CNS aging. PGRN production is also modulated by inflammation and infection, but no data are available on the production and role of PGRN during CNS HIV infection. Methods: To determine the relationships between PGRN and HIV disease, neurocognition, and inflammation, we analyzed 107 matched CSF and plasma samples from CHARTER, a well-characterized HIV cohort. Levels of PGRN were determined by ELISA and compared to levels of several inflammatory mediators (IFN gamma, IL-6, IL-10, IP-10, MCP-1, TNF alpha, IL-1 beta, IL-4 and IL-13), as well as clinical, virologic and demographic parameters. The relationship between HIV infection and PGRN was also examined in HIV-infected primary human microglial cultures. Results: In plasma, PGRN levels correlated with the viral load (VL, p < 0.001). In the CSF of subjects with undetectable VL, lower PGRN was associated with neurocognitive impairment (p = 0.046). CSF PGRN correlated with CSF IP-10, TNF alpha and IL-10, and plasma PGRN correlated with plasma IP-10. In vitro, microglial HIV infection increased PGRN production and PGRN knockdown increased HIV replication, demonstrating that PGRN is an innate antiviral protein. Conclusions: We propose that PGRN plays dual roles in people living with HIV disease. With active HIV replication, PGRN is induced in infected macrophages and microglia and functions as an antiviral protein. In individuals without active viral replication, decreased PGRN production contributes to neurocognitive dysfunction, probably through a diminution of its neurotrophic functions. Our results have implications for the pathogenesis, biomarker studies and therapy for HIV diseases including HIV-associated neurocognitive dysfunction (HAND).	[Suh, Hyeon-Sook; Choi, Namjong; Lee, Sunhee C.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Lo, Yungtai] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Letendre, Scott] Univ Calif San Diego, Dept Neurol, San Diego, CA 92103 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Diego	Suh, HS (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	hyeon-sook.suh@einstein.yu.edu; sunhee.lee@einstein.yu.edu	Letendre, Scott L./GLU-6874-2022		NIH [KO1 MH084705, RO1 MH55477, 1S10RR031646, N01 MH22005, HHSN271201000036C, HHSN271201000030C]; Einstein CFAR [P30AI051519]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH084705, R01MH055477, N01MH022005, P30MH062512] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein CFAR; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the NIH awards KO1 MH084705 (HS), RO1 MH55477 (SCL), 1S10RR031646 (SL), the Einstein CFAR P30AI051519. The CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) was supported by the NIH awards N01 MH22005, HHSN271201000036C and HHSN271201000030C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; ARKINS S, 1995, MOL ENDOCRINOL, V9, P350, DOI 10.1210/me.9.3.350; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Butovsky O, 2006, J CLIN INVEST, V116, P905, DOI 10.1172/JCI26836; Cassol E, 2013, J NEUROIMMUNE PHARM, V8, P1087, DOI 10.1007/s11481-013-9512-2; Chantry D, 1998, J LEUKOCYTE BIOL, V64, P49, DOI 10.1002/jlb.64.1.49; Chihara T, 2012, J IMMUNOL, V188, P3620, DOI 10.4049/jimmunol.1101593; Clerici M, 1996, BLOOD, V88, P574, DOI 10.1182/blood.V88.2.574.bloodjournal882574; Clutton G, 2013, EUR J IMMUNOL, V43, P2875, DOI 10.1002/eji.201343646; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Daniel R, 2003, DEV DYNAM, V227, P593, DOI 10.1002/dvdy.10341; De ML, 2011, J MOL NEUROSCI; De Riz M, 2010, NEUROSCI LETT, V469, P234, DOI 10.1016/j.neulet.2009.12.002; Eisfeld C, 2013, CNS DRUGS, V27, P31, DOI 10.1007/s40263-012-0018-x; Federico M, 2001, BLOOD, V98, P2752, DOI 10.1182/blood.V98.9.2752; Fenoglio C, 2009, J ALZHEIMERS DIS, V18, P603, DOI 10.3233/JAD-2009-1170; Fields J, 2014, J NEUROIMMUNE PHARM; Galimberti D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032164; Gelman BB, 2012, J ACQUIR IMMUNE DEFI; Gelman BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046178; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Jian JL, 2013, J LEUKOCYTE BIOL, V93, P199, DOI 10.1189/jlb.0812429; Johnson RT, 1996, ANN NEUROL, V39, P392, DOI 10.1002/ana.410390319; Kaul M, 2009, CURR OPIN NEUROL, V22, P315, DOI 10.1097/WCO.0b013e328329cf3c; LEE SHC, 1992, LAB INVEST, V67, P465; LEE SHC, 1993, AM J PATHOL, V143, P1032; Li X, 2002, J BIOL CHEM, V277, P45129, DOI 10.1074/jbc.M205165200; Marcotte TD, 2013, J NEUROIMMUNE PHARM; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; McArthur JC, 2004, ARCH NEUROL-CHICAGO, V61, P1687, DOI 10.1001/archneur.61.11.1687; McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053; Meeker RB, 2011, J NEUROVIROL, V17, P258, DOI 10.1007/s13365-011-0034-5; Moore DJ, 2011, J NEUROVIROL, V17, P50, DOI 10.1007/s13365-010-0009-y; Okura H, 2010, J ATHEROSCLER THROMB, V17, P568, DOI 10.5551/jat.3921; Ong CHP, 2006, AM J PHYSIOL-REG I, V291, pR1602, DOI 10.1152/ajpregu.00616.2005; Park B, 2011, IMMUNITY, V34, P505, DOI 10.1016/j.immuni.2011.01.018; Perry SW, 2005, NEUROTOX RES, V8, P161, DOI 10.1007/BF03033827; Petkau TL, 2010, J COMP NEUROL, V518, P3931, DOI 10.1002/cne.22430; Philips T, 2010, J NEUROPATH EXP NEUR, V69, P1191, DOI 10.1097/NEN.0b013e3181fc9aea; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Si QS, 2004, J NEUROVIROL, V10, P284, DOI 10.1080/13550280490499533; Si QS, 2002, VIROLOGY, V301, P342, DOI 10.1006/viro.2002.1613; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Sleegers K, 2010, ANNU REV NEUROSCI, V33, P71, DOI 10.1146/annurev-neuro-060909-153144; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Suh HS, 2013, J NEUROIMMUNE PHARM; Suh HS, 2007, J VIROL, V81, P9838, DOI 10.1128/JVI.00792-07; Suh HS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-37; Suh HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035115; Suh HS, 2010, AM J PATHOL, V177, P2446, DOI 10.2353/ajpath.2010.100399; Suh HS, 2009, CURR TOP MICROBIOL, V336, P63, DOI 10.1007/978-3-642-00549-7_4; Suh HS, 2009, VIROLOGY, V392, P246, DOI 10.1016/j.virol.2009.07.001; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; Vercellino M, 2011, MULT SCLER J, V17, P1194, DOI 10.1177/1352458511406164; Wang HY, 2011, FEMS IMMUNOL MED MIC, V63, P82, DOI 10.1111/j.1574-695X.2011.00833.x; Wex T, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-63; Woods SP, 2004, J CLIN EXP NEUROPSYC, V26, P759, DOI 10.1080/13803390490509565; Wynes MW, 2003, J IMMUNOL, V171, P3550, DOI 10.4049/jimmunol.171.7.3550; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568	69	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98184	10.1371/journal.pone.0098184	http://dx.doi.org/10.1371/journal.pone.0098184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878635	gold, Green Published, Green Submitted			2022-12-25	WOS:000338101500035
J	Xie, CQ; Wang, QN; He, Y				Xie, Chuanqi; Wang, Qiaonan; He, Yong			Identification of Different Varieties of Sesame Oil Using Near-Infrared Hyperspectral Imaging and Chemometrics Algorithms	PLOS ONE			English	Article							SUCCESSIVE PROJECTIONS ALGORITHM; SPECTROSCOPY; DISCRIMINATION; CLASSIFICATION; QUALITY; LEAVES	This study investigated the feasibility of using near infrared hyperspectral imaging (NIR-HSI) technique for non-destructive identification of sesame oil. Hyperspectral images of four varieties of sesame oil were obtained in the spectral region of 8741734 nm. Reflectance values were extracted from each region of interest (ROI) of each sample. Competitive adaptive reweighted sampling (CARS), successive projections algorithm (SPA) and x-loading weights (x-LW) were carried out to identify the most significant wavelengths. Based on the sixty-four, seven and five wavelengths suggested by CARS, SPA and x-LW, respectively, two classified models (least squares-support vector machine, LS-SVM and linear discriminant analysis, LDA) were established. Among the established models, CARS-LS-SVM and CARS-LDA models performed well with the highest classification rate (100%) in both calibration and prediction sets. SPA-LS-SVM and SPA-LDA models obtained better results (95.59% and 98.53% of classification rate in prediction set) with only seven wavelengths (938, 1160, 1214, 1406, 1656, 1659 and 1663 nm). The x-LW-LS-SVM and x-LW-LDA models also obtained satisfactory results (>80% of classification rate in prediction set) with the only five wavelengths (921, 925, 995, 1453 and 1663 nm). The results showed that NIR-HSI technique could be used to identify the varieties of sesame oil rapidly and non-destructively, and CARS, SPA and x-LW were effective wavelengths selection methods.	[Xie, Chuanqi; Wang, Qiaonan; He, Yong] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	He, Y (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China.	yhe@zju.edu.cn	He, Yong/E-3218-2010	He, Yong/0000-0001-6752-1757	863 National High-Tech Research and Development Plan [2012AA101903]; Ningbo Department of Science and Technology [2011C11024]; Fundamental Research Funds for the Central Universities of China [2012FZA6005, 2013QNA6011]	863 National High-Tech Research and Development Plan(National High Technology Research and Development Program of China); Ningbo Department of Science and Technology; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This work was supported by 863 National High-Tech Research and Development Plan (Project No: 2012AA101903), Ningbo Department of Science and Technology (2011C11024) and the Fundamental Research Funds for the Central Universities of China (2012FZA6005, 2013QNA6011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MCU, 2001, CHEMOMETR INTELL LAB, V57, P65, DOI 10.1016/S0169-7439(01)00119-8; Azeez MA, 2011, EUR J LIPID SCI TECH, V113, P238, DOI 10.1002/ejlt.201000080; Barbin DF, 2012, ANAL CHIM ACTA, V719, P30, DOI 10.1016/j.aca.2012.01.004; Chen XJ, 2011, FOOD BIOPROCESS TECH, V4, P753, DOI 10.1007/s11947-009-0199-6; Criado M, 2010, EUR J LIPID SCI TECH, V112, P246, DOI 10.1002/ejlt.200900159; ElMasry G, 2012, J FOOD ENG, V110, P127, DOI 10.1016/j.jfoodeng.2011.11.028; ElMasry G, 2011, J FOOD ENG, V103, P333, DOI 10.1016/j.jfoodeng.2010.10.031; Galvao RKH, 2008, CHEMOMETR INTELL LAB, V92, P83, DOI 10.1016/j.chemolab.2007.12.004; Kamruzzaman M, 2011, J FOOD ENG, V104, P332, DOI 10.1016/j.jfoodeng.2010.12.024; Li HD, 2009, ANAL CHIM ACTA, V648, P77, DOI 10.1016/j.aca.2009.06.046; Li XL, 2012, SENSORS-BASEL, V12, P9847, DOI 10.3390/s120709847; Lin P, 2012, FOOD BIOPROCESS TECH, V5, P235, DOI 10.1007/s11947-009-0302-z; Liu F, 2009, ANAL CHIM ACTA, V635, P45, DOI 10.1016/j.aca.2009.01.017; Liu F, 2008, FOOD RES INT, V41, P562, DOI 10.1016/j.foodres.2008.03.011; Luna AS, 2013, SPECTROCHIM ACTA A, V100, P115, DOI 10.1016/j.saa.2012.02.085; Mondal N, 2010, J AM OIL CHEM SOC, V87, P1263, DOI 10.1007/s11746-010-1615-9; Pizarro C, 2013, FOOD CHEM, V138, P915, DOI 10.1016/j.foodchem.2012.11.087; Riovanto R, 2011, J AGR FOOD CHEM, V59, P10356, DOI 10.1021/jf202578f; Sharmila V, 2007, GENET MOL BIOL, V30, P80, DOI 10.1590/S1415-47572007000100015; Sowmya M, 2009, FOOD HYDROCOLLOID, V23, P1827, DOI 10.1016/j.foodhyd.2009.02.008; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; Wei X, 2014, FOOD BIOPROCESS TECH, V7, P1371, DOI 10.1007/s11947-013-1164-y; Wei X, 2014, FOOD BIOPROCESS TECH, V7, P184, DOI 10.1007/s11947-013-1053-4; Wu D, 2013, FOOD BIOPROCESS TECH, V6, P2943, DOI 10.1007/s11947-012-0928-0; Wu D, 2013, TALANTA, V111, P39, DOI 10.1016/j.talanta.2013.03.041; Wu D, 2012, FOOD CHEM, V135, P2147, DOI 10.1016/j.foodchem.2012.07.011; Wu D, 2009, J AGR FOOD CHEM, V57, P1697, DOI 10.1021/jf8030343; Xie CQ, 2012, SPECTROSC SPECT ANAL, V32, P3324, DOI 10.3964/j.issn.1000-0593(2012)12-3324-05; Zhang XL, 2012, SENSORS-BASEL, V12, P17234, DOI 10.3390/s121217234; Zhang XL, 2013, IND CROP PROD, V42, P416, DOI 10.1016/j.indcrop.2012.06.021	30	19	20	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98522	10.1371/journal.pone.0098522	http://dx.doi.org/10.1371/journal.pone.0098522			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879306	Green Published, Green Submitted, gold			2022-12-25	WOS:000338101500066
J	Weber-Chrysochoou, C; Crisafulli, D; Kemp, AS; Britton, WJ; Marks, GB				Weber-Chrysochoou, Christina; Crisafulli, Daniele; Kemp, Andrew Stewart; Britton, Warwick John; Marks, Guy Barrington		CAPS Investigators	Allergen-Specific IL-5 Responses in Early Childhood Predict Asthma at Age Eight	PLOS ONE			English	Article							HOUSE-DUST MITE; BRONCHIAL HYPERRESPONSIVENESS; AUSTRALIAN SCHOOLCHILDREN; CYTOKINE PRODUCTION; 2 POPULATIONS; IGE LEVELS; ATOPY; ASSOCIATION; MEPOLIZUMAB; PREVENTION	Background: The pattern of development of allergen-specific T cell cytokine responses in early childhood and their relation to later disease is poorly understood. Here we describe longitudinal changes in allergen-stimulated T cell cytokine responses and their relation to asthma and allergic disease during the first 8 years of life. Methods: Subjects with a family history of asthma, who were enrolled antenatally in the Childhood Asthma Prevention Study (public trials registration number ACTRN12605000042640), had skin prick tests, clinical evaluation for asthma and eczema, and in vitro assessment of T cell cytokine responses to HDM extract performed at ages 18 months (n = 281), 3 years (n = 349), 5 years (n = 370) and 8 years (n = 275). We measured interleukin (IL-) 13 at 3, 5 and 8 years, and IL-5, IL-10, and interferon-gamma (IFN-gamma), at 18 months, 3, 5 and 8 years by ELISA. A cohort analysis was undertaken. Independent effects of cytokine responses at each age on the risk of asthma and allergic outcomes at age 8 years were estimated by multivariable logistic regression. Results: HDM-specific IL-5 responses increased with age. HDM-specific IL-13 and IL-10 responses peaked at age 5 years. HDM-specific IL-5 responses at 3 years, 5 years and 8 years were significantly associated with the presence of asthma and atopy at 8 years. IL-13 responses at 3 years, 5 years and 8 years were significantly associated with atopy at 8 years, but this association was not independent of the effect of IL-5. Other HDM-specific cytokine responses were not independently related to asthma or eczema at 8 years. Conclusion: HDM-specific IL-5 responses at age 3 years or later are the best measure of T cell function for predicting asthma at age 8 years.	[Weber-Chrysochoou, Christina; Crisafulli, Daniele; Marks, Guy Barrington] Woolcock Inst Med Res, Sydney, NSW, Australia; [Kemp, Andrew Stewart; Britton, Warwick John; Marks, Guy Barrington] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Marks, Guy Barrington] Univ New S Wales, South Western Sydney Clin Sch, Liverpool Hlth Serv Hosp, Dept Resp Med, Sydney, NSW, Australia; [Weber-Chrysochoou, Christina; Britton, Warwick John] Univ Sydney, Centenary Inst Canc Med & Cell Biol, Dept Immunol, Sydney, NSW 2006, Australia; [Kemp, Andrew Stewart] Childrens Hosp Westmead, Dept Allergy & Immunol, Sydney, NSW, Australia	University of Sydney; Woolcock Institute of Medical Research; University of Sydney; University of New South Wales Sydney; University of Sydney; Centenary Institute; University of Sydney	Marks, GB (corresponding author), Woolcock Inst Med Res, Sydney, NSW, Australia.	guy.marks@sydney.edu.au	Marks, Guy B./F-5058-2013	Marks, Guy B./0000-0002-8976-8053; Garden, Frances/0000-0003-1653-3031; Britton, Warwick/0000-0001-6721-9646	National Health and Medical Research Council of Australia; Cooperative Research Centre for Asthma; New South Wales Department of Health; Children's Hospital Westmead; Swiss National Science Foundation [PBZHB-114742]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cooperative Research Centre for Asthma(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); New South Wales Department of Health; Children's Hospital Westmead; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	National Health and Medical Research Council of Australia; Cooperative Research Centre for Asthma; New South Wales Department of Health; Children's Hospital Westmead; Swiss National Science Foundation, PBZHB-114742 (funding for CW); contributions of goods and services were made by Allergopharma Joachim Ganzer KG Germany, John Sands Australia, Hasbro, Toll Refrigerated, AstraZeneca Australia, and Nu-Mega Ingredients Pty Ltd. Goods were provided at reduced cost by Auspharm, Allersearch and Meadow Lea Foods. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush RK, 2008, ALLERGY ASTHMA PROC, V29, P575, DOI 10.2500/aap.2008.29.3172; Crestani E, 2007, J ALLERGY CLIN IMMUN, V120, P820, DOI 10.1016/j.jaci.2007.05.033; Guerra S, 2004, AM J RESP CRIT CARE, V169, P70, DOI 10.1164/rccm.200304-499OC; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hollams EM, 2009, J ALLERGY CLIN IMMUN, V124, P463, DOI 10.1016/j.jaci.2009.06.019; Macaubas C, 2003, LANCET, V362, P1192, DOI 10.1016/S0140-6736(03)14542-4; Marks GB, 2002, CLIN EXP ALLERGY, V32, P355, DOI 10.1046/j.1365-2222.2002.01292.x; Mihrshahi S, 2001, CONTROL CLIN TRIALS, V22, P333, DOI 10.1016/S0197-2456(01)00112-X; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Niggemann B, 2006, ALLERGY, V61, P855, DOI 10.1111/j.1398-9995.2006.01068.x; PEAT JK, 1987, CLIN ALLERGY, V17, P291, DOI 10.1111/j.1365-2222.1987.tb02017.x; PEAT JK, 1987, CLIN ALLERGY, V17, P283, DOI 10.1111/j.1365-2222.1987.tb02016.x; Peat JK, 1996, ALLERGY, V51, P804, DOI 10.1111/j.1398-9995.1996.tb00026.x; Prescott SL, 2003, ALLERGY, V58, P1187, DOI 10.1034/j.1398-9995.2003.00263.x; SALOME CM, 1987, CLIN ALLERGY, V17, P271, DOI 10.1111/j.1365-2222.1987.tb02015.x; Toelle BG, 2010, J ALLERGY CLIN IMMUN, V126, P388, DOI 10.1016/j.jaci.2010.04.031; Turner SW, 2007, CLIN EXP ALLERGY, V37, P371, DOI 10.1111/j.1365-2222.2007.02668.x; van der Velden VHJ, 2001, CLIN EXP ALLERGY, V31, P997, DOI 10.1046/j.1365-2222.2001.01176.x; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Weber-Chrysochoou C, 2007, J ALLERGY CLIN IMMUN, V120, P286, DOI 10.1016/j.jaci.2007.06.034; Wolfe R, 2000, AM J RESP CRIT CARE, V162, P2177, DOI 10.1164/ajrccm.162.6.9812019; Xu Y, 2009, BUILD ENVIRON, V45, P330; Zimmermann N, 2003, J ALLERGY CLIN IMMUN, V111, P227, DOI 10.1067/mai.2003.139	24	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97995	10.1371/journal.pone.0097995	http://dx.doi.org/10.1371/journal.pone.0097995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875149	Green Published, gold, Green Submitted			2022-12-25	WOS:000336790800019
J	Choi, YH; Kim, K				Choi, Yoon-Hyeong; Kim, KyooSang			Noise-Induced Hearing Loss in Korean Workers: Co-Exposure to Organic Solvents and Heavy Metals in Nationwide Industries	PLOS ONE			English	Article							AUDITORY-EVOKED-POTENTIALS; OCCUPATIONAL-EXPOSURE; INDUCED OTOTOXICITY; LEAD-EXPOSURE; BRAIN-STEM; INNER-EAR; CADMIUM; TOLUENE; SURVEILLANCE; IMPAIRMENT	Background: Noise exposure is a well-known contributor to work-related hearing loss. Recent biological evidence suggests that exposure to ototoxic chemicals such as organic solvents and heavy metals may be additional contributors to hearing loss. However, in industrial settings, it is difficult to determine the risks of hearing loss due to these chemicals in workplaces accompanied by excessive noise exposure. A few studies suggest that the effect of noise may be enhanced by ototoxic chemicals. Therefore, this study investigated whether co-exposure to organic solvents and/or heavy metals in the workplace modifies the risk of noise exposure on hearing loss in a background of excessive noise. Methods: We examined 30,072 workers nationwide in a wide range of industries from the Korea National Occupational Health Surveillance 2009. Data on industry-based exposure (e.g., occupational noise, heavy metals, and organic solvents) and subject-specific health outcomes (e.g., audiometric examination) were collected. Noise was measured as the daily 8-h time-weighted average level. Air conduction hearing thresholds were measured from 0.5 to 6 kHz, and pure-tone averages (PTA) (i.e., means of 2, 3, and 4 kHz) were computed. Results: In the multivariate linear model, PTA increment with occupational noise were 1.64-fold and 2.15-fold higher in individuals exposed to heavy metals and organic solvents than in unexposed individuals, respectively. Conclusion: This study provides nationwide evidence that co-exposure to heavy metals and/or organic solvents may exacerbate the effect of noise exposure on hearing loss in workplaces. These findings suggest that workers in industries dealing with heavy metals or organic solvents are susceptible to such risks.	[Choi, Yoon-Hyeong] Gachon Univ, Grad Sch Med, Dept Prevent Med, Inchon, South Korea; [Kim, KyooSang] Korea Occupat Safety & Hlth Agcy, Occupat Safety & Hlth Res Inst, Inchon, South Korea	Gachon University	Kim, K (corresponding author), Seoul Med Ctr, Dept Occupat Environm Med, Seoul, South Korea.	kyoosang@daum.net						ABBATE C, 1993, INT ARCH OCC ENV HEA, V64, P389, DOI 10.1007/BF00517943; Beckett WS, 2003, J OCCUP ENVIRON MED, V45, P1029, DOI 10.1097/01.jom.0000088878.64921.1e; Campo P, 2001, HEARING RES, V154, P170, DOI 10.1016/S0378-5955(01)00218-0; Cappaert NLM, 2001, HEARING RES, V162, P67, DOI 10.1016/S0378-5955(01)00373-2; CDC, 2013, OCC HEAR LOSS SURV; CDC, 2001, WORK REL HEAR LOSS; Choi Y-H, 2012, ENV HLTH PE IN PRESS; Choi YH, 2012, ENVIRON HEALTH PERSP, V120, P1544, DOI 10.1289/ehp.1104863; Choi YH, 2012, OCCUP ENVIRON MED, V69, P176, DOI 10.1136/oem.2011.064758; Chuang HY, 2007, SCI TOTAL ENVIRON, V387, P79, DOI 10.1016/j.scitotenv.2007.07.032; CROFTON KM, 1994, HEARING RES, V80, P25, DOI 10.1016/0378-5955(94)90005-1; DISCALZI G, 1993, INT J PSYCHOPHYSIOL, V14, P21, DOI 10.1016/0167-8760(93)90080-9; European Agency for Safety and Health at Work (EU-OSHA), 2009, COMB EXP NOIS OT SUB; Fuente A, 2006, INT J AUDIOL, V45, P367, DOI 10.1080/14992020600753205; Fuente A, 2009, J OCCUP ENVIRON MED, V51, P1202, DOI 10.1097/JOM.0b013e3181bae17c; JACOBSEN P, 1993, OCCUP MED-OXFORD, V43, P180, DOI 10.1093/occmed/43.4.180; Johnson AC, 2010, ARBETE HALSA, V44, p177p; Jones LG, 2008, J COMP NEUROL, V506, P1003, DOI 10.1002/cne.21563; Kim K-S, 2007, AUDIOLOGY, V3, P9; Kim SJ, 2008, ENVIRON HEALTH PERSP, V116, P854, DOI 10.1289/ehp.10467; LASKY RE, 1995, NEUROTOXICOL TERATOL, V17, P633, DOI 10.1016/0892-0362(95)02006-3; Maguin K, 2009, TOXICOL SCI, V107, P473, DOI 10.1093/toxsci/kfn242; Meyer JD, 2002, OCCUP MED-OXFORD, V52, P75, DOI 10.1093/occmed/52.2.75; MORATA TC, 1993, SCAND J WORK ENV HEA, V19, P245, DOI 10.5271/sjweh.1477; Morata TC, 2003, J OCCUP ENVIRON MED, V45, P676, DOI 10.1097/01.jom.0000071507.96740.70; Morata TC, 1997, SCAND J WORK ENV HEA, V23, P289, DOI 10.5271/sjweh.222; OSHRI, 2010, RES OCC EXP REL DIS; OSHRI, 2009, OCC HLTH SURV STAND; OSHRI, 2009, STAND METH MAN PUR T; Ozcaglar HU, 2001, ACTA OTO-LARYNGOL, V121, P393; Palmer KT, 2002, OCCUP ENVIRON MED, V59, P634, DOI 10.1136/oem.59.9.634; Park J, 1999, INT ARCH OCC ENV HEA, V72, P411, DOI 10.1007/s004200050394; Park SK, 2010, HEARING RES, V269, P48, DOI 10.1016/j.heares.2010.07.004; Rabinowitz PM, 2006, EAR HEARING, V27, P742, DOI 10.1097/01.aud.0000240544.79254.bc; Sabolic I, 2006, NEPHRON PHYSIOL, V104, P107, DOI 10.1159/000095539; Sass-Kortsak Andrea M., 1995, Annals of Epidemiology, V5, P15, DOI 10.1016/1047-2797(94)00036-S; Shargorodsky J, 2011, ARCH OTOLARYNGOL, V137, P1177, DOI 10.1001/archoto.2011.202; Sliwinska-Kowalska M, 2005, ENVIRON TOXICOL PHAR, V19, P547, DOI 10.1016/j.etap.2004.12.018; Sliwinska-Kowalska M, 2004, J OCCUP ENVIRON MED, V46, P30, DOI 10.1097/01.jom.0000105912.29242.5b; Sliwinska-Kowalska M, 2003, J OCCUP ENVIRON MED, V45, P15, DOI 10.1097/01.jom.0000048169.87707.c2; Sliwinska-Kowalska M, 2001, SCAND J WORK ENV HEA, V27, P335, DOI 10.5271/sjweh.622; Sliwinska-Kowalska Mariola, 2007, International Journal of Occupational Medicine and Environmental Health, V20, P215, DOI 10.2478/v10001-007-0021-5; Sliwinska-Kowalska M, 2008, OCCUP ENVIRON MED, V65, P222, DOI 10.1136/oem.2007.035907; SPANDOW O, 1988, AM J OTOLARYNG, V9, P327, DOI 10.1016/S0196-0709(88)80041-3; Stanbury M, 2008, J OCCUP ENVIRON MED, V50, P72, DOI 10.1097/JOM.0b013e31815b568c; Varney NR, 1998, CLIN NEUROPSYCHOL, V12, P107, DOI 10.1076/clin.12.1.107.1729; Vyskocil A, 2012, TOXICOL IND HEALTH, V28, P796, DOI 10.1177/0748233711425067; Wallhagen MI, 1997, AM J PUBLIC HEALTH, V87, P440, DOI 10.2105/AJPH.87.3.440; Wu TN, 1998, PREV MED, V27, P65, DOI 10.1006/pmed.1997.0238; YAMAMURA K, 1989, FUND APPL TOXICOL, V13, P509, DOI 10.1016/0272-0590(89)90287-X	50	24	25	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97538	10.1371/journal.pone.0097538	http://dx.doi.org/10.1371/journal.pone.0097538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870407	Green Published, Green Submitted, gold			2022-12-25	WOS:000336858300014
J	Kim, HG; Lee, JS; Choi, MK; Han, JM; Son, CG				Kim, Hyeong-Geug; Lee, Jin-Seok; Choi, Min-Kyung; Han, Jong-Min; Son, Chang-Gue			Ethanolic Extract of Astragali Radix and Salviae Radix Prohibits Oxidative Brain Injury by Psycho-Emotional Stress in Whisker Removal Rat Model	PLOS ONE			English	Article							KAPPA-B; INFLAMMATION; DISORDERS; MYELOPHIL; RESPONSES; MICE; DEPRESSION; DISEASE; DAMAGE; CELLS	Myelophil, an ethanolic extract of Astragali Radix and Salviae Radix, has been clinically used to treat chronic fatigue and stress related disorders in South Korea. In this study, we investigated the protective effects of Myelophil on a whisker removal-induced psycho-emotional stress model. SD rats were subjected to whisker removal after oral administration of Myelophil or ascorbic acid for consecutive 4 days. Whisker removal considerably increased total reactive oxygen species in serum levels as well as cerebral cortex and hippocampal regions in brain tissues. Lipidperoxidation levels were also increased in the cerebral cortex, hippocampus regions, and brain tissue injuries as shown in histopathology and immunohistochemistry. However, Myelophil significantly ameliorated these alterations, and depletion of glutathione contents in both cerebral cortex and hippocampus regions respectively. Serum levels of corticosterone and adrenaline were notably altered after whisker removal stress, whereas these abnormalities were significantly normalized by pre-treatment with Myelophil. The NF-kappa B was notably activated in both cerebral cortex and hippocampus after whisker removal stress, while it was efficiently blocked by pre-treatment with Myelophil. Myelophil also significantly normalizes alterations of tumor necrosis factor-alpha, interleukin (IL)-1 beta, IL-6 and interferon-gamma in both gene expressions and protein levels. These results suggest that Myelophil has protective effects on brain damages in psycho-emotional stress, and the underlying mechanisms involve regulation of inflammatory proteins, especially NF-kappa B modulation.	[Kim, Hyeong-Geug; Lee, Jin-Seok; Choi, Min-Kyung; Han, Jong-Min; Son, Chang-Gue] Daejeon Univ, Oriental Med Coll, Daejeon Oriental Hosp, Liver & Immunol Res Ctr, Taejon, South Korea	Daejeon University	Son, CG (corresponding author), Daejeon Univ, Oriental Med Coll, Daejeon Oriental Hosp, Liver & Immunol Res Ctr, Taejon, South Korea.	ckson@dju.ac.kr	son, chang gue/ABC-2215-2021		Oriental Medicine R&D Project, Ministry of Health Welfare [B100045]; KM-Based Herbal Drug Research Group of Korea Institute of Oriental Medicine, Rep. of Korea [K13101]	Oriental Medicine R&D Project, Ministry of Health Welfare; KM-Based Herbal Drug Research Group of Korea Institute of Oriental Medicine, Rep. of Korea	This study was supported by a grant (B100045) from the Oriental Medicine R&D Project, Ministry of Health & Welfare, and a grant (K13101) from KM-Based Herbal Drug Research Group of Korea Institute of Oriental Medicine, Rep. of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashcraft KA, 2008, BRAIN BEHAV IMMUN, V22, P1231, DOI 10.1016/j.bbi.2008.06.008; Braun S, 2000, NEUROSCI LETT, V295, P101, DOI 10.1016/S0304-3940(00)01603-7; Busciglio J, 1998, ANN NY ACAD SCI, V851, P429, DOI 10.1111/j.1749-6632.1998.tb09021.x; Chen T, 2011, BRAIN RES BULL, V84, P163, DOI 10.1016/j.brainresbull.2010.11.015; Cho JH, 2009, COMPLEMENT THER MED, V17, P141, DOI 10.1016/j.ctim.2008.11.003; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Colaianna M, 2013, ANTIOXID REDOX SIGN, V18, P1385, DOI 10.1089/ars.2012.4569; Dimitrijevic M, 2012, IMMUNOL RES, V52, P64, DOI 10.1007/s12026-012-8275-9; Dinkel K, 2002, J NEUROVIROL, V8, P513, DOI 10.1080/13550280290100914; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; Hayashi I, 2007, MUTAT RES-GEN TOX EN, V631, P55, DOI 10.1016/j.mrgentox.2007.04.006; HERBERT V, 1994, STEM CELLS, V12, P289, DOI 10.1002/stem.5530120305; Hu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050764; Ishiwata H, 2005, NEUROSCIENCE, V133, P893, DOI 10.1016/j.neuroscience.2005.03.048; Jaremka LM, 2013, DEPRESS ANXIETY, V30, P288, DOI 10.1002/da.22078; KAMAL AAM, 1989, ENVIRON RES, V49, P173, DOI 10.1016/S0013-9351(89)80062-3; Kambayashi Y, 2009, J CLIN BIOCHEM NUTR, V44, P46, DOI 10.3164/jcbn.08-162; Kim HG, 2013, J ETHNOPHARMACOL, V148, P505, DOI 10.1016/j.jep.2013.04.046; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Laflamme N, 1999, J NEUROSCI, V19, P10923, DOI 10.1523/JNEUROSCI.19-24-10923.1999; Lederbogen F, 2012, NERVENARZT, V83, P1448, DOI 10.1007/s00115-012-3666-7; Lee JS, 2012, PROG NEURO-PSYCHOPH, V39, P339, DOI 10.1016/j.pnpbp.2012.07.006; Oka T, 2013, BIOPSYCHOSOC MED, V7, DOI 10.1186/1751-0759-7-7; Rahman MM, 2008, J AGR FOOD CHEM, V56, P7545, DOI 10.1021/jf800930s; Rinwa P, 2013, ARCH PHARM RES, DOI 10.1007/s12272-013-0205-4; Sato H, 2010, J CLIN BIOCHEM NUTR, V47, P224, DOI 10.3164/jcbn.10-58; Sinha R, 2003, PSYCHOPHARMACOLOGY, V170, P62, DOI 10.1007/s00213-003-1525-8; Talwar SK, 2002, NATURE, V417, P37, DOI 10.1038/417037a; Traeger L, 2013, ONCOL NURS FORUM, V40, pE327, DOI 10.1188/13.ONF.E327-E336; Videbech P, 2001, UGESKRIFT LAEGER, V163, P6568; Wang L, 2007, EVID-BASED COMPL ALT, V4, P195, DOI 10.1093/ecam/nel080; WHEELER CR, 1990, ANAL BIOCHEM, V184, P193, DOI 10.1016/0003-2697(90)90668-Y; Wong DL, 2008, ANN NY ACAD SCI, V1148, P249, DOI 10.1196/annals.1410.048; Zhang WJ, 2003, THROMB HAEMOSTASIS, V90, P904, DOI 10.1160/TH03-03-0136	36	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98329	10.1371/journal.pone.0098329	http://dx.doi.org/10.1371/journal.pone.0098329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870587	Green Submitted, Green Published, gold			2022-12-25	WOS:000336858300036
J	Kang, WX; Liu, Y; Wu, QX; Yue, XS				Kang, Wenxiong; Liu, Yang; Wu, Qiuxia; Yue, Xishun			Contact-Free Palm-Vein Recognition Based on Local Invariant Features	PLOS ONE			English	Article							ILLUMINATION NORMALIZATION; FEATURE-EXTRACTION; GRAY-SCALE; PATTERNS	Contact-free palm-vein recognition is one of the most challenging and promising areas in hand biometrics. In view of the existing problems in contact-free palm-vein imaging, including projection transformation, uneven illumination and difficulty in extracting exact ROIs, this paper presents a novel recognition approach for contact-free palm-vein recognition that performs feature extraction and matching on all vein textures distributed over the palm surface, including finger veins and palm veins, to minimize the loss of feature information. First, a hierarchical enhancement algorithm, which combines a DOG filter and histogram equalization, is adopted to alleviate uneven illumination and to highlight vein textures. Second, RootSIFT, a more stable local invariant feature extraction method in comparison to SIFT, is adopted to overcome the projection transformation in contact-free mode. Subsequently, a novel hierarchical mismatching removal algorithm based on neighborhood searching and LBP histograms is adopted to improve the accuracy of feature matching. Finally, we rigorously evaluated the proposed approach using two different databases and obtained 0.996% and 3.112% Equal Error Rates (EERs), respectively, which demonstrate the effectiveness of the proposed approach.	[Kang, Wenxiong; Liu, Yang; Yue, Xishun] S China Univ Technol, Coll Automat Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Wu, Qiuxia] S China Univ Technol, Guangzhou Inst Modern Ind Technol, Guangzhou, Guangdong, Peoples R China	South China University of Technology; South China University of Technology	Kang, WX (corresponding author), S China Univ Technol, Coll Automat Sci & Engn, Guangzhou, Guangdong, Peoples R China.	auwxkang@scut.edu.cn			National Natural Science Foundation of China [61105019]; Science and Technology Planning Project of Guangdong Province [2012B010100021]; Fundamental Research Funds for the Central Universities, SCUT [2014ZG0041, 2013ZB0006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province; Fundamental Research Funds for the Central Universities, SCUT(Fundamental Research Funds for the Central Universities)	This work is supported by the National Natural Science Foundation of China (No. 61105019), the Science and Technology Planning Project of Guangdong Province (No. 2012B010100021), and the Fundamental Research Funds for the Central Universities, SCUT (No. 2014ZG0041, No. 2013ZB0006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ELECTR POW SYST RES; Arandjelovic R, 2012, PROC CVPR IEEE, P2911, DOI 10.1109/CVPR.2012.6248018; Bay H, 2006, LECT NOTES COMPUT SC, V3951, P404, DOI 10.1007/11744023_32; Chen J, 2010, IEEE T PATTERN ANAL, V32, P1705, DOI 10.1109/TPAMI.2009.155; Choi JH, 2009, SPIE IS T ELECT IMAG; Chum O, 2005, PROC CVPR IEEE, P220, DOI 10.1109/cvpr.2005.221; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Han WY, 2012, EXPERT SYST APPL, V39, P13225, DOI 10.1016/j.eswa.2012.05.079; Hao Y, 2008, IEEE IMAGE PROC, P281, DOI 10.1109/ICIP.2008.4711746; Juan Luo, 2009, INT J IMAGE PROCESSI, V3, P143, DOI DOI 10.1007/S11270-006-2859-8; Kang BJ, 2011, OPT ENG, V50, DOI 10.1117/1.3530023; Kang WX, 2012, PATTERN RECOGN LETT, V33, P1916, DOI 10.1016/j.patrec.2012.02.020; Kang WX, 2010, SCI CHINA INFORM SCI, V53, P2062, DOI 10.1007/s11432-010-4064-z; Kim HG, 2012, LECT NOTES COMPUT SC, V7432, P21, DOI 10.1007/978-3-642-33191-6_3; Ladoux PO, 2009, LECT NOTES COMPUT SC, V5558, P1290, DOI 10.1007/978-3-642-01793-3_130; Lee EC, 2011, SENSORS-BASEL, V11, P2319, DOI 10.3390/s110302319; Lee EC, 2009, INT J IMAG SYST TECH, V19, P179, DOI 10.1002/ima.20193; Lee JC, 2012, PATTERN RECOGN LETT, V33, P1520, DOI 10.1016/j.patrec.2012.04.007; Li Xiuyan, 2011, Chinese Journal of Scientific Instrument, V32, P831; Li Xueyan, 2007, 2007 1st International Conference on Bioinformatics and Biomedical Engineering, P612, DOI 10.1109/ICBBE.2007.160; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mirmohamadsadeghi L., 2011, P 5 INT C BIOM WASH, P1, DOI DOI 10.1109/IJCB.2011.6117804; Miura N, 2004, MACH VISION APPL, V15, P194, DOI 10.1007/s00138-004-0149-2; Miura N, 2007, IEICE T INF SYST, VE90D, P1185, DOI 10.1093/ietisy/e90-d.8.1185; Morel JM, 2009, SIAM J IMAGING SCI, V2, P438, DOI 10.1137/080732730; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pan M, 2011, LECT NOTES COMPUT SC, V7098, P116, DOI 10.1007/978-3-642-25449-9_15; Qian X., 2009, P INT C COMP INT SOF, P1, DOI [DOI 10.1109/CISE.2009.5366021, DOI 10.1109/TENCON.2009.5396125]; Rosdi BA, 2011, SENSORS-BASEL, V11, P11357, DOI 10.3390/s111211357; Song W, 2011, PATTERN RECOGN LETT, V32, P1541, DOI 10.1016/j.patrec.2011.04.021; Tan XY, 2007, LECT NOTES COMPUT SC, V4778, P168; Wang B, 2011, IEEE SIGNAL PROC LET, V18, P462, DOI 10.1109/LSP.2011.2158998; Wang L, 2007, IET COMPUT VIS, V1, P113, DOI 10.1049/iet-cvi:20070009; Wang L, 2008, PATTERN RECOGN, V41, P920, DOI 10.1016/j.patcog.2007.07.012; Wang YD, 2010, INT CONF SIGN PROCES, P1671, DOI 10.1109/ICOSP.2010.5656717; Yang J, 2013, INFORM SCI IN PRESS; Yang JF, 2012, PATTERN RECOGN LETT, V33, P1569, DOI 10.1016/j.patrec.2012.04.018; Yang W, 2013, INFORM SCI IN PRESS; Zhang D, 2010, IEEE T INSTRUM MEAS, V59, P480, DOI 10.1109/TIM.2009.2028772; Zhang YB, 2007, LECT NOTES COMPUT SC, V4781, P154; Zhou YB, 2011, IEEE T INF FOREN SEC, V6, P1259, DOI 10.1109/TIFS.2011.2158423	42	30	31	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97548	10.1371/journal.pone.0097548	http://dx.doi.org/10.1371/journal.pone.0097548			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866176	Green Published, gold, Green Submitted			2022-12-25	WOS:000336914100016
J	Zhao, T; Du, H; Ding, X; Walls, K; Yan, C				Zhao, T.; Du, H.; Ding, X.; Walls, K.; Yan, C.			Activation of mTOR pathway in myeloid-derived suppressor cells stimulates cancer cell proliferation and metastasis in lal(-/-) mice	ONCOGENE			English	Article							LYSOSOMAL ACID LIPASE; SYSTEMIC INFLAMMATION; EXPRESSION; DISEASE; GROWTH; LUNG; ANGIOGENESIS; CHEMOTHERAPY; CARCINOMA; CORRELATE	Inflammation critically contributes to cancer metastasis, in which myeloid-derived suppressor cells (MDSCs) are an important participant. Although MDSCs are known to suppress immune surveillance, their roles in directly stimulating cancer cell proliferation and metastasis currently remain unclear. Lysosomal acid lipase (LAL) deficiency causes systemic expansion and infiltration of MDSCs in multiple organs and subsequent inflammation. In the LAL-deficient (lal(-/-)) mouse model, melanoma metastasized massively in allogeneic lal(-/-) mice, which was suppressed in allogeneic lal(+/+) mice owing to immune rejection. Here we report for the first time that MDSCs from lal(-/-) mice directly stimulated B16 melanoma cell in vitro proliferation and in vivo growth and metastasis. Cytokines, that is, interleukin-1 beta and tumor necrosis factor-alpha from MDSCs are required for B16 melanoma cell proliferation in vitro. Myeloid-specific expression of human LAL (hLAL) in lal(-/-) mice rescues these malignant phenotypes in vitro and in vivo. The tumor-promoting function of lal(-/-) MDSCs is mediated, at least in part, through overactivation of the mammalian target of rapamycin (mTOR) pathway. Knockdown of mTOR, Raptor or Rictor in lal(-/-) MDSCs suppressed their stimulation on proliferation of cancer cells, including B16 melanoma, Lewis lung carcinoma and transgenic mouse prostate cancer-C2 cancer cells. Our results indicate that LAL has a critical role in regulating MDSCs' ability to directly stimulate cancer cell proliferation and overcome immune rejection of cancer metastasis in allogeneic mice through modulation of the mTOR pathway, which provides a mechanistic basis for targeting MDSCs to reduce the risk of cancer metastasis. Therefore MDSCs possess dual functions to facilitate cancer metastasis: suppress immune surveillance and stimulate cancer cell proliferation and growth.	[Zhao, T.; Du, H.; Ding, X.; Walls, K.; Yan, C.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Du, H.; Yan, C.] Indiana Univ Sch Med, IU Simon Canc Ctr, Indianapolis, IN 46202 USA; [Yan, C.] Indiana Univ Sch Med, Ctr Immunobiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Du, H (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, 975 W Walnut St,IB424G, Indianapolis, IN 46202 USA.	hongdu@iupui.edu; coyan@iupui.edu	ding, xinchun/P-5490-2017		National Institutes of Health [CA138759, CA152099, HL087001]; NATIONAL CANCER INSTITUTE [R01CA138759, R01CA152099] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health Grants CA138759, CA152099 (to CY) and HL087001 (to HD).	Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Ding XC, 2014, AM J PATHOL, V184, P397, DOI 10.1016/j.ajpath.2013.10.015; Du H, 2001, J LIPID RES, V42, P489; Elleder M, 2000, J HEPATOL, V32, P528, DOI 10.1016/S0168-8278(00)80407-9; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hoechst B, 2009, HEPATOLOGY, V50, P799, DOI 10.1002/hep.23054; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Ko JS, 2009, CLIN CANCER RES, V15, P2148, DOI 10.1158/1078-0432.CCR-08-1332; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lian XM, 2005, AM J PATHOL, V167, P813, DOI 10.1016/S0002-9440(10)62053-6; Lian XM, 2004, AM J PHYSIOL-LUNG C, V286, pL801, DOI 10.1152/ajplung.00335.2003; Mandruzzato S, 2009, J IMMUNOL, V182, P6562, DOI 10.4049/jimmunol.0803831; Meyer C, 2011, P NATL ACAD SCI USA, V108, P17111, DOI 10.1073/pnas.1108121108; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Qu P, 2011, J IMMUNOL, V187, P3854, DOI 10.4049/jimmunol.1003358; Qu P, 2011, BLOOD, V117, P4476, DOI 10.1182/blood-2010-07-298380; Qu P, 2010, AM J PATHOL, V176, P2394, DOI 10.2353/ajpath.2010.091063; Qu P, 2009, LUNG CANCER, V63, P341, DOI 10.1016/j.lungcan.2008.05.025; Qu P, 2009, J IMMUNOL, V182, P1648, DOI 10.4049/jimmunol.182.3.1648; Rothe G, 1997, ATHEROSCLEROSIS, V130, P215, DOI 10.1016/S0021-9150(97)06065-6; Talmadge JE, 2013, NAT REV CANCER, V13, P739, DOI 10.1038/nrc3581; Wang L, 2013, J IMMUNOL, V190, P794, DOI 10.4049/jimmunol.1202088; Wu L, 2012, BLOOD, V119, P115, DOI 10.1182/blood-2011-06-363093; Yan C, 2006, AM J PATHOL, V169, P916, DOI 10.2353/ajpath.2006.051327; Yan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030701; Zhao T, 2010, AM J PHYSIOL-ENDOC M, V299, pE110, DOI 10.1152/ajpendo.00192.2010	31	42	42	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 9	2015	34	15					1938	1948		10.1038/onc.2014.143	http://dx.doi.org/10.1038/onc.2014.143			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CF7GY	24882582	Green Accepted, Green Submitted, Bronze			2022-12-25	WOS:000352725600008
J	Korte, S; Strater, AS; Druppel, V; Oberleithner, H; Jeggle, P; Grossmann, C; Fobker, M; Nofer, JR; Brand, E; Kusche-Vihrog, K				Korte, Stefanie; Straeter, Alexandra S.; Drueppel, Verena; Oberleithner, Hans; Jeggle, Pia; Grossmann, Claudia; Fobker, Manfred; Nofer, Jerzy-Roch; Brand, Eva; Kusche-Vihrog, Kristina			Feedforward activation of endothelial ENaC by high sodium	FASEB JOURNAL			English	Article						EnNaC; atomic force microscopy; endothelium; aldosterone; mineralocorticoid receptor; FAD286	EPITHELIAL NA+-CHANNEL; NITRIC-OXIDE SYNTHASE; VASCULAR ENDOTHELIUM; MINERALOCORTICOID RECEPTORS; ALDOSTERONE BIOSYNTHESIS; BLOOD-PRESSURE; PLASMA SODIUM; SALT; CELLS; HYPERTENSION	Kidney epithelial sodium channels (ENaCs) are known to be inactivated by high sodium concentrations (feedback inhibition). Recently, the endothelial sodium channel (EnNaC) was identified to control the nanomechanical properties of the endothelium. EnNaC-dependent endothelial stiffening reduces the release of nitric oxide, the hallmark of endothelial dysfunction. To study the regulatory impact of sodium on EnNaC, endothelial cells (EA.hy926 and ex vivo mouse endothelium) were incubated in aldosterone-free solutions containing either low (130 mM) or high (150 mM) sodium concentrations. By applying atomic force microscopy- based nanoindentation, an unexpected positive correlation between increasing sodium concentrations and cortical endothelial stiffness was observed, which can be attributed to functional EnNaC. In particular, an acute rise in sodium concentration (+20 mM) was sufficient to increase EnNaC membrane abundance by 90% and stiffening of the endothelial cortex by 18%. Despite the absence of exogenous aldosterone, these effects were prevented by the aldosterone synthase inhibitor FAD286 (100 nM) or the mineralocorticoid receptor (MR)-antagonist spironolactone (100 nM), indicating endogenous aldosterone synthesis and MR-dependent signaling. Interestingly, in the presence of high-sodium concentrations, FAD286 increased the transcription of the MR by 69%. Taken together, a novel feedforward activation of EnNaC by sodium is proposed that contrasts ENaC feedback inhibition in kidney.	[Korte, Stefanie; Straeter, Alexandra S.; Drueppel, Verena; Oberleithner, Hans; Jeggle, Pia; Kusche-Vihrog, Kristina] Univ Munster, Inst Physiol 2, D-48149 Munster, Germany; [Grossmann, Claudia] Univ Halle Wittenberg, Julius Bernstein Inst Physiol, D-06108 Halle, Germany; [Fobker, Manfred; Nofer, Jerzy-Roch] Univ Munster, Ctr Lab Med, D-48149 Munster, Germany; [Brand, Eva] Univ Hosp Muenster, Dept Nephrol Hypertens & Rheumatol, Munster, Germany	University of Munster; Martin Luther University Halle Wittenberg; University of Munster; University of Munster	Kusche-Vihrog, K (corresponding author), Inst Physiol 2, Robert Koch Str 27b, D-48149 Munster, Germany.	kusche@uni-muenster.de	Kampmeier, Stefanie/GNW-3599-2022	Kampmeier, Stefanie/0000-0002-5013-159X	Deutsche Forschungsgemeinschaft [OB 63/18, KU 1496/7-1]; Else-Kroner-Fresenius Stiftung [2010_A116]; Innovative Medical Research (IMF) of the University of Munster [KU 120808]; Centre of Excellence (Cells in Motion; CIM), University of Munster; COST Action TD1002; COST Action BM 1301	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else-Kroner-Fresenius Stiftung; Innovative Medical Research (IMF) of the University of Munster; Centre of Excellence (Cells in Motion; CIM), University of Munster; COST Action TD1002; COST Action BM 1301	The authors thank Dr. Jurgen Reinhardt (Novartis, Basel, Swizerland) for kind supply of FAD286 and Marianne Wilhelmi and Anja Blanque for excellent technical assistance. The authors are grateful to Johanna Nedele (Department of Internal Medicine D, University of Munster), Lina Golle for assistance with the qRT-PCR experiments, Anne Wiesinger, and Otto Lindemann (Institute of Physiology II, University of Munster) for further technical advice. Work was supported by grants of the Deutsche Forschungsgemeinschaft (Koselleck OB 63/18, KU 1496/7-1), the Else-Kroner-Fresenius Stiftung (2010_A116), Innovative Medical Research (IMF) of the University of Munster (KU 120808), and by the Centre of Excellence (Cells in Motion; CIM), University of Munster. The authors also thank COST Action TD1002 and COST Action BM 1301 for supporting their networking activities. This paper is dedicated to the late Professor Hugh de Wardener, Imperial College London, who read and commented on a former version of this work.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Bragulat E, 2001, HYPERTENSION, V37, P444, DOI 10.1161/01.HYP.37.2.444; Brown NJ, 2013, NAT REV NEPHROL, V9, P459, DOI 10.1038/nrneph.2013.110; Caprio M, 2008, CIRC RES, V102, P1359, DOI 10.1161/CIRCRESAHA.108.174235; Cutaia M, 1996, J APPL PHYSIOL, V81, P509, DOI 10.1152/jappl.1996.81.1.509; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Delcayre C, 2000, KIDNEY INT, V57, P1346, DOI 10.1046/j.1523-1755.2000.00973.x; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; Falkenstein E, 2000, KIDNEY INT, V57, P1390, DOI 10.1046/j.1523-1755.2000.00980.x; Fels J, 2010, BBA-MOL BASIS DIS, V1802, P1193, DOI 10.1016/j.bbadis.2010.03.006; Fels J, 2010, PFLUG ARCH EUR J PHY, V460, P915, DOI 10.1007/s00424-010-0871-8; FUCHS W, 1977, J PHYSIOL-LONDON, V267, P137, DOI 10.1113/jphysiol.1977.sp011805; Fujita T, 2008, J MOL MED, V86, P729, DOI 10.1007/s00109-008-0343-1; Funder JW, 2006, HYPERTENSION, V47, P634, DOI 10.1161/01.HYP.0000203732.03784.3b; Funder JW, 2004, ENDOCRINOLOGY, V145, P4793, DOI 10.1210/en.2004-1057; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Golestaneh N, 2001, BIOCHEM BIOPH RES CO, V280, P1300, DOI 10.1006/bbrc.2001.4275; Gomez-Sanchez EP, 2004, ENDOCRINOLOGY, V145, P4796, DOI 10.1210/en.2004-0295; GomezSanchez CE, 1997, ENDOCRINOLOGY, V138, P3369, DOI 10.1210/en.138.8.3369; Gorelik J, 2005, P NATL ACAD SCI USA, V102, P15000, DOI 10.1073/pnas.0507008102; He FJ, 2005, HYPERTENSION, V45, P98, DOI 10.1161/01.HYP.0000149431.79450.a2; Huang BS, 2009, AM J PHYSIOL-REG I, V296, pR994, DOI 10.1152/ajpregu.90903.2008; Jeggle P, 2013, HYPERTENSION, V61, P1053, DOI 10.1161/HYPERTENSIONAHA.111.199455; Kakizoe Y, 2009, J HYPERTENS, V27, P1679, DOI 10.1097/HJH.0b013e32832c7d23; Korte S, 2012, PFLUG ARCH EUR J PHY, V463, P269, DOI 10.1007/s00424-011-1038-y; Kusche-Vihrog K., 2014, PFLUGERS ARCH, V10, P146; Kusche-Vihrog K, 2008, PFLUG ARCH EUR J PHY, V455, P849, DOI 10.1007/s00424-007-0341-0; Kusche-Vihrog K, 2011, HYPERTENSION, V57, P231, DOI 10.1161/HYPERTENSIONAHA.110.163444; Kusche-Vihrog K, 2010, STEROIDS, V75, P544, DOI 10.1016/j.steroids.2009.09.003; Lang F, 2011, HYPERTENSION, V57, P146, DOI 10.1161/HYPERTENSIONAHA.110.164558; Lang F, 2009, EXPERT OPIN THER TAR, V13, P1303, DOI 10.1517/14728220903260807; Li J, 2009, J NUTR, V139, P447, DOI 10.3945/jn.108.097451; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Lifton RP, 2002, COLD SPRING HARB SYM, V67, P445, DOI 10.1101/sqb.2002.67.445; Maier LS, 1997, AM J PHYSIOL-HEART C, V273, pH1246, DOI 10.1152/ajpheart.1997.273.3.H1246; Mazzochi C, 2006, J BIOL CHEM, V281, P6528, DOI 10.1074/jbc.M509386200; McEneaney V, 2008, MOL ENDOCRINOL, V22, P881, DOI 10.1210/me.2007-0225; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; Morizane S, 2012, ARTERIOSCL THROM VAS, V32, P1194, DOI 10.1161/ATVBAHA.111.242719; Nagase M, 2007, HYPERTENSION, V50, P877, DOI 10.1161/HYPERTENSIONAHA.107.091058; Ni ZM, 2001, AM J HYPERTENS, V14, P155, DOI 10.1016/S0895-7061(00)01234-6; Oberleithner H, 2005, KIDNEY INT, V67, P1680, DOI 10.1111/j.1523-1755.2005.00263.x; Oberleithner H, 2009, P NATL ACAD SCI USA, V106, P2829, DOI 10.1073/pnas.0813069106; Oberleithner H, 2007, P NATL ACAD SCI USA, V104, P16281, DOI 10.1073/pnas.0707791104; Oberleithner H, 2006, J CELL SCI, V119, P1926, DOI 10.1242/jcs.02886; Oda T, 2001, BIOPHYS J, V80, P841, DOI 10.1016/S0006-3495(01)76063-8; PALMER LG, 1988, J GEN PHYSIOL, V92, P121, DOI 10.1085/jgp.92.1.121; Perez FR, 2009, HYPERTENSION, V53, P1000, DOI 10.1161/HYPERTENSIONAHA.108.128520; Rossier BC, 2002, J GEN PHYSIOL, V120, P67, DOI 10.1085/jgp.20028638; Sanders PW, 2009, AM J PHYSIOL-RENAL, V297, pF237, DOI 10.1152/ajprenal.00027.2009; Snyder PM, 2002, ENDOCR REV, V23, P258, DOI 10.1210/er.23.2.258; Stockand JD, 2002, AM J PHYSIOL-RENAL, V282, pF559, DOI 10.1152/ajprenal.00320.2001; TAKEDA R, 1995, STEROIDS, V60, P120, DOI 10.1016/0039-128X(94)00026-9; Takeda Y, 1997, HYPERTENSION, V29, P45, DOI 10.1161/01.HYP.29.1.45; Takeda Y, 2004, MOL CELL ENDOCRINOL, V217, P75, DOI 10.1016/j.mce.2003.10.012; Titze J, 2002, AM J PHYSIOL-RENAL, V283, pF134, DOI 10.1152/ajprenal.00323.2001; Titze J, 2010, CURR OPIN NEPHROL HY, V19, P385, DOI 10.1097/MNH.0b013e32833aeb3b; Volk T, 2004, PFLUG ARCH EUR J PHY, V447, P884, DOI 10.1007/s00424-003-1193-x; Wang S, 2009, MICROCIRCULATION, V16, P276, DOI 10.1080/10739680802653150; Warnock DG, 2014, NAT REV NEPHROL, V10, P146, DOI 10.1038/nrneph.2013.275; Warnock DG, 2013, HYPERTENSION, V61, P952, DOI 10.1161/HYPERTENSIONAHA.113.00768; Warnock DG, 1998, KIDNEY INT, V53, P18, DOI 10.1046/j.1523-1755.1998.00728.x; Wildling L, 2009, PFLUG ARCH EUR J PHY, V458, P223, DOI 10.1007/s00424-008-0615-1; WILLIAMS GH, 1972, J CLIN INVEST, V51, P2645, DOI 10.1172/JCI107082	64	29	30	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					4015	4025		10.1096/fj.14-250282	http://dx.doi.org/10.1096/fj.14-250282			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24868010	Green Published			2022-12-25	WOS:000340845900019
J	Alhasan, AA; Spielhofer, J; Kusche-Gullberg, M; Kirby, JA; Ali, S				Alhasan, Abd A.; Spielhofer, Julia; Kusche-Gullberg, Marion; Kirby, John A.; Ali, Simi			Role of 6-O-Sulfated Heparan Sulfate in Chronic Renal Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; IN-VIVO; FGF; EXPRESSION; ANTIBODIES; BINDING; KIDNEY; CELLS; PROTEOGLYCANS; DOMAINS	Heparan sulfate (HS) plays a crucial role in the fibrosis associated with chronic allograft dysfunction by binding and presenting cytokines and growth factors to their receptors. These interactions critically depend on the distribution of 6-O-sulfated glucosamine residues, which is generated by glucosaminyl-6-O-sulfotransferases (HS6STs) and selectively removed by cell surface HS-6-O-endosulfatases (SULFs). Using human renal allografts we found increased expression of 6-O-sulfated HS domains in tubular epithelial cells during chronic rejection as compared with the controls. Stimulation of renal epithelial cells with TGF-beta induced SULF2 expression. To examine the role of 6-O-sulfated HS in the development of fibrosis, we generated stable HS6ST1 and SULF2 overexpressing renal epithelial cells. Compared with mock transfectants, the HS6ST1 transfectants showed significantly increased binding of FGF2 (p = 0.0086) and pERK activation. HS6ST1 transfectants displayed a relative increase in mono-6-O-sulfated disaccharides accompanied by a decrease in iduronic acid 2-O-sulfated disaccharide structures. In contrast, SULF2 transfectants showed significantly reduced FGF2 binding and phosphorylation of ERK. Structural analysis of HS showed about 40% down-regulation in 6-O-sulfation with a parallel increase in iduronic acid mono-2-O-sulfated disaccharides. To assess the relevance of these data in vivo we established a murine model of fibrosis (unilateral ureteric obstruction (UUO)). HS-specific phage display antibodies (HS3A8 and RB4EA12) showed significant increase in 6-O-sulfation in fibrotic kidney compared with the control. These results suggest an important role of 6-O-sulfation in the pathogenesis of fibrosis associated with chronic rejection.	[Alhasan, Abd A.; Spielhofer, Julia; Kirby, John A.; Ali, Simi] Newcastle Univ, Appl Immunobiol & Transplantat Res Grp, Inst Cellular Med, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Kusche-Gullberg, Marion] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway	Newcastle University - UK; University of Bergen	Kirby, JA (corresponding author), Newcastle Univ, Appl Immunobiol & Transplantat Res Grp, Inst Cellular Med, Sch Med, 3rd Floor Leech Bldg, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	john.kirby@ncl.ac.uk; simi.ali@newcastle.ac.uk	Kusche-Gullberg, Marion/P-4466-2016	Kusche-Gullberg, Marion/0000-0002-5636-1695; Kirby, John/0000-0003-2543-4131	Ministry of Higher Education, Syrian Arab Republic; Norwegian Cancer Society [3292722-2012]	Ministry of Higher Education, Syrian Arab Republic; Norwegian Cancer Society(Norwegian Cancer Society)	This work was supported by a grant from the Ministry of Higher Education, Syrian Arab Republic (to A. A. A.) and by the Norwegian Cancer Society Grant 3292722-2012 (to M. K.-G.).	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ali S, 2003, TRANSPLANTATION, V75, P1773, DOI 10.1097/01.TP.0000065805.97974.93; Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Celie JWAM, 2012, KIDNEY INT, V81, P651, DOI 10.1038/ki.2011.425; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; Do AT, 2006, J BIOL CHEM, V281, P5348, DOI 10.1074/jbc.M509584200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Feyzi E, 1998, J BIOL CHEM, V273, P13395, DOI 10.1074/jbc.273.22.13395; Feyzi E, 1997, J BIOL CHEM, V272, P5518, DOI 10.1074/jbc.272.9.5518; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Habuchi H, 2003, BIOCHEM J, V371, P131, DOI 10.1042/BJ20021259; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; Jayson GC, 1998, J BIOL CHEM, V273, P51, DOI 10.1074/jbc.273.1.51; Joosten SA, 2002, AM J PATHOL, V160, P1301, DOI 10.1016/S0002-9440(10)62557-6; Kamimura K, 2006, J CELL BIOL, V174, P773, DOI 10.1083/jcb.200603129; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Lensen JFM, 2005, J AM SOC NEPHROL, V16, P1279, DOI 10.1681/ASN.2004050413; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; LYON M, 1994, J BIOL CHEM, V269, P11216; Masola V, 2012, J BIOL CHEM, V287, P1478, DOI 10.1074/jbc.M111.279836; Mohammadi M, 2005, CURR OPIN STRUC BIOL, V15, P506, DOI 10.1016/j.sbi.2005.09.002; Mulloy B, 2006, BIOCHEM SOC T, V34, P409, DOI 10.1042/BST0340409; Rienstra H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009095; Robertson H, 2004, J AM SOC NEPHROL, V15, P390, DOI 10.1097/01.ASN.0000108521.39082.E1; Rops AL, 2008, KIDNEY INT, V73, P52, DOI 10.1038/sj.ki.5002573; Rosen SD, 2010, EXPERT OPIN THER TAR, V14, P935, DOI 10.1517/14728222.2010.504718; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Smeds E, 2003, BIOCHEM J, V372, P371, DOI 10.1042/BJ20021665; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200; Tatrai P, 2010, J HISTOCHEM CYTOCHEM, V58, P429, DOI 10.1369/jhc.2010.955161; ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200; van den Born J, 2005, J BIOL CHEM, V280, P20516, DOI 10.1074/jbc.M502065200; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; vandenBorn J, 1996, J BIOL CHEM, V271, P22802, DOI 10.1074/jbc.271.37.22802; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Wong WK, 2003, TRANSPLANTATION, V75, P505, DOI 10.1097/01.TP.0000045708.39879.C7; Yue XP, 2008, J BIOL CHEM, V283, P20397, DOI 10.1074/jbc.M802850200; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793	44	20	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20295	20306		10.1074/jbc.M114.554691	http://dx.doi.org/10.1074/jbc.M114.554691			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24878958	Green Published, hybrid			2022-12-25	WOS:000339395200041
J	Rainero, E; Cianflone, C; Porporato, PE; Chianale, F; Malacarne, V; Bettio, V; Ruffo, E; Ferrara, M; Benecchia, F; Capello, D; Paster, W; Locatelli, I; Bertoni, A; Filigheddu, N; Sinigaglia, F; Norman, JC; Baldanzi, G; Graziani, A				Rainero, Elena; Cianflone, Cristina; Porporato, Paolo Ettore; Chianale, Federica; Malacarne, Valeria; Bettio, Valentina; Ruffo, Elisa; Ferrara, Michele; Benecchia, Fabio; Capello, Daniela; Paster, Wolfgang; Locatelli, Irene; Bertoni, Alessandra; Filigheddu, Nicoletta; Sinigaglia, Fabiola; Norman, Jim C.; Baldanzi, Gianluca; Graziani, Andrea			The Diacylglycerol Kinase alpha/Atypical PKC/beta 1 Integrin Pathway in SDF-1 alpha Mammary Carcinoma Invasiveness	PLOS ONE			English	Article							BREAST-CANCER CELLS; ANCHORAGE-INDEPENDENT GROWTH; CHRONIC LYMPHOCYTIC-LEUKEMIA; ATYPICAL PKC-ZETA; MATRIX METALLOPROTEINASES; RAC ACTIVATION; ALPHA-4-BETA-1 INTEGRIN; TUMOR MICROENVIRONMENT; LUNG-CANCER; IN-VIVO	Diacylglycerol kinase a (DGK alpha), by phosphorylating diacylglycerol into phosphatidic acid, provides a key signal driving cell migration and matrix invasion. We previously demonstrated that in epithelial cells activation of DGK alpha activity promotes cytoskeletal remodeling and matrix invasion by recruiting atypical PKC at ruffling sites and by promoting RCP-mediated recycling of alpha 5 beta 1 integrin to the tip of pseudopods. In here we investigate the signaling pathway by which DGK alpha mediates SDF-1 alpha-induced matrix invasion of MDA-MB-231 invasive breast carcinoma cells. Indeed we showed that, following SDF-1 alpha stimulation, DGKa is activated and localized at cell protrusion, thus promoting their elongation and mediating SDF-1 alpha induced MMP-9 metalloproteinase secretion and matrix invasion. Phosphatidic acid generated by DGK alpha promotes localization at cell protrusions of atypical PKCs which play an essential role downstream of DGK alpha by promoting Rac-mediated protrusion elongation and localized recruitment of beta 1 integrin and MMP-9. We finally demonstrate that activation of DGK alpha, atypical PKCs signaling and beta 1 integrin are all essential for MDA-MB-231 invasiveness. These data indicates the existence of a SDF-1 alpha induced DGK alpha - atypical PKC - beta 1 integrin signaling pathway, which is essential for matrix invasion of carcinoma cells.	[Rainero, Elena; Norman, Jim C.; Baldanzi, Gianluca; Graziani, Andrea] Beatson Inst Canc Res, Integrin Biol Lab, Glasgow G61 1BD, Lanark, Scotland; [Cianflone, Cristina; Porporato, Paolo Ettore; Chianale, Federica; Malacarne, Valeria; Bettio, Valentina; Ruffo, Elisa; Ferrara, Michele; Benecchia, Fabio; Capello, Daniela; Locatelli, Irene; Bertoni, Alessandra; Filigheddu, Nicoletta; Sinigaglia, Fabiola] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy; [Paster, Wolfgang] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Beatson Institute; University of Eastern Piedmont Amedeo Avogadro; University of Oxford	Baldanzi, G (corresponding author), Beatson Inst Canc Res, Integrin Biol Lab, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.	gianluca.baldanzi@med.unipmn.it	Porporato, Paolo E./A-9932-2018; Graziani, Andrea/AAB-6301-2022; Locatelli, Irene/ABH-4738-2020; Capello, Daniela/J-4110-2012; Bettio, Valentina/AFT-9834-2022; graziani, andrea/B-2554-2009; Locatelli, Irene/AAN-3168-2020; Baldanzi, Gianluca/AAO-7673-2021; Ferrara, Michele/I-8849-2018; Filigheddu, Nicoletta/N-7219-2015	Porporato, Paolo E./0000-0001-8519-1552; Graziani, Andrea/0000-0002-6302-2317; Capello, Daniela/0000-0001-9157-8753; graziani, andrea/0000-0002-6302-2317; Baldanzi, Gianluca/0000-0002-1370-9903; Filigheddu, Nicoletta/0000-0002-3848-611X; Locatelli, Irene/0000-0002-8467-2132; Malacarne, Valeria/0000-0001-5893-8606; Ferrara, Michele/0000-0002-3142-483X; NORMAN, Jim/0000-0002-0098-3014; Paster, Wolfgang/0000-0002-5537-2886; Rainero, Elena/0000-0003-1402-8701; Ruffo, Elisa/0000-0003-1990-7377	AIRC, Italian Association for Cancer Research [IG 13524, IG 5392]; CARIPLO Foundation [2010-0737]; mobility grant of CIB, Consorzio Interuniversitario Biotecnologie; EMBO; University Piemonte Orientale; Compagnia di San Paolo; Fondo Di Solidarieta' Edo Tempia Valenta Per Lotta Contro I Tumori; Cancer Research UK [18277] Funding Source: researchfish	AIRC, Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); CARIPLO Foundation(Fondazione Cariplo); mobility grant of CIB, Consorzio Interuniversitario Biotecnologie; EMBO(European Molecular Biology Organization (EMBO)); University Piemonte Orientale; Compagnia di San Paolo(Compagnia di San Paolo); Fondo Di Solidarieta' Edo Tempia Valenta Per Lotta Contro I Tumori; Cancer Research UK(Cancer Research UK)	This work was supported by: AIRC, Italian Association for Cancer Research, (IG 13524 and IG 5392 grants) www.airc.it, and CARIPLO Foundation (2010-0737 grant) www.fondazionecariplo.it. CC was supported by a mobility grant of CIB, Consorzio Interuniversitario Biotecnologie www.cibiotech.it. GB was supported by EMBO (short term fellowships) www.embo.org and University Piemonte Orientale (Young Investigators) www.unipmn.it. VM was supported by Compagnia di San Paolo www.compagnia.torino.it/. DC was supported by Fondo Di Solidarieta' Edo Tempia Valenta Per Lotta Contro I Tumori www.fondoedotempia.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azab AK, 2009, BLOOD, V114, P619, DOI 10.1182/blood-2009-01-199281; Bacchiocchi R, 2005, BLOOD, V106, P2175, DOI 10.1182/blood-2005-01-0316; Baldanzi G, 2008, ONCOGENE, V27, P942, DOI 10.1038/sj.onc.1210717; Baldanzi G, 2004, ONCOGENE, V23, P4828, DOI 10.1038/sj.onc.1207633; BALDANZI G, 2011, CANC SCI; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Chen G, 2012, J BIOL CHEM, V287, P12132, DOI 10.1074/jbc.M111.302299; Chianale F, 2007, MOL BIOL CELL, V18, P4859, DOI 10.1091/mbc.E07-02-0177; Chianale F, 2010, P NATL ACAD SCI USA, V107, P4182, DOI 10.1073/pnas.0908326107; Cutrupi S, 2000, EMBO J, V19, P4614, DOI 10.1093/emboj/19.17.4614; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dominguez CL, 2013, CANCER DISCOV, V3, P782, DOI 10.1158/2159-8290.CD-12-0215; Fernandis AZ, 2004, ONCOGENE, V23, P157, DOI 10.1038/sj.onc.1206910; Filigheddu N, 2007, ANTICANCER RES, V27, P1489; Filigheddu N, 2011, CELL SIGNAL, V23, P1988, DOI 10.1016/j.cellsig.2011.07.009; Flores I, 1999, J IMMUNOL, V163, P708; Flores I, 1996, J BIOL CHEM, V271, P10334, DOI 10.1074/jbc.271.17.10334; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Itoh Y, 2002, ESSAYS BIOCHEM, V38, P21, DOI 10.1042/bse0380021; Kang H, 2005, BREAST CANCER RES, V7, pR402, DOI 10.1186/bcr1022; Kang H, 2005, INT J ONCOL, V26, P1429; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Korkaya H, 2011, J CLIN INVEST, V121, P3804, DOI 10.1172/JCI57099; Kumar A, 2011, J IMMUNOL, V186, P951, DOI 10.4049/jimmunol.1002019; Lapteva N, 2005, CANCER GENE THER, V12, P84, DOI 10.1038/sj.cgt.7700770; Legrand C, 1999, J CELL BIOL, V146, P517, DOI 10.1083/jcb.146.2.517; Li HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2680; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; Luker KE, 2006, CANCER LETT, V238, P30, DOI 10.1016/j.canlet.2005.06.021; MERIDA I, 2009, ADV ENZYME REGUL; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Morello V, 2011, ONCOGENE, V30, P4087, DOI 10.1038/onc.2011.107; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murray NR, 2011, J CELL PHYSIOL, V226, P879, DOI 10.1002/jcp.22463; Murray NR, 2004, J CELL BIOL, V164, P797, DOI 10.1083/jcb.200311011; Nabeshima K, 2002, PATHOL INT, V52, P255, DOI 10.1046/j.1440-1827.2002.01343.x; Odemis V, 2007, J CELL SCI, V120, P4050, DOI 10.1242/jcs.010009; Petit I, 2005, J CLIN INVEST, V115, P168, DOI 10.1172/JCI200521773; Rainero E, 2012, J CELL BIOL, V196, P277, DOI 10.1083/jcb.201109112; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Redondo-Munoz J, 2006, BLOOD, V108, P3143, DOI 10.1182/blood-2006-03-007294; Redondo-Munoz J, 2010, CANCER CELL, V17, P160, DOI 10.1016/j.ccr.2009.12.044; Sato M, 2013, PHARMACOLOGY, V92, P99, DOI 10.1159/000351849; SCHAAP D, 1990, FEBS LETT, V275, P151, DOI 10.1016/0014-5793(90)81461-V; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Takeishi K, 2012, J HEPATOL, V57, P77, DOI 10.1016/j.jhep.2012.02.026; Taulli R, 2005, CANCER GENE THER, V12, P456, DOI 10.1038/sj.cgt.7700815; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Trusolino L, 2000, FASEB J, V14, P1629, DOI 10.1096/fj.14.11.1629; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221; Yanagisawa K, 2007, BBA-MOL CELL BIOL L, V1771, P462, DOI 10.1016/j.bbalip.2006.12.008; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702; Yu YC, 2007, EUR J CANCER PREV, V16, P430, DOI 10.1097/01.cej.0000236259.88146.a4	54	26	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97144	10.1371/journal.pone.0097144	http://dx.doi.org/10.1371/journal.pone.0097144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887021	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300013
J	Tseng, CN; Karlof, E; Chang, YT; Lengquist, M; Rotzius, P; Berggren, PO; Hedin, U; Eriksson, EE				Tseng, Chi-Nan; Karlof, Eva; Chang, Ya-Ting; Lengquist, Mariette; Rotzius, Pierre; Berggren, Per-Olof; Hedin, Ulf; Eriksson, Einar E.			Contribution of Endothelial Injury and Inflammation in Early Phase to Vein Graft Failure: The Causal Factors Impact on the Development of Intimal Hyperplasia in Murine Models	PLOS ONE			English	Article							P-SELECTIN; NEOINTIMAL HYPERPLASIA; ARTERIAL INJURY; DEFICIENT; SUSCEPTIBILITY; PLATELET; CELLS	Objectives: Autologous veins are preferred conduits in by-pass surgery. However, long-term results are hampered by limited patency due to intimal hyperplasia. Although mechanisms involved in development of intimal hyperplasia have been established, the role of inflammatory processes is still unclear. Here, we studied leukocyte recruitment and intimal hyperplasia in inferior vena cava grafts transferred to abdominal aorta in mice. Methods and Results: Several microscopic techniques were used to study endothelium denudation and regeneration and leukocyte recruitment on endothelium. Scanning electron microscopy demonstrated denudation of vein graft endothelium 7 days post-transfer and complete endothelial regeneration by 28 days. Examination of vein grafts transferred to mice transgenic for green fluorescent protein under Tie2 promoter in endothelial cells showed regeneration of graft endothelium from the adjacent aorta. Intravital microscopy revealed recruitment of leukocytes in vein grafts at 7 days in wild type mice, which had tapered off by 28 days. At 28 and 63 days there was significant development of intimal hyperplasia. In contrast; no injury, leukocyte recruitment nor intimal hyperplasia occurred in arterial grafts. Leukocyte recruitment was reduced in vein grafts in mice deficient in E-and P-selectin. In parallel, intimal hyperplasia was reduced in vein grafts in mice deficient in E-and P-selectin and in wild type mice receiving P-selectin/E-selectin function-blocking antibodies. Conclusion: The results show that early phase endothelial injury and inflammation are crucial processes in intimal hyperplasia in murine vein grafts. The data implicate endothelial selectins as targets for intervention of vein graft disease.	[Tseng, Chi-Nan; Karlof, Eva; Chang, Ya-Ting; Lengquist, Mariette; Rotzius, Pierre; Hedin, Ulf; Eriksson, Einar E.] Karolinska Inst, Karolinska Univ Hosp, Dept Mol Med & Surg, Stockholm, Sweden; [Berggren, Per-Olof] Karolinska Inst, Karolinska Univ Hosp, Rolf Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Tseng, CN (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Mol Med & Surg, Stockholm, Sweden.	neon1995.tw@gmail.com		Berggren, Per-Olof/0000-0001-8991-413X; Hedin, Ulf/0000-0001-9212-3945; Tseng, Chi-Nan/0000-0003-2069-3636	Swedish Heart-Lung Foundation [20060691, 20080365, 20080606, 20090701]; Swedish Research Council [K2009-65X-2233-01-3]; Karolinska Institutet	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Heart-Lung Foundation (project number: 20060691, 20080365, 20080606 and 20090701), the Swedish Research Council (project number: K2009-65X-2233-01-3), and Karolinska Institutet. The sponsors had no role in the study design, data collection, data analysis, and interpretation of data. The sponsors were not involve in the writing of the manuscript or in the decision to submit the manuscript for publication.	Anggrahini DW, 2009, CARDIOVASC RES, V82, P143, DOI 10.1093/cvr/cvp026; Bullard DC, 1996, J EXP MED, V183, P2329, DOI 10.1084/jem.183.5.2329; Cooley BC, 1998, MICROSURG, V18, P234, DOI 10.1002/(SICI)1098-2752(1998)18:4<234::AID-MICR3>3.0.CO;2-J; Deb S, 2012, J AM COLL CARDIOL, V60, P28, DOI 10.1016/j.jacc.2012.03.037; Ehsan A, 2002, CIRCULATION, V105, P1686, DOI 10.1161/01.CIR.0000013775.02396.93; Eriksson EE, 2005, ARTERIOSCL THROM VAS, V25, P723, DOI 10.1161/01.ATV.0000157578.51417.6f; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; GRONDIN CM, 1984, J THORAC CARDIOV SUR, V87, P161; Itoh Y, 2010, ARTERIOSCL THROM VAS, V30, P1725, DOI 10.1161/ATVBAHA.110.207365; Jeremy JY, 2011, PHARMACOL RES, V63, P483, DOI 10.1016/j.phrs.2010.10.018; Jung U, 1999, J IMMUNOL, V162, P6755; Liehn EA, 2004, ARTERIOSCL THROM VAS, V24, P1891, DOI 10.1161/01.ATV.0000143135.71440.75; Nakao A, 2011, CARDIOVASC RES, V89, P457, DOI 10.1093/cvr/cvq298; Phillips JW, 2003, CIRCULATION, V107, P2244, DOI 10.1161/01.CIR.0000065604.56839.18; Rocha SF, 2009, ANGIOGENESIS, V12, P139, DOI 10.1007/s10456-009-9132-x; Salzberg SP, 2006, CIRCULATION, V114, pI302, DOI 10.1161/CIRCULATIONAHA.105.001339; Sata M, 2004, ARTERIOSCL THROM VAS, V24, P1147, DOI 10.1161/01.ATV.0000134296.22448.eb; Schachner T, 2004, ANN THORAC SURG, V77, P1580, DOI 10.1016/j.athoracsur.2003.10.008; Shyu KG, 2006, CARDIOVASC RES, V72, P359, DOI 10.1016/j.cardiores.2006.09.017; Soehnlein O, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002531; Sterpetti AV, 1996, J VASC SURG, V23, P568, DOI 10.1016/S0741-5214(96)80034-6; Thatte HS, 2001, ANN THORAC SURG, V72, pS2245, DOI 10.1016/S0003-4975(01)03272-6; Wang K, 2005, ARTERIOSCL THROM VAS, V25, P1584, DOI 10.1161/01.ATV.0000172687.01179.d4; Westerband A, 2001, J VASC SURG, V33, P561, DOI 10.1067/mva.2001.112230; Yoshioka T, 2006, CARDIOVASC RES, V70, P61, DOI 10.1016/j.cardiores.2005.12.013; Yu P, 2010, J VASC SURG, V52, P444, DOI 10.1016/j.jvs.2010.03.048; Zhang LS, 2004, ARTERIOSCL THROM VAS, V24, P2277, DOI 10.1161/01.ATV.0000147766.68987.0d; Zou YP, 2000, CIRC RES, V86, P434, DOI 10.1161/01.RES.86.4.434; Zou YP, 1998, AM J PATHOL, V153, P1301, DOI 10.1016/S0002-9440(10)65675-1	29	32	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98904	10.1371/journal.pone.0098904	http://dx.doi.org/10.1371/journal.pone.0098904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887332	Green Submitted, gold, Green Published			2022-12-25	WOS:000336956300121
J	Woltmann, A; Chen, BW; Lascorz, J; Johansson, R; Eyfjord, JE; Hamann, U; Manjer, J; Enquist-Olsson, K; Henriksson, R; Herms, S; Hoffmann, P; Hemminki, K; Lenner, P; Forsti, A				Woltmann, Andrea; Chen, Bowang; Lascorz, Jesus; Johansson, Robert; Eyfjord, Jorunn E.; Hamann, Ute; Manjer, Jonas; Enquist-Olsson, Kerstin; Henriksson, Roger; Herms, Stefan; Hoffmann, Per; Hemminki, Kari; Lenner, Per; Forsti, Asta			Systematic Pathway Enrichment Analysis of a Genome-Wide Association Study on Breast Cancer Survival Reveals an Influence of Genes Involved in Cell Adhesion and Calcium Signaling on the Patients' Clinical Outcome	PLOS ONE			English	Article							METASTASIS; SIGNATURE; RISK	Genome-wide association studies (GWASs) may help to understand the effects of genetic polymorphisms on breast cancer (BC) progression and survival. However, they give only a focused view, which cannot capture the tremendous complexity of this disease. Therefore, we investigated data from a previously conducted GWAS on BC survival for enriched pathways by different enrichment analysis tools using the two main annotation databases Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). The goal was to identify the functional categories (GO terms and KEGG pathways) that are consistently overrepresented in a statistically significant way in the list of genes generated from the single nucleotide polymorphism (SNP) data. The SNPs with allelic p-value cut-offs 0.005 and 0.01 were annotated to the genes by excluding or including a 20 kb up-and down-stream sequence of the genes and analyzed by six different tools. We identified eleven consistently enriched categories, the most significant ones relating to cell adhesion and calcium ion binding. Moreover, we investigated the similarity between our GWAS and the enrichment analyses of twelve published gene expression signatures for breast cancer prognosis. Five of them were commonly used and commercially available, five were based on different aspects of metastasis formation and two were developed from meta-analyses of published prognostic signatures. This comparison revealed similarities between our GWAS data and the general and the specific brain metastasis gene signatures as well as the Oncotype DX signature. As metastasis formation is a strong indicator of a patient's prognosis, this result reflects the survival aspect of the conducted GWAS and supports cell adhesion and calcium signaling as important pathways in cancer progression.	[Woltmann, Andrea; Chen, Bowang; Lascorz, Jesus; Hemminki, Kari; Forsti, Asta] German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany; [Johansson, Robert; Henriksson, Roger; Lenner, Per] Umea Univ, Dept Radiat Sci & Oncol, Umea, Sweden; [Eyfjord, Jorunn E.] Univ Iceland, Fac Med, Canc Res Lab, Reykjavik, Iceland; [Hamann, Ute] German Canc Res Ctr, Heidelberg, Germany; [Manjer, Jonas] Lund Univ, Malmo Diet & Canc Study, Malmo, Sweden; [Manjer, Jonas] Skane Univ Hosp, Dept Plast Surg, Malmo, Sweden; [Manjer, Jonas] Lund Univ, Malmo, Sweden; [Enquist-Olsson, Kerstin] Umea Univ, Dept Publ Hlth & Clin Med Nutr, Umea, Sweden; [Henriksson, Roger] Canc Ctr Stockholm Gotland, Stockholm, Sweden; [Herms, Stefan; Hoffmann, Per] Univ Bonn, Inst Human Genet, Dept Genom, Bonn, Germany; [Herms, Stefan; Hoffmann, Per] Univ Basel, Div Med Genet, Basel, Switzerland; [Herms, Stefan; Hoffmann, Per] Univ Basel, Dept Biomed, Basel, Switzerland; [Hemminki, Kari; Forsti, Asta] Lund Univ, Clin Res Ctr, Ctr Primary Hlth Care Res, Malmo, Sweden	Helmholtz Association; German Cancer Research Center (DKFZ); Umea University; University of Iceland; Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; Lund University; Skane University Hospital; Lund University; Umea University; University of Bonn; University of Basel; University of Basel; Lund University	Woltmann, A (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, Heidelberg, Germany.	a.woltmann@dkfz-heidelberg.de	Herms, Stefan/J-1949-2014; Hoffmann, Per/A-5149-2010; Henriksson, Roger/AAI-8608-2020	Herms, Stefan/0000-0002-2786-8200; Hoffmann, Per/0000-0002-6573-983X; 	EU 6th framework grant Cancer Control using Population-based Registries and Biobanks (CCPRB) [LSHC-CT-2004-503465]	EU 6th framework grant Cancer Control using Population-based Registries and Biobanks (CCPRB)	The genome-wide association study was supported by the EU 6th framework grant Cancer Control using Population-based Registries and Biobanks (CCPRB, LSHC-CT-2004-503465). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Azzato EM, 2010, J NATL CANCER I, V102, P650, DOI 10.1093/jnci/djq057; Azzato EM, 2010, CANCER EPIDEM BIOMAR, V19, P1140, DOI 10.1158/1055-9965.EPI-10-0085; Baum B, 2011, J CELL BIOL, V192, P907, DOI 10.1083/jcb.201009141; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Gyorffy B, 2009, BREAST CANCER RES TR, V118, P433, DOI 10.1007/s10549-008-0242-8; Hemminki K, 2008, BREAST CANCER RES TR, V110, P177, DOI 10.1007/s10549-007-9692-7; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kaaks R, 2002, CANCER CAUSE CONTROL, V13, P307, DOI 10.1023/A:1015270324325; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Lascorz J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018867; Lauss M, 2008, BREAST CANCER RES TR, V110, P235, DOI 10.1007/s10549-007-9716-3; Li SF, 2008, ADV CANCER RES, V101, P45, DOI 10.1016/S0065-230X(08)00403-X; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Manjer J, 2001, EUR J CANCER PREV, V10, P489, DOI 10.1097/00008469-200112000-00003; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pukkala E, 2007, ACTA ONCOL, V46, P286, DOI 10.1080/02841860701203545; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Shu XO, 2012, CANCER RES, V72, P1182, DOI 10.1158/0008-5472.CAN-11-2561; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tryggvadottir L, 2006, JNCI-J NATL CANCER I, V98, P116, DOI 10.1093/jnci/djj012; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1	34	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98229	10.1371/journal.pone.0098229	http://dx.doi.org/10.1371/journal.pone.0098229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886783	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300049
J	Chuang, YW; Chang, WM; Chen, KH; Hong, CZ; Chang, PJ; Hsu, HC				Chuang, Yi-Wen; Chang, Wen-Ming; Chen, Kai-Hua; Hong, Chang-Zern; Chang, Pey-Jium; Hsu, Hung-Chih			Lysophosphatidic Acid Enhanced the Angiogenic Capability of Human Chondrocytes by Regulating Gi/NF-kappa B-Dependent Angiogenic Factor Expression	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; OVARIAN-CANCER CELLS; ENDOTHELIAL-CELLS; INTERLEUKIN-8; PATHWAY; LYSOPHOSPHOLIPIDS; TRANSACTIVATION; DIFFERENTIATION; PROLIFERATION; OSTEOBLASTS	Lysophosphatidic acid (LPA) has been found to mediate myeloid differentiation, stimulate osteogenesis, alter cell proliferation and migration, and inhibit apoptosis in chondrocytes. The effect of LPA on the angiogenic capability of chondrocytes is not clear. This study aimed to investigate its effect on the angiogenic capability of human chondrocytes and the underlying mechanism of these effects. Human chondrocyte cell line, CHON-001, commercialized human chondrocytes (HC) derived from normal human articular cartilage, and human vascular endothelial cells (HUVECs) were used as cell models in this study. The angiogenic capability of chondrocytes was determined by capillary tube formation, monolayer permeability, cell migration, and cell proliferation. An angiogenesis protein array kit was used to evaluate the secretion of angiogenic factors in conditioned medium. Angiogenin, insulin-like growth factor-binding protein 1 (IGFBP-1), interleukin (IL)-8, monocyte chemoattractant protein-1 (MCP-1), matrix metalloproteinase (MMP)-9, and vascular endothelial growth factor (VEGF) mRNA and protein expressions were evaluated by Q-RT-PCR and EIA, respectively. LPA receptor (LPAR) expression was determined by RT-PCR. Signaling pathways were clarified using inhibitors, Western blot analysis, and reporter assays. The LPA treatment promoted the angiogenic capability of CHON-001 cells and HC, resulting in enhanced HUVEC capillary tube formation, monolayer permeability, migration, and cell growth. Angiogenin, IGFBP-1, IL-8, MCP-1, MMP-9, and VEGF mRNA and protein expressions were significantly enhanced in LPA-treated chondrocytes. LPA2, 3, 4 and 6 were expressed in CHON-001 and HC cells. Pretreatment with the Gi/o type G protein inhibitor, pertussis toxin (PTX), and the NF-kappa B inhibitor, PDTC, significantly inhibited LPA-induced angiogenin, IGFBP-1, IL-8, MCP-1, MMP-9, and VEGF expressions in chondrocytes. The PTX pretreatment also inhibited LPA-mediated NF-kappa B activation, suggesting the presence of active Gi/NF-kappa B signaling in CHON-001 and HC cells. The effect of LPA on the angiogenesis-inducing capacity of chondrocytes may be due to the increased angiogenesis factor expression via the Gi/NF-kappa B signaling pathway.	[Chuang, Yi-Wen; Chang, Wen-Ming; Chen, Kai-Hua; Hsu, Hung-Chih] Chia Yi Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Chiayi, Taiwan; [Chuang, Yi-Wen; Chang, Wen-Ming; Chen, Kai-Hua; Hsu, Hung-Chih] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi, Taiwan; [Hong, Chang-Zern] HungKuang Univ, Dept Phys Therapy, Taichung, Taiwan; [Chang, Pey-Jium; Hsu, Hung-Chih] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Hungkuang University; Chang Gung University	Hsu, HC (corresponding author), Chia Yi Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Chiayi, Taiwan.	dr.tonyhsu@gmail.com		Chang, Pey-Jium/0000-0002-6492-0346	Chang Gung Memorial Hospital [CMRPG6B0481]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	The funding was from the research grant of Chang Gung Memorial Hospital ( Grant Number: CMRPG6B0481, website:www.cgmh.org.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi M, 2009, OSTEOARTHR CARTILAGE, V17, P271, DOI 10.1016/j.joca.2008.06.019; Aki Y, 2008, ARCH ORAL BIOL, V53, P207, DOI 10.1016/j.archoralbio.2007.08.006; Burke SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046986; Cecil DL, 2005, ARTHRITIS RHEUM-US, V52, P144, DOI 10.1002/art.20748; Chen RJ, 2012, INT J CANCER, V131, P789, DOI 10.1002/ijc.26476; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Chou CH, 2009, INT J RADIAT ONCOL, V75, P1553, DOI 10.1016/j.ijrobp.2009.08.034; Chou CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066268; DeNiro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059021; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Evseenko D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063718; Fang XJ, 2000, ANN NY ACAD SCI, V905, P188; Gotoh M, 2012, BIOCHEM SOC T, V40, P31, DOI 10.1042/BST20110608; Gschwind A, 2002, CANCER RES, V62, P6329; Hurst-Kennedy J, 2010, J STEROID BIOCHEM, V122, P264, DOI 10.1016/j.jsbmb.2010.05.010; Karsenty G, 2001, ENDOCRINOLOGY, V142, P2731, DOI 10.1210/en.142.7.2731; Kim KW, 2009, SPINE J, V9, P323, DOI 10.1016/j.spinee.2008.05.003; Kim MK, 2005, BIOCHEM PHARMACOL, V70, P1764, DOI 10.1016/j.bcp.2005.09.015; KING TV, 1991, J BONE JOINT SURG BR, V73, P587, DOI 10.1302/0301-620X.73B4.1712788; Kriegel MA, 2012, P NATL ACAD SCI USA, V109, P3457, DOI 10.1073/pnas.1115308109; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lim HD, 2012, J PINEAL RES, V53, P225, DOI 10.1111/j.1600-079X.2012.00991.x; Lin CL, 2007, BIOCHEM BIOPH RES CO, V363, P1001, DOI 10.1016/j.bbrc.2007.09.081; Maes C, 2002, MECH DEVELOP, V111, P61, DOI 10.1016/S0925-4773(01)00601-3; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Murph M, 2006, CLIN CANCER RES, V12, P6598, DOI 10.1158/1078-0432.CCR-06-1721; Nadra R, 2003, J CELL BIOCHEM, V88, P911, DOI 10.1002/jcb.10396; Ortega N, 2010, DIS MODEL MECH, V3, P224, DOI 10.1242/dmm.004226; Pages C, 2001, PROSTAG OTH LIPID M, V64, P1, DOI 10.1016/S0090-6980(01)00110-1; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; Petreaca ML, 2007, MOL BIOL CELL, V18, P5014, DOI 10.1091/mbc.E07-01-0004; Santhekadur PK, 2012, J BIOL CHEM, V287, P13952, DOI 10.1074/jbc.M111.321646; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; Schwartz BM, 2001, GYNECOL ONCOL, V81, P291, DOI 10.1006/gyno.2001.6124; Segar CE, 2013, CURR PHARM DESIGN, V19, P3403, DOI 10.2174/1381612811319190007; Strakova Z, 2000, ENDOCRINOLOGY, V141, P4664, DOI 10.1210/en.141.12.4664; Tigyi G, 2010, BRIT J PHARMACOL, V161, P241, DOI 10.1111/j.1476-5381.2010.00815.x; Tseng HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057955; Xu XY, 2010, CANCER-AM CANCER SOC, V116, P1739, DOI 10.1002/cncr.24907; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Zelzer E, 2002, DEVELOPMENT, V129, P1893	42	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e95180	10.1371/journal.pone.0095180	http://dx.doi.org/10.1371/journal.pone.0095180			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879414	Green Published, gold, Green Submitted			2022-12-25	WOS:000338101500002
J	Seo, AN; Kwak, Y; Kim, DW; Kang, SB; Choe, G; Kim, WH; Lee, HS				Seo, An Na; Kwak, Yoonjin; Kim, Duck-Woo; Kang, Sung-Bum; Choe, Gheeyoung; Kim, Woo Ho; Lee, Hye Seung			HER2 Status in Colorectal Cancer: Its Clinical Significance and the Relationship between HER2 Gene Amplification and Expression	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; CETUXIMAB PLUS IRINOTECAN; PHASE-II TRIAL; BREAST-CANCER; GASTRIC-CANCER; MONOCLONAL-ANTIBODIES; PROGNOSTIC-FACTOR; RECTAL-CANCER; NEU ONCOGENE; SURVIVAL	This study aimed at determining the incidence and clinical implications of HER2 status in primary colorectal cancer (CRC). HER2 status was investigated in two retrospective cohorts of 365 consecutive CRC patients (cohort 1) and 174 advanced CRC patients with synchronous or metachronous distant metastasis (cohort 2). HER2 status was determined by performing dual-color silver in-situ hybridization (SISH), mRNA in-situ hybridization (ISH), and immunohistochemistry (IHC). The incidence of HER2 protein overexpression (IHC 2+/3+) was approximately 6% (22 of 365 in cohort 1; 10 of 174 in cohort 2). HER2 gene amplification was observed in 5.8% of the patients from cohort 1 and 6.3% of the patients from cohort 2. HER2 gene amplification was more frequently observed in CRCs located in the rectum than in the right and left colon (P = 0.013 in cohort 1; P = 0.009 in cohort 2). HER2 status, determined by IHC, ISH, and dual-color SISH, was not significantly associated with aggressive CRC behaviour or patients' prognosis in both the cohorts. Of the combined cohort with a total of 539 cases, the concordance rate was 95.5% between dual-color SISH and IHC detection methods. On excluding equivocally immunostained cases (IHC 2+), the concordance rate was 97.7%. HER2 mRNA overtranscription, detected by ISH, significantly correlated with protein overexpression and gene amplification (P<0.001). HER2 gene amplification was identified in a minority of CRC patients with high concordance rates between dual-color SISH and IHC detection methods. Although HER2 status did not predict patients' prognosis, our findings may serve as a basis for future studies on patient selection for HER2 targeted therapy.	[Seo, An Na] Kyungpook Natl Univ, Sch Med, Kyungpook Natl Univ Hosp, Dept Pathol, Taegu, South Korea; [Kwak, Yoonjin; Choe, Gheeyoung; Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Kim, Duck-Woo; Kang, Sung-Bum] Seoul Natl Univ, Bundang Hosp, Dept Surg, Songnam, South Korea; [Choe, Gheeyoung; Lee, Hye Seung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, South Korea	Kyungpook National University; Kyungpook National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Lee, HS (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, South Korea.	hye2@snu.ac.kr	Lee, Hye Seung/G-6419-2011	Lee, Hye Seung/0000-0002-1667-7986	Seoul National University Bundang Hospital Research Fund [02-2013-041]	Seoul National University Bundang Hospital Research Fund	This study was supported by grant number 02-2013-041 from the Seoul National University Bundang Hospital Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Blok EJ, 2013, CLIN MED INSIGHTS-ON, V7, P41, DOI 10.4137/CMO.S10811; Boers JE, 2011, HISTOPATHOLOGY, V58, P383, DOI 10.1111/j.1365-2559.2011.03760.x; Budinska E, 2013, J PATHOL, V231, P63, DOI 10.1002/path.4212; Clark JW, 2003, P AM SOC CLIN ONCOL, V22; Conradi LC, 2013, AM J SURG PATHOL, V37, P522, DOI 10.1097/PAS.0b013e318272ff4d; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Edge S, 2010, AJCC CANC STAGING MA, V7th; Essapen S, 2004, INT J ONCOL, V24, P241; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Gschwind A, 2004, NAT REV CANCER, V4, P361, DOI 10.1038/nrc1360; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kavanagh DO, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-1; Kim MA, 2013, HUM PATHOL, V44, P487, DOI 10.1016/j.humpath.2012.06.022; Korkaya H, 2013, CANCER RES, V73, P3489, DOI 10.1158/0008-5472.CAN-13-0260; Kruszewski WJ, 2010, DIS MARKERS, V29, P207, DOI [10.1155/2010/109063, 10.3233/DMA-2010-0742]; Langer R, 2011, MODERN PATHOL, V24, P908, DOI 10.1038/modpathol.2011.52; Lech G, 2014, NEOPLASMA, V61, P1, DOI 10.4149/neo_2014_003; Lee HE, 2013, EUR J CANCER, V49, P1448, DOI 10.1016/j.ejca.2012.10.018; Lee HS, 2007, CLIN CANCER RES, V13, P4154, DOI 10.1158/1078-0432.CCR-07-0173; Marsoni S, 2013, J CLIN ONCOL, V31; Marx AH, 2010, HUM PATHOL, V41, P1577, DOI 10.1016/j.humpath.2010.02.018; Mojarad EN, 2013, IMMUNOTHERAPY-UK, V5, P1267, DOI 10.2217/imt.13.131; Oh JR, 2012, FAM CANCER, V11, P459, DOI 10.1007/s10689-012-9536-4; Osako T, 1998, ONCOLOGY-BASEL, V55, P548, DOI 10.1159/000011911; Park DI, 2007, INT J COLORECTAL DIS, V22, P491, DOI 10.1007/s00384-006-0192-8; Prins MJD, 2013, ANN ONCOL, V24, P1290, DOI 10.1093/annonc/mds640; Ramanathan RK, 2004, CANCER INVEST, V22, P858, DOI 10.1081/CNV-200039645; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Rossi HA, 2002, CANCER J, V8, P268, DOI 10.1097/00130404-200205000-00011; Schoppmann SF, 2010, AM J SURG PATHOL, V34, P1868, DOI 10.1097/PAS.0b013e3181f8be17; Sclafani F, 2013, ANN ONCOL, V24, P3123, DOI 10.1093/annonc/mdt408; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tafe LJ, 2011, ARCH PATHOL LAB MED, V135, P1460, DOI 10.5858/arpa.2010-0541-OA; TANDON AK, 1989, J CLIN ONCOL, V7, P1120, DOI 10.1200/JCO.1989.7.8.1120; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	41	106	117	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98528	10.1371/journal.pone.0098528	http://dx.doi.org/10.1371/journal.pone.0098528			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879338	gold, Green Published, Green Submitted			2022-12-25	WOS:000338101500067
J	Pereira, ACF; Fonseca, FSA; Mota, GR; Fernandes, AKC; Fagundes, M; Reis-Junior, R; Faria, ML				Pereira, Anielle C. F.; Fonseca, Francine S. A.; Mota, Gleicielle R.; Fernandes, Ane K. C.; Fagundes, Marcilio; Reis-Junior, Ronaldo; Faria, Mauricio L.			Ecological Interactions Shape the Dynamics of Seed Predation in Acrocomia aculeata (Arecaceae)	PLOS ONE			English	Article							INSECT HERBIVORES; FUNGI; BEETLES; COMMUNITY; IMPACT; PLANTS; ANTS; COLONIZATION; POPULATIONS; DISPERSERS	Background: The complex network of direct and indirect relationships determines not only the species abundances but also the community characteristics such as diversity and stability. In this context, seed predation is a direct interaction that affects the reproductive success of the plant. For Acrocomia aculeata, the seed predation by Pachymerus cardo and Speciomerus revoili in post-dispersal may destroy more than 70% of the propagules and is influenced by the herbivory of the fruits during pre-dispersal. Fruits of plants with a higher level of herbivory during pre-dispersal are less attacked by predators in post-dispersal. We proposed a hypothesis that describes this interaction as an indirect defense mediated by fungi in a multitrophic interaction. As explanations, we proposed the predictions: i) injuries caused by herbivores in the fruits of A. aculeata favor fungal colonization and ii) the colonization of A. acuelata fruit by decomposing fungi reduces the selection of the egg-laying site by predator. Methodology/Principal Findings: For prediction (i), differences in the fungal colonization in fruits with an intact or damaged epicarp were evaluated in fruits exposed in the field. For prediction (ii), we performed fruit observations in the field to determine the number of eggs of P. cardo and/or S. revoili per fruit and the amount of fungal colonization in the fruits. In another experiment, in the laboratory, we use P. cardo females in a triple-choice protocol. Each insect to choose one of the three options: healthy fruits, fruits with fungus, or an empty pot. The proposed hypothesis was corroborated. Fruits with injuries in the epicarp had a higher fungal colonization, and fruits colonized by fungi were less attractive for egg-laying by seed predators. Conclusion/Significance: This study emphasizes the importance of exploring the networks of interactions between multitrophic systems to understand the dynamics and maintenance of natural populations.	[Pereira, Anielle C. F.; Mota, Gleicielle R.; Fernandes, Ane K. C.; Fagundes, Marcilio; Reis-Junior, Ronaldo; Faria, Mauricio L.] Univ Estadual Montes Claros, Dept Gen Biol, Montes Claros, MG, Brazil; [Fonseca, Francine S. A.] Univ Estadual Campinas, Inst Chem, Campinas, SP, Brazil; [Fonseca, Francine S. A.] Univ Fed Minas Gerais, Inst Agr Sci, Montes Claros, MG, Brazil	Universidade Estadual de Montes Claros; Universidade Estadual de Campinas; Universidade Federal de Minas Gerais	Pereira, ACF (corresponding author), Univ Estadual Montes Claros, Dept Gen Biol, Montes Claros, MG, Brazil.	aniellecristina@gmail.com	Fagundes, Marcilio/Y-7784-2019; Reis Junior, Ronaldo/E-2353-2016; Faria, Mauricio L/E-2415-2016; Fonseca, Francine/AAQ-1528-2020; de Faria, Maurício/AAS-5253-2020	Fagundes, Marcilio/0000-0001-5915-6331; de Faria, Maurício/0000-0003-4976-1874	Petroleo Brasileiro SA (Petrobras); intervention Foundation Arthur Bernardes (Funarbe) [0050.0061571.10.9.]	Petroleo Brasileiro SA (Petrobras); intervention Foundation Arthur Bernardes (Funarbe)	This paper was funded by Petroleo Brasileiro SA (Petrobras), with the intervention Foundation Arthur Bernardes (Funarbe), through the project: Desenvolvimento tecnologico para exploracao sustentavel da macauba (Acrocomia aculeata) - Subproject I, grant number 0050.0061571.10.9. Website:http://www.petrobras.com.br/pt/ The funders had role in decision to publish. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	ABRAMS PA, 1995, AM NAT, V146, P112, DOI 10.1086/285789; Agarwal VM, 2007, J APPL ENTOMOL, V131, P493, DOI 10.1111/j.1439-0418.2007.01197.x; Almeida S. P., 1998, CERRADO APROVEITAMEN; Amarasekare P, 2003, J ANIM ECOL, V72, P713, DOI 10.1046/j.1365-2656.2003.00744.x; ANDERSEN AN, 1989, OECOLOGIA, V81, P310, DOI 10.1007/BF00377076; ANDERSON RC, 1986, NEW PHYTOL, V102, P523, DOI 10.1111/j.1469-8137.1986.tb00828.x; Begon M, 2006, ECOLGY INDIVIDUALS E; Bennett AE, 2006, AM NAT, V167, P141, DOI 10.1086/499379; Birch ANE, 1989, POLSKIE PISMO ENTOMO, V57, P3; Carrenho Rosilaine, 2007, Acta Bot. Bras., V21, P723, DOI 10.1590/S0102-33062007000300018; CENTER TD, 1974, ECOLOGY, V55, P1096, DOI 10.2307/1940359; CHRISTENSEN M, 1989, MYCOLOGIA, V81, P1, DOI 10.2307/3759446; Clement CR, 2005, AGROCIENCIAS, V9, P67; Cornelissen TG, 2001, AUSTRAL ECOL, V26, P246, DOI 10.1046/j.1442-9993.2001.01109.x; Crawley M. J, 2002, STAT COMPUTING INTRO; CRIST TO, 1993, ECOLOGY, V74, P2231, DOI 10.2307/1939576; DasSilva F. R., 2007, REV BRASILEIRA BIOCI, V5, P681; Del-Claro K, 2004, NEOTROP ENTOMOL, V33, P665, DOI 10.1590/S1519-566X2004000600002; Delobel A, 1995, AMAZONIANA, V13, P209; Donatti CI, 2009, ECOL RES, V24, P1187, DOI 10.1007/s11284-009-0601-x; Dostal P, 2010, BASIC APPL ECOL, V11, P676, DOI 10.1016/j.baae.2010.10.001; Faeth SH, 2002, OIKOS, V98, P25, DOI 10.1034/j.1600-0706.2002.980103.x; Fagundes M, 2005, ECOL ENTOMOL, V30, P28, DOI 10.1111/j.0307-6946.2005.00668.x; Gallery RE, 2007, ECOLOGY, V88, P582, DOI 10.1890/05-1207; GUIMARAES D. P., 2010, INDICES PLUVIOMETRIC; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Horn BW, 2006, CAN J MICROBIOL, V52, P951, DOI 10.1139/W06-050; HUANG CF, 1991, OECOLOGIA, V85, P530, DOI 10.1007/BF00323765; Instituto Nacional de Metereologia, 2013, BANC DAD MET ENS PES; JANZEN D H, 1971, Principes, V15, P89; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; JANZEN DH, 1980, J ECOL, V68, P929, DOI 10.2307/2259466; JANZEN DH, 1977, AM NAT, V111, P691, DOI 10.1086/283200; Johnson Clarence Dan, 1995, Principes, V39, P25; Karimzadeh J, 2013, J INSECT BEHAV, V26, P35, DOI 10.1007/s10905-012-9331-y; KREMER RJ, 1993, ECOL APPL, V3, P42, DOI 10.2307/1941791; Kruess A, 2002, OECOLOGIA, V130, P563, DOI 10.1007/s00442-001-0829-9; Lee Eun-Hwa, 2012, Mycobiology, V40, P168, DOI 10.5941/MYCO.2012.40.3.168; Leishman M. R., 2000, SEEDS ECOLOGY REGENE, P31, DOI [DOI 10.1126/science.1156831, DOI 10.1079/9780851994321.0031]; Lorenzi G.M.A.C., 2006, VISAO ACAD, V7; MADEJ CW, 1991, OECOLOGIA, V88, P296, DOI 10.1007/BF00320825; Miller T.E., 1987, P33; MILLER TE, 1994, AM NAT, V143, P1007, DOI 10.1086/285646; MILLS JT, 1983, PHYTOPATHOLOGY, V73, P330, DOI 10.1094/Phyto-73-330; Miranda IPA, 2001, FRUTOS PALMEIRAS AMA, P7; Mooney KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034403; Mordecai EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039083; Mouttet R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018840; NAKAMURA RR, 1995, OECOLOGIA, V102, P324, DOI 10.1007/BF00329799; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; Paris CI, 2011, PLANT SIGNAL BEHAV, V6, P547, DOI 10.4161/psb.6.4.14839; Pires TP, 2013, IND CROP PROD, V44, P200, DOI 10.1016/j.indcrop.2012.09.029; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Price PW., 1997, INSECT ECOLOGY, V3rd edn; Ramirez N, 2010, PERSPECT PLANT ECOL, V12, P193, DOI 10.1016/j.ppees.2010.04.001; Ramos F. A., 2001, Brazilian Journal of Biology, V61, P449, DOI 10.1590/S1519-69842001000300014; Ribeiro SP, 2006, J ECOL, V94, P932, DOI 10.1111/j.1365-2745.2006.01133.x; Saari S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009845; SCARIOT A, 1995, BIOTROPICA, V27, P168, DOI 10.2307/2388992; Scariot Aldicir, 1998, Principes, V42, P5; SCARIOT AO, 1991, BIOTROPICA, V23, P12, DOI 10.2307/2388683; Schafer M, 2004, PLANT ECOL, V175, P19, DOI 10.1023/B:VEGE.0000048096.00772.23; SCHOWALTER T. D., 2006, INSECT ECOLOGY ECOSY; Secretaria Municipal de Desenvolvimento Economico Turismo Ciencia e Tecnologia, 2013, COL INF MUN MONT CLA; Shepherd VE, 1998, J TROP ECOL, V14, P199, DOI 10.1017/S0266467498000169; Silvius KM, 2002, J ECOL, V90, P1024, DOI 10.1046/j.1365-2745.2002.00728.x; STANFORD N. P., 2005, ECOLOGIA MANEJO PATO, P61; Steffler Carla Elisabete, 2008, Palms, V52, P133; STRAUSS SY, 1991, TRENDS ECOL EVOL, V6, P206, DOI 10.1016/0169-5347(91)90023-Q; Tack AJM, 2013, FUNCT ECOL, V27, P633, DOI 10.1111/1365-2435.12087; Tariq M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069013; Thompson JN, 1999, SCIENCE, V284, P2116, DOI 10.1126/science.284.5423.2116; Torres-Alruiz MD, 2013, ECOL MODEL, V250, P363, DOI 10.1016/j.ecolmodel.2012.11.024; Tscharntke T., 2002, MULTITROPHIC LEVEL I; WEBBER J, 1981, NATURE, V292, P449, DOI 10.1038/292449a0; Wicklow DT, 1983, FUNGAL COMMUNITY ITS; WOOTTON JT, 1993, AM NAT, V141, P71, DOI 10.1086/285461; WRIGHT SJ, 1990, OIKOS, V58, P272, DOI 10.2307/3545217	79	16	16	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98026	10.1371/journal.pone.0098026	http://dx.doi.org/10.1371/journal.pone.0098026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875386	Green Submitted, Green Published, gold			2022-12-25	WOS:000336790800021
J	Schulte, EC; Schramm, K; Schurmann, C; Lichtner, P; Herder, C; Roden, M; Gieger, C; Peters, A; Trenkwalder, C; Hogl, B; Frauscher, B; Berger, K; Fietze, I; Gross, N; Stiasny-Kolster, K; Oertel, W; Bachmann, CG; Paulus, W; Zimprich, A; Volzke, H; Schminke, U; Nauck, M; Illig, T; Meitinger, T; Muller-Myhsok, B; Prokisch, H; Winkelmann, J				Schulte, Eva C.; Schramm, Katharina; Schurmann, Claudia; Lichtner, Peter; Herder, Christian; Roden, Michael; Gieger, Christian; Peters, Annette; Trenkwalder, Claudia; Hoegl, Birgit; Frauscher, Birgit; Berger, Klaus; Fietze, Ingo; Gross, Nadine; Stiasny-Kolster, Karin; Oertel, Wolfgang; Bachmann, Cornelius G.; Paulus, Walter; Zimprich, Alexander; Voelzke, Henry; Schminke, Ulf; Nauck, Matthias; Illig, Thomas; Meitinger, Thomas; Mueller-Myhsok, Bertram; Prokisch, Holger; Winkelmann, Juliane			Blood cis-eQTL Analysis Fails to Identify Novel Association Signals among Sub-Threshold Candidates from Genome-Wide Association Studies in Restless Legs Syndrome	PLOS ONE			English	Article							GENE-EXPRESSION; RISK; POPULATION; DISEASE; HEALTH; KORA; VARIANTS; LINKAGE; TRAITS; COHORT	Restless legs syndrome (RLS) is a common neurologic disorder characterized by nightly dysesthesias affecting the legs primarily during periods of rest and relieved by movement. RLS is a complex genetic disease and susceptibility factors in six genomic regions have been identified by means of genome-wide association studies (GWAS). For some complex genetic traits, expression quantitative trait loci (eQTLs) are enriched among trait-associated single nucleotide polymorphisms (SNPs). With the aim of identifying new genetic susceptibility factors for RLS, we assessed the 332 best-associated SNPs from the genome-wide phase of the to date largest RLS GWAS for cis-eQTL effects in peripheral blood from individuals of European descent. In 740 individuals belonging to the KORA general population cohort, 52 cis-eQTLs with p(nominal) < 10(-3) were identified, while in 976 individuals belonging to the SHIP-TREND general population study 53 cis-eQTLs with p(nominal) < 10(-3) were present. 23 of these cis-eQTLs overlapped between the two cohorts. Subsequently, the twelve of the 23 cis-eQTL SNPs, which were not located at an already published RLS-associated locus, were tested for association in 2449 RLS cases and 1462 controls. The top SNP, located in the DET1 gene, was nominally significant (p < 0.05) but did not withstand correction for multiple testing (p = 0.42). Although a similar approach has been used successfully with regard to other complex diseases, we were unable to identify new genetic susceptibility factor for RLS by adding this novel level of functional assessment to RLS GWAS data.	[Schulte, Eva C.; Gross, Nadine; Winkelmann, Juliane] Tech Univ Munich, Klinikum Rechts Isar, Neurol Klin & Poliklin, D-80290 Munich, Germany; [Schulte, Eva C.; Schramm, Katharina; Meitinger, Thomas; Prokisch, Holger; Winkelmann, Juliane] Helmholtz Zentrum Munchen, Inst Humangenet, Munich, Germany; [Schramm, Katharina; Lichtner, Peter; Meitinger, Thomas; Prokisch, Holger; Winkelmann, Juliane] Tech Univ Munich, Klinikum Rechts Isar, Inst Humangenet, D-80290 Munich, Germany; [Trenkwalder, Claudia] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Herder, Christian; Roden, Michael] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Herder, Christian; Roden, Michael] German Ctr Diabet Res DZD eV, Dusseldorf, Germany; [Roden, Michael] Univ Hosp Dusseldorf, Univ Clin Endocrinol & Diabetol, Dusseldorf, Germany; [Gieger, Christian] Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Munich, Germany; [Peters, Annette] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Munich, Germany; [Trenkwalder, Claudia] Paracelsus Elena Klin, Kassel, Germany; [Trenkwalder, Claudia] Univ Gottingen, Univ Med Ctr, Dept Neurosurg, D-37073 Gottingen, Germany; [Hoegl, Birgit; Frauscher, Birgit] Med Univ Innsbruck, Neurol Klin, A-6020 Innsbruck, Austria; [Berger, Klaus] Univ Munster, Inst Epidemiol & Sozialmed, D-48149 Munster, Germany; [Fietze, Ingo] Charite, Zentrum Schlafmed, D-13353 Berlin, Germany; [Stiasny-Kolster, Karin; Oertel, Wolfgang] Univ Marburg, Neurol Klin, Marburg, Germany; [Stiasny-Kolster, Karin] Somnomar Inst Med Forsch & Schlafmed, Marburg, Germany; [Bachmann, Cornelius G.] Paracelsus Klin Osnabruck, Abt Neurol, Osnabruck, Germany; [Paulus, Walter] Univ Gottingen, Univ Med Ctr, Dept Clin Neurophysiol, D-37073 Gottingen, Germany; [Zimprich, Alexander] Med Univ Wien, Neurol Klin, Vienna, Austria; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Schminke, Ulf] Univ Med Greifswald, Inst Neurol, Greifswald, Germany; [Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Illig, Thomas] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Munich, Germany; [Illig, Thomas] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Munich, Germany; [Mueller-Myhsok, Bertram] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Mueller-Myhsok, Bertram; Winkelmann, Juliane] Munich Cluster Syst Neurol SyNergy, Munich, Germany	Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Ernst Moritz Arndt Universitat Greifswald; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Gottingen; Medical University of Innsbruck; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Philipps University Marburg; University of Gottingen; Medical University of Vienna; Greifswald Medical School; Greifswald Medical School; Greifswald Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; University of Munich	Winkelmann, J (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Neurol Klin & Poliklin, D-80290 Munich, Germany.	winkelmann@lrz.tum.de	Roden, Michael/AAD-3843-2019; Peters, Annette/A-6117-2011; Meitinger, Thomas/O-1318-2015; Schurmann, Claudia/L-1204-2016; Paulus, Walter/A-3544-2009; Schulte, Eva C./AAT-2410-2021; Trenkwalder, Claudia/AHD-1232-2022; Trenkwalder, Claudia/ABD-6559-2021; Zimprich, Alexander/A-5232-2017	Peters, Annette/0000-0001-6645-0985; Schurmann, Claudia/0000-0003-4158-9192; Paulus, Walter/0000-0001-5549-8377; Trenkwalder, Claudia/0000-0001-6407-1199; Zimprich, Alexander/0000-0002-1668-5177; Schulte, Eva Christina/0000-0003-3105-5672; Prokisch, Holger/0000-0003-2379-6286; Hogl, Birgit/0000-0003-1894-7641; Gieger, Christian/0000-0001-6986-9554; Meitinger, Thomas/0000-0002-8838-8403; Winkelmann, Juliane/0000-0003-2667-9691; Fietze, Ingo/0000-0001-5567-5206	Helmholtz Zentrum Munchen, Munich, Germany from the German Bundesministerium fur Bildung und Forschung [03.2007-02.2011 FKZ 01ET0713]; Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012]; Deutsche Forschungsgemeinschaft [DFG GRK840-D2]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania [03IS2061A]; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg, West Pomerania	Helmholtz Zentrum Munchen, Munich, Germany from the German Bundesministerium fur Bildung und Forschung; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg, West Pomerania	Recruitment of the KORA cohort was supported by institutional (Helmholtz Zentrum Munchen, Munich, Germany) and government funding from the German Bundesministerium fur Bildung und Forschung (03.2007-02.2011 FKZ 01ET0713). SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Deutsche Forschungsgemeinschaft (DFG GRK840-D2), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. This work is also part of the research project Greifswald Approach to Individualized Medicine (GANI_MED), which is funded by the Federal Ministry of Education and Research and the Ministry of Cultural Affairs of the Federal State of Mecklenburg-West Pomerania (03IS2061A). Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany and the Federal State of Mecklenburg, West Pomerania. Whole-body MR imaging was supported by a joint grant from Siemens Healthcare, Erlangen, Germany and the Federal State of Mecklenburg West Pomerania. The University of Greifswald is a member of the 'Center of Knowledge Interchange' program of the Siemens AG and the Cache Campus program of the InterSystems GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Hernandez DG, 2012, NEUROBIOL DIS, V47, P20, DOI 10.1016/j.nbd.2012.03.020; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Mehta D, 2012, EUR J HUM GENET; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Okada Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002455; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x; Richards AL, 2012, MOL PSYCHIATR, V17, P193, DOI 10.1038/mp.2011.11; Schormair B, 2008, NAT GENET, V40, P946, DOI 10.1038/ng.190; Schurmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050938; Spieler D, 2014, GENOME RES, V24, P592, DOI 10.1101/gr.166751.113; Stefansson H, 2007, NEW ENGL J MED, V357, P639, DOI 10.1056/NEJMoa072743; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Wild PS, 2011, CIRC-CARDIOVASC GENE, V4, P403, DOI 10.1161/CIRCGENETICS.110.958728; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Winkelman JW, 2008, NEUROLOGY, V70, P35, DOI 10.1212/01.wnl.0000287072.93277.c9; Winkelmann J, 2005, J NEUROL, V252, P67, DOI 10.1007/s00415-005-0604-7; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099; Winkelmann J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002171	28	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98092	10.1371/journal.pone.0098092	http://dx.doi.org/10.1371/journal.pone.0098092			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875634	gold, Green Published, Green Submitted			2022-12-25	WOS:000336790800023
J	Werner, EE; Davis, CJ; Skelly, DK; Relyea, RA; Benard, MF; McCauley, SJ				Werner, Earl E.; Davis, Christopher J.; Skelly, David K.; Relyea, Rick A.; Benard, Michael F.; McCauley, Shannon J.			Cross-Scale Interactions and the Distribution-Abundance Relationship	PLOS ONE			English	Article							OCCUPANCY RELATIONSHIPS; SPECIES ABUNDANCE; RANGE SIZE; METAPOPULATION DYNAMICS; ECOLOGICAL THRESHOLDS; REGIONAL DISTRIBUTION; POPULATION-DYNAMICS; LARVAL AMPHIBIANS; LOCAL ABUNDANCE; HABITAT	Positive interspecific relationships between local abundance and extent of regional distribution are among the most ubiquitous patterns in ecology. Although multiple hypotheses have been proposed, the mechanisms underlying distribution-abundance (d-a) relationships remain poorly understood. We examined the intra- and interspecific distribution-abundance relationships for a metacommunity of 13 amphibian species sampled for 15 consecutive years. Mean density of larvae in occupied ponds was positively related to number of ponds occupied by species; employing the fraction of ponds uniquely available to each species this same relationship sharply decelerates. The latter relationship suggested that more abundant species inhabited most available habitats annually, whereas rarer species were dispersal limited. We inferred the mechanisms responsible for this pattern based on the dynamics of one species, Pseudacris triseriata, which transitioned between a rare, narrowly distributed species to a common, widely distributed species and then back again. Both transitions were presaged by marked changes in mean local densities driven by climatic effects on habitat quality. We identified threshold densities separating these population regime shifts that differed with landscape configuration. Our data suggest that these transitions were caused by strong cross-scale interactions between local resource/niche processes and larger scale metapopulation processes. The patterns we observed have relevance for understanding the mechanisms of interspecific d-a relationships and critical thresholds associated with habitat fragmentation.	[Werner, Earl E.; Davis, Christopher J.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Skelly, David K.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Relyea, Rick A.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Benard, Michael F.] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA; [McCauley, Shannon J.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada	University of Michigan System; University of Michigan; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Case Western Reserve University; University of Toronto; University Toronto Mississauga	Werner, EE (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	eewerner@umich.edu		McCauley, Shannon/0000-0001-9649-6693; Benard, Michael/0000-0002-8585-3816	NSF LTREB [DEB-9727014, DEB-0454519]	NSF LTREB(National Science Foundation (NSF))	NSF LTREB grants DEB-9727014 and DEB-0454519 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; BEISWENGER R E, 1975, Herpetologica, V31, P222; Blackburn TM, 2006, J ANIM ECOL, V75, P1426, DOI 10.1111/j.1365-2656.2006.01167.x; Borregaard MK, 2010, Q REV BIOL, V85, P3, DOI 10.1086/650265; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carpenter SR, 2008, ECOL LETT, V11, P128, DOI 10.1111/j.1461-0248.2007.01131.x; Delzell DE, 1958, SPATIAL MOVEMENT GRO; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Ficetola GF, 2009, ECOGRAPHY, V32, P1075, DOI 10.1111/j.1600-0587.2009.05571.x; Freckleton RP, 2005, J ANIM ECOL, V74, P353, DOI 10.1111/j.1365-2656.2005.00931.x; Freckleton RP, 2006, AM NAT, V167, P260, DOI 10.1086/498655; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; GASTON KJ, 1990, OIKOS, V58, P329, DOI 10.2307/3545224; Gaston KJ, 1997, J ANIM ECOL, V66, P579, DOI 10.2307/5951; Gonzalez A, 1998, SCIENCE, V281, P2045, DOI 10.1126/science.281.5385.2045; GYLLENBERG M, 1992, THEOR POPUL BIOL, V42, P35, DOI 10.1016/0040-5809(92)90004-D; HANSKI I, 1982, OIKOS, V38, P210, DOI 10.2307/3544021; Hanski Ilkka, 1993, P108; Harte J, 2001, AM NAT, V157, P374, DOI 10.1086/319323; Hillis DM, 2005, MOL PHYLOGENET EVOL, V34, P299, DOI 10.1016/j.ympev.2004.10.007; Holt RD, 1997, OIKOS, V78, P183, DOI 10.2307/3545815; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; LAWTON JH, 1993, TRENDS ECOL EVOL, V8, P409, DOI 10.1016/0169-5347(93)90043-O; Lawton JH, 1996, BIRD STUDY, V43, P3, DOI 10.1080/00063659609460991; Leibold MA, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P439; McCauley SJ, 2007, OIKOS, V116, P121, DOI 10.1111/j.2006.0030-1299.15105.x; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Moilanen A, 2002, ECOLOGY, V83, P1131, DOI 10.1890/0012-9658(2002)083[1131:SCMISE]2.0.CO;2; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Mullins ML, 2004, J HERPETOL, V38, P166, DOI 10.1670/67-03A; OOSTERBAAN RJ, 1990, P S LAND DRAIN SAL C, V3, P373; Oosterbaan RJ, 2005, STAT SIGN SEGM LIN R; Ostman O, 2011, OECOLOGIA, V165, P687, DOI 10.1007/s00442-010-1752-8; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; Relyea RA, 2003, ECOLOGY, V84, P1827, DOI 10.1890/0012-9658(2003)084[1827:HPRTCP]2.0.CO;2; Relyea RA, 2001, ECOLOGY, V82, P541, DOI 10.1890/0012-9658(2001)082[0541:TRBPRA]2.0.CO;2; Rodionov S, 2005, ICES J MAR SCI, V62, P328, DOI 10.1016/j.icesjms.2005.01.013; Rodionov SN, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019448; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Schoener T.W., 1986, P91; SegReg, 2008, SEGM LIN REGR BREAKP; SHAFFER HB, 1991, SYST ZOOL, V40, P284, DOI 10.2307/2992323; Skelly DK, 1996, COPEIA, P599; Skelly DK, 2002, ECOLOGY, V83, P983, DOI 10.1890/0012-9658(2002)083[0983:FCATPO]2.0.CO;2; SKELLY DK, 1995, ECOLOGY, V76, P150, DOI 10.2307/1940638; SMITH DC, 1995, AM NAT, V145, P211, DOI 10.1086/285737; Smith MA, 2005, ECOGRAPHY, V28, P110; Spencer WA, 1964, RELATIONSHIP DISPERS; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Team RDC, 2019, R LANG ENV STAT COMP; Venier LA, 1996, OIKOS, V76, P564, DOI 10.2307/3546349; Venier LA, 1998, OIKOS, V82, P483, DOI 10.2307/3546369; Verberk WCEP, 2010, J ANIM ECOL, V79, P589, DOI 10.1111/j.1365-2656.2010.01660.x; Werner EE, 2007, OIKOS, V116, P1713, DOI 10.1111/j.2007.0030-1299.16039.x; Werner EE, 2007, OIKOS, V116, P1697, DOI 10.1111/j.2007.0030-1299.15935.x; Werner EE, 2009, ECOL MONOGR, V79, P503, DOI 10.1890/08-1047.1; Winfree R, 2005, AM NAT, V165, P707, DOI 10.1086/430009; With KA, 1999, CONSERV BIOL, V13, P314, DOI 10.1046/j.1523-1739.1999.013002314.x; Zuckerberg B, 2009, J ANIM ECOL, V78, P172, DOI 10.1111/j.1365-2656.2008.01463.x	65	9	9	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97387	10.1371/journal.pone.0097387	http://dx.doi.org/10.1371/journal.pone.0097387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875899	Green Published, gold			2022-12-25	WOS:000336790800006
J	Azmi, AM; Al-Ssulami, A				Azmi, Aqil M.; Al-Ssulami, Abdulrakeeb			Encoded Expansion: An Efficient Algorithm to Discover Identical String Motifs	PLOS ONE			English	Article							GIBBS SAMPLING METHOD; DNA; IDENTIFICATION; SEQUENCES; SIGNALS; SITES; MEME; WEB	A major task in computational biology is the discovery of short recurring string patterns known as motifs. Most of the schemes to discover motifs are either stochastic or combinatorial in nature. Stochastic approaches do not guarantee finding the correct motifs, while the combinatorial schemes tend to have an exponential time complexity with respect to motif length. To alleviate the cost, the combinatorial approach exploits dynamic data structures such as trees or graphs. Recently (Karci (2009) Efficient automatic exact motif discovery algorithms for biological sequences, Expert Systems with Applications 36: 7952-7963) devised a deterministic algorithm that finds all the identical copies of string motifs of all sizes >= 2 in theoretical time complexity of O(n(2)L+L-2), and a space complexity of O(nL(2)), where n is the length of the input sequence and L is the length of the longest possible string motif. In this paper, we present a significant improvement on Karci's original algorithm. The algorithm that we propose reports all identical string motifs of sizes >= 2 that occur at least tau times. Our algorithm starts with string motifs of size 2, and at each iteration it expands the candidate string motifs by one symbol throwing out those that occur less than t times in the entire input sequence. We use a simple array and data encoding to achieve theoretical worst-case time complexity of O(nL), and a space complexity of O(n): Encoding of the substrings can speed up the process of comparison between string motifs. Experimental results on random and real biological sequences confirm that our algorithm has indeed a linear time complexity and it is more scalable in terms of sequence length than the existing algorithms.	[Azmi, Aqil M.; Al-Ssulami, Abdulrakeeb] King Saud Univ, Dept Comp Sci, Coll Comp & Informat Sci, Riyadh, Saudi Arabia	King Saud University	Azmi, AM (corresponding author), King Saud Univ, Dept Comp Sci, Coll Comp & Informat Sci, Riyadh, Saudi Arabia.	aqil@ksu.edu.sa	Azmi, Aqil M/L-3780-2019; Azmi, Aqil M/AAR-2299-2020	Azmi, Aqil M/0000-0002-0983-2861; Azmi, Aqil M/0000-0002-0983-2861	Research Center of the College of Computer and Information Sciences (CCIS) at King Saud University	Research Center of the College of Computer and Information Sciences (CCIS) at King Saud University	This work was supported by a special fund of the Research Center of the College of Computer and Information Sciences (CCIS) at King Saud University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bailey TL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-179; BAILEY TL, 1995, MACH LEARN, V21, P51, DOI 10.1007/BF00993379; Brown P, 2013, BIOINFORMATICS, V29, P1696, DOI 10.1093/bioinformatics/btt248; Crochemore M., 1994, TEXT ALGORITHMS; Defrance M, 2009, BIOINFORMATICS, V25, P2715, DOI 10.1093/bioinformatics/btp490; Fauteux F, 2008, BIOINFORMATICS, V24, P2303, DOI 10.1093/bioinformatics/btn444; Grundy WN, 1996, COMPUT APPL BIOSCI, V12, P303; GuhaThakurta D, 2006, NUCLEIC ACIDS RES, V34, P3585, DOI 10.1093/nar/gkl372; Gusfield D., 1997, ALGORITHMS STRINGS T; Huang CW, 2011, IEEE ACM T COMPUT BI, V8, P959, DOI 10.1109/TCBB.2010.92; Karci A, 2009, EXPERT SYST APPL, V36, P7952, DOI 10.1016/j.eswa.2008.10.087; LAWRENCE CE, 1990, PROTEINS, V7, P41, DOI 10.1002/prot.340070105; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Liu JS, 1995, J AM STAT ASSOC, V90, P1156, DOI 10.2307/2291508; Marschall T, 2009, BIOINFORMATICS, V25, pI356, DOI 10.1093/bioinformatics/btp188; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Riviere R, 2008, J DISCRET ALGORITHMS, V6, P192, DOI 10.1016/j.jda.2007.06.001; Shida K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-486; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Sze SH, 2006, LECT NOTES BIOINFORM, P198; Thijs G, 2002, J COMPUT BIOL, V9, P447, DOI 10.1089/10665270252935566; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Vanet A, 1999, RES MICROBIOL, V150, P779, DOI 10.1016/S0923-2508(99)00115-1; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Yu Q, 2013, INT J BIOL SCI, V9, P412, DOI 10.7150/ijbs.5786; Yu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048442	28	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e95148	10.1371/journal.pone.0095148	http://dx.doi.org/10.1371/journal.pone.0095148			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871320	Green Published, gold, Green Submitted			2022-12-25	WOS:000336858300001
J	Bouwer, FL; Van Zuijen, TL; Honing, H				Bouwer, Fleur L.; Van Zuijen, Titia L.; Honing, Henkjan			Beat Processing Is Pre-Attentive for Metrically Simple Rhythms with Clear Accents: An ERP Study	PLOS ONE			English	Article							MISMATCH NEGATIVITY; NEURONAL ENTRAINMENT; COMPARING MUSICIANS; METER; DISCRIMINATION; PREDICTION; DYNAMICS; HUMANS; SOUNDS; MODEL	The perception of a regular beat is fundamental to music processing. Here we examine whether the detection of a regular beat is pre-attentive for metrically simple, acoustically varying stimuli using the mismatch negativity (MMN), an ERP response elicited by violations of acoustic regularity irrespective of whether subjects are attending to the stimuli. Both musicians and non-musicians were presented with a varying rhythm with a clear accent structure in which occasionally a sound was omitted. We compared the MMN response to the omission of identical sounds in different metrical positions. Most importantly, we found that omissions in strong metrical positions, on the beat, elicited higher amplitude MMN responses than omissions in weak metrical positions, not on the beat. This suggests that the detection of a beat is pre-attentive when highly beat inducing stimuli are used. No effects of musical expertise were found. Our results suggest that for metrically simple rhythms with clear accents beat processing does not require attention or musical expertise. In addition, we discuss how the use of acoustically varying stimuli may influence ERP results when studying beat processing.	[Bouwer, Fleur L.; Honing, Henkjan] Univ Amsterdam, Inst Log Language & Computat, Amsterdam, Netherlands; [Bouwer, Fleur L.; Honing, Henkjan] Univ Amsterdam, ABC, Amsterdam, Netherlands; [Van Zuijen, Titia L.] Univ Amsterdam, Res Inst Child Dev & Educ, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; University of Amsterdam	Bouwer, FL (corresponding author), Univ Amsterdam, Inst Log Language & Computat, Amsterdam, Netherlands.	bouwer@uva.nl	van Zuijen, Titia/F-5063-2012; Honing, Henkjan/A-1362-2012	Honing, Henkjan/0000-0001-7046-7923; Bouwer, Fleur/0000-0001-7064-7481; van Zuijen, Titia/0000-0002-2578-4396	Research Priority Area "Brain & Cognition" at the University of Amsterdam; Hendrik Muller chair designated on behalf of the Royal Netherlands Academy of Arts and Sciences (KNAW)	Research Priority Area "Brain & Cognition" at the University of Amsterdam; Hendrik Muller chair designated on behalf of the Royal Netherlands Academy of Arts and Sciences (KNAW)	The research of FB and HH is supported by the Research Priority Area "Brain & Cognition" at the University of Amsterdam. HH is supported by the Hendrik Muller chair designated on behalf of the Royal Netherlands Academy of Arts and Sciences (KNAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendixen A, 2009, J NEUROSCI, V29, P8447, DOI 10.1523/JNEUROSCI.1493-09.2009; Bolger D, 2013, ACTA PSYCHOL, V142, P238, DOI 10.1016/j.actpsy.2012.11.012; CARLYON RP, 1988, HEARING RES, V32, P65, DOI 10.1016/0378-5955(88)90147-5; Carpenter S, 2012, SCIENCE, V335, P1558, DOI 10.1126/science.335.6076.1558; Chapin HL, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00224; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; Cooper G., 1960, RHYTHMIC STRUCTURE M; Dau T, 1996, J ACOUST SOC AM, V99, P3623, DOI 10.1121/1.414960; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fujioka T, 2004, J COGNITIVE NEUROSCI, V16, P1010, DOI 10.1162/0898929041502706; Fujioka T, 2012, J NEUROSCI, V32, P1791, DOI 10.1523/JNEUROSCI.4107-11.2012; Geiser E, 2010, EUR J NEUROSCI, V32, P1979, DOI 10.1111/j.1460-9568.2010.07462.x; Geiser E, 2009, CORTEX, V45, P93, DOI 10.1016/j.cortex.2007.09.010; Grahn JA, 2009, J NEUROSCI, V29, P7540, DOI 10.1523/JNEUROSCI.2018-08.2009; Herholz SC, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-42; Honing H, 2014, NEUROBIOLOG IN PRESS; Honing H, 2013, PSYCHOLOGY OF MUSIC, THIRD EDITION, P369, DOI 10.1016/B978-0-12-381460-9.00009-2; Honing H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051369; Honing H, 2012, ANN NY ACAD SCI, V1252, P85, DOI 10.1111/j.1749-6632.2011.06402.x; Jaramillo M, 2000, NEUROSCI LETT, V290, P101, DOI 10.1016/S0304-3940(00)01344-6; Ladinig O, 2011, MUSIC PERCEPT, V28, P444; Ladinig O, 2009, MUSIC PERCEPT, V26, P377, DOI 10.1525/MP.2009.26.4.377; Large EW, 2008, PSYCHOLOGY OF TIME, P189, DOI 10.1016/B978-0-08046-977-5.00006-5; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; London J., 2012, HEARING TIME; Moore BCJ, 1997, J AUDIO ENG SOC, V45, P224; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; Novitski N, 2004, COGNITIVE BRAIN RES, V20, P26, DOI 10.1016/j.cogbrainres.2003.12.011; Nozaradan S, 2012, J NEUROSCI, V32, P17572, DOI 10.1523/JNEUROSCI.3203-12.2012; Nozaradan S, 2011, J NEUROSCI, V31, P10234, DOI 10.1523/JNEUROSCI.0411-11.2011; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Sabri M, 2001, COGNITIVE BRAIN RES, V12, P171, DOI 10.1016/S0926-6410(01)00026-X; Schwartze M, 2011, BIOL PSYCHOL, V87, P146, DOI 10.1016/j.biopsycho.2011.02.021; Snyder JS, 2005, COGNITIVE BRAIN RES, V24, P117, DOI 10.1016/j.cogbrainres.2004.12.014; Sussman ES, 2007, J PSYCHOPHYSIOL, V21, P164, DOI 10.1027/0269-8803.21.34.164; Tierney A, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00014; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; van Zuijen TL, 2005, COGNITIVE BRAIN RES, V23, P270, DOI 10.1016/j.cogbrainres.2004.10.007; van Zuijen TL, 2004, J COGNITIVE NEUROSCI, V16, P331, DOI 10.1162/089892904322984607; Winkler I, 2007, J PSYCHOPHYSIOL, V21, P147, DOI 10.1027/0269-8803.21.34.147; Winkler I, 2009, P NATL ACAD SCI USA, V106, P2468, DOI 10.1073/pnas.0809035106; ZWICKER E, 1984, J ACOUST SOC AM, V75, P219, DOI 10.1121/1.390398	43	42	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97467	10.1371/journal.pone.0097467	http://dx.doi.org/10.1371/journal.pone.0097467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870123	Green Published, Green Submitted, gold			2022-12-25	WOS:000336858300011
J	Vinson, MR; Angradi, TR				Vinson, Mark R.; Angradi, Ted R.			Muskie Lunacy: Does the Lunar Cycle Influence Angler Catch of Muskellunge (Esox masquinongy)?	PLOS ONE			English	Article							MOON PHASE; FISH; PERIODICITY; BEHAVIOR; SALMON; RATES; REGRESSION; MIGRATION; FISHERIES; LANDINGS	We analyzed angling catch records for 341,959 muskellunge (Esox masquinongy) from North America to test for a cyclic lunar influence on the catch. Using periodic regression, we showed that the number caught was strongly related to the 29-day lunar cycle, and the effect was consistent across most fisheries. More muskellunge were caught around the full and new moon than at other times. At night, more muskellunge were caught around the full moon than the new moon. The predicted maximum relative effect was approximate to 5% overall. Anglers fishing exclusively on the peak lunar day would, on average, catch 5% more muskellunge than anglers fishing on random days. On some lakes and at night, the maximum relative effect was higher. We obtained angler effort data for Wisconsin, Mille Lacs (MN), and Lake Vermilion (MN). For Lake Vermilion there was a significant effect of the lunar cycle on angler effort. We could therefore not conclude that the lunar effect on catch was due to an effect on fish behavior alone. Several factors affected the amount of variation explained by the lunar cycle. The lunar effect was stronger for larger muskellunge (> 102 cm) than for smaller fish, stronger in midsummer than in June or October, and stronger for fish caught at high latitudes (>48 degrees N) than for fish caught further south. There was no difference in the lunar effect between expert and novice muskellunge anglers. We argue that this variation is evidence that the effect of the lunar cycle on catch is mediated by biological factors and is not due solely to angler effort and reflects lunar synchronization in feeding. This effect has been attributed to variation among moon phases in lunar illumination, but our results do not support that hypothesis for angler-caught muskellunge.	[Vinson, Mark R.] US Geol Survey, Great Lakes Sci Ctr, Lake Super Biol Stn, Ashland, WI 54806 USA; [Angradi, Ted R.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Midcontinent Ecol Div, Duluth, MN USA	United States Department of the Interior; United States Geological Survey; United States Environmental Protection Agency	Vinson, MR (corresponding author), US Geol Survey, Great Lakes Sci Ctr, Lake Super Biol Stn, Ashland, WI 54806 USA.	mvinson@usgs.gov	Callahan, Charles D/L-1641-2013		U.S. Geological Survey; U.S. Environmental Protection Agency	U.S. Geological Survey(United States Geological Survey); U.S. Environmental Protection Agency(United States Environmental Protection Agency)	This work was supported by the U.S. Geological Survey and the U.S. Environmental Protection Agency. The views expressed in this paper are the authors' and do not necessarily reflect U.S. Geological Survey or U.S. Environmental Protection Agency policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], HALF MILLION MUSKIE; [Anonymous], 2011, PROTECTING RESTORING; Bigelow KA, 1999, FISH OCEANOGR, V8, P178, DOI 10.1046/j.1365-2419.1999.00105.x; Bucher J, 2013, REAL SCOOP MOON PHAS; Cooke SJ, 2007, PHYSIOL BIOCHEM ZOOL, V80, P480, DOI 10.1086/520618; Crossman E.J., 1986, American Fisheries Society Special Publication, P1; deBruyn AMH, 2001, MAR ECOL PROG SER, V214, P307, DOI 10.3354/meps214307; Dettloff J, 2004, TOPWATER TACTICS TAL; DeVries P, 2004, T AM FISH SOC, V133, P1379, DOI 10.1577/T03-173.1; Donabauer S, 2011, HIST REV NO PIKE ESO; Gaudreau N, 2000, CAN J FISH AQUAT SCI, V57, P581, DOI 10.1139/cjfas-57-3-581; GRAU EG, 1982, AQUACULTURE, V28, P49, DOI 10.1016/0044-8486(82)90007-2; Hanson KC, 2008, FISHERIES MANAG ECOL, V15, P357, DOI 10.1111/j.1365-2400.2008.00634.x; Hernandez-Leon S, 2008, FISH FISH, V9, P138, DOI 10.1111/j.1467-2979.2008.00272.x; Heting S, 2013, PIECES BIG MUSKIE PU; Horky P, 2006, FOLIA ZOOL, V55, P411; Jason, 2013, MUSKIES MOON PHASES; Jepsen N, 2001, ECOL FRESHW FISH, V10, P26, DOI 10.1034/j.1600-0633.2001.100104.x; Johannes RE, 2000, FISH FISH, V1, P257, DOI 10.1046/j.1467-2979.2000.00019.x; Kerr, 2011, DISTRIBUTION MANAGEM; Kerr SJ, 2007, ENVIRON BIOL FISH, V79, P61, DOI 10.1007/s10641-006-9120-6; Knight JA, 1936, MODERN ANGLER INCLUD; Kobler A, 2009, OECOLOGIA, V161, P837, DOI 10.1007/s00442-009-1415-9; Kuparinen A, 2009, J FISH BIOL, V74, P2401, DOI 10.1111/j.1095-8649.2009.02255.x; Kuparinen A, 2010, FISH RES, V105, P111, DOI 10.1016/j.fishres.2010.03.011; Landsman S, 2011, THESIS CARLETON U OT; Libini CL, 2012, INDIAN J FISH, V59, P81; LOBEL PS, 1978, PAC SCI, V32, P193; Lowry M, 2007, FISH RES, V88, P15, DOI 10.1016/j.fishres.2007.07.011; LUECKE C, 1993, T AM FISH SOC, V122, P112, DOI 10.1577/1548-8659(1993)122<0112:EOMADO>2.3.CO;2; Madrid JAB T, 2008, FOOD INTAKE FISH; Moore MV, 2001, INT VER THEOR ANGEW, V27, P779; Mosindy TE, 2007, ENVIRON BIOL FISH, V79, P71, DOI 10.1007/s10641-006-9167-4; Ortega-Garcia S, 2008, FISH RES, V93, P190, DOI 10.1016/j.fishres.2008.04.005; PALOMARES ML, 1989, AUST J MAR FRESH RES, V40, P259, DOI 10.1071/MF9890259; Ritter Erich, 2013, Open Fish Science Journal, V6, P71; ROSSITER A, 1991, NATURWISSENSCHAFTEN, V78, P182, DOI 10.1007/BF01136210; Samoilys MA, 1997, MAR ECOL PROG SER, V160, P149, DOI 10.3354/meps160149; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Simonson T. D., 2012, WISCONSIN DEP NATURA, VFH-508-2012; Stevenson BC, 2013, ENVIRON ECOL STAT, P1; TAYLOR MH, 1984, T AM FISH SOC, V113, P484, DOI 10.1577/1548-8659(1984)113<484:LSOFR>2.0.CO;2; Thomas MH, 2011, STATUS FISHERIES MIC; Younk JA, 2007, ENVIRON BIOL FISH, V79, P125, DOI 10.1007/s10641-006-9168-3; Zar J. H., 2009, BIOSTATISTICAL ANAL	47	13	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98046	10.1371/journal.pone.0098046	http://dx.doi.org/10.1371/journal.pone.0098046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871329	Green Published, gold, Green Submitted			2022-12-25	WOS:000336858300023
J	Kim, CH; Paik, D; Rus, F; Silverman, N				Kim, Chan-Hee; Paik, Donggi; Rus, Florentina; Silverman, Neal			The Caspase-8 Homolog Dredd Cleaves Imd and Relish but Is Not Inhibited by p35	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; DROSOPHILA; ACTIVATION; PROTEIN; SPECIFICITY; COMPLEX; DRONC; EXPRESSION; DEFENSE; PATHWAY	In Drosophila, the Imd pathway is activated by diaminopimelic acid-type peptidoglycan and triggers the humoral innate immune response, including the robust induction of antimicrobial peptide gene expression. Imd and Relish, two essential components of this pathway, are both endoproteolytically cleaved upon immune stimulation. Genetic analyses have shown that these cleavage events are dependent on the caspase-8 like Dredd, suggesting that Imd and Relish are direct substrates of Dredd. Among the seven Drosophila caspases, we find that Dredd uniquely promotes Imd and Relish processing, and purified recombinant Dredd cleaves Imd and Relish in vitro. In addition, interdomain cleavage of Dredd is not required for Imd or Relish processing and is not observed during immune stimulation. Baculovirus p35, a suicide substrate of executioner caspases, is not cleaved by purified Dredd in vitro. Consistent with this biochemistry but contrary to earlier reports, p35 does not interfere with Imd signaling in S2* cells or in vivo.	[Kim, Chan-Hee; Paik, Donggi; Rus, Florentina; Silverman, Neal] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Silverman, N (corresponding author), 364 Plantat St, Worcester, MA 01605 USA.	Neal.Silverman@umassmed.edu	Kim, Chan-Hee/C-6849-2016	Kim, Chan-Hee/0000-0002-5315-4981; Silverman, Neal/0000-0002-4259-456X; Paik, Donggi/0000-0003-1031-0371	National Institutes of Health [AI60025]; National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-357-2007-1-C00085, NRF-352-2009-1-C00105]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI060025, R01AI060025] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI60025 (to N. S.) and by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by Ministry of Education, Science and Technology Grants NRF-357-2007-1-C00085 (to C. K.) and NRF-352-2009-1-C00105 (to D. P.).	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Baum JS, 2007, CELL DEATH DIFFER, V14, P1508, DOI 10.1038/sj.cdd.4402155; Boyer L, 2011, IMMUNITY, V35, P536, DOI 10.1016/j.immuni.2011.08.015; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Chen P, 1998, DEV BIOL, V201, P202, DOI 10.1006/dbio.1998.9000; Denault JB, 2007, BIOCHEM J, V405, P11, DOI 10.1042/BJ20070288; Denault Jean-Bernard, 2008, V414, P191; Erturk-Hasdemir D, 2009, P NATL ACAD SCI USA, V106, P9779, DOI 10.1073/pnas.0812022106; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Ganesan S, 2011, CURR TOP MICROBIOL, V349, P25, DOI 10.1007/82_2010_107; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Green DR, 2011, MEANS END APOPTOSIS; Guntermann S, 2011, J BIOL CHEM, V286, P30284, DOI 10.1074/jbc.M111.220285; Hawkins CJ, 2000, J BIOL CHEM, V275, P27084; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hay BA, 2006, ANNU REV CELL DEV BI, V22, P623, DOI 10.1146/annurev.cellbio.21.012804.093845; Hu SM, 2000, J BIOL CHEM, V275, P30761, DOI 10.1074/jbc.C000341200; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; Lee G, 2011, J COMP NEUROL, V519, P34, DOI 10.1002/cne.22498; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Meinander A, 2012, EMBO J, V31, P2770, DOI 10.1038/emboj.2012.121; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; Naitza S, 2002, IMMUNITY, V17, P575, DOI 10.1016/S1074-7613(02)00454-5; Oberst A, 2010, J BIOL CHEM, V285, P16632, DOI 10.1074/jbc.M109.095083; Paquette N, 2010, MOL CELL, V37, P172, DOI 10.1016/j.molcel.2009.12.036; Pop C, 2011, BIOCHEM J, V433, P447, DOI 10.1042/BJ20101738; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Stennicke HR, 1999, J BIOL CHEM, V274, P8359, DOI 10.1074/jbc.274.13.8359; Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Vernooy SY, 2000, J CELL BIOL, V150, pF69, DOI 10.1083/jcb.150.2.F69; WHITE E, 1987, J VIROL, V61, P426, DOI 10.1128/JVI.61.2.426-435.1987; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Xu GZ, 2001, NATURE, V410, P494, DOI 10.1038/35068604; Zhou Q, 1998, BIOCHEMISTRY-US, V37, P10757, DOI 10.1021/bi980893w	40	28	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20092	20101		10.1074/jbc.M113.544841	http://dx.doi.org/10.1074/jbc.M113.544841			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24891502	Green Published, hybrid			2022-12-25	WOS:000339395200023
J	Lee, J; Miyazaki, M; Romeo, GR; Shoelson, SE				Lee, Jongsoon; Miyazaki, Masaya; Romeo, Giulio R.; Shoelson, Steven E.			Insulin Receptor Activation with Transmembrane Domain Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; TYROSINE KINASE; BETA-SUBUNIT; ERYTHROPOIETIN RECEPTOR; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; POINT MUTATION; SIGNAL-TRANSDUCTION; NEU ONCOGENE; IN-VITRO	Complementary surfaces are buried when peptide hormones, growth factors, or cytokines bind and activate cellular receptors. Although these extended surfaces provide high affinity and specificity to the interactions, they also present great challenges to the design of small molecules that might either mimic or antagonize the process. We show that the insulin receptor (IR) and downstream signals can be activated by targeting a site outside of its ligand-binding domain. A 24-residue peptide having the IR transmembrane (TM) domain sequence activates IR, but not related growth factor receptors, through specific interactions with the receptor TM domain. Like insulin-dependent activation, IR-TM requires that IR have a competent ATP-binding site and kinase activation loop. IR-TM also activates mutated receptors from patients with severe insulin resistance, which do not respond to insulin. These results show that IR can be activated through a pathway that bypasses its canonical ligand-binding domain.	[Lee, Jongsoon; Shoelson, Steven E.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Lee, J (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, One Joslin Pl, Boston, MA 02115 USA.	jongsoon.lee@joslin.harvard.edu; m.miyazaki@aist.go.jp; steven.shoelson@joslin.harvard.edu	Miyazaki, Masaya/F-8520-2012; Lee, Jongsoon/AAG-1674-2020	Miyazaki, Masaya/0000-0003-4031-7224; Lee, Jongsoon/0000-0002-0891-5059	National Institutes of Health [R21 DK80380, R01 DK45943, R37 DK51729, R01 DK73547, T32 DK007260, P30 DK36836]; American Diabetes Association [RA 110BS97]; Helen and Morton Adler Chair; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK051729, P30DK036836, R21DK080380, R01DK051729, T32DK007260, R01DK073547, R01DK043123, R01DK045943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Helen and Morton Adler Chair; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 DK80380 (to J. L.), R01 DK45943, R37 DK51729, and R01 DK73547 (to S. E. S.), T32 DK007260 (to G. R. R.), and P30 DK36836 (to Joslin Diabetes Research Center). This work was also supported by American Diabetes Association Grant RA 110BS97 (to J. L.) and the Helen and Morton Adler Chair (to S. E. S.).	ACCILI D, 1995, DIABETES METAB REV, V11, P47, DOI 10.1002/dmr.5610110105; Air EL, 2002, NAT MED, V8, P179, DOI 10.1038/nm0202-179; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BARON V, 1992, J BIOL CHEM, V267, P23290; BARON V, 1990, BIOCHEMISTRY-US, V29, P4634, DOI 10.1021/bi00471a019; BONISCHNETZLER M, 1988, J BIOL CHEM, V263, P6822; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; CHEATHAM B, 1993, P NATL ACAD SCI USA, V90, P7336, DOI 10.1073/pnas.90.15.7336; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CLARK S, 1993, BIOCHEM J, V292, P217, DOI 10.1042/bj2920217; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Damjanovich S, 1997, P NATL ACAD SCI USA, V94, P13134, DOI 10.1073/pnas.94.24.13134; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; FRATTALI AL, 1992, J BIOL CHEM, V267, P19521; Gardin A, 1999, FASEB J, V13, P1347, DOI 10.1096/fasebj.13.11.1347; HERRERA R, 1986, J BIOL CHEM, V261, P1980; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Lee J, 1997, BIOCHEMISTRY-US, V36, P2701, DOI 10.1021/bi961815g; LEE JS, 1993, J BIOL CHEM, V268, P4092; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; Li QX, 2014, BBA-BIOMEMBRANES, V1838, P1313, DOI 10.1016/j.bbamem.2014.01.005; Livnah O, 1996, SCIENCE, V273, P464, DOI 10.1126/science.273.5274.464; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Luo RZT, 1999, SCIENCE, V285, P1077, DOI 10.1126/science.285.5430.1077; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MADDUX BA, 1991, J BIOL CHEM, V266, P6731; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; Ottensmeyer FP, 2000, BIOCHEMISTRY-US, V39, P12103, DOI 10.1021/bi0015921; PERLMAN R, 1989, J BIOL CHEM, V264, P8946; Petti LM, 1998, ONCOGENE, V16, P843, DOI 10.1038/sj.onc.1201590; PILCH PF, 1980, J BIOL CHEM, V255, P1722; Pillutla RC, 2002, J BIOL CHEM, V277, P22590, DOI 10.1074/jbc.M202119200; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Schaffer L, 2003, P NATL ACAD SCI USA, V100, P4435, DOI 10.1073/pnas.0830026100; SCHENKER E, 1988, BIOCHEM BIOPH RES CO, V157, P140, DOI 10.1016/S0006-291X(88)80024-X; SHOELSON SE, 1991, BIOCHEMISTRY-US, V30, P7740, DOI 10.1021/bi00245a010; Smith BJ, 2010, P NATL ACAD SCI USA, V107, P6771, DOI 10.1073/pnas.1001813107; STAGSTED J, 1990, CELL, V62, P297, DOI 10.1016/0092-8674(90)90367-N; STAGSTED J, 1993, J BIOL CHEM, V268, P1770; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; TAKAHASHI K, 1995, J BIOL CHEM, V270, P19041, DOI 10.1074/jbc.270.32.19041; TAOUIS M, 1994, J BIOL CHEM, V269, P27762; TAYLOR SI, 1992, ENDOCR REV, V13, P566, DOI 10.1210/er.13.3.566; TREUTLEIN HR, 1992, BIOCHEMISTRY-US, V31, P12726, DOI 10.1021/bi00166a003; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; VANDERGEER P, 1994, ANNU REV CELL BIOL, V10, P251, DOI 10.1146/annurev.cellbio.10.1.251; Ward CW, 2013, BIOESSAYS, V35, P945, DOI 10.1002/bies.201300065; Waters MJ, 2006, J MOL ENDOCRINOL, V36, P1, DOI 10.1677/jme.1.01933; WAUGH SM, 1989, BIOCHEMISTRY-US, V28, P2722, DOI 10.1021/bi00432a053; WAUGH SM, 1989, BIOCHEMISTRY-US, V28, P3448, DOI 10.1021/bi00434a045; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; Wells JA, 2014, SCIENCE, V344, P703, DOI 10.1126/science.1254799; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; WHITE MF, 1988, J BIOL CHEM, V263, P2969; WILDEN PA, 1992, J BIOL CHEM, V267, P16660; WILDEN PA, 1992, J BIOL CHEM, V267, P13719; YAMADA K, 1992, J BIOL CHEM, V267, P12452; Yip CC, 2003, J BIOL CHEM, V278, P27329, DOI 10.1074/jbc.R300021200; Zhang B, 1999, SCIENCE, V284, P974, DOI 10.1126/science.284.5416.974	66	39	41	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19769	19777		10.1074/jbc.M114.578641	http://dx.doi.org/10.1074/jbc.M114.578641			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24867955	Green Published, hybrid			2022-12-25	WOS:000339326800048
J	Mahesh, G; Jeong, E; Ng, FS; Liu, YX; Gunawardhana, K; Houl, JH; Yildirim, E; Amunugama, R; Jones, R; Allen, DL; Edery, I; Kim, EY; Hardin, PE				Mahesh, Guruswamy; Jeong, EunHee; Ng, Fanny S.; Liu, Yixiao; Gunawardhana, Kushan; Houl, Jerry H.; Yildirim, Evrim; Amunugama, Ravi; Jones, Richard; Allen, David L.; Edery, Isaac; Kim, Eun Young; Hardin, Paul E.			Phosphorylation of the Transcription Activator CLOCK Regulates Progression through a similar to 24-h Feedback Loop to Influence the Circadian Period in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SLEEP PHASE SYNDROME; DOUBLE-TIME; PROTEIN; KINASE; GENE; RHYTHMS; OSCILLATOR; SITE; MELANOGASTER; MECHANISMS	Circadian (congruent to 24 h) clocks control daily rhythms in metabolism, physiology, and behavior in animals, plants, and microbes. In Drosophila, these clocks keep circadian time via transcriptional feedback loops in which CLOCK-CYCLE (CLK-CYC) initiates transcription of period (per) and timeless (tim), accumulating levels of PER and TIM proteins feed back to inhibit CLK-CYC, and degradation of PER andTIM allows CLK-CYC to initiate the next cycle of transcription. The timing of key events in this feedback loop are controlled by, or coincide with, rhythms in PER and CLK phosphorylation, where PER and CLK phosphorylation is high during transcriptional repression. PER phosphorylation at specific sites controls its subcellular localization, activity, and stability, but comparatively little is known about the identity and function of CLK phosphorylation sites. Here we identify eight CLK phosphorylation sites via mass spectrometry and determine how phosphorylation at these sites impacts behavioral and molecular rhythms by transgenic rescue of a new Clk null mutant. Eliminating phosphorylation at four of these sites accelerates the feedback loop to shorten the circadian period, whereas loss of CLK phosphorylation at serine 859 increases CLK activity, thereby increasing PER levels and accelerating transcriptional repression. These results demonstrate that CLK phosphorylation influences the circadian period by regulating CLK activity and progression through the feedback loop.	[Mahesh, Guruswamy; Ng, Fanny S.; Liu, Yixiao; Gunawardhana, Kushan; Houl, Jerry H.; Hardin, Paul E.] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; [Mahesh, Guruswamy; Ng, Fanny S.; Liu, Yixiao; Gunawardhana, Kushan; Houl, Jerry H.; Hardin, Paul E.] Texas A&M Univ, Ctr Biol Clocks Res, College Stn, TX 77843 USA; [Jeong, EunHee; Kim, Eun Young] Ajou Univ, Dept Brain Sci, Sch Med, Suwon 443380, South Korea; [Amunugama, Ravi; Jones, Richard; Allen, David L.] MS Bioworks LLC, Ann Arbor, MI 48108 USA; [Yildirim, Evrim; Edery, Isaac] Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Ajou University; Rutgers State University New Brunswick	Hardin, PE (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.	phardin@bio.tamu.edu	Mahesh, Guruswamy/G-2004-2019	Mahesh, Guruswamy/0000-0002-4873-0091; Hardin, Paul/0000-0002-3370-9011	National Institutes of Health [NS034958, NS052854]; Korean National Research Foundation [NRF-2012R1A5A051422, NRF-2012R1A5A048183]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052854, R01NS034958] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean National Research Foundation(National Research Foundation of Korea); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS034958 (to I. E.) and NS052854 (to P. E. H.) and Korean National Research Foundation Grants NRF-2012R1A5A051422 and NRF-2012R1A5A048183 (to E. Y. K.).	Akten B, 2003, NAT NEUROSCI, V6, P251, DOI 10.1038/nn1007; Allada R, 2003, EMBO J, V22, P3367, DOI 10.1093/emboj/cdg318; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Bae K, 2000, J NEUROSCI, V20, P1746; BAYLIES MK, 1992, NEURON, V9, P575, DOI 10.1016/0896-6273(92)90194-I; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Bischof Johannes, 2008, V420, P175, DOI 10.1007/978-1-59745-583-1_10; Chiu JC, 2008, GENE DEV, V22, P1758, DOI 10.1101/gad.1682708; Chiu JC, 2011, CELL, V145, P357, DOI 10.1016/j.cell.2011.04.002; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Garbe DS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003749; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Hall JC, 2003, ADV GENET, V48, P1, DOI 10.1016/S0065-2660(03)48000-0; Hao HP, 1999, J NEUROSCI, V19, P987; Hardin PE, 2011, ADV GENET, V74, P141, DOI 10.1016/B978-0-12-387690-4.00005-2; Helfrich-Forster C, 2005, GENES BRAIN BEHAV, V4, P65, DOI 10.1111/j.1601-183X.2004.00092.X; Houl JH, 2006, J BIOL RHYTHM, V21, P93, DOI 10.1177/0748730405283697; Hung HC, 2009, J BIOL CHEM, V284, P23734, DOI 10.1074/jbc.M109.025064; Iitaka C, 2005, J BIOL CHEM, V280, P29397, DOI 10.1074/jbc.M503526200; Kadener S, 2008, PLOS BIOL, V6, P965, DOI 10.1371/journal.pbio.0060119; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; Kim EY, 2007, MOL CELL BIOL, V27, P5014, DOI 10.1128/MCB.02339-06; Kim EY, 2012, GENE DEV, V26, P490, DOI 10.1101/gad.182378.111; Kim EY, 2006, P NATL ACAD SCI USA, V103, P6178, DOI 10.1073/pnas.0511215103; Kim EY, 2002, NEURON, V34, P69, DOI 10.1016/S0896-6273(02)00639-6; Kivimae S, 2008, PLOS BIOL, V6, P1570, DOI 10.1371/journal.pbio.0060183; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Ko HW, 2010, J NEUROSCI, V30, P12664, DOI 10.1523/JNEUROSCI.1586-10.2010; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lin JM, 2005, J NEUROSCI, V25, P11175, DOI 10.1523/JNEUROSCI.2159-05.2005; Lin JM, 2002, NATURE, V420, P816, DOI 10.1038/nature01235; Luo WF, 2012, GENE DEV, V26, P2536, DOI 10.1101/gad.200584.112; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; Menet JS, 2010, GENE DEV, V24, P358, DOI 10.1101/gad.1883910; Nawathean P, 2005, METHOD ENZYMOL, V393, P610, DOI 10.1016/S0076-6879(05)93032-2; Pfeiffenberger C., 2010, DROSOPHILA NEUROBIOL, P483; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Rothenfluh A, 2000, CURR BIOL, V10, P1399, DOI 10.1016/S0960-9822(00)00786-7; Shim HS, 2007, EMBO REP, V8, P366, DOI 10.1038/sj.embor.7400920; SMITH RF, 1981, MOL GEN GENET, V183, P243, DOI 10.1007/BF00270625; Spengler ML, 2009, CELL CYCLE, V8, P4138, DOI 10.4161/cc.8.24.10273; Szabo A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001645; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Tsuchiya Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000305; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Veraksa A, 2005, DEV DYNAM, V232, P827, DOI 10.1002/dvdy.20272; Xu Y, 2007, CELL, V128, P59, DOI 10.1016/j.cell.2006.11.043; Yang P, 2006, PROTEOMICS, V6, P927, DOI 10.1002/pmic.200500230; Yoshitane H, 2009, MOL CELL BIOL, V29, P3675, DOI 10.1128/MCB.01864-08; Yu WJ, 2011, CURR BIOL, V21, P756, DOI 10.1016/j.cub.2011.02.037; Yu WJ, 2009, MOL CELL BIOL, V29, P1452, DOI 10.1128/MCB.01777-08; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406	58	22	22	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19681	19693		10.1074/jbc.M114.568493	http://dx.doi.org/10.1074/jbc.M114.568493			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24872414	hybrid, Green Published			2022-12-25	WOS:000339326800040
J	Thom, SR; Bhopale, VM; Yang, M				Thom, Stephen R.; Bhopale, Veena M.; Yang, Ming			Neutrophils Generate Microparticles during Exposure to Inert Gases Due to Cytoskeletal Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; PROTEIN DISULFIDE-ISOMERASE; ACTIN S-NITROSYLATION; NITRIC-OXIDE SYNTHASE; CNS OXYGEN-TOXICITY; SINGLET OXYGEN; DECOMPRESSION; ACTIVATION; AIR; MECHANISM	This investigation was to elucidate the mechanism for microparticle (MP) formation triggered by exposures to high pressure inert gases. Human neutrophils generate MPs at a threshold of similar to 186 kilopascals with exposures of 30 min or more. Murine cells are similar, but MP production occurs at a slower rate and continues for similar to 4 h, whether or not cells remain under pressure. Neutrophils exposed to elevated gas but not hydrostatic pressure produce MPs according to the potency series: argon similar or equal to nitrogen > helium. Following a similar pattern, gases activate type-2 nitric-oxide synthase (NOS-2) and NADPH oxidase (NOX). MP production does not occur with neutrophils exposed to a NOX inhibitor (Nox2ds) or a NOS-2 inhibitor (1400W) or with cells from mice lacking NOS-2. Reactive species cause S-nitrosylation of cytosolic actin that enhances actin polymerization. Protein cross-linking and immunoprecipitation studies indicate that increased polymerization occurs because of associations involving vasodilator-stimulated phosphoprotein, focal adhesion kinase, the H+/K+ ATPase beta (flippase), the hematopoietic cell multidrug resistance protein ABC transporter (floppase), and protein-disulfide isomerase in proximity to short actin filaments. Using chemical inhibitors or reducing cell concentrations of any of these proteins with small inhibitory RNA abrogates NOS-2 activation, reactive species generation, actin polymerization, and MP production. These effects were also inhibited in cells exposed to UV light, which photoreverses S-nitrosylated cysteine residues and by co-incubations with the antioxidant ebselen or cytochalasin D. The autocatalytic cycle of protein activation is initiated by inert gas-mediated singlet O-2 production.	[Thom, Stephen R.; Bhopale, Veena M.; Yang, Ming] Univ Maryland, Dept Emergency Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Thom, SR (corresponding author), Univ Maryland, Dept Emergency Med, 655 W Baltimore St,Bressler Res Bldg,Rm 4-01, Baltimore, MD 21201 USA.	sthom@smail.umaryland.edu			Office of Naval Research	Office of Naval Research(Office of Naval Research)	This work was supported by a grant from the Office of Naval Research.	Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Alfonso P, 2006, PROTEOMICS, V6, pS262, DOI 10.1002/pmic.200500350; Allen DB, 1997, ARCH SURG-CHICAGO, V132, P991; Arieli R, 2005, J APPL PHYSIOL, V98, P144, DOI 10.1152/japplphysiol.00506.2004; BELL RM, 1981, J LIPID RES, V22, P391; BERGHAGE TE, 1979, UNDERSEA BIOMED RES, V6, P379; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; BITTERMAN N, 1987, UNDERSEA BIOMED RES, V14, P477; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Brandes RP, 2014, ANTIOXID REDOX SIGN, V20, P887, DOI 10.1089/ars.2013.5414; BRAUER RW, 1982, J APPL PHYSIOL, V53, P192, DOI 10.1152/jappl.1982.53.1.192; Cauwenberghs S, 2006, FEBS LETT, V580, P5313, DOI 10.1016/j.febslet.2006.08.082; Chapple SJ, 2013, REDOX BIOL, V1, P319, DOI 10.1016/j.redox.2013.04.001; Csanyi G, 2011, FREE RADICAL BIO MED, V51, P1116, DOI 10.1016/j.freeradbiomed.2011.04.025; Daniliuc S, 2003, J IMMUNOL, V171, P3225, DOI 10.4049/jimmunol.171.6.3225; David HN, 2008, FASEB J, V22, P1275, DOI 10.1096/fj.07-9420com; Di Mascio P, 1997, BIOL CHEM, V378, P1071; ECKENHOFF RG, 1990, J APPL PHYSIOL, V69, P914, DOI 10.1152/jappl.1990.69.3.914; Enjeti AK, 2008, SEMIN THROMB HEMOST, V34, P683, DOI 10.1055/s-0028-1104547; Flynn E. T. J., 1971, P 4 S UND PHYS NEW Y, P179, DOI [10.1016/b978-0-12-434750-2.50028-9, DOI 10.1016/B978-0-12-434750-2.50028-9]; Freyssinet JM, 2010, THROMB RES, V125, pS46, DOI 10.1016/j.thromres.2010.01.036; Gharib B, 2001, CR ACAD SCI III-VIE, V324, P719, DOI 10.1016/S0764-4469(01)01350-6; Glogauer M, 2000, J CELL BIOL, V150, P785, DOI 10.1083/jcb.150.4.785; Gollmer A, 2011, PHOTOCHEM PHOTOBIOL, V87, P671, DOI 10.1111/j.1751-1097.2011.00900.x; Hild M, 1999, J PHYS CHEM A, V103, P6091, DOI 10.1021/jp9906942; Huttelmaier S, 1998, CURR BIOL, V8, P479, DOI 10.1016/S0960-9822(98)70199-X; Jackson TS, 1998, CIRC RES, V83, P916; JANDL RC, 1978, J CLIN INVEST, V61, P1176, DOI 10.1172/JCI109033; Kasorn A, 2009, J IMMUNOL, V183, P1032, DOI 10.4049/jimmunol.0802984; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Kramarenko GG, 2006, PHOTOCHEM PHOTOBIOL, V82, P1634, DOI 10.1562/2006-01-12-RN-774; Li MY, 2001, PHOTOCHEM PHOTOBIOL, V74, P760, DOI 10.1562/0031-8655(2001)074<0760:QOSMOO>2.0.CO;2; Lillo RS, 2000, J APPL PHYSIOL, V89, P2107, DOI 10.1152/jappl.2000.89.6.2107; Madden LA, 2010, AVIAT SPACE ENVIR MD, V81, P41, DOI 10.3357/ASEM.2610.2010; MILLER SL, 1969, NATURE, V221, P468, DOI 10.1038/221468a0; Minaev BF, 2003, SPECTROCHIM ACTA A, V59, P3387, DOI 10.1016/S1386-1425(03)00165-3; Morel O, 2011, ARTERIOSCL THROM VAS, V31, P15, DOI 10.1161/ATVBAHA.109.200956; OSTLUND A, 1994, J APPL PHYSIOL, V76, P439, DOI 10.1152/jappl.1994.76.1.439; Paes AMD, 2011, J LEUKOCYTE BIOL, V90, P799, DOI 10.1189/jlb.0610324; Pagel PS, 2008, ANESTH ANALG, V107, P762, DOI 10.1213/ane.0b013e3181815995; Pecci L, 2001, BIOCHEM BIOPH RES CO, V289, P305, DOI 10.1006/bbrc.2001.5971; Pescatore LA, 2012, J BIOL CHEM, V287, P29290, DOI 10.1074/jbc.M112.394551; Pirro M, 2008, ATHEROSCLEROSIS, V197, P757, DOI 10.1016/j.atherosclerosis.2007.07.012; Pontier JM, 2012, APPL PHYSIOL NUTR ME, V37, P888, DOI [10.1139/h2012-067, 10.1139/H2012-067]; Popescu NI, 2010, BLOOD, V116, P993, DOI 10.1182/blood-2009-10-249607; Sanders RD, 2010, CRIT CARE, V14, DOI 10.1186/cc8847; Santos CXC, 2009, J LEUKOCYTE BIOL, V86, P989, DOI 10.1189/jlb.0608354; SHIMAMORI H, 1984, J CHEM PHYS, V81, P1271, DOI 10.1063/1.447813; Swift LM, 2000, AM J PHYSIOL-HEART C, V278, pH982, DOI 10.1152/ajpheart.2000.278.3.H982; THOM SR, 1987, UNDERSEA BIOMED RES, V14, P485; THOM SR, 1984, APPL ENVIRON MICROB, V47, P780, DOI 10.1128/AEM.47.4.780-787.1984; THOM SR, 1992, ARCH BIOCHEM BIOPHYS, V295, P391, DOI 10.1016/0003-9861(92)90532-2; Thom SR, 2008, J BIOL CHEM, V283, P10822, DOI 10.1074/jbc.M709200200; Thom SR, 2013, J APPL PHYSIOL, V114, P1396, DOI 10.1152/japplphysiol.00106.2013; Thom SR, 2013, J APPL PHYSIOL, V114, P550, DOI 10.1152/japplphysiol.01386.2012; Thom SR, 2013, J BIOL CHEM, V288, P4810, DOI 10.1074/jbc.M112.426353; Thom SR, 2012, J BIOL CHEM, V287, P30346, DOI 10.1074/jbc.M112.355875; Thom SR, 2012, J APPL PHYSIOL, V112, P1268, DOI 10.1152/japplphysiol.01305.2011; Thom SR, 2011, J BIOL CHEM, V286, P32854, DOI 10.1074/jbc.M111.255778; Thom SR, 2011, J APPL PHYSIOL, V110, P340, DOI 10.1152/japplphysiol.00811.2010; Tomazzolli R, 2006, ANAL BIOCHEM, V350, P105, DOI 10.1016/j.ab.2005.11.037; Vann RD, 2011, LANCET, V377, P153, DOI 10.1016/S0140-6736(10)61085-9; Vince RV, 2009, EUR J APPL PHYSIOL, V105, P507, DOI 10.1007/s00421-008-0927-z; von Montfort C, 2006, BIOL CHEM, V387, P1399, DOI 10.1515/BC.2006.175; Weast R. C., 1984, HDB CHEM PHYS; Wehman AM, 2011, CURR BIOL, V21, P1951, DOI 10.1016/j.cub.2011.10.040; Yang M, 2013, J APPL PHYSIOL, V115, P1481, DOI 10.1152/japplphysiol.00745.2013; Yang M, 2012, J APPL PHYSIOL, V112, P204, DOI 10.1152/japplphysiol.00953.2011	69	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	27					18831	18845		10.1074/jbc.M113.543702	http://dx.doi.org/10.1074/jbc.M113.543702			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL3WV	24867949	Green Published, hybrid			2022-12-25	WOS:000339062900018
J	Csordas, G; Varga, GIB; Honti, V; Jankovics, F; Kurucz, E; Ando, I				Csordas, Gabor; Varga, Gergely I. B.; Honti, Viktor; Jankovics, Ferenc; Kurucz, Eva; Ando, Istvan			In Vivo Immunostaining of Hemocyte Compartments in Drosophila for Live Imaging	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSE; NERVOUS-SYSTEM; LYMPH GLAND; EXPRESSION; LARVAL; BLOOD; PHAGOCYTOSIS; TRANSPORT; LINEAGES; RECEPTOR	In recent years, Drosophila melanogaster has become an attractive model organism in which to study the structure and development of the cellular immune components. The emergence of immunological markers greatly accelerated the identification of the immune cells (hemocytes), while the creation of genetic reporter constructs allowed unique insight into the structural organization of hematopoietic tissues. However, investigation of the hemocyte compartments by the means of immunological markers requires dissection and fixation, which regularly disrupt the delicate structure and hamper the microanatomical characterization. Moreover, the investigation of transgenic reporters alone can be misleading as their expression often differs from the native expression pattern of their respective genes. We describe here a method that combines the reporter constructs and the immunological tools in live imaging, thereby allowing use of the array of available immunological markers while retaining the structural integrity of the hematopoietic compartments. The procedure allows the reversible immobilization of Drosophila larvae for high-resolution confocal imaging and the time-lapse video analysis of in vivo reporters. When combined with our antibody injection-based in situ immunostaining assay, the resulting double labeling of the hemocyte compartments can provide new information on the microanatomy and functional properties of the hematopoietic tissues in an intact state. Although this method was developed to study the immune system of Drosophila melanogaster, we anticipate that such a combination of genetic and immunological markers could become a versatile technique for in vivo studies in other biological systems too.	[Csordas, Gabor; Varga, Gergely I. B.; Honti, Viktor; Kurucz, Eva; Ando, Istvan] Hungarian Acad Sci, Biol Res Ctr, Immunol Unit, Inst Genet, H-6701 Szeged, Hungary; [Jankovics, Ferenc] Hungarian Acad Sci, Biol Res Ctr, Dev Genet Unit, Inst Genet, H-6701 Szeged, Hungary	Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Academy of Sciences; Hungarian Biological Research Center	Ando, I (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Immunol Unit, Inst Genet, H-6701 Szeged, Hungary.	ando.istvan@brc.mta.hu		Csordas, Gabor/0000-0001-6871-6839; Jankovics, Ferenc/0000-0001-9697-4472	Hungarian Science Foundation, OTKA [NK 101730, TAMOP 4.2.2.A-11/1KONV-2012-0035]; European Union; State of Hungary; European Social Fund [TAMOP 4.2.4.A/2-11-1-2012-0001]	Hungarian Science Foundation, OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF))	This research was financed by grants from the Hungarian Science Foundation, OTKA grant NK 101730 to (IA) (www.otka.hu), and TAMOP 4.2.2.A-11/1KONV-2012-0035 to (IA) (www.ujszechenyiterv.gov.hu). This research was supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/2-11-1-2012-0001 'National Excellence Program' (for VH and GIBV) (www.nemzetikivalosag.hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre NH, 2005, COMP BIOCHEM PHYS A, V140, P363, DOI 10.1016/j.cbpb.2005.01.019; Beetz S, 2004, J INSECT PHYSIOL, V50, P805, DOI 10.1016/j.jinsphys.2004.06.003; Dreschers S., 1994, European Journal of Cell Biology, V63, P82; Dushay MS, 1998, AM J HUM GENET, V62, P10, DOI 10.1086/301694; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Fuger P, 2007, NAT PROTOC, V2, P3285, DOI 10.1038/nprot.2007.472; Ghannad-Rezaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029869; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Honti V, 2010, MOL IMMUNOL, V47, P1997, DOI 10.1016/j.molimm.2010.04.017; Honti V, 2009, IMMUNOL LETT, V126, P83, DOI 10.1016/j.imlet.2009.08.004; HULTMARK D, 1994, NATURE, V367, P116, DOI 10.1038/367116a0; Jankovics F, 2006, DEV CELL, V11, P375, DOI 10.1016/j.devcel.2006.07.014; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; King JG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-55; Krzemien J, 2010, DEV BIOL, V346, P310, DOI 10.1016/j.ydbio.2010.08.003; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Kurucz E, 2007, ACTA BIOL HUNG, V58, P95, DOI 10.1556/ABiol.58.2007.Suppl.8; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Makhijani K, 2011, DEVELOPMENT, V138, P5379, DOI 10.1242/dev.067322; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; Martinek N, 2008, J CELL SCI, V121, P1671, DOI 10.1242/jcs.021931; Miller KE, 2005, CURR BIOL, V15, P684, DOI 10.1016/j.cub.2005.02.061; Minakhina S, 2006, GENETICS, V174, P253, DOI 10.1534/genetics.106.061978; Nakahara Y, 2009, DEV COMP IMMUNOL, V33, P439, DOI 10.1016/j.dci.2008.09.005; Olofsson B, 2005, DEV BIOL, V279, P233, DOI 10.1016/j.ydbio.2004.12.020; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; RIZKI MOHAMMED TAHIR MIRZA, 1957, J MORPH, V100, P437, DOI 10.1002/jmor.1051000303; RIZKI MTM, 1959, J BIOPHYS BIOCHEM CY, V5, P235, DOI 10.1083/jcb.5.2.235; RIZKI TM, 1980, EXPERIENTIA, V36, P1223, DOI 10.1007/BF01976142; ROEHRBORN G, 1961, EXPERIENTIA, V17, P507; SAMAKOVLIS C, 1990, EMBO J, V9, P2969, DOI 10.1002/j.1460-2075.1990.tb07489.x; Schmid A, 2008, NAT NEUROSCI, V11, P659, DOI 10.1038/nn.2122; SHRESTHA R, 1982, DEV GROWTH DIFFER, V24, P83; Sinenko SA, 2004, ONCOGENE, V23, P9120, DOI 10.1038/sj.onc.1208156; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; Stofanko M, 2008, GENETICS, V180, P253, DOI 10.1534/genetics.108.089094; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; Tokusumi T, 2009, GENESIS, V47, P771, DOI 10.1002/dvg.20561; Ulvila J, 2011, APMIS, V119, P651, DOI 10.1111/j.1600-0463.2011.02792.x; Vilmos P, 2009, EUR J CELL BIOL, V88, P609, DOI 10.1016/j.ejcb.2009.05.006; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101; Zsamboki J, 2013, CENT EUR J BIOL, V8, P633, DOI 10.2478/s11535-013-0183-4	42	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98191	10.1371/journal.pone.0098191	http://dx.doi.org/10.1371/journal.pone.0098191			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892745	Green Submitted, Green Published, gold			2022-12-25	WOS:000336911400039
J	Rich, ME; deCardenas, EJ; Lee, HJ; Caldwell, HK				Rich, Megan E.; deCardenas, Emily J.; Lee, Heon-Jin; Caldwell, Heather K.			Impairments in the Initiation of Maternal Behavior in Oxytocin Receptor Knockout Mice	PLOS ONE			English	Article							EDINBURGH-POSTNATAL-DEPRESSION; BRAIN OXYTOCIN; SOMATOSENSORY DETERMINANTS; PERIAQUEDUCTAL GRAY; POSTPARTUM PERIOD; NURSING BEHAVIOR; GENE-EXPRESSION; VASOPRESSIN 1A; OESTROUS CYCLE; LACTATING RATS	Oxytocin (Oxt) acting through its single receptor subtype, the Oxtr, is important for the coordination of physiology and behavior associated with parturition and maternal care. Knockout mouse models have been helpful in exploring the contributions of Oxt to maternal behavior, including total body Oxt knockout (Oxt -/-) mice, forebrain conditional Oxtr knockout (Oxtr FB/FB) mice, and total body Oxtr knockout (Oxtr -/-) mice. Since Oxtr -/- mice are unable to lactate, maternal behavior has only been examined in virgin females, or in dams within a few hours of parturition, and there have been no studies that have examined their anxiety-like and depression-like behavior following parturition. To improve our understanding of how the absence of Oxt signaling affects maternal behavior, mood and anxiety, we designed a study using Oxtr -/- mice that separated nursing behavior from other aspects of maternal care, such as licking and grooming by thelectomizing (i.e. removing the nipples) of Oxtr +/+ mice and sham-thelectomizing Oxtr -/- mice, and pairing both genotypes with a wet nurse. We then measured pup abandonment, maternal behavior, and postpartum anxiety-like and depression-like behaviors. We hypothesized that genetic disruption of the Oxtr would impact maternal care, mood and anxiety. Specifically, we predicted that Oxtr -/- dams would have impaired maternal care and increased anxiety-like and depression-like behaviors in the postpartum period. We found that Oxtr -/- dams had significantly higher levels of pup abandonment compared to controls, which is consistent with previous work in Oxtr FB/FB mice. Interestingly, Oxtr -/- dams that initiated maternal care did not differ from wildtype controls in measures of maternal behavior. We also did not find any evidence of altered anxiety-like or depressive-like behavior in the postpartum period of Oxtr -/- dams. Thus, our data suggest that Oxt lowers the threshold for the initiation of maternal behavior.	[Rich, Megan E.; deCardenas, Emily J.; Caldwell, Heather K.] Kent State Univ, Dept Biol Sci, Neuroendocrinol & Behav Lab, Kent, OH 44242 USA; [Rich, Megan E.; Caldwell, Heather K.] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Lee, Heon-Jin] Kyungpook Natl Univ, Sch Dent, Dept Oral Microbiol, Taegu, South Korea; [Lee, Heon-Jin] Kyungpook Natl Univ, Brain Sci & Engn Inst, Taegu, South Korea	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Kyungpook National University; Kyungpook National University	Caldwell, HK (corresponding author), Kent State Univ, Dept Biol Sci, Neuroendocrinol & Behav Lab, Kent, OH 44242 USA.	hcaldwel@kent.edu		Lee, Heon-Jin/0000-0002-1911-5014; Caldwell, Heather/0000-0002-2172-3860	Kent State Department of Biological Sciences	Kent State Department of Biological Sciences	The research was funded by the Kent State Department of Biological Sciences. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale TL, 1995, ADV EXP MED BIOL, V395, P269; Bale TL, 2001, J NEUROSCI, V21, P2546, DOI 10.1523/JNEUROSCI.21-07-02546.2001; Baumgartner T, 2008, NEURON, V58, P639, DOI 10.1016/j.neuron.2008.04.009; Bealer SL, 2006, AM J PHYSIOL-REG I, V291, pR53, DOI 10.1152/ajpregu.00766.2005; Bergant AM, 1999, J PSYCHOSOM RES, V46, P391, DOI 10.1016/S0022-3999(98)00116-0; Bifulco A, 2004, BRIT J PSYCHIAT, V184, pS31, DOI 10.1192/bjp.184.46.s31; Blanks AM, 2003, BJOG-INT J OBSTET GY, V110, P46, DOI 10.1016/S1470-0328(03)00024-7; Blume A, 2008, EUR J NEUROSCI, V27, P1947, DOI 10.1111/j.1460-9568.2008.06184.x; Bosch OJ, 2005, J NEUROSCI, V25, P6807, DOI 10.1523/JNEUROSCI.1342-05.2005; Bosch OJ, 2008, P NATL ACAD SCI USA, V105, P17139, DOI 10.1073/pnas.0807412105; Bosch OJ, 2012, HORM BEHAV, V61, P293, DOI 10.1016/j.yhbeh.2011.11.002; BROIDA J, 1982, BEHAV NEURAL BIOL, V35, P76, DOI 10.1016/S0163-1047(82)91318-8; Caldwell HK, 2006, NEUROPEPTIDES, V40, P325, DOI 10.1016/j.npep.2006.08.001; Caldwell HK, 2012, ADV EXP MED BIOL, V739, P187, DOI 10.1007/978-1-4614-1704-0_12; Caldwell HK, 2010, HORM BEHAV, V58, P257, DOI 10.1016/j.yhbeh.2010.03.008; CALDWELL JD, 1987, NEUROENDOCRINOLOGY, V46, P39, DOI 10.1159/000124794; Champagne F, 2001, P NATL ACAD SCI USA, V98, P12736, DOI 10.1073/pnas.221224598; Dhakar MB, 2012, HORM BEHAV; FAHRBACH SE, 1985, NEUROENDOCRINOLOGY, V40, P526, DOI 10.1159/000124125; Feijo L, 2006, INFANT BEHAV DEV, V29, P476, DOI 10.1016/j.infbeh.2006.02.003; Feldman R, 2007, PSYCHOL SCI, V18, P965, DOI 10.1111/j.1467-9280.2007.02010.x; Francis DD, 2000, J NEUROENDOCRINOL, V12, P1145, DOI 10.1046/j.1365-2826.2000.00599.x; Heinrichs M, 2008, PROG BRAIN RES, V170, P337, DOI 10.1016/S0079-6123(08)00428-7; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; INSEL TR, 1986, NEUROENDOCRINOLOGY, V44, P515, DOI 10.1159/000124694; INSEL TR, 1992, PSYCHONEUROENDOCRINO, V17, P3, DOI 10.1016/0306-4530(92)90073-G; INSEL TR, 1989, PHYSIOL BEHAV, V45, P1033, DOI 10.1016/0031-9384(89)90234-5; JONES SE, 1987, BEHAV GENET, V17, P87, DOI 10.1007/BF01066013; KENDRICK KM, 1992, ANN NY ACAD SCI, V652, P102, DOI 10.1111/j.1749-6632.1992.tb34349.x; KENDRICK KM, 1992, BRAIN RES, V569, P199, DOI 10.1016/0006-8993(92)90631-I; KENDRICK KM, 1987, NEUROENDOCRINOLOGY, V46, P56, DOI 10.1159/000124796; Kimura T, 2006, TXB PERINATAL MED, P619; LANDGRAF R, 1992, ANN NY ACAD SCI, V652, P326, DOI 10.1111/j.1749-6632.1992.tb34364.x; Lee HJ, 2008, ENDOCRINOLOGY, V149, P3256, DOI 10.1210/en.2007-1710; LINCOLN DW, 1982, J REPROD FERTIL, V65, P571, DOI 10.1530/jrf.0.0650571; Lonstein JS, 2007, FRONT NEUROENDOCRIN, V28, P115, DOI 10.1016/j.yfrne.2007.05.002; Lonstein JS, 2005, HORM BEHAV, V47, P241, DOI 10.1016/j.yhbeh.2004.11.001; Lonstein JS, 1997, J NEUROSCI, V17, P3364; Lonstein JS, 1997, HORM BEHAV, V32, P155, DOI 10.1006/hbeh.1997.1416; Lonstein JS, 1999, HORM BEHAV, V36, P242, DOI 10.1006/hbeh.1999.1544; Lyons-Ruth K, 1986, New Dir Child Dev, P61; Macbeth AH, 2010, BEHAV NEUROSCI, V124, P677, DOI 10.1037/a0020799; MAESTRIPIERI D, 1991, J COMP PSYCHOL, V105, P295, DOI 10.1037/0735-7036.105.3.295; MANNING M, 1989, J MED CHEM, V32, P382, DOI 10.1021/jm00122a016; MCCARTHY MM, 1990, HORM BEHAV, V24, P365, DOI 10.1016/0018-506X(90)90015-P; Meddle SL, 2007, ENDOCRINOLOGY, V148, P5095, DOI 10.1210/en.2007-0615; MEZEY E, 1991, ENDOCRINOLOGY, V129, P1814, DOI 10.1210/endo-129-4-1814; MOOS F, 1989, EXP BRAIN RES, V76, P593, DOI 10.1007/BF00248916; Nephew BC, 2009, BEHAV NEUROSCI, V123, P949, DOI 10.1037/a0016734; NEUMANN I, 1993, NEUROSCIENCE, V53, P65, DOI 10.1016/0306-4522(93)90285-N; NEUMANN I, 1989, J NEUROENDOCRINOL, V1, P305, DOI 10.1111/j.1365-2826.1989.tb00120.x; Neumann ID, 2000, NEUROSCIENCE, V95, P567; Nishimori K, 1996, P NATL ACAD SCI USA, V93, P11699, DOI 10.1073/pnas.93.21.11699; NUMAN M, 1994, ACTA PAEDIATR, V83, P19, DOI 10.1111/j.1651-2227.1994.tb13261.x; NUMAN M, 1985, PHYSIOL BEHAV, V35, P417, DOI 10.1016/0031-9384(85)90318-X; PEDERSEN CA, 1979, P NATL ACAD SCI USA, V76, P6661, DOI 10.1073/pnas.76.12.6661; PEDERSEN CA, 1985, NEUROPEPTIDES, V6, P175, DOI 10.1016/0143-4179(85)90108-8; Pedersen CA, 2006, GENES BRAIN BEHAV, V5, P274, DOI 10.1111/j.1601-183X.2005.00162.x; Pedersen CA, 1997, ANN NY ACAD SCI, V807, P126, DOI 10.1111/j.1749-6632.1997.tb51916.x; PEDERSEN CA, 1982, SCIENCE, V216, P648, DOI 10.1126/science.7071605; Pedersen CA, 2003, PHYSIOL BEHAV, V80, P233, DOI 10.1016/j.physbeh.2003.07.011; Ragnauth AK, 2004, NEUROENDOCRINOLOGY, V80, P92, DOI 10.1159/000081844; Ring RH, 2006, PSYCHOPHARMACOLOGY, V185, P218, DOI 10.1007/s00213-005-0293-z; Ross LE, 2004, ACTA PSYCHIAT SCAND, V109, P457, DOI 10.1111/j.1600-0047.2004.00296.x; Skrundz M, 2011, NEUROPSYCHOPHARMACOL, V36, P1886, DOI 10.1038/npp.2011.74; STERN JM, 1990, PHYSIOL BEHAV, V47, P993, DOI 10.1016/0031-9384(90)90026-Z; STERN JM, 1992, PSYCHOBIOLOGY, V20, P71; Stuart S, 1998, J NERV MENT DIS, V186, P420, DOI 10.1097/00005053-199807000-00006; Takayanagi Y, 2005, P NATL ACAD SCI USA, V102, P16096, DOI 10.1073/pnas.0505312102; Teissedre F, 2004, ENCEPHALE, V30, P376; Teissedre F, 2004, CAN J PSYCHIAT, V49, P51, DOI 10.1177/070674370404900108; VANLEENGOED E, 1987, J ENDOCRINOL, V112, P275, DOI 10.1677/joe.0.1120275; VANTOL HHM, 1988, ENDOCRINOLOGY, V122, P945, DOI 10.1210/endo-122-3-945; Wersinger SR, 2007, GENES BRAIN BEHAV, V6, P540, DOI 10.1111/j.1601-183X.2006.00281.x; WHITTEN WK, 1956, J ENDOCRINOL, V13, P399, DOI 10.1677/joe.0.0130399; WHITTEN WK, 1958, J ENDOCRINOL, V17, P307, DOI 10.1677/joe.0.0170307; Windle RJ, 1997, ENDOCRINOLOGY, V138, P2829, DOI 10.1210/en.138.7.2829; Young LJ, 1997, J NEUROENDOCRINOL, V9, P859, DOI 10.1046/j.1365-2826.1997.00654.x; Young WS, 1996, J NEUROENDOCRINOL, V8, P847, DOI 10.1046/j.1365-2826.1996.05266.x; ZINGG HH, 1988, MOL BRAIN RES, V4, P1, DOI 10.1016/0169-328X(88)90011-3	81	60	60	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98839	10.1371/journal.pone.0098839	http://dx.doi.org/10.1371/journal.pone.0098839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892749	Green Submitted, Green Published, gold			2022-12-25	WOS:000336911400099
J	Gagne-Sansfacon, J; Allaire, JM; Jones, C; Boudreau, F; Perreault, N				Gagne-Sansfacon, Jessica; Allaire, Joannie M.; Jones, Christine; Boudreau, Francois; Perreault, Nathalie			Loss of Sonic Hedgehog Leads to Alterations in Intestinal Secretory Cell Maturation and Autophagy	PLOS ONE			English	Article							STEM-CELLS; PROMOTES AUTOPHAGY; SIGNALING PATHWAY; MULTIPLE ASPECTS; TENSIN HOMOLOG; HUMAN COLON; HOMEOSTASIS; GENE; EXPRESSION; DIFFERENTIATION	Background: Intestinal epithelial cells express the Sonic and Indian hedgehog ligands. Despite the strong interest in gut hedgehog signaling in GI diseases, no studies have specifically addressed the singular role of intestinal epithelial cell Sonic hedgehog signaling. The aim of this study was to investigate the specific role of Sonic hedgehog in adult ileal epithelial homeostasis. Methodology/Principal Findings: A Sonic hedgehog intestinal epithelial conditional knockout mouse model was generated. Assessment of ileal histological abnormalities, crypt epithelial cell proliferation, epithelial cell fate, junctional proteins, signaling pathways, as well as ultrastructural analysis of intracellular organelles were performed in control and mutant mice. Mice lacking intestinal epithelial Sonic Hedgehog displayed decreased ileal crypt/villus length, decreased crypt proliferation as well as a decrease in the number of ileal mucin-secreting goblet cells and antimicrobial peptide-secreting Paneth cells during adult life. These secretory cells also exhibited disruption of their secretory products in mutant mice. Ultrastructural microscopy analysis revealed a dilated ER lumen in secretory cells. This phenotype was also associated with a decrease in autophagy. Conclusions/Significance: Altogether, these findings indicate that the loss of Sonic hedgehog can lead to ileal secretory cell modifications indicative of endoplasmic reticulum stress, accompanied by a significant reduction in autophagy.	[Gagne-Sansfacon, Jessica; Allaire, Joannie M.; Jones, Christine; Boudreau, Francois; Perreault, Nathalie] Univ Sherbrooke, Dept Anat & Biol Cellulaire, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Perreault, N (corresponding author), Univ Sherbrooke, Dept Anat & Biol Cellulaire, Fac Med & Sci Sante, Sherbrooke, PQ J1K 2R1, Canada.	Nathalie.Perreault@USherbrooke.ca		Allaire, Joannie/0000-0002-2665-5617	Canadian Institutes of Health Research (CIHR) [MOP-111104]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was supported by the Canadian Institutes of Health Research (CIHR) MOP-111104 to NP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire JM, 2011, AM J PHYSIOL-GASTR L, V300, pG586, DOI 10.1152/ajpgi.00041.2010; Auclair BA, 2007, GASTROENTEROLOGY, V133, P887, DOI 10.1053/j.gastro.2007.06.066; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Boudreau F, 2002, J BIOL CHEM, V277, P31909, DOI 10.1074/jbc.M204622200; Boudreau F, 2007, FASEB J, V21, P3853, DOI 10.1096/fj.07-8113com; Buller NVJA, 2012, PHYSIOLOGY, V27, P148, DOI 10.1152/physiol.00003.2012; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Dharmani P, 2009, J INNATE IMMUN, V1, P123, DOI 10.1159/000163037; Einerhand AWC, 2002, EUR J GASTROEN HEPAT, V14, P757, DOI 10.1097/00042737-200207000-00008; FALK P, 1994, AM J PHYSIOL, V266, pG987, DOI 10.1152/ajpgi.1994.266.6.G987; Gao N, 2010, GENE DEV, V24, P1295, DOI 10.1101/gad.1921510; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Kaser A, 2010, MUCOSAL IMMUNOL, V3, P11, DOI 10.1038/mi.2009.122; Kaser A, 2011, EXP CELL RES, V317, P2772, DOI 10.1016/j.yexcr.2011.07.008; Kaser A, 2011, GASTROENTEROLOGY, V140, P1738, DOI 10.1053/j.gastro.2011.02.048; Kaser A, 2009, SEMIN IMMUNOL, V21, P156, DOI 10.1016/j.smim.2009.01.001; Katoh Y, 2005, CANCER BIOL THER, V4, P1050, DOI 10.4161/cbt.4.10.2184; Kim JH, 2005, DEV DYNAM, V234, P984, DOI 10.1002/dvdy.20542; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kosinski C, 2010, GASTROENTEROLOGY, V139, P893, DOI 10.1053/j.gastro.2010.06.014; Langlois MJ, 2009, FASEB J, V23, P1835, DOI 10.1096/fj.08-123125; Li HJ, 2012, AM J PHYSIOL-HEART C, V303, pH1319, DOI 10.1152/ajpheart.00160.2012; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Maloum F, 2011, AM J PHYSIOL-GASTR L, V300, pG1065, DOI 10.1152/ajpgi.00176.2010; Mao J, 2010, DEVELOPMENT, V137, P1721, DOI 10.1242/dev.044586; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Menard D, 2006, CELL SIGNALING AND GROWTH FACTORS IN DEVELOPMENT: FROM MOLECULES TO ORGANOGENESIS, P755; Milla LA, 2012, BIOL RES, V45, P223, DOI 10.4067/S0716-97602012000300004; Nielsen CM, 2004, LAB INVEST, V84, P1631, DOI 10.1038/labinvest.3700197; Patel KK, 2013, EMBO J, V32, P3130, DOI 10.1038/emboj.2013.233; Perreault N, 2001, J BIOL CHEM, V276, P43328, DOI 10.1074/jbc.M104366200; Petralia RS, 2013, BIOL OPEN, V2, P499, DOI 10.1242/bio.20134275; Prasad S, 2005, LAB INVEST, V85, P1139, DOI 10.1038/labinvest.3700316; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Roy SAB, 2012, WORLD J GASTROENTERO, V18, P1579, DOI 10.3748/wjg.v18.i14.1579; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Stappenbeck TS, 2010, MUCOSAL IMMUNOL, V3, P8, DOI 10.1038/mi.2009.121; Stappenbeck TS, 2009, GASTROENTEROLOGY, V137, P30, DOI 10.1053/j.gastro.2009.05.013; SWEETSER DA, 1988, P NATL ACAD SCI USA, V85, P9611, DOI 10.1073/pnas.85.24.9611; Traber Peter G., 1995, P21; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; van den Brink GR, 2007, CANCER CELL, V11, P109, DOI 10.1016/j.ccr.2007.01.003; van den Brink GR, 2006, GUT, V55, P912, DOI 10.1136/gut.2005.085902; van Dop WA, 2010, GASTROENTEROLOGY, V139, P1665, DOI 10.1053/j.gastro.2010.07.045; Van Dop WA, 2010, GASTROENTEROLOGY, V138, P426, DOI 10.1053/j.gastro.2009.12.013; Varnat F, 2006, GASTROENTEROLOGY, V131, P538, DOI 10.1053/j.gastro.2006.05.004; Varnat F, 2010, EMBO MOL MED, V2, P440, DOI 10.1002/emmm.201000098; Varnat F, 2010, MECH DEVELOP, V127, P73, DOI 10.1016/j.mod.2009.10.005; Wang Y, 2013, HEPATOLOGY, V58, P995, DOI 10.1002/hep.26394; Zacharias WJ, 2011, DEV BIOL, V355, P152, DOI 10.1016/j.ydbio.2011.04.025; Zacharias WJ, 2010, GASTROENTEROLOGY, V138, P2368, DOI 10.1053/j.gastro.2010.02.057; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	59	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98751	10.1371/journal.pone.0098751	http://dx.doi.org/10.1371/journal.pone.0098751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887421	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300104
J	Wang, WY; Wu, XM; Wang, L; Meng, QG; Liu, WH				Wang, Wenyan; Wu, Xiangmeng; Wang, Li; Meng, Qingguo; Liu, Wanhui			Stereoselective Property of 20(S)-Protopanaxadiol Ocotillol Type Epimers Affects Its Absorption and Also the Inhibition of P-Glycoprotein	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; IN-VITRO; RAT PLASMA; 20(S)-GINSENOSIDE RH2; LIQUID-CHROMATOGRAPHY; MULTIDRUG-RESISTANCE; GINSENOSIDE RG(3); RG3; TRANSPORTERS; METABOLITES	Stereoselectivity has been proved to be tightly related to drug action including pharmacodynamics and pharmacokinetics. (20S, 24R)-epoxy-dammarane-3,12,25-triol (24R-epimer) and (20S, 24S)-epoxy-dammarane-3,12,25-triol (24S-epimer), a pair of 20(S)-protopanaxadiol (PPD) ocotillol type epimers, were the main metabolites of PPD. Previous studies have shown that 24R-epimer and 24S-epimer had stereoselectivity in pharmacological action and pharmacokinetics. In the present study, the aim was to further study the pharmacokinetic characteristics of both epimers, investigate their absorption mechanism and analyze the selectivity effects of ocotillol type side chain and C24 stereo-configuration on P-glycoprotein (P-gp) in vivo and in vitro. Results showed that the absolute bioavailability of 24R-epimer was about 14-fold higher than that of 24S-epimer, and a linear kinetic characteristic was acquired in doses of 5-20 mg/kg for both epimers after oral administration. Furthermore, the apparent permeability coefficients of 24R-epimer were 5-7 folds higher than that of 24S-epimer having lower efflux ratios in Caco-2 cell models. Moreover, both 24R-epimer and 24S-epimer had similar inhibitory effects on P-gp by increasing cellular retention of rhodamine 123 in Caco-2 cells and decreasing efflux of digoxin across Caco-2 cell monolayers. In situ in vivo experiments showed that the inhibition of 24R-epimer on P-gp was stronger than that of 24S-epimer by single-pass intestinal perfusion of rhodamine 123 in rats. Western blot analyses demonstrated that both epimers had no action on P-gp expression in Caco-2 cells. In conclusion, with respect to the stereoselectivity, C24 S-configuration of the ocotillol type epimers processed a poor transmembrane permeability and could be distinguished by P-gp. Sharing a dammarane skeleton, both 24R-epimer and 24S-epimer were potent inhibitors of P-gp. This study provides a new case of stereoselective pharmacokinetics of chiral compounds which contributes to know the chiral characteristics of P-gp and structure-action relationship of PPD type and ocotillol type ginsenosides as a P-gp inhibitor.	[Wang, Wenyan; Wu, Xiangmeng; Wang, Li; Meng, Qingguo; Liu, Wanhui] Yantai Univ, Sch Pharm, Yantai, Shandong, Peoples R China	Yantai University	Meng, QG (corresponding author), Yantai Univ, Sch Pharm, Yantai, Shandong, Peoples R China.	qinggmeng@163.com; wanhui@luye.cn	Wu, Xiangmeng/ABB-9299-2021; Wu, Xiangmeng/AAW-3149-2021	Wu, Xiangmeng/0000-0001-5767-7555	National Natural Science Foundation of China [81102880]; Research Awards Fund for Excellent Young Scientists of Shandong Province [BS2011YY062]; Natural Science Foundation of Shandong Province [ZR2012HM036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Awards Fund for Excellent Young Scientists of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by National Natural Science Foundation of China No. 81102880 (WW), Research Awards Fund for Excellent Young Scientists of Shandong Province No. BS2011YY062 (WW), and Natural Science Foundation of Shandong Province No. ZR2012HM036 (QM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Bae EA, 2002, BIOL PHARM BULL, V25, P58, DOI 10.1248/bpb.25.58; Bae SH, 2013, J SEP SCI, V36, P1904, DOI 10.1002/jssc.201300107; Bhatia P, 2008, XENOBIOTICA, V38, P656, DOI [10.1080/00498250802109207, 10.1080/00498250802109207 ]; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Fei XF, 2002, ACTA PHARMACOL SIN, V23, P315; Gu Y, 2010, XENOBIOTICA, V40, P602, DOI 10.3109/00498254.2010.500744; He Y, 2010, CHIRALITY, V22, P684, DOI 10.1002/chir.20815; Hutt Andrew J., 2007, Drug Metabolism and Drug Interactions, V22, P79; Izzo AA, 2009, DRUGS, V69, P1777, DOI 10.2165/11317010-000000000-00000; Jia WWG, 2004, CAN J PHYSIOL PHARM, V82, P431, DOI 10.1139/Y04-049; Jin J, 2006, BIOCHEM BIOPH RES CO, V345, P1308, DOI 10.1016/j.bbrc.2006.04.152; Kasai R, 2000, CHEM PHARM BULL, V48, P1226; Kawase A, 2014, J NAT MED-TOKYO, V68, P395, DOI 10.1007/s11418-013-0791-y; Kim HS, 2004, ARCH PHARM RES, V27, P429, DOI 10.1007/BF02980085; Kim SW, 2003, BIOCHEM PHARMACOL, V65, P75, DOI 10.1016/S0006-2952(02)01446-6; Kwak JO, 2010, EUR J PHARMACOL, V627, P92, DOI 10.1016/j.ejphar.2009.11.008; Kwok HH, 2012, BIOCHEM PHARMACOL, V83, P893, DOI 10.1016/j.bcp.2011.12.039; Lancet JE, 2009, LEUKEMIA RES, V33, P1055, DOI 10.1016/j.leukres.2008.09.015; Lee HU, 2005, BIOL PHARM BULL, V28, P1992, DOI 10.1248/bpb.28.1992; Li LA, 2011, DRUG METAB DISPOS, V39, P472, DOI 10.1124/dmd.110.036723; Li Xiao, 2005, Sichuan Da Xue Xue Bao Yi Xue Ban, V36, P217; Liu J, 2010, FITOTERAPIA, V81, P902, DOI 10.1016/j.fitote.2010.05.020; Liu J, 2009, BIOORG MED CHEM LETT, V19, P3320, DOI 10.1016/j.bmcl.2009.04.054; Lu JM, 2009, CURR VASC PHARMACOL, V7, P293, DOI 10.2174/157016109788340767; Maki N, 2003, J BIOL CHEM, V278, P18132, DOI 10.1074/jbc.M210413200; MOCHIZUKI M, 1995, BIOL PHARM BULL, V18, P1197, DOI 10.1248/bpb.18.1197; Popovich DG, 2004, CAN J PHYSIOL PHARM, V82, P183, DOI 10.1139/Y04-001; Prueksaritanont T, 2003, XENOBIOTICA, V33, P1125, DOI 10.1080/00498250310001609174; Qi LW, 2011, NAT PROD REP, V28, P467, DOI 10.1039/c0np00057d; Shinkai K, 1996, JPN J CANCER RES, V87, P357, DOI 10.1111/j.1349-7006.1996.tb00230.x; Sun SY, 2012, XENOBIOTICA, V42, P1197, DOI 10.3109/00498254.2012.702247; Thomas Hilary, 2003, Cancer Control, V10, P159; Tian JW, 2005, NEUROSCI LETT, V374, P92, DOI 10.1016/j.neulet.2004.10.030; Wang TA, 2010, FITOTERAPIA, V81, P783, DOI 10.1016/j.fitote.2010.04.005; Wang WY, 2012, J CHROMATOGR B, V887, P19, DOI 10.1016/j.jchromb.2011.12.032; Wei XJ, 2012, INT IMMUNOL, V24, P465, DOI 10.1093/intimm/dxs043; Xie HT, 2005, J CHROMATOGR B, V818, P167, DOI 10.1016/j.jchromb.2004.12.028; Xie XW, 2006, J UROLOGY, V175, P1926, DOI 10.1016/S0022-5347(05)00891-8; Zhang H, 2007, PHYTOCHEMISTRY, V68, P2523, DOI 10.1016/j.phytochem.2007.05.028; Zhang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035768; Zhang JW, 2010, DRUG METAB DISPOS, V38, P2179, DOI 10.1124/dmd.110.034793; Zhang Rui, 2008, Zhongguo Yaolixue Tongbao, V24, P1504; Zhao Y, 2009, PLANTA MED, V75, P1124, DOI 10.1055/s-0029-1185477; Zhu S, 2004, CHEM PHARM BULL, V52, P995, DOI 10.1248/cpb.52.995	45	19	22	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98887	10.1371/journal.pone.0098887	http://dx.doi.org/10.1371/journal.pone.0098887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887182	gold, Green Submitted, Green Published			2022-12-25	WOS:000336956300118
J	Arreola, A; Cowey, CL; Coloff, JL; Rathmell, JC; Rathmell, WK				Arreola, Alexandra; Cowey, C. Lance; Coloff, Jonathan L.; Rathmell, Jeffrey C.; Rathmell, W. Kimryn			HIF1 alpha and HIF2 alpha Exert Distinct Nutrient Preferences in Renal Cells	PLOS ONE			English	Article							HYPOXIA; HIF-2-ALPHA; GLUTAMINE; HIF-1; IDENTIFICATION; ADAPTATION; BINDING; GENES; LEADS	Background: Hypoxia Inducible Factors (HIF1 alpha and HIF2 alpha) are commonly stabilized and play key roles related to cell growth and metabolic programming in clear cell renal cell carcinoma. The relationship of these factors to discretely alter cell metabolic activities has largely been described in cancer cells, or in hypoxic conditions, where other confounding factors undoubtedly compete. These transcription factors and their specific roles in promoting cancer metabolic phenotypes from the earliest stages are poorly understood in pre-malignant cells. Methods: We undertook an analysis of SV40-transformed primary kidney epithelial cells derived from newborn mice genetically engineered to express a stabilized HIF1 alpha or HIF2 alpha transgene. We examined the metabolic profile in relation to each gene. Results: Although the cells proliferated similarly, the metabolic profile of each genotype of cell was markedly different and correlated with altered gene expression of factors influencing components of metabolic signaling. HIF1 alpha promoted high levels of glycolysis as well as increased oxidative phosphorylation in complete media, but oxidative phosphorylation was suppressed when supplied with single carbon source media. HIF2 alpha, in contrast, supported oxidative phosphorylation in complete media or single glucose carbon source, but these cells were not responsive to glutamine nutrient sources. This finding correlates to HIF2 alpha-specific induction of Glul, effectively reducing glutamine utilization by limiting the glutamate pool, and knockdown of Glul allows these cells to perform oxidative phosphorylation in glutamine media. Conclusion: HIF1 alpha and HIF2 alpha support highly divergent patterns of kidney epithelial cell metabolic phenotype. Expression of these factors ultimately alters the nutrient resource utilization and energy generation strategy in the setting of complete or limiting nutrients.	[Arreola, Alexandra; Rathmell, W. Kimryn] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Arreola, Alexandra; Rathmell, W. Kimryn] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Cowey, C. Lance; Rathmell, W. Kimryn] Univ N Carolina, Div Hematol & Oncol, Dept Med, Chapel Hill, NC USA; [Coloff, Jonathan L.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University	Rathmell, WK (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.	rathmell@med.unc.edu			NIH NRSA [F31CA154080];  [R01-CA121781]; NATIONAL CANCER INSTITUTE [P30CA014236, F31CA154080, R01CA121781, P30CA016086, K24CA172355] Funding Source: NIH RePORTER	NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	AA was funded by NIH NRSA Grant F31CA154080. WKR was funded by R01-CA121781. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; BELL CL, 1988, AM J HUM GENET, V43, P293; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Davidson A. J, 2009, MOUSE KIDNEY DEV; del Peso L, 2003, J BIOL CHEM, V278, P48690, DOI 10.1074/jbc.M308862200; Egeblad M, 2005, COLD SH Q B, V70, P383, DOI 10.1101/sqb.2005.70.007; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Gameiro PA, 2013, CELL METAB, V17, P372, DOI 10.1016/j.cmet.2013.02.002; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Iliopoulos O, 1996, P NATL ACAD SCI USA, V93, P10595, DOI 10.1073/pnas.93.20.10595; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Kurban G, 2006, CANCER RES, V66, P1313, DOI 10.1158/0008-5472.CAN-05-2560; Lai YL, 2011, J PROTEOME RES, V10, P5175, DOI 10.1021/pr200642c; Linehan WM, 2013, SEMIN CANCER BIOL, V23, P46, DOI 10.1016/j.semcancer.2012.06.002; Lutz MS, 2006, CANCER RES, V66, P6903, DOI 10.1158/0008-5472.CAN-06-0501; Maxwell PH, 1995, DEVELOPMENT, V121, P4005; Nadanaciva S, 2007, TOXICOL IN VITRO, V21, P902, DOI 10.1016/j.tiv.2007.01.011; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Polyak K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003244; Rankin EB, 2008, ONCOGENE, V27, P5354, DOI 10.1038/onc.2008.160; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Rathmell WK, 2004, CANCER RES, V64, P8595, DOI 10.1158/0008-5472.CAN-04-1430; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; SHERIDAN AM, 1993, AM J PHYSIOL, V265, pF342, DOI 10.1152/ajprenal.1993.265.3.F342; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; SOUBA WW, 1993, ANN SURG, V218, P715, DOI 10.1097/00000658-199312000-00004; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; White NMA, 2013, COLD SPRING HARBOR P, P1; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105	43	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98705	10.1371/journal.pone.0098705	http://dx.doi.org/10.1371/journal.pone.0098705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879016	gold, Green Published, Green Submitted			2022-12-25	WOS:000338101500081
J	Medina-Martinez, I; Barron, V; Roman-Bassaure, E; Juarez-Torres, E; Guardado-Estrada, M; Espinosa, AM; Bermudez, M; Fernandez, F; Venegas-Vega, C; Orozco, L; Zenteno, E; Kofman, S; Berumen, J				Medina-Martinez, Ingrid; Barron, Valeria; Roman-Bassaure, Edgar; Juarez-Torres, Eligia; Guardado-Estrada, Mariano; Espinosa, Ana Maria; Bermudez, Miriam; Fernandez, Fernando; Venegas-Vega, Carlos; Orozco, Lorena; Zenteno, Edgar; Kofman, Susana; Berumen, Jaime			Impact of Gene Dosage on Gene Expression, Biological Processes and Survival in Cervical Cancer: A Genome-Wide Follow-Up Study	PLOS ONE			English	Article							MOLECULAR CYTOGENETIC CHARACTERIZATION; HUMAN-PAPILLOMAVIRUS TYPE-16; NF-KAPPA-B; CHROMOSOMAL-ABERRATIONS; GLUCOSE-METABOLISM; RECURRENT PATTERN; MITOTIC PATHWAY; HYBRIDIZATION; GAIN; CARCINOMA	We investigated the role of tumor copy number (CN)-altered genome (CN-AG) in the carcinogenesis of cervical cancer (CC), especially its effect on gene expression, biological processes, and patient survival. Fifty-nine human papillomavirus 16 (HPV16)-positive CCs were investigated with microarrays-31 for mapping CN-AG and 55 for global gene expression, with 27 CCs in common. Five-year survival was investigated in 55 patients. Deletions and amplifications >2.5 Mb were defined as CN alterations. The %CN-AG varied from 0 to 32.2% (mean = 8.1 +/- 8.9). Tumors were classified as low (mean = 0.5 +/- 0.6, n = 11), medium (mean = 5.4 +/- 2.4, n = 10), or high (mean = 19.2 +/- 6.6, n = 10) CN. The highest %CN-AG was found in 3q, which contributed an average of 55% of all CN alterations. Genome-wide, only 5.3% of CN-altered genes were deregulated directly by gene dosage. In contrast, the rate in fully duplicated 3q was twice as high. Amplification of 3q explained 23.2% of deregulated genes in whole tumors (r(2) = 0.232, p = 0.006; analysis of variance), including genes located in 3q and other chromosomes. A total of 862 genes were deregulated exclusively in high-CN tumors, but only 22.9% were CN altered. This suggests that the remaining genes are not deregulated directly by gene dosage, but by mechanisms induced in trans by CN-altered genes. Anaphase-promoting complex/cyclosome (APC/C)-dependent proteasome proteolysis, glycolysis, and apoptosis were upregulated, whereas cell adhesion and angiogenesis were downregulated exclusively in high-CN tumors. The high %CN-AG and upregulated gene expression profile of APC/C-dependent proteasome proteolysis were associated with poor patient survival (p<0.05, log-rank test). Along with glycolysis, they were linearly associated with FIGO stage (r>0.38, p<0.01, Spearman test). Therefore, inhibition of APC/C-dependent proteasome proteolysis and glycolysis could be useful for CC treatment. However, whether they are indispensable for tumor growth remains to be demonstrated.	[Medina-Martinez, Ingrid; Barron, Valeria; Juarez-Torres, Eligia; Guardado-Estrada, Mariano; Espinosa, Ana Maria; Bermudez, Miriam; Berumen, Jaime] Univ Nacl Autonoma Mexico, Fac Med, Hosp Gen Mexico, Unidad Med Genom, Mexico City 04510, DF, Mexico; [Roman-Bassaure, Edgar] Hosp Gen Mexico City, Serv Oncol, Mexico City, DF, Mexico; [Fernandez, Fernando; Venegas-Vega, Carlos; Kofman, Susana] Univ Nacl Autonoma Mexico, Fac Med, Hosp Gen Mexico, Serv Genet, Mexico City 04510, DF, Mexico; [Orozco, Lorena] Inst Nacl Med Genom, Lab Genom Enfermedades Complejas, Mexico City, DF, Mexico; [Zenteno, Edgar] Univ Nacl Autonoma Mexico, Fac Med, Dept Bioquim, Mexico City 04510, DF, Mexico; [Berumen, Jaime] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Mexico City 04510, DF, Mexico	Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; Hospital General de Mexico; Hospital General de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Berumen, J (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Hosp Gen Mexico, Unidad Med Genom, Mexico City 04510, DF, Mexico.	jaimeberumen@hotmail.com	Berumen, Jaime/F-7914-2018; Fernández-Ramírez, Fernando/GPK-5724-2022; Berumen, Jaime/AAL-5577-2020	Berumen, Jaime/0000-0001-6707-3317; Berumen, Jaime/0000-0001-6707-3317; Orozco, Lorena/0000-0002-5801-9180; Fernandez-Ramirez, Fernando/0000-0002-7016-1948; Zenteno, Edgar/0000-0001-5603-4072; ESPINOSA GARCIA, ANA MARIA/0000-0003-3255-4051; VENEGAS-VEGA, CARLOS ALBERTO/0000-0001-5609-418X	National Council of Science and Technology (CONACYT) [8135/A1, 24341, 80680, 133273]; National University of Mexico [SDI.PTID.05.2]	National Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National University of Mexico	This work was supported by the National Council of Science and Technology (CONACYT, www.conacyt.mx), grant numbers 8135/A1, 24341 (to JB), 80680 (to SK) and 133273 (to FF) and the National University of Mexico (www.unam.mx), grant number SDI.PTID.05.2 (to JB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz M, 2006, GENE CHROMOSOME CANC, V45, P829, DOI 10.1002/gcc.20343; Alameda F, 2009, HUM PATHOL, V40, P1474, DOI 10.1016/j.humpath.2009.03.013; Allen DG, 2000, BRIT J CANCER, V83, P1659, DOI 10.1054/bjoc.2000.1509; Andersson S, 2006, BRIT J CANCER, V95, P331, DOI 10.1038/sj.bjc.6603253; Atkin NB, 2000, CYTOGENET CELL GENET, V91, P44, DOI 10.1159/000056816; Belloni E, 2011, ONCOGENE, V30, P1117, DOI 10.1038/onc.2010.478; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Buitrago-Perez A, 2009, CURR GENOMICS, V10, P26, DOI 10.2174/138920209787581235; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Dowen SE, 2003, ONCOGENE, V22, P2531, DOI 10.1038/sj.onc.1206296; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Guardado-Estrada M, 2012, J HUM GENET, V57, P269, DOI 10.1038/jhg.2012.17; Harris CP, 2003, GENE CHROMOSOME CANC, V36, P233, DOI 10.1002/gcc.10158; Heselmeyer K, 1997, GENE CHROMOSOME CANC, V19, P233, DOI 10.1002/(SICI)1098-2264(199708)19:4<233::AID-GCC5>3.0.CO;2-Y; Heselmeyer K, 1996, P NATL ACAD SCI USA, V93, P479, DOI 10.1073/pnas.93.1.479; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johnson RF, 2012, TRENDS BIOCHEM SCI, V37, P317, DOI 10.1016/j.tibs.2012.04.002; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kirchhoff M, 1999, GENE CHROMOSOME CANC, V24, P144, DOI 10.1002/(SICI)1098-2264(199902)24:2<144::AID-GCC7>3.0.CO;2-9; Kloth JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-53; Lyng H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-268; Ma YY, 2000, ONCOGENE, V19, P2739, DOI 10.1038/sj.onc.1203597; Macville M, 1999, CANCER RES, V59, P141; Manos MM, 1989, USE POLYMERASE CHAIN, P209; Espinosa AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055975; Matthews CP, 2000, P SOC EXP BIOL MED, V223, P316, DOI 10.1046/j.1525-1373.2000.22345.x; MITRA AB, 1995, J NATL CANCER I, V87, P742, DOI 10.1093/jnci/87.10.742; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Narayan G, 2007, GENE CHROMOSOME CANC, V46, P373, DOI 10.1002/gcc.20418; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Patel D, 2010, J VIROL, V84, P10956, DOI 10.1128/JVI.00259-10; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P103, DOI 10.1016/j.ijgo.2009.02.012; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Rao PH, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-5; Ried T, 1999, GENE CHROMOSOME CANC, V25, P195, DOI 10.1002/(SICI)1098-2264(199907)25:3<195::AID-GCC1>3.0.CO;2-8; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Scotto L, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-58; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Sugita M, 2000, CANCER GENET CYTOGEN, V117, P9, DOI 10.1016/S0165-4608(99)00135-1; Teissier S, 2007, J VIROL, V81, P9368, DOI 10.1128/JVI.00427-07; Thierry F, 2004, CANCER RES, V64, P895, DOI 10.1158/0008-5472.CAN-03-2349; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Umayahara K, 2002, GENE CHROMOSOME CANC, V33, P98, DOI 10.1002/gcc.1215; VANDENBRULE AJC, 1990, J CLIN MICROBIOL, V28, P2739, DOI 10.1128/JCM.28.12.2739-2743.1990; Vazquez Mena O, 2012, PLOS ONE, V7; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201; Wilting SM, 2008, GENE CHROMOSOME CANC, V47, P890, DOI 10.1002/gcc.20590; Yang YC, 2001, CANCER GENET CYTOGEN, V131, P48, DOI 10.1016/S0165-4608(01)00510-6; YOSHIKAWA H, 1991, JPN J CANCER RES, V82, P524, DOI 10.1111/j.1349-7006.1991.tb01882.x; Yugawa T, 2009, REV MED VIROL, V19, P97, DOI 10.1002/rmv.605; Zhai Y, 2007, CANCER RES, V67, P10163, DOI 10.1158/0008-5472.CAN-07-2056	54	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97842	10.1371/journal.pone.0097842	http://dx.doi.org/10.1371/journal.pone.0097842			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879114	Green Submitted, Green Published, gold			2022-12-25	WOS:000338101500025
J	Merali, Z; Gao, MM; Bowes, T; Chen, J; Evans, K; Kassner, A				Merali, Zamir; Gao, Meah MingYang; Bowes, Tim; Chen, Jian; Evans, Kenneth; Kassner, Andrea			Neuroproteome Changes after Ischemia/Reperfusion Injury and Tissue Plasminogen Activator Administration in Rats: A Quantitative iTRAQ Proteomics Study	PLOS ONE			English	Article							AMINO-ACID TRANSPORTERS; CEREBRAL-CORTEX; GLUTAMATE RELEASE; ISCHEMIC-INJURY; KAPPA-B; STROKE; BRAIN; EXPRESSION; STRATEGIES; UPDATE	The thrombolytic, recombinant tissue plasminogen activator (rt-PA) is the only approved therapy for acute ischemic stroke (AIS). When administered after AIS, rt-PA has many adverse pleiotropic actions, which are currently poorly understood. The identification of proteins showing differential expression after rt-PA administration may provide insight into these pleiotropic actions. In this study we used a 2D-LC MS/MS iTRAQ proteomic analysis, western blotting, and pathway analysis to analyze changes in protein expression 24-hours after rt-PA administration in the cortical brain tissue of 36 rats that underwent a sham or transient middle cerebral artery occlusion surgery. After rt-PA administration we reported alterations in the expressions of 18 proteins, many of which were involved in excitatory neurotransmitter function or cytoskeletal structure. The expression changes of GAD2 and EAAT1 were validated with western blot. The interactions between the identified proteins were analyzed with the IPA pathway analysis tool and three proteins: DPYSL2, RTN4, and the NF-kappa B complex, were found to have characteristics of being key proteins in the network. The differential protein expressions we observed may reflect pleiotropic actions of rt-PA after experimental stroke, and shine light on the mechanisms of rt-PA's adverse effects. This may have important implications in clinical settings where thrombolytic therapy is used to treat AIS.	[Gao, Meah MingYang; Bowes, Tim; Kassner, Andrea] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada; [Merali, Zamir; Kassner, Andrea] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Chen, Jian; Evans, Kenneth] Ontario Canc Biomarker Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Kassner, A (corresponding author), Univ Toronto, Dept Med Imaging, Toronto, ON, Canada.	Andrea.kassner@utoronto.ca			Canada Research Chair Program; Canadian Institutes of Health Research [94383, 111113]	Canada Research Chair Program(Canada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canada Research Chair Program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) and the Canadian Institutes of Health Research (94383, 111113) (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bambauer KZ, 2006, ARCH NEUROL-CHICAGO, V63, P661, DOI 10.1001/archneur.63.5.661; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Beschorner R, 2007, HISTOPATHOLOGY, V50, P897, DOI 10.1111/j.1365-2559.2007.02703.x; Bolay H, 2002, STROKE, V33, P1369, DOI 10.1161/01.STR.0000013708.54623.DE; Brown DL, 2005, ANN EMERG MED, V46, P56, DOI 10.1016/j.annemergmed.2004.12.025; Carrol JE, 2000, NEUROREPORT, V11, pR1; Datta A, 2011, J PROTEOME RES, V10, P5199, DOI 10.1021/pr200673y; Datta A, 2010, J PROTEOME RES, V9, P472, DOI 10.1021/pr900829h; Davalos A, 1997, STROKE, V28, P708, DOI 10.1161/01.STR.28.4.708; Diz AP, 2009, ELECTROPHORESIS, V30, P2967, DOI 10.1002/elps.200900210; Muller GDES, 2013, J MOL NEUROSCI, V50, P154, DOI 10.1007/s12031-012-9888-0; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Douen AG, 2000, J NEUROCHEM, V75, P812, DOI 10.1046/j.1471-4159.2000.0750812.x; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Focking M, 2006, ACTA NEUROBIOL EXP, V66, P273; Gan CS, 2007, J PROTEOME RES, V6, P821, DOI 10.1021/pr060474i; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hazell AS, 2007, NEUROCHEM INT, V50, P941, DOI 10.1016/j.neuint.2007.04.026; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Inagaki N, 2000, J BIOL CHEM, V275, P27165; Indraswari F, 2009, NEUROCHEM INT, V55, P235, DOI 10.1016/j.neuint.2009.03.005; Iwakuma M, 2003, NEUROSCI RES, V45, P285, DOI 10.1016/S0168-0102(02)00233-X; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jeyaseelan K, 2008, EXPERT OPIN PHARMACO, V9, P887, DOI 10.1517/14656566.9.6.887; Jia ZY, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/617539; Karp NA, 2009, PROTEOMICS, V9, P388, DOI 10.1002/pmic.200800485; Kern F, 2013, BIOCHEM J, V455, P217, DOI 10.1042/BJ20130579; Kiran M, 2013, J PROTEOME RES, V12, P5436, DOI 10.1021/pr4002788; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Lee TYJ, 2003, MICROSC RES TECHNIQ, V60, P115, DOI 10.1002/jemt.10250; Lin L, 2012, J AM SOC NEPHROL, V23, P1329, DOI 10.1681/ASN.2011111123; Liu T., 2009, METHODS MOL BIOL, V566, P201, DOI 10.1007/978-1-59745-562-6_14; Matthews CC, 2007, J NEUROSCI RES, V85, P855, DOI 10.1002/jnr.21187; McDowell GS, 2013, J PROTEOME RES, V12, P3809, DOI 10.1021/pr400032m; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mitka M, 2003, JAMA-J AM MED ASSOC, V289, P1363, DOI 10.1001/jama.289.11.1363; NAG S, 1995, ACTA NEUROPATHOL, V90, P454; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Phillis JW, 2000, BRAIN RES, V868, P105, DOI 10.1016/S0006-8993(00)02303-9; Seal RP, 1999, ANNU REV PHARMACOL, V39, P431, DOI 10.1146/annurev.pharmtox.39.1.431; Sung JH, 2009, J PINEAL RES, V46, P300, DOI 10.1111/j.1600-079X.2008.00661.x; Ueno Y, 2012, STROKE, V43, P2221, DOI 10.1161/STROKEAHA.111.646224; Uluc K, 2011, FOCUS CEREBRAL ISCHE, pe1978; White CN, 2004, CLIN BIOCHEM, V37, P636, DOI 10.1016/j.clinbiochem.2004.05.004; Winiewski JR, 2009, NATURE METHODS, V6; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006; Zhou Y, 2008, J PROTEOME RES, V7, P2507, DOI 10.1021/pr800108k	50	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98706	10.1371/journal.pone.0098706	http://dx.doi.org/10.1371/journal.pone.0098706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879061	Green Submitted, Green Published, gold			2022-12-25	WOS:000338101500082
J	Silva, ED; de Abreu, CB; Orlando, TC; Wisniewski, C; dos Santos-Wisniewski, MJ				Silva, Erika dos Santos; de Abreu, Cinthia Bruno; Orlando, Tereza Cristina; Wisniewski, Celio; dos Santos-Wisniewski, Maria Jose			Alona iheringula Sinev & Kotov, 2004 (Crustacea, Anomopoda, Chydoridae, Aloninae): Life Cycle and DNA Barcode with Implications for the Taxonomy of the Aloninae Subfamily	PLOS ONE			English	Article							BIOLOGICAL IDENTIFICATIONS; CLADOCERA; BRANCHIOPODA; HISTORY; TEMPERATURE; DIVERSITY; PREDATION; RESERVOIR; BIOMASS; GROWTH	Knowledge of reproductive rates and life cycle of the Cladocera species is essential for population dynamic studies, secondary production and food webs, as well as the management and preservation of aquatic ecosystems. The present study aimed to understand the life cycle and growth of Alona iheringula Kotov & Sinev, 2004 (Crustacea, Anomopoda, Chydoridae), a Neotropical species, as well as its DNA barcoding, providing new information on the Aloninae taxonomy. The specimens were collected in the dammed portion of the Cabo Verde River (21 degrees 26'05" S and 46 degrees 10'57" W), in the Furnas Reservoir, Minas Gerais State, Brazil. Forty neonates were observed individually two or three times a day under controlled temperature (25 +/- 1 degrees C), photoperiod (12 h light/12 h dark) and feeding (Pseudokirchneriella subcapitata at a concentration of 10(5) cells.mL(-1) and a mixed suspension of yeast and fish feed in equal proportion). Individual body growth was measured daily under optical microscope using a micrometric grid and 40x magnification. The species had a mean size of 413(+/- 29) mu m, a maximum size of 510 mu m and reached maturity at 3.24(+/- 0.69) days of age. Mean fecundity was 2 eggs per female per brood and the mean number of eggs produced per female during the entire life cycle was 47.6(+/- 6.3) eggs per female. The embryonic development time was 1.79(+/- 0.23) days and the maximum longevity was 54 days. The species had eight instars throughout its life cycle and four instars between neonate and primipara stage. The present study using molecular data (a 461 bp smaller COI fragment) demonstrated a deep divergence in the Aloninae subfamily.	[Silva, Erika dos Santos; de Abreu, Cinthia Bruno; Orlando, Tereza Cristina; dos Santos-Wisniewski, Maria Jose] Univ Fed Alfenas UNIFAL MG, Inst Ciencias Nat, Alfenas, MG, Brazil; [Wisniewski, Celio] Univ Fed Alfenas UNIFAL MG, Inst Ciencias Exatas, Alfenas, MG, Brazil	Universidade Federal de Alfenas; Universidade Federal de Alfenas	dos Santos-Wisniewski, MJ (corresponding author), Univ Fed Alfenas UNIFAL MG, Inst Ciencias Nat, Gabriel Monteiro da Silva 700, Alfenas, MG, Brazil.	zeze.wisniewski@unifal-mg.edu.br	Abreu, Cínthia/ABD-8213-2021; Orlando, Tereza/GPX-8165-2022	Bruno de Abreu, Cinthia/0000-0002-2782-8268	Eletrobras Furnas (Programa de PD Aneel); FAPEMIG (Biota Minas) [APQ-03549-09]; FAPEMIG (Universal APQ) [01518-09]; PIBICT/FAPEMIG Program 029	Eletrobras Furnas (Programa de PD Aneel); FAPEMIG (Biota Minas)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPEMIG (Universal APQ)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); PIBICT/FAPEMIG Program 029	Funding for this research was provided by Eletrobras Furnas (Programa de P&D Aneel) and FAPEMIG (Biota Minas APQ-03549-09 and Universal APQ 01518-09) grants and an undergraduate fellowship to C. B. A. (PIBICT/FAPEMIG Program 029/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABNT, 2009, ASS BRAS NORM TECN N; ALLAN JD, 1976, AM NAT, V110, P165, DOI 10.1086/283056; Barnett AJ, 2007, FRESHWATER BIOL, V52, P796, DOI 10.1111/j.1365-2427.2007.01733.x; Bekker EI, 2012, ZOOTAXA, P1; Belyaeva M, 2009, MOL PHYLOGENET EVOL, V50, P534, DOI 10.1016/j.ympev.2008.11.007; BOTTRELL HH, 1975, OECOLOGIA, V19, P129, DOI 10.1007/BF00369097; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Bucklin A., 2000, P533, DOI 10.1016/B978-012327645-2/50012-8; CETESB, 1992, AG MET AV TOX POL OR; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; De Lima IHAG, 1997, ACTA LIMNOL BRAS, V9, P149; dos Santos-Wisniewski MJ, 2011, BIOTA NEOTROP, V11, P287, DOI 10.1590/S1676-06032011000300024; Duggan IC, 2012, AQUAT INVASIONS, V7, P585, DOI 10.3391/ai.2012.7.4.015; Durigan JG, 1994, REV UNIMAR, V16, P229; Elias-Gutierrez M, 2008, ZOOTAXA, P1; Elias-Gutierrez M, 2008, HIDROBIOLOGICA, V18, P63; Elmoor-Loureiro L. M. A., 1997, MANUAL IDENTIFICACAO; Elmoor-Loureiro LMA, 2004, ZOOTAXA, P1; Elmoor-Loureiro LMA, 2007, REV BRAS ZOOL, V24, P344, DOI 10.1590/S0101-81752007000200012; Eskinazi-Sant'Anna E.M., 2005, Acta Limnologica Brasiliensia, V17, P199; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forro L, 2008, HYDROBIOLOGIA, V595, P177, DOI 10.1007/s10750-007-9013-5; Fryer G, 1993, FRESHWATER CRUSTACEA; Golterman HL, 1978, METHODS PHYS CHEM AN; Hardy E. R., 1994, Acta Amazonica, V24, P119; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hwang JS, 2009, ZOOL STUD, V48, P738; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jeffery NW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018364; Kotov AA, 1997, HYDROBIOLOGIA, V354, P83, DOI 10.1023/A:1003063407127; Kotov AA, 2006, ENTOMOL REV, V86, P210, DOI [10.1134/S0013873806110157, DOI 10.1134/S0013873806110157]; Kotov Alexey A., 2004, Arthropoda Selecta, V13, P95; Lowe-McConnell RH, 1980, IBP HDB, V22; LYNCH M, 1980, Q REV BIOL, V55, P23, DOI 10.1086/411614; Martinez-Jeronimo F, 2011, CRUSTACEANA, V84, P187, DOI 10.1163/001121610X551827; Matsumura-Tundisi T, 2005, HYDROBIOLOGIA, V542, P367, DOI 10.1007/s10750-004-9461-0; Matsumura-Tundisi T, 2006, ACTA LIMNOL BRAS, V18, P305; Melao MG, 2006, ACTA LIMNOL BRAS, V18, P433; MUNRO IG, 1975, OECOLOGIA, V20, P157, DOI 10.1007/BF00369028; MURUGAN N, 1982, HYDROBIOLOGIA, V89, P9, DOI 10.1007/BF00017533; Nogueira MG, 2005, ECOLOGIA RESERVATORI, V2005; Pompeo M. L. M., 1999, PERSPECTIVAS LIMNOLO, P45; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rietzler AC, 1998, ANAIS DO VI SEMINARI, V8, P1159; ROBERTSON AL, 1988, FRESHWATER BIOL, V20, P75, DOI 10.1111/j.1365-2427.1988.tb01719.x; Rocha O, 2000, INVERTEBRADOS AGUA D, V4, P109; Rocha Odete, 2011, Biota Neotropica, V11, P1; Sacherova V, 2003, BIOL J LINN SOC, V79, P629, DOI 10.1046/j.1095-8312.2003.00216.x; Santos RM, 2010, BRAZ J BIOL, V70, P879, DOI 10.1590/S1519-69842010000400019; Shan R. K.c., 1969, Hydrobiologia, V34, P513; Sharma S, 1998, INDIAN J ANIM SCI, V68, P101; Sinev Artem Y., 1999, Arthropoda Selecta, V8, P131; Sinev AY, 2010, ZOOTAXA, P1; Sinev AY, 2001, HYDROBIOLOGIA, V464, P113, DOI 10.1023/A:1013935100483; Smirnov NN, 1971, CRUSTACEA, V1, P1; Smirnov NN, 1974, PROGRAM SCI TRANSLAT, V1, P1; Sousa Francisco Diogo Rocha, 2008, Biota Neotrop., V8, P159, DOI 10.1590/S1676-06032008000100019; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomaz SM, 2003, ECOLOGIA MANEJO MACR, P19; Toledo AP, 1983, C BRAS ENG SAN CAMB, P1; Valdez-Moreno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036636; Van Damme K, 2010, ZOOTAXA, P1; Venkataraman K, 1990, J ANDAMAN SCI ASS, V6, P127; Viti T, 2013, IHERINGIA SER ZOOL, V103, P110, DOI 10.1590/S0073-47212013000200005; Young SS, 2012, ZOOL STUD, V51, P222	65	7	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97050	10.1371/journal.pone.0097050	http://dx.doi.org/10.1371/journal.pone.0097050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878503	Green Published, gold, Green Submitted			2022-12-25	WOS:000338101500011
J	Will, M; Bader, GD; Conard, NJ				Will, Manuel; Bader, Gregor D.; Conard, Nicholas J.			Characterizing the Late Pleistocene MSA Lithic Technology of Sibudu, KwaZulu-Natal, South Africa	PLOS ONE			English	Article							MIDDLE-STONE-AGE; DIEPKLOOF ROCK SHELTER; MODERN HUMAN-BEHAVIOR; POST-HOWIESONS POORT; WESTERN-CAPE; BLOMBOS CAVE; STILL BAY; KLASIES RIVER; ARCHAEOLOGICAL APPLICATION; BEDDING CONSTRUCTION	Studies of the African Middle Stone Age (MSA) have become central for defining the cultural adaptations that accompanied the evolution of modern humans. While much of recent research in South Africa has focused on the Still Bay and Howiesons Poort (HP), periods following these technocomplexes were often neglected. Here we examine lithic assemblages from Sibudu that post-date the HP to further the understanding of MSA cultural variability during the Late Pleistocene. Sibudu preserves an exceptionally thick, rich, and high-resolution archaeological sequence that dates to similar to 58 ka, which has recently been proposed as type assemblage for the "Sibudan''. This study presents a detailed analysis of the six uppermost lithic assemblages from these deposits (BM-BSP) that we excavated from 2011-2013. We define the key elements of the lithic technology and compare our findings to other assemblages post-dating the HP. The six lithic assemblages provide a distinct and robust cultural signal, closely resembling each other in various technological, techno-functional, techno-economic, and typological characteristics. These results refute assertions that modern humans living after the HP possessed an unstructured and unsophisticated MSA lithic technology. While we observed several parallels with other contemporaneous MSA sites, particularly in the eastern part of southern Africa, the lithic assemblages at Sibudu demonstrate a distinct and so far unique combination of techno-typological traits. Our findings support the use of the Sibudan to help structuring this part of the southern African MSA and emphasize the need for further research to identify the spatial and temporal extent of this proposed cultural unit.	[Will, Manuel; Bader, Gregor D.; Conard, Nicholas J.] Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany; [Conard, Nicholas J.] Univ Tubingen, Senckenberg Ctr Human Evolut & Paleoecol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN)	Will, M (corresponding author), Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany.	manuel.will@uni-tuebingen.de		Will, Manuel/0000-0001-8116-2543; Conard, Nicholas/0000-0002-4633-0385; Bader, Gregor/0000-0003-0621-9209	Heidelberger Akademie der Wissenschaft; Tubingen Senckenberg Center for Human Evolution and Paleoecology; Deutsche Forschungsgemeinschaft [CO 226/27-1]; Doctoral Dissertation Grant of the Studienstiftung des deutschen Volkes; Deutsche Forschungsgemeinschaft; Tuebingen University	Heidelberger Akademie der Wissenschaft; Tubingen Senckenberg Center for Human Evolution and Paleoecology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Doctoral Dissertation Grant of the Studienstiftung des deutschen Volkes; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University	The excavation and research at Sibudu was funded by the Heidelberger Akademie der Wissenschaft, the Tubingen Senckenberg Center for Human Evolution and Paleoecology, and the Deutsche Forschungsgemeinschaft grant (CO 226/27-1). MW's work on this study was supported by a Doctoral Dissertation Grant of the Studienstiftung des deutschen Volkes. We acknowledge support by the Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alperson-Afil N., 2007, PALEOANTHROPOLOGY, V2007, P1; Ambrose S.H., 2002, ARCHEOLOGICAL PAPERS, V12, P9; Andrefsky W., 1998, LITHICS MACROSCOPIC; [Anonymous], J ARCHAEOLOGICAL MET, DOI DOI 10.1007/BF02229424; Backwell L, 2008, J ARCHAEOL SCI, V35, P1566, DOI 10.1016/j.jas.2007.11.006; BINFORD LR, 1980, AM ANTIQUITY, V45, P4, DOI 10.2307/279653; Bishop WW, 1966, CURR ANTHROPOL, V7, P253; Bisson MS, 2000, J ARCHAEOL METHOD TH, V7, P1, DOI 10.1023/A:1009578011590; BLEED P, 2011, PALEOANTHROPOLOGY, P297, DOI DOI 10.4207/PA.2011.ART60; Boeda E, 2013, QUATERN INT, V295, P191, DOI 10.1016/j.quaint.2012.07.020; Boeda E., 1993, BULL SOC PREHIST FR, V90, P392, DOI DOI 10.3406/BSPF.1993.9669; Boeda E., 1990, PAL O, V2, P43, DOI DOI 10.3406/PAL.1990.988; Boeda E., 2001, IND OUTILS BIFACIAUX, P51; Bonilauri S., 2010, THESIS U PARIS OUEST; Braun D. R., 2003, OLDOWAN RATHER MORE, P132; Braun DR, 2005, LITHIC TECHNOL, V30, P107, DOI 10.1080/01977261.2005.11721029; Brew J.O., 1946, PAPERS PEABODY MUSEU, V21, P44; Brown KS, 2012, NATURE, V491, P590, DOI 10.1038/nature11660; Brown KS, 2009, SCIENCE, V325, P859, DOI 10.1126/science.1175028; Cain C.R., 2006, SOUTH AFR HUMANIT, V18, P241; Cain CR, 2004, S AFR J SCI, V100, P195; Clark G.A., 1983, HUNTER GATHERER EC P, P131; Clark J.D., 1966, S AFRICAN ARCHAEOLOG, V21, P114, DOI [https://doi.org/10.2307/3888427, DOI 10.2307/3888427]; Cochrane G.W.G., 2006, SOUTH AFR HUMANIT, V18, P69; Cochrane G.W.G., 2008, S AFRICAN ARCHAEOLOG, V10, P157; Conard NJ, 2012, S AFR ARCHAEOL BULL, V67, P180; Conard NJ, 2010, P NATL ACAD SCI USA, V107, P7621, DOI 10.1073/pnas.1001458107; Conard NJ, 1997, J ANTHROPOL RES, V53, P147, DOI 10.1086/jar.53.2.3631275; Conard NJ, 2004, S AFR ARCHAEOL BULL, V59, P12, DOI 10.2307/3889318; Conard NJ, 2008, S AFR ARCHAEOL SOC G, V10, P175; Conard NJ, 2005, TOOLS SYMBOLS EARLY, P294; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; d'Errico F, 2007, J HUM EVOL, V52, P142, DOI 10.1016/j.jhevol.2006.08.003; d'Errico F, 2012, J ARCHAEOL SCI, V39, P2479, DOI 10.1016/j.jas.2012.01.040; d'Errico F, 2012, J ARCHAEOL SCI, V39, P942, DOI 10.1016/j.jas.2011.10.032; de la Pen~a P., 2013, S AFR ARCHAEOL BULL, V68, P119; Deacon H.J., 1988, S AFR ARCHAEOL B, V43, P5, DOI [DOI 10.2307/3887608, 10.2307/3887608]; DEACON HJ, 1989, HUMAN REVOLUTION, P547; Dibble H. L, 1992, MIDDLE PALEOLITHIC A, P1; DIBBLE HL, 1987, AM ANTIQUITY, V52, P109, DOI 10.2307/281062; Dibble HL, 2005, AM ANTIQUITY, V70, P545, DOI 10.2307/40035313; Douglass MJ, 2008, AM ANTIQUITY, V73, P513, DOI 10.2307/25470502; Forster P, 2004, PHILOS T R SOC B, V359, P255, DOI 10.1098/rstb.2003.1394; Goldberg P, 2009, ARCHAEOL ANTHROP SCI, V1, P95, DOI 10.1007/s12520-009-0008-1; Goodwin A., 1929, STONE AGE CULTURES S, V27; Harper PTN, 1997, S AFR J SCI, V93, P470; Henshilwood C, 2004, SCIENCE, V304, P404, DOI 10.1126/science.1095905; Henshilwood CS, 2012, J WORLD PREHIST, V25, P205, DOI 10.1007/s10963-012-9060-3; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Henshilwood CS, 2011, CURR ANTHROPOL, V52, P361, DOI 10.1086/660022; Henshilwood CS, 2003, CURR ANTHROPOL, V44, P627, DOI 10.1086/377665; Henshilwood CS, 2001, J HUM EVOL, V41, P631, DOI 10.1006/jhev.2001.0515; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Henshilwood CS, 2005, TOOLS SYMBOLS EARLY, P451; Hodgskiss T, 2013, J AFR ARCHAEOL, V11, P75, DOI 10.3213/2191-5784-10232; Holdaway S.J., 2004, RECORD STONE STUDY A; HULL KL, 1987, AM ANTIQUITY, V52, P772, DOI 10.2307/281385; Inizan ML, 1995, TECHNOLOGIE PIERRE T, V4; Jacobs Z, 2008, S AFRICAN ARCHAEOLOG, V10, P9; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Jacobs Zenobia, 2009, Commun Integr Biol, V2, P191; Kaplan J, 1990, SOUTH AFR HUMANIT, P94; Kaplan JM., 1989, GOODWIN SERIES, V6, P7, DOI DOI 10.2307/3858128; Klein RG, 2004, P NATL ACAD SCI USA, V101, P5708, DOI 10.1073/pnas.0400528101; Krukowski S., 1939, ENCYKLOPEDIA POLSKA, V4, P1; Langejans GHJ, 2012, J ARCHAEOL SCI, V39, P1694, DOI 10.1016/j.jas.2011.12.036; Lepot M., 1993, THESIS U PARIS 10; Lombard M, 2004, S AFR ARCHAEOL BULL, V59, P37, DOI 10.2307/3889241; Lombard M, 2005, J HUM EVOL, V48, P279, DOI 10.1016/j.jhevol.2004.11.006; Lombard M., 2006, SOUTH AFR HUMANIT, V18, P57; Lombard M, 2008, J ARCHAEOL SCI, V35, P26, DOI 10.1016/j.jas.2007.02.021; Lombard M, 2012, S AFR ARCHAEOL BULL, V67, P123; Lombard M, 2012, QUATERN INT, V270, P140, DOI 10.1016/j.quaint.2012.02.033; Lombard M, 2011, ANTIQUITY, V85, P1433, DOI 10.1017/S0003598X00062153; Lombard M, 2010, S AFR ARCHAEOL BULL, V65, P224; Lombard M, 2010, ANTIQUITY, V84, P635, DOI 10.1017/S0003598X00100134; Lombard M, 2010, J ARCHAEOL SCI, V37, P1773, DOI 10.1016/j.jas.2010.02.015; Lombard M, 2009, S AFR ARCHAEOL BULL, V64, P4; Mackay A, 2014, J HUM EVOL IN PRESS; Mackay A., 2009, THESIS AUSTR NATL U; Mackay A, 2008, J ARCHAEOL SCI, V35, P614, DOI 10.1016/j.jas.2007.05.013; Mackay A, 2008, J ARCHAEOL SCI, V35, P1521, DOI 10.1016/j.jas.2007.10.015; Mackay A, 2010, S AFR ARCHAEOL BULL, V65, P132; Mackay A, 2011, J ARCHAEOL SCI, V38, P1430, DOI 10.1016/j.jas.2011.02.006; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Marean CW, 2010, J HUM EVOL, V59, P425, DOI 10.1016/j.jhevol.2010.07.011; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; McCall GS, 2007, J ARCHAEOL SCI, V34, P1738, DOI 10.1016/j.jas.2006.12.015; McCall GS, 2012, AFR ARCHAEOL REV, V29, P7, DOI 10.1007/s10437-012-9107-y; McCall GS, 2011, S AFR ARCHAEOL BULL, V66, P89; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Mellars P. A., 2007, RETHINKING HUMAN REV, P1; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Miller CE, 2013, J ARCHAEOL SCI, V40, P3432, DOI 10.1016/j.jas.2013.02.014; Miller CE, 2012, J ARCHAEOL SCI, V39, P3039, DOI 10.1016/j.jas.2012.02.007; Minichillo T, 2006, J HUM EVOL, V50, P359, DOI 10.1016/j.jhevol.2005.08.013; Mitchell P., 2008, S AFRICAN ARCHAEOLOG, V10, P52; Mohapi M, 2013, SOUTH AFR HUMANIT, V25, P25; Mohapi M, 2012, S AFR ARCHAEOL BULL, V67, P5; Odell H.G., 2004, LITHIC ANAL; Orton J, 2008, J ARCHAEOL SCI, V35, P1090, DOI 10.1016/j.jas.2007.08.002; Pelegrin J., 2000, MEMOIRES PREHISTOIRE, P73; Peresani M., PALEO, V10, P123, DOI [10.3406/pal.1998.1133, DOI 10.3406/PAL.1998.1133]; PORRAZ G, 2005, THESIS U PROVENCE; Porraz G, 2013, J ARCHAEOL SCI, V40, P3542, DOI 10.1016/j.jas.2013.02.024; Porraz G, 2013, J ARCHAEOL SCI, V40, P3376, DOI 10.1016/j.jas.2013.02.012; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Rito T, 2013, PLOS ONE; Roth BJ, 1998, AM ANTIQUITY, V63, P47, DOI 10.2307/2694775; Roussel M, 2009, BULL SOC PREHIST FR, V106, P219, DOI 10.3406/bspf.2009.13846; Schiegl S., 2006, SOUTH AFR HUMANIT, V18, P149; Schiffer M.B., 1987, FORMATION PROCESSES; Shott Michael J., 2003, LITHIC TECHNOL, V28, P95, DOI DOI 10.1080/01977261.2003.11721005; Singer R., 1982, MIDDLE STONE AGE KLA; Soressi M., 2011, PALEOANTHROPOLOGY, V334, P334, DOI DOI 10.4207/PA.2011.ART63; Soriano S., 2001, IND OUTILS BIFACIAUX, V98, P77; Soriano S, 2007, J ARCHAEOL SCI, V34, P681, DOI 10.1016/j.jas.2006.06.017; SULLIVAN AP, 1985, AM ANTIQUITY, V50, P755, DOI 10.2307/280165; Texier PJ, 2013, J ARCHAEOL SCI, V40, P3412, DOI 10.1016/j.jas.2013.02.021; Texier PJ, 2010, P NATL ACAD SCI USA, V107, P6180, DOI 10.1073/pnas.0913047107; Torrence R., 1989, TIME ENERGY STONE TO; Tostevin GB., 2003, STRANSKA SKALA ORIGI, P77; Tribolo C, 2013, J ARCHAEOL SCI, V40, P3401, DOI 10.1016/j.jas.2012.12.001; Tribolo C., 2003, THESIS U BORDEAUX 1; Villa P, 2005, J ARCHAEOL SCI, V32, P399, DOI 10.1016/j.jas.2004.11.007; VILLA P, 1991, J ANTHROPOL RES, V47, P193, DOI 10.1086/jar.47.2.3630325; Villa P, 2010, J ARCHAEOL SCI, V37, P630, DOI 10.1016/j.jas.2009.10.028; Villa P., 2006, SOUTH AFR HUMANIT, V18, P89; Villa P, 2009, J ARCHAEOL SCI, V36, P441, DOI 10.1016/j.jas.2008.09.028; Volman T., 1981, THESIS U CHICAGO; Volman T.P., 1984, P169; Wadley L, 2004, ANTIQUITY, V78, P661, DOI 10.1017/S0003598X00113298; Wadley L, 2004, S AFR J SCI, V100, P145; Wadley L., 2006, SN HUMANITIES, V18, P315; Wadley L, 2006, SOUTH AFR HUMANIT, V18, P1; Wadley L, 2006, S AFR HUMANIT, V18; Wadley L., 1989, S AFR ARCHAEOL BULL, V44, P23, DOI DOI 10.2307/3888316; Wadley L, 2008, S AFRICAN ARCHAEOLOG, V1, P122; Wadley L, 2008, J ARCHAEOL SCI, V35, P2594, DOI 10.1016/j.jas.2008.04.017; Wadley L, 2007, J HUM EVOL, V52, P681, DOI 10.1016/j.jhevol.2007.01.002; Wadley L, 2013, S AFR ARCHAEOL BULL, V68, P41; Wadley L, 2011, SOUTH AFR HUMANIT, V23, P87; Wadley L, 2011, SCIENCE, V334, P1388, DOI 10.1126/science.1213317; Wadley L, 2012, QUATERN INT, V247, P341, DOI 10.1016/j.quaint.2010.10.026; Wadley L, 2010, J ARCHAEOL SCI, V37, P2397, DOI 10.1016/j.jas.2010.04.012; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Will M, 2013, J HUM EVOL, V64, P518, DOI 10.1016/j.jhevol.2013.02.012; Wurz S, 2002, J ARCHAEOL SCI, V29, P1001, DOI 10.1006/jasc.2001.0799; Wurz S., 2000, THESIS U STELLENBOSC; Wurz S, 2013, CURR ANTHROPOL, V54, pS305, DOI 10.1086/673283; Ziegler M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2897	153	43	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98359	10.1371/journal.pone.0098359	http://dx.doi.org/10.1371/journal.pone.0098359			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK0KM	24878544	Green Published, gold, Green Submitted			2022-12-25	WOS:000338101500052
J	Aguilar, X; Blomberg, J; Brannstrom, K; Olofsson, A; Schleucher, J; Bjorklund, S				Aguilar, Ximena; Blomberg, Jeanette; Brannstrom, Kristoffer; Olofsson, Anders; Schleucher, Jurgen; Bjorklund, Stefan			Interaction Studies of the Human and Arabidopsis thaliana Med25-ACID Proteins with the Herpes Simplex Virus VP16-and Plant-Specific Dreb2a Transcription Factors	PLOS ONE			English	Article							RNA-POLYMERASE-II; RESPONSIVE GENE-EXPRESSION; 9-AMINO-ACID TRANSACTIVATION DOMAIN; HUMAN MEDIATOR COMPLEX; ACTIVATION DOMAIN; LIGAND-BINDING; FLOWERING TIME; SUBUNIT MED25; NMR STRUCTURE; P53	Mediator is an evolutionary conserved multi-protein complex present in all eukaryotes. It functions as a transcriptional coregulator by conveying signals from activators and repressors to the RNA polymerase II transcription machinery. The Arabidopsis thaliana Med25 (aMed25) ACtivation Interaction Domain (ACID) interacts with the Dreb2a activator which is involved in plant stress response pathways, while Human Med25-ACID (hMed25) interacts with the herpes simplex virus VP16 activator. Despite low sequence similarity, hMed25-ACID also interacts with the plant-specific Dreb2a transcriptional activator protein. We have used GST pull-down-, surface plasmon resonance-, isothermal titration calorimetry and NMR chemical shift experiments to characterize interactions between Dreb2a and VP16, with the hMed25 and aMed25-ACIDs. We found that VP16 interacts with aMed25-ACID with similar affinity as with hMed25-ACID and that the binding surface on aMed25-ACID overlaps with the binding site for Dreb2a. We also show that the Dreb2a interaction region in hMed25-ACID overlaps with the earlier reported VP16 binding site. In addition, we show that hMed25-ACID/Dreb2a and aMed25-ACID/Dreb2a display similar binding affinities but different binding energetics. Our results therefore indicate that interaction between transcriptional regulators and their target proteins in Mediator are less dependent on the primary sequences in the interaction domains but that these domains fold into similar structures upon interaction.	[Aguilar, Ximena] Umea Univ, Dept Chem, Umea, Sweden; [Blomberg, Jeanette; Brannstrom, Kristoffer; Olofsson, Anders; Schleucher, Jurgen; Bjorklund, Stefan] Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden	Umea University; Umea University	Bjorklund, S (corresponding author), Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden.	stefan.bjorklund@medchem.umu.se	Brännström, Kristoffer/AAC-1204-2020		Swedish Research Council; Swedish Cancer Society; Kempe Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Kempe Foundation	S.B., J.S. and A.O. were supported by grants from the the Swedish Research Council, and S. B. was supported by grants from Swedish Cancer Society and the Kempe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akke M, 2012, BIOCHEM SOC T, V40, P419, DOI 10.1042/BST20110750; Aukerman MJ, 1997, PLANT CELL, V9, P1317, DOI 10.1105/tpc.9.8.1317; Backstrom S, 2007, MOL CELL, V26, P717, DOI 10.1016/j.molcel.2007.05.007; Blomberg J, 2012, NUCLEIC ACIDS RES, V40, P5938, DOI 10.1093/nar/gks265; Bontems F, 2011, J STRUCT BIOL, V174, P245, DOI 10.1016/j.jsb.2010.10.011; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; Choi Y, 2000, J BIOL CHEM, V275, P15912, DOI 10.1074/jbc.275.21.15912; D'Alessio JA, 2009, MOL CELL, V36, P924, DOI 10.1016/j.molcel.2009.12.011; DAHLMANWRIGHT K, 1995, P NATL ACAD SCI USA, V92, P1699, DOI 10.1073/pnas.92.5.1699; Devlin PF, 1998, PLANT CELL, V10, P1479, DOI 10.1105/tpc.10.9.1479; Di Lello P, 2006, MOL CELL, V22, P731, DOI 10.1016/j.molcel.2006.05.007; Eletsky Alexander, 2011, Journal of Structural and Functional Genomics, V12, P159, DOI 10.1007/s10969-011-9115-1; Elfving N, 2011, P NATL ACAD SCI USA, V108, P8245, DOI 10.1073/pnas.1002981108; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Fuxreiter M, 2008, NAT CHEM BIOL, V4, P728, DOI 10.1038/nchembio.127; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Han EH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044007; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Ikeda K, 2002, GENES CELLS, V7, P49, DOI 10.1046/j.1356-9597.2001.00492.x; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jonker HRA, 2005, BIOCHEMISTRY-US, V44, P827, DOI 10.1021/bi0482912; Kastritis PL, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0835; Kidd BN, 2009, PLANT CELL, V21, P2237, DOI 10.1105/tpc.109.066910; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KLEMM RD, 1995, P NATL ACAD SCI USA, V92, P5788, DOI 10.1073/pnas.92.13.5788; KOBAYASHI N, 1995, MOL CELL BIOL, V15, P6465; Langlois C, 2008, J AM CHEM SOC, V130, P10596, DOI 10.1021/ja800975h; Lee HK, 2007, EMBO J, V26, P3545, DOI 10.1038/sj.emboj.7601797; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; LIN YS, 1991, NATURE, V353, P569, DOI 10.1038/353569a0; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Mathur S, 2011, PLANT PHYSIOL, V157, P1609, DOI 10.1104/pp.111.188300; McEwan IJ, 1996, BIOCHEMISTRY-US, V35, P9584, DOI 10.1021/bi960793v; Meyer KD, 2010, NAT STRUCT MOL BIOL, V17, P753, DOI 10.1038/nsmb.1816; Milbradt AG, 2011, NAT STRUCT MOL BIOL, V18, P410, DOI 10.1038/nsmb.1999; Mills JL, 2009, BIOCHEMISTRY-US, V48, P7411, DOI 10.1021/bi900535j; Mittler G, 2003, EMBO J, V22, P6494, DOI 10.1093/emboj/cdg619; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Park JM, 2000, MOL CELL BIOL, V20, P8709, DOI 10.1128/MCB.20.23.8709-8719.2000; Piskacek S, 2007, GENOMICS, V89, P756, DOI 10.1016/j.ygeno.2007.02.003; Richardt S, 2010, PLANT MOL BIOL, V72, P27, DOI 10.1007/s11103-009-9550-6; Riechmann JL, 1998, BIOL CHEM, V379, P633; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Sandholzer J, 2007, BIOCHEM BIOPH RES CO, V360, P370, DOI 10.1016/j.bbrc.2007.06.095; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Sela D, 2013, J BIOL CHEM, V288, P26179, DOI 10.1074/jbc.M113.496968; Shen F, 1996, J BIOL CHEM, V271, P4827; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Taatjes DJ, 2004, NAT STRUCT MOL BIOL, V11, P664, DOI 10.1038/nsmb789; Toth-Petroczy A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000243; Uesugi M, 1999, P NATL ACAD SCI USA, V96, P14801, DOI 10.1073/pnas.96.26.14801; Uesugi M, 1997, SCIENCE, V277, P1310, DOI 10.1126/science.277.5330.1310; Verger A, 2013, NUCLEIC ACIDS RES, V41, P4847, DOI 10.1093/nar/gkt199; Vojnic E, 2011, NAT STRUCT MOL BIOL, V18, P404, DOI 10.1038/nsmb.1997; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; XIAO H, 1994, MOL CELL BIOL, V14, P7013, DOI 10.1128/MCB.14.10.7013; Yamamoto S, 2009, J VIROL, V83, P6300, DOI 10.1128/JVI.00054-09; Yang FJ, 2004, P NATL ACAD SCI USA, V101, P2339, DOI 10.1073/pnas.0308676100; Yang M, 2008, J VIROL, V82, P12154, DOI 10.1128/JVI.01693-08; ZHU H, 1994, J BIOL CHEM, V269, P3489; Ziarek JJ, 2011, METHOD ENZYMOL, V493, P241, DOI 10.1016/B978-0-12-381274-2.00010-8	69	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98575	10.1371/journal.pone.0098575	http://dx.doi.org/10.1371/journal.pone.0098575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874105	Green Published, Green Submitted, gold			2022-12-25	WOS:000336790800049
J	Beck-Cormier, S; Escande, M; Souilhol, C; Vandormael-Pournin, S; Sourice, S; Pilet, P; Babinet, C; Cohen-Tannoudji, M				Beck-Cormier, Sarah; Escande, Marie; Souilhol, Celine; Vandormael-Pournin, Sandrine; Sourice, Sophie; Pilet, Paul; Babinet, Charles; Cohen-Tannoudji, Michel			Notchless Is Required for Axial Skeleton Formation in Mice	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; SIGNALING PATHWAY; GENE; EXPRESSION; PROTEIN; SEGMENTATION; EPIBLAST; MORPHOGENESIS; MAINTENANCE; APOPTOSIS	Maintenance of cell survival is essential for proper embryonic development. In the mouse, Notchless homolog 1 (Drosophila) (Nle1) is instrumental for survival of cells of the inner cell mass upon implantation. Here, we analyze the function of Nle1 after implantation using the Meox2(tm1(cre)Sor) mouse that expresses the Cre recombinase specifically in the epiblast at E5.5. First, we find that NLE1 function is required in epiblast cells, as Nle1-deficient cells are rapidly eliminated. In this report, we also show that the Meox2(Cre) transgene is active in specific tissues during organogenesis. In particular, we detect high Cre expression in the vertebral column, ribs, limbs and tailbud. We took advantage of this dynamic expression profile to analyze the effects of inducing mosaic deletion of Nle1 in the embryo. We show that Nle1 deletion in this context, results in severe developmental anomalies leading to lethality at birth. Mutant embryos display multiple developmental defects in particular during axial skeletal formation. We also provide evidence that axial defects are due to an increase in apoptotic cell death in the somite at E9.5. These data demonstrate an essential role for Nle1 during organogenesis and in particular during axial development.	[Beck-Cormier, Sarah; Escande, Marie; Souilhol, Celine; Vandormael-Pournin, Sandrine; Babinet, Charles; Cohen-Tannoudji, Michel] Inst Pasteur, Dept Dev Stem Cell Biol, Mouse Funct Genet, Paris, France; [Beck-Cormier, Sarah; Vandormael-Pournin, Sandrine; Babinet, Charles; Cohen-Tannoudji, Michel] Inst Pasteur, Ctr Natl Rech Scientif, URA 2578, Paris, France; [Beck-Cormier, Sarah; Sourice, Sophie] Inst Natl Sante & Rech Med, STEP Grp Skeletal Tissue Engn & Physiopathol, LIOAD, Nantes, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm)	Beck-Cormier, S (corresponding author), Inst Natl Sante & Rech Med, STEP Grp Skeletal Tissue Engn & Physiopathol, LIOAD, Nantes, France.	m-cohen@pasteur.fr	Paul, Pilet/A-3755-2015; Beck-Cormier, Sarah/P-3091-2014	Beck-Cormier, Sarah/0000-0001-5258-1933; Cohen-Tannoudji, Michel/0000-0002-6405-2657	Centre National de la Recherche Scientifique; Institut Pasteur; Agence Nationale de la Recherche [JC05_41835]; Centre National de la Recherche Scientifique (Bourse de Doctorat pour les Ingenieurs)	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (Bourse de Doctorat pour les Ingenieurs)	This work was supported by the Centre National de la Recherche Scientifique, the Institut Pasteur and the Agence Nationale de la Recherche (contract no JC05_41835). CS received grants from the Centre National de la Recherche Scientifique (Bourse de Doctorat pour les Ingenieurs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassler J, 2010, MOL CELL, V38, P712, DOI 10.1016/j.molcel.2010.05.024; Clark AL, 2013, NAT REV CARDIOL, V10, P156, DOI 10.1038/nrcardio.2012.191; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Cormier S, 2006, MOL CELL BIOL, V26, P3541, DOI 10.1128/MCB.26.9.3541-3549.2006; Davis S, 2004, DEV BIOL, V270, P47, DOI 10.1016/j.ydbio.2004.01.048; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Delgado I, 2008, DEV DYNAM, V237, P649, DOI 10.1002/dvdy.21452; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Douville JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029099; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Dunwoodie SL, 2002, DEVELOPMENT, V129, P1795; Essalmani R, 2008, P NATL ACAD SCI USA, V105, P5750, DOI 10.1073/pnas.0709428105; Gazave E, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-249; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Jory A, 2009, STEM CELLS, V27, P2769, DOI 10.1002/stem.220; Kim WJ, 2012, MOL CELL BIOL, V32, P3382, DOI 10.1128/MCB.06331-11; Kirn-Safran CB, 2007, DEV DYNAM, V236, P447, DOI 10.1002/dvdy.21046; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Le Bouteiller M, 2013, J EXPT MED; Le Bouteiller M, 2013, J EXP MED, V210, P2351, DOI 10.1084/jem.20122019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lossie AC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-106; Lu CC, 2004, DEV BIOL, V273, P149, DOI 10.1016/j.ydbio.2004.06.004; Mankoo BS, 1999, NATURE, V400, P69, DOI 10.1038/21892; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Pierfelice T, 2011, NEURON, V69, P840, DOI 10.1016/j.neuron.2011.02.031; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Reijntjes S, 2007, INT J DEV BIOL, V51, P753, DOI 10.1387/ijdb.072332sr; Royet J, 1998, EMBO J, V17, P7351, DOI 10.1093/emboj/17.24.7351; Shim M, 2010, J BIOL CHEM, V285, P16206, DOI 10.1074/jbc.M109.078576; Skopicki HA, 1997, CIRC RES, V80, P452, DOI 10.1161/01.RES.80.4.452; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Trainor PA, 2013, BIOCHIM BIOPHYS ACTA, V842, P769; Watkins-Chow DE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003094; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417; Wu ZH, 2005, NAT MED, V11, P959, DOI 10.1038/nm1287; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Zucker RM, 1998, CYTOMETRY, V33, P348, DOI 10.1002/(SICI)1097-0320(19981101)33:3<348::AID-CYTO9>3.0.CO;2-C	45	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98507	10.1371/journal.pone.0098507	http://dx.doi.org/10.1371/journal.pone.0098507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875805	Green Submitted, Green Published, gold			2022-12-25	WOS:000336790800045
J	Paljarvi, T; Martikainen, P; Leinonen, T; Pensola, T; Makela, P				Paljarvi, Tapio; Martikainen, Pekka; Leinonen, Taina; Pensola, Tiina; Makela, Pia			Non-Employment Histories of Middle-Aged Men and Women Who Died from Alcohol-Related Causes: A Longitudinal Retrospective Study	PLOS ONE			English	Article							DISORDERS; DRINKING; HEALTH; UNEMPLOYMENT; DISABILITY; EMPLOYMENT; IMPACT; CONSUMPTION; DEPENDENCE; CHILDHOOD	Background: Long-term patterning of non-employment among problem drinkers is poorly understood. We determined the level and timing of non-employment, and the relative contribution of various types of non-employment among middle-aged persons who died of alcohol-related causes. Methods: We conducted a longitudinal retrospective register-based study of Finnish men and women aged 45-64 years who died of alcohol-related causes (n = 15 552) or other causes (n = 39 166) in the period 2000-07, or who survived (n = 204 422) until the end of 2007. We traced back the number of days in employment and non-employment for up to 17 years before death or before the end of the study period for the survivors. Results: The majority (>= 56%) of persons who died of alcohol-related causes were in employment up to ten years before death. Over the 17-year period before death, those who died of alcohol-related causes were in employment on average two years less (mean 6.3 years, 95% CI 6.2-6.4) than those dying of other causes (8.2, 8.1-8.3), and five years less than survivors (11.6, 11.5-11.7), when sex and age were adjusted for. The relative role of various types of non-employment differed markedly across the two mortality groups. Among those who died of alcohol-related causes, unemployment accounted for 54% of the total burden of non-employment, in comparison with 29% among those who died of other causes. In contrast, disability pension accounted for 41% of the total burden of non-employment among those who died of alcohol-related causes, but 65% among those who died of other causes. Conclusions: The results indicate the feasibility of preventing movement out of employment among middle-aged men and women with severe alcohol-related harm, provided that they are identified early on during their working careers and offered effective interventions.	[Paljarvi, Tapio; Makela, Pia] Natl Inst Hlth & Welf, Alcohol & Drugs Unit, Helsinki, Finland; [Martikainen, Pekka; Leinonen, Taina] Univ Helsinki, Populat Res Unit, Helsinki, Finland; [Pensola, Tiina] Finnish Inst Occupat Hlth, Hlth & Work Abil, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; Finnish Institute of Occupational Health	Paljarvi, T (corresponding author), Natl Inst Hlth & Welf, Alcohol & Drugs Unit, Helsinki, Finland.	tapio.paljarvi@thl.fi	Mäkelä, Pia/C-5679-2015	Mäkelä, Pia/0000-0002-3343-2139; Paljarvi, Tapio/0000-0002-5324-9825; Martikainen, Pekka/0000-0001-9374-1438	Academy of Finland [259289]; Commission of the European Communities Seventh Framework Programme [278511]	Academy of Finland(Academy of Finland); Commission of the European Communities Seventh Framework Programme	This work was supported by a grant from the Academy of Finland (grant no. 259289) and the Commission of the European Communities Seventh Framework Programme (grant no. 278511). This study is part of the DEMETRIQ project. The study does not necessarily reflect the Commission's views and in no way anticipates the Commission's future policy in this area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola K, 2011, J AFFECT DISORDERS, V134, P365, DOI 10.1016/j.jad.2011.05.028; Ahs A, 2012, INT J BEHAV MED, V19, P29, DOI 10.1007/s12529-010-9129-2; Bauld L, 2013, POLICY STUD-UK, V34, P360, DOI 10.1080/01442872.2013.804303; Cloud W, 2008, SUBST USE MISUSE, V43, P1971, DOI 10.1080/10826080802289762; Durkin A, 2010, ALCOHOL ALCOHOLISM, V45, P374, DOI 10.1093/alcalc/agq025; Edlund MJ, 2009, PSYCHIAT SERV, V60, P1618, DOI 10.1176/ps.2009.60.12.1618; Grant BF, 1997, J STUD ALCOHOL, V58, P365, DOI 10.15288/jsa.1997.58.365; Halme JT, 2008, ALCOHOL CLIN EXP RES, V32, P1615, DOI 10.1111/j.1530-0277.2008.00740.x; Harris E, 2009, MED J AUSTRALIA, V191, P119, DOI 10.5694/j.1326-5377.2009.tb02709.x; Hay G, 2010, 94 HM GOVT DEP WORK; Hedden SL, 2011, ADDICT BEHAV, V36, P1213, DOI 10.1016/j.addbeh.2011.07.026; Henkel Dieter, 2011, Curr Drug Abuse Rev, V4, P4; Hermansson U, 2010, ALCOHOL ALCOHOLISM, V45, P252, DOI 10.1093/alcalc/agq021; Herttua K, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001094; Home Office, 2010, DRUG STRAT 2010 RED; Johansson E, 2007, HEALTH ECON, V16, P739, DOI 10.1002/hec.1201; John U, 2013, ALCOHOL CLIN EXP RES, V37, P156, DOI 10.1111/j.1530-0277.2012.01863.x; Kokko K, 2000, DEV PSYCHOL, V36, P463, DOI 10.1037/0012-1649.36.4.463; MacDonald Z, 2004, HEALTH ECON, V13, P139, DOI 10.1002/hec.816; Makela P, 2011, ADDICTION, V106, P1239, DOI 10.1111/j.1360-0443.2010.03356.x; Mansson NO, 1999, ANN EPIDEMIOL, V9, P341, DOI 10.1016/S1047-2797(99)00014-9; Maurage P, 2012, NEUROPSYCHOPHARMACOL, V37, P2067, DOI 10.1038/npp.2012.54; McCormack RP, 2013, LANCET, V382, P995, DOI 10.1016/S0140-6736(12)62206-5; Mullahy J, 1996, J HEALTH ECON, V15, P409, DOI 10.1016/S0167-6296(96)00489-4; Osler M, 2006, AM J EPIDEMIOL, V163, P654, DOI 10.1093/aje/kwj084; Paljarvi T, 2005, ADDICTION, V100, P1851, DOI 10.1111/j.1360-0443.2005.01258.x; Rechel B, 2013, LANCET, V381, P1312, DOI 10.1016/S0140-6736(12)62087-X; Roche AM, 2008, ADDICTION, V103, P738, DOI 10.1111/j.1360-0443.2008.02154.x; Roman PM, 1996, AM J HEALTH PROMOT, V11, P136, DOI 10.4278/0890-1171-11.2.136; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Selvik R., 2004, J EMPLOYEE ASSISTANC, V34, P18; Sidorchuk A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042083; Skogen JC, 2012, ADDICTION, V107, P98, DOI 10.1111/j.1360-0443.2011.03551.x; Thoma P, 2013, NEUROSCI BIOBEHAV R, V37, P448, DOI 10.1016/j.neubiorev.2013.01.024; United Nations, 2013, WORLD POP AG 2013; Upmark M, 1999, J EPIDEMIOL COMMUN H, V53, P223, DOI 10.1136/jech.53.4.223; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6	37	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98620	10.1371/journal.pone.0098620	http://dx.doi.org/10.1371/journal.pone.0098620			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UR	24874518	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000336790800052
J	Seubert, J; Gregory, KM; Chamberland, J; Dessirier, JM; Lundstrom, JN				Seubert, Janina; Gregory, Kristen M.; Chamberland, Jessica; Dessirier, Jean-Marc; Lundstroem, Johan N.			Odor Valence Linearly Modulates Attractiveness, but Not Age Assessment, of Invariant Facial Features in a Memory-Based Rating Task	PLOS ONE			English	Article							AMYGDALA ACTIVATION; EMOTION; INTEGRATION; FACES; RECOGNITION; EXPRESSIONS; PERCEPTION; SYSTEMS	Scented cosmetic products are used across cultures as a way to favorably influence one's appearance. While cross-modal effects of odor valence on perceived attractiveness of facial features have been demonstrated experimentally, it is unknown whether they represent a phenomenon specific to affective processing. In this experiment, we presented odors in the context of a face battery with systematic feature manipulations during a speeded response task. Modulatory effects of linear increases of odor valence were investigated by juxtaposing subsequent memory-based ratings tasks - one predominantly affective (attractiveness) and a second, cognitive (age). The linear modulation pattern observed for attractiveness was consistent with additive effects of face and odor appraisal. Effects of odor valence on age perception were not linearly modulated and may be the result of cognitive interference. Affective and cognitive processing of faces thus appear to differ in their susceptibility to modulation by odors, likely as a result of privileged access of olfactory stimuli to affective brain networks. These results are critically discussed with respect to potential biases introduced by the preceding speeded response task.	[Seubert, Janina; Gregory, Kristen M.; Lundstroem, Johan N.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Chamberland, Jessica; Dessirier, Jean-Marc] Unilever R&D, Sensat Percept & Behav, Trumbull, CT USA; [Seubert, Janina; Lundstroem, Johan N.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lundstroem, Johan N.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	Monell Chemical Senses Center; Unilever; Karolinska Institutet; University of Pennsylvania	Seubert, J (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	jseubert@monell.org	Lundström, Johan N/E-9482-2014; Seubert, Janina/G-8775-2014	Lundström, Johan N/0000-0002-3529-8981; Seubert, Janina/0000-0001-9630-9261	Unilever Corporation; Knut and Alice Wallenberg Foundation [KAW 2012.0141]; Swedish Research Council [VRHS2009-2337]; German Research Foundation (DFG) [SE 2147-1]	Unilever Corporation(Unilever); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); German Research Foundation (DFG)(German Research Foundation (DFG))	This study was funded in part by an investigator-initiated grant from the Unilever Corporation. JNL is funded by the Knut and Alice Wallenberg Foundation (KAW 2012.0141) and a grant from the Swedish Research Council (VRHS2009-2337). JS is funded by a research fellowship by the German Research Foundation (DFG, SE 2147-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Banks SJ, 2012, NEUROSCI LETT, V514, P71, DOI 10.1016/j.neulet.2012.02.059; Barrett LF, 2009, PHILOS T R SOC B, V364, P1325, DOI 10.1098/rstb.2008.0312; BAUML KH, 1994, PERCEPT PSYCHOPHYS, V56, P163, DOI 10.3758/BF03213895; Boesveldt S, 2010, BIOL PSYCHOL, V84, P313, DOI 10.1016/j.biopsycho.2010.03.006; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Bzdok D, 2012, CEREB CORTEX, V22, P951, DOI 10.1093/cercor/bhr166; Chatterjee A, 2009, NEUROPSYCHOLOGY, V23, P135, DOI 10.1037/a0014430; Classen C., 1994, AROMA CULTURAL HIST; de Araujo IE, 2005, NEURON, V46, P671, DOI 10.1016/j.neuron.2005.04.021; Dematte ML, 2007, CHEM SENSES, V32, P603, DOI 10.1093/chemse/bjm030; Dolcos F, 2006, J NEUROSCI, V26, P2072, DOI 10.1523/JNEUROSCI.5042-05.2006; Ethofer T, 2006, PROG BRAIN RES, V156, P345, DOI 10.1016/S0079-6123(06)56019-4; Forscher EC, 2012, J NEUROSCI, V32, P2159, DOI 10.1523/JNEUROSCI.5094-11.2012; Habel U, 2007, NEUROPSYCHOLOGIA, V45, P2369, DOI 10.1016/j.neuropsychologia.2007.01.023; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hummel T, 2001, ANN OTO RHINOL LARYN, V110, P976, DOI 10.1177/000348940111001015; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; KIRKSMITH MD, 1990, CHEM SIGNAL, V5, P48; Kristjansson A, 2013, J EXP PSYCHOL HUMAN, V39, P298, DOI 10.1037/a0028683; Leppanen JM, 2003, EMOTION, V3, P315, DOI 10.1037/1528-3542.3.4.315; Lundstrom JN, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00597; Lundstrom JN, 2010, INT J PSYCHOPHYSIOL, V78, P179, DOI 10.1016/j.ijpsycho.2010.07.007; MCGRAW KO, 1989, J GENET PSYCHOL, V150, P251, DOI 10.1080/00221325.1989.9914595; Miller SS, 2013, CHEM SENSES, V38, P167, DOI 10.1093/chemse/bjs086; Mitro S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038110; Olofsson JK, 2012, PSYCHOL SCI, V23, P1224, DOI 10.1177/0956797612441951; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Pessoa L, 2003, PROG BRAIN RES, V144, P171, DOI 10.1016/S0079-6123(03)14401-2; Pollatos O, 2007, CHEM SENSES, V32, P583, DOI 10.1093/chemse/bjm027; Quinn KA, 2005, J PERS SOC PSYCHOL, V88, P467, DOI 10.1037/0022-3514.88.3.467; Rach S, 2011, PSYCHOL RES-PSYCH FO, V75, P77, DOI 10.1007/s00426-010-0289-0; Rolls ET, 2004, ANAT REC PART A, V281A, P1212, DOI 10.1002/ar.a.20126; Seubert J, 2013, NEUROIMAGE, V66, P333, DOI 10.1016/j.neuroimage.2012.10.030; Seubert J, 2010, NEUROIMAGE, V53, P746, DOI 10.1016/j.neuroimage.2010.07.012; Small DM, 2012, NEURAL BASES MULTISE; Stein BE., 1993, MERGING SENSES; Townsend J.T., 1978, COGNITIVE THEORY, V3, P200; Townsend J. T., 1983, STOCHASTIC MODELING; van Reekum CM, 1999, COGNITION EMOTION, V13, P831, DOI 10.1080/026999399379104; Vroomen J, 2001, COGN AFFECT BEHAV NE, V1, P382, DOI 10.3758/CABN.1.4.382; Walla P, 2010, SENSORS-BASEL, V10, P8185, DOI 10.3390/s100908185; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zhou W, 2009, PSYCHOL SCI, V20, P177, DOI 10.1111/j.1467-9280.2009.02263.x	45	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98347	10.1371/journal.pone.0098347	http://dx.doi.org/10.1371/journal.pone.0098347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UR	24874703	Green Published, Green Submitted, gold			2022-12-25	WOS:000336790800034
J	Libraty, DH; Zhang, L; Obcena, A; Brion, JD; Capeding, RZ				Libraty, Daniel H.; Zhang, Lei; Obcena, AnaMae; Brion, Job D.; Capeding, Rosario Z.			Circulating Levels of Soluble MICB in Infants with Symptomatic Primary Dengue Virus Infections	PLOS ONE			English	Article							SERUM-LEVELS; NKG2D	Dengue is the most prevalent arthropod-borne viral illness in humans. A MHC class I polypeptide-related sequence B (MICB) single nucleotide polymorphism (SNP) was previously associated with symptomatic dengue compared to non-dengue causes of acute febrile illnesses in infants. We measured circulating levels of soluble (s)MICB in the sera of infants with symptomatic primary dengue virus infections. We found that serum levels of sMICB increased between pre-infection and acute illness among infants with symptomatic primary dengue virus infections. The likelihood of being hospitalized with an acute primary DENV infection during infancy also tended to be higher with increasing acute illness sMICB levels. The elevation of sMICB during acute primary DENV infections in infants likely represents an immune evasion strategy and contributes to the severity of the acute illness.	[Libraty, Daniel H.; Zhang, Lei] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA; [Obcena, AnaMae; Capeding, Rosario Z.] Res Inst Trop Med, Dept Med, Manila, Philippines; [Brion, Job D.] San Pablo City Hlth Off, San Pablo, Philippines; [Capeding, Rosario Z.] Res Inst Trop Med, Dept Microbiol, Manila, Philippines	University of Massachusetts System; University of Massachusetts Worcester; Research Institute for Tropical Medicine - Philippines; Research Institute for Tropical Medicine - Philippines	Libraty, DH (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01655 USA.	daniel.libraty@umassmed.edu			National Institutes of Health/National Institute of Allergy and Infectious Diseases [R01 AI091820]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091820] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from National Institutes of Health/National Institute of Allergy and Infectious Diseases R01 AI091820. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Chitadze G, 2013, SCAND J IMMUNOL, V78, P120, DOI 10.1111/sji.12072; Chung HW, 2011, CANCER SCI, V102, P1673, DOI 10.1111/j.1349-7006.2011.01989.x; Gonzalez S, 2006, CURR TOP MICROBIOL, V298, P121; HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; Khor CC, 2011, NAT GENET, V43, P1139, DOI 10.1038/ng.960; Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171; Tamaki S, 2010, ANTICANCER RES, V30, P4097; Whitehorn J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059067	10	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98509	10.1371/journal.pone.0098509	http://dx.doi.org/10.1371/journal.pone.0098509			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24869966	Green Submitted, Green Published, gold			2022-12-25	WOS:000336858300050
J	Solem, CT; Snedecor, SJ; Khachatryan, A; Nedrow, K; Tawadrous, M; Chambers, R; Haider, S; Simpson, K				Solem, Caitlyn T.; Snedecor, Sonya J.; Khachatryan, Alexandra; Nedrow, Katherine; Tawadrous, Margaret; Chambers, Richard; Haider, Seema; Simpson, Kit			Cost of Treatment in a US Commercially Insured, HIV-1-Infected Population	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; VIROLOGICAL FAILURE; HEALTH-CARE; HIV; ADHERENCE; OUTCOMES	Objective: Recent treatment patterns and cost data associated with HIV in the United States are limited. This study assessed first-line persistence and healthcare costs of HIV-1 in patients by treatment line and CD4 cell count. Methods: MarketScan Commercial Claims and Encounters Database (2007-2011) and Lab Database (2007-2010) were used to construct two HIV-1 cohorts: 1) newly treated HIV-1-infected patients with >= 6 months' continuous enrollment prior to first third-agent drug claim (Newly Treated Cohort) and 2) CD4 cell count test results (CD4 Measurements Cohort). All patients were >= 18 years old and without hepatitis co-infection. The Kaplan-Meier method was used to measure treatment switch rates. Generalized linear models (gamma distribution, log link) were used to compare healthcare costs by treatment line and CD4 cell count controlling for potential confounders. Results: Newly treated patients (n = 8,617) had mean age of 41, 82% were male, and 20% had experienced AIDS-defining events at baseline. Over 20% of newly treated patients switched initial treatment regimen within 2 years. Average unadjusted (and covariate-adjusted) total healthcare cost/year was $33,674 ($28,861) for first-line, $39,191 ($35,805) for second-line, and $39,882 ($40,804) for third-line treatment. Covariate-adjusted costs of care on second-and third-line treatments were significantly more expensive than first-line treatment (24% [p<0.001] and 41% [p=0.006] higher, respectively). The CD4 Measurements Cohort included 803 CD4 measurements (mean age 49, 76% male, 8% experienced an AIDS-defining event). Costs associated with CD4 measurements <100 cells/mu L were 92% higher than those with >350 cells/mu L (p<0.001). For higher CD4 cell counts, the majority of expenditures were for antiretrovirals (64% of total for CD4 > 350 cells/mu L). Conclusions: Despite modern advances in antiretroviral therapy and medical care, direct medical costs of HIV-1-infected patients increase after treatment switch and with lower CD4 counts, consistent with previous costing studies.	[Solem, Caitlyn T.; Snedecor, Sonya J.; Khachatryan, Alexandra] Pharmerit Int, Bethesda, MD 20814 USA; [Nedrow, Katherine; Tawadrous, Margaret; Haider, Seema] Pfizer Inc, Groton, CT 06340 USA; [Chambers, Richard] Pfizer Inc, Philadelphia, PA USA; [Simpson, Kit] Med Univ S Carolina, Charleston, SC 29425 USA	Pfizer; Pfizer; Medical University of South Carolina	Snedecor, SJ (corresponding author), Pharmerit Int, Bethesda, MD 20814 USA.	ssnedecor@pharmerit.com	Tawadrous, Margaret/AAY-3551-2020	Solem, Caitlyn/0000-0002-4914-8052	ViiV Healthcare	ViiV Healthcare	The study was sponsored by ViiV Healthcare, who also funded editorial assistance during the development of this manuscript. All authors participated in study design, data collection and analysis, decision to publish, and preparation and review of manuscript.	Centers for Disease Control and Prevention, 2014, CTR DIS CONTR PREV H; Centers for Disease Control and Prevention, 2008, MMWR-MORBID MORTAL W, V57, pRR; Chen RY, 2006, CLIN INFECT DIS, V42, P1003, DOI 10.1086/500453; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fong R, 2013, SEX HEALTH, V10, P442, DOI 10.1071/SH13043; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gebo KA, 2010, AIDS, V24, P2705, DOI 10.1097/QAD.0b013e32833f3c14; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hogg R, 2013, 7 IAS C HIV PATH TRE; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; Martin S, 2007, 4 IAS C HIV PATH TRE; Meenan RT, 2010, CLIN MED RES, V8, P52, DOI [DOI 10.3121/CMR.8.1.52-A, 10.3121/cmr.8.1.52-a]; National Center forHealth Statistics, 2011, HLTH US 2010 SPEC FE; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Rodger AJ, 2013, AIDS, V27, P973, DOI 10.1097/QAD.0b013e32835cae9c; Rosenblum M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007196; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Snedecor SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072784; Stansell J, 2000, 7 C RETR OPP INF SAN	19	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98152	10.1371/journal.pone.0098152	http://dx.doi.org/10.1371/journal.pone.0098152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866200	gold, Green Submitted, Green Published			2022-12-25	WOS:000336914100036
J	Karabasheva, D; Cole, NB; Donaldson, JG				Karabasheva, Darya; Cole, Nelson B.; Donaldson, Julie G.			Roles for Trafficking and O-Linked Glycosylation in the Turnover of Model Cell Surface Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING ENZYME; DI-LEUCINE MOTIF; MEMBRANE-PROTEIN; SOLUBLE INTERLEUKIN-2-RECEPTOR; CYTOPLASMIC TAIL; FUSION PROTEINS; LIGAND-BINDING; RECEPTOR; CLEAVAGE; ENDOCYTOSIS	Proteins targeted to the plasma membrane (PM) of cells are degraded at different rates. Sorting motifs contained within the cytoplasmic domains of transmembrane proteins, post-translational modifications (e. g. ubiquitination), and assembly into multiprotein or protein-lipid complexes all may affect the efficiency of endocytosis and recycling and influence the delivery to degradative compartments. Using the SNAP-tag labeling system, we examined the turnover of a model PM protein, the alpha chain of the interleukin-2 receptor (Tac). The surface lifetimes of SNAP-Tac fusions were influenced by their mode of entry into cells (clathrin-dependent versus clathrin-independent), their orientation in the PM (transmembrane versus glycosylphosphatidylinositol-anchored), and ubiquitination in their cytosolic domains. In addition, shedding of SNAP-Tac into the medium was greatly influenced by its O-linked glycosylation status. For a number of PM proteins, delivery to lysosomes and ectodomain shedding represent distinct parallel mechanisms to determine protein half-life.	[Karabasheva, Darya; Cole, Nelson B.; Donaldson, Julie G.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Cole, NB (corresponding author), NHLBI, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	ncole@mail.nih.gov			National Institutes of Health from the Intramural Research Program in the NHLBI [HL006060]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006060] Funding Source: NIH RePORTER	National Institutes of Health from the Intramural Research Program in the NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL006060 from the Intramural Research Program in the NHLBI.	Agueznay NEH, 2007, CLIN EXP IMMUNOL, V150, P114, DOI 10.1111/j.1365-2249.2007.03464.x; Baran P, 2013, J BIOL CHEM, V288, P14756, DOI 10.1074/jbc.M113.466169; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bodor Dani L, 2012, Curr Protoc Cell Biol, VChapter 8, DOI 10.1002/0471143030.cb0808s55; Bojkowska K, 2011, CHEM BIOL, V18, P805, DOI 10.1016/j.chembiol.2011.03.014; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Clague MJ, 2012, DEV CELL, V23, P457, DOI 10.1016/j.devcel.2012.08.011; Cole N.B., 2013, CURR PROTOC PROTEIN, V73; Cole NB, 2012, ACS CHEM BIOL, V7, P464, DOI 10.1021/cb2004252; De Paiva CS, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-31; Emami-Nemini A, 2013, NAT PROTOC, V8, P1307, DOI 10.1038/nprot.2013.073; Eyster CA, 2011, MOL BIOL CELL, V22, P3218, DOI 10.1091/mbc.E10-11-0874; Foraker AB, 2012, J CELL BIOL, V198, P591, DOI 10.1083/jcb.201205116; Gautier A, 2009, J AM CHEM SOC, V131, P17954, DOI 10.1021/ja907818q; Godlee C, 2013, J CELL BIOL, V203, P717, DOI 10.1083/jcb.201307100; GREENE WC, 1986, ANNU REV IMMUNOL, V4, P69, DOI 10.1146/annurev.iy.04.040186.000441; HAFT CR, 1994, J BIOL CHEM, V269, P26286; Haglund K, 2004, J CELL SCI, V117, P2557, DOI 10.1242/jcs.01148; Harder JL, 2012, TRAFFIC, V13, P1170, DOI 10.1111/j.1600-0854.2012.01376.x; HARE JF, 1991, P NATL ACAD SCI USA, V88, P5902, DOI 10.1073/pnas.88.13.5902; Hayashida K, 2010, ANAT REC, V293, P925, DOI 10.1002/ar.20757; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hinkle CL, 2004, J BIOL CHEM, V279, P24179, DOI 10.1074/jbc.M312141200; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; Horiuchi Keisuke, 2013, Keio Journal of Medicine, V62, P29, DOI 10.2302/kjm.2012-0003-RE; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; HUMPHREY JS, 1993, J CELL BIOL, V120, P1123, DOI 10.1083/jcb.120.5.1123; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Keppler A, 2006, BIOTECHNIQUES, V41, P167, DOI 10.2144/000112216; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Kinlough CL, 2011, J BIOL CHEM, V286, P39072, DOI 10.1074/jbc.M111.289504; KOZARSKY K, 1988, P NATL ACAD SCI USA, V85, P4335, DOI 10.1073/pnas.85.12.4335; KOZARSKY KF, 1988, MOL CELL BIOL, V8, P3357, DOI 10.1128/MCB.8.8.3357; KUAN SF, 1989, J BIOL CHEM, V264, P19271; LEMANSKY P, 1990, J CELL BIOL, V110, P1525, DOI 10.1083/jcb.110.5.1525; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Li RL, 2003, BIOCHEM BIOPH RES CO, V303, P446, DOI 10.1016/S0006-291X(03)00354-1; Luo S, 2006, ANAL BIOCHEM, V350, P233, DOI 10.1016/j.ab.2005.10.048; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Maldonado-Baez L, 2013, EXP CELL RES, V319, P2759, DOI 10.1016/j.yexcr.2013.08.008; MARKS MS, 1995, J CELL BIOL, V131, P351, DOI 10.1083/jcb.131.2.351; MIEDEL MC, 1989, J BIOL CHEM, V264, P21097; Morris JC, 2000, ANN RHEUM DIS, V59, P109, DOI 10.1136/ard.59.suppl_1.i109; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Okiyoneda T, 2011, CURR OPIN CELL BIOL, V23, P483, DOI 10.1016/j.ceb.2011.04.012; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; REDDY P, 1989, J BIOL CHEM, V264, P17329; ROBB RJ, 1987, J IMMUNOL, V139, P855; RUBIN LA, 1990, ANN INTERN MED, V113, P619, DOI 10.7326/0003-4819-113-8-619; RUBIN LA, 1985, J IMMUNOL, V135, P3172; RUTLEDGE EA, 1994, BLOOD, V83, P580; Rutledge EA, 1996, J CELL PHYSIOL, V168, P284, DOI 10.1002/(SICI)1097-4652(199608)168:2<284::AID-JCP7>3.0.CO;2-L; Schapiro FB, 2004, MOL BIOL CELL, V15, P2884, DOI 10.1091/mbc.E03-09-0653; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schwager SLU, 1999, BIOCHEMISTRY-US, V38, P10388, DOI 10.1021/bi990357j; Sheu BC, 2001, CANCER RES, V61, P237; Tanno H, 2013, J BIOCHEM, V153, P497, DOI 10.1093/jb/mvt028; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Wright MH, 2011, CELL BIOCHEM BIOPHYS, V60, P39, DOI 10.1007/s12013-011-9181-9; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0	64	9	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19477	19490		10.1074/jbc.M114.564666	http://dx.doi.org/10.1074/jbc.M114.564666			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24891503	Green Published, hybrid			2022-12-25	WOS:000339326800023
J	Mariano, VS; Zorzetto-Fernandes, AL; da Silva, TA; Ruas, LP; Nohara, LL; de Almeida, IC; Roque-Barreira, MC				Mariano, Vania Sammartino; Zorzetto-Fernandes, Andre Luiz; da Silva, Thiago Aparecido; Ruas, Luciana Pereira; Nohara, Lilian L.; de Almeida, Igor Correia; Roque-Barreira, Maria Cristina			Recognition of TLR2 N-Glycans: Critical Role in ArtinM Immunomodulatory Activity	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-2; PARACOCCIDIOIDES-BRASILIENSIS INFECTION; MURINE PERITONEAL-MACROPHAGES; ARTOCARPUS-INTEGRIFOLIA; PATTERN-RECOGNITION; INDUCED EXPRESSION; CUTTING EDGE; IMMUNE-RESPONSE; DENDRITIC CELLS; UP-REGULATION	TLR2 plays a critical role in the protection against Paracoccidioides brasiliensis conferred by ArtinM administration. ArtinM, a D-mannose-binding lectin from Artocarpus heterophyllus, induces IL-12 production in macrophages and dendritic cells, which accounts for the T helper1 immunity that results from ArtinM administration. We examined the direct interaction of ArtinM with TLR2using HEK293A cells transfected with TLR2, alone or in combination with TLR1 or TLR6, together with accessory proteins. Stimulation with ArtinM induced NF-kappa B activation and interleukin (IL)-8 production in cells transfected with TLR2, TLR2/1, or TLR2/6. Murine macrophages that were stimulated with ArtinM had augmented TLR2 mRNA expression. Furthermore, pre-incubation of unstimulated macrophages with an anti-TLR2 antibody reduced the cell labeling with ArtinM. In addition, a microplate assay revealed that ArtinM bound to TLR2 molecules that had been captured by specific antibodies from a macrophages lysate. Notably, ArtinM binding to TLR2 was selectively inhibited when the lectin was pre-incubated with mannotriose. The biological relevance of the direct interaction of ArtinM with TLR2 glycans was assessed using macrophages from TLR2-KOmice, which produced significantly lower levels of IL-12 and IL-10 in response to ArtinM than macrophages from wild-type mice. Pre-treatment of murine macrophages with pharmacological inhibitors of signaling molecules demonstrated the involvement of p38 MAPK and JNK in the IL-12 production induced by ArtinM and the involvement ofPI3K in IL-10 production. Thus, ArtinM interacts directly with TLR2 or TLR2 heterodimers in a carbohydrate recognition-dependent manner and functions as a TLR2 agonist with immunomodulatory properties.	[Mariano, Vania Sammartino; Zorzetto-Fernandes, Andre Luiz; da Silva, Thiago Aparecido; Ruas, Luciana Pereira; Roque-Barreira, Maria Cristina] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-09500900 Sao Paulo, Brazil; [Nohara, Lilian L.; de Almeida, Igor Correia] Univ Texas El Paso, Dept Biol Sci, Border Biomed Res Ctr, El Paso, TX 79968 USA	Universidade de Sao Paulo; University of Texas System; University of Texas El Paso	Roque-Barreira, MC (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-09500900 Sao Paulo, Brazil.	mcrbarre@fmrp.usp.br	Roque-Barreira, Maria-Cristina/A-4552-2008; da Silva, Thiago Aparecido/I-2315-2015; Ruas, Luciana/A-4259-2013; Mariano, Vânia Sammartino/AAV-1851-2020; Mariano, Vania/L-1953-2014	Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; da Silva, Thiago Aparecido/0000-0001-5017-6539; Ruas, Luciana/0000-0002-1028-7872; Mariano, Vânia Sammartino/0000-0002-5399-5676; Almeida, Igor/0000-0002-2443-8213	National Institutes of Health (NIH) [5G12MD007592]; FAPESP [2006/60642-2]; Biomolecule Analysis, Cytometry, Screening and Imaging, and Genomic Analysis Core Facilities at BBRC/UTEP (NIH/NIMHD) [5G12MD007592]; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Biomolecule Analysis, Cytometry, Screening and Imaging, and Genomic Analysis Core Facilities at BBRC/UTEP (NIH/NIMHD); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was partly supported by the National Institutes of Health (NIH) grant 5G12MD007592 (to BBRC/UTEP), and by grants from FAPESP (2006/60642-2). We are thankful to the Biomolecule Analysis, Cytometry, Screening and Imaging, and Genomic Analysis Core Facilities at BBRC/UTEP (NIH/NIMHD grant 5G12MD007592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi S, 2000, J IMMUNOL, V164, P3471, DOI 10.4049/jimmunol.164.7.3471; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Beckett EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039460; Cardoso MRD, 2011, VACCINE, V29, P9183, DOI 10.1016/j.vaccine.2011.09.136; Carneiro AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076233; Chau TA, 2009, NAT MED, V15, P641, DOI 10.1038/nm.1965; Coltri KC, 2008, AM J PATHOL, V173, P423, DOI 10.2353/ajpath.2008.080126; Coltri KC, 2010, MED MYCOL, V48, P792, DOI 10.3109/13693780903501671; Custodio LA, 2011, INT IMMUNOPHARMACOL, V11, P1510, DOI 10.1016/j.intimp.2011.05.005; DePaolo RW, 2008, CELL HOST MICROBE, V4, P350, DOI 10.1016/j.chom.2008.09.004; Dessing MC, 2008, J INFECT DIS, V197, P245, DOI 10.1086/524873; Dziarski R, 2001, J IMMUNOL, V166, P1938, DOI 10.4049/jimmunol.166.3.1938; Flo TH, 2001, J LEUKOCYTE BIOL, V69, P474; Ganiko L, 1998, GLYCOCONJUGATE J, V15, P527; Hadley JS, 2005, INFECT IMMUN, V73, P7613, DOI 10.1128/IAI.73.11.7613-7619.2005; Hajishengallis G, 2005, J BIOL CHEM, V280, P38902, DOI 10.1074/jbc.M507326200; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Henneke P, 2001, J IMMUNOL, V167, P7069, DOI 10.4049/jimmunol.167.12.7069; Hernandez JC, 2011, AIDS RES HUM RETROV, V27, P1099, DOI [10.1089/aid.2010.0302, 10.1089/AID.2010.0302]; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Kataoka H, 2006, CELL MICROBIOL, V8, P1199, DOI 10.1111/j.1462-5822.2006.00702.x; Kim SY, 2013, EUR J PHARMACOL, V721, P294, DOI 10.1016/j.ejphar.2013.09.022; Landmann R, 1996, INFECT IMMUN, V64, P1762, DOI 10.1128/IAI.64.5.1762-1769.1996; Liang S, 2007, J BIOL CHEM, V282, P7532, DOI 10.1074/jbc.M611722200; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Moreno AN, 2003, INT ARCH ALLERGY IMM, V132, P221, DOI 10.1159/000074303; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Panunto-Castelo A, 2001, GLYCOBIOLOGY, V11, P1035, DOI 10.1093/glycob/11.12.1035; Pereira-Da-Silva G, 2006, BBA-GEN SUBJECTS, V1760, P86, DOI 10.1016/j.bbagen.2005.09.011; Qian C, 2013, ANN NY ACAD SCI, V1283, P67, DOI 10.1111/j.1749-6632.2012.06786.x; Rogers J, 2007, INFECT IMMUN, V75, P3205, DOI 10.1128/IAI.01950-06; SANTOSDEOLIVEIRA R, 1994, J IMMUNOL, V153, P1798; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schroder NWJ, 2004, J IMMUNOL, V173, P2683, DOI 10.4049/jimmunol.173.4.2683; Shams H, 2003, FEMS IMMUNOL MED MIC, V36, P63, DOI 10.1016/S0928-8244(03)00039-7; Shin HS, 2013, PATHOG DIS, V69, P149, DOI 10.1111/2049-632X.12074; Sladek Z, 2009, RES VET SCI, V86, P235, DOI 10.1016/j.rvsc.2008.07.016; Sodhi A, 2007, GLYCOCONJUGATE J, V24, P573, DOI 10.1007/s10719-007-9054-z; Sodhi A, 2007, INT IMMUNOPHARMACOL, V7, P454, DOI 10.1016/j.intimp.2006.11.014; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Teixeira CR, 2006, VACCINE, V24, P3001, DOI 10.1016/j.vaccine.2005.11.067; Traore K., 2012, ISRN ONCOL, V2012; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Unitt J, 2011, BIOCHEM PHARMACOL, V81, P1324, DOI 10.1016/j.bcp.2011.03.010; Uphoff CC, 1999, METHOD MOL BIOL, V731, P93; van de Veerdonk FL, 2008, CURR OPIN MICROBIOL, V11, P305, DOI 10.1016/j.mib.2008.06.002; Wagner C, 2003, SHOCK, V19, P5, DOI 10.1097/00024382-200301000-00002; Weber ANR, 2004, J BIOL CHEM, V279, P34589, DOI 10.1074/jbc.M403830200	55	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98512	10.1371/journal.pone.0098512	http://dx.doi.org/10.1371/journal.pone.0098512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892697	Green Submitted, Green Published, gold			2022-12-25	WOS:000336911400059
J	Vayssade, C; de Fazio, C; Quaglietti, B; Auguste, A; Ris, N; Fauvergue, X				Vayssade, Chloe; de Fazio, Celine; Quaglietti, Bastien; Auguste, Alexandra; Ris, Nicolas; Fauvergue, Xavier			Inbreeding Depression in a Parasitoid Wasp with Single-Locus Complementary Sex Determination	PLOS ONE			English	Article							DIFFERENT HABITATS; ENERGY ALLOCATION; POPULATION-SIZE; GENETIC LOAD; FITNESS; RATIO; CONSEQUENCES; PERSPECTIVE; EXTINCTION; BIOLOGY	Inbreeding and inbreeding depression are key processes in small or isolated populations and are therefore central concerns for the management of threatened or (re) introduced organisms. Haplodiploid species of the order Hymenoptera have a particular status with regard to inbreeding depression. Although recessive deleterious alleles that are expressed in males should be purged, an alternative form of inbreeding depression exists in species with single-locus complementary sex determination (sl-CSD). Under sl-CSD, genetically-related parents have a high probability of producing sterile sons instead of fertile daughters. In this article, we study inbreeding depression in Venturia canescens (Hymenoptera: Ichneumonidae), a parasitoid wasp with sl-CSD. We used a crossing design to manipulate relatedness according to three levels: within-family, between-family and between-population. For each level, several fitness components were measured on parents and female offspring. We found a 20% reduction in egg load at emergence for inbred crosses. Inbred crosses also yielded a higher proportion of males, as expected in a species with sl-CSD. Mating probability, presence of daughters among offspring, body size, symmetry and longevity were unaffected by inbreeding.	[Vayssade, Chloe; de Fazio, Celine; Quaglietti, Bastien; Auguste, Alexandra; Ris, Nicolas; Fauvergue, Xavier] INRA, UMR 1355, Inst Sophia Agrobiotech, Sophia Antipolis, France; [Vayssade, Chloe; de Fazio, Celine; Quaglietti, Bastien; Auguste, Alexandra; Ris, Nicolas; Fauvergue, Xavier] Univ Nice Sophia Antipolis, UMR, Inst Sophia Agrobiotech, Sophia Antipolis, France; [Vayssade, Chloe; de Fazio, Celine; Quaglietti, Bastien; Auguste, Alexandra; Ris, Nicolas; Fauvergue, Xavier] CNRS, UMR 7254, Inst Sophia Agrobiotech, Sophia Antipolis, France	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur	Fauvergue, X (corresponding author), INRA, UMR 1355, Inst Sophia Agrobiotech, Sophia Antipolis, France.	xavier.fauvergue@sophia.inra.fr	fauvergue, xavier/B-9108-2012	fauvergue, xavier/0000-0002-3579-7721; Ris, Nicolas/0000-0003-1183-234X	Agence Nationale de la Recherche [ANR-2010-BLAN-1717]; Fondation pour la Recherche sur la Biodiversite [AAP-IN-2009-052]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche sur la Biodiversite	This work was supported by the Agence Nationale de la Recherche (www.agence-nationale-recherche.fr), grant ANR-2010-BLAN-1717 'Sextinction' attributed to XF, and the Fondation pour la Recherche sur la Biodiversite (www.fondationbiodiversite.fr), grant AAP-IN-2009-052 'Vortex' attributed to XF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos W, 2001, HEREDITY, V87, P257, DOI 10.1046/j.1365-2540.2001.00940.x; Antolin MF, 1999, RES POPUL ECOL, V41, P29, DOI 10.1007/PL00011979; Asplen MK, 2009, J EVOLUTION BIOL, V22, P1762, DOI 10.1111/j.1420-9101.2009.01774.x; Bateson P., 1983, MATE CHOICE; Benvenuto C, 2012, EVOL APPL, V5, P498, DOI 10.1111/j.1752-4571.2012.00279.x; Beukeboom L. W., 1999, P 8 M EXP APPL ENT N, V10, P23; Beukeboom LW, 2001, NETH J ZOOL, V51, P1, DOI 10.1163/156854201750210805; BRUCKNER D, 1978, EVOLUTION, V32, P456, DOI [10.2307/2407613, 10.1111/j.1558-5646.1978.tb00661.x]; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; DeRose MA, 1999, EVOLUTION, V53, P1288, DOI 10.2307/2640831; Desouhant E, 2003, ECOL ENTOMOL, V28, P257, DOI 10.1046/j.1365-2311.2003.00511.x; Driessen G, 1999, J ANIM ECOL, V68, P445, DOI 10.1046/j.1365-2656.1999.00296.x; Dudash MR, 1998, NATURE, V393, P682, DOI 10.1038/31468; Eliopoulos PA, 2003, PHYSIOL ENTOMOL, V28, P268, DOI 10.1111/j.1365-3032.2003.00341.x; Ellmer M, 2004, INT J PLANT SCI, V165, P1055, DOI 10.1086/423868; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Falconer D. S., 1989, Introduction to quantitative genetics.; Fauvergue X, 2012, EVOL APPL, V5, P424, DOI 10.1111/j.1752-4571.2012.00272.x; Fischer M, 2003, CONSERV GENET, V4, P325, DOI 10.1023/A:1024051129024; Foray V, 2011, NATURWISSENSCHAFTEN, V98, P683, DOI 10.1007/s00114-011-0818-8; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Gilpin M.E., 1986, P19; Glemin S, 2003, EVOLUTION, V57, P2678; Grillenberger BK, 2008, MOL ECOL, V17, P2854, DOI 10.1111/j.1365-294X.2008.03800.x; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; HARVEY JA, 1994, ECOLOGY, V75, P1420, DOI 10.2307/1937465; Harvey JA, 1997, ENTOMOL EXP APPL, V84, P93, DOI 10.1023/A:1003007730958; Harvey JA, 2001, J INSECT BEHAV, V14, P573, DOI 10.1023/A:1012219116341; Hassell MP, 2000, J ANIM ECOL, V69, P543, DOI 10.1046/j.1365-2656.2000.00445.x; Heber S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2228; Hedrick PW, 2000, ANNU REV ECOL SYST, V31, P139, DOI 10.1146/annurev.ecolsys.31.1.139; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Henter HJ, 2003, EVOLUTION, V57, P1793, DOI 10.1111/j.0014-3820.2003.tb00587.x; HERRE EA, 1985, SCIENCE, V228, P896, DOI 10.1126/science.228.4701.896; Karkkainen K, 1999, EVOLUTION, V53, P1354, DOI [10.2307/2640882, 10.1111/j.1558-5646.1999.tb05400.x]; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kristensen TN, 2010, TRENDS ECOL EVOL, V25, P44, DOI 10.1016/j.tree.2009.06.014; Leberg PL, 2008, MOL ECOL, V17, P334, DOI 10.1111/j.1365-294X.2007.03433.x; Luna MG, 2004, ENVIRON ENTOMOL, V33, P765, DOI 10.1603/0046-225X-33.3.765; Lynch M., 1998, GENETICS ANAL QUANTI; Mattila ALK, 2012, P NATL ACAD SCI USA, V109, pE2496, DOI 10.1073/pnas.1205789109; Metzger M, 2010, J ANIMAL ECOLOGY; Metzger M, 2008, ECOL ENTOMOL, V33, P167, DOI 10.1111/j.1365-2311.2007.00953.x; Metzger M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013505; Moller AP, 1997, AM NAT, V149, P916, DOI 10.1086/286030; NUNNEY L, 1993, TRENDS ECOL EVOL, V8, P234, DOI 10.1016/0169-5347(93)90197-W; ODE PJ, 1995, ANIM BEHAV, V49, P1239, DOI 10.1006/anbe.1995.0156; Peer K, 2005, EVOLUTION, V59, P317; Pelosse P, 2007, EVOL ECOL, V21, P669, DOI 10.1007/s10682-006-9145-5; Pelosse P, 2010, ENTOMOL EXP APPL, V135, P68, DOI 10.1111/j.1570-7458.2009.00965.x; R Core Team, 2012, R LANG ENV STAT COMP; Roberts HLS, 2004, J INSECT PHYSIOL, V50, P195, DOI 10.1016/j.jinsphys.2003.11.007; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Saito Y, 2000, J EVOLUTION BIOL, V13, P668, DOI 10.1046/j.1420-9101.2000.00198.x; Schrempf A, 2006, HEREDITY, V97, P75, DOI 10.1038/sj.hdy.6800846; Tortajada AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008195; Werren John H., 1993, P42; Whitehorn PR, 2011, P ROY SOC B-BIOL SCI, V278, P1195, DOI 10.1098/rspb.2010.1550; Whitehorn PR, 2009, BMC EVOLUTIONARY BIO; Wright SI, 2008, INT J PLANT SCI, V169, P105, DOI 10.1086/523366; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102	64	11	11	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97733	10.1371/journal.pone.0097733	http://dx.doi.org/10.1371/journal.pone.0097733			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892828	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400020
J	Beaumont, PE; McHugh, B; Findlay, EG; Mackellar, A; Mackenzie, KJ; Gallo, RL; Govan, JRW; Simpson, AJ; Davidson, DJ				Beaumont, Paula E.; McHugh, Brian; Findlay, Emily Gwyer; Mackellar, Annie; Mackenzie, Karen J.; Gallo, Richard L.; Govan, John R. W.; Simpson, A. John; Davidson, Donald J.			Cathelicidin Host Defence Peptide Augments Clearance of Pulmonary Pseudomonas aeruginosa Infection by Its Influence on Neutrophil Function In Vivo	PLOS ONE			English	Article							LUNG MUCOSAL IMMUNITY; ANTIMICROBIAL-PEPTIDE; CYSTIC-FIBROSIS; ANTIBACTERIAL PEPTIDES; ACTIN BUNDLES; LL-37; RECEPTOR; CELLS; GENE; DIFFERENTIATION	Cathelicidins are multifunctional cationic host-defence peptides (CHDP; also known as antimicrobial peptides) and an important component of innate host defence against infection. In addition to microbicidal potential, these peptides have properties with the capacity to modulate inflammation and immunity. However, the extent to which such properties play a significant role during infection in vivo has remained unclear. A murine model of acute P. aeruginosa lung infection was utilised, demonstrating cathelicidin-mediated enhancement of bacterial clearance in vivo. The delivery of exogenous synthetic human cathelicidin LL-37 was found to enhance a protective pro-inflammatory response to infection, effectively promoting bacterial clearance from the lung in the absence of direct microbicidal activity, with an enhanced early neutrophil response that required both infection and peptide exposure and was independent of native cathelicidin production. Furthermore, although cathelicidin-deficient mice had an intact early cellular inflammatory response, later phase neutrophil response to infection was absent in these animals, with significantly impaired clearance of P. aeruginosa. These findings demonstrate the importance of the modulatory properties of cathelicidins in pulmonary infection in vivo and highlight a key role for cathelicidins in the induction of protective pulmonary neutrophil responses, specific to the infectious milieu. In additional to their physiological roles, CHDP have been proposed as future antimicrobial therapeutics. Elucidating and utilising the modulatory properties of cathelicidins has the potential to inform the development of synthetic peptide analogues and novel therapeutic approaches based on enhancing innate host defence against infection with or without direct microbicidal targeting of pathogens.	[Beaumont, Paula E.; McHugh, Brian; Findlay, Emily Gwyer; Mackellar, Annie; Mackenzie, Karen J.; Simpson, A. John; Davidson, Donald J.] Univ Edinburgh, Queens Med Res Inst, Ctr Inflammat Res, MRC, Edinburgh, Midlothian, Scotland; [Gallo, Richard L.] Univ Calif San Diego, Dept Med, Div Dermatol, San Diego, CA 92103 USA; [Gallo, Richard L.] VA San Diego Hlth Care Syst, San Diego, CA USA; [Govan, John R. W.] Univ Edinburgh, New Royal Infirm, Edinburgh Infect Dis, Edinburgh, Midlothian, Scotland; [Simpson, A. John] Newcastle Univ, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Edinburgh; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Edinburgh; Newcastle University - UK	Davidson, DJ (corresponding author), Univ Edinburgh, Queens Med Res Inst, Ctr Inflammat Res, MRC, Edinburgh, Midlothian, Scotland.	donald.davidson@ed.ac.uk	Gallo, Richard L/A-8931-2009	Gallo, Richard L/0000-0002-1401-7861; Mackenzie, Karen/0000-0002-5441-1476; Simpson, John/0000-0003-4731-7294; McHugh, Brian/0000-0003-4747-0643	Asthma UK/MRC Joint PhD Studentship [S08/001]; MRC Clinical Research Training Fellowship [G0701350]; NIH [R01-AR052728, R01-AI052453, R01 AI0833358]; MRC Senior Non-clinical Fellowship [G1002046]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052453, R01AI083358, R01AI052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052728] Funding Source: NIH RePORTER; MRC [G0701350, G0901697, G1002046] Funding Source: UKRI; Medical Research Council [G1002046, G0701350, G0901697] Funding Source: researchfish; Asthma UK [S08/001] Funding Source: researchfish	Asthma UK/MRC Joint PhD Studentship; MRC Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC Senior Non-clinical Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	PEB was supported by an Asthma UK/MRC Joint PhD Studentship (S08/001). KJM was supported by a MRC Clinical Research Training Fellowship (G0701350). RLG was supported by NIH grants R01-AR052728, R01-AI052453 and R01 AI0833358. DJD was supported by a MRC Senior Non-clinical Fellowship (G1002046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alalwani SM, 2010, EUR J IMMUNOL, V40, P1118, DOI 10.1002/eji.200939275; Bals R, 1999, INFECT IMMUN, V67, P6084, DOI 10.1128/IAI.67.11.6084-6089.1999; Barlow PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025333; Barlow PG, 2010, AM J RESP CELL MOL, V43, P692, DOI 10.1165/rcmb.2009-0250OC; Beaumont PE, 2013, ANTIMICROBIAL PEPTID, P97; Bowdish DME, 2005, CURR PROTEIN PEPT SC, V6, P35, DOI 10.2174/1389203053027494; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; British Thoracic Society, 2006, BURD LUNG DIS STAT R; Bucki R, 2007, EUR RESPIR J, V29, P624, DOI 10.1183/09031936.00080806; Carmeli Y, 1999, ANTIMICROB AGENTS CH, V43, P1379, DOI 10.1128/AAC.43.6.1379; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Davidson DJ, 2003, P C C I D, V7, P71; Davidson DJ, 2004, J IMMUNOL, V172, P1146, DOI 10.4049/jimmunol.172.2.1146; Gallo RL, 1997, J BIOL CHEM, V272, P13088, DOI 10.1074/jbc.272.20.13088; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Hermes DM, 2013, J MED MICROBIOL, V62, P1184, DOI 10.1099/jmm.0.059220-0; Huang LC, 2007, INVEST OPHTH VIS SCI, V48, P4498, DOI 10.1167/iovs.07-0274; Iimura M, 2005, J IMMUNOL, V174, P4901, DOI 10.4049/jimmunol.174.8.4901; Kovach MA, 2012, J IMMUNOL, V189, P304, DOI 10.4049/jimmunol.1103196; Kurosaka K, 2005, J IMMUNOL, V174, P6257, DOI 10.4049/jimmunol.174.10.6257; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Li HN, 2009, J LEUKOCYTE BIOL, V86, P891, DOI 10.1189/jlb.0209050; Lipsky BA, 2008, CLIN INFECT DIS, V47, P1537, DOI 10.1086/593185; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mader JS, 2009, MOL CANCER RES, V7, P689, DOI 10.1158/1541-7786.MCR-08-0274; Mansbach JM, 2012, J ALLERGY CLIN IMMUN, V130, P1007, DOI 10.1016/j.jaci.2012.07.044; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Nagaoka I, 2001, J IMMUNOL, V167, P3329, DOI 10.4049/jimmunol.167.6.3329; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Pestonjamasp VK, 2001, PEPTIDES, V22, P1643, DOI 10.1016/S0196-9781(01)00499-5; Pompilio A, 2011, PEPTIDES, V32, P1807, DOI 10.1016/j.peptides.2011.08.002; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; Rivas-Santiago B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059119; Sarker P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020637; Schaller-Bals S, 2002, AM J RESP CRIT CARE, V165, P992, DOI 10.1164/ajrccm.165.7.200110-020; Schauber J, 2008, J ALLERGY CLIN IMMUN, V122, P261, DOI 10.1016/j.jaci.2008.03.027; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Semple F, 2012, J INNATE IMMUN, V4, P337, DOI 10.1159/000336619; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Steinmann J, 2009, ANTIMICROB AGENTS CH, V53, P5127, DOI 10.1128/AAC.00818-09; Tjabringa GS, 2006, INT ARCH ALLERGY IMM, V140, P103, DOI 10.1159/000092305; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; van der Does AM, 2012, J LEUKOCYTE BIOL, V92, P735, DOI 10.1189/jlb.0412178; van der Does AM, 2010, J IMMUNOL, V185, P1442, DOI 10.4049/jimmunol.1000376; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Wang YQ, 1998, J PROTEIN CHEM, V17, P522; Wantha S, 2013, CIRC RES, V112, P792, DOI 10.1161/CIRCRESAHA.112.300666; Weiner DJ, 2003, AM J RESP CELL MOL, V28, P738, DOI 10.1165/rcmb.2002-0191OC; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yim S, 2007, J CYST FIBROS, V6, P403, DOI 10.1016/j.jcf.2007.03.003; Yu FS, 2010, J IMMUNOL, V185, P1142, DOI 10.4049/jimmunol.1000509; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang ZF, 2009, EUR J IMMUNOL, V39, P3181, DOI 10.1002/eji.200939496	57	61	63	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e99029	10.1371/journal.pone.0099029	http://dx.doi.org/10.1371/journal.pone.0099029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887410	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300123
J	Goud, PT; Goud, AP; Najafi, T; Gonik, B; Diamond, MP; Saed, GM; Zhang, XJ; Abu-Soud, HM				Goud, Pravin T.; Goud, Anuradha P.; Najafi, Tohid; Gonik, Bernard; Diamond, Michael P.; Saed, Ghassan M.; Zhang, Xueji; Abu-Soud, Husam M.			Direct Real-Time Measurement of Intra-Oocyte Nitric Oxide Concentration In Vivo	PLOS ONE			English	Article							NO; RELEASE; TARGETS; CORTEX; BRAIN	Nitric oxide (NO) is reported to play significant a role in oocyte activation and maturation, implantation, and early embryonic development. Previously we have shown that NO forms an important component of the oocyte microenvironment, and functions effectively to delay oocyte aging. Thus, precise information about intra-oocyte NO concentrations [NO] will result in designing more accurate treatment plans in assisted reproduction. In this work, the direct, real-time and quantitative intra-oocyte [NO] was measured utilizing an L-shaped amperometric integrated NO-selective electrode. This method not only provides an elegant and convenient approach to real-time the measurement of NO in physiological environments, but also mimics the loss of NO caused by rapid NO diffusion combined with its reactivity in the biological milieu. This experiment suggests that the NO levels of oocytes obtained from young animals are significantly higher than those of oocytes obtained from old animals. Additionally the NO levels stay constant during the measurements; however, the intra-oocyte [NO] is reduced significantly (70-75% reduction) in response to L-NAME incubation, suggesting that NO measurements are truly NOS based rather than caused by an unknown interfering substance in our system. We believe this first demonstration of the direct quantitative measurement of [NO] in situ in an intact cellular complex should be useful in tracking real-time and rapid changes at nanomolar levels. Moreover, this finding confirms and extends our previous work showing that supplementation with NO delays the oocyte aging process.	[Goud, Pravin T.; Najafi, Tohid; Gonik, Bernard; Saed, Ghassan M.; Abu-Soud, Husam M.] Wayne State Univ, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, CS Mott Ctr Human Growth & Dev, Detroit, MI 48202 USA; [Goud, Pravin T.] Univ Calif Davis, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Sacramento, CA 95817 USA; [Goud, Pravin T.] Calif IVF Fertil Ctr, Davis, CA USA; [Goud, Pravin T.] Calif IVF Fertil Ctr, Sacramento, CA USA; [Goud, Anuradha P.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Diamond, Michael P.] Georgia Regents Univ, Dept Obstet & Gynecol, Augusta, GA USA; [Zhang, Xueji] World Precis Instruments, Sarasota, FL USA; [Zhang, Xueji] Univ Sci & Technol, Res Ctr Bioengn & Sensing Technol, Beijing, Peoples R China; [Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI USA	Wayne State University; University of California System; University of California Davis; University of California System; University of California Davis; University System of Georgia; Augusta University; University of Science & Technology Beijing; Wayne State University	Abu-Soud, HM (corresponding author), Wayne State Univ, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, CS Mott Ctr Human Growth & Dev, Detroit, MI 48202 USA.	habusoud@med.wayne.edu	zhang, xueji/B-1904-2010; zhang, xueji/ABE-6497-2020	zhang, xueji/0000-0002-0035-3821; Diamond, Michael/0000-0001-6353-4489	National Institutes of Health [RO1 HL066367]; Children's Hospital of Michigan; National Nature Science Foundation of China [21127007, 21005037]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Michigan; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health RO1 HL066367, a grant from Children's Hospital of Michigan (H.M.A-S) and National Nature Science Foundation of China (Grant No. 21127007, 21005037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; ABUSOUD HM, 1993, J BIOL CHEM, V268, P7699; ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; Bates J. N., 1992, NEUROPROTOCOLS, V1, P141; Brovkovych V, 1999, J PHARMACEUT BIOMED, V19, P135, DOI 10.1016/S0731-7085(98)00090-9; Ciszewski A, 2003, ELECTROCHEMICAL DETE; Gainutdinov KL, 2013, B EXP BIOL MED+, V154, P635, DOI 10.1007/s10517-013-2018-3; Goud AP, 2005, BIOCHEMISTRY-US, V44, P11361, DOI 10.1021/bi050711f; Goud AP, 2005, REPROD BIOMED ONLINE, V11, P43, DOI 10.1016/S1472-6483(10)61297-7; Goud P, 1997, FERTIL STERIL, V67, P979, DOI 10.1016/S0015-0282(97)90147-3; Goud PT, 2008, FREE RADICAL BIO MED, V45, P453, DOI 10.1016/j.freeradbiomed.2008.04.035; GROSS SS, 1995, ANNU REV PHYSIOL, V57, P737, DOI 10.1146/annurev.ph.57.030195.003513; Guevara I, 1998, CLIN CHIM ACTA, V274, P177, DOI 10.1016/S0009-8981(98)00060-6; Hall CN, 2008, J PHYSIOL-LONDON, V586, P3597, DOI 10.1113/jphysiol.2008.154724; Hetrick EM, 2009, ANNU REV ANAL CHEM, V2, P409, DOI 10.1146/annurev-anchem-060908-155146; Hrbac J, 2007, BIOELECTROCHEMISTRY, V71, P46, DOI 10.1016/j.bioelechem.2006.09.007; Hunter RA, 2013, ANAL CHEM, V85, P1957, DOI 10.1021/ac303787p; ICHIMORI K, 1994, REV SCI INSTRUM, V65, P2714, DOI 10.1063/1.1144674; Khorram Omid, 2002, Rev Endocr Metab Disord, V3, P145, DOI 10.1023/A:1015459029397; LANCASTER JR, 1992, J BIOL CHEM, V267, P10994; LARFARS G, 1995, J IMMUNOL METHODS, V184, P53, DOI 10.1016/0022-1759(95)00074-K; Laver JR, 2008, METHOD ENZYMOL, V436, P113, DOI 10.1016/S0076-6879(08)36007-8; Levine DZ, 2001, AM J PHYSIOL-RENAL, V281, pF189, DOI 10.1152/ajprenal.2001.281.1.F189; MALINSKI T, 1993, J CEREBR BLOOD F MET, V13, P355, DOI 10.1038/jcbfm.1993.48; Noack E., 1992, NEUROPROTOCOLS, V1, P133; Palm F, 2005, DIABETES, V54, P3282, DOI 10.2337/diabetes.54.11.3282; Pervin S, 2007, CANCER RES, V67, P289, DOI 10.1158/0008-5472.CAN-05-4623; Pittner J, 2005, KIDNEY INT, V67, P227, DOI 10.1111/j.1523-1755.2005.00073.x; Saed GM, 2005, FERTIL STERIL, V84, P235, DOI 10.1016/j.fertnstert.2005.01.105; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Wakatsuki H, 1998, J PHYSIOL-LONDON, V513, P71, DOI 10.1111/j.1469-7793.1998.071by.x; Xiangji Z, 1996, ANAL CHEM, V68, P1748; Zhang XJ, 2004, FRONT BIOSCI-LANDMRK, V9, P3434, DOI 10.2741/1492; Zhang XJ, 2000, ELECTROANALYSIS, V12	34	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98720	10.1371/journal.pone.0098720	http://dx.doi.org/10.1371/journal.pone.0098720			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887331	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300101
J	Kellner, R; Hanschke, C; Begerow, D				Kellner, Ronny; Hanschke, Christian; Begerow, Dominik			Patterns of Variation at Ustilago maydis Virulence Clusters 2A and 19A Largely Reflect the Demographic History of Its Populations	PLOS ONE			English	Article							SMUT FUNGI; MAIZE DOMESTICATION; GENOME; EVOLUTION; SEQUENCES; PROTEINS; GENETICS; INSIGHTS	The maintenance of an intimate interaction between plant-biotrophic fungi and their hosts over evolutionary times involves strong selection and adaptative evolution of virulence-related genes. The highly specialised maize pathogen Ustilago maydis is assigned with a high evolutionary capability to overcome host resistances due to its high rates of sexual recombination, large population sizes and long distance dispersal. Unlike most studied fungus-plant interactions, the U. maydis - Zea mays pathosystem lacks a typical gene-for-gene interaction. It exerts a large set of secreted fungal virulence factors that are mostly organised in gene clusters. Their contribution to virulence has been experimentally demonstrated but their genetic diversity within U. maydis remains poorly understood. Here, we report on the intraspecific diversity of 34 potential virulence factor genes of U. maydis. We analysed their sequence polymorphisms in 17 isolates of U. maydis from Europe, North and Latin America. We focused on gene cluster 2A, associated with virulence attenuation, cluster 19A that is crucial for virulence, and the cluster-independent effector gene pep1. Although higher compared to four house-keeping genes, the overall levels of intraspecific genetic variation of virulence clusters 2A and 19A, and pep1 are remarkably low and commensurate to the levels of 14 studied non-virulence genes. In addition, each gene is present in all studied isolates and synteny in cluster 2A is conserved. Furthermore, 7 out of 34 virulence genes contain either no polymorphisms or only synonymous substitutions among all isolates. However, genetic variation of clusters 2A and 19A each resolve the large scale population structure of U. maydis indicating subpopulations with decreased gene flow. Hence, the genetic diversity of these virulence-related genes largely reflect the demographic history of U. maydis populations.	[Kellner, Ronny] Max Planck Inst Terr Microbiol, MPRG Fungal Biodivers, D-35043 Marburg, Germany; [Kellner, Ronny; Hanschke, Christian; Begerow, Dominik] Ruhr Univ Bochum, Dept Geobot, Bochum, Germany	Max Planck Society; Ruhr University Bochum	Kellner, R (corresponding author), Max Planck Inst Terr Microbiol, MPRG Fungal Biodivers, D-35043 Marburg, Germany.	ronny.kellner@mpi-marburg.mpg.de	Kellner, Ronny/H-3106-2019	Kellner, Ronny/0000-0002-4618-0110; Begerow, Dominik/0000-0002-8286-1597	Deutsche Forschungsgemeinschaft (DFG) [BE 2201/8-1]; Ruhr-University Bochum	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ruhr-University Bochum	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, BE 2201/8-1) and the Ruhr-University Bochum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes CW, 2004, MYCOLOGIA, V96, P1236, DOI 10.2307/3762140; Basse CW, 2000, MOL CELL BIOL, V20, P329, DOI 10.1128/MCB.20.1.329-339.2000; Bauer R, 1997, CAN J BOT, V75, P1273, DOI 10.1139/b97-842; BAUER R, 1995, CAN J BOT, V73, P867, DOI 10.1139/b95-095; Baumgarten AM, 2007, THEOR APPL GENET, V114, P1229, DOI 10.1007/s00122-007-0513-5; Brefort T, 2009, ANNU REV PHYTOPATHOL, V47, P423, DOI 10.1146/annurev-phyto-080508-081923; Catanzariti AM, 2007, FEMS MICROBIOL LETT, V269, P181, DOI 10.1111/j.1574-6968.2007.00684.x; Doehlemann G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000290; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; FU YX, 1993, GENETICS, V133, P693; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kellner R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002436; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Kirkman T. W., 1996, STAT USE; Kohn LM, 2005, ANNU REV PHYTOPATHOL, V43, P279, DOI 10.1146/annurev.phyto.43.040204.135958; Kumar Nei, 2000, MOL EVOLUTION PHYLOG; Laurie JD, 2012, PLANT CELL, V24, P1733, DOI 10.1105/tpc.112.097261; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Librado P, 2009, DNASP V5 SOFTWARE CO, P5; Liu KJ, 2003, GENETICS, V165, P2117; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Munkacsi AB, 2008, P ROY SOC B-BIOL SCI, V275, P1037, DOI 10.1098/rspb.2007.1636; Munkacsi AB, 2007, EVOLUTION, V61, P388, DOI 10.1111/j.1558-5646.2007.00036.x; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pierce JV, 2012, MBIO, V3, DOI 10.1128/mBio.00117-12; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Schirawski J, 2010, SCIENCE, V330, P1546, DOI 10.1126/science.1195330; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Stock J, 2012, J BIOTECHNOL, V161, P80, DOI 10.1016/j.jbiotec.2012.03.004; Stoll M, 2005, MYCOL RES, V109, P342, DOI 10.1017/S0953756204002229; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Stukenbrock EH, 2011, GENOME RES, V21, P2157, DOI 10.1101/gr.118851.110; Stukenbrock EH, 2009, MOL PLANT MICROBE IN, V22, P371, DOI 10.1094/MPMI-22-4-0371; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian F, 2009, P NATL ACAD SCI USA, V106, P9979, DOI 10.1073/pnas.0901122106; van Heerwaarden J, 2011, P NATL ACAD SCI USA, V108, P1088, DOI 10.1073/pnas.1013011108; Vollmeister E, 2010, CURR OPIN MICROBIOL, V13, P693, DOI 10.1016/j.mib.2010.08.013; White T., 1990, PCR PROTOCOLS GUIDE, P315; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yang Z, 1997, MOL BIOL EVOL, V15, P568; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	49	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98837	10.1371/journal.pone.0098837	http://dx.doi.org/10.1371/journal.pone.0098837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887029	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300113
J	Weiss, K; Parzefall, C; Herzner, G				Weiss, Katharina; Parzefall, Christopher; Herzner, Gudrun			Multifaceted Defense against Antagonistic Microbes in Developing Offspring of the Parasitoid Wasp Ampulex compressa (Hymenoptera, Ampulicidae)	PLOS ONE			English	Article							COCKROACHES PERIPLANETA-AMERICANA; METARHIZIUM-ANISOPLIAE; SECONDARY METABOLITES; POTENTIAL VECTORS; ENDOPHYTIC FUNGUS; PATHOGENIC FUNGI; GLAND SECRETION; BACTERIA; NAPHTHALENE; LARVAE	Effective antimicrobial strategies are essential adaptations of insects to protect themselves, their offspring, and their foods from microbial pathogens and decomposers. Larvae of the emerald cockroach wasp, Ampulex compressa, sanitize their cockroach hosts, Periplaneta americana, with a cocktail of nine antimicrobials comprising mainly (R)-(-)-mellein and micromolide. The blend of these antimicrobials has broad-spectrum antimicrobial activity. Here we explore the spatio-temporal pattern of deployment of antimicrobials during the development from egg to adult as well as their physico-chemical properties to assess how these aspects may contribute to the success of the antimicrobial strategy. Using gas chromatography/mass spectrometry (GC/MS) we show that larvae start sanitizing their food as soon as they have entered their host to feed on its tissue. Subsequently, they impregnate the cockroach carcass with antimicrobials to create a hygienic substrate for cocoon spinning inside the host. Finally, the antimicrobials are incorporated into the cocoon. The antimicrobial profiles on cockroach and wasp cocoon differed markedly. While micromolide persisted on the cockroaches until emergence of the wasps, solid-phase microextraction sampling and GC/MS analysis revealed that (R)-(-)-mellein vaporized from the cockroaches and accumulated in the enclosed nest. In microbial challenge assays (R)-(-)-mellein in the headspace of parasitized cockroaches inhibited growth of entomopathogenic and opportunistic microbes (Serratia marcescens, Aspergillus sydowii, Metarhizium brunneum). We conclude that, in addition to food sanitation, A. compressa larvae enclose themselves in two defensive walls by impregnating the cocoon and the cockroach cuticle with antimicrobials. On top of that, they use vaporous (R)-(-)-mellein to sanitize the nest by fumigation. This multifaceted antimicrobial defense strategy involving the spatially and temporally coordinated deployment of several antimicrobials in solution and vapor form has apparently evolved to reliably protect the larvae themselves and their food against a broad range of antagonistic microbes.	[Weiss, Katharina; Parzefall, Christopher; Herzner, Gudrun] Univ Regensburg, Inst Zool, Evolutionary Ecol Grp, D-93053 Regensburg, Germany	University of Regensburg	Herzner, G (corresponding author), Univ Regensburg, Inst Zool, Evolutionary Ecol Grp, Univ Str 31, D-93053 Regensburg, Germany.	gudrun.herzner@biologie.uni-regensburg.de			Forschungsrat of the University of Regensburg	Forschungsrat of the University of Regensburg	Gudrun Herzner gratefully acknowledges financial support from the Forschungsrat of the University of Regensburg (http://www.uni-regensburg.de/forschung/forschungsrat/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang-Kucuker M, 1999, ZBL BAKT, V289, P781; BATRA SWT, 1969, SCIENCE, V165, P607, DOI 10.1126/science.165.3893.607; Baumholtz MA, 1997, INT J DERMATOL, V36, P90, DOI 10.1046/j.1365-4362.1997.00077.x; Beckage NE, 2008, INSECT IMMUNOLOGY, P1; Bischoff JF, 2009, MYCOLOGIA, V101, P512, DOI 10.3852/07-202; Bulmer MS, 2009, P NATL ACAD SCI USA, V106, P12652, DOI 10.1073/pnas.0904063106; Cardoza YJ, 2006, ECOL ENTOMOL, V31, P636, DOI 10.1111/j.1365-2311.2006.00829.x; Chaichanawongsaroj Nuntaree, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P681; Chen J, 1998, NATURE, V392, P558, DOI 10.1038/33305; Chen J, 1998, J AGR FOOD CHEM, V46, P2337, DOI 10.1021/jf9709717; Chouvenc T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1885; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; Cotter SC, 2010, ECOL LETT, V13, P1114, DOI 10.1111/j.1461-0248.2010.01500.x; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Dai JR, 2001, J NAT PROD, V64, P125, DOI 10.1021/np000381u; Degenkolb T, 2011, J CHEM ECOL, V37, P724, DOI 10.1007/s10886-011-9978-4; El-Mehalawy A. A., 2005, International Journal of Agriculture and Biology, V7, P188; Fakoorziba MR, 2010, ANN TROP MED PARASIT, V104, P521, DOI 10.1179/136485910X12786389891326; Feng Z, 2010, J MICROBIOL BIOTECHN, V20, P985, DOI 10.4014/jmb.1002.02012; FUHRER E, 1986, J INSECT PHYSIOL, V32, P361, DOI 10.1016/0022-1910(86)90049-1; Fuhrer E, 2001, J APPL ENTOMOL, V125, P235, DOI 10.1046/j.1439-0418.2001.00529.x; Gasch T, 2013, J INSECT PHYSIOL, V59, P1186, DOI 10.1016/j.jinsphys.2013.09.006; GOCHNAUER TA, 1979, J INVERTEBR PATHOL, V34, P57, DOI 10.1016/0022-2011(79)90053-3; Griffiths HM, 2010, ECOL ENTOMOL, V35, P529, DOI 10.1111/j.1365-2311.2010.01212.x; Gross J, 2008, J CHEM ECOL, V34, P179, DOI 10.1007/s10886-007-9416-9; Gross J, 2009, RES CHRYSOMELIDAE, V2, P177; Gross J, 2010, J CHEM ECOL, V36, P1180, DOI 10.1007/s10886-010-9867-2; Haak U, 1996, CHEMOECOLOGY, V7, P85, DOI 10.1007/BF01239485; Hamilton C, 2011, J INSECT PHYSIOL, V57, P1259, DOI 10.1016/j.jinsphys.2011.05.016; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Heitmans Wijnand R.B., 1990, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V1, P13; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Herzner G, 2007, CURR BIOL, V17, pR46, DOI 10.1016/j.cub.2006.11.060; Herzner G, 2013, P NATL ACAD SCI USA, V110, P1369, DOI 10.1073/pnas.1213384110; Herzner G, 2011, ANIM BEHAV, V82, P321, DOI 10.1016/j.anbehav.2011.05.006; Herzner G, 2011, ZOOLOGY, V114, P36, DOI 10.1016/j.zool.2010.10.002; Holler U, 1999, J NAT PROD, V62, P114, DOI 10.1021/np980341e; Iranshahi M, 2004, Z NATURFORSCH C, V59, P506; JANZEN DH, 1977, AM NAT, V111, P691, DOI 10.1086/283200; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Keasar T, 2006, ETHOLOGY, V112, P699, DOI 10.1111/j.1439-0310.2006.01214.x; Koehler S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-3; Krohn K, 1997, PHYTOCHEMISTRY, V45, P313, DOI 10.1016/S0031-9422(96)00854-0; Kroiss J, 2010, NAT CHEM BIOL, V6, P261, DOI [10.1038/NCHEMBIO.331, 10.1038/nchembio.331]; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Lemos AA, 2006, MYCOSES, V49, P23, DOI 10.1111/j.1439-0507.2005.01179.x; Li B, 2011, BRAZ J MICROBIOL, V42, P96, DOI 10.1590/S1517-83822011000100013; Libersat F, 2003, J COMP PHYSIOL A, V189, P497, DOI 10.1007/s00359-003-0432-0; Ma CY, 2005, PLANTA MED, V71, P261, DOI 10.1055/s-2005-837826; Muneer M, 2005, J MOL CATAL A-CHEM, V234, P151, DOI 10.1016/j.molcata.2005.02.025; Oliveira CM, 2011, PHYTOCHEM LETT, V4, P93, DOI 10.1016/j.phytol.2010.11.003; Pai HH, 2005, ACTA TROP, V93, P259, DOI 10.1016/j.actatropica.2004.11.006; Pai HH, 2004, INFECT CONT HOSP EP, V25, P979, DOI 10.1086/502330; Prado Marinésia Aparecida, 2006, Braz J Infect Dis, V10, P26, DOI 10.1590/S1413-86702006000100006; Reber A, 2011, J EVOLUTION BIOL, V24, P954, DOI 10.1111/j.1420-9101.2011.02230.x; Reynolds S., 2009, INSECT INFECT IMMUNI; Rohrich CR, 2012, BIOL LETTERS, V8, P308, DOI 10.1098/rsbl.2011.0760; Rosengaus RB, 2000, J CHEM ECOL, V26, P21, DOI 10.1023/A:1005481209579; Rosengaus RB, 2004, INSECT SOC, V51, P259, DOI 10.1007/s00040-004-0749-x; Rosengaus RB, 2013, NATURWISSENSCHAFTEN, V100, P1051, DOI 10.1007/s00114-013-1110-x; Rozen DE, 2008, P NATL ACAD SCI USA, V105, P17890, DOI 10.1073/pnas.0805403105; Rukachaisirikul V, 2009, TETRAHEDRON, V65, P10590, DOI 10.1016/j.tet.2009.10.084; Schmidtberg H, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0006; SCHULZ B, 1995, MYCOL RES, V99, P1007, DOI 10.1016/S0953-7562(09)80766-1; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Secil ES, 2012, BIOLOGIA, V67, P767, DOI 10.2478/s11756-012-0070-5; Sikorowski P. P., 2001, American Entomologist, V47, P51; SUN CM, 1993, J NAT PROD, V56, P953, DOI 10.1021/np50096a024; Suwannarach N, 2013, CROP PROT, V45, P63, DOI 10.1016/j.cropro.2012.11.015; THOMPSON PR, 1978, J COMP PHYSIOL, V126, P257, DOI 10.1007/BF00688935; Tragust S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-225; Tragust S, 2013, CURR BIOL, V23, P76, DOI 10.1016/j.cub.2012.11.034; Trienens M, 2010, OIKOS, V119, P1765, DOI 10.1111/j.1600-0706.2010.18088.x; Tunc S, 2007, INT J FOOD MICROBIOL, V113, P263, DOI 10.1016/j.ijfoodmicro.2006.07.004; Vanninen I, 1997, ENTOMOPHAGA, V42, P377, DOI 10.1007/BF02769831; Vilcinskas Andreas, 2013, Proc Biol Sci, V280, P20122113, DOI 10.1098/rspb.2012.2113; Wang L, 2008, ANN MICROBIOL, V58, P579, DOI 10.1007/BF03175561; Williams FX, 1942, P HAWAII ENTOMOL SOC, V11, P221; Wiltz BA, 1998, ENVIRON ENTOMOL, V27, P936, DOI 10.1093/ee/27.4.936; Wright MS, 2000, MYCOLOGIA, V92, P42, DOI 10.2307/3761448; Yek SH, 2012, P ROY SOC B-BIOL SCI, V279, P4215, DOI 10.1098/rspb.2012.1458; Yuan H, 2008, BIOORG MED CHEM LETT, V18, P5311, DOI 10.1016/j.bmcl.2008.08.027; Zhao JH, 2012, WORLD J MICROB BIOT, V28, P2107, DOI 10.1007/s11274-012-1015-4	83	16	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98784	10.1371/journal.pone.0098784	http://dx.doi.org/10.1371/journal.pone.0098784			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886721	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300108
J	Yang, QP; Li, Z; Cao, JJ; Zhang, SD; Zhang, HJ; Wu, XY; Zhang, QW; Liu, XX				Yang, Qingpo; Li, Zhen; Cao, Jinjun; Zhang, Songdou; Zhang, Huaijiang; Wu, Xiaoyun; Zhang, Qingwen; Liu, Xiaoxia			Selection and Assessment of Reference Genes for Quantitative PCR Normalization in Migratory Locust Locusta migratoria (Orthoptera: Acrididae)	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE CHAIN-REACTION; POTENTIAL REFERENCE GENES; SUITABLE REFERENCE GENES; ACETYL-COA HYDROLASE; ACTIN MESSENGER-RNA; RT-PCR; HOUSEKEEPING GENES; BETA-ACTIN; RIBOSOMAL-RNA	Locusta migratoria is a classic hemimetamorphosis insect and has caused widespread economic damage to crops as a migratory pest. Researches on the expression pattern of functional genes in L. migratoria have drawn focus in recent years, especially with the release of genome information. Real-time quantitative PCR is the most reproducible and sensitive approach for detecting transcript expression levels of target genes, but optimal internal standards are key factors for its accuracy and reliability. Therefore, it's necessary to provide a systematic stability assessment of internal control for well-performed tests of target gene expression profile. In this study, twelve candidate genes (Ach, Act, Cht2, EF1 alpha, RPL32, Hsp70, Tub, RP49, SDH, GAPDH, 18S, and His) were analyzed with four statistical methods: the delta Ct approach, geNorm, Bestkeeper and NormFinder. The results from these analyses aimed to choose the best suitable reference gene across different experimental situations for gene profile study in L. migratoria. The result demonstrated that for different developmental stages, EF1 alpha, Hsp70 and RPL32 exhibited the most stable expression status for all samples; EF1 alpha and RPL32 were selected as the best reference genes for studies involving embryo and larvae stages, while SDH and RP49 were identified for adult stage. The best-ranked reference genes across different tissues are RPL32, Hsp70 and RP49. For abiotic treatments, the most appropriate genes we identified were as follows: Act and SDH for larvae subjected to different insecticides; RPL32 and Ach for larvae exposed to different temperature treatments; and Act and Ach for larvae suffering from starvation. The present report should facilitate future researches on gene expression in L. migratoria with accessibly optimal reference genes under different experimental contexts.	[Yang, Qingpo; Li, Zhen; Cao, Jinjun; Zhang, Songdou; Zhang, Huaijiang; Wu, Xiaoyun; Zhang, Qingwen; Liu, Xiaoxia] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Wu, Xiaoyun] Beijing Vocat Coll Agr, Dept Hort, Beijing, Peoples R China	China Agricultural University	Liu, XX (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	liuxiaoxia611@cau.edu.cn			National "973" Project [2012CB114103]	National "973" Project(National Basic Research Program of China)	This study was supported by grants from the National "973" Project (No. 2012CB114103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Bear A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011563; Bemeur C, 2004, NEUROSCI LETT, V357, P211, DOI 10.1016/j.neulet.2003.12.081; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Chapuis MP, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-7; Chen Yong-Lin, 2000, Entomological Knowledge, V37, P50; Cicinnati VR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-350; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Deindl E, 2002, MOL CELL BIOCHEM, V236, P139, DOI 10.1023/A:1016166127465; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Docimo T, 2013, F1000RESEARCH; Fernandes JMO, 2008, COMP BIOCHEM PHYS B, V150, P23, DOI 10.1016/j.cbpb.2008.01.003; Guo W, 2010, J INSECT PHYSIOL, V56, P943, DOI 10.1016/j.jinsphys.2010.05.007; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; HUNTER T, 1977, CELL, V12, P767, DOI 10.1016/0092-8674(77)90276-8; Infante C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-28; Jiang HB, 2010, MOL BIOL REP, V37, P1019, DOI 10.1007/s11033-009-9803-0; Kang L, 2004, P NATL ACAD SCI USA, V101, P17611, DOI 10.1073/pnas.0407753101; Keeley L.L., 1985, P211; Kidd M, 2007, PHYSIOL GENOMICS, V30, P363, DOI 10.1152/physiolgenomics.00251.2006; Koch I, 2002, DRUG METAB DISPOS, V30, P1108, DOI 10.1124/dmd.30.10.1108; Kosir R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-60; Kristensen TN, 2006, GENETICS, V173, P1329, DOI 10.1534/genetics.105.054486; Lee FJS, 1996, BBA-PROTEIN STRUCT M, V1297, P105, DOI 10.1016/0167-4838(96)00109-4; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Lu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068059; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Marchal Elisabeth, 2013, BMC Res Notes, V6, P237, DOI 10.1186/1756-0500-6-237; Maroniche GA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-308; MOSHIER JA, 1993, EXP GERONTOL, V28, P249, DOI 10.1016/0531-5565(93)90032-9; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Perez R, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-79; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Piana C, 2008, EUR J PHARM BIOPHARM, V69, P1187, DOI 10.1016/j.ejpb.2008.03.008; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Qin GH, 2011, PEST MANAG SCI, V67, P697, DOI 10.1002/ps.2110; Qin WS, 2003, CELL STRESS CHAPERON, V8, P144, DOI 10.1379/1466-1268(2003)008<0144:CACOAM>2.0.CO;2; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Schmid H, 2003, KIDNEY INT, V64, P356, DOI 10.1046/j.1523-1755.2003.00074.x; SCHULZ WA, 1991, FEBS LETT, V292, P264, DOI 10.1016/0014-5793(91)80880-C; Sellars MJ, 2007, J BIOTECHNOL, V129, P391, DOI 10.1016/j.jbiotec.2007.01.029; Serazin-Leroy V, 1998, MOL CELL PROBE, V12, P283, DOI 10.1006/mcpr.1998.0182; SHELTON AM, 1993, J ECON ENTOMOL, V86, P697, DOI 10.1093/jee/86.3.697; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Steenkamp ET, 1999, APPL ENVIRON MICROB, V65, P3401; Sturzenbaum SR, 2001, COMP BIOCHEM PHYS B, V130, P281, DOI 10.1016/S1096-4959(01)00440-7; Suematsu N, 2002, ACTA BIOCHIM POL, V49, P937; Talaat AM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf103; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Ullmannova V, 2003, FOLIA BIOL-PRAGUE, V49, P211; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang GH, 2008, INSECT SCI, V15, P405, DOI 10.1111/j.1744-7917.2008.00227.x; Wang XH, 2003, CRYOLETTERS, V24, P331; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Watson S, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-130; Winnebeck EC, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14119; Zhang CB, 2009, CURR GENET, V55, P399, DOI 10.1007/s00294-009-0254-x; Zhang JZ, 2010, INSECT BIOCHEM MOLEC, V40, P824, DOI 10.1016/j.ibmb.2010.08.001; Zhao DJ, 2012, FEBS OPEN BIO, V2, P235, DOI 10.1016/j.fob.2012.08.001; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815; Zhou XX, 2009, PESTIC BIOCHEM PHYS, V93, P77, DOI 10.1016/j.pestbp.2008.11.007; Zhu E.L., 1999, OCCURRENCE MANAGEMEN; Zimoch L, 2002, CELL TISSUE RES, V308, P287, DOI 10.1007/s00441-002-0546-7	79	48	53	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98164	10.1371/journal.pone.0098164	http://dx.doi.org/10.1371/journal.pone.0098164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887329	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300041
J	Lou, YF; Zou, ZZ; Chen, PJ; Huang, GB; Li, B; Zheng, DQ; Yu, XR; Luo, XY				Lou, Yun-feng; Zou, Zheng-zhi; Chen, Pin-jia; Huang, Guo-bin; Li, Bin; Zheng, De-qing; Yu, Xiu-rong; Luo, Xiao-yong			Combination of Gefitinib and DNA Methylation Inhibitor Decitabine Exerts Synergistic Anti-Cancer Activity in Colon Cancer Cells	PLOS ONE			English	Article							XIAP-ASSOCIATED FACTOR-1; GASTRIC-CANCER; IN-VITRO; EGFR; GROWTH; XAF1; RESISTANCE; EXPRESSION; THERAPY; KINASE	Despite recent advances in the treatment of human colon cancer, the chemotherapy efficacy against colon cancer is still unsatisfactory. In the present study, effects of concomitant inhibition of the epidermal growth factor receptor (EGFR) and DNA methyltransferase were examined in human colon cancer cells. We demonstrated that decitabine (a DNA methyltransferase inhibitor) synergized with gefitinib (an EGFR inhibitor) to reduce cell viability and colony formation in SW1116 and LOVO cells. However, the combination of the two compounds displayed minimal toxicity to NCM460 cells, a normal human colon mucosal epithelial cell line. The combination was also more effective at inhibiting the AKT/mTOR/S6 kinase pathway. In addition, the combination of decitabine with gefitinib markedly inhibited colon cancer cell migration. Furthermore, gefitinib synergistically enhanced decitabine-induced cytotoxicity was primarily due to apoptosis as shown by Annexin V labeling that was attenuated by z-VAD-fmk, a pan caspase inhibitor. Concomitantly, cell apoptosis resulting from the co-treatment of gefitinib and decitabine was accompanied by induction of BAX, cleaved caspase 3 and cleaved PARP, along with reduction of Bcl-2 compared to treatment with either drug alone. Interestingly, combined treatment with these two drugs increased the expression of XIAP-associated factor 1 (XAF1) which play an important role in cell apoptosis. Moreover, small interfering RNA (siRNA) depletion of XAF1 significantly attenuated colon cancer cells apoptosis induced by the combination of the two drugs. Our findings suggested that gefitinib in combination with decitabine exerted enhanced cell apoptosis in colon cancer cells were involved in mitochondrial-mediated pathway and induction of XAF1 expression. In conclusion, based on the observations from our study, we suggested that the combined administration of these two drugs might be considered as a novel therapeutic regimen for treating colon cancer.	[Lou, Yun-feng; Chen, Pin-jia; Li, Bin; Yu, Xiu-rong; Luo, Xiao-yong] Zhengzhou Univ, Affiliated Luoyang Cent Hosp, Dept Oncol, Luoyang, Peoples R China; [Zou, Zheng-zhi] S China Normal Univ, Coll Biophoton, MOE Key Lab Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Zou, Zheng-zhi] S China Normal Univ, Coll Biophoton, Inst Laser Life Sci, Guangzhou, Guangdong, Peoples R China; [Huang, Guo-bin; Zheng, De-qing] Sun Yat Sen Univ, Affiliated Donghua Hosp, Dept Gastroenterol, Dongguan, Peoples R China	Zhengzhou University; South China Normal University; South China Normal University; Sun Yat Sen University	Luo, XY (corresponding author), Zhengzhou Univ, Affiliated Luoyang Cent Hosp, Dept Oncol, Luoyang, Peoples R China.	xiaoyongluo68@163.com	bin, li/AAK-6880-2020		South China Normal University Science Fund for Young Scholars [13KJ19]; Bureau of Dongguan city science and Technology key project Fund [201028]	South China Normal University Science Fund for Young Scholars; Bureau of Dongguan city science and Technology key project Fund	The work was supported by the South China Normal University Science Fund for Young Scholars (Grant No. 13KJ19 to Zheng-zhi Zou), the Bureau of Dongguan city science and Technology 2010 key project Fund (Grant No. 201028 to Xiao-yong Luo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin K, 2014, ONCOL LETT, V7, P255, DOI 10.3892/ol.2013.1662; Azad N, 2013, NAT REV CLIN ONCOL, V10, P256, DOI 10.1038/nrclinonc.2013.42; Bariol C, 2003, AM J PATHOL, V162, P1361, DOI 10.1016/S0002-9440(10)63932-6; Bender CM, 1998, CANCER RES, V58, P95; Braun AH, 2005, ANTI-CANCER DRUG, V16, P1099, DOI 10.1097/00001813-200511000-00009; Byun DS, 2003, CANCER RES, V63, P7068; Carr TD, 2012, CANCER PREV RES, V5, P1394, DOI 10.1158/1940-6207.CAPR-12-0272-T; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chung SK, 2007, GASTROENTEROLOGY, V132, P2459, DOI 10.1053/j.gastro.2007.04.024; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Correale P, 2010, EUR J CANCER, V46, P1703, DOI 10.1016/j.ejca.2010.03.005; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Flageng MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074618; Fong WG, 2000, GENOMICS, V70, P113, DOI 10.1006/geno.2000.6364; Giannopoulou E, 2009, CANCER CHEMOTH PHARM, V63, P973, DOI 10.1007/s00280-008-0820-9; Griffiths EA, 2013, ADV EXP MED BIOL, V754, P253, DOI 10.1007/978-1-4419-9967-2_13; Haraldsdottir S, 2013, J GASTROINTEST ONCOL, V4, P285, DOI 10.3978/j.issn.2078-6891.2013.028; Hsiao SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083266; Huang S, 2013, MOL CANCER THER, V12, P2772, DOI 10.1158/1535-7163.MCT-13-0587; Issa JP, 2008, CANCER PREV RES, V1, P219, DOI 10.1158/1940-6207.CAPR-08-0029; Jones HE, 2006, BRIT J CANCER, V95, P172, DOI 10.1038/sj.bjc.6603237; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Karahoca M, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-3; Kim DJ, 2011, CANCER PREV RES, V4, P1842, DOI 10.1158/1940-6207.CAPR-11-0158; Li XQ, 2010, AUTOPHAGY, V6, P1066, DOI 10.4161/auto.6.8.13366; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Luca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059689; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Rajput S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061342; Schneider BG, 2013, CANCER PREV RES, V6, P253, DOI 10.1158/1940-6207.CAPR-13-0067; Schwartz PA, 2013, P NATL ACAD SCI US; Shen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081628; Smith DL, 2014, ARCH PATHOL LAB MED, V138, P371, DOI 10.5858/arpa.2013-0002-OA; Toda D, 2006, ANTICANCER RES, V26, P129; Toker A, 2008, MOL CELL, V31, P6, DOI 10.1016/j.molcel.2008.06.007; Troiani T, 2006, MOL CANCER THER, V5, P1883, DOI 10.1158/1535-7163.MCT-06-0055; van Laarhoven HWM, 2004, EUR J GASTROEN HEPAT, V16, P283, DOI 10.1097/01.meg.0000108279.74393.52; Wang JD, 2006, GASTROENTEROLOGY, V130, P747, DOI 10.1053/j.gastro.2005.12.017; Wang J, 2009, CARCINOGENESIS, V30, P1507, DOI 10.1093/carcin/bgp155; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043213; Wang K, 2007, BIOORG MED CHEM LETT, V17, P1455, DOI 10.1016/j.bmcl.2006.11.056; Wang LS, 2013, NUTR CANCER, V65, P118, DOI 10.1080/01635581.2013.741759; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Wu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037572; Yang CH, 2005, CANCER RES, V65, P6943, DOI 10.1158/0008-5472.CAN-05-0641; Yang DF, 2012, J IMMUNOL, V188, P4441, DOI 10.4049/jimmunol.1103035; Yang XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031601; Yao JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037197; Zeller C, 2012, ONCOGENE, V31, P4567, DOI 10.1038/onc.2011.611; Zou B, 2006, GASTROENTEROLOGY, V131, P1835, DOI 10.1053/j.gastro.2006.09.050; Zou ZZ, 2012, AUTOPHAGY, V8, P1798, DOI 10.4161/auto.22110	52	39	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97719	10.1371/journal.pone.0097719	http://dx.doi.org/10.1371/journal.pone.0097719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874286	Green Published, gold, Green Submitted			2022-12-25	WOS:000336790800011
J	Yu, W; Zha, WL; Guo, S; Cheng, HK; Wu, JL; Liu, C				Yu, Wei; Zha, Wenliang; Guo, Shuang; Cheng, Hongke; Wu, Jiliang; Liu, Chao			Flos Puerariae Extract Prevents Myocardial Apoptosis via Attenuation Oxidative Stress in Streptozotocin-Induced Diabetic Mice	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; CARDIAC DYSFUNCTION; HIGH GLUCOSE; IN-VITRO; CARDIOMYOPATHY; RATS; PATHWAY; KINASE; ACTIVATION; DAMAGE	Background: Diabetic cardiomyopathy (DCM) suggests a direct cellular insult to myocardium. Apoptosis is considered as one of the hallmarks of DCM. Oxidative stress plays a key role in the pathogenesis of DCM. In this study, we explored the prevention of myocardial apoptosis by crude extract from Flos Puerariae (FPE) in experimental diabetic mice. Methods: Experimental diabetic model was induced by intraperitoneally injection of streptozotocin (STZ, 50 mg/kg/day) for five consecutive days in C57BL/6J mice. FPE (100, 200 mg/kg) was orally administrated once a day for ten weeks. Cardiac structure changes, apoptosis, superoxide production, NADPH oxidase subunits expression (gp91(phox), p47(phox), and p67(phox)), and related regulatory factors were assessed in the heart of mice. Results: Diabetic mice were characterized by high blood glucose (>= 11.1 mmol/L) and reduced body weight. In the end of the experiment, aberrant myofilament structure, as well as TUNEL positive cardiac cells coupled with increased Bax/Bcl-2 ratio and Caspase-3 expression was found in diabetic mice. Moreover, ROS formation, the ratio of NADP(+)/NADPH and NADPH oxidase subunits expression of gp91(phox) and p47(phox), lipid peroxidation level was significantly increased, while antioxidant enzyme SOD and GSH-Px activity were reduced in the myocardial tissue of diabetic mice. In contrast, treatment with FPE resulted in a normalized glucose and weight profile. FPE administration also preserved myocardial structure and reduced apoptotic cardiac cell death in diabetic mice. The elevated markers of oxidative stress were significantly reversed by FPE supplementation. Further, FPE treatment markedly inhibited the increased Bax/Bcl-2 ratio and Caspase-3 expression, as well as suppressed JNK and P38 MAPK activation in the heart of diabetic mice. Conclusions: Our data demonstrate for the first time that FPE may have therapeutic potential for STZ-induced diabetic cardiomyopathy through preventing myocardial apoptosis via attenuation oxidative stress. And this effect is probably mediated by JNK and P38 MAPK signaling pathway.	[Yu, Wei; Zha, Wenliang; Guo, Shuang; Cheng, Hongke; Wu, Jiliang; Liu, Chao] Hubei Univ Sci & Technol, Hubei Prov Key Lab Cardiovasc Cerebrovasc & Metab, Xianning, Peoples R China	Hubei University of Science & Technology	Wu, JL (corresponding author), Hubei Univ Sci & Technol, Hubei Prov Key Lab Cardiovasc Cerebrovasc & Metab, Xianning, Peoples R China.	xywjl@163.com; xn_liuchao@163.com			National Natural Science Foundation of China [31101026]; Hubei Universities of outstanding young scientific and technological innovation team plans [T201213]; Hubei Province Natural Science Fund Project of outstanding youth project [2012FFA005]; Young talent project of Hubei Province Education Office [Q20122804]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Universities of outstanding young scientific and technological innovation team plans; Hubei Province Natural Science Fund Project of outstanding youth project; Young talent project of Hubei Province Education Office	This work was supported by grants from the National Natural Science Foundation of China to Dr. Chao Liu (No. 31101026), Hubei Universities of outstanding young scientific and technological innovation team plans to Dr. Chao Liu (No. T201213), Hubei Province Natural Science Fund Project of outstanding youth project to Dr. Chao Liu (No. 2012FFA005), Young talent project of Hubei Province Education Office to Dr. Wei Yu (No. Q20122804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Berry C, 2008, HEART, V94, P296, DOI 10.1136/hrt.2006.110999; Bloomgarden ZT, 2008, DIABETES CARE, V31, P1913, DOI 10.2337/dc08-zb09; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Cai Fei, 2014, African Journal of Pharmacy and Pharmacology, V8, P1; Cai L, 2006, J AM COLL CARDIOL, V48, P1688, DOI 10.1016/j.jacc.2006.07.022; Cai Lu, 2003, Cardiovasc Toxicol, V3, P219, DOI 10.1385/CT:3:3:219; Chang Sheng-Huang, 2011, Evid Based Complement Alternat Med, V2011, P950150, DOI 10.1093/ecam/neq075; Chavali V, 2013, DIABET METAB SYND OB, V6, P151, DOI 10.2147/DMSO.S30968; Engel D, 2004, AM J PHYSIOL-HEART C, V287, pH1303, DOI 10.1152/ajpheart.00053.2004; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Fiordaliso F, 2004, J MOL CELL CARDIOL, V37, P959, DOI 10.1016/j.yjmcc.2004.07.008; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Han T, 2012, FOOD CHEM TOXICOL, V50, P409, DOI 10.1016/j.fct.2011.10.066; He K, 2011, J ETHNOPHARMACOL, V137, P1135, DOI 10.1016/j.jep.2011.07.033; Ho FM, 2000, CIRCULATION, V101, P2618, DOI 10.1161/01.CIR.101.22.2618; Jie BZ, 2012, MOL CELL BIOCHEM, V370, P35, DOI 10.1007/s11010-012-1395-7; Kuo WW, 2013, INT J CARDIOL, V168, P270, DOI 10.1016/j.ijcard.2012.09.080; Lakshmanan AP, 2012, BIOCHEM PHARMACOL, V83, P653, DOI 10.1016/j.bcp.2011.11.018; Lee KT, 2000, ARCH PHARM RES, V23, P461, DOI 10.1007/BF02976573; Lee MK, 2001, AM J CHINESE MED, V29, P343, DOI 10.1142/S0192415X01000368; Li CJ, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-73; Li D, 2013, MOL VIS, V19, P1999; Li ZH, 2007, J CLIN BIOCHEM NUTR, V41, P58, DOI 10.3164/jcbn.2007008; Litwin SE, 2013, DIABETES, V62, P3329, DOI 10.2337/db13-0683; Maisch B, 2011, HERZ, V36, P102, DOI 10.1007/s00059-011-3429-4; Miki T, 2013, HEART FAIL REV, V18, P149, DOI 10.1007/s10741-012-9313-3; Nakagami H, 2001, DIABETES, V50, P1472, DOI 10.2337/diabetes.50.6.1472; Rajamani U, 2010, AM J PHYSIOL-CELL PH, V299, pC139, DOI 10.1152/ajpcell.00020.2010; Rajesh M, 2012, DIABETES, V61, P716, DOI 10.2337/db11-0477; Reinking BE, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-43; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Soetikno V, 2012, EUR J PHARM SCI, V47, P604, DOI 10.1016/j.ejps.2012.04.018; Thallas-Bonke V, 2008, DIABETES, V57, P460, DOI 10.2337/db07-1119; Thandavarayan RA, 2009, AM J PHYSIOL-HEART C, V297, pH911, DOI 10.1152/ajpheart.00124.2009; Tsai KH, 2012, J CELL PHYSIOL, V227, P1347, DOI 10.1002/jcp.22847; Wang JL, 2011, MOL MED, V17, P172, DOI 10.2119/molmed.2010.00114; Yong R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073428; Yu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052013	39	28	36	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98044	10.1371/journal.pone.0098044	http://dx.doi.org/10.1371/journal.pone.0098044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865768	Green Published, gold, Green Submitted			2022-12-25	WOS:000336914100031
J	Veiga-da-Cunha, M; Chevalier, N; Stroobant, V; Vertommen, D; Van Schaftingen, E				Veiga-da-Cunha, Maria; Chevalier, Nathalie; Stroobant, Vincent; Vertommen, Didier; Van Schaftingen, Emile			Metabolite Proofreading in Carnosine and Homocarnosine Synthesis MOLECULAR IDENTIFICATION OF PM20D2 AS beta-ALANYL-LYSINE DIPEPTIDASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-2-HYDROXYGLUTARIC ACIDURIA; MOLECULAR-IDENTIFICATION; SERUM CARNOSINASE; BRAIN; PURIFICATION; REPAIR; GENE; ENZYME; DEHYDROGENASE; MUTATIONS	Carnosine synthase is the ATP-dependent ligase responsible for carnosine (beta-alanyl-histidine) and homocarnosine (gamma-aminobutyryl- histidine) synthesis in skeletal muscle and brain, respectively. This enzyme uses, also at substantial rates, lysine, ornithine, and arginine instead of histidine, yet the resulting dipeptides are virtually absent from muscle or brain, suggesting that they are removed by a "metaboliterepair" enzyme. Usingaradiolabeledsubstrate, we found that rat skeletal muscle, heart, and brain contained a cytosolic beta-alanyl-lysine dipeptidase activity. This enzyme, which has the characteristics of a metalloenzyme, was purified approximate to 200-fold from rat skeletal muscle. Mass spectrometry analysis of the fractions obtained at different purification stages indicated parallel enrichment of PM20D2, a peptidase of unknown function belonging to the metallopeptidase 20 family. Western blotting showed coelution of PM20D2 with beta-alanyl-lysine dipeptidase activity. Recombinant mouse PM20D2 hydrolyzed beta-alanyl-lysine, beta-alanyl-ornithine, gamma-aminobutyryl-lysine, and gamma-aminobutyryl-ornithine as its best substrates. It also actedat lower rateson beta-alanyl-arginine and gamma-aminobutyryl-arginine but virtually not on carnosine or homocarnosine. Although acting preferentially on basic dipeptides derived from beta-alanine or gamma-aminobutyrate,PM20D2 also acted at lower rates on some "classic dipeptides" like alpha-alanyl-lysine and alpha-lysyl-lysine. The same activity profile was observed with human PM20D2, yet this enzyme was similar to 100-200-fold less active on all substrates tested than the mouse enzyme. Cotransfection in HEK293T cells of mouse or human PM20D2 together with carnosine synthase prevented the accumulation of abnormal dipeptides (beta-alanyl-lysine, beta-alanyl-ornithine, gamma-aminobutyryl-lysine), thus favoring the synthesis of carnosine and homocarnosine and confirming the metabolite repair role of PM20D2.	[Veiga-da-Cunha, Maria; Chevalier, Nathalie; Van Schaftingen, Emile] Catholic Univ Louvain, de Duve Inst, Welbio, B-1200 Brussels, Belgium; [Veiga-da-Cunha, Maria; Chevalier, Nathalie; Van Schaftingen, Emile] Catholic Univ Louvain, de Duve Inst, Physiol Chem Lab, B-1200 Brussels, Belgium; [Stroobant, Vincent] Catholic Univ Louvain, de Duve Inst, Ludwig Inst Canc Res, B-1200 Brussels, Belgium; [Vertommen, Didier] Catholic Univ Louvain, de Duve Inst, Prot Phosphorylat Unit, B-1200 Brussels, Belgium	Universite Catholique Louvain; WELBIO; Universite Catholique Louvain; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain	Veiga-da-Cunha, M (corresponding author), Catholic Univ Louvain, de Duve Inst, BCHM 7539,Ave Hippocrate 75, B-1200 Brussels, Belgium.	maria.veiga@uclouvain.be	Van+Schaftingen, Emile/AAF-5532-2020	Van Schaftingen, Emile/0000-0002-6199-7647; Vertommen, Didier/0000-0001-7648-8282	Fonds National de la Recherche Scientifique (FNRS); Interuniversity Attraction Poles Programme, Belgian Science Policy [Networks P7/43]	Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles Programme, Belgian Science Policy(Belgian Federal Science Policy Office)	This work was supported by grants from the Fonds National de la Recherche Scientifique (FNRS) and the Interuniversity Attraction Poles Programme, Belgian Science Policy (Networks P7/43).	Arts IS, 2013, MBIO, V4, DOI 10.1128/mBio.00912-13; Bauer K, 2005, NEUROCHEM RES, V30, P1339, DOI 10.1007/s11064-005-8806-z; Bitto E, 2009, PROTEINS, V74, P61, DOI 10.1002/prot.22124; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Botelho TO, 2011, J BIOL CHEM, V286, P25697, DOI 10.1074/jbc.M111.247437; Drozak J, 2010, J BIOL CHEM, V285, P9346, DOI 10.1074/jbc.M109.095505; Gjessing L R, 1990, J Neural Transm Suppl, V29, P91; Green JM, 2010, J BACTERIOL, V192, P2407, DOI 10.1128/JB.01362-09; Haliloglu G, 2008, NEUROPEDIATRICS, V39, P119, DOI 10.1055/s-2008-1081217; HORINISHI H, 1978, J NEUROCHEM, V31, P909, DOI 10.1111/j.1471-4159.1978.tb00127.x; JACKSON MC, 1991, CLIN CHIM ACTA, V196, P193, DOI 10.1016/0009-8981(91)90073-L; KALYANKAR GD, 1959, J BIOL CHEM, V234, P3210; Kaur H, 2009, J BIOL CHEM, V284, P14493, DOI 10.1074/jbc.M808952200; KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3175, DOI 10.1073/pnas.85.9.3175; Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5; KUMON A, 1970, BIOCHIM BIOPHYS ACTA, V200, P466, DOI 10.1016/0005-2795(70)90103-0; KUNZE N, 1986, EUR J BIOCHEM, V160, P605, DOI 10.1111/j.1432-1033.1986.tb10081.x; LENNEY JF, 1983, CLIN CHIM ACTA, V132, P157, DOI 10.1016/0009-8981(83)90243-7; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/NCHEMBIO.1141, 10.1038/nchembio.1141]; Linster CL, 2011, J BIOL CHEM, V286, P42992, DOI 10.1074/jbc.M111.281527; Marbaix AY, 2011, J BIOL CHEM, V286, P41246, DOI 10.1074/jbc.C111.310847; MATSUOKA M, 1969, BIOCHIM BIOPHYS ACTA, V177, P169, DOI 10.1016/0304-4165(69)90083-X; NAKAJIMA T, 1969, J NEUROCHEM, V16, P417, DOI 10.1111/j.1471-4159.1969.tb10382.x; Rzem R, 2007, J INHERIT METAB DIS, V30, P681, DOI 10.1007/s10545-007-0487-0; Rzem R, 2006, BIOCHIMIE, V88, P113, DOI 10.1016/j.biochi.2005.06.005; Rzem R, 2004, P NATL ACAD SCI USA, V101, P16849, DOI 10.1073/pnas.0404840101; Sass JO, 2006, AM J HUM GENET, V78, P401, DOI 10.1086/500563; Stellingwerff T, 2012, AMINO ACIDS, V42, P2461, DOI 10.1007/s00726-011-1054-4; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; Van Schaftingen E, 2013, J INHERIT METAB DIS, V36, P427, DOI 10.1007/s10545-012-9571-1; Veiga-da-Cunha M, 2012, J BIOL CHEM, V287, P7246, DOI 10.1074/jbc.M111.323485; Veiga-da-Cunha M, 2010, J BIOL CHEM, V285, P18888, DOI 10.1074/jbc.M110.110924	33	26	28	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19726	19736		10.1074/jbc.M114.576579	http://dx.doi.org/10.1074/jbc.M114.576579			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24891507	Green Published, hybrid			2022-12-25	WOS:000339326800044
J	Andrade, AL; Ternes, YM; Vieira, MA; Moreira, WG; Lamaro-Cardoso, J; Kipnis, A; Cardoso, MR; Brandileone, MC; Moura, I; Pimenta, FC; Carvalho, MD; Saraiva, FO; Toscano, CM; Minamisava, R				Andrade, Ana Lucia; Ternes, Yves Mauro; Vieira, Maria Aparecida; Moreira, Weslley Garcia; Lamaro-Cardoso, Juliana; Kipnis, Andre; Cardoso, Maria Regina; Brandileone, Maria Cristina; Moura, Iaci; Pimenta, Fabiana C.; Carvalho, Maria da Gloria; Saraiva, Fabricia Oliveira; Toscano, Cristiana Maria; Minamisava, Ruth			Direct Effect of 10-Valent Conjugate Pneumococcal Vaccination on Pneumococcal Carriage in Children Brazil	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; DOSING SCHEDULES; IMPACT; COLONIZATION; DISEASE; EFFICACY; VACCINES; PROGRAM	Background: 10-valent conjugate pneumococcal vaccine/PCV10 was introduced in the Brazilian National Immunization Program along the year of 2010. We assessed the direct effectiveness of PCV10 vaccination in preventing nasopharyngeal/NP pneumococcal carriage in infants. Methods: A cross-sectional population-based household survey was conducted in Goiania Brazil, from December/2010-February/2011 targeting children aged 7-11 m and 15-18 m. Participants were selected using a systematic sampling. NP swabs, demographic data, and vaccination status were collected from 1,287 children during home visits. Main outcome and exposure of interest were PCV10 vaccine-type carriage and dosing schedules (3p+0, 2p+0, and one catch-up dose), respectively. Pneumococcal carriage was defined by a positive culture and serotyping was performed by Quellung reaction. Rate ratio/RR was calculated as the ratio between the prevalence of vaccine-types carriage in children exposed to different schedules and unvaccinated for PCV10. Adjusted RR was estimated using Poisson regression. PCV10 effectiveness/VE on vaccine-type carriage was calculated as 1-RR*100. Results: The prevalence of pneumococcal carriage was 41.0% (95% CI: 38.4-43.7). Serotypes covered by PCV10 and PCV13 were 35.2% and 53.0%, respectively. Vaccine serotypes 6B (11.6%), 23F (7.8%), 14 (6.8%), and 19F (6.6%) were the most frequently observed. After adjusted for confounders, children who had received 2p+0 or 3p+0 dosing schedule presented a significant reduction in pneumococcal vaccine-type carriage, with PCV10 VE equal to 35.9% (95% CI: 4.2-57.1; p = 0.030) and 44.0% (95% CI: 14.-63.5; p = 0.008), respectively, when compared with unvaccinated children. For children who received one catch-up dose, no significant VE was detected (p = 0.905). Conclusion: PCV10 was associated with high protection against vaccine-type carriage with 2p+0 and 3p+0 doses for children vaccinated before the second semester of life. The continuous evaluation of carriage serotypes distribution is likely to be useful for evaluating the long-term effectiveness and impact of pneumococcal vaccination on serotypes reduction.	[Andrade, Ana Lucia; Ternes, Yves Mauro; Moreira, Weslley Garcia; Saraiva, Fabricia Oliveira; Toscano, Cristiana Maria] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil; [Ternes, Yves Mauro] Secretariat Hlth Municipal Goiania, Epidemiol Branch, Goiania, Go, Brazil; [Vieira, Maria Aparecida] Pontifical Catholic Univ Goias, Goiania, Go, Brazil; [Moreira, Weslley Garcia; Lamaro-Cardoso, Juliana; Kipnis, Andre] Univ Fed Goias, Bacteriol Lab, Goiania, Go, Brazil; [Cardoso, Maria Regina] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil; [Brandileone, Maria Cristina] Adolfo Lutz Inst, Sao Paulo, Brazil; [Moura, Iaci; Pimenta, Fabiana C.; Carvalho, Maria da Gloria] Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA USA; [Minamisava, Ruth] Univ Fed Goias, Fac Nursing, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade de Sao Paulo; Instituto Adolfo Lutz; Centers for Disease Control & Prevention - USA; Universidade Federal de Goias	Andrade, AL (corresponding author), Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.	alssandrade@gmail.com	Kipnis, Andre/M-7485-2017; Kipnis, Andre/ABG-5707-2020; Andrade, Ana Lucia/L-5751-2013	Kipnis, Andre/0000-0001-5950-106X; Kipnis, Andre/0000-0001-5950-106X; Cardoso, Maria Regina/0000-0001-6092-9215; Oliveira, Fabricia da Silva/0000-0001-9419-5280; TOSCANO, CRISTIANA/0000-0002-9453-2643; Minamisava, Ruth/0000-0001-9352-5567	National Council for Scientific and Technological Development (CNPq); National Institute of Science and Technology for Health (IATS) [573826/2008-0, 306096/2010-2]; Research Foundation of the Goias State/ FAPEG-GO, Brazil [PRONEX/07-2009]; Foundation for Research Support/ FUNAPE-GO, Federal University of Goias [34131]; Fogarty International Center Global Infectious Diseases Research Training Program; National Institutes of Health [D43TW006592]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute of Science and Technology for Health (IATS); Research Foundation of the Goias State/ FAPEG-GO, Brazil; Foundation for Research Support/ FUNAPE-GO, Federal University of Goias; Fogarty International Center Global Infectious Diseases Research Training Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding provided by National Council for Scientific and Technological Development (CNPq) and National Institute of Science and Technology for Health (IATS) (#573826/2008-0; 306096/2010-2); Research Foundation of the Goias State/ FAPEG-GO, Brazil (Grant: PRONEX/07-2009); Foundation for Research Support/ FUNAPE-GO, Federal University of Goias (#34131). This work was supported in part by a Fogarty International Center Global Infectious Diseases Research Training Program grant, National Institutes of Health, to the University of Pittsburgh (D43TW006592). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso ET, 2013, EMERG INFECT DIS, V19, P589, DOI 10.3201/eid1904.121198; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P129; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P258; Auranen K, 2013, BIOMETRICS, V69, P235, DOI 10.1111/j.1541-0420.2012.01826.x; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Brazil Ministry of Health, 2010, PROP INTR VAC PNEUM, P14; Brazil Ministry of Health, 2014, SIST INF PROGR NAC I; BROOME CV, 1980, NEW ENGL J MED, V303, P549, DOI 10.1056/NEJM198009043031003; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Cohen R, 2012, PEDIATR INFECT DIS J, V31, P297, DOI 10.1097/INF.0b013e318247ef84; Cooper D, 2011, VACCINE, V29, P7207, DOI 10.1016/j.vaccine.2011.06.056; Fernandez J, 2000, J INFECT DIS, V182, P1553, DOI 10.1086/315870; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Fleming-Dutra KE, 2014, PEDIATR INFECT DIS J, V33, pS152, DOI 10.1097/INF.0000000000000083; Franco CM, 2010, PEDIATR INFECT DIS J, V29, P77, DOI 10.1097/INF.0b013e3181af7e90; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Grivea IN, 2008, PEDIATR INFECT DIS J, V27, P519, DOI 10.1097/INF.0b013e318168d28a; Halloran ME., 2010, DESIGN ANAL VACCINE; Hanquet G, 2013, VACCINE, V31, P5634, DOI 10.1016/j.vaccine.2013.07.006; Huang SS, 2009, PEDIATRICS, V124, pE1, DOI 10.1542/peds.2008-3099; Jansen AGSC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001480.pub3; Kellner JD, 2008, PEDIATR INFECT DIS J, V27, P526, DOI 10.1097/INF.0b013e3181658c5c; Kuo CY, 2011, VACCINE, V29, P5171, DOI 10.1016/j.vaccine.2011.05.034; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; Miernyk K, 2011, J CLIN MICROBIOL, V49, P3209, DOI 10.1128/JCM.00610-11; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Park IH, 2012, MBIO, V3, DOI 10.1128/mBio.00035-12; Parra EL, 2013, VACCINE, V31, P4033, DOI 10.1016/j.vaccine.2013.04.074; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Prymula R, 2011, VACCINE, V29, P1959, DOI 10.1016/j.vaccine.2010.12.086; Roca A, 2012, CLIN INFECT DIS, V55, P816, DOI 10.1093/cid/cis554; Roca A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001107; Scott JR, 2012, J INFECT DIS, V205, P280, DOI 10.1093/infdis/jir730; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Spijkerman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039730; Spijkerman J, 2011, EMERG INFECT DIS, V17, P584, DOI 10.3201/eid1704.101115; Tocheva AS, 2011, VACCINE, V29, P4400, DOI 10.1016/j.vaccine.2011.04.004; van den Bergh MR, 2013, CLIN INFECT DIS, V56, pE30, DOI 10.1093/cid/cis922; Vestrheim DF, 2010, CLIN VACCINE IMMUNOL, V17, P325, DOI 10.1128/CVI.00435-09; Whitney CG, 2006, LANCET, V368, P1495, DOI 10.1016/S0140-6736(06)69637-2; Whitney CG, 2014, PEDIATR INFECT DIS J, V33, pS172, DOI 10.1097/INF.0000000000000076; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	46	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98128	10.1371/journal.pone.0098128	http://dx.doi.org/10.1371/journal.pone.0098128			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892409	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400036
J	Jansson, KH; Castillo, DG; Morris, JW; Boggs, ME; Czymmek, KJ; Adams, EL; Schramm, LP; Sikes, RA				Jansson, Keith H.; Castillo, Deborah G.; Morris, Joseph W.; Boggs, Mary E.; Czymmek, Kirk J.; Adams, Elizabeth L.; Schramm, Lawrence P.; Sikes, Robert A.			Identification of Beta-2 as a Key Cell Adhesion Molecule in PCa Cell Neurotropic Behavior: A Novel Ex Vivo and Biophysical Approach	PLOS ONE			English	Article							GATED SODIUM-CHANNELS; RADICAL PROSTATECTOMY SPECIMENS; DORSAL-ROOT GANGLIA; PERINEURAL INVASION; CANCER CELLS; EXTRACELLULAR-MATRIX; RHOC GTPASE; LNCAP MODEL; IN-VITRO; SUBUNITS	Prostate cancer (PCa) is believed to metastasize through the blood/lymphatics systems; however, PCa may utilize the extensive innervation of the prostate for glandular egress. The interaction of PCa and its nerve fibers is observed in 80% of PCa and is termed perineural invasion (PNI). PCa cells have been observed traveling through the endoneurium of nerves, although the underlying mechanisms have not been elucidated. Voltage sensitive sodium channels (VSSC) are multimeric transmembrane protein complexes comprised of a pore-forming a subunit and one or two auxiliary beta (beta) subunits with inherent cell adhesion molecule (CAM) functions. The beta-2 isoform (gene SCN2B) interacts with several neural CAMs, while interacting putatively with other prominent neural CAMs. Furthermore, beta-2 exhibits elevated mRNA and protein levels in highly metastatic and castrate-resistant PCa. When overexpressed in weakly aggressive LNCaP cells (2BECFP), beta-2 alters LNCaP cell morphology and enhances LNCaP cell metastasis associated behavior in vitro. We hypothesize that PCa cells use beta-2 as a CAM during PNI and subsequent PCa metastasis. The objective of this study was to determine the effect of beta-2 expression on PCa cell neurotropic metastasis associated behavior. We overexpressed beta-2 as a fusion protein with enhanced cyan fluorescence protein (ECFP) in weakly aggressive LNCaP cells and observed neurotropic effects utilizing our novel ex vivo organotypic spinal cord co-culture model, and performed functional assays with neural matrices and atomic force microscopy. With increased beta-2 expression, PCa cells display a trend of enhanced association with nerve axons. On laminin, a neural CAM, overexpression of beta-2 enhances PCa cell migration, invasion, and growth. 2BECFP cells exhibit marked binding affinity to laminin relative to LNECFP controls, and recombinant beta-2 ectodomain elicits more binding events to laminin than BSA control. Functional overexpression of VSSC beta subunits in PCa may mediate PCa metastatic behavior through association with neural matrices.	[Jansson, Keith H.; Morris, Joseph W.; Sikes, Robert A.] Univ Delaware, Dept Biol Sci, Lab Canc Ontogeny & Therapeut, Newark, DE 19716 USA; [Jansson, Keith H.; Morris, Joseph W.; Boggs, Mary E.; Czymmek, Kirk J.; Sikes, Robert A.] Univ Delaware, Ctr Translat Canc Res, Newark, DE USA; [Castillo, Deborah G.; Schramm, Lawrence P.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Czymmek, Kirk J.; Adams, Elizabeth L.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE USA	University of Delaware; University of Delaware; Johns Hopkins University; University of Delaware	Sikes, RA (corresponding author), Univ Delaware, Dept Biol Sci, Lab Canc Ontogeny & Therapeut, Newark, DE 19716 USA.	rasikes@udel.edu		Czymmek, Kirk/0000-0002-5471-7395	University of Delaware Center for Translational Cancer Research; University of Delaware Graduate Fellows Award; INBRE core waiver; COBRE NIH [P20 RR015588]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446] Funding Source: NIH RePORTER	University of Delaware Center for Translational Cancer Research; University of Delaware Graduate Fellows Award; INBRE core waiver; COBRE NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding of this research was made possible through support by the University of Delaware Center for Translational Cancer Research, The University of Delaware Graduate Fellows Award, INBRE core waiver, and COBRE NIH P20 RR015588. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aman TK, 2009, J NEUROSCI, V29, P2027, DOI 10.1523/JNEUROSCI.4531-08.2009; Ayala GE, 2006, CANCER RES, V66, P5159, DOI 10.1158/0008-5472.CAN-05-1847; Ayala GE, 2006, PROSTATE, V66, P266, DOI 10.1002/pros.20323; Ayala GE, 2004, CANCER RES, V64, P6082, DOI 10.1158/0008-5472.CAN-04-0838; Ayala GE, 2001, PROSTATE, V49, P213, DOI 10.1002/pros.1137; Ayala GE, 2008, CLIN CANCER RES, V14, P7593, DOI 10.1158/1078-0432.CCR-08-1164; Bastatas L, 2012, BBA-GEN SUBJECTS, V1820, P1111, DOI 10.1016/j.bbagen.2012.02.006; Batson O V, 1995, Clin Orthop Relat Res, P4; Batson O V, 1967, Prog Clin Cancer, V3, P1; Brackenbury WJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00053; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Carlin Bruce I., 2000, Cancer, V88, P2989, DOI 10.1002/1097-0142(20000615)88:12+<2989::AID-CNCR14>3.3.CO;2-H; Castillo DG, 2011, CHARACTERIZATION AXO; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; Chen CL, 2012, J BIOL CHEM, V287, P39061, DOI 10.1074/jbc.M112.397646; Diss JKJ, 2008, PROSTATE CANCER P D, V11, P325, DOI 10.1038/sj.pcan.4501012; Djamgoz MBA, 2013, RECENT PAT ANTI-CANC, V8, P66; Edlund M, 2001, CELL GROWTH DIFFER, V12, P99; ELDRIDGE CF, 1987, J CELL BIOL, V105, P1023, DOI 10.1083/jcb.105.2.1023; ELDRIDGE CF, 1989, J NEUROSCI, V9, P625; Epstein J I, 1998, Semin Urol Oncol, V16, P124; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fiske JL, 2006, CANCER METAST REV, V25, P493, DOI 10.1007/s10555-006-9017-z; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Grieco TM, 2005, NEURON, V45, P233, DOI 10.1016/j.neuron.2004.12.035; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hebert-Blouin MN, 2011, CLIN ANAT, V24, P101, DOI 10.1002/ca.21079; Hebert-Blouin MN, 2010, ACTA NEUROCHIR, V152, P1567, DOI 10.1007/s00701-010-0682-x; Hellerstedt BA, 2002, CA-CANCER J CLIN, V52, P154, DOI 10.3322/canjclin.52.3.154; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Isom LL, 1996, NATURE, V383, P307, DOI 10.1038/383307b0; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Jansson KH, 2012, PROSTATE, V72, P1080, DOI 10.1002/pros.21512; Jeon HG, 2009, INT J UROL, V16, P682, DOI 10.1111/j.1442-2042.2009.02331.x; Jin H, 2012, APPL MICROBIOL BIOT, V93, P1715, DOI 10.1007/s00253-011-3865-3; Kamiya N, 2012, INT J UROL, V19, P968, DOI 10.1111/j.1442-2042.2012.03098.x; Kazarinova-Noyes K, 2001, J NEUROSCI, V21, P7517, DOI 10.1523/JNEUROSCI.21-19-07517.2001; Koeneman KS, 1999, PROSTATE, V39, P246; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Ladha SS, 2006, MUSCLE NERVE, V34, P659, DOI 10.1002/mus.20597; Lee IH, 2007, INT J RADIAT ONCOL, V68, P1059, DOI 10.1016/j.ijrobp.2007.01.039; Lee JT, 2010, KOREAN J UROL, V51, P745, DOI 10.4111/kju.2010.51.11.745; Lekka M, 2012, MICRON, V43, P1259, DOI 10.1016/j.micron.2012.01.019; Lekka M, 2012, ARCH BIOCHEM BIOPHYS, V518, P151, DOI 10.1016/j.abb.2011.12.013; Li QS, 2008, BIOCHEM BIOPH RES CO, V374, P609, DOI 10.1016/j.bbrc.2008.07.078; Liebig C, 2009, J CLIN ONCOL, V27, P5131, DOI 10.1200/JCO.2009.22.4949; Liebig C, 2009, CANCER-AM CANCER SOC, V115, P3379, DOI 10.1002/cncr.24396; Lin M, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-21; Loberg RD, 2005, J CELL BIOCHEM, V96, P439, DOI 10.1002/jcb.20522; Ma J, 2008, J GASTROEN HEPATOL, V23, P1852, DOI 10.1111/j.1440-1746.2008.05579.x; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Malhotra JD, 2002, J BIOL CHEM, V277, P26681, DOI 10.1074/jbc.M202354200; Marchesi F, 2010, CYTOKINE GROWTH F R, V21, P77, DOI 10.1016/j.cytogfr.2009.11.001; Masieri L, 2010, UROL INT, V85, P396, DOI 10.1159/000315491; McEwen DP, 2004, J BIOL CHEM, V279, P16044, DOI 10.1074/jbc.M400856200; McVary KT, 1998, PROSTATE, P2; MCVARY KT, 1994, BIOL REPROD, V51, P99, DOI 10.1095/biolreprod51.1.99; Meadows L, 2001, J NEUROCHEM, V76, P1871, DOI 10.1046/j.1471-4159.2001.00192.x; Mundy GR, 2000, CANC SKELETON; NAGLE RB, 1994, J CELL BIOCHEM, P232; Ng JC, 2004, J UROLOGY, V172, P2249, DOI 10.1097/01.ju.0000143973.22897.f8; OBREMSKI VJ, 1995, DEV BIOL, V168, P124, DOI 10.1006/dbio.1995.1066; Ozcan F, 2001, EUR UROL, V40, P308, DOI 10.1159/000049791; Panizza B, 2013, CURR ONCOL REP, V15, P128, DOI 10.1007/s11912-012-0288-y; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; PLATIKA D, 1985, P NATL ACAD SCI USA, V82, P3499, DOI 10.1073/pnas.82.10.3499; Powell MS, 2005, PROSTATE, V65, P52, DOI 10.1002/pros.20245; Sequeira L, 2008, CLIN EXP METASTAS, V25, P569, DOI 10.1007/s10585-008-9173-3; Shariat SF, 2004, J UROLOGY, V171, P1122, DOI 10.1097/01.ju.0000113249.82533.28; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Srinivasan J, 1998, P NATL ACAD SCI USA, V95, P15753, DOI 10.1073/pnas.95.26.15753; Sroka IC, 2010, J CELL PHYSIOL, V224, P283, DOI 10.1002/jcp.22149; THALMANN GN, 1994, CANCER RES, V54, P2577; Thalmann GN, 2000, PROSTATE, V44, P91; van Golen KL, 2000, CANCER RES, V60, P5832; Velazquez EF, 2008, AM J SURG PATHOL, V32, P974, DOI 10.1097/PAS.0b013e3181641365; VILLERS A, 1989, J UROLOGY, V142, P763, DOI 10.1016/S0022-5347(17)38881-X; Walsh PC, 2002, P WALSHS GUIDE SURVI, Vxvi; Xiao ZC, 1999, J BIOL CHEM, V274, P26511, DOI 10.1074/jbc.274.37.26511; Yu FH, 2003, J NEUROSCI, V23, P7577; Yu HHM, 2007, UROLOGY, V70, P111, DOI 10.1016/j.urology.2007.03.020	85	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98408	10.1371/journal.pone.0098408	http://dx.doi.org/10.1371/journal.pone.0098408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892658	gold, Green Published, Green Submitted			2022-12-25	WOS:000336911400048
J	Beiser, KU; Glaser, A; Kleinschmidt, K; Scholl, I; Roth, R; Li, L; Gretz, N; Mechtersheimer, G; Karperien, M; Marchini, A; Richter, W; Rappold, GA				Beiser, Katja U.; Glaser, Anne; Kleinschmidt, Kerstin; Scholl, Isabell; Roeth, Ralph; Li, Li; Gretz, Norbert; Mechtersheimer, Gunhild; Karperien, Marcel; Marchini, Antonio; Richter, Wiltrud; Rappold, Gudrun A.			Identification of Novel SHOX Target Genes in the Developing Limb Using a Transgenic Mouse Model	PLOS ONE			English	Article							IDIOPATHIC SHORT STATURE; HOMEOBOX GENE; LERI-WEILL; CHONDROCYTE PROLIFERATION; TURNER-SYNDROME; EXPRESSION; PHENOTYPES; MUTATIONS; FAMILY; DYSCHONDROSTEOSIS	Deficiency of the human short stature homeobox-containing gene (SHOX) has been identified in several disorders characterized by reduced height and skeletal anomalies such as Turner syndrome, Leri-Weill dyschondrosteosis and Langer mesomelic dysplasia as well as isolated short stature. SHOX acts as a transcription factor during limb development and is expressed in chondrocytes of the growth plates. Although highly conserved in vertebrates, rodents lack a SHOX orthologue. This offers the unique opportunity to analyze the effects of human SHOX expression in transgenic mice. We have generated a mouse expressing the human SHOXa cDNA under the control of a murine Col2a1 promoter and enhancer (Tg(Col2a1-SHOX)). SHOX and marker gene expression as well as skeletal phenotypes were characterized in two transgenic lines. No significant skeletal anomalies were found in transgenic compared to wildtype mice. Quantitative and in situ hybridization analyses revealed that Tg(Col2a1-SHOX), however, affected extracellular matrix gene expression during early limb development, suggesting a role for SHOX in growth plate assembly and extracellular matrix composition during long bone development. For instance, we could show that the connective tissue growth factor gene Ctgf, a gene involved in chondrogenic and angiogenic differentiation, is transcriptionally regulated by SHOX in transgenic mice. This finding was confirmed in human NHDF and U2OS cells and chicken micromass culture, demonstrating the value of the SHOX-transgenic mouse for the characterization of SHOX-dependent genes and pathways in early limb development.	[Beiser, Katja U.; Glaser, Anne; Scholl, Isabell; Roeth, Ralph; Marchini, Antonio; Rappold, Gudrun A.] Univ Heidelberg Hosp, Dept Human Mol Genet, Heidelberg, Germany; [Kleinschmidt, Kerstin; Richter, Wiltrud] Orthopaed Univ Hosp, Div Expt Orthopaed, Heidelberg, Germany; [Li, Li; Gretz, Norbert] Heidelberg Univ, Med Fac Mannheim, Med Res Ctr ZMF, Mannheim, Germany; [Mechtersheimer, Gunhild] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Karperien, Marcel] Univ Twente, Dept Dev Bioengn, NL-7500 AE Enschede, Netherlands; [Marchini, Antonio] German Canc Res Ctr, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Twente; Helmholtz Association; German Cancer Research Center (DKFZ)	Rappold, GA (corresponding author), Univ Heidelberg Hosp, Dept Human Mol Genet, Heidelberg, Germany.	gudrun.rappold@med.uni-heidelberg.de	Marchini, Antonio/AAG-7151-2019; Marchini, Antonio/ABD-3328-2020; Richter, Wiltrud/V-3217-2017; Karperien, Marcel/R-3270-2018	Richter, Wiltrud/0000-0003-4694-2768; Karperien, Marcel/0000-0003-0751-0604; Marchini, Antonio/0000-0003-3157-4552	Deutsche Forschungsgemeinschaft [RA 380/13-2]; Baden-Wurttemberg Foundation [1.1601.07]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Baden-Wurttemberg Foundation	This work was supported by the Deutsche Forschungsgemeinschaft (grant number RA 380/13-2; URL: www.dfg.de) and the Baden-Wurttemberg Foundation (grant number 1.1601.07; URL: www.bwstiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aza-Carmona M, 2011, HUM MOL GENET, V20, P1547, DOI 10.1093/hmg/ddr032; Belin V, 1998, NAT GENET, V19, P67, DOI 10.1038/ng0198-67; Benito-Sanz S, 2012, EUR J HUM GENET, V20, P125, DOI 10.1038/ejhg.2011.210; Blaschke RJ, 1998, P NATL ACAD SCI USA, V95, P2406, DOI 10.1073/pnas.95.5.2406; Blum WF, 2007, J CLIN ENDOCR METAB, V92, P219, DOI 10.1210/jc.2006-1409; CHEAH KSE, 1991, DEVELOPMENT, V111, P945; Chen J, 2009, J MED GENET, V46, P834, DOI 10.1136/jmg.2009.067785; Cicha I, 2009, BIOFACTORS, V35, P200, DOI 10.1002/biof.30; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; Cobb J, 2006, P NATL ACAD SCI USA, V103, P4511, DOI 10.1073/pnas.0510544103; Decker E, 2011, HUM MOL GENET, V20, P1524, DOI 10.1093/hmg/ddr030; Dhar A., 2010, Experimental Oncology, V32, P2; Durand C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018115; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Jorge AAL, 2007, CLIN ENDOCRINOL, V66, P130, DOI 10.1111/j.1365-2265.2006.02698.x; Kanaka-Gantenbein Christina, 2004, Horm Res, V61, P205, DOI 10.1159/000076532; Leask Andrew, 2002, Curr Rheumatol Rep, V4, P136, DOI 10.1007/s11926-002-0009-x; Liu HB, 2011, J BIOL CHEM, V286, P17029, DOI 10.1074/jbc.M111.234252; Long FX, 2001, DEVELOPMENT, V128, P541; Marchini A, 2004, J BIOL CHEM, V279, P37103, DOI 10.1074/jbc.M307006200; Marchini A, 2007, HUM MOL GENET, V16, P3081, DOI 10.1093/hmg/ddm266; Minina E, 2001, DEVELOPMENT, V128, P4523; Munns C F, 2001, Hand Surg, V6, P13, DOI 10.1142/S0218810401000424; Munns CJF, 2004, J CLIN ENDOCR METAB, V89, P4130, DOI 10.1210/jc.2003-032230; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; Rao E, 2001, HUM MOL GENET, V10, P3083, DOI 10.1093/hmg/10.26.3083; Rappold GA, 2002, UNDERSTANDING SHOX D; Rappold G, 2007, J MED GENET, V44, P306, DOI 10.1136/jmg.2006.046581; Rosilio M, 2012, J CLIN ENDOCR METAB, V97, pE1257, DOI 10.1210/jc.2011-3460; Ross JL, 2001, J CLIN ENDOCR METAB, V86, P5674, DOI 10.1210/jc.86.12.5674; Sabherwal N, 2004, J CELL SCI, V117, P3041, DOI 10.1242/jcs.01152; Schneider KU, 2005, HUM MUTAT, V26, P44, DOI 10.1002/humu.20187; Schneider KU, 2005, AM J HUM GENET, V77, P89, DOI 10.1086/431655; Shears DJ, 2002, AM J MED GENET, V110, P153, DOI 10.1002/ajmg.10421; Shears DJ, 1998, NAT GENET, V19, P70, DOI 10.1038/ng0198-70; Soucek O, 2011, CLIN ENDOCRINOL, V74, P445, DOI 10.1111/j.1365-2265.2010.03955.x; Stahl PD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.289pe59; Tiecke E, 2006, DEV BIOL, V298, P585, DOI 10.1016/j.ydbio.2006.07.008; Tomita N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059226; Vickerman L, 2011, DEV BIOL, V350, P323, DOI 10.1016/j.ydbio.2010.11.031; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; Yu L, 2007, DEV BIOL, V306, P549, DOI 10.1016/j.ydbio.2007.03.518	44	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98543	10.1371/journal.pone.0098543	http://dx.doi.org/10.1371/journal.pone.0098543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887312	Green Submitted, Green Published, gold			2022-12-25	WOS:000336956300079
J	Saucedo-Garcia, A; Anaya, AL; Espinosa-Garcia, FJ; Gonzalez, MC				Saucedo-Garcia, Aurora; Luisa Anaya, Ana; Espinosa-Garcia, Francisco J.; Gonzalez, Maria C.			Diversity and Communities of Foliar Endophytic Fungi from Different Agroecosystems of Coffea arabica L. in Two Regions of Veracruz, Mexico	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; BIODIVERSITY CONSERVATION; VEGETATION STRUCTURE; SPECIES-DIVERSITY; LEAVES; FOREST; PATHOGEN; PATTERNS; RICHNESS; SYSTEMS	Over the past 20 years, the biodiversity associated with shaded coffee plantations and the role of diverse agroforestry types in biodiversity conservation and environmental services have been topics of debate. Endophytic fungi, which are microorganisms that inhabit plant tissues in an asymptomatic manner, form a part of the biodiversity associated with coffee plants. Studies on the endophytic fungi communities of cultivable host plants have shown variability among farming regions; however, the variability in fungal endophytic communities of coffee plants among different coffee agroforestry systems is still poorly understood. As such, we analyzed the diversity and communities of foliar endophytic fungi inhabiting Coffea arabica plants growing in the rustic plantations and simple polycultures of two regions in the center of Veracruz, Mexico. The endophytic fungi isolates were identified by their morphological traits, and the majority of identified species correspond to species of fungi previously reported as endophytes of coffee leaves. We analyzed and compared the colonization rates, diversity, and communities of endophytes found in the different agroforestry systems and in the different regions. Although the endophytic diversity was not fully recovered, we found differences in the abundance and diversity of endophytes among the coffee regions and differences in richness between the two different agroforestry systems of each region. No consistent pattern of community similarity was found between the coffee agroforestry systems, but we found that rustic plantations shared the highest number of morphospecies. The results suggest that endophyte abundance, richness, diversity, and communities may be influenced predominantly by coffee region, and to a lesser extent, by the agroforestry system. Our results contribute to the knowledge of the relationships between agroforestry systems and biodiversity conservation and provide information regarding some endophytic fungi and their communities as potential management tools against coffee plant pests and pathogens.	[Saucedo-Garcia, Aurora] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Saucedo-Garcia, Aurora; Luisa Anaya, Ana] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Func, Mexico City 04510, DF, Mexico; [Espinosa-Garcia, Francisco J.] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Lab Ecol Quim, Morelia, Michoacan, Mexico; [Gonzalez, Maria C.] Univ Nacl Autonoma Mexico, Dept Bot, Inst Biol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Anaya, AL (corresponding author), Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Func, Mexico City 04510, DF, Mexico.	analanaya@ecologia.unam.mx	Espinosa-García, F. J./B-4040-2016	Espinosa-García, F. J./0000-0001-9173-1957	PAPIIT-DGAPA (UNAM) Project [IN209611]	PAPIIT-DGAPA (UNAM) Project	The present research received the financial support from PAPIIT-DGAPA (UNAM) Project IN209611 given to ALA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Angelini P, 2012, FUNGAL ECOL, V5, P683, DOI 10.1016/j.funeco.2012.03.001; Arita HT, 2008, AM NAT, V172, P519, DOI 10.1086/590954; Arita HT, 2012, GLOBAL ECOL BIOGEOGR, V21, P282, DOI 10.1111/j.1466-8238.2011.00662.x; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Arnold AE, 2003, MYCOLOGIA, V95, P388, DOI 10.2307/3761880; Avalos-Sartorio B, 2010, AGROFOREST SYST, V78, P169, DOI 10.1007/s10457-009-9248-4; Carrion G, 2006, NATURALEZA INTERACCI; Colwell RK., 2013, STAT ESTIMATION SPEC; Davis EC, 2003, AM J BOT, V90, P1661, DOI 10.3732/ajb.90.11.1661; Douanla-Meli C, 2013, FUNGAL ECOL, V6, P212, DOI 10.1016/j.funeco.2013.01.004; Ek-Ramos MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066049; ESPINOSAGARCIA FJ, 1990, NEW PHYTOL, V116, P89, DOI 10.1111/j.1469-8137.1990.tb00513.x; FISHER PJ, 1994, NEW PHYTOL, V127, P133, DOI 10.1111/j.1469-8137.1994.tb04267.x; Frohlich J, 2000, MYCOL RES, V104, P1202, DOI 10.1017/S095375620000263X; Gallina S., 2008, AGROECOSISTEMAS CAFE, P161; Gamboa MA, 2001, BIOTROPICA, V33, P352, DOI 10.1111/j.1744-7429.2001.tb00187.x; Gamboa Miguel A., 2002, Mycopathologia, V156, P41, DOI 10.1023/A:1021362217723; Gange AC, 2007, J ECOL, V95, P614, DOI 10.1111/j.1365-2745.2007.01245.x; Gazis R, 2010, FUNGAL ECOL, V3, P240, DOI 10.1016/j.funeco.2009.12.001; Gordon C, 2007, AGR ECOSYST ENVIRON, V118, P256, DOI 10.1016/j.agee.2006.05.023; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hata K, 2008, MYCOSCIENCE, V49, P229, DOI 10.1007/s10267-008-0411-y; Heredia Abarca G, 2008, AGROECOSISTEMAS CAFE, V14, P193; Hernandez-Martinez G., 2008, AGROECOSISTEMAS CAFE, P15; Hernandez-Martinez G, 2009, AGR ECOSYST ENVIRON, V134, P89, DOI 10.1016/j.agee.2009.05.020; Herre EA, 2007, ECOLOGY, V88, P550, DOI 10.1890/05-1606; Higgins KL, 2011, MYCOLOGIA, V103, P247, DOI 10.3852/09-158; Hoffman MT, 2008, MYCOL RES, V112, P331, DOI 10.1016/j.mycres.2007.10.014; Jiang H, 2011, ANN MICROBIOL, V61, P655, DOI 10.1007/s13213-010-0186-1; Johnston PR, 2012, FUNGAL BIOL-UK, V116, P401, DOI 10.1016/j.funbio.2011.12.010; Joshee S, 2009, MYCOL RES, V113, P1003, DOI 10.1016/j.mycres.2009.06.004; Junker C, 2012, FUNGAL ECOL, V5, P657, DOI 10.1016/j.funeco.2012.05.002; Lacap DC, 2003, FUNGAL DIVERS, V12, P53; Lashermes P, 1999, MOL GEN GENET, V261, P259, DOI 10.1007/s004380050965; Lodge DJ, 1996, MYCOLOGIA, V88, P733, DOI 10.2307/3760967; Lopez-Gomez AA, 2008, AGR ECOSYST ENVIRON, V124, P160, DOI 10.1016/j.agee.2007.09.008; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Manson R., 2008, AGROECOSISTEMAS CAFE; Arias RM, 2012, AGROFOREST SYST, V85, P179, DOI 10.1007/s10457-011-9414-3; Matsumura E, 2013, FUNGAL BIOL-UK, V117, P191, DOI 10.1016/j.funbio.2013.01.007; Moguel P, 1999, CONSERV BIOL, V13, P11, DOI 10.1046/j.1523-1739.1999.97153.x; Muller MM, 1998, MYCOL RES, V102, P1183, DOI 10.1017/S0953756298006285; Osono T, 2002, MYCOLOGIA, V94, P421, DOI 10.2307/3761776; Osono T, 2013, MYCOSCIENCE, V54, P54, DOI 10.1016/j.myc.2012.08.003; Pan JJ, 2009, MICROB ECOL, V58, P668, DOI 10.1007/s00248-009-9543-7; Pancher M, 2012, APPL ENVIRON MICROB, V78, P4308, DOI 10.1128/AEM.07655-11; Perfecto I, 2005, ECOL ECON, V54, P435, DOI 10.1016/j.ecolecon.2004.10.009; Perfecto I, 2003, BIODIVERS CONSERV, V12, P1239, DOI 10.1023/A:1023039921916; Perfecto I, 2008, ANN NY ACAD SCI, V1134, P173, DOI 10.1196/annals.1439.011; PETRINI L, 1985, Sydowia, V38, P216; PETRINI O, 1982, CAN J BOT, V60, P789, DOI 10.1139/b82-102; PETRINI O, 1991, MICROBIAL ECOLOGY LE, P179, DOI DOI 10.1007/978-1-4612-3168-4_9; Phoulivong S, 2010, FUNGAL DIVERS, V44, P33, DOI 10.1007/s13225-010-0046-0; Posada Francisco, 2006, Mycoscience, V47, P284, DOI 10.1007/s10267-006-0308-6; Prihastuti H, 2009, FUNGAL DIVERS, V39, P89; Qi Fenghui, 2012, PLoS One, V7, pe46785, DOI 10.1371/journal.pone.0046785; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2021, R LANG ENV STAT COMP; Rice RA, 1999, GEOGR REV, V89, P554, DOI 10.2307/216102; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Sanchez-Azofeifa A, 2012, TREES-STRUCT FUNCT, V26, P291, DOI 10.1007/s00468-011-0591-5; Santamaria J, 2005, MICROB ECOL, V50, P1, DOI 10.1007/s00248-004-0002-1; Scholtysik A, 2013, MYCOL PROG, V12, P291, DOI 10.1007/s11557-012-0835-9; Schulte RPO, 2005, J THEOR BIOL, V232, P305, DOI 10.1016/j.jtbi.2004.08.014; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Seghers D, 2004, APPL ENVIRON MICROB, V70, P1475, DOI 10.1128/AEM.70.3.1475-1482.2004; Sette LD, 2006, WORLD J MICROB BIOT, V22, P1185, DOI 10.1007/s11274-006-9160-2; Stone JK, 2000, BOOK SOIL P, P3; Teodoro A, 2008, AGR ECOSYST ENVIRON, V125, P120, DOI 10.1016/j.agee.2007.12.004; Toledo VM, 2012, J SUSTAIN AGR, V36, P353, DOI 10.1080/10440046.2011.583719; Unterseher M, 2007, MYCOL PROG, V6, P201, DOI 10.1007/s11557-007-0541-1; Unterseher M, 2013, FUNGAL DIVERS, V60, P43, DOI 10.1007/s13225-013-0222-0; Unterseher M, 2010, FUNGAL ECOL, V3, P366, DOI 10.1016/j.funeco.2010.03.001; Unterseher M, 2009, MYCOL RES, V113, P645, DOI 10.1016/j.mycres.2009.02.002; Van Hilten HJ, 2011, COFFEE EXPORTERS GUI; Vandermeer J, 2010, BIOSCIENCE, V60, P527, DOI 10.1525/bio.2010.60.7.8; Vega FE, 2008, BIOL CONTROL, V46, P72, DOI 10.1016/j.biocontrol.2008.01.008; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; Fernandes MDV, 2009, BRAZ J PHARM SCI, V45, P677; WALLER J.M, 2007, COFFEE PESTS DIS THE; WALLER JM, 1993, MYCOL RES, V97, P989, DOI 10.1016/S0953-7562(09)80867-8; Wang Y, 2007, CAN J BOT, V85, P911, DOI 10.1139/B07-084; Wu LS, 2013, CURR MICROBIOL, V66, P40, DOI 10.1007/s00284-012-0235-z; Zimmerman NB, 2012, P NATL ACAD SCI USA, V109, P13022, DOI 10.1073/pnas.1209872109	88	40	42	2	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98454	10.1371/journal.pone.0098454	http://dx.doi.org/10.1371/journal.pone.0098454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887512	gold, Green Published, Green Submitted			2022-12-25	WOS:000336956300067
J	Tilley, LD; Krishnamurthy, S; Westwood, NJ; Ward, GE				Tilley, Lucas D.; Krishnamurthy, Shruthi; Westwood, Nicholas J.; Ward, Gary E.			Identification of TgCBAP, a Novel Cytoskeletal Protein that Localizes to Three Distinct Subcompartments of the Toxoplasma gondii Pellicle	PLOS ONE			English	Article							MEMBRANE COMPLEX; COMPONENT; PARASITE; GENE	The cytoskeletons of Toxoplasma gondii and related apicomplexan parasites are highly polarized, with apical and basal regions comprised of distinct protein complexes. Components of these complexes are known to play important roles in parasite shape, cell division, and host cell invasion. During an effort to discover the biologically relevant target of a small-molecule inhibitor of T. gondii invasion (Conoidin A), we discovered a novel cytoskeletal protein that we named TgCBAP (Conserved Basal Apical Peripheral protein). Orthologs of TgCBAP are only found in the genomes of other apicomplexans; they contain no identifiable domains or motifs and their function(s) is unknown. As a first step toward elucidating the function of this highly conserved family of proteins, we disrupted the TgCBAP gene by double homologous recombination. Parasites lacking TgCBAP are as sensitive to the effects of Conoidin A as wild-type parasites, demonstrating that TgCBAP is not the biologically relevant target of Conoidin A. However, Delta TgCBAP parasites are significantly shorter than wild-type parasites and have a growth defect in culture. Furthermore, TgCBAP has an unusual subcellular localization, forming small rings at the apical and basal ends of the parasite and localizing to punctate, ring-like structures around the parasite periphery. These data identify a new marker of the apical and basal subcompartments of T. gondii, reveal a potentially novel compartment along the parasite periphery, and identify TgCBAP as a determinant of parasite size that is required for a maximally efficient lytic cycle.	[Tilley, Lucas D.; Krishnamurthy, Shruthi; Ward, Gary E.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; [Westwood, Nicholas J.] Univ St Andrews, Sch Chem, St Andrews, Fife, Scotland; [Westwood, Nicholas J.] Univ St Andrews, St Andrews, Fife, Scotland; [Westwood, Nicholas J.] EaStCHEM, St Andrews, Fife, Scotland	University of Vermont; University of St Andrews; University of St Andrews; University of St Andrews	Ward, GE (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.	Gary.Ward@uvm.edu		Ward, Gary/0000-0003-4138-3055; Westwood, Nicholas/0000-0003-0630-0138	US Public Health Service grant [AI054961]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI054961, R01AI054961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER	US Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US Public Health Service grant AI054961 (GEW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-White BR, 2011, CELL MICROBIOL, V13, P18, DOI 10.1111/j.1462-5822.2010.01514.x; Barkhuff WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023977; Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; BECKERS CJM, 1994, J CELL BIOL, V127, P947, DOI 10.1083/jcb.127.4.947; Boothroyd John C., 1995, MBL (Marine Biology Laboratory) Lectures in Biology, V12, P211; Carey KL, 2004, P NATL ACAD SCI USA, V101, P7433, DOI 10.1073/pnas.0307769101; Dobrowolski JM, 1997, CELL MOTIL CYTOSKEL, V37, P253, DOI 10.1002/(SICI)1097-0169(1997)37:3&lt;253::AID-CM7&gt;3.0.CO;2-7; Fernandez-Suarez M, 2008, J AM CHEM SOC, V130, P9251, DOI 10.1021/ja801445p; Fox BA, 2009, EUKARYOT CELL, V8, P520, DOI 10.1128/EC.00357-08; Gubbels MJ, 2006, J CELL SCI, V119, P2236, DOI 10.1242/jcs.02949; Gubbels MJ, 2004, MOL BIOCHEM PARASIT, V137, P99, DOI 10.1016/j.molbiopara.2004.05.007; Haraldsen JD, 2009, ORG BIOMOL CHEM, V7, P3040, DOI 10.1039/b901735f; Heaslip AT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000754; Hu K, 2002, J CELL BIOL, V156, P1039, DOI 10.1083/jcb.200112086; Hu K, 2006, PLOS PATHOG, V2, P121, DOI 10.1371/journal.ppat.0020013; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Lorestani A, 2012, CYTOSKELETON, V69, P1069, DOI 10.1002/cm.21077; Lorestani A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012302; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; Meissner M, 2007, CURR OPIN MICROBIOL, V10, P349, DOI 10.1016/j.mib.2007.07.006; MESSINA M, 1995, GENE, V165, P213, DOI 10.1016/0378-1119(95)00548-K; Mital J, 2007, MOL MECH PARASITE IN; Mondragon R, 1996, J EUKARYOT MICROBIOL, V43, P120, DOI 10.1111/j.1550-7408.1996.tb04491.x; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; NICHOLS BA, 1987, J PROTOZOOL, V34, P217, DOI 10.1111/j.1550-7408.1987.tb03162.x; PORCHET E, 1977, Z PARASITENKD, V54, P101, DOI 10.1007/BF00380795; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Soldati D, 1996, FEBS LETT, V389, P80, DOI 10.1016/0014-5793(96)00572-8; Tremp AZ, 2008, J BIOL CHEM, V283, P27604, DOI 10.1074/jbc.M801302200; VIVIER E, 1969, J CELL BIOL, V43, P329, DOI 10.1083/jcb.43.2.312	31	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98492	10.1371/journal.pone.0098492	http://dx.doi.org/10.1371/journal.pone.0098492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887026	Green Published, gold			2022-12-25	WOS:000336956300073
J	Zhou, L; Shi, YH; Guo, R; Liang, MG; Zhu, XY; Wang, CZ				Zhou, Lu; Shi, Yinghua; Guo, Rui; Liang, Minggen; Zhu, Xiaoyan; Wang, Chengzhang			Digital Gene-Expression Profiling Analysis of the Cholesterol-Lowering Effects of Alfalfa Saponin Extract on Laying Hens	PLOS ONE			English	Article							EGG-YOLK CHOLESTEROL; PEA APHID; RNA-SEQ; PERFORMANCE; METABOLISM; RATS; IDENTIFICATION; STEROLS; PATHWAY; CHICKEN	Background: To prevent cardiovascular disease, people are advised to limit their intake of dietary cholesterol to less than 300 mg/day. Egg consumption has been seriously reduced because of the high levels of cholesterol. The purpose of the present study was to evaluate the cholesterol-lowering effects of alfalfa saponin extract (ASE) in yolk and the molecular mechanisms underlying these effects using digital gene-expression profiling analysis. Liver and ovary tissues were isolated from laying hens fed with ASE for RNA sequencing. Results: The cholesterol content of the yolks of eggs from hens fed 120 mg/kg ASE declined considerably on day 60. Other groups (60, 240, 480 mg/kg ASE group) also showed decreases, but they were not significant. Digital gene expression generated over nine million reads per sample, producing expression data for least 12,384 genes. Among these genes, 110 genes showed greater than normal expression in the liver and 107 genes showed greater than normal expression in the ovary. Cholesterol 7 alpha-hydroxylase (Cyp7a1) and apolipoprotein H (Apoh), which act in the synthesis of bile acid and cholesterol efflux, showed more expression in the livers of hens given dietary ASE supplementation. In the ovary, levels of very low density lipoprotein receptor (Vldlr), apolipoprotein B (Apob), apovitellenin 1 (ApovldlII) and vitellogenin (VtgI, VtgII and VtgIII) in ovary decreased with dietary ASE supplementation. Conclusion: Transcriptome analysis revealed that the molecular mechanisms underlying the cholesterol-lowering effects of ASE were partially mediated by enhancement of cholesterol efflux in the liver and this reduced of cholesterol deposition in the ovary.	[Zhou, Lu; Shi, Yinghua; Guo, Rui; Liang, Minggen; Zhu, Xiaoyan; Wang, Chengzhang] Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China	Henan Agricultural University	Wang, CZ (corresponding author), Henan Agr Univ, Coll Anim Sci & Vet Med, Zhengzhou, Peoples R China.	wangcz@henau.edu.cn			China Forage and Grass Research System [CARS-35-20]	China Forage and Grass Research System	This research was supported by China Forage and Grass Research System (CARS-35-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrose S, 2010, BRIT POULTRY SCI, V51, P797, DOI 10.1080/00071668.2010.526924; Afrose S, 2011, J ANIM PHYSIOL AN N, V95, P693, DOI 10.1111/j.1439-0396.2010.01098.x; Anders S., 2010, HTSEQ ANAL HIGH THRO; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Avato P, 2006, PHYTOTHER RES, V20, P454, DOI 10.1002/ptr.1876; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045466; BUJO H, 1994, EMBO J, V13, P5165, DOI 10.1002/j.1460-2075.1994.tb06847.x; Chinetti G, 2001, NAT MED, V7, P53, DOI 10.1038/83348; Chowdhury SR, 2002, POULTRY SCI, V81, P1856, DOI 10.1093/ps/81.12.1856; COULSON CB, 1960, BRIT J NUTR, V14, P121, DOI 10.1079/BJN19600019; De Geyter E, 2012, PEST MANAG SCI, V68, P164, DOI 10.1002/ps.2235; Deng W, 2012, J ANIM PHYSIOL AN N, V96, P85, DOI 10.1111/j.1439-0396.2010.01125.x; Dong XF, 2007, POULTRY SCI, V86, P1955, DOI 10.1093/ps/86.9.1955; Elkin RG, 2006, WORLD POULTRY SCI J, V62, P665, DOI 10.1017/S0043933906001206; Golawska S, 2008, ENTOMOL EXP APPL, V128, P147, DOI 10.1111/j.1570-7458.2008.00709.x; GRIFFIN HD, 1992, WORLD POULTRY SCI J, V48, P101, DOI 10.1079/WPS19920010; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HARGIS PS, 1988, WORLD POULTRY SCI J, V44, P17, DOI 10.1079/WPS19880002; Kaya S, 2003, J VET MED A, V50, P14, DOI 10.1046/j.1439-0442.2003.00487.x; Kim JH, 2004, POULTRY SCI, V83, P1539, DOI 10.1093/ps/83.9.1539; Klita PT, 1996, J ANIM SCI, V74, P1144; KUKSIS A, 1992, BIOCHIM BIOPHYS ACTA, V1124, P205, DOI 10.1016/0005-2760(92)90132-F; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Lin KY, 2001, LIFE SCI, V69, P707, DOI 10.1016/S0024-3205(01)01164-X; LU CD, 1987, J NUTR, V117, P919, DOI 10.1093/jn/117.5.919; MALINOW MR, 1981, J CLIN INVEST, V67, P156, DOI 10.1172/JCI110008; MALINOW MR, 1977, AM J CLIN NUTR, V30, P2061, DOI 10.1093/ajcn/30.12.2061; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; McDerment NA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-494; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NAKAUE HS, 1980, POULTRY SCI, V59, P2744, DOI 10.3382/ps.0592744; OLESZEK W, 1993, J CHEM ECOL, V19, P1063, DOI 10.1007/BF00987369; Pan J, 2007, THESIS HENAN AGR U Z; Pesti GM, 1998, POULTRY SCI, V77, P1540, DOI 10.1093/ps/77.10.1540; Ponte PIP, 2004, POULTRY SCI, V83, P810, DOI 10.1093/ps/83.5.810; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sam LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017305; SIM JS, 1984, CAN J ANIM SCI, V64, P977, DOI 10.4141/cjas84-110; Smith MF, 1999, J REPROD FERTIL, P367; Song YB, 2012, J SCI FOOD AGR, V92, P388, DOI 10.1002/jsfa.4589; Spence JD, 2012, ATHEROSCLEROSIS; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; WASHBURN KW, 1974, POULTRY SCI, V53, P109, DOI 10.3382/ps.0530109; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Wright HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058598; Wu JT, 2011, AFR J PHARM PHARMACO, V5, P2444, DOI 10.5897/AJPP11.185; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Young M. D., 2010, METHOD GENE ONTOLOGY; Yu CH, 2011, J HEALTH SCI, V57, P401, DOI 10.1248/jhs.57.401; Zhang RZ, 1999, J FOOD BIOCHEM, V23, P351, DOI 10.1111/j.1745-4514.1999.tb00025.x	52	15	18	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98578	10.1371/journal.pone.0098578	http://dx.doi.org/10.1371/journal.pone.0098578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886784	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300089
J	Bredart, S; Cornet, A; Rakic, JM				Bredart, Serge; Cornet, Alyssa; Rakic, Jean-Marie			Recognition Memory for Colored and Black-and-White Scenes in Normal and Color Deficient Observers (Dichromats)	PLOS ONE			English	Article							VISUAL MEMORY	Color deficient (dichromat) and normal observers' recognition memory for colored and black-and-white natural scenes was evaluated through several parameters: the rate of recognition, discrimination (A'), response bias (B '' D), response confidence, and the proportion of conscious recollections (Remember responses) among hits. At the encoding phase, 36 images of natural scenes were each presented for 1 sec. Half of the images were shown in color and half in black-and-white. At the recognition phase, these 36 pictures were intermixed with 36 new images. The participants' task was to indicate whether an image had been presented or not at the encoding phase, to rate their level of confidence in his her/his response, and in the case of a positive response, to classify the response as a Remember, a Know or a Guess response. Results indicated that accuracy, response discrimination, response bias and confidence ratings were higher for colored than for black-and-white images; this advantage for colored images was similar in both groups of participants. Rates of Remember responses were not higher for colored images than for black-and-white ones, whatever the group. However, interestingly, Remember responses were significantly more often based on color information for colored than for black-and-white images in normal observers only, not in dichromats.	[Bredart, Serge; Cornet, Alyssa] Univ Liege, Dept Psychol, Liege, Belgium; [Rakic, Jean-Marie] Univ Hosp, Dept Ophthalmol, Liege, Belgium	University of Liege; University of Liege	Bredart, S (corresponding author), Univ Liege, Dept Psychol, Liege, Belgium.	serge.bredart@ulg.ac.be		Bredart, Serge/0000-0002-2250-5603	University of Liege [OTP PSYCEPCO01-01]	University of Liege(University of Liege)	The research was funded by the University of Liege (OTP PSYCEPCO01-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakeman R., 1986, OBSERVING INTERACTIO, DOI [10.1017/cbo9780511527685, DOI 10.1017/CBO9780511527685]; Bonnardel V, 2014, ENCY COLOR SCI TECHN; Bonnardel V, 2006, VISUAL NEUROSCI, V23, P637, DOI 10.1017/S0952523806233558; Bosten JM, 2005, CURR BIOL, V15, pR950, DOI 10.1016/j.cub.2005.11.031; Gardiner JM, 1998, CONSCIOUS COGN, V7, P1, DOI 10.1006/ccog.1997.0321; Gardiner JM, 2000, OXFORD HDB MEMORY PP, P229; Gegenfurtner KR, 1998, VISION RES, V38, P1041, DOI 10.1016/S0042-6989(97)00200-9; Gegenfurtner KR, 2000, CURR BIOL, V10, P805, DOI 10.1016/S0960-9822(00)00563-7; JAMESON D, 1978, SENS PROCESS, V2, P146; Lillo J, 2014, COLOR RES A IN PRESS, DOI [10.1002/col.21802, DOI 10.1002/COL.21802]; Lillo J, 2011, NEW DIRECTIONS IN COLOUR STUDIES, P293; Simunovic MP, 2010, EYE, V24, P747, DOI 10.1038/eye.2009.251; Spence I, 2006, PSYCHOL SCI, V17, P1, DOI 10.1111/j.1467-9280.2005.01656.x; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Wichmann FA, 2002, J EXP PSYCHOL LEARN, V28, P509, DOI 10.1037//0278-7393.28.3.509; Wixted JT, 2010, PSYCHOL REV, V117, P1025, DOI 10.1037/a0020874	16	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98757	10.1371/journal.pone.0098757	http://dx.doi.org/10.1371/journal.pone.0098757			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK0KM	24879303	Green Published, gold, Green Submitted			2022-12-25	WOS:000338101500084
J	Chen, C; Wei, XT; Xiao, HJ; He, HM; Xia, QW; Xue, FS				Chen, Chao; Wei, XiaoTang; Xiao, HaiJun; He, HaiMin; Xia, QinWen; Xue, FangSen			Diapause Induction and Termination in Hyphantria cunea (Drury) (Lepidoptera: Arctiinae)	PLOS ONE			English	Article							FALL WEBWORM; INSECT PHOTOPERIODISM; REPRODUCTIVE DIAPAUSE; GEOGRAPHIC-VARIATION; CLOCK MECHANISM; PUPAL DIAPAUSE; TEMPERATURE; MOTH; INTENSITY; JAPAN	The fall webworm, Hyphantria cunea (Drury), enters facultative diapause as a pupa in response to short-day conditions during autumn. Photoperiodic response curves showed that the critical day length for diapause induction was 14 h 30 min, 14 h 25 min and 13 h 30 min at 22, 25 and 28 degrees C, respectively. The photoperiodic responses under non-24 h light-dark cycles demonstrated that night length played an essential role in the determination of diapause. Experiments using a short day length interrupted by a 1-h light pulse exhibited two troughs of diapause inhibition and the effect of diapause inhibition was greater in the early scotophase than in the late scotophase. The diapause-inducing short day lengths of 8, 10 and 12 h evoked greater intensities of diapause than did 13 and 14 h. Diapause can be terminated without exposure to chilling, but chilling at 5 degrees C for 90 and 120 d significantly accelerated diapause development, reduced mortality, and synchronized adult emergence. Additionally, the potential for H. cunea from the temperate region (Qingdao) to emerge and overwinter under field conditions in subtropical regions (Nanchang) of China was evaluated. Pupae that were transferred to Nanchang in early July showed a 60% survival rate and extremely dispersed pupal period (from 12 to 82 days), suggesting that some pupae may undergo summer diapause. Diapausing temperate region pupae that were moved out-of-doors in Nanchang during October showed approximately 20% overwintering survival; moreover, those pupae that overwintered successfully emerged the next spring during a period when their host plants would be available. The results indicate that this moth has the potential to expand its range into subtropical regions of China.	[Chen, Chao; Xiao, HaiJun; He, HaiMin; Xia, QinWen; Xue, FangSen] Jiangxi Agr Univ, Inst Entomol, Nanchang, Jiangxi, Peoples R China; [Wei, XiaoTang] Qingdao Entry Exit Inspect & Quarantine Bur, Qingdao, Shandong, Peoples R China	Jiangxi Agricultural University	Xue, FS (corresponding author), Jiangxi Agr Univ, Inst Entomol, Nanchang, Jiangxi, Peoples R China.	xue_fangsen@hotmail.com	XIAO, Haijun/AAJ-5321-2021; Xiao, Haijun/HGE-3088-2022	XIAO, Haijun/0000-0002-0832-0493; Xiao, Haijun/0000-0002-0832-0493	National Natural Science Foundation of P. R. China [31260430]; Administration of Quality Supervision, Inspection and Quarantine of the P. R. China China (AQSIQ) Science and Technology Project [2012IK282]	National Natural Science Foundation of P. R. China(National Natural Science Foundation of China (NSFC)); Administration of Quality Supervision, Inspection and Quarantine of the P. R. China China (AQSIQ) Science and Technology Project	The research was supported by grants from National Natural Science Foundation of P. R. China (31260430) and Administration of Quality Supervision, Inspection and Quarantine of the P. R. China China (AQSIQ) Science and Technology Project (2012IK282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKISSON PL, 1964, AM NAT, V98, P357, DOI 10.1086/282332; Beck S.D., 1980, INSECT PHOTOPERIODIS, DOI 10.1016/b978-0-120-84380-0.x5001-7; BECK SD, 1989, J INSECT PHYSIOL, V35, P75, DOI 10.1016/0022-1910(89)90039-5; Broufas GD, 2006, ENVIRON ENTOMOL, V35, P1216, DOI 10.1603/0046-225X(2006)35[1216:EOCEAP]2.0.CO;2; Chen C, 2014, B ENTOMOL RES, V104, P12, DOI 10.1017/S0007485313000266; Damos PT, 2010, PHYSIOL ENTOMOL, V35, P64, DOI 10.1111/j.1365-3032.2009.00715.x; Danks HV, 1987, INSECT DORMANCY ECOL; Gomi T, 1997, OECOLOGIA, V111, P160, DOI 10.1007/s004420050220; Gomi T, 1996, EXPERIENTIA, V52, P273, DOI 10.1007/BF01920722; Gomi T, 1996, FUNCT ECOL, V10, P384, DOI 10.2307/2390287; Gomi T, 2007, ECOL RES, V22, P855, DOI 10.1007/s11284-006-0327-y; Goryshin N. I., 1968, P192; Han R, 2005, J APPL ENTOMOL, V129, P105, DOI 10.1111/j.1439-0418.2005.00941.x; He HM, 2009, J INSECT PHYSIOL, V55, P1003, DOI 10.1016/j.jinsphys.2009.07.004; HODEK I, 1988, ENTOMOL EXP APPL, V49, P153, DOI 10.1007/BF00188248; Hodek I, 2002, EUR J ENTOMOL, V99, P163, DOI 10.14411/eje.2002.024; Ji R, 2003, CHINESE J APPL ENTOM, V10, P13; KIMURA MT, 1990, J INSECT PHYSIOL, V36, P147, DOI 10.1016/0022-1910(90)90115-V; KIMURA MT, 1983, PHYSIOL ENTOMOL, V8, P181, DOI 10.1111/j.1365-3032.1983.tb00347.x; KIMURA Y, 1993, PHYSIOL ENTOMOL, V18, P240, DOI 10.1111/j.1365-3032.1993.tb00594.x; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Li SX, 2009, CHINESE AGR SCI B, V25, P202; Li YP, 2001, J INSECT PHYSIOL, V47, P1181, DOI 10.1016/S0022-1910(01)00099-3; MASAKI S, 1968, Applied Entomology and Zoology, V3, P55; MASAKI S, 1984, CIBA F SYMP, V104, P7; MASAKI S, 1977, ADAPTATION SPECIATIO, P31; Mironidis GK, 2012, B ENTOMOL RES, V102, P139, DOI 10.1017/S0007485311000484; PETERSON DM, 1968, J INSECT PHYSIOL, V14, P519, DOI 10.1016/0022-1910(68)90067-X; Roditakis NE, 2001, PHYSIOL ENTOMOL, V26, P329, DOI 10.1046/j.0307-6962.2001.00253.x; Saunders DS, 2013, J INSECT PHYSIOL, V59, P1, DOI 10.1016/j.jinsphys.2012.11.003; SAUNDERS DS, 1987, EXPERIENTIA, V43, P935, DOI 10.1007/BF01951677; Saunders DS, 2002, INSECT CLOCKS; Takeda M, 2005, ENTOMOL SCI, V8, P211, DOI 10.1111/j.1479-8298.2005.00117.x; TAKEDA M, 1979, ENTOMOL EXP APPL, V25, P317, DOI 10.1007/BF00302794; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Wang XP, 2009, PHYSIOL ENTOMOL, V34, P158, DOI 10.1111/j.1365-3032.2008.00668.x; Wang XP, 2004, J INSECT PHYSIOL, V50, P373, DOI 10.1016/j.jinsphys.2004.01.002; WARREN LO, 1970, ARKANSAS AGR EXPT ST, V759, P1; Wei XT, 2001, J INSECT PHYSIOL, V47, P1367, DOI 10.1016/S0022-1910(01)00125-1; Wei XT, 2006, PLANT QUARANTINE, V20, P14; Xiao HJ, 2010, J INSECT PHYSIOL, V56, P1558, DOI 10.1016/j.jinsphys.2010.05.012; Xiao HJ, 2009, J INSECT PHYSIOL, V55, P488, DOI 10.1016/j.jinsphys.2008.12.012; XUE FS, 1993, J APPL ENTOMOL, V116, P170; Yang ZQ, 2006, BIOCONTROL, V51, P401, DOI 10.1007/s10526-006-9010-z; Zhang S.F., 1985, HYPHANTRIA CUNEA	45	18	21	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98145	10.1371/journal.pone.0098145	http://dx.doi.org/10.1371/journal.pone.0098145			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878546	Green Published, gold, Green Submitted			2022-12-25	WOS:000338101500032
J	Hashimoto, M; Fujii, T; Hamaguchi, M; Furu, M; Ito, H; Terao, C; Yamamoto, K; Yamamoto, W; Matsuo, T; Mori, M; Ohmura, K; Kawabata, H; Mimori, T				Hashimoto, Motomu; Fujii, Takao; Hamaguchi, Masahide; Furu, Moritoshi; Ito, Hiromu; Terao, Chikashi; Yamamoto, Keiichi; Yamamoto, Wataru; Matsuo, Takashi; Mori, Masato; Ohmura, Koichiro; Kawabata, Hiroshi; Mimori, Tsuneyo			Increase of Hemoglobin Levels by Anti-IL-6 Receptor Antibody (Tocilizumab) in Rheumatoid Arthritis	PLOS ONE			English	Article							ANEMIA; HEPCIDIN; INFLAMMATION; DISEASE; INTERLEUKIN-6; GOLIMUMAB; MEDIATOR	Objective: To compare the effect of tocilizumab (TCZ) with other biologic therapies in improving anemia of rheumatoid arthritis (RA) patients. Methods: We compared the change of hemoglobin (Hb) levels in a cohort of 147 consecutive RA patients who were treated with biologics for more than 12 weeks. Twenty eight patients were treated with TCZ, and 119 patients were treated with biologics other than TCZ (87 with TNF inhibitors and 32 with abatacept). The change of Hb levels from baseline to week 12 was compared between the TCZ and the non-TCZ groups. We performed univariate and multivariate analyses with adjustment of potential confounders such as baseline characteristics, concomitant treatment, and the clinical response to treatment. Results: Hb levels generally increased after biologic therapies both in the TCZ and the non-TCZ groups. The increase of Hb levels was greater in the TCZ group than in the non-TCZ groups (1.1 g/dL in the TCZ group vs 0.3 g/dL in the non-TCZ group, p = 0.009). Univariate analysis revealed that increase of Hb levels was also significantly associated with lower Hb, higher Low Hemoglobin Density, and higher CRP levels at baseline and greater reduction in the clinical disease activity index. TCZ therapy was significantly associated with the increase of Hb levels even after adjustment for these factors by multivariate analysis (p < 0.001, effect size 0.08-0.12). Conclusion: TCZ therapy is an independent factor associated with the increase of Hb level after biologic therapies in RA patients. It will help in selecting appropriate biologics for RA patients with anemia.	[Hashimoto, Motomu; Fujii, Takao; Furu, Moritoshi; Ito, Hiromu; Yamamoto, Wataru] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan; [Fujii, Takao; Matsuo, Takashi; Mori, Masato; Ohmura, Koichiro; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Hamaguchi, Masahide] Osaka Univ, Immunol Frontier Res Ctr, Dept Expt Immunol, Osaka, Japan; [Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan; [Terao, Chikashi] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Yamamoto, Keiichi] Natl Cerebral & Cardiovasc Ctr, Dept Informat Governance, Div Clin & Epidemiol Database, Osaka, Japan; [Yamamoto, Wataru] Kurashiki Sweet Hosp, Dept Hlth Informat Management, Kurashiki, Okayama, Japan; [Kawabata, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan	Kyoto University; Kyoto University; Osaka University; Kyoto University; Kyoto University; National Cerebral & Cardiovascular Center - Japan; Kyoto University	Hashimoto, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan.	mohashim@kuhp.kyoto-u.ac.jp	Yamamoto, Keiichi/AFQ-9006-2022	Yamamoto, Keiichi/0000-0003-3278-5001; Hamaguchi, Masahide/0000-0002-8651-4445	Mitsubishi Tanabe Pharma Co.; Bristol-Myers K.K.; Chugai Pharmaceutical Co., Ltd.; AbbVie GK.; Eisai Co., Ltd.; Astellas Pharma Inc.; Pfizer Japan Inc.; Takeda Pharmaceutical Co.; Santen Pharmaceutical Co., Ltd.; Asahi Kasei Pharma Corporation; Daiichi Sankyo Co., Ltd; Bristol-Myers Squibb K.K.; Mitsubishi Tanabe Pharma Corporation; Takeda Pharmaceutical Co., Ltd.	Mitsubishi Tanabe Pharma Co.; Bristol-Myers K.K.; Chugai Pharmaceutical Co., Ltd.; AbbVie GK.; Eisai Co., Ltd.(Eisai Co Ltd); Astellas Pharma Inc.(Astellas Pharmaceuticals); Pfizer Japan Inc.(Pfizer); Takeda Pharmaceutical Co.(Takeda Pharmaceutical Company Ltd); Santen Pharmaceutical Co., Ltd.; Asahi Kasei Pharma Corporation; Daiichi Sankyo Co., Ltd(Daiichi Sankyo Company Limited); Bristol-Myers Squibb K.K.(Bristol-Myers Squibb); Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation); Takeda Pharmaceutical Co., Ltd.(Takeda Pharmaceutical Company Ltd)	The authors have read the journal's policy and have the following conflicts: M. Hashimoto, T.F., M.F., H.I., and T. Mimori are affiliated with a department that is supported financially by five pharmaceutical companies (Mitsubishi Tanabe Pharma Co., Bristol-Myers K.K., Chugai Pharmaceutical Co., Ltd., AbbVie GK., Eisai Co., Ltd.). M.H. and M.F. has received grant and research support from Astellas Pharma Inc. and Pfizer Japan Inc. H.I. has received grant and research support from Astellas Pharma Inc., Pfizer Japan Inc., NTT communications, and Takeda Pharmaceutical Co., Ltd. T.F. has received grant and research support from Takeda Pharmaceutical Co., Santen Pharmaceutical Co., Ltd., Astellas Pharma Inc., Asahi Kasei Pharma Corporation, and Daiichi Sankyo Co., Ltd. T.M. has received grant and research support from Asahi Kasei Pharma Corporation, Astellas Pharma Inc., Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Japan Inc., Santen Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd., and speakers bureau from AbbVie GK., Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Japan Inc., and Takeda Pharmaceutical Co., Ltd. K.O. has received grant and research support from AbbVie GK., Astellas Pharma Inc., Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, and speakers bureau from AbbVie GK., Astellas Pharma, Bristol-Myers Squibb K.K., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Pfizer Japan Inc., and Takeda Pharmaceutical Co., Ltd. The sponsors were not involved in the study design; in the collection, analysis, interpretation of data; in the writing of this manuscript; or in the decision to submit the article for publication. The authors, their immediate families, and any research foundations with which they are affiliated have not received any financial payments or other benefits from any commercial entity related to the subject of this article. The authors declare that although they are affiliated with a department that is supported financially by pharmaceutical companies, the authors received no current funding for this study and this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Demirag MD, 2009, INTERNAL MED, V48, P421, DOI 10.2169/internalmedicine.48.1578; Doyle MK, 2013, RHEUMATOLOGY, V52, P1214, DOI 10.1093/rheumatology/kes381; Doyle MK, 2009, SEMIN ARTHRITIS RHEU, V39, P123, DOI 10.1016/j.semarthrit.2008.08.002; Ferrucci L, 2010, BLOOD, V115, P3810, DOI 10.1182/blood-2009-02-201087; Furst DE, 2013, RHEUMATOLOGY, V52, P1845, DOI 10.1093/rheumatology/ket233; Furu M, 2014, SCAND J RHE IN PRESS; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Han CL, 2007, J RHEUMATOL, V34, P2177; Laftah AH, 2004, BLOOD, V103, P3940, DOI 10.1182/blood-2003-03-0953; Maccio A, 2005, BLOOD, V106, P362, DOI 10.1182/blood-2005-01-0160; Matsuyama M, 2007, INTERNAL MED, V46, P771, DOI 10.2169/internalmedicine.46.6262; Moller B, 2014, ANN RHEUM DIS, V73, P691, DOI 10.1136/annrheumdis-2012-202709; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nikolaisen C, 2008, J RHEUMATOL, V35, P380; Papadaki HA, 2002, BLOOD, V100, P474, DOI 10.1182/blood-2002-01-0136; Raj DSC, 2009, SEMIN ARTHRITIS RHEU, V38, P382, DOI 10.1016/j.semarthrit.2008.01.006; Smolen JS, 2013, ANN RHEUM DIS, V72, P482, DOI 10.1136/annrheumdis-2012-202469; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Song SNJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4323; Song SNJ, 2010, BLOOD, V116, P3627, DOI 10.1182/blood-2010-03-271791; Terao C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059341; Thomas DW, 2013, BRIT J HAEMATOL, V161, P639, DOI 10.1111/bjh.12311; Urrechaga E, 2012, INT J LAB HEMATOL, V34, P47, DOI 10.1111/j.1751-553X.2011.01355.x; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Wolfe F, 2006, J RHEUMATOL, V33, P1516	27	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98202	10.1371/journal.pone.0098202	http://dx.doi.org/10.1371/journal.pone.0098202			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878740	gold, Green Published, Green Submitted			2022-12-25	WOS:000338101500037
J	Manning, EN; Barnes, J; Cash, DM; Bartlett, JW; Leung, KK; Ourselin, S; Fox, NC				Manning, Emily N.; Barnes, Josephine; Cash, David M.; Bartlett, Jonathan W.; Leung, Kelvin K.; Ourselin, Sebastien; Fox, Nick C.		Alzheimers Dis NeuroImaging Initia	APOE epsilon 4 Is Associated with Disproportionate Progressive Hippocampal Atrophy in AD	PLOS ONE			English	Article							APOLIPOPROTEIN-E EPSILON-4; TEMPORAL-LOBE ATROPHY; ALZHEIMERS-DISEASE; BRAIN ATROPHY; VOLUME LOSS; E GENOTYPE; LONGITUDINAL CHANGE; MRI; RATES; MATTER	Objectives: To investigate whether APOE epsilon 4 carriers have higher hippocampal atrophy rates than non-carriers in Alzheimer's disease (AD), mild cognitive impairment (MCI) and controls, and if so, whether higher hippocampal atrophy rates are still observed after adjusting for concurrent whole-brain atrophy rates. Methods: MRI scans from all available visits in ADNI (148 AD, 307 MCI, 167 controls) were used. MCI subjects were divided into "progressors'' (MCI-P) if diagnosed with AD within 36 months or "stable'' (MCI-S) if a diagnosis of MCI was maintained. A joint multi-level mixed-effect linear regression model was used to analyse the effect of epsilon 4 carrier-status on hippocampal and whole-brain atrophy rates, adjusting for age, gender, MMSE and brain-to-intracranial volume ratio. The difference in hippocampal rates between epsilon 4 carriers and non-carriers after adjustment for concurrent whole-brain atrophy rate was then calculated. Results: Mean adjusted hippocampal atrophy rates in epsilon 4 carriers were significantly higher in AD, MCI-P and MCI-S (p <= 0.011, all tests) compared with epsilon 4 non-carriers. After adjustment for whole-brain atrophy rate, the difference in mean adjusted hippocampal atrophy rate between epsilon 4 carriers and non-carriers was reduced but remained statistically significant in AD and MCI-P. Conclusions: These results suggest that the APOE epsilon 4 allele drives atrophy to the medial-temporal lobe region in AD.	[Manning, Emily N.; Barnes, Josephine; Cash, David M.; Leung, Kelvin K.; Ourselin, Sebastien; Fox, Nick C.] UCL Inst Neurol, Dementia Res Ctr, London, England; [Cash, David M.; Leung, Kelvin K.; Ourselin, Sebastien] UCL, Ctr Med Image Comp, London, England; [Bartlett, Jonathan W.] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England	University of London; University College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Manning, EN (corresponding author), UCL Inst Neurol, Dementia Res Ctr, London, England.	e.manning@ucl.ac.uk	Barnes, Josesphine/P-5698-2014; Cash, David/V-3617-2019; Fox, Nick C/B-1319-2009	Cash, David/0000-0001-7833-616X; Fox, Nick C/0000-0002-6660-657X; Manning, Emily Ndakola/0000-0002-4505-3611; Bartlett, Jonathan/0000-0001-7117-0195	Alzheimer's Research UK; Brain Research Trust; Wolfson Foundation; AVID; Bristol-Myers Squibb; Elan Pharmaceuticals; Eisai; Lilly Research Laboratories; GE Healthcare; IXICO; Janssen Alzheimer Immunotherapy; Johnson Johnson; Janssen-Cilig; Lundbeck; Neurochem Inc; Novartis Pharma AG; Pfizer Inc; Sanofi-Aventis and Wyeth Pharmaceuticals; NIHR Biomedical Research Unit (Dementia) at UCL; EPSRC; NIA; EPSRC [EP/H046410/1, EP/J020990/1, EP/K005278]; EU-FP7 project VPH-DARE@IT [FP7-ICT-2011-9-601055]; National Institute for Health Research University College London Hospitals Biomedical Research Centre (High Impact Initiative); IXICO Ltd.; Siemens Molecular Imaging; MIRADA Medical Solution; General Electric Healthcare; National Institute for Health Research Queen Square Dementia Biomedical Research Unit - Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; NIH [P30 AG010129, K01 AG030514]; Alzheimers Research UK [ARUK-SRF2013-5, ARUK-PG2014-25] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H046410/1, EP/J020990/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10134, NF-SI-0508-10123] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P30AG010129, K01AG030514, U01AG024904, U24AG021886] Funding Source: NIH RePORTER	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Brain Research Trust; Wolfson Foundation; AVID; Bristol-Myers Squibb(Bristol-Myers Squibb); Elan Pharmaceuticals; Eisai(Eisai Co Ltd); Lilly Research Laboratories(Eli Lilly); GE Healthcare(General ElectricGE Healthcare); IXICO; Janssen Alzheimer Immunotherapy; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Janssen-Cilig; Lundbeck(Lundbeck Corporation); Neurochem Inc; Novartis Pharma AG; Pfizer Inc(Pfizer); Sanofi-Aventis and Wyeth Pharmaceuticals; NIHR Biomedical Research Unit (Dementia) at UCL; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU-FP7 project VPH-DARE@IT; National Institute for Health Research University College London Hospitals Biomedical Research Centre (High Impact Initiative)(General Electric); IXICO Ltd.; Siemens Molecular Imaging; MIRADA Medical Solution; General Electric Healthcare(General ElectricGE Healthcare); National Institute for Health Research Queen Square Dementia Biomedical Research Unit - Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Dementia Research Centre is supported by Alzheimer's Research UK, Brain Research Trust, and The Wolfson Foundation. Professor Fox's research group has received payment for consultancy or for conducting studies from AVID, Bristol-Myers Squibb, Elan Pharmaceuticals, Eisai, Lilly Research Laboratories, GE Healthcare, IXICO, Janssen Alzheimer Immunotherapy, Johnson & Johnson, Janssen-Cilig, Lundbeck, Neurochem Inc, Novartis Pharma AG, Pfizer Inc, Sanofi-Aventis and Wyeth Pharmaceuticals. NCF has an NIHR Senior Investigator award and receives support from the Wolfson Foundation; NIHR Biomedical Research Unit (Dementia) at UCL; the EPSRC; Alzheimer's Research UK and the NIA. NCF receives no personal compensation for the activities mentioned above. Prof. Ourselin receives funding from the EPSRC (EP/H046410/1, EP/J020990/1, EP/K005278), the EU-FP7 project VPH-DARE@IT (FP7-ICT-2011-9-601055), and the National Institute for Health Research University College London Hospitals Biomedical Research Centre (High Impact Initiative). SO has received personal compensation for activities and research support from IXICO Ltd. Dr. Ourselin also received financial support for his research from Siemens Molecular Imaging, MIRADA Medical Solution, General Electric Healthcare and equipment support from Medtronic Navigation, Inc. Dr. Barnes is supported by an Alzheimer's Research UK senior fellowship and received honoraria for reviewing grants for Fundacao para a Ciencia e a Tecnologia-Portugal in 2011. Dr. Cash is supported by a grant from an anonymous charitable foundation. This research was supported by the National Institute for Health Research Queen Square Dementia Biomedical Research Unit Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N. V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www. fnih. org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, Rev October 16, 2012 San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129 and K01 AG030514. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta F, 2009, P NATL ACAD SCI USA, V106, P2018, DOI 10.1073/pnas.0812697106; Barnes J, 2004, NEUROIMAGE, V23, P574, DOI 10.1016/j.neuroimage.2004.06.028; Chiang GC, 2010, NEUROLOGY, V75, P1976, DOI 10.1212/WNL.0b013e3181ffe4d1; Chiang Gloria C, 2011, Alzheimers Dement, V7, P514, DOI 10.1016/j.jalz.2010.12.010; Cohen RM, 2001, NEUROLOGY, V57, P2223, DOI 10.1212/WNL.57.12.2223; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crivello F, 2010, NEUROIMAGE, V53, P1064, DOI 10.1016/j.neuroimage.2009.12.116; Drzezga A, 2009, NEUROLOGY, V72, P1487, DOI 10.1212/WNL.0b013e3181a2e8d0; Eisenberg DTA, 2010, AM J PHYS ANTHROPOL, V143, P100, DOI 10.1002/ajpa.21298; Geroldi C, 1999, NEUROLOGY, V53, P1825, DOI 10.1212/WNL.53.8.1825; Hashimoto M, 2001, NEUROLOGY, V57, P1461, DOI 10.1212/WNL.57.8.1461; Hashimoto R, 2009, GENES BRAIN BEHAV, V8, P43, DOI 10.1111/j.1601-183X.2008.00440.x; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 1998, NEUROLOGY, V51, P993, DOI 10.1212/WNL.51.4.993; Jak AJ, 2007, DEMENT GERIATR COGN, V23, P382, DOI 10.1159/000101340; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Khan W, 2013, J ALZHEIMERS DIS; LEHTOVIRTA M, 1995, NEUROSCIENCE, V67, P65, DOI 10.1016/0306-4522(95)00014-A; Leung KK, 2012, NEUROIMAGE, V59, P3995, DOI 10.1016/j.neuroimage.2011.10.068; Leung KK, 2011, NEUROIMAGE, V55, P1091, DOI 10.1016/j.neuroimage.2010.12.067; Leung KK, 2010, NEUROIMAGE, V51, P1345, DOI 10.1016/j.neuroimage.2010.03.018; Lo RY, 2011, ARCH NEUROL-CHICAGO, V68, P1257, DOI 10.1001/archneurol.2011.123; Lu PH, 2011, J ALZHEIMERS DIS, V23, P433, DOI 10.3233/JAD-2010-101398; Moffat SD, 2000, NEUROLOGY, V55, P134, DOI 10.1212/WNL.55.1.134; Mori E, 2002, ANN NEUROL, V51, P209, DOI 10.1002/ana.10093; Morra JH, 2009, NEUROIMAGE, V45, pS3, DOI 10.1016/j.neuroimage.2008.10.043; NARAYANA PA, 1988, MAGN RESON IMAGING, V6, P271, DOI 10.1016/0730-725X(88)90401-8; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048895; Pievani M, 2009, NEUROIMAGE, V45, P1090, DOI 10.1016/j.neuroimage.2009.01.009; Risacher SL, 2010, NEUROBIOL AGING, V31, P1401, DOI 10.1016/j.neurobiolaging.2010.04.029; Schuff N, 2009, BRAIN, V132, P1067, DOI 10.1093/brain/awp007; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Spampinato MV, 2011, RADIOLOGY, V258, P843, DOI 10.1148/radiol.10100307; van de Pol LA, 2007, NEUROLOGY, V69, P1491, DOI 10.1212/01.wnl.0000277458.26846.96; van der Flier WM, 2009, NAT REV NEUROL, V5, P361, DOI 10.1038/nrneurol.2009.94; van Es MA, 2009, NAT GENET, V41, P1047, DOI 10.1038/ng1009-1047; Wang PN, 2009, PSYCHIAT RES-NEUROIM, V171, P221, DOI 10.1016/j.pscychresns.2008.05.002; Wolz R, 2010, NEUROIMAGE, V52, P109, DOI 10.1016/j.neuroimage.2010.04.006; Wright RO, 2003, PEDIATR RES, V54, P819, DOI 10.1203/01.PDR.0000090927.53818.DE	39	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97608	10.1371/journal.pone.0097608	http://dx.doi.org/10.1371/journal.pone.0097608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878738	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000338101500018
J	Wu, L; Chen, XP; Cui, ZL; Zhang, WF; Zhang, FS				Wu, Liang; Chen, Xinping; Cui, Zhenling; Zhang, Weifeng; Zhang, Fusuo			Establishing a Regional Nitrogen Management Approach to Mitigate Greenhouse Gas Emission Intensity from Intensive Smallholder Maize Production	PLOS ONE			English	Article							CROP SYSTEM MANAGEMENT; NUTRIENT MANAGEMENT; FERTILIZER; CHINA; AGRICULTURE; YIELD	The overuse of Nitrogen (N) fertilizers on smallholder farms in rapidly developing countries has increased greenhouse gas (GHG) emissions and accelerated global N consumption over the past 20 years. In this study, a regional N management approach was developed based on the cost of the agricultural response to N application rates from 1,726 on-farm experiments to optimize N management across 12 agroecological subregions in the intensive Chinese smallholder maize belt. The grain yield and GHG emission intensity of this regional N management approach was investigated and compared to field-specific N management and farmers' practices. The regional N rate ranged from 150 to 219 kg N ha(-1) for the 12 agroecological subregions. Grain yields and GHG emission intensities were consistent with this regional N management approach compared to field-specific N management, which indicated that this regional N rate was close to the economically optimal N application. This regional N management approach, if widely adopted in China, could reduce N fertilizer use by more than 1.4 MT per year, increase maize production by 31.9 MT annually, and reduce annual GHG emissions by 18.6 MT. This regional N management approach can minimize net N losses and reduce GHG emission intensity from over-and underapplications, and therefore can also be used as a reference point for regional agricultural extension employees where soil and/or plant N monitoring is lacking.	[Wu, Liang; Chen, Xinping; Cui, Zhenling; Zhang, Weifeng; Zhang, Fusuo] China Agr Univ, Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China	China Agricultural University	Cui, ZL (corresponding author), China Agr Univ, Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China.	cuizl@cau.edu.cn	Zhang, Fusuo/AAV-4517-2021		National Basic Research Program of China (973, Program) [2009CB118606]; Special Fund for Agro-scientific Research in the Public Interest [201103003]	National Basic Research Program of China (973, Program)(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest	The work has been funded by the National Basic Research Program of China (973, Program: 2009CB118606) (website: http://www.973.gov.cn/AreaAppl.aspx). National Maize Production System in China (CARS-02-24)(website: http://119.253.58.231/). Special Fund for Agro-scientific Research in the Public Interest (201103003)(website: http://www.hymof.net.cn/webapp/login.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barning R, 2008, THESIS U HOHENHEIM; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; CHEN XP, 2003, THESIS U HOHENHEIM; Conant RT, 2011, FRONT ECOL ENVIRON, V9, P169, DOI 10.1890/090153; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Cui Z. L., 2005, THESIS CHINA AGR U; Cui ZL, 2008, AGRON J, V100, P517, DOI 10.2134/agronj2007.0194; Cui ZL, 2013, GLOBAL CHANGE BIOL, V19, P2467, DOI 10.1111/gcb.12213; Cui ZL, 2010, AMBIO, V39, P376, DOI 10.1007/s13280-010-0076-6; De Klein C., 2006, 2006 IPCC GUIDELINES; Dobermann A, 2003, AGRON J, V95, P924, DOI 10.2134/agronj2003.0924; Etim N. A. A., 2010, Journal of Agriculture and Social Sciences, V6, P24; Forster P., 2007, PHYS SCI BASIS CONTR; Gebbers R, 2010, SCIENCE, V327, P828, DOI 10.1126/science.1183899; Good AG, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001124; Grassini P, 2012, P NATL ACAD SCI USA, V109, P1074, DOI 10.1073/pnas.1116364109; Heffer P., 2009, ASSESSMENT FERTILIZE; Hoben JP, 2011, GLOBAL CHANGE BIOL, V17, P1140, DOI 10.1111/j.1365-2486.2010.02349.x; Hou P, 2012, FIELD CROP RES, V129, P1, DOI 10.1016/j.fcr.2012.01.006; Huang JK, 2008, J SOIL WATER CONSERV, V63, p165A, DOI 10.2489/jswc.63.5.165A; IFA, IFA IFA STAT; Khan SA, 2001, SOIL SCI SOC AM J, V65, P1751, DOI 10.2136/sssaj2001.1751; Lu YY, 2006, CHEMOSPHERE, V65, P1915, DOI 10.1016/j.chemosphere.2006.07.035; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; Meng Q F, 2012, THESIS CHINA AGR U; National Bureau of Statistics of China (Various years), CHIN STAT YB; OECE, ENV IND AGR METH RES; Richards LA., 1954, DIAGNOSIS IMPROVEMEN; Sawyer J, 2006, CONCEPTS RATIONALE R, P15; Smith P., 2007, CONTRIBUTION WORKING; SOPER RJ, 1963, CAN J SOIL SCI, V43, P350, DOI DOI 10.4141/CJSS63-041; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; VAN REEUWIJK L., 1993, PROCEDURES SOIL ANAL, V4th; WALKLEY A, 1947, SOIL SCI, V63, P251, DOI 10.1097/00010694-194704000-00001; Wallach D, 1949, APPL STAT, P641; Wang J., 2004, THESIS CHINA AGR U B; Wehrmann J., 1988, Nitrogen efficiency in agricultural soils. Proceedings Symposium Edinburgh, 16-18 Sept. 1987., P38; Zhang FS, 2012, ADV AGRON, V116, P1, DOI 10.1016/B978-0-12-394277-7.00001-4; Zhang FS, 2011, J ENVIRON QUAL, V40, P1051, DOI 10.2134/jeq2010.0292; Zhang WF, 2013, P NATL ACAD SCI USA, V110, P8375, DOI 10.1073/pnas.1210447110; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	43	41	44	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98481	10.1371/journal.pone.0098481	http://dx.doi.org/10.1371/journal.pone.0098481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875747	Green Published, gold, Green Submitted			2022-12-25	WOS:000336790800044
J	Gao, Y; Hamers, N; Rakhshandehroo, M; Berger, R; Lough, J; Kalkhoven, E				Gao, Yuan; Hamers, Nicole; Rakhshandehroo, Maryam; Berger, Ruud; Lough, John; Kalkhoven, Eric			Allele Compensation in Tip60(+/-) Mice Rescues White Adipose Tissue Function In Vivo	PLOS ONE			English	Article							NUCLEAR RECEPTOR COREPRESSOR; DNA-DAMAGE RESPONSE; ACETYLTRANSFERASE TIP60; ENERGY-BALANCE; GAMMA; ADIPOGENESIS; HOMEOSTASIS; P300; ADIPOCYTES; EXPRESSION	Adipose tissue is a key regulator of energy homestasis. The amount of adipose tissue is largely determined by adipocyte differentiation (adipogenesis), a process that is regulated by the concerted actions of multiple transcription factors and cofactors. Based on in vitro studies in murine 3T3-L1 preadipocytes and human primary preadipocytes, the transcriptional cofactor and acetyltransferase Tip60 was recently identified as an essential adipogenic factor. We therefore investigated the role of Tip60 on adipocyte differentiation and function, and possible consequences on energy homeostasis, in vivo. Because homozygous inactivation results in early embryonic lethality, Tip60(+/-) mice were used. Heterozygous inactivation of Tip60 had no effect on body weight, despite slightly higher food intake by Tip60(+/-) mice. No major effects of heterozygous inactivation of Tip60 were observed on adipose tissue and liver, and Tip60(+/-) displayed normal glucose tolerance, both on a low fat and a high fat diet. While Tip60 mRNA was reduced to 50% in adipose tissue, the protein levels were unaltered, suggesting compensation by the intact allele. These findings indicate that the in vivo role of Tip60 in adipocyte differentiation and function cannot be properly addressed in Tip60(+/-) mice, but requires the generation of adipose tissue-specific knock out animals or specific knock-in mice.	[Gao, Yuan; Hamers, Nicole; Rakhshandehroo, Maryam; Berger, Ruud; Kalkhoven, Eric] Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands; [Gao, Yuan; Hamers, Nicole; Berger, Ruud; Kalkhoven, Eric] Netherlands Metab Ctr, Leiden, Netherlands; [Lough, John] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Lough, John] Med Coll Wisconsin, Cardiovasc Ctr, Milwaukee, WI 53226 USA	Utrecht University; Utrecht University Medical Center; Medical College of Wisconsin; Medical College of Wisconsin	Kalkhoven, E (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Utrecht, Netherlands.	E.Kalkhoven@umcutrecht.nl			research programme of The Netherlands Metabolomics Centre; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)	research programme of The Netherlands Metabolomics Centre; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by the research programme of The Netherlands Metabolomics Centre, which is part of The Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bugge A, 2009, MOL ENDOCRINOL, V23, P794, DOI 10.1210/me.2008-0236; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Fisher JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031569; Gao Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3656; Gehrking KM, 2011, HUM MOL GENET, V20, P2204, DOI 10.1093/hmg/ddr108; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Gronniger E, 2010, CELL BIOL INT, V34, P737, DOI 10.1042/CBI20090299; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hu YF, 2009, DEV DYNAM, V238, P2912, DOI 10.1002/dvdy.22110; Hummasti S, 2006, MOL ENDOCRINOL, V20, P1261, DOI 10.1210/me.2006-0025; Jeninga EH, 2007, MOL ENDOCRINOL, V21, P1049, DOI 10.1210/me.2006-0485; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Koppen A, 2010, FEBS LETT, V584, P3250, DOI 10.1016/j.febslet.2010.06.035; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Roth JF, 2003, EMBO J, V22, P5186, DOI 10.1093/emboj/cdg473; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Schipper HS, 2012, J CLIN INVESTIGATION; Shikama N, 2003, EMBO J, V22, P5175, DOI 10.1093/emboj/cdg502; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; van Beekum O, 2008, ENDOCRINOLOGY, V149, P1840, DOI 10.1210/en.2007-0977; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98343	10.1371/journal.pone.0098343	http://dx.doi.org/10.1371/journal.pone.0098343			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870614	gold, Green Submitted, Green Published			2022-12-25	WOS:000336858300037
J	Sondhi, S; Sharma, P; Saini, S; Puri, N; Gupta, N				Sondhi, Sonica; Sharma, Prince; Saini, Shilpa; Puri, Neena; Gupta, Naveen			Purification and Characterization of an Extracellular, Thermo-Alkali-Stable, Metal Tolerant Laccase from Bacillus tequilensis SN4	PLOS ONE			English	Article							BACTERIAL LACCASE; SUBSTRATE	A novel extracellular thermo-alkali-stable laccase from Bacillus tequilensis SN4 (SN4LAC) was purified to homogeneity. The laccase was a monomeric protein of molecular weight 32 KDa. UV-visible spectrum and peptide mass fingerprinting results showed that SN4LAC is a multicopper oxidase. Laccase was active in broad range of phenolic and non-phenolic substrates. Catalytic efficiency (k(cat)/K-m) showed that 2, 6-dimethoxyphenol was most efficiently oxidized by the enzyme. The enzyme was inhibited by conventional inhibitors of laccase like sodium azide, cysteine, dithiothreitol and beta-mercaptoethanol. SN4LAC was found to be highly thermostable, having temperature optimum at 85 degrees C and could retain more than 80% activity at 70 degrees C for 24 h. The optimum pH of activity for 2, 6-dimethoxyphenol, 2, 2'-azino bis[3-ethylbenzthiazoline-6-sulfonate], syringaldazine and guaiacol was 8.0, 5.5, 6.5 and 8.0 respectively. Enzyme was alkali-stable as it retained more than 75% activity at pH 9.0 for 24 h. Activity of the enzyme was significantly enhanced by Cu2+, Co2+, SDS and CTAB, while it was stable in the presence of halides, most of the other metal ions and surfactants. The extracellular nature and stability of SN4LAC in extreme conditions such as high temperature, pH, heavy metals, halides and detergents makes it a highly suitable candidate for biotechnological and industrial applications.	[Sondhi, Sonica; Sharma, Prince; Saini, Shilpa; Gupta, Naveen] Panjab Univ, Dept Microbiol, Chandigarh 160014, India; [Puri, Neena] Guru Nanak Khalsa Coll, Dept Ind Microbiol, Yamunanagar, Haryana, India	Panjab University	Gupta, N (corresponding author), Panjab Univ, Dept Microbiol, BMS Block, Chandigarh 160014, India.	gupta27_naveen@yahoo.com	Gupta, Naveen/AAR-9410-2020; Sondhi, Sonica/AAC-3809-2021	Sondhi, Sonica/0000-0002-5919-1345				Adamafio N. A., 2012, Asian Journal of Biochemistry, V7, P143; Arias ME, 2003, APPL ENVIRON MICROB, V69, P1953, DOI 10.1128/AEM.69.4.1953-1958.2003; Baldrian P, 2002, FEMS MICROBIOL LETT, V206, P69, DOI 10.1111/j.1574-6968.2002.tb10988.x; Brijwani K., 2010, Enzyme Research, V2010, P149748, DOI 10.4061/2010/149748; Chauhan P.S., 2014, INT J PHARM BIO SCI, V5, P176; Degerli N, 2001, ANAL BIOCHEM, V297, P192, DOI 10.1006/abio.2001.5335; DEGRYSE E, 1978, ARCH MICROBIOL, V117, P189, DOI 10.1007/BF00402307; Deng Y, 2011, J BACTERIOL, V193, P2070, DOI 10.1128/JB.00129-11; Diamantidis G, 2000, SOIL BIOL BIOCHEM, V32, P919, DOI 10.1016/S0038-0717(99)00221-7; Gomes J, 1998, Adv Biochem Eng Biotechnol, V59, P1; Gunne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052360; Johannes C, 2000, J BIOTECHNOL, V78, P193, DOI 10.1016/S0168-1656(00)00208-X; Kaushik G, 2013, APPL BIOCHEM MICRO+, V49, P352, DOI 10.1134/S0003683813040169; Koschorreck K, 2008, APPL MICROBIOL BIOT, V79, P217, DOI 10.1007/s00253-008-1417-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Mohammadian M, 2010, J IND MICROBIOL BIOT, V37, P863, DOI 10.1007/s10295-010-0734-5; Molina-Guijarro JM, 2009, INT MICROBIOL, V12, P13, DOI 10.2436/20.1501.01.77; MOORE BM, 1990, J BIOL CHEM, V265, P4982; Murugesan K, 2009, J HAZARD MATER, V168, P523, DOI 10.1016/j.jhazmat.2009.02.075; Niladevi KN, 2008, BIORESOURCE TECHNOL, V99, P4583, DOI 10.1016/j.biortech.2007.06.056; Reiss R, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-9; Robles A, 2002, ENZYME MICROB TECH, V31, P516, DOI 10.1016/S0141-0229(02)00142-4; Ruijssenaars HJ, 2004, APPL MICROBIOL BIOT, V65, P177, DOI 10.1007/s00253-004-1571-0; Ryan S, 2003, ENZYME MICROB TECH, V33, P766, DOI 10.1016/S0141-0229(03)00162-5; Sharma P, 2007, WORLD J MICROB BIOT, V23, P823, DOI 10.1007/s11274-006-9305-3; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shraddha, 2011, Enzyme Res, V2011, P217861, DOI 10.4061/2011/217861; Sondhi S, 2015, 3 BIOTECH, V5, P175, DOI 10.1007/s13205-014-0207-z; Telke AA, 2011, BIORESOURCE TECHNOL, V102, P1752, DOI 10.1016/j.biortech.2010.08.086; van Wezel GP, 2006, APPL ENVIRON MICROB, V72, P6863, DOI 10.1128/AEM.01853-06; Zhang C, 2013, J AGR FOOD CHEM, V61, P5468, DOI 10.1021/jf4010498	33	107	114	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e96951	10.1371/journal.pone.0096951	http://dx.doi.org/10.1371/journal.pone.0096951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871763	gold, Green Submitted, Green Published			2022-12-25	WOS:000336858300006
J	Sammond, DW; Yarbrough, JM; Mansfield, E; Bomble, YJ; Hobdey, SE; Decker, SR; Taylor, LE; Resch, MG; Bozell, JJ; Himmel, ME; Vinzant, TB; Crowley, MF				Sammond, Deanne W.; Yarbrough, John M.; Mansfield, Elisabeth; Bomble, Yannick J.; Hobdey, Sarah E.; Decker, Stephen R.; Taylor, Larry E.; Resch, Michael G.; Bozell, Joseph J.; Himmel, Michael E.; Vinzant, Todd B.; Crowley, Michael F.			Predicting Enzyme Adsorption to Lignin Films by Calculating Enzyme Surface Hydrophobicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; TRICHODERMA-REESEI; CRYSTAL-STRUCTURE; ACIDOTHERMUS-CELLULOLYTICUS; THERMOMYCES-LANUGINOSUS; CELLOBIOHYDROLASE-I; CATALYTIC CORE; PROTEIN; HYDROLYSIS; CELLULOSE	The inhibitory action of lignin on cellulase cocktails is a major challenge to the biological saccharification of plant cell wall polysaccharides. Although the mechanism remains unclear, hydrophobic interactions between enzymes and lignin are hypothesized to drive adsorption. Here we evaluate the role of hydrophobic interactions in enzyme-lignin binding. The hydrophobicity of the enzyme surface was quantified using an estimation of the clustering of nonpolar atoms, identifying potential interaction sites. The adsorption of enzymes to lignin surfaces, measured using the quartz crystal microbalance, correlates to the hydrophobic cluster scores. Further, these results suggest a minimum hydrophobic cluster size for a protein to preferentially adsorb to lignin. The impact of electrostatic contribution was ruled out by comparing the isoelectric point (pI) values to the adsorption of proteins to lignin surfaces. These results demonstrate the ability to predict enzyme-lignin adsorption and could potentially be used to design improved cellulase cocktails, thus lowering the overall cost of biofuel production.	[Sammond, Deanne W.; Yarbrough, John M.; Bomble, Yannick J.; Hobdey, Sarah E.; Decker, Stephen R.; Taylor, Larry E.; Resch, Michael G.; Himmel, Michael E.; Vinzant, Todd B.; Crowley, Michael F.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80401 USA; [Resch, Michael G.] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO 80401 USA; [Mansfield, Elisabeth] NIST, Appl Chem & Mat Div, Boulder, CO 80305 USA; [Bozell, Joseph J.] Univ Tennessee, Ctr Renewable Carbon, Ctr Catalyt Convers Biomass C3Bio, Knoxville, TN 37917 USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; National Institute of Standards & Technology (NIST) - USA; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Crowley, MF (corresponding author), Natl Renewable Energy Lab, Biosci Ctr, 16253 Denver West Pkwy, Golden, CO 80401 USA.	Michael.Crowley@nrel.gov	Mansfield, Elisabeth/C-5258-2012; Mansfield, Elisabeth/N-8387-2019; crowley, michael/A-4852-2013	Mansfield, Elisabeth/0000-0003-2463-0966; Mansfield, Elisabeth/0000-0003-2463-0966; Decker, Stephen/0000-0001-7002-9034; Bomble, Yannick/0000-0001-7624-8000; crowley, michael/0000-0001-5163-9398; Yarbrough, John/0000-0001-5424-552X	U.S. Department of Energy [DE-AC36-08GO28308]; National Renewable Energy Laboratory; Department of Energy Office of Energy Efficiency and Renewable Energy, Bioenergy Technologies Office; Center for Direct Catalytic Conversion of Biomass to Biofuels (C3Bio), an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0000997]	U.S. Department of Energy(United States Department of Energy (DOE)); National Renewable Energy Laboratory(United States Department of Energy (DOE)); Department of Energy Office of Energy Efficiency and Renewable Energy, Bioenergy Technologies Office(United States Department of Energy (DOE)); Center for Direct Catalytic Conversion of Biomass to Biofuels (C3Bio), an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by the U.S. Department of Energy under Contract DE-AC36-08GO28308 with the National Renewable Energy Laboratory and by the Department of Energy Office of Energy Efficiency and Renewable Energy, Bioenergy Technologies Office. This work was also supported by the Center for Direct Catalytic Conversion of Biomass to Biofuels (C3Bio), an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Award Number DE-SC0000997.	Baker JO, 2005, APPL BIOCHEM BIOTECH, V121, P129, DOI 10.1385/ABAB:121:1-3:0129; Ballesteros I, 1998, APPL BIOCHEM BIOTECH, V70-2, P369, DOI 10.1007/BF02920152; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brethauer S, 2011, BIORESOURCE TECHNOL, V102, P6295, DOI 10.1016/j.biortech.2011.02.016; Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; Bujacz A, 2012, ACTA CRYSTALLOGR D, V68, P1278, DOI 10.1107/S0907444912027047; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; DEMELER B, 2005, ULTRASCAN COMPREHENS, P210; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Dutta AK, 2008, J COLLOID INTERF SCI, V324, P55, DOI 10.1016/j.jcis.2008.04.065; El Hage R, 2010, POLYM DEGRAD STABIL, V95, P997, DOI 10.1016/j.polymdegradstab.2010.03.012; El Hage R, 2009, POLYM DEGRAD STABIL, V94, P1632, DOI 10.1016/j.polymdegradstab.2009.07.007; Erdtman H., 1972, J POLYM SCI B, V10, P228, DOI [10.1002/pol.1972.110100315, DOI 10.1002/POL.1972.110100315]; Eriksson T, 2002, ENZYME MICROB TECH, V31, P353, DOI 10.1016/S0141-0229(02)00134-5; Grabber JH, 2005, CROP SCI, V45, P820, DOI 10.2135/cropsci2004.0191; Gruber K, 1998, BIOCHEMISTRY-US, V37, P13475, DOI 10.1021/bi980864l; Hakulinen N, 2000, J STRUCT BIOL, V132, P180, DOI 10.1006/jsbi.2000.4318; Haven MO, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-165; Jacak R, 2012, PROTEINS, V80, P825, DOI 10.1002/prot.23241; Jeoh T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-10; Kaar WE, 1998, BIOTECHNOL BIOENG, V59, P419, DOI 10.1002/(SICI)1097-0290(19980820)59:4&lt;419::AID-BIT4&gt;3.0.CO;2-J; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; KURAKAKE M, 1994, BIORESOURCE TECHNOL, V49, P247, DOI 10.1016/0960-8524(94)90048-5; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lijnzaad P, 1996, PROTEINS, V25, P389, DOI 10.1002/(SICI)1097-0134(199607)25:3<389::AID-PROT10>3.3.CO;2-S; Lijnzaad P, 1996, PROTEINS, V26, P192; Lou HM, 2013, CHEMSUSCHEM, V6, P919, DOI 10.1002/cssc.201200859; Miyanaga A, 2004, J BIOL CHEM, V279, P44907, DOI 10.1074/jbc.M405390200; Nakagame S, 2011, BIORESOURCE TECHNOL, V102, P4507, DOI 10.1016/j.biortech.2010.12.082; Nakagame S, 2011, BIOTECHNOL BIOENG, V108, P538, DOI 10.1002/bit.22981; Pingali SV, 2011, J BIOL CHEM, V286, P32801, DOI 10.1074/jbc.M111.263004; Qing Q, 2010, BIORESOURCE TECHNOL, V101, P5941, DOI 10.1016/j.biortech.2010.03.003; Rahikainen JL, 2013, BIORESOURCE TECHNOL, V133, P270, DOI 10.1016/j.biortech.2013.01.075; Rahikainen JL, 2013, ENZYME MICROB TECH, V53, P315, DOI 10.1016/j.enzmictec.2013.07.003; Rastogi P A, 2000, Methods Mol Biol, V132, P47; Resch MG, 2013, ENERG ENVIRON SCI, V6, P1858, DOI 10.1039/c3ee00019b; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Sakon J, 1996, BIOCHEMISTRY-US, V35, P10648, DOI 10.1021/bi9604439; Selig MJ, 2008, BIORESOURCE TECHNOL, V99, P4997, DOI 10.1016/j.biortech.2007.09.064; Shrivastava S, 2013, WORLD J MICROB BIOT, V29, P2407, DOI 10.1007/s11274-013-1409-y; SUNDBERG M, 1991, BIOTECHNOL APPL BIOC, V13, P1; Suzuki K, 2013, BIOCHEM J, V452, P211, DOI 10.1042/BJ20130054; TORRONEN A, 1995, BIOCHEMISTRY-US, V34, P847, DOI 10.1021/bi00003a019; Turon X, 2008, LANGMUIR, V24, P3880, DOI 10.1021/la7032753; Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391; Wilkins MR, 1999, METH MOL B, V112, P531; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Yang B, 2006, BIOTECHNOL BIOENG, V94, P611, DOI 10.1002/bit.20750; Zunszain Patricia A, 2003, BMC Struct Biol, V3, P6, DOI 10.1186/1472-6807-3-6	53	91	95	5	96	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20960	20969		10.1074/jbc.M114.573642	http://dx.doi.org/10.1074/jbc.M114.573642			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24876380	Green Published, hybrid			2022-12-25	WOS:000339396600049
J	Bai, XJ; Brenes-Arguedas, T; Ye, J; Wang, XG; Lin, F; Yuan, ZQ; Shi, S; Xing, DL; Hao, ZQ				Bai, Xuejiao; Brenes-Arguedas, Tania; Ye, Ji; Wang, Xugao; Lin, Fei; Yuan, Zuoqiang; Shi, Shuai; Xing, Dingliang; Hao, Zhanqing			Dynamics of Two Multi-Stemmed Understory Shrubs in Two Temperate Forests	PLOS ONE			English	Article							OLD-GROWTH; VEGETATIVE REPRODUCTION; BIOSPHERE RESERVE; LONG-TERM; TREES; OVERSTORY; COMMUNITIES; COMPETITION; DEMOGRAPHY; DIVERSITY	A multi-stemmed growth form may be an important trait enabling the persistence of individual shrubs in the forest understory. With the aim of evaluating the role of multiple stems, neighbor competition and soil nutrients in shrub performance, we study the dynamics of two temperate multi-stemmed shrub species. We modeled stem growth and survival of Corylus mandshurica and Acer barbinerve in two temperate forests with differing structure in northeastern China. One forest was an old growth broad-leaved Korean pine (Pinus koraiensis) mixed forest; the other was a secondary poplar-birch forest. Growth of the two species and survival of C. mandshurica increased with stem number in the old growth forest, but not the secondary forest, suggesting the benefits of a multi-stemmed growth form are facultative. C. mandshurica also suffered more from overstory neighbor competition in the old growth forest, which may suggest that this species is less shade-tolerant than A. barbinerve. Moreover, the performance of the two species were clearly influenced by understory neighbors and soil variables in the old growth forest relative to the secondary forest, which may be due to different forest structure. We conclude that multiple stems are not always important for the persistence of shrub species. Even within the same species, the multi-stemmed benefits might be facultative, differing among forests and neighborhood compositions.	[Bai, Xuejiao] Shenyang Agr Univ, Coll Forestry, Shenyang 110161, Liaoning Provin, Peoples R China; [Bai, Xuejiao; Ye, Ji; Wang, Xugao; Lin, Fei; Yuan, Zuoqiang; Shi, Shuai; Xing, Dingliang; Hao, Zhanqing] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Liaoning Provin, Peoples R China; [Brenes-Arguedas, Tania] Ctr Cient Trop, San Jose, Costa Rica; [Lin, Fei; Shi, Shuai; Xing, Dingliang] Univ Chinese Acad Sci, Beijing, Peoples R China	Shenyang Agricultural University; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hao, ZQ (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang 110016, Liaoning Provin, Peoples R China.	hzq@iae.ac.cn	Wang, Xugao/B-1111-2015; Xing, Dingliang/T-3134-2019	Wang, Xugao/0000-0003-1207-8852; Xing, Dingliang/0000-0001-9133-6674	National Natural Science Foundation of China [31300378, 31300517]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (No. 31300378 and No. 31300517). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anning AK, 2013, FOREST ECOL MANAG, V307, P74, DOI 10.1016/j.foreco.2013.07.008; Armesto JJ, 2007, OLD GROWTH FORESTS F, P367; Baayen RH, 2011, LANGUAGER DATA SETS; Bai Xue-jiao, 2010, Yingyong Shengtai Xuebao, V21, P1899; Bates D. M., 2010, LME4 MIXED EFFECTS M; Beckage B, 2000, CAN J FOREST RES, V30, P1617, DOI 10.1139/cjfr-30-10-1617; Bellingham PJ, 2009, J ECOL, V97, P472, DOI 10.1111/j.1365-2745.2009.01479.x; Chen YongLiang, 1998, Journal of Northeast Forestry University, V26, P7; Clarke PJ, 2005, J ECOL, V93, P544, DOI 10.1111/j.1365-2745.2005.00971.x; Condit R, 1999, PHILOS T R SOC B, V354, P1739, DOI 10.1098/rstb.1999.0517; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; Del Tredici P, 2001, BOT REV, V67, P121, DOI 10.1007/BF02858075; FINEGAN B, 1984, NATURE, V312, P109, DOI 10.1038/312109a0; Fujiki D, 2006, ECOL RES, V21, P380, DOI 10.1007/s11284-006-0169-7; Gracia M, 2007, FOREST ECOL MANAG, V242, P391, DOI 10.1016/j.foreco.2007.01.056; Grothendieck G, 2010, SQLDF PERFORM SQL SE; Guan JY, 1999, B BOT RES, V19, P100; Hao ZhanQing, 1994, Chinese Journal of Applied Ecology, V5, P16; HARCOMBE PA, 1983, OECOLOGIA, V57, P49, DOI 10.1007/BF00379561; Kanno H, 2004, PLANT ECOL, V170, P43, DOI 10.1023/B:VEGE.0000019027.88318.54; Kanno H, 2001, J VEG SCI, V12, P391, DOI 10.2307/3236853; Kobe RK, 1997, OIKOS, V80, P226, DOI 10.2307/3546590; KOOP H, 1987, VEGETATIO, V72, P103; Matsushita M, 2010, BOTANY, V88, P174, DOI 10.1139/B09-108; McKenzie D, 2000, CAN J FOREST RES, V30, P1655, DOI 10.1139/cjfr-30-10-1655; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; Nock CA, 2011, GLOBAL CHANGE BIOL, V17, P1049, DOI 10.1111/j.1365-2486.2010.02222.x; O'Brien MJ, 2007, FOREST ECOL MANAG, V240, P178, DOI 10.1016/j.foreco.2006.12.025; Ribeiro PJ, 2011, GEOR ANAL GEOSTATIST; SHAO GF, 1994, FOREST ECOL MANAG, V70, P169, DOI 10.1016/0378-1127(94)90084-1; Stone R, 2006, SCIENCE, V313, P1379, DOI 10.1126/science.313.5792.1379; Tanentzap AJ, 2012, J ECOL, V100, P171, DOI 10.1111/j.1365-2745.2011.01879.x; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WHITNEY GG, 1984, ECOLOGY, V65, P403, DOI 10.2307/1941403; Wilson Brayton T., 1995, P91, DOI 10.1016/B978-012276460-8/50006-0; Wirth C, 2009, ECOL STUD-ANAL SYNTH, V207, P1, DOI 10.1007/978-3-540-92706-8; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Xu H.C., 2001, NATURAL FORESTS PINU; Yang H., 1985, RES FOR ECOSYST, V5, P1; Yang X, 2003, BIODIVERS CONSERV, V12, P883, DOI 10.1023/A:1022841107685; Yoshida T, 1997, FOREST ECOL MANAG, V95, P35, DOI 10.1016/S0378-1127(97)00007-8; YOUNG SS, 1992, MT RES DEV, V12, P269, DOI 10.2307/3673670; Ziegler SS, 2000, GLOBAL ECOL BIOGEOGR, V9, P373, DOI 10.1046/j.1365-2699.2000.00191.x	43	4	4	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98200	10.1371/journal.pone.0098200	http://dx.doi.org/10.1371/journal.pone.0098200			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887513	Green Submitted, gold, Green Published			2022-12-25	WOS:000336956300046
J	Gracanin, A; Timmermans-Sprang, EPM; van Wolferen, ME; Rao, NAS; Grizelj, J; Vince, S; Hellmen, E; Mol, JA				Gracanin, Ana; Timmermans-Sprang, Elpetra P. M.; van Wolferen, Monique E.; Rao, Nagesha A. S.; Grizelj, Juraj; Vince, Silvijo; Hellmen, Eva; Mol, Jan A.			Ligand-Independent Canonical Wnt Activity in Canine Mammary Tumor Cell Lines Associated with Aberrant LEF1 Expression	PLOS ONE			English	Article							POLYPOSIS-COLI PROTEIN; BETA-CATENIN; BREAST-CANCER; E-CADHERIN; GENE-EXPRESSION; PATHWAY; PROLIFERATION; TRANSCRIPTION; APC; METHYLATION	Pet dogs very frequently develop spontaneous mammary tumors and have been suggested as a good model organism for breast cancer research. In order to obtain an insight into underlying signaling mechanisms during canine mammary tumorigenesis, in this study we assessed the incidence and the mechanism of canonical Wnt activation in a panel of 12 canine mammary tumor cell lines. We show that a subset of canine mammary cell lines exhibit a moderate canonical Wnt activity that is dependent on Wnt ligands, similar to what has been described in human breast cancer cell lines. In addition, three of the tested canine mammary cell lines have a high canonical Wnt activity that is not responsive to inhibitors of Wnt ligand secretion. Tumor cell lines with highly active canonical Wnt signaling often carry mutations in key members of the Wnt signaling cascade. These cell lines, however, carry no mutations in the coding regions of intracellular Wnt pathway components (APC, beta-catenin, GSK3 beta, CK1 alpha and Axin1) and have a functional beta-catenin destruction complex. Interestingly, however, the cell lines with high canonical Wnt activity specifically overexpress LEF1 mRNA and the knock-down of LEF1 significantly inhibits TCF-reporter activity. In addition, LEF1 is overexpressed in a subset of canine mammary carcinomas, implicating LEF1 in ligand-independent activation of canonical Wnt signaling in canine mammary tumors. We conclude that canonical Wnt activation may be a frequent event in canine mammary tumors both through Wnt ligand-dependent and novel ligand-independent mechanisms.	[Gracanin, Ana; Timmermans-Sprang, Elpetra P. M.; van Wolferen, Monique E.; Mol, Jan A.] Univ Utrecht, Dept Clin Sci Compan Anim, Utrecht, Netherlands; [Rao, Nagesha A. S.] Radboud Univ Nijmegen, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands; [Grizelj, Juraj; Vince, Silvijo] Fac Vet Med, Clin Obestr & Reprod, Zagreb, Croatia; [Hellmen, Eva] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden	Utrecht University; Radboud University Nijmegen; University of Zagreb; Swedish University of Agricultural Sciences	Mol, JA (corresponding author), Univ Utrecht, Dept Clin Sci Compan Anim, Utrecht, Netherlands.	j.a.mol@uu.nl		Vince, Silvijo/0000-0002-1883-3225; Grizelj, Juraj/0000-0001-5963-3409	Dutch Society for Scientific Research (NWO) [017.004.081]	Dutch Society for Scientific Research (NWO)	This work was supported by the Mozaiek Grant 017.004.081 (to A.G.) from the Dutch Society for Scientific Research (NWO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai LB, 2006, CARCINOGENESIS, V27, P1341, DOI 10.1093/carcin/bgi379; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Benhaj K, 2006, ONCOL REP, V15, P701; Bjorklund P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004243; Browne SJ, 1998, CELL DEATH DIFFER, V5, P206, DOI 10.1038/sj.cdd.4400331; Carmon KS, 2008, MOL CANCER RES, V6, P1017, DOI 10.1158/1541-7786.MCR-08-0039; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Doleschall M, 2007, DEV COMP IMMUNOL, V31, P945, DOI 10.1016/j.dci.2006.12.007; Easwaran V, 1999, J BIOL CHEM, V274, P16641, DOI 10.1074/jbc.274.23.16641; De Matos AJF, 2007, APMIS, V115, P327, DOI 10.1111/j.1600-0463.2007.apm_544.x; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Gama A, 2008, VET J, V177, P45, DOI 10.1016/j.tvjl.2007.05.024; Ghogomu SM, 2006, J BIOL CHEM, V281, P1755, DOI 10.1074/jbc.M505869200; Hansen K, 2004, EUR J CANCER, V40, P858, DOI 10.1016/j.ejca.2003.11.031; Hatsell S, 2003, J MAMMARY GLAND BIOL, V8, P145, DOI 10.1023/A:1025944723047; HELLMEN E, 1992, IN VITRO CELL DEV-AN, V28A, P309, DOI 10.1007/BF02877054; Hollestelle A, 2010, BREAST CANCER RES TR, V122, P125, DOI 10.1007/s10549-009-0545-4; Hovanes K, 2000, NUCLEIC ACIDS RES, V28, P1994, DOI 10.1093/nar/28.9.1994; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Hsieh TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042750; Kim SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008979; Klarmann GJ, 2008, EPIGENETICS-US, V3, P59, DOI 10.4161/epi.3.2.5899; Krol M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083995; Kuphal F, 2006, EXP CELL RES, V312, P457, DOI 10.1016/j.yexcr.2005.11.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Mikheev AM, 2008, BREAST CANCER RES TR, V112, P263, DOI 10.1007/s10549-007-9867-2; MISDORP W, 1988, VET QUART, V10, P26, DOI 10.1080/01652176.1988.9694142; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; Pinho SS, 2012, TRANSL RES, V159, P165, DOI 10.1016/j.trsl.2011.11.005; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Restucci B, 2007, ANTICANCER RES, V27, P3083; Rieger ME, 2010, MOL CELL BIOL, V30, P4267, DOI 10.1128/MCB.01418-09; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Schlosshauer PW, 2000, CARCINOGENESIS, V21, P1453, DOI 10.1093/carcin/21.7.1453; SCHNEIDER R, 1969, JNCI-J NATL CANCER I, V43, P1249; Uva P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-135; Uyama R, 2006, VET COMP ONCOL, V4, P104, DOI 10.1111/j.1476-5810.2006.00098.x; van de Wetering M, 2001, CANCER RES, V61, P278; vanLeeuwen IS, 1996, ANTICANCER RES, V16, P3737; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Virmani AK, 2001, CLIN CANCER RES, V7, P1998; Yang L, 2011, ONCOGENE, V30, P4437, DOI 10.1038/onc.2011.145	44	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98698	10.1371/journal.pone.0098698	http://dx.doi.org/10.1371/journal.pone.0098698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887235	gold, Green Published, Green Submitted			2022-12-25	WOS:000336956300099
J	Li, J; Zhao, L; Yang, T; Zeng, YJ; Yang, K				Li, Jun; Zhao, Li; Yang, Ting; Zeng, Yi-Jun; Yang, Kang			c-Ski Inhibits Autophagy of Vascular Smooth Muscle Cells Induced by oxLDL and PDGF	PLOS ONE			English	Article							FINE-STRUCTURE; LYSOSOMES; ATHEROSCLEROSIS; DEATH; 7-KETOCHOLESTEROL; EXPRESSION; REPRESSOR; RECEPTOR	Autophagy is increasingly being recognized as a critical determinant of vascular smooth muscle cell (VSMC) biology. Previously, we have demonstrated that c-Ski inhibits VSMC proliferation stimulated by transforming growth factor beta (TGF-beta), but it is not clear whether c-Ski has the similar protective role against other vascular injury factors and whether regulation of autophagy is involved in its protective effects on VSMC. Accordingly, in this study, rat aortic A10 VSMCs were treated with 40 mu g/ml oxidized low-density lipoprotein (oxLDL) or 20 ng/ml platelet-derived growth factor (PDGF), both of which were autophagy inducers and closely related to the abnormal proliferation of VSMCs. Overexpression of c-Ski in A10 cells significantly suppressed the oxLDL- and PDGF-induced autophagy. This action of c-Ski resulted in inhibiting the cell proliferation, the decrease of contractile phenotype marker alpha-SMA expression while the increase of synthetic phenotype marker osteopontin expression stimulated by oxLDL or PDGF. Inversely, knockdown of c-Ski by RNAi enhanced the stimulatory effects of oxLDL or PDGF on A10 cell growth and phenotype transition. And further investigation found that inhibition of AKT phosphorylation to downregulate proliferating cell nuclear antigen (PCNA) expression, was involved in the regulation of autophagy and associated functions by c-Ski in the oxLDL- and PDGF-stimulated VSMCs. Collectively, c-Ski may play an important role in inhibiting autophagy to protect VSMCs against some harsh stress including oxLDL and PDGF.	[Li, Jun; Yang, Kang] Third Mil Med Univ, Southwest Hosp, Dept Cardiothorac Surg, Chongqing, Peoples R China; [Zhao, Li; Yang, Ting; Zeng, Yi-Jun] Third Mil Med Univ, Dept Biochem & Mol Biol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Li, J (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Cardiothorac Surg, Chongqing, Peoples R China.	tmmubiodss@aliyun.com			National Natural Science Foundation of China [81172817]; Natural Science Foundation of Chongqing, China [CSTC2009BB5317]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Chongqing, China(Natural Science Foundation of Chongqing)	This work is supported by National Natural Science Foundation of China (No. 81172817), Natural Science Foundation of Chongqing, China (No. CSTC2009BB5317). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Bonnon C, 2012, CELL TISSUE RES, V347, P51, DOI 10.1007/s00441-011-1180-z; Bowen-Pope DF, 2011, ARTERIOSCL THROM VAS, V31, P2397, DOI 10.1161/ATVBAHA.108.179556; BUCK RC, 1962, BRIT J EXP PATHOL, V43, P236; Bundy RE, 2000, GEN PHARMACOL-VASC S, V34, P73, DOI 10.1016/S0306-3623(00)00047-1; Dai XY, 2013, KIDNEY INT, V83, P1042, DOI 10.1038/ki.2012.482; Damiani E, 1998, FEBS LETT, V425, P123, DOI 10.1016/S0014-5793(98)00212-9; Ding ZF, 2013, INT J CARDIOL, V168, P1378, DOI 10.1016/j.ijcard.2012.12.045; GEER JC, 1961, AM J PATHOL, V38, P263; GEER JC, 1968, AM J PATHOL, V52, P265; GOLDFISCHER S, 1975, AM J PATHOL, V78, P497; GOLDFISCHER S, 1975, HUM PATHOL, V6, P633, DOI 10.1016/S0046-8177(75)80047-5; Harris J, 2011, CYTOKINE, V56, P140, DOI 10.1016/j.cyto.2011.08.022; He CY, 2013, AM J PATHOL, V183, P626, DOI 10.1016/j.ajpath.2013.04.028; Hill BG, 2008, BIOCHEM J, V410, P525, DOI 10.1042/BJ20071063; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Li HJ, 2012, AM J PHYSIOL-HEART C, V303, pH1319, DOI 10.1152/ajpheart.00160.2012; Li J, 2014, CELL SIGNAL, V26, P724; Li J, 2013, CELL SIGNAL, V25, P159, DOI 10.1016/j.cellsig.2012.09.001; Li J, 2012, CELL PHYSIOL BIOCHEM, V30, P1059, DOI 10.1159/000341482; Mack CP, 2011, ARTERIOSCL THROM VAS, V31, P1495, DOI 10.1161/ATVBAHA.110.221135; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marcelain K, 2012, J CELL PHYSIOL, V227, P278, DOI 10.1002/jcp.22733; Martinet W, 2008, BRIT J PHARMACOL, V154, P1236, DOI 10.1038/bjp.2008.181; Martinet W, 2008, CURR ATHEROSCLER REP, V10, P216, DOI 10.1007/s11883-008-0034-y; Maziere C, 2010, FREE RADICAL BIO MED, V48, P1382, DOI 10.1016/j.freeradbiomed.2010.02.022; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Orford JL, 2000, AM J CARDIOL, V86, p6H, DOI 10.1016/S0002-9149(00)01094-8; PARKER F, 1966, AM J PATHOL, V48, P451; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Rudijanto Achmad, 2007, Acta Med Indones, V39, P86; Salabei JK, 2013, FREE RADICAL BIO MED, V65, P693, DOI 10.1016/j.freeradbiomed.2013.08.003; Salabei JK, 2013, BIOCHEM J, V451, P375, DOI 10.1042/BJ20121344; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; SHIO H, 1974, AM J PATHOL, V76, P1; TAPP RL, 1969, BRIT J EXP PATHOL, V50, P356; WOLINSKY H, 1974, CIRC RES, V34, P233, DOI 10.1161/01.RES.34.2.233; Xu KD, 2010, J LIPID RES, V51, P2581, DOI 10.1194/jlr.M005702; Zheng YH, 2012, J CELL PHYSIOL, V227, P127, DOI 10.1002/jcp.22709	45	8	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98902	10.1371/journal.pone.0098902	http://dx.doi.org/10.1371/journal.pone.0098902			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887307	gold, Green Published, Green Submitted			2022-12-25	WOS:000336956300120
J	Pretsch, A; Nagl, M; Schwendinger, K; Kreiseder, B; Wiederstein, M; Pretsch, D; Genov, M; Hollaus, R; Zinssmeister, D; Debbab, A; Hundsberger, H; Eger, A; Proksch, P; Wiesner, C				Pretsch, Alexander; Nagl, Michael; Schwendinger, Katja; Kreiseder, Birgit; Wiederstein, Martina; Pretsch, Dagmar; Genov, Miroslav; Hollaus, Ralph; Zinssmeister, Daniela; Debbab, Abdesamad; Hundsberger, Harald; Eger, Andreas; Proksch, Peter; Wiesner, Christoph			Antimicrobial and Anti-Inflammatory Activities of Endophytic Fungi Talaromyces wortmannii Extracts against Acne-Inducing Bacteria	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; FACTOR-KAPPA-B; PROPIONIBACTERIUM-ACNES; ACTIVATOR PROTEIN-1; INTERLEUKIN-8; PATHOGENESIS; INDUCTION	Acne vulgaris is the most common skin disease, causing significant psychosocial problems such as anxiety and depression similar to a chronic illness for those afflicted. Currently, obtainable agents for acne treatment have limited use. Thus, development of novel agents to treat this disease is a high medical need. The anaerobic bacterium Propionibacterium acnes has been implicated in the inflammatory phase of acne vulgaris by activating pro-inflammatory mediators such as the interleukin-8 (IL-8) via the NF-kappa B and MAPK pathways. Talaromyces wortmannii is an endophytic fungus, which is known to produce high bioactive natural compounds. We hypothesize that compound C but also the crude extract from T. wortmannii may possess both antibacterial activity especially against P. acnes and also anti-inflammatory properties by inhibiting TNF-alpha-induced ICAM-1 expression and P. acnes-induced IL-8 release. Treatment of keratinocytes (HaCaT) with P. acnes significantly increased NF-kappa B and activator protein-1 (AP-1) activation, as well as IL-8 release. Compound C inhibited P. acnes-mediated activation of NF-kappa B and AP-1 by inhibiting I kappa B degradation and the phosphorylation of ERK and JNK MAP kinases, and IL-8 release in a dose-dependent manner. Based on these results, compound C has effective antimicrobial activity against P. acnes and anti-inflammatory activity, and we suggest that this substance or the crude extract are alternative treatments for antibiotic/anti-inflammatory therapy for acne vulgaris.	[Pretsch, Alexander; Nagl, Michael; Schwendinger, Katja; Kreiseder, Birgit; Wiederstein, Martina; Pretsch, Dagmar; Genov, Miroslav; Hollaus, Ralph; Zinssmeister, Daniela; Wiesner, Christoph] SeaLife Pharma GmbH, Tulln, Austria; [Hundsberger, Harald; Eger, Andreas] Univ Appl Sci, Krems, Austria; [Debbab, Abdesamad; Proksch, Peter] Univ Dusseldorf, Inst Pharmaceut Biol & Biotechnol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Wiesner, C (corresponding author), SeaLife Pharma GmbH, Tulln, Austria.	wiesner@sealifepharma.com	Proksch, Peter/AAR-4593-2020; Genov, Miroslav/Y-9726-2019	Wiesner, Christoph/0000-0002-3281-0695; Genov, Miroslav/0000-0001-6854-4387; hundsberger, harald/0000-0002-8479-1633	Deutsche Bundes Stiftung fur Umwelt (DPU); Forschungsforderungsgesellschaft (FFG) [2427070]	Deutsche Bundes Stiftung fur Umwelt (DPU); Forschungsforderungsgesellschaft (FFG)	The studies were funded by the "Deutsche Bundes Stiftung fur Umwelt (DPU)" and the "Forschungsforderungsgesellschaft (FFG; eCall Nr. 2427070)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azimi H, 2012, FITOTERAPIA, V83, P1306, DOI 10.1016/j.fitote.2012.03.026; Bara R, 2013, J MED CHEM, V56, P3257, DOI 10.1021/jm301816a; Chen QJ, 2002, J DERMATOL SCI, V29, P97, DOI 10.1016/S0923-1811(02)00013-0; Debbab A, 2010, MICROB BIOTECHNOL, V3, P544, DOI 10.1111/j.1751-7915.2010.00179.x; Dong YS, 2006, J NAT PROD, V69, P128, DOI 10.1021/np0502894; Ebada SS, 2008, NAT PROTOC, V3, P1820, DOI 10.1038/nprot.2008.182; FRISVAD JC, 1990, ANTON LEEUW INT J G, V57, P179, DOI 10.1007/BF00403953; Grange PA, 2009, J DERMATOL SCI, V56, P106, DOI 10.1016/j.jdermsci.2009.08.001; GUIN JD, 1979, ACTA DERM-VENEREOL, V59, P552; HOEFFLER U, 1977, J CLIN MICROBIOL, V6, P555; Humphrey S, 2012, Skin Therapy Lett, V17, P1; Jappe U, 2003, ACTA DERM-VENEREOL, V83, P241, DOI 10.1080/00015550310016463; Jugeau S, 2005, BRIT J DERMATOL, V153, P1105, DOI 10.1111/j.1365-2133.2005.06933.x; Kang S, 2005, AM J PATHOL, V166, P1691, DOI 10.1016/S0002-9440(10)62479-0; Khanjani S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/504952; Kim J, 2002, J IMMUNOL, V169, P1535, DOI 10.4049/jimmunol.169.3.1535; Koreck A, 2003, DERMATOLOGY, V206, P96, DOI 10.1159/000068476; Kurokawa I, 2009, EXP DERMATOL, V18, P821, DOI 10.1111/j.1600-0625.2009.00890.x; Lakshminarayanan V, 1997, J BIOL CHEM, V272, P32910, DOI 10.1074/jbc.272.52.32910; Mouser PE, 2003, J INVEST DERMATOL, V121, P1226, DOI 10.1046/j.1523-1747.2003.12550_6.x; Nagy I, 2005, J INVEST DERMATOL, V124, P931, DOI 10.1111/j.0022-202X.2005.23705.x; PUHVEL SM, 1972, J INVEST DERMATOL, V58, P66, DOI 10.1111/1523-1747.ep12551495; Radic N, 2012, PHYTOMEDICINE, V19, P1270, DOI 10.1016/j.phymed.2012.09.007; Rahman I, 2000, BIOCHEM PHARMACOL, V60, P1041, DOI 10.1016/S0006-2952(00)00392-0; Rasool M, 2006, BIOL PHARM BULL, V29, P2483, DOI 10.1248/bpb.29.2483; Rice LB, 1996, ANTIBIOTICS LAB MED, P282; Romay C, 2003, CURR PROTEIN PEPT SC, V4, P207, DOI 10.2174/1389203033487216; Thiboutot D, 2004, J INVEST DERMATOL, V123, P1, DOI 10.1111/j.1523-1747.2004.t01-2-.x; Thiboutot D, 2009, J AM ACAD DERMATOL, V60, pS1, DOI 10.1016/j.jaad.2009.01.019; VOWELS BR, 1995, INFECT IMMUN, V63, P3158, DOI 10.1128/IAI.63.8.3158-3165.1995; Wawruch M, 2002, Bratisl Lek Listy, V103, P270; White GM, 1998, J AM ACAD DERMATOL, V39, pS34, DOI 10.1016/S0190-9622(98)70442-6; Wiesner Christoph, 2007, Drug Metab Lett, V1, P254, DOI 10.2174/187231207783221385; Yu YY, 2010, CHINESE MED J-PEKING, V123, P1017, DOI 10.3760/cma.j.issn.0366-6999.2010.08.008; ZACHARIAE COC, 1993, ACTA DERM-VENEREOL, P1; Zouboulis CC, 2005, EXP DERMATOL, V14, P144, DOI 10.1111/j.0906-6705.2005.0285c.x	36	30	31	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97929	10.1371/journal.pone.0097929	http://dx.doi.org/10.1371/journal.pone.0097929			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887557	gold, Green Published, Green Submitted			2022-12-25	WOS:000336956300027
J	Strauss, AS; Wang, D; Stock, M; Gretscher, RR; Groth, M; Boland, W; Burse, A				Strauss, Anja S.; Wang, Ding; Stock, Magdalena; Gretscher, Rene R.; Groth, Marco; Boland, Wilhelm; Burse, Antje			Tissue-Specific Transcript Profiling for ABC Transporters in the Sequestering Larvae of the Phytophagous Leaf Beetle Chrysomela populi	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; P-GLYCOPROTEIN ATPASE; MULTIDRUG-RESISTANCE; DROSOPHILA-MELANOGASTER; MOLECULAR-BASIS; GENE FAMILY; SUBCELLULAR-LOCALIZATION; HELICOVERPA-ARMIGERA; CONFERS RESISTANCE; CHEMICAL DEFENSE	Background: Insects evolved ingenious adaptations to use extraordinary food sources. Particularly, the diet of herbivores enriched with noxious plant secondary metabolites requires detoxification mechanisms. Sequestration, which involves the uptake, transfer, and concentration of occasionally modified phytochemicals into specialized tissues or hemolymph, is one of the most successful detoxification strategies found in most insect orders. Due to the ability of ATP-binding cassette (ABC) carriers to transport a wide range of molecules including phytochemicals and xenobiotics, it is highly likely that they play a role in this sequestration process. To shed light on the role of ABC proteins in sequestration, we describe an inventory of putative ABC transporters in various tissues in the sequestering juvenile poplar leaf beetle, Chrysomela populi. Results: In the transcriptome of C. populi, we predicted 65 ABC transporters. To link the proteins with a possible function, we performed comparative phylogenetic analyses with ABC transporters of other insects and of humans. While tissue-specific profiling of each ABC transporter subfamily suggests that ABCB, C and G influence the plant metabolite absorption in the gut, ABCC with 14 members is the preferred subfamily responsible for the excretion of these metabolites via Malpighian tubules. Moreover, salicin, which is sequestered from poplar plants, is translocated into the defensive glands for further deterrent production. In these glands and among all identified ABC transporters, an exceptionally high transcript level was observed only for Cpabc35 (Cpmrp). RNAi revealed the deficiency of other ABC pumps to compensate the function of CpABC35, demonstrating its key role during sequestration. Conclusion: We provide the first comprehensive phylogenetic study of the ABC family in a phytophagous beetle species. RNA-seq data from different larval tissues propose the importance of ABC pumps to achieve a homeostasis of plant-derived compounds and offer a basis for future analyses of their physiological function in sequestration processes.	[Strauss, Anja S.; Wang, Ding; Stock, Magdalena; Gretscher, Rene R.; Boland, Wilhelm; Burse, Antje] Max Planck Inst Chem Ecol, D-07745 Jena, Thuringia, Germany; [Groth, Marco] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Thuringia, Germany	Max Planck Society; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Burse, A (corresponding author), Max Planck Inst Chem Ecol, Beutenberg Campus,Hans Knoell Str 8, D-07745 Jena, Thuringia, Germany.	aburse@ice.mpg.de	Boland, Wilhelm/K-7762-2012	Boland, Wilhelm/0000-0001-6784-2534; Groth, Marco/0000-0002-9199-8990; Gretscher, Rene/0000-0002-0249-4978; Strauss, Anja/0000-0003-2528-4735	Deutsche Forschungsgemeinschaft [BU 1862/2-1]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work has been supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp; grant number, BU 1862/2-1) and the Max Planck Society (http://www.mpg.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawi MK, 2011, ESSAYS BIOCHEM, V50, P63, DOI [10.1042/BSE0500063, 10.1042/bse0500063]; Albrecht C, 2007, PFLUG ARCH EUR J PHY, V453, P581, DOI 10.1007/s00424-006-0047-8; Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Andersen DS, 2007, J BIOL CHEM, V282, P14752, DOI 10.1074/jbc.M701361200; Annilo T, 2006, GENOMICS, V88, P1, DOI 10.1016/j.ygeno.2006.03.001; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Atsumi S, 2012, P NATL ACAD SCI USA, V109, pE1591, DOI 10.1073/pnas.1120698109; Aung T, 2011, P NATL ACAD SCI USA, V108, P15336, DOI 10.1073/pnas.1102855108; Aurade RM, 2012, ARCH INSECT BIOCHEM, V79, P47, DOI 10.1002/arch.21004; Aurade RM, 2010, BBA-BIOMEMBRANES, V1798, P1135, DOI 10.1016/j.bbamem.2010.02.019; Bangert I, 2011, BIOL CHEM, V392, P61, DOI 10.1515/BC.2011.007; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BAUER LS, 1993, J EUKARYOT MICROBIOL, V40, P135, DOI 10.1111/j.1550-7408.1993.tb04893.x; Bayeva M, 2013, CIRC RES, V113, P279, DOI 10.1161/CIRCRESAHA.113.301552; Begun DJ, 2000, HEREDITY, V85, P184, DOI 10.1046/j.1365-2540.2000.00729.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bodemann RR, 2012, P ROY SOC B-BIOL SCI, V279, P4126, DOI 10.1098/rspb.2012.1342; Broccardo C, 1999, BBA-BIOMEMBRANES, V1461, P395, DOI 10.1016/S0005-2736(99)00170-4; Broehan G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-6; Bryan J, 2007, PFLUG ARCH EUR J PHY, V453, P703, DOI 10.1007/s00424-006-0116-z; Buss DS, 2008, PESTIC BIOCHEM PHYS, V90, P141, DOI 10.1016/j.pestbp.2007.12.001; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chavan H, 2013, J BIOL CHEM, V288, P22658, DOI 10.1074/jbc.M113.485284; Chavan H, 2011, TOXICOL SCI, V120, P519, DOI 10.1093/toxsci/kfr008; Chen KG, 2009, PIGM CELL MELANOMA R, V22, P740, DOI 10.1111/j.1755-148X.2009.00630.x; Chen ZS, 2011, FEBS J, V278, P3226, DOI 10.1111/j.1742-4658.2011.08235.x; Chloupkova M, 2003, J MOL BIOL, V331, P155, DOI 10.1016/S0022-2836(03)00666-1; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Dassa E, 2011, ESSAYS BIOCHEM, V50, P19, DOI [10.1042/BSE0500019, 10.1042/bse0500019]; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dermauw W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-317; Discher S, 2009, CHEMBIOCHEM, V10, P2223, DOI 10.1002/cbic.200900226; Dong JS, 2005, MOL CELL BIOL, V25, P9859, DOI 10.1128/MCB.25.22.9859-9873.2005; Dow JAT, 2006, J INSECT PHYSIOL, V52, P365, DOI 10.1016/j.jinsphys.2005.10.007; Elferink RPJO, 2007, PFLUG ARCH EUR J PHY, V453, P601, DOI 10.1007/s00424-006-0062-9; Elliott AM, 2009, MOL CANCER RES, V7, P79, DOI 10.1158/1541-7786.MCR-08-0235; Evans JM, 2008, J EXP BIOL, V211, P890, DOI 10.1242/jeb.014837; Ewart GD, 1998, METHOD ENZYMOL, V292, P213; Fischer S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-69; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gomez-Zurita J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000360; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; Gross J, 2002, J CHEM ECOL, V28, P317, DOI 10.1023/A:1017934124650; HAUNERLAND NH, 1995, ANNU REV ENTOMOL, V40, P121, DOI 10.1146/annurev.en.40.010195.001005; Heckel DG, 2012, PESTIC BIOCHEM PHYS, V104, P103, DOI 10.1016/j.pestbp.2012.05.007; Herget M, 2007, PFLUG ARCH EUR J PHY, V453, P591, DOI 10.1007/s00424-006-0083-4; Hock T, 2000, P NATL ACAD SCI USA, V97, P9519, DOI 10.1073/pnas.160271797; Holland IB, 2011, ESSAYS BIOCHEM, V50, P1, DOI [10.1042/BSE0500001, 10.1042/bse0500001]; Hunt JF, 2013, COLD SPRING HARB PER, V3; Ichikawa Y, 2012, P NATL ACAD SCI USA, V109, P4152, DOI 10.1073/pnas.1119338109; Itoh TQ, 2011, GENES CELLS, V16, P1159, DOI 10.1111/j.1365-2443.2011.01559.x; Jalil YA, 2008, AM J PHYSIOL-CELL PH, V294, pC579, DOI 10.1152/ajpcell.00612.2006; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Jones CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045995; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kashiwayama Y, 2009, EXP CELL RES, V315, P190, DOI 10.1016/j.yexcr.2008.10.031; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawanobe T, 2012, BIOCHEM BIOPH RES CO, V418, P736, DOI 10.1016/j.bbrc.2012.01.090; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Kerr ID, 2011, BRIT J PHARMACOL, V164, P1767, DOI 10.1111/j.1476-5381.2010.01177.x; Kerr ID, 2004, BIOCHEM BIOPH RES CO, V315, P166, DOI 10.1016/j.bbrc.2004.01.044; Kiss K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037378; Kretzschmar T, 2011, ESSAYS BIOCHEM, V50, P145, DOI [10.1042/BSE0500145, 10.1042/bse0500145]; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; Krishnamurthy P, 2011, CURR PHARM BIOTECHNO, V12, P647, DOI 10.2174/138920111795163995; Kuhn J, 2004, P NATL ACAD SCI USA, V101, P13808, DOI 10.1073/pnas.0402576101; Labbe R, 2011, INSECT MOL BIOL, V20, P243, DOI 10.1111/j.1365-2583.2010.01064.x; LANDER E S, 1988, Genomics, V2, P231; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lanning CL, 1996, BBA-GEN SUBJECTS, V1291, P155, DOI 10.1016/0304-4165(96)00060-8; Li JW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003596; Liu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048156; Liu SK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-53; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo L, 2013, INSECT BIOCHEM MOLEC, V43, P627, DOI 10.1016/j.ibmb.2013.04.006; Mackenzie SM, 1999, BBA-BIOMEMBRANES, V1419, P173, DOI 10.1016/S0005-2736(99)00064-4; Michalski C, 2008, J BIOL CHEM, V283, P19219, DOI 10.1074/jbc.M802236200; Moitra Karobi, 2011, Drug Metabolism and Drug Interactions, V26, P105, DOI 10.1515/DMDI.2011.015; Morita M, 2012, BBA-MOL BASIS DIS, V1822, P1387, DOI 10.1016/j.bbadis.2012.02.009; MURRAY CL, 1994, J NEUROBIOL, V25, P23, DOI 10.1002/neu.480250103; OHARE K, 1984, J MOL BIOL, V180, P437, DOI 10.1016/0022-2836(84)90021-4; Opitz SEW, 2009, CHEMOECOLOGY, V19, P117, DOI 10.1007/s00049-009-0018-6; Overbeck TR, 2013, ONCOLOGY-BASEL, V84, P362, DOI 10.1159/000348884; PASTEELS JM, 1990, J CHEM ECOL, V16, P211, DOI 10.1007/BF01021280; PASTEELS JM, 1983, PHYSIOL ENTOMOL, V8, P307, DOI 10.1111/j.1365-3032.1983.tb00362.x; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Petschenka G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3089; Petzold A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-185; Podsiadlowski L, 1998, COMP BIOCHEM PHYS B, V121, P443, DOI 10.1016/S0305-0491(98)10137-2; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Popovic M, 2010, MAR ENVIRON RES, V69, pS11, DOI 10.1016/j.marenvres.2009.10.016; Porretta D, 2008, MED VET ENTOMOL, V22, P48, DOI 10.1111/j.1365-2915.2008.00712.x; Quan GX, 2002, INSECT MOL BIOL, V11, P217, DOI 10.1046/j.1365-2583.2002.00328.x; Quazi F, 2011, ESSAYS BIOCHEM, V50, P265, DOI [10.1042/BSE0500265, 10.1042/bse0500265]; Ricardo S, 2009, SCIENCE, V323, P943, DOI 10.1126/science.1166239; Roth CW, 2003, MOL CELLS, V15, P150; RYALL RL, 1974, INSECT BIOCHEM, V4, P47, DOI 10.1016/0020-1790(74)90041-9; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Slot AJ, 2011, ESSAYS BIOCHEM, V50, P179, DOI [10.1042/BSE0500179, 10.1042/bse0500179]; SMILEY JT, 1985, SCIENCE, V229, P649, DOI 10.1126/science.229.4714.649; Sorensen JS, 2006, J CHEM ECOL, V32, P1181, DOI 10.1007/s10886-006-9079-y; Srinivas R, 2004, COMP BIOCHEM PHYS C, V137, P261, DOI 10.1016/j.cca.2004.02.002; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stieger B, 2007, PFLUG ARCH EUR J PHY, V453, P611, DOI 10.1007/s00424-006-0152-8; Stock M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084461; Strauss AS, 2013, ELIFE, V2, DOI 10.7554/eLife.01096; Sturm A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-170; SULLIVAN DT, 1974, J EXP ZOOL, V188, P225, DOI 10.1002/jez.1401880210; SULLIVAN DT, 1975, BIOCHEM GENET, V13, P603, DOI 10.1007/BF00484918; Sumitani M, 2005, INSECT BIOCHEM MOLEC, V35, P231, DOI 10.1016/j.ibmb.2004.12.006; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Tamaki A, 2011, ESSAYS BIOCHEM, V50, P209, DOI [10.1042/BSE0500209, 10.1042/bse0500209]; Tapadia MG, 2005, CELL STRESS CHAPERON, V10, P7, DOI 10.1379/CSC-67R.1; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; Tarr PT, 2009, BBA-MOL CELL BIOL L, V1791, P584, DOI 10.1016/j.bbalip.2009.01.007; Tatematsu K, 2011, GENES CELLS, V16, P331, DOI 10.1111/j.1365-2443.2011.01490.x; Termonia A, 2001, P NATL ACAD SCI USA, V98, P3909, DOI 10.1073/pnas.061034598; Tian Y, 2012, IUBMB LIFE, V64, P795, DOI 10.1002/iub.1071; Toguebaye B.S., 1988, Series Entomologica (Dordrecht), V42, P399; Tsuchida M, 2008, BIOCHEM BIOPH RES CO, V369, P369, DOI 10.1016/j.bbrc.2008.02.027; Tsybovsky Y, 2013, STRUCTURE, V21, P854, DOI 10.1016/j.str.2013.03.001; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; Ulrich DL, 2012, J BIOL CHEM, V287, P12679, DOI 10.1074/jbc.M111.336180; Wang B, 2009, J MEMBRANE BIOL, V231, P1, DOI 10.1007/s00232-009-9200-6; Wang LY, 2013, INSECT BIOCHEM MOLEC, V43, P562, DOI 10.1016/j.ibmb.2013.03.011; Wang Y, 2013, NEW PHYTOL, V197, P886, DOI 10.1111/nph.12063; Woodward OM, 2011, FEBS J, V278, P3215, DOI 10.1111/j.1742-4658.2011.08171.x; Xie XD, 2012, MOL BIOL REP, V39, P7281, DOI 10.1007/s11033-012-1558-3; Yasui K, 2004, CANCER RES, V64, P1403, DOI 10.1158/0008-5472.CAN-3263-2; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Yu M, 2013, CANCER METAST REV, V32, P211, DOI 10.1007/s10555-012-9402-8; Zarubica A, 2007, PFLUG ARCH EUR J PHY, V453, P569, DOI 10.1007/s00424-006-0108-z; Zhou SF, 2008, XENOBIOTICA, V38, P802, DOI 10.1080/00498250701867889 ; Zhou SF, 2008, CURR MED CHEM, V15, P1981, DOI 10.2174/092986708785132870	144	26	27	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98637	10.1371/journal.pone.0098637	http://dx.doi.org/10.1371/journal.pone.0098637			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887102	Green Published, gold			2022-12-25	WOS:000336956300096
J	Vokhshoori, NL; McCarthy, MD				Vokhshoori, Natasha L.; McCarthy, Matthew D.			Compound-Specific delta N-15 Amino Acid Measurements in Littoral Mussels in the California Upwelling Ecosystem: A New Approach to Generating Baseline delta N-15 Isoscapes for Coastal Ecosystems	PLOS ONE			English	Article							PACIFIC SUBTROPICAL GYRE; TROPHIC POSITION; NITROGEN; PATTERNS; ZOOPLANKTON; DYNAMICS; CARBON; FRACTIONATION; ISOTOPES; DIET	We explored delta N-15 compound-specific amino acid isotope data (CSI-AA) in filter-feeding intertidal mussels (Mytilus californianus) as a new approach to construct integrated isoscapes of coastal primary production. We examined spatial delta N-15 gradients in the California Upwelling Ecosystem (CUE), determining bulk delta N-15 values of mussel tissue from 28 sites between Port Orford, Oregon and La Jolla, California, and applying CSI-AA at selected sites to decouple trophic effects from isotopic values at the base of the food web. Bulk delta N-15 values showed a strong linear trend with latitude, increasing from North to South (from similar to 7 parts per thousand to similar to 12 parts per thousand, R-2 = 0.759). In contrast, CSI-AA trophic position estimates showed no correlation with latitude. The delta N-15 trend is therefore most consistent with a baseline delta N-15 gradient, likely due to the mixing of two source waters: low delta N-15 nitrate from the southward flowing surface California Current, and the northward transport of the California Undercurrent (CUC), with N-15-enriched nitrate. This interpretation is strongly supported by a similar linear gradient in delta N-15 values of phenylalanine (delta N-15(Phe)), the best AA proxy for baseline delta N-15 values. We hypothesize delta N-15(Phe) values in intertidal mussels can approximate annual integrated delta N-15 values of coastal phytoplankton primary production. We therefore used delta N-15(Phe) values to generate the first compound-specific nitrogen isoscape for the coastal Northeast Pacific, which indicates a remarkably linear gradient in coastal primary production delta N-15 values. We propose that delta N-15(Phe) isoscapes derived from filter feeders can directly characterize baseline delta N-15 values across major biochemical provinces, with potential applications for understanding migratory and feeding patterns of top predators, monitoring effects of climate change, and study of paleoarchives.	[Vokhshoori, Natasha L.; McCarthy, Matthew D.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Vokhshoori, NL (corresponding author), Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA.	nvokhsho@ucsc.edu; mccarthy@pmc.ucsc.edu		vokhshoori, natasha/0000-0003-3412-7934	Friends of Long Marine Lab; Myers Oceanographic Trust; University of California, Santa Cruz, Open Access Fund	Friends of Long Marine Lab; Myers Oceanographic Trust; University of California, Santa Cruz, Open Access Fund	Sources of funding that have supported this work were awards received from Friends of Long Marine Lab (http://seymourcenter.ucsc.edu/about-us/people/board/; http://seymourcenter.ucsc.edu/wp-content/uploads/2013/10/SREA-2013-2014-guidelines.pdf) and from the Myers Oceanographic Trust. Funding for Open Access provided by the University of California, Santa Cruz, Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksnes DL, 2009, LIMNOL OCEANOGR, V54, P1272, DOI 10.4319/lo.2009.54.4.1272; Altabet MA, 1999, DEEP-SEA RES PT I, V46, P655, DOI 10.1016/S0967-0637(98)00084-3; ASMUS RM, 1991, J EXP MAR BIOL ECOL, V148, P215, DOI 10.1016/0022-0981(91)90083-9; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bracken MES, 2012, MAR ECOL PROG SER, V459, P53, DOI 10.3354/meps09764; Brandes JA, 2007, CHEM REV, V107, P577, DOI 10.1021/cr050377t; Checkley DM, 2009, PROG OCEANOGR, V83, P49, DOI 10.1016/j.pocean.2009.07.028; Chikaraishi Y, 2007, MAR ECOL PROG SER, V342, P85, DOI 10.3354/meps342085; Chikaraishi Y, 2009, LIMNOL OCEANOGR-METH, V7, P740, DOI 10.4319/lom.2009.7.740; Choy CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050133; CLINE JD, 1972, LIMNOL OCEANOGR, V17, P885, DOI 10.4319/lo.1972.17.6.0885; CODISPOTI LA, 1976, LIMNOL OCEANOGR, V21, P379, DOI 10.4319/lo.1976.21.3.0379; Dale JJ, 2011, MAR ECOL PROG SER, V433, P221, DOI 10.3354/meps09171; Decima M, 2013, LIMNOL OCEANOGR, V58, P624, DOI 10.4319/lo.2013.58.2.0624; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DOBUSH GR, 1985, CAN J ZOOL, V63, P1917, DOI 10.1139/z85-285; DUGGINS DO, 1989, SCIENCE, V245, P170, DOI 10.1126/science.245.4914.170; Ford HL, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2008PA001677; Germain LR, 2013, MAR ECOL PROG SER, V482, P265, DOI 10.3354/meps10257; Graham B.S., 2009, USING ISOSCAPES TRAC, P299, DOI DOI 10.1007/978-90-481-3354-3_14; Grantham BA, 2004, NATURE, V429, P749, DOI 10.1038/nature02605; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Hannides CCS, 2013, LIMNOL OCEANOGR, V58, P1931, DOI 10.4319/lo.2013.58.6.1931; Hannides CCS, 2009, LIMNOL OCEANOGR, V54, P50, DOI 10.4319/lo.2009.54.1.0050; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kahru M, 2000, GEOPHYS RES LETT, V27, P2937, DOI 10.1029/2000GL011486; Kienast SS, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000650; Larsen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073441; Liu ZH, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002044; Lorrain A, 2009, MAR ECOL PROG SER, V391, P293, DOI 10.3354/meps08215; McCarthy MD, 2007, GEOCHIM COSMOCHIM AC, V71, P4727, DOI 10.1016/j.gca.2007.06.061; McCarthy MD, 2013, GEOCHIM COSMOCHIM AC, V103, P104, DOI 10.1016/j.gca.2012.10.037; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McKinnell SM, 2010, PICES SPECIAL PUBLIC, V4, P393; McMahon KW, 2013, LIMNOL OCEANOGR, V58, P697, DOI 10.4319/lo.2013.58.2.0697; Olson RJ, 2010, PROG OCEANOGR, V86, P124, DOI 10.1016/j.pocean.2010.04.026; Polovina JJ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031745; Popp BN, 2007, TERR ECOL SER, V1, P173; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; Raikow DF, 2001, LIMNOL OCEANOGR, V46, P514, DOI 10.4319/lo.2001.46.3.0514; Rau GH, 2003, DEEP-SEA RES PT II, V50, P2431, DOI 10.1016/S0967-0645(03)00128-0; Ruiz-Cooley RI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059651; Rykaczewski RR, 2008, P NATL ACAD SCI USA, V105, P1965, DOI 10.1073/pnas.0711777105; Rykaczewski RR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045019; Schwing FB, 1996, NOAA TECH REP NMFS S, V231, P144; Seminoff JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037403; Sherwood OA, 2013, NATURE, P1; Sigman DM, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000384; Sigman DM, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002458; Sigman DM, 2009, ENCY OCEAN SCI; Somes CJ, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044537; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Vokhshoori N, 2013, THESIS U CALIFORNIA; Vokhshoori NL, 2014, MAR ECOL PROG SER, V504, P59, DOI 10.3354/meps10746; Voss M, 2001, DEEP-SEA RES PT I, V48, P1905, DOI 10.1016/S0967-0637(00)00110-2; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Waser N, 2010, LIMNOL OCEANOGR, V43, P215; White AE, 2013, PROG OCEANOGR, V109, P1, DOI 10.1016/j.pocean.2012.09.002	59	49	49	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98087	10.1371/journal.pone.0098087	http://dx.doi.org/10.1371/journal.pone.0098087			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887109	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300037
J	Halphen, I; Elie, C; Brousse, V; Le Bourgeois, M; Allali, S; Bonnet, D; de Montalembert, M				Halphen, Isabelle; Elie, Caroline; Brousse, Valentine; Le Bourgeois, Muriel; Allali, Slimane; Bonnet, Damien; de Montalembert, Mariane			Severe Nocturnal and Postexercise Hypoxia in Children and Adolescents with Sickle Cell Disease	PLOS ONE			English	Article							REGURGITANT JET VELOCITY; HEMOGLOBIN OXYGEN DESATURATION; 6-MINUTE WALK TEST; PULMONARY-HYPERTENSION; PULSE OXIMETRY; OXYHEMOGLOBIN DESATURATION; LUNG-FUNCTION; EXERCISE; SATURATION; HYPOXEMIA	Hypoxia is a common feature in children with sickle cell disease (SCD) that is inconsistently associated with painful crises and acute chest syndrome. To assess the prevalence and risk factors of hypoxia, we recorded daytime, nocturnal, and postexercise pulse oximetry (SpO(2)) values in 39 SCD patients with a median age of 10.8 years. Median daytime SpO2 was 97% (range, 89%-100%), and 36% of patients had daytime hypoxia defined as SpO(2)< 96%. Median nocturnal SpO(2) was 94.7% (range, 87.7%-99.5%), 50% of patients had nocturnal hypoxia defined as SpO(2)<= 93%, and 11(37%) patients spent more than 10% of their total sleep time with SpO(2)< 90%. Median postexercise SpO(2) was 94% (range, 72%-100%) and 44.7% of patients had postexercise hypoxia defined as an SpO(2) decrease >= 3% after a 6-minute walk test. Among patients with normal daytime SpO(2), 35% had nocturnal and 42% postexercise hypoxia. Compared to 9 patients without daytime, nocturnal, or postexercise hypoxia, 25 patients with hypoxia under at least one of these three conditions had greater anemia severity (P = 0.01), lower HbF levels (P = 0.04), and higher aspartate aminotransferase levels (P = 0.03). Males predominated among patients with postexercise hypoxia (P = 0.004). Hypoxia correlated neither with painful crises nor with acute chest syndrome. Of 32 evaluable patients, 6 (18.8%) had a tricuspid regurgitation velocity >= 2.6 m/s, and this feature was associated with anemia (P = 0.044). Median percentage of the predicted distance covered during a 6-minute walk test was 86% [46-120]; the distance was negatively associated with LDH (P = 0.044) and with a past history of acute chest syndrome (P = 0.009). In conclusion, severe episodes of nocturnal and postexercise hypoxia are common in children with SCD, even those with normal daytime SpO(2).	[Halphen, Isabelle] Hop Necker Enfants Malad, AP HP, Pediat Emergency Dept, Paris, France; [Elie, Caroline; Bonnet, Damien; de Montalembert, Mariane] Paris Descartes Univ, Paris, France; [Elie, Caroline] Hop Necker Enfants Malad, AP HP, Dept Biostat, Paris, France; [Brousse, Valentine; Allali, Slimane; de Montalembert, Mariane] Hop Necker Enfants Malad, AP HP, Dept Pediat, Paris, France; [Brousse, Valentine; Allali, Slimane; de Montalembert, Mariane] Hop Necker Enfants Malad, AP HP, Sickle Cell Clin, Paris, France; [Le Bourgeois, Muriel] Hop Necker Enfants Malad, AP HP, Pediat Pneumol & Allergol Dept, Paris, France; [Bonnet, Damien] Paris Descartes Univ, Necker M3C, AP HP, Dept Pediat Cardiol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	de Montalembert, M (corresponding author), Paris Descartes Univ, Paris, France.	mariane.demontal@nck.aphp.fr	Allali, Slimane/AGW-0037-2022	Allali, Slimane/0000-0001-7068-4530				Ambrusko SJ, 2006, PEDIATR BLOOD CANCER, V47, P907, DOI 10.1002/pbc.20791; Campbell A, 2009, BRIT J HAEMATOL, V147, P352, DOI 10.1111/j.1365-2141.2009.07854.x; Chapusette R, 2013, BLOOD, V122; Chaudry RA, 2011, ARCH DIS CHILD, V96, P131, DOI 10.1136/adc.2010.184028; Colombatti R, 2011, HEMATOL REP, V3, P34, DOI 10.4081/hr.2011.e12; Colombatti R, 2010, BRIT J HAEMATOL, V150, P601, DOI 10.1111/j.1365-2141.2010.08269.x; Cox SE, 2013, ISRN HEMATOLOGY, DOI DOI 10.1155/2013/472909; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Dahoui HA, 2010, PEDIATR BLOOD CANCER, V54, P398, DOI 10.1002/pbc.22306; Fitzgerald RK, 2001, CRIT CARE MED, V29, P1803, DOI 10.1097/00003246-200109000-00025; Geiger R, 2007, J PEDIATR-US, V150, P395, DOI 10.1016/j.jpeds.2006.12.052; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Gladwin MT, 2003, CIRCULATION, V107, P271, DOI 10.1161/01.CIR.0000044943.12533.A8; Gordeuk VR, 2011, HAEMATOL-HEMATOL J, V96, P33, DOI 10.3324/haematol.2010.030767; Gulmans VAM, 1996, PEDIATR PULM, V22, P85, DOI 10.1002/(SICI)1099-0496(199608)22:2<85::AID-PPUL1>3.0.CO;2-I; Hagar RW, 2008, BRIT J HAEMATOL, V140, P104, DOI 10.1111/j.1365-2141.2007.06822.x; Hargrave DR, 2003, BLOOD, V101, P846, DOI 10.1182/blood-2002-05-1392; Hassan J, 2010, BRIT J SPORT MED, V44, P270, DOI 10.1136/bjsm.2008.048512; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; Kaul DK, 2000, J CLIN INVEST, V106, P411, DOI 10.1172/JCI9225; Kirkham FJ, 2001, LANCET, V357, P1656, DOI 10.1016/S0140-6736(00)04821-2; Lanzkron S, 2013, PUBLIC HEALTH REP, V128, P110, DOI 10.1177/003335491312800206; Lee MT, 2009, BRIT J HAEMATOL, V146, P437, DOI 10.1111/j.1365-2141.2009.07779.x; Liem RI, 2009, PEDIATR PULM, V44, P281, DOI 10.1002/ppul.20996; Loughlin GM, 1996, AM J RESP CRIT CARE, V153, P866; Marshall MJ, 2009, HAEMATOL-HEMATOL J, V94, P1006, DOI 10.3324/haematol.2008.005215; Miller AC, 2012, AM J RESP CRIT CARE, V185, P1154, DOI 10.1164/rccm.201111-2082CI; MILNER PF, 1974, ARCH INTERN MED, V133, P565, DOI 10.1001/archinte.133.4.565; Minniti CR, 2009, HAEMATOL-HEMATOL J, V94, P340, DOI 10.3324/haematol.13812; Mullin JE, 2010, PEDIATR BLOOD CANCER, V54, P1017, DOI 10.1002/pbc.22420; Needleman JP, 1999, PEDIATR PULM, V28, P418, DOI 10.1002/(SICI)1099-0496(199912)28:6<418::AID-PPUL6>3.0.CO;2-D; Nelson SC, 2007, J PEDIAT HEMATOL ONC, V29, P334, DOI 10.1097/MPH.0b013e31805d8f32; Onyekwere OC, 2008, PEDIATR CARDIOL, V29, P309, DOI 10.1007/s00246-007-9018-x; Ortiz FO, 1999, AM J RESP CRIT CARE, V159, P447, DOI 10.1164/ajrccm.159.2.9806108; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; Pashankar FD, 2008, PEDIATRICS, V121, P777, DOI 10.1542/peds.2007-0730; Pashankar FD, 2009, BRIT J HAEMATOL, V144, P736, DOI 10.1111/j.1365-2141.2008.07501.x; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pereira FM, 2011, J BRAS PNEUMOL, V37, P735, DOI 10.1590/S1806-37132011000600006; Quinn CT, 2005, BRIT J HAEMATOL, V131, P129, DOI 10.1111/j.1365-2141.2005.05738.x; RACKOFF WR, 1993, BLOOD, V81, P3422; Sachdev V, 2011, CIRCULATION, V124, P1452, DOI 10.1161/CIRCULATIONAHA.111.032920; Setty BNY, 2003, LANCET, V362, P1450, DOI 10.1016/S0140-6736(03)14689-2; Singh SA, 2008, PEDIATR BLOOD CANCER, V50, P1258, DOI 10.1002/pbc.21480; Uong EC, 2006, J PEDIATR-US, V149, P707, DOI 10.1016/j.jpeds.2006.06.038; Waltz X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077830; Waltz X, 2013, HAEMATOLOGICA, V98, P1039, DOI 10.3324/haematol.2013.083576	47	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97462	10.1371/journal.pone.0097462	http://dx.doi.org/10.1371/journal.pone.0097462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878576	Green Published, gold, Green Submitted			2022-12-25	WOS:000338101500014
J	Hedegaard, J; Thorsen, K; Lund, MK; Hein, AMK; Hamilton-Dutoit, SJ; Vang, S; Nordentoft, I; Birkenkamp-Demtroder, K; Kruhoffer, M; Hager, H; Knudsen, B; Andersen, CL; Sorensen, KD; Pedersen, JS; Orntoft, TF; Dyrskjot, L				Hedegaard, Jakob; Thorsen, Kasper; Lund, Mette Katrine; Hein, Anne-Mette K.; Hamilton-Dutoit, Stephen Jacques; Vang, Soren; Nordentoft, Iver; Birkenkamp-Demtroder, Karin; Kruhoffer, Mogens; Hager, Henrik; Knudsen, Bjarne; Andersen, Claus Lindbjerg; Sorensen, Karina Dalsgaard; Pedersen, Jakob Skou; Orntoft, Torben Falck; Dyrskjot, Lars			Next-Generation Sequencing of RNA and DNA Isolated from Paired Fresh-Frozen and Formalin-Fixed Paraffin-Embedded Samples of Human Cancer and Normal Tissue	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; CHROMATIN IMMUNOPRECIPITATION; PATHOLOGY TISSUE; COPY-NUMBER; CARCINOMA; SPECIMENS; RESOLUTION; ARTIFACTS; SIGNATURE; PCR	Formalin-fixed, paraffin-embedded (FFPE) tissues are an invaluable resource for clinical research. However, nucleic acids extracted from FFPE tissues are fragmented and chemically modified making them challenging to use in molecular studies. We analysed 23 fresh-frozen (FF), 35 FFPE and 38 paired FF/FFPE specimens, representing six different human tissue types (bladder, prostate and colon carcinoma; liver and colon normal tissue; reactive tonsil) in order to examine the potential use of FFPE samples in next-generation sequencing (NGS) based retrospective and prospective clinical studies. Two methods for DNA and three methods for RNA extraction from FFPE tissues were compared and were found to affect nucleic acid quantity and quality. DNA and RNA from selected FFPE and paired FF/FFPE specimens were used for exome and transcriptome analysis. Preparations of DNA Exome-Seq libraries was more challenging (29.5% success) than that of RNA-Seq libraries, presumably because of modifications to FFPE tissue-derived DNA. Libraries could still be prepared from RNA isolated from two-decade old FFPE tissues. Data were analysed using the CLC Bio Genomics Workbench and revealed systematic differences between FF and FFPE tissue-derived nucleic acid libraries. In spite of this, pairwise analysis of DNA Exome-Seq data showed concordance for 70-80% of variants in FF and FFPE samples stored for fewer than three years. RNA-Seq data showed high correlation of expression profiles in FF/FFPE pairs (Pearson Correlations of 0.90 +/- 0.05), irrespective of storage time (up to 244 months) and tissue type. A common set of 1,494 genes was identified with expression profiles that were significantly different between paired FF and FFPE samples irrespective of tissue type. Our results are promising and suggest that NGS can be used to study FFPE specimens in both prospective and retrospective archive-based studies in which FF specimens are not available.	[Hedegaard, Jakob; Thorsen, Kasper; Vang, Soren; Nordentoft, Iver; Birkenkamp-Demtroder, Karin; Andersen, Claus Lindbjerg; Sorensen, Karina Dalsgaard; Pedersen, Jakob Skou; Orntoft, Torben Falck; Dyrskjot, Lars] Aarhus Univ Hosp, Mol Diagnost Lab, Dept Mol Med MOMA, DK-8000 Aarhus, Denmark; [Lund, Mette Katrine; Kruhoffer, Mogens] AROS Appl Biotechnol AS, Aarhus, Denmark; [Hein, Anne-Mette K.; Knudsen, Bjarne] CLC Bio, Aarhus, Denmark; [Hamilton-Dutoit, Stephen Jacques; Hager, Henrik] Aarhus Univ Hosp, Inst Pathol, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University	Hedegaard, J (corresponding author), Aarhus Univ Hosp, Mol Diagnost Lab, Dept Mol Med MOMA, DK-8000 Aarhus, Denmark.	Jakob.Hedegaard@ki.au.dk	Birkenkamp-Demtröder, Karin/AAN-1764-2021; Nordentoft, Iver/C-6345-2017; Pedersen, Jakob/G-3382-2012; Andersen, Claus L/C-1477-2017; Birkenkamp-Demtröder, Karin/C-1981-2017; Andersen, Claus Lindbjerg/A-9217-2012	Birkenkamp-Demtröder, Karin/0000-0001-8057-6277; Pedersen, Jakob/0000-0002-7236-4001; Sorensen, Karina Dalsgaard/0000-0002-4902-5490; Andersen, Claus Lindbjerg/0000-0002-7406-2103; Nordentoft, Iver Kristiansen/0000-0003-4856-4086; Hamilton-Dutoit, Stephen/0000-0003-2158-3885; Dyrskjot, Lars/0000-0001-7061-9851; Vang, Soren/0000-0002-1899-4205	Danish National Advanced Technology Foundation; John and Birthe Meyer Foundation; Danish Cancer Society; The Danish Cancer Society [R72-A4591] Funding Source: researchfish	Danish National Advanced Technology Foundation; John and Birthe Meyer Foundation; Danish Cancer Society(Danish Cancer Society); The Danish Cancer Society(Danish Cancer Society)	This work was supported by grants from The Danish National Advanced Technology Foundation (http://hoejteknologifonden.dk/), The John and Birthe Meyer Foundation and The Danish Cancer Society (http://www.cancer.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; Babraham Bioinformatics, 2014, FASTQC; Boeckx C, 2011, DIAGN MOL PATHOL, V20, P203, DOI 10.1097/PDM.0b013e3182230937; Do HD, 2013, CLIN CHEM, V59, P1376, DOI 10.1373/clinchem.2012.202390; Do HD, 2012, ONCOTARGET, V3, P546; Dyrskjot L, 2005, CLIN CANCER RES, V11, P4029, DOI 10.1158/1078-0432.CCR-04-2095; Dyrskjot L, 2012, BRIT J CANCER, V107, P1392, DOI 10.1038/bjc.2012.412; Fanelli M, 2011, NAT PROTOC, V6, P1905, DOI 10.1038/nprot.2011.406; Fanelli M, 2010, P NATL ACAD SCI USA, V107, P21535, DOI 10.1073/pnas.1007647107; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Kerick M, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-68; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Meng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064393; Morlan JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042882; Norton N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081925; Oster B, 2013, INT J CANCER, V132, P2303, DOI 10.1002/ijc.27921; R Core Team, 2014, R LANG ENV STAT COMP; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Sinicropi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040092; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Tuononen K, 2013, GENE CHROMOSOME CANC, V52, P503, DOI 10.1002/gcc.22047; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Wood HM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq510; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907	29	221	225	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98187	10.1371/journal.pone.0098187	http://dx.doi.org/10.1371/journal.pone.0098187			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878701	gold, Green Published			2022-12-25	WOS:000338101500036
J	Lee, G; Sparks, R; Ali, S; Shih, NNC; Feldman, MD; Spangler, E; Rebbeck, T; Tomaszewski, JE; Madabhushi, A				Lee, George; Sparks, Rachel; Ali, Sahirzeeshan; Shih, Natalie N. C.; Feldman, Michael D.; Spangler, Elaine; Rebbeck, Timothy; Tomaszewski, John E.; Madabhushi, Anant			Co-Occurring Gland Angularity in Localized Subgraphs: Predicting Biochemical Recurrence in Intermediate-Risk Prostate Cancer Patients	PLOS ONE			English	Article							RADICAL PROSTATECTOMY; POSTOPERATIVE NOMOGRAM; CELL-GRAPHS; PROBABILITY; PROGRESSION; VALIDATION; DEATH	Quantitative histomorphometry (QH) refers to the application of advanced computational image analysis to reproducibly describe disease appearance on digitized histopathology images. QH thus could serve as an important complementary tool for pathologists in interrogating and interpreting cancer morphology and malignancy. In the US, annually, over 60,000 prostate cancer patients undergo radical prostatectomy treatment. Around 10,000 of these men experience biochemical recurrence within 5 years of surgery, a marker for local or distant disease recurrence. The ability to predict the risk of biochemical recurrence soon after surgery could allow for adjuvant therapies to be prescribed as necessary to improve long term treatment outcomes. The underlying hypothesis with our approach, co-occurring gland angularity (CGA), is that in benign or less aggressive prostate cancer, gland orientations within local neighborhoods are similar to each other but are more chaotically arranged in aggressive disease. By modeling the extent of the disorder, we can differentiate surgically removed prostate tissue sections from (a) benign and malignant regions and (b) more and less aggressive prostate cancer. For a cohort of 40 intermediate-risk (mostly Gleason sum 7) surgically cured prostate cancer patients where half suffered biochemical recurrence, the CGA features were able to predict biochemical recurrence with 73% accuracy. Additionally, for 80 regions of interest chosen from the 40 studies, corresponding to both normal and cancerous cases, the CGA features yielded a 99% accuracy. CGAs were shown to be statistically signicantly (p<0.05) better at predicting BCR compared to state-of-the-art QH methods and postoperative prostate cancer nomograms.	[Lee, George; Ali, Sahirzeeshan; Madabhushi, Anant] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Sparks, Rachel] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA; [Shih, Natalie N. C.; Feldman, Michael D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA; [Spangler, Elaine; Rebbeck, Timothy] Univ Penn, Dept Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Tomaszewski, John E.] SUNY Buffalo, Dept Pathol & Anat Sci, Buffalo, NY 14260 USA	Case Western Reserve University; Rutgers State University New Brunswick; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Lee, G (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	george.lee@case.edu; anant.madabhushi@case.edu	Sparks, Rachel/AAM-5586-2020; Rebbeck, Timothy/GLU-8348-2022; Madabhushi, Anant/AAG-2908-2019	Sparks, Rachel/0000-0003-1553-7903; Rebbeck, Timothy/0000-0002-4799-1900; Madabhushi, Anant/0000-0002-5741-0399	Department of Defense [W81XWH-12-1-0171, W81XWH-11-1-0179]; National Cancer Institute of the National Institutes of Health [R01CA136535-01, R01CA140772-01, R21CA167811-01]; National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health [R43EB015199-01]; National Science Foundation [IIP-1248316]; QED award from the University City Science Center; Rutgers University; NATIONAL CANCER INSTITUTE [R21CA167811, P30CA016520, R01CA140772, R01CA136535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R43EB015199] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Science Foundation(National Science Foundation (NSF)); QED award from the University City Science Center; Rutgers University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by Department of Defense (W81XWH-12-1-0171); Department of Defense (W81XWH-11-1-0179); National Cancer Institute of the National Institutes of Health under award numbers R01CA136535-01, R01CA140772-01, and R21CA167811-01; the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health under award number R43EB015199-01; the National Science Foundation under award number IIP-1248316; and the QED award from the University City Science Center and Rutgers University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2013, P SPIE 8676, V8676; Ali S, 2012, IEEE T MED IMAGING, V31, P1448, DOI 10.1109/TMI.2012.2190089; Allsbrook WC, 2001, HUM PATHOL, V32, P81, DOI 10.1053/hupa.2001.21135; Bilgin C, 2007, P ANN INT IEEE EMBS, P5311, DOI 10.1109/IEMBS.2007.4353540; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; ChristensBarry WA, 1997, J HOPKINS APL TECH D, V18, P226; Cooperberg MR, 2006, CANCER, V107, P2384, DOI 10.1002/cncr.22262; D'Amico AV, 2004, NEW ENGL J MED, V351, P125, DOI 10.1056/NEJMoa032975; Demir C, 2005, BIOINFORMATICS, V21, P7, DOI 10.1093/bioinformatics/bti1100; Doyle S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-282; Epstein JI, 2010, J UROLOGY, V183, P433, DOI 10.1016/j.juro.2009.10.046; Fagerland MW, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-78; Gunduz C, 2004, BIOINFORMATICS, V20, P145, DOI 10.1093/bioinformatics/bth933; Gunduz-Demir C, 2007, MATH BIOSCI, V209, P514, DOI 10.1016/j.mbs.2007.03.005; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Han M, 2003, J UROLOGY, V169, P517, DOI 10.1016/S0022-5347(05)63946-8; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hinev AI, 2011, J BUON, V16, P316; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Jafari-Khouzani K, 2003, IEEE T BIO-MED ENG, V50, P697, DOI 10.1109/TBME.2003.812194; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kattan MW, 1999, J CLIN ONCOL, V17, P1499, DOI 10.1200/JCO.1999.17.5.1499; LEE G, 2013, BIOMEDICAL IMAGING I, P113; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Monaco JP, 2010, MED IMAGE ANAL, V14, P617, DOI 10.1016/j.media.2010.04.007; Pinto F, 2006, UROL INT, V76, P202, DOI 10.1159/000091619; Stark JR, 2009, J CLIN ONCOL, V27, P3459, DOI 10.1200/JCO.2008.20.4669; Stephenson AJ, 2005, J CLIN ONCOL, V23, P7005, DOI 10.1200/JCO.2005.01.867; Tabesh A, 2007, IEEE T MED IMAGING, V26, P1366, DOI 10.1109/TMI.2007.898536; Trock BJ, 2008, JAMA-J AM MED ASSOC, V299, P2760, DOI 10.1001/jama.299.23.2760; Veltri RW, 2010, PROSTATE, V70, P1333, DOI 10.1002/pros.21168	31	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97954	10.1371/journal.pone.0097954	http://dx.doi.org/10.1371/journal.pone.0097954			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875018	Green Published, gold			2022-12-25	WOS:000336790800018
J	Sauvage, E; Derouaux, A; Fraipont, C; Joris, M; Herman, R; Rocaboy, M; Schloesser, M; Dumas, J; Kerff, F; Nguyen-Disteche, M; Charlier, P				Sauvage, Eric; Derouaux, Adeline; Fraipont, Claudine; Joris, Marine; Herman, Raphael; Rocaboy, Mathieu; Schloesser, Marie; Dumas, Jacques; Kerff, Frederic; Nguyen-Disteche, Martine; Charlier, Paulette			Crystal Structure of Penicillin-Binding Protein 3 (PBP3) from Escherichia coli	PLOS ONE			English	Article							BETA-LACTAM RESISTANCE; CELL-DIVISION; LYTIC TRANSGLYCOSYLASE; MEMBRANE-PROTEINS; GLOBULAR-PROTEINS; COMPLEX; LOCALIZATION; INHIBITOR; MACHINERY; MECHANISM	In Escherichia coli, penicillin-binding protein 3 (PBP3), also known as FtsI, is a central component of the divisome, catalyzing cross-linking of the cell wall peptidoglycan during cell division. PBP3 is mainly periplasmic, with a 23 residues cytoplasmic tail and a single transmembrane helix. We have solved the crystal structure of a soluble form of PBP3 (PBP3(57-577)) at 2.5 angstrom revealing the two modules of high molecular weight class B PBPs, a carboxy terminal module exhibiting transpeptidase activity and an amino terminal module of unknown function. To gain additional insight, the PBP3 Val88-Ser165 subdomain (PBP3(88-165)), for which the electron density is poorly defined in the PBP3 crystal, was produced and its structure solved by SAD phasing at 2.1 angstrom. The structure shows a three dimensional domain swapping with a beta-strand of one molecule inserted between two strands of the paired molecule, suggesting a possible role in PBP3(57-577) dimerization.	[Sauvage, Eric; Derouaux, Adeline; Fraipont, Claudine; Joris, Marine; Herman, Raphael; Rocaboy, Mathieu; Schloesser, Marie; Kerff, Frederic; Nguyen-Disteche, Martine; Charlier, Paulette] Univ Liege, Ctr Ingn Prot, Inst Phys B5a, Liege, Belgium; [Sauvage, Eric; Derouaux, Adeline; Fraipont, Claudine; Joris, Marine; Herman, Raphael; Rocaboy, Mathieu; Schloesser, Marie; Kerff, Frederic; Nguyen-Disteche, Martine; Charlier, Paulette] Inst Chim B6a, Liege, Belgium; [Dumas, Jacques] Sanofi R&D, Prot Prod, F-94403 Vitry Sur Seine, France	University of Liege; Sanofi-Aventis; Sanofi France	Sauvage, E (corresponding author), Univ Liege, Ctr Ingn Prot, Inst Phys B5a, Liege, Belgium.	Eric.Sauvage@ulg.ac.be			Belgian Program on Interuniversity Poles of Attraction; Fonds de la Recherche Scientifique [IISN 4.4505.09, IISN 4.4509.11, FRFC 2.4511.06F]; University of Liege (Fonds speciaux) [C-06/19, C-09/75]; FRIA (Fonds de la Recherche pour l'Industrie et l'Agriculture) fellowship (F.R.S.-FNRS, Brussels, Belgium)	Belgian Program on Interuniversity Poles of Attraction(Belgian Federal Science Policy Office); Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); University of Liege (Fonds speciaux)(University of Liege); FRIA (Fonds de la Recherche pour l'Industrie et l'Agriculture) fellowship (F.R.S.-FNRS, Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS)	This work was supported in part by the Belgian Program on Interuniversity Poles of Attraction initiated by the Belgian State, Prime Minister's Office, Science Policy programming (IAP no. P6/19), the Fonds de la Recherche Scientifique, (IISN 4.4505.09, IISN 4.4509.11, FRFC 2.4511.06F), the University of Liege (Fonds speciaux, Credit classique, C-06/19 and C-09/75), and a return grant to AD. M. J. is recipient of a FRIA (Fonds de la Recherche pour l'Industrie et l'Agriculture) fellowship (F.R.S.-FNRS, Brussels, Belgium). FK is research associates of the FRS-FNRS, Belgium. Jacques Dumas is employed by Sanofi-Aventis. Sanofi-Aventis provided support in the form of salary for author JD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Bertsche U, 2006, MOL MICROBIOL, V61, P675, DOI 10.1111/j.1365-2958.2006.05280.x; Buddelmeijer N, 2004, MOL MICROBIOL, V52, P1315, DOI 10.1111/j.1365-2958.2004.04044.x; Chen Y, 2009, J AM CHEM SOC, V131, P14345, DOI 10.1021/ja903773f; Contreras-Martel C, 2009, J MOL BIOL, V387, P899, DOI 10.1016/j.jmb.2009.02.024; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DAI K, 1993, J BACTERIOL, V175, P3790, DOI 10.1128/JB.175.12.3790-3797.1993; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Di Lallo G, 2003, MICROBIOL-SGM, V149, P3353, DOI 10.1099/mic.0.26580-0; Dzhekieva L, 2010, BIOCHEMISTRY-US, V49, P6411, DOI 10.1021/bi100757c; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Fedarovich A, 2010, J MOL BIOL, V398, P54, DOI 10.1016/j.jmb.2010.02.046; FRAIPONT C, 1994, BIOCHEM J, V298, P189, DOI 10.1042/bj2980189; Fraipont C, 2011, MICROBIOL-SGM, V157, P251, DOI 10.1099/mic.0.040071-0; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Han S, 2011, J AM CHEM SOC, V133, P20536, DOI 10.1021/ja208835z; Jennings GT, 2002, EUR J BIOCHEM, V269, P3722, DOI 10.1046/j.1432-1033.2002.03064.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Kishida H, 2006, BIOCHEMISTRY-US, V45, P783, DOI 10.1021/bi051533t; Leimanis S, 2006, J BACTERIOL, V188, P6298, DOI 10.1128/JB.00334-06; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P50; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lovering AL, 2008, J MOL BIOL, V383, P167, DOI 10.1016/j.jmb.2008.08.020; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Marrec-Fairley M, 2000, MOL MICROBIOL, V37, P1019, DOI 10.1046/j.1365-2958.2000.02054.x; Massova I, 1998, ANTIMICROB AGENTS CH, V42, P1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Muller P, 2007, J BIOL CHEM, V282, P36394, DOI 10.1074/jbc.M706390200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGASAWA H, 1989, J BACTERIOL, V171, P5890, DOI 10.1128/jb.171.11.5890-5893.1989; Nicola G, 2005, BIOCHEMISTRY-US, V44, P8207, DOI 10.1021/bi0473004; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pares S, 1996, NAT STRUCT BIOL, V3, P284, DOI 10.1038/nsb0396-284; Powell AJ, 2009, J BIOL CHEM, V284, P1202, DOI 10.1074/jbc.M805761200; ROMEIS T, 1994, J BIOL CHEM, V269, P21603; Sainsbury S, 2011, J MOL BIOL, V405, P173, DOI 10.1016/j.jmb.2010.10.024; Sauvage E, 2002, CELL MOL LIFE SCI, V59, P1223, DOI 10.1007/s00018-002-8500-0; Sauvage E, 2007, J MOL BIOL; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; SPRATT BG, 1975, NATURE, V254, P516, DOI 10.1038/254516a0; Sung MT, 2009, P NATL ACAD SCI USA, V106, P8824, DOI 10.1073/pnas.0904030106; TASCHNER PEM, 1988, J BACTERIOL, V170, P4828, DOI 10.1128/jb.170.10.4828-4837.1988; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wissel MC, 2004, J BACTERIOL, V186, P490, DOI 10.1128/JB.186.2.490-502.2004; Yoshida H, 2012, J MOL BIOL, V423, P351, DOI 10.1016/j.jmb.2012.07.012; Young KD, 2003, MOL MICROBIOL, V49, P571, DOI 10.1046/j.1365-2958.2003.03607.x; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	58	40	42	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98042	10.1371/journal.pone.0098042	http://dx.doi.org/10.1371/journal.pone.0098042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875494	Green Published, Green Submitted, gold			2022-12-25	WOS:000336790800022
J	Morishita, M; Nabeka, H; Shimokawa, T; Miyawaki, K; Doihara, T; Saito, S; Kobayashi, N; Matsuda, S				Morishita, Midori; Nabeka, Hiroaki; Shimokawa, Tetsuya; Miyawaki, Kyojy; Doihara, Takuya; Saito, Shouichiro; Kobayashi, Naoto; Matsuda, Seiji			Temporal Changes in Prosaposin Expression in the Rat Dentate Gyrus after Birth	PLOS ONE			English	Article							FACIAL-NERVE NUCLEUS; ACTIVATOR PROTEIN; BETA-GLUCOSIDASE; MESSENGER-RNA; SAPOSIN-C; IN-VITRO; ADULT; NEUROGENESIS; IDENTIFICATION; PRECURSOR	Neurogenesis in the hippocampal dentate gyrus occurs constitutively throughout postnatal life. Adult neurogenesis includes a multistep process that ends with the formation of a postmitotic and functionally integrated new neuron. During adult neurogenesis, various markers are expressed, including GFAP, nestin, Pax6, polysialic acid-neural cell adhesion molecule (PSA-NCAM), neuronal nuclei (NeuN), doublecortin, TUC-4, Tuj-1, and calretinin. Prosaposin is the precursor of saposins A-D; it is found in various organs and can be excreted. Strong prosaposin expression has been demonstrated in the developing brain including the hippocampus, and its neurotrophic activity has been proposed. This study investigated changes in prosaposin in the dentate gyrus of young and adult rats using double immunohistochemistry with antibodies to prosaposin, PSA-NCAM, and NeuN. Prosaposin immunoreactivity was intense in the dentate gyrus at postnatal day 3 (P3) and P7, but decreased gradually after P14. In the dentate gyrus at P28, immature PSA-NCAM-positive neurons localized exclusively in the subgranular zone were prosaposin-negative, whereas mature Neu-N-positive neurons were positive for prosaposin. Furthermore, these prosaposin-negative immature neurons were saposin B-positive, suggesting that the neurons take up and degrade prosaposin. In situ hybridization assays showed that prosaposin in the adult dentate gyrus is dominantly the Pro+9 type, a secreted type of prosaposin. These results imply that prosaposin secreted from mature neurons stimulates proliferation and maturation of immature neurons in the dentate gyrus.	[Morishita, Midori; Nabeka, Hiroaki; Shimokawa, Tetsuya; Miyawaki, Kyojy; Doihara, Takuya; Matsuda, Seiji] Ehime Univ, Grad Sch Med, Dept Anat & Embryol, Toon, Ehime, Japan; [Miyawaki, Kyojy] Shikokuchuoh Med Welf Gen Coll, Shikokuchuoh, Ehime, Japan; [Saito, Shouichiro] Gifu Univ, Fac Appl Biol Sci, Lab Vet Anat, Gifu, Japan; [Kobayashi, Naoto] Ehime Univ, Grad Sch Med, Med Educ Ctr, Toon, Ehime, Japan	Ehime University; Gifu University; Ehime University	Shimokawa, T (corresponding author), Ehime Univ, Grad Sch Med, Dept Anat & Embryol, Toon, Ehime, Japan.	tshimo@m.ehime-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, of Japan [25450466, 24590254, 25462295]	Ministry of Education, Culture, Sports, Science and Technology, of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by grants to TS (No. 25450466), NK (No. 24590254), and SM (No. 25462295), from the Ministry of Education, Culture, Sports, Science and Technology, of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Campana WM, 2000, J PERIPHER NERV SYST, V5, P126, DOI 10.1046/j.1529-8027.2000.00019.x; Chen J, 2008, NEUROSCI RES, V60, P82, DOI 10.1016/j.neures.2007.09.010; Cohen T, 2004, MOL BRAIN RES, V129, P8, DOI 10.1016/j.molbrainres.2004.06.027; COLLARD MW, 1988, BIOCHEMISTRY-US, V27, P4557, DOI 10.1021/bi00412a050; Dai CF, 2000, AM J OTOL, V21, P115, DOI 10.1016/S0196-0709(00)80084-8; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FU Q, 1994, J MOL NEUROSCI, V5, P59, DOI 10.1007/BF02736694; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gao HL, 2013, NEUROSCIENCE, V236, P373, DOI 10.1016/j.neuroscience.2013.01.007; Gould E, 1999, BIOL PSYCHIAT, V46, P1472, DOI 10.1016/S0006-3223(99)00247-4; Henseler M, 1996, AM J HUM GENET, V58, P65; HINENO T, 1991, BIOCHEM BIOPH RES CO, V176, P668, DOI 10.1016/S0006-291X(05)80236-0; Hiraiwa M, 2003, J NEUROTRAUM, V20, P755, DOI 10.1089/089771503767869980; HOLTSCHMIDT H, 1991, J BIOL CHEM, V266, P7556; Hosoda Y, 2007, CELL TISSUE RES, V330, P197, DOI 10.1007/s00441-007-0464-9; Hozumi I, 1999, NEUROSCI LETT, V267, P73, DOI 10.1016/S0304-3940(99)00325-0; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Kotani Y, 1996, J NEUROCHEM, V66, P2197; Kuhn HG, 1996, J NEUROSCI, V16, P2027; LAMONTAGNE S, 1994, J BIOL CHEM, V269, P20528; Madar-Shapiro L, 1999, BIOCHEM J, V337, P433, DOI 10.1042/0264-6021:3370433; Misasi R, 2001, FASEB J, V15, P467, DOI 10.1096/fj.00-0217com; Morita F, 2001, J CEREBR BLOOD F MET, V21, P1295, DOI 10.1097/00004647-200111000-00005; Morris MA, 2001, FASEB J, V15, pA1026, DOI 10.1096/fj.00-0603fje; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; OBRIEN JS, 1988, SCIENCE, V241, P1098, DOI 10.1126/science.2842863; OBRIEN JS, 1994, P NATL ACAD SCI USA, V91, P9593, DOI 10.1073/pnas.91.20.9593; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Qi XY, 1996, J BIOL CHEM, V271, P6874, DOI 10.1074/jbc.271.12.6874; SANO A, 1988, J BIOL CHEM, V263, P19597; SANO A, 1994, BIOCHEM BIOPH RES CO, V204, P994, DOI 10.1006/bbrc.1994.2558; SANO A, 1989, BIOCHEM BIOPH RES CO, V165, P1191, DOI 10.1016/0006-291X(89)92728-9; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; Seki T, 1995, NEUROREPORT, V6, P2479, DOI 10.1097/00001756-199512150-00010; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; Shimokawa T, 2013, CELL TISSUE RES, V352, P685, DOI 10.1007/s00441-013-1575-0; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sikora J, 2007, ACTA NEUROPATHOL, V113, P163, DOI 10.1007/s00401-006-0148-7; Sun LP, 2010, ARCH BIOCHEM BIOPHYS, V502, P130, DOI 10.1016/j.abb.2010.08.007; Terashita T, 2013, ACTA OTO-LARYNGOL, V133, P462, DOI 10.3109/00016489.2012.750430; Tsuboi K, 1998, DEV BRAIN RES, V110, P249, DOI 10.1016/S0165-3806(98)00109-6; Unuma K, 2005, NEUROSCI RES, V52, P220, DOI 10.1016/j.neures.2005.03.009; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; WEILER S, 1995, PROTEIN SCI, V4, P756; Xue B, 2011, NEUROSCI RES, V71, P22, DOI 10.1016/j.neures.2011.06.001; Yokota N, 2001, STROKE, V32, P168, DOI 10.1161/01.STR.32.1.168; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao Q, 1997, MOL REPROD DEV, V48, P1, DOI 10.1002/(SICI)1098-2795(199709)48:1&lt;1::AID-MRD1&gt;3.0.CO;2-N	52	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e95883	10.1371/journal.pone.0095883	http://dx.doi.org/10.1371/journal.pone.0095883			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871372	Green Published, Green Submitted, gold			2022-12-25	WOS:000336858300003
J	Arakaki, R; Eguchi, H; Yamada, A; Kudo, Y; Iwasa, A; Enkhmaa, T; Hotta, F; Mitamura-Aizawa, S; Mitamura, Y; Hayashi, Y; Ishimaru, N				Arakaki, Rieko; Eguchi, Hiroshi; Yamada, Akiko; Kudo, Yasusei; Iwasa, Akihiko; Enkhmaa, Tserennadmid; Hotta, Fumika; Mitamura-Aizawa, Sayaka; Mitamura, Yoshinori; Hayashi, Yoshio; Ishimaru, Naozumi			Anti-Inflammatory Effects of Rebamipide Eyedrop Administration on Ocular Lesions in a Murine Model of Primary Sjogren's Syndrome	PLOS ONE			English	Article							AUTOIMMUNE EXOCRINOPATHY; HARDERIAN-GLAND; MOUSE MODEL; LACTOFERRIN; EXPRESSION; AUTOANTIGEN; DISRUPTION; CELLS; SERUM	Background: Topical therapy is effective for dry eye, and its prolonged effects should help in maintaining the quality of life of patients with dry eye. We previously reported that the oral administration of rebamipide (Reb), a mucosal protective agent, had a potent therapeutic effect on autoimmune lesions in a murine model of Sjogren's syndrome (SS). However, the effects of topical treatment with Reb eyedrops on the ocular lesions in the murine model of SS are unknown. Methods and Finding: Reb eyedrops were administered to the murine model of SS aged 4-8 weeks four times daily. Inflammatory lesions of the extraorbital and intraorbital lacrimal glands and Harderian gland tissues were histologically evaluated. The direct effects of Reb on the lacrimal glands were analyzed using cultured lacrimal gland cells. Tear secretions of Reb-treated mice were significantly increased compared with those of untreated mice. In addition to the therapeutic effect of Reb treatment on keratoconjunctivitis, severe inflammatory lesions of intraorbital lacrimal gland tissues in this model of SS were resolved. The mRNA expression levels of IL-10 and mucin 5Ac in conjunctival tissues from Reb-treated mice was significantly increased compared with those of control mice. Moreover, lactoferrin production from lacrimal gland cells was restored by Reb treatment. Conclusion: Topical Reb administration had an anti-inflammatory effect on the ocular autoimmune lesions in the murine model of SS and a protective effect on the ocular surfaces.	[Arakaki, Rieko; Yamada, Akiko; Kudo, Yasusei; Iwasa, Akihiko; Hayashi, Yoshio; Ishimaru, Naozumi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 770, Japan; [Eguchi, Hiroshi; Enkhmaa, Tserennadmid; Hotta, Fumika; Mitamura-Aizawa, Sayaka; Mitamura, Yoshinori] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Ophthalmol, Tokushima 770, Japan	Tokushima University; Tokushima University	Ishimaru, N (corresponding author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 770, Japan.	ishimaru.n@tokushima-u.ac.jp		Kudo, Yasusei/0000-0002-0392-7720	Funding Program for Next Generation World-Leading Researchers in Japan [LS090]; Ministry of Education, Science, Sport, and Culture of Japan [21792077, 23659946]	Funding Program for Next Generation World-Leading Researchers in Japan; Ministry of Education, Science, Sport, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by the Funding Program for Next Generation World-Leading Researchers in Japan (LS090), a Grant-in-Aid for Scientific Research (no. 21792077 and 23659946) from the Ministry of Education, Science, Sport, and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Balasubramanian SA, 2012, EXP EYE RES, V96, P132, DOI 10.1016/j.exer.2011.12.010; Bamba R, 2009, LARYNGOSCOPE, V119, P1922, DOI 10.1002/lary.20292; Chiorini JA, 2009, J AUTOIMMUN, V33, P190, DOI 10.1016/j.jaut.2009.09.009; Choi HS, 2013, LIFE SCI, V93, P69, DOI 10.1016/j.lfs.2013.05.019; DOANE MG, 1978, AM J OPHTHALMOL, V85, P383, DOI 10.1016/S0002-9394(14)77735-9; Dogru M, 2007, OPHTHALMOLOGY, V114, P2366, DOI 10.1016/j.ophtha.2007.06.027; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Fujihara T, 1998, J OCUL PHARMACOL TH, V14, P99, DOI 10.1089/jop.1998.14.99; Gesase AP, 1996, CELL TISSUE RES, V285, P501, DOI 10.1007/s004410050666; Goren MB, 1997, CORNEA, V16, P501, DOI 10.1097/00003226-199707000-00023; HANEJI N, 1994, J IMMUNOL, V153, P2769; Haneji N, 1997, SCIENCE, V276, P604, DOI 10.1126/science.276.5312.604; Iijima K, 2009, DIGEST DIS SCI, V54, P1500, DOI 10.1007/s10620-008-0507-4; Ishimaru N, 1999, AM J PATHOL, V155, P173, DOI 10.1016/S0002-9440(10)65111-5; Ishimaru N, 2000, AM J PATHOL, V156, P1557, DOI 10.1016/S0002-9440(10)65027-4; Ishimaru N, 2009, J IMMUNOL, V182, P6576, DOI 10.4049/jimmunol.0802289; Ishimaru N, 2008, J EXP MED, V205, P2915, DOI 10.1084/jem.20080174; JABS DA, 1994, ADV EXP MED BIOL, V350, P623; Kawashima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033148; Kinoshita S, 2014, AM J OPHTHALMOL, V157, P576, DOI 10.1016/j.ajo.2013.11.010; Kohashi M, 2008, ARTHRITIS RHEUM, V58, P389, DOI 10.1002/art.23163; Lavoie TN, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/549107; Lee BH, 2012, CLIN REV ALLERG IMMU, V42, P35, DOI 10.1007/s12016-011-8288-5; Mavragani CP, 2013, CURR OPIN RHEUMATOL, V25, P623, DOI 10.1097/BOR.0b013e328363eaa5; Naito Y, 2006, REDOX REP, V11, P243, DOI 10.1179/135100006X155021; Naito Y, 2010, EXPERT REV GASTROENT, V4, P261, DOI [10.1586/egh.10.25, 10.1586/EGH.10.25]; NETO ERV, 1992, J ANAT, V180, P75; Nielsen SM, 2010, J GASTROENTEROL, V45, P1121, DOI 10.1007/s00535-010-0271-z; Peri Y, 2012, BEST PRACT RES CL RH, V26, P105, DOI 10.1016/j.berh.2012.01.012; Quinto GG, 2012, CORNEA, V31, P424, DOI 10.1097/ICO.0b013e31823f0a64; Saegusa K, 2002, J CLIN INVEST, V110, P361, DOI 10.1172/JCI200214682; Saegusa K, 2000, J IMMUNOL, V165, P2251, DOI 10.4049/jimmunol.165.4.2251; SAKAI T, 1981, ARCH HISTOL JAPON, V44, P299, DOI 10.1679/aohc1950.44.299; Sanjabi S, 2009, CURR OPIN PHARMACOL, V9, P447, DOI 10.1016/j.coph.2009.04.008; SATOH Y, 1992, ACTA ANAT, V143, P7; Tanaka H, 2013, BRIT J OPHTHALMOL, V97, P912, DOI 10.1136/bjophthalmol-2012-302868; Tei M, 2000, INVEST OPHTH VIS SCI, V41, P82; Tsubota K, 2001, INVEST OPHTH VIS SCI, V42, P101; Urashima H, 2012, J OCUL PHARMACOL TH, V28, P264, DOI 10.1089/jop.2011.0147; Yoshimura A, 2003, CURR OPIN IMMUNOL, V15, P704, DOI 10.1016/j.coi.2003.09.004	40	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98390	10.1371/journal.pone.0098390	http://dx.doi.org/10.1371/journal.pone.0098390			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866156	gold, Green Submitted, Green Published			2022-12-25	WOS:000336914100055
J	Tani, Y; Isobe, Y; Imoto, Y; Segi-Nishida, E; Sugimoto, Y; Arai, H; Arita, M				Tani, Yukako; Isobe, Yosuke; Imoto, Yuki; Segi-Nishida, Eri; Sugimoto, Yukihiko; Arai, Hiroyuki; Arita, Makoto			Eosinophils control the resolution of inflammation and draining lymph node hypertrophy through the proresolving mediators and CXCL13 pathway in mice	FASEB JOURNAL			English	Article						lipid mediator; lipoxygenase	LIPID MEDIATORS; IN-VIVO; MACROPHAGES; CHEMOKINE; FOLLICLES; RECEPTOR; LYMPHANGIOGENESIS; NEUTROPHILS; EXPRESSION; LIPOXINS	Resolution of inflammation is critical to restoration of tissue function after an inflammatory response. We previously demonstrated that 12/15-lipoxygenase (12/15-LOX)-expressing eosinophils contribute to this process in murine zymosan-induced peritonitis. In this study, eosinophils promoted resolution by regulating expression of macrophage CXCL13. Microarray analysis revealed that eosinophils significantly increased (similar to 3-fold) the expression of macrophage CXCL13 by a 12/15-LOX-dependent mechanism. CXCL13 depletion caused a resolution defect, with the reduced appearance of phagocytes carrying engulfed zymosan in the draining lymph nodes. Inflamed lymph node hypertrophy, a critical feature of the resolution process, was reduced by similar to 60% in eosinophil-deficient mice, and adoptive transfer of eosinophils or administration of CXCL13 corrected this defect. Administration of the 12/15-LOX-derived mediator lipoxin A(4) (LXA(4)) increased the expression of CXCL13 and restored the defect of lymph node hypertrophy in eosinophil-deficient mice. These results demonstrate that eosinophils control the resolution of inflammation and draining lymph node hypertrophy through proresolving lipid mediators and the CXCL13 pathway in mice.	[Tani, Yukako; Isobe, Yosuke; Arai, Hiroyuki; Arita, Makoto] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Isobe, Yosuke; Arita, Makoto] RIKEN Ctr Integrat Med Sci, Lab Metabol, Kanagawa, Japan; [Arita, Makoto] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Saitama, Japan; [Imoto, Yuki; Segi-Nishida, Eri] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Kyoto, Japan; [Sugimoto, Yukihiko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Biochem, Kumamoto, Japan	University of Tokyo; RIKEN; Japan Science & Technology Agency (JST); Kyoto University; Kumamoto University	Arita, M (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	marita@mol.f.u-tokyo.ac.jp	Segi-Nishida, Eri/K-5059-2019; Sugimoto, Yukihiko/AAV-6470-2021	Sugimoto, Yukihiko/0000-0001-6973-932X; Arita, Makoto/0000-0001-9902-0463; Segi-Nishida, Eri/0000-0002-0803-6513	Japanese Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO); Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [25460096] Funding Source: KAKEN	Japanese Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Michiko Kamio and Ryo Iwamoto (Business-Academia Collaborative Laboratory, Graduate School of Pharmaceutical Sciences, University of Tokyo) for skillful technical assistance. This study was supported by the Japanese Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO) and a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to M. A.). The authors report no conflicts of interest.	Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; COLGAN SP, 1993, J CLIN INVEST, V92, P75, DOI 10.1172/JCI116601; Cupedo T, 2005, J IMMUNOL, V174, P21, DOI 10.4049/jimmunol.174.1.21; Cyster JG, 2000, IMMUNOL REV, V176, P181; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Kataru RP, 2009, BLOOD, V113, P5650, DOI 10.1182/blood-2008-09-176776; LARSEN GL, 1983, ANNU REV IMMUNOL, V1, P335, DOI 10.1146/annurev.iy.01.040183.002003; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lawrence T, 2007, INT J EXP PATHOL, V88, P85, DOI 10.1111/j.1365-2613.2006.00507.x; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mebius RE, 1996, P NATL ACAD SCI USA, V93, P11019, DOI 10.1073/pnas.93.20.11019; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2005, PROSTAG LEUKOTR ESS, V73, P141, DOI 10.1016/j.plefa.2005.05.002; Stables MJ, 2011, BLOOD, V118, pE192, DOI 10.1182/blood-2011-04-345330; TOMINAGA A, 1991, J EXP MED, V173, P429, DOI 10.1084/jem.173.2.429; van de Pavert SA, 2009, NAT IMMUNOL, V10, P1193, DOI 10.1038/ni.1789; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284	36	27	27	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					4036	4043		10.1096/fj.14-251132	http://dx.doi.org/10.1096/fj.14-251132			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24891522	Green Published			2022-12-25	WOS:000340845900021
J	Jiang, J; Yang, JF; Feng, P; Zuo, B; Dong, NZ; Wu, QY; He, Y				Jiang, Jiang; Yang, Jianfeng; Feng, Ping; Zuo, Bin; Dong, Ningzheng; Wu, Qingyu; He, Yang			N-Glycosylation Is Required for Matriptase-2 Autoactivation and Ectodomain Shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-DEFICIENCY ANEMIA; SERINE-PROTEASE MATRIPTASE-2; CELL-SURFACE; MOLECULAR-MECHANISMS; ZYMOGEN ACTIVATION; BREAST-CANCER; TMPRSS6 GENE; CORIN; EXPRESSION; MUTATIONS	Matriptase-2 is a hepatic membrane serine protease that regulates iron homeostasis. Defects in matriptase-2 cause iron deficiency anemia. In cells, matriptase-2 is synthesized as a zymogen. To date, how matriptase-2 expression and activation are regulated remains poorly understood. Here we expressed human matriptase-2 in HEK293 and hepatic BEL-7402, SMMC7721, and QGY-7703 cells. By labeling cell surface proteins and Western analysis, we examined matriptase-2 cell surface expression, zymogen activation, and ectodomain shedding. Our results show that matriptase-2 was activated on the cell surface but not intracellularly. Activated matriptase-2 underwent ectodomain shedding, producing soluble fragments in the conditioned medium. By testing inactive mutants, R576A and S762A, we found that matriptase-2 activation and shedding were mediated by its own catalytic activity and that the one-chain form of matriptase-2 had little activity in ectodomain shedding. We made additional matriptase-2 mutants, N136Q, N184Q, N216Q, N338Q, N433Q, N453Q, and N518Q, in which each of the predicted N-glycosylation sites was mutated. All of these mutants were expressed on the cell surface. However, mutants N216Q, N453Q, and N518Q, but not the other mutants, had impaired zymogen activation and ectodomain shedding. Our results indicate that N-glycans at specific sites are critical for matriptase-2 activation. Together, these data provide new insights into the cell surface expression, zymogen activation, and ectodomain shedding of matriptase-2.	[Jiang, Jiang; Yang, Jianfeng; Zuo, Bin; Dong, Ningzheng; Wu, Qingyu; He, Yang] Soochow Univ, Cyrus Tang Hematol Ctr, Affiliated Hosp 2, Suzhou 215006, Peoples R China; [Jiang, Jiang; Yang, Jianfeng; Zuo, Bin; Dong, Ningzheng; Wu, Qingyu; He, Yang] Soochow Univ, Minist Educ, Engn Ctr Hematol Dis, Affiliated Hosp 2, Suzhou 215006, Peoples R China; [Jiang, Jiang; Feng, Ping] Soochow Univ, Dept Clin Labs, Affiliated Hosp 2, Suzhou 215006, Peoples R China; [Dong, Ningzheng; He, Yang] Soochow Univ, Minist Hlth, Key Lab Thrombosis & Hemostasis, Jiangsu Inst Hematol,Affiliated Hosp 1, Suzhou 215006, Peoples R China; [Dong, Ningzheng; Wu, Qingyu; He, Yang] Soochow Univ, Collaborat Innovat Ctr Hematol, Suzhou 215006, Peoples R China; [Wu, Qingyu] Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China; Cleveland Clinic Foundation	Wu, QY (corresponding author), Cleveland Clin, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wuq@ccf.org; heyang1963@163.com		Wu, Qingyu/0000-0003-0561-9315	National Natural Science Foundation of China [81170247, 81370718, 31161130356]; Danish-Chinese Center on Proteases and Cancer; Chinese Ministry of Education [213016A]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Special Program of Medical Science Grant [BL2012005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Danish-Chinese Center on Proteases and Cancer; Chinese Ministry of Education(Ministry of Education, China); Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Special Program of Medical Science Grant	This work was supported in part by National Natural Science Foundation of China Grants 81170247, 81370718, and 31161130356; the Danish-Chinese Center on Proteases and Cancer; Key Project of Chinese Ministry of Education Grant 213016A; Priority Academic Program Development of Jiangsu Higher Education Institutions; and Jiangsu Special Program of Medical Science Grant BL2012005.	Altamura S, 2010, BIOCHEM J, V431, P363, DOI 10.1042/BJ20100668; Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; Arribas J, 1997, J BIOL CHEM, V272, P17160, DOI 10.1074/jbc.272.27.17160; Becherer JD, 2003, CURR TOP DEV BIOL, V54, P101, DOI 10.1016/S0070-2153(03)54006-6; Beliveau F, 2011, J BIOL CHEM, V286, P29035, DOI 10.1074/jbc.M111.223461; Beutler E, 2010, BLOOD CELL MOL DIS, V44, P16, DOI 10.1016/j.bcmd.2009.09.001; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897; Cui YJ, 2009, KIDNEY INT, V76, P1137, DOI 10.1038/ki.2009.357; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; De Falco L, 2010, HUM MUTAT, V31, pE1390, DOI 10.1002/humu.21243; Dong NZ, 2013, J BIOL CHEM, V288, P7867, DOI 10.1074/jbc.M112.411512; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Edison ES, 2009, BRIT J HAEMATOL, V147, P766, DOI 10.1111/j.1365-2141.2009.07879.x; Enns CA, 2012, J BIOL CHEM, V287, P35104, DOI 10.1074/jbc.M112.363937; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Folgueras AR, 2008, BLOOD, V112, P2539, DOI 10.1182/blood-2008-04-149773; Gladysheva IP, 2008, BIOCHEM BIOPH RES CO, V373, P130, DOI 10.1016/j.bbrc.2008.05.181; Guillem F, 2008, BLOOD, V112, P2089, DOI 10.1182/blood-2008-05-154740; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Hartikainen JM, 2006, CLIN CANCER RES, V12, P1454, DOI 10.1158/1078-0432.CCR-05-1417; Hooper JD, 2001, J BIOL CHEM, V276, P857, DOI 10.1074/jbc.R000020200; Hooper JD, 2003, BIOCHEM J, V373, P689, DOI 10.1042/BJ20030390; Jiang JJ, 2011, J BIOL CHEM, V286, P10066, DOI 10.1074/jbc.M110.185082; Jiang JJ, 2010, CLIN CHEM, V56, P959, DOI 10.1373/clinchem.2009.140558; Liao X, 2007, J BIOL CHEM, V282, P27728, DOI 10.1074/jbc.M703687200; Melis MA, 2008, HAEMATOL-HEMATOL J, V93, P1473, DOI 10.3324/haematol.13342; Miyake Y, 2010, BBA-PROTEINS PROTEOM, V1804, P156, DOI 10.1016/j.bbapap.2009.09.025; Moharir A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074299; Murphy G, 2009, SEMIN CELL DEV BIOL, V20, P138, DOI 10.1016/j.semcdb.2008.09.004; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Qi XF, 2011, J BIOL CHEM, V286, P20963, DOI 10.1074/jbc.M110.217570; Ramsay AJ, 2008, FRONT BIOSCI-LANDMRK, V13, P569, DOI 10.2741/2702; Ramsay AJ, 2009, HUM MOL GENET, V18, P3673, DOI 10.1093/hmg/ddp315; Ramsay AJ, 2009, HAEMATOL-HEMATOL J, V94, P840, DOI 10.3324/haematol.2008.001867; RODRIGUEZ CG, 1995, J BIOL CHEM, V270, P25178, DOI 10.1074/jbc.270.42.25178; Sato T, 2011, INT J HEMATOL, V94, P101, DOI 10.1007/s12185-011-0881-0; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Silvestri L, 2009, BLOOD, V113, P5605, DOI 10.1182/blood-2008-12-195594; Stirnberg M, 2010, BIOCHEM J, V430, P87, DOI 10.1042/BJ20091565; Tuhkanen H, 2013, INT J CANCER, V133, P2334, DOI 10.1002/ijc.28254; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200; Webb SL, 2012, ONCOL REP, V28, P1491, DOI 10.3892/or.2012.1945; Yan W, 2000, P NATL ACAD SCI USA, V97, P8525, DOI 10.1073/pnas.150149097; Zhao NN, 2013, J CLIN INVEST, V123, P2337, DOI 10.1172/JCI67225	47	28	28	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19500	19507		10.1074/jbc.M114.555110	http://dx.doi.org/10.1074/jbc.M114.555110			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24867957	Green Published, hybrid			2022-12-25	WOS:000339326800025
J	Iyer, V; Sampson, KJ; Kass, RS				Iyer, Vivek; Sampson, Kevin J.; Kass, Robert S.			Modeling Tissue- and Mutation- Specific Electrophysiological Effects in the Long QT Syndrome: Role of the Purkinje Fiber	PLOS ONE			English	Article							IDIOPATHIC VENTRICULAR-FIBRILLATION; ANDERSEN-TAWIL-SYNDROME; RECTIFIER K+ CURRENT; COMPUTATIONAL MODEL; LQT-3 MUTATION; MYOCYTES; ABLATION; BRUGADA; TACHYCARDIA; SIMULATION	Congenital long QT syndrome is a heritable family of arrhythmias caused by mutations in 13 genes encoding ion channel complex proteins. Mounting evidence has implicated the Purkinje fiber network in the genesis of ventricular arrhythmias. In this study, we explore the hypothesis that long QT mutations can demonstrate different phenotypes depending on the tissue type of expression. Using computational models of the human ventricular myocyte and the Purkinje fiber cell, the biophysical alteration in channel function in LQT1, LQT2, LQT3, and LQT7 are modeled. We identified that the plateau potential was important in LQT1 and LQT2, in which mutation led to minimal action potential prolongation in Purkinje fiber cells. The phenotype of LQT3 mutation was dependent on the biophysical alteration induced as well as tissue type. The canonical Delta KPQ mutation causes severe action potential prolongation in both tissue types. For LQT3 mutation F1473C, characterized by shifted channel availability, a more severe phenotype was seen in Purkinje fiber cells with action potential prolongation and early afterdepolarizations. The LQT3 mutation S1904L demonstrated striking effects on action potential duration restitution and more severe action potential prolongation in Purkinje fiber cells at higher heart rates. Voltage clamp simulations highlight the mechanism of effect of these mutations in different tissue types, and impact of drug therapy is explored. We conclude that arrhythmia formation in long QT syndrome may depend not only on the basis of mutation and biophysical alteration, but also upon tissue of expression. The Purkinje fiber network may represent an important therapeutic target in the management of patients with heritable channelopathies.	[Iyer, Vivek; Sampson, Kevin J.; Kass, Robert S.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10027 USA	Columbia University	Iyer, V (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10027 USA.	vi2108@columbia.edu			National Heart Lung and Blood Institute at the National Institutes of Health [K08HL116790]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL116790] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart Lung and Blood Institute at the National Institutes of Health http://www.nhlbi.nih.gov/[grant number K08HL116790 to VI]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baher AA, 2011, HEART RHYTHM, V8, P599, DOI 10.1016/j.hrthm.2010.11.038; Bankston JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001258; Bankston JR, 2007, CHANNELS, V1, P273, DOI 10.4161/chan.4956; Ben Caref E, 2008, EUROPACE, V10, P1218, DOI 10.1093/europace/eun248; Bendahhou S, 2003, J BIOL CHEM, V278, P51779, DOI 10.1074/jbc.M310278200; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; BEUCKELMANN DJ, 1992, BASIC RES CARDIOL, V87, P235; Bosch RF, 1998, CARDIOVASC RES, V38, P441, DOI 10.1016/S0008-6363(98)00021-2; Boyden PA, 2010, HEART RHYTHM, V7, P127, DOI 10.1016/j.hrthm.2009.09.017; Clancy CE, 2002, CIRCULATION, V105, P1208, DOI 10.1161/hc1002.105183; Clancy CE, 1999, NATURE, V400, P566, DOI 10.1038/23034; CRIJNS HJGM, 1995, J CARDIOVASC ELECTR, V6, P486, DOI 10.1111/j.1540-8167.1995.tb00421.x; Dumaine R, 2007, J MOL CELL CARDIOL, V42, P378, DOI 10.1016/j.yjmcc.2006.10.019; Dun W, 2008, J MOL CELL CARDIOL, V45, P617, DOI 10.1016/j.yjmcc.2008.08.001; Fredj S, 2006, CIRC RES, V99, P1225, DOI 10.1161/01.RES.0000251305.25604.b0; Gintant GA, 2001, J CARDIOVASC PHARM, V37, P607, DOI 10.1097/00005344-200105000-00012; Haissaguerre M, 2002, CIRCULATION, V106, P962, DOI 10.1161/01.CIR.0000027564.55739.B1; Haissaguerre M, 2003, CIRCULATION, V108, P925, DOI 10.1161/01.CIR.0000088781.99943.95; Haissaguerre M, 2002, LANCET, V359, P677, DOI 10.1016/S0140-6736(02)07807-8; Iyer V, 2004, BIOPHYS J, V87, P1507, DOI 10.1529/biophysj.104.043299; Li GR, 1999, AM J PHYSIOL-HEART C, V276, pH98, DOI 10.1152/ajpheart.1999.276.1.H98; Li GR, 1996, CIRC RES, V78, P689, DOI 10.1161/01.RES.78.4.689; Magyar J, 2000, PFLUG ARCH EUR J PHY, V441, P144, DOI 10.1007/s004240000400; Napolitano C, 2012, CIRCULATION, V125, P2027, DOI 10.1161/CIRCULATIONAHA.111.055947; Pourrier M, 2003, CIRC RES, V93, P189, DOI 10.1161/01.RES.0000084851.60947.B5; Sampson KJ, 2010, J PHYSIOL-LONDON, V588, P2643, DOI 10.1113/jphysiol.2010.187328; Seemann G, 2007, AM J PHYSIOL-HEART C, V292, pH549, DOI 10.1152/ajpheart.00701.2006; Silver ES, 2009, J INTERV CARD ELECTR, V26, P41, DOI 10.1007/s10840-009-9428-1; Smith Andrew H, 2006, Indian Pacing Electrophysiol J, V6, P32; Sung RJ, 2006, AM J PHYSIOL-HEART C, V291, pH2597, DOI 10.1152/ajpheart.00393.2006; ten Tusscher KHWJ, 2004, AM J PHYSIOL-HEART C, V286, pH1573, DOI 10.1152/ajpheart.00794.2003; Terrenoire C, 2013, J GEN PHYSIOL, V141, P61, DOI 10.1085/jgp.201210899; Tristani-Firouzi M, 2002, J CLIN INVEST, V110, P381, DOI 10.1172/JCI200215183; Weerasooriya R, 2003, HERZ, V28, P598, DOI 10.1007/s00059-003-2491-y; Xiao L, 2013, CIRC RES, V112, P1310, DOI 10.1161/CIRCRESAHA.112.300227	35	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97720	10.1371/journal.pone.0097720	http://dx.doi.org/10.1371/journal.pone.0097720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892747	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400019
J	Okabe, H; Delgado, E; Lee, JM; Yang, J; Kinoshita, H; Hayashi, H; Tsung, A; Behari, J; Beppu, T; Baba, H; Monga, SP				Okabe, Hirohisa; Delgado, Evan; Lee, Jung Min; Yang, Jing; Kinoshita, Hiroki; Hayashi, Hiromitsu; Tsung, Allan; Behari, Jaideep; Beppu, Toru; Baba, Hideo; Monga, Satdarshan P.			Role of Leukocyte Cell-Derived Chemotaxin 2 as a Biomarker in Hepatocellular Carcinoma	PLOS ONE			English	Article							MOUSE-LIVER TUMORS; BETA-CATENIN; CANCER; LECT2; PROMOTION; PATHWAY; MICE; HEPATOCARCINOGENESIS; IDENTIFICATION; REGENERATION	We sought to identify a secreted biomarker for beta-catenin activation commonly seen in hepatocellular carcinoma (HCC). By examination of our previously published genearray of hepatocyte-specific beta-catenin knockout (KO) livers, we identified secreted factors whose expression may be beta-catenin-dependent. We verified expression and secretion of the leading factor in HCC cells transfected with mutated (Hep3B(S33Y))-beta-catenin. Serum levels of biomarker were next investigated in a mouse model of HCC with beta-catenin gene (Ctnnb1) mutations and eventually in HCC patients. Leukocyte cell-derived chemotaxin-2 (LECT2) expression was decreased in KO livers. Hep3B(S33Y) expressed and secreted more LECT2 in media as compared to Hep3B(WT). Mice developing HCC with Ctnnb1 mutations showed significantly higher serum LECT2 levels. However patients with CTNNB1 mutations showed LECT2 levels of 54.28 +/- 22.32 ng/mL (Mean +/- SD; n = 8) that were insignificantly different from patients with non-neoplastic chronic liver disease (32.8 +/- 21.1 ng/mL; n = 15) or healthy volunteers (33.2 +/- 7.2 ng/mL; n = 11). Intriguingly, patients without beta-catenin mutations showed significantly higher serum LECT2 levels (54.26 +/- 22.25 ng/mL; n = 46). While beta-catenin activation was evident in a subset of non-mutant beta-catenin HCC group with high LECT2 expression, serum LECT2 was unequivocally similar between beta-catenin-active and -normal group. Further analysis showed that LECT2 levels greater than 50 ng/ml diagnosed HCC in patients irrespective of beta-catenin mutations with specificity of 96.1% and positive predictive value of 97.0%. Thus, LECT2 is regulated by beta-catenin in HCC in both mice and men, but serum LECT2 reflects beta-catenin activity only in mice. Serum LECT2 could be a potential biomarker of HCC in patients.	[Okabe, Hirohisa; Delgado, Evan; Lee, Jung Min; Yang, Jing; Monga, Satdarshan P.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; [Okabe, Hirohisa; Kinoshita, Hiroki; Hayashi, Hiromitsu; Beppu, Toru; Baba, Hideo] Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, Kumamoto, Japan; [Tsung, Allan] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA; [Behari, Jaideep; Monga, Satdarshan P.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Beppu, Toru] Kumamoto Univ Hosp, Dept Multidisciplinary Treatment Gastroenterol Ca, Kumamoto, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kumamoto University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kumamoto University	Monga, SP (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	smonga@pitt.edu		Delgado, Evan/0000-0003-2706-0946; Monga, Satdarshan/0000-0002-8437-3378	NIH [1R01DK62277, R01DK100287]; Endowed Chair for Experimental Pathology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100287, R01DK062277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endowed Chair for Experimental Pathology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by NIH grants 1R01DK62277, R01DK100287 and Endowed Chair for Experimental Pathology to SPM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anson M, 2012, J CLIN INVEST, V122, P586, DOI 10.1172/JCI43937; Awuah PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039771; Aydinlik H, 2001, ONCOGENE, V20, P7812, DOI 10.1038/sj.onc.1204982; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Cadoret A, 2002, ONCOGENE, V21, P8293, DOI 10.1038/sj.onc.1206118; Dahmani R, 2011, CLIN RES HEPATOL GAS, V35, P709, DOI 10.1016/j.clinre.2011.05.010; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Han ZG, 2012, ANNU REV GENOM HUM G, V13, P171, DOI 10.1146/annurev-genom-090711-163752; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Lachenmayer A, 2012, CLIN CANCER RES, V18, P4997, DOI 10.1158/1078-0432.CCR-11-2322; Lee JM, 2013, CANC LETT; Loeppen S, 2002, CANCER RES, V62, P5685; Monga SPS, 2011, INT J BIOCHEM CELL B, V43, P1021, DOI 10.1016/j.biocel.2009.09.001; Nejak-Bowen KN, 2009, J BIOL CHEM, V284, P28115, DOI 10.1074/jbc.M109.047258; Nejak-Bowen KN, 2011, SEMIN CANCER BIOL, V21, P44, DOI 10.1016/j.semcancer.2010.12.010; Okabe H, 2012, INT J CANCER, V131, P2234, DOI 10.1002/ijc.27496; Okumura A, 2013, BIOSCI TRENDS, V7, P276, DOI 10.5582/bst.2013.v7.6.276; Ovejero C, 2004, HEPATOLOGY, V40, P167, DOI 10.1002/hep.20286; Rignall B, 2011, CARCINOGENESIS, V32, P52, DOI 10.1093/carcin/bgq226; Sato Y, 2004, TRANSPL P, V36, P2357, DOI 10.1016/j.transproceed.2004.07.006; Sato Y, 2004, TRANSPL P, V36, P2359, DOI 10.1016/j.transproceed.2004.07.007; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591; Wickline ED, 2013, NEOPLASIA, V15, P421, DOI 10.1593/neo.122098; Yamagoe S, 1997, BIOCHEM BIOPH RES CO, V237, P116, DOI 10.1006/bbrc.1997.7095; Yamagoe S, 1996, IMMUNOL LETT, V52, P9, DOI 10.1016/0165-2478(96)02572-2; Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607; Zhang XF, 2010, HEPATOLOGY, V52, P954, DOI 10.1002/hep.23747	29	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98817	10.1371/journal.pone.0098817	http://dx.doi.org/10.1371/journal.pone.0098817			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892551	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000336911400097
J	Vannini, A; Roncarati, D; Spinsanti, M; Scarlato, V; Danielli, A				Vannini, Andrea; Roncarati, Davide; Spinsanti, Marco; Scarlato, Vincenzo; Danielli, Alberto			In Depth Analysis of the Helicobacter pylori cag Pathogenicity Island Transcriptional Responses	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; VIRULENCE GENE-EXPRESSION; III SECRETION SYSTEM; IV SECRETION; GROWTH-PHASE; IRON; VIVO; INTERLEUKIN-8; ARCHITECTURE; INDUCTION	The severity of symptoms elicited by the widespread human pathogen Helicobacter pylori is strongly influenced by the genetic diversity of the infecting strain. Among the most important pathogen factors that carry an increased risk for gastric cancer are specific genotypes of the cag pathogenicity island (cag-PAI), encoding a type IV secretion system (T4SS) responsible for the translocation of the CagA effector oncoprotein. To date, little is known about the regulatory events important for the expression of a functional cag-T4SS. Here we demonstrate that the cag-PAI cistrons are subjected to a complex network of direct and indirect transcriptional regulations. We show that promoters of cag operons encoding structural T4SS components display homogeneous transcript levels, while promoters of cag operons encoding accessory factors vary considerably in their basal transcription levels and responses. Most cag promoters are transcriptionally responsive to growth-phase, pH and other stress-factors, although in many cases in a pleiotropic fashion. Interestingly, transcription from the Pcag zeta promoter controlling the expression of transglycolase and T4SS stabilizing factors, is triggered by co-culture with a gastric cell line, providing an explanation for the increased formation of the secretion system observed upon bacterial contact with host cells. Finally, we demonstrate that the highly transcribed cagA oncogene is repressed by iron limitation through a direct apo-Fur regulation mechanism. Together the results shed light on regulatory aspects of the cag-PAI, which may be involved in relevant molecular and etiological aspects of H. pylori pathogenesis.	[Vannini, Andrea; Roncarati, Davide; Spinsanti, Marco; Scarlato, Vincenzo; Danielli, Alberto] Univ Bologna, Dept Pharm & Biotechnol FaBiT, Bologna, Italy	University of Bologna	Scarlato, V (corresponding author), Univ Bologna, Dept Pharm & Biotechnol FaBiT, Bologna, Italy.	vincenzo.scarlato@unibo.it; alberto.danielli@unibo.it	DANIELLI, ALBERTO/AFQ-1474-2022; Scarlato, Vincenzo/B-8558-2019	DANIELLI, ALBERTO/0000-0002-9414-9898; Scarlato, Vincenzo/0000-0003-4227-677X; RONCARATI, DAVIDE/0000-0001-6923-6087; VANNINI, ANDREA/0000-0002-3767-3132	Italian Ministry of Instruction University and Research [2007LHN9JL, 2010P3S8BR]; Fondazione del Monte di Bologna [FDM756]; University of Bologna; PhD program in Functional Biology of Molecular and Cellular Systems of the University of Bologna	Italian Ministry of Instruction University and Research(Ministry of Education, Universities and Research (MIUR)); Fondazione del Monte di Bologna; University of Bologna; PhD program in Functional Biology of Molecular and Cellular Systems of the University of Bologna	This research was supported by grants from the Italian Ministry of Instruction University and Research (grant 2007LHN9JL to AD and grant 2010P3S8BR to VS), by Fondazione del Monte di Bologna (FDM756) to AD, and by the University of Bologna to VS. AV was the recipient of a fellowship from the PhD program in Functional Biology of Molecular and Cellular Systems of the University of Bologna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agriesti F, 2014, NUCLEIC ACIDS RES, V42, P3138, DOI 10.1093/nar/gkt1258; Backert S, 2005, TRENDS MICROBIOL, V13, P476, DOI 10.1016/j.tim.2005.08.002; Booniakuakul JK, 2004, J INFECT DIS, V190, P946, DOI 10.1086/423142; Boonjakuakul JK, 2005, INFECT IMMUN, V73, P4895, DOI 10.1128/IAI.73.8.4895-4904.2005; Bourzac KM, 2005, CELL MICROBIOL, V7, P911, DOI 10.1111/j.1462-5822.2005.00541.x; Busler VJ, 2006, J BACTERIOL, V188, P4787, DOI 10.1128/JB.00066-06; Carpenter BM, 2013, J BACTERIOLOGY; Christie PJ, 2004, BBA-MOL CELL RES, V1694, P219, DOI 10.1016/j.bbamcr.2004.02.013; Danielli A, 2006, J BACTERIOL, V188, P4654, DOI 10.1128/JB.00120-06; Danielli A, 2010, FEMS MICROBIOL REV, V34, P738, DOI 10.1111/j.1574-6976.2010.00233.x; Danielli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000938; Danielli A, 2009, J BACTERIOL, V191, P3717, DOI 10.1128/JB.01741-08; de Reuse H, 2007, FEMS IMMUNOL MED MIC, V50, P165, DOI 10.1111/j.1574-695X.2007.00244.x; Delany I, 2001, MOL MICROBIOL, V42, P1297, DOI 10.1046/j.1365-2958.2001.02696.x; Ellermeier CD, 2005, MOL MICROBIOL, V57, P691, DOI 10.1111/j.1365-2958.2005.04737.x; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Ernst FD, 2005, MICROBIOL-SGM, V151, P533, DOI 10.1099/mic.0.27404-0; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Fischer W, 2011, FEBS J, V278, P1203, DOI 10.1111/j.1742-4658.2011.08036.x; Gancz H, 2006, INFECT IMMUN, V74, P602, DOI 10.1128/IAI.74.1.602-614.2006; Gieseler S, 2005, MICROBES INFECT, V7, P437, DOI 10.1016/j.micinf.2004.11.018; Johnson EM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00017; Joyce EA, 2001, INFECT IMMUN, V69, P4202, DOI 10.1128/IAI.69.7.4202-4209.2001; Karita M, 1996, INFECT IMMUN, V64, P4501, DOI 10.1128/IAI.64.11.4501-4507.1996; Kikuchi K, 2012, MICROBES INFECT, V14, P470, DOI 10.1016/j.micinf.2011.12.003; Kim N, 2004, INFECT IMMUN, V72, P2358, DOI 10.1128/IAI.72.4.2358-2368.2004; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Merrell DS, 2003, INFECT IMMUN, V71, P3529, DOI 10.1128/IAI.71.6.3529-3539.2003; Muller A, 2012, J CLIN INVEST, V122, P1192, DOI 10.1172/JCI61578; Noto JM, 2013, J CLIN INVEST, V123, P479, DOI 10.1172/JCI64373; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Pflock M, 2006, J BACTERIOL, V188, P3449, DOI 10.1128/JB.188.10.3449-3462.2006; Pich OQ, 2012, MOL MICROBIOL, V84, P921, DOI 10.1111/j.1365-2958.2012.08066.x; Rieder G, 1997, INFECT IMMUN, V65, P3622, DOI 10.1128/IAI.65.9.3622-3630.1997; Roncarati D, 2007, J BACTERIOL, V189, P7234, DOI 10.1128/JB.00626-07; Roncarati D, 2011, J BACTERIOL, V193, P5629, DOI 10.1128/JB.05295-11; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Scott DR, 2007, P NATL ACAD SCI USA, V104, P7235, DOI 10.1073/pnas.0702300104; Sexton JA, 2004, INFECT IMMUN, V72, P5983, DOI 10.1128/IAI.72.10.5983-5992.2004; Shaffer CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002237; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sieira R, 2013, FUTURE MICROBIOL, V8, P1193, DOI 10.2217/fmb.13.83; Spohn G, 1997, MOL MICROBIOL, V26, P361, DOI 10.1046/j.1365-2958.1997.5831949.x; Szczebara F, 1999, FEMS MICROBIOL LETT, V175, P165, DOI 10.1016/S0378-1097(99)00188-3; Ta LH, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00046; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Terradot L, 2011, FEBS J, V278, P1213, DOI 10.1111/j.1742-4658.2011.08037.x; Thompson LJ, 2003, INFECT IMMUN, V71, P2643, DOI 10.1128/IAI.71.5.2643-2655.2003; Vannini A, 2012, APPL ENVIRON MICROB, V78, P6524, DOI 10.1128/AEM.01252-12; Wen Y, 2003, INFECT IMMUN, V71, P5921, DOI 10.1128/IAI.71.10.5921-5939.2003; Yahr TL, 2006, MOL MICROBIOL, V62, P631, DOI 10.1111/j.1365-2958.2006.05412.x; Zhang ZW, 2002, J MED MICROBIOL, V51, P495, DOI 10.1099/0022-1317-51-6-495	52	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98416	10.1371/journal.pone.0098416	http://dx.doi.org/10.1371/journal.pone.0098416			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892739	gold, Green Published, Green Submitted			2022-12-25	WOS:000336911400049
J	Bill, A; Rosethorne, EM; Kent, TC; Fawcett, L; Burchell, L; van Diepen, MT; Marelli, A; Batalov, S; Miraglia, L; Orth, AP; Renaud, NA; Charlton, SJ; Gosling, M; Gaither, LA; Groot-Kormelink, PJ				Bill, Anke; Rosethorne, Elizabeth M.; Kent, Toby C.; Fawcett, Lindsay; Burchell, Lynn; van Diepen, Michiel T.; Marelli, Anthony; Batalov, Sergey; Miraglia, Loren; Orth, Anthony P.; Renaud, Nicole A.; Charlton, Steven J.; Gosling, Martin; Gaither, L. Alex; Groot-Kormelink, Paul J.			High Throughput Mutagenesis for Identification of Residues Regulating Human Prostacyclin (hIP) Receptor Expression and Function	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; DIRECTED PROTEIN EVOLUTION; DNA-POLYMERASE; SYNTHETIC MUTATIONS; CYSTEINE RESIDUES; LIGAND-BINDING; MICE LACKING; IN-VITRO; FIDELITY; ACTIVATION	The human prostacyclin receptor (hIP receptor) is a seven-transmembrane G protein-coupled receptor (GPCR) that plays a critical role in vascular smooth muscle relaxation and platelet aggregation. hIP receptor dysfunction has been implicated in numerous cardiovascular abnormalities, including myocardial infarction, hypertension, thrombosis and atherosclerosis. Genomic sequencing has discovered several genetic variations in the PTGIR gene coding for hIP receptor, however, its structure-function relationship has not been sufficiently explored. Here we set out to investigate the applicability of high throughput random mutagenesis to study the structure-function relationship of hIP receptor. While chemical mutagenesis was not suitable to generate a mutagenesis library with sufficient coverage, our data demonstrate error-prone PCR (epPCR) mediated mutagenesis as a valuable method for the unbiased screening of residues regulating hIP receptor function and expression. Here we describe the generation and functional characterization of an epPCR derived mutagenesis library compromising >4000 mutants of the hIP receptor. We introduce next generation sequencing as a useful tool to validate the quality of mutagenesis libraries by providing information about the coverage, mutation rate and mutational bias. We identified 18 mutants of the hIP receptor that were expressed at the cell surface, but demonstrated impaired receptor function. A total of 38 non-synonymous mutations were identified within the coding region of the hIP receptor, mapping to 36 distinct residues, including several mutations previously reported to affect the signaling of the hIP receptor. Thus, our data demonstrates epPCR mediated random mutagenesis as a valuable and practical method to study the structure-function relationship of GPCRs.	[Bill, Anke; Renaud, Nicole A.; Gaither, L. Alex] Novartis Inst Biomed Res, Cambridge, MA USA; [Rosethorne, Elizabeth M.; Kent, Toby C.; Fawcett, Lindsay; Burchell, Lynn; van Diepen, Michiel T.; Charlton, Steven J.; Gosling, Martin; Groot-Kormelink, Paul J.] Novartis Inst Biomed Res, Resp Dis Area, Horsham, W Sussex, England; [Marelli, Anthony; Batalov, Sergey; Miraglia, Loren; Orth, Anthony P.] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Groot-Kormelink, Paul J.] Novartis Inst Biomed Res, Musculoskeletal Dis Area, Basel, Switzerland	Novartis; Novartis; Novartis; Novartis	Groot-Kormelink, PJ (corresponding author), Novartis Inst Biomed Res, Resp Dis Area, Horsham, W Sussex, England.	paul.groot-kormelink@novartis.com		Batalov, Sergey/0000-0002-0925-0554; van Diepen, Michiel/0000-0001-8156-4294; Bill, Anke/0000-0003-1244-7574; Charlton, Steven/0000-0001-8841-2752; Rosethorne, Elizabeth/0000-0001-6877-2320	Novartis Institutes for Biomedical Research	Novartis Institutes for Biomedical Research	The work was funded by Novartis Institutes for Biomedical Research. The authors contributed to the manuscript as follows: PJGK, AM, APO, and LM designed and made the IPR mutant library as well as contributed to the overall design and conclusions of the study and the writing of the paper. AB, TCK, ER, LF, LB, and MTvD designed the functional screen, screened the IPR mutant library and followed up on the resulting mutants as well as contributed to the overall design and conclusions of the study and the writing of the paper. AB and NAR designed and executed the NGS dataset and analyzed the NGS results. PJGK and SB created the mutation rate program. PJGK, AB, TCK, ER, APO, SJC, MG and LAG all had considerable input in the design of the study, the conclusions made from the study and the writing of the paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arehart E, 2008, CIRC RES, V102, P986, DOI 10.1161/CIRCRESAHA.107.165936; BECKMAN RA, 1985, BIOCHEMISTRY-US, V24, P5810, DOI 10.1021/bi00342a019; Binkowski BF, 2011, METHODS MOL BIOL, V756, P263, DOI 10.1007/978-1-61779-160-4_14; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Cline J, 1996, NUCLEIC ACIDS RES, V24, P3546, DOI 10.1093/nar/24.18.3546; Drummond DA, 2005, J MOL BIOL, V350, P806, DOI 10.1016/j.jmb.2005.05.023; Eckert K A, 1991, PCR Methods Appl, V1, P17; ECKERT KA, 1993, J BIOL CHEM, V268, P13462; Egan KM, 2004, SCIENCE, V306, P1954, DOI 10.1126/science.1103333; Fan F, 2008, ACS CHEM BIOL, V3, P346, DOI 10.1021/cb8000414; Giguere V, 2004, EUR J PHARMACOL, V494, P11, DOI 10.1016/j.ejphar.2004.04.041; KADONAGA JT, 1985, NUCLEIC ACIDS RES, V13, P1733, DOI 10.1093/nar/13.5.1733; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; Kuwano K, 2007, J PHARMACOL EXP THER, V322, P1181, DOI 10.1124/jpet.107.124248; Labrou NE, 2010, CURR PROTEIN PEPT SC, V11, P91, DOI 10.2174/138920310790274617; Martin KA, 2009, PROG MOL BIOL TRANSL, V89, P133, DOI 10.1016/S1877-1173(09)89006-6; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Rasila TS, 2009, ANAL BIOCHEM, V388, P71, DOI 10.1016/j.ab.2009.02.008; Saito S, 2003, J HUM GENET, V48, P461, DOI 10.1007/s10038-003-0062-y; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Selifonova O, 2001, APPL ENVIRON MICROB, V67, P3645, DOI 10.1128/AEM.67.8.3645-3649.2001; SHORTLE D, 1978, P NATL ACAD SCI USA, V75, P2170, DOI 10.1073/pnas.75.5.2170; Stitham J, 2007, BRIT J PHARMACOL, V152, P513, DOI 10.1038/sj.bjp.0707413; Stitham J, 2004, BIOCHEMISTRY-US, V43, P8974, DOI 10.1021/bi0496788; Stitham J, 2003, J BIOL CHEM, V278, P4250, DOI 10.1074/jbc.M207420200; Stitham J, 2002, J BIOL CHEM, V277, P15439, DOI 10.1074/jbc.M201187200; Stitham J, 2002, MOL PHARMACOL, V61, P1202, DOI 10.1124/mol.61.5.1202; Stitham J, 2007, GENE, V396, P180, DOI 10.1016/j.gene.2007.03.016; Stitham J, 2007, PROSTAG OTH LIPID M, V82, P95, DOI 10.1016/j.prostaglandins.2006.05.010; Stitham J, 2006, J BIOL CHEM, V281, P37227, DOI 10.1074/jbc.M604042200; Stitham J, 2011, J BIOL CHEM, V286, P7060, DOI 10.1074/jbc.M110.124933; STOLARSKI R, 1987, BIOCHEMISTRY-US, V26, P4332, DOI 10.1021/bi00388a022; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; Vanhercke T, 2005, ANAL BIOCHEM, V339, P9, DOI 10.1016/j.ab.2004.11.032; Wang D, 2000, J COMPUT BIOL, V7, P143, DOI 10.1089/10665270050081423; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wong TS, 2006, J MOL BIOL, V355, P858, DOI 10.1016/j.jmb.2005.10.082; Wong TS, 2006, COMB CHEM HIGH T SCR, V9, P271, DOI 10.2174/138620706776843192; Xiao CY, 2001, CIRCULATION, V104, P2210, DOI 10.1161/hc4301.098058; Zhang ZB, 2001, MOL PHARMACOL, V60, P480	42	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97973	10.1371/journal.pone.0097973	http://dx.doi.org/10.1371/journal.pone.0097973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886841	Green Published, Green Accepted, gold			2022-12-25	WOS:000336956300030
J	Gong, WZ; Qi, PF; Du, JB; Sun, X; Wu, XL; Song, C; Liu, WG; Wu, YS; Yu, XB; Yong, TW; Wang, XC; Yang, F; Yan, YH; Yang, WY				Gong, Wanzhuo; Qi, Pengfei; Du, Junbo; Sun, Xin; Wu, Xiaoling; Song, Chun; Liu, Weiguo; Wu, Yushan; Yu, Xiaobo; Yong, Taiwen; Wang, Xiaochun; Yang, Feng; Yan, Yanhong; Yang, Wenyu			Transcriptome Analysis of Shade-Induced Inhibition on Leaf Size in Relay Intercropped Soybean	PLOS ONE			English	Article							GENE-EXPRESSION; GLUCOSE PYROPHOSPHORYLASE; LIGHT IRRADIANCE; CELL-DIVISION; CO2 DIFFUSION; ARABIDOPSIS; AUXIN; COMPLEX; GROWTH; AVOIDANCE	Multi-species intercropping is a sustainable agricultural practice worldwide used to utilize resources more efficiently. In intercropping systems, short crops often grow under vegetative shade of tall crops. Soybean, one important legume, is often planted in intercropping. However, little is known about the mechanisms of shade inhibition effect on leaf size in soybean leaves at the transcriptome level. We analyzed the transcriptome of shaded soybean leaves via RNA-Seq technology. We found that transcription 1085 genes in mature leaves and 1847 genes in young leaves were significantly affected by shade. Gene ontology analyses showed that expression of genes enriched in polysaccharide metabolism was down-regulated, but genes enriched in auxin stimulus were up-regulated in mature leaves; and genes enriched in cell cycling, DNA-replication were down-regulated in young leaves. These results suggest that the inhibition of higher auxin content and shortage of sugar supply on cell division and cell expansion contribute to smaller and thinner leaf morphology, which highlights potential research targets such as auxin and sugar regulation on leaves for crop adaptation to shade in intercropping.	[Gong, Wanzhuo; Du, Junbo; Sun, Xin; Wu, Xiaoling; Liu, Weiguo; Wu, Yushan; Yu, Xiaobo; Yong, Taiwen; Wang, Xiaochun; Yang, Feng; Yang, Wenyu] Sichuan Agr Univ, Coll Agron, Chengdu, Peoples R China; [Gong, Wanzhuo; Du, Junbo; Sun, Xin; Wu, Xiaoling; Song, Chun; Liu, Weiguo; Wu, Yushan; Yu, Xiaobo; Yong, Taiwen; Wang, Xiaochun; Yang, Feng; Yang, Wenyu] Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Chengdu, Peoples R China; [Qi, Pengfei] Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Peoples R China; [Song, Chun] Sichuan Agr Univ, Coll Resource & Environm, Chengdu, Peoples R China; [Yan, Yanhong] Sichuan Agr Univ, Coll Anim Sci & Technol, Yaan, Peoples R China	Sichuan Agricultural University; Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University; Sichuan Agricultural University; Sichuan Agricultural University	Yang, WY (corresponding author), Sichuan Agr Univ, Coll Agron, Chengdu, Peoples R China.	wenyu.yang@263.net	Song, Chun/B-8298-2019	Song, Chun/0000-0001-9927-2599; Wu, Yushan/0000-0003-4190-0294	National Natural Science Foundation of China [31171476, 531071373]; National Program on Key Basic Research Project [1 2011CB100402]; China Agriculture Research System [CARS-04-PS19]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key Basic Research Project(National Basic Research Program of China); China Agriculture Research System	This work was supported by National Natural Science Foundation of China (No. 31171476 & 531071373), National Program on Key Basic Research Project (1 2011CB100402), and the China Agriculture Research System (CARS-04-PS19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YO, 2010, CARBOHYD RES, V345, P55, DOI 10.1016/j.carres.2009.08.025; Ainsworth EA, 2006, PLANT PHYSIOL, V142, P135, DOI 10.1104/pp.106.086256; Akihiro T, 2005, PLANT CELL PHYSIOL, V46, P937, DOI 10.1093/pcp/pci101; Ballare CL, 1999, TRENDS PLANT SCI, V4, P97, DOI 10.1016/S1360-1385(99)01383-7; Beemster GTS, 2005, PLANT PHYSIOL, V138, P734, DOI 10.1104/pp.104.053884; Bolon YT, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-41; Campbell P, 1999, TRENDS PLANT SCI, V4, P361, DOI 10.1016/S1360-1385(99)01468-5; Casal JJ, 2012, SHADE AVOIDANCE ARAB, pe0157; Casal JJ, 2013, ANNU REV PLANT BIOL, V64, P403, DOI 10.1146/annurev-arplant-050312-120221; Chen H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-122; Cleland RE, 2004, PLANT HORMONES: BIOSYNTHESIS, SIGNAL TRANSDUCTION, ACTION, P204; Cookson SJ, 2006, ANN BOT-LONDON, V97, P443, DOI 10.1093/aob/mcj047; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Echarte L, 2011, FIELD CROP RES, V121, P423, DOI 10.1016/j.fcr.2011.01.011; Endler A, 2011, MOL PLANT, V4, P199, DOI 10.1093/mp/ssq079; Evans JR, 2013, PLANT PHYSIOL, V162, P1780, DOI 10.1104/pp.113.219006; Evans JR, 2009, J EXP BOT, V60, P2235, DOI 10.1093/jxb/erp117; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Francis C.A., 1989, ADV AGRON, V42, P1; Franklin KA, 2005, ANN BOT-LONDON, V96, P169, DOI 10.1093/aob/mci165; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Gao Y, 2010, AGR WATER MANAGE, V98, P199, DOI 10.1016/j.agwat.2010.08.021; Ghosh PK, 2009, EUR J AGRON, V31, P43, DOI 10.1016/j.eja.2009.03.002; Gommers CMM, 2013, TRENDS PLANT SCI, V18, P65, DOI 10.1016/j.tplants.2012.09.008; Gonzalez N, 2012, TRENDS PLANT SCI, V17, P332, DOI 10.1016/j.tplants.2012.02.003; Granier C, 2000, J PLANT GROWTH REGUL, V19, P45, DOI 10.1007/s003440000006; Halliday KJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001586; HENDRIX DL, 1993, CROP SCI, V33, P1306, DOI 10.2135/cropsci1993.0011183X003300060037x; Horiguchi G, 2006, J PLANT RES, V119, P37, DOI 10.1007/s10265-005-0232-4; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Kadowaki M, 2001, J AGRON CROP SCI, V186, P37, DOI 10.1046/j.1439-037x.2001.00451.x; Keller CP, 2007, PHYSIOL PLANTARUM, V130, P580, DOI 10.1111/j.1399-3054.2007.00916.x; Keller CP, 2011, PLANT SIGNAL BEHAV, V6, P1997, DOI 10.4161/psb.6.12.18026; Kim KH, 2011, DNA RES, V18, P483, DOI 10.1093/dnares/dsr033; Kozuka T, 2005, PLANT CELL PHYSIOL, V46, P213, DOI 10.1093/pcp/pci016; Kurepin LV, 2007, J EXP BOT, V58, P2145, DOI 10.1093/jxb/erm068; Kurepin LV, 2011, PLANT GROWTH REGUL, V65, P255, DOI 10.1007/s10725-011-9596-8; Langeveld SMJ, 2002, PLANT PHYSIOL, V129, P278, DOI 10.1104/pp.010720; Lerouxel O, 2006, CURR OPIN PLANT BIOL, V9, P621, DOI 10.1016/j.pbi.2006.09.009; Libault M, 2009, PLANT PHYSIOL, V151, P1207, DOI 10.1104/pp.109.144030; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljung K, 2001, PLANT J, V28, P465, DOI 10.1046/j.1365-313X.2001.01173.x; Malezieux E, 2009, AGRON SUSTAIN DEV, V29, P43, DOI 10.1051/agro:2007057; Matsye PD, 2011, PLANT MOL BIOL, V77, P513, DOI 10.1007/s11103-011-9828-3; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murchie EH, 2005, J EXP BOT, V56, P449, DOI 10.1093/jxb/eri100; Mutwil M, 2008, CURR OPIN PLANT BIOL, V11, P252, DOI 10.1016/j.pbi.2008.03.007; Nagano AJ, 2012, CELL, V151, P1358, DOI 10.1016/j.cell.2012.10.048; Niinemets U, 2010, ECOL RES, V25, P693, DOI 10.1007/s11284-010-0712-4; OGREN E, 1993, PLANTA, V189, P182, DOI 10.1007/BF00195075; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Perrot-Rechenmann C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001446; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Sasidharan R, 2010, PLANT PHYSIOL, V154, P978, DOI 10.1104/pp.110.162057; Sato Y, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-10; Scarpella E, 2010, COLD SPRING HARBOR P, V2; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Terashima I, 2006, J EXP BOT, V57, P343, DOI 10.1093/jxb/erj014; Terashima I, 2001, J PLANT RES, V114, P93, DOI 10.1007/PL00013972; Terashima I, 2011, PLANT PHYSIOL, V155, P108, DOI 10.1104/pp.110.165472; Tholen D, 2012, PLANT SCI, V197, P92, DOI 10.1016/j.plantsci.2012.09.005; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsukaya H, 2005, INT J DEV BIOL, V49, P547, DOI 10.1387/ijdb.041921ht; Tsukaya H, 2006, ANNU REV PLANT BIOL, V57, P477, DOI 10.1146/annurev.arplant.57.032905.105320; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Van Volkenburgh E, 1999, PLANT CELL ENVIRON, V22, P1463, DOI 10.1046/j.1365-3040.1999.00514.x; Vandenbussche F, 2005, CURR OPIN PLANT BIOL, V8, P462, DOI 10.1016/j.pbi.2005.07.007; Vandenbussche F, 2003, PLANT PHYSIOL, V133, P517, DOI 10.1104/pp.103.022665; Vile D, 2005, ANN BOT-LONDON, V96, P1129, DOI 10.1093/aob/mci264; Walters RG, 2005, J EXP BOT, V56, P435, DOI 10.1093/jxb/eri060; Wang J.W., 2009, PLANT QUARANTINE, V1, P1, DOI DOI 10.1371/J0URNAL.PGEN.1000350; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206	79	40	49	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98465	10.1371/journal.pone.0098465	http://dx.doi.org/10.1371/journal.pone.0098465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886785	gold, Green Submitted, Green Published			2022-12-25	WOS:000336956300069
J	Jafari, B; Elias, JA; Mohsenin, V				Jafari, Behrouz; Elias, Jack A.; Mohsenin, Vahid			Increased Plasma YKL-40/Chitinase-3-Like-Protein-1 Is Associated with Endothelial Dysfunction in Obstructive Sleep Apnea	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ALL-CAUSE MORTALITY; GROWTH-FACTOR; YKL-40 LEVELS; CARDIOVASCULAR-DISEASE; RISK-FACTOR; ATHEROSCLEROSIS; HYPERTENSION; PROTEINS; GP38K	Purpose: Obstructive sleep apnea (OSA) is a common disorder affecting 15-24% of the adults and is associated with increased risk of hypertension and atherosclerosis. The exact mechanisms underlying hypertension in OSA are not entirely clear. YKL-40/Chitinase-3-like protein-1 is a circulating moiety with roles in injury, repair and angiogenesis that is dysregulated in atherosclerosis and a number of other diseases. We sought to determine the role of YKL-40 in endothelial dysfunction and hypertension in OSA. Methods: We studies 23 normotensive OSA (N-OSA) and 14 hypertensive OSA (H-OSA) without diabetes and apparent cardiovascular disease. Endothelial-dependent nitric oxide-mediated vasodilatory capacity was assessed by flow-mediated vasodilation (FMD). YKL-40, vascular endothelial growth factor (VEGF) and the soluble form of VEGF receptor-1 or sFlt-1 were measured in plasma using ELISA methodology. Results: N-OSA subjects aged 49.1 +/- 2.3 years and H-OSA aged 51.3 +/- 1.9 years with BMI 36.1 +/- 1.6 and 37.6 +/- 1.9 kg/m(2), respectively. The apnea-hypopnea index (AHI) was 41 +/- 5 events/hr in N-OSA and 46 +/- 6 in H-OSA with comparable degree of oxygen desaturations during sleep. FMD was markedly impaired in H-OSA (8.3%+/- 0.8) compared to N-OSA (13.2%+/- 0.6, P < 0.0001). Plasma YKL-40 was significantly elevated in H-OSA (55.2 +/- 7.9 ng/ml vs. 35.6 +/- 4.2 ng/ml in N-OSA, P = 0.02) and had an inverse relationship with FMD (r = -0.52, P = 0.013). There was a significant positive correlation between sFlt-1/VEGF, a measure of decreased VEGF availability, and YKL-40 (r = 0.42, P = 0.04). Conclusion: The levels of plasma YKL-40 were elevated in H-OSA group and inversely correlated with the endothelial-dependent vasodilatory capacity whereas there was a positive correlation between sFlt-1/VEGF and YKL-40. These findings suggest that YKL-40 is dysregulated, in part, due to perturbation of VEGF signaling, and may contribute to endothelial dysfunction and hypertension in OSA.	[Jafari, Behrouz] Univ Calif Irvine, Sect Pulm Crit Care & Sleep Med, Irvine, CA USA; [Elias, Jack A.] Warren Alpert Sch Med, Providence, RI USA; [Mohsenin, Vahid] Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT 06520 USA; John B Pierce Lab, New Haven, CT USA	University of California System; University of California Irvine; Yale University; Yale University; The John B Pierce Laboratory, Inc	Mohsenin, V (corresponding author), Yale Univ, Sch Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT 06520 USA.	Vahid.mohsenin@yale.edu	Jafari, Behrouz/W-9280-2019	Jafari, Behrouz/0000-0003-3463-8558	National Institutes of Health [5T32HL07778, HL093017]; Yale University;  [U01-HL-108638]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL108638, R01HL093017, T32HL007778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from National Institutes of Health to BJ (5T32HL07778) and JAE (HL093017), as well as by Yale University, Section of Pulmonary, Critical Care and Sleep Medicine intramural grant and U01-HL-108638. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkeson A, 2009, PROG CARDIOVASC DIS, V51, P351, DOI 10.1016/j.pcad.2008.08.002; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; Catalan V, 2011, J CLIN ENDOCR METAB, V96, P200, DOI 10.1210/jc.2010-0994; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Drager LF, 2005, AM J RESP CRIT CARE, V172, P613, DOI 10.1164/rccm.200503-340OC; Ferrara N, 2001, Am J Physiol Cell Physiol, V280, pC1358; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harutyunyan M, 2013, IMMUNOBIOLOGY, V218, P945, DOI 10.1016/j.imbio.2012.10.015; Harutyunyan M, 2012, IMMUNOBIOLOGY, V217, P652, DOI 10.1016/j.imbio.2011.11.003; He CH, 2013, CELL REP, V4, P830, DOI 10.1016/j.celrep.2013.07.032; Jafari B, 2012, AM J HYPERTENS, V25, P854, DOI 10.1038/ajh.2012.56; Johansen JS, 1996, BRIT J RHEUMATOL, V35, P553; Karumanchi SA, 2006, METH MOLEC MED, V122, P393; Kastrup J, 2009, EUR HEART J, V30, P1066, DOI 10.1093/eurheartj/ehp049; Kjaergaard AD, 2010, ANN NEUROL, V68, P672, DOI 10.1002/ana.22220; Lazarus Alon, 2011, Proc Am Thorac Soc, V8, P508, DOI 10.1513/pats.201102-021MW; Lu FX, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.024; Ma Wei-hong, 2012, BMC Cardiovasc Disord, V12, P35, DOI 10.1186/1471-2261-12-35; Malinda KM, 1999, EXP CELL RES, V250, P168, DOI 10.1006/excr.1999.4511; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mohsenin V, 2011, RESP MED, V105, P801, DOI 10.1016/j.rmed.2011.01.001; Mohsenin V, 2009, SLEEP MED, V10, P759, DOI 10.1016/j.sleep.2008.09.005; Nishikawa KC, 2003, EXP CELL RES, V287, P79, DOI 10.1016/S0014-4827(03)00069-7; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Rathcke CN, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-61; Rathcke CN, 2010, INT J CARDIOL, V143, P35, DOI 10.1016/j.ijcard.2009.01.043; Rondbjerg AK, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-54; Rossi R, 2004, J AM COLL CARDIOL, V44, P1636, DOI 10.1016/j.jacc.2004.07.027; Saidi A, 2008, INT J CANCER, V122, P2187, DOI 10.1002/ijc.23313; SHACKELTON LM, 1995, J BIOL CHEM, V270, P13076, DOI 10.1074/jbc.270.22.13076; Shah NA, 2010, SLEEP BREATH, V14, P131, DOI 10.1007/s11325-009-0298-7; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Valipour A, 2004, RESP MED, V98, P1180, DOI 10.1016/j.rmed.2004.04.009; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704	38	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98629	10.1371/journal.pone.0098629	http://dx.doi.org/10.1371/journal.pone.0098629			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878721	Green Published, gold			2022-12-25	WOS:000338101500076
J	Wu, IC; Lin, MY; Yu, FJ; Hsieh, HM; Chiu, KF; Wu, MT				Wu, I-Chen; Lin, Ming-Yen; Yu, Fang-Jung; Hsieh, Hui-Min; Chiu, Kuei-Fen; Wu, Ming-Tsang			A Short-Term Effect of Low-Dose Aspirin on Major Hemorrhagic Risks in Primary Prevention: A Case-Crossover Design	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; RANDOMIZED-TRIAL; LUNG-CANCER; EVENTS; STROKE; ASSOCIATION; BENEFITS; DRUGS	Background: Very few studies have examined the risk of short-term adverse hemorrhage of low-dose aspirin use in primary prevention. This case-crossover study examined the transient effect of low-dose aspirin use on major hemorrhagic risks. Methods: A representative database of 1,000,000 patients randomly sampled from the Taiwan's National Health Insurance Research Database in 2000 was analyzed. The study cohort consisted of a total of 501,946 individuals, aged 30-95 years old, at risk of a major bleeding event in 2000. A case-crossover study was used to retrieve data on 10,905 incident patients with major hemorrhagic complications (3,781 cerebral and 7,124 gastrointestinal) and prescribed low-dose aspirin (<= 300 mg/day) from 2000-2008. A 56-day time window (similar to 2 months) was used as the case period for which the odds ratio (OR) was estimated using the ratio of patients exposed during the 56-day case period only (1-56 days before the index date) compared to its corresponding 56-day control period only (57-112 days before the index date). Results: Four hundred eighty-nine (4.5%) of the 10,905 hemorrhagic patients had used low-dose aspirin during the 56-day case only period; 294 (2.7%) of the same patients had used low-dose aspirin during control only period. Low-dose aspirin use increase the risk of developing a major hemorrhage 1.33-fold (95% CI = 1.13-1.55, P<0.0001). Significance was found prominent in 4,453 non-hypertensive and non-diabetic subjects (Adjusted odds ratio = 1.88, 95% CI = 1.21-2.91). Conclusion: Transient low-dose aspirin use increases risk for major hemorrhagic events in Han Chinese.	[Wu, I-Chen; Lin, Ming-Yen; Yu, Fang-Jung; Hsieh, Hui-Min; Wu, Ming-Tsang] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Wu, I-Chen; Yu, Fang-Jung; Wu, Ming-Tsang] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Chiu, Kuei-Fen] Kaohsiung Municipal Tatung Hosp, Kaohsiung, Taiwan; [Wu, Ming-Tsang] Kaohsiung Municipal Hsiaokang Hosp, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Wu, MT (corresponding author), Kaohsiung Med Univ, Kaohsiung, Taiwan.	960021@cc.kmuh.org.tw	Wu, Ming-Tsang/G-5637-2012; Lin, Ming Yen/A-8637-2010	Wu, Ming-Tsang/0000-0001-7307-7816; Lin, Ming Yen/0000-0002-8194-4833	Kaohsiung Medical University Hospital [KMUH97-7G65]; National Science Council [NSC 101-2314-B-037-037-MY3]; Taiwan's National Health Research Institutes [NHRI-EX102-10209PI]	Kaohsiung Medical University Hospital; National Science Council(Ministry of Science and Technology, Taiwan); Taiwan's National Health Research Institutes	This study was supported by grants from Kaohsiung Medical University Hospital (KMUH97-7G65), the National Science Council (NSC 101-2314-B-037-037-MY3), and Taiwan's National Health Research Institutes (NHRI-EX102-10209PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed HM, 2012, AM J CARDIOL, V109, P288, DOI 10.1016/j.amjcard.2011.08.042; Calonge N, 2009, ANN INTERN MED, V150, P396; Caso V, 2012, EUR J INTERN MED, V23, P580, DOI 10.1016/j.ejim.2012.04.010; Chan AT, 2012, LANCET, V379, P1569, DOI 10.1016/S0140-6736(11)61654-1; Chang CH, 2011, J CLIN ONCOL, V29, P3001, DOI 10.1200/JCO.2011.35.1908; Chen PC, 2011, STROKE, V42, P3034, DOI 10.1161/STROKEAHA.111.615534; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; De Berardis G, 2012, JAMA-J AM MED ASSOC, V307, P2286, DOI 10.1001/jama.2012.5034; DiNicolantonio JJ, 2012, JAMA-J AM MED ASSOC, V308, P1088, DOI 10.1001/2012.jama.10717; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; Hankey GJ, 2006, LANCET, V367, P606, DOI 10.1016/S0140-6736(06)68040-9; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Lai CH, 2011, STROKE, V42, P2615, DOI 10.1161/STROKEAHA.111.617076; Lai SW, 2012, CLIN LUNG CANCER, V13, P143, DOI 10.1016/j.cllc.2011.10.002; Lee SM, 2013, STROKE, V44, P2139, DOI 10.1161/STROKEAHA.111.674077; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lin JS, 2010, BEHAV COUNSELING PRO; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Meade Tom, 2012, Handb Exp Pharmacol, P565, DOI 10.1007/978-3-642-29423-5_23; Morimoto T, 2004, AM J MED, V117, P459, DOI 10.1016/j.amjmed.2004.04.017; Nemerovski CW, 2012, PHARMACOTHERAPY, V32, P1020, DOI 10.1002/phar.1127; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Raju NC, 2012, CURR OPIN CARDIOL, V27, P499, DOI 10.1097/HCO.0b013e328356ae95; Rembold CM, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-12-201206190-02003; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Schneeweiss S, 1997, PHARMACOEPIDEM DR S, V6, pS51, DOI 10.1002/(SICI)1099-1557(199710)6:3+<S51::AID-PDS301>3.3.CO;2-J; Siller-Matula JM, 2012, JAMA-J AM MED ASSOC, V307, P2318, DOI 10.1001/jama.2012.6152; Tantry US, 2005, EXPERT OPIN PHARMACO, V6, P2027, DOI 10.1517/14656566.6.12.2027; The Medical Research Council's General Practice Research Framework, 1988, LANCET, V351, P233; Thornley S, 2012, INTERN MED J, V42, P46, DOI 10.1111/j.1445-5994.2012.02902.x; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; US Centers for Diseases Control and Prevention, INT CLASS DIS 9 REV; Wu CS, 2011, AM J PSYCHIAT, V168, P511, DOI 10.1176/appi.ajp.2010.10071064; Yamane K, 2012, J ATHEROSCLER THROMB, V19, P1142, DOI 10.5551/jat.14100	39	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98326	10.1371/journal.pone.0098326	http://dx.doi.org/10.1371/journal.pone.0098326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879431	Green Submitted, gold, Green Published			2022-12-25	WOS:000338101500050
J	Christiaen, SEA; Motherway, MO; Bottacini, F; Lanigan, N; Casey, PG; Huys, G; Nelis, HJ; van Sinderen, D; Coenye, T				Christiaen, Steven E. A.; Motherway, Mary O'Connell; Bottacini, Francesca; Lanigan, Noreen; Casey, Pat G.; Huys, Geert; Nelis, Hans J.; van Sinderen, Douwe; Coenye, Tom			Autoinducer-2 Plays a Crucial Role in Gut Colonization and Probiotic Functionality of Bifidobacterium breve UCC2003	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; COMMENSAL-HOST INTERACTION; DNA-MICROARRAY DATA; QUORUM-SENSING ROLE; CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; IMMUNE MODULATION; IRON ACQUISITION; LUXS; LACTOBACILLUS	In the present study we show that luxS of Bifidobacterium breve UCC2003 is involved in the production of the interspecies signaling molecule autoinducer-2 (AI-2), and that this gene is essential for gastrointestinal colonization of a murine host, while it is also involved in providing protection against Salmonella infection in Caenorhabditis elegans. We demonstrate that a B. breve luxS-insertion mutant is significantly more susceptible to iron chelators than the WT strain and that this sensitivity can be partially reverted in the presence of the AI-2 precursor DPD. Furthermore, we show that several genes of an iron starvation-induced gene cluster, which are downregulated in the luxS-insertion mutant and which encodes a presumed iron-uptake system, are transcriptionally upregulated under in vivo conditions. Mutation of two genes of this cluster in B. breve UCC2003 renders the derived mutant strains sensitive to iron chelators while deficient in their ability to confer gut pathogen protection to Salmonella-infected nematodes. Since a functional luxS gene is present in all tested members of the genus Bifidobacterium, we conclude that bifidobacteria operate a LuxS-mediated system for gut colonization and pathogen protection that is correlated with iron acquisition.	[Christiaen, Steven E. A.; Nelis, Hans J.; Coenye, Tom] Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium; [Motherway, Mary O'Connell; Bottacini, Francesca; Lanigan, Noreen; Casey, Pat G.; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Motherway, Mary O'Connell; Bottacini, Francesca; Lanigan, Noreen; Casey, Pat G.; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Huys, Geert] Univ Ghent, Microbiol Lab, B-9000 Ghent, Belgium; [Huys, Geert] Univ Ghent, BCCM LMG Bacteria Collect, B-9000 Ghent, Belgium	Ghent University; University College Cork; University College Cork; Ghent University; Ghent University	Coenye, T (corresponding author), Univ Ghent, Lab Pharmaceut Microbiol, B-9000 Ghent, Belgium.	Coenye@UGent.be	Huys, Geert R.B./V-8633-2019; Coenye, Tom/Z-1928-2019; Coenye, Tom/A-6291-2014; Van Sinderen, Douwe/A-6778-2015; Huys, Geert/M-6781-2019; Bottacini, Francesca/AAO-2431-2021	Huys, Geert R.B./0000-0002-7092-4837; Coenye, Tom/0000-0002-6407-0601; Coenye, Tom/0000-0002-6407-0601; Van Sinderen, Douwe/0000-0003-1823-7957; Bottacini, Francesca/0000-0002-0142-2956; O'Connell Motherway, Mary/0000-0001-9164-9320	IWT Vlaanderen (Instituut voor Innovatie door Wetenschap en Technologie Vlaanderen); Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office; HRB postdoctoral fellowship [PDTM/20011/9]; IRCSET postgraduate fellowship; Science Foundation Ireland (SFI) [07/CE/B1368, SFI/12/RC/2273]	IWT Vlaanderen (Instituut voor Innovatie door Wetenschap en Technologie Vlaanderen); Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office; HRB postdoctoral fellowship; IRCSET postgraduate fellowship; Science Foundation Ireland (SFI)(Science Foundation Ireland)	This work was financially supported by IWT Vlaanderen (Instituut voor Innovatie door Wetenschap en Technologie Vlaanderen), and the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office. This publication has emanated from research conducted with the financial support of a HRB postdoctoral fellowship (Grant no. PDTM/20011/9) awarded to MOCM and Science Foundation Ireland (SFI) awards under Grant Numbers 07/CE/B1368 and SFI/12/RC/2273; FB acknowledges financial assistance through an IRCSET postgraduate fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Martin P, 2007, APPL MICROBIOL BIOT, V76, P1395, DOI 10.1007/s00253-007-1115-5; Barrett E, 2013, ARCH DIS CHILD-FETAL, V98, pF334, DOI 10.1136/archdischild-2012-303035; Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9; BASSLER BL, 1993, MOL MICROBIOL, V9, P773, DOI 10.1111/j.1365-2958.1993.tb01737.x; Brackman G, 2011, ANTIMICROB AGENTS CH, V55, P2655, DOI 10.1128/AAC.00045-11; Brown JS, 2002, MICROBES INFECT, V4, P1149, DOI 10.1016/S1286-4579(02)01640-4; Buck BL, 2009, J APPL MICROBIOL, V107, P269, DOI 10.1111/j.1365-2672.2009.04204.x; Butler CC, 2012, BMJ CLIN RES ED, V344, pe682; Cabana MD, 2010, J PEDIATR-US, V157, P864, DOI 10.1016/j.jpeds.2010.09.023; Carlisle EM, 2013, CURR OPIN PEDIATR, V25, P382, DOI 10.1097/MOP.0b013e3283600e91; Chen CC, 2013, SEMIN PEDIATR SURG, V22, P94, DOI 10.1053/j.sempedsurg.2013.01.006; Choi J, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0983-5; Clark LC, 2014, CELL MICROBIOL, V16, P27, DOI 10.1111/cmi.12234; Cooper VS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007961; Corr SC, 2007, FEMS IMMUNOL MED MIC, V50, P380, DOI 10.1111/j.1574-695X.2007.00264.x; Cronin M, 2012, BIOENGINEERED, V3, P157, DOI 10.4161/bbug.18985; Damman CJ, 2012, AM J GASTROENTEROL, V107, P1452, DOI 10.1038/ajg.2012.93; de la Nava JG, 2003, BIOINFORMATICS, V19, P2328, DOI 10.1093/bioinformatics/btg318; de Vrese M, 2008, ADV BIOCHEM ENG BIOT, V111, P1, DOI 10.1007/10_2008_097; Fanning S, 2012, GUT MICROBES, V3, P420, DOI 10.4161/gmic.20630; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gordon CP, 2013, J MED CHEM, V56, P1389, DOI 10.1021/jm3014635; Gourbeyre P, 2011, J LEUKOCYTE BIOL, V89, P685, DOI 10.1189/jlb.1109753; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; Hasselmann C, 2003, CLIN MICROBIOL INFEC, V9; Hodgkinson JT, 2007, ACS CHEM BIOL, V2, P715, DOI 10.1021/cb700227k; Ikeda T, 2007, APPL ENVIRON MICROB, V73, P6404, DOI 10.1128/AEM.00704-07; Isolauri E, 2002, CURR OPIN ALLERGY CL, V2, P263, DOI 10.1097/00130832-200206000-00018; James CE, 2006, INFECT IMMUN, V74, P3834, DOI 10.1128/IAI.01768-05; Janssens J C A, 2007, Commun Agric Appl Biol Sci, V72, P35; Jonkers D, 2012, DRUGS, V72, P803, DOI 10.2165/11632710-000000000-00000; Kim SY, 2003, MOL MICROBIOL, V48, P1647, DOI 10.1046/j.1365-2958.2003.03536.x; Kim Y, 2012, INFECT IMMUN, V80, P2500, DOI 10.1128/IAI.06350-11; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kortman GAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029968; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; Lebeer S, 2008, APPL ENVIRON MICROB, V74, P4711, DOI 10.1128/AEM.00133-08; Lebeer S, 2007, J BACTERIOL, V189, P860, DOI 10.1128/JB.01394-06; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Li D, 2013, J CLIN PHARM THER, V38, P445, DOI 10.1111/jcpt.12084; Li L, 2011, MICROB PATHOGENESIS, V50, P293, DOI 10.1016/j.micpath.2011.02.002; Lin HY, 2013, J FORM MED ASS; Long AD, 2001, J BIOL CHEM, V276, P19937, DOI 10.1074/jbc.M010192200; Masco L, 2003, SYST APPL MICROBIOL, V26, P557, DOI 10.1078/072320203770865864; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; Motherway MO, 2009, MICROB BIOTECHNOL, V2, P321, DOI 10.1111/j.1751-7915.2008.00071.x; Mshvildadze M, 2010, EARLY HUM DEV, V86, pS67, DOI 10.1016/j.earlhumdev.2010.01.018; O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010; Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023; Pereira CS, 2013, FEMS MICROBIOL REV, V37, P156, DOI 10.1111/j.1574-6976.2012.00345.x; Pollumaa L, 2012, SENSORS-BASEL, V12, P3327, DOI 10.3390/s120303327; Portal-Celhay C, 2012, INFECT IMMUN, V80, P1288, DOI 10.1128/IAI.05522-11; Rautava S, 2012, NAT REV GASTRO HEPAT, V9, P565, DOI 10.1038/nrgastro.2012.144; Reid G, 2006, FEMS IMMUNOL MED MIC, V46, P149, DOI 10.1111/j.1574-695X.2005.00026.x; Rezzonico F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-154; Russell DA, 2011, INT J FOOD MICROBIOL, V149, P88, DOI 10.1016/j.ijfoodmicro.2011.06.003; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrook J, 2001, MOL CLONING LAB MANU; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Shlomai NO, 2014, NEONATOLOGY, V105, P64, DOI 10.1159/000354891; Siciliano RA, 2012, CURR OPIN MICROBIOL, V15, P390, DOI 10.1016/j.mib.2012.03.006; Sivamaruthi BS, 2011, J BASIC MICROB, V51, P540, DOI 10.1002/jobm.201000377; Sjobolm S, 2006, MOL MICROBIOL, V60, P1474, DOI 10.1111/j.1365-2958.2006.05210.x; Soni KA, 2008, FOODBORNE PATHOG DIS, V5, P147, DOI 10.1089/fpd.2007.0050; Stiernagle Theresa, 2006, WormBook, P1; Sun JB, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-36; Sun ZK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088260, 10.1371/journal.pone.0088328]; Surette MG, 1999, MOL MICROBIOL, V31, P585, DOI 10.1046/j.1365-2958.1999.01199.x; Turovskiy Y, 2007, ADV APPL MICROBIOL, V62, P191, DOI 10.1016/S0065-2164(07)62007-3; Turroni F, 2014, CELL MOL LIFE SCI, V71, P183, DOI 10.1007/s00018-013-1318-0; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957; van der Vinne AN, 2005, VET MICROBIOL, V110, P53, DOI 10.1016/j.vetmic.2005.06.011; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Ventura M, 2012, TRENDS MICROBIOL, V20, P467, DOI 10.1016/j.tim.2012.07.002; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Wilson CM, 2012, J BACTERIOL, V194, P1743, DOI 10.1128/JB.06318-11; WINSON MK, 1995, P NATL ACAD SCI USA, V92, P9427, DOI 10.1073/pnas.92.20.9427; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Xavier KB, 2005, J BACTERIOL, V187, P238, DOI 10.1128/JB.187.1.238-248.2005	81	51	80	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98111	10.1371/journal.pone.0098111	http://dx.doi.org/10.1371/journal.pone.0098111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871429	Green Published, gold, Green Submitted			2022-12-25	WOS:000336858300025
J	Liao, JY; Zhang, Q; Liao, Y; Cai, B; Chen, J; Li, LX; Wang, LL				Liao, Jingyu; Zhang, Qi; Liao, Yun; Cai, Bei; Chen, Jie; Li, Lixin; Wang, Lanlan			Association of T-Cell Immunoglobulin and Mucin Domain-Containing Molecule 3 (Tim-3) Polymorphisms with Susceptibility and Disease Progression of HBV Infection	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; HEPATOCELLULAR-CARCINOMA; ANTITUMOR IMMUNITY; VIRUS-INFECTION; EXPRESSION; BLOCKADE; DYSFUNCTION; EXHAUSTION; AUTOIMMUNE; INDUCTION	Purpose: T-cell immunoglobulin and mucin domain-containing molecule 3 (Tim-3) plays an important role in regulating T cells in hepatitis B virus (HBV) infection and hepatocellular carcinoma (HCC). However, few researches have reported the association of Tim-3 genetic variants with susceptibility and progression of HBV infection. In this study, we focused on the association of Tim-3 polymorphisms with HBV infection, HBsAg seroclearance and hepatocellular carcinoma. Methods: A total of 800 subjects were involved in this study. Four groups were studied here, including HBV, HBsAg seroclearance, HBV-associated HCC and healthy controls. Three single-nucleotide polymorphisms (SNPs) of Tim-3, rs246871, rs25855 and rs31223 were genotyped to analyze the association of Tim-3 polymorphisms with susceptibility and disease progression of HBV infection. Results: Our study found that rs31223 and rs246871 were associated with disease progression of HBV infection, while none of the three SNPs was relevant to HBV susceptibility. The minor allele "C'' of rs31223 was found to be associated with an increased probability of HBsAg seroclearance (P = 0.033) and genotype "CC'' of rs246871 to be associated with an increased probability of HBV-associated HCC (P = 0.007). In accordance, haplotypic analysis of the three polymorphisms also showed that the haplotype block CGC* and TGC* were significantly associated with HBsAg seroclearance (P<0.05) while haplotype block CAT*, CGT*, TAC* and TGT* were significantly associated with HBV-associated HCC (all P<0.05). Conclusions: Genetic variants of Tim-3 have an important impact on disease progression of HBV infection. With specific Tim-3 polymorphisms, patients infected with HBV could be potential candidates of HCC and HBsAg seroclearance.	[Liao, Jingyu; Zhang, Qi; Liao, Yun; Cai, Bei; Chen, Jie; Li, Lixin; Wang, Lanlan] Sichuan Univ, Dept Lab Med, West China Hosp, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Wang, LL (corresponding author), Sichuan Univ, Dept Lab Med, West China Hosp, Chengdu 610064, Sichuan, Peoples R China.	wanglanlan85@126.com			National Natural Science Foundation of China [81072443, 81273256]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Natural Science Foundation of China (No. 81072443 and 81273256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Cao EH, 2007, IMMUNITY, V26, P311, DOI 10.1016/j.immuni.2007.01.016; Cao Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053834, 10.1371/journal.pone.0055021]; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Gao Q, 2009, CLIN CANCER RES, V15, P971, DOI 10.1158/1078-0432.CCR-08-1608; Gao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030676; Golden-Mason L, 2009, J VIROL, V83, P9122, DOI 10.1128/JVI.00639-09; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Ju Y, 2010, J HEPATOL, V52, P322, DOI 10.1016/j.jhep.2009.12.005; Ju Y, 2009, CELL MOL IMMUNOL, V6, P35, DOI 10.1038/cmi.2009.5; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Li H, 2012, HEPATOLOGY, V56, P1342, DOI 10.1002/hep.25777; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Nagahara K, 2008, J IMMUNOL, V181, P7660, DOI 10.4049/jimmunol.181.11.7660; Ndhlovu LC, 2012, BLOOD, V119, P3734, DOI 10.1182/blood-2011-11-392951; Nebbia G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047648; Ngiow SF, 2011, CANCER RES, V71, P3540, DOI 10.1158/0008-5472.CAN-11-0096; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Takamura S, 2010, J IMMUNOL, V184, P4696, DOI 10.4049/jimmunol.0903478; Wu W, 2012, EUR J IMMUNOL, V42, P1180, DOI 10.1002/eji.201141852; Wu W, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-113; Yan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058006; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	31	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98280	10.1371/journal.pone.0098280	http://dx.doi.org/10.1371/journal.pone.0098280			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867713	Green Published, Green Submitted, gold			2022-12-25	WOS:000336914100046
J	Rayner, LE; Hui, GK; Gor, J; Heenan, RK; Dalby, PA; Perkins, SJ				Rayner, Lucy E.; Hui, Gar Kay; Gor, Jayesh; Heenan, Richard K.; Dalby, Paul A.; Perkins, Stephen J.			The Fab Conformations in the Solution Structure of Human Immunoglobulin G4 (IgG4) Restrict Access to Its Fc Region IMPLICATIONS FOR FUNCTIONAL ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY; HYDRODYNAMIC PROPERTIES; SOLUTION SCATTERING; NEUTRON-SCATTERING; CRYSTAL-STRUCTURE; GAMMA RECEPTOR; ARM EXCHANGE; COMPLEMENT C1Q; HUMAN-ANTIBODY; FRAGMENT	Human IgG4 antibody shows therapeutically useful properties compared with the IgG1, IgG2, and IgG3 subclasses. Thus IgG4 does not activate complement and shows conformational variability. These properties are attributable to its hinge region, which is the shortest of the four IgG subclasses. Using high throughput scattering methods, we studied the solution structure of wild-type IgG4(Ser(222)) and a hinge mutant IgG4(Pro(222)) in different buffers and temperatures where the proline substitution suppresses the formation of half-antibody. Analytical ultracentrifugation showed that both IgG4 forms were principally monomeric with sedimentation coefficients s(20,w)(0) of 6.6-6.8 S. A monomer-dimer equilibrium was observed in heavy water buffer at low temperature. Scattering showed that the x-ray radius of gyration R-g was unchanged with concentration in 50-250 mM NaCl buffers, whereas the neutron R-g values showed a concentration-dependent increase as the temperature decreased in heavy water buffers. The distance distribution curves (P(r)) revealed two peaks, M1 and M2, that shifted below 2 mg/ml to indicate concentration-dependent IgG4 structures in addition to IgG4 dimer formation at high concentration in heavy water. Constrained x-ray and neutron scattering modeling revealed asymmetric solution structures for IgG4(Ser(222)) with extended hinge structures. The IgG4(Pro(222)) structure was similar. Both IgG4 structures showed that their Fab regions were positioned close enough to the Fc region to restrict C1q binding. Our new molecular models for IgG4 explain its inability to activate complement and clarify aspects of its stability and function for therapeutic applications.	[Rayner, Lucy E.; Hui, Gar Kay; Gor, Jayesh; Perkins, Stephen J.] UCL, Dept Struct & Mol Biol, Div Biosci, London WC1E 6BT, England; [Dalby, Paul A.] UCL, Dept Biochem Engn, Div Engn, London WC1E 6BT, England; [Heenan, Richard K.] ISIS Facil, Sci & Technol Facil Council, Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England	University of London; University College London; University of London; University College London; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Perkins, SJ (corresponding author), UCL, Dept Struct & Mol Biol, Div Biosci, Darwin Bldg,Gower St, London WC1E 6BT, England.	s.perkins@ucl.ac.uk	Dalby, Paul A/C-1639-2008	Dalby, Paul A/0000-0002-0980-8167	Biotechnology and Biological Sciences Research Council; Collaborative Computational Project for advanced analyses of structural data in chemical biology and soft condensed matter (CCP-SAS), a joint Engineering and Physical Sciences Research Council [EP/K039121/1]; National Science Foundation [CHE-1265821]; BBSRC [BB/E013104/1, BB/I017119/1] Funding Source: UKRI; EPSRC [EP/K039121/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I017119/1, BB/E013104/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K039121/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Collaborative Computational Project for advanced analyses of structural data in chemical biology and soft condensed matter (CCP-SAS), a joint Engineering and Physical Sciences Research Council; National Science Foundation(National Science Foundation (NSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council and in part by the Collaborative Computational Project for advanced analyses of structural data in chemical biology and soft condensed matter (CCP-SAS), a joint Engineering and Physical Sciences Research Council (Grant EP/K039121/1) and National Science Foundation (Grant CHE-1265821) project.	Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; Aalberse RC, 1999, INT ARCH ALLERGY IMM, V118, P187, DOI 10.1159/000024062; Abe Y, 2010, BIOCHEM J, V432, P101, DOI 10.1042/BJ20100641; ANGAL S, 1993, MOL IMMUNOL, V30, P105, DOI 10.1016/0161-5890(93)90432-B; Ashton AW, 1997, J MOL BIOL, V272, P408, DOI 10.1006/jmbi.1997.1271; Bloom JW, 1997, PROTEIN SCI, V6, P407; Boehm MK, 1999, J MOL BIOL, V286, P1421, DOI 10.1006/jmbi.1998.2556; BRADY RL, 1991, J MOL BIOL, V219, P603, DOI 10.1016/0022-2836(91)90656-Q; BREKKE OH, 1995, IMMUNOL TODAY, V16, P85, DOI 10.1016/0167-5699(95)80094-8; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; BYRON O, 1990, BIOCHEM SOC T, V18, P1030, DOI 10.1042/bst0181030; Clark MR, 1997, CHEM IMMUNOL, V65, P88; Davies AM, 2014, J MOL BIOL, V426, P630, DOI 10.1016/j.jmb.2013.10.039; Davies AM, 2013, MOL IMMUNOL, V54, P1, DOI 10.1016/j.molimm.2012.10.029; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DELATORRE JG, 1994, BIOPHYS J, V67, P530, DOI 10.1016/S0006-3495(94)80512-0; GHIRLANDO R, 1995, BIOCHEMISTRY-US, V34, P13320, DOI 10.1021/bi00041a007; Glatter O., 1982, SMALL ANGLE X RAY SC; GREGORY L, 1987, MOL IMMUNOL, V24, P821, DOI 10.1016/0161-5890(87)90184-2; GUDDAT LW, 1993, P NATL ACAD SCI USA, V90, P4271, DOI 10.1073/pnas.90.9.4271; Hamilton R.G., 2001, HUMAN IGG SUBCLASSES; Harris LJ, 1998, J MOL BIOL, V275, P861, DOI 10.1006/jmbi.1997.1508; Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+; Heenan R. K., 2011, NEUTRON NEWS, V22, P19, DOI DOI 10.1080/10448632.2011.569531; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Kato K, 2000, IMMUNOL TODAY, V21, P310, DOI 10.1016/S0167-5699(00)01666-2; Kato K, 2000, J MOL BIOL, V295, P213, DOI 10.1006/jmbi.1999.3351; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Labrijn AF, 2011, J IMMUNOL, V187, P3238, DOI 10.4049/jimmunol.1003336; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Longman E, 2003, EUR BIOPHYS J BIOPHY, V32, P503, DOI 10.1007/s00249-003-0314-y; Lu JH, 2011, J BIOL CHEM, V286, P40608, DOI 10.1074/jbc.M111.257550; Lu YL, 2008, J PHARM SCI-US, V97, P960, DOI 10.1002/jps.21016; Lu YL, 2007, BIOPHYS J, V93, P3733, DOI 10.1529/biophysj.107.108993; Narayanan T, 2001, NUCL INSTRUM METH A, V467, P1005, DOI 10.1016/S0168-9002(01)00553-8; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Owens R, 1997, IMMUNOTECHNOLOGY, V3, P107, DOI 10.1016/S1380-2933(97)00066-3; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Perkins SJ, 2001, BIOPHYS CHEM, V93, P129, DOI 10.1016/S0301-4622(01)00216-2; PERKINS SJ, 1983, J MOL BIOL, V168, P847, DOI 10.1016/S0022-2836(83)80078-3; Perkins S, 2008, BIOCHEM SOC T, V36, P37, DOI 10.1042/BST0360037; Perkins SJ, 2009, J R SOC INTERFACE, V6, pS679, DOI 10.1098/rsif.2009.0164.focus; PILZ I, 1973, BIOCHEMISTRY-US, V12, P4998, DOI 10.1021/bi00748a028; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Radaev S, 2002, MOL IMMUNOL, V38, P1073, DOI 10.1016/S0161-5890(02)00036-6; Rayner LE, 2013, J MOL BIOL, V425, P506, DOI 10.1016/j.jmb.2012.11.019; Richardson J. S., 1989, PREDICTION PROTEIN S, P1; Rispens T, 2011, J AM CHEM SOC, V133, P10302, DOI 10.1021/ja203638y; Rispens T, 2010, MOL IMMUNOL, V47, P1592, DOI 10.1016/j.molimm.2010.02.021; Rispens T, 2009, J IMMUNOL, V182, P4275, DOI 10.4049/jimmunol.0804338; Rose RJ, 2011, STRUCTURE, V19, P1274, DOI 10.1016/j.str.2011.06.016; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Schneider S, 2012, MOL IMMUNOL, V51, P66, DOI 10.1016/j.molimm.2012.02.111; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Tamm A, 1997, Int Rev Immunol, V16, P57, DOI 10.3109/08830189709045703; TAO MH, 1993, J EXP MED, V178, P661, DOI 10.1084/jem.178.2.661; TAO MH, 1991, J EXP MED, V173, P1025, DOI 10.1084/jem.173.4.1025; Taylor FR, 2006, ANAL BIOCHEM, V353, P204, DOI 10.1016/j.ab.2006.02.022; Thommesen JE, 2000, MOL IMMUNOL, V37, P995, DOI 10.1016/S0161-5890(01)00010-4; Wang W, 2007, J PHARM SCI-US, V96, P1, DOI 10.1002/jps.20727; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1	73	30	30	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 25	2014	289	30					20740	20756		10.1074/jbc.M114.572404	http://dx.doi.org/10.1074/jbc.M114.572404			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NS	24876381	Green Published, hybrid			2022-12-25	WOS:000339396600031
J	Pace, DA; McKnight, CA; Liu, J; Jimenez, V; Moreno, SNJ				Pace, Douglas A.; McKnight, Ciara A.; Liu, Jing; Jimenez, Veronica; Moreno, Silvia N. J.			Calcium Entry in Toxoplasma gondii and Its Enhancing Effect of Invasion-linked Traits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CALCIUM; HOST-CELLS; CA2+ RELEASE; CHANNELS; TACHYZOITES; SECRETION; MOBILIZATION; MEMBRANE; PROTEINS; MOTILITY	During invasion and egress from their host cells, Apicomplexan parasites face sharp changes in the surrounding calcium ion (Ca2+) concentration. Our work with Toxoplasma gondii provides evidence for Ca2+ influx from the extracellular milieu leading to cytosolic Ca2+ increase and enhancement of virulence traits, such as gliding motility, conoid extrusion, microneme secretion, and host cell invasion. Assays of Mn2+ and Ba2+ uptake do not support a canonical store-regulated Ca2+ entry mechanism. Ca2+ entry was blocked by the L-type Ca2+ channel inhibitor nifedipine and stimulated by the increase in cytosolic Ca2+ and by the specific L-type Ca2+ channel agonist Bay K-8644. Our results demonstrate that Ca2+ entry is critical for parasite virulence. We propose a regulated Ca2+ entry mechanism activated by cytosolic Ca2+ that has an enhancing effect on invasion-linked traits.	[Pace, Douglas A.; McKnight, Ciara A.; Liu, Jing; Jimenez, Veronica; Moreno, Silvia N. J.] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [McKnight, Ciara A.; Moreno, Silvia N. J.] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA; [Liu, Jing] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; China Agricultural University	Moreno, SNJ (corresponding author), Univ Georgia, Dept Cellular Biol, 350A Paul D Coverdell Ctr, Athens, GA 30602 USA.	smoreno@uga.edu			National Institutes of Health [AI096836, AI101167, AI060546]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096836, T32AI060546, R00AI101167, K99AI101167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI096836 (to S. N. J. M.) and AI101167 (to V. J.) and National Institutes of Health T32 Training Grant AI060546 (to D. A. P. and the Center for Tropical and Emerging Global Diseases).	Arrizabalaga G, 2004, INT J PARASITOL, V34, P361, DOI 10.1016/j.ijpara.2003.11.017; Beraldo FH, 2007, J PINEAL RES, V43, P360, DOI 10.1111/j.1600-079X.2007.00486.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Cai XJ, 2008, MOL BIOL EVOL, V25, P1357, DOI 10.1093/molbev/msn077; Capiod T, 2011, BIOCHIMIE, V93, P2075, DOI 10.1016/j.biochi.2011.07.015; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Christel C, 2012, BBA-GEN SUBJECTS, V1820, P1243, DOI 10.1016/j.bbagen.2011.12.012; Collins SR, 2011, TRENDS CELL BIOL, V21, P202, DOI 10.1016/j.tcb.2011.01.002; Docampo R., 2014, EUR J PHARM; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Kafsack BFC, 2004, MOL BIOCHEM PARASIT, V136, P309, DOI 10.1016/j.molbiopara.2004.04.004; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Koshy AA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002825; LACAMPAGNE A, 1994, BBA-BIOMEMBRANES, V1191, P205, DOI 10.1016/0005-2736(94)90250-X; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Miranda K, 2010, MOL MICROBIOL, V76, P1358, DOI 10.1111/j.1365-2958.2010.07165.x; MONDRAGON R, 1994, J EUKARYOT MICROBIOL, V41, P330, DOI 10.1111/j.1550-7408.1994.tb06086.x; Mondragon R, 1996, J EUKARYOT MICROBIOL, V43, P120, DOI 10.1111/j.1550-7408.1996.tb04491.x; Moreno SNJ, 1996, BIOCHEM J, V313, P655, DOI 10.1042/bj3130655; Nagamune K, 2006, MOL BIOL EVOL, V23, P1613, DOI 10.1093/molbev/msl026; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pezzella N, 1997, EUR J CELL BIOL, V74, P92; Prole DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026218; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; SCHWAB JC, 1994, P NATL ACAD SCI USA, V91, P509, DOI 10.1073/pnas.91.2.509; Smyth JT, 2006, J BIOL CHEM, V281, P11712, DOI 10.1074/jbc.M510541200; Tomita T, 2009, J IMMUNOL, V183, P6667, DOI 10.4049/jimmunol.0900516; Vieira MCF, 2000, MOL BIOCHEM PARASIT, V106, P157, DOI 10.1016/S0166-6851(99)00182-6; Wan KL, 1997, MOL BIOCHEM PARASIT, V84, P203, DOI 10.1016/S0166-6851(96)02796-X; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495; YAMAMOTO H, 1984, EUR J PHARMACOL, V102, P555, DOI 10.1016/0014-2999(84)90581-8	36	40	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19637	19647		10.1074/jbc.M114.565390	http://dx.doi.org/10.1074/jbc.M114.565390			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24867952	Green Published, hybrid			2022-12-25	WOS:000339326800036
J	Winkler, T; Mahoney, EJ; Sinner, D; Wylie, CC; Dahia, CL				Winkler, Tamara; Mahoney, Eric J.; Sinner, Debora; Wylie, Christopher C.; Dahia, Chitra Lekha			Wnt Signaling Activates Shh Signaling in Early Postnatal Intervertebral Discs, and Re-Activates Shh Signaling in Old Discs in the Mouse	PLOS ONE			English	Article							NUCLEUS PULPOSUS CELLS; WNT/BETA-CATENIN; STEM-CELLS; IN-VITRO; C-MYC; GROWTH; DIFFERENTIATION; EXPRESSION; IDENTIFICATION; INHIBITORS	Intervertebral discs (IVDs) are strong fibrocartilaginous joints that connect adjacent vertebrae of the spine. As discs age they become prone to failure, with neurological consequences that are often severe. Surgical repair of discs treats the result of the disease, which affects as many as one in seven people, rather than its cause. An ideal solution would be to repair degenerating discs using the mechanisms of their normal differentiation. However, these mechanisms are poorly understood. Using the mouse as a model, we previously showed that Shh signaling produced by nucleus pulposus cells activates the expression of differentiation markers, and cell proliferation, in the postnatal IVD. In the present study, we show that canonical Wnt signaling is required for the expression of Shh signaling targets in the IVD. We also show that Shh and canonical Wnt signaling pathways are down-regulated in adult IVDs. Furthermore, this down-regulation is reversible, since re-activation of the Wnt or Shh pathways in older discs can re-activate molecular markers of the IVD that are lost with age. These data suggest that biological treatments targeting Wnt and Shh signaling pathways may be feasible as a therapeutic for degenerative disc disease.	[Dahia, Chitra Lekha] Hosp Special Surg, Tissue Engn Regenerat & Repair Program, New York, NY 10021 USA; [Wylie, Christopher C.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Winkler, Tamara; Mahoney, Eric J.] Cincinnati Childrens Hosp Med Ctr, Div Orthopaed Surg, Cincinnati, OH 45229 USA; [Sinner, Debora] Cincinnati Childrens Hosp Med Ctr, Perinatal Inst Div Neonatol Perinatal & Pulm Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Dahia, CL (corresponding author), Hosp Special Surg, Tissue Engn Regenerat & Repair Program, 535 E 70th St, New York, NY 10021 USA.	dahiac@hss.edu	Sinner, Debora/AAL-1761-2021	Sinner, Debora/0000-0002-0704-5223	Orthopaedic Research Education Foundation [11-228]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065530] Funding Source: NIH RePORTER	Orthopaedic Research Education Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The funding was kindly provided to Dr. Chitra Dahia by Orthopaedic Research Education Foundation to support this research. The grant number is 11-228. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Y, 2010, DEVELOPMENT, V137, P3221, DOI 10.1242/dev.054668; Alvarez-Medina R, 2009, DEVELOPMENT, V136, P3301, DOI 10.1242/dev.041772; Baek SH, 2003, P NATL ACAD SCI USA, V100, P3245, DOI 10.1073/pnas.0330217100; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bluske KK, 2012, DEVELOPMENT, V139, P2692, DOI 10.1242/dev.072314; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carpenter AC, 2010, GENESIS, V48, P554, DOI 10.1002/dvg.20651; Cho SW, 2011, DEVELOPMENT, V138, P1807, DOI 10.1242/dev.056051; Choi KS, 2011, P NATL ACAD SCI USA, V108, P9484, DOI 10.1073/pnas.1007566108; Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Cornett B, 2013, DEV BIOL, V379, P38, DOI 10.1016/j.ydbio.2013.03.010; Dahia CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035944; Dahia CL, 2009, SPINE, V34, P447, DOI 10.1097/BRS.0b013e3181990c64; Dahia CL, 2009, SPINE, V34, P456, DOI 10.1097/BRS.0b013e3181913e98; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DiPaola CP, 2005, J ORTHOP RES, V23, P1112, DOI 10.1016/j.orthres.2005.03.008; EPSTEIN JA, 1962, J NEUROL NEUROSUR PS, V25, P165, DOI 10.1136/jnnp.25.2.165; Fujita N, 2008, BIOCHEM BIOPH RES CO, V372, P367, DOI 10.1016/j.bbrc.2008.05.044; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hiyama A, 2011, J CELL PHYSIOL, V226, P1139, DOI 10.1002/jcp.22438; Hiyama A, 2010, ARTHRITIS RHEUM-US, V62, P3036, DOI 10.1002/art.27599; Hiyama A, 2010, J BONE MINER RES, V25, P1179, DOI 10.1359/jbmr.091202; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Jandial Rahul, 2008, Neurosurg Focus, V24, pE21, DOI 10.3171/FOC/2008/24/3-4/E20; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kondo N, 2011, SPINE, V36, pE513, DOI 10.1097/BRS.0b013e3181f52cb5; Kronenberg H M, 2001, Novartis Found Symp, V232, P144; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Le Maitre CL, 2005, J PATHOL, V207, P445, DOI 10.1002/path.1862; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Martinez-Ferre A, 2013, J NEUROSCI, V33, P3967, DOI 10.1523/JNEUROSCI.0726-12.2013; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Polychronopoulos P, 2004, J MED CHEM, V47, P935, DOI 10.1021/jm031016d; POSTACCHINI F, 1984, SPINE, V9, P596, DOI 10.1097/00007632-198409000-00010; Pratsinis H, 2007, EUR SPINE J, V16, P1858, DOI 10.1007/s00586-007-0408-9; Radtke F, 2006, CURR MOL MED, V6, P275, DOI 10.2174/156652406776894527; Riffell JL, 2012, NAT REV DRUG DISCOV, V11, P923, DOI 10.1038/nrd3868; Risbud MV, 2006, SPINE, V31, P884, DOI 10.1097/01.brs.0000209335.57767.b5; Rodrigues-Pinto R, 2013, BONE JOINT RES, V2, P169, DOI 10.1302/2046-3758.28.2000184; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sizer Phillip S Jr, 2002, Pain Pract, V2, P98, DOI 10.1046/j.1533-2500.2002.02012.x; Smolders LA, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4157; Smolders LA, 2012, J ORTHOP RES, V30, P950, DOI 10.1002/jor.22000; Sohn P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-29; Tsai TT, 2007, SPINE, V32, P495, DOI 10.1097/01.brs.0000257341.88880.f1; Tseng AS, 2006, CHEM BIOL, V13, P957, DOI 10.1016/j.chembiol.2006.08.004; Urban JPG, 2000, AM ZOOL, V40, P53, DOI 10.1668/0003-1569(2000)040[0053:TNOTID]2.0.CO;2; Vadlakondalf L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00085; Wang Zhibo, 2013, INT J DISTRIB SENS N, V2013, P1; Yang SH, 2013, SPINE J; Ye SA, 2011, J HUAZHONG U SCI-MED, V31, P657, DOI 10.1007/s11596-011-0577-y; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08; Zhang HN, 2008, SPINE, V33, pE525, DOI 10.1097/BRS.0b013e31817c561b; Zhu Y, 2013, J ORTHOP RES, V31, P1144, DOI 10.1002/jor.22337	62	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98444	10.1371/journal.pone.0098444	http://dx.doi.org/10.1371/journal.pone.0098444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892825	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400050
J	Kim, S; Hwang, J; Xuan, J; Jung, YH; Cha, HS; Kim, KH				Kim, Sooah; Hwang, Jiwon; Xuan, Jinhua; Jung, Young Hoon; Cha, Hoon-Suk; Kim, Kyoung Heon			Global Metabolite Profiling of Synovial Fluid for the Specific Diagnosis of Rheumatoid Arthritis from Other Inflammatory Arthritis	PLOS ONE			English	Article							CYCLIC CITRULLINATED PEPTIDE; ANTI-GAMMA-GLOBULIN; TRANSCRIPTOME ANALYSIS; METABOLOMICS; ANTIBODIES; DISEASE; TESTS; CELLS	Currently, reliable biomarkers that can be used to distinguish rheumatoid arthritis (RA) from other inflammatory diseases are unavailable. To find possible distinctive metabolic patterns and biomarker candidates for RA, we performed global metabolite profiling of synovial fluid samples. Synovial fluid samples from 38 patients with RA, ankylosing spondylitis, Behcet's disease, and gout were analyzed by gas chromatography/time-of-flight mass spectrometry (GC/TOF MS). Orthogonal partial least-squares discriminant and hierarchical clustering analyses were performed for the discrimination of RA and non-RA groups. Variable importance for projection values were determined, and the Wilcoxon-Mann-Whitney test and the breakdown and one-way analysis of variance were conducted to identify potential biomarkers for RA. A total of 105 metabolites were identified from synovial fluid samples. The score plot of orthogonal partial least squares discriminant analysis showed significant discrimination between the RA and non-RA groups. The 20 metabolites, including citrulline, succinate, glutamine, octadecanol, isopalmitic acid, and glycerol, were identified as potential biomarkers for RA. These metabolites were found to be associated with the urea and TCA cycles as well as fatty acid and amino acid metabolism. The metabolomic analysis results demonstrated that global metabolite profiling by GC/TOF MS might be a useful tool for the effective diagnosis and further understanding of RA.	[Kim, Sooah; Xuan, Jinhua; Jung, Young Hoon; Kim, Kyoung Heon] Korea Univ, Grad Sch, Dept Biotechnol, Seoul, South Korea; [Hwang, Jiwon; Cha, Hoon-Suk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea	Korea University; Sungkyunkwan University (SKKU); Samsung Medical Center	Cha, HS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea.	hoonsuk.cha@samsung.com; khekim@korea.ac.kr	Kim, Kyoung Heon/F-1059-2013; Jung, Young Hoon/F-1703-2013	Kim, Kyoung Heon/0000-0003-4600-8668; Jung, Young Hoon/0000-0002-0781-3608	Advanced Biomass R&D Center of Korea - Korean Government [2011-0031353]; National Foundation of Research - Korean Government [2013059103]	Advanced Biomass R&D Center of Korea - Korean Government; National Foundation of Research - Korean Government	This work was supported by the Advanced Biomass R&D Center of Korea (2011-0031353) and the National Foundation of Research (2013059103), both funded by the Korean Government. Experiments were performed by using the facilities of the Institute of Biomedical Science and Food Safety at the Korea University Food Safety Hall. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bas S, 2002, RHEUMATOLOGY, V41, P809, DOI 10.1093/rheumatology/41.7.809; BELL JD, 1991, MAGN RESON MED, V17, P414, DOI 10.1002/mrm.1910170213; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; BORENSTEIN DG, 1982, ARTHRITIS RHEUM, V25, P947, DOI 10.1002/art.1780250806; CAMMARATA RJ, 1967, J AMER MED ASSOC, V199, P455, DOI 10.1001/jama.199.7.455; Chen TL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004945; Connor SC, 2010, MOL BIOSYST, V6, P909, DOI 10.1039/b914182k; Denkert C, 2006, CANCER RES, V66, P10795, DOI 10.1158/0008-5472.CAN-06-0755; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Huang ZZ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007922; Hugle T, 2012, CLIN EXP RHEUMATOL, V30, P240; Humphreys JH, 2013, CURR OPIN RHEUMATOL, V25, P157, DOI 10.1097/BOR.0b013e32835cfc41; Hutschenreuther A, 2012, ANAL METHODS-UK, V4, P1953, DOI 10.1039/c2ay25046b; JETTEN MSM, 1994, APPL MICROBIOL BIOT, V41, P47, DOI 10.1007/s002530050105; Kallberg H, 2007, AM J HUM GENET, V80, P867, DOI 10.1086/516736; KREMER JM, 1990, ARTHRITIS RHEUM, V33, P810, DOI 10.1002/art.1780330607; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Lasko TA, 2005, J BIOMED INFORM, V38, P404, DOI 10.1016/j.jbi.2005.02.008; Lauridsen MB, 2010, J PROTEOME RES, V9, P4545, DOI 10.1021/pr1002774; Lee DY, 2012, MOL CELL PROTEOMICS, V11, P973, DOI 10.1074/mcp.M111.016733; Lee DY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-7; LITWIN SD, 1965, ARTHRITIS RHEUM, V8, P538, DOI 10.1002/art.1780080408; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; Madsen RK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3243; Mamas M, 2011, ARCH TOXICOL, V85, P5, DOI 10.1007/s00204-010-0609-6; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tanino M, 2009, BIOCHEM BIOPH RES CO, V387, P261, DOI 10.1016/j.bbrc.2009.06.149; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Teixeira VH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006803; Umetrics A. B., 2005, USERS GUIDE SIMCA P; Villas-Boas SG., 2007, METABOLOME ANAL INTR, DOI [10.1002/0470105518, DOI 10.1002/0470105518]; Vinayavekhin N, 2010, ACS CHEM BIOL, V5, P91, DOI 10.1021/cb900271r; Xie GX, 2012, METABOLOMICS, V8, P220, DOI 10.1007/s11306-011-0302-7; Zhai G, 2010, ANN RHEUM DIS, V69, P1227, DOI 10.1136/ard.2009.120857; Zhang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030181	39	95	104	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97501	10.1371/journal.pone.0097501	http://dx.doi.org/10.1371/journal.pone.0097501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887281	Green Submitted, Green Published, gold			2022-12-25	WOS:000336956300020
J	Kodama, N; Kimura, T; Yonemura, S; Kaneda, S; Ohashi, M; Ikeno, H				Kodama, Naomi; Kimura, Toshifumi; Yonemura, Seiichiro; Kaneda, Satoshi; Ohashi, Mizue; Ikeno, Hidetoshi			Automated Analysis of Two-Dimensional Positions and Body Lengths of Earthworms (Oligochaeta); MimizuTrack	PLOS ONE			English	Article							REPRODUCTION; INDIVIDUALS; TRACKING; ECOLOGY; GROWTH	Earthworms are important soil macrofauna inhabiting almost all ecosystems. Their biomass is large and their burrowing and ingestion of soils alters soil physicochemical properties. Because of their large biomass, earthworms are regarded as an indicator of "soil heath''. However, primarily because the difficulties in quantifying their behavior, the extent of their impact on soil material flow dynamics and soil health is poorly understood. Image data, with the aid of image processing tools, are a powerful tool in quantifying the movements of objects. Image data sets are often very large and time-consuming to analyze, especially when continuously recorded and manually processed. We aimed to develop a system to quantify earthworm movement from video recordings. Our newly developed program successfully tracked the two-dimensional positions of three separate parts of the earthworm and simultaneously output the change in its body length. From the output data, we calculated the velocity of the earthworm's movement. Our program processed the image data three times faster than the manual tracking system. To date, there are no existing systems to quantify earthworm activity from continuously recorded image data. The system developed in this study will reduce input time by a factor of three compared with manual data entry and will reduce errors involved in quantifying large data sets. Furthermore, it will provide more reliable measured values, although the program is still a prototype that needs further testing and improvement. Combined with other techniques, such as measuring metabolic gas emissions from earthworm bodies, this program could provide continuous observations of earthworm behavior in response to environmental variables under laboratory conditions. In the future, this standardized method will be applied to other animals, and the quantified earthworm movement will be incorporated into models of soil material flow dynamics or behavior in response to chemical substances present in the soil.	[Kodama, Naomi; Yonemura, Seiichiro; Kaneda, Satoshi] Natl Inst Agroenvironm Sci NIAES, Tsukuba, Ibaraki, Japan; [Kimura, Toshifumi; Ohashi, Mizue; Ikeno, Hidetoshi] Univ Hyogo, Sch Human Sci & Environm, Himeji, Hyogo 6712201, Japan	University of Hyogo	Kodama, N (corresponding author), Natl Inst Agroenvironm Sci NIAES, 3-1-3 Kannondai, Tsukuba, Ibaraki, Japan.	naomi.kodama@googlemail.com	Ikeno, Hidetoshi/O-3034-2018	Ikeno, Hidetoshi/0000-0002-5134-5485	Sumitomo Foundation [123225]	Sumitomo Foundation	This work was supported by Grant for Environmental Research Projects from the Sumitomo Foundation (Contract nr.:123225.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; Bartlett MD, 2010, EUR J SOIL BIOL, V46, P67, DOI 10.1016/j.ejsobi.2009.11.006; Blakemore R. J., 2006, ASSESSMENT CONTROL B, P173; Colomb J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042247; Curry JP, 2007, PEDOBIOLOGIA, V50, P463, DOI 10.1016/j.pedobi.2006.09.001; D'Souza D., 2010, APPL ENVIRON SOIL SC, V2010, P1, DOI [DOI 10.1155/2010/678360, 10.1155/2010/678360]; Darwin C., 1892, FORMATION VEGETABLE; Edwards C.A., 1996, BIOL ECOLOGY EARTHWO, V3rd; Feldman A, 2003, AUTOMATIC IDENTIFICA, P53; Helling B, 2000, ECOTOX ENVIRON SAFE, V46, P108, DOI 10.1006/eesa.1999.1880; Hilditch C.J., 1969, MACH INTELL, P403; Ishizuka K, 2001, B SEIKEI U, V33, P1; JOSCHKO M, 1993, GEODERMA, V56, P209, DOI 10.1016/0016-7061(93)90111-W; KIMURA T, 2012, TRACKING MULTIPLE HO, P36; Kimura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084656; Kimura T, 2011, APIDOLOGIE, V42, P607, DOI 10.1007/s13592-011-0060-6; Lavelle P., 2001, SOIL ECOLOGY; LIGTHART TN, 1993, GEODERMA, V57, P129, DOI 10.1016/0016-7061(93)90151-A; Lubbers IM, 2013, NAT CLIM CHANGE, V3, P187, DOI [10.1038/nclimate1692, 10.1038/NCLIMATE1692]; Mathew MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033483; Mersch DP, 2013, SCIENCE, V340, P1090, DOI 10.1126/science.1234316; Michaelsen W, 1891, OLIGOCHAETEN NATURHI; Nakano A, 2012, J PLANT NUTR SOIL SC, V175, P775, DOI 10.1002/jpln.201100316; NEUHAUSER EF, 1990, SOIL BIOL BIOCHEM, V22, P175, DOI 10.1016/0038-0717(90)90083-C; Rizvandi NB, 2008, SKELETON ANAL POPULA; Straw AD, 2011, J R SOC INTERFACE, V8, P395, DOI 10.1098/rsif.2010.0230; Uchida T, 2004, APPL SOIL ECOL, V27, P153, DOI 10.1016/j.apsoil.2004.04.003; Wei G, 2004, IEEE T BIO-MED ENG, V51, P1811, DOI 10.1109/TBME.2004.831532; Yamaguchi E, 1965, ILLUSTRATED ENCY FAU, V1, P547	29	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97986	10.1371/journal.pone.0097986	http://dx.doi.org/10.1371/journal.pone.0097986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886977	Green Submitted, gold, Green Published			2022-12-25	WOS:000336956300032
J	Lourenco, JD; Neves, LP; Olivo, CR; Duran, A; Almeida, FM; Arantes, PMM; Prado, CM; Leick, EA; Tanaka, AS; Martins, MA; Sasaki, SD; Lopes, FDTQS				Lourenco, Juliana D.; Neves, Luana P.; Olivo, Clarice R.; Duran, Adriana; Almeida, Francine M.; Arantes, Petra M. M.; Prado, Carla M.; Leick, Edna Aparecida; Tanaka, Aparecida S.; Martins, Milton A.; Sasaki, Sergio D.; Lopes, Fernanda D. T. Q. S.			A Treatment with a Protease Inhibitor Recombinant from the Cattle Tick (Rhipicephalus Boophilus microplus) Ameliorates Emphysema in Mice	PLOS ONE			English	Article							SMOKE-INDUCED EMPHYSEMA; ELASTASE INHIBITOR; LUNG; EXPRESSION; MECHANICS; PRESSURE; MODEL	Aims: To determine whether a serine protease inhibitor treatment can prevent or minimize emphysema in mice. Methods: C57BL/6 mice were subjected to porcine pancreatic elastase (PPE) nasal instillation to induce emphysema and were treated with a serine protease inhibitor (rBmTI-A) before (Protocol 1) and after (Protocol 2) emphysema development. In both protocols, we evaluated lung function to evaluate the airway resistance (Raw), tissue damping (Gtis) and tissue elastance (Htis). The inflammatory profile was analyzed in the bronchoalveolar lavage (BALF) and through the use of morphometry; we measured the mean linear intercept (Lm) (to verify alveolar enlargement), the volume proportion of collagen and elastic fibers, and the numbers of macrophages and metalloprotease 12 (MMP-12) positive cells in the parenchyma. We showed that at both time points, even after the emphysema was established, the rBmTI-A treatment was sufficient to reverse the loss of elastic recoil measured by Htis, the alveolar enlargement and the increase in the total number of cells in the BALF, with a primary decrease in the number of macrophages. Although, the treatment did not control the increase in macrophages in the lung parenchyma, it was sufficient to decrease the number of positive cells for MMP-12 and reduce the volume of collagen fibers, which was increased in PPE groups. These findings attest to the importance of MMP-12 in PPE-induced emphysema and suggest that this metalloprotease could be an effective therapeutic target.	[Lourenco, Juliana D.; Olivo, Clarice R.; Almeida, Francine M.; Arantes, Petra M. M.; Leick, Edna Aparecida; Martins, Milton A.; Lopes, Fernanda D. T. Q. S.] Univ Sao Paulo, Dept Med, Sao Paulo, Brazil; [Prado, Carla M.] Univ Fed Sao Paulo, Dept Biol Sci, Sao Paulo, Brazil; [Tanaka, Aparecida S.] UNIFESP EPM, Dept Bioquim, Sao Paulo, Brazil; [Neves, Luana P.; Duran, Adriana; Sasaki, Sergio D.] UFABC, Ctr Ciencias Nat & Humanas, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Lopes, FDTQS (corresponding author), Univ Sao Paulo, Dept Med, Sao Paulo, Brazil.	fernandadtqsl@gmail.com	Lourenço, Juliana D./C-5326-2013; Martins, Milton A/L-7541-2017; Prado, Carla M/G-3327-2012; Sasaki, Sergio Daishi/AAR-2928-2021; Tanaka, Aparecida/ADF-5338-2022; Tanaka, Aparecida S/L-8754-2017; de Almeida, Francine Maria/S-2314-2019; Almeida, Francine Maria/H-3733-2013; Martins, Milton A/D-6658-2012; Leick, Edna/C-6432-2012; Olivo, Clarice Rosa/K-2236-2012	Lourenço, Juliana D./0000-0002-9291-5237; Prado, Carla M/0000-0003-1160-0442; Sasaki, Sergio Daishi/0000-0002-6233-3316; Tanaka, Aparecida S/0000-0001-9407-805X; de Almeida, Francine Maria/0000-0001-9755-5034; Almeida, Francine Maria/0000-0001-9755-5034; DTQS Lopes, Fernanda/0000-0002-6402-3055	Laboratorios de Investigacao Medica do Hospital das Clinicas da Faculdade de Medicina da USP (LIM/HC); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp)	Laboratorios de Investigacao Medica do Hospital das Clinicas da Faculdade de Medicina da USP (LIM/HC); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by Laboratorios de Investigacao Medica do Hospital das Clinicas da Faculdade de Medicina da USP (LIM/HC) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham T, 2000, J STRUCTURAL BIOL S2, P189; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; BATES JHT, 1989, J APPL PHYSIOL, V67, P488, DOI 10.1152/jappl.1989.67.1.488; Boyle JR, 1998, J VASC SURG, V27, P354, DOI 10.1016/S0741-5214(98)70367-2; Faria AC, 2010, CLINICS, P443; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P1666, DOI 10.1164/ajrccm.152.5.7582312; Global Initiative for Chronic Obstructive Lung Disease, 2013, GLOBAL STRATEGY DIAG; Gomes RFM, 2000, J APPL PHYSIOL, V89, P908, DOI 10.1152/jappl.2000.89.3.908; GROSS P, 1965, ARCH ENVIRON HEALTH, V11, P50, DOI 10.1080/00039896.1965.10664169; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Ito S, 2005, J APPL PHYSIOL, V98, P503, DOI 10.1152/japplphysiol.00590.2004; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; Keatings VM, 1997, THORAX, V52, P372, DOI 10.1136/thx.52.4.372; Kuraki T, 2002, AM J RESP CRIT CARE, V166, P496, DOI 10.1164/rccm.2103118; Lopes FDTQS, 2013, HISTOL HISTOPATHOL, V28, P269, DOI 10.14670/HH-28.269; MARGRAF LR, 1991, AM REV RESPIR DIS, V143, P391; MARTIN TR, 1985, AM REV RESPIR DIS, V132, P254; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Otlewski J, 2005, EMBO J, V24, P1303, DOI 10.1038/sj.emboj.7600611; Robbesom AA, 2008, MODERN PATHOL, V21, P297, DOI 10.1038/modpathol.3801004; Sasaki SD, 2008, VET PARASITOL, V155, P133, DOI 10.1016/j.vetpar.2008.03.031; Senior RM, 1998, AM J RESP CRIT CARE, V157, pS139, DOI 10.1164/ajrccm.157.4.nhlbi-12; Shapiro SD, 2002, BIOCHEM SOC T, V30, P98, DOI 10.1042/BST0300098; Shifren Adrian, 2006, Proc Am Thorac Soc, V3, P428, DOI 10.1513/pats.200601-009AW; Siracusa LD, 1996, GENOME RES, V6, P300, DOI 10.1101/gr.6.4.300; Stockley RA, 1998, CLIN PULM MED, V5, P203; Takayama M, 2001, J APPL PHYSIOL, V91, P1800, DOI 10.1152/jappl.2001.91.4.1800; Tanaka AS, 1999, IMMUNOPHARMACOLOGY, V45, P171, DOI 10.1016/S0162-3109(99)00074-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Willadsen P, 1999, PARASITOL TODAY, V15, P258, DOI 10.1016/S0169-4758(99)01472-6; Wright JL, 2002, AM J RESP CRIT CARE, V166, P954, DOI 10.1164/rccm.200202-098OC; Zacchigna L, 2006, CELL, V124, P929, DOI 10.1016/j.cell.2005.12.035; Zhu Y, 2001, Respir Res, V2, P300, DOI 10.1186/rr73	35	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98216	10.1371/journal.pone.0098216	http://dx.doi.org/10.1371/journal.pone.0098216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886716	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300048
J	Pires, R; Jelinek, HF; Wainer, J; Valle, E; Rocha, A				Pires, Ramon; Jelinek, Herbert F.; Wainer, Jacques; Valle, Eduardo; Rocha, Anderson			Advancing Bag-of-Visual-Words Representations for Lesion Classification in Retinal Images	PLOS ONE			English	Article							COLOR FUNDUS PHOTOGRAPHS; DIABETIC-RETINOPATHY; MICROANEURYSM DETECTION; AUTOMATED DETECTION; IDENTIFICATION; DIAGNOSIS; SYSTEM	Diabetic Retinopathy (DR) is a complication of diabetes that can lead to blindness if not readily discovered. Automated screening algorithms have the potential to improve identification of patients who need further medical attention. However, the identification of lesions must be accurate to be useful for clinical application. The bag-of-visual-words (BoVW) algorithm employs a maximum-margin classifier in a flexible framework that is able to detect the most common DR-related lesions such as microaneurysms, cotton-wool spots and hard exudates. BoVW allows to bypass the need for pre- and post-processing of the retinographic images, as well as the need of specific ad hoc techniques for identification of each type of lesion. An extensive evaluation of the BoVW model, using three large retinograph datasets (DR1, DR2 and Messidor) with different resolution and collected by different healthcare personnel, was performed. The results demonstrate that the BoVW classification approach can identify different lesions within an image without having to utilize different algorithms for each lesion reducing processing time and providing a more flexible diagnostic system. Our BoVW scheme is based on sparse low-level feature detection with a Speeded-Up Robust Features (SURF) local descriptor, and mid-level features based on semi-soft coding with max pooling. The best BoVW representation for retinal image classification was an area under the receiver operating characteristic curve (AUC-ROC) of 97.8% (exudates) and 93.5% (red lesions), applying a cross-dataset validation protocol. To assess the accuracy for detecting cases that require referral within one year, the sparse extraction technique associated with semi-soft coding and max pooling obtained an AUC of 94.2 +/- 2.0%, outperforming current methods. Those results indicate that, for retinal image classification tasks in clinical practice, BoVW is equal and, in some instances, surpasses results obtained using dense detection (widely believed to be the best choice in many vision problems) for the low-level descriptors.	[Pires, Ramon; Wainer, Jacques; Rocha, Anderson] Univ Campinas Unicamp, Inst Comp, Sao Paulo, Brazil; [Jelinek, Herbert F.] Khalifa Univ, Dept Biomed Engn, Abu Dhabi, U Arab Emirates; [Jelinek, Herbert F.] Macquarie Univ, Australian Sch Adv Med, N Ryde, NSW, Australia; [Valle, Eduardo] Univ Campinas UNICAMP, Sch Elect & Comp Engn, Sao Paulo, Brazil	Universidade Estadual de Campinas; Khalifa University of Science & Technology; Macquarie University; Universidade Estadual de Campinas	Pires, R (corresponding author), Univ Campinas Unicamp, Inst Comp, Sao Paulo, Brazil.	pires.ramon@ic.unicamp.br	Jelinek, Herbert F/S-6779-2019; Wainer, Jacques/B-4241-2012; Wainer, Jacques/AAQ-6029-2021; Jelinek, Herbert/AAQ-6825-2020	Jelinek, Herbert F/0000-0001-5457-6193; Wainer, Jacques/0000-0001-5201-1244; Wainer, Jacques/0000-0001-5201-1244; Pires, Ramon/0000-0002-0023-1971; Alves do Valle Jr, Eduardo/0000-0001-5396-9868	Sao Paulo Research Foundation FAPESP [2010/05647-4, 2011/15349-3]; National Counsel of Technological and Scientific Development (CNPq) [307018/2010-5, 304352/2012-8]; Microsoft Research; Samsung Eletronica da Amazonia	Sao Paulo Research Foundation FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Microsoft Research(Microsoft); Samsung Eletronica da Amazonia(Samsung)	This work was supported in part by Sao Paulo Research Foundation FAPESP (http://www.fapesp.br) under Grant 2010/05647-4 and Grant 2011/15349-3, National Counsel of Technological and Scientific Development (CNPq) (http://www.cnpq.br) under Grant 307018/2010-5 and Grant 304352/2012-8, Microsoft Research (http://research.microsoft.com) and Samsung Eletronica da Amazonia (http://www.samsung.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2013, JAMA OPHTHALMOL, V131, P351, DOI 10.1001/jamaophthalmol.2013.1743; Abramoff MD, 2008, DIABETES CARE, V31, P193, DOI 10.2337/dc07-1312; Acharya UR, 2009, P I MECH ENG H, V223, P545, DOI 10.1243/09544119JEIM486; Ahmed J, 2006, DIABETES CARE, V29, P2205, DOI 10.2337/dc06-0295; [Anonymous], 1991, Ophthalmology, V98, P786; Antal B, 2012, IEEE T BIO-MED ENG, V59, P1720, DOI 10.1109/TBME.2012.2193126; Avila S, 2013, COMPUT VIS IMAGE UND, V117, P453, DOI 10.1016/j.cviu.2012.09.007; Baeza-Yates R, 1999, MODERN INFORM RETRIE, V1; Barriga ES, 2010, I S BIOMED IMAGING, P1349, DOI 10.1109/ISBI.2010.5490247; Bay H, 2008, COMPUT VIS IMAGE UND, V110, P346, DOI 10.1016/j.cviu.2007.09.014; Boureau Y. L., 2010, IEEE INT C COMP VIS; Boureau Y-L., 2010, P 27 INT C MACH LEAR, P111, DOI DOI 10.5555/3104322.3104338; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chatfield K, 2011, PROCEEDINGS OF THE BRITISH MACHINE VISION CONFERENCE 2011, DOI 10.5244/C.25.76; Chew EY, 2003, OPHTHALMOLOGY, V110, P1675, DOI 10.1016/S0161-6420(03)00815-7; Cornforth D., 2005, P WDIC2005 ARPS WORK, P163; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Decenciere E, 2013, TELEOPHTA MACHINE LE; Deepak KS, 2012, IEEE T MED IMAGING, V31, P766, DOI 10.1109/TMI.2011.2178856; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; Fleming AD, 2007, PHYS MED BIOL, V52, P7385, DOI 10.1088/0031-9155/52/24/012; Fleming AD, 2006, IEEE T MED IMAGING, V25, P1223, DOI 10.1109/TMI.2006.879953; Fleming AD, 2010, BRIT J OPHTHALMOL, V94, P706, DOI 10.1136/bjo.2008.149807; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Giancardo L, 2011, IEEE ENG MED BIO, P5939, DOI 10.1109/IEMBS.2011.6091562; Giancardo L, 2010, SPIE MED IMAGING; Giancardo L, 2012, MED IMAGE ANAL, V16, P216, DOI 10.1016/j.media.2011.07.004; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; Jelinek HF, 2009, IFMBE PROC, V25, P127, DOI 10.1007/978-3-642-03891-4_34; Jelinek H.F., 2012, P 25 IEEE INT S COMP, P1, DOI [10.1109/CBMS.2012.6266342, DOI 10.1109/CBMS.2012.6266342]; Jelinek HF, 2011, IEEE ENG MED BIO, P5951, DOI 10.1109/IEMBS.2011.6091471; Jelinek HJ, 2006, CLIN EXP OPTOM, V89, P299, DOI 10.1111/j.1444-0938.2006.00071.x; KLEIN R, 1989, ARCH OPHTHALMOL-CHIC, V107, P237, DOI 10.1001/archopht.1989.01070010243030; Lazar I, 2013, IEEE T MED IMAGING, V32, P400, DOI 10.1109/TMI.2012.2228665; Li YQ, 2011, TELEMED E-HEALTH, V17, P627, DOI 10.1089/tmj.2011.0004; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Mitchell P., 2008, GUIDELINES MANAGEMEN; Nayak J, 2008, J MED SYST, V32, P107, DOI 10.1007/s10916-007-9113-9; Nemenyi P., 1963, DISTRIBUTION FREE MU; Niemeijer M, 2007, INVEST OPHTH VIS SCI, V48, P2260, DOI 10.1167/iovs.06-0996; Perronnin F., 2012, P IEEE C COMP VIS PA, P1, DOI [DOI 10.1109/CVPR, 10.1109/CVPR]; Phillips PJ, 2012, MED TODAY, V5, P83; Pires R, 2012, INT C GRAPH PATT IM; Pires R, 2013, IEEE T BIO-MED ENG, V60, P3391, DOI 10.1109/TBME.2013.2278845; Precioso F, 2012, SPRINGERBRIEFS COMPU, P21; Rocha A, 2012, IEEE T BIO-MED ENG, V59, P2244, DOI 10.1109/TBME.2012.2201717; Sanchez CI, 2009, SPIE MED IMAGING; Sanchez CI, 2009, MED IMAGE ANAL, V13, P650, DOI 10.1016/j.media.2009.05.005; Sinthanayothin C, 2002, DIABETIC MED, V19, P105, DOI 10.1046/j.1464-5491.2002.00613.x; Sivic J, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1470, DOI 10.1109/iccv.2003.1238663; Soares JVB, 2006, IEEE T MED IMAGING, V25, P1214, DOI 10.1109/TMI.2006.879967; Sopharak A, 2008, COMPUTERIZED MED IMA, V32, P8; van Gemert JC, 2010, IEEE T PATTERN ANAL, V32, P1271, DOI 10.1109/TPAMI.2009.132; Welfer D, 2010, COMPUT MED IMAG GRAP, V34, P228, DOI 10.1016/j.compmedimag.2009.10.001; World Health Organization, 2013, DIAB PROGR; Yun WL, 2008, INFORM SCIENCES, V178, P106, DOI 10.1016/j.ins.2007.07.020; Zhang B, 2009, SPIE MED IMAGING	57	48	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e96814	10.1371/journal.pone.0096814	http://dx.doi.org/10.1371/journal.pone.0096814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886780	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300009
J	Ravona-Springer, R; Heymann, A; Schmeidler, J; Moshier, E; Godbold, J; Sano, M; Leroith, D; Johnson, S; Preiss, R; Koifman, K; Hoffman, H; Silverman, JM; Beeri, MS				Ravona-Springer, Ramit; Heymann, Anthony; Schmeidler, James; Moshier, Erin; Godbold, James; Sano, Mary; Leroith, Derek; Johnson, Sterling; Preiss, Rachel; Koifman, Keren; Hoffman, Hadas; Silverman, Jeremy M.; Beeri, Michal Schnaider			Trajectories in Glycemic Control over Time Are Associated with Cognitive Performance in Elderly Subjects with Type 2 Diabetes	PLOS ONE			English	Article							ALZHEIMER-DISEASE; BLOOD-PRESSURE; OLDER-ADULTS; DEMENTIA; RISK; DEPRESSION; SCALE; HYPOGLYCEMIA; MORTALITY; MELLITUS	Objective: To study the relationships of long-term trajectories of glycemic control with cognitive performance in cognitively normal elderly with type 2 diabetes (T2D). Methods: Subjects (n = 835) pertain to a diabetes registry (DR) established in 1998 with an average of 18 HbA1c measurements per subject, permitting identification of distinctive trajectory groups of HbA1c and examining their association with cognitive function in five domains: episodic memory, semantic categorization, attention/working memory, executive function, and overall cognition. Analyses of covariance compared cognitive function among the trajectory groups adjusting for sociodemographic, cardiovascular, diabetes-related covariates and depression. Results: Subjects averaged 72.8 years of age. Six trajectories of HbA1c were identified, characterized by HbA1c level at entry into the DR (Higher/Lower), and trend over time (Stable/Decreasing/Increasing). Both groups with a trajectory of decreasing HbA1c levels had high HbA1c levels at entry into the DR (9.2%, 10.7%), and high, though decreasing, HbA1c levels over time. They had the worst cognitive performance, particularly in overall cognition (p < 0.02) and semantic categorization (p < 0.01), followed by that of subjects whose HbA1c at entry into the DR was relatively high (7.2%, 7.8%) and increased over time. Subjects with stable HbA1c over time had the lowest HbA1c levels at entry (6.0%, 6.8%) and performed best in cognitive tests. Conclusion: Glycemic control trajectories, which better reflect chronicity of T2D than a single HbA1c measurement, predict cognitive performance. A trajectory of stable HbA1c levels over time is associated with better cognitive function.	[Ravona-Springer, Ramit; Koifman, Keren] Sheba Med Ctr, Memory Clin, Ramat Gan, Israel; [Heymann, Anthony] Tel Aviv Univ, Dept Family Med, IL-69978 Tel Aviv, Israel; [Schmeidler, James; Sano, Mary; Silverman, Jeremy M.; Beeri, Michal Schnaider] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA; [Moshier, Erin; Godbold, James] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY USA; [Leroith, Derek] Icahn Sch Med Mt Sinai, Dept Med, New York, NY USA; [Johnson, Sterling] Univ Wisconsin, Ctr Geriatr Res Educ & Clin, Madison VA Hosp, Madison, WI 53706 USA; [Johnson, Sterling] Univ Wisconsin, Alzheimers Dis Res Ctr, Dept Med, Madison, WI 53706 USA; [Preiss, Rachel; Hoffman, Hadas] Maccabi Hlth Serv, Tel Aviv, Israel; [Beeri, Michal Schnaider] Sheba Med Ctr, Joseph Sagol Neurosci Ctr, Ramat Gan, Israel	Chaim Sheba Medical Center; Tel Aviv University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Geriatric Research Education & Clinical Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Chaim Sheba Medical Center	Ravona-Springer, R (corresponding author), Sheba Med Ctr, Memory Clin, Ramat Gan, Israel.	ramit.ravona@sheba.health.gov.il	Silverman, Jeremy M./AAO-4268-2020	heymann, anthony/0000-0003-2353-9933	American Federation for Aging Research (AFAR); Alzheimer's Association [NIRG-11-205083]; NIA grant [R01 AG034087]; VH [NIA-AG02219]; Helen Bader Foundation; Irma T. Hirschl Scholar Award; Leroy Schecter Foundation Award; National Institute of Aging from the United States Department of Veterans Affairs [P01-AG02219]	American Federation for Aging Research (AFAR); Alzheimer's Association(Alzheimer's Association); NIA grant; VH; Helen Bader Foundation; Irma T. Hirschl Scholar Award; Leroy Schecter Foundation Award; National Institute of Aging from the United States Department of Veterans Affairs	This study was supported by the American Federation for Aging Research (AFAR), Young investigator award 2011 and NIRG-11-205083 Alzheimer's Association, 2012 to RRS, NIA grant R01 AG034087 to MSB, NIA-AG02219 (VH), the Helen Bader Foundation and the Irma T. Hirschl Scholar Award as well as the Leroy Schecter Foundation Award to MSB. National Institute of Aging grant P01-AG02219, a Merit Award to JMS from the United States Department of Veterans Affairs; Berkman Charitable Trust. The funders have no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Ahren B, 2013, VASC HEALTH RISK MAN, V9, P155, DOI 10.2147/VHRM.S33934; Ahtiluoto S, 2010, NEUROLOGY, V75, P1195, DOI 10.1212/WNL.0b013e3181f4d7f8; Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Andersson C, 2012, DIABETOLOGIA, V55, P2348, DOI 10.1007/s00125-012-2584-3; Beeri MS, 2004, NEUROLOGY, V63, P1902, DOI 10.1212/01.WNL.0000144278.79488.DD; Bellelli G, 2002, ARCH INTERN MED, V162, P483, DOI 10.1001/archinte.162.4.483; Blacker D, 2007, ARCH NEUROL-CHICAGO, V64, P862, DOI 10.1001/archneur.64.6.862; Chen YC, 2010, ARCH GERONTOL GERIAT, V50, pS48, DOI 10.1016/S0167-4943(10)70013-3; Christman AL, 2011, DIABETOLOGIA, V54, P1645, DOI 10.1007/s00125-011-2095-7; Conradsson M, 2013, AGING MENT HEALTH, V17, P638, DOI 10.1080/13607863.2012.758231; Cooray G, 2011, PSYCHONEUROENDOCRINO, V36, P77, DOI 10.1016/j.psyneuen.2010.06.009; Crane PK, 2013, NEW ENGL J MED, V369, P1863; Cukierman-Yaffe T, 2009, DIABETES CARE, V32, P221, DOI 10.2337/dc08-1153; Enzinger C, 2005, NEUROLOGY, V64, P1704, DOI 10.1212/01.WNL.0000161871.83614.BB; Fernaeus SE, 1998, J CLIN EXP NEUROPSYC, V20, P137, DOI 10.1076/jcen.20.2.137.1170; Fillenbaum GG, 1996, AGING-CLIN EXP RES, V8, P379, DOI 10.1007/BF03339599; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gebregziabher M, 2010, AM J EPIDEMIOL, V171, P1090, DOI 10.1093/aje/kwq070; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Heymann AD, 2006, DIABETES RES CLIN PR, V71, P290, DOI 10.1016/j.diabres.2005.07.002; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Jones BL, 2001, SOCIOL METHOD RES, V29; Kishore P, 2012, CURR DIABETES REP, V12, P255, DOI 10.1007/s11892-012-0268-5; Launer LJ, 2011, LANCET NEUROL, V10, P969, DOI 10.1016/S1474-4422(11)70188-0; Lin EHB, 2010, DIABETES CARE, V33, P264, DOI 10.2337/dc09-1068; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Manschot SM, 2007, DIABETOLOGIA, V50, P2388, DOI 10.1007/s00125-007-0792-z; Milicevic Z, 2008, DIABETES CARE, V31, pS155, DOI 10.2337/dc08-s240; Mokini Zhirajr, 2006, Pediatr Endocrinol Rev, V4, P138; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Rajala U, 2005, J HUM HYPERTENS, V19, P85, DOI 10.1038/sj.jhh.1001779; Ravona-Springer R, 2013, DIABETES CARE, V36, P3139, DOI 10.2337/dc12-2250; Ravona-Springer R, 2012, J ALZHEIMERS DIS, V30, P299, DOI 10.3233/JAD-2012-120106; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Spreen O., 1977, NEUROSENSORY CTR COM; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; TURNER RC, 1995, DIABETES, V44, P1249; Wechsler D, 1987, WMS R WECHSLER MEMOR; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; Yaffe K, 2013, JAMA INTERN MED, V173, P1300, DOI 10.1001/jamainternmed.2013.6176; Yaffe K, 2012, ARCH NEUROL-CHICAGO, V69, P1170, DOI 10.1001/archneurol.2012.1117; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zhong Y, 2012, BIOMED ENVIRON SCI, V25, P1, DOI 10.3967/0895-3988.2012.01.001	47	47	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97384	10.1371/journal.pone.0097384	http://dx.doi.org/10.1371/journal.pone.0097384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887092	Green Published, gold			2022-12-25	WOS:000336956300016
J	Bhattarai, GP; Cronin, JT				Bhattarai, Ganesh P.; Cronin, James T.			Hurricane Activity and the Large-Scale Pattern of Spread of an Invasive Plant Species	PLOS ONE			English	Article							REED PHRAGMITES-AUSTRALIS; COMMON REED; CLIMATE-CHANGE; BIOLOGICAL INVASIONS; CHESAPEAKE BAY; TROPICAL CYCLONES; CRYPTIC INVASION; UNITED-STATES; NORTH-AMERICA; SALT MARSHES	Disturbances are a primary facilitator of the growth and spread of invasive species. However, the effects of large-scale disturbances, such as hurricanes and tropical storms, on the broad geographic patterns of invasive species growth and spread have not been investigated. We used historical aerial imagery to determine the growth rate of invasive Phragmites australis patches in wetlands along the Atlantic and Gulf Coasts of the United States. These were relatively undisturbed wetlands where P. australis had room for unrestricted growth. Over the past several decades, invasive P. australis stands expanded in size by 6-35% per year. Based on tropical storm and hurricane activity over that same time period, we found that the frequency of hurricane-force winds explained 81% of the variation in P. australis growth over this broad geographic range. The expansion of P. australis stands was strongly and positively correlated with hurricane frequency. In light of the many climatic models that predict an increase in the frequency and intensity of hurricanes over the next century, these results suggest a strong link between climate change and species invasion and a challenging future ahead for the management of invasive species.	[Bhattarai, Ganesh P.; Cronin, James T.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Bhattarai, GP (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	gbhatt2@tigers.lsu.edu	Cronin, James/V-2781-2019	Cronin, James/0000-0001-7111-6412; Bhattarai, Ganesh/0000-0003-1285-0531	National Science Foundation [DEB-1050084]; Louisiana Environmental Education Commission Grant; Louisiana State University-Biograds; Carrie Lynn Yoder Memorial Fellowships	National Science Foundation(National Science Foundation (NSF)); Louisiana Environmental Education Commission Grant; Louisiana State University-Biograds; Carrie Lynn Yoder Memorial Fellowships	Financial support provided by National Science Foundation Grant DEB-1050084 to JTC, and Louisiana Environmental Education Commission Grant, Louisiana State University-Biograds and Carrie Lynn Yoder Memorial Fellowships to GPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsberry L, 2000, ECOL APPL, V10, P1110, DOI 10.1890/1051-0761(2000)010[1110:CIATEO]2.0.CO;2; Bart David, 2006, Wetlands Ecology and Management, V14, P53, DOI 10.1007/s11273-005-2566-z; Bellingham PJ, 2005, J VEG SCI, V16, P675; Bender MA, 2010, SCIENCE, V327, P454, DOI 10.1126/science.1180568; Bertness MD, 2002, P NATL ACAD SCI USA, V99, P1395, DOI 10.1073/pnas.022447299; BLOOD ER, 1991, BIOTROPICA, V23, P348, DOI 10.2307/2388251; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Censky EJ, 1998, NATURE, V395, P556, DOI 10.1038/26886; CHABRECK RH, 1973, ECOLOGY, V54, P1118, DOI 10.2307/1935578; Chambers RM, 2008, WETLANDS, V28, P1097, DOI 10.1672/07-61.1; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; Dibble KL, 2013, BIOL INVASIONS, V15, P1725, DOI 10.1007/s10530-012-0404-9; Diez JM, 2012, FRONT ECOL ENVIRON, V10, P249, DOI 10.1890/110137; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Emanuel K, 2007, J CLIMATE, V20, P5497, DOI 10.1175/2007JCLI1571.1; Guo WY, 2013, GLOBAL CHANGE BIOL, V19, P3406, DOI 10.1111/gcb.12295; Hazelton ELG, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu001; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holdredge C, 2010, OIKOS, V119, P1776, DOI 10.1111/j.1600-0706.2010.18647.x; Holland GJ, 2010, MON WEATHER REV, V138, P4393, DOI 10.1175/2010MWR3317.1; Howard RJ, 2006, ENVIRON EXP BOT, V56, P301, DOI 10.1016/j.envexpbot.2005.03.003; Hsu SA, 1998, J COASTAL RES, V14, P667; Hsu SA., 2005, NATL WEATHER ASS ELE, V6, P1; Kettenring KM, 2011, J APPL ECOL, V48, P1305, DOI 10.1111/j.1365-2664.2011.02024.x; King RS, 2007, ESTUAR COAST, V30, P469, DOI 10.1007/BF02819393; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Lambert AM, 2007, ENVIRON ENTOMOL, V36, P451, DOI 10.1603/0046-225X(2007)36[451:SONANC]2.0.CO;2; Lambertini C, 2012, AM J BOT, V99, P538, DOI 10.3732/ajb.1100396; Lelong B, 2007, DIVERS DISTRIB, V13, P430, DOI 10.1111/j.1472-4642.2007.00351.x; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Martin LJ, 2013, ESTUAR COAST, V36, P626, DOI 10.1007/s12237-013-9593-4; Meyerson LA, 2010, INVAS PLANT SCI MANA, V3, P515, DOI 10.1614/IPSM-D-09-00052.1; Michener WK, 1997, ECOL APPL, V7, P770, DOI 10.1890/1051-0761(1997)007[0770:CCHATS]2.0.CO;2; Minchinton TE, 2006, J ECOL, V94, P342, DOI 10.1111/j.1365-2745.2006.01099.x; Moles AT, 2012, J ECOL, V100, P116, DOI 10.1111/j.1365-2745.2011.01915.x; NIERING W A, 1977, Connecticut Arboretum Bulletin, V22, P2; Paerl HW, 2001, P NATL ACAD SCI USA, V98, P5655, DOI 10.1073/pnas.101097398; Pielke RA, 2005, B AM METEOROL SOC, V86, P1571, DOI 10.1175/BAMS-86-11-1571; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pysek P, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P73; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; Rice D, 2000, WETLANDS, V20, P280, DOI 10.1672/0277-5212(2000)020[0280:CAEOPA]2.0.CO;2; Rosso Pablo H., 2008, Proceedings of the SPIE - The International Society for Optical Engineering, V7110, DOI 10.1117/12.800269; Ruiz GM, 1997, AM ZOOL, V37, P621; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Saltonstall K, 2002, P NATL ACAD SCI USA, V99, P2445, DOI 10.1073/pnas.032477999; Shearer JF, 2012, TN121 USACE ERDC EL; Silliman BR, 2004, CONSERV BIOL, V18, P1424, DOI 10.1111/j.1523-1739.2004.00112.x; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; Turner RE, 2006, SCIENCE, V314, P449, DOI 10.1126/science.1129116; Vasquez EA, 2005, MAR ECOL PROG SER, V298, P1, DOI 10.3354/meps298001; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Williams DA, 2012, J AQUAT PLANT MANAGE, V50, P69; Windham L, 2003, ECOL APPL, V13, P883, DOI 10.1890/02-5005	59	34	35	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98478	10.1371/journal.pone.0098478	http://dx.doi.org/10.1371/journal.pone.0098478			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878928	Green Published, gold			2022-12-25	WOS:000338101500062
J	Cheng, XQ; Sherman, J; Murphy, W; Ratovitski, E; Canady, J; Keidar, M				Cheng, Xiaoqian; Sherman, Jonathan; Murphy, William; Ratovitski, Edward; Canady, Jerome; Keidar, Michael			The Effect of Tuning Cold Plasma Composition on Glioblastoma Cell Viability	PLOS ONE			English	Article							ATMOSPHERIC PLASMA; MELANOMA-CELLS; IN-VIVO; CANCER; PEROXYNITRITE; EXPRESSION; APOPTOSIS; THERAPY; NEEDLE; DEATH	Previous research in cold atmospheric plasma (CAP) and cancer cell interaction has repeatedly proven that the cold plasma induced cell death. It is postulated that the reactive oxygen species (ROS) and reactive nitrogen species (RNS) play a major role in the CAP cancer therapy. In this paper, we seek to determine a mechanism of CAP therapy on glioblastoma cells (U87) through an understanding of the composition of the plasma, including treatment time, voltage, flow-rate and plasma-gas composition. In order to determine the threshold of plasma treatment on U87, normal human astrocytes (E6/E7) were used as the comparison cell line. Our data showed that the 30 sec plasma treatment caused 3-fold cell death in the U87 cells compared to the E6/E7 cells. All the other compositions of cold plasma were performed based on this result: plasma treatment time was maintained at 30 s per well while other plasma characteristics such as voltage, flow rate of source gas, and composition of source gas were changed one at a time to vary the intensity of the reactive species composition in the plasma jet, which may finally have various effect on cells reflected by cell viability. We defined a term "plasma dosage'' to summarize the relationship of all the characteristics and cell viability.	[Cheng, Xiaoqian; Ratovitski, Edward; Keidar, Michael] George Washington Univ, Dept Mech & Aerosp Engn, Washington, DC 20052 USA; [Sherman, Jonathan] George Washington Univ, Dept Neurosurg, Washington, DC USA; [Murphy, William] George Washington Univ, Dept Elect & Comp Engn, Washington, DC USA; [Ratovitski, Edward] Johns Hopkins Univ, Sch Med, Head & Neck Canc Res Div, Baltimore, MD USA; [Canady, Jerome] USMI, Inst Adv Biol & Tech Sci, Takoma Pk, MD USA	George Washington University; George Washington University; George Washington University; Johns Hopkins University	Keidar, M (corresponding author), George Washington Univ, Dept Mech & Aerosp Engn, Washington, DC 20052 USA.	keidar@gwu.edu		Cheng, Xiaoqian/0000-0002-2544-4260	Katzen Research Grant	Katzen Research Grant	Support was provided by a Katzen Research Grant (http://www.katzencancer.org/index.php/research/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; Barekzi N, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/42/422002; Beckman J, 1996, AM J PHYSL SOC; Brulle L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052653; Chen W, 2012, J APPL PHYS, V112, DOI 10.1063/1.4732135; Dunnbier M, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/43/435203; Georgescu N, 2010, IEEE T PLASMA SCI, V38, P1949, DOI 10.1109/TPS.2010.2041075; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Keidar M, 2013, PLASMA ENGINEERING: APPLICATIONS FROM AEROSPACE TO BIO- AND NANOTECHNOLOGY, P1; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Keidar M, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4801516; Kim JY, 2011, BIOSENS BIOELECTRON, V28, P333, DOI 10.1016/j.bios.2011.07.039; Kim SJ, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3462293; Leduc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115021; Lee HJ, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115026; Liu DW, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3186073; Lukes P, 2014, PLASMA SOURCES SCI T, V23, DOI 10.1088/0963-0252/23/1/015019; Morris Angela D, 2009, J Dent Hyg, V83, P55; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Nehra V, 2008, INT J ENG-IRAN, V2, P53; Nersisyan G, 2004, PLASMA SOURCES SCI T, V13, P582, DOI 10.1088/0963-0252/13/4/005; Nie QY, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115015; Ohgaki Hiroko, 2009, V472, P323, DOI 10.1007/978-1-60327-492-0_14; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Partecke LI, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-473; Pearse R. W. B., 1976, IDENTIFICATION MOL S; Shashurin A, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3020223; Stoffels E, 2006, PLASMA SOURCES SCI T, V15, pS169, DOI 10.1088/0963-0252/15/4/S03; Virag L, 2003, TOXICOL LETT, V140, P113, DOI 10.1016/S0378-4274(02)00508-8; Volotskova O, 2012, SCI REP-UK, V2, DOI 10.1038/srep00636; Walk RM, 2013, J PEDIATR SURG, V48, P67, DOI 10.1016/j.jpedsurg.2012.10.020; Walsh JL, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2982497; Winter J, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/29/295401; Yan X, 2012, PLASMA PROCESS POLYM, V9, P59, DOI 10.1002/ppap.201100031; Yonson S, 2006, J PHYS D APPL PHYS, V39, P3508, DOI 10.1088/0022-3727/39/16/S08; Yousfi M, 2014, FUND CLIN PHARMACOL, V28, P123, DOI 10.1111/fcp.12018; Zhang XH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2959735; Zirnheld JL, 2010, IEEE T PLASMA SCI, V38, P948, DOI 10.1109/TPS.2010.2041470; Ziuzina D, 2013, J APPL MICROBIOL, V114, P778, DOI 10.1111/jam.12087; Zucker SN, 2012, CANCER BIOL THER, V13, P1299, DOI 10.4161/cbt.21787	43	131	132	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98652	10.1371/journal.pone.0098652	http://dx.doi.org/10.1371/journal.pone.0098652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878760	Green Published, Green Submitted, gold			2022-12-25	WOS:000338101500078
J	Nadrowski, K; Pietsch, K; Baruffol, M; Both, S; Gutknecht, J; Bruelheide, H; Heklau, H; Kahl, A; Kahl, T; Niklaus, P; Krober, W; Liu, XJ; Mi, XC; Michalski, S; von Oheimb, G; Purschke, O; Schmid, B; Fang, T; Welk, E; Wirth, C				Nadrowski, Karin; Pietsch, Katherina; Baruffol, Martin; Both, Sabine; Gutknecht, Jessica; Bruelheide, Helge; Heklau, Heike; Kahl, Anja; Kahl, Tiemo; Niklaus, Pascal; Kroeber, Wenzel; Liu, Xiaojuan; Mi, Xiangcheng; Michalski, Stefan; von Oheimb, Goddert; Purschke, Oliver; Schmid, Bernhard; Fang, Teng; Welk, Erik; Wirth, Christian			Tree Species Traits but Not Diversity Mitigate Stem Breakage in a Subtropical Forest following a Rare and Extreme Ice Storm	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; GLOBAL PATTERNS; DAMAGE; DISTURBANCE; PLANTATIONS; ECONOMICS; DYNAMICS; IMPACT; LEAF	Future climates are likely to include extreme events, which in turn have great impacts on ecological systems. In this study, we investigated possible effects that could mitigate stem breakage caused by a rare and extreme ice storm in a Chinese subtropical forest across a gradient of forest diversity. We used Bayesian modeling to correct stem breakage for tree size and variance components analysis to quantify the influence of taxon, leaf and wood functional traits, and stand level properties on the probability of stem breakage. We show that the taxon explained four times more variance in individual stem breakage than did stand level properties; trees with higher specific leaf area (SLA) were less susceptible to breakage. However, a large part of the variation at the taxon scale remained unexplained, implying that unmeasured or undefined traits could be used to predict damage caused by ice storms. When aggregated at the plot level, functional diversity and wood density increased after the ice storm. We suggest that for the adaption of forest management to climate change, much can still be learned from looking at functional traits at the taxon level.	[Nadrowski, Karin; Pietsch, Katherina; Kahl, Anja; Wirth, Christian] Univ Leipzig, D-04109 Leipzig, Germany; [Baruffol, Martin; Niklaus, Pascal; Schmid, Bernhard] Univ Zurich, Zurich, Switzerland; [Both, Sabine; Bruelheide, Helge; Heklau, Heike; Kroeber, Wenzel; Welk, Erik] Univ Halle Wittenberg, D-06108 Halle, Germany; [Gutknecht, Jessica] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Germany; [Kahl, Tiemo] Univ Freiburg, Waldbau Inst, D-79106 Freiburg, Germany; [Liu, Xiaojuan; Mi, Xiangcheng] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Michalski, Stefan] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, Halle, Germany; [von Oheimb, Goddert] Leuphana Univ Luneburg, Inst Ecol, Luneburg, Germany; [Purschke, Oliver] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Fang, Teng] Gutianshan Natl Nat Reserve, Kaihua, Peoples R China	Leipzig University; University of Zurich; Martin Luther University Halle Wittenberg; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Freiburg; Chinese Academy of Sciences; Institute of Botany, CAS; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leuphana University Luneburg	Nadrowski, K (corresponding author), Univ Leipzig, D-04109 Leipzig, Germany.	nadrowski@uni-leipzig.de	Niklaus, Pascal A/G-5786-2010; von Oheimb, Goddert/O-9483-2015; Liu, Xiaojuan/B-4947-2017; Both, Sabine/GRO-4210-2022; Gutknecht, Jessica/AAI-3682-2021; Schmid, Bernhard/C-8625-2009; Bruelheide, Helge/G-3907-2013; Michalski, Stefan G/O-5774-2015; Wirth, Christian/A-4446-2016; WELK, Erik/AGL-4971-2022; Baruffol, Martin/A-2406-2014	Niklaus, Pascal A/0000-0002-2360-1357; von Oheimb, Goddert/0000-0001-7408-425X; Schmid, Bernhard/0000-0002-8430-3214; Bruelheide, Helge/0000-0003-3135-0356; Michalski, Stefan G/0000-0002-8969-7355; Kahl, Anja/0000-0001-5497-8520; Purschke, Oliver/0000-0003-0444-0882; Nadrowski, Karin/0000-0001-5358-5469; Both, Sabine/0000-0003-4437-5106; Baruffol, Martin/0000-0001-9358-5885	German Science Foundation [DFG FOR 891/1, DFG FOR 891/2]; National Science Foundation of China [NSFC 30710103907, 30930005]	German Science Foundation(German Research Foundation (DFG)); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the German Science Foundation (http://www.dfg.de, DFG FOR 891/1 & 2) and by the National Science Foundation of China (http://www.nsfc.gov.cn, NSFC 30710103907 and 30930005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraloto C, 2010, ECOL LETT, V13, P1338, DOI 10.1111/j.1461-0248.2010.01517.x; Barrufol M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081246; Bates D, 2012, LME4 LINEAR MIXED EF; Bohnke M, 2014, J VEG SCI, V25, P897, DOI 10.1111/jvs.12114; Bohnke M, 2012, TREES-STRUCT FUNCT, V26, P641, DOI 10.1007/s00468-011-0632-0; Bohnke M, 2012, LEAF TRAITS CHEM 130; Bohnke M, 2010, XYLEM TRAITS TREE SP; Bolker B., 2007, ECOLOGICAL MODELS DA; Bragg DC, 2003, FOREST ECOL MANAG, V186, P99, DOI 10.1016/S0378-1127(03)00230-5; Bruelheide H, 2013, METHODS ECOL EVOL, DOI 10.1111/2041-210X.12126; Bruelheide H, 2013, COMP STUDY PLOT CSP; Bruelheide H, 2011, ECOL MONOGR, V81, P25, DOI 10.1890/09-2172.1; Cain M. D., 2002, General Technical Report - Southern Research Station, USDA Forest Service, P579; Duguay SM, 2001, ENVIRON MONIT ASSESS, V67, P97, DOI 10.1023/A:1006464511158; Field C.B., 2011, INTERGOVERNMENTAL PA; Geissler C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049618; Graham MH, 2001, OIKOS, V93, P505, DOI 10.1034/j.1600-0706.2001.930317.x; Gutschick VP, 2003, NEW PHYTOL, V160, P21, DOI 10.1046/j.1469-8137.2003.00866.x; He Qian, 2010, Chinese Journal of Plant Ecology, V34, P195, DOI 10.3773/j.issn.1005-264x.2010.02.011; Hector A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017434; Holzwarth F, 2013, J ECOL, V101, P220, DOI 10.1111/1365-2745.12015; Jentsch A, 2011, J ECOL, V99, P689, DOI 10.1111/j.1365-2745.2011.01817.x; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; King DJ, 2005, NAT HAZARDS, V35, P321, DOI 10.1007/s11069-004-1795-4; Kraemer MJ, 2010, NRS60 USDA FOR SERV; Krober W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035742; Lafon CW, 2004, J VEG SCI, V15, P267, DOI 10.1111/j.1654-1103.2004.tb02261.x; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lang AC, 2012, ECOL RES, V27, P181, DOI 10.1007/s11284-011-0887-3; Lang AC, 2010, FOREST ECOL MANAG, V260, P1708, DOI 10.1016/j.foreco.2010.08.015; Lou LuHuan, 2000, Journal of Beijing Forestry University, V22, P33; Ma Ze-Qing, 2010, Chinese Journal of Plant Ecology, V34, P204, DOI 10.3773/j.issn.1005-264x.2010.02.012; Man XingXing, 2011, Biodiversity Science, V19, P197, DOI 10.3724/SP.J.1003.2011.09220; Michalski S., 2013, PHYLOGENETIC TREE WO; Nadrowski K., 2013, DEVIATIONS STEM BREA; Nadrowski K, 2009, CORE WOOD DENSITY PA; Nadrowski K, 2013, LIVING KILLED TREES; Nadrowski K, 2013, METHODS ECOL EVOL, V4, P201, DOI 10.1111/2041-210x.12009; Nadrowski K, 2010, CURR OPIN ENV SUST, V2, P75, DOI 10.1016/j.cosust.2010.02.003; Plummer M, 2012, RJAGS BAYESIAN GRAPH; Quinn GP, 2003, EXPT DESIGN DATA ANA; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Research Institute of Wood Industry of the Chinese Academy of Forestry, 1982, PHYS MECH PROP PRIM; Shipley B, 2006, ECOLOGY, V87, P535, DOI 10.1890/05-1051; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; Stueve KM, 2007, AREA, V39, P20, DOI 10.1111/j.1475-4762.2007.00722.x; Su Zhi-Yao, 2010, Chinese Journal of Plant Ecology, V34, P213, DOI 10.3773/j.issn.1005-264x.2010.02.013; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wang X, 2009, SCI SILVAE SIN, V45, P42; Wu YT, 2012, ECOSYSTEMS, V15, P624, DOI 10.1007/s10021-012-9533-3; Yu MingJian, 2001, Journal of Zhejiang University (Agriculture and Life Sciences), V27, P375; Zanne AE, 2010, AM J BOT, V97, P207, DOI 10.3732/ajb.0900178; Zhang Lei, 2011, Biodiversity Science, V19, P206, DOI 10.3724/SP.J.1003.2011.10237; Zhou BZ, 2011, B AM METEOROL SOC, V92, P47, DOI 10.1175/2010BAMS2857.1; Zhou BZ, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2009JG001234	55	6	6	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e96022	10.1371/journal.pone.0096022	http://dx.doi.org/10.1371/journal.pone.0096022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879434	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000338101500004
J	Hosoda, K; Habuchi, M; Suzuki, S; Miyazaki, M; Takikawa, G; Sakurai, T; Kashiwagi, A; Sueyoshi, M; Matsumoto, Y; Kiuchi, A; Mori, K; Yomo, T				Hosoda, Kazufumi; Habuchi, Masumi; Suzuki, Shingo; Miyazaki, Mikako; Takikawa, Go; Sakurai, Takahiro; Kashiwagi, Akiko; Sueyoshi, Makoto; Matsumoto, Yusuke; Kiuchi, Ayako; Mori, Kotaro; Yomo, Tetsuya			Adaptation of a Cyanobacterium to a Biochemically Rich Environment in Experimental Evolution as an Initial Step toward a Chloroplast-Like State	PLOS ONE			English	Article							AMINO-ACID-TRANSPORT; SP PCC 6803; SELECTION; MUTATION; CHLAMYDOMONAS; FITNESS; GENE; ACCUMULATION; DYNAMICS; PCC-6803	Chloroplasts originated from cyanobacteria through endosymbiosis. The original cyanobacterial endosymbiont evolved to adapt to the biochemically rich intracellular environment of the host cell while maintaining its photosynthetic function; however, no such process has been experimentally demonstrated. Here, we show the adaptation of a model cyanobacterium, Synechocystis sp. PCC 6803, to a biochemically rich environment by experimental evolution. Synechocystis sp. PCC 6803 does not grow in a biochemically rich, chemically defined medium because several amino acids are toxic to the cells at approximately 1 mM. We cultured the cyanobacteria in media with the toxic amino acids at 0.1 mM, then serially transferred the culture, gradually increasing the concentration of the toxic amino acids. The cells evolved to show approximately the same specific growth rate in media with 0 and 1 mM of the toxic amino acid in approximately 84 generations and evolved to grow faster in the media with 1 mM than in the media with 0 mM in approximately 181 generations. We did not detect a statistically significant decrease in the autotrophic growth of the evolved strain in an inorganic medium, indicating the maintenance of the photosynthetic function. Whole-genome resequencing revealed changes in the genes related to the cell membrane and the carboxysome. Moreover, we quantitatively analyzed the evolutionary changes by using simple mathematical models, which evaluated the evolution as an increase in the half-maximal inhibitory concentration (IC50) and estimated quantitative characteristics of the evolutionary process. Our results clearly demonstrate not only the potential of a model cyanobacterium to adapt to a biochemically rich environment without a significant decrease in photosynthetic function but also the properties of its evolutionary process, which sheds light of the evolution of chloroplasts at the initial stage.	[Hosoda, Kazufumi] Osaka Univ, Inst Acad Initiat, Suita, Osaka, Japan; [Habuchi, Masumi; Mori, Kotaro; Yomo, Tetsuya] Osaka Univ, Dept Frontier Biosci, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Suzuki, Shingo] RIKEN, Quantitat Biol Ctr, Suita, Osaka, Japan; [Miyazaki, Mikako; Kiuchi, Ayako] Osaka Univ, Dept Biotechnol, Grad Sch Engn, Suita, Osaka, Japan; [Takikawa, Go; Sakurai, Takahiro; Sueyoshi, Makoto; Matsumoto, Yusuke; Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Dept Bioinformat Engn, Suita, Osaka, Japan; [Kashiwagi, Akiko] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan; [Yomo, Tetsuya] Japan Sci & Technol Agcy, ERATO, Suita, Osaka, Japan	Osaka University; Osaka University; RIKEN; Osaka University; Osaka University; Hirosaki University; Japan Science & Technology Agency (JST)	Yomo, T (corresponding author), Osaka Univ, Dept Frontier Biosci, Grad Sch Frontier Biosci, Suita, Osaka, Japan.	yomo@ist.osaka-u.ac.jp	Suzuki, Shingo/O-3651-2014	Suzuki, Shingo/0000-0003-1332-3194	JSPS KAKENHI [25650147]; "Global COE Program" of MEXT, Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); "Global COE Program" of MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported in part by JSPS KAKENHI grant number 25650147, and the "Global COE Program" of MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapakis CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018877; Bell G, 1997, HEREDITY, V78, P498, DOI 10.1038/hdy.1997.78; Bell GAC, 1997, HEREDITY, V78, P490, DOI 10.1038/sj.hdy.6881220; Bergman B, 2008, PLANT BIOTECHNOL-NAR, V25, P213, DOI 10.5511/plantbiotechnology.25.213; BRODIE ED, 1995, TRENDS ECOL EVOL, V10, P313, DOI 10.1016/S0169-5347(00)89117-X; Casadesus J, 2013, J BIOL CHEM, V288, P13929, DOI 10.1074/jbc.R113.472274; CHAUVAT F, 1989, MOL GEN GENET, V216, P51, DOI 10.1007/BF00332230; Drake JW, 1998, GENETICS, V148, P1667; Eisenhut M, 2007, FEMS MICROBIOL LETT, V277, P232, DOI 10.1111/j.1574-6968.2007.00960.x; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; Fisher R.A., 1930, GENETICAL THEORY NAT; FLORES E, 1990, ARCH MICROBIOL, V154, P521; Gorelova OA, 2003, MICROBIOLOGY+, V72, P318, DOI 10.1023/A:1024252116667; HAN K, 1988, BIOTECHNOL BIOENG, V32, P430, DOI 10.1002/bit.260320404; Hihara Y, 1997, PHOTOSYNTH RES, V53, P243, DOI 10.1023/A:1005879905365; Hosoda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017105; IWASA Y, 1988, J THEOR BIOL, V135, P265, DOI 10.1016/S0022-5193(88)80243-1; Kanesaki Y, 2012, DNA RES, V19, P67, DOI 10.1093/dnares/dsr042; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; KINGMAN JFC, 1978, J APPL PROBAB, V15, P1, DOI 10.2307/3213231; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kryazhimskiy S, 2009, P NATL ACAD SCI USA, V106, P18638, DOI 10.1073/pnas.0905497106; LABARRE J, 1987, J BACTERIOL, V169, P4668, DOI 10.1128/jb.169.10.4668-4673.1987; Margulis L., 1993, SYMBIOSIS CELL EVOLU; Martin W, 1999, EUR J PHYCOL, V34, P287, DOI 10.1017/S0967026299002231; Mereschkovsky K.S, 1905, BIOL ZBL, V85, P593, DOI DOI 10.1017/S0967026299002231; Mori K, 2011, J EUKARYOT MICROBIOL, V58, P37, DOI 10.1111/j.1550-7408.2010.00517.x; Morris JJ, 2012, MBIO, V3, DOI 10.1128/mBio.00036-12; Morris JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016805; Nilsson M, 2002, NEW PHYTOL, V156, P517, DOI 10.1046/j.1469-8137.2002.00534.x; OGAWA T, 1994, J BACTERIOL, V176, P2374, DOI 10.1128/JB.176.8.2374-2378.1994; Qiao JJ, 2013, GENE, V512, P6, DOI 10.1016/j.gene.2012.10.004; Raven JA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-209; Reboud X, 1997, HEREDITY, V78, P507, DOI 10.1038/hdy.1997.79; Srivastava A. K., 2013, STRESS BIOL CYANOBAC; STANIER RY, 1971, BACTERIOL REV, V35, P171, DOI 10.1128/MMBR.35.2.171-205.1971; Taiz L., 2018, FUNDAMENTALS PLANT P; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Whitton B., 2012, ECOLOGY CYANOBACTERI, DOI [DOI 10.1007/978-94-007-3855-3, DOI 10.1007/978-94-007-3855-3_24]; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766	40	5	5	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98337	10.1371/journal.pone.0098337	http://dx.doi.org/10.1371/journal.pone.0098337			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874568	gold, Green Published, Green Submitted			2022-12-25	WOS:000336790800033
J	Li, R; Yuan, MX; Ma, KS; Li, XW; Tang, CL; Zhang, XH; Guo, DY; Yan, XC				Li, Rui; Yuan, Meng-Xia; Ma, Kuan-sheng; Li, Xiao-Wu; Tang, Chun-Lin; Zhang, Xiao-Hang; Guo, De-Yu; Yan, Xiao-Chu			Detailed Analysis of Temporal Features on Contrast Enhanced Ultrasound May Help Differentiate Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma in Cirrhosis	PLOS ONE			English	Article							CLINICAL-PRACTICE RECOMMENDATIONS; FOCAL LIVER-LESIONS; DIAGNOSTIC-ACCURACY; SURVEILLANCE; GUIDELINES; MISDIAGNOSIS; MANAGEMENT; RISK; CEUS; MRI	Aim: To verify if detailed analysis of temporal enhancement patterns on contrast enhanced ultrasound (CEUS) may help differentiate intrahepatic cholangiocarcinoma (ICC) from hepatocellular carcinoma (HCC) in cirrhosis. Methods: Thirty three ICC and fifty HCC in cirrhosis were enrolled in this study. The contrast kinetics of ICC and HCC was analyzed and compared. Results: Statistical analysis did not reveal significant difference between ICC and HCC in the time of contrast first appearance and arterial peak maximum time. ICC displayed much earlier washout than that of HCC (47.93 +/- 26.45 seconds vs 90.86 +/- 31.26 seconds) in the portal phase, and most ICC (87.9%) showed washout before 60 seconds than HCC (16.0%). Much more ICC (78.8%) revealed marked washout than HCC (12.0%) while most HCC (88.0%) showed mild washout or no washout in late part of the portal phase (90-120 seconds). Twenty six out of thirty three ICC (78.8%) demonstrated both early washout(<60seconds) and marked washout in late part of the portal phase, whereas, only six of fifty HCC (12.0%) showed these temporal enhancement features (p = 0.000). When both early washout and marked washout in the portal phase are taken as diagnostic criterion for ICC, the diagnostic sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 78.8%, 88.0%, 81.3%, 86.3%, and 84.3% respectively by CEUS. Conclusions: Analysis of detailed temporal enhancement features on CEUS is helpful differentiate ICC from HCC in cirrhosis. If a nodule in cirrhotic liver displays hyper-enhancement in the arterial phase followed by early and marked washout in the portal phase, the nodule is highly suspicious of ICC rather than HCC.	[Li, Rui; Yuan, Meng-Xia; Tang, Chun-Lin; Zhang, Xiao-Hang] Third Mil Med Univ, Southwest Hosp, Dept Ultrasound, Chongqing, Peoples R China; [Ma, Kuan-sheng; Li, Xiao-Wu] Third Mil Med Univ, Southwest Hosp, Dept Hepatobiliary Pancreat Surg, Chongqing, Peoples R China; [Guo, De-Yu; Yan, Xiao-Chu] Third Mil Med Univ, Southwest Hosp, Dept Pathol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Li, R (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Ultrasound, Chongqing, Peoples R China.	raylee7991@163.com	Li, Xiaowu/AAF-2769-2020					[Anonymous], 2011, HEPATOLOGY, V54, P1898; Barreiros AP, 2012, J HEPATOL, V57, P930, DOI 10.1016/j.jhep.2012.04.018; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Bolondi L, 2001, GUT, V48, P251, DOI 10.1136/gut.48.2.251; Bolondi L, 2007, DIGEST LIVER DIS, V39, P187, DOI 10.1016/j.dld.2006.08.008; Boozari B, 2011, DIGEST LIVER DIS, V43, P484, DOI 10.1016/j.dld.2011.01.001; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chen LD, 2010, EUR RADIOL, V20, P743, DOI 10.1007/s00330-009-1599-8; Claudon M, 2008, ULTRASCHALL MED, V29, P28, DOI 10.1055/s-2007-963785; Claudon M, 2013, ULTRASCHALL MED, V34, P11, DOI 10.1055/s-0032-1325499; Davila JA, 2010, HEPATOLOGY, V52, P132, DOI 10.1002/hep.23615; Dietrich CF, 2006, WORLD J GASTROENTERO, V12, P1699, DOI 10.3748/wjg.v12.i11.1699; Galassi M, 2013, LIVER INT, V33, P771, DOI 10.1111/liv.12124; Iavarone M, 2013, J HEPATOL, V58, P1188, DOI 10.1016/j.jhep.2013.02.013; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Lencioni R, 2008, J HEPATOL, V48, P848, DOI 10.1016/j.jhep.2008.02.005; Li R, 2013, ABDOM IMAGING, V38, P112, DOI 10.1007/s00261-012-9854-x; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Rimola J, 2012, J HEPATOL, V56, P1317, DOI 10.1016/j.jhep.2012.01.004; Rimola J, 2009, HEPATOLOGY, V50, P791, DOI 10.1002/hep.23071; Sangiovanni A, 2010, GUT, V59, P638, DOI 10.1136/gut.2009.187286; Serste T, 2012, HEPATOLOGY, V55, P800, DOI 10.1002/hep.24746; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Strobel D, 2008, ULTRASCHALL MED, V29, P499, DOI 10.1055/s-2008-1027806; Tranquart F, 2009, J RADIOL, V90, P109, DOI 10.1016/S0221-0363(09)70089-7; Vilana R, 2010, HEPATOLOGY, V51, P2020, DOI 10.1002/hep.23600; Yang JD, 2011, CLIN GASTROENTEROL H, V9, P617, DOI 10.1016/j.cgh.2011.03.027	28	44	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98612	10.1371/journal.pone.0098612	http://dx.doi.org/10.1371/journal.pone.0098612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874413	Green Submitted, Green Published, gold			2022-12-25	WOS:000336790800051
J	Ng, FL; Phang, SM; Periasamy, V; Yunus, K; Fisher, AC				Ng, Fong-Lee; Phang, Siew-Moi; Periasamy, Vengadesh; Yunus, Kamran; Fisher, Adrian C.			Evaluation of Algal Biofilms on Indium Tin Oxide (ITO) for Use in Biophotovoltaic Platforms Based on Photosynthetic Performance	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; LIGHT EXPOSURE; PHOTOPROTECTION; MICROALGAE; RESPONSES; DIATOMS; PROTEIN; ENERGY	In photosynthesis, a very small amount of the solar energy absorbed is transformed into chemical energy, while the rest is wasted as heat and fluorescence. This excess energy can be harvested through biophotovoltaic platforms to generate electrical energy. In this study, algal biofilms formed on ITO anodes were investigated for use in the algal biophotovoltaic platforms. Sixteen algal strains, comprising local isolates and two diatoms obtained from the Culture Collection of Marine Phytoplankton (CCMP), USA, were screened and eight were selected based on the growth rate, biochemical composition and photosynthesis performance using suspension cultures. Differences in biofilm formation between the eight algal strains as well as their rapid light curve (RLC) generated using a pulse amplitude modulation (PAM) fluorometer, were examined. The RLC provides detailed information on the saturation characteristics of electron transport and overall photosynthetic performance of the algae. Four algal strains, belonging to the Cyanophyta (Cyanobacteria) Synechococcus elongatus (UMACC 105), Spirulina platensis. (UMACC 159) and the Chlorophyta Chlorella vulgaris (UMACC 051), and Chlorella sp. (UMACC 313) were finally selected for investigation using biophotovoltaic platforms. Based on power output per Chl-a content, the algae can be ranked as follows: Synechococcus elongatus (UMACC 105) (6.38x10(-5) Wm(-2)/mu gChl-a)>Chlorella vulgaris UMACC 051 (2.24x10(-5) Wm(-2)/mu gChl-a)>Chlorella sp.(UMACC 313) (1.43x10(-5) Wm(-2)/mu gChl-a)>Spirulina platensis (UMACC 159) (4.90x10(-6) Wm(-2)/mu gChl-a). Our study showed that local algal strains have potential for use in biophotovoltaic platforms due to their high photosynthetic performance, ability to produce biofilm and generation of electrical power.	[Ng, Fong-Lee; Phang, Siew-Moi] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Ng, Fong-Lee; Phang, Siew-Moi] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Periasamy, Vengadesh] Univ Malaya, Dept Phys, Fac Sci, Low Dimens Mat Res Ctr, Kuala Lumpur, Malaysia; [Yunus, Kamran; Fisher, Adrian C.] Univ Cambridge, Dept Chem Engn & Biotechnol, CREST, Cambridge, England	Universiti Malaya; Universiti Malaya; Universiti Malaya; University of Cambridge	Phang, SM (corresponding author), Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia.	phang@um.edu.my	Ng, Fong Lee/V-2267-2017; PERIASAMY, VENGADESH/B-9993-2010; Phang, Siew Moi/A-7653-2008	PERIASAMY, VENGADESH/0000-0002-0435-4944; 	University of Malaya Research Grant [J-21002-73823]; University of Malaya Postgraduate Research Fund [PG051-2012B]; IOES-Cambridge Biophotovoltaic Cell Research Grant [TC004-2010A]; Fundamental Research Grant [KPT1059-2012]; Malaysian Palm Oil Board (MPOB) Grant [55-02-03-1054]; Knowledge Management Grant [RP001O-13SUS]; High Impact Research Grant; EPSRC [EP/F006586/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F006586/1] Funding Source: researchfish	University of Malaya Research Grant; University of Malaya Postgraduate Research Fund(Universiti Malaya); IOES-Cambridge Biophotovoltaic Cell Research Grant; Fundamental Research Grant; Malaysian Palm Oil Board (MPOB) Grant; Knowledge Management Grant; High Impact Research Grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the High Impact Research Grant, University of Malaya Research Grant (J-21002-73823), University of Malaya Postgraduate Research Fund (PG051-2012B), IOES-Cambridge Biophotovoltaic Cell Research Grant (TC004-2010A), Fundamental Research Grant (KPT1059-2012), Malaysian Palm Oil Board (MPOB) Grant (55-02-03-1054) and Knowledge Management Grant (RP001O-13SUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro HM, 2011, APPL ENERG, V88, P3402, DOI 10.1016/j.apenergy.2010.12.014; American Public Health Association (APHA), 1998, AM PHYS ED REV, V20th; Blatti JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042949; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bombelli Paolo, 2011, Commun Agric Appl Biol Sci, V76, P89; Bonnineau C, 2012, ECOTOXICOLOGY, V21, P1208, DOI 10.1007/s10646-012-0876-5; Boulay C, 2008, BBA-BIOENERGETICS, V1777, P1344, DOI 10.1016/j.bbabio.2008.07.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cartaxana P, 2008, LIMNOL OCEANOGR-METH, V6, P466, DOI 10.4319/lom.2008.6.466; Chu WL, 2009, J APPL PHYCOL, V21, P641, DOI 10.1007/s10811-008-9396-3; Consalvey M, 2004, PHOTOSYNTH RES, V81, P91, DOI 10.1023/B:PRES.0000028397.86495.b5; Daroch M, 2013, APPL ENERG, V102, P1371, DOI 10.1016/j.apenergy.2012.07.031; Declerck P, 2010, ENVIRON MICROBIOL, V12, P557, DOI 10.1111/j.1462-2920.2009.02025.x; Ferreira T, 2010, IMAGE J USER GUIDE; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hwang J, 2006, ORG ELECTRON, V7, P387, DOI 10.1016/j.orgel.2006.04.005; Inglesby AE, 2013, PHYS CHEM CHEM PHYS, V15, P6903, DOI 10.1039/c3cp51076j; Jackson DD, 1896, REP MASS STATE BOARD, P410; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Jordan L, 2009, J MAR BIOL ASSOC UK, P1; Keng FSL, 2013, J APPL PHYCOL, V25, P1377, DOI 10.1007/s10811-013-9990-x; Kochert A. G., 1978, HDB PHYCOLOGICAL MET; Lavaud J, 2007, LIMNOL OCEANOGR, V52, P1188, DOI 10.4319/lo.2007.52.3.1188; Li Y, 2008, BIOTECHNOL PROGR, V24, P815, DOI 10.1021/bp070371k; Lim SL, 2010, BIORESOURCE TECHNOL, V101, P7314, DOI 10.1016/j.biortech.2010.04.092; Luimstra VM, 2014, J APPL PHYCOL, V26, P15, DOI 10.1007/s10811-013-0051-2; Mao LF, 2013, INT J ENERGY ENVIR E, V4, DOI 10.1186/2251-6832-4-17; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McCormick AJ, 2011, ENERG ENVIRON SCI, V4, P4699, DOI 10.1039/c1ee01965a; McMinn A, 2010, POLAR BIOL, V33, P1547, DOI 10.1007/s00300-010-0844-6; McMinn Andrew, 2006, Polar Bioscience, P30; Mustafa EM, 2012, J APPL PHYCOL, V24, P953, DOI 10.1007/s10811-011-9716-x; Ng FL, 2013, ADV MAT RES, V895, P116; NICHOLS HW, 1965, J PHYCOL, V1, P34, DOI 10.1111/j.1529-8817.1965.tb04552.x; Nishio K, 2010, APPL MICROBIOL BIOT, V86, P957, DOI 10.1007/s00253-009-2400-2; Ozkan A, 2013, BIOFOULING, V29, P469, DOI 10.1080/08927014.2013.782397; Ozkan A, 2012, BIORESOURCE TECHNOL, V114, P542, DOI 10.1016/j.biortech.2012.03.055; Pankowski A, 2009, AQUAT BIOL, V4, P273, DOI 10.3354/ab00116; Perkins RG, 2001, MAR ECOL PROG SER, V223, P101, DOI 10.3354/meps223101; PHANG SM, 1988, BIOL WASTE, V25, P177, DOI 10.1016/0269-7483(88)90078-X; Phang SM., 1999, CATALOGUE STRAINS U; PLATT T, 1980, J MAR RES, V38, P687; Prince RC, 2005, CRIT REV MICROBIOL, V31, P19, DOI 10.1080/10408410590912961; Reeves S, 2011, POLAR BIOL, V34, P1019, DOI 10.1007/s00300-011-0961-x; Rismani-Yazdi H, 2008, J POWER SOURCES, V180, P683, DOI 10.1016/j.jpowsour.2008.02.074; Roeselers G, 2006, FEMS MICROBIOL ECOL, V58, P169, DOI 10.1111/j.1574-6941.2006.00172.x; Sauer K., 2007, MICROBE AM SOC MICRO, V2, P347, DOI [10.1128/microbe.2.347.1, DOI 10.1128/MICR0BE.2.347.1]; Serodio J, 2006, PHOTOSYNTH RES, V90, P29, DOI [10.1007/s11120-006-9105-5, 10.1007/s11120-006-9101-9]; Strickland J.D.H., 1968, FISH RES BD CAN B, V167, P311; van Leeuwenhoek A, 1684, PHIL T, V14, P568; Vejeysri V, 2013, J APPL PHYCOL, DOI [10.1007/s10811-013-0160, DOI 10.1007/S10811-013-0160]; Vieira S, 2009, MAR BIOL, V156, P1007, DOI 10.1007/s00227-009-1144-y; Wiltshire KH, 1997, J SEDIMENT RES, V67, P977, DOI 10.1306/D4268694-2B26-11D7-8648000102C1865D; Wong CY, 2007, J APPL PHYCOL, V19, P689, DOI 10.1007/s10811-007-9214-3; Yagishita T, 1997, SOL ENERGY, V61, P347, DOI 10.1016/S0038-092X(97)00069-8	55	43	43	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97643	10.1371/journal.pone.0097643	http://dx.doi.org/10.1371/journal.pone.0097643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874081	gold, Green Published, Green Submitted			2022-12-25	WOS:000336790800009
J	Urquhart, EA; Zaitchik, BF; Waugh, DW; Guikema, SD; Del Castillo, CE				Urquhart, Erin A.; Zaitchik, Benjamin F.; Waugh, Darryn W.; Guikema, Seth D.; Del Castillo, Carlos E.			Uncertainty in Model Predictions of Vibrio vulnificus Response to Climate Variability and Change: A Chesapeake Bay Case Study	PLOS ONE			English	Article							SEASONAL DYNAMICS; COASTAL WATERS; PARAHAEMOLYTICUS; SALINITY; CHOLERAE; INFECTIONS; OYSTERS; ECOLOGY	The effect that climate change and variability will have on waterborne bacteria is a topic of increasing concern for coastal ecosystems, including the Chesapeake Bay. Surface water temperature trends in the Bay indicate a warming pattern of roughly 0.3-0.4 degrees C per decade over the past 30 years. It is unclear what impact future warming will have on pathogens currently found in the Bay, including Vibrio spp. Using historical environmental data, combined with three different statistical models of Vibrio vulnificus probability, we explore the relationship between environmental change and predicted Vibrio vulnificus presence in the upper Chesapeake Bay. We find that the predicted response of V. vulnificus probability to high temperatures in the Bay differs systematically between models of differing structure. As existing publicly available datasets are inadequate to determine which model structure is most appropriate, the impact of climatic change on the probability of V. vulnificus presence in the Chesapeake Bay remains uncertain. This result points to the challenge of characterizing climate sensitivity of ecological systems in which data are sparse and only statistical models of ecological sensitivity exist.	[Urquhart, Erin A.; Zaitchik, Benjamin F.; Waugh, Darryn W.] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [Guikema, Seth D.] Johns Hopkins Univ, Dept Geog & Environm Engn, Baltimore, MD 21218 USA; [Del Castillo, Carlos E.] NASA, Ocean Ecol Lab, Goddard Space Flight Ctr, Greenbelt, MD USA	Johns Hopkins University; Johns Hopkins University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Urquhart, EA (corresponding author), Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA.	erinu@jhu.edu	Waugh, Darryn W/K-3688-2016; Urquhart, Erin/A-2336-2015; Zaitchik, Benjamin/AAB-3298-2020	Waugh, Darryn W/0000-0001-7692-2798; Urquhart, Erin/0000-0001-7141-9499; Zaitchik, Benjamin/0000-0002-0698-0658	Johns Hopkins University Department of Earth and Planetary Sciences	Johns Hopkins University Department of Earth and Planetary Sciences	This work was financially supported by the Johns Hopkins University Department of Earth and Planetary Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin HM, 2002, AM FISH S S, V32, P155; BAIRD D, 1989, ECOL MONOGR, V59, P329, DOI 10.2307/1943071; Baker-Austin C, 2013, NAT CLIM CHANGE, V3, P73, DOI [10.1038/nclimate1628, 10.1038/NCLIMATE1628]; Breiman L, 1996, TECHNICAL REPORT; Cantet F, 2013, RES MICROBIOLOGY; COLWELL RR, 1977, SCIENCE, V198, P394, DOI 10.1126/science.910135; de Magny GC, 2009, ECOHEALTH, V6, P378, DOI 10.1007/s10393-009-0273-6; de Magny GC, 2008, P NATL ACAD SCI USA, V105, P17676, DOI 10.1073/pnas.0809654105; Deepanjali A, 2005, APPL ENVIRON MICROB, V71, P3575, DOI 10.1128/AEM.71.7.3575-3580.2005; Ebi KL, 2008, CLIMATIC CHANGE, V88, P5, DOI 10.1007/s10584-006-9233-0; Eiler A, 2006, APPL ENVIRON MICROB, V72, P6004, DOI 10.1128/AEM.00917-06; Faraway J.J., 2004, EXTENDING LINEAR MOD; Gibson JR, 2000, LIMNOL OCEANOGR, V45, P1764, DOI 10.4319/lo.2000.45.8.1764; Hastie T.J., 2017, STAT SCI; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; Heidelberg JF, 2002, APPL ENVIRON MICROB, V68, P5488, DOI 10.1128/AEM.68.11.5488-5497.2002; Hofstra N, 2011, CURR OPIN ENV SUST, V3, P471, DOI 10.1016/j.cosust.2011.10.006; Jacobs J, 2010, NOAA TECHNICAL MEMOR, V112, P1; Johnson CN, 2012, APPL ENVIRON MICROB, V78, P7249, DOI 10.1128/AEM.01296-12; KANEKO T, 1973, J BACTERIOL, V113, P24, DOI 10.1128/JB.113.1.24-32.1973; KAPER JB, 1981, ESTUARIES, V4, P321, DOI 10.2307/1352156; KLONTZ KC, 1988, ANN INTERN MED, V109, P318, DOI 10.7326/0003-4819-109-4-318; Lipp EK, 2002, CLIN MICROBIOL REV, V15, P757, DOI 10.1128/CMR.15.4.757-770.2002; Lipp EK, 2001, HYDROBIOLOGIA, V460, P165, DOI 10.1023/A:1013127517860; Louis VR, 2003, APPL ENVIRON MICROB, V69, P2773, DOI 10.1128/AEM.69.5.2773-2785.2003; Maryland Department of Health, 2013, CAS SEL NOT COND REP; Najjar R, 2009, CLIMATIC CHANGE, V95, P139, DOI 10.1007/s10584-008-9521-y; Najjar RG, 2010, ESTUAR COAST SHELF S, V86, P1, DOI 10.1016/j.ecss.2009.09.026; Oberbeckmann S, 2012, MICROB ECOL, V63, P543, DOI 10.1007/s00248-011-9990-9; Schets FM, 2004, J WATER HEALTH, V2, P191, DOI 10.2166/wh.2004.0017; Secor D, 2008, 69 YEAR RECORD WARMI; Shapiro RL, 1998, J INFECT DIS, V178, P752, DOI 10.1086/515367; Urquhart EA, 2014, J ENV INFOR IN PRESS; Urquhart EA, 2013, REMOTE SENS ENVIRON, V135, P167, DOI 10.1016/j.rse.2013.03.034; Urquhart EA, 2012, REMOTE SENS ENVIRON, V123, P522, DOI 10.1016/j.rse.2012.04.008; Virginia Department of Health, 2013, VIRG REP DIS SURV DA; Wright AC, 1996, APPL ENVIRON MICROB, V62, P717, DOI 10.1128/AEM.62.2.717-724.1996	37	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98256	10.1371/journal.pone.0098256	http://dx.doi.org/10.1371/journal.pone.0098256			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874082	Green Published, gold, Green Submitted			2022-12-25	WOS:000336790800029
J	Gao, CX; Sang, N; Huang, R				Gao, Changxin; Sang, Nong; Huang, Rui			Biologically Inspired Scene Context for Object Detection Using a Single Instance	PLOS ONE			English	Article							ATTENDED OBJECTS; ATTENTION; ROTATION; FAILURE; FIELDS	This paper presents a novel object detection method using a single instance from the object category. Our method uses biologically inspired global scene context criteria to check whether every individual location of the image can be naturally replaced by the query instance, which indicates whether there is a similar object at this location. Different from the traditional detection methods that only look at individual locations for the desired objects, our method evaluates the consistency of the entire scene. It is therefore robust to large intra-class variations, occlusions, a minor variety of poses, low-revolution conditions, background clutter etc., and there is no off-line training. The experimental results on four datasets and two video sequences clearly show the superior robustness of the proposed method, suggesting that global scene context is important for visual detection/localization.	[Gao, Changxin; Sang, Nong; Huang, Rui] Huazhong Univ Sci & Technol, Sch Automat, Key Lab, Minist Educ Image Proc & Intelligent Control, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Gao, CX (corresponding author), Huazhong Univ Sci & Technol, Sch Automat, Key Lab, Minist Educ Image Proc & Intelligent Control, Wuhan 430074, Peoples R China.	cgao@hust.edu.cn	Huang, Rui/AAC-8207-2022; Gao, Changxin/L-4841-2016	Huang, Rui/0000-0002-7950-1662; Gao, Changxin/0000-0003-2736-3920	Project of the National Natural Science Foundation of China [61105014]; Fundamental Research Funds for the Central Universities [HUST:2013TS132]	Project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research is supported by the Project of the National Natural Science Foundation of China (No. 61105014), and the Fundamental Research Funds for the Central Universities (No. HUST:2013TS132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2004, IEEE T PATTERN ANAL, V26, P1475, DOI 10.1109/TPAMI.2004.108; BARM, 2005, J VISION, V5, pA88; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; Biederman I., 1995, INVITATION COGNITIVE, P121; Biederman I., 1988, COMPUTATIONAL PROCES; CALLEGUILLOS C, 2010, COMPUTER VISION IMAG, V114, P712; Carbonetto P, 2004, LECT NOTES COMPUT SC, V3021, P350; Choi MS, 2002, PATTERN RECOGN, V35, P119, DOI 10.1016/S0031-3203(01)00025-5; Cox D, 2004, SCIENCE, V304, P115, DOI 10.1126/science.1093110; Dalal N., 2005, IEEE COMPUTER SOC C, DOI [DOI 10.1109/CVPR.2005.177, 10.1109/CVPR.2005.177]; Dinh TB, 2011, PROC CVPR IEEE, P1177, DOI 10.1109/CVPR.2011.5995733; Gao CX, 2012, OPT LETT, V37, P76, DOI 10.1364/OL.37.000076; Gao C, 2011, CURR ORG CHEM, V15, P1, DOI 10.2174/138527211793797846; Greene M. R., 2005, J VISION, V5, p70a; He XM, 2004, PROC CVPR IEEE, P695; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Hochberg Julian, 1968, CONT THEORY RES VISU, P309; Hollingworth A, 2002, J EXP PSYCHOL HUMAN, V28, P113, DOI 10.1037//0096-1523.28.1.113; KRATTENTHALER W, 1994, IEEE IMAGE PROC, P208, DOI 10.1109/ICIP.1994.413305; Levin DT, 1997, PSYCHON B REV, V4, P501, DOI 10.3758/BF03214339; Mitroff SR, 2004, PERCEPT PSYCHOPHYS, V66, P1268, DOI 10.3758/BF03194997; Murphy K, 2004, ADV NEUR IN, V16, P1499; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Oliva A, 2000, COGNITIVE PSYCHOL, V41, P176, DOI 10.1006/cogp.1999.0728; Oliva A, 2007, TRENDS COGN SCI, V11, P520, DOI 10.1016/j.tics.2007.09.009; Oliva Aude, 2005, P251, DOI 10.1016/B978-012375731-9/50045-8; POTTER MC, 1975, SCIENCE, V187, P965, DOI 10.1126/science.1145183; Rabinovich A, 2007, IEEE I CONF COMP VIS, P1237, DOI 10.1109/iccv.2007.4408986; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Russell B. C., 2005, TECHNICAL REPORT; Sanocki T, 1997, PSYCHOL SCI, V8, P374, DOI 10.1111/j.1467-9280.1997.tb00428.x; SCHYNS PG, 1994, PSYCHOL SCI, V5, P195, DOI 10.1111/j.1467-9280.1994.tb00500.x; Shechtman E, 2007, IEEE T PATTERN ANAL, V29, P2045, DOI 10.1109/TPAMI.2007.1119; Shotton J, 2007, INT J COMPUT VISION, V81, P2, DOI DOI 10.1007/S11263-007-0109-1; Siagian C, 2007, IEEE T PATTERN ANAL, V29, P300, DOI 10.1109/TPAMI.2007.40; Simons DJ, 1997, TRENDS COGN SCI, V1, P261, DOI 10.1016/S1364-6613(97)01080-2; Simons DJ, 1998, PSYCHON B REV, V5, P644, DOI 10.3758/BF03208840; Torralba A, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P273; Torralba A, 2003, INT J COMPUT VISION, V53, P169, DOI 10.1023/A:1023052124951; Ullah F, 2004, PATTERN RECOGN, V37, P201, DOI 10.1016/S0031-3203(03)00184-5; VANDERBRUG GJ, 1977, IEEE T COMPUT, V26, P384, DOI 10.1109/TC.1977.1674847; Wu Y, 2009, PROC CVPR IEEE, P33, DOI 10.1109/CVPRW.2009.5206719; Yeo CH, 2008, IEEE T CIRC SYST VID, V18, P1006, DOI 10.1109/TCSVT.2008.927112; YOSHIMURA S, 1994, IROS '94 - INTELLIGENT ROBOTS AND SYSTEMS: ADVANCED ROBOTIC SYSTEMS AND THE REAL WORLD, VOLS 1-3, P2086, DOI 10.1109/IROS.1994.407577	44	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98447	10.1371/journal.pone.0098447	http://dx.doi.org/10.1371/journal.pone.0098447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TS	24871350	Green Published, gold, Green Submitted			2022-12-25	WOS:000336858300045
J	Nahrgang, J; Varpe, O; Korshunova, E; Murzina, S; Hallanger, IG; Vieweg, I; Berge, J				Nahrgang, Jasmine; Varpe, Oystein; Korshunova, Ekaterina; Murzina, Svetlana; Hallanger, Ingeborg G.; Vieweg, Ireen; Berge, Jorgen			Gender Specific Reproductive Strategies of an Arctic Key Species (Boreogadus saida) and Implications of Climate Change	PLOS ONE			English	Article							CAPELIN MALLOTUS-VILLOSUS; LIFE-HISTORY STRATEGIES; POLAR COD; CALANUS-FINMARCHICUS; ICE; LEPECHIN; GLACIALIS; SHIFTS; FJORD; BIODIVERSITY	The Arctic climate is changing at an unprecedented rate. What consequences this may have on the Arctic marine ecosystem depends to a large degree on how its species will respond both directly to elevated temperatures and more indirectly through ecological interactions. But despite an alarming recent warming of the Arctic with accompanying sea ice loss, reports evaluating ecological impacts of climate change in the Arctic remain sparse. Here, based upon a large-scale field study, we present basic new knowledge regarding the life history traits for one of the most important species in the entire Arctic, the polar cod (Boreogadus saida). Furthermore, by comparing regions of contrasting climatic influence (domains), we present evidence as to how its growth and reproductive success is impaired in the warmer of the two domains. As the future Arctic is predicted to resemble today's Atlantic domains, we forecast changes in growth and life history characteristics of polar cod that will lead to alteration of its role as an Arctic keystone species. This will in turn affect community dynamics and energy transfer in the entire Arctic food chain.	[Nahrgang, Jasmine; Korshunova, Ekaterina; Hallanger, Ingeborg G.; Vieweg, Ireen; Berge, Jorgen] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Tromso, Norway; [Nahrgang, Jasmine; Varpe, Oystein; Berge, Jorgen] Univ Ctr Svalbard, Longyearbyen, Norway; [Varpe, Oystein; Korshunova, Ekaterina] Akvaplan Niva, Fram Ctr, Tromso, Norway; [Murzina, Svetlana] Russian Acad Sci, Karelian Res Ctr, Inst Biol, Petrozavodsk, Russia	UiT The Arctic University of Tromso; University Centre Svalbard (UNIS); Akvaplan-niva; Russian Academy of Sciences; Karelian Research Centre of the Russian Academy of Sciences; Institute of Biology of Karelian Research Centre RAS	Nahrgang, J (corresponding author), UiT Arctic Univ Norway, Dept Arctic & Marine Biol, Tromso, Norway.	jasmine.m.nahrgang@uit.no	Varpe, Øystein/B-9693-2008; Berge, Jørgen/E-7544-2015; Nahrgang, Jasmine/AAQ-3594-2020; Murzina, Svetlana A./A-7624-2014	Varpe, Øystein/0000-0002-5895-6983; Berge, Jørgen/0000-0003-0900-5679; Nahrgang, Jasmine/0000-0002-4202-5922; Murzina, Svetlana A./0000-0002-9705-2741; Vieweg, Ireen/0000-0003-1983-5211; Hallanger, Ingeborg G./0000-0002-9476-4401	Norwegian Research Council through the EWMA [195160]; Polarisation [nr 214184/F20]; UiT - The Arctic University of Norway (Tromso); Svalbard Science Forum [RiS 5148]; Barents secretariat; Akvaplan-niva; President of the Russian Federation [NSh-1410.2014.4]; NFR - project CircA [214271/F20]	Norwegian Research Council through the EWMA; Polarisation; UiT - The Arctic University of Norway (Tromso); Svalbard Science Forum; Barents secretariat; Akvaplan-niva(Akvaplan-niva); President of the Russian Federation; NFR - project CircA	The work is partly financed by the Norwegian Research Council through the EWMA (nr 195160) and Polarisation (nr 214184/F20) projects, UiT - The Arctic University of Norway (Tromso), Arctic Field Grant (RiS 5148, Svalbard Science Forum), Barents secretariat, Akvaplan-niva and the President of the Russian Federation (Grant NSh-1410.2014.4). Fieldwork and the time allocated for JB and OV was supported by the NFR funded project CircA (nr 214271/F20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvain S, 2013, REMOTE SENS ENVIRON, V132, P195, DOI 10.1016/j.rse.2013.01.014; Andriashev A.P., 1954, FISHES NO SEAS USSR; Anisimov OA, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P653; Arnkvaern G, 2005, POLAR BIOL, V28, P528, DOI 10.1007/s00300-005-0715-8; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Benoit D, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004276; Bjorge A, 2010, NAMMCO SCI PUBLICATI, V8, P7, DOI [DOI 10.7557/3.2668, 10.7557/3.2668]; Bluhm BA, 2011, OCEANOGRAPHY, V24, P232, DOI 10.5670/oceanog.2011.75; Bouchard C, 2011, PROG OCEANOGR, V90, P105, DOI 10.1016/j.pocean.2011.02.008; BRADSTREET MSW, 1982, ARCTIC, V35, P28; Christiansen JS, 2008, J EXP MAR BIOL ECOL, V360, P47, DOI 10.1016/j.jembe.2008.04.003; Christiansen JS, 2012, POLAR BIOL, V35, P1247, DOI 10.1007/s00300-012-1170-y; Cottier F, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002757; CRAIG PC, 1982, CAN J FISH AQUAT SCI, V39, P395, DOI 10.1139/f82-057; Crawley MJ, 2007, R LANG ENV STAT COMP; Dalpadado P, 2012, ICES J MAR SCI, V69, P1303, DOI 10.1093/icesjms/fss063; Dolgov AV, 2011, BARENTS SEA ECOSYSTE, P193; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Enberg K, 2012, MAR ECOL-EVOL PERSP, V33, P1, DOI 10.1111/j.1439-0485.2011.00460.x; FALKPETERSEN IB, 1986, SARSIA, V71, P235, DOI 10.1080/00364827.1986.10419693; Ferguson Steven H, 2012, Aquat Biosyst, V8, P3, DOI 10.1186/2046-9063-8-3; Fevolden SE, 1999, SARSIA, V84, P99, DOI 10.1080/00364827.1999.10420437; FORTIER L, 1995, MAR ECOL PROG SER, V120, P11, DOI 10.3354/meps120011; Gillispie J.G., 1997, American Fisheries Society Symposium, V19, P81; Gjertz I, 2001, POLAR BIOL, V24, P209, DOI 10.1007/s003000000197; GJOSAETER H, 1994, ICES J MAR SCI, V51, P115, DOI 10.1006/jmsc.1994.1011; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Hansen BB, 2013, SCIENCE, V339, P313, DOI 10.1126/science.1226766; HOP H, 1995, CAN J FISH AQUAT SCI, V52, P541, DOI 10.1139/f95-055; Hop H, 2013, MAR BIOL RES, V9, P878, DOI 10.1080/17451000.2013.775458; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Huse G, 1998, CAN J FISH AQUAT SCI, V55, P631, DOI 10.1139/cjfas-55-3-631; Jonsson H, 2010, MAR POLLUT BULL, V60, P390, DOI 10.1016/j.marpolbul.2009.10.014; Kjellerup S, 2012, MAR ECOL PROG SER, V447, P87, DOI 10.3354/meps09551; Kortsch S, 2012, P NATL ACAD SCI USA, V109, P14052, DOI 10.1073/pnas.1207509109; Kovacs KM, 2012, MAR MAMMAL SCI, V28, P414, DOI 10.1111/j.1748-7692.2011.00479.x; Lear WH, 1979, CAFSAC RES DOC, V79, P17; LEGGETT WC, 1978, J FISH RES BOARD CAN, V35, P1469, DOI 10.1139/f78-230; LONNE OJ, 1989, POLAR BIOL, V9, P187, DOI 10.1007/BF00297174; Marshall CT, 1999, NATURE, V402, P288, DOI 10.1038/46272; Nahrgang J, 2010, MAR POLLUT BULL, V60, P1336, DOI 10.1016/j.marpolbul.2010.03.004; Nilsen F, 2008, CONT SHELF RES, V28, P1838, DOI 10.1016/j.csr.2008.04.015; Olsen E, 2010, ICES J MAR SCI, V67, P87, DOI 10.1093/icesjms/fsp229; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Renaud PE, 2012, POLAR BIOL, V35, P401, DOI 10.1007/s00300-011-1085-z; REZNICK DN, 1987, OECOLOGIA, V73, P401, DOI 10.1007/BF00385257; Sameoto DD, 1984, REV CURRENT INFORM A; Skjaeraasen JE, 2012, P NATL ACAD SCI USA, V109, P8995, DOI 10.1073/pnas.1200223109; Slagstad D, 2011, PROG OCEANOGR, V90, P117, DOI 10.1016/j.pocean.2011.02.009; Stearns S.C., 1992, pi; Wallace MI, 2010, LIMNOL OCEANOGR, V55, P831, DOI 10.4319/lo.2009.55.2.0831; Wang MY, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037820; Wassmann P, 2011, GLOBAL CHANGE BIOL, V17, P1235, DOI 10.1111/j.1365-2486.2010.02311.x; Wienerroither R, 2011, IMR PINRO JOINT REPO, V1-2011; YOUNG TP, 1981, AM NAT, V118, P27, DOI 10.1086/283798	56	48	48	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98452	10.1371/journal.pone.0098452	http://dx.doi.org/10.1371/journal.pone.0098452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871481	Green Published, Green Submitted, gold			2022-12-25	WOS:000336858300046
J	Rohlmann, A; Pohl, D; Bender, A; Graichen, F; Dymke, J; Schmidt, H; Bergmann, G				Rohlmann, Antonius; Pohl, David; Bender, Alwina; Graichen, Friedmar; Dymke, Joern; Schmidt, Hendrik; Bergmann, Georg			Activities of Everyday Life with High Spinal Loads	PLOS ONE			English	Article							VERTEBRAL BODY REPLACEMENT; MEASURED IN-VIVO; INTRADISCAL PRESSURE; LUMBAR SPINE; DISK PRESSURE; IMPLANT; ELEMENT; WALKING; WEIGHT; HEIGHT	Activities with high spinal loads should be avoided by patients with back problems. Awareness about these activities and knowledge of the associated loads are important for the proper design and pre-clinical testing of spinal implants. The loads on an instrumented vertebral body replacement have been telemetrically measured for approximately 1000 combinations of activities and parameters in 5 patients over a period up to 65 months postoperatively. A database containing, among others, extreme values for load components in more than 13,500 datasets was searched for 10 activities that cause the highest resultant force, bending moment, torsional moment, or shear force in an anatomical direction. The following activities caused high resultant forces: lifting a weight from the ground, forward elevation of straight arms with a weight in hands, moving a weight laterally in front of the body with hanging arms, changing the body position, staircase walking, tying shoes, and upper body flexion. All activities have in common that the center of mass of the upper body was moved anteriorly. Forces up to 1650 N were measured for these activities of daily life. However, there was a large intra-and inter-individual variation in the implant loads for the various activities depending on how exercises were performed. Measured shear forces were usually higher in the posterior direction than in the anterior direction. Activities with high resultant forces usually caused high values of other load components.	[Rohlmann, Antonius; Pohl, David; Bender, Alwina; Graichen, Friedmar; Dymke, Joern; Schmidt, Hendrik; Bergmann, Georg] Charite, Julius Wolff Inst, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rohlmann, A (corresponding author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.	antonius.rohlmann@charite.de	Rohlmann, Antonius/E-4778-2011	Rohlmann, Antonius/0000-0002-0083-2793; Schmidt, Hendrik/0000-0003-3300-8685; Bender, Alwina/0000-0002-4444-6309	Deutsche Forschungsgemeinschaft [Ro 581/18-1, Ro 581/20-1, Schm 2572/3-1]; Deutsche Arthrose-Hilfe, Frankfurt	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Arthrose-Hilfe, Frankfurt	Funding for this study was obtained from the Deutsche Forschungsgemeinschaft [Ro 581/18-1, Ro 581/20-1 and Schm 2572/3-1] and the Deutsche Arthrose-Hilfe, Frankfurt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON GBJ, 1977, CLIN ORTHOP RELAT R, P156; BRINCKMANN P, 1991, SPINE, V16, P641, DOI 10.1097/00007632-199106000-00008; CHOLEWICKI J, 1994, J BIOMECH, V27, P1287, DOI 10.1016/0021-9290(94)90282-8; Dreischarf M, 2013, MED ENG PHYS, V35, P1385, DOI 10.1016/j.medengphy.2013.03.007; Graichen F, 2007, IEEE T BIO-MED ENG, V54, P253, DOI 10.1109/TBME.2006.886857; Han KS, 2013, MED ENG PHYS, V35, P969, DOI 10.1016/j.medengphy.2012.09.009; Magerl F, 1994, Eur Spine J, V3, P184, DOI 10.1007/BF02221591; Marras WS, 2009, ERGONOMICS, V52, P384, DOI 10.1080/00140130802376075; McGill SM, 2013, ERGONOMICS, V56, P293, DOI 10.1080/00140139.2012.752528; NACHEMSON A., 1966, CLIN ORTHO RELAT RES, V45, P107; NACHEMSON AL, 1981, SPINE, V6, P93, DOI 10.1097/00007632-198101000-00020; Rohlmann A, 1997, J BIOMECH, V30, P41, DOI 10.1016/S0021-9290(96)00103-0; Rohlmann A, 2014, GAIT POSTURE, V39, P750, DOI 10.1016/j.gaitpost.2013.10.010; Rohlmann A, 2013, EUR SPINE J, V22, P2575, DOI 10.1007/s00586-013-3057-1; Rohlmann A, 2012, CLIN BIOMECH, V27, P754, DOI 10.1016/j.clinbiomech.2012.04.006; Rohlmann A, 2001, ERGONOMICS, V44, P781, DOI 10.1080/00140130120943; Rohlmann A, 2000, J BIOMECH, V33, P1099, DOI 10.1016/S0021-9290(00)00075-0; Rohlmann A, 2007, MED ENG PHYS, V29, P580, DOI 10.1016/j.medengphy.2006.06.012; Rohlmann A, 2013, J BIOMECH, V46, P511, DOI 10.1016/j.jbiomech.2012.10.022; Rohlmann A, 2011, SPINE J, V11, P870, DOI 10.1016/j.spinee.2011.06.017; Rohlmann A, 2010, EUR SPINE J, V19, P1129, DOI 10.1007/s00586-010-1346-5; Sato K, 1999, SPINE, V24, P2468, DOI 10.1097/00007632-199912010-00008; SCHULTZ AB, 1981, SPINE, V6, P76, DOI 10.1097/00007632-198101000-00017; Shirazi-Adl A, 2006, J BIOMECH, V39, P267, DOI 10.1016/j.jbiomech.2004.11.022; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Wilke HJ, 2001, CLIN BIOMECH, V16, pS111, DOI 10.1016/S0268-0033(00)00103-0	26	50	51	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98510	10.1371/journal.pone.0098510	http://dx.doi.org/10.1371/journal.pone.0098510			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866883	Green Published, Green Submitted, gold			2022-12-25	WOS:000336914100062
J	Nakasone, N; Nakamura, YS; Higaki, K; Oumi, N; Ohno, K; Ninomiya, H				Nakasone, Naoe; Nakamura, Yuko S.; Higaki, Katsumi; Oumi, Nao; Ohno, Kousaku; Ninomiya, Haruaki			Endoplasmic Reticulum-associated Degradation of Niemann-Pick C1 EVIDENCE FOR THE ROLE OF HEAT SHOCK PROTEINS AND IDENTIFICATION OF LYSINE RESIDUES THAT ACCEPT UBIQUITIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; STEROL-SENSING DOMAIN; DISEASE TYPE-C; QUALITY-CONTROL; UBIQUITIN LIGASE; NPC1 PROTEIN; CHOLESTEROL; CHIP; ACCUMULATION; FIBROBLASTS	Most cases with Niemann-Pick disease type C carry mutations in NPC1. Some of the mutations, including the most frequent I1061T, give rise to unstable proteins selected for endoplasmic reticulum-associated degradation. The purpose of the current study was to shed mechanistic insights into the degradation process. A proteasome inhibitor MG132 prolonged the life span of the wild-type NPC1 expressed in COS cells. The expressed protein associated with multiple chaperones including heat shock protein 90 (Hsp90), Hsp70, heat shock cognate protein 70 (Hsc70), and calnexin. Accordingly, expression of an E3 ligase CHIP (carboxyl terminus of Hsp70-interacting protein) enhanced MG132-induced accumulation of ubiquitylated NPC1. Co-expression and RNAi knockdown experiments in HEK cells indicated that Hsp70/Hsp90 stabilized NPC1, whereas Hsc70 destabilized it. In human fibroblasts carrying the I1061T mutation, adenovirus-mediated expression of Hsp70 or treatment with an HSP-inducer geranylgeranylacetone (GGA) increased the level of the mutant protein. In GGA-treated cells, the rescued protein was localized in the late endosome and ameliorated cholesterol accumulation. MALDI-TOF mass spectrometry revealed three lysine residues at amino acids 318, 792, and 1180 as potential ubiquitin-conjugation sites. Substitutions of the three residues with alanine yielded a mutant protein with a steady-state level more than three times higher than that of the wild-type. Introduction of the same substitutions to the I1061T mutant resulted in an increase in its protein level and functional restoration. These findings indicated the role of HSPs in quality control of NPC1 and revealed the role of three lysine residues as ubiquitin-conjugation sites.	[Nakasone, Naoe; Ninomiya, Haruaki] Tottori Univ, Fac Med, Dept Regulat Biol, Yonago, Tottori 6838503, Japan; [Ohno, Kousaku] Tottori Univ, Fac Med, Dept Child Neurol, Yonago, Tottori 6838503, Japan; [Nakamura, Yuko S.] Tottori Inst Ind Technol, Dept Appl Biotechnol, Yonago, Tottori 6840041, Japan; [Higaki, Katsumi] Tottori Univ, Div Funct Genom, Res Ctr Biosci & Technol, Yonago, Tottori 6838503, Japan; [Oumi, Nao] Tottori Univ Hosp, Ctr Canc, Yonago, Tottori 6838504, Japan	Tottori University; Tottori University; Tottori University; Tottori University	Ninomiya, H (corresponding author), Tottori Univ, Fac Med, Dept Regulat Biol, Yonago, Tottori 6838503, Japan.	ninomiya@med.tottori-u.ac.jp			Ara Parseghian Medical Research Foundation	Ara Parseghian Medical Research Foundation	This work was supported in part by a research grant from Ara Parseghian Medical Research Foundation (to H. N.).	Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Dai Q, 2005, J BIOL CHEM, V280, P38673, DOI 10.1074/jbc.M507986200; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Gelsthorpe ME, 2008, J BIOL CHEM, V283, P8229, DOI 10.1074/jbc.M708735200; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Higgins ME, 1999, MOL GENET METAB, V68, P1, DOI 10.1006/mgme.1999.2882; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Iwai C, 2013, CARDIOVASC RES, V100, P520, DOI 10.1093/cvr/cvt200; Katsuno M, 2005, P NATL ACAD SCI USA, V102, P16801, DOI 10.1073/pnas.0506249102; Li PL, 2011, CIRC RES, V108, P458, DOI 10.1161/CIRCRESAHA.110.227835; Lin H, 2004, BBA-MOL BASIS DIS, V1689, P219, DOI 10.1016/j.bbadis.2004.03.007; Matsumura Y, 2013, J BIOL CHEM, V288, P31069, DOI 10.1074/jbc.M113.479345; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Millat G, 2001, AM J HUM GENET, V68, P1373, DOI 10.1086/320606; Munkacsi AB, 2011, J BIOL CHEM, V286, P23842, DOI 10.1074/jbc.M111.227645; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Needham PG, 2013, BBA-MOL CELL RES, V1833, P2447, DOI 10.1016/j.bbamcr.2013.03.018; Ohgane K, 2013, CHEM BIOL, V20, P391, DOI 10.1016/j.chembiol.2013.02.009; Ohsaki Y, 2006, J CELL SCI, V119, P2643, DOI 10.1242/jcs.02993; Patterson M., 2001, METABOLIC MOL BASES, VII, P3611; Pipalia NH, 2011, P NATL ACAD SCI USA, V108, P5620, DOI 10.1073/pnas.1014890108; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Sevin M, 2007, BRAIN, V130, P120, DOI 10.1093/brain/awl260; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Sugimoto Y, 2001, P NATL ACAD SCI USA, V98, P12391, DOI 10.1073/pnas.221181998; Ting YK, 2011, BRIT J PHARMACOL, V162, P1832, DOI 10.1111/j.1476-5381.2011.01204.x; Vanier MT, 2004, BBA-MOL CELL BIOL L, V1685, P14, DOI 10.1016/j.bbalip.2004.08.007; Wang DX, 2005, ANAL CHEM, V77, P1458, DOI 10.1021/ac048834d; Yamamoto T, 2000, J MED GENET, V37, P707, DOI 10.1136/jmg.37.9.707; Yamamoto T, 2004, BRAIN DEV-JPN, V26, P245, DOI 10.1016/S0387-7604(03)00162-1; Yu T, 2012, HUM MOL GENET, V21, P3205, DOI 10.1093/hmg/dds145; Zampieri S, 2012, JIMD REP, V2, P59, DOI 10.1007/8904_2011_49	38	46	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19714	19725		10.1074/jbc.M114.549915	http://dx.doi.org/10.1074/jbc.M114.549915			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24891511	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000339326800043
J	Buesser, P; Tomassini, M				Buesser, Pierre; Tomassini, Marco			The Role of Opportunistic Migration in Cyclic Games	PLOS ONE			English	Article							EVOLUTION; BIODIVERSITY; COOPERATION; PROMOTES	We study cyclic evolutionary games in a spatial diluted grid environment in which agents strategically interact locally but can also opportunistically move to other positions within a given migration radius. We find that opportunistic migration can inverse the cyclic prevalence between the strategies when the frequency of random imitation is large enough compared to the payoff-driven imitation. At the transition the average size of the patterns diverges and this threatens diversity of strategies.	[Buesser, Pierre; Tomassini, Marco] Univ Lausanne, Fac Business & Econ, Lausanne, Switzerland	University of Lausanne	Buesser, P (corresponding author), Univ Lausanne, Fac Business & Econ, Lausanne, Switzerland.	pierre.buesser@unil.ch			Swiss National Foundation [200021-146616]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	P. Buesser received Swiss National Foundation grant n. 200021-146616; M. Tomassini is self-supported. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktipis CA, 2004, J THEOR BIOL, V231, P249, DOI 10.1016/j.jtbi.2004.06.020; Buesser P, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.042806; Chen Z, 2011, PHYSICA A, V390, P1615, DOI 10.1016/j.physa.2011.01.004; Cong R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035776; deForest R, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062138; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Hofbauer J., 1998, EVOLUTIONARY GAMES P; JACKSON JBC, 1975, P NATL ACAD SCI USA, V72, P5160, DOI 10.1073/pnas.72.12.5160; Jiang LL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036108; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Ni XA, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066211; Reichenbach T, 2007, NATURE, V448, P1046, DOI 10.1038/nature06095; Sandholm WH., 2010, POPULATION GAMES EVO; Semmann D, 2003, NATURE, V425, P390, DOI 10.1038/nature01986; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Szabo G, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036107; Szabo G, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.062903; Szabo G, 2004, J PHYS A-MATH GEN, V37, P2599, DOI 10.1088/0305-4470/37/7/006; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2010, PHYS REV E, V80; Szolnoki A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.036110; TAINAKA K, 1991, EUROPHYS LETT, V15, P399, DOI 10.1209/0295-5075/15/4/006; Vukov J, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022123; Wang Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00369; Wang Z, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.037101	26	0	0	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98190	10.1371/journal.pone.0098190	http://dx.doi.org/10.1371/journal.pone.0098190			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892660	Green Submitted, Green Published, gold			2022-12-25	WOS:000336911400038
J	Little, JP; Bleedorn, JA; Sutherland, BJ; Sullivan, R; Kalscheur, VL; Ramaker, MA; Schaefer, SL; Hao, ZL; Muir, P				Little, Jeffrey P.; Bleedorn, Jason A.; Sutherland, Brian J.; Sullivan, Ruth; Kalscheur, Vicki L.; Ramaker, Megan A.; Schaefer, Susan L.; Hao, Zhengling; Muir, Peter			Arthroscopic Assessment of Stifle Synovitis in Dogs with Cranial Cruciate Ligament Rupture	PLOS ONE			English	Article							RESISTANT ACID-PHOSPHATASE; PLATEAU LEVELING OSTEOTOMY; CATHEPSIN-K; JOINT; OSTEOARTHRITIS; PATHOGENESIS; POPULATIONS; PROGRESSION; SUBLUXATION; EXPRESSION	Cranial cruciate ligament rupture (CR) is a degenerative condition in dogs that typically has a non-contact mechanism. Subsequent contralateral rupture often develops in dogs with unilateral CR. Synovitis severity is an important factor that promotes ligament degradation. Consequently, we wished to evaluate the utility of arthroscopy for assessment of stifle synovitis in dogs with CR. Herein, we report results of a prospective study of 27 dogs with unilateral CR and bilateral radiographic osteoarthritis. Arthroscopic images and synovial biopsies from the lateral and medial joint pouches were obtained bilaterally and graded for synovial hypertrophy, vascularity, and synovitis. Synovial tartrate-resistant acid phosphatase-positive (TRAP(+)) macrophages, CD3(+) T lymphocytes, Factor VIII+ blood vessels, and synovial intima thickness were quantified histologically and related to arthroscopic observations. Risk of subsequent contralateral CR was examined using survival analysis. We found that arthroscopic scores were increased in the index stifle, compared with the contralateral stifle (p < 0.05). Numbers of CD3(+) T lymphocytes (S-R = 0.50, p < 0.05) and TRAP(+) cells in joint pouches (S-R = 0.59, p < 0.01) were correlated between joint pairs. Arthroscopic grading of vascularity and synovitis was correlated with number density of Factor VIII+ vessels (S-R > 0.34, p < 0.05). Arthroscopic grading of villus hypertrophy correlated with numbers of CD3(+) T lymphocytes (SR = 0.34, p, 0.05). Synovial intima thickness was correlated with arthroscopic hypertrophy, vascularity, and synovitis (S-R > 0.31, p < 0.05). Strong intra-observer and moderate inter-observer agreement for arthroscopic scoring was found. Dog age and arthroscopic vascularity significantly influenced risk of contralateral CR over time. We conclude that arthroscopic grading of synovitis is a precise tool that correlates with histologic synovitis. Arthroscopy is useful for assessment of stifle synovitis in client-owned dogs, and could be used in longitudinal clinical trials to monitor synovial responses to disease-modifying therapy.	[Little, Jeffrey P.; Bleedorn, Jason A.; Sutherland, Brian J.; Kalscheur, Vicki L.; Ramaker, Megan A.; Schaefer, Susan L.; Hao, Zhengling; Muir, Peter] Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA; [Sullivan, Ruth] Univ Wisconsin, Comparat Pathol Lab, Res Anim Resources Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Muir, P (corresponding author), Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA.	muirp@vetmed.wisc.edu	Muir, Peter/AAH-8057-2021; Bleedorn, Jason A/AAE-2115-2019; Mickelson, Megan/AAB-4563-2020	Muir, Peter/0000-0003-0028-6005; Bleedorn, Jason A/0000-0003-2987-7722; Mickelson, Megan/0000-0002-8197-9315	Companion Animal Fund, School of Veterinary Medicine, University of Wisconsin-Madison; Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000427]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER	Companion Animal Fund, School of Veterinary Medicine, University of Wisconsin-Madison; Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by a grant from the Companion Animal Fund, School of Veterinary Medicine, University of Wisconsin-Madison. The project described was also supported by the Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS), grant UL1TR000427. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Af Klint E, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2714; Ayral X, 1996, BAILLIERE CLIN RHEUM, V10, P477, DOI 10.1016/S1521-6942(96)80009-X; Bleedorn JA, 2011, VET SURG, V40, P531, DOI 10.1111/j.1532-950X.2011.00841.x; Bondeson J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2099; Bresnihan B, 1998, BRIT J RHEUMATOL, V37, P636; Buote N, 2009, VET SURG, V38, P481, DOI 10.1111/j.1532-950X.2009.00532.x; Cabrera SY, 2008, JAVMA-J AM VET MED A, V232, P889, DOI 10.2460/javma.232.6.889; Chu PG, 2001, APPL IMMUNOHISTO M M, V9, P97, DOI 10.1097/00022744-200106000-00001; Comerford EJ, 2011, VET COMP ORTHOPAED, V24, P91, DOI 10.3415/VCOT-10-04-0055; Conzemius MG, 2005, JAVMA-J AM VET MED A, V226, P232, DOI 10.2460/javma.2005.226.232; Cook JL, 2010, VET SURG, V39, P270, DOI 10.1111/j.1532-950X.2010.00653.x; Danielsson F, 2004, VET COMP ORTHOPAED, V17, P237; de Bruin T, 2007, VET REC, V161, P745, DOI 10.1136/vr.161.22.745; Doom M, 2008, VET IMMUNOL IMMUNOP, V125, P143, DOI 10.1016/j.vetimm.2008.05.023; DOVERSPIKE M, 1993, J AM ANIM HOSP ASSOC, V29, P167; Erne JB, 2009, JAVMA-J AM VET MED A, V235, P386, DOI 10.2460/javma.235.4.386; Faldyna M, 2004, ACTA VET BRNO, V73, P79, DOI 10.2754/avb200473010079; Fuller MC, 2014, JAVMA-J AM VET MED A, V244, P328, DOI 10.2460/javma.244.3.328; GALLOWAY RH, 1995, J AM ANIM HOSP ASSOC, V31, P289, DOI 10.5326/15473317-31-4-289; GOLDBERG VM, 1982, J BONE JOINT SURG AM, V64, P900, DOI 10.2106/00004623-198264060-00014; Hayashi K, 2011, VET SURG, V40, P192, DOI 10.1111/j.1532-950X.2010.00777.x; Hulse D, 2010, VET SURG, V39, P350, DOI 10.1111/j.1532-950X.2010.00676.x; Innes JF, 2004, VET RADIOL ULTRASOUN, V45, P143, DOI 10.1111/j.1740-8261.2004.04024.x; Kent MS, 2002, AM J VET RES, V63, P363, DOI 10.2460/ajvr.2002.63.363; Kim SE, 2011, AM J VET RES, V72, P410, DOI 10.2460/ajvr.72.3.410; Kjelgaard-Hansen M, 2004, THESIS ROYAL VET AGR; Lemburg AK, 2004, VET IMMUNOL IMMUNOP, V97, P231, DOI 10.1016/j.vetimm.2003.09.007; LINDBLAD S, 1985, ARTHRITIS RHEUM, V28, P977, DOI 10.1002/art.1780280904; Martano M, 2004, VET RES COMMUN, V28, P299, DOI 10.1023/B:VERC.0000045431.82158.4e; Might KR, 2013, VET SURG, V42, P392, DOI 10.1111/j.1532-950X.2012.01064.x; MOORE KW, 1995, AUST VET J, V72, P281, DOI 10.1111/j.1751-0813.1995.tb03555.x; Muir P, 2005, VET SURG, V34, P239, DOI 10.1111/j.1532-950X.2005.00036.x; Muir P, 2002, AM J VET RES, V63, P1279, DOI 10.2460/ajvr.2002.63.1279; Muir P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025331; Muir P, 2011, VET SURG, V40, P753, DOI 10.1111/j.1532-950X.2011.00867.x; Ohno K, 2006, J VET MED SCI, V68, P1275, DOI 10.1292/jvms.68.1275; PAUS AC, 1990, SCAND J RHEUMATOL, V19, P202, DOI 10.3109/03009749009095044; Preziosi R, 2004, J COMP PATHOL, V130, P143, DOI 10.1016/j.jcpa.2003.10.003; REINKE JD, 1982, J AM ANIM HOSP ASSOC, V18, P257; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Seed SM, 2009, GERIATRICS-US, V64, P20; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; Sumner JP, 2010, VET SURG, V39, P936, DOI 10.1111/j.1532-950X.2010.00738.x; Sutton S, 2009, VET J, V179, P10, DOI 10.1016/j.tvjl.2007.08.013; Wilke VL, 2005, JAVMA-J AM VET MED A, V227, P1604, DOI 10.2460/javma.2005.227.1604; Wilkerson MJ, 2005, VET IMMUNOL IMMUNOP, V106, P179, DOI 10.1016/j.vetimm.2005.02.020	46	22	22	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97329	10.1371/journal.pone.0097329	http://dx.doi.org/10.1371/journal.pone.0097329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892866	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400011
J	Xia, WT; Bai, J; Wu, XM; Wei, Y; Feng, SY; Li, L; Zhang, J; Xiong, GX; Fan, YP; Shi, JB; Li, HB				Xia, Wentong; Bai, Jing; Wu, Xingmei; Wei, Yi; Feng, Shaoyan; Li, Lei; Zhang, Jia; Xiong, Guanxia; Fan, Yunping; Shi, Jianbo; Li, Huabin			Interleukin-17A Promotes MUC5AC Expression and Goblet Cell Hyperplasia in Nasal Polyps via the Act1-Mediated Pathway	PLOS ONE			English	Article							MUCIN GENE-EXPRESSION; HUMAN AIRWAY CELLS; CHRONIC RHINOSINUSITIS; MESSENGER-RNA; EPITHELIAL-CELLS; INFLAMMATION; ACT1; FEATURES; DISEASE; STIMULATION	Background: Recent studies demonstrated that nasal polyps (NP) patients in China and other Asian regions possessed distinct Th17-dominant inflammation and enhanced tissue remodeling. However, the mechanism underlying these observations is not fully understood. This study sought to evaluate the association of interleukin (IL)-17A with MUC5AC expression and goblet cell hyperplasia in Chinese NP patients and to characterize the signaling pathway underlying IL-17A-induced MUC5AC expression in vitro. Method: We enrolled 25 NP patients and 22 normal controls and examined the expression of IL-17A, MUC5AC and act1 in polyp tissues by immunohistochemical (IHC) staining, quantitative polymerase chain reaction (qPCR) and western blot. Moreover, by using an in vitro culture system of polyp epithelial cells (PECs), IL-17A-induced gene expression was screened in cultured PECs by DNA microarray. The expression of IL-17RA, IL-17RC, act1 and MUC5AC and the activation of the MAPK pathway (ERK, p38 and JNK), were further examined in cultured PECs and NCI-H292 cells by qPCR and western blotting, respectively. Results: We found that increased IL-17A production was significantly correlated with MUC5AC and act1 expression and goblet cell hyperplasia in polyp tissues (p<0.05). IL-17A significantly stimulated the expression of IL-17RA, IL-17RC, act1 and MUC5AC, and the activation of the MAPK pathway in cultured PECs and NCI-H292 cells (p<0.05). In addition, IL-17RA, IL-17RC and act1 siRNA significantly blocked IL-17A-induced MUC5AC production in vitro (p<0.05). Conclusion: Our results suggest that IL-17A plays a crucial role in stimulating the production of MUC5AC and goblet cell hyperplasia through the act1-mediated signaling pathway and may suggest a promising strategy for the management of Th17-dominant NP patients.	[Xia, Wentong; Bai, Jing; Wu, Xingmei; Wei, Yi; Zhang, Jia; Xiong, Guanxia; Shi, Jianbo; Li, Huabin] Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolarygol Hosp, Allergy & Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Xia, Wentong; Li, Lei; Li, Huabin] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai 200030, Peoples R China; [Feng, Shaoyan; Fan, Yunping] Sun Yat Sen Univ, Affiliated Hosp 5, Dept Otolaryngol, Zhuhai, Peoples R China	Sun Yat Sen University; Shanghai Jiao Tong University; Sun Yat Sen University	Li, HB (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Otorhinolarygol Hosp, Allergy & Canc Ctr, Guangzhou 510275, Guangdong, Peoples R China.	allergyli@163.com			National Nature and Science Grant of China [81070772, 81271054]; Program for New Century Excellent Talents in University [NCET-10-0851]	National Nature and Science Grant of China; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This study is supported by National Nature and Science Grant of China (No. 81070772, 81271054) and Program for New Century Excellent Talents in University (No. NCET-10-0851). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alevy YG, 2012, J CLIN INVEST, V122, P4555, DOI 10.1172/JCI64896; Ali MS, 2005, ACTA OTO-LARYNGOL, V125, P618, DOI 10.1080/00016480510027538; Burgel PR, 2004, EUR RESPIR J, V24, P594, DOI 10.1183/09031936.04.00014404; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Chen Y, 2003, J BIOL CHEM, V278, P17036, DOI 10.1074/jbc.M210429200; Curran DR, 2010, AM J RESP CELL MOL, V42, P268, DOI 10.1165/rcmb.2009-0151TR; Datta S, 2010, J IMMUNOL, V184, P1484, DOI 10.4049/jimmunol.0902423; Derycke L, 2012, J CYST FIBROS, V11, P193, DOI 10.1016/j.jcf.2011.11.007; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fouser LA, 2008, IMMUNOL REV, V226, P87, DOI 10.1111/j.1600-065X.2008.00712.x; Fujisawa T, 2009, J IMMUNOL, V183, P6236, DOI 10.4049/jimmunol.0900614; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Halwani R, 2013, CHEST, V143, P494, DOI 10.1378/chest.12-0598; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hsu J, 2011, AM J RHINOL ALLERGY, V25, P285, DOI 10.2500/ajra.2011.25.3680; Hu XD, 2013, J INT MED RES, V41, P777, DOI 10.1177/0300060513478089; Kanoh S, 2011, CLIN EXP ALLERGY, V41, P1747, DOI 10.1111/j.1365-2222.2011.03852.x; Kim CH, 2000, LARYNGOSCOPE, V110, P2110, DOI 10.1097/00005537-200012000-00026; Kim JW, 2007, OTOLARYNG HEAD NECK, V137, P925, DOI 10.1016/j.otohns.2007.07.036; Liu CN, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000382; Martinez-Anton A, 2008, ALLERGY, V63, P1368, DOI 10.1111/j.1398-9995.2008.01678.x; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Molet SM, 2003, LARYNGOSCOPE, V113, P1803, DOI 10.1097/00005537-200310000-00027; Peters AT, 2010, J ALLERGY CLIN IMMUN, V125, P397, DOI 10.1016/j.jaci.2009.10.072; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Shi LL, 2013, ALLERGY, V68, P101, DOI 10.1111/all.12064; Shi PQ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001653; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Tanabe T, 2011, AM J RESP CELL MOL, V45, P1075, DOI 10.1165/rcmb.2010-0327OC; Turner J, 2009, BIOCHEM SOC T, V37, P877, DOI 10.1042/BST0370877; Van Crombruggen K, 2011, J ALLERGY CLIN IMMUN, V128, P728, DOI 10.1016/j.jaci.2011.07.049; Vazquez-Tello A, 2010, CLIN EXP ALLERGY, V40, P1312, DOI 10.1111/j.1365-2222.2010.03544.x; Wang HT, 2013, EUR ARCH OTO-RHINO-L, V270, P1867, DOI 10.1007/s00405-012-2295-x; Zijlstra GJ, 2012, EUR RESPIR J, V39, P439, DOI 10.1183/09031936.00017911	34	30	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98915	10.1371/journal.pone.0098915	http://dx.doi.org/10.1371/journal.pone.0098915			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892823	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400110
J	Minervini, G; Panizzoni, E; Giollo, M; Masiero, A; Ferrari, C; Tosatto, SCE				Minervini, Giovanni; Panizzoni, Elisabetta; Giollo, Manuel; Masiero, Alessandro; Ferrari, Carlo; Tosatto, Silvio C. E.			Design and Analysis of a Petri Net Model of the Von Hippel-Lindau (VHL) Tumor Suppressor Interaction Network	PLOS ONE			English	Article							EXPRESSION; HIF-1-ALPHA; MUTATION; GLUCOSE; CANCER; PVHL; CELL; IDENTIFICATION; HIF-1; P53	Von Hippel-Lindau (VHL) syndrome is a hereditary condition predisposing to the development of different cancer forms, related to germline inactivation of the homonymous tumor suppressor pVHL. The best characterized function of pVHL is the ubiquitination dependent degradation of Hypoxia Inducible Factor (HIF) via the proteasome. It is also involved in several cellular pathways acting as a molecular hub and interacting with more than 200 different proteins. Molecular details of pVHL plasticity remain in large part unknown. Here, we present a novel manually curated Petri Net (PN) model of the main pVHL functional pathways. The model was built using functional information derived from the literature. It includes all major pVHL functions and is able to credibly reproduce VHL syndrome at the molecular level. The reliability of the PN model also allowed in silico knockout experiments, driven by previous model analysis. Interestingly, PN analysis suggests that the variability of different VHL manifestations is correlated with the concomitant inactivation of different metabolic pathways.	[Minervini, Giovanni; Panizzoni, Elisabetta; Giollo, Manuel; Masiero, Alessandro; Tosatto, Silvio C. E.] Univ Padua, Dept Biomed Sci, Padua, Italy; [Giollo, Manuel; Ferrari, Carlo] Univ Padua, Dept Informat Engn, Padua, Italy	University of Padua; University of Padua	Tosatto, SCE (corresponding author), Univ Padua, Dept Biomed Sci, Padua, Italy.	silvio.tosatto@unipd.it	Ferrari, Carlo/AAU-8107-2021; Tosatto, Silvio/B-2840-2009; Minervini, Giovanni/D-1200-2013	Tosatto, Silvio/0000-0003-4525-7793; Minervini, Giovanni/0000-0001-7013-5785; FERRARI, CARLO/0000-0003-3665-0446	Associazione Italiana per la Ricerca sul Cancro(AIRC) [MFAG 12740]	Associazione Italiana per la Ricerca sul Cancro(AIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Associazione Italiana per la Ricerca sul Cancro(AIRC) Grant MFAG 12740 to ST. GM is an AIRC research fellow (http://www.airc.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaas E, 2007, J EXP BIOL, V210, P1548, DOI 10.1242/jeb.003731; Berndt JD, 2009, TRENDS BIOCHEM SCI, V34, P101, DOI 10.1016/j.tibs.2008.12.002; Bortfeldt Ralf H, 2011, Stud Health Technol Inform, V162, P244; Chaouiya C, 2007, BRIEF BIOINFORM, V8, P210, DOI 10.1093/bib/bbm029; Choi JW, 2004, CANCER RES, V64, P35, DOI 10.1158/0008-5472.CAN-03-0145; Fels DR, 2005, TRENDS BIOCHEM SCI, V30, P426, DOI 10.1016/j.tibs.2005.06.009; Frew IJ, 2007, CURR OPIN CELL BIOL, V19, P685, DOI 10.1016/j.ceb.2007.10.001; Frew IJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe30; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gnarra JR, 1997, P NATL ACAD SCI USA, V94, P9102, DOI 10.1073/pnas.94.17.9102; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Stefanie G, 2008, BIOSYSTEMS, V92, P189, DOI 10.1016/j.biosystems.2008.02.005; Heather LC, 2013, CIRC-HEART FAIL, V6, P1058, DOI 10.1161/CIRCHEARTFAILURE.112.000342; Heiner M, 2004, BIOSYSTEMS, V75, P15, DOI 10.1016/j.biosystems.2004.03.003; Heiner M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008600; Heiner M, 2009, NAT COMPUT SER, P367, DOI 10.1007/978-3-540-88869-7_19; Hergovich A, 2006, MOL CELL BIOL, V26, P5784, DOI 10.1128/MCB.00232-06; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kim BY, 2008, EXP MOL MED, V40, P71, DOI 10.3858/emm.2008.40.1.71; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kohn KW, 2004, MOL BIOL CELL, V15, P3042, DOI 10.1091/mbc.e03-12-0897; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Leonardi E, 2009, FEBS LETT, V583, P3704, DOI 10.1016/j.febslet.2009.10.070; Leonardi E, 2011, ANN HUM GENET, V75, P483, DOI 10.1111/j.1469-1809.2011.00647.x; Li QF, 2006, CELL RES, V16, P548, DOI 10.1038/sj.cr.7310072; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Maynard MA, 2005, FASEB J, V19, P1396, DOI 10.1096/fj.05-3788com; Minervini G, 2013, FEBS LETT, V587, P2996, DOI 10.1016/j.febslet.2013.07.019; Murphy EP, 1997, MOL ENDOCRINOL, V11, P39, DOI 10.1210/me.11.1.39; Okabe T, 1998, Nihon Rinsho, V56, P1734; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Richardson SM, 2008, HISTOCHEM CELL BIOL, V129, P503, DOI 10.1007/s00418-007-0372-9; Roe JS, 2006, CELL CYCLE, V5, P2054, DOI 10.4161/cc.5.18.3247; Rohr C, 2010, BIOINFORMATICS, V26, P974, DOI 10.1093/bioinformatics/btq050; Sackmann A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-482; Schoenfeld AR, 2000, P NATL ACAD SCI USA, V97, P8507, DOI 10.1073/pnas.97.15.8507; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Smith TG, 2008, BRIT J HAEMATOL, V141, P325, DOI 10.1111/j.1365-2141.2008.07029.x; Soga T, 2013, CANCER SCI, V104, P275, DOI 10.1111/cas.12085; Stolle C, 1998, HUM MUTAT, V12, P417, DOI 10.1002/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K; Tabernero J, 2007, MOL CANCER RES, V5, P203, DOI 10.1158/1541-7786.MCR-06-0404; TAKEDA J, 1993, DIABETES, V42, P773, DOI 10.2337/diabetes.42.5.773; Tang N, 2006, MOL CELL, V26, DOI [10.1128/MCB.26.7.2519, DOI 10.1128/MCB.26.7.2519]; Thoma CR, 2009, NAT CELL BIOL, V11, P994, DOI 10.1038/ncb1912; Thomas JG, 2001, GENOME RES, V11, P1227, DOI 10.1101/gr.165101; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Vortmeyer A, 2002, ONCOGENE, V21, P1167, DOI 10.1038/sj.onc.1205121; Weitz JS, 2007, PLOS BIOL, V5, P10, DOI 10.1371/journal.pbio.0050011; Wu M, 2013, BIOINFORMATICS, V29, P1541, DOI 10.1093/bioinformatics/btt186; Yu YH, 2007, PLOS COMPUT BIOL, V3, P1657, DOI 10.1371/journal.pcbi.0030171; Zhu JL, 2000, MOL CELL ENDOCRINOL, V164, P205, DOI 10.1016/S0303-7207(00)00207-0	53	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e96986	10.1371/journal.pone.0096986	http://dx.doi.org/10.1371/journal.pone.0096986			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886840	Green Published, gold			2022-12-25	WOS:000336956300010
J	Vilhelmsen, L; Zimmermann, D				Vilhelmsen, Lars; Zimmermann, Dominique			Baltorussus Total Makeover: Rejuvenation and Sex Change in an Ancient Parasitoid Wasp Lineage	PLOS ONE			English	Article							HYMENOPTERA INSECTA; ORUSSIDAE INSECTA; PHYLOGENY; MORPHOLOGY; EVOLUTION; FOSSILS; WAIST; AMBER; TREE	The Orussidae is a small and rare but phylogenetically important family of parasitoid wasps. The fossil record of the family is also very poor. Baltorussus velteni was described from Baltic amber from an allegedly female specimen. This and another recently discovered specimen are examined with microCT scanning and standard microscopy. We reveal that both the holotype and the new specimen are actually males. Furthermore, the results of the microCT scanning allow us to integrate the fossils in a morphological data set assembled for extant Orussidae. Phylogenetic analyses consistently retrieve Baltorussus as a separate basal lineage within the crown group, whereas two Cretaceous fossils are placed as stem group orussids and a Dominican amber fossil in an extant genus. Based on the positions of the fossils, we estimate that the extant Orussidae radiated in the mid-Cretaceous (approx. 100 Ma ago). This is considerably younger than a previously suggested Early Jurassic date (180 Ma ago), which was primarily based on biogeographic evidence.	[Vilhelmsen, Lars] Nat Hist Museum Denmark, Copenhagen, Denmark; [Zimmermann, Dominique] Nat Hist Museum Vienna, Zool Dept 2, Vienna, Austria		Vilhelmsen, L (corresponding author), Nat Hist Museum Denmark, Copenhagen, Denmark.	lbvilhelmsen@snm.ku.dk	Vilhelmsen, Lars/A-3396-2013; Vilhelmsen, Lars/AAC-6747-2020	Vilhelmsen, Lars/0000-0002-5593-5722; Vilhelmsen, Lars/0000-0002-5593-5722	University of Copenhagen; Natural History Museum Vienna	University of Copenhagen; Natural History Museum Vienna	The only funding going into this work is the salaries of the people involved, provided from the University of Copenhagen and the Natural History Museum Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basibuyuk Hasan H., 2000, P305; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Engel Michael S., 2008, Transactions of the Kansas Academy of Science, V111, P39, DOI 10.1660/0022-8443(2008)111[39:AOWWIA]2.0.CO;2; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2003, CLADISTICS, V19, P324, DOI 10.1016/S0748-3007(03)00060-4; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Grimaldi David, 2005, pi; KLEINTEICH T., 2008, P SPIE D, V7078D, P1; Klopfstein S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069344; Maddison W. P., 2011, MESQUITE 2 75; Rasnitsyn A.P., 1969, T PALEONTOL I ACAD S, V123, P1; RASNITSYN AP, 1988, ORIENT INSECTS, V22, P115, DOI 10.1080/00305316.1988.11835485; Rasnitsyn AP, 1977, PALEONTOL J+, V11, P349; Ronquist F, 2012, SYST BIOL, V61, P973, DOI 10.1093/sysbio/sys058; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ross HH, 1937, ILLINOIS BIOL MONOGR, V15, P1, DOI DOI 10.5962/BHL.TITLE.50339; Schedl Wolfgang, 2011, Zeitschrift der Arbeitsgemeinschaft Oesterreichischer Entomologen, V63, P33; Schulmeister S, 2003, ORG DIVERS EVOL, V3, P253, DOI 10.1078/1439-6092-00078; Sharkey MJ, 2012, CLADISTICS, V28, P80, DOI 10.1111/j.1096-0031.2011.00366.x; SNODGRASS R. E., 1941, SMITHSONIAN MISC COLL, V99, P1; Vilhelmsen L, 2000, ZOOMORPHOLOGY, V119, P185, DOI 10.1007/PL00008493; Vilhelmsen L, 2004, BIOL J LINN SOC, V82, P139, DOI 10.1111/j.1095-8312.2004.00327.x; Vilhelmsen L, 2003, ZOOL J LINN SOC-LOND, V139, P337, DOI 10.1046/j.1096-3642.2003.00080.x; Vilhelmsen L, 2002, INSECT SYST EVOL, V33, P387, DOI 10.1163/187631202X00217; Vilhelmsen L, 2001, ZOOMORPHOLOGY, V121, P63, DOI 10.1007/s004350100046; Vilhelmsen L, 1996, ZOOL SCR, V25, P143, DOI 10.1111/j.1463-6409.1996.tb00156.x; Vilhelmsen L, 2013, INVERTEBR SYST, V27, P450, DOI 10.1071/IS13006; Vilhelmsen L, 2011, ARTHROPOD STRUCT DEV, V40, P2, DOI 10.1016/j.asd.2010.10.001; Vilhelmsen L, 2010, ZOOL J LINN SOC-LOND, V159, P22, DOI 10.1111/j.1096-3642.2009.00576.x	29	9	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98412	10.1371/journal.pone.0098412	http://dx.doi.org/10.1371/journal.pone.0098412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887435	Green Submitted, Green Published, gold			2022-12-25	WOS:000336956300065
J	Wang, F; Chang, GM; Geng, X				Wang, Fei; Chang, Guangming; Geng, Xin			NGF and TERT Co-Transfected BMSCs Improve the Restoration of Cognitive Impairment in Vascular Dementia Rats	PLOS ONE			English	Article							MARROW STROMAL CELLS; NERVE GROWTH-FACTOR; STEM-CELLS; IN-VITRO; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; TELOMERE LENGTH; EXPRESSION; MEMORY; DYSFUNCTION	Vascular dementia (VaD) is a mental disorder caused by brain damage due to cerebrovascular disease, and incidence of VaD is rising. To date, there is no known effective cure for VaD, so effort in developing an effective treatment for VaD is of great importance. The differentiation plasticity of BMSCs, in conjunction with its weak immunogenicity, makes manipulated BMSCs an attractive strategy for disease treatment. However, BMSCs often display disabled differentiation, premature aging, and unstable proliferation, reducing their neuroprotective function. These problems may be caused by the lack of telomerase activity in BMSCs. Our results show that NGF-TERT co-transfected BMSCs have a better therapeutic effect than BMSCs lacking NGF and TERT expression, demonstrated by significant improvements in learning and memory in VaD rats. The underlying mechanism might be increased expression of NGF, TrkA and SYN in the hippocampal CA1 area, which has potential implication in advancing therapeutics for VaD.	[Wang, Fei] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin, Peoples R China; [Chang, Guangming] Tianjin Med Univ, Gen Hosp, Dept Clin Lab, Tianjin, Peoples R China; [Geng, Xin] Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin, Peoples R China; [Geng, Xin] Tianjin Key Lab Cellular & Mol Immunol, Tianjin, Peoples R China; [Geng, Xin] Minist China, Key Lab Educ, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Geng, X (corresponding author), Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin, Peoples R China.	gengx@tmu.edu.cn			Chinese National Natural Science Foundation [81100805]; Tianjin Education Committee Technology Development Grant [20080107]; Foundation of Key Laboratory of Genetic Engineering of the Ministry of Education [201302]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Tianjin Education Committee Technology Development Grant; Foundation of Key Laboratory of Genetic Engineering of the Ministry of Education	This work was supported by Chinese National Natural Science Foundation Grant (No. 81100805), Tianjin Education Committee Technology Development Grant (No. 20080107), and the Foundation of Key Laboratory of Genetic Engineering of the Ministry of Education (201302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyemi RO, 2013, CURR ALZHEIMER RES, V10, P642; Banfi A, 2002, TISSUE ENG, V8, P901, DOI 10.1089/107632702320934001; Baskys A, 2012, EXP GERONTOL, V47, P887, DOI 10.1016/j.exger.2012.07.002; Baxter MA, 2004, STEM CELLS, V22, P675, DOI 10.1634/stemcells.22-5-675; de Jesus BB, 2012, EMBO MOL MED, V4, P691, DOI 10.1002/emmm.201200245; Bianchi G, 2003, EXP CELL RES, V287, P98, DOI 10.1016/S0014-4827(03)00138-1; Birch AM, 2013, NEUROPHARMACOLOGY, V75, P255, DOI 10.1016/j.neuropharm.2013.07.023; Birch AM, 2013, HIPPOCAMPUS, V23, P437, DOI 10.1002/hipo.22103; Boccardi V, 2012, EMBO MOL MED, V4, P685, DOI 10.1002/emmm.201200246; Bokara KK, 2011, STEM CELLS DEV, V20, P527, DOI 10.1089/scd.2010.0312; Ding J, 2011, J NEUROSCI RES, V89, P222, DOI 10.1002/jnr.22535; Dong Y, 2013, CURR MOL MED, V13, P488; Fontanet P, 2013, J NEUROSCI, V33, P15940, DOI 10.1523/JNEUROSCI.0928-13.2013; Garcia-Gutierrez MS, 2013, NEUROPHARMACOLOGY, V73, P388, DOI 10.1016/j.neuropharm.2013.05.034; GAROFALO L, 1992, P NATL ACAD SCI USA, V89, P2639, DOI 10.1073/pnas.89.7.2639; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Ikejima C, 2009, STROKE, V40, P2709, DOI 10.1161/STROKEAHA.108.542308; Li HY, 2013, CHEMOSPHERE, V92, P52, DOI 10.1016/j.chemosphere.2013.02.061; Li MD, 2014, REGEN MED, V9, P27, DOI [10.2217/RME.13.80, 10.2217/rme.13.80]; Li S, 2013, EXP GERONTOL, V48, P778, DOI 10.1016/j.exger.2013.04.014; Liu XF, 2014, PROG NEUROBIOL, V115, P92, DOI 10.1016/j.pneurobio.2013.11.007; NI JW, 1994, BRAIN RES, V653, P231, DOI 10.1016/0006-8993(94)90394-8; O'Callaghan RM, 2009, HIPPOCAMPUS, V19, P1019, DOI 10.1002/hipo.20591; Ogura F, 2014, STEM CELLS DEV, V23, P717, DOI 10.1089/scd.2013.0473; Ojeda D, 2014, J NEUROSCI RES, V92, P267, DOI 10.1002/jnr.23294; Pantoni L, 2005, STROKE, V36, P619, DOI 10.1161/01.STR.0000155686.73908.3e; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Pham TM, 2002, PHARMACOL BIOCHEM BE, V73, P167, DOI 10.1016/S0091-3057(02)00783-9; Razavi S, 2013, BIOCHEM BIOPH RES CO, V440, P381, DOI 10.1016/j.bbrc.2013.09.069; Sanchez-Ortiz E, 2012, J NEUROSCI, V32, P4065, DOI 10.1523/JNEUROSCI.6314-11.2012; Sun S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083523; Tanaka N, 2013, PSYCHOGERIATRICS, V13, P199, DOI 10.1111/psyg.12012; Tang H, 2013, BIOCHEM BIOPH RES CO, V440, P502, DOI 10.1016/j.bbrc.2013.09.053; van Gorp S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt209; Wagner W, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt145; Wang F, 2010, J MOL NEUROSCI, V41, P145, DOI 10.1007/s12031-009-9311-7; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075477; Wang ZT, 2009, J MOL NEUROSCI, V38, P265, DOI 10.1007/s12031-009-9208-5; Willyard C, 2013, NATURE, V503, pS4, DOI 10.1038/503S4a; Yoon JK, 2010, NUCL MED BIOL, V37, P381, DOI 10.1016/j.nucmedbio.2009.12.001; Zhang H, 2014, NEUROCHEM RES, V39, P276, DOI 10.1007/s11064-013-1219-5; Zhang N, 2013, NEUROSCI B	42	17	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98774	10.1371/journal.pone.0098774	http://dx.doi.org/10.1371/journal.pone.0098774			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887495	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300107
J	Helbo, S; Gow, AJ; Jamil, A; Howes, BD; Smulevich, G; Fago, A				Helbo, Signe; Gow, Andrew J.; Jamil, Amna; Howes, Barry D.; Smulevich, Giulietta; Fago, Angela			Oxygen-Linked S-Nitrosation in Fish Myoglobins: A Cysteine-Specific Tertiary Allosteric Effect	PLOS ONE			English	Article							RESONANCE RAMAN-SPECTROSCOPY; AMINO-ACID-SEQUENCE; RAINBOW-TROUT; NITRIC-OXIDE; FUNCTIONAL-PROPERTIES; NITROSOHEMOGLOBIN; HEMOGLOBIN; BINDING; MODULATION; AFFINITY	The discovery that cysteine (Cys) S-nitrosation of trout myoglobin (Mb) increases heme O-2 affinity has revealed a novel allosteric effect that may promote hypoxia-induced nitric oxide (NO) delivery in the trout heart and improve myocardial efficiency. To better understand this allosteric effect, we investigated the functional effects and structural origin of S-nitrosation in selected fish Mbs differing by content and position of reactive cysteine (Cys) residues. The Mbs from the Atlantic salmon and the yellowfin tuna, containing two and one reactive Cys, respectively, were S-nitrosated in vitro by reaction with Cys-NO to generate Mb-SNO to a similar yield (similar to 0.50 SH/ heme), suggesting reaction at a specific Cys residue. As found for trout, salmon Mb showed a low O2 affinity (P-50 = 2.7 torr) that was increased by S-nitrosation (P-50 = 1.7 torr), whereas in tuna Mb, O-2 affinity (P-50 = 0.9 torr) was independent of S-nitrosation. O-2 dissociation rates (K-off) of trout and salmon Mbs were not altered when Cys were in the SNO or N-ethylmaleimide (NEM) forms, suggesting that S-nitrosation should affect O-2 affinity by raising the O-2 association rate (kon). Taken together, these results indicate that O-2-linked Snitrosation may occur specifically at Cys107, present in salmon and trout Mb but not in tuna Mb, and that it may relieve protein constraints that limit O-2 entry to the heme pocket of the unmodified Mb by a yet unknown mechanism. UV-Vis and resonance Raman spectra of the NEM-derivative of trout Mb (functionally equivalent to Mb-SNO and not photolabile) were identical to those of the unmodified Mb, indicating that S-nitrosation does not affect the extent or nature of heme-ligand stabilization of the fully ligated protein. The importance of S-nitrosation of Mb in vivo is confirmed by the observation that Mb-SNO is present in trout hearts and that its level can be significantly reduced by anoxic conditions.	[Helbo, Signe; Fago, Angela] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Gow, Andrew J.; Jamil, Amna] Rutgers State Univ, Dept Pharmacol & Toxicol, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA; [Howes, Barry D.; Smulevich, Giulietta] Univ Florence, Dept Chem Ugo Schiff, Sesto Fiorentino, FI, Italy	Aarhus University; Rutgers State University New Brunswick; University of Florence	Fago, A (corresponding author), Aarhus Univ, Dept Biosci, Aarhus, Denmark.	angela.fago@biology.au.dk	Fago, Angela/J-5946-2013; Gow, Andrew/AAR-2309-2020; Gow, Andrew/N-8566-2013	Fago, Angela/0000-0001-7315-2628; Gow, Andrew/0000-0003-0876-5158; Gow, Andrew/0000-0003-0876-5158; Smulevich, Giulietta/0000-0003-3021-8919	Danish Council for Independent Research, Natural Sciences [10-084565]; Lundbeck foundation; Local Italian grants; National Institute of Health (NIH) [HL086621]; Summer Undergraduate Research Fellowship (SURF) Program at Rutgers University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R25ES020721] Funding Source: NIH RePORTER	Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Lundbeck foundation(Lundbeckfonden); Local Italian grants; National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Summer Undergraduate Research Fellowship (SURF) Program at Rutgers University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the Danish Council for Independent Research, Natural Sciences (grant 10-084565 to AF) the Lundbeck foundation (to AF), by the Local Italian grants (ex 60%) (to GS), by the National Institute of Health (NIH grant HL086621 to AJG), and the Summer Undergraduate Research Fellowship (SURF) Program at Rutgers University (to AJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Ascenzi P, 2013, BBA-PROTEINS PROTEOM, V1834, P1750, DOI 10.1016/j.bbapap.2013.02.012; Bonaventura C, 1999, J BIOL CHEM, V274, P24742, DOI 10.1074/jbc.274.35.24742; BOUTILIER RG, 1984, FISH PHYSIOL, V10, P403; Egawa T, 2005, J INORG BIOCHEM, V99, P72, DOI 10.1016/j.jinorgbio.2004.10.017; Fago A, 2013, BBA-PROTEINS PROTEOM, V1834, P1894, DOI 10.1016/j.bbapap.2013.04.017; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Giardina B, 1996, J BIOL CHEM, V271, P16999, DOI 10.1074/jbc.271.29.16999; Gow A, 2007, J CHROMATOGR B, V851, P140, DOI 10.1016/j.jchromb.2007.01.052; GRASSETTI DR, 1967, ARCH BIOCHEM BIOPHYS, V119, P41, DOI 10.1016/0003-9861(67)90426-2; Gros G, 2010, J EXP BIOL, V213, P2713, DOI 10.1242/jeb.043075; HARTMUND T, 1995, J COMP PHYSIOL B, V165, P219, DOI 10.1007/BF00260813; Helbo S, 2013, BBA-PROTEINS PROTEOM, V1834, P1832, DOI 10.1016/j.bbapap.2013.01.037; Helbo S, 2013, COMP BIOCHEM PHYS A, V165, P40, DOI 10.1016/j.cbpa.2013.01.020; Helbo S, 2012, J EXP BIOL, V215, P3403, DOI 10.1242/jeb.073726; Helbo S, 2012, AM J PHYSIOL-REG I, V302, pR693, DOI 10.1152/ajpregu.00501.2011; Helbo S, 2011, AM J PHYSIOL-REG I, V300, pR101, DOI 10.1152/ajpregu.00374.2010; Howes BD, 2012, J INORG BIOCHEM, V109, P1, DOI 10.1016/j.jinorgbio.2012.01.007; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Madden PW, 2004, COMP BIOCHEM PHYS B, V137, P341, DOI 10.1016/j.cbpc.2003.12.008; MAEDA N, 1981, J BIOL CHEM, V256, P4301; Marcinek DJ, 2001, AM J PHYSIOL-REG I, V280, pR1123, DOI 10.1152/ajpregu.2001.280.4.R1123; Patel RP, 1999, J BIOL CHEM, V274, P15487, DOI 10.1074/jbc.274.22.15487; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Pedersen CL, 2010, J EXP BIOL, V213, P2755, DOI 10.1242/jeb.041624; Rayner BS, 2005, J BIOL CHEM, V280, P9985, DOI 10.1074/jbc.M410564200; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; Schreiter ER, 2007, J BIOL CHEM, V282, P19773, DOI 10.1074/jbc.M701363200; SPIRO TG, 1985, ADV PROTEIN CHEM, V37, P111, DOI 10.1016/S0065-3233(08)60064-9; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; WATTS DA, 1983, BIOCHIM BIOPHYS ACTA, V742, P310, DOI 10.1016/0167-4838(83)90316-3; WEBER RE, 1992, J APPL PHYSIOL, V72, P1611, DOI 10.1152/jappl.1992.72.4.1611; Wittenberg JB, 2003, J EXP BIOL, V206, P2011, DOI 10.1242/jeb.00243	33	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97012	10.1371/journal.pone.0097012	http://dx.doi.org/10.1371/journal.pone.0097012			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879536	Green Published, gold, Green Submitted			2022-12-25	WOS:000338101500010
J	Kim, A; Im, M; Yim, NH; Kim, T; Ma, JY				Kim, Aeyung; Im, Minju; Yim, Nam-Hui; Kim, Taesoo; Ma, Jin Yeul			A Novel Herbal Medicine, KIOM-C, Induces Autophagic and Apoptotic Cell Death Mediated by Activation of JNK and Reactive Oxygen Species in HT1080 Human Fibrosarcoma Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; CANCER-CELLS; NONCANONICAL AUTOPHAGY; INDUCTION; PATHWAYS; CHEMOTHERAPY; INHIBITION; CROSSTALK; SURVIVAL; GROWTH	KIOM-C was recently demonstrated to have anti-metastatic activity in highly malignant cancer cells via suppression of NF-kappa B-mediated MMP-9 activity. In addition, it was reported to be effective for clearance of the influenza virus by increasing production of anti-viral cytokines, such as TNF-alpha and IFN-gamma, and efficacious in the treatment of pigs suffering from porcine circovirus-associated disease (PCVAD). In this study, we investigated whether KIOM-C induces cancer cell death and elucidated the underlying anti-cancer mechanisms. In addition, we examined whether KIOM-C oral administration suppresses in vivo tumor growth of HT1080 cells in athymic nude mice. We initially found that KIOM-C at concentrations of 500 and 1000 mu g/ml caused dose- and time-dependent cell death in cancer cells, but not normal hepatocytes, to approximately 50% of control levels. At the early stage of KIOM-C treatment (12 h), cells were arrested in G(1) phase, which was accompanied by up-regulation of p21 and p27, down-regulation of cyclin D1, and subsequent increases in apoptotic and autophagic cells. Following KIOM-C treatment, the extent of caspase-3 activation, PARP cleavage, Beclin-1 expression, and LC3-II conversion was remarkably up-regulated, but p62 expression was down-regulated. Phosphorylation of AMPK, ULK, JNK, c-jun, and p53 was increased significantly in response to KIOM-C treatment. The levels of intracellular ROS and CHOP expression were also increased. In particular, the JNK-specific inhibitor SP600125 blocked KIOM-C-induced ROS generation and CHOP expression almost completely, which consequently almost completely rescued cell death, indicating that JNK activation plays a critical role in KIOM-C-induced cell death. Furthermore, daily oral administration of 85 and 170 mg/kg KIOM-C efficiently suppressed the tumorigenic growth of HT1080 cells, without systemic toxicity. These results collectively suggest that KIOM-C efficiently induces cancer cell death by both autophagy and apoptosis via activation of JNK signaling pathways, and KIOM-C represents a safe and potent herbal therapy for treating malignancies.	[Kim, Aeyung; Im, Minju; Yim, Nam-Hui; Kim, Taesoo; Ma, Jin Yeul] KIOM, KM Based Herbal Drug Dev Grp, Taejon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Ma, JY (corresponding author), KIOM, KM Based Herbal Drug Dev Grp, Taejon, South Korea.	jyma@kiom.re.kr			Ministry of Education, Science and Technology (MEST), Republic of Korea [K13050]	Ministry of Education, Science and Technology (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work has been supported by a Grant K13050 awarded to Korea Institute of Oriental Medicine (KIOM) from Ministry of Education, Science and Technology (MEST), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; Chung TaeHo, 2012, Journal of Medicinal Plants Research, V6, P4456, DOI 10.5897/JMPR10.691; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; Duan WJ, 2011, BIOL PHARM BULL, V34, P47, DOI 10.1248/bpb.34.47; Duan WJ, 2010, J PHARMACOL SCI, V113, P48, DOI 10.1254/jphs.09315FP; Evans T, 2005, SEM RESP CRIT CARE M, V26, P304, DOI 10.1055/s-2005-871989; Filippi-Chiela EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020849; GIOVARELLI M, 1986, INT J CANCER, V37, P141, DOI 10.1002/ijc.2910370122; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Gururajan M, 2005, BLOOD, V106, P1382, DOI 10.1182/blood-2004-10-3819; Haberzettl P, 2013, REDOX BIOL, V1, P56, DOI 10.1016/j.redox.2012.10.003; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Kim A, 2014, ONCOL REP, V31, P287, DOI 10.3892/or.2013.2822; Kim EH, 2013, ANTIVIR RES, V98, P386, DOI 10.1016/j.antiviral.2013.04.006; Kiyohara H, 2004, EVID-BASED COMPL ALT, V1, P83, DOI 10.1093/ecam/neh004; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Liu YL, 2010, AUTOPHAGY, V6, P1057, DOI 10.4161/auto.6.8.13365; Maddika S, 2007, DRUG RESIST UPDATE, V10, P13, DOI 10.1016/j.drup.2007.01.003; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mates JM, 2000, INT J BIOCHEM CELL B, V32, P157, DOI 10.1016/S1357-2725(99)00088-6; Miller D K, 1997, Semin Immunol, V9, P35, DOI 10.1006/smim.1996.0058; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Park SH, 2013, FOOD CHEM TOXICOL, V56, P100, DOI 10.1016/j.fct.2013.02.022; Petrylak DP, 2005, UROLOGY, V65, P3, DOI 10.1016/j.urology.2005.03.053; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Song KS, 2008, AUTOPHAGY, V4, P650, DOI 10.4161/auto.6057; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tan ML, 2009, PHARM RES-DORDR, V26, P1547, DOI 10.1007/s11095-009-9895-1; Torres M, 2003, BIOFACTORS, V17, P287, DOI 10.1002/biof.5520170128; Trejo-Solis C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-156; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996; Xie CM, 2011, FREE RADICAL BIO MED, V51, P1365, DOI 10.1016/j.freeradbiomed.2011.06.016; Zhang YH, 2009, ARCH BIOCHEM BIOPHYS, V489, P25, DOI 10.1016/j.abb.2009.07.017; Zhao MT, 2011, CELL METAB, V13, P119, DOI 10.1016/j.cmet.2011.01.009; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x	41	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98703	10.1371/journal.pone.0098703	http://dx.doi.org/10.1371/journal.pone.0098703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878898	Green Submitted, gold, Green Published			2022-12-25	WOS:000338101500080
J	Pereira, JL; Queiroz, RML; Charneau, SO; Felix, CR; Ricart, CAO; da Silva, FL; Steindorff, AS; Ulhoa, CJ; Noronha, EF				Pereira, Jackeline L.; Queiroz, Rayner M. L.; Charneau, Sebastien O.; Felix, Carlos R.; Ricart, Carlos A. O.; da Silva, Francilene Lopes; Steindorff, Andrei Stecca; Ulhoa, Cirano J.; Noronha, Eliane F.			Analysis of Phaseolus vulgaris Response to Its Association with Trichoderma harzianum (ALL-42) in the Presence or Absence of the Phytopathogenic Fungi Rhizoctonia solani and Fusarium solani	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; CINNAMOYL-COA REDUCTASE; ARABIDOPSIS-THALIANA; PROTEOMIC ANALYSIS; SYSTEMIC RESISTANCE; DIFFERENTIAL EXPRESSION; PSEUDOMONAS-SYRINGAE; BIOCONTROL ACTIVITY; DEFENSE RESPONSES; GENE-EXPRESSION	The present study was carried out to evaluate the ability of Trichoderma harzianum (ALL 42-isolated from Brazilian Cerrado soil) to promote common bean growth and to modulate its metabolism and defense response in the presence or absence of the phytopathogenic fungi Rhizoctonia solani and Fusarium solani using a proteomic approach. T. harzianum was able to promote common bean plants growth as shown by the increase in root/foliar areas and by size in comparison to plants grown in its absence. The interaction was shown to modulate the expression of defense-related genes (Glu1, pod3 and lox1) in roots of P. vulgaris. Proteomic maps constructed using roots and leaves of plants challenged or unchallenged by T. harzianum and phytopathogenic fungi showed differences. Reference gels presented differences in spot distribution (absence/presence) and relative volumes of common spots (up or down-regulation). Differential spots were identified by peptide fingerprinting MALDI-TOF mass spectrometry. A total of 48 identified spots (19 for leaves and 29 for roots) were grouped into protein functional classes. For leaves, 33%, 22% and 11% of the identified proteins were categorized as pertaining to the groups: metabolism, defense response and oxidative stress response, respectively. For roots, 17.2%, 24.1% and 10.3% of the identified proteins were categorized as pertaining to the groups: metabolism, defense response and oxidative stress response, respectively.	[Pereira, Jackeline L.; Queiroz, Rayner M. L.; Charneau, Sebastien O.; Felix, Carlos R.; Ricart, Carlos A. O.; da Silva, Francilene Lopes; Steindorff, Andrei Stecca; Noronha, Eliane F.] Univ Brasilia UNB, Dept Cellular Biol, Brasilia, DF, Brazil; [Ulhoa, Cirano J.] Fed Univ Goias UFG, Inst Biol Sci, Goiania, Go, Brazil	Universidade de Brasilia; Universidade Federal de Goias	Ulhoa, CJ (corresponding author), Fed Univ Goias UFG, Inst Biol Sci, Goiania, Go, Brazil.	ulhoa@icb.ufg.br	Ulhoa, CIRANO/AAV-9374-2020; Noronha, Eliane F./D-4812-2016; Steindorff, Andrei Stecca/I-3084-2013; Charneau, Sébastien/AAD-1145-2019	Steindorff, Andrei Stecca/0000-0002-2052-2848; Charneau, Sébastien/0000-0002-9364-7289; Noronha, Eliane Ferreira/0000-0002-4081-4979; Ulhoa, Cirano/0000-0002-4171-6465	Research and Projects Financing (FINEP); National Council for Scientific and Technological Development (CNPq) [FINEP/CT-AGRO AGRO/Acao Transversal - 01.07.0551.00/Ref. 0845/07]; FAPDF; FAPEGO. (Foundation for research support fromGoias state, Brazil)	Research and Projects Financing (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPDF(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); FAPEGO. (Foundation for research support fromGoias state, Brazil)	This work was funded by Research and Projects Financing (FINEP), National Council for Scientific and Technological Development (CNPq) ( FINEP/CT-AGRO AGRO/Acao Transversal - 01.07.0551.00/Ref. 0845/07) and FAPDF. C.J.U. is supported by a biotechnology research grant from FAPEGO. (Foundation for research support fromGoias state, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Muniz CH, 2012, PHYSIOL PLANTARUM, V144, P59, DOI 10.1111/j.1399-3054.2011.01522.x; ALSCHER RG, 1989, PHYSIOL PLANTARUM, V77, P457, DOI 10.1111/j.1399-3054.1989.tb05667.x; Contreras-Cornejo HA, 2009, PLANT PHYSIOL, V149, P1579, DOI 10.1104/pp.108.130369; Bart RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001123; Rubio MB, 2012, MICROBIOL-SGM, V158, P119, DOI 10.1099/mic.0.052118-0; Brotman Y, 2008, PLANT PHYSIOL, V147, P779, DOI 10.1104/pp.108.116293; Almeida FBDR, 2007, BIOTECHNOL LETT, V29, P1189, DOI 10.1007/s10529-007-9372-z; Bu QY, 2008, CELL RES, V18, P756, DOI 10.1038/cr.2008.53; Chacon MR, 2007, INT MICROBIOL, V10, P19, DOI 10.2436/20.1501.01.4; Carvalho DDC, 2011, PESQUI AGROPECU BRAS, V46, P822, DOI 10.1590/S0100-204X2011000800006; Dalton DA, 2009, PLANT PHYSIOL, V150, P521, DOI 10.1104/pp.109.136630; Djonovic S, 2007, MOL PLANT PATHOL, V8, P469, DOI [10.1111/j.1364-3703.2007.00407.x, 10.1111/J.1364-3703.2007.00407.X]; Geraldine AM, 2012, THESIS U FEDERAL GOI; Gonzalez-Fernandez R, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/932527; Guerrero-Gonzalez ML, 2011, PLANT CELL REP, V30, P1465, DOI 10.1007/s00299-011-1055-5; Hagedorn DJ, 1986, HDB BEAN DIS, pA3374; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Hermosa R, 2012, MICROBIOL-SGM, V158, P17, DOI 10.1099/mic.0.052274-0; Hoyos-Carvajal L, 2009, FUNGAL GENET BIOL, V46, P615, DOI 10.1016/j.fgb.2009.04.006; Hu R, 2010, BMC PLANT BIOL, V15, P145; Jensen MK, 2010, BIOCHEM J, V426, P183, DOI 10.1042/BJ20091234; Kawasaki T, 2006, P NATL ACAD SCI USA, V103, P230, DOI 10.1073/pnas.0509875103; KEEN NT, 1979, PHYSIOL PLANT PATHOL, V14, P265, DOI 10.1016/0048-4059(79)90048-1; Lauvergeat V, 2001, PHYTOCHEMISTRY, V57, P1187, DOI 10.1016/S0031-9422(01)00053-X; Lieberherr D, 2003, PLANT CELL PHYSIOL, V44, P750, DOI 10.1093/pcp/pcg093; Marra R, 2006, APPL ENVIRON MICROB, V65, P1061; Marsolais F, 2010, J PROTEOMICS, V73, P1587, DOI 10.1016/j.jprot.2010.03.013; Martinez-Medina A, 2011, PHYTOCHEMISTRY, V72, P223, DOI 10.1016/j.phytochem.2010.11.008; Melech-Bonfil S, 2010, PLANT J, V64, P379, DOI 10.1111/j.1365-313X.2010.04333.x; Monteiro VN, 2010, CURR MICROBIOL, V61, P298, DOI 10.1007/s00284-010-9611-8; Montero-Barrientos M, 2011, APPL ENVIRON MICROB, V77, P3009, DOI 10.1128/AEM.02486-10; Moran-Diez E, 2009, MOL PLANT MICROBE IN, V22, P1021, DOI 10.1094/MPMI-22-8-1021; Mukherjee AK, 2010, J PROTEOMICS, V73, P709, DOI 10.1016/j.jprot.2009.10.005; Natarajan S, 2005, ANAL BIOCHEM, V342, P214, DOI 10.1016/j.ab.2005.04.046; Oh SK, 2005, PLANTA, V222, P876, DOI 10.1007/s00425-005-0030-1; Paba J, 2004, J PROTEOME RES, V3, P517, DOI 10.1021/pr034075o; Palmieri MC, 2012, J EXP BOT, V63, P6237, DOI 10.1093/jxb/ers279; Perazzolli M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-660; Punja ZK, 2003, TRENDS BIOTECHNOL, V21, P400, DOI 10.1016/S0167-7799(03)00193-8; Qualhato TF, 2013, BIOTECHNOL LETT, V35, P1461, DOI 10.1007/s10529-013-1225-3; Rate DN, 2001, PLANT J, V27, P203, DOI 10.1046/j.0960-7412.2001.1075umedoc.x; Shibu MA, 2012, J AGR FOOD CHEM, V60, P10723, DOI 10.1021/jf3025634; Shoresh M, 2005, PHYTOPATHOLOGY, V95, P76, DOI 10.1094/PHYTO-95-0076; Shoresh M, 2008, PLANT PHYSIOL, V147, P2147, DOI 10.1104/pp.108.123810; Shoresh M, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-136; Silva OF, 2011, DADOS CONJUNTURA PRO; Smith AMO, 2004, J BIOL CHEM, V279, P51944, DOI 10.1074/jbc.M408920200; Sun LJ, 2010, MOL PLANT MICROBE IN, V23, P1470, DOI 10.1094/MPMI-01-10-0029; Toledo-Souza ED, 2009, PESQUI AGROPECU TROP, V39, P13; Torres AR, 2009, BRAZ J MICROBIOL, V40, P852, DOI 10.1590/S1517-838220090004000016; Tucci M, 2011, MOL PLANT PATHOL, V12, P341, DOI 10.1111/j.1364-3703.2010.00674.x; Vallad G, 2001, THEOR APPL GENET, V103, P1046, DOI 10.1007/s001220100705; Valledor L, 2008, J PROTEOME RES, V7, P2616, DOI 10.1021/pr7006285; Vargas WA, 2009, PLANT PHYSIOL, V151, P792, DOI 10.1104/pp.109.141291; Wang XH, 2006, CHIN J CHROMATOGR, V24, P486; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Wegulo SN, 2005, CAN J PLANT SCI, V85, P749, DOI 10.4141/P04-076; Xiao S, 2011, PLANT PHYSIOL, V156, P2069, DOI 10.1104/pp.111.176933; Xiao S, 2011, PROG LIPID RES, V50, P141, DOI 10.1016/j.plipres.2010.11.002; Xiao S, 2009, PLANT PHYSIOL BIOCH, V47, P479, DOI 10.1016/j.plaphy.2008.12.002; Yedidia I, 2003, APPL ENVIRON MICROB, V69, P7343, DOI 10.1128/AEM.69.12.7343-7353.2003; Yedidia I, 1999, APPL ENVIRON MICROB, V65, P1061; Yoshioka Y, 2012, PEST MANAG SCI, V68, P60, DOI 10.1002/ps.2220; [No title captured]	64	33	35	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98234	10.1371/journal.pone.0098234	http://dx.doi.org/10.1371/journal.pone.0098234			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878929	Green Submitted, gold, Green Published			2022-12-25	WOS:000338101500041
J	Azhar, A; El-Bassossy, HM				Azhar, Ahmad; El-Bassossy, Hany M.			Pentoxifylline Alleviates Cardiac Ischemia and Dysfunction Following Experimental Angina in Insulin Resistance	PLOS ONE			English	Article							INHIBITOR; RESPONSES; MODELS; ACID	We have previously shown that pentoxifylline (PTX) protects from vascular complications associated with insulin resistance (IR). Here, we investigated the protective effect of PTX against cardiac ischemia and dysfunction following experimental angina in IR. IR, along with its accompanying cardiac dysfunction, was induced in rats by a high-fructose (10% in drinking water) high-fat diet for 12 weeks. PTX was administered daily (30 mu g.kg(-1)) during the last 4 weeks of the study. Experimental angina was induced by isoproterenol (10 mu g.kg(-1)) administered by intravenous injection. Both before (baseline) and after the experimental angina, cardiac contractility was assessed by continuous recording in anesthetized rats via a microtip catheter inserted in the left ventricle, and cardiac conductivity was determined by a surface electrocardiograph. Serum glucose, insulin, tumor necrosis factor-alpha (TNF alpha), and adiponectin levels and lipid profile were also determined. Feeding the rats a high-fructose high-fat diet produced IR, as evidenced by significant hyperinsulinemia and hyperglycemia, and PTX administration did not affect this IR. When subjected to experimental angina, IR hearts were less resistant to the ischemia following induction of angina (reflected by the large ST height depression) compared with controls, and PTX completely prevented the excessive ST height depression in IR animals. In addition, left ventricular pressure development was largely attenuated during and after induction of angina in IR animals compared with controls. PTX administration prevented the excessive attenuation in ventricular pressure development in IR animals. IR was associated with elevated levels of the inflammatory cytokine TNF alpha, whereas PTX treatment elevated the serum level of the anti-inflammatory cytokine adiponectin. PTX alleviates cardiac ischemia and dysfunction following experimental angina in IR directly through inhibition of the low-grade inflammation that accompanies IR.	[Azhar, Ahmad] King Abdulaziz Univ, Dept Pediat, Fac Med, Jeddah 21413, Saudi Arabia; [El-Bassossy, Hany M.] King Abdulaziz Univ, Dept Pharmacol, Fac Pharm, Jeddah 21413, Saudi Arabia; [El-Bassossy, Hany M.] Zagazig Univ, Fac Pharm, Dept Pharmacol, Zagazig, Egypt	King Abdulaziz University; King Abdulaziz University; Egyptian Knowledge Bank (EKB); Zagazig University	Azhar, A (corresponding author), King Abdulaziz Univ, Dept Pediat, Fac Med, Jeddah 21413, Saudi Arabia.	azcardio@hotmail.com	Azhar, Ahmad/K-4257-2013; El-Bassossy, Hany/O-2242-2019; El-Bassossy, Hany M/I-1576-2012	El-Bassossy, Hany/0000-0002-6838-6945; El-Bassossy, Hany M/0000-0002-6838-6945	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [45-140-1433]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant No. (45-140-1433). The authors, therefore, acknowledge with thanks DSR technical and financial support. DSR did not have any role in in study design; in the collection, analysis or interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Busija DW, 2006, ANTIOXID REDOX SIGN, V8, P1131, DOI 10.1089/ars.2006.8.1131; Chen H, 2006, PHARMACOL RES, V53, P469, DOI 10.1016/j.phrs.2006.03.003; DeFronzo RA, 1996, J DIABETES COMPLICAT, V10, P243, DOI 10.1016/1056-8727(96)00046-3; DHURANDH.RW, 1972, AM J CARDIOL, V30, P902, DOI 10.1016/0002-9149(72)90018-5; El-Bassossy HM, 2011, N-S ARCH PHARMACOL, V384, P277, DOI 10.1007/s00210-011-0669-z; FIELD KJ, 1993, LAB ANIM, V27, P258, DOI 10.1258/002367793780745471; Loganathan R, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-7; Mahmoud MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063784; Marks JB, 2000, J DIABETES COMPLICAT, V14, P108, DOI 10.1016/S1056-8727(00)00065-9; Maslov LN, 2006, B EXP BIOL MED+, V142, P557, DOI 10.1007/s10517-006-0417-4; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; MORI T, 1995, BRIT J PHARMACOL, V116, P1668, DOI 10.1111/j.1476-5381.1995.tb16389.x; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Osadchii O, 2005, EUR J PHARMACOL, V514, P201, DOI 10.1016/j.ejphar.2005.03.022; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Radovits T, 2009, BRIT J PHARMACOL, V156, P909, DOI 10.1111/j.1476-5381.2008.00098.x; Radovits T, 2009, AM J PHYSIOL-HEART C, V297, pH125, DOI 10.1152/ajpheart.00165.2009; RASKIN P, 1994, J DIABETES COMPLICAT, V8, P195, DOI 10.1016/1056-8727(94)90043-4; Robinson DA, 1996, J SURG RES, V66, P51, DOI 10.1006/jsre.1996.0371; Schafer S, 2006, EUR J HEART FAIL, V8, P2, DOI 10.1016/j.ejheart.2005.04.011; SEIFFGE D, 1984, IRCS MED SCI-BIOCHEM, V12, P91; Shaw SM, 2009, EUR J HEART FAIL, V11, P113, DOI 10.1093/eurjhf/hfn040; Soliman EZ, 2011, HEART, V97, P1597, DOI 10.1136/hrt.2010.215871; Williams IL, 2003, BRIT J DIABETES VASC, V3, P18; Yamamoto S, 2000, JPN J PHARMACOL, V84, P196, DOI 10.1254/jjp.84.196; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yasue H, 1983, CIRC RES, V52, pI; Zhang Ming, 2008, Zhongguo Yaolixue Tongbao, V24, P937	28	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98281	10.1371/journal.pone.0098281	http://dx.doi.org/10.1371/journal.pone.0098281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874295	Green Published, gold, Green Submitted			2022-12-25	WOS:000336790800031
J	Rodrigues-Sousa, T; Ladeirinha, AF; Santiago, AR; Carvalheiro, H; Raposo, B; Alarcao, A; Cabrita, A; Holmdahl, R; Carvalho, L; Souto-Carneiro, MM				Rodrigues-Sousa, Tiago; Ladeirinha, Ana Filipa; Santiago, Ana Raquel; Carvalheiro, Helena; Raposo, Bruno; Alarcao, Ana; Cabrita, Antonio; Holmdahl, Rikard; Carvalho, Lina; Margarida Souto-Carneiro, M.			Deficient Production of Reactive Oxygen Species Leads to Severe Chronic DSS-Induced Colitis in Ncf1/p47(phox)-Mutant Mice	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SODIUM-SULFATE; REGULATORY T-CELLS; INTESTINAL INFLAMMATION; NITRIC-OXIDE; ULCERATIVE-COLITIS; DENDRITIC CELLS; CROHNS-DISEASE; MACROPHAGES	Background: Colitis is a common clinical complication in chronic granulomatous disease (CGD), a primary immunodeficiency caused by impaired oxidative burst. Existing experimental data from NADPH-oxidase knockout mice propose contradictory roles for the involvement of reactive oxygen species in colitis chronicity and severity. Since genetically controlled mice with a point-mutation in the Ncf1 gene are susceptible to chronic inflammation and autoimmunity, we tested whether they presented increased predisposition to develop chronic colitis. Methods: Colitis was induced in Ncf1-mutant and wild-type mice by a 1st 7-days cycle of dextran sulfate sodium (DSS), intercalated by a 7-days resting period followed by a 2nd 7-days DSS-cycle. Cytokines were quantified locally in the colon inflammatory infiltrates and in the serum. Leukocyte infiltration and morphological alterations of the colon mucosa were assessed by immunohistochemistry. Results: Clinical scores demonstrated a more severe colitis in Ncf1-mutant mice than controls, with no recovery during the resting period and a severe chronic colitis after the 2nd cycle, confirmed by histopathology and presence of infiltrating neutrophils, macrophages, plasmocytes and lymphocytes in the colon. Severe colitis was mediated by increased local expression of cytokines (IL-6, IL-10, TNF-alpha, IFN-gamma and IL-17A) and phosphorylation of Leucine-rich repeat kinase 2 (LRRK2). Serological cytokine titers of those inflammatory cytokines were more elevated in Ncf1-mutant than control mice, and were accompanied by systemic changes in functional subsets of monocytes, CD4(+)T and B cells. Conclusion: This suggests that an ineffective oxidative burst leads to severe chronic colitis through local accumulation of peroxynitrites, pro-inflammatory cytokines and lymphocytes and systemic immune deregulation similar to CGD.	[Rodrigues-Sousa, Tiago; Carvalheiro, Helena; Margarida Souto-Carneiro, M.] Univ Coimbra, CNC Ctr Neurociencias & Biol Celular, ImmunoMetabol Pharmacol Grp, Coimbra, Portugal; [Ladeirinha, Ana Filipa; Alarcao, Ana; Carvalho, Lina] Univ Coimbra, Fac Med, Dept Anat Patol, Coimbra, Portugal; [Santiago, Ana Raquel] Univ Coimbra, Fac Med, Inst Biomed Invest Luz & Imagem, Coimbra, Portugal; [Raposo, Bruno; Holmdahl, Rikard] Karolinska Inst, Stockholm, Sweden; [Cabrita, Antonio] Univ Coimbra, Fac Med, Dept Patol Expt, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Karolinska Institutet; Universidade de Coimbra	Souto-Carneiro, MM (corresponding author), Univ Coimbra, CNC Ctr Neurociencias & Biol Celular, ImmunoMetabol Pharmacol Grp, Coimbra, Portugal.	margarida.carneiro@cnc.uc.pt	Souto-Carneiro, Margarida/C-4386-2016; Raposo, Bruno RA/C-5265-2013; Holmdahl, Rikard/AAI-7682-2020; Carvalho, Lina/AAC-6810-2020; Santiago, Ana Raquel/I-6566-2013; Carvalheiro, Helena/N-2179-2014	Souto-Carneiro, Margarida/0000-0001-6923-0590; Carvalho, Lina/0000-0001-8349-4488; Santiago, Ana Raquel/0000-0002-7541-7041; Carvalheiro, Helena/0000-0003-0698-818X; Cabrita, Antonio/0000-0001-5165-5849; Rodrigues de Sousa, Tiago Joao/0000-0003-0355-5944	Fundacao para a Ciencia e Tecnologia [SFRH/BD/60467/2009]; Marie Curie grant [PERG-GA-2008-239422]; Swedish Research Council; EU; FEDER/COMPETE/Fundacao para a Ciencia e Tecnologia [Pest/C-SAU/LA0001/2013-2014]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Marie Curie grant(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); EU(European Commission); FEDER/COMPETE/Fundacao para a Ciencia e Tecnologia	H. Carvalheiro was funded by Fundacao para a Ciencia e Tecnologia grant SFRH/BD/60467/2009. This work was funded by the Marie Curie grant PERG-GA-2008-239422 to M. M. Souto-Carneiro, by the Swedish Research Council and the EU FP7 project Neurinox to R. Holmdahl and by the FEDER/COMPETE/Fundacao para a Ciencia e Tecnologia project Pest/C-SAU/LA0001/2013-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Bao SS, 2011, IMMUNOL CELL BIOL, V89, P853, DOI 10.1038/icb.2011.4; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bento AF, 2012, BIOCH PHARM; Bleesing JJ, 2006, J IMMUNOL, V176, P7096, DOI 10.4049/jimmunol.176.11.7096; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Conway KL, 2012, J IMMUNOL, V189, P3631, DOI 10.4049/jimmunol.1103746; COOPER HS, 1993, LAB INVEST, V69, P238; D'Angelo C, 2009, J IMMUNOL, V183, P4609, DOI 10.4049/jimmunol.0900345; Deffert C, 2012, J PATHOLOGY; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Elso CM, 2004, GENES IMMUN, V5, P93, DOI 10.1038/sj.gene.6364042; Falcone EL, 2012, CURR OPIN INFECT DIS; Fernandez-Boyanapalli R, 2010, J IMMUNOL, V185, P4030, DOI 10.4049/jimmunol.1001778; Gelderman KA, 2007, J CLIN INVEST, V117, P3020, DOI 10.1172/JCI31935; Gelderman KA, 2006, P NATL ACAD SCI USA, V103, P12831, DOI 10.1073/pnas.0604571103; Hall LJ, 2011, DIGEST DIS SCI, V56, P79, DOI 10.1007/s10620-010-1240-3; Hosomi S, 2011, CLIN EXP IMMUNOL, V163, P215, DOI 10.1111/j.1365-2249.2010.04290.x; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Krieglstein CF, 2001, J EXP MED, V194, P1207, DOI 10.1084/jem.194.9.1207; Lewis CJ, 2011, EUR J IMMUNOL, V41, P2562, DOI 10.1002/eji.201141396; Liu S, 2009, INFLAMM BOWEL DIS, V15, P1213, DOI 10.1002/ibd.20890; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mori M, 2005, AM J PHYSIOL-GASTR L, V289, pG1024, DOI 10.1152/ajpgi.00247.2005; Naito Y, 2004, INT J MOL MED, V14, P191; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Pizzolla A, 2012, J IMMUNOL, V188, P5003, DOI 10.4049/jimmunol.1103430; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Schappi MG, 2003, J PEDIATR GASTR NUTR, V36, P623, DOI 10.1097/00005176-200305000-00006; Shih TC, 2008, WORLD J GASTROENTERO, V14, P1759, DOI 10.3748/wjg.14.1759; Smeekens SP, 2012, J INTERF CYTOK RES, V32, P159, DOI 10.1089/jir.2011.0046; Talero E, 2011, INFLAMM BOWEL DIS, V17, P696, DOI 10.1002/ibd.21420; Vasilevsky S, 2011, AM J PATHOL, V178, P2774, DOI 10.1016/j.ajpath.2011.02.038; Weigmann B, 2008, J EXP MED, V205, P2099, DOI 10.1084/jem.20072484; Yang JJ, 2013, J EXP MED, V210, P1447, DOI 10.1084/jem.20122494; Yasukawa K, 2012, FREE RADICAL RES, V46, P1427, DOI 10.3109/10715762.2012.732698; Yu JE, 2011, CLIN IMMUNOL, V138, P14, DOI 10.1016/j.clim.2010.08.003	41	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97532	10.1371/journal.pone.0097532	http://dx.doi.org/10.1371/journal.pone.0097532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24873968	Green Submitted, Green Published, gold			2022-12-25	WOS:000336790800008
J	Jones, EA; Kananurak, A; Bevins, CL; Hollox, EJ; Bakaletz, LO				Jones, Eric A.; Kananurak, Anchasa; Bevins, Charles L.; Hollox, Edward J.; Bakaletz, Lauren O.			Copy Number Variation of the Beta Defensin Gene Cluster on Chromosome 8p Influences the Bacterial Microbiota within the Nasopharynx of Otitis-Prone Children	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; TYMPANOSTOMY TUBES; MEDIA; COLONIZATION; EXPRESSION; BETA-DEFENSIN-2; DISEASE; POLYMORPHISMS; ASSOCIATIONS; EFFUSION	As there is increasing evidence that aberrant defensin expression is related to susceptibility for infectious disease and inflammatory disorders, we sought to determine if copy number of the beta-defensin gene cluster located on chromosome 8p23.1 (DEFB107, 106, 105, 104, 103, DEFB4 and SPAG11), that shows copy number variation as a block, was associated with susceptibility to otitis media (OM). The gene DEFB103 within this complex encodes human beta defensin-3 (hBD-3), an antimicrobial peptide (AP) expressed by epithelial cells that line the mammalian airway, important for defense of mucosal surfaces and previously shown to have bactericidal activity in vitro against multiple human pathogens, including the three that predominate in OM. To this end, we conducted a retrospective case-control study of 113 OM prone children and 267 controls aged five to sixty months. We identified the copy number of the above defined beta-defensin gene cluster (DEFB-CN) in each study subject by paralogue ratio assays. The mean DEFB-CN was indistinguishable between subjects classified as OM prone based on a recent history of multiple episodes of OM and control subjects who had no history of OM (4.4 +/- 0.96 versus 4.4 +/- 1.08, respectively: Odds Ratio [OR]: 1.16 (95% CI: 0.61, 2.20). Despite a lack of direct association, we observed a statistically significant correlation between DEFB-CN and nasopharyngeal bacterial colonization patterns. Collectively, our findings suggested that susceptibility to OM might be mediated by genetic variation among individuals, wherein a DEFB-CN less than 4 exerts a marked influence on the microbiota of the nasopharynx, specifically with regard to colonization by the three predominant bacterial pathogens of OM.	[Jones, Eric A.; Bakaletz, Lauren O.] Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Ctr Microbial Pathogenesis,Dept Pediat,Res Inst, Columbus, OH 43210 USA; [Kananurak, Anchasa; Bevins, Charles L.] Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA; [Hollox, Edward J.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of California System; University of California Davis; University of Leicester	Bakaletz, LO (corresponding author), Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Ctr Microbial Pathogenesis,Dept Pediat,Res Inst, Columbus, OH 43210 USA.	Lauren.Bakaletz@NationwideChildrens.org	Bevins, Charles L/P-4438-2015; Bakaletz, Lauren/GMW-8490-2022	Bevins, Charles L/0000-0003-2725-2622; Hollox, Edward/0000-0002-0115-2298	National Institutes of Health [R01 DC005847, R01 DC003915, N01-AI-30040]; Medical Research Council [GO801123]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032738, N01AI030040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003915, R01DC005847] Funding Source: NIH RePORTER; Medical Research Council [G0801123] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the National Institutes of Health (www.nih.gov), R01 DC005847 and R01 DC003915 to LOB, subcontract on N01-AI-30040 to LOB and Medical Research Council (www.mrc.ac.uk/index.htm) New Investigator Grant, GO801123 to EJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Bakar S, 2009, P NATL ACAD SCI USA, V106, P853, DOI 10.1073/pnas.0809073106; Aldhous MC, 2010, HUM MOL GENET, V19, P4930, DOI 10.1093/hmg/ddq411; Alsarraf R, 1999, ARCH OTOLARYNGOL, V125, P12, DOI 10.1001/archotol.125.1.12; Armbruster CE, 2010, MBIO, V1, DOI 10.1128/mBio.00102-10; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; BALDWIN RL, 1993, AM J OTOL, V14, P601; Bentley RW, 2010, AM J GASTROENTEROL, V105, P354, DOI 10.1038/ajg.2009.582; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Boruk M, 2007, OTOLARYNG HEAD NECK, V136, P159, DOI 10.1016/j.otohns.2006.09.005; BRIGHT RA, 1993, AM J PUBLIC HEALTH, V83, P1026, DOI 10.2105/AJPH.83.7.1026; Cantsilieris S, 2013, HUM MUTAT, V34, P1, DOI 10.1002/humu.22172; Casey JR, 2010, PEDIATR INFECT DIS J, V29, P304, DOI 10.1097/INF.0b013e3181c1bc48; Casselbrant ML, 2005, CURR OPIN ALLERGY CL, V5, P1, DOI 10.1097/00130832-200502000-00002; Emonts M, 2007, PEDIATRICS, V120, P814, DOI 10.1542/peds.2007-0524; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; FADEN H, 1991, ANN OTO RHINOL LARYN, V100, P612, DOI 10.1177/000348949110000802; Faden H, 2001, EUR J PEDIATR, V160, P407, DOI 10.1007/s004310100754; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Fernandez-Jimenez N, 2010, HUM IMMUNOL, V71, P833, DOI 10.1016/j.humimm.2010.05.012; Fode P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016768; Fujimori I, 1996, EUR ARCH OTO-RHINO-L, V253, P260; Ganz T, 2005, COMB CHEM HIGH T SCR, V8, P209, DOI 10.2174/1386207053764594; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Hafren L, 2012, INT J PEDIATR OTORHI, V76, P41, DOI 10.1016/j.ijporl.2011.09.026; Haggard M, 2008, VACCINE, V26, pG20, DOI 10.1016/j.vaccine.2008.11.009; Hollox EJ, 2008, CYTOGENET GENOME RES, V123, P148, DOI 10.1159/000184702; Ilia S, 2008, PEDIATR INFECT DIS J, V27, P929, DOI 10.1097/INF.0b013e318174e0b0; Jansen PAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004725; Janssens W, 2010, AM J RESP CRIT CARE, V182, P163, DOI 10.1164/rccm.200905-0767OC; Jenke ACW, 2012, PEDIATR RES, V72, P513, DOI 10.1038/pr.2012.110; Jones EA, 2013, J INNATE IMMUN, V5, P24, DOI 10.1159/000339961; Kaplan B, 1997, PEDIATR INFECT DIS J, V16, pS9, DOI 10.1097/00006454-199702001-00003; LEACH AJ, 1994, PEDIATR INFECT DIS J, V13, P983, DOI 10.1097/00006454-199411000-00009; Lee HY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-87; Lee HY, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-12; Lysenko ES, 2005, PLOS PATHOG, V1, P3, DOI 10.1371/journal.ppat.0010001; Marom T, 2012, CURR ALLERGY ASTHM R, V12, P551, DOI 10.1007/s11882-012-0303-2; McGillivary G, 2009, CELL MICROBIOL, V11, P1399, DOI 10.1111/j.1462-5822.2009.01339.x; Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226; Pettigrew MM, 2008, EMERG INFECT DIS, V14, P1584, DOI 10.3201/eid1410.080119; Pettigrew MM, 2012, APPL ENVIRON MICROB, V78, P6262, DOI 10.1128/AEM.01051-12; Revai K, 2008, CLIN INFECT DIS, V46, pE34, DOI 10.1086/525856; Rosenfeld RM, 2013, OTOLARYNG HEAD NECK, V149, pS1, DOI 10.1177/0194599813487302; Rovers MM, 2008, VACCINE, V26, pG2, DOI 10.1016/j.vaccine.2008.11.005; Rye MS, 2011, MAMM GENOME, V22, P66, DOI 10.1007/s00335-010-9295-1; Sassen ML, 1997, AM J OTOLARYNG, V18, P324, DOI 10.1016/S0196-0709(97)90027-2; Shin DJ, 2006, ACTA OTO-LARYNGOL, V126, P1040, DOI 10.1080/00016480600672626; Short KR, 2011, J INFECT DIS, V204, P1857, DOI 10.1093/infdis/jir618; Taudien Stefan, 2012, BMC Res Notes, V5, P629, DOI 10.1186/1756-0500-5-629; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Underwood MA, 2010, PEDIATRICS, V125, P1237, DOI 10.1542/peds.2009-3289; Wain LV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084192; WILLIAMS RL, 1993, JAMA-J AM MED ASSOC, V270, P1344, DOI 10.1001/jama.270.11.1344	53	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98269	10.1371/journal.pone.0098269	http://dx.doi.org/10.1371/journal.pone.0098269			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867293	Green Published, Green Submitted, gold			2022-12-25	WOS:000336914100043
J	Chen, B; Zhao, L; Li, X; Ji, YS; Li, N; Xu, XF; Chen, ZY				Chen, Bing; Zhao, Ling; Li, Xian; Ji, Yun-Song; Li, Na; Xu, Xu-Feng; Chen, Zhe-Yu			Syntaxin 8 Modulates the Post-synthetic Trafficking of the TrkA Receptor and Inflammatory Pain Transmission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NEUROTROPHIN RECEPTORS; NOCICEPTIVE NEURONS; GENE-TRANSFER; SURVIVAL; NGF; LOCALIZATION; EXPRESSION; ENDOSOMES; ROLES	Nerve growth factor (NGF) promotes the survival, maintenance, and neurite outgrowth of sensory and sympathetic neurons, and the effects are mediated by TrkA receptor signaling. Thus, the cell surface location of the TrkA receptor is crucial for NGF-mediated functions. However, the regulatory mechanism underlying TrkA cell surface levels remains incompletely understood. In this study, we identified syntaxin 8 (STX8), a Q-SNARE protein, as a novel TrkA-binding protein. Overexpression and knockdown studies showed that STX8 facilitates TrkA transport from the Golgi to the plasma membrane and regulates the surface levels of TrkA but not TrkB receptors. Furthermore, STX8 modulates downstream NGF-induced TrkA signaling and, consequently, the survival of NGF-dependent dorsal root ganglia neurons. Finally, knockdown of STX8 in rat dorsal root ganglia by recombinant adeno-associated virus serotype 6-mediated RNA interference led to analgesic effects on formalin-induced inflammatory pain. These findings demonstrate that STX8 is a modulator of TrkA cell surface levels and biological functions.	[Chen, Bing; Zhao, Ling; Li, Xian; Ji, Yun-Song; Li, Na; Xu, Xu-Feng; Chen, Zhe-Yu] Shandong Univ, Sch Med, Dept Neurobiol, Shandong Prov Key Lab Mental Disorders, Jinan 250012, Shandong, Peoples R China	Shandong University	Chen, ZY (corresponding author), Shandong Univ, Sch Med, Dept Neurobiol, Shandong Prov Key Lab Mental Disorders, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	zheyuchen@sdu.edu.cn			National 973 Basic Research Program of China [2012CB911000, 2010CB912004]; National Natural Science Foundation of China [31130026, 31101027]; State Program of National Natural Science Foundation of China for Innovative Research Group [81321061]; Foundation for Excellent Young Scientist of Shandong Province [BS2010SW023]	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Program of National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); Foundation for Excellent Young Scientist of Shandong Province	This work was supported by National 973 Basic Research Program of China Grants 2012CB911000 and 2010CB912004, National Natural Science Foundation of China Grants 31130026 and 31101027, the State Program of National Natural Science Foundation of China for Innovative Research Group Grant 81321061, and the Foundation for Excellent Young Scientist of Shandong Province Grant BS2010SW023.	Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; AVERILL S, 1995, EUR J NEUROSCI, V7, P1484, DOI 10.1111/j.1460-9568.1995.tb01143.x; Bilan F, 2004, J CELL SCI, V117, P1923, DOI 10.1242/jcs.01070; Bodmer D, 2011, NEURON, V70, P1085, DOI 10.1016/j.neuron.2011.04.025; Chao M, 1998, BRAIN RES REV, V26, P295, DOI 10.1016/S0165-0173(97)00036-2; Chen ZY, 2005, MOL BIOL CELL, V16, P5761, DOI 10.1091/mbc.E05-07-0651; Fang X, 2005, J NEUROSCI, V25, P4868, DOI 10.1523/JNEUROSCI.0249-05.2005; Gee HY, 2010, J BIOL CHEM, V285, P35519, DOI 10.1074/jbc.M110.162438; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang SH, 2009, J BIOL CHEM, V284, P15126, DOI 10.1074/jbc.M809763200; Jacques SJ, 2012, MOL CELL NEUROSCI, V49, P464, DOI 10.1016/j.mcn.2012.03.002; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; Ma WY, 2010, J PHARMACOL SCI, V114, P79, DOI 10.1254/jphs.10119FP; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Manickam V, 2011, BLOOD, V117, P1425, DOI 10.1182/blood-2010-06-291690; Mantyh PW, 2011, ANESTHESIOLOGY, V115, P189, DOI 10.1097/ALN.0b013e31821b1ac5; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MU XJ, 1993, J NEUROSCI, V13, P4029; NAKAGAWARA A, 1995, GENOMICS, V25, P538, DOI 10.1016/0888-7543(95)80055-Q; Prekeris R, 1999, MOL BIOL CELL, V10, P3891, DOI 10.1091/mbc.10.11.3891; Saxena S, 2005, MOL CELL NEUROSCI, V28, P571, DOI 10.1016/j.mcn.2004.11.011; Selak S, 2009, NEURON, V63, P357, DOI 10.1016/j.neuron.2009.07.017; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Subramaniam VN, 2000, J CELL SCI, V113, P997; Teng FYH, 2001, GENOME BIOL, V2; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Towne C, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-52; Ugolini G, 2007, P NATL ACAD SCI USA, V104, P2985, DOI 10.1073/pnas.0611253104; Ulrich E, 1998, ONCOGENE, V16, P825, DOI 10.1038/sj.onc.1201842; Valdez G, 2005, J NEUROSCI, V25, P5236, DOI 10.1523/JNEUROSCI.5104-04.2005; Vulchanova L, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-31; Wan J, 2008, J NEUROSCI, V28, P9002, DOI 10.1523/JNEUROSCI.0767-08.2008; Watson JJ, 2006, J PHARMACOL EXP THER, V316, P1122, DOI 10.1124/jpet.105.095844; White FA, 1996, J NEUROSCI, V16, P4662; Wright KM, 2007, CELL DEATH DIFFER, V14, P625, DOI 10.1038/sj.cdd.4402024; Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6; Yu T, 2011, TRAFFIC, V12, P521, DOI 10.1111/j.1600-0854.2010.01156.x; Zhang Y, 2009, J BIOL CHEM, V284, P12469, DOI 10.1074/jbc.M809214200; Zhao L, 2009, J CELL SCI, V122, P3123, DOI 10.1242/jcs.047712	43	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19556	19569		10.1074/jbc.M114.567925	http://dx.doi.org/10.1074/jbc.M114.567925			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24872407	Green Published, hybrid			2022-12-25	WOS:000339326800030
J	Chandhok, G; Schmitt, N; Sauer, V; Aggarwal, A; Bhatt, M; Schmidt, HHJ				Chandhok, Gursimran; Schmitt, Nadine; Sauer, Vanessa; Aggarwal, Annu; Bhatt, Mohit; Schmidt, Hartmut H. J.			The Effect of Zinc and D-Penicillamine in a Stable Human Hepatoma ATP7B Knockout Cell Line	PLOS ONE			English	Article							WILSON-DISEASE GENE; COPPER-TRANSPORTING ATPASE; EVANS-CINNAMON RATS; HEPG2 CELLS; LEC RATS; FUNCTIONAL-PROPERTIES; METALLOTHIONEIN; EXPRESSION; INDUCTION; HEPATITIS	Mutations in the copper (Cu) transporter gene ATP7B, the primary cause of Wilson disease (WD), result in high liver Cu and death of hepatocytes. Cu chelators and zinc salts are the two most important drugs used in the treatment of WD patients; however, the molecular mechanisms of the drugs with regard to ATP7B expression have not been determined. A targeted knockout of ATP7B (KO) was established in the most widely used human hepatoma cell line, HepG2 for molecular studies of the pathogenesis and treatment of the disease. KO cells showed similar growth, Cu uptake, release, and gene expression as compared to parental cells. However, in the presence of Cu, morphological changes, oxidative stress, apoptosis, and loss of viability were observed. Induction of metallothionein (MT1X) after Cu exposure was significantly reduced in KO cells. Following zinc treatment, MT1X expression was strongly induced and a high percentage of KO cells could be rescued from Cu induced toxicity. D-penicillamine treatment had a minor effect on the viability of KO cells whereas the parental cell line showed a pronounced improvement. Combined treatment displayed a highly synergistic effect in KO cells. The data suggest that zinc has a previously unrecognized effect on the viability of hepatocytes that lack ATP7B due to a high induction of MT1X expression that compensates low gene expression after Cu exposure. A combination therapy that simultaneously targets at MT1X induction and Cu chelation improves the overall survival of hepatocytes for most efficient therapy of patients having WD.	[Chandhok, Gursimran; Schmitt, Nadine; Sauer, Vanessa; Schmidt, Hartmut H. J.] Munster Univ Hosp, Clin Transplantat Med, Munster, Germany; [Chandhok, Gursimran; Aggarwal, Annu; Bhatt, Mohit] Kokilaben Dhirubhai Ambani Hosp & Med Res Inst, Wilson Dis Clin, Mumbai, Maharashtra, India	University of Munster	Schmidt, HHJ (corresponding author), Munster Univ Hosp, Clin Transplantat Med, Munster, Germany.	hepar@ukmuenster.de		Bhatt, Mohit/0000-0002-5233-3371	European Commission [247506]	European Commission(European CommissionEuropean Commission Joint Research Centre)	GC was partly funded by European Commission (WilsonIndia project 247506). All the other funding was from internal sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal A, INT REV NEU IN PRESS, V110, P313; Aggarwal A, 2013, ANN HUM GENET, V77, P299, DOI 10.1111/ahg.12024; Brewer GJ, 2005, J HEPATOL, V42, pS13, DOI 10.1016/j.jhep.2004.11.013; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Cater MA, 2006, GASTROENTEROLOGY, V130, P493, DOI 10.1053/j.gastro.2005.10.054; Delangle P, 2012, DALTON T, V41, P6359, DOI 10.1039/c2dt12188c; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; Ferenci P, 2006, HUM GENET, V120, P151, DOI 10.1007/s00439-006-0202-5; Forbes JR, 1998, AM J HUM GENET, V63, P1663, DOI 10.1086/302163; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Graham John M, 2002, ScientificWorldJournal, V2, P1638; Gupte A, 2007, FREE RADICAL BIO MED, V43, P1271, DOI 10.1016/j.freeradbiomed.2007.07.003; HEILMAIER HE, 1986, TOXICOLOGY, V42, P23, DOI 10.1016/0300-483X(86)90089-2; HOOGENRAAD TU, 1979, EUR NEUROL, V18, P205, DOI 10.1159/000115077; Huster D, 2006, AM J PATHOL, V168, P423, DOI 10.2353/ajpath.2006.050312; Huster D, 2003, GASTROENTEROLOGY, V124, P335, DOI 10.1053/gast.2003.50066; Huster D, 2012, GASTROENTEROLOGY, V142, P947, DOI 10.1053/j.gastro.2011.12.048; Jimenez I, 2002, TOXICOL IN VITRO, V16, P167, DOI 10.1016/S0887-2333(01)00117-5; Klein D, 2003, ARCH TOXICOL, V77, P568, DOI 10.1007/s00204-003-0493-4; Lang PA, 2007, NAT MED, V13, P164, DOI 10.1038/nm1539; LODEMANN E, 1981, BIOCHEM BIOPH RES CO, V102, P775, DOI 10.1016/S0006-291X(81)80199-4; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Matsumoto A, 1998, FREE RADICAL RES, V28, P383, DOI 10.3109/10715769809070807; MCQUAID A, 1992, J LAB CLIN MED, V119, P744; Medici V, 2005, LIVER INT, V25, P888, DOI 10.1111/j.1478-3231.2005.01108.x; Nair J, 2005, CARCINOGENESIS, V26, P1307, DOI 10.1093/carcin/bgi073; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Roelofsen H, 2000, GASTROENTEROLOGY, V119, P782, DOI 10.1053/gast.2000.17834; Santon A, 2003, BBA-MOL BASIS DIS, V1637, P91, DOI 10.1016/S0925-4439(02)00218-1; Sauer V, 2010, BIOCHEM BIOPH RES CO, V395, P307, DOI 10.1016/j.bbrc.2010.03.158; SCHEINBERG IH, 1987, LANCET, V2, P95, DOI 10.1016/S0140-6736(87)92753-X; Schilsky M L, 2001, Curr Gastroenterol Rep, V3, P54, DOI 10.1007/s11894-001-0041-4; Schilsky ML, 1998, HEPATOLOGY, V28, P1347, DOI 10.1002/hep.510280525; SCHILSKY ML, 1989, J CLIN INVEST, V84, P1562, DOI 10.1172/JCI114333; Siaj R, 2012, WORLD J GASTROENTERO, V18, P5542, DOI 10.3748/wjg.v18.i39.5542; SOKOL RJ, 1994, GASTROENTEROLOGY, V107, P1788, DOI 10.1016/0016-5085(94)90822-2; Song MO, 2005, MOL CELL BIOCHEM, V279, P141, DOI 10.1007/s11010-005-8286-0; Stapelbroek JM, 2004, J HEPATOL, V41, P758, DOI 10.1016/j.jhep.2004.07.017; STOCKERT RJ, 1986, HEPATOLOGY, V6, P60, DOI 10.1002/hep.1840060112; TANZI RE, 1993, NAT GENET, V5, P344, DOI 10.1038/ng1293-344; Tsivkovskii R, 2002, J BIOL CHEM, V277, P976, DOI 10.1074/jbc.M109368200; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052; Yeh CT, 2005, CARCINOGENESIS, V26, P2138, DOI 10.1093/carcin/bgi185	43	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98809	10.1371/journal.pone.0098809	http://dx.doi.org/10.1371/journal.pone.0098809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892424	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400096
J	Stahli, BE; Yonekawa, K; Altwegg, LA; Wyss, C; Hof, D; Fischbacher, P; Brauchlin, A; Schulthess, G; Krayenbuhl, PA; von Eckardstein, A; Hersberger, M; Neidhart, M; Gay, S; Novopashenny, I; Wolters, R; Frank, M; Wischnewsky, MB; Luscher, TF; Maier, W				Staehli, Barbara Elisabeth; Yonekawa, Keiko; Altwegg, Lukas Andreas; Wyss, Christophe; Hof, Danielle; Fischbacher, Philipp; Brauchlin, Andreas; Schulthess, Georg; Krayenbuehl, Pierre-Alexandre; von Eckardstein, Arnold; Hersberger, Martin; Neidhart, Michel; Gay, Steffen; Novopashenny, Igor; Wolters, Regine; Frank, Michelle; Wischnewsky, Manfred Bernd; Luescher, Thomas Felix; Maier, Willibald			Clinical Criteria Replenish High-Sensitive Troponin and Inflammatory Markers in the Stratification of Patients with Suspected Acute Coronary Syndrome	PLOS ONE			English	Article							NATRIURETIC PEPTIDE LEVELS; ACID-BINDING PROTEIN; TIMI RISK SCORE; MYOCARDIAL-INFARCTION; PROGNOSTIC VALUE; EARLY-DIAGNOSIS; MULTIMARKER APPROACH; PLASMA-PROTEIN; HEART-FAILURE; CHEST-PAIN	Objectives: In patients with suspected acute coronary syndrome (ACS), rapid triage is essential. The aim of this study was to establish a tool for risk prediction of 30-day cardiac events (CE) on admission. 30-day cardiac events (CE) were defined as early coronary revascularization, subsequent myocardial infarction, or cardiovascular death within 30 days. Methods and Results: This single-centre, prospective cohort study included 377 consecutive patients presenting to the emergency department with suspected ACS and for whom troponin T measurements were requested on clinical grounds. Fifteen biomarkers were analyzed in the admission sample, and clinical parameters were assessed by the TIMI risk score for unstable angina/Non-ST myocardial infarction and the GRACE risk score. Sixty-nine (18%) patients presented with and 308 (82%) without ST-elevations, respectively. Coronary angiography was performed in 165 (44%) patients with subsequent percutaneous coronary intervention - accounting for the majority of CE - in 123 (33%) patients, respectively. Eleven out of 15 biomarkers were elevated in patients with CE compared to those without. High-sensitive troponin T (hs-cTnT) was the best univariate biomarker to predict CE in Non-ST-elevation patients (AUC 0.80), but did not yield incremental information above clinical TIMI risk score (AUC 0.80 vs 0.82, p = 0.69). Equivalence testing of AUCs of risk models and non-inferiority testing demonstrated that the clinical TIMI risk score alone was non-inferior to its combination with hs-cTnT in predicting CE. Conclusions: In patients presenting without ST-elevations, identification of those prone to CE is best based on clinical assessment based on TIMI risk score criteria and hs-cTnT.	[Staehli, Barbara Elisabeth; Yonekawa, Keiko; Altwegg, Lukas Andreas; Wyss, Christophe; Brauchlin, Andreas; Frank, Michelle; Luescher, Thomas Felix; Maier, Willibald] Univ Zurich Hosp, Cardiovasc Ctr, Dept Cardiol, CH-8091 Zurich, Switzerland; [Yonekawa, Keiko; Krayenbuehl, Pierre-Alexandre] Univ Zurich Hosp, Div Internal Med, CH-8091 Zurich, Switzerland; [Hof, Danielle; von Eckardstein, Arnold] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; [Fischbacher, Philipp; Schulthess, Georg] Hosp Mannedorf, Dept Internal Med, Mannedorf, Switzerland; [Hersberger, Martin] Univ Zurich, Childrens Hosp, Inst Clin Chem & Biochem, Zurich, Switzerland; [Neidhart, Michel; Gay, Steffen] Univ Zurich Hosp, Ctr Expt Rheumatol, Dept Rheumatol, CH-8091 Zurich, Switzerland; [Novopashenny, Igor; Wolters, Regine; Wischnewsky, Manfred Bernd] Univ Bremen, FB Math & Comp Sci, D-28359 Bremen, Germany	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University Children's Hospital Zurich; University of Zurich; University of Zurich; University Zurich Hospital; University of Bremen	Maier, W (corresponding author), Univ Zurich Hosp, Cardiovasc Ctr, Dept Cardiol, CH-8091 Zurich, Switzerland.	karmaiew@usz.uzh.ch		Hersberger, Martin/0000-0002-4472-329X; Neidhart, Michel/0000-0002-9656-5967	Swiss National Research Foundation [3200B0-112661, 33CM30-1241112/1, 3100-068118.02/1]; Roche Diagnostics GmbH	Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Roche Diagnostics GmbH	This study has partially been supported by grants of the Swiss National Research Foundation (http://www.snf.ch/E/Pages/default.aspx; no. 3200B0-112661, Special Programme University Medicine: Grant Nr 33CM30-1241112/1 and 3100-068118.02/1) and Roche Diagnostics GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Altwegg LA, 2007, EUR HEART J, V28, P941, DOI 10.1093/eurheartj/ehm078; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Bayes-Genis A, 2001, NEW ENGL J MED, V345, P1022, DOI 10.1056/NEJMoa003147; Bijsterveld NR, 2003, J AM COLL CARDIOL, V42, P2083, DOI 10.1016/j.jacc.2003.05.014; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goodacre S, 2005, HEART, V91, P229, DOI 10.1136/hrt.2003.027599; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; HAMM CW, 1992, NEW ENGL J MED, V327, P146, DOI 10.1056/NEJM199207163270302; Healy AM, 2006, CIRCULATION, V113, P2278, DOI 10.1161/CIRCULATIONAHA.105.607333; Hochholzer W, 2011, CLIN CHEM, V57, P1318, DOI 10.1373/clinchem.2011.162073; James SK, 2006, J AM COLL CARDIOL, V48, P1146, DOI 10.1016/j.jacc.2006.05.056; Khan DA, 2011, KOREAN J LAB MED, V31, P172, DOI 10.3343/kjlm.2011.31.3.172; Krauser DG, 2005, AM HEART J, V149, P744, DOI 10.1016/j.ahj.2004.07.010; Mantenti ERF, 2006, CLIN CARDIOL, V29, P405, DOI 10.1002/clc.4960290907; McCann CJ, 2009, AM J CARDIOL, V103, P22, DOI 10.1016/j.amjcard.2008.08.026; Morris AC, 2006, HEART, V92, P1333, DOI 10.1136/hrt.2005.080226; Morrow DA, 2007, CLIN CHEM, V53, P552, DOI 10.1373/clinchem.2006.084194; Oemrawsingh RM, 2011, HEART, V97, P1061, DOI 10.1136/hrt.2010.197392; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; Reichlin T, 2011, CIRCULATION, V124, P136, DOI 10.1161/CIRCULATIONAHA.111.023937; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Sabatine MS, 2002, CIRCULATION, V105, P1760, DOI 10.1161/01.CIR.0000015464.18023.0A; Saunders JT, 2011, CIRCULATION, V123, P1367, DOI 10.1161/CIRCULATIONAHA.110.005264; Schaub N, 2011, CLIN CHEM; Scirica BM, 2002, AM J CARDIOL, V90, P303, DOI 10.1016/S0002-9149(02)02468-2; Seino Y, 2003, AM J MED, V115, P185, DOI 10.1016/S0002-9343(03)00325-5; Shand JA, 2011, HEART, V97, P605, DOI 10.1136/hrt.2011.223404; Tello-Montoliu A, 2007, J INTERN MED, V262, P651, DOI 10.1111/j.1365-2796.2007.01871.x; Thygesen K, 2010, EUR HEART J, V31, P2197, DOI 10.1093/eurheartj/ehq251; Vora Amit N, 2012, J Thromb Thrombolysis, V34, P229, DOI 10.1007/s11239-012-0705-y; Wang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065539; Wang TJ, 2002, AM J CARDIOL, V90, P254, DOI 10.1016/S0002-9149(02)02464-5	36	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98626	10.1371/journal.pone.0098626	http://dx.doi.org/10.1371/journal.pone.0098626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892556	Green Accepted, Green Published, gold			2022-12-25	WOS:000336911400077
J	Yao, TC; Tu, YL; Chang, SW; Tsai, HJ; Gu, PW; Ning, HC; Hua, MC; Liao, SL; Tsai, MH; Chiu, CY; Lai, SH; Yeh, KW; Huang, JL				Yao, Tsung-Chieh; Tu, Yu-Ling; Chang, Su-Wei; Tsai, Hui-Ju; Gu, Po-Wen; Ning, Hsian-Chen; Hua, Man-Chin; Liao, Sui-Ling; Tsai, Ming-Han; Chiu, Chih-Yung; Lai, Shen-Hao; Yeh, Kuo-Wei; Huang, Jing-Long		PATCH Study Grp	Suboptimal Vitamin D Status in a Population-Based Study of Asian Children: Prevalence and Relation to Allergic Diseases and Atopy	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; EXHALED NITRIC-OXIDE; D DEFICIENCY; RISK-FACTORS; ADOLESCENTS; ASTHMA; SENSITIZATION; IGE	Background: New evidence shows high prevalence of vitamin D deficiency in many countries and some studies suggest a possible link between vitamin D status and allergic diseases. The objectives of this study were to determine the prevalence of suboptimal vitamin D status in a population sample of Asian children and to investigate the relationship of vitamin D status with allergic diseases and atopy. Methods: Children aged 5-18 years (N = 1315) in the Prediction of Allergies in Taiwanese CHildren (PATCH) study were evaluated using questionnaires, anthropometric measurements, and serum levels of 25-hydroxyvitamin D [25(OH) D] and total and specific immunoglobulin E (IgE). Results: The mean concentration of serum 25(OH) D was 20.4 ng/mL (SD: 7.1 ng/mL). Vitamin D deficiency (defined as serum 25(OH) D < 20 ng/mL) was present in 670 subjects (51.0%), while vitamin D insufficiency (defined as serum 25(OH) D, 30 ng/mL) was observed in 1187 subjects (90.3%). Older age (P < 0.001), female gender (P < 0.001), higher body mass index (P = 0.001), winter and spring seasons (compared to summer; P both < 0.001), and passive smoking (P = 0.011) were independently associated with low serum 25(OH) D levels. After adjusting for potential confounders, serum 25(OH) D status had no association with asthma, rhinitis, eczema, atopy, or total serum IgE (all P > 0.05). Conclusions: Low serum 25(OH) D levels are remarkably common in this population sample of Asian children, suggesting that millions of children living in Taiwan may have suboptimal levels of vitamin D, which should be a matter of public health concern. Our results provides epidemiological evidence against the association of vitamin D status with various allergic diseases and atopy in Asian children.	[Yao, Tsung-Chieh; Tu, Yu-Ling; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Mem Hosp, Dept Pediat, Div Allergy Asthma & Rheumatol, Taoyuan, Taiwan; [Yao, Tsung-Chieh; Tu, Yu-Ling; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Yao, Tsung-Chieh; Tu, Yu-Ling; Hua, Man-Chin; Liao, Sui-Ling; Tsai, Ming-Han; Chiu, Chih-Yung; Lai, Shen-Hao; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan; [Tu, Yu-Ling] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Taoyuan, Taiwan; [Chang, Su-Wei] Chang Gung Univ, Coll Med, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan; [Tsai, Hui-Ju] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Miaoli, Taiwan; [Tsai, Hui-Ju] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Tsai, Hui-Ju] Kaohsiung Univ, Dept Genome Med, Kaohsiung, Taiwan; [Gu, Po-Wen; Ning, Hsian-Chen] Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan; [Hua, Man-Chin; Liao, Sui-Ling; Tsai, Ming-Han; Chiu, Chih-Yung] Chang Gung Mem Hosp, Dept Pediat, Keelung, Taiwan; [Lai, Shen-Hao] Chang Gung Mem Hosp, Dept Pediat, Div Pediat Pulmonol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; National Health Research Institutes - Taiwan; Northwestern University; Feinberg School of Medicine; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yao, TC (corresponding author), Chang Gung Mem Hosp, Dept Pediat, Div Allergy Asthma & Rheumatol, Taoyuan, Taiwan.	yao@adm.cgmh.org.tw; long@adm.cgmh.org.tw	Yeh, Kuo-Wei/V-3725-2019; Chiu, CY/Q-4238-2019; Tsai, Hui-Ju/E-3937-2010	Huang, Jing-Long/0000-0001-9280-920X; Huang, Jing-Long/0000-0002-3530-7753	National Science Council of Taiwan [NSC 101-2314-B-182A-044, NSC 102-2314-B-182A-048, NSC 101-2314-B-400-009-MY2]; Chang Gung Memorial Hospital [CMRPG260291similar to260293, CMRPG2B0071similar to2B0073, CMRPG4B0031similar to4B0033]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was funded by the National Science Council of Taiwan (grants NSC 101-2314-B-182A-044, NSC 102-2314-B-182A-048, and NSC 101-2314-B-400-009-MY2) and by Chang Gung Memorial Hospital (grants CMRPG260291 similar to 260293, CMRPG2B0071 similar to 2B0073, and CMRPG4B0031 similar to 4B0033). The funders only provided financial support for conducting this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absoud M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022179; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Ballardini N, 2006, ALLERGY, V61, P337, DOI 10.1111/j.1398-9995.2005.00936.x; Bener A, 2012, INT ARCH ALLERGY IMM, V157, P168, DOI 10.1159/000323941; Carpenter TO, 2012, AM J CLIN NUTR, V95, P137, DOI 10.3945/ajcn.111.018721; El Taieb MA, 2013, DERMATITIS, V24, P296, DOI 10.1097/DER.0000000000000010; El-Hajj Fuleihan G, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e53; Emmen JMA, 2012, CLIN CHEM LAB MED, V50, P1969, DOI 10.1515/cclm-2011-0085; Freishtat RJ, 2010, J PEDIATR-US, V156, P948, DOI 10.1016/j.jpeds.2009.12.033; Gonzalez-Gross M, 2012, BRIT J NUTR, V107, P755, DOI 10.1017/S0007114511003527; Gordon CM, 2004, ARCH PEDIAT ADOL MED, V158, P531, DOI 10.1001/archpedi.158.6.531; Henry HL, 2010, J STEROID BIOCHEM, V121, P4, DOI 10.1016/j.jsbmb.2010.05.008; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollams EM, 2011, EUR RESPIR J, V38, P1320, DOI 10.1183/09031936.00029011; Hypponen E, 2009, ALLERGY, V64, P613, DOI 10.1111/j.1398-9995.2008.01865.x; Looker AC, 2002, BONE, V30, P771, DOI 10.1016/S8756-3282(02)00692-0; Mansbach JM, 2009, PEDIATRICS, V124, P1404, DOI 10.1542/peds.2008-2041; Marwaha RK, 2005, AM J CLIN NUTR, V82, P477, DOI 10.1093/ajcn/82.2.477; McGrath JJ, 2001, MED J AUSTRALIA, V174, P150, DOI 10.5694/j.1326-5377.2001.tb143195.x; Ovesen L, 2003, P NUTR SOC, V62, P813, DOI 10.1079/PNS2003297; Rockell JE, 2005, J NUTR, V135, P2602, DOI 10.1093/jn/135.11.2602; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; SALLIS JF, 1993, CRIT REV FOOD SCI, V33, P403, DOI 10.1080/10408399309527639; SEDRANI SH, 1984, ANN NUTR METAB, V28, P181, DOI 10.1159/000176801; Sharief S, 2011, J ALLERGY CLIN IMMUN, V127, P1195, DOI 10.1016/j.jaci.2011.01.017; Tolppanen AM, 2012, J CLIN ENDOCR METAB, V97, P1202, DOI 10.1210/jc.2011-2516; Tu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080996; Valtuena J, 2013, J NUTR SCI VITAMINOL, V59, P161; Weng FL, 2007, AM J CLIN NUTR, V86, P150, DOI 10.1093/ajcn/86.1.150; Wjst M, 2007, ALLERGY, V62, P1085, DOI 10.1111/j.1398-9995.2007.01437.x; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Yao TC, 2014, ALLERGY, V69, P678, DOI 10.1111/all.12378; Yao TC, 2012, EUR RESPIR J, V39, P378, DOI 10.1183/09031936.00013911; Yao TC, 2011, CLIN EXP ALLERGY, V41, P556, DOI 10.1111/j.1365-2222.2010.03687.x; Yao TC, 2011, J ASTHMA, V48, P503, DOI 10.3109/02770903.2011.576743	36	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e99105	10.1371/journal.pone.0099105	http://dx.doi.org/10.1371/journal.pone.0099105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892430	Green Submitted, Green Published, gold			2022-12-25	WOS:000336911400126
J	Chawla, S; Rahar, B; Singh, M; Bansal, A; Saraswat, D; Saxena, S				Chawla, Sonam; Rahar, Babita; Singh, Mrinalini; Bansal, Anju; Saraswat, Deepika; Saxena, Shweta			Exogenous Sphingosine-1-Phosphate Boosts Acclimatization in Rats Exposed to Acute Hypobaric Hypoxia: Assessment of Haematological and Metabolic Effects	PLOS ONE			English	Article							FACILITATES ACCLIMATIZATION; OXIDATIVE STRESS; SUPPLEMENTATION; EXPRESSION; TOLERANCE; ALTITUDE; KINASE; MICE; ATP	Background: The physiological challenges posed by hypobaric hypoxia warrant exploration of pharmacological entities to improve acclimatization to hypoxia. The present study investigates the preclinical efficacy of sphingosine-1-phosphate (S1P) to improve acclimatization to simulated hypobaric hypoxia. Experimental Approach: Efficacy of intravenously administered S1P in improving haematological and metabolic acclimatization was evaluated in rats exposed to simulated acute hypobaric hypoxia (7620 m for 6 hours) following S1P pre-treatment for three days. Major Findings: Altitude exposure of the control rats caused systemic hypoxia, hypocapnia (plausible sign of hyperventilation) and respiratory alkalosis due to suboptimal renal compensation indicated by an overt alkaline pH of the mixed venous blood. This was associated with pronounced energy deficit in the hepatic tissue along with systemic oxidative stress and inflammation. S1P pre-treatment improved blood oxygen-carrying-capacity by increasing haemoglobin, haematocrit, and RBC count, probably as an outcome of hypoxia inducible factor-1 alpha mediated erythropoiesis and renal S1P receptor 1 mediated haemoconcentation. The improved partial pressure of oxygen in the blood could further restore aerobic respiration and increase ATP content in the hepatic tissue of S1P treated animals. S1P could also protect the animals from hypoxia mediated oxidative stress and inflammation. Conclusion: The study findings highlight S1P's merits as a preconditioning agent for improving acclimatization to acute hypobaric hypoxia exposure. The results may have long term clinical application for improving physiological acclimatization of subjects venturing into high altitude for occupational or recreational purposes.	[Chawla, Sonam; Rahar, Babita; Singh, Mrinalini; Bansal, Anju; Saraswat, Deepika; Saxena, Shweta] Minist Def, Def Res & Dev Org, Inst Physiol & Allied Sci, Expt Biol Div, Delhi, India	Defence Research & Development Organisation (DRDO)	Saxena, S (corresponding author), Minist Def, Def Res & Dev Org, Inst Physiol & Allied Sci, Expt Biol Div, Lucknow Rd, Delhi, India.	shweta.dipas@gmail.com	Chawla, Sonam/AAV-5929-2020	Chawla, Sonam/0000-0002-6187-4778; , shweta/0000-0001-8171-4264	Defence Research and Development Organization, India [S&T-09 DIP-251 A 2.3]	Defence Research and Development Organization, India(Defence Research & Development Organisation (DRDO))	This work was funded by the Defence Research and Development Organization, India (www.drdo.gov.in) Project Grant No. S&T-09 DIP-251 A 2.3 to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Chawla S, 2014, LIPIDS, V49, P191, DOI 10.1007/s11745-013-3860-9; DOUSSET JC, 1983, CLIN CHIM ACTA, V129, P319, DOI 10.1016/0009-8981(83)90035-9; Dumont Lionel, 2005, Travel Med Infect Dis, V3, P183, DOI 10.1016/j.tmaid.2004.12.001; Elliott S, 2008, BRIT J PHARMACOL, V154, P529, DOI 10.1038/bjp.2008.89; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fagan K A, 2001, Respir Res, V2, P306, DOI 10.1186/rr74; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Graham R, 2012, IRON PHYSIOLOGY AND, P126; Guyton AC, 2005, TEXTBOOK OF MEDICAL; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hughes JE, 2008, CIRC RES, V102, P950, DOI 10.1161/CIRCRESAHA.107.170779; Ilavazhagan G, 2001, AVIAT SPACE ENVIR MD, V72, P899; Jung HJ, 2010, CURR NEUROVASC RES, V7, P201; Katz A, 1990, Exerc Sport Sci Rev, V18, P1; Keul P, 2007, HEART FAIL REV, V12, P301, DOI 10.1007/s10741-007-9038-x; Kim JD, 1996, AGING-CLIN EXP RES, V8, P123, DOI 10.1007/BF03339566; Kobayashi N, 2009, J BIOL CHEM, V284, P21192, DOI 10.1074/jbc.M109.006163; KORNBERG A, 1955, METHOD ENZYMOL, V1, P441, DOI 10.1016/0076-6879(55)01072-0; Laursen BE, 2008, VASC PHARMACOL, V49, P71, DOI 10.1016/j.vph.2008.03.001; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Lopez V, 2009, HIGH ALT MED BIOL, V10, P373, DOI 10.1089/ham.2008.1072; Luks AM, 2012, HIGH ALT MED BIOL, V13, P147, DOI 10.1089/ham.2012.1055; Magalhaes J, 2004, AVIAT SPACE ENVIR MD, V75, P16; OKAMURA JM, 1990, J CLIN LAB ANAL, V4, P231, DOI 10.1002/jcla.1860040316; Powell FL, 1998, RESP PHYSIOL, V112, P123, DOI 10.1016/S0034-5687(98)00026-7; PUGH L G, 1962, Br Med J, V2, P621; Reynafarje C, 1966, LIFE HIGH ALTITUDES, V140, P32; Rolfs A, 1997, J BIOL CHEM, V272, P20055, DOI 10.1074/jbc.272.32.20055; SHEPHERD D, 1966, BIOCHEM BIOPH RES CO, V22, P89, DOI 10.1016/0006-291X(66)90607-3; SHIMIZU S, 1989, JPN J PHYSIOL, V39, P833, DOI 10.2170/jjphysiol.39.833; Shrivastava K, 2008, HIGH ALT MED BIOL, V9, P63, DOI 10.1089/ham.2008.1046; Singh M, 2010, J PHARM PHARMACOL, V62, P1729, DOI 10.1111/j.2042-7158.2010.01163.x; Srinivasan S, 2008, DIABETES, V57, P484, DOI 10.2337/db07-0855; SUPOWIT SC, 1976, BIOCHIM BIOPHYS ACTA, V422, P48, DOI 10.1016/0005-2744(76)90007-3; Takuwa Y, 2012, BIOFACTORS, V38, P329, DOI 10.1002/biof.1030; Taylor AT, 2011, RAMBAM MAIMONIDES ME, V2, DOI 10.5041/RMMJ.10022; Veeger C., 1969, METHODS ENZYMOLOGY, VXIII, P81, DOI [https://doi.org/10.1016/0076-6879(69)13020-7, DOI 10.1016/0076-6879(69)13020-7]; Wacker BK, 2012, J NEUROCHEM, V123, P954, DOI 10.1111/jnc.12047; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Wright A, 2008, EXPERT OPIN PHARMACO, V9, P119, DOI 10.1517/14656566.9.1.119; Yang JF, 2005, J IMMUNOL, V175, P6580, DOI 10.4049/jimmunol.175.10.6580; Yasuo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053927; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhu Q, 2011, AM J PHYSIOL-RENAL, V301, pF35, DOI 10.1152/ajprenal.00014.2011	45	12	12	13	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98025	10.1371/journal.pone.0098025	http://dx.doi.org/10.1371/journal.pone.0098025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887065	gold, Green Published, Green Submitted			2022-12-25	WOS:000336956300034
J	Giri, S; Rattan, R; Deshpande, M; Maguire, JL; Johnson, Z; Graham, RP; Shridhar, V				Giri, Shailendra; Rattan, Ramandeep; Deshpande, Mandar; Maguire, Jacie L.; Johnson, Zachary; Graham, Rondell P.; Shridhar, Viji			Preclinical Therapeutic Potential of a Nitrosylating Agent in the Treatment of Ovarian Cancer	PLOS ONE			English	Article							NF-KAPPA-B; S-NITROSYLATION; IN-VITRO; CONSTITUTIVE ACTIVATION; SIGNAL TRANSDUCERS; STAT 3; GROWTH; CISPLATIN; INHIBITION; TRANSCRIPTION-3	This study examines the role of s-nitrosylation in the growth of ovarian cancer using cell culture based and in vivo approaches. Using the nitrosylating agent, S-nitrosoglutathione (GSNO), a physiological nitric oxide molecule, we show that GSNO treatment inhibited proliferation of chemoresponsive and chemoresistant ovarian cancer cell lines (A2780, C200, SKVO3, ID8, OVCAR3, OVCAR4, OVCAR5, OVCAR7, OVCAR8, OVCAR10, PE01 and PE04) in a dose dependent manner. GSNO treatment abrogated growth factor (HB-EGF) induced signal transduction including phosphorylation of Akt, p42/44 and STAT3, which are known to play critical roles in ovarian cancer growth and progression. To examine the therapeutic potential of GSNO in vivo, nude mice bearing intra-peritoneal xenografts of human A2780 ovarian carcinoma cell line (2 x 10(-6)) were orally administered GSNO at the dose of 1 mg/kg body weight. Daily oral administration of GSNO significantly attenuated tumor mass (p < 0.001) in the peritoneal cavity compared to vehicle (phosphate buffered saline) treated group at 4 weeks. GSNO also potentiated cisplatin mediated tumor toxicity in an A2780 ovarian carcinoma nude mouse model. GSNO's nitrosylating ability was reflected in the induced nitrosylation of various known proteins including NF kappa B p65, Akt and EGFR. As a novel finding, we observed that GSNO also induced nitrosylation with inverse relationship at tyrosine 705 phosphorylation of STAT3, an established player in chemoresistance and cell proliferation in ovarian cancer and in cancer in general. Overall, our study underlines the significance of S-nitrosylation of key cancer promoting proteins in modulating ovarian cancer and proposes the therapeutic potential of nitrosylating agents (like GSNO) for the treatment of ovarian cancer alone or in combination with chemotherapeutic drugs.	[Giri, Shailendra; Maguire, Jacie L.; Johnson, Zachary; Shridhar, Viji] Mayo Clin, Coll Med, Dept Expt Pathol, Rochester, MN USA; [Graham, Rondell P.] Mayo Clin, Coll Med, Dept Anat Clin Pathol, Rochester, MN USA; [Rattan, Ramandeep] Henry Ford Hlth Syst, Womens Hlth Serv, Detroit, MI USA; [Giri, Shailendra; Deshpande, Mandar] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA	Mayo Clinic; Mayo Clinic; Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital	Giri, S (corresponding author), Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA.	SGiri1@hfhs.org; shridhar.vijayalakshmi@mayo.edu	Seal, Sudipta/A-7698-2012	Graham, Rondell/0000-0002-8686-4867; Rattan, Ramandeep/0000-0002-3532-6057; Giri, Shailendra/0000-0002-7123-829X	Marsha Rivkin Scholar grant; Department of Defense OCRP award [W81XWH-12-1-0270]	Marsha Rivkin Scholar grant; Department of Defense OCRP award(United States Department of Defense)	This work is supported by Marsha Rivkin Scholar grant and Department of Defense OCRP award W81XWH-12-1-0270 to SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Anttila MA, 2007, GYNECOL ONCOL, V105, P97, DOI 10.1016/j.ygyno.2006.10.049; Bratasz A, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-9; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Burke WM, 2001, ONCOGENE, V20, P7925, DOI 10.1038/sj.onc.1204990; Cabrales P, 2009, RESUSCITATION, V80, P707, DOI 10.1016/j.resuscitation.2009.03.001; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chattopadhyay M, 2010, CANCER LETT, V298, P204, DOI 10.1016/j.canlet.2010.07.006; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Duan ZF, 2006, CLIN CANCER RES, V12, P5055, DOI 10.1158/1078-0432.CCR-06-0861; Engels K, 2008, CANCER RES, V68, P5159, DOI 10.1158/0008-5472.CAN-08-0406; Estrada C, 1997, BIOCHEM J, V326, P369, DOI 10.1042/bj3260369; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Friedlander ML, 1998, SEMIN ONCOL, V25, P305; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Germain D, 2007, CLIN CANCER RES, V13, P5665, DOI 10.1158/1078-0432.CCR-06-2491; Giri S, 2006, J LIPID RES, V47, P1478, DOI 10.1194/jlr.M600084-JLR200; Giri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054578; Hao M, 2009, J OBSTET GYNAECOL RE, V35, P918, DOI 10.1111/j.1447-0756.2009.01045.x; Haq E, 2007, J OCUL PHARMACOL TH, V23, P221, DOI 10.1089/jop.2007.0023; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Huang F, 2008, ACTA BIOCH BIOPH SIN, V40, P519, DOI 10.1111/j.1745-7270.2008.00424.x; Huang M, 2000, GYNECOL ONCOL, V79, P67, DOI 10.1006/gyno.2000.5931; Ikuta K, 2005, ONCOL REP, V13, P217; Jiang QY, 2013, J OBSTET GYNAECOL RE, V39, P701, DOI 10.1111/j.1447-0756.2012.02007.x; Kandala PK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-9; Kato K, 2000, BBA-GENE STRUCT EXPR, V1493, P91, DOI 10.1016/S0167-4781(00)00168-8; Kelleher ZT, 2007, J BIOL CHEM, V282, P30667, DOI 10.1074/jbc.M705929200; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Khan M, 2005, J CEREBR BLOOD F MET, V25, P177, DOI 10.1038/sj.jcbfm.9600012; Klimp AH, 2001, CANCER RES, V61, P7305; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin TS, 2000, ONCOGENE, V19, P2496, DOI 10.1038/sj.onc.1203486; Liu M, 2014, CANCER INVEST, V32, P8, DOI 10.3109/07357907.2013.861471; Luo C, 2004, DRUG DISCOV TODAY, V9, P268, DOI 10.1016/S1359-6446(03)03014-9; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; Matsumoto A, 2003, SCIENCE, V301, P657, DOI 10.1126/science.1079319; Meinhold-Heerlein I, 2005, ONCOGENE, V24, P1053, DOI 10.1038/sj.onc.1208298; Meyer T, 2007, EXPERT OPIN THER TAR, V11, P1355, DOI 10.1517/14728222.11.10.1355; Murillo-Carretero M, 2009, FREE RADICAL BIO MED, V46, P471, DOI 10.1016/j.freeradbiomed.2008.10.048; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Nomelini RS, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/186584; Numajiri N, 2011, P NATL ACAD SCI USA, V108, P10349, DOI 10.1073/pnas.1103503108; Prasad R, 2007, GLIA, V55, P65, DOI 10.1002/glia.20436; Prasad R, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-14; Rath KS, 2014, CANC RES; Rattan R, 2011, J CELL MOL MED, V15, P166, DOI 10.1111/j.1582-4934.2009.00954.x; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Roberts D, 2005, BRIT J CANCER, V92, P1149, DOI 10.1038/sj.bjc.6602447; Savarese TM, 2002, CYTOKINE, V17, P324, DOI 10.1006/cyto.2002.1022; Selvendiran K, 2008, CELL CYCLE, V7, P81, DOI 10.4161/cc.7.1.5103; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Silver DL, 2004, CANCER RES, V64, P3550, DOI 10.1158/0008-5472.CAN-03-3959; Song H, 2004, INT J ONCOL, V24, P1017; Song JI, 2000, ONCOGENE, V19, P2489, DOI 10.1038/sj.onc.1203483; Stevens EV, 2010, MOL PHARMACEUT, V7, P775, DOI 10.1021/mp9002865; Sun ZL, 2013, ASIAN PAC J CANCER P, V14, P4823, DOI 10.7314/APJCP.2013.14.8.4823; Switzer CH, 2012, MOL CANCER RES, V10, P1203, DOI 10.1158/1541-7786.MCR-12-0124; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zeineldin R, 2010, J ONCOL, V2010, DOI 10.1155/2010/414676; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321; Zhao SH, 2011, RADIOL ONCOL, V45, P196, DOI 10.2478/v10019-011-0013-8	68	15	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97897	10.1371/journal.pone.0097897	http://dx.doi.org/10.1371/journal.pone.0097897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887420	Green Submitted, Green Published, gold			2022-12-25	WOS:000336956300024
J	Graham, DB; Osborne, DG; Piotrowski, JT; Gomez, TS; Gmyrek, GB; Akilesh, HM; Dani, A; Billadeau, DD; Swat, W				Graham, Daniel B.; Osborne, Douglas G.; Piotrowski, Joshua T.; Gomez, Timothy S.; Gmyrek, Grzegorz B.; Akilesh, Holly M.; Dani, Adish; Billadeau, Daniel D.; Swat, Wojciech			Dendritic Cells Utilize the Evolutionarily Conserved WASH and Retromer Complexes to Promote MHCII Recycling and Helper T Cell Priming	PLOS ONE			English	Article							CLASS-II TRANSPORT; SUBSETS IN-VIVO; ANTIGEN PRESENTATION; PLASMA-MEMBRANE; DOWN-REGULATION; PEPTIDE COMPLEXES; PROTEIN; TRAFFICKING; RECEPTOR; UBIQUITINATION	Immature dendritic cells (DCs) maintain a highly dynamic pool of recycling MHCII that promotes sampling of environmental antigens for presentation to T helper cells. However, the molecular basis of MHCII recycling and the cellular machinery that orchestrates MHCII trafficking are incompletely understood. Using a mouse model we show that WASH, an actin regulatory protein that facilitates retromer function, is essential for MHCII recycling and efficient priming of T helper cells. We further demonstrate that WASH deficiency results in impaired MHCII surface levels, recycling, and an accumulation of polyubiquitinated MHCII complexes, which are subsequently slated for premature lysosomal degradation. Consequently, conditional deletion of the Wash gene in DCs impairs priming of both conventional and autoimmune T helper cells in vivo and attenuates disease progression in a model of experimental autoimmune encephalitis (EAE). Thus, we identify a novel mechanism in which DCs employ the evolutionarily conserved WASH and retromer complex for MHCII recycling in order to regulate T helper cell priming.	[Graham, Daniel B.; Gmyrek, Grzegorz B.; Akilesh, Holly M.; Dani, Adish; Swat, Wojciech] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Immunobiol, St Louis, MO USA; [Osborne, Douglas G.; Piotrowski, Joshua T.; Gomez, Timothy S.; Billadeau, Daniel D.] Mayo Clin, Coll Med, Div Oncol Res, Dept Immunol, Rochester, MN 55905 USA; [Osborne, Douglas G.; Piotrowski, Joshua T.; Gomez, Timothy S.; Billadeau, Daniel D.] Mayo Clin, Coll Med, Schulze Ctr Novel Therapeut, Rochester, MN USA	Washington University (WUSTL); Mayo Clinic; Mayo Clinic	Billadeau, DD (corresponding author), Mayo Clin, Coll Med, Div Oncol Res, Dept Immunol, Rochester, MN 55905 USA.	billadeau.daniel@mayo.edu; swat@wustl.edu			National Institutes of Health [R01AI061077, R01AI065474]; Allergic Diseases Training grant [T32 AI07047]; MSTP [5T32-GM065841]; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007047, R01AI061077, R01AI065474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065841] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allergic Diseases Training grant; MSTP; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01AI061077 to W. S., R01AI065474 to D. D. B., Allergic Diseases Training grant T32 AI07047 to T. S. G. and D.G.O., MSTP Training grant program 5T32-GM065841 to J.T.P., Leukemia and Lymphoma Society Scholar awards to W. S. and D. D. B., and Special Fellowship award to D. B. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Berger AC, 2009, J CELL SCI, V122, P1, DOI 10.1242/jcs.035089; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Collins BM, 2008, TRAFFIC, V9, P1811, DOI 10.1111/j.1600-0854.2008.00777.x; Cullen PJ, 2012, NAT CELL BIOL, V14, P29, DOI 10.1038/ncb2374; Derivery E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039774; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Dudziak D, 2007, SCIENCE, V315, P107, DOI 10.1126/science.1136080; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Gomez TS, 2012, MOL BIOL CELL, V23, P3215, DOI 10.1091/mbc.E12-02-0101; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Graham DB, 2007, J EXP MED, V204, P2889, DOI 10.1084/jem.20071283; Graham DB, 2010, BLOOD, V116, P3208, DOI 10.1182/blood-2009-10-250415; Hao YH, 2013, CELL, V152, P1051, DOI 10.1016/j.cell.2013.01.051; Harbour ME, 2012, BIOCHEM J, V442, P209, DOI 10.1042/BJ20111761; Harbour ME, 2010, J CELL SCI, V123, P3703, DOI 10.1242/jcs.071472; Jia D, 2012, MOL BIOL CELL, V23, P2352, DOI 10.1091/mbc.E11-12-1059; Jia D, 2010, P NATL ACAD SCI USA, V107, P10442, DOI 10.1073/pnas.0913293107; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; McGough IJ, 2011, TRAFFIC, V12, P963, DOI 10.1111/j.1600-0854.2011.01201.x; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Paul P, 2011, CELL, V145, P268, DOI 10.1016/j.cell.2011.03.023; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Piotrowski JT, 2013, MOL CELL BIOL, V33, P958, DOI 10.1128/MCB.01288-12; Poloso NJ, 2004, CURR OPIN IMMUNOL, V16, P103, DOI 10.1016/j.coi.2003.11.009; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Santambrogio L, 2006, IMMUNITY, V25, P857, DOI 10.1016/j.immuni.2006.11.007; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Seaman MNJ, 2013, TRENDS CELL BIOL, V23, P522, DOI 10.1016/j.tcb.2013.04.010; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Sullivan BM, 2008, J VIROL, V82, P602, DOI 10.1128/JVI.01571-07; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Thery C, 1998, J IMMUNOL, V161, P2106; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; van Niel G, 2008, CURR OPIN CELL BIOL, V20, P437, DOI 10.1016/j.ceb.2008.05.011; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Walseng E, 2008, J BIOL CHEM, V283, P14717, DOI 10.1074/jbc.M801070200; Walseng E, 2010, P NATL ACAD SCI USA, V107, P20465, DOI 10.1073/pnas.1010990107; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Zech T, 2011, J CELL SCI, V124, P3753, DOI 10.1242/jcs.080986	47	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98606	10.1371/journal.pone.0098606	http://dx.doi.org/10.1371/journal.pone.0098606			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886983	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300092
J	Houbraken, M; Demeyer, S; Michoel, T; Audenaert, P; Colle, D; Pickavet, M				Houbraken, Maarten; Demeyer, Sofie; Michoel, Tom; Audenaert, Pieter; Colle, Didier; Pickavet, Mario			The Index-Based Subgraph Matching Algorithm with General Symmetries (ISMAGS): Exploiting Symmetry for Faster Subgraph Enumeration	PLOS ONE			English	Article							NETWORK	Subgraph matching algorithms are used to find and enumerate specific interconnection structures in networks. By enumerating these specific structures/subgraphs, the fundamental properties of the network can be derived. More specifically in biological networks, subgraph matching algorithms are used to discover network motifs, specific patterns occurring more often than expected by chance. Finding these network motifs yields information on the underlying biological relations modelled by the network. In this work, we present the Index-based Subgraph Matching Algorithm with General Symmetries (ISMAGS), an improved version of the Index-based Subgraph Matching Algorithm (ISMA). ISMA quickly finds all instances of a predefined motif in a network by intelligently exploring the search space and taking into account easily identifiable symmetric structures. However, more complex symmetries (possibly involving switching multiple nodes) are not taken into account, resulting in superfluous output. ISMAGS overcomes this problem by using a customised symmetry analysis phase to detect all symmetric structures in the network motif subgraphs. These structures are then converted to symmetry-breaking constraints used to prune the search space and speed up calculations. The performance of the algorithm was tested on several types of networks (biological, social and computer networks) for various subgraphs with a varying degree of symmetry. For subgraphs with complex (multi-node) symmetric structures, high speed-up factors are obtained as the search space is pruned by the symmetry-breaking constraints. For subgraphs with no or simple symmetric structures, ISMAGS still reduces computation times by optimising set operations. Moreover, the calculated list of subgraph instances is minimal as it contains no instances that differ by only a subgraph symmetry. An implementation of the algorithm is freely available at https://github.com/mhoubraken/ISMAGS.	[Houbraken, Maarten; Audenaert, Pieter; Colle, Didier; Pickavet, Mario] Univ Ghent, Dept Informat Technol, iMinds, B-9000 Ghent, Belgium; [Demeyer, Sofie; Michoel, Tom] Univ Edinburgh, Roslin Inst, Div Genet & Genom, Edinburgh EH8 9YL, Midlothian, Scotland	Ghent University; IMEC; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Houbraken, M (corresponding author), Univ Ghent, Dept Informat Technol, iMinds, B-9000 Ghent, Belgium.	Maarten.Houbraken@intec.ugent.be	Pickavet, Mario J/E-9530-2019	Pickavet, Mario J/0000-0001-5817-7886; Demeyer, Sofie/0000-0002-8193-5734; Michoel, Tom/0000-0003-4749-4725; Colle, Didier/0000-0002-1428-0301	Research Foundation - Flanders (FWO-Vlaanderen); Roslin Institute; Ghent University	Research Foundation - Flanders (FWO-Vlaanderen)(FWO); Roslin Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ghent University(Ghent University)	Funded by the Research Foundation - Flanders (FWO-Vlaanderen), Ghent University and the Roslin Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1971, P 2 ACM S SYMBOLIC A; [Anonymous], 2009, P 18 INT C WORLD WID, DOI DOI 10.1145/1526709.1526809; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Cook S. A., 1971, Proceedings of the 3rd annual ACM symposium on theory of computing, P151; Cordella L. P., 1999, Proceedings 10th International Conference on Image Analysis and Processing, P1172, DOI 10.1109/ICIAP.1999.797762; Cordella L. P., 2001, 3 IAPR TC15 WORKSH G, P149; Darga PT, 2004, DES AUT CON, P530; Demeyer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061183; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Grochow JA, 2007, LECT NOTES COMPUT SC, V4453, P92; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kashtan N., 2002, TECHNICAL REPORT; Katebi H, 2012, TURING 100 EPIC, P181; LUBIW A, 1981, SIAM J COMPUT, V10, P11, DOI 10.1137/0210002; McKay B.D., 1981, PRACTICAL GRAPH ISOM; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Petersen J, 1898, INTERMED MATH, V5, P225; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Puget JF, 2005, 19TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI-05), P272; Ribeiro P, 2010, P 2010 ACM S APPL CO, P1559, DOI DOI 10.1145/1774088.1774422; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; ULLMANN JR, 1976, J ACM, V23, P31, DOI 10.1145/321921.321925; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Wernicke S, 2005, LECT NOTES COMPUT SC, V3692, P165	25	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97896	10.1371/journal.pone.0097896	http://dx.doi.org/10.1371/journal.pone.0097896			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879305	Green Published, gold, Green Submitted			2022-12-25	WOS:000338101500026
J	Massilamany, C; Marciano-Cabral, F; da Rocha-Azevedo, B; Jamerson, M; Gangaplara, A; Steffen, D; Zabad, R; Illes, Z; Sobel, RA; Reddy, J				Massilamany, Chandirasegaran; Marciano-Cabral, Francine; da Rocha-Azevedo, Bruno; Jamerson, Melissa; Gangaplara, Arunakumar; Steffen, David; Zabad, Rana; Illes, Zsolt; Sobel, Raymond A.; Reddy, Jay			SJL Mice Infected with Acanthamoeba castellanii Develop Central Nervous System Autoimmunity through the Generation of Cross-Reactive T Cells for Myelin Antigens	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS PATIENTS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; BLOOD-BRAIN-BARRIER; FREE-LIVING AMEBAS; PROTEOLIPID PROTEIN; BASIC-PROTEIN; CEREBROSPINAL-FLUID; BYSTANDER ACTIVATION; DISEASE; IDENTIFICATION	We recently reported that Acanthamoeba castellanii (ACA), an opportunistic pathogen of the central nervous system (CNS) possesses mimicry epitopes for proteolipid protein (PLP) 139-151 and myelin basic protein 89-101, and that the epitopes induce experimental autoimmune encephalomyelitis (EAE) in SJL mice reminiscent of the diseases induced with their corresponding cognate peptides. We now demonstrate that mice infected with ACA also show the generation of crossreactive T cells, predominantly for PLP 139-151, as evaluated by T cell proliferation and IA(s)/dextramer staining. We verified that PLP 139-151-sensitized lymphocytes generated in infected mice contained a high proportion of T helper 1 cytokineproducing cells, and they can transfer disease to naive animals. Likewise, the animals first primed with suboptimal dose of PLP 139-151 and later infected with ACA, developed EAE, suggesting that ACA infection can trigger CNS autoimmunity in the presence of preexisting repertoire of autoreactive T cells. Taken together, the data provide novel insights into the pathogenesis of Acanthamoeba infections, and the potential role of infectious agents with mimicry epitopes to self-antigens in the pathogenesis of CNS diseases such as multiple sclerosis.	[Massilamany, Chandirasegaran; Gangaplara, Arunakumar; Steffen, David; Reddy, Jay] Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA; [Marciano-Cabral, Francine; Jamerson, Melissa] Virginia Commonwealth Univ, Sch Med, Richmond, VA USA; [da Rocha-Azevedo, Bruno] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Zabad, Rana] Univ Nebraska, Med Ctr, Omaha, NE USA; [Illes, Zsolt] Univ Pecs, Pecs, Hungary; [Illes, Zsolt] Univ Southern Denmark, Odense, Denmark; [Sobel, Raymond A.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Sobel, Raymond A.] VA Hlth Care Syst, Palo Alto, CA USA	University of Nebraska System; University of Nebraska Lincoln; Virginia Commonwealth University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Nebraska System; University of Nebraska Medical Center; University of Pecs; University of Southern Denmark; Stanford University	Reddy, J (corresponding author), Univ Nebraska, Sch Vet Med & Biomed Sci, Lincoln, NE 68588 USA.	nreddy2@unl.edu	da Rocha-Azevedo, Bruno/N-6385-2014; Steffen, David/ABI-5565-2020; Reddy, Jay/K-7200-2014; Gangaplara, Arunakumar/K-5922-2019; Driemeier, David/H-3461-2012; ZABAD, RANA/AAD-3895-2022; da+Rocha-Azevedo, Bruno/K-5348-2019; Zabad, Rana Khalil/AAX-7285-2021; Massilamany, Chandirasegaran/D-9305-2016	da Rocha-Azevedo, Bruno/0000-0002-4684-161X; Steffen, David/0000-0002-5166-2296; Reddy, Jay/0000-0003-4082-9254; Gangaplara, Arunakumar/0000-0001-6307-9391; Driemeier, David/0000-0003-3766-0654; ZABAD, RANA/0000-0003-3170-7108; Massilamany, Chandirasegaran/0000-0002-0205-282X; Illes, Zsolt/0000-0001-9655-0450; Sobel, Raymond/0000-0002-0477-9002	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065494] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50-HG002790] Funding Source: Medline; NIGMS NIH HHS [5R01-GM065494] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson AC, 2000, J EXP MED, V191, P761, DOI 10.1084/jem.191.5.761; Bennett J, 2010, J NEUROIMMUNOL, V229, P180, DOI 10.1016/j.jneuroim.2010.08.011; Brindley N, 2009, EXP PARASITOL, V121, P254, DOI 10.1016/j.exppara.2008.11.009; Buenafe AC, 2007, J NEUROIMMUNOL, V182, P32, DOI 10.1016/j.jneuroim.2006.09.004; Cabral GA, 2004, J NEUROIMMUNOL, V147, P127, DOI 10.1016/j.jneuroim.2003.10.027; Chappell CL, 2001, CLIN DIAGN LAB IMMUN, V8, P724, DOI 10.1128/CDLI.8.4.724-730.2001; Cirone M, 2002, J MED VIROL, V68, P268, DOI 10.1002/jmv.10190; Claerhout I, 1999, Bull Soc Belge Ophtalmol, V274, P71; CULBERTSON C, 1961, AM J CLIN PATHOL, V35, P195, DOI 10.1093/ajcp/35.3.195; CULBERTSON C. G., 1959, AMER JOUR PATHOL, V35, P185; CULBERTSON CG, 1958, SCIENCE, V127, P1506, DOI 10.1126/science.127.3313.1506; Ellestad KK, 2009, J IMMUNOL, V183, P298, DOI 10.4049/jimmunol.0803576; Ferber IA, 1996, J IMMUNOL, V156, P5; Floris S, 2004, BRAIN, V127, P616, DOI 10.1093/brain/awh068; FORGHANI B, 1978, J CLIN MICROBIOL, V7, P63; Fujinami RS, 2006, CLIN MICROBIOL REV, V19, P80, DOI 10.1128/CMR.19.1.80-94.2006; Greer JM, 1996, J IMMUNOL, V156, P371; Huseby ES, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00064; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Khan N. A., 2005, American Journal of Immunology, V1, P24; Khan NA, 2003, MICROB PATHOGENESIS, V34, P277, DOI 10.1016/S0882-4010(03)00061-5; Khan NA, 2008, J MED MICROBIOL, V57, P1051, DOI 10.1099/jmm.0.2008/000976-0; Kidney DD, 1998, AM J ROENTGENOL, V171, P809, DOI 10.2214/ajr.171.3.9725321; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; LEINIKKI P, 1982, J NEUROL SCI, V57, P249, DOI 10.1016/0022-510X(82)90031-4; Mancuso R, 2010, J MED VIROL, V82, P1051, DOI 10.1002/jmv.21764; Marciano-Cabral F, 2003, CLIN MICROBIOL REV, V16, P273, DOI 10.1128/CMR.16.2.273-307.2003; Marciano-Cabral F, 2001, J EUKARYOT MICROBIOL, p4S; Marciano-Cabral F, 2000, J EUKARYOT MICROBIOL, V47, P29, DOI 10.1111/j.1550-7408.2000.tb00007.x; MARTINEZ AJ, 1985, INFECTION, V13, P251, DOI 10.1007/BF01645432; Massilamany C, 2011, NON-FLAVIVIRUS ENCEPHALITIS, P307; Massilamany C, 2011, INT IMMUNOL, V23, P729, DOI 10.1093/intimm/dxr084; Massilamany C, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-40; Massilamany C, 2011, J NEUROIMMUNOL, V230, P95, DOI 10.1016/j.jneuroim.2010.09.011; Massilamany C, 2010, J NEUROIMMUNOL, V219, P17, DOI 10.1016/j.jneuroim.2009.11.006; McClellan K, 2002, EXP EYE RES, V75, P285, DOI [10.1016/S0014-4835(02)92015-4, 10.1006/exer.2002.2015]; MEINL E, 1993, J CLIN INVEST, V92, P2633, DOI 10.1172/JCI116879; Moore FGA, 2002, ACTA NEUROL SCAND, V106, P63, DOI 10.1034/j.1600-0404.2002.01251.x; Nogai A, 2005, J IMMUNOL, V175, P959, DOI 10.4049/jimmunol.175.2.959; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Olsen JK, 2001, J CLIN INVEST, V108, P311; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pohl D, 2009, J NEUROL SCI, V286, P62, DOI 10.1016/j.jns.2009.03.028; Reddy J, 2004, P NATL ACAD SCI USA, V101, P15434, DOI 10.1073/pnas.0404444101; Rumah KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076359; Schroeder JM, 2001, J CLIN MICROBIOL, V39, P1903, DOI 10.1128/JCM.39.5.1903-1911.2001; Schuster FL, 2002, CLIN MICROBIOL REV, V15, P342, DOI 10.1128/CMR.15.3.342-354.2002; Segal BM, 1997, J IMMUNOL, V158, P5087; Shadidi KR, 2001, RHEUMATOLOGY, V40, P1120, DOI 10.1093/rheumatology/40.10.1120; SOBEL RA, 1990, J NEUROPATH EXP NEUR, V49, P468, DOI 10.1097/00005072-199009000-00002; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Sowka J. W., 2001, HDB OCULAR DIS MANAG; TANAKA Y, 1994, PARASITOL RES, V80, P549, DOI 10.1007/BF00933001; TUOHY VK, 1989, J IMMUNOL, V142, P1523; Vanderlugt CL, 2002, NAT REV IMMUNOL, V2, P85, DOI 10.1038/nri724; Waldner H, 2004, J CLIN INVEST, V113, P990, DOI 10.1172/JCI200419388; WICHER V, 1979, CLIN EXP IMMUNOL, V37, P114; Wucherpfennig KW, 1997, J CLIN INVEST, V100, P1114, DOI 10.1172/JCI119622; Zepp J, 2011, TRENDS IMMUNOL, V32, P232, DOI 10.1016/j.it.2011.02.007; Zhang Y, 2004, INVEST OPHTH VIS SCI, V45, P1904, DOI 10.1167/iovs.03-1073	61	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98506	10.1371/journal.pone.0098506	http://dx.doi.org/10.1371/journal.pone.0098506			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879066	Green Published, gold			2022-12-25	WOS:000338101500064
J	Gagnon, JA; Valen, E; Thyme, SB; Huang, P; Ahkmetova, L; Pauli, A; Montague, TG; Zimmerman, S; Richter, C; Schier, AF				Gagnon, James A.; Valen, Eivind; Thyme, Summer B.; Huang, Peng; Ahkmetova, Laila; Pauli, Andrea; Montague, Tessa G.; Zimmerman, Steven; Richter, Constance; Schier, Alexander F.			Efficient Mutagenesis by Cas9 Protein-Mediated Oligonucleotide Insertion and Large-Scale Assessment of Single-Guide RNAs	PLOS ONE			English	Article							CRISPR-CAS9 SYSTEM; HUMAN GENOME; ZEBRAFISH; CRISPR/CAS; POLYMERASE; DNA; NUCLEASES; MICE	The CRISPR/Cas9 system has been implemented in a variety of model organisms to mediate site-directed mutagenesis. A wide range of mutation rates has been reported, but at a limited number of genomic target sites. To uncover the rules that govern effective Cas9-mediated mutagenesis in zebrafish, we targeted over a hundred genomic loci for mutagenesis using a streamlined and cloning-free method. We generated mutations in 85% of target genes with mutation rates varying across several orders of magnitude, and identified sequence composition rules that influence mutagenesis. We increased rates of mutagenesis by implementing several novel approaches. The activities of poor or unsuccessful single-guide RNAs (sgRNAs) initiating with a 59 adenine were improved by rescuing 59 end homogeneity of the sgRNA. In some cases, direct injection of Cas9 protein/sgRNA complex further increased mutagenic activity. We also observed that low diversity of mutant alleles led to repeated failure to obtain frame-shift mutations. This limitation was overcome by knock-in of a stop codon cassette that ensured coding frame truncation. Our improved methods and detailed protocols make Cas9-mediated mutagenesis an attractive approach for labs of all sizes.	[Gagnon, James A.; Valen, Eivind; Thyme, Summer B.; Huang, Peng; Ahkmetova, Laila; Pauli, Andrea; Montague, Tessa G.; Zimmerman, Steven; Richter, Constance; Schier, Alexander F.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Huang, Peng] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Schier, Alexander F.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Schier, Alexander F.] MIT, Broad Inst, Cambridge, MA 02139 USA; [Schier, Alexander F.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; University of Calgary; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Gagnon, JA (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	james.gagnon@gmail.com; schier@fas.harvard.edu	Richter, Constance/P-8714-2019; Valen, Eivind/A-8617-2011; Huang, Peng/U-8384-2019	Huang, Peng/0000-0001-7954-8869; Schier, Alexander Franz/0000-0001-7645-5325; Montague, Tessa/0000-0002-5918-6327; Valen, Eivind/0000-0003-1840-6108; Richter, Constance/0000-0003-3312-0941; Thyme, Summer/0000-0003-3593-4148; Gagnon, James/0000-0003-3978-6058	American Cancer Society; Human Frontier Science Program; Damon Runyon Cancer Research Foundation; EMBO; NSDEG; Life Sciences Research Foundation; NIH [R01 GM056211, R01 HL109525, R21 HD072733]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD076935, R21HD072733] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109525] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056211] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Human Frontier Science Program(Human Frontier Science Program); Damon Runyon Cancer Research Foundation; EMBO(European Molecular Biology Organization (EMBO)); NSDEG; Life Sciences Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the American Cancer Society (JAG), Human Frontier Science Program (EV, AP), Damon Runyon Cancer Research Foundation (SBT), EMBO(CR), NSDEG (TGM), Life Sciences Research Foundation (CR), and NIH grants R01 GM056211, R01 HL109525, and R21 HD072733 (JAG, EV, SBT, PH, LA, AP, TGM, SZ, CR, AFS). All authors supported by these grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carroll D, 2014, ANN REV BIOCH; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Helm M, 1999, RNA, V5, P618, DOI 10.1017/S1355838299982328; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Imburgio D, 2000, BIOCHEMISTRY-US, V39, P10419, DOI 10.1021/bi000365w; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Kuzmine I, 2003, J BIOL CHEM, V278, P2819, DOI 10.1074/jbc.M208405200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Sander JD, 2014, NAT BIOTECHNOL; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; STUMP WT, 1993, NUCLEIC ACIDS RES, V21, P5480, DOI 10.1093/nar/21.23.5480; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Xiao A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt464	25	526	561	5	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98186	10.1371/journal.pone.0098186	http://dx.doi.org/10.1371/journal.pone.0098186			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24873830	gold, Green Published			2022-12-25	WOS:000336790800027
J	Wang, DM; Wu, SH; Yao, YJ				Wang, Dong-Mei; Wu, Sheng-Hua; Yao, Yi-Jian			Clarification of the Concept of Ganoderma orbiforme with High Morphological Plasticity	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; SUBUNIT RIBOSOMAL DNA; OIL PALM; SEQUENCE; POLYPORES; TAXONOMY; LUCIDUM; DISEASE; FUNGI; RDNA	Ganoderma has been considered a very difficult genus among the polypores to classify and is currently in a state of taxonomic chaos. In a study of Ganoderma collections including numerous type specimens, we found that six species namely G. cupreum, G. densizonatum, G. limushanense, G. mastoporum, G. orbiforme, G. subtornatum, and records of G. fornicatum from Mainland China and Taiwan are very similar to one another in basidiocarp texture, pilear cuticle structure, context color, pore color and basidiospore characteristics. Further, we sequenced the nrDNA ITS region (ITS1 and ITS2) and partial mtDNA SSU region of the studied materials, and performed phylogenetic analyses based on these sequence data. The nrDNA ITS sequence analysis results show that the eight nrDNA ITS sequences derived from this study have single-nucleotide polymorphisms in ITS1 and/or ITS2 at inter- and intra- individual levels. In the nrDNA ITS phylogenetic trees, all the sequences from this study are grouped together with those of G. cupreum and G. mastoporum retrieved from GenBank to form a distinct clade. The mtDNA SSU sequence analysis results reveal that the five mtDNA SSU sequences derived from this study are clustered together with those of G. cupreum retrieved from GenBank and also form a distinct clade in the mtDNA SSU phylogenetic trees. Based on morphological and molecular data, we conclude that the studied taxa are conspecific. Among the names assigned to this species, G. fornicatum given to Asian collections has nomenclatural priority over the others. However, the type of G. fornicatum from Brazil is probably lost and a modern description based on the type lacks. The identification of the Asian collections to G. fornicatum therefore cannot be confirmed. To the best of our knowledge, G. orbiforme is the earliest valid name for use.	[Wang, Dong-Mei; Yao, Yi-Jian] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Wang, Dong-Mei; Wu, Sheng-Hua] Natl Museum Nat Sci, Dept Bot, Taichung, Taiwan	Chinese Academy of Sciences; Institute of Microbiology, CAS	Wang, DM (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	wangdmwendy@gmail.com	WANG, DONG-MEI/K-5799-2016		National Science Council (ROC) [NSC96-2816-B-178-001]; National Natural Science Foundation of China [30270006]	National Science Council (ROC)(Ministry of Science and Technology, Taiwan); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Postdoctoral Fellowship Grant of National Science Council (ROC), NO. NSC96-2816-B-178-001, and the National Natural Science Foundation of China (30270006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Corner EJH, 1983, BEIH NOV HEDW, V75, P1; Dai YC, 2007, FOREST PATHOL, V37, P105, DOI 10.1111/j.1439-0329.2007.00485.x; Dai YC, 2009, INT J MED MUSHROOMS, V11, P287, DOI 10.1615/IntJMedMushr.v11.i3.80; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Flood J, 2000, GANODERMA DIS PERENN; Fries E, 1836, EPICRISIS SYSTEMATIS, Vi-xii; Fries E. M., 1830, LINNAEA, V5, P497; Gottlieb AM, 2000, MYCOL RES, V104, P1033, DOI 10.1017/S095375620000304X; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HOLMGREN PK, 1998, INDEX HERBARIORUM GL; Hong SG, 2004, MYCOLOGIA, V96, P742, DOI 10.2307/3762108; Hong SG, 2002, MYCOLOGIA, V94, P823, DOI 10.2307/3761697; Hseu RS, 1990, THESIS NATL TAIWAN U; HUMPHREY C. J., 1931, Philipp. J. of Sci, V45, P483; IMAZEKI R., 1939, BULL TOKYO SCI MUS, V1, P29; Isaka M, 2013, PHYTOCHEMISTRY, V87, P133, DOI 10.1016/j.phytochem.2012.11.022; Kinge TR, 2011, MYCOSPHERE, V2, P179; Kirk PM, 2008, AINSWORTH BISBYS DIC; Lin ZB, 2009, LINGZHI MYSTERY SCI; Lloyd CG, 1912, MYCOL WRIT, V3, P95; Moncalvo J. M., 2000, Ganoderma diseases of perennial crops, P23, DOI 10.1079/9780851993881.0023; Moncalvo J.M., 1995, GANODERMA SYSTEMATIC, V59, P31; MONCALVO JM, 1995, MYCOLOGIA, V87, P223, DOI 10.2307/3760908; Moncalvo JM., 1997, SYNOPSIS FUNGORUM, V11; Murrill WA, 1902, B TORREY BOT CLUB, V29, P599, DOI DOI 10.2307/2478682; Murrill WA, 1973, BIBL MYCOL, V40, P1; Murrill WA, 1907, B TORREY BOT CLUB, V34, P465; Murrill WA, 1908, N AM FLORA, V9, P113; Park Young-Jin, 2012, Mycobiology, V40, P71, DOI 10.5941/MYCO.2012.40.1.071; Patouillard NT, 1889, BULL SOC MYCOL FR, V5, P64; Ryvarden L, 2000, MYCOLOGIA, V92, P180, DOI 10.2307/3761462; RYVARDEN L, 1995, P CONTRIB S A, V59, P19; Ryvarden L., 1991, SYNOPSIS FUNGORUM, V5, DOI DOI 10.2307/3760304; Sankaran KV, 2005, MYCOPATHOLOGIA, V159, P143, DOI 10.1007/s11046-004-4437-1; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Smith BJ, 2000, MYCOL RES, V104, P943, DOI 10.1017/S0953756200002458; Smith BJ, 2003, AUST SYST BOT, V16, P487, DOI 10.1071/SB02001; STEYAERT R L, 1980, Bulletin du Jardin Botanique National de Belgique, V50, P135, DOI 10.2307/3667780; STEYAERT R. L., 1967, Bull. Jard. bot. Nat. Belg., V37, P465, DOI 10.2307/3667472; Steyaert RL, 1972, PERSOONIA, V7, P55; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Utomo C, 2005, MYCOPATHOLOGIA, V159, P159, DOI 10.1007/s11046-004-4439-z; Wang DM, 2005, MYCOTAXON, V93, P61; Wang DM, 2005, CAN J MICROBIOL, V51, P113, DOI 10.1139/W04-118; Wang DM, 2008, MYCOTAXON, V104, P297; Wang DM, 2007, MYCOTAXON, V102, P373; Wang DM, 2009, BOT STUD, V50, P451; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wu SH, 2007, MYCOLOGIA, V99, P302, DOI 10.3852/mycologia.99.2.302; Zhao J.-D., 1979, Acta Microbiologica Sinica, V19, P265; Zhao JD, 1995, GANODERMA SYSTEMATIC, P1; Zhao JD, 2000, FLORA FUNGORUM SINIC; Zhao JD, 1986, ACTA MYCOLOGICA SINI, V5, P219	54	15	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98733	10.1371/journal.pone.0098733	http://dx.doi.org/10.1371/journal.pone.0098733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875218	Green Published, Green Submitted, gold			2022-12-25	WOS:000336790800058
J	Lu, Y; Wang, Q; Wang, DH; Zhou, H; Hu, YJ; Yang, WX				Lu, Yang; Wang, Qi; Wang, Da-Hui; Zhou, Hong; Hu, Yan-Jun; Yang, Wan-Xi			Functional Analysis of KIF3A and KIF3B during Spermiogenesis of Chinese Mitten Crab Eriocheir sinensis	PLOS ONE			English	Article							HETEROTRIMERIC KINESIN; SUPERFAMILY PROTEINS; MOLECULAR MOTORS; I-TASSER; TESTIS; GENE; TRANSPORT; SPERMATOGENESIS; IDENTIFICATION; EXPRESSION	Background: Spermatogenesis represents the transformation process at the level of cellular development. KIF3A and KIF3B are believed to play some roles in the assembly and maintenance of flagella, intracellular transport of materials including organelles and proteins, and other unknown functions during this process. During spermatogenesis in Eriocheir sinensis, if the sperm shaping machinery is dependent on KIF3A and KIF3B remains unknown. Methodology/Principal Findings: The cDNA of KIF3A and KIF3B were obtained by designing degenerate primers, 3'RACE, and 5'RACE. We detected the genetic presence of kif3a and kif3b in the heart, muscle, liver, gill, and testis of E. sinensis through RT-PCR. By western blot analysis, the protein presence of KIF3A and KIF3B in heart, muscle, gill, and testis reflected the content in protein level. Using in situ hybridization and immunofluorescence, we could track the dynamic location of KIF3A and KIF3B during different developmental phases of sperm. KIF3A and KIF3B were found surrounding the nucleus in early spermatids. In intermediate spermatids, these proteins expressed at high levels around the nucleus and extended to the final phase. During the nuclear shaping period, KIF3A and KIF3B reached their maximum in the late spermatids and were located around the nucleus and concentrated in the acrosome to some extent. Conclusions/Significance: Our results revealed that KIF3A and KIF3B were involved in the nuclear and cellular morphogenesis at the levels of mRNA and protein. These proteins can potentially facilitate the intracellular transport of organelles, proteins, and other cargoes. The results represent the functions of KIF3A and KIF3B in the spermatogenesis of Crustacea and clarify phylogenetic relationships among the Decapoda.	[Lu, Yang; Wang, Qi; Wang, Da-Hui; Zhou, Hong; Yang, Wan-Xi] Zhejiang Univ, Sperm Lab, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Yan-Jun] Zhejiang Univ, Dept Reprod Endocrinol, Womens Hosp, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhou, H (corresponding author), Zhejiang Univ, Sperm Lab, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	zhouhong@zuaa.zju.edu.cn; hyj101@163.com; wxyang@spermlab.org	Yang, Wan-Xi/D-4401-2011	Yang, Wan-Xi/0000-0001-5695-0150; Yang, Wan-Xi/0000-0001-9304-195X	National Natural Science Foundation of China [41276151, 31072198]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/publish/portal1/tab131/) (No. 41276151 and 31072198). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Betley JN, 2004, CURR BIOL, V14, P219, DOI 10.1016/j.cub.2004.01.028; Bhullar B, 2003, J BIOL CHEM, V278, P16159, DOI 10.1074/jbc.M213126200; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Chennathukuzhi V, 2003, P NATL ACAD SCI USA, V100, P15566, DOI 10.1073/pnas.2536695100; Christensen GL, 2006, MOL HUM REPROD, V12, P257, DOI 10.1093/molehr/gal006; Dang R, 2012, MOL BIOL REP, V39, P5589, DOI 10.1007/s11033-011-1363-4; Du Nanshan, 1988, Oceanologia et Limnologia Sinica, V19, P71; Garcia EBG, 2009, LANCET ONCOL, V10, P727, DOI 10.1016/S1470-2045(09)70167-6; Henson JH, 1997, CELL MOTIL CYTOSKEL, V38, P29, DOI 10.1002/(SICI)1097-0169(1997)38:1<29::AID-CM4>3.0.CO;2-C; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hirokawa N, 2000, TRAFFIC, V1, P29, DOI 10.1034/j.1600-0854.2000.010105.x; Hirokawa N, 2004, EXP CELL RES, V301, P50, DOI 10.1016/j.yexcr.2004.08.010; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Ho NY, 2008, MAR POLLUT BULL, V57, P425, DOI 10.1016/j.marpolbul.2008.02.044; Hu JR, 2012, MOL BIOL REP, V39, P4207, DOI 10.1007/s11033-011-1206-3; Kapitein LC, 2011, MOL CELL NEUROSCI, V46, P9, DOI 10.1016/j.mcn.2010.08.015; Kotaja N, 2005, J BIOL CHEM, V280, P31739, DOI 10.1074/jbc.M505971200; Koyama E, 2007, DEVELOPMENT, V134, P2159, DOI 10.1242/dev.001586; Lehti MS, 2013, MOL CELL ENDOCRINOL, V377, P44, DOI 10.1016/j.mce.2013.06.030; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; Marszalek JR, 2000, BBA-MOL CELL RES, V1496, P142, DOI 10.1016/S0167-4889(00)00015-X; Medina PMB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003054; Miller MG, 1999, BIOL REPROD, V60, P1047, DOI 10.1095/biolreprod60.4.1047; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Pollard TD, 2003, NATURE, V422, P741, DOI 10.1038/nature01598; Ramalho-Santos J, 2002, BIOL REPROD, V67, P1043, DOI 10.1095/biolreprod67.4.1043; RASHID DJ, 1995, J MOL BIOL, V252, P157, DOI 10.1006/jmbi.1995.0484; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saade M, 2007, EXP CELL RES, V313, P614, DOI 10.1016/j.yexcr.2006.11.011; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Shah C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001022; Shimizu K, 1996, J BIOL CHEM, V271, P27013, DOI 10.1074/jbc.271.43.27013; Simeo CG, 2010, J MORPHOL, V271, P394, DOI 10.1002/jmor.10805; Sun X, 2011, MOL BIOL REP, V38, P3993, DOI 10.1007/s11033-010-0517-0; Sun XA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012738; Surpili MJ, 2003, BIOCHEMISTRY-US, V42, P15369, DOI 10.1021/bi034575v; TABISH M, 1995, J MOL BIOL, V247, P377, DOI 10.1006/jmbi.1994.0146; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tang EI, 2013, J ENDOCRINOL, V217, pR13, DOI 10.1530/JOE-12-0586; Tsai MY, 2000, MOL BIOL CELL, V11, P2161, DOI 10.1091/mbc.11.6.2161; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Wagner MK, 2000, CURR BIOL, V10, pR149, DOI 10.1016/S0960-9822(00)00328-6; Wang DH, 2010, COMP BIOCHEM PHYS A, V157, P123, DOI 10.1016/j.cbpa.2010.05.015; Wang R, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-9; Wang W, 2010, COMP BIOCHEM PHYS A, V157, P237, DOI 10.1016/j.cbpa.2010.07.004; Wang WK, 2010, EURASIP J ADV SIG PR, DOI 10.1155/2010/695750; Wedaman KP, 1996, J CELL BIOL, V132, P371, DOI 10.1083/jcb.132.3.371; Yang Wan-Xi, 1999, Acta Zoologica Sinica, V45, P178; Yang Wanxi, 2000, Yingyong Shengtai Xuebao, V11, P763; Yu KM, 2009, CELL TISSUE RES, V337, P113, DOI 10.1007/s00441-009-0800-3; Zama U, 2004, TISSUE CELL, V36, P29, DOI 10.1016/j.tice.2003.08.003; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zou Y, 2002, BIOL REPROD, V66, P843, DOI 10.1095/biolreprod66.3.843	55	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97645	10.1371/journal.pone.0097645	http://dx.doi.org/10.1371/journal.pone.0097645			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870586	Green Published, Green Submitted, gold			2022-12-25	WOS:000336858300016
J	Kassavetis, GA; Kadonaga, JT				Kassavetis, George A.; Kadonaga, James T.			The Annealing Helicase and Branch Migration Activities of Drosophila HARP	PLOS ONE			English	Article							GENOME STABILITY; RNA-DNA; REPLICATION STRESS; TRANSCRIPTION; PROTEIN; IDENTIFICATION; CHROMATIN; PCNA	HARP (SMARCAL1, MARCAL1) is an annealing helicase that functions in the repair and restart of damaged DNA replication forks through its DNA branch migration and replication fork regression activities. HARP is conserved among metazoans. HARP from invertebrates differs by the absence of one of the two HARP-specific domain repeats found in vertebrates. The annealing helicase and branch migration activity of invertebrate HARP has not been documented. We found that HARP from Drosophila melanogaster retains the annealing helicase activity of human HARP, the ability to disrupt D-loops and to branch migrate Holliday junctions, but fails to regress model DNA replication fork structures. A comparison of human and Drosophila HARP on additional substrates revealed that both HARPs are competent in branch migrating a bidirectional replication bubble composed of either DNA:DNA or RNA:DNA hybrid. Human, but not Drosophila, HARP is also capable of regressing a replication fork structure containing a highly stable poly rG:dC hybrid. Persistent RNA:DNA hybrids in vivo can lead to replication fork arrest and genome instability. The ability of HARP to strand transfer hybrids may signify a hybrid removal function for this enzyme, in vivo.	[Kassavetis, George A.; Kadonaga, James T.] Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kassavetis, GA (corresponding author), Univ Calif San Diego, Mol Biol Sect, La Jolla, CA 92093 USA.	gkassavetis@ucsd.edu			National Institute of General Medical Sciences/National Institutes of Health [R01 GM058272]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058272] Funding Source: NIH RePORTER	National Institute of General Medical Sciences/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute of General Medical Sciences/National Institutes of Health to JTK (R01 GM058272). This was our sole source of funding for the research submitted in the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Baradaran-Heravi A, 2012, HUM MOL GENET, V21, P2572, DOI 10.1093/hmg/dds083; Belotserkovskii BP, 2010, P NATL ACAD SCI USA, V107, P12816, DOI 10.1073/pnas.1007580107; Betous R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063149; Betous R, 2013, CELL REP, V3, P1958, DOI 10.1016/j.celrep.2013.05.002; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; CASEY J, 1977, NUCLEIC ACIDS RES, V4, P1539, DOI 10.1093/nar/4.5.1539; Chakraborty P, 2010, NUCLEIC ACIDS RES, V38, P4722, DOI 10.1093/nar/gkq240; Ciccia A, 2012, MOL CELL, V47, P396, DOI 10.1016/j.molcel.2012.05.024; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Ghosal G, 2011, EMBO REP, V12, P574, DOI 10.1038/embor.2011.74; Grierson PM, 2012, HUM MOL GENET, V21, P1172, DOI 10.1093/hmg/ddr545; Huang C, 2010, DEV BIOL, V339, P89, DOI 10.1016/j.ydbio.2009.12.018; Kim N, 2012, NAT REV GENET, V13, P204, DOI 10.1038/nrg3152; Li XL, 2006, GENE DEV, V20, P1838, DOI 10.1101/gad.1438306; Shin JH, 2006, J BIOL CHEM, V281, P26914, DOI 10.1074/jbc.M605518200; SILVEIRA MH, 1995, NUCLEIC ACIDS RES, V23, P1083, DOI 10.1093/nar/23.6.1083; Torigoe SE, 2011, MOL CELL, V43, P638, DOI 10.1016/j.molcel.2011.07.017; WHITEHALL SK, 1995, GENE DEV, V9, P2974, DOI 10.1101/gad.9.23.2974; Yuan JS, 2012, MOL CELL, V47, P410, DOI 10.1016/j.molcel.2012.05.025; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233; Yusufzai T, 2010, P NATL ACAD SCI USA, V107, P20970, DOI 10.1073/pnas.1011196107; Yusufzai T, 2009, GENE DEV, V23, P2400, DOI 10.1101/gad.1831509	28	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98173	10.1371/journal.pone.0098173	http://dx.doi.org/10.1371/journal.pone.0098173			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866343	Green Published, gold			2022-12-25	WOS:000336914100037
J	Peterson, A; Hanberger, L; Akesson, K; Bojestig, M; Gare, BA; Samuelsson, U				Peterson, Anette; Hanberger, Lena; Akesson, Karin; Bojestig, Mats; Gare, Boel Andersson; Samuelsson, Ulf			Improved Results in Paediatric Diabetes Care Using a Quality Registry in an Improvement Collaborative: A Case Study in Sweden	PLOS ONE			English	Article							METABOLIC-CONTROL; GLYCEMIC CONTROL; ADOLESCENTS; CHILDREN; HYPOGLYCEMIA; COMPLICATIONS; MANAGEMENT	Background: Several studies show that good metabolic control is important for children and adolescents with type 1 diabetes. In Sweden, there are large differences in mean haemoglobin A1c (HbA1c) in different hospitals and difficulties implementing national guidelines in everyday practice. This study shows how the participation in an improvement collaborative could facilitate improvements in the quality of care by paediatric diabetes teams. The Swedish paediatric diabetes quality registry, SWEDIABKIDS was used as a tool and resource for feedback and outcome measures. Methods: Twelve teams at paediatric diabetes centres, caring for 30% (2302/7660) of patients in Sweden, participated in an 18-month quality improvement program. Each team defined treatment targets, areas needing improvement, and action plans. The main outcome was the centre patients' mean HbA1c levels, but other clinical variables and change concepts were also studied. Data from the previous six months were compared with the first six months after starting the program, and the long-term follow up after another eleven months. Results: All centres reduced mean HbA1c during the second and third periods compared with the first. The mean reduction for all was 3.7 mmol/mol (p<0.001), compared with non-participating centres who improved their mean HbA1c with 1.7 mmol/mol during the same period. Many of the participating centres reduced the frequency of severe hypoglycaemia and/or ketoacidosis, and five centres reached their goal of ensuring that all patients had some sort of physical activity at least once weekly. Change concepts were, for example, improved guidelines, appointment planning, informing the patients, improving teamwork and active use of the registry, and health promotion activities. Conclusions: By involving paediatric diabetes teams in a quality improvement collaborative together with access to a quality register, the quality of paediatric diabetes care can improve, thereby contributing to a reduced risk of late complications for children and adolescents with diabetes.	[Hanberger, Lena; Samuelsson, Ulf] Linkoping Univ Hosp, Res Ctr, Div Pediat & Diabetes, Dept Clin & Expt Med, S-58185 Linkoping, Sweden; [Akesson, Karin] Cty Hosp Ryhov, Dept Pediat, Jonkoping, Sweden; [Peterson, Anette; Akesson, Karin; Bojestig, Mats; Gare, Boel Andersson] Jonkoping Univ, Sch Hlth Sci, Jonkoping Acad Improvement Hlth & Welf, Jonkoping, Sweden; [Peterson, Anette; Akesson, Karin; Bojestig, Mats; Gare, Boel Andersson] Jonkoping Cty Council, Jonkoping, Sweden; [Hanberger, Lena] Linkoping Univ, Dept Med & Hlth Sci, Div Nursing Sci, Linkoping, Sweden	Linkoping University; Jonkoping University; Linkoping University	Peterson, A (corresponding author), Jonkoping Univ, Sch Hlth Sci, Jonkoping Acad Improvement Hlth & Welf, Jonkoping, Sweden.	anette.peterson@lj.se			Swedish Association of Local Authorities and Regions (SALAR)	Swedish Association of Local Authorities and Regions (SALAR)	This work was supported by the Swedish Association of Local Authorities and Regions (SALAR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson P, 2008, BARN UNGDOMSDIABETES, P163; [Anonymous], 1993, NEW ENGL J MED, V329, P977; Bangstad HJ, 2009, PEDIATR DIABETES, V10, P82, DOI 10.1111/j.1399-5448.2009.00578.x; Batalden P B, 1993, Jt Comm J Qual Improv, V19, P424; Berwick DM, 2003, MED CARE, V41, pI30; Carlhed R, 2009, CIRC-CARDIOVASC QUAL, V2, P458, DOI 10.1161/CIRCOUTCOMES.108.842146; Danne T, 2001, DIABETES CARE, V24, P1342, DOI 10.2337/diacare.24.8.1342; de Beaufort CE, 2007, DIABETES CARE, V30, P2245, DOI 10.2337/dc07-0475; Godfrey M.M., 2013, J NURSING MANAGEMENT; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hanberger L, 2012, DIABETES RES CLIN PR, V96, P331, DOI 10.1016/j.diabres.2012.01.016; Hanberger L, 2008, DIABETES CARE, V31, P927, DOI 10.2337/dc07-1863; Hansen LO, 2010, QUAL SAF HEALTH CARE, V19, P275, DOI 10.1136/qshc.2009.036087; Kilo C M, 1998, Qual Manag Health Care, V6, P1; Langley GL., 2009, IMPROVEMENT GUIDE PR, V2nd; Mortensen HB, 1997, DIABETES CARE, V20, P714, DOI 10.2337/diacare.20.5.714; Nelson EC, 1996, JOINT COMM J QUAL IM, V22, P243, DOI 10.1016/S1070-3241(16)30228-0; Nordfeldt S, 2001, ACTA PAEDIATR, V90, P137; Nordwall M, 2009, PEDIATR DIABETES, V10, P168, DOI 10.1111/j.1399-5448.2008.00472.x; Olsen BS, 2004, J DIABETES COMPLICAT, V18, P160, DOI 10.1016/S1056-8727(03)00073-4; Peterson Anette, 2007, Qual Manag Health Care, V16, P25; Riddell MC, 2006, PEDIATR DIABETES, V7, P60, DOI 10.1111/j.1399-543X.2006.00146.x; Swift PGF, 2010, PEDIATR DIABETES, V11, P271, DOI 10.1111/j.1399-5448.2009.00596.x; Wild D, 2007, PATIENT EDUC COUNS, V68, P10, DOI 10.1016/j.pec.2007.05.003; Wilson Tim, 2003, Jt Comm J Qual Saf, V29, P85	25	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97875	10.1371/journal.pone.0097875	http://dx.doi.org/10.1371/journal.pone.0097875			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5NG	24867418	Green Published, gold, Green Submitted			2022-12-25	WOS:000336914100025
J	Yardehnavi, N; Behdani, M; Bagheri, KP; Mahmoodzadeh, A; Khanahmad, H; Shahbazzadeh, D; Habibi-Anbouhi, M; Ghassabeh, GH; Muyldermans, S				Yardehnavi, Najmeh; Behdani, Mahdi; Bagheri, Kamran Pooshang; Mahmoodzadeh, Amir; Khanahmad, Hossein; Shahbazzadeh, Delavar; Habibi-Anbouhi, Mahdi; Ghassabeh, Gholamreza Hassanzadeh; Muyldermans, Serge			A camelid antibody candidate for development of a therapeutic agent against Hemiscorpius lepturus envenomation	FASEB JOURNAL			English	Article						scorpionism; nanobody; phage display; heavy-chain antibody; HCAb	TOXIN; AFFINITY; NANOBODY; DOMAINS; HEAVY; VENOM	Hemiscorpius lepturus scorpionism poses one of the most dangerous health problems in many parts of the world. The common therapy consists of using antivenom antibody fragments derived from a polyclonal immune response raised in horses. However, this immunotherapy creates serious side effects, including anaphylactic shock sometimes even leading to death. Thus, many efforts have been made to introduce new replacement therapeutics that cause less adverse reactions. One of the most attractive approaches to replacing the available therapy is offered by single-domain antibody fragments, or nanobodies (Nbs). We immunized dromedaries with H. lepturus toxin and identified a functional recombinant Nb (referred to as F7Nb) against heminecrolysin (HNc), the major known hemolytic and dermonecrotic fraction of H. lepturus venom. This Nb was retrieved from the immune library by phage display selection. The in vitro neutralization tests indicated that 17.5 nmol of the F7Nb can inhibit 45% of the hemolytic activity of 1 EC100 (7.5 mu g/ml) of HNc. The in vivo neutralization tests demonstrated that F7Nb had good antihemolytic and antidermonecrotic effects against HNc in all tested mice. Surprisingly, F7Nb (8.75 nmol) neutralized 1 LD100 of HNc (10 mu g) via an intracerebroventricular route or 1 LD100 (80 mu g) via a subcutaneous route. All of the control mice died. Hence, this Nb is a potential leading novel candidate for treating H. lepturus scorpionism in the near future.	[Yardehnavi, Najmeh; Behdani, Mahdi; Bagheri, Kamran Pooshang; Mahmoodzadeh, Amir; Shahbazzadeh, Delavar] Pasteur Inst Iran, Biotechnol Res Ctr, Venom & Biotherapeut Mol Lab, Tehran, Iran; [Habibi-Anbouhi, Mahdi] Pasteur Inst Iran, Natl Cell Bank Iran, Tehran, Iran; [Khanahmad, Hossein] Isfahan Univ Med Sci, Dept Genet & Mol Biol, Esfahan, Iran; [Ghassabeh, Gholamreza Hassanzadeh] VIB, NSF, Brussels, Belgium; [Muyldermans, Serge] VIB, Struct Biol Res Ctr, Brussels, Belgium; [Ghassabeh, Gholamreza Hassanzadeh; Muyldermans, Serge] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Isfahan University Medical Science; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Shahbazzadeh, D (corresponding author), Pasteur Inst Iran, Biotechnol Res Ctr, Pastor St, Tehran 1316543551, Iran.	shahbazzadeh@pasteur.ac.ir	Habibi-Anbouhi, Mahdi/Q-1681-2016; Behdani, Mahdi/ABG-3723-2021; Yardehnavi, Najmeh/J-4682-2016; Muyldermans, Serge V/C-6418-2016; Khanahmad, Hossein/W-1688-2017; Behdani, Mahdi/W-3322-2017; Shahbazzadeh, Delavar/J-4577-2017; Bagheri, Kamran Pooshang/G-4856-2018; Muyldermans, Serge/AAC-7374-2019	Habibi-Anbouhi, Mahdi/0000-0002-3151-152X; Behdani, Mahdi/0000-0002-4839-5123; Yardehnavi, Najmeh/0000-0001-9298-1480; Muyldermans, Serge V/0000-0002-3678-3575; Behdani, Mahdi/0000-0002-4839-5123; Bagheri, Kamran Pooshang/0000-0003-0125-3918; Muyldermans, Serge/0000-0002-3678-3575; Mahmoodzadeh, Amir/0000-0002-0523-8152	Pasteur Institute of Iran	Pasteur Institute of Iran	This work was a segment of a research project supported by a grant from Pasteur Institute of Iran. N.Y. and M.B. are equal first authors.	Al-Badri ZM, 2008, BIOMACROMOLECULES, V9, P2805, DOI 10.1021/bm800569x; Alvarenga LM, 2003, TOXICON, V42, P725, DOI 10.1016/j.toxicon.2003.09.006; Ardekani L. S., 2013, INT J INFECT DIS; BEATTY JD, 1987, J IMMUNOL METHODS, V100, P173, DOI 10.1016/0022-1759(87)90187-6; Behdani M., 2010, Tehran University Medical Journal, V68, P268; Behdani M, 2012, MOL IMMUNOL, V50, P35, DOI 10.1016/j.molimm.2011.11.013; Ben Abderrazek R, 2011, PROTEIN ENG DES SEL, V24, P727, DOI 10.1093/protein/gzr037; Borchani L, 2011, TOXICON, V58, P130, DOI 10.1016/j.toxicon.2011.05.016; BouhaoualaZahar B, 1996, EUR J BIOCHEM, V238, P653, DOI 10.1111/j.1432-1033.1996.0653w.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Conrath KE, 2001, J BIOL CHEM, V276, P7346, DOI 10.1074/jbc.M007734200; Dehghani R., 2016, REV STATUS SCORPION, P73; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hmila I, 2008, MOL IMMUNOL, V45, P3847, DOI 10.1016/j.molimm.2008.04.011; Hmila I, 2010, FASEB J, V24, P3479, DOI 10.1096/fj.09-148213; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; Lefranc MP, 2005, DEV COMP IMMUNOL, V29, P185, DOI 10.1016/j.dci.2004.07.003; Lin Y, 2011, AFR J BIOTECHNOL, V10, P18294, DOI 10.5897/AJB11.2640; Muyldermans S, 2001, J Biotechnol, V74, P277; Sambrook J, 2001, MOL CLONING LAB MANU; Shahbazzadeh D, 2007, BIOCHEM J, V404, P89, DOI 10.1042/BJ20061404; Srairi-Abid N, 2008, FEBS J, V275, P4641, DOI 10.1111/j.1742-4658.2008.06607.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thys B, 2010, ANTIVIR RES, V87, P257, DOI 10.1016/j.antiviral.2010.05.012; Valavi E, 2008, Indian J Nephrol, V18, P166, DOI 10.4103/0971-4065.45293; Vincke Cecile, 2012, Methods Mol Biol, V911, P15, DOI 10.1007/978-1-61779-968-6_2; World Health Organization, 2008, PROP WHO GUID PROD C	29	17	22	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					4004	4014		10.1096/fj.13-247478	http://dx.doi.org/10.1096/fj.13-247478			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24891523	Green Published			2022-12-25	WOS:000340845900018
J	Brunotte, L; Flies, J; Bolte, H; Reuther, P; Vreede, F; Schwemmle, M				Brunotte, Linda; Flies, Joe; Bolte, Hardin; Reuther, Peter; Vreede, Frank; Schwemmle, Martin			The Nuclear Export Protein of H5N1 Influenza A Viruses Recruits Matrix 1 (M1) Protein to the Viral Ribonucleoprotein to Mediate Nuclear Export	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NS2 PROTEIN; CYTOPLASMIC TRANSPORT; ADAPTIVE MUTATIONS; RNA; BINDING; REPLICATION; MEMBRANE; SIGNAL; IDENTIFICATION; INTERMEDIATE	In influenza A virus-infected cells, replication and transcription of the viral genome occurs in the nucleus. To be packaged into viral particles at the plasma membrane, encapsidated viral genomes must be exported from the nucleus. Intriguingly, the nuclear export protein (NEP) is involved in both processes. Although NEP stimulates viral RNA synthesis by binding to the viral polymerase, its function during nuclear export implicates interaction with viral ribonucleoprotein (vRNP)-associated M1. The observation that both interactions are mediated by the C-terminal moiety of NEP raised the question whether these two features of NEP are linked functionally. Here we provide evidence that the interaction between M1 and the vRNP depends on the NEP C terminus and its polymerase activity-enhancing property for the nuclear export of vRNPs. This suggests that these features of NEP are linked functionally. Furthermore, our data suggest that the N-terminal domain of NEP interferes with the stability of the vRNP-M1-NEP nuclear export complex, probably mediated by its highly flexible intramolecular interaction with the NEP C terminus. On the basis of our data, we propose a new model for the assembly of the nuclear export complex of Influenza A vRNPs.	[Brunotte, Linda; Flies, Joe; Bolte, Hardin; Reuther, Peter; Schwemmle, Martin] Univ Med Ctr Freiburg, Inst Virol, D-79104 Freiburg, Germany; [Vreede, Frank] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX 3RE, England	University of Freiburg; University of Oxford	Schwemmle, M (corresponding author), Univ Med Ctr Freiburg, Inst Virol, Hermann Herder Str 11, D-79104 Freiburg, Germany.	martin.schwemmle@uniklinik-freiburg.de		Reuther, Peter/0000-0002-5198-8165	Bundesministerium fur Bildung und Forschung (FluResearchNet); Deutsche Forschungsgesellschaft [SCHW 632/11-2]; Studienstiftung des deutschen Volkes fellowship; Medical Research Council [G1100138] Funding Source: researchfish; MRC [G1100138] Funding Source: UKRI	Bundesministerium fur Bildung und Forschung (FluResearchNet)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Bundesministerium fur Bildung und Forschung (FluResearchNet) and by Deutsche Forschungsgesellschaft Grant SCHW 632/11-2).; Recipient of a Studienstiftung des deutschen Volkes fellowship.	Akarsu H, 2003, EMBO J, V22, P4646, DOI 10.1093/emboj/cdg449; Amorim MJ, 2011, J VIROL, V85, P4143, DOI 10.1128/JVI.02606-10; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; Bruce EA, 2010, J VIROL, V84, P5848, DOI 10.1128/JVI.00307-10; Bui M, 1996, J VIROL, V70, P8391, DOI 10.1128/JVI.70.12.8391-8401.1996; Bullido R, 2001, J VIROL, V75, P4912, DOI 10.1128/JVI.75.10.4912-4917.2001; COMPANS RW, 1972, J VIROL, V10, P795, DOI 10.1128/JVI.10.4.795-800.1972; Elster C, 1997, J GEN VIROL, V78, P1589, DOI 10.1099/0022-1317-78-7-1589; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Huang SP, 2013, J VIROL, V87, P767, DOI 10.1128/JVI.06519-11; Hutchinson EC, 2013, VIRUSES-BASEL, V5, P2424, DOI 10.3390/v5102424; Jo S, 2010, MICROBES INFECT, V12, P1079, DOI 10.1016/j.micinf.2010.06.011; KAWAKAMI K, 1983, J BIOCHEM-TOKYO, V93, P989, DOI 10.1093/oxfordjournals.jbchem.a134254; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; LAMB RA, 1983, ANNU REV BIOCHEM, V52, P467, DOI 10.1146/annurev.bi.52.070183.002343; Ma K, 2001, VIROLOGY, V282, P215, DOI 10.1006/viro.2001.0833; Manz B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1804; Manz B, 2010, J VIROL, V84, P8316, DOI 10.1128/JVI.00850-10; MARTIN K, 1991, CELL, V67, P117, DOI 10.1016/0092-8674(91)90576-K; Momose F, 2007, MICROBES INFECT, V9, P1422, DOI 10.1016/j.micinf.2007.07.007; Neumann G, 2000, J VIROL, V74, P547, DOI 10.1128/JVI.74.1.547-551.2000; Neumann G, 2000, EMBO J, V19, P6751, DOI 10.1093/emboj/19.24.6751; Noton SL, 2007, J GEN VIROL, V88, P2280, DOI 10.1099/vir.0.82809-0; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; PONS MW, 1969, VIROLOGY, V39, P250, DOI 10.1016/0042-6822(69)90045-2; REES PJ, 1981, J GEN VIROL, V53, P125, DOI 10.1099/0022-1317-53-1-125; Reuther P, 2014, J VIROL, V88, P263, DOI 10.1128/JVI.01495-13; RICHARDSON JC, 1991, ARCH VIROL, V116, P69, DOI 10.1007/BF01319232; Robb NC, 2009, J GEN VIROL, V90, P1398, DOI 10.1099/vir.0.009639-0; RUIGROK RWH, 1995, J GEN VIROL, V76, P1009, DOI 10.1099/0022-1317-76-4-1009; SHAPIRO GI, 1987, J VIROL, V61, P764, DOI 10.1128/JVI.61.3.764-773.1987; Shimizu T, 2011, FEBS LETT, V585, P41, DOI 10.1016/j.febslet.2010.11.017; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Tchatalbachev S, 2001, RNA, V7, P979, DOI 10.1017/S1355838201002424; Turrell L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2589; Whittaker G, 1996, J VIROL, V70, P2743, DOI 10.1128/JVI.70.5.2743-2756.1996; Wu WWH, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-49; YASUDA J, 1993, VIROLOGY, V196, P249, DOI 10.1006/viro.1993.1473; Ye ZP, 1999, J VIROL, V73, P7467, DOI 10.1128/JVI.73.9.7467-7473.1999; York A, 2013, P NATL ACAD SCI USA, V110, pE4238, DOI 10.1073/pnas.1315068110	42	49	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20067	20077		10.1074/jbc.M114.569178	http://dx.doi.org/10.1074/jbc.M114.569178			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24891509	Green Published, hybrid			2022-12-25	WOS:000339395200021
J	Meyer, MB; Benkusky, NA; Lee, CH; Pike, JW				Meyer, Mark B.; Benkusky, Nancy A.; Lee, Chang-Hun; Pike, J. Wesley			Genomic Determinants of Gene Regulation by 1,25-Dihydroxyvitamin D-3 during Osteoblast-lineage Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; BINDING-SITES; TRANSCRIPTION FACTOR; OSTEOCALCIN GENE; TARGET GENES; BONE-FORMATION; NULL MICE; RUNX2; PROMOTER; ACTIVATION	The biological effects of 1 alpha,25-dihydroxyvitamin D-3 (1,25 (OH)(2)D-3) on osteoblast differentiation and function differ significantly depending upon the cellular state of maturation. To explore this phenomenon mechanistically, we examined the impact of 1,25(OH)(2)D-3 on the transcriptomes of both pre-osteoblastic (POBs) and differentiated osteoblastic (OBs) MC3T3-E1 cells, and assessed localization of the vitamin D receptor (VDR) at sites of action on a genome-scale using ChIP sequence analysis. We observed that the 1,25(OH)(2)D-3-induced transcriptomes of POBs and OBs were quantitatively and qualitatively different, supporting not only the altered biology observed but the potential for a change in VDR interaction at the genome as well. This idea was confirmed through discovery that VDR cistromes in POBs and OBs were also strikingly different. Depletion of VDR-binding sites in OBs, due in part to reduced VDR expression, was the likely cause of the loss of VDR-target gene interaction. Continued novel regulation by 1,25(OH) 2D(3), however, suggested that factors in addition to the VDR might also be involved. Accordingly, we show that transcriptomic modifications are also accompanied by changes in genome binding of the master osteoblast regulator RUNX2 and the chromatin remodeler CCAAT/enhancer-binding protein beta. Importantly, genome occupancy was also highlighted by the presence of epigenetic enhancer signatures that were selectively changed in response to both differentiation and 1,25(OH) 2D(3). The impact of VDR, RUNX2, and C/EBP beta on osteoblast differentiation is exemplified by their actions at the Runx2 and Sp7 gene loci. We conclude that each of these mechanisms may contribute to the diverse actions of 1,25(OH) 2D(3) on differentiating osteoblasts.	[Meyer, Mark B.; Benkusky, Nancy A.; Lee, Chang-Hun; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Pike, JW (corresponding author), Univ Wisconsin, Dept Biochem, Hector F Deluca Biochem Labs, Rm 543D,433 Babcock Dr, Madison, WI 53706 USA.	pike@biochem.wisc.edu			National Institutes of Health from NIDDK [DK-072281]; National Institutes of Health from NIAMS [AR-045173]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072281] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; National Institutes of Health from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-072281 from NIDDK and AR-045173 from NIAMS (to J. W. P.).	Amling M, 1999, ENDOCRINOLOGY, V140, P4982, DOI 10.1210/en.140.11.4982; Bikle DD, 2012, CURR OSTEOPOROS REP, V10, P151, DOI 10.1007/s11914-012-0098-z; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Bouillon R, 2008, J BONE MINER RES, V23, P974, DOI 10.1359/JBMR.080420; Carlberg C, 2007, J STEROID BIOCHEM, V103, P338, DOI 10.1016/j.jsbmb.2006.12.044; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Dallas SL, 2010, ANN NY ACAD SCI, V1192, P437, DOI 10.1111/j.1749-6632.2009.05246.x; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dowd DR, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P291; Drissi H, 2002, EXP CELL RES, V274, P323, DOI 10.1006/excr.2002.5474; Eisman John A, 2014, Bonekey Rep, V3, P499, DOI 10.1038/bonekey.2013.233; ELFORD PR, 1987, CALCIFIED TISSUE INT, V41, P151, DOI 10.1007/BF02563795; Franceschi RT, 2003, CONNECT TISSUE RES, V44, P109, DOI 10.1080/03008200390152188; Franceschi RT, 2003, J CELL BIOCHEM, V88, P446, DOI 10.1002/jcb.10369; Gardiner EM, 2000, FASEB J, V14, P1908, DOI 10.1096/fj.99-1075com; Gutierrez S, 2002, J BIOL CHEM, V277, P1316, DOI 10.1074/jbc.M106611200; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Inoue Y, 2005, BIOCHEM J, V390, P325, DOI 10.1042/BJ20041799; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Jensen ED, 2007, CRIT REV EUKAR GENE, V17, P187; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Jonason JH, 2009, J DENT RES, V88, P693, DOI 10.1177/0022034509341629; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Kriebitzsch C, 2011, J BONE MINER RES, V26, P2991, DOI 10.1002/jbmr.493; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee SM, 2014, ENDOCRINOLOGY, V155, P2064, DOI 10.1210/en.2014-1107; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Lian JB, 2001, STEROIDS, V66, P159, DOI 10.1016/S0039-128X(00)00160-4; Lieben L, 2013, J STEROID BIOCHEM, V136, P102, DOI 10.1016/j.jsbmb.2012.09.019; Lieben L, 2012, J CLIN INVEST, V122, P1803, DOI 10.1172/JCI45890; Lieben L, 2011, BEST PRACT RES CL EN, V25, P561, DOI 10.1016/j.beem.2011.05.008; Liu JC, 2011, J BIOL CHEM, V286, P30057, DOI 10.1074/jbc.M111.241505; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Marcellini S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-78; Meyer MB, 2007, J BIOL CHEM, V282, P22344, DOI 10.1074/jbc.M703475200; Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Meyer MB, 2014, J STEROID BIOCHEM, V144, P19, DOI 10.1016/j.jsbmb.2013.09.005; Meyer MB, 2013, J STEROID BIOCHEM, V136, P120, DOI 10.1016/j.jsbmb.2012.08.006; Meyer MB, 2012, MOL ENDOCRINOL, V26, P37, DOI 10.1210/me.2011-1109; Meyer MB, 2010, J STEROID BIOCHEM, V121, P136, DOI 10.1016/j.jsbmb.2010.02.011; Meyer MB, 2010, J BIOL CHEM, V285, P15599, DOI 10.1074/jbc.M110.119958; Murayama A, 2004, EMBO J, V23, P1598, DOI 10.1038/sj.emboj.7600157; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Panda DK, 2004, J BIOL CHEM, V279, P16754, DOI 10.1074/jbc.M310271200; Peng YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056451; Pike JW, 2007, J STEROID BIOCHEM, V103, P389, DOI 10.1016/j.jsbmb.2006.12.050; Pike JW, 2014, J STEROID BIOCHEM, V144, P5, DOI 10.1016/j.jsbmb.2013.11.004; Pike J Wesley, 2014, Bonekey Rep, V3, P482, DOI 10.1038/bonekey.2013.216; Plum LA, 2010, NAT REV DRUG DISCOV, V9, P941, DOI 10.1038/nrd3318; Schroeder Tania M., 2005, Birth Defects Research, V75, P213, DOI 10.1002/bdrc.20043; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Steinberg XP, 2012, BIOCHEMISTRY-US, V51, P952, DOI 10.1021/bi201593q; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; UDAGAWA N, 1989, ENDOCRINOLOGY, V125, P1805, DOI 10.1210/endo-125-4-1805; Wang YJ, 2014, J BONE MINER RES, V29, P685, DOI 10.1002/jbmr.2081; Welboren WJ, 2007, MOL ONCOL, V1, P138, DOI 10.1016/j.molonc.2007.04.001; Yamamoto H, 2003, J BIOL CHEM, V278, P31756, DOI 10.1074/jbc.M304737200; Zella LA, 2006, MOL ENDOCRINOL, V20, P1231, DOI 10.1210/me.2006-0015; Zella LA, 2010, MOL ENDOCRINOL, V24, P128, DOI 10.1210/me.2009-0140	67	68	71	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19539	19554		10.1074/jbc.M114.578104	http://dx.doi.org/10.1074/jbc.M114.578104			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24891508	hybrid, Green Published			2022-12-25	WOS:000339326800029
J	Soares, F; Tattoli, I; Rahman, MA; Robertson, SJ; Belcheva, A; Liu, D; Streutker, C; Winer, S; Winer, DA; Martin, A; Philpott, DJ; Arnoult, D; Girardin, SE				Soares, Fraser; Tattoli, Ivan; Rahman, Muhammed A.; Robertson, Susan J.; Belcheva, Antoaneta; Liu, Daniel; Streutker, Catherine; Winer, Shawn; Winer, Daniel A.; Martin, Alberto; Philpott, Dana J.; Arnoult, Damien; Girardin, Stephen E.			The Mitochondrial Protein NLRX1 Controls the Balance between Extrinsic and Intrinsic Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOD-LIKE RECEPTOR; IMMUNITY; CELLS	NLRX1 is a mitochondrial Nod-like receptor (NLR) protein whose function remains enigmatic. Here, we observed that NLRX1 expression was glucose-regulated and blunted by SV40 transformation. In transformed but not primary murine embryonic fibroblasts, NLRX1 expression mediated resistance to an extrinsic apoptotic signal, whereas conferring susceptibility to intrinsic apoptotic signals, such as glycolysis inhibition, increased cytosolic calcium and endoplasmic reticulum stress. In a murine model of colorectal cancer induced by azoxymethane, NLRX1-/- mice developed fewer tumors than wild type mice. In contrast, in a colitis-associated cancer model combining azoxymethane and dextran sulfate sodium, NLRX1-/- mice developed a more severe pathology likely due to the increased sensitivity to dextran sulfate sodium colitis. Together, these results identify NLRX1 as a critical mitochondrial protein implicated in the regulation of apoptosis in cancer cells. The unique capacity of NLRX1 to regulate the cellular sensitivity toward intrinsic versus extrinsic apoptotic signals suggests a critical role for this protein in numerous physiological processes and pathological conditions.	[Soares, Fraser; Tattoli, Ivan; Rahman, Muhammed A.; Liu, Daniel; Streutker, Catherine; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M6G 2T6, Canada; [Tattoli, Ivan; Rahman, Muhammed A.; Robertson, Susan J.; Belcheva, Antoaneta; Martin, Alberto; Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON M6G 2T6, Canada; [Streutker, Catherine] Univ Toronto, St Michaels Hosp, Toronto, ON M6G 2T6, Canada; [Winer, Shawn; Winer, Daniel A.] Univ Toronto, Toronto Gen Hosp, Dept Pathol, Toronto, ON M6G 2T6, Canada; [Arnoult, Damien] Hop Paul Brousse, INSERM, U1014, F-94807 Villejuif, France	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Girardin, SE (corresponding author), Univ Toronto, Med Sci Bldg,Rm 6336, Toronto, ON M5S 1A8, Canada.	stephen.girardin@utoronto.ca	Tattoli, Ivan/H-2600-2017; Arnoult, Damien/R-2032-2018	Tattoli, Ivan/0000-0001-7925-4609; Soares, Fraser/0000-0002-3977-7939; Martin, Alberto/0000-0002-0795-0418; Belcheva, Antoaneta/0000-0001-5061-7533	Canadian Institutes of Health Research (CIHR); Burroughs Wellcome Fund; Banting and Best Graduate Scholarship from CIHR; Canadian Cancer Society	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Banting and Best Graduate Scholarship from CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) (to D. J. P. and S. E. G.), the Burroughs Wellcome Fund (to S. E. G.), a Banting and Best Graduate Scholarship from CIHR (to F. S.), and the Canadian Cancer Society (to S. E. G.).	Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Augenlicht L, 1999, ADV EXP MED BIOL, V470, P15; Carneiro LAM, 2009, CELL HOST MICROBE, V5, P123, DOI 10.1016/j.chom.2008.12.011; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Cowling V, 2002, CELL DEATH DIFFER, V9, P1046, DOI 10.1038/sj.cdd.4401065; Danielsson F, 2013, P NATL ACAD SCI USA, V110, P6853, DOI 10.1073/pnas.1216436110; Dimberg LY, 2013, ONCOGENE, V32, P1341, DOI 10.1038/onc.2012.164; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Geddes K, 2011, NAT MED, V17, P837, DOI 10.1038/nm.2391; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Ling A, 2012, J BIOL CHEM, V287, P28705, DOI 10.1074/jbc.M111.333146; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Rebsamen M, 2011, CELL DEATH DIFFER, V18, P1387, DOI 10.1038/cdd.2011.64; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Sasaki O, 2013, BBA-MOL CELL RES, V1833, P1017, DOI 10.1016/j.bbamcr.2013.01.010; Soares F, 2013, INNATE IMMUN-LONDON, V19, P438, DOI 10.1177/1753425912467383; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161	19	50	52	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19317	19330		10.1074/jbc.M114.550111	http://dx.doi.org/10.1074/jbc.M114.550111			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24867956	Green Published, hybrid			2022-12-25	WOS:000339326800009
J	Soliman, A; Ayele, BT; Daayf, F				Soliman, Atta; Ayele, Belay T.; Daayf, Fouad			Biochemical and Molecular Characterization of Barley Plastidial ADP-Glucose Transporter (HvBT1)	PLOS ONE			English	Article							CYTOSOLIC SMALL-SUBUNIT; ESCHERICHIA-COLI; STARCH SYNTHESIS; GENE; PYROPHOSPHORYLASE; EXPRESSION; ENDOSPERM; PROTEIN; BIOSYNTHESIS; SYSTEM	In cereals, ADP-glucose transporter protein plays an important role in starch biosynthesis. It acts as a main gate for the transport of ADP-glucose, the main precursor for starch biosynthesis during grain filling, from the cytosol into the amyloplasts of endospermic cells. In this study, we have shed some light on the molecular and biochemical characteristics of barley plastidial ADP-glucose transporter, HvBT1. Phylogenetic analysis of several BT1 homologues revealed that BT1 homologues are divided into two distinct groups. The HvBT1 is assigned to the group that represents BT homologues from monocotyledonous species. Some members of this group mainly work as nucleotide sugar transporters. Southern blot analysis showed the presence of a single copy of HvBT1 in barley genome. Gene expression analysis indicated that HvBT1 is mainly expressed in endospermic cells during grain filling; however, low level of its expression was detected in the autotrophic tissues, suggesting the possible role of HvBT1 in autotrophic tissues. The cellular and subcellular localization of HvBT1 provided additional evidence that HvBT1 targets the amyloplast membrane of the endospermic cells. Biochemical characterization of HvBT1 using E. coli system revealed that HvBT1 is able to transport ADP-glucose into E. coli cells with an affinity of 614.5 mu M and in counter exchange of ADP with an affinity of 334.7 mu M. The study also showed that AMP is another possible exchange substrate. The effect of non-labeled ADP-glucose and ADP on the uptake rate of [alpha-P-32] ADP-glucose indicated the substrate specificity of HvBT1 for ADP-glucose and ADP.	[Soliman, Atta; Ayele, Belay T.; Daayf, Fouad] Univ Manitoba, Dept Plant Sci, Fac Agr & Food Sci, Winnipeg, MB R3T 2N2, Canada; [Soliman, Atta] Tanta Univ, Fac Agr, Dept Genet, Tanta, El Gharbia, Egypt	University of Manitoba; Egyptian Knowledge Bank (EKB); Tanta University	Daayf, F (corresponding author), Univ Manitoba, Dept Plant Sci, Fac Agr & Food Sci, Winnipeg, MB R3T 2N2, Canada.	Fouad.Daayf@umanitoba.ca	Daayf, Fouad/P-3901-2019	Daayf, Fouad/0000-0001-8912-0460	ministry of Higher Education, Egypt; Agri-Food Research and Development Initiative, Manitoba, Canada [ARDI-10-1042]	ministry of Higher Education, Egypt(Ministry of Higher Education & Scientific Research (MHESR)); Agri-Food Research and Development Initiative, Manitoba, Canada	AS was financially supported by a Ph.D. scholarship from the ministry of Higher Education, Egypt. BTA and FD received grant #ARDI-10-1042 from Agri-Food Research and Development Initiative, Manitoba, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bahaji A, 2014, BIOTECHNOL ADV, V32, P87, DOI 10.1016/j.biotechadv.2013.06.006; Bahaji A, 2011, PLANT CELL PHYSIOL, V52, P597, DOI 10.1093/pcp/pcr019; Belmonte M, 2006, J EXP BOT, V56, P23; Bernaudat F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029191; Bowsher CG, 2007, J EXP BOT, V58, P1321, DOI 10.1093/jxb/erl297; Brown W, 2008, NATURE ED, V1, P202; Canton FR, 1999, PLANT MOL BIOL, V40, P623, DOI 10.1023/A:1006219205062; CAO HP, 1995, PHYSIOL PLANTARUM, V95, P176, DOI 10.1111/j.1399-3054.1995.tb00825.x; Cao HP, 1996, PHYSIOL PLANTARUM, V97, P665, DOI 10.1111/j.1399-3054.1996.tb00530.x; Chen DQ, 2006, GENE THER MOL BIOL, V10A, P1; Denyer K, 1996, PLANT J, V10, P1135, DOI 10.1046/j.1365-313X.1996.10061135.x; GHOSH HP, 1966, J BIOL CHEM, V241, P4491; GIROUX MJ, 1994, MOL GEN GENET, V243, P400, DOI 10.1007/BF00280470; James MG, 2003, CURR OPIN PLANT BIOL, V6, P215, DOI 10.1016/S1369-5266(03)00042-6; Johnson PE, 2003, PLANT PHYSIOL, V131, P684, DOI 10.1104/pp.013094; Kirchberger S, 2008, PLANT J, V56, P51, DOI 10.1111/j.1365-313X.2008.03583.x; Kirchberger S, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702484200; LAEMMLI UK, 1970, J MOL BIOL, V49, P99, DOI 10.1016/0022-2836(70)90379-7; Lee DW, 2011, METHODS MOL BIOL, V774, P59, DOI 10.1007/978-1-61779-234-2_4; Leroch M, 2005, J BIOL CHEM, V280, P17992, DOI 10.1074/jbc.M412462200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Millar AH, 2003, PLANT PHYSIOL, V131, P443, DOI 10.1104/pp.009985; Narayanan A, 2011, PROTEIN SCI, V20, P51, DOI 10.1002/pro.535; Patron NJ, 2004, PLANT PHYSIOL, V135, P2088, DOI 10.1104/pp.104.045203; Picault N, 2004, TRENDS PLANT SCI, V9, P138, DOI 10.1016/j.tplants.2004.01.007; Rosti S, 2006, J EXP BOT, V57, P3619, DOI 10.1093/jxb/erl110; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Shannon JC, 1996, PLANT PHYSIOL, V110, P835, DOI 10.1104/pp.110.3.835; Tahir M, 2006, TREE PHYSIOL, V26, P1257, DOI 10.1093/treephys/26.10.1257; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tetlow IJ, 2003, J EXP BOT, V54, P715, DOI 10.1093/jxb/erg088; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tjaden J, 1998, J BIOL CHEM, V273, P9630, DOI 10.1074/jbc.273.16.9630; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	36	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98524	10.1371/journal.pone.0098524	http://dx.doi.org/10.1371/journal.pone.0098524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892865	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400061
J	Sun, LH; Zhuo, K; Lin, BR; Wang, HH; Liao, JL				Sun, Longhua; Zhuo, Kan; Lin, Borong; Wang, Honghong; Liao, Jinling			The Complete Mitochondrial Genome of Meloidogyne graminicola (Tylenchina): A Unique Gene Arrangement and Its Phylogenetic Implications	PLOS ONE			English	Article							PLANT-PARASITIC NEMATODES; AMINO-ACID REPLACEMENT; CONTROL REGION; RNA GENES; EVOLUTION; DNA; MODEL; IDENTIFICATION; SEQUENCES; SELECTION	Meloidogyne graminicola is one of the most economically important plant parasitic-nematodes (PPNs). In the present study, we determined the complete mitochondrial (mt) DNA genome sequence of this plant pathogen. Compared with other PPNs genera, this genome (19,589 bp) is only slightly smaller than that of Pratylenchus vulnus (21,656 bp). The nucleotide composition of the whole mtDNA sequence of M. graminicola is significantly biased toward A and T, with T being the most favored nucleotide and C being the least favored. The A+T content of the entire genome is 83.51%. The mt genome of M. graminicola contains 36 genes (lacking atp8) that are transcribed in the same direction. The gene arrangement of the mt genome of M. graminicola is unique. A total of 21 out of 22 tRNAs possess a DHU loop only, while tRNA(Ser(AGN)) lacks a DHU loop. The two large noncoding regions (2,031 bp and 5,063 bp) are disrupted by tRNA(Ser(UCN)). Phylogenetic analysis based on concatenated amino acid sequences of 12 protein-coding genes support the monophylies of the three orders Rhabditida, Mermithida and Trichinellida, the suborder Rhabditina and the three infraorders Spiruromorpha, Oxyuridomorpha and Ascaridomorpha, but do not support the monophylies of the two suborders Spirurina and Tylenchina, and the three infraorders Rhabditomorpha, Panagrolaimomorpha and Tylenchomorpha. The four Tylenchomorpha species including M. graminicola, P. vulnus, H. glycines and R. similis from the superfamily Tylenchoidea are placed within a well-supported monophyletic clade, but far from the other two Tylenchomorpha species B. xylophilus and B. mucronatus of Aphelenchoidea. In the clade of Tylenchoidea, M. graminicola is sister to P. vulnus, and H. glycines is sister to R. similis, which suggests root-knot nematodes has a closer relationship to Pratylenchidae nematodes than to cyst nematodes.	[Sun, Longhua; Zhuo, Kan; Lin, Borong; Wang, Honghong; Liao, Jinling] South China Agr Univ, Lab Plant Nematol, Guangzhou, Guangdong, Peoples R China; [Sun, Longhua; Zhuo, Kan; Lin, Borong; Wang, Honghong; Liao, Jinling] South China Agr Univ, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University	Zhuo, K (corresponding author), South China Agr Univ, Lab Plant Nematol, Guangzhou, Guangdong, Peoples R China.	zhuokan@scau.edu.cn; jlliao@scau.edu.cn			National Key Basic Research Program of China (973 Program) [2013CB127501]; special fund for agro-scientific research in the public interest of China [201103018]; National Natural Science Foundation of China [31171824]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); special fund for agro-scientific research in the public interest of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Key Basic Research Program of China (973 Program) (No. 2013CB127501), the special fund for agro-scientific research in the public interest of China (number 201103018) and the National Natural Science Foundation of China (No. 31171824). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abascal F, 2007, MOL BIOL EVOL, V24, P1; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bert W, 2008, MOL PHYLOGENET EVOL, V48, P728, DOI 10.1016/j.ympev.2008.04.011; Besnard G, 2014, CR BIOL, V337, P295, DOI 10.1016/j.crvi.2014.03.003; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; De Ley Paul, 2002, P1; Decraemer W, 2006, PLANT NEMATOLOGY, P3, DOI [10.1079/9781845930561.0003, 10.1079/9781780641515.0003]; Geraert E, 1997, NEMATOLOGICA, V43, P283, DOI 10.1163/005025997X00049; Gibson T, 2007, J MOL EVOL, V65, P308, DOI 10.1007/s00239-007-9007-y; Gibson T, 2007, J MOL EVOL, V64, P463, DOI 10.1007/s00239-006-0187-7; Gibson T, 2011, GENOME, V54, P565, DOI [10.1139/G11-024, 10.1139/g11-024]; Gross SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024534; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HARRIS TS, 1990, J NEMATOL, V22, P518; Hassanin A, 2005, SYST BIOL, V54, P277, DOI 10.1080/10635150590947843; He Y, 2005, J MOL EVOL, V61, P819, DOI 10.1007/s00239-005-0102-7; Holterman M, 2009, PHYTOPATHOLOGY, V99, P227, DOI 10.1094/PHYTO-99-3-0227; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Hu M, 2006, TRENDS PARASITOL, V22, P78, DOI 10.1016/j.pt.2005.12.003; HUGALL A, 1994, GENETICS, V136, P903; Hugall A, 1997, MOL BIOL EVOL, V14, P40, DOI 10.1093/oxfordjournals.molbev.a025700; Humphreys-Pereira DA, 2014, MOL BIOCHEM PARASIT, V194, P20, DOI 10.1016/j.molbiopara.2014.04.003; Humphreys-Pereira DA, 2013, NEMATOLOGY, V15, P315, DOI 10.1163/15685411-00002684; Jacob Joachim E M, 2009, BMC Res Notes, V2, P192, DOI 10.1186/1756-0500-2-192; Jex AR, 2010, NUCLEIC ACIDS RES, V38, P522, DOI 10.1093/nar/gkp883; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lavrov DV, 2007, INTEGR COMP BIOL, V47, P734, DOI 10.1093/icb/icm045; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Liu GH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-414; Liu GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042172; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lunt DH, 1998, MOL ECOL, V7, P1441, DOI 10.1046/j.1365-294x.1998.00495.x; MAGGENTI A R, 1987, Revue de Nematologie, V10, P135; Mancini E, 2008, GENOME, V51, P196, DOI 10.1139/G07-116; Moreira C, 2014, MITOCHONDR DNA, V25, P420, DOI 10.3109/19401736.2013.809438; Morrison D. A., 2010, ARXIV10013813V1; Nicol JM, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P21, DOI 10.1007/978-94-007-0434-3_2; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OKIMOTO R, 1994, J MOL EVOL, V39, P598, DOI 10.1007/BF00160405; OKIMOTO R, 1991, NUCLEIC ACIDS RES, V19, P1619, DOI 10.1093/nar/19.7.1619; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; POWERS TO, 1993, J NEMATOL, V25, P1; Powers TO, 2005, J NEMATOL, V37, P226; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rybarczyk-Mydlowska K, 2014, NEMATOLOGY, V16, P125, DOI 10.1163/15685411-00002750; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Siddiqi M. R., 2000, TYLENCHIDA PARASITES; Subbotin SA, 2006, NEMATOLOGY, V8, P455, DOI 10.1163/156854106778493420; Sultana T, 2013, GENE, V520, P39, DOI 10.1016/j.gene.2013.02.006; Sultana T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-12; Tan HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023008; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Whipple LE, 1998, FUND APPL NEMATOL, V21, P265; WOLSTENHOLME DR, 1987, P NATL ACAD SCI USA, V84, P1324, DOI 10.1073/pnas.84.5.1324; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; ZHANG DX, 1995, J MOL EVOL, V40, P382, DOI 10.1007/BF00164024	62	31	31	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98558	10.1371/journal.pone.0098558	http://dx.doi.org/10.1371/journal.pone.0098558			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892428	gold, Green Published, Green Submitted			2022-12-25	WOS:000336911400066
J	Leech, R; Scott, G; Carhart-Harris, R; Turkheimer, F; Taylor-Robinson, SD; Sharp, DJ				Leech, Robert; Scott, Gregory; Carhart-Harris, Robin; Turkheimer, Federico; Taylor-Robinson, Simon D.; Sharp, David J.			Spatial Dependencies between Large-Scale Brain Networks	PLOS ONE			English	Article							DEFAULT-MODE NETWORK; NEURONAL AVALANCHES; RESTING-STATE; COMPETITION; ECHOES; ENERGY	Functional neuroimaging reveals both increases (task-positive) and decreases (task-negative) in neural activation with many tasks. Many studies show a temporal relationship between task positive and task negative networks that is important for efficient cognitive functioning. Here we provide evidence for a spatial relationship between task positive and negative networks. There are strong spatial similarities between many reported task negative brain networks, termed the default mode network, which is typically assumed to be a spatially fixed network. However, this is not the case. The spatial structure of the DMN varies depending on what specific task is being performed. We test whether there is a fundamental spatial relationship between task positive and negative networks. Specifically, we hypothesize that the distance between task positive and negative voxels is consistent despite different spatial patterns of activation and deactivation evoked by different cognitive tasks. We show significantly reduced variability in the distance between within-condition task positive and task negative voxels than across-condition distances for four different sensory, motor and cognitive tasks - implying that deactivation patterns are spatially dependent on activation patterns (and vice versa), and that both are modulated by specific task demands. We also show a similar relationship between positively and negatively correlated networks from a third 'rest' dataset, in the absence of a specific task. We propose that this spatial relationship may be the macroscopic analogue of microscopic neuronal organization reported in sensory cortical systems, and that this organization may reflect homeostatic plasticity necessary for efficient brain function.	[Leech, Robert; Scott, Gregory; Carhart-Harris, Robin; Sharp, David J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Div Brain Sci, London, England; [Turkheimer, Federico] Kings Coll London, Dept Neuroimaging, Inst Psychiat, London WC2R 2LS, England; [Taylor-Robinson, Simon D.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England	Imperial College London; University of London; King's College London; Imperial College London	Leech, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Div Brain Sci, London, England.	r.leech@imperial.ac.uk	Leech, Robert/AAE-8254-2019; Sharp, David J/A-2119-2013; Turkheimer, Federico E/B-9485-2012	Leech, Robert/0000-0002-5801-6318; Turkheimer, Federico E/0000-0002-3766-3815; Scott, Gregory/0000-0001-8063-5871	Human Connectome Project, WUMinn Consortium - 16 NIH Institutes and Centers [1U54MH091657]; McDonnell Center for Systems Neuroscience at Washington University; MRC [G1100809, G0701951, MR/K015192/1] Funding Source: UKRI; Medical Research Council [G0701951, G1100809, MR/K015192/1] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-048] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER	Human Connectome Project, WUMinn Consortium - 16 NIH Institutes and Centers; McDonnell Center for Systems Neuroscience at Washington University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	One of the three datasets analyzed was provided by the Human Connectome Project, WUMinn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Beggs JM, 2003, J NEUROSCI, V23, P11167; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Braga RM, 2013, J NEUROSCI, V33, P14031, DOI 10.1523/JNEUROSCI.0570-13.2013; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Cocchi L, 2013, TRENDS COGN SCI, V17, P493, DOI 10.1016/j.tics.2013.08.006; Daugman J.G., 1990, COMPUTATIONAL NEUROS, P403; Dougan L, 2011, P NATL ACAD SCI USA, V108, P9759, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Expert P, 2011, J R SOC INTERFACE, V8, P472, DOI 10.1098/rsif.2010.0416; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Glasser M.F., 2013, NEUROIMAGE; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Harel N, 2002, J CEREBR BLOOD F MET, V22, P908, DOI 10.1097/00004647-200208000-00002; Harrison BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022964; He BYJ, 2011, J NEUROSCI, V31, P13786, DOI 10.1523/JNEUROSCI.2111-11.2011; Hellyer PJ, 2014, J NEUROSCI, V34, P451, DOI 10.1523/JNEUROSCI.1853-13.2014; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Laughlin SB, 2001, CURR OPIN NEUROBIOL, V11, P475, DOI 10.1016/S0959-4388(00)00237-3; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; McPhail MJW, 2013, NEUROLOGY, V80, P1041, DOI 10.1212/WNL.0b013e31828726e1; Plenz D, 2007, TRENDS NEUROSCI, V30, P101, DOI 10.1016/j.tins.2007.01.005; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Seghier ML, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00281; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Singh KD, 2008, NEUROIMAGE, V41, P100, DOI 10.1016/j.neuroimage.2008.01.051; Smith SM, 2012, P NATL ACAD SCI USA, V109, P3131, DOI 10.1073/pnas.1121329109; Tagliazucchi E, 2012, FRONTIERS PHYSL; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758	35	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98500	10.1371/journal.pone.0098500	http://dx.doi.org/10.1371/journal.pone.0098500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887067	Green Submitted, gold, Green Published			2022-12-25	WOS:000336956300074
J	Liu, CY; Ward, PJ; English, AW				Liu, Caiyue; Ward, Patricia J.; English, Arthur W.			The Effects of Exercise on Synaptic Stripping Require Androgen Receptor Signaling	PLOS ONE			English	Article							PERIPHERAL-NERVE REGENERATION; RAT SPINAL-CORD; VESICULAR GLUTAMATE TRANSPORTERS; HAMSTER FACIAL MOTONEURONS; ELECTRICAL-STIMULATION; SKELETAL-MUSCLE; SCIATIC-NERVE; DIFFERENTIAL REGULATION; INDUCED ACCELERATION; AXON REGENERATION	Following peripheral nerve injury, synapses are withdrawn from axotomized motoneurons. Moderate daily treadmill exercise, which promotes axon regeneration of cut peripheral nerves, also influences this synaptic stripping. Different exercise protocols are required to promote axon regeneration in male and female animals, but the sex requirements for an effect of exercise on synaptic stripping are unknown. In male and female C57BL/6 mice, the sciatic nerve was transected in the mid-thigh. Mice were then exercised five days per week for two weeks, beginning on the third post-transection day. Half of the exercised mice were trained by walking slowly (10 M/min) on a level treadmill for one hour per day (continuous training). Other mice were interval trained; four short (two min) sprints at 20 M/min separated by five minute rest periods. A third group was untrained. The extent of synaptic contacts made by structures immunoreactive to vesicular glutamate transporter 1 and glutamic acid decarboxylase 67 onto axotomized motoneurons was studied in confocal images of retrogradely labeled cells. Both types of presumed synaptic contacts were reduced markedly in unexercised mice following nerve transection, relative to intact mice. No significant reduction was found in continuous trained males or interval trained females. Reductions in these contacts in interval trained males and continuous trained females were identical to that observed in untrained mice. Treatments with the anti-androgen, flutamide, blocked the effect of sex-appropriate exercise on synaptic contacts in both males and females. Moderate daily exercise has a potent effect on synaptic inputs to axotomized motoneurons. Successful effects of exercise have different requirements in males and females, but require androgen receptor signaling in both sexes.	[Liu, Caiyue] Second Mil Med Univ, Changzheng Hosp, Dept Plast & Reconstruct Surg, Shanghai, Peoples R China; [Ward, Patricia J.; English, Arthur W.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA	Naval Medical University; Emory University	English, AW (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.	medae@emory.edu		Ward, Patricia/0000-0002-5379-3644	NIH from the USPHS [NS057190, HD032571]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD032571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057190] Funding Source: NIH RePORTER	NIH from the USPHS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by NIH Grants NS057190 and HD032571 from the USPHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa K, 2008, J APPL PHYSIOL, V104, P67, DOI 10.1152/japplphysiol.00558.2007; Al-Majed AA, 2000, J NEUROSCI, V20, P2602; Aldskogius H, 1999, J NEUROSCI RES, V58, P33, DOI 10.1002/(SICI)1097-4547(19991001)58:1<33::AID-JNR5>3.3.CO;2-D; Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; Alvarez FJ, 2011, J NEUROPHYSIOL, V106, P2450, DOI 10.1152/jn.01095.2010; Berg A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059647; Berg A, 2012, EXP NEUROL, V237, P8, DOI 10.1016/j.expneurol.2012.06.008; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Brown TJ, 2001, RESTOR NEUROL NEUROS, V18, P191; Brown TJ, 1999, RESTOR NEUROL NEUROS, V15, P289; Brown TJ, 2013, RESTOR NEUROL NEUROS, V31, P169, DOI 10.3233/RNN-120287; Coirini H, 2002, NEUROSCIENCE, V113, P883, DOI 10.1016/S0306-4522(02)00224-5; COPE TC, 1993, J NEUROPHYSIOL, V70, P1787, DOI 10.1152/jn.1993.70.5.1787; De Bono JP, 2006, AM J PHYSIOL-REG I, V290, pR926, DOI 10.1152/ajpregu.00694.2005; de Carrizosa MADL, 2009, J NEUROSCI, V29, P575, DOI 10.1523/JNEUROSCI.5312-08.2009; English AW, 2011, ANN ANAT, V193, P354, DOI 10.1016/j.aanat.2011.02.013; Fargo KN, 2008, J NEUROTRAUM, V25, P561, DOI 10.1089/neu.2007.0466; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; FUNAKOSHI H, 1993, J CELL BIOL, V123, P455, DOI 10.1083/jcb.123.2.455; Garcia-Ovejero D, 2005, BRAIN RES REV, V48, P273, DOI 10.1016/j.brainresrev.2004.12.018; Gomez-Pinilla F, 2002, J NEUROPHYSIOL, V88, P2187, DOI 10.1152/jn.00152.2002; Gomez-Pinilla F, 2001, EUR J NEUROSCI, V13, P1078, DOI 10.1046/j.0953-816x.2001.01484.x; Gordon Tessa, 2009, Neurosurg Focus, V26, pE3, DOI 10.3171/FOC.2009.26.2.E3; Gottfried-Blackmore A, 2008, J STEROID BIOCHEM, V109, P96, DOI 10.1016/j.jsbmb.2007.12.013; GRAEBER MB, 1986, J NEUROCYTOL, V15, P363; GRIESBECK O, 1995, J NEUROSCI RES, V42, P21, DOI 10.1002/jnr.490420104; Hoke A, 2013, EXP NEUROL, V239, pA1, DOI 10.1016/j.expneurol.2012.12.011; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Hughes DI, 2005, P NATL ACAD SCI USA, V102, P9038, DOI 10.1073/pnas.0503646102; Jones KJ, 1999, J NEUROSCI RES, V57, P817, DOI 10.1002/(SICI)1097-4547(19990915)57:6<817::AID-JNR6>3.0.CO;2-Q; Jones KJ, 1997, J NEUROCYTOL, V26, P257, DOI 10.1023/A:1018596316465; Jones SL, 2012, ENDOCRINOLOGY, V153, P5928, DOI 10.1210/en.2012-1578; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; Krakowiak JR, 2010, ABSTR SOC NEUROSCI; KUJAWA KA, 1995, EXP NEUROL, V133, P138, DOI 10.1006/exnr.1995.1016; KUJAWA KA, 1989, EXP NEUROL, V105, P80, DOI 10.1016/0014-4886(89)90174-X; Lenth RV., 2006, JAVA APPLETS POWER S; Matsumoto A, 2005, STRESS, V8, P133, DOI 10.1080/10253890500140642; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Montero F, 2010, J PHYSIOL-LONDON, V588, P3425, DOI 10.1113/jphysiol.2010.195396; Moreno-Lopez B, 2011, MOL NEUROBIOL, V43, P41, DOI 10.1007/s12035-010-8159-8; OLIVEIRA A, 2008, PNAS, V101, P17843; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; Patte-Mensah C, 2004, J COMP NEUROL, V477, P286, DOI 10.1002/cne.20251; Perry VH, 2010, ASN NEURO, V2, P281, DOI 10.1042/AN20100024; Rakotoarivelo C, 2004, NEUROENDOCRINOLOGY, V80, P284, DOI 10.1159/000083611; Rotterman TM, 2014, J NEUROSCI, V34, P3475, DOI 10.1523/JNEUROSCI.4768-13.2014; Sabatier MJ, 2008, EXP NEUROL, V211, P489, DOI 10.1016/j.expneurol.2008.02.013; Saldanha CJ, 2009, FRONT NEUROENDOCRIN, V30, P106, DOI 10.1016/j.yfrne.2009.04.016; Scholz T, 2009, J RECONSTR MICROSURG, V25, P339, DOI 10.1055/s-0029-1215529; Sharma N, 2010, EXP NEUROL, V223, P183, DOI 10.1016/j.expneurol.2009.04.031; Smith E. R., 1977, METHOD PSYCHOBIOL, VIII, P259, DOI [10. 1016/B978-0-12-461003-3. 50014-3, DOI 10.1016/B978-0-12-461003-3.50014-3]; Sunico CR, 2010, J NEUROSCI, V30, P973, DOI 10.1523/JNEUROSCI.3911-09.2010; Sunico CR, 2005, J NEUROSCI, V25, P1448, DOI 10.1523/JNEUROSCI.4600-04.2005; Thams S, 2008, BRAIN RES REV, V57, P265, DOI 10.1016/j.brainresrev.2007.06.016; Thompson NJ, 2014, DEV NEUROBIOL, V74, P531, DOI 10.1002/dneu.22147; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Turgeon JL, 2006, ENDOCR REV, V27, P575, DOI 10.1210/er.2005-0020; Udina E, 2011, MUSCLE NERVE, V43, P500, DOI 10.1002/mus.21912; Wang Y, 2006, EUR J NEUROSCI, V23, P141, DOI 10.1111/j.1460-9568.2005.04547.x; Wilhelm JC, 2012, J NEUROSCI, V32, P5002, DOI 10.1523/JNEUROSCI.1411-11.2012; Wood K, 2012, DEV NEUROBIOL, V72, P688, DOI 10.1002/dneu.20960; Zelano J, 2009, J COMP NEUROL, V517, P670, DOI 10.1002/cne.22186	63	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98633	10.1371/journal.pone.0098633	http://dx.doi.org/10.1371/journal.pone.0098633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887087	gold, Green Submitted, Green Published			2022-12-25	WOS:000336956300095
J	Shin, H; Cho, Y; Choe, DH; Jeong, Y; Cho, S; Kim, SC; Cho, BK				Shin, HyeonSeok; Cho, Yoobok; Choe, Dong-hui; Jeong, Yujin; Cho, Suhyung; Kim, Sun Chang; Cho, Byung-Kwan			Exploring the Functional Residues in a Flavin-Binding Fluorescent Protein Using Deep Mutational Scanning	PLOS ONE			English	Article							DIRECTED EVOLUTION; REPORTER PROTEINS; LIGHT; OXYGEN; IDENTIFICATION; GENERATION; MUTANTS; DOMAINS	Flavin mononucleotide (FMN)-based fluorescent proteins are versatile reporters that can monitor various cellular processes in both aerobic and anaerobic conditions. However, the understanding of the role of individual amino acid residues on the protein function has been limited and has restricted the development of better functional variants. Here we examine the functional amino acid residues of Escherichia coli flavin mononucleotide binding fluorescent protein (EcFbFP) using the application of high-throughput sequencing of functional variants, termed deep mutational scanning. The variants were classified into 329 function-retained (FR) and 259 function-loss (FL) mutations, and further the mutational enrichment in each amino acid residues was weighed to find the functionally important residues of EcFbFP. We show that the crucial amino acid residues of EcFbFP lie among the FMN-binding pocket, turns and loops of the protein where conformation changes occur, and spatially clustered residues near the E56-K97 salt bridges. In addition, the mutational sensitivity of the critical residues was confirmed by site-directed mutagenesis. The deep mutational scanning of EcFbFP has demonstrated important implications for constructing better functioning protein variants.	[Shin, HyeonSeok; Cho, Yoobok; Choe, Dong-hui; Jeong, Yujin; Cho, Suhyung; Kim, Sun Chang; Cho, Byung-Kwan] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon, South Korea; [Shin, HyeonSeok; Cho, Yoobok; Choe, Dong-hui; Jeong, Yujin; Cho, Suhyung; Kim, Sun Chang; Cho, Byung-Kwan] Korea Adv Inst Sci & Technol, KAIST Inst BioCentury, Taejon, South Korea; [Kim, Sun Chang; Cho, Byung-Kwan] Intelligent Synthet Biol Ctr, Taejon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Cho, BK (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon, South Korea.	bcho@kaist.ac.kr	Kim, Sun Chang/C-2026-2011; Kim, Sun/GSN-4867-2022; Cho, Byung-Kwan/C-1830-2011	Choe, Donghui/0000-0003-1107-7380; Shin, HyeonSeok/0000-0001-7618-035X	Intelligent Synthetic Biology Center of Global Frontier Project [2011-0031957, 2011-0031962]; Basic Core Technology Development Program for the Oceans and the Polar Regions - Ministry of Education, Science and Technology [2011-0021053]	Intelligent Synthetic Biology Center of Global Frontier Project; Basic Core Technology Development Program for the Oceans and the Polar Regions - Ministry of Education, Science and Technology	The authors acknowledge financial support from the Intelligent Synthetic Biology Center of Global Frontier Project (2011-0031957, 2011-0031962) and the Basic Core Technology Development Program for the Oceans and the Polar Regions (2011-0021053) funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Drepper T, 2010, APPL ENVIRON MICROB, V76, P5990, DOI 10.1128/AEM.00701-10; Ernst A, 2010, MOL BIOSYST, V6, P1782, DOI 10.1039/c0mb00061b; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Golovin A, 2005, PROTEINS, V58, P190, DOI 10.1002/prot.20288; Hao N, 2011, NUCLEIC ACIDS RES, V39, P3695, DOI 10.1093/nar/gkq1336; HODEL AC, 1995, PROTEIN SCI, V4, P484; Jones MA, 2007, J BIOL CHEM, V282, P6405, DOI 10.1074/jbc.M605969200; Lengauer T, 1996, CURR OPIN STRUC BIOL, V6, P402, DOI 10.1016/S0959-440X(96)80061-3; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Losi A, 2005, PHOTOCHEM PHOTOBIOL, V81, P1145, DOI 10.1562/2005-05-25-RA-541; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; McLaughlin RN, 2012, NATURE, V491, P138, DOI 10.1038/nature11500; Metz S, 2012, NUCLEIC ACIDS RES, V40, P5901, DOI 10.1093/nar/gks243; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Mukherjee A, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-20; Polstein LR, 2012, J AM CHEM SOC, V134, P16480, DOI 10.1021/ja3065667; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Sawano A, 2000, Nucleic Acids Res, V28, pE78, DOI 10.1093/nar/28.16.e78; Shafikhani S, 1997, BIOTECHNIQUES, V23, P304, DOI 10.2144/97232rr01; Song XF, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003129; Taylor BL, 1999, ANNU REV MICROBIOL, V53, P103, DOI 10.1146/annurev.micro.53.1.103; Tielker D, 2009, EUKARYOT CELL, V8, P913, DOI 10.1128/EC.00394-08; Traxlmayr MW, 2012, J MOL BIOL, V423, P397, DOI 10.1016/j.jmb.2012.07.017; URFER R, 1992, PROTEIN SCI, V1, P31; Walter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043921; Whitehead TA, 2012, NAT BIOTECHNOL, V30, P543, DOI 10.1038/nbt.2214; Wu NC, 2013, J VIROL, V87, P1193, DOI 10.1128/JVI.01658-12	30	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97817	10.1371/journal.pone.0097817	http://dx.doi.org/10.1371/journal.pone.0097817			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887409	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300023
J	DiSantostefano, RL; Sampson, T; Le, HV; Hinds, D; Davis, KJ; Bakerly, ND				DiSantostefano, Rachael L.; Sampson, Tim; Hoa Van Le; Hinds, David; Davis, Kourtney J.; Bakerly, Nawar Diar			Risk of Pneumonia with Inhaled Corticosteroid versus Long-Acting Bronchodilator Regimens in Chronic Obstructive Pulmonary Disease: A New-User Cohort Study	PLOS ONE			English	Article							DIAGNOSED COPD; DOUBLE-BLIND; MORTALITY; HOSPITALIZATIONS; EXACERBATIONS; VALIDATION; TIME	Observational studies using case-control designs have showed an increased risk of pneumonia associated inhaled corticosteroid (ICS)-containing medications in patients with chronic obstructive pulmonary disease (COPD). New-user observational cohort designs may minimize biases associated with previous case-control designs. Objective: To estimate the association between ICS and pneumonia among new users of ICS relative to inhaled long-acting bronchodilator (LABD) monotherapy. Methods: Pneumonia events in COPD patients >= 45 years old were compared among new users of ICS medications (n = 11,555; ICS, ICS/long-acting beta(2)-agonist [LABA] combination) and inhaled LABD monotherapies (n = 6,492; LABA, longacting muscarinic antagonists) using Cox proportional hazards models, with propensity scores to adjust for confounding. Setting: United Kingdom electronic medical records with linked hospitalization and mortality data (2002-2010). New users were censored at earliest of: pneumonia event, death, changing/discontinuing treatment, or end of follow-up. Outcomes: severe pneumonia (primary) and any pneumonia (secondary). Results: Following adjustment, new use of ICS-containing medications was associated with an increased risk of pneumonia hospitalization (n = 322 events; HR = 1.55, 95% CI: 1.14, 2.10) and any pneumonia (n = 702 events; HR = 1.49, 95% CI: 1.22, 1.83). Crude incidence rates of any pneumonia were 48.7 and 30.9 per 1000 person years among the ICS-containing and LABD cohorts, respectively. Excess risk of pneumonia with ICS was reduced when requiring >= 1 month or >= 6 months of new use. There was an apparent dose-related effect, with greater risk at higher daily doses of ICS. There was evidence of channeling bias, with more severe patients prescribed ICS, for which the analysis may not have completely adjusted. Conclusions: The results of this new-user cohort study are consistent with published findings; ICS were associated with a 20-50% increased risk of pneumonia in COPD, which reduced with exposure time. This risk must be weighed against the benefits when prescribing ICS to patients with COPD.	[DiSantostefano, Rachael L.; Sampson, Tim; Hoa Van Le; Hinds, David; Davis, Kourtney J.] GlaxoSmithKline, Worldwide Epidemiol, Res Triangle Pk, NC 27709 USA; [Bakerly, Nawar Diar] Salford Royal NHS Fdn Trust, Manchester, Lancs, England; [Bakerly, Nawar Diar] Univ Manchester, Manchester, Lancs, England	GlaxoSmithKline; Salford Royal NHS Foundation Trust; University of Manchester	DiSantostefano, RL (corresponding author), GlaxoSmithKline, Worldwide Epidemiol, Res Triangle Pk, NC 27709 USA.	Rachael.L.DiSantostefano@gsk.com		Diar Bakerly, Nawar/0000-0003-2102-1997	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This study was funded by GlaxoSmithKline. The funder provided support in the form of salaries for authors RLD, TS, HVL, DH and KJD, but did not have any additional role in the study design, data collection and analysis or preparation of the manuscript. The decision to submit for publication is required by GSK policy as part of being transparent regarding research activities. The specific roles of these authors are articulated in the ` author contributions' section. Editorial support in the form of development of the manuscript first draft in consultation with the authors, editorial suggestions to draft versions of this paper, assembling tables and figures, collating author comments, copyediting, fact checking, referencing and graphic services was provided by David Cutler, PhD and Laura Maguire, MChem at Gardiner-Caldwell Communications (Macclesfield, UK), and was funded by GlaxoSmithKline. The open-access charge was paid for by GlaxoSmithKline.	Andrejak C, 2013, THORAX, V68, P256, DOI 10.1136/thoraxjnl-2012-201772; [Anonymous], 2013, QUAL OUTC FRAM QOF G; Arai T, 2005, NEUROLOGY, V64, P573, DOI 10.1212/01.WNL.0000150897.14961.0F; Barnes NC, 2006, AM J RESP CRIT CARE, V173, P736, DOI 10.1164/rccm.200508-1321OC; Calverley PMA, 2011, CHEST, V139, P505, DOI 10.1378/chest.09-2992; Communities and Local Government, 2008, ENGLISH INDICES DEPR; Crim C, 2009, EUR RESPIR J, V34, P641, DOI 10.1183/09031936.00193908; Davis KJ, 2013, EUR RESPIR J S57, P1005; Dong YH, 2014, CHEST, V145, P1286, DOI 10.1378/chest.13-2137; Dransfield MT, 2013, LANCET RESP MED, V1, P210, DOI 10.1016/S2213-2600(13)70040-7; Drummond MB, 2008, JAMA-J AM MED ASSOC, V300, P2407, DOI 10.1001/jama.2008.717; Ernst P, 2007, AM J RESP CRIT CARE, V176, P162, DOI 10.1164/rccm.200611-1630OC; European Network of Centres for Pharmacoepidemiology and Pharmacovigilance, WEUSKOP6416 EVALUATI; Global Initiative for Asthma (GINA), 2012, GLOB STRAT ASTHM MAN; GOLD, 2011, GLOB STRAT DIAGN MAN; Guess HA, 2006, PHARMACOEPIDEM DR S, V15, P81, DOI 10.1002/pds.1164; Hansell A, 1999, THORAX, V54, P413, DOI 10.1136/thx.54.5.413; Health & Social Care Information Centre, HOSP EP STAT; Holguin F, 2005, CHEST, V128, P2005, DOI 10.1378/chest.128.4.2005; Janson C, 2013, BMJ-BRIT MED J, V346, pf3306; Jara M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000841; Nannini LJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006829.pub2; Joo MJ, 2010, RESP MED, V104, P246, DOI 10.1016/j.rmed.2009.10.002; Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1; Lambert BL, 2005, J CLIN PSYCHOPHARM, V25, P12, DOI 10.1097/01.jcp.0000150224.38630.ae; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; Mannino DM, 2009, RESP MED, V103, P224, DOI 10.1016/j.rmed.2008.09.005; Meropol SB, 2012, PHARMACOEPIDEM DR S, V21, P659, DOI 10.1002/pds.3207; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; Molinos L, 2009, J INFECTION, V58, P417, DOI 10.1016/j.jinf.2009.03.003; Mullerova H, 2012, RESP MED, V106, P1124, DOI 10.1016/j.rmed.2012.04.008; Obiora E, 2013, THORAX, V68, P163, DOI 10.1136/thoraxjnl-2012-202374; Office for National Statistics, 21 CENT MORT FIL 200; Pereira JM, 2012, SEMIN RESP CRIT CARE, V33, P272, DOI 10.1055/s-0032-1315639; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Restrepo MI, 2006, EUR RESPIR J, V28, P346, DOI 10.1183/09031936.06.00131905; Robins J.M., 2000, STAT MODELS EPIDEMIO, P95, DOI DOI 10.1007/978-1-4612-1284-3_2; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Robins JM, 1998, 1997 P AM STAT ASS S, P1, DOI DOI 10.1097/EDE.0B013E318245847E; Rossi SE, 2000, RADIOGRAPHICS, V20, P1245, DOI 10.1148/radiographics.20.5.g00se081245; Rubin DB, 2004, PHARMACOEPIDEM DR S, V13, P855, DOI 10.1002/pds.968; Schneeweiss S, 2010, PHARMACOEPIDEM DR S, V19, P858, DOI 10.1002/pds.1926; Schneider C, 2010, EUR J EPIDEMIOL, V25, P253, DOI 10.1007/s10654-010-9435-7; Sharafkhaneh A, 2012, RESP MED, V106, P257, DOI 10.1016/j.rmed.2011.07.020; Simon L, 2001, JAMA-J AM MED ASSOC, V286, P2398; Singh S, 2010, CURR OPIN PULM MED, V16, P118, DOI 10.1097/MCP.0b013e328334c085; Snider JT, 2012, CURR MED RES OPIN, V28, P1959, DOI 10.1185/03007995.2012.743459; Soriano JB, 2001, EUR J EPIDEMIOL, V17, P1075, DOI 10.1023/A:1021235123382; Soriano JB, 2005, CHEST, V128, P2099, DOI 10.1378/chest.128.4.2099; Spencer S, 2011, COCHRANE DB SYST REV, V12; Strom B, 2002, PHARMACOEPIDEM DR S, P375; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Suissa S, 2013, THORAX, V68, P1029, DOI 10.1136/thoraxjnl-2012-202872; Tamim H, 2007, PHARMACOEPIDEM DR S, V16, P250, DOI 10.1002/pds.1360; Toy EL, 2011, RESP MED, V105, P435, DOI 10.1016/j.rmed.2010.09.006; Yawn BP, 2013, INT J CHRONIC OBSTR, V8, P295, DOI 10.2147/COPD.S42366	56	34	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97149	10.1371/journal.pone.0097149	http://dx.doi.org/10.1371/journal.pone.0097149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878543	Green Published, gold, Green Submitted			2022-12-25	WOS:000338101500012
J	Iacobucci, GJ; Rahman, NA; Valtuena, AA; Nayak, TK; Gunawardena, S				Iacobucci, Gary J.; Rahman, Noura Abdel; Valtuena, Aida Andrades; Nayak, Tapan Kumar; Gunawardena, Shermali			Spatial and Temporal Characteristics of Normal and Perturbed Vesicle Transport	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; KINESIN-HEAVY-CHAIN; TUMOR-SUPPRESSOR GENE; FAST AXONAL-TRANSPORT; CHOLINE-ACETYLTRANSFERASE; SYNAPTIC-TRANSMISSION; DROSOPHILA NEURONS; MICROTUBULE ORGANIZATION; CULTURED HIPPOCAMPAL; CYTOPLASMIC DYNEIN	Efficient intracellular transport is essential for healthy cellular function and structural integrity, and problems in this pathway can lead to neuronal cell death and disease. To spatially and temporally evaluate how transport defects are initiated, we adapted a primary neuronal culture system from Drosophila larval brains to visualize the movement dynamics of several cargos/organelles along a 90 micron axonal neurite over time. All six vesicles/organelles imaged showed robust bidirectional motility at both day 1 and day 2. Reduction of motor proteins decreased the movement of vesicles/organelles with increased numbers of neurite blocks. Neuronal growth was also perturbed with reduction of motor proteins. Strikingly, we found that all blockages were not fixed, permanent blocks that impeded transport of vesicles as previously thought, but that some blocks were dynamic clusters of vesicles that resolved over time. Taken together, our findings suggest that non-resolving blocks may likely initiate deleterious pathways leading to death and degeneration, while resolving blocks may be benign. Therefore evaluating the spatial and temporal characteristics of vesicle transport has important implications for our understanding of how transport defects can affect other pathways to initiate death and degeneration.	[Iacobucci, Gary J.; Rahman, Noura Abdel; Valtuena, Aida Andrades; Gunawardena, Shermali] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Nayak, Tapan Kumar] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Gunawardena, S (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	sg99@buffalo.edu	Iacobucci, Gary/GQH-4517-2022	Nayak, Tapan/0000-0002-3054-5867; gunawardena, shermali/0000-0001-8776-9397; Nayak, Tapan/0000-0002-3706-6092; Andrades Valtuena, Aida/0000-0002-1737-2228	John R. Oishei Foundation; NIH/NINDS [R03-NS084386-01]; University at Buffalo (UB) Center for Undergraduate Research; UB Department of Biological Sciences Alumni Undergraduate Research Fellowship; Victoria Finnerty Undergraduate Travel Award from the Genetics Society of America; Fundacio Joan Riera i Gubau (Santa Coloma de Farners, Spain); Itaca-Banc Santander from Barcelona, Spain at UB; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS084386] Funding Source: NIH RePORTER	John R. Oishei Foundation; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University at Buffalo (UB) Center for Undergraduate Research; UB Department of Biological Sciences Alumni Undergraduate Research Fellowship; Victoria Finnerty Undergraduate Travel Award from the Genetics Society of America; Fundacio Joan Riera i Gubau (Santa Coloma de Farners, Spain); Itaca-Banc Santander from Barcelona, Spain at UB; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funds from the John R. Oishei Foundation and partially by funds from NIH/NINDS (R03-NS084386-01) to SG. GJI was supported by a University at Buffalo (UB) Center for Undergraduate Research and Creative Activities fellowship, the UB Department of Biological Sciences Alumni Undergraduate Research Fellowship and the Victoria Finnerty Undergraduate Travel Award from the Genetics Society of America. AAV was supported by Fundacio Joan Riera i Gubau (Santa Coloma de Farners, Spain) and beca salari Itaca-Banc Santander from Barcelona, Spain, while at UB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andlauer Till F M, 2012, Cold Spring Harb Protoc, V2012, P481, DOI 10.1101/pdb.prot068593; Baqri R, 2006, J NEUROBIOL, V66, P378, DOI 10.1002/neu.20230; Barandeh F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029424; Barkus RV, 2008, MOL BIOL CELL, V19, P274, DOI 10.1091/mbc.E07-03-0261; Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468; Bowman AB, 1999, J CELL BIOL, V146, P165; BRADY ST, 1990, P NATL ACAD SCI USA, V87, P1061, DOI 10.1073/pnas.87.3.1061; Brendza RP, 2000, MOL BIOL CELL, V11, P1329, DOI 10.1091/mbc.11.4.1329; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Colin E, 2008, EMBO J, V27, P2124, DOI 10.1038/emboj.2008.133; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Daro E, 1996, P NATL ACAD SCI USA, V93, P9559, DOI 10.1073/pnas.93.18.9559; Darya K, 2009, BRAIN RES, V1280, P1, DOI 10.1016/j.brainres.2009.05.026; De Strooper B, 2000, J CELL SCI, V113, P1857; Deitcher DL, 1998, J NEUROSCI, V18, P2028; DiAntonio A, 2006, INT REV NEUROBIOL, V75, P165, DOI 10.1016/S0074-7742(06)75008-5; Djagaeva I, 2012, GENETICS, V192, P173, DOI 10.1534/genetics.112.140798; Encalada SE, 2011, CELL, V144, P551, DOI 10.1016/j.cell.2011.01.021; Falzone TL, 2009, J NEUROSCI, V29, P5758, DOI 10.1523/JNEUROSCI.0780-09.2009; Fretham SJB, 2012, HIPPOCAMPUS, V22, P1691, DOI 10.1002/hipo.22004; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; Fuger P, 2007, NAT PROTOC, V2, P3285, DOI 10.1038/nprot.2007.472; Fye S, 2010, J VIS EXP; Gardzinski P, 2007, J PHYSIOL-LONDON, V581, P75, DOI 10.1113/jphysiol.2006.127472; Ghannad-Rezaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029869; GHOSH RN, 1995, J CELL BIOL, V128, P549, DOI 10.1083/jcb.128.4.549; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Gorczyca D, 2007, J NEUROSCI, V27, P1033, DOI 10.1523/JNEUROSCI.3160-06.2007; Gross SP, 2004, PHYS BIOL, V1, pR1, DOI 10.1088/1478-3967/1/2/R01; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Gunawardena S, 2013, HUM MOL GENET, V22, P3828, DOI 10.1093/hmg/ddt237; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; HAYASHI I, 1994, IN VITRO CELL DEV-AN, V30A, P202; Hemar A, 1997, J NEUROSCI, V17, P9026; Henthorn KS, 2011, MOL BIOL CELL, V22, P4038, DOI 10.1091/mbc.E10-07-0572; Her LS, 2008, J NEUROSCI, V28, P13662, DOI 10.1523/JNEUROSCI.4144-08.2008; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Hoerndli FJ, 2013, NEURON, V80, P1421, DOI 10.1016/j.neuron.2013.10.050; Hong Zheng K, 2013, HUM MOL GENET; Horiuchi D, 2007, CURR BIOL, V17, P1313, DOI 10.1016/j.cub.2007.06.062; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Hurd DD, 1996, GENETICS, V144, P1075; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; KATZ F, 1988, EMBO J, V7, P3471, DOI 10.1002/j.1460-2075.1988.tb03222.x; Kim H, 2007, J CELL BIOL, V176, P641, DOI 10.1083/jcb.200608128; Kimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P429, DOI 10.1177/002215540305100404; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Kraft R, 1998, J NEUROSCI, V18, P8886; Kraft R, 2006, J NEUROSCI, V26, P8734, DOI 10.1523/JNEUROSCI.2106-06.2006; Lee D, 2003, J NEUROSCI, V23, P4625; Lee D, 1999, J NEUROSCI, V19, P5311; Lee S, 2011, J NEUROSCI, V31, P7817, DOI 10.1523/JNEUROSCI.6412-10.2011; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Liu ZH, 2011, J NEUROSCI, V31, P2052, DOI 10.1523/JNEUROSCI.3278-10.2011; Liu ZW, 2010, J NEUROSCI, V30, P11624, DOI 10.1523/JNEUROSCI.0410-10.2010; Lo KY, 2011, NEUROSCI LETT, V491, P168, DOI 10.1016/j.neulet.2011.01.018; Lu W, 2013, CURR BIOL, V23, P1018, DOI 10.1016/j.cub.2013.04.050; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; Magrane J, 2013, HUM MOL GENET; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Mastroberardino PG, 2009, NEUROBIOL DIS, V34, P417, DOI 10.1016/j.nbd.2009.02.009; Miller KE, 2006, J CELL BIOL, V173, P373, DOI 10.1083/jcb.200510097; Mondal S, 2011, TRAFFIC, V12, P372, DOI 10.1111/j.1600-0854.2010.01157.x; Mukherjee A, 2011, MED IMAGE ANAL, V15, P354, DOI 10.1016/j.media.2010.12.005; Muresan Z, 2005, J CELL BIOL, V171, P615, DOI 10.1083/jcb.200502043; ODOWD DK, 1995, J NEUROBIOL, V27, P113, DOI 10.1002/neu.480270111; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Pack-Chung E, 2007, NAT NEUROSCI, V10, P980, DOI 10.1038/nn1936; Pathak R, 2013, SMALL GTPASES, P4; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Rao A, 2000, J NEUROSCI, V20, P8344, DOI 10.1523/JNEUROSCI.20-22-08344.2000; Ray K, 1999, J CELL BIOL, V147, P507, DOI 10.1083/jcb.147.3.507; Reis GF, 2012, MOL BIOL CELL, V23, P1700, DOI 10.1091/mbc.E11-11-0938; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Russo GJ, 2009, J NEUROSCI, V29, P5443, DOI 10.1523/JNEUROSCI.5417-08.2009; Sadananda A, 2012, TRAFFIC, V13, P979, DOI 10.1111/j.1600-0854.2012.01361.x; Sandstrom DJ, 2008, ANESTHESIOLOGY, V108, P434, DOI 10.1097/ALN.0b013e318164cfda; Sandstrom DJ, 2004, J PHYSIOL-LONDON, V558, P489, DOI 10.1113/jphysiol.2004.065748; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; Schmidt MR, 2007, BIOL CELL, V99, P333, DOI 10.1042/BC20070007; Schmidt MR, 2009, P NATL ACAD SCI USA, V106, P15344, DOI 10.1073/pnas.0904268106; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Sheng JS, 2012, NEURON, V74, P6, DOI 10.1016/j.neuron.2012.03.013; SNOW PM, 1987, J NEUROSCI, V7, P4137; Stone MC, 2008, MOL BIOL CELL, V19, P4122, DOI 10.1091/mbc.E07-10-1079; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Torroja L, 1996, J NEUROSCI, V16, P4638; Torroja L, 1999, J NEUROSCI, V19, P7793; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; VANDEGOOR J, 1995, P NATL ACAD SCI USA, V92, P5739, DOI 10.1073/pnas.92.12.5739; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Weaver C, 2013, TRAFFIC, V14, P295, DOI 10.1111/tra.12037; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; WU CF, 1983, J NEUROSCI, V3, P1888; Wu CL, 2005, J NEUROSCI, V25, P9557, DOI 10.1523/JNEUROSCI.2532-05.2005; YAMAMOTO D, 1989, J EXP BIOL, V145, P173; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zajac AL, 2013, CURR BIOL, V23, P1173, DOI 10.1016/j.cub.2013.05.015; Zala D, 2013, CELL, V152, P479, DOI 10.1016/j.cell.2012.12.029; Zhang Y, 2011, JOVE-J VIS EXP, DOI 10.3791/2331; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	120	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97237	10.1371/journal.pone.0097237	http://dx.doi.org/10.1371/journal.pone.0097237			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878565	gold, Green Published, Green Submitted			2022-12-25	WOS:000338101500013
J	Lu, F; Xue, JX; Hu, YC; Gan, L; Shi, Y; Yang, HS; Wei, YQ				Lu, Fang; Xue, Jian-xin; Hu, Yu-chang; Gan, Lu; Shi, Yi; Yang, Han-shuo; Wei, Yu-quan			CARP Is a Potential Tumor Suppressor in Gastric Carcinoma and a Single-Nucleotide Polymorphism in CARP Gene Might Increase the Risk of Gastric Carcinoma	PLOS ONE			English	Article							CELL-CYCLE KINASES; CANCER; P27; EPIDEMIOLOGY; DEGRADATION; INHIBITORS; P27(KIP1); ROLES; P53; EXPRESSION	Background: The caspase-associated recruitment domain-containing protein (CARP) is expressed in almost all tissues. Recently, the tumor-suppressive function of CARP was discovered and attracted increasing attention. This study aimed to investigate the role of CARP in the carcinogenesis of human gastric carcinoma. Methodology/Principal Findings: Compared with normal gastric tissue, the downregulation of CARP expression was observed in gastric carcinoma tissue by cDNA array and tissue microarray assay. In vitro, the gastric carcinoma cell line (BGC823) was stably transfected with pcDNA3.1B-CARP or plus CARP siRNA, and we used MTT, flow cytometry, cell migration on type I collagen, cell-matrix adhesion assay and western blot analysis to investigate the potential anti-tumor effects of CARP. The data showed that overexpressing CARP suppressed the malignancy of gastric carcinoma BGC-823 cell line, including significant increases in apoptosis, as well as obvious decreases in cell proliferation, migration, adhesion ability, and tumor growth. The tumor-suppressive effects of CARP were almost restored by siRNA-directed CARP silence. In addition, overexpression of CARP induced G1 arrest, decreased the expressions of cyclin E and CDK2, and increased the expressions of p27, p53 and p21. In vivo, the tumor-suppressive effect of CARP was also verified. A single-nucleotide polymorphism (SNP) genotype of CARP (rs2297882) was located in the Kozak sequence of the CARP gene. The reporter gene assay showed that rs2297882 TT caused an obvious downregulation of activity of CARP gene promoter in BGC-823 cells. Furthermore, the association between rs2297882 and human gastric carcinoma susceptibility was analyzed in 352 cases and 889 controls. It displayed that the TT genotype of rs2297882 in the CARP gene was associated with an increased risk of gastric carcinoma. Conclusions/Significance: CARP is a potential tumor suppressor of gastric carcinoma and the rs2297882 C. T phenotype of CARP may serve as a predictor of gastric carcinoma.	[Lu, Fang; Gan, Lu; Yang, Han-shuo; Wei, Yu-quan] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu 610064, Peoples R China; [Lu, Fang; Shi, Yi] Sichuan Acad Med Sci, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Peoples R China; [Lu, Fang; Shi, Yi] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Xue, Jian-xin] Sichuan Univ, Dept Thorac Oncol, Ctr Canc, West China Hosp, Chengdu 610064, Peoples R China; [Xue, Jian-xin] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu 610064, Peoples R China; [Hu, Yu-chang] China Three Gorges Univ, Inst Pathol, Yichang, Peoples R China	Sichuan University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan University; Sichuan University; China Three Gorges University	Yang, HS (corresponding author), Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu 610064, Peoples R China.	yangyanshuo13@163.com			National Natural Science Foundation of China [81101698, 81272216]; China Postdoctoral Science Foundation [2012T50722]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was financially supported by grants from the National Natural Science Foundation of China (81101698 to Xue Jianxin and 81272216 to Yang Hanshou), and China Postdoctoral Science Foundation (2012T50722 to Xue Jianxin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M., 2013, CURR OPIN PHARM; Berg JP, 2007, HUM PATHOL, V38, P1621, DOI 10.1016/j.humpath.2007.03.007; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Bornschein J, 2011, HELICOBACTER, V16, P45, DOI 10.1111/j.1523-5378.2011.00880.x; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Damiano JS, 2004, CURR DRUG TARGETS, V5, P367, DOI 10.2174/1389450043345470; Daw EW, 2007, HUM MOL GENET, V16, P2463, DOI 10.1093/hmg/ddm202; Fan B, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-316; Fiandalo M. V., 2012, Experimental Oncology, V34, P165; Fidler I J, 1978, Adv Cancer Res, V28, P149, DOI 10.1016/S0065-230X(08)60648-X; Guggenheim DE, 2013, J SURG ONCOL, V107, P230, DOI 10.1002/jso.23262; HARPER JW, 1993, CELL, V75, P805; Larrea MD, 2009, CELL CYCLE, V8, P3455, DOI 10.4161/cc.8.21.9789; Lee EW, 2006, MOL CELLS, V22, P133; Liu BH, 2002, BIOCHEM BIOPH RES CO, V293, P1396, DOI 10.1016/S0006-291X(02)00379-0; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; McAllister SS, 2003, MOL CELL BIOL, V23, P216, DOI 10.1128/MCB.23.1.216-228.2003; Oh W, 2006, J BIOL CHEM, V281, P17457, DOI 10.1074/jbc.M601857200; Pan YL, 2004, BIOCHEM BIOPH RES CO, V315, P686, DOI 10.1016/j.bbrc.2004.01.108; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Philipp-Staheli J, 2004, ONCOGENE, V23, P905, DOI 10.1038/sj.onc.1207220; Qin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076486; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shi Y, 2011, ONCOGENE, V30, P4107, DOI 10.1038/onc.2011.116; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Stadtlander CTKH, 1999, CARCINOGENESIS, V20, P2195, DOI 10.1093/carcin/20.12.2195; Stewart ZA, 1999, MOL CELL BIOL, V19, P205; Stone Andrew, 2012, Critical Reviews in Oncogenesis, V17, P175; Tang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074527; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Zhang XC, 2008, J CELL BIOCHEM, V103, P1219, DOI 10.1002/jcb.21504	33	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97743	10.1371/journal.pone.0097743	http://dx.doi.org/10.1371/journal.pone.0097743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870804	gold, Green Published, Green Submitted			2022-12-25	WOS:000336858300018
J	Ahn, M; Bajsarowicz, K; Oehler, A; Lemus, A; Bankiewicz, K; DeArmond, SJ				Ahn, Misol; Bajsarowicz, Krystyna; Oehler, Abby; Lemus, Azucena; Bankiewicz, Krystof; DeArmond, Stephen J.			Convection-Enhanced Delivery of AAV2-PrPshRNA in Prion-Infected Mice	PLOS ONE			English	Article							ADENOASSOCIATED VIRUS TYPE-2; PROLONGS SURVIVAL; DISEASE; QUINACRINE; PROTEIN; BRAIN; PRP; MODEL; DEGENERATION; TRANSDUCTION	Prion disease is caused by a single pathogenic protein (PrPSc), an abnormal conformer of the normal cellular prion protein PrPC. Depletion of PrPC in prion knockout mice makes them resistant to prion disease. Thus, gene silencing of the Prnp gene is a promising effective therapeutic approach. Here, we examined adeno-associated virus vector type 2 encoding a short hairpin RNA targeting Prnp mRNA (AAV2-PrP-shRNA) to suppress PrPC expression both in vitro and in vivo. AAV2-PrP-shRNA treatment suppressed PrP levels and prevented dendritic degeneration in RML-infected brain aggregate cultures. Infusion of AAV2-PrP-shRNA-eGFP into the thalamus of CD-1 mice showed that eGFP was transported to the cerebral cortex via anterograde transport and the overall PrPC levels were reduced by similar to 70% within 4 weeks. For therapeutic purposes, we treated RML-infected CD-1 mice with AAV2-PrP-shRNA beginning at 50 days post inoculation. Although AAV2-PrP-shRNA focally suppressed PrPSc formation in the thalamic infusion site by similar to 75%, it did not suppress PrPSc formation efficiently in other regions of the brain. Survival of mice was not extended compared to the untreated controls. Global suppression of PrPC in the brain is required for successful therapy of prion diseases.	[Ahn, Misol; Bajsarowicz, Krystyna; Oehler, Abby; Lemus, Azucena; DeArmond, Stephen J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Bankiewicz, Krystof] Univ Calif San Francisco, Dept Neurosurg & Neurol, San Francisco, CA 94143 USA; [Ahn, Misol; DeArmond, Stephen J.] Univ Calif San Francisco, Dept Inst Neurodegenerat Dis, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	DeArmond, SJ (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	stephen.dearmond@ucsf.edu		Ahn, Misol/0000-0002-6088-8481	National institute on Aging of the National Institutes of Health [K01AG039386]; UCSF SOM REAC; UCSF Bridge fund; Stephen C & Patricia A Schott foundation; NATIONAL INSTITUTE ON AGING [K01AG039386] Funding Source: NIH RePORTER	National institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UCSF SOM REAC; UCSF Bridge fund; Stephen C & Patricia A Schott foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this publication was supported by the National institute on Aging of the National Institutes of Health under award number K01AG039386, the UCSF SOM REAC award (Mainprice Memorial Foundation and Cox J Fund) and the UCSF Bridge fund as well as by a gift from the Stephen C & Patricia A Schott foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039112; Bajsarowicz K, 2012, J NEUROPATH EXP NEUR, V71, P449, DOI 10.1097/NEN.0b013e3182544680; Bartus RT, 2011, NEUROBIOL DIS, V44, P38, DOI 10.1016/j.nbd.2011.05.026; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Bouzamondo-Bernstein E, 2004, J NEUROPATH EXP NEUR, V63, P882, DOI 10.1093/jnen/63.8.882; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1994, MOL MED, V1, P19; Chiu TL, 2009, INT J ONCOL, V35, P1361, DOI 10.3892/ijo_00000454; Collins SJ, 2002, ANN NEUROL, V52, P503, DOI 10.1002/ana.10336; Cunningham J, 2008, MOL THER, V16, P1267, DOI 10.1038/mt.2008.111; DeArmond S.J., 2002, GREENFIELDS NEUROPAT, V7th, P273; Dohgu S, 2004, CELL MOL NEUROBIOL, V24, P205, DOI 10.1023/B:CEMN.0000018617.21378.95; Eberling JL, 2009, HUM GENE THER, V20, P511, DOI 10.1089/hum.2008.201; Forsayeth JR, 2006, MOL THER, V14, P571, DOI 10.1016/j.ymthe.2006.04.008; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Gayrard V, 2005, BRIT J PHARMACOL, V144, P386, DOI 10.1038/sj.bjp.0706072; Ghaemmaghami S, 2011, J MOL BIOL, V413, P527, DOI 10.1016/j.jmb.2011.07.021; Ghaemmaghami S, 2010, J BIOL CHEM, V285, P10415, DOI 10.1074/jbc.M109.045112; Ghaemmaghami S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000673; Hadaczek P, 2006, HUM GENE THER, V17, P291, DOI 10.1089/hum.2006.17.291; Hadaczek P, 2009, HUM GENE THER, V20, P225, DOI 10.1089/hum.2008.151; Haviv Y, 2008, ARCH NEUROL-CHICAGO, V65, P762, DOI 10.1001/archneur.65.6.762; Ishikura N, 2005, P NATL ACAD SCI USA, V102, P886, DOI 10.1073/pnas.0408612101; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; Kawasaki Y, 2007, J VIROL, V81, P12889, DOI 10.1128/JVI.01563-07; Kempster S, 2007, NEUROREPORT, V18, P479, DOI 10.1097/WNR.0b013e328058678d; Klingenstein R, 2006, J NEUROCHEM, V98, P748, DOI 10.1111/j.1471-4159.2006.03889.x; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MORRISON PF, 1994, AM J PHYSIOL, V266, pR292, DOI 10.1152/ajpregu.1994.266.1.R292; Muramoto T, 1997, NAT MED, V3, P750, DOI 10.1038/nm0797-750; Pfeifer A, 2006, J CLIN INVEST, V116, P3204, DOI 10.1172/JCI29236; Prusiner SB, 2001, HARRISONS PRINCIPLES, P2486; Salegio EA, 2013, GENE THER, V20, P348, DOI 10.1038/gt.2012.27; Samaranch L, 2012, HUM GENE THER, V23, P382, DOI 10.1089/hum.2011.200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spilman P, 2008, P NATL ACAD SCI USA, V105, P10595, DOI 10.1073/pnas.0803671105; Su XM, 2010, MOL THER, V18, P1490, DOI 10.1038/mt.2010.114; Su XM, 2009, HUM GENE THER, V20, P1627, DOI 10.1089/hum.2009.103; Vetrugno V, 2009, J GEN VIROL, V90, P1775, DOI 10.1099/vir.0.009936-0; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105	43	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98496	10.1371/journal.pone.0098496	http://dx.doi.org/10.1371/journal.pone.0098496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866748	gold, Green Published, Green Submitted			2022-12-25	WOS:000336914100061
J	Meli, M; Pagano, K; Ragona, L; Colombo, G				Meli, Massimiliano; Pagano, Katiuscia; Ragona, Laura; Colombo, Giorgio			Investigating the Dynamic Aspects of Drug-Protein Recognition through a Combination of MD and NMR Analyses: Implications for the Development of Protein-Protein Interaction Inhibitors	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; BACKBONE DYNAMICS; SPECTROSCOPY; FLEXIBILITY; RELAXATION; SIMULATION; DISCOVERY; SELECTION; DESIGN	In this paper, we investigate the dynamic aspects of the molecular recognition between a small molecule ligand and a flat, exposed protein surface, representing a typical target in the development of protein-protein interaction inhibitors. Specifically, we analyze the complex between the protein Fibroblast Growth Factor 2 (FGF2) and a recently discovered small molecule inhibitor, labeled sm27 for which the binding site and the residues mainly involved in small molecule recognition have been previously characterized. We have approached this problem using microsecond MD simulations and NMR-based characterizations of the dynamics of the apo and holo states of the system. Using direct combination and cross-validation of the results of the two techniques, we select the set of conformational states that best recapitulate the principal dynamic and structural properties of the complex. We then use this information to generate a multi-structure representation of the sm27-FGF2 interaction. We propose this kind of representation and approach as a useful tool in particular for the characterization of systems where the mutual dynamic influence between the interacting partners is expected to play an important role. The results presented can also be used to generate new rules for the rational expansion of the chemical diversity space of FGF2 inhibitors.	[Meli, Massimiliano; Colombo, Giorgio] CNR, Ist Chim Riconoscimento, I-20133 Milan, Italy; [Pagano, Katiuscia; Ragona, Laura] CNR, Ist Studio Macromol, I-20133 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio delle Macromolecole (ISMAC-CNR)	Colombo, G (corresponding author), CNR, Ist Chim Riconoscimento, I-20133 Milan, Italy.	g.colombo@icrm.cnr.it	Pagano, Katiuscia/AAB-9495-2020; Meli, Massimiliano/AAY-8570-2020; Ragona, Laura/AAB-9691-2020; Colombo, Giorgio/A-2730-2012	Meli, Massimiliano/0000-0003-3304-6104; Ragona, Laura/0000-0003-3893-7117; Colombo, Giorgio/0000-0002-1318-668X; pagano, katiuscia/0000-0002-0462-2056	AIRC (Associazione Italiana Ricerca sul Cancro) [IG.11775]	AIRC (Associazione Italiana Ricerca sul Cancro)	GC acknowledges a grant from AIRC (Associazione Italiana Ricerca sul Cancro), Grant IG.11775. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Carlson HA, 2002, CURR OPIN CHEM BIOL, V6, P447, DOI 10.1016/S1367-5931(02)00341-1; Case DA, 2012, AMBER 12; Colombo G, 2010, J BIOL CHEM, V285, P8733, DOI 10.1074/jbc.M109.085605; d'Auvergne EJ, 2003, J BIOMOL NMR, V25, P25, DOI 10.1023/A:1021902006114; DALVIT C, 1995, J BIOMOL NMR, V5, P306, DOI 10.1007/BF00211757; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dibenedetto D, 2013, BIOCHEMISTRY-US, V52, P6672, DOI 10.1021/bi400367r; Hardy JA, 2004, CURR OPIN STRUC BIOL, V14, P706, DOI 10.1016/j.sbi.2004.10.009; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; KEELER J, 1994, METHOD ENZYMOL, V239, P145; Keskin O, 2007, PROTEIN PROTEIN INTE, p222A; Keskin O, 2008, CHEM REV, V108, P1225, DOI 10.1021/cr040409x; Lexa KW, 2012, Q REV BIOPHYS, V45, P301, DOI 10.1017/S0033583512000066; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Meli M, 2006, J MED CHEM, V49, P7721, DOI 10.1021/jm060836y; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Moroni E, 2014, J CHEM INF MODEL; Morra G, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002433; Morra G, 2010, J CHEM THEORY COMPUT, V6, P2978, DOI 10.1021/ct100334n; Morra G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000323; Moy FJ, 1996, BIOCHEMISTRY-US, V35, P13552, DOI 10.1021/bi961260p; Niccolai N, 2001, J BIOL CHEM, V276, P42455, DOI 10.1074/jbc.M107387200; Nieto L, 2013, CHEMBIOCHEM, V14, P1732, DOI 10.1002/cbic.201300313; Pagano K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036990; Panjkovich A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-273; Prompers JJ, 2002, J AM CHEM SOC, V124, P4522, DOI 10.1021/ja012750u; Schroder C, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2198802; Taraboletti G, 2010, ONCOTARGET, V1, P662; van Gunsteren WF, 2008, CURR OPIN STRUC BIOL, V18, P149, DOI 10.1016/j.sbi.2007.12.007; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Zhuravleva A, 2007, J MOL BIOL, V367, P1079, DOI 10.1016/j.jmb.2007.01.051	38	12	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97153	10.1371/journal.pone.0097153	http://dx.doi.org/10.1371/journal.pone.0097153			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24865844	Green Published, Green Submitted, gold			2022-12-25	WOS:000336914100012
J	Goldgof, M; Xiao, CY; Chanturiya, T; Jou, W; Gavrilova, O; Reitman, ML				Goldgof, Margalit; Xiao, Cuiying; Chanturiya, Tatyana; Jou, William; Gavrilova, Oksana; Reitman, Marc L.			The Chemical Uncoupler 2,4-Dinitrophenol (DNP) Protects against Diet-induced Obesity and Improves Energy Homeostasis in Mice at Thermoneutrality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BROWN ADIPOSE-TISSUE; ENVIRONMENTAL TEMPERATURES; THERMOGENESIS; COLD; EXPENDITURE; METABOLISM; BALANCE; DINITROPHENOL; GENE; ANIMALS	The chemical uncoupler 2,4-dinitrophenol (DNP) was an effective and widely used weight loss drug in the early 1930s. However, the physiology of DNP has not been studied in detail because toxicity, including hyperthermia and death, reduced interest in the clinical use of chemical uncouplers. To investigate DNP action, mice fed a high fat diet and housed at 30 degrees C (to minimize facultative thermogenesis) were treated with 800 mg/liter DNP in drinking water. DNP treatment increased energy expenditure by similar to 17%, but did not change food intake. DNP-treated mice weighed 26% less than controls after 2 months of treatment due to decreased fat mass, without a change in lean mass. DNP improved glucose tolerance and reduced hepatic steatosis without observed toxicity. DNP treatment also reduced circulating T3 and T4 levels, Ucp1 expression, and brown adipose tissue activity, demonstrating that DNP-mediated heat generation substituted for brown adipose tissue thermogenesis. At 22 degrees C, a typical vivarium temperature that is below thermoneutrality, DNP treatment had no effect on body weight, adiposity, or glucose homeostasis. Thus, environmental temperature should be considered when assessing an anti-obesity drug in mice, particularly agents acting on energy expenditure. Furthermore, the beneficial effects of DNP suggest that chemical uncouplers deserve further investigation for the treatment of obesity and its comorbidities.	[Goldgof, Margalit; Xiao, Cuiying; Reitman, Marc L.] NIDDK, Diabet Endocrinol & Obes Branch, NIH, Bethesda, MD 20892 USA; [Chanturiya, Tatyana; Jou, William; Gavrilova, Oksana] NIDDK, Mouse Metab Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Reitman, ML (corresponding author), Bldg 10-CRC,Rm 5-5940,10 Ctr Dr, Bethesda, MD 20892 USA.	marc.reitman@nih.gov	Reitman, Marc/B-4448-2013	Reitman, Marc/0000-0002-0426-9475	National Institutes of Health, NIDDK, Intramural Research Program [DK075062, DK075063]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZICDK070002, ZIADK075062, ZIADK075063] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Intramural Research Program Grants DK075062 and DK075063.	Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIN; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Castillo M, 2011, DIABETES, V60, P1082, DOI 10.2337/db10-0758; Celi FS, 2010, EUR J ENDOCRINOL, V163, P863, DOI 10.1530/EJE-10-0627; Colman E, 2007, REGUL TOXICOL PHARM, V48, P115, DOI 10.1016/j.yrtph.2007.03.006; da Silva CCC, 2008, AGING CELL, V7, P552, DOI 10.1111/j.1474-9726.2008.00407.x; DAUNCEY MJ, 1981, BRIT J NUTR, V45, P257, DOI 10.1079/BJN19810102; Directorate-Generale for health and consumers, 2010, STRAT EUR NUTR OV OB; Du Bois E. F., 1924, BASAL METABOLISM HLT, P243; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Gavrilova O, 2000, DIABETES, V49, P1910, DOI 10.2337/diabetes.49.11.1910; Gordon CJ, 2012, J THERM BIOL, V37, P654, DOI 10.1016/j.jtherbio.2012.08.004; Grujic D, 1997, J BIOL CHEM, V272, P17686, DOI 10.1074/jbc.272.28.17686; Grundlingh J, 2011, J MED TOXICOL, V7, P205, DOI 10.1007/s13181-011-0162-6; HARVEY DG, 1959, J PHARM PHARMACOL, V11, P462, DOI 10.1111/j.2042-7158.1959.tb12583.x; Herrington LP, 1940, AM J PHYSIOL, V129, P0123, DOI 10.1152/ajplegacy.1940.129.1.123; Horner WD, 1942, ARCH OPHTHALMOL-CHIC, V27, P1097; KAISER J A, 1964, Ther Ggw, V103, P232; Karp CL, 2012, J EXP MED, V209, P1069, DOI 10.1084/jem.20120988; KLEIBER M, 1975, FIRE LIFE, P179; Kraschnewski JL, 2010, INT J OBESITY, V34, P1644, DOI 10.1038/ijo.2010.94; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lodhi IJ, 2009, CELL METAB, V9, P111, DOI 10.1016/j.cmet.2009.01.004; LOOMIS WF, 1948, J BIOL CHEM, V173, P807; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Lou PH, 2007, BIOCHEM J, V407, P129, DOI 10.1042/BJ20070606; MAYER J, 1956, AM J CLIN NUTR, V4, P169, DOI 10.1093/ajcn/4.2.169; MAYER J, 1954, AM J PHYSIOL, V177, P544, DOI 10.1152/ajplegacy.1954.177.3.544; MOUNT LE, 1971, J PHYSIOL-LONDON, V217, P315, DOI 10.1113/jphysiol.1971.sp009573; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Nikonova L, 2008, FASEB J, V22, P3925, DOI 10.1096/fj.08-108266; Nillni EA, 2010, FRONT NEUROENDOCRIN, V31, P134, DOI 10.1016/j.yfrne.2010.01.001; Ogden CL, 2013, PREVALENCE OBESITY A, V131, P1; Overton JM, 2010, INT J OBESITY, V34, pS53, DOI 10.1038/ijo.2010.240; Perkins R. G., 1919, PUB HLTH REP, V24, P2335, DOI DOI 10.2307/4575357; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Ravussin Y, 2013, INT J OBESITY, V37, P399, DOI 10.1038/ijo.2012.105; Ravussin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085876; Ribeiro MO, 2001, J CLIN INVEST, V108, P97, DOI 10.1172/JCI12584; Rippe C, 2000, AM J PHYSIOL-ENDOC M, V279, pE293, DOI 10.1152/ajpendo.2000.279.2.E293; Schmidt-Nielsen K, 1984, SCALING WHY IS ANIMA, P75; Stanier M. W., 1984, ENERGY BALANCE THERM, P38; SUSULIC VS, 1995, J BIOL CHEM, V270, P29483, DOI 10.1074/jbc.270.49.29483; Tainter ML, 1935, J AMER MED ASSOC, V105, P0332, DOI 10.1001/jama.1935.02760310006002; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; US Food and Drug Administration, 2005, GUID IND EST MAX SAF; Wijers SLJ, 2011, J CLIN ENDOCR METAB, V96, pE598, DOI 10.1210/jc.2010-1957	51	83	86	3	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19341	19350		10.1074/jbc.M114.568204	http://dx.doi.org/10.1074/jbc.M114.568204			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24872412	hybrid, Green Published			2022-12-25	WOS:000339326800011
J	Abdallah, HM; Al-Abd, AM; Asaad, GF; Abdel-Naim, AB; El-Halawany, AM				Abdallah, Hossam M.; Al-Abd, Ahmed M.; Asaad, Gihan F.; Abdel-Naim, Ashraf B.; El-Halawany, Ali M.			Isolation of Antiosteoporotic Compounds from Seeds of Sophora japonica	PLOS ONE			English	Article							ASSAY; VIABILITY	Chemical investigation of Sophora japonica seeds resulted in the isolation of seven metabolites identified as: genistin (1), sophoricoside (2), sophorabioside (3), sophoraflavonoloside (4), genistein 7,4'-di-O-beta-D-glucopyransoide (5), kaempferol 3-O-alpha-L-rhamnopyranosyl(1 -> 6)beta-D-glucopyranosyl(1 -> 2)beta-D-glucopyranoside (6) and rutin (7). Compounds 1, 2 and 5 showed significant estrogenic proliferative effect in MCF-7 cell in sub-cytotoxic concentration range. Compounds 1 and 2 showed minimal cell membrane damaging effect using LDH leakage assay. Accordingly, compound 2 (sophoricoside, (SPH)) was selected for further in-vivo studies as a potential anti-osteoporosis agent. The anti-osteoporotic effect of SPH was assessed in ovarectomized (OVX) rats after oral administration (15 mg/kg and 30 mg/kg) for 45 days compared to estradiol (10 mu g/kg) as a positive control. Only in a dose of 30 mg/kg, SPH regained the original mechanical bone hardness compared to normal non-osteoporotic group. However, SPH (15 mg/kg) significantly increased the level of alkaline phosphatase (ALP) to normal level. Treatment with SPH (30 mg/kg) increased the level of ALP to be higher than normal group. SPH (15 mg/kg) did not significantly increase the serum level of osteocalcin (OC) compared to OVX group. On the other hand, treatment with SPH (30 mg/kg) significantly increased the level of OC to 78% higher than normal non-ovarectomized animals group. In addition, SPH (15 mg/kg) decreased the bone resorption marker, acid phosphatase (ACP) to normal level and SPH (30 mg/kg) further diminished the level of serum ACP. Histopathologically, sophoricoside ameliorated the ovarectomy induced osteoporosis in a dose dependent manner. The drug showed thicker bony trabeculae, more osteoid, and more osteoblastic rimming compared to OVX group.	[Abdallah, Hossam M.; El-Halawany, Ali M.] King Abdulaziz Univ, Fac Pharm, Dept Nat Prod, Jeddah 21413, Saudi Arabia; [Abdallah, Hossam M.; El-Halawany, Ali M.] Cairo Univ, Fac Pharm, Dept Pharmacognosy, Cairo, Egypt; [Al-Abd, Ahmed M.; Asaad, Gihan F.] Natl Res Ctr, Dept Pharmacol, Div Med, Giza, Egypt; [Al-Abd, Ahmed M.; Abdel-Naim, Ashraf B.] King Abdulaziz Univ, Fac Pharm, Dept Pharmacol & Toxicol, Jeddah 21413, Saudi Arabia; [Asaad, Gihan F.] Jazan Univ, Dept Pharmacol, Fac Pharm, Jazan, Saudi Arabia	King Abdulaziz University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); King Abdulaziz University; Jazan University	El-Halawany, AM (corresponding author), King Abdulaziz Univ, Fac Pharm, Dept Nat Prod, Jeddah 21413, Saudi Arabia.	ali.elhalawany@pharma.cu.edu.eg	El-Halawany, Ali M./ABE-2550-2021; Al-Abd, Ahmed/J-2826-2012; Asaad, Gihan/AAB-8649-2022; Abdel-Naim, Ashraf B/J-3199-2012; El-Halawany, Ali M/K-8120-2012; Afifi, Hossam Mohamed/B-7711-2016; Abdallah, Hossam/H-9654-2012	Al-Abd, Ahmed/0000-0001-7872-4867; Asaad, Gihan/0000-0002-7679-5968; Abdel-Naim, Ashraf B/0000-0002-0400-9075; El-Halawany, Ali M/0000-0002-5864-1674; Afifi, Hossam Mohamed/0000-0002-0234-7492; Abdallah, Hossam/0000-0002-0234-7492; , Gihan/0000-0002-8017-6668	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [208/166/1433]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	This project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah, under grant no. 208/166/1433. The authors, therefore, acknowledge with thanks DSR technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addar M, 2004, CLIN EXP OBSTET GYN, V32, P135; Brzezinski A, 1999, EUR J OBSTET GYN R B, V85, P47, DOI 10.1016/S0301-2115(98)00281-4; COWAN JD, 1984, CANC DRUG DEL, V1, P95, DOI 10.1089/cdd.1984.1.95; Du Ning, 2003, Zhong Xi Yi Jie He Xue Bao, V1, P44; El-Halawany AM, 2010, PHARM BIOL, V48, P177, DOI 10.3109/13880200903062663; Fu JY, 1999, CALCIFIED TISSUE INT, V64, P229, DOI 10.1007/s002239900608; GERHARDT W, 1974, CLIN CHIM ACTA, V53, P291, DOI 10.1016/0009-8981(74)90267-8; Grishkovets V. I., 1995, Chemistry of Natural Compounds, V31, P596, DOI 10.1007/BF01164887; GRUBER HE, 1984, METABOLISM, V33, P295, DOI 10.1016/0026-0495(84)90187-2; ISHIDA H, 1989, YAKUGAKU ZASSHI, V109, P179, DOI 10.1248/yakushi1947.109.3_179; Jia TL, 2003, BIOCHEM PHARMACOL, V65, P709, DOI 10.1016/S0006-2952(02)01585-X; Ko YJ, 2012, J ETHNOPHARMACOL, V139, P558, DOI 10.1016/j.jep.2011.11.050; Mahmoud AM, 2012, J ENZYM INHIB MED CH, V27, P673, DOI 10.3109/14756366.2011.607446; Min B, 1999, PLANTA MED, V65, P408, DOI 10.1055/s-1999-14016; Mosli HA, 2013, TOXICOL LETT, V220, P247, DOI 10.1016/j.toxlet.2013.05.002; Mostafa K, 2003, B FAC PHARM, V41, P253; Mukhamedova Kh. S., 1997, Chemistry of Natural Compounds, V33, P445, DOI 10.1007/BF02282362; Nagareddy Prabhakara Reddy, 2005, Journal of Pharmacological and Toxicological Methods, V52, P350; OBRANT KJ, 1989, CALCIFIED TISSUE INT, V44, P157, DOI 10.1007/BF02556558; Phillips CA, 2009, ACTA HISTOCHEM, V111, P166, DOI 10.1016/j.acthis.2008.03.003; Sadat-Ali M, 2004, SAUDI MED J, V25, P1623; Shim JG, 2005, ARCH PHARM RES, V28, P106, DOI 10.1007/BF02975144; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Tang YP, 2002, J ASIAN NAT PROD RES, V4, P123, DOI 10.1080/10286020290027407; Tang YP, 2001, J NAT PROD, V64, P1107, DOI 10.1021/np010081s; Wang ZL, 2006, PHYTOMEDICINE, V13, P718, DOI 10.1016/j.phymed.2005.09.005; WATANABE K, 1993, CHEM PHARM BULL, V41, P394, DOI 10.1248/cpb.41.394; Yoon HJ, 2013, NUTR RES, V33, P1053, DOI 10.1016/j.nutres.2013.08.004	28	35	38	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98559	10.1371/journal.pone.0098559	http://dx.doi.org/10.1371/journal.pone.0098559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892557	Green Submitted, gold, Green Published			2022-12-25	WOS:000336911400067
J	Baker, LL; Jonsen, ID; Flemming, JEM; Lidgard, DC; Bowen, WD; Iverson, SJ; Webber, DM				Baker, Laurie L.; Jonsen, Ian D.; Flemming, Joanna E. Mills; Lidgard, Damian C.; Bowen, William D.; Iverson, Sara J.; Webber, Dale M.			Probability of Detecting Marine Predator-Prey and Species Interactions Using Novel Hybrid Acoustic Transmitter-Receiver Tags	PLOS ONE			English	Article							PERFORMANCE; TRACKING; DESIGN; BIOTELEMETRY; CIRCULATION; MOVEMENT; HABITAT; SEALS	Understanding the nature of inter-specific and conspecific interactions in the ocean is challenging because direct observation is usually impossible. The development of dual transmitter/receivers, Vemco Mobile Transceivers (VMT), and satellite-linked (e. g. GPS) tags provides a unique opportunity to better understand between and within species interactions in space and time. Quantifying the uncertainty associated with detecting a tagged animal, particularly under varying field conditions, is vital for making accurate biological inferences when using VMTs. We evaluated the detection efficiency of VMTs deployed on grey seals, Halichoerus grypus, off Sable Island (NS, Canada) in relation to environmental characteristics and seal behaviour using generalized linear models (GLM) to explore both post-processed detection data and summarized raw VMT data. When considering only post-processed detection data, only about half of expected detections were recorded at best even when two VMT-tagged seals were estimated to be within 50-200 m of one another. At a separation of 400 m, only about 15% of expected detections were recorded. In contrast, when incomplete transmissions from the summarized raw data were also considered, the ratio of complete transmission to complete and incomplete transmissions was about 70% for distances ranging from 50-1000 m, with a minimum of around 40% at 600 m and a maximum of about 85% at 50 m. Distance between seals, wind stress, and depth were the most important predictors of detection efficiency. Access to the raw VMT data allowed us to focus on the physical and environmental factors that limit a transceiver's ability to resolve a transmitter's identity.	[Baker, Laurie L.; Jonsen, Ian D.; Lidgard, Damian C.; Iverson, Sara J.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Flemming, Joanna E. Mills] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada; [Bowen, William D.] Fisheries & Oceans Canada, Bedford Inst Oceanog, Populat Ecol Div, Dartmouth, NS B2Y 4A2, Canada; [Webber, Dale M.] VEMCO Ltd, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Bedford Institute of Oceanography; Fisheries & Oceans Canada	Baker, LL (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	Laurie.Baker@dal.ca	Bowen, William/AAE-7204-2022	Bowen, William/0000-0001-8334-5677; Iverson, Sara/0000-0003-2842-4094; Jonsen, Ian/0000-0001-5423-6076; Mills Flemming, Joanna/0000-0002-3517-3089	Natural Sciences and Engineering Research Council of Canada (NSERC) [NETGP 375118 - 08]; Dalhousie Graduate Fellowship; NSERC; Department of Fisheries and Oceans Canada	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Dalhousie Graduate Fellowship; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Department of Fisheries and Oceans Canada	This study and a graduate student stipend to L. Baker were supported by a research network grant (NETGP 375118 - 08) from the Natural Sciences and Engineering Research Council of Canada (NSERC) for the Ocean Tracking Network; L. Baker was additionally supported by a Dalhousie Graduate Fellowship. Additional support was provided by NSERC Discovery Grants to J. Mills Flemming, D. Bowen and S. Iverson, and by the Department of Fisheries and Oceans Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; Austin D, 2006, ECOLOGY, V87, P3095, DOI 10.1890/0012-9658(2006)87[3095:LMDAHT]2.0.CO;2; Barnett A, 2012, OIKOS, V121, P882, DOI 10.1111/j.1600-0706.2011.20000.x; Barnett A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015464; Beck CA, 2007, J ANIM ECOL, V76, P490, DOI 10.1111/j.1365-2656.2007.01215.x; Bowles AE, 2010, J ACOUST SOC AM, V128, P3223, DOI 10.1121/1.3493438; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Bryant E, 2007, TR01 WILDTR TEL SYST; Cantor M, 2013, PHILOS T R SOC B, P368; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Cooke SJ, 2012, AFS 142 ANN M AFS; Finstad B, 2005, J FISH BIOL, V66, P86, DOI 10.1111/j.0022-1112.2005.00581.x; Gjelland KO, 2013, METHODS ECOL EVOL, V4, P665, DOI 10.1111/2041-210X.12057; Gorini L, 2012, MAMMAL REV, V42, P55, DOI 10.1111/j.1365-2907.2011.00189.x; Hazel J, 2009, J EXP MAR BIOL ECOL, V374, P58, DOI 10.1016/j.jembe.2009.04.009; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; How JR, 2012, MAR FRESHWATER RES, V63, P312, DOI 10.1071/MF11194; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Kastelein RA, 2009, J ACOUST SOC AM, V125, P1222, DOI 10.1121/1.3050283; Kessel ST, 2013, REV FISH BIOL FISHER, P1; Kuperman WA, 2004, PHYS TODAY, V57, P55, DOI 10.1063/1.1825269; LARGE WG, 1981, J PHYS OCEANOGR, V11, P324, DOI 10.1175/1520-0485(1981)011<0324:OOMFMI>2.0.CO;2; Lidgard DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048962; Lidgard DC, 2005, BEHAV ECOL, V16, P541, DOI 10.1093/beheco/ari023; Lindegren M, 2010, P ROY SOC B-BIOL SCI, V277, P2121, DOI 10.1098/rspb.2010.0353; Medwin H., 1997, FUNDAMENTALS ACOUSTI, DOI [10.1016/B978-0-12-487570-8.X5000-4, DOI 10.1016/B978-0-12-487570-8.X5000-4]; Mellish JAE, 1999, PHYSIOL BIOCHEM ZOOL, V72, P677, DOI 10.1086/316708; O'Dor RK, 2007, AUSTR SOC FISH BIOL, P6; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; Simpfendorfer CA, 2008, CAN J FISH AQUAT SCI, V65, P482, DOI 10.1139/F07-180; Singh L, 2009, AFR J MAR SCI, V31, P355, DOI 10.2989/AJMS.2009.31.3.8.996; SMITH PC, 1991, CONT SHELF RES, V11, P977, DOI 10.1016/0278-4343(91)90088-N; SUTCLIFFE WH, 1976, J FISH RES BOARD CAN, V33, P98, DOI 10.1139/f76-012; Thorstad EB, 2000, J FISH BIOL, V57, P531, DOI 10.1006/jfbi.2000.1315; Voegeli FA, 1996, OVERVIEW UNDERWATER, V50, P277; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Winship AJ, 2012, METHODS ECOL EVOL, V3, P291, DOI 10.1111/j.2041-210X.2011.00161.x; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2; Zuur Alain F., 2009, P1	39	5	5	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98117	10.1371/journal.pone.0098117	http://dx.doi.org/10.1371/journal.pone.0098117			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892286	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400035
J	Christensen, LL; Holm, A; Rantala, J; Kallioniemi, O; Rasmussen, MH; Ostenfeld, MS; Dagnaes-Hansen, F; Oster, B; Schepeler, T; Tobiasen, H; Thorsen, K; Sieber, OM; Gibbs, P; Lamy, P; Hansen, TF; Jakobsen, A; Riising, EM; Helin, K; Lubinski, J; Hagemann-Madsen, R; Laurberg, S; Orntoft, TF; Andersen, CL				Christensen, Lise Lotte; Holm, Anja; Rantala, Juha; Kallioniemi, Olli; Rasmussen, Mads H.; Ostenfeld, Marie S.; Dagnaes-Hansen, Frederik; Oster, Bodil; Schepeler, Troels; Tobiasen, Heidi; Thorsen, Kasper; Sieber, Oliver M.; Gibbs, Peter; Lamy, Philippe; Hansen, Torben F.; Jakobsen, Anders; Riising, Eva M.; Helin, Kristian; Lubinski, Jan; Hagemann-Madsen, Rikke; Laurberg, Soren; Orntoft, Torben F.; Andersen, Claus L.			Functional Screening Identifies miRNAs Influencing Apoptosis and Proliferation in Colorectal Cancer	PLOS ONE			English	Article							CELL-PROLIFERATION; EXPRESSION PROFILES; MICRORNA; MICROARRAY; SURVIVAL; TRANSCRIPTION; VALIDATION; CARCINOMA; ONCOGENES; ENHANCER	MicroRNAs (miRNAs) play a critical role in many biological processes and are aberrantly expressed in human cancers. Particular miRNAs function either as tumor suppressors or oncogenes and appear to have diagnostic and prognostic significance. Although numerous miRNAs are dys-regulated in colorectal cancer (CRC) only a small fraction has been characterized functionally. Using high-throughput functional screening and miRNA profiling of clinical samples the present study aims at identifying miRNAs important for the control of cellular growth and/or apoptosis in CRC. The high-throughput functional screening was carried out in six CRC cell lines transfected with a pre-miR library including 319 synthetic human pre-miRs. Phenotypic alterations were evaluated by immunostaining of cleaved cPARP (apoptosis) or MKI67 (proliferation). Additionally, TaqMan Human MicroRNA Array Set v2.0 was used to profile the expression of 667 miRNAs in 14 normal colon mucosa and 46 microsatellite stable stage II CRC patients. Among the miRNAs that induced growth arrest and apoptosis in the CRC cell lines, and at same time were dys-regulated in the clinical samples, miR-375 was selected for further analysis. Independent in vitro analysis of transient and stable transfected CRC cell lines confirmed that miR-375 reduces cell viability through the induction of apoptotic death. We identified YAP1 as a direct miR-375 target in CRC and show that HELLS and NOLC1 are down-stream targets. Knock-down of YAP1 mimicked the phenotype induced by miR-375 over-expression indicating that miR-375 most likely exerts its pro-apoptotic role through YAP1 and its anti-apoptotic down-stream targets BIRC5 and BCL2L1. Finally, in vivo analysis of mouse xenograft tumors showed that miR-375 expression significantly reduced tumor growth. We conclude that the high-throughput screening successfully identified miRNAs that induce apoptosis and/or inhibit proliferation in CRC cells. Finally, combining the functional screening with profiling of CRC tissue samples we identified clinically relevant miRNAs and miRNA targets in CRC.	[Christensen, Lise Lotte; Rasmussen, Mads H.; Oster, Bodil; Schepeler, Troels; Tobiasen, Heidi; Thorsen, Kasper; Lamy, Philippe; Orntoft, Torben F.; Andersen, Claus L.] Univ Aarhus, Colorectal Canc Res Grp, Dept Mol Med MOMA, Aarhus Univ Hosp, Aarhus, Denmark; [Holm, Anja] Glostrup Cty Hosp, Glostrup Res Inst, Glostrup, Denmark; [Holm, Anja] Univ Copenhagen, Glostrup Hosp, Mol Sleep Lab, Dept Diagnost, Glostrup, Denmark; [Holm, Anja] Univ Copenhagen, Glostrup Hosp, Danish Ctr Sleep Med, Dept Clin Neurophysiol, Glostrup, Denmark; [Rantala, Juha; Kallioniemi, Olli] VTT Tech Res Ctr Finland, Turku, Finland; [Ostenfeld, Marie S.] Univ Aarhus, Bladder Canc Res Grp, Dept Mol Med MOMA, Aarhus Univ Hosp, Aarhus, Denmark; [Dagnaes-Hansen, Frederik] Univ Aarhus, Dept Biomed, Aarhus, Denmark; [Sieber, Oliver M.; Gibbs, Peter] Ludwig Inst Canc Res, Ludwig Colon Canc Initiat Lab, Melbourne, Vic 3050, Australia; [Sieber, Oliver M.; Gibbs, Peter] Univ Melbourne, Fac Med, Fac Med Dent & Hlth Sci, Dept Surg, Melbourne, Vic, Australia; [Gibbs, Peter] Royal Melbourne & Western Hosp, Dept Med Oncol, Melbourne, Vic, Australia; [Hansen, Torben F.; Jakobsen, Anders] Univ Southern Denmark, Dept Oncol, Vejle Hosp, Vejle, Denmark; [Riising, Eva M.; Helin, Kristian] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Lubinski, Jan] Pomeranian Med Univ, Dept Pathol & Genet, Szczecin, Poland; [Hagemann-Madsen, Rikke] Univ Aarhus, Aarhus Univ Hosp, Dept Pathol, Aarhus, Denmark; [Laurberg, Soren] Univ Aarhus, Aarhus Univ Hosp, Dept Surg, Aarhus, Denmark	Aarhus University; University of Copenhagen; University of Copenhagen; University of Copenhagen; VTT Technical Research Center Finland; Aarhus University; Aarhus University; Ludwig Institute for Cancer Research; University of Melbourne; University of Southern Denmark; Lillebaelt Hospital; University of Copenhagen; Pomeranian Medical University; Aarhus University; Aarhus University	Christensen, LL (corresponding author), Univ Aarhus, Colorectal Canc Res Grp, Dept Mol Med MOMA, Aarhus Univ Hosp, Aarhus, Denmark.	liselotte.christensen@ki.au.dk; cla@ki.au.dk	Helin, Kristian/K-2526-2019; Helin, Kristian/HDM-8306-2022; Sieber, Oliver/M-9473-2015; Sieber, Oliver/ABA-9211-2021; Hansen, Torben F/J-8065-2012; Holm, Anja/AAN-7702-2020; Kallioniemi, Olli P/H-5111-2011; Andersen, Claus L/C-1477-2017; Andersen, Claus Lindbjerg/A-9217-2012	Helin, Kristian/0000-0003-1975-6097; Sieber, Oliver/0000-0001-9480-0786; Sieber, Oliver/0000-0001-9480-0786; Kallioniemi, Olli P/0000-0002-3231-0332; Gibbs, Peter/0000-0003-1423-4484; Madi Riising, Eva/0000-0003-3152-5769; Rasmussen, Mads Heilskov/0000-0001-5723-6303; Jakobsen, Anders/0000-0003-2110-2615; Andersen, Claus Lindbjerg/0000-0002-7406-2103; Rantala, Juha/0000-0002-4999-5585; Hansen, Torben/0000-0001-8748-3831; Hansen, Torben/0000-0001-7476-671X; Lubinski, Jan/0000-0003-2931-3003; Holm, Anja/0000-0001-8796-1872; Dagnaes-Hansen, Frederik/0000-0002-6622-0853	Danish National Advanced Technology Foundation; John and Birthe Meyer Foundation; Danish Council for Independent Research (Medical Sciences); Danish Council for Strategic Research; Lundbeck Foundation; The European Union [SYSCOL HEALTH-F5-2010-258236]	Danish National Advanced Technology Foundation; John and Birthe Meyer Foundation; Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Lundbeck Foundation(Lundbeckfonden); The European Union(European Commission)	This work was supported by the Danish National Advanced Technology Foundation, the John and Birthe Meyer Foundation, the Danish Council for Independent Research (Medical Sciences), the Danish Council for Strategic Research, the Lundbeck Foundation and The European Union's Seventh Framework Program (SYSCOL HEALTH-F5-2010-258236). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2010, MOL CELL BIOL, V30, P4197, DOI 10.1128/MCB.00316-10; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Avnit-Sagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005033; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boyle P, 2000, BRIT MED J, V321, P805, DOI 10.1136/bmj.321.7264.805; Cekaite L, 2012, NEOPLASIA, V14, P868, DOI 10.1593/neo.121094; Chang KH, 2011, INT J COLORECTAL DIS, V26, P1415, DOI 10.1007/s00384-011-1279-4; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Ding L, 2010, CELL RES, V20, P784, DOI 10.1038/cr.2010.79; Faltejskova P, 2012, J CELL MOL MED, V16, P2655, DOI 10.1111/j.1582-4934.2012.01579.x; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Hwang YC, 2009, AM J PATHOL, V175, P342, DOI 10.2353/ajpath.2009.080931; Izumiya M, 2011, CANCER SCI, V102, P1615, DOI 10.1111/j.1349-7006.2011.02007.x; Izumiya M, 2010, CARCINOGENESIS, V31, P1354, DOI 10.1093/carcin/bgq112; Bueno MJ, 2008, CELL CYCLE, V7, P3143, DOI 10.4161/cc.7.20.6833; Kong KL, 2012, GUT, V61, P33, DOI 10.1136/gutjnl-2011-300178; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Li XL, 2011, DIGEST DIS SCI, V56, P2849, DOI 10.1007/s10620-011-1711-1; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Mazar J, 2011, FEBS LETT, V585, P2467, DOI 10.1016/j.febslet.2011.06.025; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Nakano H, 2010, INT J CANCER, V127, P1072, DOI 10.1002/ijc.25143; Nishimura Y, 2013, BRIT J CANCER, V108, P1324, DOI 10.1038/bjc.2013.65; Ostenfeld MS, 2005, CANCER RES, V65, P8975, DOI 10.1158/0008-5472.CAN-05-0269; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rantala JK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-162; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Schepeler T, 2012, ONCOGENE, V31, P2750, DOI 10.1038/onc.2011.453; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schetter AJ, 2009, CLIN CANCER RES, V15, P5878, DOI 10.1158/1078-0432.CCR-09-0627; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Subramanian S, 2010, J CELL PHYSIOL, V223, P289, DOI 10.1002/jcp.22066; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; von Eyss B, 2012, EMBO J, V31, P972, DOI 10.1038/emboj.2011.451; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang SY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-163; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Yan HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020628; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang S, 2008, JOVE-J VIS EXP, V19, pe920	60	46	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e96767	10.1371/journal.pone.0096767	http://dx.doi.org/10.1371/journal.pone.0096767			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892549	gold, Green Published, Green Submitted			2022-12-25	WOS:000336911400007
J	Doktor, TK; Schroder, LD; Andersen, HS; Broner, S; Kitewska, A; Sorensen, CB; Andresen, BS				Doktor, Thomas Koed; Schroder, Lisbeth Dahl; Andersen, Henriette Skovgaard; Broner, Sabrina; Kitewska, Anna; Sorensen, Charlotte Brandt; Andresen, Brage Storstein			Absence of an Intron Splicing Silencer in Porcine Smn1 Intron 7 Confers Immunity to the Exon Skipping Mutation in Human SMN2	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; SURVIVAL-MOTOR-NEURON; MOUSE MODEL; DETERMINING GENE; ANIMAL-MODEL; IN-VIVO; ENHANCERS; IDENTIFICATION; MICE; INCLUSION	Spinal Muscular Atrophy is caused by homozygous loss of SMN1. All patients retain at least one copy of SMN2 which produces an identical protein but at lower levels due to a silent mutation in exon 7 which results in predominant exclusion of the exon. Therapies targeting the splicing of SMN2 exon 7 have been in development for several years, and their efficacy has been measured using either in vitro cellular assays or in vivo small animal models such as mice. In this study we evaluated the potential for constructing a mini-pig animal model by introducing minimal changes in the endogenous porcine Smn1 gene to maintain the native genomic structure and regulation. We found that while a Smn2-like mutation can be introduced in the porcine Smn1 gene and can diminish the function of the ESE, it would not recapitulate the splicing pattern seen in human SMN2 due to absence of a functional ISS immediately downstream of exon 7. We investigated the ISS region and show here that the porcine ISS is inactive due to disruption of a proximal hnRNP A1 binding site, while a distal hnRNP A1 binding site remains functional but is unable to maintain the functionality of the ISS as a whole.	[Doktor, Thomas Koed; Andersen, Henriette Skovgaard; Broner, Sabrina; Andresen, Brage Storstein] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense M, Denmark; [Schroder, Lisbeth Dahl; Sorensen, Charlotte Brandt] Aarhus Univ, Dept Biomed, Aarhus C, Denmark; [Kitewska, Anna] Polish Acad Sci, Inst Anim Reprod & Food Res, Olsztyn, Poland	University of Southern Denmark; Aarhus University; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences	Andresen, BS (corresponding author), Univ Southern Denmark, Dept Biochem & Mol Biol, Odense M, Denmark.	bragea@bmb.sdu.dk	Doktor, Thomas K/G-9923-2014; Andresen, Brage/D-2515-2012; Doktor, Thomas/AAB-2216-2020	Doktor, Thomas K/0000-0002-5315-8325; Andresen, Brage/0000-0001-7488-3035; Doktor, Thomas/0000-0002-5315-8325; Sorensen, Charlotte Brandt/0000-0002-4469-8696; Wieckowska, Anna/0000-0001-6103-3875; Broner, Sabrina/0000-0002-0508-2434	Riisfort Foundation; Lundbeck foundation; Danish Medical Research Council (FSS) [271-07-342, 11-107174]; Villum Fonden [00007292] Funding Source: researchfish	Riisfort Foundation; Lundbeck foundation(Lundbeckfonden); Danish Medical Research Council (FSS)(Danish Medical Research Council); Villum Fonden(Villum Fonden)	This work was supported by a grant from The Riisfort Foundation (BSA), the Lundbeck foundation ( BSA) and The Danish Medical Research Council (FSS grants no. 271-07-342 and no. 11-107174) to BSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Cartegni L, 2002, NAT GENET, V30, P377, DOI 10.1038/ng854; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Cooper TA, 1997, AM J HUM GENET, V61, P259, DOI 10.1086/514856; Coulter LR, 1997, MOL CELL BIOL, V17, P2143, DOI 10.1128/MCB.17.4.2143; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dickson A, 2008, HUM GENE THER, V19, P1307, DOI 10.1089/hgt.2008.067; Doktor TK, 2011, HUM MUTAT, V32, P220, DOI 10.1002/humu.21419; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Geib T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008204; Gladman JT, 2010, HUM MOL GENET, V19, P4239, DOI 10.1093/hmg/ddq343; Gogliotti RG, 2011, NEUROBIOL DIS, V43, P142, DOI 10.1016/j.nbd.2011.03.002; Heier CR, 2010, HUM MOL GENET, V19, P3906, DOI 10.1093/hmg/ddq330; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Jablonka S, 2000, HUM MOL GENET, V9, P341, DOI 10.1093/hmg/9.3.341; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Lorson MA, 2008, DEV DYNAM, V237, P2268, DOI 10.1002/dvdy.21642; Luo YL, 2012, TRANSGENIC RES, V21, P671, DOI 10.1007/s11248-011-9563-1; Madocsai C, 2005, MOL THER, V12, P1013, DOI 10.1016/j.ymthe.2005.08.022; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Nielsen KB, 2007, AM J HUM GENET, V80, P416, DOI 10.1086/511992; Park GH, 2010, CURR NEUROL NEUROSCI, V10, P108, DOI 10.1007/s11910-010-0095-5; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Rigo F, 2012, J CELL BIOL, V199, P21, DOI 10.1083/jcb.201207087; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schweingruber C, 2013, BBA-GENE REGUL MECH, V1829, P612, DOI 10.1016/j.bbagrm.2013.02.005; Sironi M, 2004, NUCLEIC ACIDS RES, V32, P1783, DOI 10.1093/nar/gkh341; Smith PJ, 2006, HUM MOL GENET, V15, P2490, DOI 10.1093/hmg/ddl171; Velasco E, 1996, HUM MOL GENET, V5, P257, DOI 10.1093/hmg/5.2.257; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Wolstencroft EC, 2005, HUM MOL GENET, V14, P1199, DOI 10.1093/hmg/ddi131; Zatkova A, 2004, HUM MUTAT, V24, P491, DOI 10.1002/humu.20103; Zhang CL, 2008, P NATL ACAD SCI USA, V105, P5797, DOI 10.1073/pnas.0801692105; Zhang XHF, 2005, MOL CELL BIOL, V25, P7323, DOI 10.1128/MCB.25.16.7323-7332.2005; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304	47	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98841	10.1371/journal.pone.0098841	http://dx.doi.org/10.1371/journal.pone.0098841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892836	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400100
J	Martinez-Clemente, J; Lopez-Arnau, R; Abad, S; Pubill, D; Escubedo, E; Camarasa, J				Martinez-Clemente, Jose; Lopez-Arnau, Raul; Abad, Sonia; Pubill, David; Escubedo, Elena; Camarasa, Jorge			Dose and Time-Dependent Selective Neurotoxicity Induced by Mephedrone in Mice	PLOS ONE			English	Article							MDMA-INDUCED NEUROTOXICITY; SELF-INJURIOUS-BEHAVIOR; BATH SALTS; 3,4-METHYLENEDIOXYPYROVALERONE MDPV; DESIGNER STIMULANT; DOPAMINE; DRUG; SEROTONIN; RATS; ECSTASY	Mephedrone is a drug of abuse marketed as 'bath salts". There are discrepancies concerning its long-term effects. We have investigated the neurotoxicity of mephedrone in mice following different exposition schedules. Schedule 1: four doses of 50 mg/kg. Schedule 2: four doses of 25 mg/kg. Schedule 3: three daily doses of 25 mg/kg, for two consecutive days. All schedules induced, in some animals, an aggressive behavior and hyperthermia as well as a decrease in weight gain. Mephedrone (schedule 1) induced dopaminergic and serotoninergic neurotoxicity that persisted 7 days after exposition. At a lower dose (schedule 2) only a transient dopaminergic injury was found. In the weekend consumption pattern (schedule 3), mephedrone induced dopamine and serotonin transporter loss that was accompanied by a decrease in tyrosine hydroxylase and tryptophan hydroxylase 2 expression one week after exposition. Also, mephedrone induced a depressive-like behavior, as well as a reduction in striatal D2 density, suggesting higher susceptibility to addictive drugs. In cultured cortical neurons, mephedrone induced a concentration-dependent cytotoxic effect. Using repeated doses for 2 days in an elevated ambient temperature we evidenced a loss of frontal cortex dopaminergic and hippocampal serotoninergic neuronal markers that suggest injuries at nerve endings.	[Escubedo, Elena] Univ Barcelona, Fac Pharm, Dept Pharmacol & Therapeut Chem, Pharmacol Sect, Barcelona, Spain; Univ Barcelona, Fac Pharm, Inst Biomed IBUB, Barcelona, Spain	University of Barcelona; University of Barcelona	Escubedo, E (corresponding author), Univ Barcelona, Fac Pharm, Dept Pharmacol & Therapeut Chem, Pharmacol Sect, Barcelona, Spain.	eescubedo@ub.edu	López-Arnau, Raúl/Q-5896-2018; Escubedo, Elena/K-5295-2014; Sanchez, David Pubill/H-3013-2016	López-Arnau, Raúl/0000-0001-8904-7398; Escubedo, Elena/0000-0002-5078-366X; Sanchez, David Pubill/0000-0002-6627-4501; Sonia, ABAD/0000-0001-8238-0016	Generalitat de Catalunya [SGR977]; Plan Nacional sobre Drogas [2010/005, 2012/102]; Ministerio de Ciencia e Innovacion [SAF2010-15948]; Plan Nacional sobre Drogas; Generalitat de Catalunya	Generalitat de Catalunya(Generalitat de Catalunya); Plan Nacional sobre Drogas; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Plan Nacional sobre Drogas; Generalitat de Catalunya(Generalitat de Catalunya)	Funding for this study was provided by grants from Generalitat de Catalunya (SGR977), Plan Nacional sobre Drogas (2010/005; 2012/102) and Ministerio de Ciencia e Innovacion (SAF2010-15948). Martinez-Clemente is a recipient of a fellowship from the Plan Nacional sobre Drogas and Lopez-Arnau is a recipient of a fellowship from Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angoa-Perez M, 2012, J NEUROCHEM, V120, P1097, DOI 10.1111/j.1471-4159.2011.07632.x; BATTAGLIA G, 1988, PHARMACOL BIOCHEM BE, V29, P269, DOI 10.1016/0091-3057(88)90155-4; Baumann MH, 2013, NEUROPSYCHOPHARMACOL, V38, P552, DOI 10.1038/npp.2012.204; Baumann MH, 2012, NEUROPSYCHOPHARMACOL, V37, P1192, DOI 10.1038/npp.2011.304; Biezonski DK, 2011, CURR NEUROPHARMACOL, V9, P84, DOI 10.2174/157015911795017146; Borek HA, 2012, ANN EMERG MED, V60, P103, DOI 10.1016/j.annemergmed.2012.01.005; Brunt TM, 2011, J PSYCHOPHARMACOL, V25, P1543, DOI 10.1177/0269881110378370; Calapai G, 2001, PHARMACOPSYCHIATRY, V34, P45, DOI 10.1055/s-2001-15180; Cameron K, 2013, PSYCHOPHARMACOLOGY, V227, P493, DOI 10.1007/s00213-013-2967-2; Capela JP, 2013, NEUROTOXICOLOGY, V34, P254, DOI 10.1016/j.neuro.2012.09.005; Clark RA, 2012, J PSYCHOPHARMACOL, V26, P1136, DOI 10.1177/0269881111420313; de la Torre R, 2004, THER DRUG MONIT, V26, P137, DOI 10.1097/00007691-200404000-00009; den Hollander B, 2013, PHARMACOL BIOCHEM BE, V103, P501, DOI 10.1016/j.pbb.2012.10.006; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Escubedo E, 2005, J PHARMACOL EXP THER, V315, P658, DOI 10.1124/jpet.105.089748; Fantegrossi WE, 2013, NEUROPSYCHOPHARMACOL, V38, P563, DOI 10.1038/npp.2012.233; Groman SM, 2012, J NEUROSCI, V32, P5843, DOI 10.1523/JNEUROSCI.0029-12.2012; Gunderson EW, 2013, J ADDICT MED, V7, P153, DOI 10.1097/ADM.0b013e31829084b7; Hadlock GC, 2011, J PHARMACOL EXP THER, V339, P530, DOI 10.1124/jpet.111.184119; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Kasick DP, 2012, AM J DRUG ALCOHOL AB, V38, P176, DOI 10.3109/00952990.2011.643999; Kehr J, 2011, BRIT J PHARMACOL, V164, P1949, DOI 10.1111/j.1476-5381.2011.01499.x; Kuhn DM, 2007, J NEUROCHEM, V103, P1567, DOI 10.1111/j.1471-4159.2007.04855.x; LOGAN BJ, 1988, EUR J PHARMACOL, V152, P227, DOI 10.1016/0014-2999(88)90717-0; Lopez-Arnau R, 2012, BRIT J PHARMACOL, V167, P407, DOI 10.1111/j.1476-5381.2012.01998.x; Martinez-Clemente J, 2013, PSYCHOPHARMACOLOGY, V229, P295, DOI 10.1007/s00213-013-3108-7; Martinez-Clemente J, 2012, EUR NEUROPSYCHOPHARM, V22, P231, DOI 10.1016/j.euroneuro.2011.07.009; Maskell PD, 2011, J ANAL TOXICOL, V35, P188, DOI 10.1093/anatox/35.3.188; McElrath K, 2011, INT J DRUG POLICY, V22, P120, DOI 10.1016/j.drugpo.2010.11.001; McGregor IS, 2003, PSYCHOPHARMACOLOGY, V168, P465, DOI 10.1007/s00213-003-1452-8; Measham F, 2010, DRUGS ALCOHOL TODAY, V10, P14, DOI 10.5042/daat.2010.0123; Meng H, 2012, TOXICOL LETT, V208, P62, DOI 10.1016/j.toxlet.2011.10.010; Motbey CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045473; O'Shea E, 2006, BRIT J PHARMACOL, V148, P778, DOI 10.1038/sj.bjp.0706783; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Prosser JM, 2012, J MED TOXICOL, V8, P33, DOI 10.1007/s13181-011-0193-z; PU CF, 1993, DEV BRAIN RES, V72, P325; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rockhold RW, 1997, ANN EMERG MED, V29, P383, DOI 10.1016/S0196-0644(97)70351-2; Sanchez V, 2004, J PSYCHOPHARMACOL, V18, P412, DOI 10.1177/026988110401800312; SCHEFFEL U, 1992, NEUROPHARMACOLOGY, V31, P881, DOI 10.1016/0028-3908(92)90126-A; Schifano F, 2011, PSYCHOPHARMACOLOGY, V214, P593, DOI 10.1007/s00213-010-2070-x; Schroter CJ, 1999, J IMMUNOL METHODS, V227, P161, DOI 10.1016/S0022-1759(99)00079-4; Shishido T, 2000, PHARMACOL BIOCHEM BE, V66, P579, DOI 10.1016/S0091-3057(00)00219-7; Simmler LD, 2013, BRIT J PHARMACOL, V168, P458, DOI 10.1111/j.1476-5381.2012.02145.x; Vardakou I, 2011, TOXICOL LETT, V201, P191, DOI 10.1016/j.toxlet.2010.12.014; Varner KJ, 2013, PSYCHOPHARMACOLOGY, V225, P675, DOI 10.1007/s00213-012-2855-1; Verdaguer E, 2002, NEUROREPORT, V13, P413, DOI 10.1097/00001756-200203250-00010; Vidal-Infer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043107; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Wagner GC, 2004, NEUROPHARMACOLOGY, V46, P700, DOI 10.1016/j.neuropharm.2003.11.009; Wikstrom M, 2010, J ANAL TOXICOL, V34, P594, DOI 10.1093/jat/34.9.594; Winstock A, 2011, ADDICTION, V106, P1991, DOI 10.1111/j.1360-0443.2011.03502.x; Winstock A, 2010, LANCET, V376, P1537, DOI 10.1016/S0140-6736(10)62021-1; Wood DM, 2011, EMERG MED J, V28, P280, DOI 10.1136/emj.2010.092288; Wright MJ, 2012, BRIT J PHARMACOL, V167, P1342, DOI 10.1111/j.1476-5381.2012.02091.x; Wright MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044652	57	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e99002	10.1371/journal.pone.0099002	http://dx.doi.org/10.1371/journal.pone.0099002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892744	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400119
J	Zhou, KK; Jiang, MS; Liu, YL; Qu, YL; Shi, GJ; Yang, XG; Qin, XF; Wang, XH				Zhou, Kangkang; Jiang, Mingshan; Liu, Yuanli; Qu, Yilin; Shi, Guojing; Yang, Xinguang; Qin, Xiaofa; Wang, Xiuhong			Effect of Bile Pigments on the Compromised Gut Barrier Function in a Rat Model of Bile Duct Ligation	PLOS ONE			English	Article							BACTERIAL TRANSLOCATION; OBSTRUCTIVE-JAUNDICE; BILIRUBIN; SALTS; BILIVERDIN; MORPHOLOGY; DIAGNOSIS; SYSTEMS; INJURY	Background: Studies have shown that the absence of bile in the gut lumen, either by bile duct ligation or bile diversion, induces mucosal injury. However, the mechanism remains elusive. In this study, the role of bile pigments in gut barrier function was investigated in a rat model of bile duct ligation. Methods: Male Sprague Dawley (SD) rats were used in this study. After ligation of bile duct, the animals were administrated with free bilirubin, bilirubin ditaurate, or biliverdin by intragastric gavage. 1, 2, or 3 days later, the animals were sacrificed and the damage of mucosa was assessed by histological staining as well as biochemical parameters such as changes of diamine oxidase (DAO) and D-lactate (D-Lac) in the blood. Trypsin and chymotrypsin of the gut were also measured to determine how these digestive proteases may relate to the observed effects of bile pigments. Results: Bile duct ligation (BDL) caused significant increases in gut trypsin and chymotrypsin along with damage of the mucosa as demonstrated by the histological findings under microscope, the reduced expression of tight junction molecules like occludin, and significant changes in DAO and D-lac in the blood. Free bilirubin but not bilirubin ditaurate or biliverdin showed significant inhibitions on trypsin and chymotrypsin as well as alleviated changes of histological and biochemical parameters related to gut barrier disruption. Conclusion: Bile may protect the gut from damage through inhibiting digestive proteases like trypsin and chymotrypsin by free bilirubin.	[Zhou, Kangkang; Liu, Yuanli; Qu, Yilin; Shi, Guojing; Yang, Xinguang; Wang, Xiuhong] Harbin Med Univ, Dept Biochem & Mol Biol, Heilongjiang Prov Sci & Technol Innovat Team, Higher Educ Inst Infect, Harbin, Peoples R China; [Zhou, Kangkang; Liu, Yuanli; Qu, Yilin; Shi, Guojing; Yang, Xinguang; Wang, Xiuhong] Harbin Med Univ, Dept Biochem & Mol Biol, Heilongjiang Prov Sci & Technol Innovat Team, Higher Educ Inst Immun, Harbin, Peoples R China; [Jiang, Mingshan] Harbin Med Univ, Affiliated Hosp 2, Dept Gen Surg, Harbin, Peoples R China; [Qin, Xiaofa] Rutgers New Jersey Med Sch, Dept Surg, Newark, NJ USA	Harbin Medical University; Harbin Medical University; Harbin Medical University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Wang, XH (corresponding author), Harbin Med Univ, Dept Biochem & Mol Biol, Heilongjiang Prov Sci & Technol Innovat Team, Higher Educ Inst Infect, Harbin, Peoples R China.	wangxh700417@yahoo.com.cn			National Natural Science Foundation of China [30973596]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by The National Natural Science Foundation of China (No. 30973596). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basinska A, 2003, BETA GLUCORONIDASE P, P386; Biancheri P, 2013, CELL TISSUE RES, V351, P269, DOI 10.1007/s00441-012-1390-z; BRANDT RB, 1980, ANAL BIOCHEM, V102, P39, DOI 10.1016/0003-2697(80)90314-0; Bulmer AC, 2011, BRIT J PHARMACOL, V164, P1857, DOI 10.1111/j.1476-5381.2011.01413.x; Bulmer AC, 2008, ATHEROSCLEROSIS, V199, P390, DOI 10.1016/j.atherosclerosis.2007.11.022; Cakmakci M, 1996, EUR J SURG, V162, P567; DELANEY JP, 1992, SURGERY, V112, P587; FALLON MB, 1995, AM J PHYSIOL-CELL PH, V269, pC1057, DOI 10.1152/ajpcell.1995.269.4.C1057; Gencay C, 2008, WORLD J GASTROENTERO, V14, P3410, DOI 10.3748/wjg.14.3410; Gruber L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071661; Gurleyik E, 2006, J INVEST SURG, V19, P283, DOI 10.1080/08941930600889391; GUSLANDI M, 1983, GUT, V24, P594, DOI 10.1136/gut.24.6.594; HENRIKSON CK, 1989, LAB INVEST, V60, P72; KEELING JW, 1976, J PATHOL, V118, P157, DOI 10.1002/path.1711180305; LOWBEER TS, 1970, GUT, V11, P486, DOI 10.1136/gut.11.6.486; LUK GD, 1983, J CLIN INVEST, V71, P1308, DOI 10.1172/JCI110881; MCDONAGH AF, 1972, BIOCHEM J, V129, P797, DOI 10.1042/bj1290797; Mowat AP, 1987, GUT, V28, P365; NAKAGAMI T, 1993, BIOCHIM BIOPHYS ACTA, V1158, P189, DOI 10.1016/0304-4165(93)90013-X; Ogata Y, 2003, J SURG RES, V115, P18, DOI 10.1016/S0022-4804(03)00308-1; Qin XF, 2007, GUT, V56, P1641, DOI 10.1136/gut.2007.132076; ROD TO, 1977, ACTA PATH MICRO IM B, V85, P271; SALO JA, 1983, SURGERY, V93, P525; SLOCUM MM, 1992, AM SURGEON, V58, P305; SMITH SM, 1986, J INFECT DIS, V154, P658, DOI 10.1093/infdis/154.4.658; SPIVAK W, 1986, BIOCHEM J, V234, P101, DOI 10.1042/bj2340101; Vitek L, 2003, EUR J CLIN INVEST, V33, P799, DOI 10.1046/j.1365-2362.2003.01214.x; Vos TA, 1999, HEPATOLOGY, V29, P1833, DOI 10.1002/hep.510290638; Whitson BA, 2006, TURNING GREEN GOLD; Zsila F, 2011, BIOMACROMOLECULES, V12, P221, DOI 10.1021/bm1012103	30	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98905	10.1371/journal.pone.0098905	http://dx.doi.org/10.1371/journal.pone.0098905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892651	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400108
J	Bellas, C; Garcia, D; Vicente, Y; Kilany, L; Abraira, V; Navarro, B; Provencio, M; Martin, P				Bellas, Carmen; Garcia, Diego; Vicente, Yolanda; Kilany, Linah; Abraira, Victor; Navarro, Belen; Provencio, Mariano; Martin, Paloma			Immunohistochemical and Molecular Characteristics with Prognostic Significance in Diffuse Large B-Cell Lymphoma	PLOS ONE			English	Article							GERMINAL CENTER PHENOTYPE; PARAFFIN-EMBEDDED TISSUE; RITUXIMAB PLUS CYCLOPHOSPHAMIDE; CHOP CONSORTIUM PROGRAM; NON-HODGKINS-LYMPHOMAS; GENE-EXPRESSION; PROTEIN EXPRESSION; RISK STRATIFICATION; CLINICAL-RELEVANCE; MYC TRANSLOCATION	Diffuse large B-cell lymphoma (DLBCL) is an aggressive non-Hodgkin lymphoma with marked biologic heterogeneity. We analyzed 100 cases of DLBCL to evaluate the prognostic value of immunohistochemical markers derived from the gene expression profiling-defined cell origin signature, including MYC, BCL2, BCL6, and FOXP1 protein expression. We also investigated genetic alterations in BCL2, BCL6, MYC and FOXP1 using fluorescence in situ hybridization and assessed their prognostic significance. BCL6 rearrangements were detected in 29% of cases, and BCL6 gene alteration (rearrangement and/or amplification) was associated with the non-germinal center B subtype (non-GCB). BCL2 translocation was associated with the GCB phenotype, and BCL2 protein expression was associated with the translocation and/or amplification of 18q21. MYC rearrangements were detected in 15% of cases, and MYC protein expression was observed in 29% of cases. FOXP1 expression, mainly of the non-GCB subtype, was demonstrated in 37% of cases. Co-expression of the MYC and BCL2 proteins, with non-GCB subtype predominance, was observed in 21% of cases. We detected an association between high FOXP1 expression and a high proliferation rate as well as a significant positive correlation between MYC overexpression and FOXP1 overexpression. MYC, BCL2 and FOXP1 expression were significant predictors of overall survival. The co-expression of MYC and BCL2 confers a poorer clinical outcome than MYC or BCL2 expression alone, whereas cases negative for both markers had the best outcomes. Our study confirms that DLBCL, characterized by the co-expression of MYC and BCL2 proteins, has a poor prognosis and establishes a significant positive correlation with MYC and FOXP1 over-expression in this entity.	[Bellas, Carmen; Garcia, Diego; Vicente, Yolanda; Kilany, Linah; Martin, Paloma] Hosp Univ Puerta de Hierro Majadahonda, Inst Invest Sanitaria, Lab Mol Pathol, Madrid, Spain; [Abraira, Victor] Hosp Univ Ramon & Cajal, CIBER Epidemiol & Salud Publ CIBERESP, Unidad Bioestadist Clin, Madrid, Spain; [Navarro, Belen] Hosp Univ Puerta de Hierro Majadahonda, Dept Hematol, Madrid, Spain; [Provencio, Mariano] Hosp Univ Puerta de Hierro Majadahonda, Inst Invest Sanitaria, Oncohematol Res Unit, Med Oncol Serv, Madrid, Spain	Hospital Puerta de Hierro-Majadahonda; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario Ramon y Cajal; Hospital Puerta de Hierro-Majadahonda; Hospital Puerta de Hierro-Majadahonda	Martin, P (corresponding author), Hosp Univ Puerta de Hierro Majadahonda, Inst Invest Sanitaria, Lab Mol Pathol, Madrid, Spain.	pmartin@idiphim.org	Acosta, Paloma Martin/AAF-7998-2021; Provencio, Mariano/ABE-8586-2020	Acosta, Paloma Martin/0000-0002-3274-4595; Provencio, Mariano/0000-0001-9053-9197; Provencio Pulla, Mariano/0000-0001-6315-7919	Fondo de Investigaciones Sanitarias [RETIC RD 06/0020/0047]; Fundacion Mutua Madrilena; Miguel Servet contract from the Fondo de Investigaciones Sanitarias	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Miguel Servet contract from the Fondo de Investigaciones Sanitarias	This work was supported by grants from the Fondo de Investigaciones Sanitarias (RETIC RD 06/0020/0047) and Fundacion Mutua Madrilena. PM is supported by a Miguel Servet contract from the Fondo de Investigaciones Sanitarias. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Banham AH, 2005, CLIN CANCER RES, V11, P1065; Barrans SL, 2004, BLOOD, V104, P2933, DOI 10.1182/blood-2004-03-1209; Barrans SL, 2003, CLIN CANCER RES, V9, P2133; Barrans SL, 2002, BLOOD, V99, P1136, DOI 10.1182/blood.V99.4.1136; Barrans SL, 2002, BRIT J HAEMATOL, V117, P322, DOI 10.1046/j.1365-2141.2002.03435.x; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Choi WWL, 2009, CLIN CANCER RES, V15, P5494, DOI 10.1158/1078-0432.CCR-09-0113; Copie-Bergman C, 2009, J CLIN ONCOL, V27, P5573, DOI 10.1200/JCO.2009.22.7058; Craig VJ, 2011, BLOOD, V117, P6227, DOI 10.1182/blood-2010-10-312231; Gascoyne RD, 1997, BLOOD, V90, P244; Goatly A, 2008, MODERN PATHOL, V21, P902, DOI 10.1038/modpathol.2008.74; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; Gutierrez-Garcia G, 2011, BLOOD, V117, P4836, DOI 10.1182/blood-2010-12-322362; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Haralambieva E, 2006, LEUKEMIA, V20, P1300, DOI 10.1038/sj.leu.2404244; Haralambieva E, 2002, J PATHOL, V198, P163, DOI 10.1002/path.1197; Hoeller S, 2010, HISTOPATHOLOGY, V57, P73, DOI 10.1111/j.1365-2559.2010.03600.x; Horn H, 2013, BLOOD, V121, P2253, DOI 10.1182/blood-2012-06-435842; Hu SM, 2013, BLOOD, V121, P4021, DOI 10.1182/blood-2012-10-460063; Huang JZ, 2002, BLOOD, V99, P2285, DOI 10.1182/blood.V99.7.2285; Iqbal J, 2007, LEUKEMIA, V21, P2332, DOI 10.1038/sj.leu.2404856; Iqbal J, 2004, AM J PATHOL, V165, P159, DOI 10.1016/S0002-9440(10)63284-1; Jais JP, 2008, LEUKEMIA, V22, P1917, DOI 10.1038/leu.2008.188; Jerkeman M, 2002, INT J ONCOL, V20, P161; Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; Kluk MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033813; Kramer MHH, 1998, BLOOD, V92, P3152, DOI 10.1182/blood.V92.9.3152.421a07_3152_3162; Kusumoto S, 2005, AM J SURG PATHOL, V29, P1067; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Li SY, 2012, MODERN PATHOL, V25, P145, DOI 10.1038/modpathol.2011.147; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Meyer PN, 2011, J CLIN ONCOL, V29, P200, DOI 10.1200/JCO.2010.30.0368; MILLER TP, 1994, BLOOD, V83, P1460, DOI 10.1182/blood.V83.6.1460.1460; Moskowitz CH, 2005, BLOOD, V106, P3383, DOI 10.1182/blood-2005-04-1603; Muris JJF, 2006, J PATHOL, V208, P714, DOI 10.1002/path.1924; Natkunam Y, 2008, J CLIN ONCOL, V26, P447, DOI 10.1200/JCO.2007.13.0690; Natkunam Y, 2007, BLOOD, V109, P1636, DOI 10.1182/blood-2006-08-039024; Niitsu N, 2007, LEUKEMIA RES, V31, P1191, DOI 10.1016/j.leukres.2006.11.004; Niitsu N, 2009, CANCER SCI, V100, P233, DOI 10.1111/j.1349-7006.2008.01035.x; Pedersen MO, 2014, EUR J HAEMATOL, V92, P42, DOI 10.1111/ejh.12212; Rao DS, 2010, IMMUNITY, V33, P48, DOI 10.1016/j.immuni.2010.06.013; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sagaert X, 2006, J CLIN ONCOL, V24, P2490, DOI 10.1200/JCO.2006.05.6150; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095; Scott DW, 2014, BLOOD, V123, P1214, DOI 10.1182/blood-2013-11-536433; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Stein H, 2008, WHO CLASSIFICATION T, V4th, P233; Valera A, 2013, HAEMATOLOGICA, V98, P1554, DOI 10.3324/haematol.2013.086173; van Imhoff GW, 2006, J CLIN ONCOL, V24, P4135, DOI 10.1200/JCO.2006.05.5897; Ventura RA, 2006, J MOL DIAGN, V8, P141, DOI 10.2353/jmoldx.2006.050083; Visco C, 2013, HAEMATOLOGICA, V98, P255, DOI 10.3324/haematol.2012.066209; Vitolo U, 1998, ANN ONCOL, V9, P55, DOI 10.1023/A:1008201729596; Wlodarska I, 2005, LEUKEMIA, V19, P1299, DOI 10.1038/sj.leu.2403813; Zhang HW, 2011, HEMATOL ONCOL, V29, P185, DOI 10.1002/hon.991	55	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98169	10.1371/journal.pone.0098169	http://dx.doi.org/10.1371/journal.pone.0098169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887414	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300043
J	Martin, RNA; McGeehan, JE; Kneale, G				Martin, Richard N. A.; McGeehan, John E.; Kneale, Geoff			Structural and Mutagenic Analysis of the RM Controller Protein C.Esp1396I	PLOS ONE			English	Article							RESTRICTION-MODIFICATION SYSTEM; TRANSCRIPTION REGULATION; EXPRESSION; ENDONUCLEASE; RECOGNITION; PROMOTER; SYMMETRY; C.AHDL; PVUII	Bacterial restriction-modification (RM) systems are comprised of two complementary enzymatic activities that prevent the establishment of foreign DNA in a bacterial cell: DNA methylation and DNA restriction. These two activities are tightly regulated to prevent over-methylation or auto-restriction. Many Type II RM systems employ a controller (C) protein as a transcriptional regulator for the endonuclease gene (and in some cases, the methyltransferase gene also). All high-resolution structures of C-protein/DNA-protein complexes solved to date relate to C.Esp1396I, from which the interactions of specific amino acid residues with DNA bases and/or the phosphate backbone could be observed. Here we present both structural and DNA binding data for a series of mutations to the key DNA binding residues of C.Esp1396I. Our results indicate that mutations to the backbone binding residues (Y37, S52) had a lesser affect on DNA binding affinity than mutations to those residues that bind directly to the bases (T36, R46), and the contributions of each side chain to the binding energies are compared. High-resolution X-ray crystal structures of the mutant and native proteins showed that the fold of the proteins was unaffected by the mutations, but also revealed variation in the flexible loop conformations associated with DNA sequence recognition. Since the tyrosine residue Y37 contributes to DNA bending in the native complex, we have solved the structure of the Y37F mutant protein/DNA complex by X-ray crystallography to allow us to directly compare the structure of the DNA in the mutant and native complexes.	[Martin, Richard N. A.; McGeehan, John E.; Kneale, Geoff] Univ Portsmouth, Inst Biomed & Biomol Sci, Sch Biol Sci, Biophys Labs, Portsmouth, Hants, England	University of Portsmouth	Kneale, G (corresponding author), Univ Portsmouth, Inst Biomed & Biomol Sci, Sch Biol Sci, Biophys Labs, Portsmouth, Hants, England.	geoff.kneale@port.ac.uk		McGeehan, John/0000-0002-6750-1462	Biotechnology and Biological Sciences Research Council [BB/H00680X/1]; University of Portsmouth; BBSRC [BB/H00680X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E500595/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Portsmouth; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors thank the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) for funding this research (research grant number BB/H00680X/1 to G. G. K. and J.E.M. and the University of Portsmouth for an IBBS studentship to N.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball N, 2009, ACTA CRYSTALLOGR D, V65, P900, DOI 10.1107/S0907444909020514; Ball NJ, 2012, NUCLEIC ACIDS RES, V40, P10532, DOI 10.1093/nar/gks718; Bogdanova E, 2008, NUCLEIC ACIDS RES, V36, P1429, DOI 10.1093/nar/gkm1116; Bogdanova E, 2009, NUCLEIC ACIDS RES, V37, P3354, DOI 10.1093/nar/gkp210; Cesnaviciene E, 2003, NUCLEIC ACIDS RES, V31, P743, DOI 10.1093/nar/gkg135; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; IVES CL, 1992, J BACTERIOL, V174, P7194, DOI 10.1128/jb.174.22.7194-7201.1992; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Knowle D, 2005, J BACTERIOL, V187, P488, DOI 10.1128/JB.187.2.488-497.2005; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Leslie AGW, 1992, RECENT CHANGES MOSFL; Loenen WAM, 2014, NUCLEIC ACIDS RES, V42, P3, DOI 10.1093/nar/gkt990; Martin RNA, 2013, ACTA CRYSTALLOGR F, V69, P962, DOI 10.1107/S174430911302126X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McGeehan JE, 2012, NUCLEIC ACIDS RES, V40, P4158, DOI 10.1093/nar/gkr1250; McGeehan JE, 2006, J MOL BIOL, V358, P523, DOI 10.1016/j.jmb.2006.02.003; McGeehan JE, 2005, J MOL BIOL, V346, P689, DOI 10.1016/j.jmb.2004.12.025; McGeehan JE, 2008, NUCLEIC ACIDS RES, V36, P4778, DOI 10.1093/nar/gkn448; Mruk I, 2008, NUCLEIC ACIDS RES, V36, P2581, DOI 10.1093/nar/gkn097; Mruk I, 2007, NUCLEIC ACIDS RES, V35, P6935, DOI 10.1093/nar/gkm837; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newman JA, 2013, J BIOL CHEM, V288, P10766, DOI 10.1074/jbc.M113.455592; RIMSELIENE R, 1995, GENE, V157, P217; Streeter SD, 2004, NUCLEIC ACIDS RES, V32, P6445, DOI 10.1093/nar/gkh975; TAKEDA Y, 1992, P NATL ACAD SCI USA, V89, P8180, DOI 10.1073/pnas.89.17.8180; TAO T, 1991, J BACTERIOL, V173, P1367, DOI 10.1128/jb.173.4.1367-1375.1991; Vijesurier RM, 2000, J BACTERIOL, V182, P477, DOI 10.1128/JB.182.2.477-487.2000; WILSON GG, 1991, ANNU REV GENET, V25, P585, DOI 10.1146/annurev.ge.25.120191.003101	34	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98365	10.1371/journal.pone.0098365	http://dx.doi.org/10.1371/journal.pone.0098365			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887147	Green Submitted, Green Published, gold			2022-12-25	WOS:000336956300058
J	Sharma, N; Baron, JC				Sharma, Nikhil; Baron, Jean-Claude			Effects of Healthy Ageing on Activation Pattern within the Primary Motor Cortex during Movement and Motor Imagery: An fMRI Study	PLOS ONE			English	Article							AGE-RELATED-CHANGES; SUBCORTICAL STROKE; HUMAN BRAIN; AREAS; MECHANISMS; SYSTEM; ADULTS; ACQUISITION; OPPOSITION; EXECUTION	The increase in older adults over the coming decades will be accompanied by a greater burden of chronic neurological diseases affecting the motor system. The motor system adapts to maintain motor performance with the primary motor cortex (BA4) emerging as a pivotal node within this neuroplastic process. Studies of ageing often consider BA4 a homogenous area but cytoarchitectonic studies have revealed two subdivisions, an anterior (BA4a) and posterior subdivision (BA4p). Here we focus upon the effects of ageing on the involvement of BA4a and BA4p during movement and motor imagery (MI). Thirty-one right-handed healthy volunteers were recruited and screened for their ability to perform imagery (5 subjects excluded). The sample was split into an older group (n = 13, mean age 56.4 SD 9.4) and a younger group (n = 13, mean age 27.4 SD 5.3). We used an fMRI block-design (auditory-paced [1 Hz] right hand finger-thumb opposition sequence [2,3,4,5, 2...]) with MI & rest and actual movement & rest. We explored the distribution-based clustering and weighted laterality index within BA4a and BA4p. The involvement of BA4p during MI (measured with distribution-based clustering) was significantly greater in the older group (p < 0.05) than in the younger group. Hemispheric balance of BA4p decreased with age during MI (Spearman rho 20.371; p < 0.05), whereas that of BA4a decreased with age during actual movement (Spearman rho = -0.458 p < 0.01). Irrespective of age, we found BA4 is involved during motor imagery, strengthening the rationale for its potential use in older subjects. These findings suggest that the functions of the subdivisions of BA4 are differentially affected by ageing and have implications regarding how ageing affects the cognitive processes underlying motor functions.	[Sharma, Nikhil; Baron, Jean-Claude] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Baron, Jean-Claude] Univ Paris, Hop St Anne, Ctr Psychiat & Neurosci, INSERM, F-75252 Paris, France	University of Cambridge; GHU PARIS Psychiatrie Neurosciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Sharma, N (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.	ns358@cam.ac.uk		Sharma, Nikhil/0000-0001-8903-2938; baron, jean-claude/0000-0002-5264-2588	Brain Entry Scholarship; Stroke Association [TSA 2003/10]; Sackler Fellowship; Medical Research Council [MRC G0001219]; MRC [G0500874] Funding Source: UKRI; Medical Research Council [G0500874] Funding Source: researchfish	Brain Entry Scholarship; Stroke Association; Sackler Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	NS is supported by a Brain Entry Scholarship, The Stroke Association (TSA 2003/10) & Sackler Fellowship. JCB is supported by the Medical Research Council (MRC G0001219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkadhi H, 2005, CEREB CORTEX, V15, P131, DOI 10.1093/cercor/bhh116; Binkofski F, 2002, J NEUROPHYSIOL, V88, P514, DOI 10.1152/jn.2002.88.1.514; Buch E, 2008, STROKE, V39, P910, DOI 10.1161/STROKEAHA.107.505313; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Calautti C, 2001, STROKE, V32, P139, DOI 10.1161/01.STR.32.1.139; Calautti C, 2007, NEUROIMAGE, V34, P322, DOI 10.1016/j.neuroimage.2006.08.026; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cramer SC, 2008, ANN NEUROL, V63, P549, DOI 10.1002/ana.21412; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Daselaar SM, 2003, NEUROBIOL AGING, V24, P1013, DOI 10.1016/S0197-4580(03)00030-7; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; Decety J, 1996, BEHAV BRAIN RES, V72, P127; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Dimyan MA, 2011, NAT REV NEUROL, V7, P76, DOI 10.1038/nrneurol.2010.200; DORFMAN LJ, 1979, NEUROLOGY, V29, P38, DOI 10.1212/WNL.29.1.38; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Friston KJ, 2006, STAT PARAMETRIC MAPP, P656; Gabbard C, 2011, ARCH GERONTOL GERIAT, V53, P206, DOI 10.1016/j.archger.2010.10.006; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Heremans E, 2011, NEUROREHAB NEURAL RE, V25, P168, DOI 10.1177/1545968310370750; Heuninckx S, 2005, J NEUROSCI, V25, P6787, DOI 10.1523/JNEUROSCI.1263-05.2005; Hovington CL, 2010, NEUROREHAB NEURAL RE, V24, P851, DOI 10.1177/1545968310374190; Hutchinson S, 2002, NEUROIMAGE, V17, P1720, DOI 10.1006/nimg.2002.1309; Johansen-Berg H, 2002, EXP BRAIN RES, V142, P13, DOI 10.1007/s00221-001-0905-8; Lafleur MF, 2002, NEUROIMAGE, V16, P142, DOI 10.1006/nimg.2001.1048; Leonard G, 2007, EXP BRAIN RES, V177, P167, DOI 10.1007/s00221-006-0657-6; Liu RSN, 2003, NEUROIMAGE, V20, P22, DOI 10.1016/S1053-8119(03)00219-2; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Malouin F, 2010, ARCH PHYS MED REHAB, V91, P1122, DOI 10.1016/j.apmr.2010.03.007; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; Mulder T, 2007, HUM MOVEMENT SCI, V26, P203, DOI 10.1016/j.humov.2007.01.001; Naccarato M, 2006, NEUROIMAGE, V32, P1250, DOI 10.1016/j.neuroimage.2006.05.003; Nedelko V, 2010, RESTOR NEUROL NEUROS, V28, P737, DOI 10.3233/RNN-2010-0542; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Personnier P, 2010, BEHAV BRAIN RES, V206, P184, DOI 10.1016/j.bbr.2009.09.011; Rathelot JA, 2009, P NATL ACAD SCI USA, V106, P918, DOI 10.1073/pnas.0808362106; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Riecker A, 2006, NEUROIMAGE, V32, P1345, DOI 10.1016/j.neuroimage.2006.05.021; Saimpont A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006714; Sharma N, 2008, NEUROIMAGE, V41, P92, DOI 10.1016/j.neuroimage.2008.02.009; Sharma N, 2012, DEV PSYCHOBIOL, V54, P254, DOI 10.1002/dev.20508; Sharma N, 2009, ANN NEUROL, V66, P604, DOI 10.1002/ana.21810; Sharma N, 2009, STROKE, V40, P1315, DOI 10.1161/STROKEAHA.108.525766; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; Simmons L, 2008, NEUROREHAB NEURAL RE, V22, P458, DOI 10.1177/1545968308315597; Ward NS, 2003, BRAIN, V126, P873, DOI 10.1093/brain/awg071; Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844; WENK GL, 1989, NEUROBIOL AGING, V10, P11, DOI 10.1016/S0197-4580(89)80005-3; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Zapparoli L, 2013, EXP BRAIN RES, V224, P519, DOI 10.1007/s00221-012-3331-1; Zwergal A, 2012, NEUROBIOL AGING, V33, P1073, DOI 10.1016/j.neurobiolaging.2010.09.022	52	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e88443	10.1371/journal.pone.0088443	http://dx.doi.org/10.1371/journal.pone.0088443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887402	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300001
J	Wang, CH; Wang, JS; Liu, YQ; Guo, XL; Zhang, CQ				Wang, Chenghua; Wang, Jinshen; Liu, Yiqing; Guo, Xueliang; Zhang, Chunqing			MUC5AC Upstream Complex Repetitive Region Length Polymorphisms Are Associated with Susceptibility and Clinical Stage of Gastric Cancer	PLOS ONE			English	Article							TANDEM REPEATS POLYMORPHISM; VARIABLE NUMBER; MICROSATELLITE INSTABILITY; INSULIN GENE; MINISATELLITE; RISK; EXPRESSION; DNA; DEFICIENT; PROMOTER	MUC5AC was deemed to be involved in gastric carcinogenesis since aberrant MUC5AC expression has been repeatedly detected in patients with gastric cancer (GC). In this study, length polymorphisms in a complicated repetitive region adjacent to MUC5AC promoter were assessed in 230 patients with GC and 328 cancer-free controls. Alleles of 1.4 and 1.8 kb were significantly more prevalent in GC group than in controls. In contrast, 2.3 and 2.8 kb alleles occurred at significantly lower frequencies in patients than in controls. Alleles were then classified into susceptible (S; 1.4 and 1.8 kb), protective (P; 2.3 and 2.8 kb) and null (N; all other alleles) categories with respect to their linkage with the susceptibility to GC. Individuals with genotype SS had a 2.7-fold increased risk of GC occurrence, but PN genotype was associated with a significantly reduced risk of this cancer. Moreover, homozygous or heterozygous individuals with one or two copies of 1.4 kb allele showed an earlier age of onset and more advanced metastasis stage compared with patients without this allele (Bonferroni corrected p = 1.35 x 10(-4) and 6.60 x 10(-4) accordingly), whereas homozygous patients with two copies of 1.8 kb allele were linked to less advanced GC TNM stage. Our results suggest that certain genetic variations in MUC5AC upstream repetitive region are associated with the susceptibility and progression of GC.	[Wang, Chenghua] Shandong Univ, Dept Emergency Ctr, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China; [Wang, Jinshen] Shandong Univ, Dept Gen Surg, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China; [Liu, Yiqing] Shandong Univ, Dept Lab Med, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China; [Guo, Xueliang] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC USA; [Zhang, Chunqing] Shandong Univ, Dept Gastroenterol, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University of North Carolina; University of North Carolina Chapel Hill; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Zhang, CQ (corresponding author), Shandong Univ, Dept Gastroenterol, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China.	zhangchunqing_sdu@163.com			National Natural Science Foundation of China [81370590]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China to Innovation Research Group (No. 81370590). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armour JAL, 2006, MUTAT RES-FUND MOL M, V598, P6, DOI 10.1016/j.mrfmmm.2006.01.013; Bafna S, 2010, ONCOGENE, V29, P2893, DOI 10.1038/onc.2010.87; Coleman MG, 2001, BRIT J CANCER, V85, P1486, DOI 10.1054/bjoc.2001.2058; CORREA P, 1994, CANCER RES, V54, pS1941; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Gonzalez CA, 2003, INT J CANCER, V107, P629, DOI 10.1002/ijc.11426; Guo X, 2013, AM J RESP CELL MOL B; Herb F, 2008, HUM MOL GENET, V17, P1052, DOI 10.1093/hmg/ddm378; HO SB, 1995, CANCER RES, V55, P2681; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Huxtable SJ, 2000, DIABETES, V49, P126, DOI 10.2337/diabetes.49.1.126; Inamori H, 2002, JPN J CANCER RES, V93, P382, DOI 10.1111/j.1349-7006.2002.tb01268.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jeong YH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001163; Jin GA, 2011, CANCER SCI, V102, P144, DOI 10.1111/j.1349-7006.2010.01782.x; Kim SM, 2014, INT J CANCER, V134, P114, DOI 10.1002/ijc.28345; Kirkbride HJ, 2001, EUR J HUM GENET, V9, P347, DOI 10.1038/sj.ejhg.5200642; Kocer B, 2004, DIGEST DIS SCI, V49, P954, DOI 10.1023/B:DDAS.0000034554.96191.66; Lee HS, 2001, CANCER, V92, P1427, DOI 10.1002/1097-0142(20010915)92:6<1427::AID-CNCR1466>3.0.CO;2-L; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lopes J, 2002, EMBO J, V21, P3201, DOI 10.1093/emboj/cdf310; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moy KA, 2010, CANCER EPIDEM BIOMAR, V19, P2287, DOI 10.1158/1055-9965.EPI-10-0362; Ninomiya H, 2006, BRIT J CANCER, V94, P1485, DOI 10.1038/sj.bjc.6603121; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; THEIN SL, 1987, BRIT J CANCER, V55, P353, DOI 10.1038/bjc.1987.71; Tsuge M, 2005, NAT GENET, V37, P1104, DOI 10.1038/ng1638; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Wang HJ, 2008, CANCER SCI, V99, P787, DOI 10.1111/j.1349-7006.2008.00729.x; Wang JY, 2003, J SURG ONCOL, V83, P253, DOI 10.1002/jso.10222; Waterworth DM, 1997, LANCET, V349, P986, DOI 10.1016/S0140-6736(96)08368-7; Xiang C, 2012, CANCER SCI, V103, P1121, DOI 10.1111/j.1349-7006.2012.02266.x	34	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98327	10.1371/journal.pone.0098327	http://dx.doi.org/10.1371/journal.pone.0098327			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887023	Green Submitted, Green Published, gold			2022-12-25	WOS:000336956300053
J	Zheng, Y; Wang, QH; Yun, CX; Wang, YJ; Smith, WW; Leng, J				Zheng, Yu; Wang, Qihui; Yun, Chenxia; Wang, Yingjun; Smith, Wanli W.; Leng, Jing			Identification of Glyceraldehyde 3-Phosphate Dehydrogenase Sequence and Expression Profiles in Tree Shrew (Tupaia belangeri)	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; HOUSEKEEPING GENES; ANIMAL-MODELS; IN-VITRO; INFECTION; NORMALIZATION; TIMESCALE	The tree shrews (Tupaia belangeri) diverged from the primate order (Primates) and are classified as Scandentia, a separate taxonomic group of mammals. The tree shrew has been suggested to use an animal model to study human disease but the genomic sequences of tree shrew is largely unidentified. Here we identified the full-length cDNA sequence of a housekeeping gene, Glyceraldehyde 3-phosphate Dehydrogenase (GAPDH), in tree shrew. We further constructed a phylogenetic family tree base on GAPDH molecules of various organisms and compared GAPDH sequences with human and other small experimental animals. These study revealed that tree shrew was closer to human than mouse, rat, rabbit and guinea pig. The Quantitative Reverse Transcription PCR and western blot analysis further demonstrated that GAPDH expressed in various tissues in tree shrew as a general conservative housekeeping proteins as in human. Our findings provide the novel genetic knowledge of the tree shrew and strong evidences that tree shrew can be an experimental model system to study human disorders.	[Zheng, Yu; Yun, Chenxia; Leng, Jing] Guangxi Univ Chinese Med, Dept Microbiol & Immunol, Nanning, Guangxi, Peoples R China; [Wang, Qihui; Wang, Yingjun] Guangxi Med Univ, Dept Immunol, Nanning, Guangxi, Peoples R China; [Leng, Jing] Guangxi Univ Chinese Med, Nanning, Guangxi, Peoples R China; [Smith, Wanli W.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	Guangxi University of Chinese Medicine; Guangxi Medical University; Guangxi University of Chinese Medicine; University System of Maryland; University of Maryland Baltimore	Leng, J (corresponding author), Guangxi Univ Chinese Med, Dept Microbiol & Immunol, Nanning, Guangxi, Peoples R China.	jingleng.gx@hotmail.com	Zheng, Yu/ABE-4364-2020	Zheng, Yu/0000-0003-0400-3615	National Natural Science Foundation of China [31160190]; Guangxi Department of Science and Technology [GKG1140003B51, GKG13470036]; Guangxi Department of Education [GJKY[2003]8]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Department of Science and Technology; Guangxi Department of Education	Grant number: 31160190, the National Natural Science Foundation of China, http://www.nsfc.gov.cn; Grant number: GKG1140003B51, the Guangxi Department of Science and Technology, http://www.gxst.gov.cn; Grant number: GKG13470036, the Guangxi Department of Science and Technology, http://www.gxst.gov.cn; Grant number: GJKY[2003]8, the Guangxi Department of Education, http://www.gxedu.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguie B, 2012, GRIDEXTRA FUNCTIONS; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao J, 2003, J MED PRIMATOL, V32, P123, DOI 10.1034/j.1600-0684.2003.00022.x; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Flugge P, 2002, IMMUNOGENETICS, V53, P984, DOI 10.1007/s00251-001-0401-0; Fuchs E., 2010, The UFAW handbook on the care and management of laboratory and other research animals, P262; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Greer S, 2010, J IMMUNOL METHODS, V355, P76, DOI 10.1016/j.jim.2010.02.006; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Kimball S, 1995, GIMP GNU IMAGE MANIP; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lu HZ, 2002, MOL THER, V6, P783, DOI 10.1006/mthe.2002.0813; MacArthur KL, 2012, WORLD J GASTROENTERO, V18, P2909, DOI 10.3748/wjg.v18.i23.2909; Mendiburu F, 2013, AGRICOLAE STAT PROCE; Palamalai V, 2010, PROTEIN SCI, V19, P255, DOI 10.1002/pro.311; R Core Team, 2021, R LANG ENV STAT COMP; Roberts TE, 2011, MOL PHYLOGENET EVOL, V60, P358, DOI 10.1016/j.ympev.2011.04.021; Rocha-Martins M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043028; SCHWAIER A, 1979, RES EXP MED, V176, P15, DOI 10.1007/BF01852107; Shimada A., 1973, Experimental Anim, V22, P351; Song SY, 1999, J MOL BIOL, V287, P719, DOI 10.1006/jmbi.1999.2628; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; The Inkscape Team, 2012, INKSC OP SOURC VECT; Tisdale EJ, 2002, J BIOL CHEM, V277, P3334, DOI 10.1074/jbc.M109744200; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Walter E, 1996, HEPATOLOGY, V24, P1, DOI 10.1002/hep.510240101; Wickham H., 2012, SCALES SCALE FUNCTIO; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xie ZC, 1998, VIROLOGY, V244, P513, DOI 10.1006/viro.1998.9127; Yan RQ, 1996, J CANCER RES CLIN, V122, P283, DOI 10.1007/BF01261404; Yang EB, 2005, HEPATO-GASTROENTEROL, V52, P613; Yang ZX, 2013, J APPL MATH, DOI 10.1155/2013/367107; Zala D, 2013, CELL, V152, P479, DOI 10.1016/j.cell.2012.12.029; Zhang XH, 2013, GENE, V522, P147, DOI 10.1016/j.gene.2013.03.113	38	4	4	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98552	10.1371/journal.pone.0098552	http://dx.doi.org/10.1371/journal.pone.0098552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887411	gold, Green Published, Green Submitted			2022-12-25	WOS:000336956300081
J	Lai, DM; Wang, FY; Dong, ZL; Zhang, QW				Lai, Dongmei; Wang, Fangyuan; Dong, Zhangli; Zhang, Qiuwan			Skin-Derived Mesenchymal Stem Cells Help Restore Function to Ovaries in a Premature Ovarian Failure Mouse Model	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; BONE-MARROW; PORCINE SKIN; GENE-EXPRESSION; GERM-CELLS; CHEMOTHERAPY; FERTILITY; OOCYTES; MARKER; MICE	Skin-derived mesenchymal stem cells (SMSCs) can differentiate into the three embryonic germ layers. For this reason, they are considered a powerful tool for therapeutic cloning and offer new possibilities for tissue therapy. Recent studies showed that skin-derived stem cells can differentiate into cells expressing germ-cell specific markers in vitro and form oocytes in vivo. The idea that SMSCs may be suitable for the treatment of intractable diseases or traumatic tissue damage has attracted attention. To determine the ability of SMSCs to reactivate injured ovaries, a mouse model with ovaries damaged by busulfan and cyclophosphamide was developed and is described here. Female skin-derived mesenchymal stem cells (F-SMSCs) and male skin-derived mesenchymal stem cells (M-SMSCs) from red fluorescence protein (RFP) transgenic adult mice were used to investigate the restorative effects of SMSCs on ovarian function. Significant increases in total body weight and the weight of reproductive organs were observed in the treated animals. Both F-SMSCs and M-SMSCs were shown to be capable of partially restoring fertility in chemotherapy-treated females. Immunostaining with RFP and anti-Mullerian hormone (AMH) antibodies demonstrated that the grafted SMSCs survived, migrated to the recipient ovaries. After SMSCs were administered to the treated mice, real-time PCR showed that the expression levels of pro-inflammatory cytokines TNF-alpha, TGF-beta, IL-8, IL-6, IL-1 beta, and IFN gamma were significantly lower in the ovaries than in the untreated controls. Consistent with this observation, expression of oogenesis marker genes Nobox, Nanos3, and Lhx8 increased in ovaries of SMSCs-treated mice. These findings suggest that SMSCs may play a role within the ovarian follicle microenvironment in restoring the function of damaged ovaries and could be useful in reproductive health.	[Lai, Dongmei] Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Ctr Res Lab, Shanghai 200030, Peoples R China; Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Dept Gynecol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Lai, DM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Int Peace Matern & Child Hlth Hosp, Ctr Res Lab, Shanghai 200030, Peoples R China.	laidongmei@hotmail.com			Shanghai Municipal Health Bureau, Shanghai, China [XBR2011069]; NSFC (National Natural Science Foundation of China) [81070533, 81370678]; Shanghai Municipal Council for Science and Technology [12431902201]	Shanghai Municipal Health Bureau, Shanghai, China; NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Council for Science and Technology	This work was supported by grants from Shanghai Municipal Health Bureau, Shanghai, China (No. XBR2011069), the NSFC (National Natural Science Foundation of China, No. 81070533 & No. 81370678), Shanghai Municipal Council for Science and Technology (No. 12431902201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumenfeld Z, 2012, BEST PRACT RES CL OB, V26, P379, DOI 10.1016/j.bpobgyn.2011.11.008; Bukovsky A, 2011, ANAT REC, V294, P1284, DOI 10.1002/ar.21422; Choi Y, 2008, BIOL REPROD, V79, P442, DOI 10.1095/biolreprod.108.069393; Dyce PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020339; Dyce PW, 2011, STEM CELLS DEV, V20, P809, DOI 10.1089/scd.2010.0395; Dyce PW, 2006, NAT CELL BIOL, V8, P384, DOI 10.1038/ncb1388; Dyce PW, 2004, BIOCHEM BIOPH RES CO, V316, P651, DOI 10.1016/j.bbrc.2004.02.093; Eggan K, 2006, NATURE, V441, P1109, DOI 10.1038/nature04929; Flaws JA, 2001, BIOL REPROD, V64, P1153, DOI 10.1095/biolreprod64.4.1153; Fleischer RT, 2011, OBSTET GYNECOL SURV, V66, P248, DOI 10.1097/OGX.0b013e318224e97b; Haniffa MA, 2007, J IMMUNOL, V179, P1595, DOI 10.4049/jimmunol.179.3.1595; Hoffman GE, 2012, J HISTOCHEM CYTOCHEM, V60, P439, DOI 10.1369/0022155412441002; Johnson J, 2005, CELL, V122, P303, DOI 10.1016/j.cell.2005.06.031; Kroeze KL, 2009, J INVEST DERMATOL, V129, P1569, DOI 10.1038/jid.2008.405; Lai DM, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-34; Lee HJ, 2007, J CLIN ONCOL, V25, P3198, DOI 10.1200/JCO.2006.10.3028; Liu X, 2013, DEV GENES EVOL, V223, P269, DOI 10.1007/s00427-013-0441-0; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; Park MR, 2013, SCI REP, V3, P1; Perez GI, 1997, NAT MED, V3, P1228, DOI 10.1038/nm1197-1228; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Qiu ZF, 2010, STEM CELLS DEV, V19, P259, DOI 10.1089/scd.2009.0058; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Riekstina U, 2008, CYTOTECHNOLOGY, V58, P153, DOI 10.1007/s10616-009-9183-2; Russell DL, 2007, HUM REPROD UPDATE, V13, P289, DOI 10.1093/humupd/dml062; Santiquet N, 2012, CELL REPROGRAM, V14, P123, DOI 10.1089/cell.2011.0066; Takehara Y, 2013, LAB INVEST, V93, P181, DOI 10.1038/labinvest.2012.167; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Utsunomiya T, 2008, INT J ONCOL, V32, P991; Visser JA, 2006, REPRODUCTION, V131, P1, DOI 10.1530/rep.1.00529; Visser JA, 2012, NAT REV ENDOCRINOL, V8, P331, DOI 10.1038/nrendo.2011.224; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; Zhao MT, 2009, CLONING STEM CELLS, V11, P111, DOI 10.1089/clo.2008.0071	33	56	64	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98749	10.1371/journal.pone.0098749	http://dx.doi.org/10.1371/journal.pone.0098749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879098	Green Published, gold, Green Submitted			2022-12-25	WOS:000338101500083
J	Li, C; Yang, XL; He, J; Hixson, JE; Gu, DF; Rao, DC; Shimmin, LC; Huang, JF; Gu, CC; Chen, JC; Li, JX; Kelly, TN				Li, Changwei; Yang, Xueli; He, Jiang; Hixson, James E.; Gu, Dongfeng; Rao, Dabeeru C.; Shimmin, Lawrence C.; Huang, Jianfeng; Gu, Charles C.; Chen, Jichun; Li, Jianxin; Kelly, Tanika N.			A Gene-Based Analysis of Variants in the Serum/Glucocorticoid Regulated Kinase (SGK) Genes with Blood Pressure Responses to Sodium Intake: The GenSalt Study	PLOS ONE			English	Article							SERUM; HERITABILITY	Background: Serum and glucocorticoid regulated kinase (SGK) plays a critical role in the regulation of renal sodium transport. We examined the association between SGK genes and salt sensitivity of blood pressure (BP) using single-marker and gene-based association analysis. Methods: A 7-day low-sodium (51.3 mmol sodium/day) followed by a 7-day high-sodium intervention (307.8 mmol sodium/day) was conducted among 1,906 Chinese participants. BP measurements were obtained at baseline and each intervention using a random-zero sphygmomanometer. Additive associations between each SNP and salt-sensitivity phenotypes were assessed using a mixed linear regression model to account for family dependencies. Gene-based analyses were conducted using the truncated p-value method. The Bonferroni-method was used to adjust for multiple testing in all analyses. Results: In single-marker association analyses, SGK1 marker rs2758151 was significantly associated with diastolic BP (DBP) response to high-sodium intervention (P = 0.0010). DBP responses (95% confidence interval) to high-sodium intervention for genotypes C/C, C/T, and T/T were 2.04 (1.57 to 2.52), 1.79 (1.42 to 2.16), and 0.85 (0.30 to 1.41) mmHg, respectively. Similar trends were observed for SBP and MAP responses although not significant (P= 0.15 and 0.0026, respectively). In addition, gene-based analyses demonstrated significant associations between SGK1 and SBP, DBP and MAP responses to high sodium intervention (P= 0.0002, 0.0076, and 0.00001, respectively). Neither SGK2 nor SGK3 were associated with the salt-sensitivity phenotypes in single-maker or gene-based analyses. Conclusions: The current study identified association of the SGK1 gene and BP salt-sensitivity in the Han Chinese population. Further studies are warranted to identify causal SGK1 gene variants.	[Li, Changwei; He, Jiang; Kelly, Tanika N.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA; [Yang, Xueli; Gu, Dongfeng; Huang, Jianfeng; Chen, Jichun; Li, Jianxin] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Yang, Xueli; Gu, Dongfeng; Huang, Jianfeng; Chen, Jichun; Li, Jianxin] Peking Union Med Coll, Beijing 100021, Peoples R China; [He, Jiang] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Hixson, James E.; Shimmin, Lawrence C.] Univ Texas Houston, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Houston, TX USA; [Rao, Dabeeru C.; Gu, Charles C.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA	Tulane University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tulane University; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Washington University (WUSTL)	Kelly, TN (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA.	tkelly@tulane.edu	He, Jiang/AAF-5303-2020; Li, Changwei/S-5615-2016; Yang, Xueli/AAW-4792-2021; Gu, C. Charles/A-7934-2010	He, Jiang/0000-0002-8286-9652; Li, Changwei/0000-0002-9203-304X; Gu, C. Charles/0000-0002-8527-8145; Hixson, James/0000-0002-0849-9315	National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD [U01HL072507, R01HL087263, R01HL090682]; American Heart Association [11SDG5130026]; FOGARTY INTERNATIONAL CENTER [D43TW009107] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090682, U01HL072507, R01HL087263] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Genetic Epidemiology Network of Salt Sensitivity (GenSalt) is supported by a cooperative agreement project grant (U01HL072507, R01HL087263, and R01HL090682) from the National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD. https://www.nhlbi.nih.gov/Drs Tanika Kelly and Changwei Li are supported by American Heart Association award number 11SDG5130026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Busjahn A, 2002, HYPERTENSION, V40, P256, DOI 10.1161/01.HYP.0000030153.19366.26; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; Faresse N, 2012, AM J PHYSIOL-RENAL, V302, pF977, DOI 10.1152/ajprenal.00535.2011; Gu DF, 2007, HYPERTENSION, V50, P116, DOI 10.1161/HYPERTENSIONAHA.107.088310; He J, 2007, J HUM HYPERTENS, V21, P639, DOI 10.1038/sj.jhh.1002207; Kelly TN, 2012, J HYPERTENS, V30, P861, DOI 10.1097/HJH.0b013e3283524949; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lang F, 2009, CURR OPIN NEPHROL HY, V18, P439, DOI 10.1097/MNH.0b013e32832f125e; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; Luft FC, 1997, AM J CLIN NUTR, V65, P612; McCormick JA, 2004, MOL BIOL CELL, V15, P4278, DOI 10.1091/mbc.E04-01-0027; MILLER JZ, 1987, AM J EPIDEMIOL, V126, P822, DOI 10.1093/oxfordjournals.aje.a114719; Nishida N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-431; Ong RTH, 2010, BIOINFORMATICS, V26, P1269, DOI 10.1093/bioinformatics/btq125; Pao AC, 2012, CURR OPIN NEPHROL HY, V21, P534, DOI 10.1097/MNH.0b013e32835571be; Perkins EA, 2012, ARTHRITIS RHEUM-US, V64, P1355, DOI 10.1002/art.33464; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Quiroz Y, 2012, NEPHROL DIAL TRANSPL, V27, piv2, DOI 10.1093/ndt/gfs421; Raikwar NS, 2008, AM J PHYSIOL-RENAL, V295, pF1440, DOI 10.1152/ajprenal.90239.2008; Rao AD, 2013, J HUM HYPERTENS, V27, P176, DOI 10.1038/jhh.2012.22; Schnackenberg CG, 2007, FASEB J, V21, pA508; Sheng X, 2012, OXF B EC ST IN PRESS; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Svetkey LP, 1996, HYPERTENSION, V28, P854, DOI 10.1161/01.HYP.28.5.854; Teo YY, 2009, GENOME RES, V19, P1849, DOI 10.1101/gr.092189.109; von Wowern F, 2005, KIDNEY INT, V68, P2164, DOI 10.1111/j.1523-1755.2005.00672.x; Wang YZ, 2011, MOL ENDOCRINOL, V25, P72, DOI 10.1210/me.2010-0294; Wiedmann S, 2008, DIABETES, V57, P209, DOI 10.2337/db07-0083; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yang JY, 2012, DIABETES, V61, P1888, DOI 10.2337/db11-1393	33	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98432	10.1371/journal.pone.0098432	http://dx.doi.org/10.1371/journal.pone.0098432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878720	Green Published, Green Submitted, gold			2022-12-25	WOS:000338101500057
J	Peace, JM; Ter-Zakarian, A; Aparicio, OM				Peace, Jared M.; Ter-Zakarian, Anna; Aparicio, Oscar M.			Rif1 Regulates Initiation Timing of Late Replication Origins throughout the S-cerevisiae Genome	PLOS ONE			English	Article							CONTROLS DNA-REPLICATION; PROTEIN PHOSPHATASE 1; CELL-CYCLE; TELOMERE LENGTH; S-PHASE; YEAST; PHOSPHORYLATION; HETEROCHROMATIN; KINASE; ACTIVATION	Chromosomal DNA replication involves the coordinated activity of hundreds to thousands of replication origins. Individual replication origins are subject to epigenetic regulation of their activity during S-phase, resulting in differential efficiencies and timings of replication initiation during S-phase. This regulation is thought to involve chromatin structure and organization into timing domains with differential ability to recruit limiting replication factors. Rif1 has recently been identified as a genome-wide regulator of replication timing in fission yeast and in mammalian cells. However, previous studies in budding yeast have suggested that Rif1' s role in controlling replication timing may be limited to subtelomeric domains and derives from its established role in telomere length regulation. We have analyzed replication timing by analyzing BrdU incorporation genome-wide, and report that Rif1 regulates the timing of late/ dormant replication origins throughout the S. cerevisiae genome. Analysis of pfa4 Delta cells, which are defective in palmitoylation and membrane association of Rif1, suggests that replication timing regulation by Rif1 is independent of its role in localizing telomeres to the nuclear periphery. Intra-S checkpoint signaling is intact in rif1 Delta cells, and checkpoint-defective mec1 Delta cells do not comparably deregulate replication timing, together indicating that Rif1 regulates replication timing through a mechanism independent of this checkpoint. Our results indicate that the Rif1 mechanism regulates origin timing irrespective of proximity to a chromosome end, and suggest instead that telomere sequences merely provide abundant binding sites for proteins that recruit Rif1. Still, the abundance of Rif1 binding in telomeric domains may facilitate Rif1-mediated repression of non-telomeric origins that are more distal from centromeres.	[Peace, Jared M.; Aparicio, Oscar M.] Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA; [Ter-Zakarian, Anna] Univ So Calif, Keck Sch Med, Program Global Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Aparicio, OM (corresponding author), Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA.	oaparici@usc.edu		Aparicio, Oscar/0000-0002-5591-0277	National Institutes of Health grant [5R01-GM065494];  [P50-HG002790]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065494] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health grant 5R01-GM065494 (to OMA) and JMP received support from P50-HG002790. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio JG, 2004, MOL CELL BIOL, V24, P4769, DOI 10.1128/MCB.24.11.4769-4780.2004; Aparicio OM, 2013, GENE DEV, V27, P117, DOI 10.1101/gad.209999.112; Bell SP, 2013, COLD SPRING HARB PER, V5; Bianchi A, 2007, CELL, V128, P1051, DOI 10.1016/j.cell.2007.01.041; Cornacchia D, 2012, EMBO J, V31, P3678, DOI 10.1038/emboj.2012.214; Dave A, 2014, CELL REP, V7, P53, DOI 10.1016/j.celrep.2014.02.019; Dunham Joseph P, 2013, Cold Spring Harb Protoc, V2013, P820, DOI 10.1101/pdb.prot074187; Gibson DG, 2004, MOL CELL BIOL, V24, P10208, DOI 10.1128/MCB.24.23.10208-10222.2004; Gilbert DM, 2001, SCIENCE, V294, P96, DOI 10.1126/science.1061724; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Hayano M, 2012, GENE DEV, V26, P137, DOI 10.1101/gad.178491.111; Hayashi MT, 2009, NAT CELL BIOL, V11, P357, DOI 10.1038/ncb1845; Herrick J, 2011, EVOLUTION, V65, P3031, DOI 10.1111/j.1558-5646.2011.01407.x; Hiraga S, 2014, GENE DEV, V28, P372, DOI 10.1101/gad.231258.113; Hirano Y, 2009, MOL CELL, V33, P312, DOI 10.1016/j.molcel.2008.12.027; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Knott SRV, 2012, CELL, V148, P99, DOI 10.1016/j.cell.2011.12.012; Knott SRV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-305; Knott SRV, 2009, GENE DEV, V23, P1077, DOI 10.1101/gad.1784309; Kumar R, 2014, DNA REPAIR AMST; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li PC, 2011, CELL CYCLE, V10, P323, DOI 10.4161/cc.10.2.14552; Lian HY, 2011, MOL BIOL CELL, V22, P1753, DOI 10.1091/mbc.E10-06-0549; Marcand S, 1998, CIBA F SYMP, V211, P76; Marcand S, 1997, CIBA F SYMP, V211, P93103; Mattarocci S, 2014, CELL REP, V7, P62, DOI 10.1016/j.celrep.2014.03.010; Natsume T, 2013, MOL CELL, V50, P661, DOI 10.1016/j.molcel.2013.05.011; Park S, 2011, P NATL ACAD SCI USA, V108, P14572, DOI 10.1073/pnas.1105262108; PAULOVICH AG, 1995, CELL, V82, P841, DOI 10.1016/0092-8674(95)90481-6; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Pohl TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002677; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Rhind N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010132; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Siow CC, 2012, NUCLEIC ACIDS RES, V40, pD682, DOI 10.1093/nar/gkr1091; Smith CD, 2003, MOL BIOL CELL, V14, P556, DOI 10.1091/mbc.E02-08-0457; Stark R., 2011, R PACKAGE VERSION; Stevenson JB, 1999, GENE DEV, V13, P146, DOI 10.1101/gad.13.2.146; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Viggiani CJ, 2010, COLD SPRING HARB PRO, V2010; Vogelauer M, 2002, MOL CELL, V10, P1223, DOI 10.1016/S1097-2765(02)00702-5; Xu DY, 2010, EMBO J, V29, P3140, DOI 10.1038/emboj.2010.186; Xue Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002417; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhong Y, 2013, J CELL BIOL, V201, P373, DOI 10.1083/jcb.201208060; Zimmerman M, 2014, TRENDS CELL BIOL, V24, P108, DOI 10.1016/j.tcb.2013.09.003	54	56	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98501	10.1371/journal.pone.0098501	http://dx.doi.org/10.1371/journal.pone.0098501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879017	Green Published, Green Submitted, gold			2022-12-25	WOS:000338101500063
J	Sluka, SHM; Akhmedov, A; Vogel, J; Unruh, D; Bogdanov, VY; Camici, GG; Luscher, TF; Ruf, W; Tanner, FC				Sluka, Susanna H. M.; Akhmedov, Alexander; Vogel, Johannes; Unruh, Dusten; Bogdanov, Vladimir Y.; Camici, Giovanni G.; Luescher, Thomas F.; Ruf, Wolfram; Tanner, Felix C.			Alternatively Spliced Tissue Factor Is Not Sufficient for Embryonic Development	PLOS ONE			English	Article							THROMBIN RECEPTOR; MICE; ANGIOGENESIS; COAGULATION; PROCOAGULANT; CONTRIBUTES; ACTIVATION; MECHANISMS; LETHALITY; GROWTH	Tissue factor (TF) triggers blood coagulation and is translated from two mRNA splice isoforms, encoding membrane-anchored full-length TF (flTF) and soluble alternatively-spliced TF (asTF). The complete knockout of TF in mice causes embryonic lethality associated with failure of the yolk sac vasculature. Although asTF plays roles in postnatal angiogenesis, it is unknown whether it activates coagulation sufficiently or makes previously unrecognized contributions to sustaining integrity of embryonic yolk sac vessels. Using gene knock-in into the mouse TF locus, homozygous asTF knock-in (asTFKI) mice, which express murine asTF in the absence of flTF, exhibited embryonic lethality between day 9.5 and 10.5. Day 9.5 homozygous asTFKI embryos expressed asTF protein, but no procoagulant activity was detectable in a plasma clotting assay. Although the alpha-smooth-muscle-actin positive mesodermal layer as well as blood islands developed similarly in day 8.5 wild-type or homozygous asTFKI embryos, erythrocytes were progressively lost from disintegrating yolk sac vessels of asTFKI embryos by day 10.5. These data show that in the absence of flTF, asTF expressed during embryonic development has no measurable procoagulant activity, does not support embryonic vessel stability by non-coagulant mechanisms, and fails to maintain a functional vasculature and embryonic survival.	[Sluka, Susanna H. M.; Akhmedov, Alexander; Camici, Giovanni G.; Luescher, Thomas F.; Tanner, Felix C.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Sluka, Susanna H. M.; Akhmedov, Alexander; Vogel, Johannes; Camici, Giovanni G.; Luescher, Thomas F.; Tanner, Felix C.] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland; [Vogel, Johannes] Univ Zurich, Inst Vet Physiol, Zurich, Switzerland; [Unruh, Dusten; Bogdanov, Vladimir Y.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Hematol Oncol, Cincinnati, OH USA; [Luescher, Thomas F.; Tanner, Felix C.] Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland; [Ruf, Wolfram] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University System of Ohio; University of Cincinnati; University of Zurich; University Zurich Hospital; Scripps Research Institute	Tanner, FC (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	felix.tanner@access.uzh.ch	Camici, Giovanni/H-1631-2018; Akhmedov, Anvarjon Akhatjonovich/AGR-5386-2022	Camici, Giovanni/0000-0002-0523-0695; Akhmedov, Anvarjon Akhatjonovich/0000-0002-4307-7281; Unruh, Dusten/0000-0003-1027-1982; Sluka, Susanna/0000-0001-9051-8492; Bogdanov, Vladimir/0000-0003-4968-1129; Vogel, Johannes/0000-0003-4181-4521	Swiss National Research Foundation [SNF 3100-06811802/1]; Swiss Heart Foundation; NIH [HL-60742]; Pfizer, Inc., New York, United States of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060742] Funding Source: NIH RePORTER	Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Swiss Heart Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer, Inc., New York, United States of America; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grants from the Swiss National Research Foundation (SNF 3100-06811802/1 to TFL), the Swiss Heart Foundation (to FCT), NIH grant HL-60742 (to WR), and a strategic research alliance with Pfizer, Inc., New York, United States of America (to TFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boing AN, 2009, J THROMB HAEMOST, V7, P1423, DOI 10.1111/j.1538-7836.2009.03521.x; Bogdanov VY, 2006, J THROMB HAEMOST, V4, P158, DOI 10.1111/j.1538-7836.2005.01680.x; Bogdanov VY, 2003, NAT MED, V9, P458, DOI 10.1038/nm841; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P6258, DOI 10.1073/pnas.93.13.6258; Carmeliet P, 1996, NATURE, V383, P73, DOI 10.1038/383073a0; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Censarek P, 2007, THROMB HAEMOSTASIS, V97, P11, DOI 10.1160/TH06-09-0524; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Cui JS, 1996, NATURE, V384, P66, DOI 10.1038/384066a0; Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671; Furlan-Freguia C, 2011, J CLIN INVEST, V121, P2932, DOI 10.1172/JCI46129; Godby RC, 2012, MOL MED, V18, P771, DOI 10.2119/molmed.2011.00416; Mackman N, 2007, THROMB HAEMOSTASIS, V97, P5, DOI 10.1160/TH06-11-0670; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Parry GCN, 1998, J CLIN INVEST, V101, P560, DOI 10.1172/JCI814; Pawlinski R, 2002, P NATL ACAD SCI USA, V99, P15333, DOI 10.1073/pnas.242501899; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Signaevsky M, 2008, SEMIN THROMB HEMOST, V34, P161, DOI 10.1055/s-2008-1079256; Smith SA, 2004, J THROMB HAEMOST, V2, P1155, DOI 10.1111/j.1538-7836.2004.00772.x; Sun WY, 1998, P NATL ACAD SCI USA, V95, P7597, DOI 10.1073/pnas.95.13.7597; Szotowski B, 2005, CIRC RES, V96, P1233, DOI 10.1161/01.RES.0000171805.24799.fa; Toomey JR, 1996, BLOOD, V88, P1583; Unruh D, 2014, INT J CANCER, V134, P9, DOI 10.1002/ijc.28327; Valencia P, 2008, P NATL ACAD SCI USA, V105, P3386, DOI 10.1073/pnas.0800250105; van den Berg YW, 2009, P NATL ACAD SCI USA, V106, P19497, DOI 10.1073/pnas.0905325106; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Zhu T, 2011, AM J PHYSIOL-REG I, V300, pR577, DOI 10.1152/ajpregu.00137.2010	27	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97793	10.1371/journal.pone.0097793	http://dx.doi.org/10.1371/journal.pone.0097793			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879059	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000338101500024
J	Curran, SA; Hollan, I; Erridge, C; Lappin, DF; Murray, CA; Sturfelt, G; Mikkelsen, K; Forre, OT; Almdahl, SM; Fagerhol, MK; Goodyear, CS; Riggio, MP				Curran, Samuel A.; Hollan, Ivana; Erridge, Clett; Lappin, David F.; Murray, Colin A.; Sturfelt, Gunnar; Mikkelsen, Knut; Forre, Oystein T.; Almdahl, Sven M.; Fagerhol, Magne K.; Goodyear, Carl S.; Riggio, Marcello P.			Bacteria in the Adventitia of Cardiovascular Disease Patients with and without Rheumatoid Arthritis	PLOS ONE			English	Article							STENOTROPHOMONAS-MALTOPHILIA; ATHEROSCLEROTIC LESIONS; PSEUDOMONAS-MESOPHILICA; SYSTEMIC INFLAMMATION; CORONARY-ARTERIES; INFECTION; METHYLOBACTERIUM; PROTEIN; PATHOGEN; RISK	The incidence of atherosclerosis is significantly increased in rheumatoid arthritis (RA). Infection is one factor that may be involved in the pathogenesis of both diseases. The cause of RA and atherosclerosis is unknown, and infection is one of the factors that may be involved in the pathogenesis of both diseases. The aims of this study were to identify bacteria in the aortic adventitia of patients with cardiovascular disease (CVD) in the presence and absence of RA, and to determine the effect of identified candidate pathogens on Toll-like receptor (TLR)-dependent signalling and the proinflammatory response. The aortic adventitia of 11 CVD patients with RA (RA+CVD) and 11 CVD patients without RA (CVD) were collected during coronary artery bypass graft surgery. Bacteria were detected in four samples from CVD patients and three samples from RA+CVD patients and identified by 16S rRNA gene sequencing. Methylobacterium oryzae was identified in all three RA+CVD samples, representing 44.1% of the bacterial flora. The effect of M. oryzae on TLR-dependent signalling was determined by transfection of HEK-293 cells. Although mild TLR2 signalling was observed, TLR4 was insensitive to M. oryzae. Human primary macrophages were infected with M. oryzae, and a TLDA qPCR array targeting 90 genes involved in inflammation and immune regulation was used to profile the transcriptional response. A significant proinflammatory response was observed, with many of the up-regulated genes encoding proinflammatory cytokines (IL-1 alpha, IL-1 beta, IL-6, TNF-alpha) and chemokines (CCR7, IL-8). The aortic adventitia of CVD patients contains a wide range of bacterial species, and the bacterial flora is significantly less diverse in RA+CVD than CVD patients. M. oryzae may stimulate an proinflammatory response that may aggravate and perpetuate the pathological processes underlying atherosclerosis in RA patients.	[Curran, Samuel A.; Lappin, David F.; Murray, Colin A.; Riggio, Marcello P.] Univ Glasgow, Sch Dent, Glasgow, Lanark, Scotland; [Hollan, Ivana] Hosp Rheumat Dis, Lillehammer, Norway; [Hollan, Ivana] Feiring Heart Clin, Feiring, Norway; [Erridge, Clett] Univ Leicester, Glenfield Gen Hosp, Dept Cardiovasc Sci, Leicester, Leics, England; [Sturfelt, Gunnar] Univ Lund Hosp, Dept Rheumatol, S-22185 Lund, Sweden; [Mikkelsen, Knut] Hosp Rheumat Dis, Lillehammer, Norway; [Forre, Oystein T.] Oslo Univ Hosp, Rikshosp, Dept Rheumatol, Oslo, Norway; [Almdahl, Sven M.] Univ Hosp North Norway, Dept Surg, Tromso, Norway; [Fagerhol, Magne K.] Ullevaal Univ Hosp, Dept Immunol & Transfus Med, Oslo, Norway; [Goodyear, Carl S.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	University of Glasgow; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Lund University; Skane University Hospital; University of Oslo; National Hospital Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Oslo; University of Glasgow	Goodyear, CS (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	Carl.Goodyear@glasgow.ac.uk; Marcello.Riggio@glasgow.ac.uk		Erridge, Clett/0000-0003-2978-346X; Goodyear, Carl/0000-0001-5926-5941; Fagerhol, Magne Kristoffer/0000-0002-5103-6981	Medical Research Council (United Kingdom); Versus Arthritis [19701] Funding Source: researchfish	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Versus Arthritis(Versus Arthritis)	This study was funded a PhD scholarship from Medical Research Council (United Kingdom) and administered through the University of Glasgow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Au K, 2011, ANN RHEUM DIS, V70, P785, DOI 10.1136/ard.2010.128637; Aubry MC, 2004, CARDIOVASC PATHOL, V13, P233, DOI 10.1016/j.carpath.2004.02.005; BRUN JG, 1992, J RHEUMATOL, V19, P859; Chiu B, 1997, CIRCULATION, V96, P2144; da Silva RM, 2006, J VASC SURG, V44, P1055, DOI 10.1016/j.jvs.2006.07.021; del Rincon I, 2001, ARTHRITIS RHEUM-US, V44, P2737, DOI 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#; Deniset JF, 2010, AM J PATHOL, V176, P1028, DOI 10.2353/ajpath.2010.090645; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2287, DOI 10.1002/art.10524; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Eue I, 2000, ATHEROSCLEROSIS, V151, P593, DOI 10.1016/S0021-9150(00)00476-7; GILARDI GL, 1984, J CLIN MICROBIOL, V20, P626, DOI 10.1128/JCM.20.4.626-629.1984; GILCHRIST MJR, 1986, J CLIN MICROBIOL, V23, P1052, DOI 10.1128/JCM.23.6.1052-1055.1986; Hammer HB, 2007, ANN RHEUM DIS, V66, P1093, DOI 10.1136/ard.2006.064741; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Hollan I, 2007, ARTHRITIS RHEUM, V56, P2072, DOI 10.1002/art.22690; Jonsson G, 2007, RHEUMATOLOGY, V46, P1133, DOI 10.1093/rheumatology/kem023; KAYE KM, 1992, CLIN INFECT DIS, V14, P1010, DOI 10.1093/clinids/14.5.1010; Lehtiniemi J, 2005, EUR J CLIN INVEST, V35, P13, DOI 10.1111/j.1365-2362.2005.01440.x; Liu JW, 1997, CLIN INFECT DIS, V24, P1008, DOI 10.1093/clinids/24.5.1008; Looney WJ, 2009, LANCET INFECT DIS, V9, P312, DOI 10.1016/S1473-3099(09)70083-0; Ma J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/827480; Madhaiyan M, 2007, INT J SYST EVOL MICR, V57, P326, DOI 10.1099/ijs.0.64603-0; Maiellaro K, 2007, CARDIOVASC RES, V75, P640, DOI 10.1016/j.cardiores.2007.06.023; McCormick MM, 2005, J BIOL CHEM, V280, P41521, DOI 10.1074/jbc.M509442200; Park YS, 2008, AM J INFECT CONTROL, V36, P29, DOI 10.1016/j.ajic.2006.12.013; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Rolston KVI, 2005, DIAGN MICR INFEC DIS, V51, P215, DOI 10.1016/j.diagmicrobio.2004.11.002; Sanders JW, 2000, CLIN INFECT DIS, V30, P936, DOI 10.1086/313815; Sattar N, 2003, CIRCULATION, V108, P2957, DOI 10.1161/01.CIR.0000099844.31524.05; Scher JU, 2011, ARTHRITIS RHEUM-US, V63, pS985; Shah PK, 2001, CIRCULATION, V103, P5; Snow MH, 2005, CURR OPIN RHEUMATOL, V17, P234; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Toyofuku T, 2011, SURG TODAY, V41, P1395, DOI 10.1007/s00595-010-4496-5; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Weyand Cornelia M., 1999, Current Opinion in Rheumatology, V11, P210, DOI 10.1097/00002281-199905000-00010; Windhorst S, 2002, J BIOL CHEM, V277, P11042, DOI 10.1074/jbc.M109525200; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Young JL, 2002, THROMB HAEMOSTASIS, V88, P554, DOI 10.1055/s-0037-1613256	41	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98627	10.1371/journal.pone.0098627	http://dx.doi.org/10.1371/journal.pone.0098627			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874661	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000336790800053
J	Kuc, S; Koster, MPH; Pennings, JLA; Hankemeier, T; Berger, R; Harms, AC; Dane, AD; Schielen, PCJI; Visser, GHA; Vreeken, RJ				Kuc, Sylwia; Koster, Maria P. H.; Pennings, Jeroen L. A.; Hankemeier, Thomas; Berger, Ruud; Harms, Amy C.; Dane, Adrie D.; Schielen, Peter C. J. I.; Visser, Gerard H. A.; Vreeken, Rob J.			Metabolomics Profiling for Identification of Novel Potential Markers in Early Prediction of Preeclampsia	PLOS ONE			English	Article							AMINO-ACID-CONCENTRATIONS; LOW-PROTEIN DIET; ASYMMETRIC DIMETHYLARGININE; 1ST-TRIMESTER PREDICTION; PLASMA HOMOCYSTEINE; BLOOD-PRESSURE; TAURINE; HYPERTENSION; CANCER; WOMEN	Objective: The first aim was to investigate specific signature patterns of metabolites that are significantly altered in first-trimester serum of women who subsequently developed preeclampsia (PE) compared to healthy pregnancies. The second aim of this study was to examine the predictive performance of the selected metabolites for both early onset [EO-PE] and late onset PE [LO-PE]. Methods: This was a case-control study of maternal serum samples collected between 8+0 and 13+6 weeks of gestation from 167 women who subsequently developed EO-PE n = 68; LO-PE n = 99 and 500 controls with uncomplicated pregnancies. Metabolomics profiling analysis was performed using two methods. One has been optimized to target eicosanoids/oxylipins, which are known inflammation markers and the other targets compounds containing a primary or secondary biogenic amine group. Logistic regression analyses were performed to predict the development of PE using metabolites alone and in combination with first trimester mean arterial pressure (MAP) measurements. Results: Two metabolites were significantly different between EO-PE and controls (taurine and asparagine) and one in case of LO-PE (glycylglycine). Taurine appeared the most discriminative biomarker and in combination with MAP predicted EO-PE with a detection rate (DR) of 55%, at a false-positive rate (FPR) of 10%. Conclusion: Our findings suggest a potential role of taurine in both PE pathophysiology and first trimester screening for EO-PE.	[Kuc, Sylwia; Koster, Maria P. H.; Visser, Gerard H. A.] UMCU, Wilhelmina Childrens Hosp, Dept Obstet, Utrecht, Netherlands; [Pennings, Jeroen L. A.] Natl Inst Publ Hlth & Environm RIVM, Lab Hlth Protect Res GBO, Bilthoven, Netherlands; [Hankemeier, Thomas; Berger, Ruud; Vreeken, Rob J.] Leiden Univ, Div Analyt Biosci, Leiden Acad Ctr Drug Res, Leiden, Netherlands; [Hankemeier, Thomas; Berger, Ruud; Harms, Amy C.; Dane, Adrie D.; Vreeken, Rob J.] Leiden Univ, Netherlands Metabol Ctr, Leiden, Netherlands; [Schielen, Peter C. J. I.] Natl Inst Publ Hlth & Environm RIVM, Lab Infect Dis & Perinatal Screening LIS, Bilthoven, Netherlands	Unilever; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Netherlands National Institute for Public Health & the Environment; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Netherlands National Institute for Public Health & the Environment	Kuc, S (corresponding author), UMCU, Wilhelmina Childrens Hosp, Dept Obstet, Utrecht, Netherlands.	S.Kuc@umcutrecht.nl	Vreeken, Rob/AAA-4563-2021; Hankemeier, Thomas/V-5407-2019; Schielen, Peter/AAP-4539-2020	Hankemeier, Thomas/0000-0001-7871-2073; Vreeken, Rob/0000-0003-3568-1371; Harms, Amy/0000-0002-2931-4295; Pennings, Jeroen L.A./0000-0002-9188-6358	Netherlands Metabolomics Centre (NMC) part of The Netherlands Genomics Initiative/Netherlands; Organization for Scientific Research	Netherlands Metabolomics Centre (NMC) part of The Netherlands Genomics Initiative/Netherlands; Organization for Scientific Research	This project was founded by Alexandre Suerman MD/PhD Stipendium, University Medical Center Utrecht, the Netherlands and (co-)financed by the Netherlands Metabolomics Centre (NMC) which is a part of The Netherlands Genomics Initiative/Netherlands; Organization for Scientific Research. No sponsor or funder had any role in the study design, the experiments or analysis of the data in this manuscript.	BAGLEY PJ, 1995, J NUTR, V125, P933; Bahado-Singh RO, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.003; Bahado-Singh RO, 2012, J MATERN-FETAL NEO M, V25, P1840, DOI 10.3109/14767058.2012.680254; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; CETIN I, 1990, AM J OBSTET GYNECOL, V162, P253, DOI 10.1016/0002-9378(90)90860-A; Cuckle H, 2000, ANTENATAL NEONATAL S, V2nd, P3; Dawson R, 2000, AMINO ACIDS, V19, P643, DOI 10.1007/s007260070014; DEKKER GA, 1995, AM J OBSTET GYNECOL, V173, P1042, DOI 10.1016/0002-9378(95)91324-6; Desforges M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.81; ECONOMIDES DL, 1989, AM J OBSTET GYNECOL, V161, P1219, DOI 10.1016/0002-9378(89)90670-4; Evans RW, 2003, REPRODUCTION, V125, P785, DOI 10.1530/rep.0.1250785; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Glew RH, 2004, CLIN CHIM ACTA, V342, P179, DOI 10.1016/j.cccn.2003.12.028; GUIDOTTI R, 1988, AM J OBSTET GYNECOL, V158, P80; Horie R, 1987, J Hypertens Suppl, V5, pS223; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Imig JD, 2012, PHYSIOL REV, V92, P101, DOI 10.1152/physrev.00021.2011; Ingec M, 2005, TOHOKU J EXP MED, V206, P225, DOI 10.1620/tjem.206.225; Jackson AA, 2002, CLIN SCI, V103, P633, DOI 10.1042/cs1030633; Kaymaz C, 2011, PRENATAL DIAG, V31, P1246, DOI 10.1002/pd.2874; Kenny LC, 2010, HYPERTENSION, V56, P741, DOI 10.1161/HYPERTENSIONAHA.110.157297; Khosrowbeygi A, 2011, Bangladesh Med Res Counc Bull, V37, P106; Kuc S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063546; Kupferminc MJ, 1999, AM J PERINAT, V16, P203, DOI 10.1055/s-2007-993859; Leichtle AB, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13801; Liesenfeld DB, 2013, CANCER EPIDEM BIOMAR, V22, P2182, DOI 10.1158/1055-9965.EPI-13-0584; Lipton SA, 1997, P NATL ACAD SCI USA, V94, P5923, DOI 10.1073/pnas.94.11.5923; Makedos Georgios, 2007, Archives of Gynecology and Obstetrics, V275, P121, DOI 10.1007/s00404-006-0223-2; Mao DW, 2010, ARCH GYNECOL OBSTET, V282, P371, DOI 10.1007/s00404-009-1234-6; MELDRUM MJ, 1994, ADV EXP MED BIOL, V359, P207; Noga MJ, 2012, METABOLOMICS, V8, P253, DOI 10.1007/s11306-011-0306-3; Odibo AO, 2011, PRENATAL DIAG, V31, P990, DOI 10.1002/pd.2822; PHILIPPS AF, 1978, AM J OBSTET GYNECOL, V131, P881, DOI 10.1016/S0002-9378(16)33136-2; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Roberts JM, 1998, SEMIN REPROD ENDOCR, V16, P5, DOI 10.1055/s-2007-1016248; Roberts JM, 2003, HYPERTENS PREGNANCY, V22, P109, DOI 10.1081/PRG-120016792; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; SAFTLAS AF, 1990, AM J OBSTET GYNECOL, V163, P460, DOI 10.1016/0002-9378(90)91176-D; Savvidis A, 2011, CLIN EXP OBSTET GYN, V38, P134; SCHOENGOLD DM, 1978, AM J OBSTET GYNECOL, V131, P490, DOI 10.1016/0002-9378(78)90108-4; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Strassburg K, 2012, ANAL BIOANAL CHEM, V404, P1413, DOI 10.1007/s00216-012-6226-x; van der Kloet FM, 2009, J PROTEOME RES, V8, P5132, DOI 10.1021/pr900499r; Visser N, 2007, OBSTET GYNECOL SURV, V62, P191, DOI 10.1097/01.ogx.0000256779.06275.c4; Wojcik OP, 2010, ATHEROSCLEROSIS, V208, P19, DOI 10.1016/j.atherosclerosis.2009.06.002; WOUTERS MGAJ, 1993, FERTIL STERIL, V60, P820; Zhang AH, 2012, ANAL BIOANAL CHEM, V404, P1239, DOI 10.1007/s00216-012-6117-1	51	50	53	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98540	10.1371/journal.pone.0098540	http://dx.doi.org/10.1371/journal.pone.0098540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24873829	Green Published, Green Submitted, gold			2022-12-25	WOS:000336790800047
J	Navas, JM; Miller, PL; Henry, LA; Hennige, SJ; Roberts, JM				Navas, Juan Moreno; Miller, Peter L.; Henry, Lea-Anne; Hennige, Sebastian J.; Roberts, J. Murray			Ecohydrodynamics of Cold-Water Coral Reefs: A Case Study of the Mingulay Reef Complex (Western Scotland)	PLOS ONE			English	Article							LOPHELIA-PERTUSA SCLERACTINIA; FOOD-SUPPLY MECHANISMS; ROCKALL TROUGH MARGIN; PHYTOPLANKTON DISTRIBUTIONS; OCEAN ACIDIFICATION; DEEP; HYDROGRAPHY; HYDRODYNAMICS; RADIOCESIUM; HEBRIDES	Ecohydrodynamics investigates the hydrodynamic constraints on ecosystems across different temporal and spatial scales. Ecohydrodynamics play a pivotal role in the structure and functioning of marine ecosystems, however the lack of integrated complex flow models for deep-water ecosystems beyond the coastal zone prevents further synthesis in these settings. We present a hydrodynamic model for one of Earth's most biologically diverse deep-water ecosystems, cold-water coral reefs. The Mingulay Reef Complex (western Scotland) is an inshore seascape of cold-water coral reefs formed by the scleractinian coral Lophelia pertusa. We applied single-image edge detection and composite front maps using satellite remote sensing, to detect oceanographic fronts and peaks of chlorophyll a values that likely affect food supply to corals and other suspension-feeding fauna. We also present a high resolution 3D ocean model to incorporate salient aspects of the regional and local oceanography. Model validation using in situ current speed, direction and sea elevation data confirmed the model's realistic representation of spatial and temporal aspects of circulation at the reef complex including a tidally driven current regime, eddies, and downwelling phenomena. This novel combination of 3D hydrodynamic modelling and remote sensing in deep-water ecosystems improves our understanding of the temporal and spatial scales of ecological processes occurring in marine systems. The modelled information has been integrated into a 3D GIS, providing a user interface for visualization and interrogation of results that allows wider ecological application of the model and that can provide valuable input for marine biodiversity and conservation applications.	[Navas, Juan Moreno; Henry, Lea-Anne; Hennige, Sebastian J.; Roberts, J. Murray] Heriot Watt Univ, Ctr Marine Biodivers & Biotechnol, Edinburgh, Midlothian, Scotland; [Miller, Peter L.] Plymouth Marine Lab, Remote Sensing Grp, Plymouth, Devon, England; [Roberts, J. Murray] Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28401 USA; [Roberts, J. Murray] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland	Heriot Watt University; Plymouth Marine Laboratory; University of North Carolina; University of North Carolina Wilmington; UHI Millennium Institute	Navas, JM (corresponding author), Heriot Watt Univ, Ctr Marine Biodivers & Biotechnol, Edinburgh, Midlothian, Scotland.	J.Moreno_Navas@hw.ac.uk; j.m.roberts@hw.ac.uk	Miller, Peter I./E-4525-2013; Roberts, Murray/D-8299-2013; Hennige, Sebastian/D-9369-2013	Miller, Peter I./0000-0002-5292-8789; Roberts, Murray/0000-0003-1688-5133; Hennige, Sebastian/0000-0002-3059-604X	European Commission [226354, 211384]; UK Ocean Acidification programme (NERC grant) [NE/H017305/1]; Heriot-Watt University's Environment & Climate Change theme; Technical University of Lisbon; Natural Environment Research Council [NE/K009028/1, NE/H017305/1, pml010008] Funding Source: researchfish; NERC [NE/H017305/1, NE/K009028/1, pml010008] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); UK Ocean Acidification programme (NERC grant); Heriot-Watt University's Environment & Climate Change theme; Technical University of Lisbon(Istanbul Technical University); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This paper is a contribution towards the European Commission FP7 projects HERMIONE (grant 226354) and EPOCA (grant 211384) and the UK Ocean Acidification programme (NERC grant NE/H017305/1). JMN and JMR acknowledge support from Heriot-Watt University's Environment & Climate Change theme and Javier Campuzano from the Technical University of Lisbon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa A., 1977, METHODS COMPUTATIONA, V17, P173, DOI DOI 10.1016/B978-0-12-460817-7.50009-4; BLACK KP, 1993, CORAL REEFS, V12, P43, DOI 10.1007/BF00303783; Burchard H., 1999, GOTM GEN OCEAN TURBU; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Craig RE, 1959, MARINE RES, V1958, P30; Danish Hydraulic Institute DHI, 1995, MIKE 21 HD HYDR MOD; Davies AJ, 2009, LIMNOL OCEANOGR, V54, P620, DOI 10.4319/lo.2009.54.2.0620; Dawson CW, 2007, ENVIRON MODELL SOFTW, V22, P1034, DOI 10.1016/j.envsoft.2006.06.008; Dodds LA, 2009, MAR ECOL PROG SER, V397, P113, DOI 10.3354/meps08143; Dorschel B, 2007, MAR GEOL, V244, P184, DOI 10.1016/j.margeo.2007.06.010; Douarin M, 2013, EARTH PLANET SC LETT, V375, P176, DOI 10.1016/j.epsl.2013.05.023; Duineveld GCA, 2012, MAR ECOL PROG SER, V444, P97, DOI 10.3354/meps09430; Dullo WC, 2008, MAR ECOL PROG SER, V371, P165, DOI 10.3354/meps07623; ELLETT DJ, 1979, P ROY SOC EDINB B, V77, P61, DOI 10.1017/S026972700001263X; ELLETT DJ, 1983, P ROY SOC EDINB B, V83, P143, DOI 10.1017/S0269727000013385; FEARNHEAD PG, 1975, DEEP-SEA RES, V22, P311, DOI 10.1016/0011-7471(75)90072-8; Fehling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034098; Findlay HS, 2013, GLOBAL CHANGE BIOL, V19, P2708, DOI 10.1111/gcb.12256; Gillibrand PA, 2003, 0803 FRS MAR LAB; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Hearn CJ, 2011, SPRINGER VERLAG EA 8, P563; Henry LA, 2013, BIOGEOSCIENCES, V10, P2737, DOI 10.5194/bg-10-2737-2013; Henry LA, 2013, BIOL CONSERV, V161, P67, DOI 10.1016/j.biocon.2013.03.002; Henry LA, 2010, CORAL REEFS, V29, P427, DOI 10.1007/s00338-009-0577-6; Hill AE, 1997, ESTUAR COAST SHELF S, V45, P473, DOI 10.1006/ecss.1996.0198; Leendertse J.J., 1978, HYDRODYNAMICS ESTUAR, P387; Long D, 2003, IR03149 BRIT GEOL SU; Lyard F, 2006, OCEAN DYNAM, V56, P394, DOI 10.1007/s10236-006-0086-x; Martins F., 2001, OCEANOLOGICA ACTA S, V24, P51, DOI [DOI 10.1016/S0399-1784(01)00092-5, 10.1016/s0399- 1784(01)00092-5]; Martins FA, 1998, HYDROINFORMATICS '98, VOLS 1 AND 2, P1403; Mauchline J, 1987, 144 SCOTT MAR BIOL A; MCKAY WA, 1986, J ENVIRON RADIOACTIV, V4, P205, DOI 10.1016/0265-931X(86)90011-1; MCKINLEY IG, 1981, ESTUAR COAST SHELF S, V13, P69, DOI 10.1016/S0302-3524(81)80106-5; Mienis F, 2007, DEEP-SEA RES PT I, V54, P1655, DOI 10.1016/j.dsr.2007.05.013; Mienis F, 2009, DEEP-SEA RES PT I, V56, P1026, DOI 10.1016/j.dsr.2009.01.006; Miller P, 2009, J MARINE SYST, V78, P327, DOI 10.1016/j.jmarsys.2008.11.019; Miller PI, 2014, MAR POLICY, V45, P318, DOI 10.1016/j.marpol.2013.09.009; Miller PI, 2014, 538 SCOTT NAT HER, P33; Mohn C, 2014, PROGR OCEAN IN PRESS; Monismith SG, 2007, ANNU REV FLUID MECH, V39, P37, DOI 10.1146/annurev.fluid.38.050304.092125; Mortensen PB, 2001, OPHELIA, V54, P83, DOI 10.1080/00785236.2001.10409457; Nihoul J. C. J, 1981, ECOHYDRODYNAMICS, P1; Nihoul JCJ, 1991, EARTH-SCI REV, V26, P163; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; PINGREE RD, 1978, DEEP-SEA RES, V25, P1011, DOI 10.1016/0146-6291(78)90584-2; PINGREE RD, 1989, PROG OCEANOGR, V23, P303, DOI 10.1016/0079-6611(89)90003-7; Proctor R, 1996, J MARINE SYST, V7, P43, DOI 10.1016/0924-7963(94)00036-0; Purser A, 2010, J EXP MAR BIOL ECOL, V395, P55, DOI 10.1016/j.jembe.2010.08.013; Roberts JM, 2009, MAR ECOL PROG SER, V397, P139, DOI 10.3354/meps08112; Roberts J. M., 2009, COLD WATER CORALS BI, DOI [10.1017/CBO9780511581588, DOI 10.1017/CBO9780511581588]; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Roberts JM, 2005, CORAL REEFS, V24, P654, DOI 10.1007/s00338-005-0049-6; SANTOS AJP, 1995, THESIS IST LISBON; SAVIDGE G, 1987, CONT SHELF RES, V7, P45, DOI 10.1016/0278-4343(87)90063-X; Simpson J. H., 1986, ROLE FRESHWATER OUTF, P295, DOI DOI 10.1007/978-3-642-70886-2_21; SIMPSON JH, 1979, ESTUAR COAST MAR SCI, V9, P713, DOI 10.1016/S0302-3524(79)80005-5; Thiem O, 2006, J MARINE SYST, V60, P207, DOI 10.1016/j.jmarsys.2005.12.004; Wagner H, 2011, J MARINE SYST, V85, P19, DOI 10.1016/j.jmarsys.2010.11.003; Waller RG, 2005, ERLANGEN EARTH C SER, P691, DOI 10.1007/3-540-27673-4_35; Walstra DJR, 2001, P COAST DYN 2001 C L, pD41; WARWICK RM, 1980, MAR ECOL PROG SER, V3, P97, DOI 10.3354/meps003097; Watmough T, 2008, MAPPING MINGULAY REE; Wheeler AJ, 2005, COLD WATER CORALS EC, P503; White M, 2005, ERLANGEN EARTH CONF, P503, DOI 10.1007/3-540-27673-4_25; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; Xing JX, 1996, J MARINE SYST, V8, P191, DOI 10.1016/0924-7963(96)00006-1	66	16	16	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98218	10.1371/journal.pone.0098218	http://dx.doi.org/10.1371/journal.pone.0098218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24873971	Green Published, gold			2022-12-25	WOS:000336790800028
J	Jeong, S; Park, S; Park, BW; Park, Y; Kwon, OJ; Kim, HS				Jeong, Seri; Park, Seho; Park, Byeong-Woo; Park, Younhee; Kwon, Oh-Joong; Kim, Hyon-Suk			Human Leukocyte Antigen-G (HLA-G) Polymorphism and Expression in Breast Cancer Patients	PLOS ONE			English	Article							G GENE; BRAZILIAN POPULATION; CELLS; SUSCEPTIBILITY; CARCINOMA; RECEPTOR; ESOPHAGEAL; MOLECULES; APOPTOSIS	Human leukocyte antigen-G (HLA-G) is known to be implicated in a tumor-driven immune escape mechanism in malignancies. The purpose of this study was to investigate HLA-G polymorphism and expression in breast cancer. HLA-G alleles were determined by direct DNA sequencing procedures from blood samples of 80 breast cancer patients and 80 healthy controls. Soluble HLA-G (sHLA-G) was measured by enzyme-linked immunosorbent assay (ELISA) from serum specimens. HLA-G expression in breast cancer lesions was also analyzed by immunohistochemistry staining. The presence of HLA-G 3' untranslated region (UTR) 14-bp sequence was analyzed and found to be associated with reduced risk of breast cancer susceptibility based on HLA-G expression in tissues (P = 0.0407). Levels of sHLA-G were higher in the breast cancer group (median 117.2 U/mL) compared to the control group (median 10.1 U/mL, P<0.001). The area under the receiver operating characteristic curve (AU-ROC) values of sHLA-G for differentiating breast cancer from normal controls and for detecting metastasis from other stages of breast cancer were 0.89 and 0.79, respectively. HLA-G polymorphism and expression may be involved in breast carcinogenesis and sHLA-G concentrations could be used as a diagnostic marker for detecting breast cancer.	[Jeong, Seri; Kim, Hyon-Suk] Yonsei Univ, Coll Med, Severance Hosp, Dept Lab Med, Seoul, South Korea; [Park, Seho; Park, Byeong-Woo] Yonsei Univ, Coll Med, Severance Hosp, Dept Surg, Seoul, South Korea; [Park, Younhee] Kwandong Univ, Dept Lab Med, Coll Med, Goyang, South Korea; [Kwon, Oh-Joong] Konkuk Univ, Coll Anim Biosci & Technol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Catholic Kwandong University; Konkuk University	Kim, HS (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Lab Med, Seoul, South Korea.	kimhs54@yuhs.ac	Kim, Hyon-Suk/R-4113-2017	Kim, Hyon-Suk/0000-0001-5662-7740; Park, Byeong-Woo/0000-0003-1353-2607; Park, Seho/0000-0001-8089-2755				Barrier BF, 2006, GYNECOL ONCOL, V103, P25, DOI 10.1016/j.ygyno.2006.01.045; Benson JR, 2009, LANCET, V373, P1463, DOI 10.1016/S0140-6736(09)60316-0; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Cao M, 2011, TISSUE ANTIGENS, V78, P120, DOI 10.1111/j.1399-0039.2011.01716.x; Carosella ED, 2008, TRENDS IMMUNOL, V29, P125, DOI 10.1016/j.it.2007.11.005; Castelli EC, 2008, TISSUE ANTIGENS, V72, P149, DOI 10.1111/j.1399-0039.2008.01091.x; Castelli EC, 2007, TISSUE ANTIGENS, V70, P62, DOI 10.1111/j.1399-0039.2007.00855.x; Chen HX, 2010, HUM IMMUNOL, V71, P892, DOI 10.1016/j.humimm.2010.06.009; Chen Y, 2012, BIOMARKERS, V17, P9, DOI 10.3109/1354750X.2011.633242; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Contini P, 2003, EUR J IMMUNOL, V33, P125, DOI 10.1002/immu.200390015; de Kruijf EM, 2010, J IMMUNOL, V185, P7452, DOI 10.4049/jimmunol.1002629; Elliott RL, 2011, CANCER BIOTHER RADIO, V26, P153, DOI 10.1089/cbr.2010.0924; Ferguson R, 2011, INT J CANC; Gaddy VT, 2004, CLIN CANCER RES, V10, P5215, DOI 10.1158/1078-0432.CCR-03-0637; He X, 2010, ANN SURG ONCOL, V17, P1459, DOI 10.1245/s10434-009-0891-9; Hortobagyi Gabriel N, 2005, Clin Breast Cancer, V6, P391, DOI 10.3816/CBC.2005.n.043; Hviid TVF, 2003, IMMUNOGENETICS, V55, P63, DOI 10.1007/s00251-003-0547-z; Hviid TVF, 2006, HUM REPROD UPDATE, V12, P209, DOI 10.1093/humupd/dmi048; Jiang YT, 2011, DNA CELL BIOL, V30, P1027, DOI 10.1089/dna.2011.1238; Lau DT, 2011, TISSUE ANTIGENS, V78, P421, DOI 10.1111/j.1399-0039.2011.01781.x; Le Gal FA, 1999, INT IMMUNOL, V11, P1351, DOI 10.1093/intimm/11.8.1351; Lin A, 2007, TISSUE ANTIGENS, V70, P427, DOI 10.1111/j.1399-0039.2007.00926.x; Matte C, 2000, HUM IMMUNOL, V61, P1150, DOI 10.1016/S0198-8859(00)00200-7; Park GM, 2004, BIOCHEM BIOPH RES CO, V313, P606, DOI 10.1016/j.bbrc.2003.11.153; Provatopoulou X, 2012, ANTICANCER RES, V32, P1021; Rahimi R, 2010, INT J IMMUNOGENET, V37, P269, DOI 10.1111/j.1744-313X.2010.00919.x; Rajagopalan S, 1999, J EXP MED, V189, P1093, DOI 10.1084/jem.189.7.1093; Rebmann V, 2003, HUM IMMUNOL, V64, P1017, DOI 10.1016/j.humimm.2003.08.354; Rousseau P, 2003, HUM IMMUNOL, V64, P1005, DOI 10.1016/j.humimm.2003.08.347; Sayed D, 2010, TISSUE ANTIGENS, V75, P40, DOI 10.1111/j.1399-0039.2009.01393.x; van der Ven K, 1998, HUM IMMUNOL, V59, P302, DOI 10.1016/S0198-8859(98)00021-4; Virnig BA, 2010, J NATL CANCER I, V102, P170, DOI 10.1093/jnci/djp482; Yan WH, 2011, CANCER LETT, V311, P123, DOI 10.1016/j.canlet.2011.07.019; Zheng N, 2011, TISSUE ANTIGENS, V77, P218, DOI 10.1111/j.1399-0039.2010.01607.x	35	48	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98284	10.1371/journal.pone.0098284	http://dx.doi.org/10.1371/journal.pone.0098284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870375	Green Published, Green Submitted, gold			2022-12-25	WOS:000336858300033
J	Kleijn, A; Kloezeman, J; Treffers-Westerlaken, E; Fulci, G; Leenstra, S; Dirven, C; Debets, R; Lamfers, M				Kleijn, Anne; Kloezeman, Jenneke; Treffers-Westerlaken, Elike; Fulci, Giulia; Leenstra, Sieger; Dirven, Clemens; Debets, Reno; Lamfers, Martine			The In Vivo Therapeutic Efficacy of the Oncolytic Adenovirus Delta24-RGD Is Mediated by Tumor-Specific Immunity	PLOS ONE			English	Article							CONDITIONALLY REPLICATIVE ADENOVIRUS; VESICULAR STOMATITIS-VIRUS; PHASE I/II TRIAL; INFLAMMATORY RESPONSE; ANTITUMOR IMMUNITY; MALIGNANT GLIOMAS; CANCER-PATIENTS; CELL-DEATH; GLIOBLASTOMA; VECTORS	The oncolytic adenovirus Delta24-RGD represents a new promising therapeutic agent for patients with a malignant glioma and is currently under investigation in clinical phase I/II trials. Earlier preclinical studies showed that Delta24-RGD is able to effectively lyse tumor cells, yielding promising results in various immune-deficient glioma models. However, the role of the immune response in oncolytic adenovirus therapy for glioma has never been explored. To this end, we assessed Delta24-RGD treatment in an immune-competent orthotopic mouse model for glioma and evaluated immune responses against tumor and virus. Delta24-RGD treatment led to long-term survival in 50% of mice and this effect was completely lost upon administration of the immunosuppressive agent dexamethasone. Delta24-RGD enhanced intra-tumoral infiltration of F4/80+ macrophages, CD4+ and CD8+ T-cells, and increased the local production of pro-inflammatory cytokines and chemokines. In treated mice, T cell responses were directed to the virus as well as to the tumor cells, which was reflected in the presence of protective immunological memory in mice that underwent tumor rechallenge. Together, these data provide evidence that the immune system plays a vital role in the therapeutic efficacy of oncolytic adenovirus therapy of glioma, and may provide angles to future improvements on Delta24-RGD therapy.	[Kleijn, Anne; Kloezeman, Jenneke; Leenstra, Sieger; Dirven, Clemens; Lamfers, Martine] ErasmusMC, Dept Neurosurg, Brain Tumor Ctr, Rotterdam, Netherlands; [Treffers-Westerlaken, Elike; Debets, Reno] ErasmusMC, Dept Med Oncol, Lab Expt Tumor Immunol, Rotterdam, Netherlands; [Fulci, Giulia] Massachusetts Gen Hosp, Dept Neurosurg, Mol Neurosurg Lab, Brain Tumor Res Ctr, Boston, MA 02114 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Massachusetts General Hospital	Lamfers, M (corresponding author), ErasmusMC, Dept Neurosurg, Brain Tumor Ctr, Rotterdam, Netherlands.	m.lamfers@erasmusmc.nl	Lamfers, Martine/C-6246-2016	Lamfers, Martine/0000-0001-7745-9029				Allen C, 2012, GENE THER; Alonso MM, 2008, MOL THER, V16, P487, DOI 10.1038/sj.mt.6300400; Alonso MM, 2007, CANCER RES, V67, P11499, DOI 10.1158/0008-5472.CAN-07-5312; Altomonte J, 2008, MOL THER, V16, P146, DOI 10.1038/sj.mt.6300343; Alvarez-Breckenridge CA, 2012, NAT MED, V18, P1827, DOI 10.1038/nm.3013; Appledorn DM, 2008, J IMMUNOL, V181, P2134, DOI 10.4049/jimmunol.181.3.2134; Badie B, 2000, J NEUROSURG, V93, P634, DOI 10.3171/jns.2000.93.4.0634; Badruddoja MA, 2003, NEURO-ONCOLOGY, V5, P235, DOI 10.1215/S1152851703000073; Bauerschmitz GJ, 2002, CANCER RES, V62, P1266; Bauerschmitz GJ, 2004, INT J CANCER, V111, P303, DOI 10.1002/ijc.20217; Blackham AU, 2012, SURGERY; Cartmell T, 1999, J NEUROSCI, V19, P1517; Chiocca EA, 2004, MOL THER, V10, P958, DOI 10.1016/j.ymthe.2004.07.021; Datta SC, 2008, J NEUROSCI METH, V175, P119, DOI 10.1016/j.jneumeth.2008.08.007; Diaz RM, 2007, CANCER RES, V67, P2840, DOI 10.1158/0008-5472.CAN-06-3974; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Freeman AI, 2006, MOL THER, V13, P221, DOI 10.1016/j.ymthe.2005.08.016; Fueyo J, 2003, J NATL CANCER I, V95, P652, DOI 10.1093/jnci/95.9.652; Fulci G, 2006, P NATL ACAD SCI USA, V103, P12873, DOI 10.1073/pnas.0605496103; Galanis E, 2005, GENE THER, V12, P437, DOI 10.1038/sj.gt.3302436; GOODWIN JS, 1986, J CLIN INVEST, V77, P1244, DOI 10.1172/JCI112427; Grauer OM, 2007, INT J CANCER, V121, P95, DOI 10.1002/ijc.22607; Grote D, 2003, CANCER RES, V63, P6463; Gujar SA, 2010, MOL CANCER THER, V9, P2924, DOI 10.1158/1535-7163.MCT-10-0590; Huang PY, 2012, MOL THER, V20, P298, DOI 10.1038/mt.2011.245; Idema S, 2007, J GENE MED, V9, P1046, DOI 10.1002/jgm.1113; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; Kanerva A, 2013, CLIN CANCER RES, V19, P2734, DOI 10.1158/1078-0432.CCR-12-2546; Karapanagiotou EM, 2012, CLIN CANCER RES, V18, P2080, DOI 10.1158/1078-0432.CCR-11-2181; Kiang A, 2006, MOL THER, V14, P588, DOI 10.1016/j.ymthe.2006.03.024; Kimball KJ, 2010, CLIN CANCER RES, V16, P5277, DOI 10.1158/1078-0432.CCR-10-0791; Kleijn A, 2011, CLIN CANCER RES, V17, P4484, DOI 10.1158/1078-0432.CCR-11-0575; Lamfers MLM, 2007, CLIN CANCER RES, V13, P7451, DOI 10.1158/1078-0432.CCR-07-1265; Lamfers MLM, 2006, MOL THER, V14, P779, DOI 10.1016/j.ymthe.2006.08.008; Lamfers MLM, 2002, CANCER RES, V62, P5736; Lesniak MS, 2004, J NEURO-ONCOL, V70, P23, DOI 10.1023/B:NEON.0000040821.50347.c5; Liikanen I, 2013, MOL THER, V21, P1212, DOI 10.1038/mt.2013.51; Markert JM, 2000, GENE THER, V7, P867, DOI 10.1038/sj.gt.3301205; Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157; Pouw N, 2010, CANCER IMMUNOL IMMUN, V59, P921, DOI 10.1007/s00262-010-0818-0; Reid TR, 2005, CANCER GENE THER, V12, P673, DOI 10.1038/sj.cgt.7700819; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rolle CE, 2012, ADV EXP MED BIOL, V746, P53, DOI 10.1007/978-1-4614-3146-6_5; Sebestyen Z, 2007, CANCER RES, V67, P11309, DOI 10.1158/0008-5472.CAN-07-0739; Sengupta S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/831090; Sprangers MC, 2003, J CLIN MICROBIOL, V41, P5046, DOI 10.1128/JCM.41.11.5046-5052.2003; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suzuki K, 2001, CLIN CANCER RES, V7, P120; Szatmari T, 2006, CANCER SCI, V97, P546, DOI 10.1111/j.1349-7006.2006.00208.x; Thomas MA, 2008, MOL THER, V16, P1665, DOI 10.1038/mt.2008.162; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Witlox AM, 2004, CLIN CANCER RES, V10, P61, DOI 10.1158/1078-0432.CCR-0609-03; Young AM, 2012, MOL THER, V20, P1676, DOI 10.1038/mt.2012.116	54	47	48	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97495	10.1371/journal.pone.0097495	http://dx.doi.org/10.1371/journal.pone.0097495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866126	Green Published, gold, Green Submitted			2022-12-25	WOS:000336914100014
J	Tao, YX; van Peer, AF; Chen, BZ; Chen, ZH; Zhu, J; Deng, YJ; Jiang, YJ; Li, SJ; Wu, TJ; Xie, BG				Tao, Yongxin; van Peer, Arend F.; Chen, Bingzhi; Chen, Zhihong; Zhu, Jian; Deng, Youjin; Jiang, Yuji; Li, Shaojie; Wu, Taju; Xie, Baogui			Gene Expression Profiling Reveals Large Regulatory Switches between Succeeding Stipe Stages in Volvariella volvacea	PLOS ONE			English	Article							CELL-POPULATION DYNAMICS; EDIBLE STRAW MUSHROOM; COPRINUS-CINEREUS; BASIDIOCARP MATURATION; MOLECULAR-CLONING; GROWTH-REGULATION; FRUIT BODIES; PROTEIN; ELONGATION; FAMILY	The edible mushroom Volvariella volvacea is an important crop in Southeast Asia and is predominantly harvested in the egg stage. One of the main factors that negatively affect its yield and value is the rapid transition from the egg to the elongation stage, which has a decreased commodity value and shelf life. To improve our understanding of the changes during stipe development and the transition from egg to elongation stage in particular, we analyzed gene transcription in stipe tissue of V. volvacea using 3'-tag based digital expression profiling. Stipe development turned out to be fairly complex with high numbers of expressed genes, and regulation of stage differences is mediated mainly by changes in expression levels of genes, rather than on/off modulation. Most explicit is the strong up-regulation of cell division from button to egg, and the very strong down-regulation hereof from egg to elongation, that continues in the maturation stage. Button and egg share cell division as means of growth, followed by a major developmental shift towards rapid stipe elongation based on cell extension as demonstrated by inactivation of cell division throughout elongation and maturation. Examination of regulatory genes up-regulated from egg to elongation identified three potential high upstream regulators for this switch. The new insights in stipe dynamics, together with a series of new target genes, will provide a sound base for further studies on the developmental mechanisms of mushroom stipes and the switch from egg to elongation in V. volvacea in particular.	[Tao, Yongxin; Zhu, Jian] Fujian Agr & Forestry Univ, Coll Hort, Fuzhou, Fujian, Peoples R China; [Tao, Yongxin; van Peer, Arend F.; Chen, Bingzhi; Chen, Zhihong; Zhu, Jian; Deng, Youjin; Xie, Baogui] Fujian Agr & Forestry Univ, Coll Life Sci, Mycol Res Ctr, Fuzhou, Fujian, Peoples R China; [Jiang, Yuji] Fujian Agr & Forestry Univ, Coll Food Sci, Fuzhou, Fujian, Peoples R China; [Li, Shaojie; Wu, Taju] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Institute of Microbiology, CAS	van Peer, AF (corresponding author), Fujian Agr & Forestry Univ, Coll Life Sci, Mycol Res Ctr, Fuzhou, Fujian, Peoples R China.	arendvanpeer@gmail.com; mrcfafu@163.com	Li, Shaojie/AAH-2077-2020	van Peer, Arend/0000-0001-7023-0045	National Key Basic Research Program of China [2014CB138302]; China Agriculture Research System [CARS24]; Scientific Research Foundation of Graduate School of Fujian Agriculture and Forestry University [1122yb007]	National Key Basic Research Program of China(National Basic Research Program of China); China Agriculture Research System; Scientific Research Foundation of Graduate School of Fujian Agriculture and Forestry University	This work was supported by grants from the National Key Basic Research Program of China (2014CB138302), the China Agriculture Research System (CARS24), and the Scientific Research Foundation of Graduate School of Fujian Agriculture and Forestry University (1122yb007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima T, 2004, FUNGAL GENET BIOL, V41, P805, DOI 10.1016/j.fgb.2004.04.003; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Bussink HJ, 1999, FEMS MICROBIOL LETT, V173, P117, DOI 10.1016/S0378-1097(99)00060-9; CHANG ST, 1971, AM J BOT, V58, P552, DOI 10.2307/2441038; CHANG ST, 1977, ECON BOT, V31, P374, DOI 10.1007/BF02866890; CHAPMAN ES, 1973, MYCOPATH MYCOL APPL, V51, P315, DOI 10.1007/BF02057802; Chen SC, 2004, FEMS MICROBIOL LETT, V230, P171, DOI 10.1016/S0378-1097(03)00878-4; COX RJ, 1975, ARCH MICROBIOL, V105, P257, DOI 10.1007/BF00447144; CRAIG GD, 1977, J GEN MICROBIOL, V102, P337, DOI 10.1099/00221287-102-2-337; Cross FR, 2011, PHILOS T R SOC B, V366, P3532, DOI 10.1098/rstb.2011.0078; Dickman MB, 1999, FUNGAL GENET BIOL, V26, P99, DOI 10.1006/fgbi.1999.1118; Ding SJ, 2007, FEMS MICROBIOL LETT, V267, P221, DOI 10.1111/j.1574-6968.2006.00550.x; EILERS FI, 1974, ARCH MICROBIOL, V96, P353, DOI 10.1007/BF00590190; GOODAY GW, 1974, T BRIT MYCOL SOC, V62, P391, DOI 10.1016/S0007-1536(74)80047-1; GRUEN HE, 1963, PLANT PHYSIOL, V38, P652, DOI 10.1104/pp.38.6.652; HAMMAD F, 1993, MYCOL RES, V97, P275, DOI 10.1016/S0953-7562(09)81120-9; HAMMAD F, 1993, MYCOL RES, V97, P269, DOI 10.1016/S0953-7562(09)81119-2; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; KAMADA T, 1977, PLANT CELL PHYSIOL, V18, P831; KAMADA T, 1983, J GEN MICROBIOL, V129, P703; KAMADA T, 1977, PLANT CELL PHYSIOL, V18, P1291, DOI 10.1093/oxfordjournals.pcp.a075551; KAMADA T, 1982, J GEN MICROBIOL, V128, P1041; KHER K, 1992, MYCOL RES, V96, P817, DOI 10.1016/S0953-7562(09)81028-9; Kues U, 2000, MICROBIOL MOL BIOL R, V64, P316, DOI 10.1128/MMBR.64.2.316-353.2000; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; [Luo Lianzhong 罗联忠], 2004, [华中农业大学学报, Journal of Huazhong Agricultural University], V23, P61; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Mau JL, 1997, J AGR FOOD CHEM, V45, P4726, DOI 10.1021/jf9703314; Maurer-Stroh S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-212; MONTGOMERY GWG, 1984, J GEN MICROBIOL, V130, P291; MONZER J, 1994, EXP MYCOL, V18, P7, DOI 10.1006/emyc.1994.1002; MOORE D, 1979, NEW PHYTOL, V83, P695, DOI 10.1111/j.1469-8137.1979.tb02301.x; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Muraguchi H, 2000, FUNGAL GENET BIOL, V29, P49, DOI 10.1006/fgbi.2000.1184; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Purschwitz J, 2006, CURR OPIN MICROBIOL, V9, P566, DOI 10.1016/j.mib.2006.10.011; RAIKHEL NV, 1993, ANNU REV PLANT PHYS, V44, P591, DOI 10.1146/annurev.pp.44.060193.003111; Sakamoto Y, 2005, CURR GENET, V48, P195, DOI 10.1007/s00294-005-0002-9; Sakamoto Y, 2012, FOOD QUALITY; Scazzocchio C, 2000, CURR OPIN MICROBIOL, V3, P126, DOI 10.1016/S1369-5274(00)00063-1; SCHWALB MN, 1974, J GEN MICROBIOL, V82, P209, DOI 10.1099/00221287-82-2-209; Shelest E, 2008, FEMS MICROBIOL LETT, V286, P145, DOI 10.1111/j.1574-6968.2008.01293.x; Shioya T, 2013, FUNGAL GENET BIOL, V58-59, P80, DOI 10.1016/j.fgb.2013.08.007; STEPHENSON NA, 1984, T BRIT MYCOL SOC, V82, P531, DOI 10.1016/S0007-1536(84)80017-0; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; Tao YX, 2013, GENE, V527, P154, DOI 10.1016/j.gene.2013.05.071; Theissen G, 1996, J MOL EVOL, V43, P484, DOI 10.1007/PL00006110; Toyoda M, 2000, BIOCHEM BIOPH RES CO, V274, P332, DOI 10.1006/bbrc.2000.3138; Wang J, 2008, BIORESOURCE TECHNOL, V99, P8524, DOI 10.1016/j.biortech.2008.03.007; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wilkinson CRM, 2004, CURR BIOL, V14, P2283, DOI 10.1016/j.cub.2004.11.058; Zhang ZF, 2010, NUCLEIC ACIDS RES, V38, pW743, DOI 10.1093/nar/gkq538	58	10	25	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97789	10.1371/journal.pone.0097789	http://dx.doi.org/10.1371/journal.pone.0097789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867220	gold, Green Submitted, Green Published			2022-12-25	WOS:000336914100023
J	Zarecki, R; Oberhardt, MA; Yizhak, K; Wagner, A; Segal, ES; Freilich, S; Henry, CS; Gophna, U; Ruppin, E				Zarecki, Raphy; Oberhardt, Matthew A.; Yizhak, Keren; Wagner, Allon; Segal, Ella Shtifman; Freilich, Shiri; Henry, Christopher S.; Gophna, Uri; Ruppin, Eytan			Maximal Sum of Metabolic Exchange Fluxes Outperforms Biomass Yield as a Predictor of Growth Rate of Microorganisms	PLOS ONE			English	Article							ESCHERICHIA-COLI; OPTIMIZATION; CONSTRAINT; OPTIMALITY; EXPRESSION; COMMUNITY; PHENOTYPE; BACTERIA; MODEL; PH	Growth rate has long been considered one of the most valuable phenotypes that can be measured in cells. Aside from being highly accessible and informative in laboratory cultures, maximal growth rate is often a prime determinant of cellular fitness, and predicting phenotypes that underlie fitness is key to both understanding and manipulating life. Despite this, current methods for predicting microbial fitness typically focus on yields [e. g., predictions of biomass yield using GEnome-scale metabolic Models (GEMs)] or notably require many empirical kinetic constants or substrate uptake rates, which render these methods ineffective in cases where fitness derives most directly from growth rate. Here we present a new method for predicting cellular growth rate, termed SUMEX, which does not require any empirical variables apart from a metabolic network (i.e., a GEM) and the growth medium. SUMEX is calculated by maximizing the SUM of molar EXchange fluxes (hence SUMEX) in a genome-scale metabolic model. SUMEX successfully predicts relative microbial growth rates across species, environments, and genetic conditions, outperforming traditional cellular objectives (most notably, the convention assuming biomass maximization). The success of SUMEX suggests that the ability of a cell to catabolize substrates and produce a strong proton gradient enables fast cell growth. Easily applicable heuristics for predicting growth rate, such as what we demonstrate with SUMEX, may contribute to numerous medical and biotechnological goals, ranging from the engineering of faster-growing industrial strains, modeling of mixed ecological communities, and the inhibition of cancer growth.	[Zarecki, Raphy; Oberhardt, Matthew A.; Yizhak, Keren; Wagner, Allon; Ruppin, Eytan] Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Zarecki, Raphy; Oberhardt, Matthew A.; Yizhak, Keren; Wagner, Allon; Ruppin, Eytan] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Oberhardt, Matthew A.; Segal, Ella Shtifman; Gophna, Uri] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, Fac Life Sci, IL-69978 Tel Aviv, Israel; [Freilich, Shiri] Agr Res Org, Newe Yaar Res Ctr, Ramat Yishay, Israel; [Henry, Christopher S.] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; United States Department of Energy (DOE); Argonne National Laboratory	Oberhardt, MA (corresponding author), Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel.	mattoby@gmail.com; ruppin@post.tau.ac.il	Gophna, Uri/AAS-8376-2020; Ruppin, Eytan/R-9698-2017	Gophna, Uri/0000-0001-5129-5652; Ruppin, Eytan/0000-0002-7862-3940; Wagner, Allon/0000-0001-5095-6009	Whitaker Foundation; Dan David Fellowship; EU; Israeli Science Foundation (ISF); Israeli Centers of Research Excellence (I-CORE); McDonnell foundation; Israeli Ministry of Health; German-Israeli Project Cooperation (DIP)	Whitaker Foundation; Dan David Fellowship; EU(European Commission); Israeli Science Foundation (ISF)(Israel Science Foundation); Israeli Centers of Research Excellence (I-CORE); McDonnell foundation; Israeli Ministry of Health; German-Israeli Project Cooperation (DIP)	MO gratefully acknowledges funding from the Whitaker Foundation (Whitaker International Scholars Program) and the Dan David Fellowship; ER gratefully acknowledges support from the EU FP7 Microme project, the Israeli Science Foundation (ISF), the Israeli Centers of Research Excellence (I-CORE), and the McDonnell foundation. UG is supported by the McDonnell foundation, the Israeli Ministry of Health and the German-Israeli Project Cooperation (DIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adadi R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002575; Brooijmans R, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-28; CHAO L, 1977, ECOLOGY, V58, P369, DOI 10.2307/1935611; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fischer S, 1999, FEBS LETT, V457, P327, DOI 10.1016/S0014-5793(99)01060-1; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Groeneveld P, 2009, FEBS J, V276, P254, DOI 10.1111/j.1742-4658.2008.06778.x; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Knorr AL, 2006, BIOINFORMATICS; Lerman JA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1928; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; O'Brien EJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.52; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Oh YK, 2007, J BIOL CHEM; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Schuetz R, 2012, SCIENCE, V336, P601, DOI 10.1126/science.1216882; Schuster S, 2008, J THEOR BIOL, V252, P497, DOI 10.1016/j.jtbi.2007.12.008; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shlomi T, 2005, P NATL ACAD SCI USA, V102, P7695, DOI 10.1073/pnas.0406346102; SMITH JM, 1978, ANNU REV ECOL SYST, V9, P31, DOI 10.1146/annurev.es.09.110178.000335; Soga N, 2012, J BIOL CHEM, V287, P9633, DOI 10.1074/jbc.M111.335356; Thiele I, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000312; Vazquez A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-7; Vieira-Silva S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000808; Whiteley M, 2001, ENVIRON MICROBIOL, V3, P43, DOI 10.1046/j.1462-2920.2001.00158.x; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]	29	7	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98372	10.1371/journal.pone.0098372	http://dx.doi.org/10.1371/journal.pone.0098372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866123	Green Submitted, Green Published, gold			2022-12-25	WOS:000336914100054
J	Jansson, MD; Damas, ND; Lees, M; Jacobsen, A; Lund, AH				Jansson, M. D.; Damas, N. D.; Lees, M.; Jacobsen, A.; Lund, A. H.			miR-339-5p regulates the p53 tumor-suppressor pathway by targeting MDM2	ONCOGENE			English	Article							NEGATIVE REGULATOR; CELL-PROLIFERATION; GROWTH ARREST; MICRORNA; CANCER; P21(WAF1/CIP1); MODULATION; ACTIVATION; LOOP	MicroRNAs (miRNAs) regulate many key cancer-relevant pathways and may themselves possess oncogenic or tumor-suppressor functions. Consequently, miRNA dysregulation has been shown to be a prominent feature in many human cancers. The p53 tumor suppressor acts as a negative regulator of cell proliferation in response to stress and represents the most commonly lost and mutated gene in human cancers. The function of p53 is inhibited by the MDM2 oncoprotein. Using a high-throughput screening approach, we identified miR-339-5p as a regulator of the p53 pathway. We demonstrate that this regulation occurs via the ability of miR-339-5p to target directly the 3'-untranslated region of MDM2 mRNA, reducing MDM2 expression and thus promoting p53 function. Consequently, overexpression of miR-339-5p positively impacts on p53-governed cellular responses such as proliferation arrest and senescence, whereas inhibition of miR-339-5p function perturbs the p53 response in cancer cells, allowing an increased proliferation rate. In addition, miR-339-5p expression is downregulated in tumors harboring wild-type TP53, suggesting that reduction of miR-339-5p level helps to suppress the p53 response in p53-competent tumor cells. Furthermore, we show that a negative correlation between miR-339-5p and MDM2 expression exists in human cancer, implying that the interaction is important for cancer development.	[Jansson, M. D.; Damas, N. D.; Lees, M.; Lund, A. H.] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Jansson, M. D.; Damas, N. D.; Lees, M.; Lund, A. H.] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark; [Jacobsen, A.] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA	University of Copenhagen; University of Copenhagen; Memorial Sloan Kettering Cancer Center	Lund, AH (corresponding author), Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark.	anders.lund@bric.ku.dk	Lund, Anders H./F-4786-2014; Skanderup, Anders Jacobsen/K-1081-2013	Lund, Anders H./0000-0002-7407-3398; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Djodij Damas, Nkerorema/0000-0002-1192-7704; Jansson, Martin/0000-0002-6946-145X	Danish National Advanced Technology Foundation; Danish National Research Foundation; Novo Nordisk Foundation; Lundbeck Foundation; Danish Cancer Society; Danish Medical Research Council; Lundbeck Foundation [R100-2011-8756, R108-2012-10312] Funding Source: researchfish	Danish National Advanced Technology Foundation; Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	Work in the authors' laboratory was supported by the Danish National Advanced Technology Foundation, the Danish National Research Foundation, the Novo Nordisk Foundation, the Lundbeck Foundation and the Danish Cancer Society. Dr Jansson was supported by a grant from the Danish Medical Research Council. We acknowledge the The Cancer Genome Atlas Research Network for our use of their publically available tumor data sets. We thank Bert Vogelstein and Kristian Helin for cell lines.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bouska A, 2008, MOL CELL BIOL, V28, P4862, DOI 10.1128/MCB.01584-07; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Burns DM, 2011, NATURE, V473, P105, DOI 10.1038/nature09908; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; FOX MH, 1980, CYTOMETRY, V1, P71, DOI 10.1002/cyto.990010114; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hu WW, 2010, MOL CELL, V38, P689, DOI 10.1016/j.molcel.2010.05.027; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kheir TB, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-29; Kumar M, 2011, ONCOGENE, V30, P843, DOI 10.1038/onc.2010.457; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Luo Y, 2012, ONCOGENE, V31, P306, DOI 10.1038/onc.2011.244; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ries S, 2000, CELL, V103, P321, DOI 10.1016/S0092-8674(00)00123-9; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Vispe S, 2009, MOL CANCER THER, V8, P2780, DOI 10.1158/1535-7163.MCT-09-0549; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Wu ZS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-542; Xiao JN, 2011, EMBO J, V30, P524, DOI 10.1038/emboj.2010.347; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200; Zhou C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063142	46	50	55	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 9	2015	34	15					1908	1918		10.1038/onc.2014.130	http://dx.doi.org/10.1038/onc.2014.130			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CF7GY	24882579				2022-12-25	WOS:000352725600005
J	Xiao, F; Qiu, H; Cui, H; Ni, X; Li, J; Liao, W; Lu, L; Ding, K				Xiao, F.; Qiu, H.; Cui, H.; Ni, X.; Li, J.; Liao, W.; Lu, L.; Ding, K.			MicroRNA-885-3p inhibits the growth of HT-29 colon cancer cell xenografts by disrupting angiogenesis via targeting BMPR1A and blocking BMP/Smad/Id1 signaling	ONCOGENE			English	Article							BONE MORPHOGENETIC PROTEIN; TUMOR ANGIOGENESIS; JUVENILE POLYPOSIS; COLORECTAL-CANCER; EXPRESSION; ID1; GENES; DICER; MICE; RNAS	The previous studies in this lab discovered that microRNA-885-3p (miR-885-3p) was regulated by a sulfated polysaccharide that bound to bone morphogenetic protein receptor, type IA (BMPR1A) to inhibit angiogenesis. However, its specific role and its mechanism of action in tumor cells have not been elucidated. We show that miR-885-3p markedly suppresses angiogenesis in vitro and in vivo. MiR-885-3p inhibits Smad1/5/8 phosphorylation and downregulates DNA-binding protein inhibitor ID-1 (Id1), a proangiogenic factor, by targeting BMPR1A, leading to impaired angiogenesis. Overexpression or silencing of BMPR1A affects angiogenesis in a Smad/Id1-dependent manner. We further show that miR-885-3p impairs the growth of HT-29 colon cancer cell xenografts in nude mice by suppressing angiogenesis through disruption of BMPR1A and Smad/Id1 signaling. These results support a novel role for miR-885-3p in tumor angiogenesis by targeting BMPR1A, which regulates a proangiogenic factor, and provide new evidence that targeting miRNAs might be an effective therapeutic strategy for improving colon cancer treatment.	[Xiao, F.; Qiu, H.; Cui, H.; Ni, X.; Li, J.; Liao, W.; Lu, L.; Ding, K.] Chinese Acad Sci, Shanghai Inst Mat Med, Glycochem & Glycobiol Lab, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Ding, K (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Glycochem & Glycobiol Lab, 555 Chong Zhi Rd, Shanghai 201203, Peoples R China.	dingkan@simm.ac.cn	CUI, Hengxiang/AAO-1326-2021; Qiu, Hong/C-5888-2011; Liao, Wenfeng/GQP-7033-2022	Qiu, Hong/0000-0002-4088-7828; Ding, Kan/0000-0002-8140-9259	National Natural Science Foundation of China (NSFC) [81171914, 31230022]; New Drug Creation and Manufacturing Program [2012ZX09301001-003]; National Science Fund for Distinguished Young Scholars in China [81125025]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); New Drug Creation and Manufacturing Program; National Science Fund for Distinguished Young Scholars in China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by grants from the National Natural Science Foundation of China (NSFC) (81171914, 31230022), the New Drug Creation and Manufacturing Program (2012ZX09301001-003) and the National Science Fund for Distinguished Young Scholars in China (81125025).	Cha ST, 2010, CANCER RES, V70, P2675, DOI 10.1158/0008-5472.CAN-09-2448; Dong Y, 2011, BRIT J CANCER, V104, P893, DOI 10.1038/bjc.2011.57; El-Bizri N, 2008, CIRC RES, V102, P380, DOI 10.1161/CIRCRESAHA.107.161059; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Goulley J, 2007, CELL METAB, V5, P207, DOI 10.1016/j.cmet.2007.01.009; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Huang YP, 2011, CELL CYCLE, V10, P3938, DOI 10.4161/cc.10.22.18107; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mishina Y, 2004, J BIOL CHEM, V279, P27560, DOI 10.1074/jbc.M404222200; Miyazono Kohei, 2002, Sci STKE, V2002, ppe40, DOI 10.1126/stke.2002.151.pe40; Okamoto K, 2012, EMBO J, V31, P1752, DOI 10.1038/emboj.2012.25; Perk J, 2006, CANCER RES, V66, P10870, DOI 10.1158/0008-5472.CAN-06-2643; Qiu H, 2010, J BIOL CHEM, V285, P32638, DOI 10.1074/jbc.M110.105544; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Suarez Y, 2009, CIRC RES, V104, P442, DOI 10.1161/CIRCRESAHA.108.191270; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; Van Hattem WA, 2008, GUT, V57, P623, DOI 10.1136/gut.2007.142927; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Wu WKK, 2011, CARCINOGENESIS, V32, P247, DOI 10.1093/carcin/bgq243; Xiao F, 2013, GLYCOBIOLOGY, V23, P524, DOI 10.1093/glycob/cwt004; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Zhou XP, 2001, AM J HUM GENET, V69, P704, DOI 10.1086/323703	26	39	45	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 9	2015	34	15					1968	1978		10.1038/onc.2014.134	http://dx.doi.org/10.1038/onc.2014.134			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CF7GY	24882581				2022-12-25	WOS:000352725600011
J	Grist, H; Daunt, F; Wanless, S; Nelson, EJ; Harris, MP; Newell, M; Burthe, S; Reid, JM				Grist, Hannah; Daunt, Francis; Wanless, Sarah; Nelson, Emily J.; Harris, Mike P.; Newell, Mark; Burthe, Sarah; Reid, Jane M.			Site Fidelity and Individual Variation in Winter Location in Partially Migratory European Shags	PLOS ONE			English	Article							PHALACROCORAX-ARISTOTELIS; POPULATION-DYNAMICS; BREEDING-SUCCESS; HABITAT QUALITY; SURVIVAL; HISTORY; CONSERVATION; CONSEQUENCES; SEGREGATION; CORMORANTS	In partially migratory populations, individuals from a single breeding area experience a range of environments during the non-breeding season. If individuals show high within-and among-year fidelity to specific locations, any annual environmental effect on individual life histories could be reinforced, causing substantial demographic heterogeneity. Quantifying within-and among-individual variation and repeatability in non-breeding season location is therefore key to predicting broad-scale environmental impacts on the dynamics of partially migratory populations. We used field resightings of colour-ringed adult European shags known to have bred on the Isle of May, Scotland, to quantify individual variation and repeatability in winter location within and among three consecutive winters. In total, 3797 resightings of 882 individuals were recorded over 622 km of coastline, including the Isle of May. These individuals comprised over 50% of the known breeding population, and encompassed representative distributions of ages and sexes. The distances from the Isle of May at which individuals were resighted during winter varied substantially, up to 486 km and 136 km north and south respectively and including the breeding colony on the Isle of May. However, resighting distances were highly repeatable within individuals; within-and among-winter repeatabilities were >0.72 and >0.59 respectively across the full September-March observation period, and >0.95 and >0.79 respectively across more restricted mid-winter periods. Repeatability did not differ significantly between males and females or among different age classes, either within or among winters. These data demonstrate that the focal shag population is partially migratory, and moreover that individuals show highly repeatable variation in winter location and hence migration strategy across consecutive winters. Such high among-individual variation and within-individual repeatability, both within and among winters, could lead to substantial life history variation, and therefore influence population dynamics and future conservation management strategies.	[Grist, Hannah; Reid, Jane M.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Grist, Hannah; Daunt, Francis; Wanless, Sarah; Nelson, Emily J.; Harris, Mike P.; Newell, Mark; Burthe, Sarah] Ctr Ecol & Hydrol, Penicuik, Midlothian, Scotland; [Grist, Hannah] Scottish Ornithologists Club, Aberlady, East Lothian, Scotland	University of Aberdeen; UK Centre for Ecology & Hydrology (UKCEH)	Daunt, F (corresponding author), Ctr Ecol & Hydrol, Penicuik, Midlothian, Scotland.	frada@ceh.ac.uk; jane.reid@abdn.ac.uk	Burthe, Sarah J/Q-9505-2016; Daunt, Francis/K-6688-2012	Burthe, Sarah J/0000-0001-8871-3432; Daunt, Francis/0000-0003-4638-3388; Grist, Hannah/0000-0001-7299-1868	Natural Environment Research Council CASE studentship; Centre for Ecology and Hydrology, Edinburgh; Scottish Ornithologists' Club; Natural Environment Research Council; Royal Society; Natural Environment Research Council [ceh010010] Funding Source: researchfish	Natural Environment Research Council CASE studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Centre for Ecology and Hydrology, Edinburgh; Scottish Ornithologists' Club; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	HG is funded by a Natural Environment Research Council CASE studentship, in partnership with the Centre for Ecology and Hydrology, Edinburgh (www.ceh.ac.uk), and the Scottish Ornithologists' Club (www.the-soc.org.uk). FD, SW, EN, MPH and MN are funded by the Natural Environment Research Council (www.nerc.ac.uk). JR is funded by the Royal Society (royalsociety.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1995, IBIS, V137, P11, DOI 10.1111/j.1474-919X.1995.tb03214.x; AEBISCHER NJ, 1986, J ANIM ECOL, V55, P613, DOI 10.2307/4743; AEBISCHER NJ, 1995, IBIS, V137, P19, DOI 10.1111/j.1474-919X.1995.tb03215.x; Alves JA, 2010, BIRD STUDY, V57, P381, DOI 10.1080/00063651003678475; [Anonymous], 2012, ISL MAY NAT NA UNPUB; Baird RW, 2008, MAR MAMMAL SCI, V24, P591, DOI 10.1111/j.1748-7692.2008.00200.x; Bakken V, 2003, NORWEGIAN BIRD RINGI, P431; Barlow EJ, 2013, IBIS, V155, P762, DOI 10.1111/ibi.12060; Bates D, 2012, LME4 LINEAR MIXED EF; Bearhop S, 2004, P ROY SOC B-BIOL SCI, V271, pS215, DOI 10.1098/rsbl.2003.0129; Belda EJ, 2007, IBIS, V149, P396, DOI 10.1111/j.1474-919X.2007.00657.x; Benton TG, 2006, P R SOC B, V273, P1173, DOI 10.1098/rspb.2006.3495; BIRKHEAD TR, 1977, J ANIM ECOL, V46, P751, DOI 10.2307/3638; Boyle WA, 2008, J ANIM ECOL, V77, P1122, DOI 10.1111/j.1365-2656.2008.01451.x; Brodersen J, 2008, ECOLOGY, V89, P1195, DOI 10.1890/07-1318.1; Brown DR, 2007, CONDOR, V109, P548, DOI 10.1650/8351.1; Chapman BB, 2011, OIKOS, V120, P1764, DOI 10.1111/j.1600-0706.2011.20131.x; Cherel Y, 2006, BIOL LETTERS, V2, P301, DOI 10.1098/rsbl.2006.0445; Clark Nigel A., 2010, Wader Study Group Bulletin, V117, P173; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Dalling JW, 2002, J ECOL, V90, P557, DOI 10.1046/j.1365-2745.2002.00695.x; Daunt F, 2007, FUNCT ECOL, V21, P561, DOI 10.1111/j.1365-2435.2007.01260.x; Daunt F, 2006, BEHAV ECOL SOCIOBIOL, V59, P381, DOI 10.1007/s00265-005-0061-4; Dias MP, 2011, P ROY SOC B-BIOL SCI, V278, P1786, DOI 10.1098/rspb.2010.2114; Dingemanse NJ, 2013, J ANIM ECOL, V82, P39, DOI 10.1111/1365-2656.12013; Dochtermann NA, 2012, CURR ZOOL, V58, P358, DOI 10.1093/czoolo/58.2.358; Eaton Mark A., 2009, British Birds, V102, P296; Edwards MA, 2009, ANIM BEHAV, V77, P23, DOI 10.1016/j.anbehav.2008.09.025; EEC, 2009, OFF J, VL20, P7; Einoder LD, 2009, FISH RES, V95, P6, DOI 10.1016/j.fishres.2008.09.024; Environmental Systems Research Institute (ESRI), 2011, ARCGIS DESKT; Esler D, 2000, J WILDLIFE MANAGE, V64, P839, DOI 10.2307/3802754; Fiedler Wolfgang, 2009, Ringing & Migration, V24, P175; Forero MG, 2002, MAR ECOL PROG SER, V234, P289, DOI 10.3354/meps234289; Frederiksen M, 2008, J ANIM ECOL, V77, P1020, DOI 10.1111/j.1365-2656.2008.01422.x; Frederiksen M, 2002, WILDLIFE BIOL, V8, P241, DOI 10.2981/wlb.2002.021; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; GALBRAITH H, 1986, ORNIS SCAND, V17, P68, DOI 10.2307/3676754; Gill JA, 2001, NATURE, V412, P436, DOI 10.1038/35086568; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Gremillet D, 1998, FUNCT ECOL, V12, P386, DOI 10.1046/j.1365-2435.1998.00199.x; Gunnarsson TG, 2005, P ROY SOC B-BIOL SCI, V272, P2319, DOI 10.1098/rspb.2005.3214; Gunnarsson TG, 2006, J ANIM ECOL, V75, P1119, DOI 10.1111/j.1365-2656.2006.01131.x; Harris MP, 2010, MAR BIOL, V157, P827, DOI 10.1007/s00227-009-1365-0; HARRIS MP, 1994, CONDOR, V96, P600, DOI 10.2307/1369462; Harris MP, 2002, MIGRATION ATLAS MOVE, P139; Harrison XA, 2011, J ANIM ECOL, V80, P4, DOI 10.1111/j.1365-2656.2010.01740.x; Hatch SA, 2011, J FIELD ORNITHOL, V82, P269, DOI 10.1111/j.1557-9263.2011.00330.x; Hobson KA, 1986, MURRELET, P65; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Iverson SA, 2006, J AVIAN BIOL, V37, P219; Lehikoinen E, 2004, ADV ECOL RES, V35, P1, DOI 10.1016/S0065-2504(04)35001-4; Lescroel A, 2009, J ANIM ECOL, V78, P798, DOI 10.1111/j.1365-2656.2009.01542.x; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Marra PP, 2001, AUK, V118, P92, DOI 10.1642/0004-8038(2001)118[0092:CODMHS]2.0.CO;2; Martin JGA, 2011, METHODS ECOL EVOL, V2, P362, DOI 10.1111/j.2041-210X.2010.00084.x; McKnight A, 2011, MAR ECOL PROG SER, V442, P241, DOI 10.3354/meps09373; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Norris DR, 2007, CONDOR, V109, P535; Norris DR, 2006, BIOL LETTERS, V2, P148, DOI 10.1098/rsbl.2005.0397; Oppel S, 2008, MAR ECOL PROG SER, V373, P149, DOI 10.3354/meps07744; OSBORNE P, 1980, IBIS, V122, P512, DOI 10.1111/j.1474-919X.1980.tb00908.x; PIPER WH, 1990, ETHOLOGY, V85, P114; POTTS GR, 1980, J ANIM ECOL, V49, P465, DOI 10.2307/4258; Pulido F, 1996, P NATL ACAD SCI USA, V93, P14642, DOI 10.1073/pnas.93.25.14642; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reid JM, 2003, J ANIM ECOL, V72, P36, DOI 10.1046/j.1365-2656.2003.00673.x; Reynolds TJ, 2011, IBIS, V153, P818, DOI 10.1111/j.1474-919X.2011.01149.x; Rodenhouse NL, 1997, ECOLOGY, V78, P2025, DOI 10.2307/2265942; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Sherry TW, 1996, ECOLOGY, V77, P36, DOI 10.2307/2265652; SNOW BARBARA K., 1963, BRIT BIRDS, V56-56, P77; Sponza S, 2013, ITAL J ZOOL, V80, P380, DOI 10.1080/11250003.2013.775365; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Velando A, 2003, WATERBIRDS, V26, P473, DOI 10.1675/1524-4695(2003)026[0000:NSCOAB]2.0.CO;2; Velando A, 2001, J ETHOL, V19, P121, DOI 10.1007/s101640170008; Vindenes Y, 2008, AM NAT, V171, P455, DOI 10.1086/528965; Wanless Sarah, 2004, P146; Warkentin IG, 1996, BIOL CONSERV, V77, P143, DOI 10.1016/0006-3207(95)00146-8; White PJ, 2007, BIOL CONSERV, V135, P502, DOI 10.1016/j.biocon.2006.10.041	81	34	35	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98562	10.1371/journal.pone.0098562	http://dx.doi.org/10.1371/journal.pone.0098562			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892676	Green Published, Green Accepted, gold			2022-12-25	WOS:000336911400068
J	Lavery, SD; Farhadi, A; Farahmand, H; Chan, TY; Azhdehakoshpour, A; Thakur, V; Jeffs, AG				Lavery, Shane D.; Farhadi, Ahmad; Farahmand, Hamid; Chan, Tin-Yam; Azhdehakoshpour, Ashkan; Thakur, Vibhavari; Jeffs, Andrew G.			Evolutionary Divergence of Geographic Subspecies within the Scalloped Spiny Lobster Panulirus homarus (Linnaeus 1758)	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENY; GENUS PANULIRUS; RIBOSOMAL DNA; DECAPODA; SPECIATION; PALINURIDAE; JMODELTEST; CRUSTACEA; ATLANTIC	Panulirus homarus is an economically important spiny lobster that is widespread through the Indo-West Pacific Region, but has an uncertain taxonomic status, with three or four geographic subspecies having been described. This study used mitochondrial (16S, COI and control region) and nuclear (18S, ITS-1) DNA sequences to examine specimens of all putative subspecies and forms from throughout their range, in order to determine their genetic validity, and understand the evolutionary history of this species. Despite the range of diversity present in the loci examined, the results were consistent across genes. P. h. rubellus from the SW Indian Ocean comprised the most divergent lineage that was reciprocally monophyletic with respect to all other P. homarus (approx. 9% divergence in COI), and has likely evolved reproductive barriers. The putative P. h. "Brown'' subspecies from the Marquesas Is in the central Pacific also comprised a somewhat divergent monophyletic lineage (approx. 3% in COI), but may simply be an allopatric population. The widespread P. h. homarus was not diverged at all from the described P. h. megasculpta from the NW Indian Ocean. The degree of evolutionary divergence of populations at the extremes distribution of the species is somewhat surprising, given the long pelagic larval stage, but suggests that allopatric speciation has been an important driver in the evolution of the genus.	[Lavery, Shane D.; Thakur, Vibhavari] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Lavery, Shane D.; Jeffs, Andrew G.] Univ Auckland, Inst Marine Sci, Auckland 1, New Zealand; [Farhadi, Ahmad; Farahmand, Hamid] Univ Tehran, Dept Fisheries, Karaj, Iran; [Chan, Tin-Yam] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung 202, Taiwan; [Chan, Tin-Yam] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung 202, Taiwan; [Azhdehakoshpour, Ashkan] IFRO Chabahar Branch, Chabahr, Iran	University of Auckland; University of Auckland; University of Tehran; National Taiwan Ocean University; National Taiwan Ocean University	Farhadi, A (corresponding author), Univ Tehran, Dept Fisheries, Karaj, Iran.	farhadia63@yahoo.com	Lavery, Shane/AFX-7929-2022; Jeffs, Andrew G/D-9474-2012; Ajdari, Ashkan/AAB-6517-2019	Lavery, Shane/0000-0003-3038-292X; Jeffs, Andrew/0000-0002-8504-1949; Farhadi, Ahmad/0000-0002-8282-4825	Australian Research Council [IH 120100032]; Worldwide Universities Network; University of Auckland; National Science Council, Taiwan, R.O.C.; University of Tehran	Australian Research Council(Australian Research Council); Worldwide Universities Network; University of Auckland; National Science Council, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); University of Tehran(University of Tehran)	The study was conducted with the financial support of the Australian Research Council's Industrial Transformation Research Hub funding scheme (project number IH 120100032) and the Worldwide Universities Network (AJ), the University of Auckland (SL), grants from the National Science Council, Taiwan, R.O.C. (TYC) and the University of Tehran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Marzouqi A., 2007, Western Indian Ocean Journal of Marine Science, V6, P159; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; BAKER CS, 1994, MOL ECOL, V3, P313, DOI 10.1111/j.1365-294X.1994.tb00071.x; BERRY P F, 1974, Crustaceana (Leiden), V27, P31, DOI 10.1163/156854074X00208; Berry PF, 1971, 28 OC RES I, P75; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Chan TY, 2009, MOL PHYLOGENET EVOL, V50, P411, DOI 10.1016/j.ympev.2008.11.020; Chan TY, 2001, CRUSTACEANA, V74, P123, DOI 10.1163/156854001505307; Chan TY, PERSONAL OBSERVATION; Chow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029280; Chu KH, 2001, MAR BIOTECHNOL, V3, P355, DOI 10.1007/s10126001-0014-5; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Diniz FM, 2005, MAR BIOTECHNOL, V7, P462, DOI 10.1007/s10126-004-4062-5; Drummond AJ, 2011, GENEIOUS AUCKLAND BI; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekman S., 1953, ZOOGEOGRAPHY SEA; FAO, 2010, FAO YB FISH ACQ STAT, P100; Farhadi A, 2013, ICES J MAR SCI, V70, P1491, DOI 10.1093/icesjms/fst097; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gaither MR, 2010, J BIOGEOGR, V37, P133, DOI 10.1111/j.1365-2699.2009.02188.x; George RW, 2006, CRUSTACEANA, V79, P397, DOI 10.1163/156854006777554848; George RW, 2005, CRUSTACEANA, V78, P1281, DOI 10.1163/156854005776759780; George RW, 2005, NEW ZEAL J MAR FRESH, V39, P493, DOI 10.1080/00288330.2005.9517328; Gopal K, 2006, MAR ECOL PROG SER, V319, P191, DOI 10.3354/meps319191; Groeneveld JC, 2007, MOL PHYLOGENET EVOL, V45, P102, DOI 10.1016/j.ympev.2007.06.002; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HALANYCH KM, 1995, SCIENCE, V267, P1641, DOI 10.1126/science.7886451; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Holthuis L, 1991, FAO FISHERIES SYNOPS, V13; Huxley VAJ, 2011, J THEOR EXP BIOL, V8, P58; Jeffs AG, 2005, NEW ZEAL J MAR FRESH, V39, P605, DOI 10.1080/00288330.2005.9517339; Jimoh AA, 2013, AQUACULTURE, V410, P25, DOI 10.1016/j.aquaculture.2013.06.013; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Li CP, 2011, ZOOL ANZ, V250, P270, DOI 10.1016/j.jcz.2011.04.003; LUTJEHARMS JRE, 1988, S AFR J SCI, V84, P236; Palero F, 2008, MOL PHYLOGENET EVOL, V48, P708, DOI 10.1016/j.ympev.2008.04.022; Palero F, 2009, MOL PHYLOGENET EVOL, V50, P152, DOI 10.1016/j.ympev.2008.10.003; Palumbi Stephen R., 1996, P205; Patek SN, 2007, LOBSTERS BIOL MANAGE, P113; Phillips BF, 2006, LOBSTERS BIOL MANAGE, P30; Phillips B, 2011, RECENT ADVANCES AND NEW SPECIES IN AQUACULTURE, P22; Phillips Bruce F., 2006, P231, DOI 10.1002/9780470995969.ch7; POLLOCK DE, 1992, B MAR SCI, V51, P135; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ptacek MB, 2001, MAR FRESHWATER RES, V52, P1037, DOI 10.1071/MF01070; Quenouille B, 2011, MOL PHYLOGENET EVOL, V58, P546, DOI 10.1016/j.ympev.2010.12.009; Ravago RG, 2002, CRUSTACEANA, V75, P1047, DOI 10.1163/156854002763270455; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; RYDER OA, 1986, TRENDS ECOL EVOL, V1, P9, DOI 10.1016/0169-5347(86)90059-5; Sarver SK, 1998, J CRUSTACEAN BIOL, V18, P177, DOI 10.2307/1549532; SPRINGER VG, 1982, SMITHSONIAN CONTR ZO, V367, P1, DOI DOI 10.5479/SI.00810282.367; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tourinho JL, 2012, MAR BIOL, V159, P1897, DOI 10.1007/s00227-012-1977-7; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Yang CH, 2012, MOL PHYLOGENET EVOL, V62, P237, DOI 10.1016/j.ympev.2011.09.019; Yeung C, 2001, MAR FRESHWATER RES, V52, P1217, DOI 10.1071/MF01110	56	39	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97247	10.1371/journal.pone.0097247	http://dx.doi.org/10.1371/journal.pone.0097247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892781	gold, Green Published, Green Submitted			2022-12-25	WOS:000336911400010
J	Martin, CR; Zaman, MM; Gilkey, C; Salguero, MV; Hasturk, H; Kantarci, A; Van Dyke, TE; Freedman, SD				Martin, Camilia R.; Zaman, Munir M.; Gilkey, Calvin; Salguero, Maria V.; Hasturk, Hatice; Kantarci, Alpdogan; Van Dyke, Thomas E.; Freedman, Steven D.			Resolvin D1 and Lipoxin A(4) Improve Alveolarization and Normalize Septal Wall Thickness in a Neonatal Murine Model of Hyperoxia-Induced Lung Injury	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BIRTH-WEIGHT INFANTS; BRONCHOPULMONARY DYSPLASIA; PRETERM INFANTS; TGF-BETA; LIPID MEDIATORS; COUNT METHOD; MOUSE LUNG; MICE; INTRAUTERINE	Background: The critical fatty acids Docosahexaenoic Acid (DHA) and Arachidonic Acid (AA) decline in preterm infants within the first postnatal week and are associated with neonatal morbidities, including bronchopulmonary dysplasia (BPD). DHA and AA are precursors to downstream metabolites that terminate the inflammatory response. We hypothesized that treatment with Resolvin D1 and/or Lipoxin A(4) would prevent lung injury in a murine model of BPD. Objective: To determine the effect of Resolvin D1 and/or Lipoxin A(4) on hyperoxia-induced lung injury. Methods: C57/BL6 pups were randomized at birth to Room Air, Hyperoxia (>90% oxygen), Hyperoxia + Resolvin D1, Hyperoxia + Lipoxin A(4), or Hyperoxia + Resolvin D1/Lipoxin A(4). Resolvin D1 and/or Lipoxin A(4) (2 ng/g) were given IP on days 0, 3, 6, and 9. On day 10, mice were sacrificed and lungs collected for morphometric analyses including Mean Linear Intercept (MLI), Radial Alveolar Count (RAC), and Septal Thickness (ST); RT-PCR analyses of biomarkers of lung development and inflammation; and ELISA for TGF beta(1) and TGF beta(2). Result: The increased ST observed with hyperoxia exposure was normalized by both Resolvin D1 and Lipoxin A(4); while, hyperoxia-induced alveolar simplification was attenuated by Lipoxin A(4). Relative to hyperoxia, Resolvin D1 reduced the gene expression of CXCL2 (2.9 fold), TIMP1 (6.7 fold), and PPAR gamma (4.8 fold). Treatment with Lipoxin A(4) also led to a reduction of CXCL2 (2.4 fold) while selectively increasing TGF beta(2) (2.1 fold) and Smad3 (1.58 fold). Conclusion: The histologic and biochemical changes seen in hyperoxia-induced lung injury in this murine model can be reversed by the addition of DHA and AA fatty acid downstream metabolites that terminate the inflammatory pathways and modulate growth factors. These fatty acids or their metabolites may be novel therapies to prevent or treat lung injury in preterm infants.	[Martin, Camilia R.] Beth Israel Deaconess Med Ctr, Dept Neonatol, Boston, MA 02215 USA; [Martin, Camilia R.; Freedman, Steven D.] Beth Israel Deaconess Med Ctr, Div Translat Res, Boston, MA 02215 USA; [Zaman, Munir M.; Gilkey, Calvin; Salguero, Maria V.; Freedman, Steven D.] Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA 02215 USA; [Hasturk, Hatice; Kantarci, Alpdogan; Van Dyke, Thomas E.] Forsyth Inst, Ctr Periodontol, Dept Appl Oral Sci, Cambridge, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Forsyth Institute	Martin, CR (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neonatol, Boston, MA 02215 USA.	cmartin1@bidmc.harvard.edu			Program for Faculty Development and Diversity; Harvard Catalyst; Harvard Clinical and Translational Science Center; National Center for Research Resources [UL1 RR 025758]; Harvard University; Charles H. Hood Foundation; National Institute of Dental and Craniofacial Research [s R01 DE15566, R01 DE19938, R21 DE20906, K23 DE18917]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K23DE018917, R21DE020906, R01DE015566, R01DE019938] Funding Source: NIH RePORTER	Program for Faculty Development and Diversity; Harvard Catalyst; Harvard Clinical and Translational Science Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Harvard University; Charles H. Hood Foundation; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work of CRM was supported by the Program for Faculty Development and Diversity supported by Harvard Catalyst, and the Harvard Clinical and Translational Science Center, from the National Center for Research Resources (award #UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the National Center for Research Resources or the National Institutes of Health. This study was also funded by the Charles H. Hood Foundation (CRM; www.hria.org/tmfservices/tmfgrants/hood.html), generous philanthropic donors to the Infant Health Research Program at Beth Israel Deaconess Medical Center, and the National Institute of Dental and Craniofacial Research (Award #s R01 DE15566, R01 DE19938, R21 DE20906, and K23 DE18917. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandre-Alcazar MA, 2007, AM J PHYSIOL-LUNG C, V292, pL537, DOI 10.1152/ajplung.00050.2006; Bannenberg G, 2010, BBA-MOL CELL BIOL L, V1801, P1260, DOI 10.1016/j.bbalip.2010.08.002; Bhandari V, 2010, SEMIN FETAL NEONAT M, V15, P223, DOI 10.1016/j.siny.2010.03.009; Bourbon J, 2005, PEDIATR RES, V57, p38R, DOI 10.1203/01.PDR.0000159630.35883.BE; Carraro S, 2013, EARLY HUM DEV, V89, pS3, DOI 10.1016/j.earlhumdev.2013.07.015; Chen H, 2005, AM J PHYSIOL-LUNG C, V288, pL683, DOI 10.1152/ajplung.00298.2004; COONEY TP, 1982, THORAX, V37, P572, DOI 10.1136/thx.37.8.572; COONEY TP, 1982, THORAX, V37, P580, DOI 10.1136/thx.37.8.580; Dasgupta C, 2009, AM J PHYSIOL-LUNG C, V296, pL1031, DOI 10.1152/ajplung.90392.2008; Dong J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-204; Eickmeier O, 2013, MUCOSAL IMMUNOL, V6, P256, DOI 10.1038/mi.2012.66; EMERY JL, 1960, ARCH DIS CHILD, V35, P544, DOI 10.1136/adc.35.184.544; Hilgendorff A., 2013, AM J RESP CELL MOL B; Hillman NH, 2011, AM J PHYSIOL-LUNG C, V300, pL232, DOI 10.1152/ajplung.00294.2010; Husain AN, 1998, HUM PATHOL, V29, P710, DOI 10.1016/S0046-8177(98)90280-5; Jeng SF, 2008, DEV MED CHILD NEUROL, V50, P51, DOI 10.1111/j.1469-8749.2007.02011.x; Jin SW, 2007, ANESTH ANALG, V104, P369, DOI 10.1213/01.ane.0000252414.00363.c4; Kumarasamy A, 2009, AM J RESP CRIT CARE, V180, P1239, DOI 10.1164/rccm.200902-0215OC; Landry JS, 2012, CAN RESPIR J, V19, P255, DOI 10.1155/2012/606507; Lapillonne A, 2010, NEONATOLOGY, V98, P397, DOI 10.1159/000320159; Levy BD, 2013, ANN REV PHYSL; Ma LY, 2012, NUTRITION, V28, P1186, DOI 10.1016/j.nut.2012.04.001; Martin CR, 2011, J PEDIATR-US, V159, P743, DOI 10.1016/j.jpeds.2011.04.039; Merritt TA, 2009, SEMIN FETAL NEONAT M, V14, P345, DOI 10.1016/j.siny.2009.08.009; Nakanishi H, 2007, AM J PHYSIOL-LUNG C, V293, pL151, DOI 10.1152/ajplung.00389.2006; Natarajan G, 2012, EARLY HUM DEV, V88, P509, DOI 10.1016/j.earlhumdev.2011.12.013; Recchiuti A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00298; Rogers LK, 2013, PHARMACOL RES, V70, P13, DOI 10.1016/j.phrs.2012.12.003; Rogers LK, 2011, J NUTR, V141, P214, DOI 10.3945/jn.110.129882; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Thebaud B, 2007, NEONATOLOGY, V91, P291, DOI 10.1159/000101344; Vicencio AG, 2004, AM J RESP CELL MOL, V31, P650, DOI 10.1165/rcmb.2004-0092OC; Vicencio AG, 2002, J APPL PHYSIOL, V93, P1123, DOI 10.1152/japplphysiol.00031.2002; Voelkel NF, 2006, AM J PHYSIOL-LUNG C, V290, pL209, DOI 10.1152/ajplung.00185.2005; Vom Hove M, 2014, J PEDIAT, V164, p[40, e44]; Wagenaar GTA, 2004, FREE RADICAL BIO MED, V36, P782, DOI 10.1016/j.freeradbiomed.2003.12.007; Wang B, 2011, PULM PHARMACOL THER, V24, P434, DOI 10.1016/j.pupt.2011.04.001; Wang Q, 2014, J IMMUNOL; Warner BB, 1998, AM J PHYSIOL-LUNG C, V275, pL110, DOI 10.1152/ajplung.1998.275.1.L110; Wendel DP, 2000, AM J RESP CELL MOL, V23, P320, DOI 10.1165/ajrcmb.23.3.3906; Yaxin W, 2013, J SURG RES; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	43	44	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98773	10.1371/journal.pone.0098773	http://dx.doi.org/10.1371/journal.pone.0098773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892762	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400090
J	Yang, X; Yang, YM; Gan, R; Zhao, LX; Li, W; Zhou, HB; Wang, XJ; Lu, JX; Meng, QH				Yang, Xiao; Yang, Yingmei; Gan, Rong; Zhao, Lingxu; Li, Wei; Zhou, Huaibin; Wang, Xiaojuan; Lu, Jianxin; Meng, Qing H.			Down-Regulation of miR-221 and miR-222 Restrain Prostate Cancer Cell Proliferation and Migration That Is Partly Mediated by Activation of SIRT1	PLOS ONE			English	Article							COLON-CANCER; EXPRESSION; TUMORIGENESIS; MICRORNAS; CARCINOMA; GROWTH; XENOGRAFTS; INHIBITION; LINES; MICE	Studies have shown that miR-221 and miR-222 are deregulated in many cancers, including prostate cancer. Nevertheless, the biological role and the underlying mechanisms of miR-221 and miR-222 in the pathogenesis of androgen-independent prostate cancer are still not clear. The proliferation, apoptosis, cell cycle distinction, and migration capacity of prostate cells were determined following transfection of miR-221 or miR-222 inhibitor. The biological impact and regulation of SIRT1 on prostate cancer cells were investigated. MiR-221 and miR-222 were highly expressed in PC-3 cells compared with in LNCap cells. After miR-221 or miR-222 expression was inhibited, the proliferation and migration rates of PC-3 cells decreased and the apoptosis rate increased. Moreover, SIRT1 protein was up-regulated in cells after they were transfected with miR-221 or miR-222 inhibitor. Cells transfected with siSIRT1 showed increased migration and a decreased apoptosis rate, but there was no significant effect on cell proliferation compared with the controls. There was a negative correlation between miR-221 or miR-222 and SIRT1, but no direct target relationship was identified. These data demonstrate that miR-221 and miR-222 are highly expressed in PC-3 cells. Their inhibition leads to reduced cell proliferation and migration and increased apoptosis in prostate cancer cells. These effects are potentially mediated by up-regulation of SIRT1.	[Yang, Xiao; Yang, Yingmei; Gan, Rong; Zhao, Lingxu; Li, Wei; Zhou, Huaibin; Wang, Xiaojuan; Lu, Jianxin] Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou, Zhejiang, Peoples R China; [Li, Wei; Zhou, Huaibin; Lu, Jianxin] Minist Educ, Key Lab Lab Med, Wenzhou, Zhejiang, Peoples R China; [Li, Wei; Zhou, Huaibin; Lu, Jianxin] Zhejiang Prov Key Lab Med Genet, Wenzhou, Zhejiang, Peoples R China; [Wang, Xiaojuan] Jinhua Peoples Hosp, Dept Clin Lab Med, Jinhua, Zhejiang, Peoples R China; [Meng, Qing H.] Univ Texas MD Anderson Canc Ctr, Dept Lab Med, Houston, TX 77030 USA	Wenzhou Medical University; University of Texas System; UTMD Anderson Cancer Center	Lu, JX (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou, Zhejiang, Peoples R China.	jxlu313@163.com; qhmeng@mdanderson.org	Lu, Jianxin/E-4485-2015; Meng, Q./GSI-6185-2022		National Natural Science Foundation of China; Zhejiang Provincial Natural Science Foundation [81170257, Y2110513]; MD Anderson Cancer Center Startup Fund	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); MD Anderson Cancer Center Startup Fund	This study was supported by grants from the National Natural Science Foundation of China and Zhejiang Provincial Natural Science Foundation (81170257 and Y2110513). This study was also partially supported by the MD Anderson Cancer Center Startup Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078023; Chen WX, 2013, TUMOR BIOL, V34, P1361, DOI 10.1007/s13277-013-0750-y; Chen Y, 2011, CANCER PREV RES, V4, P76, DOI 10.1158/1940-6207.CAPR-10-0167; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Farazi TA, 2013, ADV EXP MED BIOL, V774, P1, DOI 10.1007/978-94-007-5590-1_1; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Hao JW, 2012, ONCOL REP, V27, P1504, DOI 10.3892/or.2012.1652; Jikuzono T, 2013, INT J ONCOL, V42, P1858, DOI 10.3892/ijo.2013.1879; Jung W, 2013, KOREAN J PATHOL, V47, P332, DOI 10.4132/KoreanJPathol.2013.47.4.332; Jung-Hynes B, 2009, CELL CYCLE, V8, P1478, DOI 10.4161/cc.8.10.8408; Kabra N, 2009, J BIOL CHEM, V284, P18210, DOI 10.1074/jbc.M109.000034; KIM J, 2013, NATL GEOGR, V224, P8; Kim WT, 2013, PROSTATE INT, V1, P3, DOI 10.12954/PI.12011; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lhee Sang Jae, 2012, Int J Stem Cells, V5, P125; Li Kai, 2011, N Am J Med Sci (Boston), V4, P104; Lin Zhenghong, 2013, Genes Cancer, V4, P97, DOI 10.1177/1947601912475079; Lovaas JD, 2013, PROSTATE, V73, P522, DOI 10.1002/pros.22592; Lu YZ, 2011, J BIOL CHEM, V286, P42292, DOI 10.1074/jbc.M111.270926; Lupini Laura, 2013, Frontiers in Genetics, V4, P64, DOI 10.3389/fgene.2013.00064; Mercatelli N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004029; Munker R, 2011, CLIN SCI, V121, P141, DOI 10.1042/CS20110005; Shah MY, 2011, GENOME MED, V3, DOI 10.1186/gm272; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh Prashant Kumar, 2013, Cancers (Basel), V5, P998, DOI 10.3390/cancers5030998; Siva AC, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-17; Srivastava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076994; Sun T., 2013, ONCOGENE; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Sun T, 2009, CELL CYCLE, V8, P2315, DOI 10.4161/cc.8.15.9221; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wozney JL, 2014, CANC METASTASIS REV; Yuan HF, 2013, ONCOTARGETS THER, V6, P1399, DOI 10.2147/OTT.S37750; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367	38	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98833	10.1371/journal.pone.0098833	http://dx.doi.org/10.1371/journal.pone.0098833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892674	Green Submitted, gold, Green Published			2022-12-25	WOS:000336911400098
J	Abram, NK; Xofis, P; Tzanopoulos, J; MacMillan, DC; Ancrenaz, M; Chung, R; Peter, L; Ong, R; Lackman, I; Goossens, B; Ambu, L; Knight, AT				Abram, Nicola K.; Xofis, Panteleimon; Tzanopoulos, Joseph; MacMillan, Douglas C.; Ancrenaz, Marc; Chung, Robin; Peter, Lucy; Ong, Robert; Lackman, Isabelle; Goossens, Benoit; Ambu, Laurentius; Knight, Andrew T.			Synergies for Improving Oil Palm Production and Forest Conservation in Floodplain Landscapes	PLOS ONE			English	Article							CLASSIFICATION; EXPANSION; SABAH; DEFORESTATION; CORRIDORS; EMISSIONS; STATE; CODE	Lowland tropical forests are increasingly threatened with conversion to oil palm as global demand and high profit drives crop expansion throughout the world's tropical regions. Yet, landscapes are not homogeneous and regional constraints dictate land suitability for this crop. We conducted a regional study to investigate spatial and economic components of forest conversion to oil palm within a tropical floodplain in the Lower Kinabatangan, Sabah, Malaysian Borneo. The Kinabatangan ecosystem harbours significant biodiversity with globally threatened species but has suffered forest loss and fragmentation. We mapped the oil palm and forested landscapes (using object-based-image analysis, classification and regression tree analysis and on-screen digitising of high-resolution imagery) and undertook economic modelling. Within the study region (520,269 ha), 250,617 ha is cultivated with oil palm with 77% having high Net-Present-Value (NPV) estimates ($413/ha(-yr)-$637/ha(-yr)); but 20.5% is under-producing. In fact 6.3% (15,810 ha) of oil palm is commercially redundant (with negative NPV of $-299/ha(-yr)-$-65/ha(-yr)) due to palm mortality from flood inundation. These areas would have been important riparian or flooded forest types. Moreover, 30,173 ha of unprotected forest remain and despite its value for connectivity and biodiversity 64% is allocated for future oil palm. However, we estimate that at minimum 54% of these forests are unsuitable for this crop due to inundation events. If conversion to oil palm occurs, we predict a further 16,207 ha will become commercially redundant. This means that over 32,000 ha of forest within the floodplain would have been converted for little or no financial gain yet with significant cost to the ecosystem. Our findings have globally relevant implications for similar floodplain landscapes undergoing forest transformation to agriculture such as oil palm. Understanding landscape level constraints to this crop, and transferring these into policy and practice, may provide conservation and economic opportunities within these seemingly high opportunity cost landscapes.	[Abram, Nicola K.; Tzanopoulos, Joseph; MacMillan, Douglas C.] Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England; [Abram, Nicola K.; Ancrenaz, Marc; Lackman, Isabelle] HUTAN Kinabatangan Orang Utan Conservat Programme, Kota Kinabalu, Sabah, Malaysia; [Abram, Nicola K.] Living Landscape Alliance, Reading, Berks, England; [Abram, Nicola K.; Ancrenaz, Marc] People & Nat Consulting Int, Borneo Futures initiat, Jakarta, Indonesia; [Xofis, Panteleimon] Technol Educ Inst Kavala, Dept Forestry & Management Nat Environm, Drama, Greece; [Ancrenaz, Marc] North England Zool Soc, Chester, Cheshire, England; [Chung, Robin] CH Williams Talhar & Wong Sabah Sdn Bhd, Sandakan, Sabah, Malaysia; [Peter, Lucy; Goossens, Benoit] Sabah Wildlife Dept, Danau Girang Field Ctr, Kota Kinabalu, Sabah, Malaysia; [Ong, Robert] Sabah Wildlife Dept, Forest Res Ctr, Sandakan, Sabah, Malaysia; [Goossens, Benoit] Cardiff Univ, Sch Biosci, Organisms & Environm Div, Cardiff CF10 3AX, S Glam, Wales; [Goossens, Benoit; Ambu, Laurentius] Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Knight, Andrew T.] Imperial Coll London, Dept Life Sci, Ascot, Berks, England; [Knight, Andrew T.] Nelson Mandela Metrropolitan Univ, Dept Bot, Port Elizabeth, Eastern Cape, South Africa	University of Kent; People & Nature Consulting International; Pusat Penyelidikan Hutan; Cardiff University; Imperial College London; Nelson Mandela University	Abram, NK (corresponding author), Univ Kent, Sch Anthropol & Conservat, Durrell Inst Conservat & Ecol, Canterbury, Kent, England.	nicola_abram@hotmail.com	Knight, Andrew Thomas/C-8394-2009; Xofis, Panteleimon/AAG-9513-2019; MA, Lei/I-4597-2014; Abram, Nicola/K-2060-2014	Knight, Andrew Thomas/0000-0002-6563-0500; Xofis, Panteleimon/0000-0003-0528-3073; Abram, Nicola/0000-0003-1886-7297	RICS Research Trust; U.S. Fish and Wildlife Service's Great Ape Fund; Arcus Foundation; Department of Life Sciences at Imperial College London, UK; ARC Centre of Excellence in Environmental Decisions, University of Queensland, Australia	RICS Research Trust; U.S. Fish and Wildlife Service's Great Ape Fund; Arcus Foundation; Department of Life Sciences at Imperial College London, UK; ARC Centre of Excellence in Environmental Decisions, University of Queensland, Australia	NKA thanks RICS Research Trust, U.S. Fish and Wildlife Service's Great Ape Fund and the Arcus Foundation for financial support; Planet Action and Trimble for providing satellite imagery and the Definiens eCognition License. ATK acknowledges support from the Department of Life Sciences at Imperial College London, UK, and ARC Centre of Excellence in Environmental Decisions, University of Queensland, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram NK, 2013, SPATIAL PLANNING CON; Abram NK, 2013, ECOSYSTEM SERVICES; Alexander S, 2011, OPPORTUNITIES CHALLE; Ancrenaz M, 2004, ANIM CONSERV, V7, P375, DOI 10.1017/S136794300400157X; Ancrenaz M, ORYX IN PRESS; [Anonymous], SOIL SUIT MAP AGR; Benz UC, 2004, ISPRS J PHOTOGRAMM, V58, P239, DOI 10.1016/j.isprsjprs.2003.10.002; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Brown KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024107; Butchart SHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032529; Butler RA, 2009, TROP CONSERV SCI, V2, P1, DOI 10.1177/194008290900200102; Carlson KM, 2012, P NATL ACAD SCI USA, V109, P7559, DOI 10.1073/pnas.1200452109; CGONY, 2019, NYERI COUNTY GOVT NY; Cowling RM, 2003, BIOL CONSERV, V112, P1, DOI 10.1016/S0006-3207(02)00418-4; CRIST EP, 1984, PHOTOGRAMM ENG REM S, V50, P343; den Besten JW, 2013, EVOLUTION REDD ANAL; Estes JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044601; FAO, 2009, FAOSTAT ONL STAT SER; Feintrenie L, 2010, SMALL-SCALE FOR, V9, P379, DOI 10.1007/s11842-010-9122-2; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Foody GM, 2006, REMOTE SENS ENVIRON, V103, P179, DOI 10.1016/j.rse.2006.04.001; Garcia-Ulloa J, 2012, CONSERV LETT, V5, P366, DOI 10.1111/j.1755-263X.2012.00254.x; Gilbert N., 2012, NATURE NEWS; Gillies CS, 2008, P NATL ACAD SCI USA, V105, P19774, DOI 10.1073/pnas.0803530105; Goossens B, 2005, MOL ECOL, V14, P441, DOI 10.1111/j.1365-294X.02421.x; Hai TC, 2001, BALANCING NEED SUSTA; Heumann BW, 2011, REMOTE SENS-BASEL, V3, P2440, DOI 10.3390/rs3112440; Hoh C, 2001, OIL PALM CULTIVATION; IDS, 2007, SAB DEV CORR SOC BLU; Junk W.J., 1990, P491; Knight AT, 2007, CONSERV BIOL, V21, P1124, DOI 10.1111/j.1523-1739.2007.00690.x; Knight AT, 2010, CONSERV BIOL, V24, P1348, DOI 10.1111/j.1523-1739.2010.01494.x; Koh LP, 2009, TRENDS ECOL EVOL, V24, P67, DOI 10.1016/j.tree.2008.09.006; Lackman-Ancrenaz I, 2008, KINABATANGAN BIOSPHE; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Levin J., 2012, ANAL INCREMENTAL FIN; Li HT, 2010, INT J REMOTE SENS, V31, P1453, DOI 10.1080/01431160903475266; Lindermayer DB, 2006, HABITAT FRAGMENTATIO; Malaysian Palm Oil Board (MPOB), 2012, MAL OIL PALM STAT 20; Mantel S, 2007, BIOPHYSICAL LAND SUI; McMorrow J, 2001, GLOBAL ENVIRON CHANG, V11, P217, DOI 10.1016/S0959-3780(00)00059-5; Monserud RA, 1990, METHOD COMP GLOBAL V, P90; MPOB, 2010, PALM OIL COST PROD M; MPOB, 2010, OIL PALM IND LAB ISS; Nazeeb ATM, 2008, J OIL PALM RES, P61; Ng P. H. C., 2013, Planter, V89, P409; Paterson RRM, 2009, J PHYTOPATHOL, V157, P649, DOI 10.1111/j.1439-0434.2009.01553.x; Roever CL, 2013, BIOL CONSERV, V157, P128, DOI 10.1016/j.biocon.2012.06.025; RSPO, 2013, ROUNDT SUST PALM OIL; Sabah Forestry Department, 2007, VEG ASS CLASS LOW KI; Sabah Land Ordinance, 2010, STAT SAB LAND ORD SA; Sabah State Government, 1998, SAB WAT RES EN; Sabah Wildlife Department, 2012, SABAH WILDLIFE DEP M; Sha John C.M., 2008, Primate Conservation, V23, P107, DOI 10.1896/052.023.0112; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Stark DJ, 2009, PROBOSCIS MONKEY NAS; Teoh CH, 2000, LAND USE OIL PALM IN; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; United Nations Environment Programme (UNEP), 2011, OIL PALM PLANT THREA; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; Vermeulen S., 2006, BETTER PRACTICE SMAL, V5; Wilcove DS, 2010, BIODIVERS CONSERV, V19, P999, DOI 10.1007/s10531-009-9760-x; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	63	55	58	1	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e95388	10.1371/journal.pone.0095388	http://dx.doi.org/10.1371/journal.pone.0095388			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887555	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000336956300006
J	Brodowski, L; Burlakov, J; Myerski, AC; von Kaisenberg, CS; Grundmann, M; Hubel, CA; von Versen-Hoynck, F				Brodowski, Lars; Burlakov, Jennifer; Myerski, Ashley C.; von Kaisenberg, Constantin S.; Grundmann, Magdalena; Hubel, Carl A.; von Versen-Hoeynck, Frauke			Vitamin D Prevents Endothelial Progenitor Cell Dysfunction Induced by Sera from Women with Preeclampsia or Conditioned Media from Hypoxic Placenta	PLOS ONE			English	Article							COLONY-FORMING CELLS; 1,25-DIHYDROXYVITAMIN D-3; INHIBITS ANGIOGENESIS; D SUPPLEMENTATION; D-RECEPTOR; IN-VITRO; EXPRESSION; RISK; OXYGEN; PROLIFERATION	Context: Placenta-derived circulating factors contribute to the maternal endothelial dysfunction underlying preeclampsia. Endothelial colony forming cells (ECFC), a sub-population of endothelial progenitor cells (EPCs), are thought to be involved in vasculogenesis and endothelial repair. Low vitamin D concentrations are associated with an increased risk for preeclampsia. Objective: We hypothesized that the function of human fetal ECFCs in culture would be suppressed by exposure to preeclampsia-related factors-preeclampsia serum or hypoxic placental conditioned medium-in a fashion reversed by vitamin D. Design, Setting, Patients: ECFCs were isolated from cord blood of uncomplicated pregnancies and expanded in culture. Uncomplicated pregnancy villous placenta in explant culture were exposed to either 2% (hypoxic), 8% (normoxic) or 21% (hyperoxic) O-2 for 48 h, after which the conditioned media (CM) was collected. Outcome Measures: ECFC tubule formation (Matrigel assay) and migration were examined in the presence of either maternal serum from preeclampsia cases or uncomplicated pregnancy controls, or pooled CM, in the presence or absence of 1,25(OH)(2) vitamin D-3. Results: 1,25(OH)(2) vitamin D-3 reversed the adverse effects of preeclampsia serum or CM from hypoxic placenta on ECFCs capillary-tube formation and migration. Silencing of VDR expression by VDR siRNA, VDR blockade, or VEGF pathway blockade reduced ECFC functional abilities. Effects of VDR or VEGF blockade were partially prevented by vitamin D. Conclusion: Vitamin D promotes the capillary-like tubule formation and migration of ECFCs in culture, minimizing the negative effects of exposure to preeclampsia-related factors. Further evaluation of the role of vitamin D in ECFC regulation and preeclampsia is warranted.	[Brodowski, Lars; Burlakov, Jennifer; von Kaisenberg, Constantin S.; Grundmann, Magdalena; von Versen-Hoeynck, Frauke] Hannover Med Sch, Dept Obstet & Gynecol, Hannover, Germany; [Myerski, Ashley C.; Hubel, Carl A.] Univ Pittsburgh, Magee Womens Res Inst & Fdn, Pittsburgh, PA 15260 USA	Hannover Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Hubel, CA (corresponding author), Univ Pittsburgh, Magee Womens Res Inst & Fdn, Pittsburgh, PA 15260 USA.	chubel@mwri.magee.edu; vonVersen-Hoynck.Frauke@mh-hannover.de	von Versen-Höynck, Frauke/H-3719-2019; von Kaisenberg, Constantin/AAR-2756-2021	von Versen-Höynck, Frauke/0000-0002-1924-5695; 	National Institutes of Health [P01HD030367, UL1RR024153, UL1TR000005]; HiLF - Hannover Medical School; Boehringer Ingelheim Fonds travel grant program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD030367] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HiLF - Hannover Medical School; Boehringer Ingelheim Fonds travel grant program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The study was supported by National Institutes of Health P01HD030367 (CAH), UL1RR024153 and UL1TR000005 (University of Pittsburgh Clinical and Translational Science Institute), and a HiLF grant by Hannover Medical School. LB was supported by the Boehringer Ingelheim Fonds travel grant program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; Asahara T, 2002, J HEMATOTH STEM CELL, V11, P171, DOI 10.1089/152581602753658385; Bainbridge SA, 2009, AM J PHYSIOL-CELL PH, V297, pC440, DOI 10.1152/ajpcell.00593.2008; Barrera D, 2012, CYTOKINE, V57, P316, DOI 10.1016/j.cyto.2011.11.020; Bodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210/jc.2007-0718; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Cardus A, 2006, KIDNEY INT, V69, P1377, DOI 10.1038/sj.ki.5000304; Cardus A, 2009, ATHEROSCLEROSIS, V204, P85, DOI 10.1016/j.atherosclerosis.2008.08.020; Chen CW, 2014, CARDIOVASC RES, V101, P579, DOI 10.1093/cvr/cvu018; Chung I, 2009, CANCER RES, V69, P967, DOI 10.1158/0008-5472.CAN-08-2307; Cockell AP, 1997, BRIT J OBSTET GYNAEC, V104, P235, DOI 10.1111/j.1471-0528.1997.tb11052.x; Davis EF, 2012, PEDIATRICS, V129, pE1552, DOI 10.1542/peds.2011-3093; Dechend R, 2000, CIRCULATION, V101, P2382, DOI 10.1161/01.CIR.101.20.2382; Diaz L, 2009, J REPROD IMMUNOL, V81, P17, DOI 10.1016/j.jri.2009.02.005; Dunn WB, 2009, PLACENTA, V30, P974, DOI 10.1016/j.placenta.2009.08.008; Egorova AD, 2012, IN VITRO CELL DEV-AN, V48, P21, DOI 10.1007/s11626-011-9470-z; Evans KN, 2006, BIOL REPROD, V75, P816, DOI 10.1095/biolreprod.106.054056; Evans KN, 2004, J SOC GYNECOL INVEST, V11, P263, DOI 10.1016/j.jsgi.2004.02.002; Grundmann M, 2012, AM J PHYSIOL-CELL PH, V303, pC954, DOI 10.1152/ajpcell.00030.2012; Halhali A, 2004, J STEROID BIOCHEM, V89-90, P553, DOI 10.1016/j.jsbmb.2004.03.069; Haugen M, 2009, EPIDEMIOLOGY, V20, P720, DOI 10.1097/EDE.0b013e3181a70f08; Heazell AEP, 2008, PLACENTA, V29, P175, DOI 10.1016/j.placenta.2007.11.002; Heazell AEP, 2007, PLACENTA, V28, pS33, DOI 10.1016/j.placenta.2006.10.007; Hypponen E, 2007, EUR J CLIN NUTR, V61, P1136, DOI 10.1038/sj.ejcn.1602625; Ilekis JV, 2007, REPROD SCI, V14, P508, DOI 10.1177/1933719107306232; Ingram DA, 2008, DIABETES, V57, P724, DOI 10.2337/db07-1507; Lin C, 2009, AM J HYPERTENS, V22, P1014, DOI 10.1038/ajh.2009.101; Liu NQ, 2013, ENDOCRINOLOGY, V154, P2270, DOI 10.1210/en.2012-2270; Luppi P, 2010, REPROD SCI, V17, P643, DOI 10.1177/1933719110366164; Mantell DJ, 2000, CIRC RES, V87, P214, DOI 10.1161/01.RES.87.3.214; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; MERKE J, 1989, J CLIN INVEST, V83, P1903, DOI 10.1172/JCI114097; Miller RK, 2005, PLACENTA, V26, P439, DOI 10.1016/j.placenta.2004.10.002; Pospechova K, 2009, MOL CELL ENDOCRINOL, V299, P178, DOI 10.1016/j.mce.2008.12.003; Pringle KG, 2010, HUM REPROD UPDATE, V16, P415, DOI 10.1093/humupd/dmp046; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Reynolds J, 2014, LANCET, V383, P89; Roberts JM, 2000, SEMIN PERINATOL, V24, P24, DOI 10.1016/S0146-0005(00)80050-6; Robinson CJ, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.03.022; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Sipos PI, 2013, J CLIN ENDOCR METAB, V98, P4953, DOI 10.1210/jc.2013-2580; Sipos PI, 2013, STEM CELLS, V31, P1363, DOI 10.1002/stem.1385; SIPOS PI, 2009, PLACENTA; Smarason AK, 1996, AM J OBSTET GYNECOL, V174, P787, DOI 10.1016/S0002-9378(96)70466-0; Tabesh M, 2013, J CLIN ENDOCR METAB, V98, P3165, DOI 10.1210/jc.2013-1257; Tare M, 2011, J PHYSIOL-LONDON, V589, P4777, DOI 10.1113/jphysiol.2011.214726; von Versen-Hoynck F, 2009, PLACENTA, V30, P434, DOI 10.1016/j.placenta.2009.02.004; Wang YP, 2004, AM J OBSTET GYNECOL, V190, P817, DOI 10.1016/j.ajog.2003.09.049	49	27	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98527	10.1371/journal.pone.0098527	http://dx.doi.org/10.1371/journal.pone.0098527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887145	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300076
J	Kirkby, NS; Lundberg, MH; Wright, WR; Warner, TD; Paul-Clark, MJ; Mitchell, JA				Kirkby, Nicholas S.; Lundberg, Martina H.; Wright, William R.; Warner, Timothy D.; Paul-Clark, Mark J.; Mitchell, Jane A.			COX-2 Protects against Atherosclerosis Independently of Local Vascular Prostacyclin: Identification of COX-2 Associated Pathways Implicate Rgl1 and Lymphocyte Networks	PLOS ONE			English	Article							E-KNOCKOUT MOUSE; GASTROINTESTINAL TOXICITY; CYCLOOXYGENASE INHIBITION; ANTIINFLAMMATORY DRUGS; ATHEROGENESIS; BIOSYNTHESIS; EXPRESSION; MODEL; CYCLO-OXYGENASE-2; THROMBOXANE	Cyxlo-oxygenase (COX)-2 inhibitors, including traditional nonsteroidal anti-inflammatory drugs (NSAIDs) are associated with increased cardiovascular side effects, including myocardial infarction. We and others have shown that COX-1 and not COX-2 drives vascular prostacyclin in the healthy cardiovascular system, re-opening the question of how COX-2 might regulate cardiovascular health. In diseased, atherosclerotic vessels, the relative contribution of COX-2 to prostacyclin formation is not clear. Here we have used apoE(-/-)/COX-2(-/-) mice to show that, whilst COX-2 profoundly limits atherosclerosis, this protection is independent of local prostacyclin release. These data further illustrate the need to look for new explanations, targets and pathways to define the COX/NSAID/cardiovascular risk axis. Gene expression profiles in tissues from apoE(-/-)/COX-2(-/-) mice showed increased lymphocyte pathways that were validated by showing increased T-lymphocytes in plaques and elevated plasma Th1-type cytokines. In addition, we identified a novel target gene, rgl1, whose expression was strongly reduced by COX-2 deletion across all examined tissues. This study is the first to demonstrate that COX-2 protects vessels against atherosclerotic lesions independently of local vascular prostacyclin and uses systems biology approaches to identify new mechanisms relevant to development of next generation NSAIDs.	[Kirkby, Nicholas S.; Lundberg, Martina H.; Wright, William R.; Paul-Clark, Mark J.; Mitchell, Jane A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Kirkby, Nicholas S.; Lundberg, Martina H.; Warner, Timothy D.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England	Imperial College London; University of London; Queen Mary University London	Kirkby, NS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	n.kirkby@imperial.ac.uk; j.a.mitchell@imperial.ac.uk	Warner, Timothy D/A-1980-2009; Slingsby, Martina H/B-1476-2015	Warner, Timothy D/0000-0003-3988-4408; Slingsby, Martina H/0000-0002-2620-7582; Kirkby, Nicholas/0000-0003-3509-8549	Wellcome Trust [0852551Z108/Z]; National Institutes of Health	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by Wellcome Trust program grant 0852551Z108/Z. This forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit, which is supported and funded by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; Baker CSR, 1999, ARTERIOSCL THROM VAS, V19, P646, DOI 10.1161/01.ATV.19.3.646; Barbieri SS, 2012, CIRCULATION, V126, P1373, DOI 10.1161/CIRCULATIONAHA.112.097295; Belton OA, 2003, CIRCULATION, V108, P3017, DOI 10.1161/01.CIR.0000104565.78013.AD; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Burleigh ME, 2002, CIRCULATION, V105, P1816, DOI 10.1161/01.CIR.0000014927.74465.7F; Chan ESL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2109; Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540; De Beer MC, 2014, ARTERIOSCL THROM VAS, V34, P255, DOI 10.1161/ATVBAHA.113.302247; Egan KM, 2005, CIRCULATION, V111, P334, DOI 10.1161/01.CIR.0000153386.95356.78; Flavahan NA, 2007, TRENDS PHARMACOL SCI, V28, P106, DOI 10.1016/j.tips.2007.01.003; Funk CD, 2007, J CARDIOVASC PHARM, V50, P470, DOI 10.1097/FJC.0b013e318157f72d; Rodriguez LAG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016780; Gitlin JM, 2009, CARDIOVASC RES, V81, P400, DOI 10.1093/cvr/cvn286; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; GRYGLEWSKI RJ, 1978, ATHEROSCLEROSIS, V31, P385, DOI 10.1016/0021-9150(78)90133-8; Hernandez-Presa MA, 2002, ATHEROSCLEROSIS, V160, P49, DOI 10.1016/S0021-9150(01)00547-0; Hui YQ, 2010, CIRCULATION, V121, P2654, DOI 10.1161/CIRCULATIONAHA.109.910687; Johnson J, 2005, CIRCULATION, V111, P1422, DOI 10.1161/01.CIR.0000158435.98035.8D; Kirkby NS, 2013, FASEB J, V27, P3938, DOI 10.1096/fj.12-215533; Kirkby NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069524; Kirkby NS, 2012, P NATL ACAD SCI USA, V109, P17597, DOI 10.1073/pnas.1209192109; Kirkby NS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016906; Klingenberg R, 2007, ARTERIOSCL THROM VAS, V27, P2392, DOI 10.1161/ATVBAHA.107.149476; Koki A, 2002, ADV EXP MED BIOL, V507, P177; Liu B., 2012, FOOD BIOPROCESS TECH, V1, P1; Liu B, 2013, AM J PHYSIOL-RENAL, V305, pF1315, DOI 10.1152/ajprenal.00332.2013; MATTSSON E, 1993, EUR J SURG, V159, P15; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; MEHTA JL, 1988, P NATL ACAD SCI USA, V85, P4511, DOI 10.1073/pnas.85.12.4511; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; Mitchell JA, 2006, FASEB J, V20, P2468, DOI 10.1096/fj.06-6615com; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Narasimha A, 2007, PROSTAG OTH LIPID M, V84, P24, DOI 10.1016/j.prostaglandins.2007.03.004; Neel Nicole F, 2011, Genes Cancer, V2, P275, DOI 10.1177/1947601911407329; Olesen M, 2002, SCAND CARDIOVASC J, V36, P362, DOI 10.1080/140174302762659094; Pratico D, 2001, P NATL ACAD SCI USA, V98, P3358, DOI 10.1073/pnas.061607398; Rocca B, 1999, J CLIN INVEST, V103, P1469, DOI 10.1172/JCI6400; Rocca B, 2002, EUR J IMMUNOL, V32, P1482, DOI 10.1002/1521-4141(200205)32:5<1482::AID-IMMU1482>3.0.CO;2-O; Rott D, 2003, J AM COLL CARDIOL, V41, P1812, DOI 10.1016/S0735-1097(03)00304-8; Stemme V, 2000, EUR J VASC ENDOVASC, V20, P146, DOI 10.1053/ejvs.2000.1145; Tang SY, 2014, CIRCULATION; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Wallace JL, 2000, GASTROENTEROLOGY, V119, P706, DOI 10.1053/gast.2000.16510; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Warner TD, 2008, LANCET, V371, P270, DOI 10.1016/S0140-6736(08)60137-3; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Wong E, 2001, ATHEROSCLEROSIS, V157, P393, DOI 10.1016/S0021-9150(00)00756-5; Yu Z, 2012, P NATL ACAD SCI USA, V109, P6727, DOI 10.1073/pnas.1115313109; Zhou Y, 2013, EXPT PHYSL	52	41	41	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98165	10.1371/journal.pone.0098165	http://dx.doi.org/10.1371/journal.pone.0098165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887395	gold, Green Submitted, Green Published			2022-12-25	WOS:000336956300042
J	Beg, MS; Dwivedi, AK; Ahmad, SA; Ali, S; Olowokure, O				Beg, Muhammad Shaalan; Dwivedi, Alok Kumar; Ahmad, Syed Arif; Ali, Sadia; Olowokure, Olugbenga			Impact of Diabetes Mellitus on the Outcome of Pancreatic Cancer	PLOS ONE			English	Article							GLUCOSE-METABOLISM; ADENOCARCINOMA; SURVIVAL; CACHEXIA; RESECTION; INSULIN; METAANALYSIS; METFORMIN; WORSENS; OBESITY	Diabetes mellitus (DM) has the potential to impact the pathogenesis, treatment, and outcome of pancreatic cancer. This study evaluates the impact of DM on pancreatic cancer survival. Methods: We conducted a retrospective cohort study from the Veterans Affairs (VA) Central Cancer Registry (VACCR) for pancreatic cancer cases between 1995 and 2008. DM and no-DM cases were identified from comorbidity data. Univariate and multivariable analysis was performed. Multiple imputation method was employed to account for missing variables. Results: Of 8,466 cases of pancreatic cancer DM status was known in 4728 cases that comprised this analysis. Males accounted for 97.7% cases, and 78% were white. Overall survival was 4.2 months in DM group and 3.6 months in the no-DM group. In multivariable analysis, DM had a HR = 0.91 (0.849-0.974). This finding persisted after accounting for missing variables using multiple imputations method with the HR in DM group of 0.93 (0.867-0.997). Conclusions: Our data suggest DM is associated with a reduction in risk of death in pancreatic cancer. Future studies should be directed towards examining this association, specifically impact of DM medications on cancer outcome.	[Beg, Muhammad Shaalan] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hematol Oncol, Dallas, TX 75390 USA; [Dwivedi, Alok Kumar] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Div Biostat & Epidemiol, El Paso, TX USA; [Ahmad, Syed Arif] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH USA; [Ali, Sadia] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Endocrinol, Dallas, TX 75390 USA; [Olowokure, Olugbenga] Univ Cincinnati, Coll Med, Div Hematol Oncol, Cincinnati, OH USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Texas Tech University System; Texas Tech University; University System of Ohio; University of Cincinnati; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; University of Cincinnati	Beg, MS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hematol Oncol, Dallas, TX 75390 USA.	Muhammad.Beg@UTSouthwestern.edu			National Institutes of Health (NIH) [KL2TR00103]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was conducted with support from a National Institutes of Health (NIH) grant (KL2TR00103) awarded to MSB. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann J, 2008, J GASTROINTEST SURG, V12, P1193, DOI 10.1007/s11605-008-0505-z; Baracos VE, 2001, CANCER, V92, P1669, DOI 10.1002/1097-0142(20010915)92:6+<1669::AID-CNCR1495>3.0.CO;2-S; BASSO D, 1995, INT J CLIN LAB RES, V25, P40, DOI 10.1007/BF02592575; Ben QW, 2012, DIABETES-METAB RES, V28, P169, DOI 10.1002/dmrr.1284; Ben QW, 2011, EUR J CANCER, V47, P1928, DOI 10.1016/j.ejca.2011.03.003; Bowker SL, 2006, DIABETES CARE, V29, P1990, DOI 10.2337/dc06-0997; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Busaidy NL, 2006, J CLIN ONCOL, V24, p202S; Call R, 2010, POSTGRAD MED, V122, P158, DOI 10.3810/pgm.2010.05.2153; Cannon RM, 2012, HPB, V14, P228, DOI 10.1111/j.1477-2574.2011.00432.x; Chagpar RB, 2011, J GASTROINTEST SURG, V15, P551, DOI 10.1007/s11605-011-1448-3; Chu CK, 2010, J AM COLL SURGEONS, V210, P463, DOI 10.1016/j.jamcollsurg.2009.12.029; Chu CK, 2010, ANN SURG ONCOL, V17, P502, DOI 10.1245/s10434-009-0789-6; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Dehayem YM, 2011, ANN ENDOCRINOL-PARIS, V72, P24, DOI 10.1016/j.ando.2010.10.001; Hsu CC, 2012, J GASTROINTEST SURG, V16, P753, DOI 10.1007/s11605-011-1811-4; Huizinga Mary Margaret, 2007, Diabetes Care, V30, pe85, DOI 10.2337/dc07-0650; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Li DH, 2009, GASTROENTEROLOGY, V137, P482, DOI 10.1053/j.gastro.2009.04.013; Little R. J. A., 1987, STAT ANAL MISSING DA; Pausch T, 2012, SURGERY, V152, pS81, DOI 10.1016/j.surg.2012.05.028; PERMERT J, 1993, BRIT J SURG, V80, P1047, DOI 10.1002/bjs.1800800841; Sadeghi N, 2012, CLIN CANCER RES, V18, P2905, DOI 10.1158/1078-0432.CCR-11-2994; SAS Institute Inc, 1999, SAS STAT US GUID VER; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Syrigos KN, 1996, INT J CANCER, V66, P624, DOI 10.1002/(SICI)1097-0215(19960529)66:5<624::AID-IJC7>3.0.CO;2-V; Talar-Wojnarowska R, 2003, NEOPLASMA, V50, P383; TAYEK JA, 1992, J AM COLL NUTR, V11, P445; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; Wakasugi Hideyuki, 2001, International Journal of Clinical Oncology, V6, P50, DOI 10.1007/PL00012080	33	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98511	10.1371/journal.pone.0098511	http://dx.doi.org/10.1371/journal.pone.0098511			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879130	Green Submitted, Green Published, gold			2022-12-25	WOS:000338101500065
J	Paz, FPC; Batista, JD; Porto, JIR				Castro Paz, Francis Paola; Batista, Jacqueline da Silva; Rebelo Porto, Jorge Ivan			DNA Barcodes of Rosy Tetras and Allied Species (Characiformes: Characidae: Hyphessobrycon) from the Brazilian Amazon Basin	PLOS ONE			English	Article							FRESH-WATER FISHES; DIVERSITY; DIVERGENCE	DNA barcoding can be an effective tool for fast and accurate species-level identification based on sequencing of the mitochondrial cytochrome c oxidase subunit (COI) gene. The diversity of this fragment can be used to estimate the richness of the respective species. In this study, we explored the use of DNA barcoding in a group of ornamental freshwater fish of the genus Hyphessobrycon. We sequenced the COI from 10 species of Hyphessobrycon belonging to the "Rosy Tetra Clade'' collected from the Amazon and Negro River basins and combined our results with published data. The average conspecific and congeneric Kimura 2-parameter distances were 2.3% and 19.3%, respectively. Six of the 10 species were easily distinguishable by DNA barcoding (H. bentosi, H. copelandi, H. eques, H. epicharis, H. pulchrippinis, and H. sweglesi), whereas the remaining species (H. erythrostigma, H. pyrrhonotus, H. rosaceus and H. socolofi) lacked reciprocal monophyly. Although the COI gene was not fully diagnostic, the discovery of distinct evolutionary units in certain Hyphessobrycon species under the same specific epithet as well as haplotype sharing between different species suggest that DNA barcoding is useful for species identification in this speciose genus.	[Castro Paz, Francis Paola] Univ Ricardo Palma, Fac Ciencias Biol, Surco, Peru; [Batista, Jacqueline da Silva] Inst Nacl de Pesquisas da Amazonia, Lab Temat Biol Mol Coordenacao Biodiversidade, Manaus, AM, Brazil; [Rebelo Porto, Jorge Ivan] Inst Nacl de Pesquisas da Amazonia, Lab Genet Anim Coordenacao Biodiversidade, Manaus, AM, Brazil	Universidad Ricardo Palma; Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia	Paz, FPC (corresponding author), Univ Ricardo Palma, Fac Ciencias Biol, Surco, Peru.	francispcpaz@gmail.com	da Silva Batista, Jacqueline/AAD-4349-2020; Porto, Jorge/K-1441-2014; Porto, Jorge/T-4694-2019	da Silva Batista, Jacqueline/0000-0002-6649-6200; Porto, Jorge/0000-0003-1393-6492; 	CNPq	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	FPCP received a scholarship from the CNPq. Lab research has been continuously supported by the CNPq, CAPES and FAPEAM to JSB and JIRP. This work is part of the Brazilian Barcode of Life (BrBOL) initative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; Amaral CRL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074397; April J, 2011, P NATL ACAD SCI USA, V108, P10602, DOI 10.1073/pnas.1016437108; Ardura A, 2010, FOOD RES INT, V43, P1549, DOI 10.1016/j.foodres.2010.03.016; Asgharian H, 2011, MOL ECOL RESOUR, V11, P461, DOI 10.1111/j.1755-0998.2011.02989.x; Avise JC, 1997, P NATL ACAD SCI USA, V94, P7748, DOI 10.1073/pnas.94.15.7748; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Carvalho FR, 2013, NEOTROP ICHTHYOL, V11, P525, DOI 10.1590/S1679-62252013000300006; Colatreli Olavo Pinhatti, 2012, International Journal of Evolutionary Biology, P1; de Carvalho DC, 2011, MITOCHONDR DNA, V22, P80, DOI 10.3109/19401736.2011.588214; de Carvalho Daniel C, 2011, Mitochondrial DNA, V22 Suppl 1, P80, DOI 10.3109/19401736.2011.588214; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Eigenmann C. H., 1918, Memoirs of the Museum of Comparative Zoology at Harvard College Cambridge Mass, V43; Eigenmann CH, 1917, MEMOIRS MUSEUM COMP, V23, P1; Eigenmann CH, 1908, B MUS COMP ZOOL HARV, V52, P93; Eschmeyer WN, 2012, SPECIES FISHES FAMIL; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Froese R, 2013, FISHBASE WORLD WIDE; Garcia-Alzate CA, 2011, REV BIOL TROP, V59, P709; Gery J., 1977, CHARACOIDS WORLD; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hillis DM, 1997, REV ECOL SYST, V18, P23; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Jaafar TNAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049623; Javonillo R, 2010, MOL PHYLOGENET EVOL, V54, P498, DOI 10.1016/j.ympev.2009.08.026; Kadarusman, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040627; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kullander S.O., 2003, CHECK LIST FRESHWATE, P605; Lara A, 2010, MOL ECOL RESOUR, V10, P421, DOI 10.1111/j.1755-0998.2009.02785.x; Lima FCT, 1993, CHECKLIST FRESHWATER, P106; Lima Flavio C.T., 2001, Ichthyological Exploration of Freshwaters, V12, P105; Mabragana E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028655; Marcos Mirande J, 2009, Cladistics, V25, P574, DOI 10.1111/j.1096-0031.2009.00262.x; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Nwani CD, 2011, MITOCHONDR DNA, V22, P43, DOI 10.3109/19401736.2010.536537; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Puckridge M, 2013, MOL ECOL RESOUR, V13, P32, DOI 10.1111/1755-0998.12022; Rosso JJ, 2012, MOL ECOL RESOUR, V12, P999, DOI 10.1111/1755-0998.12010; Roxo FF, 2012, ZOOTAXA, P1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 1989, MOL CLONING LAB MANU; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Toffoli D, 2008, GENET MOL BIOL, V31, P324, DOI 10.1590/S1415-47572008000200028; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; WEITZMAN S H, 1983, Bulletin of the Museum of Comparative Zoology, V150, P339; Weitzman SH, 1997, ICHTHYOL EXPLOR FRES, V10, P1; Weitzman Stanley H., 1998, P161; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8	55	24	25	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98603	10.1371/journal.pone.0098603	http://dx.doi.org/10.1371/journal.pone.0098603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878569	Green Published, Green Submitted, gold			2022-12-25	WOS:000338101500073
J	Gil-Lopez, MJ; Segarra-Moragues, JG; Ojeda, F				Gil-Lopez, Manuel Jesus; Segarra-Moragues, Jose Gabriel; Ojeda, Fernando			Population Genetic Structure of a Sandstone Specialist and a Generalist Heath Species at Two Levels of Sandstone Patchiness across the Strait of Gibraltar	PLOS ONE			English	Article							HABITAT FRAGMENTATION; DIVERSITY; PLANT; SOFTWARE; DISTANCE; DIFFERENTIATION; CONSEQUENCES; DETERMINANTS; BIODIVERSITY; RESPROUTER	Many habitat specialist species are originally composed of small, discontinuous populations because their habitats are naturally fragmented or patchy. They may have suffered the long-term effects of natural patchiness. Mediterranean heathlands, a representative habitat in the Strait of Gibraltar region, are associated with nutrient-poor, acidic sandstone soils. Sandstone soil patches in the African side of the Strait (Tangier) are, in general, smaller and more scattered than in the European side (Algeciras). In this study, we analyze the effect of this sandstone patchiness on the population genetic diversity and structure of two Erica species from these Mediterranean heathlands that differ in their edaphic specificity, E. australis, sandstone specialist, and E. arborea, generalist. Average levels of within-population genetic diversity and gene flow between populations were significantly lower in Tangier (high sandstone patchiness) than in Algeciras (low patchiness) for the sandstone specialist, whereas no differences between both sides of the Strait were detected in the edaphic generalist. Since most endemic species in Mediterranean heathlands of the Strait of Gibraltar are sandstone specialists, these results highlight an increased vulnerability to loss of genetic diversity and local extinction of the heathland endemic flora in the Tangier side of the Strait of Gibraltar.	[Gil-Lopez, Manuel Jesus; Ojeda, Fernando] Univ Cadiz, Dept Biol, Puerto Real, Cadiz, Spain; [Segarra-Moragues, Jose Gabriel] Consejo Super Invest Cientif, Ctr Invest Desertificac, Valencia, Spain	Universidad de Cadiz; Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia; CSIC-GV-UV - Centro de Investigaciones sobre Desertificacion (CIDE)	Ojeda, F (corresponding author), Univ Cadiz, Dept Biol, Puerto Real, Cadiz, Spain.	fernando.ojeda@uca.es	Ojeda, Fernando/L-1626-2014; Segarra-Moragues, José Gabriel/I-7352-2012	Ojeda, Fernando/0000-0001-5480-0925; Segarra-Moragues, José Gabriel/0000-0003-0061-8647; Gil-Lopez, Manuel-Jesus/0000-0002-4567-4725	Project BREATHAL [CGL2011-28759/BOS]; Spanish Ministerio de Ciencia e Innovacion	Project BREATHAL; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	Project BREATHAL (CGL2011-28759/BOS) was financed by the Spanish Ministerio de Ciencia e Innovacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARROYO J, 1988, Lagascalia, V15, P615; Avise JC, 2000, PHYLOGEOGRAPHY; Bayer E, 1993, FLORA IBERICA, V485-506; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Booy G, 2000, PLANT BIOLOGY, V2, P379, DOI 10.1055/s-2000-5958; Bossuyt B, 2007, CONSERV BIOL, V21, P832, DOI 10.1111/j.1523-1739.2006.00645.x; Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; Couvet D, 2002, CONSERV BIOL, V16, P369, DOI 10.1046/j.1523-1739.2002.99518.x; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Desamore A, 2011, J BIOGEOGR, V38, P164, DOI 10.1111/j.1365-2699.2010.02387.x; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Ellstrand Norman C., 1992, New Forests, V6, P241, DOI 10.1007/BF00120647; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundez J, 2004, ISR J PLANT SCI, V52, P341, DOI 10.1560/WWNL-TQ7X-PDVM-E6KM; Fagundez J, 2010, PLANT SYST EVOL, V284, P65, DOI 10.1007/s00606-009-0240-2; Falush D, 2003, GENETICS, V164, P1567; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Segarra-Moragues JG, 2013, EVOL ECOL, V27, P117, DOI 10.1007/s10682-012-9586-y; Segarra-Moragues JG, 2010, EVOLUTION, V64, P3511, DOI 10.1111/j.1558-5646.2010.01064.x; Galan de Mera A, 2003, LAGASCALIA, V23, P27; Gibbs JP, 2001, BIOL CONSERV, V100, P15, DOI 10.1016/S0006-3207(00)00203-2; Goudet J, 2001, FSTAT V 2 9 3 2 PROG; Honnay O, 2007, CONSERV BIOL, V21, P823, DOI 10.1111/j.1523-1739.2006.00646.x; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Johnson JA, 2003, MOL ECOL, V12, P3335, DOI 10.1046/j.1365-294X.2003.02013.x; Jules ES, 1998, ECOLOGY, V79, P1645, DOI 10.1890/0012-9658(1998)079[1645:HFADCF]2.0.CO;2; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Langella O, 2000, POPULATIONS LOGICIEL; Lowe AJ, 2005, HEREDITY, V95, P255, DOI 10.1038/sj.hdy.6800725; LOWE AS, 2004, ECOLOGICAL GENETICS; Ludwig D, 1996, AM NAT, V147, P506, DOI 10.1086/285863; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; McGuire AF, 2005, INT J PLANT SCI, V166, P311, DOI 10.1086/427478; Medrano M, 2008, ANN BOT-LONDON, V102, P183, DOI 10.1093/aob/mcn086; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; NEI M, 1978, GENETICS, V89, P583; Ojeda F, 1998, J BIOGEOGR, V25, P165, DOI 10.1046/j.1365-2699.1998.251141.x; Ojeda F, 1996, J VEG SCI, V7, P63, DOI 10.2307/3236417; Ojeda F, 2000, ECOGRAPHY, V23, P148, DOI 10.1034/j.1600-0587.2000.230116.x; Ojeda F, 2001, J VEG SCI, V12, P867, DOI 10.2307/3236875; Palop-Esteban M, 2007, MOL ECOL, V16, P3814, DOI 10.1111/j.1365-294X.2007.03449.x; Paula S, 2006, PLANT ECOL, V183, P329, DOI 10.1007/s11258-005-9043-x; Pirie MD, 2011, MOL PHYLOGENET EVOL, V61, P593, DOI 10.1016/j.ympev.2011.06.007; Pluess AR, 2004, CONSERV GENET, V5, P145, DOI 10.1023/B:COGE.0000029999.10808.c2; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; Rodriguez-Sanchez F, 2008, QUATERNARY SCI REV, V27, P2100, DOI 10.1016/j.quascirev.2008.08.006; Rohlf FJ, 2002, USER GUIDE; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Segarra-Moragues JG, 2009, CONSERV GENET, V10, P1815, DOI 10.1007/s10592-009-9823-2; SLATKIN M, 1995, GENETICS, V139, P457; Soga M, 2013, J INSECT CONSERV, V17, P421, DOI 10.1007/s10841-012-9524-x; Sork VL, 2006, LANDSCAPE ECOL, V21, P821, DOI 10.1007/s10980-005-5415-9; Watson DM, 2002, J BIOGEOGR, V29, P823, DOI 10.1046/j.1365-2699.2002.00726.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wolf AT, 2000, AM J BOT, V87, P1138, DOI 10.2307/2656650; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8	63	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98602	10.1371/journal.pone.0098602	http://dx.doi.org/10.1371/journal.pone.0098602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878545	gold, Green Published, Green Submitted			2022-12-25	WOS:000338101500072
J	Eberle, J; Myburgh, R; Ahrens, D				Eberle, Jonas; Myburgh, Renier; Ahrens, Dirk			The Evolution of Morphospace in Phytophagous Scarab Chafers: No Competition - No Divergence?	PLOS ONE			English	Article							MORPHOLOGICAL EVOLUTION; PHENOTYPIC EVOLUTION; PHYLOGENETIC SIGNAL; BEETLES COLEOPTERA; DUNG BEETLES; ECOLOGY; RATES; CONSEQUENCES; ASSEMBLAGES; SERICINI	Body shape reflects species' evolution and mediates its role in the environment as it integrates gene expression, life style, and structural morphology. Its comparative analysis may reveal insight on what shapes shape, being a useful approach when other evidence is lacking. Here we investigated evolutionary patterns of body shape in the highly diverse phytophagous chafers (Scarabaeidae: Pleurosticti), a polyphagous group utilizing different parts of angiosperms. Because the reasons of their successful diversification are largely unknown, we used a phylogenetic tree and multivariate analysis on twenty linear measurements of body morphology including all major Pleurosticti lineages to infer patterns of morphospace covariation and divergence. The chafer's different feeding types resulted to be not distinguishable in the described morphospace which was largely attributed to large occupancy of the morphospace of some feeding types and to multiple convergences of feeding behavior (particularly of anthophagy). Low correlation between molecular and morphological rates of evolution, including significant rate shifts for some lineages, indicated directed selection within feeding types. This is supported by morphospace divergence within feeding types and convergent evolution in Australian Melolonthinae. Traits driving morphospace divergence were extremities and traits linked with locomotion behavior, but also body size. Being highly adaptive for burrowing and locomotion these traits showed major changes in the evolution of pleurostict scarabs. These activities also affected another trait, the metacoxal length, which is highly influenced by key innovations of the metacoxa (extended mesal process, secondary closure) particularly in one lineage, the Sericini. Significant shape divergence between major lineages and a lack of strong differentiation among closely related lineages indicated that the question about the presence or absence of competition-derived directed selection needs to be addressed for different time scales. Striking divergence between some sister lineages at their origin revealed strong driven selection towards morphospace divergence, possibly linked with resource partitioning.	[Eberle, Jonas; Myburgh, Renier; Ahrens, Dirk] Ctr Taxon & Evolutionary Res, Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Ahrens, Dirk] Nat Hist Museum, Dept Entomol, London SW7 5BD, England; [Myburgh, Renier] Univ Zurich Hosp, Div Infect Dis, CH-8091 Zurich, Switzerland; [Myburgh, Renier] Univ Zurich Hosp, Hosp Epidemiol, CH-8091 Zurich, Switzerland	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Natural History Museum London; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Ahrens, D (corresponding author), Ctr Taxon & Evolutionary Res, Zool Forsch Museum Alexander Koenig, Bonn, Germany.	ahrens.dirk_col@gmx.de	Ahrens, Dirk/AAR-1310-2021	Eberle, Jonas/0000-0003-2519-0640	German Science Foundation [AH175-1, AH175-3]	German Science Foundation(German Research Foundation (DFG))	This research was supported by the German Science Foundation (AH175-1, AH175-3) www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2000, P NATL ACAD SCI USA, V97, P4106, DOI 10.1073/pnas.97.8.4106; Ahrens D, 2006, SYST ENTOMOL, V31, P113, DOI 10.1111/j.1365-3113.2005.00307.x; Ahrens D, 2008, MOL PHYLOGENET EVOL, V47, P783, DOI 10.1016/j.ympev.2008.02.010; Ahrens D, 2011, MOL PHYLOGENET EVOL, V60, P408, DOI 10.1016/j.ympev.2011.04.011; Ahrens D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-234; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Balthasar V, 1963, MONOGRAPHIE SCARABAE, pI; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Berner D, 2011, OECOLOGIA, V166, P961, DOI 10.1007/s00442-011-1934-z; Blankers T, 2012, J EVOLUTION BIOL, V25, P634, DOI 10.1111/j.1420-9101.2012.02458.x; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Bocak L, 2014, SYST ENTOMOL, V39, P97, DOI 10.1111/syen.12037; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Browne J, 1998, SYST ENTOMOL, V23, P307, DOI 10.1046/j.1365-3113.1998.00059.x; BURNABY TP, 1966, BIOMETRICS, V22, P96, DOI 10.2307/2528217; Claude J, 2008, MORPHOMETRICS R; CONNELL JH, 1980, OIKOS, V35, P131, DOI 10.2307/3544421; Cooper N, 2009, J EVOLUTION BIOL, V22, P1024, DOI 10.1111/j.1420-9101.2009.01714.x; DOUGLAS ME, 1992, OIKOS, V65, P213, DOI 10.2307/3545012; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; ERICHSON WF, 1847, NATURGESCHICHTE INSE, V3; Ezard THG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-175; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Ferrario VF, 1995, J ANAT, V187, P593; Finn JA, 2003, ECOL ENTOMOL, V28, P1, DOI 10.1046/j.1365-2311.2002.00487.x; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GARLAND T, 1992, AM NAT, V140, P509, DOI 10.1086/285424; GAUCH HG, 1982, ECOLOGY, V63, P1643, DOI 10.2307/1940105; GILLER PS, 1994, J ANIM ECOL, V63, P629, DOI 10.2307/5229; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hanski I., 1991, P305; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Heard Stephen B., 1995, Historical Biology, V10, P151; HOLM S, 1979, SCAND J STAT, V6, P65; Horgan FG, 2005, ECOL ENTOMOL, V30, P182, DOI 10.1111/j.0307-6946.2005.00673.x; Hugall AF, 2007, EVOLUTION, V61, P2293, DOI 10.1111/j.1558-5646.2007.00188.x; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Hunter JP, 1998, TRENDS ECOL EVOL, V13, P31, DOI 10.1016/S0169-5347(97)01273-1; Inward DJG, 2011, J BIOGEOGR, V38, P1668, DOI 10.1111/j.1365-2699.2011.02509.x; JERMY T, 1985, Z ZOOL SYST EVOL, V23, P275; JOLICOEUR P, 1984, SYST ZOOL, V33, P14, DOI 10.2307/2413129; JOLICOEUR P, 1963, BIOMETRICS, V19, P497, DOI 10.2307/2527939; JOLICOEUR PIERRE, 1960, GROWTH, V24, P339; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; Klingenberg CP, 1996, NATO ADV SCI INST SE, V284, P23; Lanfear R, 2010, TRENDS ECOL EVOL, V25, P495, DOI 10.1016/j.tree.2010.06.007; Leal WS, 1998, ANNU REV ENTOMOL, V43, P39, DOI 10.1146/annurev.ento.43.1.39; Leal WS, 1998, ANN NY ACAD SCI, V855, P301, DOI 10.1111/j.1749-6632.1998.tb10586.x; Leal WS, 1999, ENV ENTOMLOLOGY BEHA, P464; Levinton J. S., 1988, GENETICS PALEONTOLOG; LOUGHRIN JH, 1995, J CHEM ECOL, V21, P1457, DOI 10.1007/BF02035145; McLachlan G.J., 2004, DISCRIMINANT ANAL ST, VVolume 544; MCPEEK MA, 1995, AM NAT, V145, P686, DOI 10.1086/285763; MCPEEK MA, 1995, EVOLUTION, V49, P749, DOI 10.1111/j.1558-5646.1995.tb02311.x; McPeek MA, 2008, AM NAT, V171, pE158, DOI 10.1086/587076; MEINECKE CC, 1975, ZOOMORPHOLOGIE, V82, P1, DOI 10.1007/BF00995905; Melville J, 2006, P ROY SOC B-BIOL SCI, V273, P557, DOI 10.1098/rspb.2005.3328; MITTER C, 1991, TRENDS ECOL EVOL, V6, P290, DOI 10.1016/0169-5347(91)90007-K; Oksanen J., 2013, PACKAGE VEGAN COMMUN; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PECK SB, 1982, CAN J ZOOL, V60, P1624, DOI 10.1139/z82-213; Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015; Polly PD, 2001, GENETICA, V112, P339, DOI 10.1023/A:1013395907225; Potter DA, 1996, ENTOMOL EXP APPL, V80, P209, DOI 10.1007/BF00194759; R Development Core Team, 2012, R LANG ENV STAT COMP; REIST JD, 1985, CAN J ZOOL, V63, P1429, DOI 10.1139/z85-213; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Ribera I, 1999, ANN ZOOL FENN, V36, P21; RICHMAN AD, 1992, NATURE, V355, P817, DOI 10.1038/355817a0; Ricklefs R. E., 1994, ECOLOGICAL MORPHOLOG; RICKLEFS RE, 1980, AUK, V97, P321; RICKLEFS RE, 1981, ECOLOGY, V62, P1474, DOI 10.2307/1941504; RITCHER PO, 1958, ANNU REV ENTOMOL, V3, P311, DOI 10.1146/annurev.en.03.010158.001523; Scholtz C.H., 1995, P355; Scholtz C. H., 2005, COLEOPTERA BEETLES V, P367, DOI DOI 10.1515/9783110904550.367; SMITH ABT, 2006, COLEOPT SOC MONO DEC, P144, DOI DOI 10.1649/0010-065X(2006)60[; Springer Mark S., 1997, P129; Teissier G., 1960, PHYSL CRUSTACEA, P537; TRAVIS J, 1983, OIKOS, V41, P434, DOI 10.2307/3544103; Venables W.N., 2002, MODERN APPL STAT S P, Vfourth, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2_10]; Wainwright P.C., 1994, ECOLOGICAL MORPHOLOG; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5	87	16	16	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98536	10.1371/journal.pone.0098536	http://dx.doi.org/10.1371/journal.pone.0098536			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875856	Green Published, Green Submitted, gold			2022-12-25	WOS:000336790800046
J	Inger, R; Bennie, J; Davies, TW; Gaston, KJ				Inger, Richard; Bennie, Jonathan; Davies, Thomas W.; Gaston, Kevin J.			Potential Biological and Ecological Effects of Flickering Artificial Light	PLOS ONE			English	Article							WHITE FLUORESCENT LIGHT; FUSION FREQUENCY; TEMPORAL RESOLUTION; INTERMITTENT ILLUMINATION; EYE; ELECTRORETINOGRAM; SENSITIVITY; ATTRACTIVENESS; MODULATION; RESPONSES	Organisms have evolved under stable natural lighting regimes, employing cues from these to govern key ecological processes. However, the extent and density of artificial lighting within the environment has increased recently, causing widespread alteration of these regimes. Indeed, night-time electric lighting is known significantly to disrupt phenology, behaviour, and reproductive success, and thence community composition and ecosystem functioning. Until now, most attention has focussed on effects of the occurrence, timing, and spectral composition of artificial lighting. Little considered is that many types of lamp do not produce a constant stream of light but a series of pulses. This flickering light has been shown to have detrimental effects in humans and other species. Whether a species is likely to be affected will largely be determined by its visual temporal resolution, measured as the critical fusion frequency. That is the frequency at which a series of light pulses are perceived as a constant stream. Here we use the largest collation to date of critical fusion frequencies, across a broad range of taxa, to demonstrate that a significant proportion of species can detect such flicker in widely used lamps. Flickering artificial light thus has marked potential to produce ecological effects that have not previously been considered.	[Inger, Richard; Bennie, Jonathan; Davies, Thomas W.; Gaston, Kevin J.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England	University of Exeter	Inger, R (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England.	richinger@gmail.com	Davies, Thomas W/H-8103-2013; Inger, Richard/D-3445-2009	Davies, Thomas W/0000-0002-4673-9893; Inger, Richard/0000-0003-1660-3706; Gaston, Kevin J./0000-0002-7235-7928; Bennie, Jonathan/0000-0003-4394-2041	European Research Council under the European Union [268504]	European Research Council under the European Union(European Research Council (ERC))	The research leading to this paper received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 268504 to K.J.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1928, J PHYSIOL-LONDON, V65, P273, DOI 10.1113/jphysiol.1928.sp002475; Ali MA, 1985, VISION VERTEBRATES; AULT S J, 1987, Journal of Raptor Research, V21, P147; AUTRUM H, 1951, Z VERGL PHYSIOL, V33, P407; AUTRUM H, 1950, Z VERGL PHYSIOL, V32, P176, DOI 10.1007/BF00344524; AUTRUM H, 1950, Z NATURFORSCH B, V5, P38, DOI 10.1515/znb-1950-0107; BARTON K, 2011, MODEL SELECTION MODE; Bates D., 2013, LME4 LINEAR MIXED EF; BERMAN SM, 1991, OPTOMETRY VISION SCI, V68, P645, DOI 10.1097/00006324-199108000-00012; BERNHOLZ CD, 1975, VISION RES, V15, P733, DOI 10.1016/0042-6989(75)90292-8; BINNIE CD, 1979, EPILEPSIA, V20, P725, DOI 10.1111/j.1528-1157.1979.tb04856.x; Bird BL, 2004, CONSERV BIOL, V18, P1435, DOI 10.1111/j.1523-1739.2004.00349.x; BORNSCHEIN H, 1961, EXPERIENTIA, V17, P185, DOI 10.1007/BF02160375; BUCHANAN BW, 1993, ANIM BEHAV, V45, P893, DOI 10.1006/anbe.1993.1109; BURNS SA, 1992, OPTOMETRY VISION SCI, V69, P95, DOI 10.1097/00006324-199202000-00002; Callahan TL, 2000, VISION RES, V40, P455, DOI 10.1016/S0042-6989(99)00194-7; Carvalho PSM, 2002, ANIM BEHAV, V64, P1, DOI 10.1006/anbe.2002.3028; Chu CC, 2006, SOUTHWEST ENTOMOL, V31, P77; Chu CC, 2004, SOUTHWEST ENTOMOL, V29, P111; COILE DC, 1989, PHYSIOL BEHAV, V45, P1087, DOI 10.1016/0031-9384(89)90092-9; Crevier DW, 1998, J NEUROPHYSIOL, V79, P1869, DOI 10.1152/jn.1998.79.4.1869; Crozier WJ, 1939, J GEN PHYSIOL, V22, P463, DOI 10.1085/jgp.22.4.463; D'eath RB, 1998, BIOL REV, V73, P267, DOI 10.1017/S0006323198005179; Davies TW, 2012, BIOL LETTERS, V8, P764, DOI 10.1098/rsbl.2012.0216; DEVOE RD, 1963, J GEN PHYSIOL, V47, P13, DOI 10.1085/jgp.47.1.13; DODT E, 1953, ACTA PHYSIOL SCAND, V30, P80; DOUGLAS RH, 1990, VISUAL SYSTEM FISH, P279; Evans JE, 2006, ANIM BEHAV, V72, P393, DOI 10.1016/j.anbehav.2005.10.031; Evans JE, 2012, ANIM BEHAV, V83, P25, DOI 10.1016/j.anbehav.2011.10.002; Ferry ES, 1892, AM J SCI, V44, P192; FLEISHMAN LJ, 1995, COPEIA, P422; FORSTER LM, 1985, NEUROBIOLOGY ARACHNI, P250; Frank TM, 1999, BIOL BULL, V196, P137, DOI 10.2307/1542559; Frank TM, 2003, INTEGR COMP BIOL, V43, P559, DOI 10.1093/icb/43.4.559; Fritsches KA, 2005, CURR BIOL, V15, P55, DOI 10.1016/j.cub.2004.12.064; Gaston KJ, 2013, BIOL REV, V88, P912, DOI 10.1111/brv.12036; Gaston KJ, 2012, J APPL ECOL, V49, P1256, DOI 10.1111/j.1365-2664.2012.02212.x; Granit R, 1934, J PHYSIOL-LONDON, V81, P1; GREEN DG, 1975, SCIENCE, V188, P1120, DOI 10.1126/science.1215989; Greenwood VJ, 2004, APPL ANIM BEHAV SCI, V86, P145, DOI 10.1016/j.applanim.2003.11.008; Gruber SH, 1969, THESIS U MIAMI CORAL; Hammer DX, 2001, COMP BIOCHEM PHYS A, V128, P805, DOI 10.1016/S1095-6433(00)00322-6; HANYU I, 1964, J CELL COMPAR PHYSL, V63, P309, DOI 10.1002/jcp.1030630306; Harding G., 1994, PHOTOSENSITIVE EPILE; HAZELL J, 1990, PSYCHOL MED, V20, P591, DOI 10.1017/S0033291700017098; Healy K, 2013, ANIM BEHAV, V86, P685, DOI 10.1016/j.anbehav.2013.06.018; Hecht S, 1933, J GEN PHYSIOL, V17, P237, DOI 10.1085/jgp.17.2.237; HENDRICKS J, 1966, J EXP ANAL BEHAV, V9, P501, DOI 10.1901/jeab.1966.9-501; Jarvis JR, 2002, VISION RES, V42, P99, DOI 10.1016/S0042-6989(01)00268-1; JENSSEN TA, 1974, VISION RES, V14, P965, DOI 10.1016/0042-6989(74)90164-3; Kempenaers B, 2010, CURR BIOL, V20, P1735, DOI 10.1016/j.cub.2010.08.028; Kennedy A, 1998, Q J EXP PSYCHOL-A, V51, P135, DOI 10.1080/713755746; Kuznetsova A., 2013, CHRISTENSEN RHB LMER; LALITHA R, 1988, Indian Journal of Physiology and Pharmacology, V32, P182; LANDIS C, 1954, PHYSIOL REV, V34, P259, DOI 10.1152/physrev.1954.34.2.259; Lisney TJ, 2012, VISION RES, V62, P125, DOI 10.1016/j.visres.2012.04.002; Lisney TJ, 2011, VISION RES, V51, P1324, DOI 10.1016/j.visres.2011.04.009; LOOP MS, 1975, VISION RES, V15, P555, DOI 10.1016/0042-6989(75)90302-8; Lu SN, 2012, CONSCIOUS COGN, V21, P928, DOI 10.1016/j.concog.2012.03.012; Lythgoe J.N., 1979, ECOLOGY VISION; Maddocks SA, 2001, GEN COMP ENDOCR, V124, P315, DOI 10.1006/gcen.2001.7718; McComb DM, 2010, PHYSIOL BIOCHEM ZOOL, V83, P299, DOI 10.1086/648394; Meyer-Rochow V.B., 1984, Zoologica (Stuttgart), V45, P1; Meyer-Rochow VB, 1997, 3 INT C PHYS SCI ST; MIALL RC, 1978, PHYSIOL ENTOMOL, V3, P99, DOI 10.1111/j.1365-3032.1978.tb00139.x; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; NOWAK LM, 1983, VISION RES, V23, P845, DOI 10.1016/0042-6989(83)90051-2; NUBOER JFW, 1992, BRIT POULTRY SCI, V33, P123, DOI 10.1080/00071669208417449; Orbach DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013912; PORCIATTI V, 1989, VISION RES, V29, P1693, DOI 10.1016/0042-6989(89)90151-X; Porter TC, 1902, P R SOC LONDON, V70, P313, DOI 10.1098/rspl.1902.0032; R Core Team, 2012, R LANG ENV STAT COMP; RENNER M, 1957, Z VERGL PHYSIOL, V40, P85, DOI 10.1007/BF00298152; Rodriguez A, 2012, ANIM CONSERV, V15, P519, DOI 10.1111/j.1469-1795.2012.00544.x; Rubene D, 2010, J EXP BIOL, V213, P3357, DOI 10.1242/jeb.042424; RUCK P, 1954, J GEN PHYSIOL, V37, P825, DOI 10.1085/jgp.37.6.825; RYDELL J, 1991, HOLARCTIC ECOL, V14, P203; RYDELL J, 1992, FUNCT ECOL, V6, P744, DOI 10.2307/2389972; Sandstrom M, 1997, J OCCUP ENVIRON MED, V39, P15, DOI 10.1097/00043764-199701000-00006; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Sekular R., 2002, PERCEPTION; SHIELDS EJ, 1980, ANN ENTOMOL SOC AM, V73, P74, DOI 10.1093/aesa/73.1.74; SHUMAKE SA, 1968, PSYCHOL REC, V18, P537, DOI 10.1007/BF03393804; Smith EL, 2005, VET REC, V157, P148, DOI 10.1136/vr.157.5.148; SRINIVASAN MV, 1984, J COMP PHYSIOL, V155, P297, DOI 10.1007/BF00610583; SYMMES D, 1962, SCIENCE, V136, P714, DOI 10.1126/science.136.3517.714; SYMS PR, 1987, ENTOMOL EXP APPL, V43, P81, DOI 10.1007/BF00350379; TANSLEY K, 1961, J CELL COMPAR PHYSL, V57, P11, DOI 10.1002/jcp.1030570104; Van Praagh JP, 1975, J APICULT RES, V11, P77; Veitch J. A., 1995, Lighting Research and Technology, V27, P243; WALLS G. L, 1934, AM J OPHTHALMOL, V17, P892, DOI DOI 10.1016/S0002-9394(34)93309-2; Waterman T.H., 1981, HDB SENSORY PHYSL, P281; WATTS FN, 1989, PSYCHOL MED, V19, P875, DOI 10.1017/S0033291700005596; WILKINS A, 1986, HUM FACTORS, V28, P75, DOI 10.1177/001872088602800108; Wilkins A. J., 1989, Lighting Research and Technology, V21, P11; WILLIAMS RA, 1985, PHYSIOL BEHAV, V34, P259, DOI 10.1016/0031-9384(85)90114-3; Woo K, 2009, NATURWISSENSCHAFTEN, V96, P415, DOI 10.1007/s00114-008-0491-8; Yu Y, 2011, OPHTHALMIC RES, V46, P80, DOI 10.1159/000323179	99	43	45	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98631	10.1371/journal.pone.0098631	http://dx.doi.org/10.1371/journal.pone.0098631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874801	Green Published, gold, Green Submitted			2022-12-25	WOS:000336790800054
J	Kawashita, E; Kanno, Y; Ikeda, K; Kuretake, H; Matsuo, O; Matsuno, H				Kawashita, Eri; Kanno, Yosuke; Ikeda, Kanako; Kuretake, Hiromi; Matsuo, Osamu; Matsuno, Hiroyuki			Altered Behavior in Mice with Deletion of the Alpha2-Antiplasmin Gene	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; LONG-TERM POTENTIATION; MAJOR SITE; LATE-PHASE; DEGRADATION; STRESS; ALPHA-2-ANTIPLASMIN; CONTRIBUTES; INHIBITOR; FIBROSIS	Background: The alpha 2-antiplasmin (alpha 2AP) protein is known to be a principal physiological inhibitor of plasmin, and is expressed in various part of the brain, including the hippocampus, cortex, hypothalamus and cerebellum, thus suggesting a potential role for alpha 2AP in brain functions. However, the involvement of alpha 2AP in brain functions is currently unclear. Objectives: The goal of this study was to investigate the effects of the deletion of the alpha 2AP gene on the behavior of mice. Methods: The motor function was examined by the wire hang test and rotarod test. To evaluate the cognitive function, a repeated rotarod test, Y-maze test, Morris water maze test, passive or shuttle avoidance test and fear conditioning test were performed. An open field test, dark/light transition test or tail suspension test was performed to determine the involvement of alpha 2AP in anxiety or depression-like behavior. Results and Conclusions: The alpha 2AP knockout (alpha 2AP(-/-)) mice exhibited impaired motor function compared with alpha 2AP(+/+) mice. The alpha 2AP(-/-) mice also exhibited impairments in motor learning, working memory, spatial memory and fear conditioning memory. Furthermore, the deletion of alpha 2AP induced anxiety-like behavior, and caused an anti-depression-like effect in tail suspension. Therefore, our findings suggest that alpha 2AP is a crucial mediator of motor function, cognitive function, anxiety-like behavior and depression-like behavior, providing new insights into the role of alpha 2AP in the brain functions.	[Kawashita, Eri; Kanno, Yosuke; Ikeda, Kanako; Kuretake, Hiromi; Matsuno, Hiroyuki] Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Dept Clin Pathol Biochem, Kyotanabe, Kyoto, Japan; [Matsuo, Osamu] Kinki Univ, Sch Med, Dept Physiol 2, Osakasayama, Osaka, Japan	Kindai University (Kinki University)	Kawashita, E (corresponding author), Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Dept Clin Pathol Biochem, Kyotanabe, Kyoto, Japan.	ekawashi@dwc.doshisha.ac.jp	MATSUO, OSAMU/AAM-9703-2020	Matsuo, Osamu/0000-0002-9806-2204	Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science [25830057]	Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science	This study was supported by Grants-in-Aid for Young Scientists (B, Grant Number 25830057), provided by the Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard S, 2012, J NEUROSCI, V32, P2002, DOI 10.1523/JNEUROSCI.1144-11.2012; Bahi A, 2012, EUR NEUROPSYCHOPHARM, V22, P672, DOI 10.1016/j.euroneuro.2012.01.008; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; BARICOS WH, 1995, KIDNEY INT, V47, P1039, DOI 10.1038/ki.1995.150; COLLEN D, 1976, EUR J BIOCHEM, V69, P209, DOI 10.1111/j.1432-1033.1976.tb10875.x; Collen D, 2001, Hematology Am Soc Hematol Educ Program, P1; Freeman R, 2014, BRAIN RES IN PRESS; Fujimoto S, 2008, J CEREBR BLOOD F MET, V28, P506, DOI 10.1038/sj.jcbfm.9600547; Ho-Tin-Noe B, 2009, MOL CELL NEUROSCI, V42, P288, DOI 10.1016/j.mcn.2009.08.001; HORTIN GL, 1988, BIOCHEM BIOPH RES CO, V155, P591, DOI 10.1016/S0006-291X(88)80535-7; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; Kanno Y, 2007, J THROMB HAEMOST, V5, P2266, DOI 10.1111/j.1538-7836.2007.02745.x; Kanno Y, 2013, ARTHRITIS RHEUM-US, V65, P492, DOI 10.1002/art.37767; Kanno Y, 2010, AM J PATHOL, V176, P238, DOI 10.2353/ajpath.2010.090150; Kawashita E, 2013, J NEUROCHEM, V126, P58, DOI 10.1111/jnc.12281; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Li J, 2013, P NATL ACAD IN PRESS, V110; Lu BGC, 2011, J BIOL CHEM, V286, P24544, DOI 10.1074/jbc.M111.229013; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Mannaioni G, 2008, J BIOL CHEM, V283, P20600, DOI 10.1074/jbc.M803015200; Menoud PA, 1996, J CLIN INVEST, V97, P2478, DOI 10.1172/JCI118694; Mizuhashi S, 2001, J NEUROSCI, V21, P6181, DOI 10.1523/JNEUROSCI.21-16-06181.2001; Nakagami Y, 2000, J NEUROSCI, V20, P2003; Okada K, 1997, THROMB HAEMOSTASIS, V78, P1104; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Parsons RG, 2013, NAT NEUROSCI, V16, P146, DOI 10.1038/nn.3296; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P18201, DOI 10.1073/pnas.0509232102; Pawlak R, 2002, NEUROSCIENCE, V113, P995, DOI 10.1016/S0306-4522(02)00166-5; Pawlak R, 2003, NAT NEUROSCI, V6, P168, DOI 10.1038/nn998; SAITO H, 1982, P NATL ACAD SCI-BIOL, V79, P5684, DOI 10.1073/pnas.79.18.5684; Seeds NW, 1999, P NATL ACAD SCI USA, V96, P14118, DOI 10.1073/pnas.96.24.14118; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Siuciak JA, 1997, PHARMACOL BIOCHEM BE, V56, P131, DOI 10.1016/S0091-3057(96)00169-4; Stout RW, 1996, AGE AGEING, V25, P256, DOI 10.1093/ageing/25.3.256; Yao Y, 2011, J CELL SCI, V124, P1486, DOI 10.1242/jcs.082834; Yuan HJ, 2009, J BIOL CHEM, V284, P12862, DOI 10.1074/jbc.M805123200	37	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97947	10.1371/journal.pone.0097947	http://dx.doi.org/10.1371/journal.pone.0097947			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874880	gold, Green Published, Green Submitted			2022-12-25	WOS:000336790800016
J	Muscatello, DJ; Amin, J; MacIntyre, CR; Newall, AT; Rawlinson, WD; Sintchenko, V; Gilmour, R; Thackway, S				Muscatello, David J.; Amin, Janaki; MacIntyre, C. Raina; Newall, Anthony T.; Rawlinson, William D.; Sintchenko, Vitali; Gilmour, Robin; Thackway, Sarah			Inaccurate Ascertainment of Morbidity and Mortality due to Influenza in Administrative Databases: A Population-Based Record Linkage Study	PLOS ONE			English	Article							NEW-SOUTH-WALES; SEASONAL INFLUENZA; RESPIRATORY-INFECTIONS; SURVEILLANCE; BURDEN; VACCINATION; DIAGNOSIS; HEALTH; ADULTS; DETERMINANTS	Background: Historically, counting influenza recorded in administrative health outcome databases has been considered insufficient to estimate influenza attributable morbidity and mortality in populations. We used database record linkage to evaluate whether modern databases have similar limitations. Methods: Person-level records were linked across databases of laboratory notified influenza, emergency department (ED) presentations, hospital admissions and death registrations, from the population (similar to 6.9 million) of New South Wales (NSW), Australia, 2005 to 2008. Results: There were 2568 virologically diagnosed influenza infections notified. Among those, 25% of 40 who died, 49% of 1451 with a hospital admission and 7% of 1742 with an ED presentation had influenza recorded on the respective database record. Compared with persons aged >= 65 years and residents of regional and remote areas, respectively, children and residents of major cities were more likely to have influenza coded on their admission record. Compared with older persons and admitted patients, respectively, working age persons and non-admitted persons were more likely to have influenza coded on their ED record. On both ED and admission records, persons with influenza type A infection were more likely than those with type B infection to have influenza coded. Among death registrations, hospital admissions and ED presentations with influenza recorded as a cause of illness, 15%, 28% and 1.4%, respectively, also had laboratory notified influenza. Time trends in counts of influenza recorded on the ED, admission and death databases reflected the trend in counts of virologically diagnosed influenza. Conclusions: A minority of the death, hospital admission and ED records for persons with a virologically diagnosed influenza infection identified influenza as a cause of illness. Few database records with influenza recorded as a cause had laboratory confirmation. The databases have limited value for estimating incidence of influenza outcomes, but can be used for monitoring variation in incidence over time.	[Muscatello, David J.; Gilmour, Robin; Thackway, Sarah] New South Wales Minist Hlth, Ctr Epidemiol & Evidence, Sydney, NSW, Australia; [Muscatello, David J.; MacIntyre, C. Raina; Newall, Anthony T.] Univ New S Wales, Sch Publ Hlth & Community Med, Kensington, NSW 2033, Australia; [Amin, Janaki] Univ New S Wales, Kirby Inst, Coogee, NSW, Australia; [Rawlinson, William D.] Prince Wales Hosp, South East Area Lab Serv, Randwick, NSW 2031, Australia; [Rawlinson, William D.] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia; [Sintchenko, Vitali] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia; [Sintchenko, Vitali] Ctr Infect Dis & Microbiol, Pathol West Inst Clin Pathol & Med Res, Westmead, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney; University of Sydney	Muscatello, DJ (corresponding author), New South Wales Minist Hlth, Ctr Epidemiol & Evidence, Sydney, NSW, Australia.	dmusc@doh.health.nsw.gov.au	Muscatello, David/AAD-9134-2019; Muscatello, David/HDO-2537-2022	Newall, Anthony/0000-0003-0836-1065; Sintchenko, Vitali/0000-0002-9261-3650; MacIntyre, C Raina/0000-0002-3060-0555; Amin, Janaki/0000-0003-2161-9366; Rawlinson, William/0000-0003-0988-7827	New South Wales Ministry of Health	New South Wales Ministry of Health	This work was supported by the New South Wales Ministry of Health (www.health.nsw.gov.au). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2010, 4390 0 PRIV HOSP AUS; Australian Bureau of Statistics, 2010, 1338 1 NSW STAT REG; Australian Bureau of Statistics, 2007, 1259 0 30 004 AUSTR; Australian Bureau of Statistics, 2010, 3218 0 REG POP GROWT; Babcock HM, 2006, INFECT CONT HOSP EP, V27, P266, DOI 10.1086/501539; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Centers for Disease Control and Prevention, 2013, OV INFL SURV US; Centre for Health Record Linkage, 2013, REC LINK WORKS; Cox B, 2010, INT J PUBLIC HEALTH, V55, P251, DOI 10.1007/s00038-010-0135-6; Doshi P, 2008, AM J PUBLIC HEALTH, V98, P939, DOI 10.2105/AJPH.2007.119933; FARR W, 1885, VITAL STATISTICS, P330; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Hampson AW, 2006, MED J AUSTRALIA, V185, pS39; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Harris MF, 2012, AUST HEALTH REV, V36, P325, DOI 10.1071/AH11080; Hiller KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073832; Horby PW, 2005, AUST NZ J PUBL HEAL, V29, P35, DOI 10.1111/j.1467-842X.2005.tb00745.x; Howard PF, 2013, INFLUENZA OTHER RESP, V7, P330, DOI 10.1111/j.1750-2659.2012.00395.x; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; Kelman CW, 2002, AUST NZ J PUBL HEAL, V26, P251, DOI 10.1111/j.1467-842X.2002.tb00682.x; Lemaitre M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-162; Macintyre CR, 2013, HEART; Memoli MJ, 2014, CLIN INFECT DIS, V58, P214, DOI 10.1093/cid/cit725; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Moore HC, 2013, J PEDIAT INFECT DIS; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Muscatello DJ, 2008, COMMUN DIS INTELL, V32, P435; Muscatello DJ, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-141; Mytton OT, 2012, EURO SURVEILL, V17, P20139; Nagata JM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-388; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Nicoll A, 2012, EURO SURVEILL, V3, P17; NSW Ministry of Health, 2013, NSW MIN HLTH ANN REP; Orsted I, 2013, INFLUENZA OTHER RESP, V7, P776, DOI 10.1111/irv.12093; Pitman RJ, 2007, J INFECTION, V54, P530, DOI 10.1016/j.jinf.2006.09.017; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Rothberg MB, 2010, CRIT CARE MED, V38, pE91, DOI 10.1097/CCM.0b013e3181c92eeb; Schanzer DL, 2013, INFLUENZA OTHER RESP, V7, P799, DOI 10.1111/irv.12011; Schindeler SK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-190; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Stein J, 2005, ANN EMERG MED, V46, P412, DOI 10.1016/j.annemergmed.2005.05.020; Takeuchi M, 2012, PEDIATR INFECT DIS J, V31, P368, DOI 10.1097/INF.0b013e318241ad06; Thompson WW, 2009, INFLUENZA OTHER RESP, V3, P37, DOI 10.1111/j.1750-2659.2009.00073.x; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; Williamson DA, 2012, INFECT CONT HOSP EP, V33, P1064, DOI 10.1086/667742; Zambon Maria, 2014, Medicine (Abingdon), V42, P45, DOI 10.1016/j.mpmed.2013.10.017; Zheng W, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-250	49	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98446	10.1371/journal.pone.0098446	http://dx.doi.org/10.1371/journal.pone.0098446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI3UR	24875306	Green Submitted, Green Published, gold			2022-12-25	WOS:000336790800040
J	Anderson, RC; Klofstad, CA; Mayew, WJ; Venkatachalam, M				Anderson, Rindy C.; Klofstad, Casey A.; Mayew, William J.; Venkatachalam, Mohan			Vocal Fry May Undermine the Success of Young Women in the Labor Market	PLOS ONE			English	Article							FORMANT FREQUENCIES INFLUENCE; VOICE PITCH; ATTRACTIVENESS; DOMINANCE; MEN; PREFERENCES; PERCEPTION; SPEAKERS; QUALITY	Vocal fry is speech that is low pitched and creaky sounding, and is increasingly common among young American females. Some argue that vocal fry enhances speaker labor market perceptions while others argue that vocal fry is perceived negatively and can damage job prospects. In a large national sample of American adults we find that vocal fry is interpreted negatively. Relative to a normal speaking voice, young adult female voices exhibiting vocal fry are perceived as less competent, less educated, less trustworthy, less attractive, and less hirable. The negative perceptions of vocal fry are stronger for female voices relative to male voices. These results suggest that young American females should avoid using vocal fry speech in order to maximize labor market opportunities.	[Anderson, Rindy C.; Klofstad, Casey A.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Klofstad, Casey A.] Univ Miami, Dept Polit Sci, Coral Gables, FL 33124 USA; [Mayew, William J.; Venkatachalam, Mohan] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA	Duke University; University of Miami; Duke University	Klofstad, CA (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	klofstad@gmail.com	Mayew, William/AAF-9570-2021	Mayew, William/0000-0001-7059-122X	Duke University; Fuqua School of Business; National Science Foundation [IOS-11-44991]	Duke University; Fuqua School of Business; National Science Foundation(National Science Foundation (NSF))	Duke University and the Fuqua School of Business provided financial and logistical support. R.C.A. was also supported by a grant from the National Science Foundation (IOS-11-44991). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051216; Bertrand M, 2010, AM ECON J-APPL ECON, V2, P228, DOI 10.1257/app.2.3.228; Boersma P., 2013, PRAAT DOING PHONETIC; Borkowska B, 2011, ANIM BEHAV, V82, P55, DOI 10.1016/j.anbehav.2011.03.024; Bruckert L, 2010, CURR BIOL, V20, P116, DOI 10.1016/j.cub.2009.11.034; Carney J, 2012, WALL STREET WOMEN IN; Chappelow C, 2012, VERBAL TICK DOOM WHY; CHILDERS DG, 1991, J ACOUST SOC AM, V90, P2394, DOI 10.1121/1.402044; Feinberg DR, 2008, PERCEPTION, V37, P615, DOI 10.1068/p5514; Feinberg DR, 2005, ANIM BEHAV, V69, P561, DOI 10.1016/j.anbehav.2004.06.012; Fraccaro PJ, 2013, ANIM BEHAV, V85, P127, DOI 10.1016/j.anbehav.2012.10.016; Hageman William, 2013, CHICAGO TRIBUNE; Harnsberger JD, 2010, J VOICE, V24, P523, DOI 10.1016/j.jvoice.2009.01.003; HOLLIEN H, 1966, J SPEECH HEAR RES, V9, P245, DOI 10.1044/jshr.0902.245; Hollien H, 1968, J ACOUST SOC AM, V3, P506; Jones BC, 2008, BIOL LETTERS, V4, P192, DOI 10.1098/rsbl.2007.0626; Jones BC, 2010, ANIM BEHAV, V79, P57, DOI 10.1016/j.anbehav.2009.10.003; Klofstad CA, 2012, P ROY SOC B-BIOL SCI, V279, P2698, DOI 10.1098/rspb.2012.0311; Lepore M, 2012, COULD VOCAL FRY GIVE; Mayew WJ, 2013, EVOL HUM BEHAV, V34, P243, DOI 10.1016/j.evolhumbehav.2013.03.001; Puts DA, 2011, PERS INDIV DIFFER, V50, P111, DOI 10.1016/j.paid.2010.09.011; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Redi L, 2001, J PHONETICS, V29, P407, DOI 10.1006/jpho.2001.0145; Shorten K, 2013, WOMEN USING VOCAL FR; Stulp G, 2013, LEADERSHIP QUART, V24, P159, DOI 10.1016/j.leaqua.2012.09.002; Tillotson K, 2012, SOME WOMEN VOCAL FRY; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Wolff SE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1673, DOI 10.1007/s00265-010-0981-5; Wolk L, 2012, J VOICE, V26, pE111, DOI 10.1016/j.jvoice.2011.04.007; Yuasa IP, 2010, AM SPEECH, V85, P315, DOI 10.1215/00031283-2010-018	31	52	52	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97506	10.1371/journal.pone.0097506	http://dx.doi.org/10.1371/journal.pone.0097506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4TS	24870387	Green Published, gold, Green Submitted			2022-12-25	WOS:000336858300013
J	Katzenberger, M; Hammond, J; Duarte, H; Tejedo, M; Calabuig, C; Relyea, RA				Katzenberger, Marco; Hammond, John; Duarte, Helder; Tejedo, Miguel; Calabuig, Cecilia; Relyea, Rick A.			Swimming with Predators and Pesticides: How Environmental Stressors Affect the Thermal Physiology of Tadpoles	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; REACTION NORMS; CLIMATE-CHANGE; ANURAN AMPHIBIANS; LIMITS DEPEND; TOLERANCE; ACCLIMATION; TEMPERATURE; MORPHOLOGY; IMPACT	To forecast biological responses to changing environments, we need to understand how a species's physiology varies through space and time and assess how changes in physiological function due to environmental changes may interact with phenotypic changes caused by other types of environmental variation. Amphibian larvae are well known for expressing environmentally induced phenotypes, but relatively little is known about how these responses might interact with changing temperatures and their thermal physiology. To address this question, we studied the thermal physiology of grey treefrog tadpoles (Hyla versicolor) by determining whether exposures to predator cues and an herbicide (Roundup) can alter their critical maximum temperature (CTmax) and their swimming speed across a range of temperatures, which provides estimates of optimal temperature (T-opt) for swimming speed and the shape of the thermal performance curve (TPC). We discovered that predator cues induced a 0.4 degrees C higher CTmax value, whereas the herbicide had no effect. Tadpoles exposed to predator cues or the herbicide swam faster than control tadpoles and the increase in burst speed was higher near T-opt. In regard to the shape of the TPC, exposure to predator cues increased T-opt by 1.5 degrees C, while exposure to the herbicide marginally lowered T-opt by 0.4 degrees C. Combining predator cues and the herbicide produced an intermediate T-opt that was 0.5 degrees C higher than the control. To our knowledge this is the first study to demonstrate a predator altering the thermal physiology of amphibian larvae (prey) by increasing CTmax, increasing the optimum temperature, and producing changes in the thermal performance curves. Furthermore, these plastic responses of CTmax and TPC to different inducing environments should be considered when forecasting biological responses to global warming.	[Katzenberger, Marco; Duarte, Helder; Tejedo, Miguel] Spanish Council Sci Res, Donana Biol Stn, Dept Evolutionary Ecol, Seville, Spain; [Hammond, John] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Calabuig, Cecilia] Fed Rural Univ Semiarid Reg, Dept Anim Sci, Mossoro, RN, Brazil; [Relyea, Rick A.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of New Mexico; Universidade Federal Rural do Semi-Arido (UFERSA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Katzenberger, M (corresponding author), Spanish Council Sci Res, Donana Biol Stn, Dept Evolutionary Ecol, Seville, Spain.	katzenberger@ebd.csic.es	calabuig, cecilia/AAG-6495-2021	calabuig, cecilia/0000-0002-1243-1700	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/60271/2009]; U.S. National Science Foundation (NSF)	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); U.S. National Science Foundation (NSF)(National Science Foundation (NSF))	This work was funded by a Fundacao para a Ciencia e Tecnologia (FCT; www.fct.pt) PhD fellowship (SFRH/BD/60271/2009) to MK and a U.S. National Science Foundation (NSF; www.nsf.gov) grant to RAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Arendt J, 2010, J MORPHOL, V271, P1044, DOI 10.1002/jmor.10851; Arendt JD, 2009, OECOLOGIA, V159, P455, DOI 10.1007/s00442-008-1210-z; Arnqvist G, 1998, ECOLOGY, V79, P1847, DOI 10.2307/176693; Barry MJ, 1998, J PLANKTON RES, V20, P1219, DOI 10.1093/plankt/20.7.1219; Barry MJ, 2000, J PLANKTON RES, V22, P1705, DOI 10.1093/plankt/22.9.1705; Barry MJ, 1999, ENVIRON POLLUT, V104, P217, DOI 10.1016/S0269-7491(98)00188-2; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; BRATTSTROM BH, 1968, COMP BIOCHEM PHYSIOL, V24, P93, DOI 10.1016/0010-406X(68)90961-4; Bronmark C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021773; Buckley LB, 2008, AM NAT, V171, pE1, DOI 10.1086/523949; CARRIER R, 1988, WATER RES, V22, P511, DOI 10.1016/0043-1354(88)90048-6; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Chown SL, 2010, CLIM RES, V43, P3, DOI 10.3354/cr00879; Chown SL, 2009, FUNCT ECOL, V23, P133, DOI 10.1111/j.1365-2435.2008.01481.x; Condon CH, 2010, J EXP BIOL, V213, P3705, DOI 10.1242/jeb.046979; David JR, 1997, J THERM BIOL, V22, P441, DOI 10.1016/S0306-4565(97)00063-6; Dayton GH, 2005, OIKOS, V111, P582, DOI 10.1111/j.1600-0706.2005.14340.x; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Domenici P, 2008, P ROY SOC B-BIOL SCI, V275, P195, DOI 10.1098/rspb.2007.1088; Duarte H, 2012, GLOBAL CHANGE BIOL, V18, P412, DOI 10.1111/j.1365-2486.2011.02518.x; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gilman SE, 2006, P NATL ACAD SCI USA, V103, P9560, DOI 10.1073/pnas.0510992103; Glennemeier KA, 2002, GEN COMP ENDOCR, V127, P16, DOI 10.1016/S0016-6480(02)00015-1; Gosner K. L., 1960, Herpetologica, V16, P183; Gvozdik L, 2008, J THERM BIOL, V33, P395, DOI 10.1016/j.jtherbio.2008.06.004; Gvozdik L, 2007, BIOL J LINN SOC, V90, P627, DOI 10.1111/j.1095-8312.2006.00752.x; Gvozdik L, 2006, EVOLUTION, V60, P2110; HANAZATO T, 1991, FRESHWATER BIOL, V26, P419, DOI 10.1111/j.1365-2427.1991.tb01408.x; Hanazato T, 1999, ENVIRON POLLUT, V105, P137, DOI 10.1016/S0269-7491(98)00203-6; Hayes TB, 2010, J EXP BIOL, V213, P921, DOI 10.1242/jeb.040865; Heath AG, 1997, ECOTOX ENVIRON SAFE, V37, P280, DOI 10.1006/eesa.1997.1563; Helmuth B, 2010, J EXP BIOL, V213, P995, DOI 10.1242/jeb.038463; Hoffmann AA, 2010, J EXP BIOL, V213, P870, DOI 10.1242/jeb.037630; Hopkins WA, 2005, ENVIRON POLLUT, V133, P531, DOI 10.1016/j.envpol.2004.06.014; Hua J, 2013, EVOL APPL, V6, P1028, DOI 10.1111/eva.12083; HUEY RB, 1979, AM ZOOL, V19, P357; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; HUTCHISON VICTOR H., 1961, PHYSIOL ZOOL, V34, P92; Izem R, 2005, AM NAT, V166, P277, DOI 10.1086/431314; Jones DK, 2011, ENVIRON TOXICOL CHEM, V30, P446, DOI 10.1002/etc.384; Jones DK, 2010, ENVIRON TOXICOL CHEM, V29, P2016, DOI 10.1002/etc.240; KATS LB, 1988, ECOLOGY, V69, P1865, DOI 10.2307/1941163; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kingsolver JG, 1998, AM ZOOL, V38, P545; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Lachenicht MW, 2010, J INSECT PHYSIOL, V56, P822, DOI 10.1016/j.jinsphys.2010.02.010; Learning in Motion Inc, 2004, MEAS MOT SOFTW V3 0; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; LYDY MJ, 1988, AQUAT TOXICOL, V12, P311, DOI 10.1016/0166-445X(88)90059-8; MAHONEY JJ, 1969, OECOLOGIA, V2, P143, DOI 10.1007/BF00379157; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Mitchell KA, 2010, FUNCT ECOL, V24, P694, DOI 10.1111/j.1365-2435.2009.01666.x; Navas CA, 2008, COMP BIOCHEM PHYS A, V151, P344, DOI 10.1016/j.cbpa.2007.07.003; Oda S, 2011, ENVIRON TOXICOL CHEM, V30, P232, DOI 10.1002/etc.378; Patra RW, 2007, ENVIRON TOXICOL CHEM, V26, P1454, DOI 10.1897/06-156R1.1; PETRANKA JW, 1987, ANIM BEHAV, V35, P420, DOI 10.1016/S0003-3472(87)80266-X; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; PORTER WP, 1969, ECOL MONOGR, V39, P227, DOI 10.2307/1948545; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Relyea RA, 2005, ECOLOGY, V86, P1723, DOI 10.1890/04-1920; Relyea RA, 2005, ECOL APPL, V15, P618, DOI 10.1890/03-5342; Relyea RA, 2003, ECOLOGY, V84, P1840, DOI 10.1890/0012-9658(2003)084[1840:PCAPGT]2.0.CO;2; Relyea RA, 2002, ECOLOGY, V83, P1953, DOI 10.2307/3071778; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Relyea RA, 2009, OECOLOGIA, V159, P363, DOI [10.1007/s00442-008-1141-8, 10.1007/s00442-008-1213-9]; Relyea RA, 2007, OECOLOGIA, V152, P389, DOI 10.1007/s00442-007-0675-5; Relyea RA, 2012, ECOL APPL, V22, P634, DOI 10.1890/11-0189.1; Relyea RA, 2009, ENVIRON TOXICOL CHEM, V28, P2004, DOI 10.1897/09-021.1; Rezende EL, 2011, FUNCT ECOL, V25, P111, DOI 10.1111/j.1365-2435.2010.01778.x; Rohlf FJ, 2010, TPSDIG VERSION 2 16; Rohlf FJ, 2010, TPSDIG2 DIGITIZE LAN; Sakamoto M, 2006, FRESHWATER BIOL, V51, P1974, DOI 10.1111/j.1365-2427.2006.01628.x; SHERMAN E, 1980, COMP BIOCHEM PHYS A, V65, P227, DOI 10.1016/0300-9629(80)90229-7; Smith JB, 2009, P NATL ACAD SCI USA, V106, P4133, DOI 10.1073/pnas.0812355106; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; Terblanche JS, 2011, J EXP BIOL, V214, P3713, DOI 10.1242/jeb.061283; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; The MathWorks Inc, 2009, MATLAB V7 8 STAT TOO; Van Buskirk J, 2000, J EXP BIOL, V203, P2149; Van Buskirk J, 2002, AM NAT, V160, P87, DOI 10.1086/340599; Van Damme R, 1999, ANIM BEHAV, V57, P347, DOI 10.1006/anbe.1998.0980; Wagner N, 2013, ENVIRON TOXICOL CHEM, V32, P1688, DOI 10.1002/etc.2268	83	29	30	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98265	10.1371/journal.pone.0098265	http://dx.doi.org/10.1371/journal.pone.0098265			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24869960	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000336858300030
J	Rutherford, JN; Demartelly, VA; Colon, DGL; Ross, CN; Tardif, SD				Rutherford, Julienne N.; Demartelly, Victoria A.; Colon, Donna G. Layne; Ross, Corinna N.; Tardif, Suzette D.			Developmental Origins of Pregnancy Loss in the Adult Female Common Marmoset Monkey (Callithrix jacchus)	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; CATCH-UP GROWTH; LITTER SIZE; INTRAUTERINE POSITION; METABOLIC SYNDROME; POSTNATAL-GROWTH; REDUCED UTERINE; BLOOD-PRESSURE; OVARIAN SIZE; BODY-WEIGHT	Background: The impact of the intrauterine environment on the developmental programming of adult female reproductive success is still poorly understood and potentially underestimated. Litter size variation in a nonhuman primate, the common marmoset monkey (Callithrix jacchus), allows us to model the effects of varying intrauterine environments (e.g. nutrient restriction, exposure to male womb-mates) on the risk of losing fetuses in adulthood. Our previous work has characterized the fetuses of triplet pregnancies as experiencing intrauterine nutritional restriction. Methodology/Principal Findings: We used over a decade of demographic data from the Southwest National Primate Research Center common marmoset colony. We evaluated differences between twin and triplet females in the number of pregnancies they produce and the proportion of those pregnancies that ended in fetal loss. We found that triplet females produced the same number of total offspring as twin females, but lost offspring during pregnancy at a significantly higher rate than did twins (38% vs. 13%, p = 0.02). Regardless of their own birth weight or the sex ratio of the litter the experienced as fetuses, triplet females lost more fetuses than did twins. Females with a male littermate experienced a significant increase in the proportion of stillbirths. Conclusions/Significance: These striking findings anchor pregnancy loss in the mother's own fetal environment and development, underscoring a "Womb to Womb" view of the lifecourse and the intergenerational consequences of development. This has important translational implications for understanding the large proportion of human stillbirths that are unexplained. Our findings provide strong evidence that a full understanding of mammalian life history and reproductive biology requires a developmental foundation.	[Rutherford, Julienne N.; Demartelly, Victoria A.] Univ Illinois, Coll Nursing, Dept Women Children & Family Hlth, Chicago, IL 60612 USA; [Rutherford, Julienne N.] Univ Illinois, Dept Anthropol, Chicago, IL USA; [Demartelly, Victoria A.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Colon, Donna G. Layne; Ross, Corinna N.] Texas Biomed Res Inst, Southwest Natl Primate Res Center, San Antonio, TX USA; [Ross, Corinna N.] Texas A&M Univ, San Antonio, TX USA; [Ross, Corinna N.; Tardif, Suzette D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Emory University; Rollins School Public Health; Texas Biomedical Research Institute; Texas A&M University System; University of Texas System; University of Texas Health San Antonio	Rutherford, JN (corresponding author), Univ Illinois, Coll Nursing, Dept Women Children & Family Hlth, Chicago, IL 60612 USA.	ruther4d@uic.edu		deMartelly, Victoria/0000-0002-4381-2418; Rutherford, Julienne/0000-0001-6536-6888	National Institutes of Health [R01-HD076018, R01-RR02022, R01-DK77639]; Office of Research Infrastructure Programs [P51 OD011133]; Southwest National Primate Research Center [P51-RR13986]; National Institute of Child Health and Human Development [K12HD055892]; National Institutes of Health Office of Research on Women's Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076018, K12HD055892] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR002022, P51RR013986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077639] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research Infrastructure Programs; Southwest National Primate Research Center; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH Office of Research on Women's Health (ORWH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The design, execution, and writing of the study was funded by National Institutes of Health grants R01-HD076018 (Rutherford), R01-RR02022 (Tardif), R01-DK77639 (Tardif & Power), Office of Research Infrastructure Programs/OD P51 OD011133 (previously P51-RR13986; Southwest National Primate Research Center), and K12HD055892 (Rutherford), a University of Illinois at Chicago Building Interdisciplinary Research Careers in Women's Health (BIRCWH) faculty scholarship from the National Institute of Child Health and Human Development and the National Institutes of Health Office of Research on Women's Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT DH, 1978, J REPROD FERTIL, V53, P155; Abbott DH, 2003, COMPARATIVE MED, V53, P339; Adair L, 2005, ANNU REV NUTR, V25, P407, DOI 10.1146/annurev.nutr.25.050304.092538; Adair LS, 2001, CIRCULATION, V104, P1034, DOI 10.1161/hc3401.095037; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Bales K, 2001, AM J PRIMATOL, V54, P211, DOI 10.1002/ajp.1031; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6; Birnie AK, 2012, HORM BEHAV, V62, P136, DOI 10.1016/j.yhbeh.2012.05.014; Burton G., 2011, PLACENTA HUMAN DEV P; CAMERON GN, 1973, J MAMMAL, V54, P489, DOI 10.2307/1379133; deKeyser N, 2012, HUM REPROD, V27, P1170, DOI 10.1093/humrep/der478; DIXSON AF, 1992, PATERNITY IN PRIMATES : GENETIC TESTS AND THEORIES, P192; Drickamer LC, 1996, ANIM BEHAV, V51, P925, DOI 10.1006/anbe.1996.0096; Drickamer LC, 1997, J ANIM SCI, V75, P2192; Emanuel I, 1997, AM J EPIDEMIOL, V146, P820; Fagerberg B, 2004, J INTERN MED, V256, P254, DOI 10.1111/j.1365-2796.2004.01361.x; Flenady V, 2011, LANCET, V377, P1331, DOI 10.1016/S0140-6736(10)62233-7; French JA, 2010, GEN COMP ENDOCR, V165, P309, DOI 10.1016/j.ygcen.2009.07.015; GAMA LT, 1991, J ANIM SCI, V69, P2727, DOI 10.2527/1991.6972727x; Godfrey K M, 2001, Public Health Nutr, V4, P611; Goldschmidt B., 2005, Israel Journal of Veterinary Medicine, V60, P86; Harris RA, 2014, P NATL ACAD SCI USA, V111, P1467, DOI 10.1073/pnas.1316037111; Hoet JJ, 1999, J PHYSIOL-LONDON, V514, P617, DOI 10.1111/j.1469-7793.1999.617ad.x; Humphries MM, 2000, ECOLOGY, V81, P2867, DOI 10.2307/177347; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Ibanez L, 2003, HUM REPROD, V18, P1565, DOI 10.1093/humrep/deg351; Ibanez L, 2000, PEDIATR RES, V47, P575, DOI 10.1203/00006450-200005000-00003; Isachenko EF, 2002, J MED PRIMATOL, V31, P350, DOI 10.1034/j.1600-0684.2002.t01-1-02002.x; JAQUISH CE, 1991, AM J PHYS ANTHROPOL, V84, P291, DOI 10.1002/ajpa.1330840306; Jaquish CE, 1997, AM J PRIMATOL, V42, P269, DOI 10.1002/(SICI)1098-2345(1997)42:4<269::AID-AJP2>3.0.CO;2-V; Lu KD, 2011, J PERINATOL, V31, P504, DOI 10.1038/jp.2010.198; LUKE B, 1992, J REPROD MED, V37, P661; Lumey LH, 1997, AM J PUBLIC HEALTH, V87, P1962, DOI 10.2105/AJPH.87.12.1962; Mellado M, 2011, ANIM PROD SCI, V51, P144, DOI 10.1071/AN10112; Mesiano S, 1997, ENDOCR REV, V18, P378, DOI 10.1210/er.18.3.378; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Ostendorf ALG, 2013, INT J LEGAL MED, V127, P447, DOI 10.1007/s00414-012-0727-1; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Power ML, 2006, AM J PRIMATOL, V68, P181, DOI 10.1002/ajp.20215; Price KC, 2000, HUM REPROD, V15, P452, DOI 10.1093/humrep/15.2.452; Rutherford JN, 2009, PLACENTA, V30, P105, DOI 10.1016/j.placenta.2008.10.010; Rutherford JN, 2008, AM J PHYS ANTHROPOL, V137, P60, DOI 10.1002/ajpa.20846; Rutherford JN, 2009, AM J HUM BIOL, V21, P745, DOI 10.1002/ajhb.20923; Rutherford JN, 2009, AM J PRIMATOL, V71, P969, DOI 10.1002/ajp.20739; SAAL FSV, 1985, BIOL REPROD, V32, P1116, DOI 10.1095/biolreprod32.5.1116; Sanchez-Morgado JM, 2003, COMPARATIVE MED, V53, P539; Savage A, 2009, AM J PRIMATOL, V71, P707, DOI 10.1002/ajp.20696; Sibley CP, 2005, PEDIATR RES, V58, P827, DOI 10.1203/01.PDR.0000181381.82856.23; Smith A, 2013, BUILDING BABIES PRIM; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Smucny DA, 2004, AM J PRIMATOL, V64, P107, DOI 10.1002/ajp.20065; Stearns S.C., 1992, pi; Tardif S, 2012, AM J PHYS A IN PRESS; Tardif SD, 1997, AM J PRIMATOL, V42, P323, DOI 10.1002/(SICI)1098-2345(1997)42:4<323::AID-AJP7>3.0.CO;2-Z; Tardif SD, 2004, AM J PRIMATOL, V62, P83, DOI 10.1002/ajp.20009; Tardif SD, 2003, COMPARATIVE MED, V53, P364; Tardif SD, 2002, ETHOLOGY, V108, P825, DOI 10.1046/j.1439-0310.2002.00815.x; TARDIF SD, 1994, ANN NY ACAD SCI, V709, P214, DOI 10.1111/j.1749-6632.1994.tb30405.x; VANDENBERGH JG, 1995, LAB ANIM SCI, V45, P567; VOMSAAL FS, 1990, BIOL REPROD, V43, P751, DOI 10.1095/biolreprod43.5.751; White PC, 2006, J CLIN INVEST, V116, P872, DOI 10.1172/JCI28296	62	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e96845	10.1371/journal.pone.0096845	http://dx.doi.org/10.1371/journal.pone.0096845			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871614	Green Published, Green Submitted, gold			2022-12-25	WOS:000336858300005
J	Leijon, S; Magnusson, AK				Leijon, Sara; Magnusson, Anna K.			Physiological Characterization of Vestibular Efferent Brainstem Neurons Using a Transgenic Mouse Model	PLOS ONE			English	Article							CHOLINE-ACETYLTRANSFERASE GENE; MEDIAL OLIVOCOCHLEAR NEURONS; SEMICIRCULAR CANAL AFFERENTS; NERVE AFFERENTS; OPSANUS-TAU; ULTRASTRUCTURAL ANALYSIS; POTASSIUM CHANNELS; CRISTAE AMPULLARES; PYRAMIDAL NEURONS; COCHLEAR NUCLEUS	The functional role of efferent innervation of the vestibular end-organs in the inner ear remains elusive. This study provides the first physiological characterization of the cholinergic vestibular efferent (VE) neurons in the brainstem by utilizing a transgenic mouse model, expressing eGFP under a choline-acetyltransferase (ChAT)-locus spanning promoter in combination with targeted patch clamp recordings. The intrinsic electrical properties of the eGFP-positive VE neurons were compared to the properties of the lateral olivocochlear (LOC) brainstem neurons, which gives rise to efferent innervation of the cochlea. Both VE and the LOC neurons were marked by their negative resting membrane potential <-75 mV and their passive responses in the hyperpolarizing range. In contrast, the response properties of VE and LOC neurons differed significantly in the depolarizing range. When injected with positive currents, VE neurons fired action potentials faithfully to the onset of depolarization followed by sparse firing with long inter-spike intervals. This response gave rise to a low response gain. The LOC neurons, conversely, responded with a characteristic delayed tonic firing upon depolarizing stimuli, giving rise to higher response gain than the VE neurons. Depolarization triggered large TEA insensitive outward currents with fast inactivation kinetics, indicating A-type potassium currents, in both the inner ear-projecting neuronal types. Immunohistochemistry confirmed expression of Kv4.3 and 4.2 ion channel subunits in both the VE and LOC neurons. The difference in spiking responses to depolarization is related to a two-fold impact of these transient outward currents on somatic integration in the LOC neurons compared to in VE neurons. It is speculated that the physiological properties of the VE neurons might be compatible with a wide-spread control over motion and gravity sensation in the inner ear, providing likewise feed-back amplification of abrupt and strong phasic signals from the semi-circular canals and of tonic signals from the gravito-sensitive macular organs.	[Leijon, Sara; Magnusson, Anna K.] Karolinska Inst, Ctr Hearing & Commun Res, Stockholm, Sweden; [Leijon, Sara; Magnusson, Anna K.] Karolinska Univ Hosp, Dept Clin Sci Intervent & Technol, Unit Audiol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Magnusson, AK (corresponding author), Karolinska Inst, Ctr Hearing & Commun Res, Stockholm, Sweden.	anna.magnusson@ki.se			Swedish Research Council [80326601]; Horselskadades Riksforbund; Stiftelsen Tysta Skolan Institute; Karolinska Institute	Swedish Research Council(Swedish Research CouncilEuropean Commission); Horselskadades Riksforbund; Stiftelsen Tysta Skolan Institute; Karolinska Institute(Karolinska Institutet)	This work was supported by grants from the Swedish Research Council grant no. 80326601, Horselskadades Riksforbund, Stiftelsen Tysta Skolan and Karolinska Institutets. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam TJ, 1999, EXP BRAIN RES, V124, P489, DOI 10.1007/s002210050645; ASCHOFF A, 1987, J COMP NEUROL, V264, P56, DOI 10.1002/cne.902640106; Birinyi A, 2001, BRAIN RES, V921, P44, DOI 10.1016/S0006-8993(01)03075-X; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; BOYLE R, 1990, J NEUROSCI, V10, P1570; Boyle R, 2009, J NEUROPHYSIOL, V102, P1513, DOI 10.1152/jn.91367.2008; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; Brown MC, 2008, NEUROSCIENCE, V154, P147, DOI 10.1016/j.neuroscience.2007.12.045; BROWN MC, 1993, J COMP NEUROL, V337, P600, DOI 10.1002/cne.903370406; CAMPBELL JP, 1988, HEARING RES, V35, P271, DOI 10.1016/0378-5955(88)90124-4; CARPENTER MB, 1987, BRAIN RES, V408, P275, DOI 10.1016/0006-8993(87)90387-8; Castellano-Munoz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013777; Chen XX, 2004, J PHYSIOL-LONDON, V559, P187, DOI 10.1113/jphysiol.2004.068114; Chi FL, 2007, NEUROENDOCRINOLOGY, V85, P131, DOI 10.1159/000101959; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; Cooper NP, 2006, J PHYSIOL-LONDON, V576, P49, DOI 10.1113/jphysiol.2006.114991; Cullen KE, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-11-j0002.2002; Darrow KN, 2006, NAT NEUROSCI, V9, P1474, DOI 10.1038/nn1807; Dodson PD, 2004, TRENDS NEUROSCI, V27, P210, DOI 10.1016/j.tins.2004.02.012; Felix RA, 2013, J NEUROPHYSIOL, V109, P2691, DOI 10.1152/jn.01041.2012; Fitzakerley JL, 2000, HEARING RES, V147, P31, DOI 10.1016/S0378-5955(00)00118-0; Fujino K, 1997, J NEUROPHYSIOL, V77, P2788, DOI 10.1152/jn.1997.77.5.2788; GACEK RR, 1974, ACTA OTO-LARYNGOL, V77, P92, DOI 10.3109/00016487409124603; GACEK RR, 1969, ACTA OTO-LARYNGOL, VS, P1; GOLDBERG JM, 1980, J NEUROPHYSIOL, V43, P986, DOI 10.1152/jn.1980.43.4.986; HIGHSTEIN SM, 1986, J COMP NEUROL, V243, P309, DOI 10.1002/cne.902430303; HIGHSTEIN SM, 1985, J NEUROPHYSIOL, V54, P370, DOI 10.1152/jn.1985.54.2.370; HIGHSTEIN SM, 1992, ANN NY ACAD SCI, V656, P108, DOI 10.1111/j.1749-6632.1992.tb25203.x; Holt JC, 2006, J NEUROSCI, V26, P13180, DOI 10.1523/JNEUROSCI.3539-06.2006; Jacob RG, 2001, CURR OPIN NEUROL, V14, P41, DOI 10.1097/00019052-200102000-00007; Jamali M, 2009, J NEUROPHYSIOL, V101, P141, DOI 10.1152/jn.91066.2008; Jerng HH, 1999, J GEN PHYSIOL, V113, P641, DOI 10.1085/jgp.113.5.641; Johnston J, 2008, EUR J NEUROSCI, V27, P1391, DOI 10.1111/j.1460-9568.2008.06116.x; KORTE GE, 1979, J COMP NEUROL, V184, P279, DOI 10.1002/cne.901840205; Lasker DM, 2008, JARO-J ASSOC RES OTO, V9, P334, DOI 10.1007/s10162-008-0120-4; Lendvai B, 2011, NEUROCHEM INT, V59, P150, DOI 10.1016/j.neuint.2011.05.015; Li C, 2005, NEUROSCI LETT, V385, P36, DOI 10.1016/j.neulet.2005.05.024; LI YP, 1993, J NEUROCHEM, V61, P748; LONNERBERG P, 1995, P NATL ACAD SCI USA, V92, P4046, DOI 10.1073/pnas.92.9.4046; Lysakowski A, 1997, J COMP NEUROL, V389, P419, DOI 10.1002/(SICI)1096-9861(19971222)389:3<419::AID-CNE5>3.0.CO;2-3; Lysakowski A, 2008, J COMP NEUROL, V511, P47, DOI 10.1002/cne.21827; Marcus DA, 2005, EXPERT OPIN PHARMACO, V6, P2691, DOI 10.1517/14656566.6.15.2691; Marlinski V, 2004, JARO-J ASSOC RES OTO, V5, P126, DOI 10.1007/s10162-003-4029-7; McCrea RA, 1999, J NEUROPHYSIOL, V82, P416, DOI 10.1152/jn.1999.82.1.416; MCCUE MP, 1994, J NEUROSCI, V14, P6071; Metts BA, 2006, EXP BRAIN RES, V172, P261, DOI 10.1007/s00221-005-0328-z; Minor LB, 1998, OTOLARYNG HEAD NECK, V118, pS5, DOI 10.1016/S0194-5998(98)70002-6; MISAWA H, 1992, J BIOL CHEM, V267, P20392; Murakami DM, 2002, P NATL ACAD SCI USA, V99, P17078, DOI 10.1073/pnas.252652299; Naciff JM, 1999, J NEUROCHEM, V72, P17, DOI 10.1046/j.1471-4159.1999.0720017.x; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Plotnik M, 2005, JARO-J ASSOC RES OTO, V6, P311, DOI 10.1007/s10162-005-0010-y; Purcell IM, 1997, J NEUROPHYSIOL, V78, P3234, DOI 10.1152/jn.1997.78.6.3234; Rabbitt RD, 2011, CURR OPIN OTOLARYNGO, V19, P376, DOI 10.1097/MOO.0b013e32834a5be1; Raphael Y, 2003, BRAIN RES BULL, V60, P397, DOI 10.1016/S0361-9230(03)00047-9; Roy JE, 2001, J NEUROSCI, V21, P2131, DOI 10.1523/JNEUROSCI.21-06-02131.2001; Rusznak Z, 2008, J HISTOCHEM CYTOCHEM, V56, P443, DOI 10.1369/jhc.2008.950303; Sadeghi SG, 2007, J NEUROPHYSIOL, V97, P1503, DOI 10.1152/jn.00829.2006; Sadeghi SG, 2009, J NEUROPHYSIOL, V101, P988, DOI 10.1152/jn.91112.2008; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; SHIMAZU H, 1966, J NEUROPHYSIOL, V29, P467, DOI 10.1152/jn.1966.29.3.467; Sterenborg JC, 2010, HEARING RES, V270, P119, DOI 10.1016/j.heares.2010.08.013; STORM JF, 1989, J PHYSIOL-LONDON, V409, P171, DOI 10.1113/jphysiol.1989.sp017491; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; Svirskis G, 2002, J NEUROSCI, V22, P11019; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006; Trifonov S, 2009, NEUROSCIENCE, V159, P344, DOI 10.1016/j.neuroscience.2008.12.054; Tzingounis AV, 2008, P NATL ACAD SCI USA, V105, P19974, DOI 10.1073/pnas.0810535105; Yao WP, 1998, MICROSC RES TECHNIQ, V41, P270, DOI 10.1002/(SICI)1097-0029(19980501)41:3<270::AID-JEMT10>3.0.CO;2-L; Yuan WL, 2005, J NEUROSCI, V25, P9185, DOI 10.1523/JNEUROSCI.2858-05.2005	70	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98277	10.1371/journal.pone.0098277	http://dx.doi.org/10.1371/journal.pone.0098277			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867596	gold, Green Published, Green Submitted			2022-12-25	WOS:000336914100045
J	Nombela, C; Nombela, M; Castell, P; Garcia, T; Lopez-Coronado, J; Herrero, MT				Nombela, Cristina; Nombela, Manuel; Castell, Pedro; Garcia, Teodoro; Lopez-Coronado, Juan; Trinidad Herrero, Maria			Alpha-Theta Effects Associated with Ageing during the Stroop Test	PLOS ONE			English	Article							COLOR-WORD TEST; ANTERIOR CINGULATE; WORKING-MEMORY; ORBITOFRONTAL CORTEX; ERROR NEGATIVITY; COUNTING STROOP; AGE-DIFFERENCES; INTERFERENCE; TASK; PERFORMANCE	The Stroop effect is considered as a standard attentional measure to study conflict resolution in humans. The response of the brain to conflict is supposed to change over time and it is impaired in certain pathological conditions. Neuropsychological Stroop test measures have been complemented with electroencephalography (EEG) techniques to evaluate the mechanisms in the brain that underlie conflict resolution from the age of 20 to 70. To study the changes in EEG activity during life, we recruited a large sample of healthy subjects of different ages that included 90 healthy individuals, divided by age into decade intervals, which performed the Stroop test while recording a 14 channel EEG. The results highlighted an interaction between age and stimulus that was focused on the prefrontal (Alpha and Theta band) and Occipital (Alpha band) areas. We concluded that behavioural Stroop interference is directly influenced by opposing Alpha and Theta activity and evolves across the decades of life.	[Nombela, Cristina; Castell, Pedro; Trinidad Herrero, Maria] Univ Murcia, Sch Med, Clin & Expt Neurosci NiCE CIBERNED, Murcia, Spain; [Nombela, Cristina] Univ Cambridge, Clin Neurosci Dept, Cambridge, England; [Nombela, Manuel] Nuestra Sra del Rosell Hosp, Dept Neurophysiol, Murcia, Spain; [Garcia, Teodoro; Lopez-Coronado, Juan] Tech Univ Cartagena, Dept Syst Engn & Automat, Murcia, Spain; [Trinidad Herrero, Maria] Univ Jaume 1, Sch Hlth Sci Med, Clin & Expt Neurosci NiCE CIBERNED, Castellon de La Plana, Spain	CIBERNED; University of Murcia; University of Cambridge; Universidad Politecnica de Cartagena; CIBERNED; Universitat Jaume I	Nombela, C (corresponding author), Univ Murcia, Sch Med, Clin & Expt Neurosci NiCE CIBERNED, Murcia, Spain.	cn331@cam.ac.uk	Otero, Cristina Nombela/AAA-1463-2019	HERRERO, MARIA TRINIDAD/0000-0003-4953-1446; Nombela Otero, Cristina/0000-0002-9806-2351	IRENE project, D.G. de Investigacion, Region of Murcia, Spain [BIO-MED 07/01/0006]; PHARMACOG-European Community [115009]; CIBERNED (Spanish Network of Research on Neurodegeneratives Diseases)	IRENE project, D.G. de Investigacion, Region of Murcia, Spain; PHARMACOG-European Community; CIBERNED (Spanish Network of Research on Neurodegeneratives Diseases)	This work was supported by BIO-MED 07/01/0006 (IRENE project, D.G. de Investigacion, Region of Murcia, Spain) to CN, PHARMACOG-European Community's Seventh Framework Program (FP7/2007-2013) for the Innovative Medicine Initiative under Grant Agreement No. 115009 and CIBERNED (Spanish Network of Research on Neurodegeneratives Diseases) to MTH and AAL actions from the Spanish Ministry of Industry (EXOLEGS project) to JLC and TG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova LG, 2012, ALZ DIS ASSOC DIS, V26, P17, DOI 10.1097/WAD.0b013e3182163b62; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Barbas H, 2007, ANN NY ACAD SCI, V1121, P10, DOI 10.1196/annals.1401.015; BARRON SA, 1976, NEUROLOGY, V26, P1011, DOI 10.1212/WNL.26.11.1011; Bondi MW, 2002, NEUROPSYCHOLOGY, V16, P335, DOI 10.1037//0894-4105.16.3.335; Bugg JM, 2007, AGING NEUROPSYCHOL C, V14, P155, DOI 10.1080/138255891007065; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Carlsson A, 1978, Adv Exp Med Biol, V113, P1; Carp J, 2009, PSYCHOPHYSIOLOGY, V46, P336, DOI 10.1111/j.1469-8986.2008.00773.x; COMALLI PE, 1962, J GENET PSYCHOL, V100, P47, DOI 10.1080/00221325.1962.10533572; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Davidson DJ, 2003, AGING NEUROPSYCHOL C, V10, P85, DOI 10.1076/anec.10.2.85.14463; DULANEY CL, 1994, J EXP PSYCHOL LEARN, V20, P470, DOI 10.1037/0278-7393.20.2.470; Eppinger B, 2007, BIOL PSYCHOL, V75, P52, DOI 10.1016/j.biopsycho.2006.12.001; Gigaux J, 2013, SCHIZOPHR RES, V143, P297, DOI 10.1016/j.schres.2012.11.019; GLASER MO, 1982, J EXP PSYCHOL HUMAN, V8, P875, DOI 10.1037/0096-1523.8.6.875; Heflin LH, 2011, NEUROPSYCHOLOGY, V25, P655, DOI 10.1037/a0023863; Hsu JL, 2008, NEUROIMAGE, V39, P566, DOI 10.1016/j.neuroimage.2007.09.017; JOSEPH JA, 1978, J GERONTOL, V33, P643, DOI 10.1093/geronj/33.5.643; Kawasaki M, 2010, EUR J NEUROSCI, V31, P1683, DOI 10.1111/j.1460-9568.2010.07217.x; Kim C, 2010, NEUROSCI LETT, V476, P156, DOI 10.1016/j.neulet.2010.04.019; Maiea-Lerenc J, 2009, INT J PSYCHOPHYSIOL, V71, P248, DOI 10.1016/j.ijpsycho.2008.10.005; Markela-Lerenc J, 2004, COGNITIVE BRAIN RES, V18, P278, DOI 10.1016/j.cogbrainres.2003.10.013; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; Nombela Cristina, 2011, Front Neurol, V2, P82, DOI 10.3389/fneur.2011.00082; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palva S, 2011, J NEUROSCI, V31, P5013, DOI 10.1523/JNEUROSCI.5592-10.2011; Petrides M, 2007, ANN NY ACAD SCI, V1121, P33, DOI 10.1196/annals.1401.035; Pompei F, 2011, NEUROIMAGE, V57, P576, DOI 10.1016/j.neuroimage.2011.04.055; PRIBRAM KH, 1953, J NEUROPHYSIOL, V16, P324, DOI 10.1152/jn.1953.16.3.324; Price JL, 2007, ANN NEW YORK ACAD SC; Raghavachari S, 2006, J NEUROPHYSIOL, V95, P1630, DOI 10.1152/jn.00409.2005; Restak R, 2012, BRAIN COMPLETE MIND; Rosenfeld JP, 2006, INT J PSYCHOPHYSIOL, V60, P240, DOI 10.1016/j.ijpsycho.2005.05.010; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Sauseng P, 2009, CURR BIOL, V19, P1846, DOI 10.1016/j.cub.2009.08.062; Schack B, 1999, J NEUROSCI METH, V93, P49, DOI 10.1016/S0165-0270(99)00117-X; Schack B, 1999, CLIN NEUROPHYSIOL, V110, P1410, DOI 10.1016/S1388-2457(99)00111-X; Schack B, 1999, INT J PSYCHOPHYSIOL, V31, P219, DOI 10.1016/S0167-8760(98)00052-X; Scholes KE, 2007, NEUROPSYCHOPHARMACOL, V32, P1600, DOI 10.1038/sj.npp.1301262; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tsujimoto T, 2006, J NEUROPHYSIOL, V95, P2987, DOI 10.1152/jn.00730.2005; Vidal F, 2003, BIOL PSYCHOL, V64, P265, DOI 10.1016/S0301-0511(03)00097-8; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0; West R, 1997, NEUROPSYCHOLOGY, V11, P421, DOI 10.1037/0894-4105.11.3.421; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Wright BC, 2003, BRIT J PSYCHOL, V94, P475, DOI 10.1348/000712603322503042; YAKOVLEV P I, 1962, Res Publ Assoc Res Nerv Ment Dis, V39, P3	49	8	8	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e95657	10.1371/journal.pone.0095657	http://dx.doi.org/10.1371/journal.pone.0095657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867024	Green Published, gold, Green Submitted			2022-12-25	WOS:000336914100002
J	Quinones, RM; Holyoak, M; Johnson, ML; Moyle, PB				Quinones, Rebecca M.; Holyoak, Marcel; Johnson, Michael L.; Moyle, Peter B.			Potential Factors Affecting Survival Differ by Run-Timing and Location: Linear Mixed-Effects Models of Pacific Salmonids (Oncorhynchus spp.) in the Klamath River, California	PLOS ONE			English	Article							DENSITY-DEPENDENT MORTALITY; MAXIMUM REPRODUCTIVE RATE; CLIMATE VARIABILITY; MARINE SURVIVAL; POPULATIONS; RECRUITMENT; IMPACTS; STOCK; FISH; LIFE	Understanding factors influencing survival of Pacific salmonids (Oncorhynchus spp.) is essential to species conservation, because drivers of mortality can vary over multiple spatial and temporal scales. Although recent studies have evaluated the effects of climate, habitat quality, or resource management (e. g., hatchery operations) on salmonid recruitment and survival, a failure to look at multiple factors simultaneously leaves open questions about the relative importance of different factors. We analyzed the relationship between ten factors and survival (1980-2007) of four populations of salmonids with distinct life histories from two adjacent watersheds (Salmon and Scott rivers) in the Klamath River basin, California. The factors were ocean abundance, ocean harvest, hatchery releases, hatchery returns, Pacific Decadal Oscillation, North Pacific Gyre Oscillation, El Nino Southern Oscillation, snow depth, flow, and watershed disturbance. Permutation tests and linear mixed-effects models tested effects of factors on survival of each taxon. Potential factors affecting survival differed among taxa and between locations. Fall Chinook salmon O. tshawytscha survival trends appeared to be driven partially or entirely by hatchery practices. Trends in three taxa (Salmon River spring Chinook salmon, Scott River fall Chinook salmon; Salmon River summer steelhead trout O. mykiss) were also likely driven by factors subject to climatic forcing (ocean abundance, summer flow). Our findings underscore the importance of multiple factors in simultaneously driving population trends in widespread species such as anadromous salmonids. They also show that the suite of factors may differ among different taxa in the same location as well as among populations of the same taxa in different watersheds. In the Klamath basin, hatchery practices need to be reevaluated to protect wild salmonids.	[Quinones, Rebecca M.; Johnson, Michael L.; Moyle, Peter B.] Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA; [Holyoak, Marcel] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Quinones, RM (corresponding author), Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA.	rmquinones@ucdavis.edu	Holyoak, Marcel/C-3475-2009	Holyoak, Marcel/0000-0001-9727-3627	Klamath National Forest; CALPCC (California Association for Licenced Professional Clinical Counselors)	Klamath National Forest; CALPCC (California Association for Licenced Professional Clinical Counselors)	Partial funding was provided by the Klamath National Forest and the CALPCC (California Association for Licenced Professional Clinical Counselors). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achord S, 2003, ECOL LETT, V6, P335, DOI 10.1046/j.1461-0248.2003.00438.x; Alvarez LHR, 1998, MATH BIOSCI, V152, P63, DOI 10.1016/S0025-5564(98)10018-4; Anderson D.R., 2008, MODEL BASED INFERENC; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; [Anonymous], 1999, REV SYNTHESIS EFFECT; Araki H, 2009, BIOL LETTERS, V5, P621, DOI 10.1098/rsbl.2009.0315; Azumaya Tomonori, 2000, North Pacific Anadromous Fish Commission Bulletin, V2, P165; Barrowman NJ, 2000, CAN J FISH AQUAT SCI, V57, P665, DOI 10.1139/cjfas-57-4-665; Bartholow JM, 2005, N AM J FISH MANAGE, V25, P152, DOI 10.1577/M04-007.1; Battin J, 2007, P NATL ACAD SCI USA, V104, P6720, DOI 10.1073/pnas.0701685104; Beamish RJ, 1997, ICES J MAR SCI, V54, P1200, DOI 10.1006/jmsc.1997.0305; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; BEAMISH RJ, 1993, CAN J FISH AQUAT SCI, V50, P1002, DOI 10.1139/f93-116; Beechie T, 2006, BIOL CONSERV, V130, P560, DOI 10.1016/j.biocon.2006.01.019; Bjorkstedt EP, 2000, CAN J FISH AQUAT SCI, V57, P459, DOI 10.1139/cjfas-57-2-459; Box GEP, 2008, TIME SERIES ANAL FOR, DOI DOI 10.1002/9781118619193; Bradford MJ, 2000, CAN J FISH AQUAT SCI, V57, P13, DOI 10.1139/cjfas-57-1-13; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Busby PJ, 1994, STATUS REV KLAMATH M; California Hatchery Scientific Review Group, 2012, CAL HATCH REV REV; Chenillat F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062281; Chilcote S, 2013, SPRING CHINOOK S FOR; CLARK CW, 1974, J CONSEIL, V36, P7; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; COHEN D, 1968, J ECOL, V56, P219, DOI 10.2307/2258075; COLE LC, 1954, Q REV BIOL, V29, P103, DOI 10.1086/400074; Cooney RT, 1998, B MAR SCI, V62, P443; Costello CJ, 1998, AM J AGR ECON, V80, P765, DOI 10.2307/1244062; Den Boer P. J., 1968, Acta Biotheoretica, V18, P165; Di Lorenzo E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032838; DiLorenzo E, 2013, N PACIFIC GYRE OSCIL; Drake D. J., 2000, California Agriculture, V54, P46, DOI 10.3733/ca.v054n06p46; Elder D, 2002, SALMON RIVER SUBBASI; Finney BP, 2000, SCIENCE, V290, P795, DOI 10.1126/science.290.5492.795; FISHER JP, 1988, CAN J FISH AQUAT SCI, V45, P1036, DOI 10.1139/f88-127; Foott JS, 2011, CONCEPTUAL MODEL DIS; Greene CM, 2004, CAN J FISH AQUAT SCI, V61, P590, DOI 10.1139/F04-024; Greene CM, 2010, BIOL LETTERS, V6, P382, DOI 10.1098/rsbl.2009.0780; Groot C, 1991, PACIFIC SALMON LIFE; Gustafson R, 2006, PACIFIC SALMON EXTIN, P24; Hard JJ, 2008, EVOL APPL, V1, P388, DOI 10.1111/j.1752-4571.2008.00020.x; Healey MC, 1995, AM FISH S S, V17, P176; Holt CA, 2010, ICES J MAR SCI, V67, P2018, DOI 10.1093/icesjms/fsq117; Hoopa Valley Tribal Fisheries Department Yurok Tribal Fisheries Department, 1999, 1998 KLAM RIV FALL C; Hubbart JA, 2007, FOREST SCI, V53, P169; Isaak DJ, 2007, ECOL APPL, V17, P352, DOI 10.1890/05-1949; Johnson RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028880; Kaeriyama M, 2004, 5 NPAFC; Katz J, 2013, ENVIRON BIOL FISH, V96, P1169, DOI 10.1007/s10641-012-9974-8; Klamath River Technical Advisory Team, 2005, KLAM RIV FALL CHIN A; Klamath River Technical Advisory Team, 2008, KLAM RIV FALL CHIN A; Klamath River Technical Advisory Team, 2011, KLAM RIV FALL CHIN A; Klamath River Technical Advisory Team, 2004, KLAM RIV FALL CHIN A; Klamath River Technical Advisory Team, 2006, KLAM RIV FALL CHIN A; Klamath River Technical Advisory Team, 2012, KLAM RIV FALL CHIN A; Klamath River Technical Advisory Team, 2013, KLAM RIV FALL CHIN A; Klamath River Technical Advisory Team, 2010, KLAM RIV FALL CHIN A; Klamath River Technical Advisory Team, 2007, KLAM RIV FALL CHIN A; Kostow K, 2009, REV FISH BIOL FISHER, V19, P9, DOI 10.1007/s11160-008-9087-9; Lackey RT, 2003, REV FISH SCI, V11, P35, DOI 10.1080/16226510390856529; Lehodey P, 2006, J CLIMATE, V19, P5009, DOI 10.1175/JCLI3898.1; Levin PS, 2001, P ROY SOC B-BIOL SCI, V268, P1153, DOI 10.1098/rspb.2001.1634; LICHATOWICH J, 1995, FISHERIES, V20, P10, DOI 10.1577/1548-8446(1995)020<0010:AATTDA>2.0.CO;2; Lynch M, 2001, CONSERV GENET, V2, P363, DOI 10.1023/A:1012550620717; Mahnken C., 1998, NORTH PAC ANADROMOUS, V1, P38; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Mantua NJ, 2013, PACIFIC DECADAL OSCI; MARSCHALL EA, 1995, CAN J FISH AQUAT SCI, V52, P136, DOI 10.1139/f95-013; Marshall M, 1996, 1995 KLAMATH RIVER F; McCann KS, 2003, CAN J FISH AQUAT SCI, V60, P971, DOI 10.1139/F03-078; MCGURK BJ, 1995, ENVIRON MANAGE, V19, P609, DOI 10.1007/BF02471972; McKelvey R., 2003, Risk and uncertainty in environmental and natural resource economics, P93; Menning K, 1996, SIERRA NEVADA ECOSYS, P33; Milner NJ, 2003, FISH RES, V62, P111, DOI 10.1016/S0165-7836(02)00157-1; Moore JW, 2010, CONSERV LETT, V3, P340, DOI 10.1111/j.1755-263X.2010.00119.x; Moyle P, 2008, SALMON STEELHEAD TRO; Moyle P.B., 2002, INLAND FISHES CALIFO; Myers J. M., 1998, STATUS REV CHINOOK S; Myers RA, 1999, CAN J FISH AQUAT SCI, V56, P2404, DOI 10.1139/cjfas-56-12-2404; Myers RA, 2004, SCIENCE, V303, P1980, DOI 10.1126/science.1095410; Myers RA, 1997, CAN J FISH AQUAT SCI, V54, P2449, DOI 10.1139/cjfas-54-10-2449; Myers RA, 2001, ICES J MAR SCI, V58, P937, DOI 10.1006/jmsc.2001.1109; MYERS RA, 1995, CAN J FISH AQUAT SCI, V52, P223, DOI 10.1139/f95-022; Myers RA, 1996, FISH B-NOAA, V94, P707; MYERS RA, 1993, CAN J FISH AQUAT SCI, V50, P1576, DOI 10.1139/f93-179; Naish KA, 2008, ADV MAR BIOL, V53, P61, DOI 10.1016/S0065-2881(07)53002-6; National Research Council, 2004, END THREAT FISH KLAM; NCRWQCB, 2005, TOT MAX DAIL LOAD TE; NCRWQCB, 2005, STAFF REP ACT PLAN S; NEAVE FERRIS, 1953, JOUR FISH RES BD CANADA, V9, P450; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; Nichols K, 2007, MONITORING INCIDENCE; Nielsen JL, 2008, AM FISHERIES SOC S, V71, P1; Olson AD, 1996, FRESHWATER REARING S; PETERMAN RM, 1978, J FISH RES BOARD CAN, V35, P1434, DOI 10.1139/f78-226; PETERMAN RM, 1984, CAN J FISH AQUAT SCI, V41, P1825, DOI 10.1139/f84-223; Peterman RM, 2000, CAN J FISH AQUAT SCI, V57, P181, DOI 10.1139/cjfas-57-1-181; Petrosky CE, 2001, CAN J FISH AQUAT SCI, V58, P1196, DOI 10.1139/cjfas-58-6-1196; Post JR, 2002, FISHERIES, V27, P6, DOI 10.1577/1548-8446(2002)027&lt;0006:CRF&gt;2.0.CO;2; Quinones RM, 2014, ENVIRON BIOL FISH, V97, P233, DOI 10.1007/s10641-013-0146-2; Quinones RM, 2011, RECOVERY PACIFIC SAL; Ray RA, 2012, J PARASITOL, V98, P520, DOI 10.1645/JP-GE-2737.1; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Rose KA, 2001, FISH FISH, V2, P293, DOI 10.1046/j.1467-2960.2001.00056.x; Rosenfeld J, 2000, CAN J FISH AQUAT SCI, V57, P766, DOI 10.1139/cjfas-57-4-766; Ruggerone GT, 2003, FISH OCEANOGR, V12, P209, DOI 10.1046/j.1365-2419.2003.00239.x; Schtickzelle N, 2007, FISH FISH, V8, P297, DOI 10.1111/j.1467-2979.2007.00256.x; Sharma R, 2001, CAN J FISH AQUAT SCI, V58, P1453, DOI 10.1139/cjfas-58-7-1453; Stone R., 2008, COMP SUSCEPTIBILITY; Sullivan CM, 1989, JUVENILE LIFE HIST A; Suttle KB, 2004, ECOL APPL, V14, P969, DOI 10.1890/03-5190; Trenberth KE, 1997, B AM METEOROL SOC, V78, P2771, DOI 10.1175/1520-0477(1997)078<2771:TDOENO>2.0.CO;2; Walters C, 1998, CAN J FISH AQUAT SCI, V55, P2533, DOI 10.1139/cjfas-55-12-2533; WALTERS CJ, 1981, CAN J FISH AQUAT SCI, V38, P704, DOI 10.1139/f81-093; Waples RS, 2009, ECOL SOC, V14; Weitkamp L.A., 1995, STATUS REV COHO SALM; WOLTER K, 2010, MULTIVARIATE ENSO IN; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336; Young KA, 1999, CAN J FISH AQUAT SCI, V56, P1700, DOI 10.1139/cjfas-56-9-1700; Yurok Tribal Fisheries Department Hoopa Valley Tribal Fisheries Department, 2000, 1999 KLAM RIV FALL C; Zabel RW, 2006, CONSERV BIOL, V20, P190, DOI 10.1111/j.1523-1739.2005.00300.x	122	7	8	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98392	10.1371/journal.pone.0098392	http://dx.doi.org/10.1371/journal.pone.0098392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24866173	Green Published, Green Submitted, gold			2022-12-25	WOS:000336914100056
J	Wei, SP; Roessler, BC; Chauvet, S; Guo, JY; Hartman, JL; Kirk, KL				Wei, Shipeng; Roessler, Bryan C.; Chauvet, Sylvain; Guo, Jingyu; Hartman, John L.; Kirk, Kevin L.			Conserved Allosteric Hot Spots in the Transmembrane Domains of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels and Multidrug Resistance Protein (MRP) Pumps	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; ATP-BINDING; CHLORIDE CHANNEL; ABC TRANSPORTERS; A-LOOP; MODEL; HYDROLYSIS; MECHANISM; CASSETTE; PEPTIDE	ATP-binding cassette (ABC) transporters are an ancient family of transmembrane proteins that utilize ATPase activity to move substrates across cell membranes. The ABCC subfamily of the ABC transporters includes active drug exporters (the multidrug resistance proteins (MRPs)) and a unique ATP-gated ion channel (cystic fibrosis transmembrane conductance regulator (CFTR)). The CFTR channel shares gating principles with conventional ligand-gated ion channels, but the allosteric network that couples ATP binding at its nucleotide binding domains (NBDs) with conformational changes in its transmembrane helices (TMs) is poorly defined. It is also unclear whether the mechanisms that govern CFTR gating are conserved with the thermodynamically distinct MRPs. Here we report a new class of gain of function (GOF) mutation of a conserved proline at the base of the pore-lining TM6. Multiple substitutions of this proline promoted ATP-free CFTR activity and activation by the weak agonist, 5' -adenylyl-beta,gamma-imidodiphosphate (AMP-PNP). TM6 proline mutations exhibited additive GOF effects when combined with a previously reported GOF mutation located in an outer collar of TMs that surrounds the pore-lining TMs. Each TM substitution allosterically rescued the ATP sensitivity of CFTR gating when introduced into an NBD mutant with defective ATP binding. Both classes of GOF mutations also rescued defective drug export by a yeast MRP (Yor1p) with ATP binding defects in its NBDs. We conclude that the conserved TM6 proline helps set the energy barrier to both CFTR channel opening and MRP-mediated drug efflux and that CFTR channels and MRP pumps utilize similar allosteric mechanisms for coupling conformational changes in their translocation pathways to ATP binding at their NBDs.	[Wei, Shipeng; Roessler, Bryan C.; Chauvet, Sylvain; Kirk, Kevin L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Guo, Jingyu; Hartman, John L.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Kirk, Kevin L.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Kirk, Kevin L.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kirk, KL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, 982B MCLM,1720 2nd Ave S, Birmingham, AL 35294 USA.	klkirk@uab.edu	Guo, Jingyu/M-9024-2017	Guo, Jingyu/0000-0001-6498-9848; Chauvet, Sylvain/0000-0002-7440-613X; Hartman, John/0000-0003-1176-6469	National Institutes of Health [RO1 DK056796]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008111] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK056796 (to K. L. K.).	Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aleksandrov AA, 2009, J PHYSIOL-LONDON, V587, P2875, DOI 10.1113/jphysiol.2009.170258; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Ambudkar SV, 2006, FEBS LETT, V580, P1049, DOI 10.1016/j.febslet.2005.12.051; Auerbach A, 2012, J PHYSIOL-LONDON, V590, P93, DOI 10.1113/jphysiol.2011.214684; Bai YH, 2010, J GEN PHYSIOL, V136, P293, DOI 10.1085/jgp.201010480; Ballesteros JA, 2000, BIOPHYS J, V79, P2754, DOI 10.1016/S0006-3495(00)76514-3; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Booth CL, 2000, BIOCHEMISTRY-US, V39, P5518, DOI 10.1021/bi992931x; Bozoky Z, 2013, P NATL ACAD SCI USA, V110, pE4427, DOI 10.1073/pnas.1315104110; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; Chang YC, 1999, BIOPHYS J, V77, P2542, DOI 10.1016/S0006-3495(99)77089-X; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Che Y, 2006, BIOPOLYMERS, V81, P392, DOI 10.1002/bip.20431; Chen J, 2012, J PHYS CHEM B, V116, P9346, DOI 10.1021/jp3042846; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Demchuk E, 1997, FOLD DES, V2, P35, DOI 10.1016/S1359-0278(97)00004-7; El-Sheikh AAK, 2008, MOL PHARMACOL, V74, P964, DOI 10.1124/mol.107.043661; Galzi JL, 1996, P NATL ACAD SCI USA, V93, P1853, DOI 10.1073/pnas.93.5.1853; Gaudet R, 2001, TECHNOL REV, V104, P20; Gentzsch M, 2007, J CELL SCI, V120, P447, DOI 10.1242/jcs.03350; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang TC, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a009498; Katzmann DJ, 1999, MOL CELL BIOL, V19, P2998; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; Kim IW, 2006, BIOCHEMISTRY-US, V45, P7605, DOI 10.1021/bi060308o; Kirk KL, 2011, J BIOL CHEM, V286, P12813, DOI 10.1074/jbc.R111.219634; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Louie RJ, 2012, GENOME MED, V4, DOI 10.1186/gm404; Mallis RJ, 2002, NAT STRUCT BIOL, V9, P900, DOI 10.1038/nsb864; McCarty NA, 2001, AM J PHYSIOL-LUNG C, V281, pL852, DOI 10.1152/ajplung.2001.281.4.L852; Meng HY, 2006, BIOPOLYMERS, V84, P192, DOI 10.1002/bip.20382; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Norimatsu Y, 2012, BIOCHEMISTRY-US, V51, P2199, DOI 10.1021/bi201888a; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Okeyo G, 2013, J BIOL CHEM, V288, P17122, DOI 10.1074/jbc.M112.442582; Qian F, 2011, PFLUG ARCH EUR J PHY, V462, P559, DOI 10.1007/s00424-011-0998-2; Qin L, 2008, BIOCHEMISTRY-US, V47, P13952, DOI 10.1021/bi801532g; Rahman KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074574; Rosenberg MF, 2011, J BIOL CHEM, V286, P42647, DOI 10.1074/jbc.M111.292268; Shah NA, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-3; Singh I, 2009, GENETICS, V181, P289, DOI 10.1534/genetics.108.092981; Szentpetery Z, 2004, ANTICANCER RES, V24, P449; Szollosi A, 2010, J GEN PHYSIOL, V136, P407, DOI 10.1085/jgp.201010434; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Tsai MF, 2010, J GEN PHYSIOL, V135, P399, DOI 10.1085/jgp.201010399; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Yuan YR, 2001, J BIOL CHEM, V276, P32313, DOI 10.1074/jbc.M100758200; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhou M, 1999, P NATL ACAD SCI USA, V96, P10466, DOI 10.1073/pnas.96.18.10466; Zhou Z, 2006, J GEN PHYSIOL, V128, P413, DOI 10.1085/jgp.200609622	66	16	16	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19942	19957		10.1074/jbc.M114.562116	http://dx.doi.org/10.1074/jbc.M114.562116			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24876383	Green Published, hybrid			2022-12-25	WOS:000339395200012
J	Goudjil, S; Imestouren, F; Armougon, A; Razafimanantsoa, L; Mahmoudzadeh, M; Wallois, F; Leke, A; Kongolo, G				Goudjil, Sabrina; Imestouren, Fatiha; Armougon, Aurelie; Razafimanantsoa, Lucie; Mahmoudzadeh, Mahdi; Wallois, Fabrice; Leke, Andre; Kongolo, Guy			Noninvasive Technique for the Diagnosis of Patent Ductus Arteriosus in Premature Infants by Analyzing Pulse Wave Phases on Photoplethysmography Signals Measured in the Right Hand and the Left Foot	PLOS ONE			English	Article							LEFT-VENTRICULAR OUTPUT; PRETERM INFANTS; PERIPHERAL-CIRCULATION; INTENSIVE-CARE; TRANSIT-TIME; PRESSURE; OXIMETRY; SHUNT	Objective: To evaluate the impact of patent ductus arteriosus (PDA) on the pulse phase difference (PPD) between the left foot (postductal region) and the right hand (preductal region). Materials and Methods: PPD was determined from arterial photoplethysmography signals (pulse waves) measured by infrared sensors routinely used for pulse oximetry in 56 premature infants less than 32 weeks gestation. Only infants with significant PDA (sPDA) diagnosed by echocardiography were treated with ibuprofen (for 3 days). Patients were classified according to whether or not they responded (Success/Failure) to this treatment. The Control group was composed of infants in whom ductus had already closed spontaneously at the time of the first echocardiography. The 3 groups were compared in terms of PPD at the beginning (T1) and at the end (T2) of the study. For patients in the Failure (n = 17) and Success groups (n = 18), T1 corresponded to the first day of treatment and T2 to the day after completion of the course of ibuprofen. In the Control group (n = 21), T1 corresponded to 1 to 3 days of life (DOL), and T2 to 4-6 DOL. Results: Compared to the Control group, PPD was higher in the Failure (at T1 and T2) and Success (at T1) groups characterized by sPDA. After ibuprofen therapy, PPD in the Success group decreased to about the level observed in the Control group. The area under the ROC curve of PPD for the diagnosis of sPDA was 0.98 (95% CI 0.96-1); for an optimal cutoff of PPD >= 1.65 deg/cm, the sensitivity was 94.2% and the specificity was 98.3%. Conclusion: In this study, PPD was correlated with ductus arteriosus status evaluated by echocardiography, indicating involvement of the ductal shunt in the mechanism of redistribution in systemic vascular territories. PPD can be considered for the diagnosis of hemodynamically significant PDA.	[Goudjil, Sabrina; Imestouren, Fatiha; Armougon, Aurelie; Leke, Andre; Kongolo, Guy] Amiens Univ Hosp, Neonatal Intens Care Unit, Amiens, France; [Razafimanantsoa, Lucie] Amiens Univ Hosp, Amiens, France; [Goudjil, Sabrina; Mahmoudzadeh, Mahdi; Wallois, Fabrice; Kongolo, Guy] Jules Verne Univ Picardie, GRAMFC, INSERM U1105, Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Goudjil, S (corresponding author), Amiens Univ Hosp, Neonatal Intens Care Unit, Amiens, France.	goudsab2002@yahoo.fr						AGATA Y, 1994, PEDIATR RES, V36, P805, DOI 10.1203/00006450-199412000-00022; Ahn JH, 2011, KOREAN J FAM MED, V32, P406, DOI 10.4082/kjfm.2011.32.7.406; Allen J, 2007, PHYSIOL MEAS, V28, pR1, DOI 10.1088/0967-3334/28/3/R01; Armitage P, 2002, STAT METHODS MED RES, P43; Beuchee A, 2003, PFLUG ARCH EUR J PHY, V446, P154, DOI 10.1007/s00424-002-0961-3; Caro C, 2012, MECH CIRCULATION, P268; Cheung YF, 2004, ARCH DIS CHILD, V89, P217, DOI 10.1136/adc.2003.025999; Chowienczyk PJ, 1999, J AM COLL CARDIOL, V34, P2007, DOI 10.1016/S0735-1097(99)00441-6; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; De Felice C, 2004, EARLY HUM DEV, V78, P45, DOI 10.1016/j.earlhumdev.2004.03.003; de-Wahl Granelli Anne, 2009, BMJ, V338, pa3037, DOI 10.1136/bmj.a3037; El Hajjar M, 2005, ARCH DIS CHILD-FETAL, V90, pF419, DOI 10.1136/adc.2003.027698; Evans N, 1996, ARCH DIS CHILD-FETAL, V75, pF183, DOI 10.1136/fn.75.3.F183; EVANS N, 1994, J PEDIATR-US, V125, P778, DOI 10.1016/S0022-3476(94)70078-8; Evans N, 2008, HEMODYNAMICS CARDIOL, P83; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FREYSCHUSS U, 1986, CLIN SCI, V70, P199, DOI 10.1042/cs0700199; Fung Y, 1981, BIOMECHANICS MECH PR, P282; Hiedl S, 2010, J PEDIATR-US, V156, P191, DOI 10.1016/j.jpeds.2009.08.034; Hoodbhoy SA, 2009, J PEDIATR-US, V154, P196, DOI 10.1016/j.jpeds.2008.07.051; Huang NE, 1999, ANNU REV FLUID MECH, V31, P417, DOI 10.1146/annurev.fluid.31.1.417; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Kelly RP, 2001, HYPERTENSION, V37, P1429, DOI 10.1161/01.HYP.37.6.1429; Landsverk SA, 2008, ANESTHESIOLOGY, V109, P849, DOI 10.1097/ALN.0b013e3181895f9f; Lo MT, 2008, EURASIP J ADV SIG PR, DOI 10.1155/2008/785243; Millasseau SC, 2000, HYPERTENSION, V36, P952, DOI 10.1161/01.HYP.36.6.952; OISHI M, 1993, PEDIATR RES, V33, P653, DOI 10.1203/00006450-199306000-00024; Oppenheimer A, 1989, DISCRETE TIME SIGNAL; Pagani J, 2003, CHEST, V124, P1487, DOI 10.1378/chest.124.4.1487; Peters J, 2001, INTENS CARE MED, V27, P1446, DOI 10.1007/s001340101034; Philips, 2007, MAN UT MON PAT INTEL; POLOGE JA, 1987, INT ANESTHESIOL CLIN, V25, P137, DOI 10.1097/00004311-198702530-00009; SHEREBRIN MH, 1990, IEEE T BIO-MED ENG, V37, P313, DOI 10.1109/10.52332; SHIMADA S, 1994, J PEDIATR-US, V125, P270, DOI 10.1016/S0022-3476(94)70210-1; Skinner J, 2000, ECHOCARDIOGRAPHY NEO, P151; Smith RP, 1999, THORAX, V54, P452, DOI 10.1136/thx.54.5.452; Stoica P, 2005, SPECTRAL ANAL SIGNAL, P4; Szpinda M, 2007, ANN ANAT, V189, P465, DOI 10.1016/j.aanat.2007.01.007; Teixeira LS, 2006, ACTA PAEDIATR, V95, P394, DOI 10.1080/08035250500482271; Wang JJ, 2004, J BIOMECH, V37, P457, DOI 10.1016/j.jbiomech.2003.09.007; Yasmin, 1999, QJM-INT J MED, V92, P595, DOI 10.1093/qjmed/92.10.595; Zuppa AA, 2014, J MATERN-FETAL NEO M, V0, P1	42	6	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98763	10.1371/journal.pone.0098763	http://dx.doi.org/10.1371/journal.pone.0098763			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892695	Green Published, gold, Green Submitted			2022-12-25	WOS:000336911400089
J	Ali, H; Ries, MI; Lankhorst, PP; van der Hoeven, RAM; Schouten, OL; Noga, M; Hankemeier, T; van Peij, NNME; Bovenberg, RAL; Vreeken, RJ; Driessen, AJM				Ali, Hazrat; Ries, Marco I.; Lankhorst, Peter P.; van der Hoeven, Rob A. M.; Schouten, Olaf L.; Noga, Marek; Hankemeier, Thomas; van Peij, Noel N. M. E.; Bovenberg, Roel A. L.; Vreeken, Rob J.; Driessen, Arnold J. M.			A Non-Canonical NRPS Is Involved in the Synthesis of Fungisporin and Related Hydrophobic Cyclic Tetrapeptides in Penicillium chrysogenum	PLOS ONE			English	Article							ASSEMBLY-LINE ENZYMOLOGY; ADENYLATION DOMAIN; SYNTHETASE; YERSINIABACTIN; BIOSYNTHESIS; EXPRESSION; PURIFICATION; BIOGENESIS; POLYKETIDE; GENES	The filamentous fungus Penicillium chrysogenum harbors an astonishing variety of nonribosomal peptide synthetase genes, which encode proteins known to produce complex bioactive metabolites from simple building blocks. Here we report a novel non-canonical tetra-modular nonribosomal peptide synthetase (NRPS) with microheterogenicity of all involved adenylation domains towards their respective substrates. By deleting the putative gene in combination with comparative metabolite profiling various unique cyclic and derived linear tetrapeptides were identified which were associated with this NRPS, including fungisporin. In combination with substrate predictions for each module, we propose a mechanism for a 'trans-acting' adenylation domain.	[Ali, Hazrat; Driessen, Arnold J. M.] Univ Groningen, Zernike Inst Adv Mat, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Ali, Hazrat; Driessen, Arnold J. M.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Ries, Marco I.; Noga, Marek; Hankemeier, Thomas; Vreeken, Rob J.] Leiden Univ, Leiden Acad Ctr Drug Res, Div Analyt Biosci, Leiden, Netherlands; [Lankhorst, Peter P.; van der Hoeven, Rob A. M.; Schouten, Olaf L.; van Peij, Noel N. M. E.; Bovenberg, Roel A. L.] DSM Biotechnol Ctr, Delft, Netherlands; [Noga, Marek; Hankemeier, Thomas; Vreeken, Rob J.] Leiden Univ, Netherlands Metabol Ctr, Leiden, Netherlands; [Bovenberg, Roel A. L.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	University of Groningen; Leiden University; Leiden University - Excl LUMC; DSM NV; Leiden University; Leiden University - Excl LUMC; University of Groningen	Driessen, AJM (corresponding author), Univ Groningen, Zernike Inst Adv Mat, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands.	a.j.m.driessen@rug.nl	Vreeken, Rob/AAA-4563-2021; Noga, Marek/O-4983-2016; Institute, Zernike/W-7033-2019; Hankemeier, Thomas/V-5407-2019; Driessen, Arnold J.M./D-1876-2012	Noga, Marek/0000-0001-8352-611X; Hankemeier, Thomas/0000-0001-7871-2073; Vreeken, Rob/0000-0003-3568-1371; Driessen, Arnold J.M./0000-0001-9258-9104; Lankhorst, Peter/0000-0002-0373-5673	STW (Stichting Technische Wetenschappen) in the framework of the Genbiotics Perspectief Programme; Higher education commission Pakistan (HEC)	STW (Stichting Technische Wetenschappen) in the framework of the Genbiotics Perspectief Programme; Higher education commission Pakistan (HEC)(Higher Education Commission of Pakistan)	HA and MR were supported by STW (Stichting Technische Wetenschappen) in the framework of the Genbiotics Perspectief Programme. HA was also supported by Higher education commission Pakistan (HEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065328; ALVAREZ E, 1987, ANTIMICROB AGENTS CH, V31, P1675, DOI 10.1128/AAC.31.11.1675; Baltz RH, 2011, J IND MICROBIOL BIOT, V38, P1747, DOI 10.1007/s10295-011-1022-8; Bleiholder C, 2008, J AM CHEM SOC, V130, P17774, DOI 10.1021/ja805074d; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Doekel S, 2008, MICROBIOL-SGM, V154, P2872, DOI 10.1099/mic.0.2008/020685-0; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Frisvad JC, 2004, STUD MYCOL, P201; Gao X, 2012, NAT CHEM BIOL, V8, P823, DOI 10.1038/NCHEMBIO.1047; Garcia-Estrada C, 2011, CHEM BIOL, V18, P1499, DOI 10.1016/j.chembiol.2011.08.012; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P11637, DOI 10.1021/bi9812571; Gehring AM, 1998, CHEM BIOL, V5, P573, DOI 10.1016/S1074-5521(98)90115-6; Grunewald J, 2006, MICROBIOL MOL BIOL R, V70, P121, DOI 10.1128/MMBR.70.1.121-146.2006; Harju S, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-8; Keating TA, 2001, CHEMBIOCHEM, V2, P99, DOI 10.1002/1439-7633(20010202)2:2<99::AID-CBIC99>3.0.CO;2-3; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; KOLAR M, 1988, GENE, V62, P127, DOI 10.1016/0378-1119(88)90586-0; Kovalchuk A, 2012, METHODS MOL BIOL, V835, P1, DOI 10.1007/978-1-61779-501-5_1; MIYAO K, 1960, B AGR CHEM SOC JAPAN, V24, P23, DOI 10.1080/03758397.1960.10857626; Mootz HD, 2002, CHEMBIOCHEM, V3, P490, DOI 10.1002/1439-7633(20020603)3:6<490::AID-CBIC490>3.0.CO;2-N; Nijland JG, 2008, FUNGAL GENET BIOL, V45, P1415, DOI 10.1016/j.fgb.2008.07.008; Noga MJ, 2012, METABOLOMICS, V8, P253, DOI 10.1007/s11306-011-0306-3; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Perez-Victoria I, 2012, J NAT PROD, V75, P1210, DOI 10.1021/np3000987; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Shaw-Reid CA, 1999, CHEM BIOL, V6, P385, DOI 10.1016/S1074-5521(99)80050-7; Stevens BW, 2006, BIOCHEMISTRY-US, V45, P15495, DOI 10.1021/bi061788m; STUDER RO, 1969, EXPERIENTIA, V25, P899, DOI 10.1007/BF01898048; Sussmuth R, 2011, NAT PROD REP, V28, P99, DOI 10.1039/c001463j; Suo ZC, 2001, P NATL ACAD SCI USA, V98, P99, DOI 10.1073/pnas.021537498; van den Berg MA, 2008, NAT BIOTECHNOL, V26, P1161, DOI 10.1038/nbt.1498; Wyatt MA, 2012, CHEMBIOCHEM, V13, P2408, DOI 10.1002/cbic.201200340; Zhang K, 2013, CHEM BIOL, V20, P92, DOI 10.1016/j.chembiol.2012.10.020	36	28	29	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98212	10.1371/journal.pone.0098212	http://dx.doi.org/10.1371/journal.pone.0098212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887561	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300047
J	Biswas, PK; Islam, MZ; Debnath, NC; Yamage, M				Biswas, Paritosh K.; Islam, Md. Zohorul; Debnath, Nitish C.; Yamage, Mat			Modeling and Roles of Meteorological Factors in Outbreaks of Highly Pathogenic Avian Influenza H5N1	PLOS ONE			English	Article							VIRUS; CHICKENS; PATTERNS	The highly pathogenic avian influenza A virus subtype H5N1 (HPAI H5N1) is a deadly zoonotic pathogen. Its persistence in poultry in several countries is a potential threat: a mutant or genetically reassorted progenitor might cause a human pandemic. Its world-wide eradication from poultry is important to protect public health. The global trend of outbreaks of influenza attributable to HPAI H5N1 shows a clear seasonality. Meteorological factors might be associated with such trend but have not been studied. For the first time, we analyze the role of meteorological factors in the occurrences of HPAI outbreaks in Bangladesh. We employed autoregressive integrated moving average (ARIMA) and multiplicative seasonal autoregressive integrated moving average (SARIMA) to assess the roles of different meteorological factors in outbreaks of HPAI. Outbreaks were modeled best when multiplicative seasonality was incorporated. Incorporation of any meteorological variable(s) as inputs did not improve the performance of any multivariable models, but relative humidity (RH) was a significant covariate in several ARIMA and SARIMA models with different autoregressive and moving average orders. The variable cloud cover was also a significant covariate in two SARIMA models, but air temperature along with RH might be a predictor when moving average (MA) order at lag 1 month is considered.	[Biswas, Paritosh K.; Islam, Md. Zohorul; Debnath, Nitish C.] Chittagong Vet & Anim Sci Univ, Dept Microbiol, Chittagong, Bangladesh; [Debnath, Nitish C.; Yamage, Mat] Food & Agr Org United Nation, Dhaka, Bangladesh	Food & Agriculture Organization of the United Nations (FAO)	Biswas, PK (corresponding author), Chittagong Vet & Anim Sci Univ, Dept Microbiol, Chittagong, Bangladesh.	biswaspk2000@yahoo.com	Islam, Zohorul/T-4023-2019	Islam, Zohorul/0000-0002-2015-5195	Food and Agriculture Organization of the United Nations [ORSO/BGD/101/USA (LOAFAOBGD-2012-002)]	Food and Agriculture Organization of the United Nations	Food and Agriculture Organization of the United Nations; Grant No: ORSO/BGD/101/USA (LOAFAOBGD-2012-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SSU, 2010, EPIDEMIOL INFECT, V138, P843, DOI 10.1017/S0950268810000178; Ahmed SSU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033938; Ahmed SSU, 2012, VACCINE, V30, P7381, DOI 10.1016/j.vaccine.2012.09.081; [Anonymous], 2013, M EPT PARTN BANGL ST; Biswas PK, 2008, EMERG INFECT DIS, V14, P1909, DOI 10.3201/eid1412.071567; Chatfield C., 2000, TIME SERIES FORECAST; du Prel JB, 2009, CLIN INFECT DIS, V49, P861, DOI 10.1086/605435; EMPRES/FAO-GLEWS, 2010, H5N1 HPAI GLOB OV MA, P5; Islam MR, 2012, TRANSBOUND EMERG DIS, V59, P460, DOI 10.1111/j.1865-1682.2011.01297.x; Kirkwood BR, 2003, ESSENTIAL MED STAT; Loth L, 2010, PREV VET MED, V96, P104, DOI 10.1016/j.prevetmed.2010.05.013; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Mahamat A, 2013, J INFECTION, V67, P141, DOI 10.1016/j.jinf.2013.03.018; Minh PQ, 2009, PREV VET MED, V89, P16, DOI 10.1016/j.prevetmed.2009.01.004; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; Si YL, 2009, GEOSPATIAL HEALTH, V4, P65, DOI 10.4081/gh.2009.211; Soebiyanto RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009450; Suarez David L., 2010, Animal Health Research Reviews, V11, P19, DOI 10.1017/S1466252310000095; Urashima M, 2003, JPN J INFECT DIS, V56, P43; Wangdi K, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-251; Webster RG, 2006, NEW ENGL J MED, V355, P543; WHO, 2013, CUM NUMB CONF HUM CA; World Health Organization, 2011, AVIAN INFLUENZA; World Organization for Animal Health, 2013, UPD AV INFL; World Organization for Animal Health, 2010, 63 COUNTR REP H5N1 A; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Zhang ZJ, 2012, VET J, V192, P417, DOI 10.1016/j.tvjl.2011.08.012	28	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98471	10.1371/journal.pone.0098471	http://dx.doi.org/10.1371/journal.pone.0098471			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886857	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300070
J	Fischer, A; Kraff, O; Maderwald, S; Beiderwellen, K; Ladd, ME; Forsting, M; Lauenstein, TC; Umutlu, L				Fischer, Anja; Kraff, Oliver; Maderwald, Stefan; Beiderwellen, Karsten; Ladd, Mark E.; Forsting, Michael; Lauenstein, Thomas C.; Umutlu, Lale			Non-Enhanced T1-Weighted Liver Vessel Imaging at 7 Tesla	PLOS ONE			English	Article							NEPHROGENIC SYSTEMIC FIBROSIS; ENHANCED MR-ANGIOGRAPHY; FAST SPIN-ECHO; PREOPERATIVE EVALUATION; HEPATIC VASCULATURE; INITIAL-EXPERIENCE; CT ANGIOGRAPHY; PRECESSION; ANATOMY; DONORS	Objectives: Aim of the study was to assess the feasibility and to compare three non-enhanced T1-weighted (w) sequences for liver vessel imaging at 7 Tesla (T). Material and Methods: 12 healthy volunteers were examined on a 7 T whole-body MR-system. The following non-enhanced sequences were acquired: T1w 2D FLASH, T1w 3D FLASH and Time of flight (TOF)-MRA. Qualitative image analysis was performed by two radiologists including over all image quality as well as vessel delineation of the liver arteries, liver veins and portal vein and the presence of artifacts using a five-point scale (5 = excellent vessel delineation to 1 = non-diagnostic). Contrast ratios (CR), SNR und CNR of the above named vessels in correlation to adjacent liver tissue were calculated for quantitative assessment. For statistical analysis, a Wilcoxon Rank Test was applied. Results: All three sequences provided a homogenous hyperintense delineation of the assessed liver vessels. Qualitative image analysis demonstrated the superiority of TOF-MRA, providing best overall image quality (TOF 4.17, 2D FLASH 3.42, 3D FLASH 3.46; p < 0.01) as well as highest image quality values for all analyzed liver vessel segments. TOF-MRA was least impaired by B-1 inhomogeneity (4.13) and susceptibility artifacts (4.63) out of all three sequences (p < 0.01). Quantitative image analysis confirmed the superiority of TOF MRA showing significant higher CR values for all liver vessels (e. g. right hepatic artery TOF 0.47, 2D FLASH 0.09, 3D FLASH 0.11 with p = 0.02 and 0.01, respectively). Providing the lowest standard deviation in noise, TOF showed highest values for SNR and CNR. Conclusions: Non-enhanced T1w imaging in general and TOF MRA in particular, appear to be promising techniques for high quality non-enhanced liver vessel assessment at 7 T.	[Fischer, Anja; Beiderwellen, Karsten; Ladd, Mark E.; Forsting, Michael; Lauenstein, Thomas C.; Umutlu, Lale] Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Fischer, Anja; Kraff, Oliver; Maderwald, Stefan; Beiderwellen, Karsten; Ladd, Mark E.; Umutlu, Lale] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Ladd, Mark E.] German Canc Res Ctr, Heidelberg, Germany	University of Duisburg Essen; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ)	Fischer, A (corresponding author), Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany.	anja.fischer@uk-essen.de	Kraff, Oliver/AAE-2238-2020; Maderwald, Stefan/B-4241-2011	Kraff, Oliver/0000-0002-6006-8934; Ladd, Mark/0000-0002-4128-9440				Aslam R, 2010, MAGN RESON IMAGING C, V18, P515, DOI 10.1016/j.mric.2010.08.005; Bernstein MA, 2006, J MAGN RESON IMAGING, V24, P735, DOI 10.1002/jmri.20698; Bitz AK, 2009, ISMRM, V4767; Carr JC, 2003, J VASC INTERV RADIOL, V14, P441, DOI 10.1097/01.RVI.0000064853.87207.42; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; Dietrich O, 2008, MAGN RESON IMAGING, V26, P754, DOI 10.1016/j.mri.2008.02.001; Duan Q, 2013, NMR BIOMED, V26, P1070, DOI 10.1002/nbm.2920; Fischer A, 2013, INVEST RADIOL, V48, P525, DOI 10.1097/RLI.0b013e3182839c2b; Grinstead JW, 2010, ISMRM, V18, P1429; Grobner T, 2007, KIDNEY INT, V72, P260, DOI 10.1038/sj.ki.5002338; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1104, DOI 10.1093/ndt/gfk062; Hoult DI, 2000, J MAGN RESON IMAGING, V12, P46, DOI 10.1002/1522-2586(200007)12:1<46::AID-JMRI6>3.0.CO;2-D; Johst S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086274; Ladd Mark E, 2007, Top Magn Reson Imaging, V18, P139, DOI 10.1097/RMR.0b013e3180f612b3; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lauenstein TC, 2007, J MAGN RESON IMAGING, V26, P1198, DOI 10.1002/jmri.21136; Lee MW, 2007, EUR RADIOL, V17, P1074, DOI 10.1007/s00330-006-0447-3; Lee MW, 2006, J MAGN RESON IMAGING, V24, P1081, DOI 10.1002/jmri.20726; Maderwald S, 2008, MAGN RESON MATER PHY, V21, P159, DOI 10.1007/s10334-007-0096-9; Metzger GJ, 2010, ISMRM, V403; Metzger GJ, 2013, MAGN RESON MED, V69, P114, DOI 10.1002/mrm.24237; Monninghoff C, 2009, ROFO-FORTSCHR RONTG, V181, P16, DOI 10.1055/s-2008-1027863; Moser E, 2012, NMR BIOMED, V25, P695, DOI 10.1002/nbm.1794; Orzada S, 2009, ISMRM, V2999; Puippe GD, 2012, EUR J RADIOL, V81, pE823, DOI 10.1016/j.ejrad.2012.02.016; Ramalho Miguel, 2007, Magn Reson Imaging Clin N Am, V15, P321, DOI 10.1016/j.mric.2007.06.003; Saba L, 2008, CLIN RADIOL, V63, P312, DOI 10.1016/j.crad.2007.05.023; Sacolick LI, 2010, MAGN RESON MED, V63, P1315, DOI 10.1002/mrm.22357; Sahani D, 2004, RADIOGRAPHICS, V24, P1367, DOI 10.1148/rg.245035224; Shimada K, 2009, AM J ROENTGENOL, V193, P106, DOI 10.2214/AJR.08.1626; Shimada K, 2009, J MAGN RESON IMAGING, V29, P1140, DOI 10.1002/jmri.21753; Shimada K, 2009, EUR J RADIOL, V70, P111, DOI 10.1016/j.ejrad.2007.12.010; Shimada K, 2009, J MAGN RESON IMAGING, V29, P474, DOI 10.1002/jmri.21636; Streitparth F, 2007, ACTA RADIOL, V48, P20, DOI 10.1080/02841850601045146; Uchida K, 2010, LIVER TRANSPLANT, V16, P1062, DOI 10.1002/lt.22109; Umutlu L, 2012, INVEST RADIOL, V36, P714; Umutlu L, 2013, ACAD RADIOL, V20, P628, DOI 10.1016/j.acra.2012.12.012; Umutlu L, 2013, EUR J RADIOL, V82, P760, DOI 10.1016/j.ejrad.2011.07.004; Umutlu L, 2011, INVEST RADIOL, V46, P425, DOI 10.1097/RLI.0b013e31820e1467; Vaughan TT, 2009, MAGN RESON MED, V61, P244, DOI 10.1002/mrm.21751; Wrede KH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084562; Wu X, 2014, QUANT IMAGING MED SU, V4, P4; [No title captured]	43	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e97465	10.1371/journal.pone.0097465	http://dx.doi.org/10.1371/journal.pone.0097465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887206	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300019
J	Rolland, B; Paille, F; Fleury, B; Cottencin, O; Benyamina, A; Aubin, HJ				Rolland, Benjamin; Paille, Francois; Fleury, Benoit; Cottencin, Olivier; Benyamina, Amine; Aubin, Henri-Jean			Off-Label Baclofen Prescribing Practices among French Alcohol Specialists: Results of a National Online Survey	PLOS ONE			English	Article							HIGH-DOSE BACLOFEN; DOUBLE-BLIND; DEPENDENT PATIENTS; USE DISORDERS; EFFICACY; SAFETY; TRIAL; DRUG; SUPPRESSION; ABSTINENCE	Objective: To evaluate, among alcohol specialists belonging to the Societe Francaise d'Alcoologie (SFA), i.e., the French Alcohol Society, the proportion of physicians who prescribed off-label baclofen for alcohol use disorders (AUDs). The secondary objective was to depict the features of individual prescribing and monitoring practices. Methods: On-line survey among 484 French alcohol specialists. Physicians were asked whether they prescribed baclofen for AUDs. If they did not, the reasons for this choice were investigated. If they did, the features of the physician's prescribing practice were explored, including the number of patients treated, the mean and maximum doses, the monitoring precautions and the pharmacovigilance reporting. Participants were also asked about their empirical findings on HDB's efficacy and safety. Results: In total, 302 physicians (response rate of 62.4%) participated in the survey. Data from 296 participants were analysed, representing 59.4% of all active prescribing physicians belonging to the SFA. HDB use was declared by 74.6% of participants (mean dose 109.5+/-43.6 mg/d; maximum dose 188+/-93.3 mg/d). However, 79.2% of prescribers had treated less than 30 patients, and 67.8% used HDB as a second-line medication. Although HDB was perceived as more efficacious than approved drugs by 54.3% of prescribers, it was also declared less safe by 62.8%. Nonetheless, 79.7% of prescribers had never filed any pharmacovigilance report. Non-prescribers (25.6%) were primarily deterred by the current lack of scientific data and official regulation. Conclusion: A majority of French alcohol specialists reported using HDB, although often on a limited number of their patients. HDB was considered efficacious but also potentially hazardous. Despite this, physicians reported minimal safety data to the health security system. While French health authorities are planning to draft a specific regulatory measure for framing off-label HDB prescribing practices, the sustained education of prescribers on spontaneous pharmacovigilance reporting should be enhanced.	[Rolland, Benjamin; Paille, Francois; Fleury, Benoit; Cottencin, Olivier; Benyamina, Amine; Aubin, Henri-Jean] Soc Francaise Alcool, Issy Les Moulineaux, France; [Rolland, Benjamin; Cottencin, Olivier] Univ Lille Nord France, CHU Lille, Serv Addictol, Lille, France; [Paille, Francois] Univ Nancy, CHU Nancy, Serv Addictol, Nancy, France; [Fleury, Benoit] CHU Bordeaux, Serv Hepatogastroenterol & Alcool, Bordeaux, France; [Benyamina, Amine; Aubin, Henri-Jean] Hop Paul Brousse, AP HP, INSERM, CERTA LAlbatros,U 669, Villejuif, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille; CHU de Nancy; Universite de Lorraine; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Rolland, B (corresponding author), Soc Francaise Alcool, Issy Les Moulineaux, France.	benjamin.rolland@chru-lille.fr	ROLLAND, Benjamin/E-7374-2013; , Aubin/AAT-9739-2021; Aubin, Henri-Jean/AAP-8605-2021; ROLLAND, Benjamin/H-6625-2019; COTTENCIN, Olivier OC/I-4024-2015	ROLLAND, Benjamin/0000-0002-8666-3635; ROLLAND, Benjamin/0000-0002-8666-3635; COTTENCIN, Olivier OC/0000-0003-3663-1405; Aubin, Henri-Jean/0000-0002-6604-6672	SFA (Societe Francaise d'Alcoologie)	SFA (Societe Francaise d'Alcoologie)	The SFA (Societe Francaise d'Alcoologie) funded the survey and supported all costs related to the publication process. The scientific board of the SFA (Dr AUBIN, Dr PAILLE, Dr BENYAMINA, Dr FLEURY) designed the survey.	Addolorato G, 2002, ALCOHOL ALCOHOLISM, V37, P504, DOI 10.1093/alcalc/37.5.504; Addolorato G, 2007, LANCET, V370, P1915, DOI 10.1016/S0140-6736(07)61814-5; Agabio R, 2013, EUR ADDICT RES, V19, P325, DOI 10.1159/000347055; Ameisen O, 2005, ALCOHOL ALCOHOLISM, V40, P147, DOI 10.1093/alcalc/agh130; Ameisen O, 2008, DERNIER VERRE; Andreuccetti G, 2012, ADDICTION, V107, P848, DOI [10.1111/j.1360-0443.2011.03754.x, 10.1111/j.1360-0443.2011.03752.x]; Auffret M, 2014, ANN PHARMACOTHER, V48, P656, DOI 10.1177/1060028014525594; Bence C, 2014, J CLIN PHARMACOL, V54, P478, DOI 10.1002/jcph.233; Bennett C, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001069; Bucknam W, 2007, ALCOHOL ALCOHOLISM, V42, P158, DOI 10.1093/alcalc/agl091; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Dal Pan GJ, 2012, CLIN PHARMACOL THER, V91, P787, DOI 10.1038/clpt.2012.24; de Beaurepaire Renaud, 2012, Front Psychiatry, V3, P103, DOI 10.3389/fpsyt.2012.00103; Dom G, 2012, ACTA CLIN BELG, V67, P315, DOI 10.2143/ACB.67.5.2062682; Dupouy J, 2014, EUR NEUROPSYCHOPHARM, V24, P192, DOI 10.1016/j.euroneuro.2013.09.008; Emmerich J, 2012, NEW ENGL J MED, V367, P1279, DOI 10.1056/NEJMp1208347; Enserink M, 2011, SCIENCE, V332, P653, DOI 10.1126/science.332.6030.653; Franchitto N, 2014, ALCOHOL ALCOHOLISM, V49, P79, DOI 10.1093/alcalc/agt169; Gache Pascal, 2011, Rev Med Suisse, V7, P1458; Garbutt JC, 2010, ALCOHOL CLIN EXP RES, V34, P1849, DOI 10.1111/j.1530-0277.2010.01273.x; Geoffroy PA, 2014, PSYCHOSOMATICS; Gorsane MA, 2012, SUBST ABUS, V33, P336, DOI 10.1080/08897077.2012.663326; Luquiens A, 2011, ALCOHOL ALCOHOLISM, V46, P586, DOI 10.1093/alcalc/agr083; Pastor A, 2012, J CLIN PSYCHOPHARM, V32, P266, DOI 10.1097/JCP.0b013e31824929b2; Rigal L, 2012, ALCOHOL ALCOHOLISM, V47, P439, DOI 10.1093/alcalc/ags028; Rolland B, 2014, J CLIN PSYCHOPHARM, V34, P153, DOI 10.1097/JCP.0000000000000054; Rolland B, 2012, ALCOHOL ALCOHOLISM, V47, P577, DOI 10.1093/alcalc/ags076; Rolland B, 2010, THERAPIE, V65, P511, DOI 10.2515/therapie/2010073; SACHAIS BA, 1977, ARCH NEUROL-CHICAGO, V34, P422, DOI 10.1001/archneur.1977.00500190056008; Villier C, 2011, EFFETS INDESIRABLES	30	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98062	10.1371/journal.pone.0098062	http://dx.doi.org/10.1371/journal.pone.0098062			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887094	gold, Green Published, Green Submitted			2022-12-25	WOS:000336956300036
J	Stilund, M; Reuschlein, AK; Christensen, T; Moller, HJ; Rasmussen, PV; Petersen, T				Stilund, Morten; Reuschlein, Ann-Kathrin; Christensen, Tove; Moller, Holger Jon; Rasmussen, Peter Vestergaard; Petersen, Thor			Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis	PLOS ONE			English	Article							SCAVENGER RECEPTOR CD163; IMMUNE; NEURODEGENERATION; INFLAMMATION; ASSOCIATION; ACTIVATION; DISEASES; LESIONS; SYSTEM; DAMAGE	Background: Soluble CD163 (sCD163) is a macrophage specific protein known to be up-regulated in serum from patients with multiple sclerosis (MS). Objective: To investigate sCD163 in serum and CSF (cerebrospinal fluid) from patients undergoing MS diagnostic work-up and analyse its potential as a diagnostic biomarker. Methods: After a full MS diagnostic work-up, including collection of paired samples of CSF and serum, 183 patients were evaluated for inclusion in this study. Patients were divided into groups based on their diagnosis. Patients with normal clinical and paraclinical findings were grouped as symptomatic controls. Serum and CSF levels of sCD163 were determined by enzyme-linked immunosorbent assay (ELISA). Results: sCD163 could be measured in all serum and CSF samples. A high sCD163 CSF/serum ratio in relation to molecular weight was found, strongly indicating local production in the CNS. Median levels of sCD163 were significantly decreased in serum and significantly elevated in CSF in patients with relapsing-remitting, and primary-progressive MS. There were, however, some overlaps of the measures between groups. In a receiver operating characteristic (ROC) analysis sCD163 CSF/serum ratio had an area under the curve of 0.72. Conclusion: The sCD163 CSF/serum ratio was significantly increased in patients with MS and may reflect macrophage activation in MS lesions. These results suggest that primary progressive MS also is driven by inflammation in which the innate immune system plays a pivotal role.	[Stilund, Morten; Rasmussen, Peter Vestergaard; Petersen, Thor] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus C, Denmark; [Reuschlein, Ann-Kathrin; Moller, Holger Jon] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus C, Denmark; [Stilund, Morten; Christensen, Tove] Aarhus Univ, Dept Biomed, Aarhus C, Denmark	Aarhus University; Aarhus University; Aarhus University	Stilund, M (corresponding author), Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus C, Denmark.	mortenleifms@gmail.com		Rasmussen, Peter Vestergaard/0000-0001-6417-7743; Christensen, Tove/0000-0003-3977-6677; Petersen, Thor/0000-0001-5633-2600; Moller, Holger Jon/0000-0001-7687-5995; Lindahl Christiansen, Ann-Kathrin/0000-0003-3917-9151	Danish Multiple Sclerosis Society [8990, 14567]	Danish Multiple Sclerosis Society	This study was funded by The Danish Multiple Sclerosis Society. Grant number(s): 8990 and 14567. Funder URL: http://scleroseforeningen.dk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS CWM, 1988, J NEUROL NEUROSUR PS, V51, P260, DOI 10.1136/jnnp.51.2.260; Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Androdias G, 2010, ANN NEUROL, V68, P465, DOI 10.1002/ana.22054; Baeten D, 2004, ARTHRITIS RHEUM-US, V50, P1611, DOI 10.1002/art.20174; BRUCK W, 1995, ANN NEUROL, V38, P788, DOI 10.1002/ana.410380514; Carpintero R, 2010, P NATL ACAD SCI USA, V107, P17692, DOI 10.1073/pnas.1009443107; Christensen JR, 2013, MULT SCLER J, V19, P877, DOI 10.1177/1352458512466929; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Davis BH, 2005, CYTOM PART B-CLIN CY, V63B, P16, DOI 10.1002/cyto.b.20031; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Ellwardt E., 2014, EXP NEUROL; Fabriek BO, 2007, J NEUROIMMUNOL, V187, P179, DOI 10.1016/j.jneuroim.2007.04.016; Fabriek BO, 2009, BLOOD, V113, P887, DOI 10.1182/blood-2008-07-167064; Fabriek BO, 2005, GLIA, V51, P297, DOI 10.1002/glia.20208; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Galea J, 2012, J NEUROCHEM, V121, P785, DOI 10.1111/j.1471-4159.2012.07716.x; Hametner S., 2013, ANN NEUROL; Hiraoka A, 2005, J GASTROENTEROL, V40, P52, DOI 10.1007/s00535-004-1493-8; Hogger P, 2001, BIOCHEM BIOPH RES CO, V288, P841, DOI 10.1006/bbrc.2001.5845; Kipp M, 2012, CNS NEUROL DISORD-DR, V11, P506, DOI 10.2174/187152712801661248; Korneck B, 2003, BRAIN RES BULL, V61, P321, DOI 10.1016/S0361-9230(03)00095-9; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lassmann H, 2011, FEBS LETT, V585, P3715, DOI 10.1016/j.febslet.2011.08.004; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Mayo L, 2012, IMMUNOL REV, V248, P170, DOI 10.1111/j.1600-065X.2012.01135.x; Mehta V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057573; Moller HJ, 2004, EUR J HAEMATOL, V72, P135, DOI 10.1046/j.0902-4441.2003.00193.x; Moller HJ, 2002, SCAND J CLIN LAB INV, V62, P29, DOI 10.1080/003655102762377466; Moller HJ, 2002, SCAND J CLIN LAB INV, V62, P293, DOI 10.1080/003655102760145852; Moller HJ, 2012, SCAND J CLIN LAB INV, V72, P1, DOI 10.3109/00365513.2011.626868; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nockher WA, 1999, J NEUROIMMUNOL, V101, P161, DOI 10.1016/S0165-5728(99)00141-1; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; R N, 2003, STATA TECHNICAL J; Skarica M, 2011, J NEUROIMMUNOL, V235, P70, DOI 10.1016/j.jneuroim.2011.02.010; Teunissen C., 2013, MULT SCLER; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Timmermann M, 2004, IMMUNOL CELL BIOL, V82, P479, DOI 10.1111/j.0818-9641.2004.01277.x; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Verreck FAW, 2006, J LEUKOCYTE BIOL, V79, P285, DOI 10.1189/jlb.0105015; Vogel DYS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-35; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Zhang Z, 2011, J NEUROIMMUNOL, V237, P73, DOI 10.1016/j.jneuroim.2011.06.006	44	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98588	10.1371/journal.pone.0098588	http://dx.doi.org/10.1371/journal.pone.0098588			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24886843	Green Published, gold, Green Submitted			2022-12-25	WOS:000336956300090
J	Chen, AY; Xia, SZ; Wilburn, P; Tully, T				Chen, Alex Y.; Xia, Shouzhen; Wilburn, Paul; Tully, Tim			Olfactory Deficits in an Alpha-Synuclein Fly Model of Parkinson's Disease	PLOS ONE			English	Article							ENVIRONMENTAL RISK-FACTORS; NEURODEGENERATIVE DISEASE; DISCRIMINATION THRESHOLDS; SYNAPTIC-TRANSMISSION; DOPAMINERGIC-NEURONS; CELL-PROLIFERATION; MUSHROOM BODIES; ANTENNAL LOBES; ODOR DETECTION; HONEY-BEE	Parkinson's disease (PD) is the most common motor neurodegenerative disorder. Olfactory dysfunction is a prevalent feature of PD. It often precedes motor symptoms by several years and is used in assisting PD diagnosis. However, the cellular and molecular bases of olfactory dysfunction in PD are not known. The fruit fly Drosophila melanogaster, expressing human alpha-synuclein protein or its mutant, A30P, captures several hallmarks of PD and has been successfully used to model PD in numerous studies. First, we report olfactory deficits in fly expressing A30P ( A30P), showing deficits in two out of three olfactory modalities, tested - olfactory acuity and odor discrimination. The remaining third modality is odor identification/naming. Second, oxidative stress is an important environmental risk factor of PD. We show that oxidative stress exacerbated the two affected olfactory modalities in younger A30P flies. Third, different olfactory receptor neurons are activated differentially by different odors in flies. In a separate experiment, we show that the odor discrimination deficit in A30P flies is general and not restricted to a specific class of chemical structure. Lastly, by restricting A30P expression to dopamine, serotonin or olfactory receptor neurons, we show that A30P expression in dopamine neurons is necessary for development of both acuity and discrimination deficits, while serotonin and olfactory receptor neurons appeared not involved. Our data demonstrate olfactory deficits in a synuclein fly PD model for exploring olfactory pathology and physiology, and for monitoring PD progression and treatment.	[Chen, Alex Y.; Xia, Shouzhen; Tully, Tim] Dart Neurosci LLC, San Diego, CA 92131 USA; [Chen, Alex Y.; Tully, Tim] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Chen, Alex Y.] SUNY Stony Brook, Grad Program Neurosci, Stony Brook, NY 11794 USA; [Wilburn, Paul] Michigan State Univ, WK Kellogg Biol Stn, Hickory Corners, MI 49060 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Michigan State University	Chen, AY (corresponding author), Dart Neurosci LLC, San Diego, CA 92131 USA.	Alexome.chen@gmail.com	Wilburn, Paul/ABG-7975-2020	Wilburn, Paul/0000-0002-3197-8410	Dart NeuroScience LLC	Dart NeuroScience LLC	This work is supported by Dart NeuroScience LLC (http://www.dartneuroscience.com). The funder provided support in the form of salaries for authors AYC, SX and TT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Acebes A, 2011, J NEUROSCI, V31, P2734, DOI 10.1523/JNEUROSCI.5046-10.2011; ANSARI KA, 1975, J CHRON DIS, V28, P493, DOI 10.1016/0021-9681(75)90058-2; Auluck PK, 2002, NAT MED, V8, P1185, DOI 10.1038/nm1102-1185; Bardy C, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnnes.2010.00002; Barzilai A, 2003, TRENDS MOL MED, V9, P126, DOI 10.1016/S1471-4914(03)00020-0; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Berendse HW, 2001, ANN NEUROL, V50, P34, DOI 10.1002/ana.1049; BERKOWICZ DA, 1994, J NEUROPHYSIOL, V71, P2557, DOI 10.1152/jn.1994.71.6.2557; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bicker G, 1999, MICROSC RES TECHNIQ, V45, P174, DOI 10.1002/(SICI)1097-0029(19990501)45:3<174::AID-JEMT5>3.3.CO;2-L; Botella JA, 2009, NEUROMOL MED, V11, P268, DOI 10.1007/s12017-009-8098-6; Burns M, 2010, CHEM BIOL INTERACT; Cicchetti F, 2005, NEUROBIOL DIS, V20, P360, DOI 10.1016/j.nbd.2005.03.018; Daly KC, 2008, CHEM SENSES, V33, P95, DOI 10.1093/chemse/bjm068; Daly KC, 2007, BEHAV NEUROSCI, V121, P794, DOI 10.1037/0735-7044.121.4.794; Dhillon Amanpreet S, 2008, J Agromedicine, V13, P37, DOI 10.1080/10599240801986215; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; DOTY RL, 1992, ANN NEUROL, V32, P97, DOI 10.1002/ana.410320116; DOTY RL, 1988, NEUROLOGY, V38, P1237, DOI 10.1212/WNL.38.8.1237; DOTY RL, 1984, SCIENCE, V226, P1441, DOI 10.1126/science.6505700; Escanilla O, 2010, EUR J NEUROSCI, V32, P458, DOI 10.1111/j.1460-9568.2010.07297.x; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x; Fong Chin-Shih, 2005, Acta Neurol Taiwan, V14, P55; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Giasson BI, 2000, NAT NEUROSCI, V3, P1227, DOI 10.1038/81737; Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hawkes C, 2003, MOVEMENT DISORD, V18, P364, DOI 10.1002/mds.10379; Hawkes CH, 2010, PARKINSONISM RELAT D, V16, P79, DOI 10.1016/j.parkreldis.2009.08.007; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Hosler JS, 2000, BEHAV NEUROSCI, V114, P514, DOI 10.1037/0735-7044.114.3.514; Huisman E, 2004, MOVEMENT DISORD, V19, P687, DOI 10.1002/mds.10713; Huisman E, 2008, MOVEMENT DISORD, V23, P1407, DOI 10.1002/mds.22009; Katzenschlager R, 2004, CURR OPIN NEUROL, V17, P417, DOI 10.1097/01.wco.0000137531.76491.c2; Kirchhof BS, 1999, J COMP NEUROL, V411, P643; Kranick SM, 2008, NEUROSIGNALS, V16, P35, DOI 10.1159/000109757; KREISSL S, 1989, J COMP NEUROL, V286, P71, DOI 10.1002/cne.902860105; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lai BCL, 2002, PARKINSONISM RELAT D, V8, P297, DOI 10.1016/S1353-8020(01)00054-2; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lelan F, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/987084; Liou HH, 1997, NEUROLOGY, V48, P1583, DOI 10.1212/WNL.48.6.1583; MANN VM, 1994, ANN NEUROL, V36, P876, DOI 10.1002/ana.410360612; Markopoulou K, 1997, NEUROLOGY, V49, P1262, DOI 10.1212/WNL.49.5.1262; Marxreiter F, 2009, EUR J NEUROSCI, V29, P879, DOI 10.1111/j.1460-9568.2009.06641.x; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Mizuno H., 2010, PARKINSONS DIS, V2011; Mobley AS, 2014, TRENDS NEUROSCI, V37, P77, DOI 10.1016/j.tins.2013.11.004; Montgomery EB, 1999, NEUROLOGY, V52, P757, DOI 10.1212/WNL.52.4.757; Montine KS, 2004, CHEM PHYS LIPIDS, V128, P117, DOI 10.1016/j.chemphyslip.2003.10.010; Muller A, 2002, J CLIN NEUROSCI, V9, P521, DOI 10.1054/jocn.2001.1071; Mwilaria EK, 2008, CHEM SENSES, V33, P267, DOI 10.1093/chemse/bjm085; Park SS, 2007, EUR J NEUROSCI, V26, P3104, DOI 10.1111/j.1460-9568.2007.05929.x; Poddighe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073156; Ponsen MM, 2004, ANN NEUROL, V56, P173, DOI 10.1002/ana.20160; Protocols CSH, 2012, FOOD MED DROS COLD S; Ross GW, 2008, ANN NEUROL, V63, P167, DOI 10.1002/ana.21291; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sobel N, 2001, P NATL ACAD SCI USA, V98, P4154, DOI 10.1073/pnas.071061598; SOFIC E, 1991, J NEUROCHEM, V56, P978, DOI 10.1111/j.1471-4159.1991.tb02017.x; STEVENS JC, 1987, PSYCHOL AGING, V2, P36, DOI 10.1037/0882-7974.2.1.36; Trinh K, 2008, J NEUROSCI, V28, P465, DOI 10.1523/JNEUROSCI.4778-07.2008; Trombley P Q, 1993, Curr Opin Neurobiol, V3, P540, DOI 10.1016/0959-4388(93)90053-2; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Ueno K, 2013, J PHYSIOL-LONDON, V591, P287, DOI 10.1113/jphysiol.2012.242909; Venda LL, 2010, TRENDS NEUROSCI, V33, P559, DOI 10.1016/j.tins.2010.09.004; von Trotha JW, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-9; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; Wei CJ, 2006, BEHAV NEUROSCI, V120, P393, DOI 10.1037/0735-7044.120.2.393; WENNING GK, 1995, ACTA NEUROL SCAND, V91, P247, DOI 10.1111/j.1600-0404.1995.tb06998.x; Wilson RI, 2011, CURR OPIN NEUROBIOL, V21, P254, DOI 10.1016/j.conb.2011.03.002; Winner B, 2011, EUR J NEUROSCI, V33, P1139, DOI 10.1111/j.1460-9568.2011.07613.x; Xia S, 2007, PLOS BIOL, V5, P2398, DOI 10.1371/journal.pbio.0050264	77	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97758	10.1371/journal.pone.0097758	http://dx.doi.org/10.1371/journal.pone.0097758			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879013	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000338101500023
J	Irvine, KL; Gangloff, M; Walsh, CM; Spring, DR; Gay, NJ; Bryant, CE				Irvine, Katherine L.; Gangloff, Monique; Walsh, Catherine M.; Spring, David R.; Gay, Nicholas J.; Bryant, Clare E.			Identification of Key Residues That Confer Rhodobacter sphaeroides LPS Activity at Horse TLR4/MD-2	PLOS ONE			English	Article							RECEPTOR 4; TLR4-MD-2 COMPLEX; STRUCTURAL BASIS; LIPID IVA; LIPOPOLYSACCHARIDE; ENDOTOXIN; RECOGNITION; MD-2; ACTIVATION; AGONIST	The molecular determinants underpinning how hexaacylated lipid A and tetraacylated precursor lipid IVa activate Toll-like receptor 4 (TLR4) are well understood, but how activation is induced by other lipid A species is less clear. Species specificity studies have clarified how TLR4/MD-2 recognises different lipid A structures, for example tetraacylated lipid IVa requires direct electrostatic interactions for agonism. In this study, we examine how pentaacylated lipopolysaccharide from Rhodobacter sphaeroides (RSLPS) antagonises human TLR4/MD-2 and activates the horse receptor complex using a computational approach and cross-species mutagenesis. At a functional level, we show that RSLPS is a partial agonist at horse TLR4/MD-2 with greater efficacy than lipid IVa. These data suggest the importance of the additional acyl chain in RSLPS signalling. Based on docking analysis, we propose a model for positioning of the RSLPS lipid A moiety (RSLA) within the MD-2 cavity at the TLR4 dimer interface, which allows activity at the horse receptor complex. As for lipid IVa, RSLPS agonism requires species-specific contacts with MD-2 and TLR4, but the R2 chain of RSLA protrudes from the MD-2 pocket to contact the TLR4 dimer in the vicinity of proline 442. Our model explains why RSLPS is only partially dependent on horse TLR4 residue R385, unlike lipid IVa. Mutagenesis of proline 442 into a serine residue, as found in human TLR4, uncovers the importance of this site in RSLPS signalling; horse TLR4 R385G/P442S double mutation completely abolishes RSLPS activity without its counterpart, human TLR4 G384R/S441P, being able to restore it. Our data highlight the importance of subtle changes in ligand positioning, and suggest that TLR4 and MD-2 residues that may not participate directly in ligand binding can determine the signalling outcome of a given ligand. This indicates a cooperative binding mechanism within the receptor complex, which is becoming increasingly important in TLR signalling.	[Irvine, Katherine L.; Walsh, Catherine M.; Bryant, Clare E.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Gangloff, Monique; Gay, Nicholas J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Spring, David R.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge; University of Cambridge; University of Cambridge	Bryant, CE (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	ceb27@cam.ac.uk	Spring, David R/K-2283-2016; Spring, David R/GRO-7225-2022; Spring, David/AAM-1944-2020	Spring, David R/0000-0001-7355-2824; Spring, David R/0000-0001-7355-2824; Spring, David/0000-0001-7355-2824; Irvine, Katherine/0000-0002-8630-3250; Gangloff, Monique/0000-0001-6131-0115	Horserace Betting Levy Board; Horserace Betting Levy Board Veterinary Research Training Scholarship; Wellcome Trust program; Medical Research Council [G1000133] Funding Source: researchfish; Wellcome Trust [100321/Z/12/Z] Funding Source: researchfish; MRC [G1000133] Funding Source: UKRI	Horserace Betting Levy Board; Horserace Betting Levy Board Veterinary Research Training Scholarship; Wellcome Trust program(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a project grant from the Horserace Betting Levy Board to CEB and a Horserace Betting Levy Board Veterinary Research Training Scholarship to KLI. This work was also supported by a Wellcome Trust program grant to NJG and CEB. CEB is a BBSRC Research Development Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Figueroa L, 2012, J IMMUNOL, V188, P4506, DOI 10.4049/jimmunol.1200202; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Lohmann KL, 2007, J ENDOTOXIN RES, V13, P235, DOI 10.1177/0968051907083193; Lohmann KL, 2003, J ENDOTOXIN RES, V9, P33, DOI [10.1177/09680519030090010301, 10.1179/096805103125001315]; Meng JM, 2010, J BIOL CHEM, V285, P27935, DOI 10.1074/jbc.M110.134668; Meng JM, 2010, J BIOL CHEM, V285, P8695, DOI 10.1074/jbc.M109.075127; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Poltorak A, 1998, BLOOD CELL MOL DIS, V24, P340, DOI 10.1006/bcmd.1998.0201; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; QURESHI N, 1988, J BIOL CHEM, V263, P5502; Resman N, 2009, J BIOL CHEM, V284, P15052, DOI 10.1074/jbc.M901429200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Stevens CW, 2013, BRIT J PHARMACOL, V168, P1421, DOI 10.1111/bph.12028; Walsh C, 2008, THESIS U CAMBRIDGE; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245	24	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98776	10.1371/journal.pone.0098776	http://dx.doi.org/10.1371/journal.pone.0098776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879320	Green Published, Green Submitted, gold			2022-12-25	WOS:000338101500085
J	Perez-Porcuna, TSM; Ascaso, C; Malheiro, A; Abellana, R; Martins, M; Sardinha, JFJ; Quinco, P; Antunes, IA; Garrido, MD; Buhrer-Sekula, S; Martinez-Espinosa, FE				Perez-Porcuna, Toma S. M.; Ascaso, Carlos; Malheiro, Adriana; Abellana, Rosa; Martins, Marilaine; Jardim Sardinha, Jose Felipe; Quinco, Patricia; Antunes, Irineide Assumpcao; Garrido, Marlucia da Silva; Buehrer-Sekula, Samira; Martinez-Espinosa, Flor Ernestina			Mycobacterium tuberculosis Infection in Young Children: Analyzing the Performance of the Diagnostic Tests	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; SKIN-TEST; IRON; EXPRESSION; CHILDHOOD; PROTEINS; IMMUNODIAGNOSIS; CONTACT; DISEASE; UTILITY	Objective: This study evaluated the performance of the Tuberculin Skin Test (TST) and Quantiferon-TB Gold in-Tube (QFT) and the possible association of factors which may modify their results in young children (0-6 years) with recent contact with an index tuberculosis case. Materials and Methods: A cross-sectional study including 135 children was conducted in Manaus, Amazonas-Brazil. The TST and QFT were performed and the tests results were analyzed in relation to the personal characteristics of the children studied and their relationship with the index case. Results: The rates of positivity were 34.8% (TST) and 26.7% (QFT), with 14.1% of indeterminations by the QFT. Concordance between tests was fair (Kappa = 0.35 P<0.001). Both the TST and QFT were associated with the intensity of exposure (Linear OR = 1.286, P = 0.005; Linear OR = 1.161, P = 0.035 respectively) with only the TST being associated with the time of exposure (Linear OR = 1.149, P = 0.009). The presence of intestinal helminths in the TST+ group was associated with negative QFT results (OR = 0.064, P = 0.049). In the TST- group lower levels of ferritin were associated with QFT+ results (Linear OR = 0.956, P = 0.036). Conclusions: Concordance between the TST and QFT was lower than expected. The factors associated with the discordant results were intestinal helminths, ferritin levels and exposure time to the index tuberculosis case. In TST+ group, helminths were associated with negative QFT results suggesting impaired cell-mediated immunity. The TST-&QFT+ group had a shorter exposure time and lower ferritin levels, suggesting that QFT is faster and ferritin may be a potential biomarker of early stages of tuberculosis infection.	[Perez-Porcuna, Toma S. M.; Quinco, Patricia; Garrido, Marlucia da Silva; Buehrer-Sekula, Samira] Univ Estado Amazonas, Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Perez-Porcuna, Toma S. M.; Ascaso, Carlos; Abellana, Rosa] Univ Barcelona, Fac Med, Dept Salut Publ, Barcelona 7, Catalunya, Spain; [Perez-Porcuna, Toma S. M.] Hosp Univ Mutua Terrassa, Unitat Invest Fundacio Mutua Terrassa, CAP Valldoreix, Serv Pediat, Terrassa, Catalunya, Spain; [Ascaso, Carlos] Inst Invest Biomed August Pi i Sunyer, Barcelona, Catalunya, Spain; [Malheiro, Adriana] Fundacao Hematol & Hemoterapia Amazonas, Lab Imunol Basica & Aplicada, Manaus, Amazonas, Brazil; [Malheiro, Adriana] Univ Fed Amazonas, Manaus, Amazonas, Brazil; [Jardim Sardinha, Jose Felipe] Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil; [Antunes, Irineide Assumpcao] Policlin Cardoso Fontes, Ctr Referencia TB, Manaus, Amazonas, Brazil; [Garrido, Marlucia da Silva] Fundacao Vigilancia Saude Estado Amazonas, Programa Controle TB, Dept Vigilancia Epidemiol, Manaus, Amazonas, Brazil; [Buehrer-Sekula, Samira] Univ Fed Goias, Inst Patol Trop & Saude Publ, Goiania, Go, Brazil; [Martinez-Espinosa, Flor Ernestina] Fundacao Oswaldo Cruz, Fiocruz Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil	Universidade do Estado do Amazonas; University of Barcelona; Hospital Universitario Mutua Terrassa; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidade Federal de Amazonas; Universidade Federal de Goias; Fundacao Oswaldo Cruz	Perez-Porcuna, TSM (corresponding author), Univ Estado Amazonas, Fundacao Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.	tomas.perez.porcuna@gmail.com	Abellana, Rosa/D-7305-2014; Garrido, Marlucia/AAK-1001-2020; Buhrer-Sekula, Samira/H-5115-2012	Abellana, Rosa/0000-0003-4487-4431; Perez-Porcuna, Tomas Maria/0000-0002-9951-7768; Buhrer-Sekula, Samira/0000-0002-5984-7770; Ascaso Terren, Carlos/0000-0002-4895-7616	Brazilian National Counsel of Technological and Scientific Development (CNPq); Foundation of Research Support of the State of Amazonas (FAPEAM); University of Barcelona	Brazilian National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation of Research Support of the State of Amazonas (FAPEAM); University of Barcelona	This work was financially supported by the Brazilian National Counsel of Technological and Scientific Development (CNPq), the Foundation of Research Support of the State of Amazonas (FAPEAM), and the University of Barcelona. Cellestis Ltd. donated QuantiFERON test kits. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida LMD, 2001, PEDIATR INFECT DIS J, V20, P1061, DOI 10.1097/00006454-200111000-00011; ANDERSEN P, 1991, INFECT IMMUN, V59, P1905, DOI 10.1128/IAI.59.6.1905-1910.1991; [Anonymous], 2011, GLOB TUB CONTR 2011; Banfield S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038556; Basaraba RJ, 2008, TUBERCULOSIS, V88, P69, DOI 10.1016/j.tube.2007.09.002; Bergamini BM, 2009, PEDIATRICS, V123, pe419, DOI 10.1542/peds.2008-1722; Borkow G, 2000, J CLIN INVEST, V106, P1053, DOI 10.1172/JCI10182; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; Connell TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002624; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Friis H, 2009, BRIT J NUTR, V102, P310, DOI 10.1017/S0007114508162122; Grare M, 2010, DIAGN MICR INFEC DIS, V66, P366, DOI 10.1016/j.diagmicrobio.2009.11.002; Haile Y, 2002, MICROBIOL-SGM, V148, P3881, DOI 10.1099/00221287-148-12-3881; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Haustein T, 2009, PEDIATR INFECT DIS J, V28, P669, DOI 10.1097/INF.0b013e3181a16394; Hesseling AC, 2009, THORAX, V64, P840, DOI 10.1136/thx.2007.085340; Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Hill PC, 2010, LANCET INFECT DIS, V10, P723, DOI 10.1016/S1473-3099(10)70164-X; Isanaka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037350; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lewinsohn DA, 2008, PEDIATR RES, V63, P115, DOI 10.1203/PDR.0b013e3181652085; LUTZ Adolpho, 1919, Memorias do Instituto Oswaldo Cruz, V11, P121, DOI 10.1590/S0074-02761919000100006; Machingaidze S, 2011, PEDIATR INFECT DIS J, V30, P694, DOI 10.1097/INF.0b013e318214b915; Maher D, 2006, INT J TUBERC LUNG D, V10, P1091; Manabe YC, 1999, P NATL ACAD SCI USA, V96, P12844, DOI 10.1073/pnas.96.22.12844; Mandalakas AM, 2011, INT J TUBERC LUNG D, V15, P1018, DOI 10.5588/ijtld.10.0631; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2009, INT J TUBERC LUNG D, V13, P84; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2006, INT J TUBERC LUNG D, V10, P942; Powell DA, 2009, PEDIATR INFECT DIS J, V28, P676, DOI 10.1097/INF.0b013e3181ad5490; Raharimanga V, 2012, TROP MED INT HEALTH, V17, P871, DOI 10.1111/j.1365-3156.2012.03013.x; Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012; Reddy PV, 2012, J BACTERIOL, V194, P567, DOI 10.1128/JB.05553-11; Co TR, 2007, CLIN EXP IMMUNOL, V147, P45, DOI 10.1111/j.1365-2249.2006.03247.x; Shanaube K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018206; Starke JR, 2003, TUBERCULOSIS, V83, P208, DOI 10.1016/S1472-9792(02)00088-4; Thom RE, 2012, VACCINE, V30, P3159, DOI 10.1016/j.vaccine.2012.03.008; Thomas TA, 2010, PEDIATRICS, V126, pE1522, DOI 10.1542/peds.2010-0885; Tristão-Sá Ricardo, 2002, Rev. Soc. Bras. Med. Trop., V35, P533, DOI 10.1590/S0037-86822002000500020; Veerapathran A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001850; WHO, WHO CHILD GROWTH STA	46	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97992	10.1371/journal.pone.0097992	http://dx.doi.org/10.1371/journal.pone.0097992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879374	Green Published, Green Submitted, gold			2022-12-25	WOS:000338101500028
J	Rollin-Pinheiro, R; Liporagi-Lopes, LC; de Meirelles, JV; de Souza, LM; Barreto-Bergter, E				Rollin-Pinheiro, Rodrigo; Liporagi-Lopes, Livia Cristina; de Meirelles, Jardel Vieira; de Souza, Lauro M.; Barreto-Bergter, Eliana			Characterization of Scedosporium apiospermum Glucosylceramides and Their Involvement in Fungal Development and Macrophage Functions	PLOS ONE			English	Article							LIPOSOMAL AMPHOTERICIN-B; CRYPTOCOCCUS-NEOFORMANS; PSEUDALLESCHERIA-BOYDII; MONOCLONAL-ANTIBODY; BIOLOGICAL FUNCTIONS; FONSECAEA-PEDROSOI; ANTIFUNGAL AGENTS; VORICONAZOLE; CASPOFUNGIN; INFECTION	Scedosporium apiospermum is an emerging fungal pathogen that causes both localized and disseminated infections in immunocompromised patients. Glucosylceramides (CMH, GlcCer) are the main neutral glycosphingolipids expressed in fungal cells. In this study, glucosylceramides (GlcCer) were extracted and purified in several chromatographic steps. Using high-performance thin layer chromatography (HPTLC) and electrospray ionization mass spectrometry (ESI-MS), N-2'-hydroxyhexadecanoyl-1-beta-D-glucopyranosyl-9- methyl-4,8-sphingadienine was identified as the main GlcCer in S. apiospermum. A monoclonal antibody (Mab) against this molecule was used for indirect immunofluorescence experiments, which revealed that this CMH is present on the surface of the mycelial and conidial forms of S. apiospermum. Treatment of S. apiospermum conidia with the Mab significantly reduced fungal growth. In addition, the Mab also enhanced the phagocytosis and killing of S. apiospermum by murine cells. In vitro assays were performed to evaluate the CMHs for their cytotoxic activities against the mammalian cell lines L. 929 and RAW, and an inhibitory effect on cell proliferation was observed. Synergistic in vitro interactions were observed between the Mab against GlcCer and both amphotericin B (AmB) and itraconazole. Because Scedosporium species develop drug resistance, the number of available antifungal drugs is limited; our data indicate that combining immunotherapy with the available drugs might be a viable treatment option. These results suggest that in S. apiospermum, GlcCer are most likely cell wall components that are targeted by antifungal antibodies, which directly inhibit fungal development and enhance macrophage function; furthermore, these results suggest the combined use of monoclonal antibodies against GlcCer and antifungal drugs for antifungal immunotherapy.	[Rollin-Pinheiro, Rodrigo; de Meirelles, Jardel Vieira; Barreto-Bergter, Eliana] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Dept Microbiol Geral, Rio De Janeiro, RJ, Brazil; [Liporagi-Lopes, Livia Cristina] Univ Fed Rio de Janeiro, Fac Farm, Dept Anal Clin & Toxicol, Rio De Janeiro, RJ, Brazil; [de Souza, Lauro M.] Univ Fed Parana, Dept Bioquim & Biol Mol, BR-80060000 Curitiba, Parana, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Parana	Barreto-Bergter, E (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Dept Microbiol Geral, Rio De Janeiro, RJ, Brazil.	eliana.bergter@micro.ufrj.br	Bergter, Eliana Barreto/E-2664-2013; Souza, Lauro/AAE-3273-2019	Souza, Lauro/0000-0001-9166-2146	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Conselho de Pesquisa da UFRJ; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Programa de Nucleos de Excelencia (PRONEX); CAPES/FAPERJ; CNPq	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho de Pesquisa da UFRJ; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Programa de Nucleos de Excelencia (PRONEX); CAPES/FAPERJ(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Conselho de Pesquisa da UFRJ, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ and Programa de Nucleos de Excelencia (PRONEX). LCLL and EBB are supported by CAPES/FAPERJ and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto-Bergter E, 2004, AN ACAD BRAS CIENC, V76, P67, DOI 10.1590/S0001-37652004000100007; Barreto-Bergter E, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00239; Blyth CC, MED MYCOL S1, V48, pS37; CaesarTonThat TC, 1997, INFECT IMMUN, V65, P5354, DOI 10.1128/IAI.65.12.5354-5357.1997; Calixto R, 2010, RES MICROBIOL, V161, P720, DOI [10.1016/J.resmic.2010.07.005, 10.1016/j.resmic.2010.07.005]; Casadevall A, 1998, ANTIMICROB AGENTS CH, V42, P1437, DOI 10.1128/AAC.42.6.1437; Cimon B, 2000, EUR J CLIN MICROBIOL, V19, P53, DOI 10.1007/s100960050011; Cortez KJ, 2008, CLIN MICROBIOL REV, V21, P157, DOI 10.1128/CMR.00039-07; Cuenca-Estrella M, 2008, ANTIMICROB AGENTS CH, V52, P1136, DOI 10.1128/AAC.01160-07; da Silva AFC, 2004, FEBS LETT, V561, P137, DOI 10.1016/S0014-5793(04)00156-5; Duarte RS, 1998, BBA-LIPID LIPID MET, V1390, P186, DOI 10.1016/S0005-2760(97)00179-3; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gilgado F, 2006, ANTIMICROB AGENTS CH, V50, P4211, DOI 10.1128/AAC.00981-06; Guarro J, 2006, MED MYCOL, V44, P295, DOI 10.1080/13693780600752507; Guimaraes AJ, 2009, INFECT IMMUN, V77, P1357, DOI 10.1128/IAI.01443-08; Han Y, 2010, INT IMMUNOPHARMACOL, V10, P1526, DOI 10.1016/j.intimp.2010.08.027; Kanafani ZA, 2004, EUR J CLIN MICROBIOL, V23, P836, DOI 10.1007/s10096-004-1233-2; Kontoyiannis DP, 2003, CANCER, V98, P292, DOI 10.1002/cncr.11479; Lackner M, 2012, MED MYCOL, V50, P497, DOI 10.3109/13693786.2011.618939; Lackner M, 2011, MYCOSES, V54, P12, DOI 10.1111/j.1439-0507.2011.02110.x; Lackner M, ANTIMICROB AGENTS CH, V56, P2635; Lamaris GA, 2008, J INFECT DIS, V198, P186, DOI 10.1086/589305; Lamaris GA, 2006, CLIN INFECT DIS, V43, P1580, DOI 10.1086/509579; Lopes LC, PLOS NEGL TROP DIS, V4, pe853; Manavathu EK, 1999, J CLIN MICROBIOL, V37, P858, DOI 10.1128/JCM.37.3.858-861.1999; Nimrichter L, 2005, INFECT IMMUN, V73, P7860, DOI 10.1128/IAI.73.12.7860-7868.2005; Nimrichter L, 2004, MICROBES INFECT, V6, P657, DOI 10.1016/j.micinf.2004.03.004; Pinto MR, 2005, GLYCOBIOLOGY, V15, P895, DOI 10.1093/glycob/cwi084; Pinto MR, 2002, GLYCOBIOLOGY, V12, P251, DOI 10.1093/glycob/12.4.251; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; Rodrigues ML, 2007, CLIN VACCINE IMMUNOL, V14, P1372, DOI 10.1128/CVI.00202-07; Rodrigues ML, 2007, EUKARYOT CELL, V6, P48, DOI 10.1128/EC.00318-06; Rodrigues ML, 2000, INFECT IMMUN, V68, P7049, DOI 10.1128/IAI.68.12.7049-7060.2000; Seifert T, 2002, J NEUROL, V249, P1109, DOI 10.1007/s00415-002-0723-3; Steinbach WJ, 2003, J CLIN MICROBIOL, V41, P3981, DOI 10.1128/JCM.41.8.3981-3985.2003; Tadros TS, 1998, HUM PATHOL, V29, P1266, DOI 10.1016/S0046-8177(98)90255-6; Toledo MS, 2001, GLYCOBIOLOGY, V11, P105, DOI 10.1093/glycob/11.2.105; Walsh T J, 1999, Transpl Infect Dis, V1, P247, DOI 10.1034/j.1399-3062.1999.010404.x; Walsh TJ, 2002, NEW ENGL J MED, V346, P225, DOI 10.1056/NEJM200201243460403; Walsh TJ, 1998, CLIN INFECT DIS, V26, P1383, DOI 10.1086/516353; Wiederhold NP, 2009, MED MYCOL, V47, P422, DOI 10.1080/13693780802510224; Xu JG, 2003, PHARMACEUT RES, V20, P169, DOI 10.1023/A:1022254617664; Zouhair R, MED MYCOL, V51, P603	44	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98149	10.1371/journal.pone.0098149	http://dx.doi.org/10.1371/journal.pone.0098149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878570	gold, Green Published, Green Submitted			2022-12-25	WOS:000338101500033
J	Liukko, ALK; Kinnunen, TT; Rytkonen-Nissinen, MA; Kailaanmaki, AHT; Randell, JT; Maillere, B; Virtanen, TI				Liukko, Aino L. K.; Kinnunen, Tuure T.; Rytkonen-Nissinen, Marja A.; Kailaanmaki, Anssi H. T.; Randell, Jukka T.; Maillere, Bernard; Virtanen, Tuomas I.			Human CD4(+) T Cell Responses to the Dog Major Allergen Can f 1 and Its Human Homologue Tear Lipocalin Resemble Each Other	PLOS ONE			English	Article							BLA G 4; IMMUNE-RESPONSES; IMMUNOGLOBULIN-E; PEPTIDE; DIFFERENTIATION; CLONING; RECOGNITION; PROTEINS; ANTIGEN; EPITOPE	Lipocalin allergens form a notable group of proteins, as they contain most of the significant respiratory allergens from mammals. The basis for the allergenic capacity of allergens in the lipocalin family, that is, the development of T-helper type 2 immunity against them, is still unresolved. As immunogenicity has been proposed to be a decisive feature of allergens, the purpose of this work was to examine human CD4(+) T cell responses to the major dog allergen Can f 1 and to compare them with those to its human homologue, tear lipocalin (TL). For this, specific T cell lines were induced in vitro from the peripheral blood mononuclear cells of Can f 1-allergic and healthy dog dust-exposed subjects with peptides containing the immunodominant T cell epitopes of Can f 1 and the corresponding TL peptides. We found that the frequency of Can f 1 and TL-specific T cells in both subject groups was low and close to each other, the difference being about two-fold. Importantly, we found that the proliferative responses of both Can f 1 and TL-specific T cell lines from allergic subjects were stronger than those from healthy subjects, but that the strength of the responses within the subject groups did not differ between these two antigens. Moreover, the phenotype of the Can f 1 and TL-specific T cell lines, determined by cytokine production and expression of cell surface markers, resembled each other. The HLA system appeared to have a minimal role in explaining the allergenicity of Can f 1, as the allergic and healthy subjects' HLA background did not differ, and HLA binding was very similar between Can f 1 and TL peptides. Along with existing data on lipocalin allergens, we conclude that strong antigenicity is not decisive for the allergenicity of Can f 1.	[Liukko, Aino L. K.; Kinnunen, Tuure T.; Rytkonen-Nissinen, Marja A.; Kailaanmaki, Anssi H. T.; Virtanen, Tuomas I.] Univ Eastern Finland, Inst Clin Med, Dept Clin Microbiol, Kuopio, Finland; [Liukko, Aino L. K.; Kinnunen, Tuure T.; Rytkonen-Nissinen, Marja A.; Kailaanmaki, Anssi H. T.; Virtanen, Tuomas I.] Univ Eastern Finland, Bioctr Kuopio, Kuopio, Finland; [Rytkonen-Nissinen, Marja A.] Univ Eastern Finland, Inst Dent, Sch Med, Kuopio, Finland; [Randell, Jukka T.] Kuopio Univ Hosp, Dept Pulm Dis, SF-70210 Kuopio, Finland; [Maillere, Bernard] Commissariat Energie Atom, Serv Ingn Mol Prot, Inst Biol & Technol, Gif Sur Yvette, France	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Liukko, ALK (corresponding author), Univ Eastern Finland, Inst Clin Med, Dept Clin Microbiol, Kuopio, Finland.	aino.liukko@uef.fi	Kinnunen, Tuure/D-4898-2011	Kinnunen, Tuure/0000-0003-1595-5371; Ronka, Aino/0000-0001-6007-3648; Kailaanmaki, Anssi/0000-0002-4737-980X; Rytkonen-Nissinen, Marja/0000-0002-2014-8315	Kuopio University Hospital [5021605]; Ida Montin Foundation; Foundation of the Finnish Anti-Tuberculosis Association; Finnish Cultural Foundation; Respiratory Foundation of Kuopio, Finland	Kuopio University Hospital; Ida Montin Foundation; Foundation of the Finnish Anti-Tuberculosis Association; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Respiratory Foundation of Kuopio, Finland	This study was financially supported by Kuopio University Hospital (project no. 5021605), the Ida Montin Foundation (http://www.idamontininsaatio.fi/pages/suomi/etusivu.php), the Foundation of the Finnish Anti-Tuberculosis Association (http://www.tb-foundation.org/), the Finnish Cultural Foundation (https://skr.fi/) and the Respiratory Foundation of Kuopio, Finland (http://www.hengityssaatio.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2006, CURR OPIN IMMUNOL, V18, P718, DOI 10.1016/j.coi.2006.09.016; Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058; Arruda LK, 1995, J BIOL CHEM, V270, P31196, DOI 10.1074/jbc.270.52.31196; Barber JS, 2013, P NATL ACAD SCI USA, V110, P8164, DOI 10.1073/pnas.1302103110; Bateman EAL, 2006, J ALLERGY CLIN IMMUN, V118, P1350, DOI 10.1016/j.jaci.2006.07.040; Bellinghausen I, 2003, IMMUNOLOGY, V108, P167, DOI 10.1046/j.1365-2567.2003.01576.x; Boldogh I, 2005, J CLIN INVEST, V115, P2169, DOI 10.1172/JCI24422; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Brogdon JL, 2002, J IMMUNOL, V168, P3825, DOI 10.4049/jimmunol.168.8.3825; Castelli FA, 2002, J IMMUNOL, V169, P6928, DOI 10.4049/jimmunol.169.12.6928; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; da Costa Santiago H, 2012, PLOS ONE, V7, DOI DOI 10.1371/JOURNAL.PONE.0040552; Danke NA, 2004, J IMMUNOL, V172, P5967, DOI 10.4049/jimmunol.172.10.5967; Emanuelsson C, 2007, MOL IMMUNOL, V44, P3256, DOI 10.1016/j.molimm.2007.01.019; Epton MJ, 2002, CLIN EXP ALLERGY, V32, P1341, DOI 10.1046/j.1365-2222.2002.01473.x; Ferreira F, 1996, J EXP MED, V183, P599, DOI 10.1084/jem.183.2.599; Ganfornina M.D., 2006, LIPOCALINS, P17; Gebe JA, 2003, EUR J IMMUNOL, V33, P1409, DOI 10.1002/eji.200323871; Gelder CM, 1996, J VIROL, V70, P4787, DOI 10.1128/JVI.70.7.4787-4790.1996; Gilles S, 2011, J ALLERGY CLIN IMMUN, V127, P454, DOI 10.1016/j.jaci.2010.12.1082; Gilles S, 2009, J IMMUNOL, V182, P6653, DOI 10.4049/jimmunol.0802613; Gregoire C, 1996, J BIOL CHEM, V271, P32951, DOI 10.1074/jbc.271.51.32951; Helm Ricki M, 2008, Clin Allergy Immunol, V21, P219; Hemmer B, 1997, J EXP MED, V185, P1651, DOI 10.1084/jem.185.9.1651; Hermann R, 2003, TISSUE ANTIGENS, V62, P162, DOI 10.1034/j.1399-0039.2003.00071.x; Hilger C, 2005, J ALLERGY CLIN IMMUN, V115, P617, DOI 10.1016/j.jaci.2004.11.052; Hilger C, 2012, CURR ALLERGY ASTHMA; Holt PG, 2005, NAT IMMUNOL, V6, P957, DOI 10.1038/ni1005-957; HOSKEN NA, 1995, J EXP MED, V182, P1579, DOI 10.1084/jem.182.5.1579; Immonen A, 2007, CLIN EXP ALLERGY, V37, P939, DOI 10.1111/j.1365-2222.2007.02722.x; Immonen A, 2003, CLIN EXP ALLERGY, V33, P834, DOI 10.1046/j.1365-2222.2003.01669.x; Immonen A, 2005, J IMMUNOL, V175, P3614, DOI 10.4049/jimmunol.175.6.3614; Immonen AK, 2007, IMMUNOLOGY, V120, P38, DOI 10.1111/j.1365-2567.2006.02475.x; Janssen EM, 2000, J IMMUNOL, V164, P580, DOI 10.4049/jimmunol.164.2.580; Jeal H, 2004, CLIN EXP ALLERGY, V34, P1919, DOI 10.1111/j.1365-2222.2004.02126.x; Juntunen R, 2009, MOL IMMUNOL, V46, P3320, DOI 10.1016/j.molimm.2009.07.022; Kauppinen A, 2012, IMMUNOBIOLOGY, V217, P8, DOI 10.1016/j.imbio.2011.08.012; Kinnunen T, 2005, INT IMMUNOL, V17, P1573, DOI 10.1093/intimm/dxh332; Kinnunen T, 2003, EUR J IMMUNOL, V33, P1717, DOI 10.1002/eji.200322952; Kinnunen T, 2005, CLIN EXP ALLERGY, V35, P797, DOI 10.1111/j.1365-2222.2005.02247.x; Kinnunen T, 2010, EUR J IMMUNOL, V40, P2460, DOI 10.1002/eji.201040328; Konieczny A, 1997, IMMUNOLOGY, V92, P577, DOI 10.1046/j.1365-2567.1997.00386.x; Korb LC, 1999, J IMMUNOL, V162, P6401; Mantyjarvi R, 1996, J ALLERGY CLIN IMMUN, V97, P1297, DOI 10.1016/S0091-6749(96)70198-7; Milner JD, 2010, J IMMUNOL, V184, P6569, DOI 10.4049/jimmunol.1000674; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; O'Garra A, 2011, NAT IMMUNOL, V12, P288, DOI 10.1038/ni.2003; Oseroff C, 2012, J IMMUNOL, V189, P679, DOI 10.4049/jimmunol.1200694; Oseroff C, 2010, J IMMUNOL, V185, P943, DOI 10.4049/jimmunol.1000405; Paddock CD, 2001, J IMMUNOL, V167, P2694, DOI 10.4049/jimmunol.167.5.2694; PARRONCHI P, 1991, P NATL ACAD SCI USA, V88, P4538, DOI 10.1073/pnas.88.10.4538; Parviainen S, 2013, SCAND J IMMUNOL, V77, P171, DOI 10.1111/sji.12023; Parviainen S, 2010, J ALLERGY CLIN IMMUN, V126, DOI 10.1016/j.jaci.2010.06.005; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; PFEIFFER C, 1995, J EXP MED, V181, P1569, DOI 10.1084/jem.181.4.1569; Platts-Mills TAE, 2007, J ALLERGY CLIN IMMUN, V119, P297, DOI 10.1016/j.jaci.2006.12.647; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Rogers PR, 1999, J IMMUNOL, V163, P1205; Saarelainen S, 2008, CLIN EXP ALLERGY, V38, P374, DOI 10.1111/j.1365-2222.2007.02895.x; Saarelainen S, 2002, INT IMMUNOL, V14, P401, DOI 10.1093/intimm/14.4.401; Saarelainen S, 2004, CLIN EXP ALLERGY, V34, P1576, DOI 10.1111/j.1365-2222.2004.02071.x; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Schountz T, 1996, J IMMUNOL, V157, P3893; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Smole U, 2010, ALLERGY; Tan YW, 2009, J BIOL CHEM, V284, P3148, DOI 10.1074/jbc.M807209200; Texier C, 2000, J IMMUNOL, V164, P3177, DOI 10.4049/jimmunol.164.6.3177; Texier C, 2001, EUR J IMMUNOL, V31, P1837, DOI 10.1002/1521-4141(200106)31:6&lt;1837::AID-IMMU1837&gt;3.0.CO;2-H; Traidl-Hoffmann C, 2005, J EXP MED, V201, P627, DOI 10.1084/jem.20041065; Turner SJ, 2009, CURR OPIN IMMUNOL, V21, P286, DOI 10.1016/j.coi.2009.05.004; Van Overtvelt L, 2008, J IMMUNOL, V180, P4514, DOI 10.4049/jimmunol.180.7.4514; Virtanen T, 1999, INT ARCH ALLERGY IMM, V120, P247, DOI 10.1159/000024277; Virtanen T, 1999, IMMUNOL TODAY, V20, P398, DOI 10.1016/S0167-5699(99)01515-7; Virtanen T, 2012, CLIN EXP ALLERGY, V42, P494, DOI 10.1111/j.1365-2222.2011.03903.x; Virtanen T, 2014, ALLERGENS A IN PRESS; Virtanen T, 2007, J ALLERGY CLIN IMMUN, V120, P724, DOI 10.1016/j.jaci.2007.04.020; Virtanen Tuomas, 2008, Clin Allergy Immunol, V21, P201; Wambre E, 2011, CLIN EXP ALLERGY, V41, P192, DOI 10.1111/j.1365-2222.2010.03641.x; Wambre E, 2008, INT ARCH ALLERGY IMM, V146, P99, DOI 10.1159/000113513; Wambre E, 2012, J ALLERGY CLIN IMMUN, V129, P544, DOI 10.1016/j.jaci.2011.08.034; Yamane H, 2012, NAT IMMUNOL, V13, P1037, DOI 10.1038/ni.2431; Zaborsky N, 2010, J IMMUNOL, V184, P725, DOI 10.4049/jimmunol.0902080; Zeiler T, 1999, J IMMUNOL, V162, P1415	83	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98461	10.1371/journal.pone.0098461	http://dx.doi.org/10.1371/journal.pone.0098461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875388	Green Submitted, Green Published, gold			2022-12-25	WOS:000336790800041
J	Misch, F; Messmer, AS; Nickel, CH; Gujan, M; Graber, A; Blume, K; Bingisser, R				Misch, Franziska; Messmer, Anna Sarah; Nickel, Christian Hans; Gujan, Madleina; Graber, Andreas; Blume, Katharina; Bingisser, Roland			Impact of Observation on Disposition of Elderly Patients Presenting to Emergency Departments with Non-Specific Complaints	PLOS ONE			English	Article							RISK-STRATIFICATION TOOL; ADVERSE HEALTH OUTCOMES; OLDER-ADULTS; SCREENING TOOL; PREDICTIVE-VALIDITY; SEVERITY INDEX; PRIMARY-CARE; TRIAGE; POPULATION; VALIDATION	Background: Emergency Departments (EDs) have to cope with an increasing number of elderly patients, often presenting with non-specific complaints (NSC), such as generalized weakness. Acute morbidity requiring early intervention is present in the majority of patients with NSC. Therefore, an early and optimal disposition plan is crucial. The objective of this study was to prospectively study the disposition process of patients presenting to the ED with NSC. Methods: For two years, all patients presenting with NSC presenting to an urban ED were screened and consecutively included. The initial disposition plan was compared to the effective transfer after observation. Optimal disposition was defined as a high accuracy regarding disposition of patients with acute morbidity to an internal medicine ward. Results: The final study population consisted of 669 patients with NSC. Admission to internal medicine increased from 297 (44%) planned admissions to 388 (58%) effective admissions after observation. Conversely, transfers to geriatric community hospitals and discharges decreased from the initially planned 372 (56%) patients to 281 (42%) effectively transferred and discharged patients. The accuracy regarding disposition of patients with acute morbidity increased from 53% to 68% after observation. Conclusion: Disposition planning in patients with NSC improves after observation, if defined by the accuracy regarding hospitalization of patients with acute morbidity. Further research should focus on risk stratification tools for timely disposition planning in order to reduce high admission rates for patients without acute morbidity and high readmission rates for discharged patients with non-specific complaints.	[Misch, Franziska; Messmer, Anna Sarah; Nickel, Christian Hans; Gujan, Madleina; Graber, Andreas; Blume, Katharina; Bingisser, Roland] Univ Basel Hosp, Emergency Dept, CH-4031 Basel, Switzerland	University of Basel	Bingisser, R (corresponding author), Univ Basel Hosp, Emergency Dept, CH-4031 Basel, Switzerland.	Roland.Bingisser@usb.ch		Messmer, Anna/0000-0002-3206-9112				Aminzadeh F, 2002, ANN EMERG MED, V39, P238, DOI 10.1067/mem.2002.121523; Antic NA, 2011, SLEEP, V34, P111, DOI 10.1093/sleep/34.1.111; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Dendukuri N, 2004, J AM GERIATR SOC, V52, P290, DOI 10.1111/j.1532-5415.2004.52073.x; Elmstahl S, 1999, AGING-CLIN EXP RES, V11, P56, DOI 10.1007/BF03399638; Exadaktylos Aristomenis K, 2008, J Trauma Manag Outcomes, V2, P11, DOI 10.1186/1752-2897-2-11; Fan J, 2006, AM J EMERG MED, V24, P540, DOI 10.1016/j.ajem.2006.01.015; George G, 2006, EMERG MED J, V23, P379, DOI 10.1136/emj.2005.029793; Graff L, 2009, AM COLL EMERGENCY PH, V176; Grossmann FF, 2012, ANN EMERG MED, V60, P317, DOI 10.1016/j.annemergmed.2011.12.013; Grossmann FF, 2011, ANN EMERG MED, V57, P257, DOI 10.1016/j.annemergmed.2010.07.021; Hastings SN, 2007, J GEN INTERN MED, V22, P1527, DOI 10.1007/s11606-007-0343-9; Hustey FM, 2007, J AM GERIATR SOC, V55, P1269, DOI 10.1111/j.1532-5415.2007.01272.x; Jayaprakash N, 2009, WEST J EMERG MED, V10, P233; KATZ S, 1970, GERONTOLOGIST, V10, P20, DOI 10.1093/geront/10.1_Part_1.20; KATZ S, 1976, MED CARE, V14, P116, DOI 10.1097/00005650-197605001-00018; Marx J., 2013, ROSENS EMERGENCY MED; MCCAIG LF, 2006, ADV DATA, V372, P1; McCusker J, 1999, J AM GERIATR SOC, V47, P1229, DOI 10.1111/j.1532-5415.1999.tb05204.x; Meldon SW, 2003, ACAD EMERG MED, V10, P224, DOI 10.1111/j.1553-2712.2003.tb01996.x; Mudge AM, 2011, J HOSP MED, V6, P61, DOI 10.1002/jhm.811; Nemec M, 2010, ACAD EMERG MED, V17, P284, DOI 10.1111/j.1553-2712.2009.00658.x; Nickel CH, 2013, AM J EMERG MED; Nickel CH, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-7; Nickel CH, 2009, SWISS MED WKLY, V139, P271, DOI smw-12620; Pines JM, 2010, ANN EMERG MED; Rudiger-Sturchler M, 2010, SWISS MED WKLY, V140, DOI [10.4414/smw.2010/13085, 10.4414/smw.2010.13085]; Ruger JP, 2007, AM J EMERG MED, V25, P794, DOI 10.1016/j.ajem.2007.01.014; Rust G, 2008, ARCH INTERN MED, V168, P1705, DOI 10.1001/archinte.168.15.1705; Rutschmann OT, 2005, SWISS MED WKLY, V135, P145; Salvi F, 2007, INTERN EMERG MED, V2, P292, DOI 10.1007/s11739-007-0081-3; Samaras N, 2010, ANN EMERG MED, V56, P261, DOI 10.1016/j.annemergmed.2010.04.015; Schumacher JG, 2006, J EMERG MED, V30, P455, DOI 10.1016/j.jemermed.2005.07.008; Schumacher JG, 2005, AM J EMERG MED, V23, P556, DOI 10.1016/j.ajem.2004.12.011; van Bokhoven MA, 2008, J CLIN EPIDEMIOL, V61, P318, DOI 10.1016/j.jclinepi.2007.05.008	36	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98097	10.1371/journal.pone.0098097	http://dx.doi.org/10.1371/journal.pone.0098097			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871340	Green Published, gold, Green Submitted			2022-12-25	WOS:000336858300024
J	Rhee, EJ; Lee, MK; Kim, JD; Jeon, WS; Bae, JC; Park, SE; Park, CY; Oh, KW; Park, SW; Lee, WY				Rhee, Eun-Jung; Lee, Min Kyung; Kim, Jong Dae; Jeon, Won Seon; Bae, Ji Cheol; Park, Se Eun; Park, Cheol-Young; Oh, Ki-Won; Park, Sung-Woo; Lee, Won-Young			Metabolic Health Is a More Important Determinant for Diabetes Development than Simple Obesity: A 4-Year Retrospective Longitudinal Study	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; RISK; ASSOCIATION; PREVALENCE; TOLERANCE; PROGNOSIS; MELLITUS	Background: Recent studies report the importance of metabolic health beyond obesity. The aim of this study is to compare the risk for diabetes development according to different status of metabolic health and obesity over a median follow-up of 48.7 months. Methods: 6,748 non-diabetic subjects (mean age 43 years) were divided into four groups according to the baseline metabolic health and obesity status: metabolically healthy non-obese (MHNO), metabolically healthy obese (MHO), metabolically unhealthy non-obese (MUHNO) and metabolically unhealthy obese (MUHO). Being metabolically healthy was defined by having less than 2 components among the 5 components, that is, high blood pressure, high fasting blood glucose, high triglyceride, low high-density lipoprotein cholesterol and being in the highest decile of homeostasis model assessment-insulin resistance (HOMA-IR) index. Obesity status was assessed by body mass index (BMI) higher than 25 kg/m 2. The development of diabetes was assessed annually from self-questionnaire, fasting glucose and HbA1c. Results: At baseline, 45.3% of the subjects were MHNO, 11.3% were MHO, 21.7% were MUHNO, and 21.7% were MUHO. During a median follow-up of 48.7 months, 277 subject (4.1%) developed diabetes. The hazard ratio for diabetes development was 1.338 in MHO group (95% CI 0.67-2.672), 4.321 in MUHNO group (95% CI 2.702-6.910) and 5.994 in MUHO group (95% CI 3.561-10.085) when MHNO group was considered as the reference group. These results were similar after adjustment for the changes of the risk factors during the follow-up period. Conclusion: The risk for future diabetes development was higher in metabolically unhealthy subgroups compared with those of metabolically healthy subjects regardless of obesity status.	[Rhee, Eun-Jung; Lee, Min Kyung; Kim, Jong Dae; Jeon, Won Seon; Park, Se Eun; Park, Cheol-Young; Oh, Ki-Won; Park, Sung-Woo; Lee, Won-Young] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea; [Bae, Ji Cheol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, WY (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea.	drlwy@hanmail.net	LEE, WON-YOUNG/C-7249-2018; Rhee, Eun-Jung/M-9294-2015; Park, Cheol-Young/C-6690-2018	LEE, WON-YOUNG/0000-0002-1082-7592; Rhee, Eun-Jung/0000-0002-6108-7758; Park, Cheol-Young/0000-0002-9415-9965				Alberti KG, 2009, CIRCULATION, V120, DOI DOI 10.1161/CIRCULATIONAHA.109.192644; Alqahtani N, 2013, INT J PREVENTIVE MED, V4, P1025; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971; Bluher M, 2012, CURR OPIN ENDOCRINOL, V19, P341, DOI 10.1097/MED.0b013e328357f0a3; Calori G, 2011, DIABETES CARE, V34, P210, DOI 10.2337/dc10-0665; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Hamer M, 2012, J CLIN ENDOCR METAB, V97, P2482, DOI 10.1210/jc.2011-3475; Hinnouho GM, 2013, DIABETES CARE, V36, P2294, DOI 10.2337/dc12-1654; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kloting N, 2010, AM J PHYSIOL-ENDOC M, V299, pE506, DOI 10.1152/ajpendo.00586.2009; Majka DS, 2009, AM J PREV MED, V36, P56, DOI 10.1016/j.amepre.2008.09.031; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McLaughlin T, 2011, J CLIN ENDOCR METAB, V96, pE1756, DOI 10.1210/jc.2011-0615; North KE, 2003, INT J OBESITY, V27, P491, DOI 10.1038/sj.ijo.0802261; Ortega FB, 2013, EUR HEART J, V34, P390, DOI 10.1093/eurheartj/ehs174; Phillips CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076188; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Samocha-Bonet D, 2012, TRENDS ENDOCRIN MET, V23, P116, DOI 10.1016/j.tem.2011.12.005; Schwartz Kendra L, 2005, BMC Fam Pract, V6, P28, DOI 10.1186/1471-2296-6-28; Seo MH, 2011, J CLIN ENDOCR METAB, V96, pE2050, DOI 10.1210/jc.2011-1857; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steering Committee of the WHO Western Pacific Region IASO & IOTF, 2000, AS PAC PERSP RED OB; Velho S, 2010, EUR J CLIN NUTR, V64, P1043, DOI 10.1038/ejcn.2010.114; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617; Yu JH, 2013, ENDOCRINOL METAB, V28, P33, DOI 10.3803/EnM.2013.28.1.33	27	41	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98369	10.1371/journal.pone.0098369	http://dx.doi.org/10.1371/journal.pone.0098369			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870949	Green Published, Green Submitted, gold			2022-12-25	WOS:000336858300039
J	Auld, AF; Ekra, KA; Shiraishi, RW; Tuho, MZ; Kouakou, JS; Mohamed, F; Ettiegne-Traore, V; Sabatier, J; Essombo, J; Adjorlolo-Johnson, G; Marlink, R; Ellerbrock, TV				Auld, Andrew F.; Ekra, Kunomboa A.; Shiraishi, Ray W.; Tuho, Moise Z.; Kouakou, Joseph S.; Mohamed, Fayama; Ettiegne-Traore, Virginie; Sabatier, Jennifer; Essombo, Joseph; Adjorlolo-Johnson, Georgette; Marlink, Richard; Ellerbrock, Tedd V.			Temporal Trends in Treatment Outcomes for HIV-1 and HIV-2-Infected Adults Enrolled in Cote d'Ivoire's National Antiretroviral Therapy Program	PLOS ONE			English	Article							PHYSICIAN-PATIENT RELATIONSHIPS; SUB-SAHARAN AFRICA; SCALE-UP; REVERSE-TRANSCRIPTASE; DRUG-RESISTANCE; INFECTED ADULTS; COTRIMOXAZOLE PROPHYLAXIS; MULTIPLE IMPUTATION; FOOD INSECURITY; SEX-DIFFERENCES	Background: In C (o) over cap te d'Ivoire during 2004-2007, numbers of ART enrollees increased from,5,000 to 36,943. Trends in nationally representative ART program outcomes have not yet been reported. Methodology/Principal Findings: We conducted a retrospective chart review to assess trends in patient characteristics and attrition [death or loss to follow-up (LTFU)] over time, among a nationally representative sample of 3,682 adults (>= 15 years) initiating ART during 2004-2007 at 34 health facilities. Among ART enrollees during 2004-2007, median age was 36, the proportion female was 67%, the proportion HIV-2-infected or dually HIV-1&2 reactive was 5%, and median baseline CD4(+) T-cell (CD4) count was 135 cells/mu L. Comparing cohorts initiating ART in 2004 with cohorts initiating ART in 2007, median baseline weight declined from 55 kg to 52 kg (p = 0.008) and the proportion weighing <45 kg increased from 17% to 22% (p = 0.014). During 2004-2007, pharmacy-based estimates of the percentage of new ART enrollees >= 95% adherent to ART declined from 74% to 60% (p = 0.026), and twelve-month retention declined from 86% to 69%, due to increases in 12-month mortality from 2%-4% and LTFU from 12%-28%. In univariate analysis, year of ART initiation was associated with increasing rates of both LTFU and mortality. Controlling for baseline CD4, weight, adherence, and other risk factors, year of ART initiation was still strongly associated with LTFU but not mortality. In multivariate analysis, weight <45 kg and adherence <95% remained strong predictors of LTFU and mortality. Conclusions: During 2004-2007, increasing prevalence among ART enrollees of measured mortality risk factors, including weight <45 kg and ART adherence <95%, might explain increases in mortality over time. However, the association between later calendar year and increasing LTFU is not explained by risk factors evaluated in this analysis. Undocumented transfers, political instability, and patient dissatisfaction with crowded facilities might explain increasing LTFU.	[Auld, Andrew F.; Shiraishi, Ray W.; Sabatier, Jennifer; Ellerbrock, Tedd V.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA 30333 USA; [Ekra, Kunomboa A.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Abidjan, Cote Ivoire; [Tuho, Moise Z.; Ettiegne-Traore, Virginie] Minist Hlth, Natl Program Med Care Persons Living HIV AIDS, Abidjan, Cote Ivoire; [Kouakou, Joseph S.; Mohamed, Fayama; Essombo, Joseph] Elizabeth Glaser Pediat AIDS Fdn, Abidjan, Cote Ivoire; [Mohamed, Fayama] Directorate Gen Budget & Finance, Dept Econ & Finance, Abidjan, Cote Ivoire; [Adjorlolo-Johnson, Georgette; Marlink, Richard] Elizabeth Glaser Pediat AIDS Fdn, Los Angeles, CA USA	Centers for Disease Control & Prevention - USA	Auld, AF (corresponding author), Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA 30333 USA.	aauld@cdc.gov		Shiraishi, Ray/0000-0001-7640-0666; Auld, Andrew/0000-0001-5089-9163	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control and Prevention (CDC)	President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Centers for Disease Control and Prevention (CDC)	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) (http://www.pepfar.gov/) through the United States Centers for Disease Control and Prevention (CDC) (http://www.cdc.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adje-Toure CA, 2003, AIDS, V17, pS49, DOI 10.1097/00002030-200317003-00007; amfAR, 2018, ZIMB DAT PEPFAR MON; [Anonymous], 2008, WORLD POP PROSP 2008; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Tran BX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046680; Bechu N, 2006, IMPACT AIDS EC FAMIL; Bennett S, 2006, LANCET, V367, P79, DOI 10.1016/S0140-6736(06)67928-2; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Boerma JT, 2006, B WORLD HEALTH ORGAN, V84, P145, DOI 10.2471/BLT.05.025189; Colson P, 2005, J MED VIROL, V75, P381, DOI 10.1002/jmv.20296; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Dang BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042980; DECOCK KM, 1993, JAMA-J AM MED ASSOC, V270, P2083, DOI 10.1001/jama.270.17.2083; Decroo T, 2011, JAIDS-J ACQ IMM DEF, V56, pE39, DOI 10.1097/QAI.0b013e3182055138; DJOMAND G, 1995, J ACQ IMMUN DEF SYND, V10, P358; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Fairley CK, 2005, HIV MED, V6, P366, DOI 10.1111/j.1468-1293.2005.00322.x; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Gottlieb GS, 2009, CLIN INFECT DIS, V48, P476, DOI 10.1086/596504; Government Accountability Office, 2012, DES EV 2012 REV; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Harries AD, 2010, TROP MED INT HEALTH, V15, P70, DOI 10.1111/j.1365-3156.2010.02506.x; Harries K, 2010, T ROY SOC TROP MED H, V104, P154, DOI 10.1016/j.trstmh.2009.08.012; Isaka Y, 2001, ARCH VIROL, V146, P743, DOI 10.1007/s007050170143; Joint United Nations Programme on HIV/AIDS, 2012, REP GLOB AIDS EP; Joint United Nations Programme on HIV/AIDS, 2013, GLOB REP UNAIDS REP; Koole O, 2012, 19 INT AIDS C WASH D; Lowrance D, 2007, JAIDS-J ACQ IMM DEF, V46, P56; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Messou E, 2011, JAIDS-J ACQ IMM DEF, V57, pS34, DOI 10.1097/QAI.0b013e3182208003; Messou E, 2011, JAIDS-J ACQ IMM DEF, V56, P356, DOI 10.1097/QAI.0b013e3182084b5a; Montaner JSG, 2010, ANN INTERN MED, V152, P131, DOI 10.7326/0003-4819-152-2-201001190-00019; Musheke M, 2013, AIDS PATIENT CARE ST; Musheke M, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.3.17366; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Owens IPF, 2002, SCIENCE, V297, P2008, DOI 10.1126/science.1076813; Pasquet A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013414; Peterson K, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/463704; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Rajaratnam JK, 2010, LANCET, V375, P1704, DOI 10.1016/S0140-6736(10)60517-X; Roberts KJ, 2002, AIDS PATIENT CARE ST, V16, P43, DOI 10.1089/108729102753429398; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Royston P, 2005, STATA J, V5, P188, DOI 10.1177/1536867X0500500204; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Rubin DB, 2004, MULTIPLE IMPUTATION; Ruelle J, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-21; Schneider J, 2004, J GEN INTERN MED, V19, P1096, DOI 10.1111/j.1525-1497.2004.30418.x; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Shimeles A, 2010, AFRICAN DEV BANK WOR; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Tirivayi Nyasha, 2012, J AIDS Clin Res, V3, P171; Tiyou A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-51; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; United Nations Development Programme, 2011, CONFL COT IV ITS EFF; Vahey DC, 2004, MED CARE, V42, P57, DOI 10.1097/01.mlr.0000109126.50398.5a; van der Ende ME, 2003, AIDS, V17, pS55, DOI 10.1097/00002030-200317003-00008; van der Loeff MFS, 2006, INT J EPIDEMIOL, V35, P1322, DOI 10.1093/ije/dyl037; van Tienen C, 2010, JAIDS-J ACQ IMM DEF, V53, P640, DOI 10.1097/QAI.0b013e3181bf1a25; Walker AS, 2010, LANCET, V375, P1278, DOI 10.1016/S0140-6736(10)60057-8; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; Weiser SD, 2012, JAIDS-J ACQ IMM DEF, V61, P179, DOI 10.1097/QAI.0b013e318261f064; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618; WHO, 2010, ANT THER HIV INF AD; Wilson D, 2009, T ROY SOC TROP MED H, V103, P601, DOI 10.1016/j.trstmh.2008.11.007; Witvrouw M, 2004, ANTIVIR THER, V9, P57; Witvrouw M, 1999, AIDS, V13, P1477, DOI 10.1097/00002030-199908200-00006; World Food Programme, 2011, WORLD FOOD PROGR FIG; Zanoni BC, 2014, AIDS PATIENT CARE ST, V28, P128, DOI 10.1089/apc.2013.0345; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI 10.1016/S0020-7519(96)80001-4	78	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e98183	10.1371/journal.pone.0098183	http://dx.doi.org/10.1371/journal.pone.0098183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5NG	24866468	Green Published, Green Submitted, gold			2022-12-25	WOS:000336914100038
J	Cannan, WJ; Tsang, BP; Wallace, SS; Pederson, DS				Cannan, Wendy J.; Tsang, Betty P.; Wallace, Susan S.; Pederson, David S.			Nucleosomes Suppress the Formation of Double-strand DNA Breaks during Attempted Base Excision Repair of Clustered Oxidative Damages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLASE ACTIVITY; AP-ENDONUCLEASE; CORE PARTICLE; URACIL; STIMULATION; RECOGNITION; HOGG1; INITIATION; HISTONES; BINDING	Exposure to ionizing radiation can produce multiple, clustered oxidative lesions in DNA. The near simultaneous excision of nearby lesions in opposing DNA strands by the base excision repair (BER) enzymes can produce double-strand DNA breaks (DSBs). This attempted BER accounts for many of the potentially lethal or mutagenic DSBs that occur in vivo. To assess the impact of nucleosomes on the frequency and pattern of BER-dependent DSB formation, we incubated nucleosomes containing oxidative damages in opposing DNA strands with selected DNA glycosylases and human apurinic/apyrimidinic endonuclease 1. Overall, nucleosomes substantially suppressed DSB formation. However, the degree of suppression varied as a function of (i) the lesion type and DNA glycosylase tested, (ii) local sequence context and the stagger between opposing strand lesions, (iii) the helical orientation of oxidative lesions relative to the underlying histone octamer, and (iv) the distance between the lesion cluster and the nucleosome edge. In some instances the binding of a BER factor to one nucleosomal lesion appeared to facilitate binding to the opposing strand lesion. DSB formation did not invariably lead to nucleosome dissolution, and in some cases, free DNA ends resulting from DSB formation remained associated with the histone octamer. These observations explain how specific structural and dynamic properties of nucleosomes contribute to the suppression of BER-generated DSBs. These studies also suggest that most BER-generated DSBs will occur in linker DNA and in genomic regions associated with elevated rates of nucleosome turnover or remodeling.	[Cannan, Wendy J.; Tsang, Betty P.; Wallace, Susan S.; Pederson, David S.] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA	University of Vermont	Pederson, DS (corresponding author), Univ Vermont, Dept Microbiol & Mol Genet, Stafford Bldg,Rm 220,95 Carrigan Dr, Burlington, VT 05405 USA.	david.pederson@uvm.edu	Cannan, Wendy J/L-6359-2016	Cannan, Wendy J/0000-0002-7629-8611; Wallace, Susan S./0000-0002-3906-0321	National Institutes of Health [P01-CA098993]; National Science Foundation [MCB-0821941]; NATIONAL CANCER INSTITUTE [P01CA098993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-CA098993 (NCI; to D. S. P.). This work was also supported by National Science Foundation Grant MCB-0821941 (to D. S. P.).	Bailey SM, 2006, DNA REPAIR, V5, P1171, DOI 10.1016/j.dnarep.2006.05.033; Bergonzo C, 2011, J AM CHEM SOC, V133, P14504, DOI 10.1021/ja205142d; Blaisdell JO, 2001, RADIAT PROT DOSIM, V97, P25, DOI 10.1093/oxfordjournals.rpd.a006634; Blaisdell JO, 2001, P NATL ACAD SCI USA, V98, P7426, DOI 10.1073/pnas.131077798; Cadet J, 2012, CANCER LETT, V327, P5, DOI 10.1016/j.canlet.2012.04.005; CHEN DS, 1991, NUCLEIC ACIDS RES, V19, P5907, DOI 10.1093/nar/19.21.5907; Chua EYD, 2012, NUCLEIC ACIDS RES, V40, P6338, DOI 10.1093/nar/gks261; Cole H. A., 2012, BIOCHIM BIOPHYS ACTA, V1819, P643; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; DONG F, 1990, P NATL ACAD SCI USA, V87, P5724, DOI 10.1073/pnas.87.15.5724; Duclos S, 2012, ISSUES TOXICOL, V13, P115, DOI 10.1039/9781849732925-00115; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Eccles LJ, 2011, MUTAT RES-FUND MOL M, V711, P134, DOI 10.1016/j.mrfmmm.2010.11.003; Einstein A, 1905, ANN PHYS-BERLIN, V17, P132; Falk M, 2008, BBA-MOL CELL RES, V1783, P2398, DOI 10.1016/j.bbamcr.2008.07.010; Flaus A, 1996, P NATL ACAD SCI USA, V93, P1370, DOI 10.1073/pnas.93.4.1370; Friedberg E C, 2006, DNA REPAIR MUTAGENES, P9; Fromme JC, 2004, CURR OPIN STRUC BIOL, V14, P43, DOI 10.1016/j.sbi.2004.01.003; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; Halliwell B, 2001, FREE RADICALS OTHER; Harrison L, 1999, J MOL BIOL, V290, P667, DOI 10.1006/jmbi.1999.2892; Harrison L, 1998, NUCLEIC ACIDS RES, V26, P932, DOI 10.1093/nar/26.4.932; HAYES JJ, 1991, P NATL ACAD SCI USA, V88, P6829, DOI 10.1073/pnas.88.15.6829; Hazra TK, 2007, DNA REPAIR, V6, P470, DOI 10.1016/j.dnarep.2006.10.011; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hill DA, 2000, BIOCHEMISTRY-US, V39, P11649, DOI 10.1021/bi001330z; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Horn PJ, 2002, NAT STRUCT BIOL, V9, P263, DOI 10.1038/nsb776; KANE CM, 1981, J BIOL CHEM, V256, P3405; Leipold MD, 2003, BIOCHEMISTRY-US, V42, P11373, DOI 10.1021/bi034951b; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Liu X, 2002, J MOL BIOL, V321, P265, DOI 10.1016/S0022-2836(02)00623-X; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maher RL, 2013, DNA REPAIR, V12, P964, DOI 10.1016/j.dnarep.2013.08.010; Marenstein DR, 2003, J BIOL CHEM, V278, P9005, DOI 10.1074/jbc.M212168200; Meira LB, 2005, ADV EXP MED BIOL, V570, P125, DOI 10.1007/1-4020-3764-3_5; Odell ID, 2013, J CELL PHYSIOL, V228, P258, DOI 10.1002/jcp.24134; Odell ID, 2011, MOL CELL BIOL, V31, P4623, DOI 10.1128/MCB.05715-11; Odell ID, 2010, DNA REPAIR, V9, P134, DOI 10.1016/j.dnarep.2009.11.005; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; PEDERSON DS, 1986, P NATL ACAD SCI USA, V83, P7206, DOI 10.1073/pnas.83.19.7206; Pope MA, 2005, DNA REPAIR, V4, P315, DOI 10.1016/j.dnarep.2004.10.003; Pope MA, 2002, J BIOL CHEM, V277, P22605, DOI 10.1074/jbc.M203037200; Prasad A, 2007, MOL CELL BIOL, V27, P8442, DOI 10.1128/MCB.00791-07; Qi Y, 2009, NATURE, V462, P762, DOI 10.1038/nature08561; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Sage E, 2011, MUTAT RES-FUND MOL M, V711, P123, DOI 10.1016/j.mrfmmm.2010.12.010; SIMPSON RT, 1983, P NATL ACAD SCI-BIOL, V80, P51, DOI 10.1073/pnas.80.1.51; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sung JS, 2000, BIOCHEMISTRY-US, V39, P10224, DOI 10.1021/bi0007066; Takata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075622; TCHOU J, 1993, J BIOL CHEM, V268, P26738; Thastrom A, 1999, J MOL BIOL, V288, P213, DOI 10.1006/jmbi.1999.2686; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; Vidal AE, 2001, NUCLEIC ACIDS RES, V29, P1285, DOI 10.1093/nar/29.6.1285; Yang HJ, 2001, NUCLEIC ACIDS RES, V29, P743, DOI 10.1093/nar/29.3.743; Yang N, 2006, DNA REPAIR, V5, P43, DOI 10.1016/j.dnarep.2005.07.003; Yang N, 2004, DNA REPAIR, V3, P1323, DOI 10.1016/j.dnarep.2004.04.014; Ye Y, 2012, BIOCHEMISTRY-US, V51, P6028, DOI 10.1021/bi3006412	62	40	41	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					19881	19893		10.1074/jbc.M114.571588	http://dx.doi.org/10.1074/jbc.M114.571588			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24891506	hybrid, Green Published			2022-12-25	WOS:000339395200007
J	Cho, YD; Yoon, WJ; Kim, WJ; Woo, KM; Baek, JH; Lee, G; Ku, Y; van Wijnen, AJ; Ryoo, HM				Cho, Young-Dan; Yoon, Won-Joon; Kim, Woo-Jin; Woo, Kyung-Mi; Baek, Jeong-Hwa; Lee, Gene; Ku, Young; van Wijnen, Andre J.; Ryoo, Hyun-Mo			Epigenetic Modifications and Canonical Wingless/int-1 Class (WNT) Signaling Enable Trans-differentiation of Nonosteogenic Cells into Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; ALKALINE-PHOSPHATASE EXPRESSION; DNA METHYLATION; BETA-CATENIN; CPG ISLANDS; PATHWAY; DEDIFFERENTIATION; MUTATIONS; DISEASE	Mesenchymal cells alter and retain their phenotype during skeletal development through activation or suppression of signaling pathways. For example, we have shown that Wnt3a only stimulates osteoblast differentiation in cells with intrinsic osteogenic potential (e.g. MC3T3-E1 pre-osteoblasts) and not in fat cell precursors or fibroblasts (3T3-L1 pre-adipocytes or NIH3T3 fibroblasts, respectively). Wnt3a promotes osteogenesis in part by stimulating autocrine production of the osteoinductive ligand Bmp2. Here, we show that the promoter regions of the genes for Bmp2 and the osteoblast marker Alp are epigenetically locked to prevent their expression in nonosteogenic cells. Both genes have conserved CpG islands that exhibit increased CpG methylation, as well as decreased acetylation and increased methylation of histone H3 lysine 9 (H3-K9) specifically in nonosteogenic cells. Treatment of pre-adipocytes or fibroblasts with the CpG-demethylating agent 5' -aza-2' -deoxycytidine or the histone deacetylase inhibitor trichostatin-A renders Bmp2 and Alp responsive to Wnt3a. Hence, drug-induced epigenetic activation of Bmp2 gene expression contributes to Wnt3a-mediated direct trans-differentiation of pre-adipocytes or fibroblasts into osteoblasts. We propose that direct conversion of nonosteogenic cells into osteoblastic cell types without inducing pluripotency may improve prospects for novel epigenetic therapies to treat skeletal afflictions.	[Cho, Young-Dan; Yoon, Won-Joon; Kim, Woo-Jin; Woo, Kyung-Mi; Baek, Jeong-Hwa; Lee, Gene; Ryoo, Hyun-Mo] Seoul Natl Univ, Sch Dent, Dept Mol Genet, Seoul 110749, South Korea; [Ku, Young] Seoul Natl Univ, Sch Dent, Dept Periodontol, Seoul 110749, South Korea; Seoul Natl Univ, Dent Res Inst, Program BK21, Seoul 110749, South Korea; [van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg & Biochem, Rochester, MN 55902 USA; [van Wijnen, Andre J.] Mayo Clin, Dept Mol Biol, Rochester, MN 55902 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Mayo Clinic; Mayo Clinic	van Wijnen, AJ (corresponding author), Mayo Clin, Dept Orthoped Surg & Biochem, 200 First St SW, Rochester, MN 55902 USA.	vanWijnen.Andre@mayo.edu; hmryoo@snu.ac.kr	van Wijnen, Andre J./AAG-3578-2019; Ryoo, Hyun-Mo/D-5839-2012; Woo, Kyung Mi/A-2793-2009; Cho, Young-Dan/AAR-4573-2021	van Wijnen, Andre J./0000-0002-4458-0946; Ryoo, Hyun-Mo/0000-0001-6769-8341; Woo, Kyung Mi/0000-0002-2782-1189; 	National Institutes of Health [R01 AR049069]; National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning [2013R1A1A3011102]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR049069. This work was also supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT, and Future Planning Grant 2013R1A1A3011102.	Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen Y, 2007, J BIOL CHEM, V282, P526, DOI 10.1074/jbc.M602700200; Cho Y. - D., 2011, J BONE MINER RES  S1, V26, P161; Cho YD, 2012, J CELL PHYSIOL, V227, P2287, DOI 10.1002/jcp.24038; Cho YD, 2009, J BIOL CHEM, V284, P25230, DOI 10.1074/jbc.M109.008391; DiNardo DNM, 2001, ONCOGENE, V20, P5331, DOI 10.1038/sj.onc.1204697; Fujita N, 1999, MOL CELL BIOL, V19, P6415; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kamiya N, 2010, J BONE MINER RES, V25, P200, DOI 10.1359/jbmr.090806; Khavinson V Kh, 2012, Adv Gerontol, V25, P11; Kim JS, 2002, CANCER RES, V62, P2744; Kim YJ, 2004, J BIOL CHEM, V279, P50773, DOI 10.1074/jbc.M404145200; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Kuroda K, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-5; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Lee MH, 1999, J CELL BIOCHEM, V73, P114, DOI 10.1002/(SICI)1097-4644(19990401)73:1<114::AID-JCB13>3.3.CO;2-D; Li GH, 2005, J BONE MINER RES, V20, P1611, DOI 10.1359/JBMR.050513; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Meivar-Levy I, 2007, HEPATOLOGY, V46, P898, DOI 10.1002/hep.21766; Moon C, 2009, TRANSPL P, V41, P1848, DOI 10.1016/j.transproceed.2009.02.101; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; Ohgane J, 2008, PLACENTA, V29, pS29, DOI 10.1016/j.placenta.2007.09.011; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Shiota K, 2004, CYTOGENET GENOME RES, V105, P325, DOI 10.1159/000078205; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yavropoulou Maria P, 2007, Hormones (Athens), V6, P279; Zhang M, 2009, J CELL BIOCHEM, V108, P896, DOI 10.1002/jcb.22319; Zhang RR, 2013, BONE, V52, P145, DOI 10.1016/j.bone.2012.09.029	43	44	49	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20120	20128		10.1074/jbc.M114.558064	http://dx.doi.org/10.1074/jbc.M114.558064			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24867947	Green Published, hybrid			2022-12-25	WOS:000339395200025
J	Manda, KM; Yedlapudi, D; Korukonda, S; Bojja, S; Kalivendi, SV				Manda, Krishna Madhuri; Yedlapudi, Deepthi; Korukonda, Srikanth; Bojja, Sreedhar; Kalivendi, Shasi V.			The Chaperone-Like Activity of alpha-Synuclein Attenuates Aggregation of Its Alternatively Spliced Isoform, 112-Synuclein In Vitro: Plausible Cross-Talk between Isoforms in Protein Aggregation	PLOS ONE			English	Article							PARKINSONS-DISEASE; POSTTRANSLATIONAL MODIFICATION; CARBOXY-TERMINUS; MESSENGER-RNA; BRAIN-REGIONS; LEWY BODIES; PATHOGENESIS; NEURODEGENERATION; OLIGOMERIZATION; FIBRILLIZATION	Abnormal oligomerization and aggregation of alpha-synuclein (alpha-syn/WT-syn) has been shown to be a precipitating factor in the pathophysiology of Parkinson's disease (PD). Earlier observations on the induced-alternative splicing of alpha-syn by Parkinsonism mimetics as well as identification of region specific abnormalities in the transcript levels of 112-synclein (112-syn) in diseased subjects underscores the role of 112-syn in the pathophysiology of PD. In the present study, we sought to identify the aggregation potential of 112-syn in the presence or absence of WT-syn to predict its plausible role in protein aggregation events. Results demonstrate that unlike WT-syn, lack of 28 aa in the C-terminus results in the loss of chaperone-like activity with a concomitant gain in vulnerability to heat-induced aggregation and time-dependent fibrillation. The effects were dose and time-dependent and a significant aggregation of 112-syn was evident at as low as 45 degrees C following 10 min of incubation. The heat-induced aggregates were found to be ill-defined structures and weakly positive towards Thioflavin-T (ThT) staining as compared to clearly distinguishable ThT positive extended fibrils resulting upon 24 h of incubation at 37 degrees C. Further, the chaperone-like activity of WT-syn significantly attenuated heat-induced aggregation of 112-syn in a dose and time-dependent manner. On contrary, WT-syn synergistically enhanced fibrillation of 112-syn. Overall, the present findings highlight a plausible cross-talk between isoforms of alpha-syn and the relative abundance of these isoforms may dictate the nature and fate of protein aggregates.	[Manda, Krishna Madhuri; Kalivendi, Shasi V.] CSIR IICT, Ctr Acad Sci & Innovat Res, Hyderabad, Andhra Pradesh, India; [Manda, Krishna Madhuri; Yedlapudi, Deepthi; Korukonda, Srikanth; Kalivendi, Shasi V.] CSIR IICT, Ctr Chem Biol, Hyderabad, Andhra Pradesh, India; [Bojja, Sreedhar] CSIR IICT, Inorgan & Phys Chem Div, Hyderabad, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Kalivendi, SV (corresponding author), CSIR IICT, Ctr Acad Sci & Innovat Res, Hyderabad, Andhra Pradesh, India.	kalivendi@iict.res.in		Yedlapudi, Deepthi/0000-0002-9811-8976	Department of Biotechnology (DBT), India; miND project from CSIR, India [BSC-115]; Council of Scientific and Industrial Research (CSIR), India; DENOVA project by CSIR, INDIA	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); miND project from CSIR, India; Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); DENOVA project by CSIR, INDIA	S.V.K. acknowledges funding from the Department of Biotechnology (DBT), India and miND project (BSC-115) from CSIR, India. The senior research fellowship from Council of Scientific and Industrial Research (CSIR), India, is gratefully acknowledged by K. M. M. D.Y. acknowledges financial support from DENOVA project by CSIR, INDIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrekopoulos C, 2004, BIOCHEM J, V378, P435, DOI 10.1042/BJ20031466; Antony T, 2003, J BIOL CHEM, V278, P3235, DOI 10.1074/jbc.M208249200; Beitz Janice M, 2014, Front Biosci (Schol Ed), V6, P65; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Beyer K, 2008, NEUROGENETICS, V9, P163, DOI 10.1007/s10048-008-0124-6; Beyer K, 2008, NEUROGENETICS, V9, P15, DOI 10.1007/s10048-007-0106-0; Beyer K, 2006, ACTA NEUROPATHOL, V112, P237, DOI 10.1007/s00401-006-0104-6; Beyer K, 2006, NEUROREPORT, V17, P1327, DOI 10.1097/01.wnr.0000224773.66904.e7; Beyer K, 2013, MOL NEUROBIOL, V47, P509, DOI 10.1007/s12035-012-8330-5; CAMPION D, 1995, GENOMICS, V26, P254, DOI 10.1016/0888-7543(95)80208-4; Cardo LF, 2014, NEUROSCI LETT, V562, P45, DOI 10.1016/j.neulet.2014.01.009; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; Hong DP, 2011, FEBS LETT, V585, P561, DOI 10.1016/j.febslet.2011.01.009; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Ischiropoulos H, 2003, ANN NY ACAD SCI, V991, P93; Kalivendi SV, 2010, FREE RADICAL BIO MED, V48, P377, DOI 10.1016/j.freeradbiomed.2009.10.045; Kim TD, 2002, BIOCHEMISTRY-US, V41, P13782, DOI 10.1021/bi026284c; Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Levitan K, 2011, J MOL BIOL, V411, P329, DOI 10.1016/j.jmb.2011.05.046; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; McCarthy JJ, 2011, NEUROGENETICS, V12, P59, DOI 10.1007/s10048-010-0263-4; McLean JR, 2012, MOL CELL NEUROSCI, V49, P230, DOI 10.1016/j.mcn.2011.11.006; McLean PJ, 2002, NEUROSCI LETT, V323, P219, DOI 10.1016/S0304-3940(02)00154-4; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Recchia A, 2004, FASEB J, V18, P617, DOI 10.1096/fj.03-0338rev; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Surguchov A, 2013, J NEUROSCI RES, V91, P161, DOI 10.1002/jnr.23149; Takeda A, 1998, AM J PATHOL, V152, P367; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; UEDA K, 1994, BIOCHEM BIOPH RES CO, V205, P1366, DOI 10.1006/bbrc.1994.2816; Ulusoy A, 2010, EUR J NEUROSCI, V32, P409, DOI 10.1111/j.1460-9568.2010.07284.x; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Volles MJ, 2003, BIOCHEMISTRY-US, V42, P7871, DOI 10.1021/bi030086j; Xia Y, 2001, J ALZHEIMERS DIS, V3, P485, DOI 10.3233/JAD-2001-3508	50	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98657	10.1371/journal.pone.0098657	http://dx.doi.org/10.1371/journal.pone.0098657			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892822	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400080
J	Melnik, TN; Majorina, MA; Larina, DS; Kashparov, IA; Samatova, EN; Glukhov, AS; Melnik, BS				Melnik, Tatiana N.; Majorina, Maria A.; Larina, Daria S.; Kashparov, Ivan A.; Samatova, Ekaterina N.; Glukhov, Anatoly S.; Melnik, Bogdan S.			Independent of Their Localization in Protein the Hydrophobic Amino Acid Residues Have No Effect on the Molten Globule State of Apomyoglobin and the Disulfide Bond on the Surface of Apomyoglobin Stabilizes This Intermediate State	PLOS ONE			English	Article							PHI-VALUE ANALYSIS; SIDE-CHAIN INTERACTIONS; FOLDING INTERMEDIATE; ALPHA-LACTALBUMIN; TRANSITION-STATES; STRUCTURAL HETEROGENEITY; THERMODYNAMIC ANALYSIS; MUTATIONAL ANALYSIS; COLD DENATURATION; SINGLE-PATHWAY	At present it is unclear which interactions in proteins reveal the presence of intermediate states, their stability and formation rate. In this study, we have investigated the effect of substitutions of hydrophobic amino acid residues in the hydrophobic core of protein and on its surface on a molten globule type intermediate state of apomyoglobin. It has been found that independent of their localization in protein, substitutions of hydrophobic amino acid residues do not affect the stability of the molten globule state of apomyoglobin. It has been shown also that introduction of a disulfide bond on the protein surface can stabilize the molten globule state. However in the case of apomyoglobin, stabilization of the intermediate state leads to relative destabilization of the native state of apomyoglobin. The result obtained allows us not only to conclude which mutations can have an effect on the intermediate state of the molten globule type, but also explains why the introduction of a disulfide bond (which seems to "strengthen" the protein) can result in destabilization of the protein native state of apomyoglobin.	[Melnik, Tatiana N.; Majorina, Maria A.; Larina, Daria S.; Kashparov, Ivan A.; Samatova, Ekaterina N.; Glukhov, Anatoly S.; Melnik, Bogdan S.] RAS, Inst Prot Res, Pushchino, Moscow Region, Russia; [Samatova, Ekaterina N.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany	Russian Academy of Sciences; Max Planck Society	Melnik, BS (corresponding author), RAS, Inst Prot Res, Pushchino, Moscow Region, Russia.	bmelnik@phys.protres.ru	Melnik, Bogdan/U-1988-2017	Melnik, Bogdan/0000-0002-9176-6452; Melnik, Tatiana/0000-0002-9081-4678	MCB program of the Russian Academy of Sciences [01201280919]; Russian Foundation for Basic Research [13-04-00923, 14-04-01729]	MCB program of the Russian Academy of Sciences; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported in part by the MCB program of the Russian Academy of Sciences (01201280919), by the Russian Foundation for Basic Research (13-04-00923 and 14-04-01729). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGASHE VR, 1995, NATURE, V377, P754, DOI 10.1038/377754a0; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; Bai P, 2001, PROTEIN SCI, V10, P55, DOI 10.1110/ps.34101; Baldwin RL, 1996, FOLD DES, V1, pR1, DOI 10.1016/S1359-0278(96)00003-X; Baldwin RL, 2013, CURR OPIN STRUC BIOL, V23, P4, DOI 10.1016/j.sbi.2012.11.004; Baryshnikova E N, 2009, Mol Biol (Mosk), V43, P136; Baryshnikova E N, 2005, Mol Biol (Mosk), V39, P330; Baryshnikova E N, 2007, Mol Biol (Mosk), V41, P674; Baryshnikova EN, 2005, PROTEIN SCI, V14, P2658, DOI 10.1110/ps.051402705; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Bhat V, 2012, ARCH BIOCHEM BIOPHYS, V528, P32, DOI 10.1016/j.abb.2012.08.009; Boehm K, 2008, BIOCHEMISTRY-US, V47, P7116, DOI 10.1021/bi800554v; Brylinski M, 2006, COMPUT BIOL CHEM, V30, P255, DOI 10.1016/j.compbiolchem.2006.04.007; Bushmarina NA, 2006, PROTEIN SCI, V15, P659, DOI 10.1110/ps.051904206; Carra JH, 2003, CLIN IMMUNOL, V108, P60, DOI 10.1016/S1521-6616(03)00058-5; Cavagnero S, 1999, J MOL BIOL, V285, P269, DOI 10.1006/jmbi.1998.2273; Chiti F, 1999, NAT STRUCT BIOL, V6, P1005; Dadlez M, 1997, BIOCHEMISTRY-US, V36, P2788, DOI 10.1021/bi962407f; Dombkowski AA, 2014, FEBS LETT, V588, P206, DOI 10.1016/j.febslet.2013.11.024; Dyuysekina AE, 2008, BIOCHEMISTRY-MOSCOW+, V73, P693, DOI 10.1134/S0006297908060102; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; ELIEZER D, 1995, SCIENCE, V270, P487, DOI 10.1126/science.270.5235.487; Faudry E, 2007, FEBS J, V274, P3601, DOI 10.1111/j.1742-4658.2007.05893.x; Fersht AR, 2004, P NATL ACAD SCI USA, V101, P7976, DOI 10.1073/pnas.0402684101; Fersht AR, 2000, P NATL ACAD SCI USA, V97, P1525, DOI 10.1073/pnas.97.4.1525; FERSHT AR, 1993, FEBS LETT, V325, P5, DOI 10.1016/0014-5793(93)81405-O; FERSHT AR, 1995, P NATL ACAD SCI USA, V92, P10869, DOI 10.1073/pnas.92.24.10869; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Fersht AR, 2000, P NATL ACAD SCI USA, V97, P14121, DOI 10.1073/pnas.260502597; Fersht AR, 1997, CURR OPIN STRUC BIOL, V7, P3, DOI 10.1016/S0959-440X(97)80002-4; FERSHT AR, 1995, PHILOS T ROY SOC B, V348, P11, DOI 10.1098/rstb.1995.0040; Garcia C, 2000, BIOCHEMISTRY-US, V39, P11227, DOI 10.1021/bi0010266; GAST K, 1994, EUR BIOPHYS J BIOPHY, V23, P297, DOI 10.1007/BF00213579; Gilmanshin R, 1997, PROTEIN SCI, V6, P2134; GOLDENBERG DP, 1989, NATURE, V338, P127, DOI 10.1038/338127a0; GOLDENBERG DP, 1985, J CELL BIOCHEM, V29, P321, DOI 10.1002/jcb.240290406; GRIKO IV, 1986, DOKL AKAD NAUK SSSR+, V291, P709; Halskau O, 2009, CURR PROTEIN PEPT SC, V10, P339, DOI 10.2174/138920309788922199; HARRISON SC, 1985, P NATL ACAD SCI USA, V82, P4028, DOI 10.1073/pnas.82.12.4028; HUGHSON FM, 1989, BIOCHEMISTRY-US, V28, P4415, DOI 10.1021/bi00436a044; Indu S, 2011, PROTEINS, V79, P244, DOI 10.1002/prot.22878; Inobe T, 2004, J MOL BIOL, V339, P199, DOI 10.1016/j.jmb.2004.03.026; JAENICKE L, 1974, ANAL BIOCHEM, V61, P623, DOI 10.1016/0003-2697(74)90429-1; Jamin M, 1998, J MOL BIOL, V276, P491, DOI 10.1006/jmbi.1997.1543; Jamin M, 2005, PROTEIN PEPTIDE LETT, V12, P229, DOI 10.2174/0929866053587174; JENNINGS PA, 1995, J BIOMOL NMR, V6, P271; JENNINGS PA, 1991, METHOD ENZYMOL, V202, P113; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; King J, 1986, Methods Enzymol, V131, P250; MATOUSCHEK A, 1989, NATURE, V340, P122, DOI 10.1038/340122a0; MATOUSCHEK A, 1990, NATURE, V346, P440, DOI 10.1038/346440a0; MATSUMURA M, 1989, P NATL ACAD SCI USA, V86, P6562, DOI 10.1073/pnas.86.17.6562; Matsumura Y, 1996, BBA-PROTEIN STRUCT M, V1292, P69, DOI 10.1016/0167-4838(95)00197-2; Melnik BS, 2008, BIOCHEM BIOPH RES CO, V369, P701, DOI 10.1016/j.bbrc.2008.02.096; Nawrocki JP, 1999, J MOL BIOL, V293, P991, DOI 10.1006/jmbi.1999.3226; Nishimura C, 2002, J MOL BIOL, V322, P483, DOI 10.1016/S0022-2836(02)00810-0; Pan T, 1997, NAT STRUCT BIOL, V4, P931, DOI 10.1038/nsb1197-931; PARKER MJ, 1995, J MOL BIOL, V253, P771, DOI 10.1006/jmbi.1995.0590; Petrovich M, 2006, J MOL BIOL, V360, P865, DOI 10.1016/j.jmb.2006.05.050; PRIVALOV PL, 1986, J MOL BIOL, V190, P487, DOI 10.1016/0022-2836(86)90017-3; PRIVALOV PL, 1971, BIOPOLYMERS, V10, P1865, DOI 10.1002/bip.360101009; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Rabbani G, 2012, CELL BIOCHEM BIOPHYS, V62, P487, DOI 10.1007/s12013-011-9335-9; Rezaei H, 2002, J MOL BIOL, V322, P799, DOI 10.1016/S0022-2836(02)00856-2; Samatova EN, 2010, BIOPHYS J, V98, P1694, DOI 10.1016/j.bpj.2009.12.4326; Samatova EN, 2009, PROTEIN SCI, V18, P2152, DOI 10.1002/pro.229; Settanni G, 2005, P NATL ACAD SCI USA, V102, P628, DOI 10.1073/pnas.0406754102; Shimanouchi T, 2013, COLLOID SURFACE B, V103, P75, DOI 10.1016/j.colsurfb.2012.10.011; Siadat Omid Ranaei, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-12; Soldi G, 2005, BIOPHYS J; Tsui V, 1999, PROTEIN SCI, V8, P45, DOI 10.1110/ps.8.1.45; Van Mierlo CPM, 1998, PROTEIN SCI, V7, P2331, DOI 10.1002/pro.5560071110; VOGL T, 1995, J MOL BIOL, V254, P481, DOI 10.1006/jmbi.1995.0632; ZAHLER WL, 1968, J BIOL CHEM, V243, P716; Zhou RH, 2004, SCIENCE, V305, P1605, DOI 10.1126/science.1101176	75	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e98645	10.1371/journal.pone.0098645	http://dx.doi.org/10.1371/journal.pone.0098645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892675	gold, Green Submitted, Green Published			2022-12-25	WOS:000336911400078
J	Bloom, DD; Fikacek, M; Short, AEZ				Bloom, Devin D.; Fikacek, Martin; Short, Andrew E. Z.			Clade Age and Diversification Rate Variation Explain Disparity in Species Richness among Water Scavenger Beetle (Hydrophilidae) Lineages	PLOS ONE			English	Article							ECOLOGICAL OPPORTUNITY; DEPENDENT DIVERSIFICATION; COLEOPTERA HYDROPHILIDAE; MOLECULAR PHYLOGENETICS; BIOME CONSERVATISM; EXTINCTION RATES; SPECIATION RATES; AQUATIC BEETLES; EVOLUTION; DIVERSITY	Explaining the disparity of species richness across the tree of life is one of the great challenges in evolutionary biology. Some lineages are exceptionally species rich, while others are relatively species poor. One explanation for heterogeneity among clade richness is that older clades are more species rich because they have had more time to accrue diversity than younger clades. Alternatively, disparity in species richness may be due to among-lineage diversification rate variation. Here we investigate diversification in water scavenger beetles (Hydrophilidae), which vary in species richness among major lineages by as much as 20 fold. Using a time-calibrated phylogeny and comparative methods, we test for a relationship between clade age and species richness and for shifts in diversification rate in hydrophilids. We detected a single diversification rate increase in Megasternini, a relatively young and species rich clade whose diversity might be explained by the stunning diversity of ecological niches occupied by this clade. We find that Amphiopini, an old clade, is significantly more species poor than expected, possibly due to its restricted geographic range. The remaining lineages show a correlation between species richness and clade age, suggesting that both clade age and variation in diversification rates explain the disparity in species richness in hydrophilids. We find little evidence that transitions between aquatic, semiaquatic, and terrestrial habitats are linked to shifts in diversification rates.	[Bloom, Devin D.; Short, Andrew E. Z.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Bloom, Devin D.; Short, Andrew E. Z.] Univ Kansas, Div Entomol, Biodivers Inst, Lawrence, KS 66045 USA; [Fikacek, Martin] Natl Museum, Dept Entomol, Prague, Czech Republic; [Fikacek, Martin] Charles Univ Prague, Fac Sci, Dept Zool, Prague, Czech Republic	University of Kansas; University of Kansas; National Museum; Charles University Prague	Short, AEZ (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.	aezshort@ku.edu		Fikacek, Martin/0000-0002-2078-6798	Czech Science Foundation [P506/12/P096]; Ministry of Culture of the Czech Republic [DKRVO 2014/13]; Ministry of Culture of the Czech Republic (National Museum) [00023272]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Culture of the Czech Republic; Ministry of Culture of the Czech Republic (National Museum)	MF received funding from the Czech Science Foundation grant P506/12/P096 and from the Ministry of Culture of the Czech Republic (DKRVO 2014/13, National Museum, 00023272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2007, EVOLUTION, V61, P2104, DOI 10.1111/j.1558-5646.2007.00182.x; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Bernhard D, 2006, ZOOL SCR, V35, P597, DOI 10.1111/j.1463-6409.2006.00251.x; Betancur-R R, 2012, ECOL LETT, V15, P822, DOI 10.1111/j.1461-0248.2012.01802.x; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bloom DD, 2012, J EVOLUTION BIOL, V25, P701, DOI 10.1111/j.1420-9101.2012.02464.x; Bloom DD, 2013, EVOLUTION, V67, P2040, DOI 10.1111/evo.12074; Burbrink FT, 2010, EVOLUTION, V64, P934, DOI 10.1111/j.1558-5646.2009.00888.x; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; de Queiroz A, 2002, SYST BIOL, V51, P917, DOI 10.1080/10635150290155980; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Drummond AJ, 2012, MOL BIOL EVOL, V25, P1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Fikacek M, ZOOLOGICAL J LINNEAN; Fikacek M, 2010, ZOOTAXA, P1; Fikacek M, 2014, ZOOL J LINN SOC-LOND, V170, P710, DOI 10.1111/zoj.12114; Fikacek M, 2012, ACTA ENT MUS NAT PRA, V52, P89; Fikacek M, 2012, SYST ENTOMOL, V37, P420, DOI 10.1111/j.1365-3113.2012.00630.x; Fikacek M, 2011, ANN ZOOL, V61, P621, DOI 10.3161/000345411X622462; Fikacek M, 2010, ACTA ENT MUS NAT PRA, V50, P445; FISCHER AG, 1960, EVOLUTION, V14, P64, DOI 10.2307/2405923; Gamble T, 2011, J EVOLUTION BIOL, V24, P231, DOI 10.1111/j.1420-9101.2010.02184.x; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Jablonski D, 2006, AM NAT, V168, P556, DOI 10.1086/507994; Jablonski D, 2008, ANNU REV ECOL EVOL S, V39, P501, DOI 10.1146/annurev.ecolsys.39.110707.173510; Kubisz Daniel, 2000, Polskie Pismo Entomologiczne, V69, P225; LABANDEIRA CC, 1993, SCIENCE, V261, P310, DOI 10.1126/science.11536548; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; Maddison WP, 2011, MESQUITE MODULAR SYS; Magallon S, 2001, EVOLUTION, V55, P1762, DOI 10.1111/j.0014-3820.2001.tb00826.x; Martin CH, 2013, SCIENCE, V339, P208, DOI 10.1126/science.1227710; McKenna Duane D., 2009, P278; McPeek MA, 2007, AM NAT, V169, pE97, DOI 10.1086/512135; McPeek MA, 2007, PALAEONTOLOGY, V50, P111, DOI 10.1111/j.1475-4983.2006.00616.x; Minoshima Yusuke, 2012, Elytra, V2, P279; Moore BR, 2009, P NATL ACAD SCI USA, V106, P4307, DOI 10.1073/pnas.0807230106; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Parent CE, 2009, AM NAT, V174, P898, DOI 10.1086/646604; Prokin AA, 2009, PALEONTOL J+, V43, P660, DOI 10.1134/S0031030109060094; Pyron RA, 2013, TRENDS ECOL EVOL, V28, P729, DOI 10.1016/j.tree.2013.09.007; Pyron RA, 2012, EVOLUTION, V66, P163, DOI 10.1111/j.1558-5646.2011.01437.x; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2007, P ROY SOC B-BIOL SCI, V274, P2915, DOI 10.1098/rspb.2007.0924; Rabosky DL, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001381; Rabosky DL, 2010, SYST BIOL, V59, P634, DOI 10.1093/sysbio/syq060; Rabosky DL, 2010, EVOLUTION, V64, P1816, DOI 10.1111/j.1558-5646.2009.00926.x; Rabosky DL, 2010, TRENDS ECOL EVOL, V25, P68, DOI 10.1016/j.tree.2009.07.002; Rabosky DL, 2009, ECOL LETT, V12, P735, DOI 10.1111/j.1461-0248.2009.01333.x; Rabosky DL, 2009, AM NAT, V173, P662, DOI 10.1086/597378; Rabosky DL, 2013, ANN REV ECOLOGY EVOL, V44; Ribera I., 2008, Aquatic insects: challenges to populations, P289, DOI 10.1079/9781845933968.0289; Ribera I, 2001, MOL ECOL, V10, P721, DOI 10.1046/j.1365-294x.2001.01218.x; Ribera I, 2003, ECOGRAPHY, V26, P145, DOI 10.1034/j.1600-0587.2003.03271.x; Ribera I, 2008, CLADISTICS, V24, P563, DOI 10.1111/j.1096-0031.2007.00192.x; Ricklefs RE, 2007, J EVOLUTION BIOL, V20, P1751, DOI 10.1111/j.1420-9101.2007.01388.x; Ricklefs RE, 2003, P ROY SOC B-BIOL SCI, V270, P2285, DOI 10.1098/rspb.2003.2489; Ricklefs RE, 2006, AM NAT, V168, P805, DOI 10.1086/508711; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sequeira AS, 2008, MOL ECOL, V17, P1089, DOI 10.1111/j.1365-294X.2007.03642.x; Short A.E.Z., 2009, Koleopterologische Rundschau, V79, P189; Short AEZ, 2011, ACTA ENT MUS NAT PRA, V51, P83; Short AEZ, 2013, SYST ENTOMOL, V38, P723, DOI 10.1111/syen.12024; SMETANA A, 1978, MEM ENTOMOL SOC CAN, P1, DOI 10.4039/entm110105fv; Stephens PR, 2003, AM NAT, V161, P112, DOI 10.1086/345091; Svensson EI, 2012, ADAPTIVE LANDSCAPE IN EVOLUTIONARY BIOLOGY, P1; Vermeij GJ, 2000, BIOL J LINN SOC, V70, P541; Vrba ES, 1987, EVOL ECOL, V1, P283, DOI 10.1007/BF02071554; Wainwright PC, 2012, SYST BIOL, V61, P1001, DOI 10.1093/sysbio/sys060; Watts C. H. S., 1998, Records of the South Australian Museum (Adelaide), V30, P93; Wiens JJ, 2011, Q REV BIOL, V86, P75, DOI 10.1086/659883; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x	76	56	56	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98430	10.1371/journal.pone.0098430	http://dx.doi.org/10.1371/journal.pone.0098430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887453	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300066
J	Dunemann, F; Schrader, O; Budahn, H; Houben, A				Dunemann, Frank; Schrader, Otto; Budahn, Holger; Houben, Andreas			Characterization of Centromeric Histone H3 (CENH3) Variants in Cultivated and Wild Carrots (Daucus sp.)	PLOS ONE			English	Article							FUNCTIONAL CENTROMERES; CAROTA; DNA; GENES; SATELLITES; APIACEAE; REVEALS; INCLUDE; MARKERS; FISH	In eukaryotes, centromeres are the assembly sites for the kinetochore, a multi-protein complex to which spindle microtubules are attached at mitosis and meiosis, thereby ensuring segregation of chromosomes during cell division. They are specified by incorporation of CENH3, a centromere specific histone H3 variant which replaces canonical histone H3 in the nucleosomes of functional centromeres. To lay a first foundation of a putative alternative haploidization strategy based on centromere-mediated genome elimination in cultivated carrots, in the presented research we aimed at the identification and cloning of functional CENH3 genes in Daucus carota and three distantly related wild species of genus Daucus varying in basic chromosome numbers. Based on mining the carrot transcriptome followed by a subsequent PCR-based cloning, homologous coding sequences for CENH3s of the four Daucus species were identified. The ORFs of the CENH3 variants were very similar, and an amino acid sequence length of 146 aa was found in three out of the four species. Comparison of Daucus CENH3 amino acid sequences with those of other plant CENH3s as well as their phylogenetic arrangement among other dicot CENH3s suggest that the identified genes are authentic CENH3 homologs. To verify the location of the CENH3 protein in the kinetochore regions of the Daucus chromosomes, a polyclonal antibody based on a peptide corresponding to the N-terminus of DcCENH3 was developed and used for anti-CENH3 immunostaining of mitotic root cells. The chromosomal location of CENH3 proteins in the centromere regions of the chromosomes could be confirmed. For genetic localization of the CENH3 gene in the carrot genome, a previously constructed linkage map for carrot was used for mapping a CENH3-specific simple sequence repeat (SSR) marker, and the CENH3 locus was mapped on the carrot chromosome 9.	[Dunemann, Frank; Schrader, Otto; Budahn, Holger] JKI, Fed Res Ctr Cultivated Plants, Inst Breeding Res Hort Crops, Quedlinburg, Germany; [Houben, Andreas] Leibniz Inst Plant Genet & Crop Plant Res IPK, Chromosome Struct & Funct Lab, Gatersleben, Germany	Julius Kuhn-Institut; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Dunemann, F (corresponding author), JKI, Fed Res Ctr Cultivated Plants, Inst Breeding Res Hort Crops, Quedlinburg, Germany.	frank.dunemann@jki.bund.de	Houben, Andreas/I-1517-2015	Houben, Andreas/0000-0003-3419-239X; Dunemann, Frank/0000-0002-3348-5177	Federal Ministry of Agriculture and Food(BMEL)	Federal Ministry of Agriculture and Food(BMEL)	This research was supported by the Federal Ministry of Agriculture and Food(BMEL)in frame of an implemented project at the Julius Kuhn-Institut, Quedlinburg, Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandro MS, 2013, THEOR APPL GENET, V126, P415, DOI 10.1007/s00122-012-1989-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1981, ANALES JARD BOT MADR; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Baranski R., 2008, TRANSGENIC PLANT J, V2, P18; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Cavagnaro PF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-386; Cavagnaro PF, 2009, MOL GENET GENOMICS, V281, P273, DOI 10.1007/s00438-008-0411-9; Ferrie AMR, 2011, PLANT CELL TISS ORG, V104, P399, DOI 10.1007/s11240-010-9770-0; Grzebelus D, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES - VEGETABLES, P91, DOI 10.1007/978-3-642-20450-0_7; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HEYWOOD VH, 1983, ISRAEL J BOT, V32, P51; Hirsch CD, 2009, MOL BIOL EVOL, V26, P2877, DOI 10.1093/molbev/msp208; Houben A, 2003, CURR OPIN PLANT BIOL, V6, P554, DOI 10.1016/j.pbi.2003.09.007; Houben A, 2007, CHROMOSOMA, V116, P275, DOI 10.1007/s00412-007-0102-z; Houben A, 2011, CHROMOSOME RES, V19, P471, DOI 10.1007/s10577-011-9207-6; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Iovene M, 2008, AM J BOT, V95, P793, DOI 10.3732/ajb.0700007; Iovene M, 2011, CHROMOSOME RES, V19, P493, DOI 10.1007/s10577-011-9202-y; Iwata A, 2013, PLANT J, V76, P47, DOI 10.1111/tpj.12269; Jiang JM, 2003, TRENDS PLANT SCI, V8, P570, DOI 10.1016/j.tplants.2003.10.011; Just BJ, 2007, THEOR APPL GENET, V114, P693, DOI 10.1007/s00122-006-0469-x; Lee HR, 2005, P NATL ACAD SCI USA, V102, P11793, DOI 10.1073/pnas.0503863102; Lermontova I, 2006, PLANT CELL, V18, P2443, DOI 10.1105/tpc.106.043174; Liu Z, 2008, CHROMOSOMA, V117, P445, DOI 10.1007/s00412-008-0161-9; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Nagaki K, 2005, CHROMOSOME RES, V13, P195, DOI 10.1007/s10577-005-0847-2; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Nagaki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051315; Nagaki K, 2009, CHROMOSOMA, V118, P249, DOI 10.1007/s00412-008-0193-1; Neumann P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002777; Pimenov M.G., 2003, KARYOTAXONOMICAL ANA, P57; Ravi M, 2013, PLANT CENTROMERE BIOLOGY, P169; Ravi M, 2010, NATURE, V464, P615, DOI 10.1038/nature08842; Sanei M, 2011, P NATL ACAD SCI USA, V108, pE498, DOI 10.1073/pnas.1103190108; Schrader O, 2003, CARYOLOGIA, V56, P149, DOI 10.1080/00087114.2003.10589318; Spalik K, 2007, J BIOGEOGR, V34, P2039, DOI 10.1111/j.1365-2699.2007.01752.x; Tek AL, 2011, CHROMOSOME RES, V19, P969, DOI 10.1007/s10577-011-9247-y; Tek AL, 2010, CHROMOSOME RES, V18, P337, DOI 10.1007/s10577-010-9119-x; Van Ooijen JW, 2006, JOINMAP 40 SOFTWARE; Wally O, 2009, PLANTA, V231, P131, DOI 10.1007/s00425-009-1031-2; Wang GX, 2011, CHROMOSOMA, V120, P353, DOI 10.1007/s00412-011-0315-z; Zhong CX, 2002, PLANT CELL, V14, P2825, DOI 10.1105/tpc.006106	43	19	19	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98504	10.1371/journal.pone.0098504	http://dx.doi.org/10.1371/journal.pone.0098504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887084	gold, Green Published			2022-12-25	WOS:000336956300075
J	Shukla, AK; Pragya, P; Chaouhan, HS; Tiwari, AK; Patel, DK; Abdin, MZ; Chowdhuri, DK				Shukla, Arvind Kumar; Pragya, Prakash; Chaouhan, Hitesh Singh; Tiwari, Anand Krishna; Patel, Devendra Kumar; Abdin, Malik Zainul; Chowdhuri, Debapratim Kar			Heat Shock Protein-70 (Hsp-70) Suppresses Paraquat-Induced Neurodegeneration by Inhibiting JNK and Caspase-3 Activation in Drosophila Model of Parkinson's Disease	PLOS ONE			English	Article							ALPHA-SYNUCLEIN TOXICITY; OXIDATIVE STRESS; CHAPERONE SUPPRESSION; DOPAMINERGIC-NEURONS; HSP70; APOPTOSIS; PROTECTS; MELANOGASTER; NIGRA; NEUROPROTECTION	Parkinson's disease (PD) is one of the most common neurodegenerative disorders with limited clinical interventions. A number of epidemiological as well as case-control studies have revealed an association between pesticide exposure, especially of paraquat (PQ) and occurrence of PD. Hsp70, a molecular chaperone by function, has been shown as one of the modulators of neurological disorders. However, paucity of information regarding the protective role of Hsp70 on PQ-induced PD like symptoms led us to hypothesize that modulation of hsp70 expression in the dopaminergic neurons would improve the health of these cells. We took advantage of Drosophila, which is a well-established model for neurological research and also possesses genetic tools for easy manipulation of gene expression with limited ethical concern. Overexpression of hsp70 was found to reduce PQ-induced oxidative stress along with JNK and caspase-3 mediated dopaminergic neuronal cell death in exposed organism. Further, anti-apoptotic effect of hsp70 was shown to confer better homeostasis in the dopaminergic neurons of PQ-exposed organism as evidenced by their improved locomotor performance and survival. The study has merit in the context of human concern since we observed protection of dopaminergic neurons in PQ-exposed organism by over-expressing a human homologue of hsp70, HSPA1L, in these cells. The effect was parallel to that observed with Drosophila hsp70. These findings reflect the potential therapeutic applicability of hsp70 against PQ-induced PD like symptoms in an organism.	[Shukla, Arvind Kumar; Pragya, Prakash; Chaouhan, Hitesh Singh; Chowdhuri, Debapratim Kar] CSIR Indian Inst Toxicol Res, Embryotoxicol Sect, Lucknow, Uttar Pradesh, India; [Tiwari, Anand Krishna] Indian Inst Adv Res, Sch Biol Sci & Biotechnol, Gandhinagar, Gujrat, India; [Patel, Devendra Kumar] CSIR Indian Inst Toxicol Res, Analyt Sect, Lucknow, Uttar Pradesh, India; [Chaouhan, Hitesh Singh] Acad Sci & Innovat Res, New Delhi, India; [Shukla, Arvind Kumar; Pragya, Prakash; Abdin, Malik Zainul] Jamia Hamdard, Dept Biotechnol, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Academy of Scientific & Innovative Research (AcSIR); Jamia Hamdard University	Chowdhuri, DK (corresponding author), CSIR Indian Inst Toxicol Res, Embryotoxicol Sect, Lucknow, Uttar Pradesh, India.	dkchowdhuri@iitr.res.in	CHAOUHAN, HITESH/AGX-7625-2022; , AKS/I-3868-2019	Zainul Abdin, Malik/0000-0001-7346-0719; Shukla, Arvind/0000-0003-3334-0450	University Grants Commission [EU249IV/2008/JUNE/318721]; Council of Scientific and Industrial Research [31/029(0199)/2008-EMR-1, 19-06/2011(i)EU-IV, NWP-UNDO/2012-17]	University Grants Commission(University Grants Commission, India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by University Grants Commission (Grant number: EU249IV/2008/JUNE/318721 to AKS), Council of Scientific and Industrial Research (Grant number: 31/029(0199)/2008-EMR-1 to PP; 19-06/2011(i)EU-IV to HSC and NWP-UNDO/2012-17 to DKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Azad P, 2011, FREE RADICAL BIO MED, V51, P530, DOI 10.1016/j.freeradbiomed.2011.05.005; Berry C, 2010, CELL DEATH DIFFER, V17, P1115, DOI 10.1038/cdd.2009.217; Broome CS, 2006, FASEB J, V20, P1549, DOI 10.1096/fj.05-4935fje; Brown RC, 2005, ENVIRON HEALTH PERSP, V113, P1250, DOI 10.1289/ehp.7567; BUS JS, 1976, ENVIRON HEALTH PERSP, V16, P139, DOI 10.2307/3428594; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Chaudhuri A, 2007, J NEUROSCI, V27, P2457, DOI 10.1523/JNEUROSCI.4239-06.2007; Chen S, 2007, J NEUROSCI RES, V85, P402, DOI 10.1002/jnr.21124; Cleren C, 2005, J NEUROCHEM, V94, P995, DOI 10.1111/j.1471-4159.2005.03253.x; CORASANITI MT, 1993, J CHROMATOGR, V643, P419, DOI 10.1016/0021-9673(93)80578-V; Coulom H, 2004, J NEUROSCI, V24, P10993, DOI 10.1523/JNEUROSCI.2993-04.2004; DANIEL JW, 1966, BRIT J IND MED, V23, P133; Demicheli V, 2007, FREE RADICAL BIO MED, V42, P1359, DOI 10.1016/j.freeradbiomed.2007.01.034; Dinis-Oliveira RJ, 2006, NEUROTOXICOLOGY, V27, P1110, DOI 10.1016/j.neuro.2006.05.012; Donaire V, 2005, BRAIN RES BULL, V67, P509, DOI 10.1016/j.brainresbull.2005.08.002; Dorsey ER, 2007, NEUROLOGY, V68, P384, DOI 10.1212/01.wnl.0000247740.47667.03; Du GP, 2010, MOL BIOL CELL, V21, P2128, DOI 10.1091/mbc.E10-03-0200; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Flower TR, 2005, J MOL BIOL, V351, P1081, DOI 10.1016/j.jmb.2005.06.060; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Fridovich I, 1997, J BIOL CHEM, V272, P18515, DOI 10.1074/jbc.272.30.18515; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; Gupta SC, 2005, BBA-GEN SUBJECTS, V1725, P81, DOI 10.1016/j.bbagen.2005.04.033; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Jordan J, 2002, BRIT J PHARMACOL, V137, P993, DOI 10.1038/sj.bjp.0704953; Kalmar B, 2009, ADV DRUG DELIVER REV, V61, P310, DOI 10.1016/j.addr.2009.02.003; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Lee JS, 2005, J BIOL CHEM, V280, P6634, DOI 10.1074/jbc.M412393200; Li LB, 2007, J BIOL CHEM, V282, P37694, DOI 10.1074/jbc.M705211200; Lim SY, 2004, J BIOL CHEM, V279, P46263, DOI 10.1074/jbc.M406555200; Liu Z, 2008, P NATL ACAD SCI USA, V105, P2693, DOI 10.1073/pnas.0708452105; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARSDEN CD, 1990, LANCET, V335, P948, DOI 10.1016/0140-6736(90)91006-V; McCormack AL, 2002, NEUROBIOL DIS, V10, P119, DOI 10.1006/nbdi.2002.0507; Merritt TJS, 2011, ANAL METHODS-UK, V3, P1428, DOI 10.1039/c0ay00759e; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Mukhopadhyay I, 2003, ENVIRON HEALTH PERSP, V111, P1926, DOI 10.1289/ehp.6339; NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Pan TH, 2005, FEBS LETT, V579, P6716, DOI 10.1016/j.febslet.2005.10.067; Peng J, 2005, J BIOL CHEM, V280, P29194, DOI 10.1074/jbc.M500984200; Peng J, 2004, J BIOL CHEM, V279, P32626, DOI 10.1074/jbc.M404596200; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Samuni Y, 2010, FREE RADICAL BIO MED, V48, P1559, DOI 10.1016/j.freeradbiomed.2010.03.001; Shen HY, 2005, J BIOL CHEM, V280, P39962, DOI 10.1074/jbc.M505524200; Singh MP, 2010, CHEMOSPHERE, V79, P577, DOI 10.1016/j.chemosphere.2010.01.054; Somayajulu-Nitu M, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-88; Tanner CM, 2012, ENV HLTH PERSPECT, V119, P866; Wang Z, 2011, J NEUROCHEM, V119, P1294, DOI 10.1111/j.1471-4159.2011.07517.x; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Witt SN, 2010, BIOPOLYMERS, V93, P218, DOI 10.1002/bip.21302; Yang LC, 2011, METHODS MOL BIOL, V793, P401, DOI 10.1007/978-1-61779-328-8_27	57	50	54	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98886	10.1371/journal.pone.0098886	http://dx.doi.org/10.1371/journal.pone.0098886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887138	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300117
J	Huang, LD; Fan, YZ; Tian, Y; Yang, Y; Liu, Y; Wang, J; Zhao, WS; Zhou, WC; Cheng, XY; Cao, P; Lu, XY; Yu, Y				Huang, Li-Dong; Fan, Ying-Zhe; Tian, Yun; Yang, Yang; Liu, Yan; Wang, Jin; Zhao, Wen-Shan; Zhou, Wen-Chao; Cheng, Xiao-Yang; Cao, Peng; Lu, Xiang-Yang; Yu, Ye			Inherent Dynamics of Head Domain Correlates with ATP-Recognition of P2X4 Receptors: Insights Gained from Molecular Simulations	PLOS ONE			English	Article							BINDING-SITES; ACTIVE-SITE; ION-CHANNEL; ACTIVATION; PAIN; MECHANISMS; RELEASE; DOCKING; TARGETS	P2X receptors are ATP-gated ion channels involved in many physiological functions, and determination of ATP-recognition (AR) of P2X receptors will promote the development of new therapeutic agents for pain, inflammation, bladder dysfunction and osteoporosis. Recent crystal structures of the zebrafish P2X4 (zfP2X4) receptor reveal a large ATP-binding pocket (ABP) located at the subunit interface of zfP2X4 receptors, which is occupied by a conspicuous cluster of basic residues to recognize triphosphate moiety of ATP. Using the engineered affinity labeling and molecular modeling, at least three sites (S1, S2 and S3) within ABP have been identified that are able to recognize the adenine ring of ATP, implying the existence of at least three distinct AR modes in ABP. The open crystal structure of zfP2X4 confirms one of three AR modes (named AR1), in which the adenine ring of ATP is buried into site S1 while the triphosphate moiety interacts with clustered basic residues. Why architecture of ABP favors AR1 not the other two AR modes still remains unexplored. Here, we examine the potential role of inherent dynamics of head domain, a domain involved in ABP formation, in AR determinant of P2X4 receptors. In silico docking and binding free energy calculation revealed comparable characters of three distinct AR modes. Inherent dynamics of head domain, especially the downward motion favors the preference of ABP for AR1 rather than AR2 and AR3. Along with the downward motion of head domain, the closing movement of loop(139-146) and loop(169-183), and structural rearrangements of K70, K72, R298 and R143 enabled ABP to discriminate AR1 from other AR modes. Our observations suggest the essential role of head domain dynamics in determining AR of P2X4 receptors, allowing evaluation of new strategies aimed at developing specific blockers/allosteric modulators by preventing the dynamics of head domain associated with both AR and channel activation of P2X4 receptors.	[Huang, Li-Dong; Yang, Yang; Liu, Yan; Wang, Jin; Zhao, Wen-Shan; Zhou, Wen-Chao; Cheng, Xiao-Yang; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol, Shanghai 200030, Peoples R China; [Huang, Li-Dong; Yang, Yang; Liu, Yan; Wang, Jin; Zhao, Wen-Shan; Zhou, Wen-Chao; Cheng, Xiao-Yang; Yu, Ye] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Shanghai 200030, Peoples R China; [Tian, Yun; Lu, Xiang-Yang; Yu, Ye] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China; [Fan, Ying-Zhe; Zhou, Wen-Chao] Shanghai Univ Chinese Tradit Med, Putuo Dist Ctr Hosp, Shanghai, Peoples R China; [Cao, Peng] Jiangsu Prov Inst Tradit Chinese Med, Nanjing, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Hunan Agricultural University; Shanghai University of Traditional Chinese Medicine; Nanjing University of Chinese Medicine	Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol, Shanghai 200030, Peoples R China.	yuye@shsmu.edu.cn		, Peng/0000-0002-2044-3074; Yu, Ye/0000-0002-4054-8543; Zhao, Wenshan/0000-0002-8018-5978	National Program on Key Basic Research Project of China [2014CB910300, 2014CB910302, 2010CB529800]; National Excellent Young Scientist Foundation of China [31222018]; National Natural Science Foundation of China [31170787]; Key National S&T Program "Major New Drug Development'' Grant [2012ZX09504001-003]; Natural Science Foundation of Shanghai [12ZR1415600]; Jiangsu Province [SBK201241903]; Shanghai Jiao Tong University-SMC Mutual Funds; Chinese Academy of Sciences, Shanghai Institute of Organic Chemistry	National Program on Key Basic Research Project of China(National Basic Research Program of China); National Excellent Young Scientist Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key National S&T Program "Major New Drug Development'' Grant; Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Jiangsu Province; Shanghai Jiao Tong University-SMC Mutual Funds; Chinese Academy of Sciences, Shanghai Institute of Organic Chemistry	This study was supported by grants from the National Program on Key Basic Research Project of China (2014CB910300, 2014CB910302, and 2010CB529800), the National Excellent Young Scientist Foundation of China (No. 31222018), National Natural Science Foundation of China (No. 31170787), Key National S&T Program "Major New Drug Development'' Grant (No. 2012ZX09504001-003), Natural Science Foundation of Shanghai (12ZR1415600), and Jiangsu Province (SBK201241903), "Shanghai Jiao Tong University-SMC Mutual Funds'' for Excellent Young Scholar and "Opening project'' of Chinese Academy of Sciences, Shanghai Institute of Organic Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Bornstein JC, 2008, PURINERG SIGNAL, V4, P197, DOI 10.1007/s11302-007-9081-z; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; CAVARELLI J, 1994, EMBO J, V13, P327, DOI 10.1002/j.1460-2075.1994.tb06265.x; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Cook SP, 1997, NATURE, V387, P505, DOI 10.1038/387505a0; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Di Virgilio F, 2009, TRENDS NEUROSCI, V32, P79, DOI 10.1016/j.tins.2008.11.003; Du J, 2012, P NATL ACAD SCI USA, V109, P4140, DOI 10.1073/pnas.1119546109; EDWARDS FA, 1992, NATURE, V359, P144, DOI 10.1038/359144a0; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Evans RJ, 2009, EUR BIOPHYS J BIOPHY, V38, P319, DOI 10.1007/s00249-008-0275-2; Fabre JE, 1999, NAT MED, V5, P1199, DOI 10.1038/13522; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gadakar PK, 2007, J CHEM INF MODEL, V47, P1446, DOI 10.1021/ci6005036; Galligan JJ, 2004, BRIT J PHARMACOL, V141, P1294, DOI 10.1038/sj.bjp.0705761; Gu JGG, 1997, NATURE, V389, P749, DOI 10.1038/39639; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Hugel S, 2000, J NEUROSCI, V20, P2121; Jiang RT, 2013, TRENDS BIOCHEM SCI, V38, P20, DOI 10.1016/j.tibs.2012.10.006; Jiang R, 2012, EMBO J, V31, P2134, DOI 10.1038/emboj.2012.75; Jiang RT, 2011, P NATL ACAD SCI USA, V108, P9066, DOI 10.1073/pnas.1102170108; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 1998, MOL PHARMACOL, V54, P372, DOI 10.1124/mol.54.2.372; Li ZY, 2008, ASSAY DRUG DEV TECHN, V6, P277, DOI 10.1089/adt.2007.121; Lorinczi E, 2012, P NATL ACAD SCI US; Miller CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002212; Mulryan K, 2000, NATURE, V403, P86, DOI 10.1038/47495; Shaw DE, 2005, J COMPUT CHEM, V26, P1318, DOI 10.1002/jcc.20267; Sim JA, 2006, J NEUROSCI, V26, P9006, DOI 10.1523/JNEUROSCI.2370-06.2006; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; White N, 2006, TRENDS PHARMACOL SCI, V27, P211, DOI 10.1016/j.tips.2006.02.004; Yamamoto K, 2006, NAT MED, V12, P133, DOI 10.1038/nm1338; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Yang Y, 2012, J BIOL CHEM, V287, P14443, DOI 10.1074/jbc.M111.334250; Yu Y, 2011, J BIOL CHEM	42	26	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e97528	10.1371/journal.pone.0097528	http://dx.doi.org/10.1371/journal.pone.0097528			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878662	gold, Green Published, Green Submitted			2022-12-25	WOS:000338101500016
J	Li, N; Zhou, P; Zheng, J; Deng, JQ; Wu, HC; Li, W; Li, F; Li, HB; Lu, JC; Zhou, YF; Zhang, C				Li, Na; Zhou, Ping; Zheng, Jian; Deng, Jieqiong; Wu, Hongchun; Li, Wei; Li, Fang; Li, Hongbin; Lu, Jiachun; Zhou, Yifeng; Zhang, Chun			A Polymorphism rs12325489C > T in the LincRNA-ENST00000515084 Exon Was Found to Modulate Breast Cancer Risk via GWAS-Based Association Analyses	PLOS ONE			English	Article							LONG NONCODING RNA; GENOME-WIDE ASSOCIATION; GENE; EXPRESSION; CARCINOMA; SUSCEPTIBILITY; DISEASE; LUNG; PLURIPOTENCY; ESTROGEN	Breast cancer, one of the most common malignancies diagnosed among women worldwide, is a complex polygenic disease in the etiology of which genetic factors play an important role. Thus far, a subset of breast cancer genetic susceptibility loci has been addressed among Asian woman through genome-wide association studies (GWASs). In this study, we identified numerous long, intergenic, noncoding RNAs (lincRNAs) enriched in these breast cancer risk-related loci and identified 16 single nucleotide polymorphisms (SNPs) located within the sequences of lincRNA exonic regions. We examined whether these 16 SNPs are associated with breast cancer risk in 2539 cancer patients and 2818 control subjects from eastern, southern, and northern Chinese populations. We found that the C allele of the rs12325489C>T polymorphism in the exonic regions of lincRNA-ENST00000515084 was associated with a significantly increased risk of breast cancer (adjusted odds ratio [OR] = 1.79; 95% confidence interval [CI] = 1.50-2.12), compared with the rs12325489TT genotype. Biochemical analysis demonstrated that the C to T base change at rs12325489C>T disrupts the binding site for miRNA-370, thereby influencing the transcriptional activity of lincRNA-ENST00000515084 in vitro and in vivo, and affecting cell proliferation and tumor growth. Our findings indicate that the rs12325489C>T polymorphism in the lincRNA-ENST00000515084 exon may be a genetic modifier in the development of breast cancer.	[Li, Na; Zheng, Jian; Deng, Jieqiong; Wu, Hongchun; Li, Wei; Li, Fang; Zhou, Yifeng] Soochow Univ, Coll Med, Dept Genet, Suzhou, Peoples R China; [Li, Na; Zhou, Ping; Zhang, Chun] Nantong Univ, Affiliated Hosp 3, Dept Gen Surg, Wuxi, Peoples R China; [Li, Hongbin] Harbin Med Univ, Affiliated Hosp 3, Dept Med Oncol, Harbin, Peoples R China; [Lu, Jiachun] Guangzhou Med Univ, Inst Chem Carcinogenesis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Soochow University - China; Nantong University; Harbin Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Zhou, YF (corresponding author), Soochow Univ, Coll Med, Dept Genet, Suzhou, Peoples R China.	zhouyifeng@suda.edu.cn; wx3hzc@hotmail.com	Li, Wei/H-8477-2018		National Scientific Foundation of China [81001278, 81171895, 81072366]; Priority Academic Program Development of Jiangsu Higher Education Institutions [PAPD2010005]; Jiangsu Provincial Natural Science Foundation [BK2011297, BK2011176]; Jiangsu Province Science and Technology Support Program [BE2012648]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [20101561]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Province Science and Technology Support Program; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This study was supported by the National Scientific Foundation of China grants 81001278, 81171895 and 81072366; A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD2010005), Jiangsu Provincial Natural Science Foundation (No. BK2011297 and BK2011176); Jiangsu Province Science and Technology Support Program (No. BE2012648) and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (No. 20101561). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cai QY, 2011, HUM MOL GENET, V20, P4991, DOI 10.1093/hmg/ddr405; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Cheng EC, 2013, DEV CELL, V25, P1, DOI 10.1016/j.devcel.2013.03.020; Chlebowski RT, 2006, JNCI-J NATL CANCER I, V98, P1767, DOI 10.1093/jnci/djj494; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Feig S A, 1997, J Natl Cancer Inst Monogr, P119; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guffanti A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-163; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Halvorsen M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001074; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jendrzejewski J, 2012, P NATL ACAD SCI USA, V109, P8646, DOI 10.1073/pnas.1205654109; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Jiang L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3225; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Lee KM, 2005, CLIN CANCER RES, V11, P4620, DOI 10.1158/1078-0432.CCR-04-2534; Lee RS, 2013, NAT GENET, V45, P1268, DOI 10.1038/ng.2805; LI H, 2011, MOL CARCINOG; Li ZH, 2014, P NATL ACAD SCI USA, V111, P1002, DOI 10.1073/pnas.1313768111; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Long JR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002532; Long JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001002; Lu JC, 2011, HUM MUTAT, V32, P1299, DOI 10.1002/humu.21574; Luo JH, 2006, HEPATOLOGY, V44, P1012, DOI 10.1002/hep.21328; Morrison LE, 2007, GENE CHROMOSOME CANC, V46, P397, DOI 10.1002/gcc.20419; Ng SY, 2013, WIRES RNA, V4, P121, DOI 10.1002/wrna.1146; Nupponen NN, 2001, CANCER METAST REV, V20, P155, DOI 10.1023/A:1015557308033; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sabarinathan R, 2013, NUCLEIC ACIDS RES, V41, pW475, DOI 10.1093/nar/gkt291; Sato K, 2010, ONCOL REP, V24, P701, DOI 10.3892/or_00000910; Smedley D, 2000, GENE CHROMOSOME CANC, V28, P121, DOI 10.1002/(SICI)1098-2264(200005)28:1<121::AID-GCC14>3.0.CO;2-O; Sotomaru Y, 2002, J BIOL CHEM, V277, P12474, DOI 10.1074/jbc.M109212200; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Vance KW, 2014, EMBO J, V33, P296, DOI 10.1002/embj.201386225; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wu HC, 2013, CARCINOGENESIS, V34, P2908, DOI 10.1093/carcin/bgt252; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Yuan SX, 2012, HEPATOLOGY, V56, P2231, DOI 10.1002/hep.25895; Zheng J, 2012, CARCINOGENESIS, V33, P2409, DOI 10.1093/carcin/bgs307; Zheng J, 2012, INT J CANCER, V130, P1981, DOI 10.1002/ijc.26253; Zheng J, 2011, MOL CARCINOGEN, V50, P689, DOI 10.1002/mc.20803; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318; Zhu ZS, 2012, CANCER RES, V72, P6163, DOI 10.1158/0008-5472.CAN-12-0010	58	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98251	10.1371/journal.pone.0098251	http://dx.doi.org/10.1371/journal.pone.0098251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879036	Green Published, gold, Green Submitted			2022-12-25	WOS:000338101500042
J	Zhou, J; Liu, FW; Pan, CY				Zhou, Jun; Liu, Fenwu; Pan, Chengyi			Effects of Cationic Polyacrylamide Characteristics on Sewage Sludge Dewatering and Moisture Evaporation	PLOS ONE			English	Article							ACTIVATED-SLUDGE; PILOT-SCALE; WASTE; DEWATERABILITY; IMPROVEMENT	The effects of the molecular weight (MW) and charge density (CD) of cationic polyacrylamide (CPAM) on sludge dewatering and moisture evaporation were investigated in this study. Results indicated that in sludge conditioning, the optimum dosages were 10, 6, 6, 4, and 4 mg g(-1) CPAM with 5 million MW and 20% CD, 5 million MW and 40% CD, 3 million MW and 40% CD, 8 million MW and 40% CD, and 5 million MW and 60% CD, respectively. The optimum dosage of CPAM was negatively correlated with its CD or MW if the CD or MW of CPAM was above 20% or 5 million. In the centrifugal dewatering of sludge, the moisture content in the conditioned sludge gradually decreased with the extension of centrifugation time, and the economical centrifugal force was 400 x g. The moisture evaporation rates of the conditioned sludge were closely related to sludge dewaterability, which was in turn significantly correlated either positively with the solid content of sludge particles that were >2 mm in size or negatively with that of particles measuring 1 mm to 2 mm in diameter. During treatment, sludge moisture content was reduced from 80% to 20% by evaporation, and the moisture evaporation rates were 1.35, 1.49, 1.62, and 2.24 times faster in the sludge conditioned using 4 mg g(-1) CPAM with 5 million MW and 60% CD than in the sludge conditioned using 4 mg g(-1) CPAM with 8 million MW and 40% CD, 6 mg g(-1) CPAM with 5 million MW and 40% CD, 6 mg g(-1) CPAM with 3 million MW and 40% CD, and 10 mg g(-1) CPAM with 5 million MW and 20% CD, respectively. Hence, the CPAM with 5 million MW and 60% CD was ideal for sludge dewatering.	[Zhou, Jun] Nanjing Tech Univ, Coll Biotechnol & Pharmaceut Engn, Nanjing, Jiangsu, Peoples R China; [Liu, Fenwu; Pan, Chengyi] Shanxi Agr Univ, Coll Resource & Environm, Environm Engn Lab, Taigu, Peoples R China	Nanjing Tech University; Shanxi Agricultural University	Liu, FW (corresponding author), Shanxi Agr Univ, Coll Resource & Environm, Environm Engn Lab, Taigu, Peoples R China.	lfwlfw2008@163.com	zhou, jun/D-5706-2015		National Natural Science Foundation of China [21307058]; Doctoral Scientific Research Starting Foundation of Shanxi Agricultural University [2012YJ06]; Jiangsu Province Science Foundation [BK20130931]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [13KJB610006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Scientific Research Starting Foundation of Shanxi Agricultural University; Jiangsu Province Science Foundation(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 21307058), the Doctoral Scientific Research Starting Foundation of Shanxi Agricultural University (No. 2012YJ06), the Jiangsu Province Science Foundation for Youths (No. BK20130931), the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (No. 13KJB610006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APHA AWWA WEF., 2005, STANDARD METHODS EXA; Bohm N, 1997, COLLOID POLYM SCI, V275, P73, DOI 10.1007/s003960050054; Buyukkamaci N, 2007, J HAZARD MATER, V144, P323, DOI 10.1016/j.jhazmat.2006.10.034; Chang GR, 2001, WATER RES, V35, P786, DOI 10.1016/S0043-1354(00)00326-2; Chen YX, 2005, J HAZARD MATER, V123, P196, DOI 10.1016/j.jhazmat.2005.03.047; Chu CP, 2001, WATER RES, V35, P1038, DOI 10.1016/S0043-1354(00)00338-9; Defrance L, 2000, BIORESOURCE TECHNOL, V73, P105, DOI 10.1016/S0960-8524(99)00163-7; Deng WY, 2009, J HAZARD MATER, V162, P186, DOI 10.1016/j.jhazmat.2008.05.022; Dewil R, 2005, J HAZARD MATER, V117, P161, DOI 10.1016/j.jhazmat.2004.09.025; Feng X, 2009, BIORESOURCE TECHNOL, V100, P1074, DOI 10.1016/j.biortech.2008.07.055; GREGORY J, 1988, COLLOID SURFACE, V31, P231, DOI 10.1016/0166-6622(88)80196-3; Hsiau PC, 1998, WATER RES, V32, P1103, DOI 10.1016/S0043-1354(97)00230-3; KATSIRIS N, 1987, WATER RES, V21, P1319, DOI 10.1016/0043-1354(87)90004-2; Kleimann J, 2005, LANGMUIR, V21, P3688, DOI 10.1021/la046911u; Laguna A, 1999, WATER SCI TECHNOL, V40, P1, DOI 10.1016/S0273-1223(99)00602-2; Li H, 2009, J HAZARD MATER, V161, P1421, DOI 10.1016/j.jhazmat.2008.04.113; Liu Fen-wu, 2011, Huanjing Kexue, V32, P2993; Liu FW, 2012, J ENVIRON SCI, V24, P1403, DOI 10.1016/S1001-0742(11)60958-3; Liu FW, 2012, J HAZARD MATER, V221, P170, DOI 10.1016/j.jhazmat.2012.04.028; Lo IMC, 2001, ENVIRON SCI TECHNOL, V35, P4691, DOI 10.1021/es010834x; Lu MC, 2003, ADV ENVIRON RES, V7, P667, DOI 10.1016/S1093-0191(02)00039-4; Lu YJ, 2009, WASTE MANAGE, V29, P1152, DOI 10.1016/j.wasman.2008.06.030; Luo HJ, 2013, BIORESOURCE TECHNOL, V139, P330, DOI 10.1016/j.biortech.2013.04.035; Ohm TI, 2010, J HAZARD MATER, V178, P483, DOI 10.1016/j.jhazmat.2010.01.107; Stefanakis AI, 2012, J HAZARD MATER, V213, P393, DOI 10.1016/j.jhazmat.2012.02.016; Thapa KB, 2009, COLLOID SURFACE A, V334, P66, DOI 10.1016/j.colsurfa.2008.10.007; Vaxelaire J, 2000, WATER RES, V34, P4318, DOI 10.1016/S0043-1354(00)00193-7; Wilen BM, 1999, WATER RES, V33, P391, DOI 10.1016/S0043-1354(98)00208-5; Wu ZH, 2012, J HAZARD MATER, V243, P357, DOI 10.1016/j.jhazmat.2012.10.054; Xu CB, 2008, WATER RES, V42, P1571, DOI 10.1016/j.watres.2007.11.007; Yang C, 2011, CHEMOSPHERE, V85, P418, DOI 10.1016/j.chemosphere.2011.07.068; Zhang WJ, 2012, ADV MATER RES-SWITZ, V518-523, P2991, DOI 10.4028/www.scientific.net/AMR.518-523.2991; Zhang ZQ, 2010, WATER RES, V44, P3087, DOI 10.1016/j.watres.2010.02.033	33	7	7	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98159	10.1371/journal.pone.0098159	http://dx.doi.org/10.1371/journal.pone.0098159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878582	gold, Green Submitted, Green Published			2022-12-25	WOS:000338101500034
J	Cundell, MJ; Price, C				Cundell, Michael John; Price, Clive			The Budding Yeast Amphiphysin Complex Is Required for Contractile Actin Ring (CAR) Assembly and Post-Contraction GEF-Independent Accumulation of Rho1-GTP	PLOS ONE			English	Article							MITOTIC-EXIT NETWORK; PROTEIN-PROTEIN INTERACTION; SACCHAROMYCES-CEREVISIAE; ACTOMYOSIN RING; SEPTUM FORMATION; MYOSIN-II; IN-VIVO; REGULATES CYTOKINESIS; CHITIN-SYNTHASE; CLEAVAGE FURROW	The late events of the budding yeast cell division cycle, cytokinesis and cell separation, require the assembly of a contractile actomyosin ring (CAR), primary and secondary septum formation followed by enzymatic degradation of the primary septum. Here we present evidence that demonstrates a role for the budding yeast amphiphysin complex, a heterodimer comprising Rvs167 and Rvs161, in CAR assembly and cell separation. The iqg1-1 allele is synthetically lethal with both rvs167 and rvs161 null mutations. We show that both Iqg1 and the amphiphysin complex are required for CAR assembly in early anaphase but cells are able to complete assembly in late anaphase when these activities are, respectively, either compromised or absent. Amphiphysin dependent CAR assembly is dependent upon the Rvs167 SH3 domain, but this function is insufficient to explain the observed synthetic lethality. Dosage suppression of the iqg1-1 allele demonstrates that endocytosis is required for the default cell separation pathway in the absence of CAR contraction but is unlikely to be required to maintain viability. The amphiphysin complex is required for normal, post-mitotic, localization of Chs3 and the Rho1 GEF, Rom2, which are responsible for secondary septum deposition and the accumulation of GTP bound Rho1 at the bud neck. It is concluded that a failure of polarity establishment in the absence of CAR contraction and amphiphysin function leads to loss of viability as a result of the consequent cell separation defect.	[Cundell, Michael John; Price, Clive] Univ Lancaster, Sch Hlth & Med, Div Biomed & Life Sci, Lancaster, England	Lancaster University	Price, C (corresponding author), Univ Lancaster, Sch Hlth & Med, Div Biomed & Life Sci, Lancaster, England.	c.price1@lancaster.ac.uk			BBSRC [BBS/S/K/2005/12131]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	M. J. C. was supported by a BBSRC funded Research studentship, BBS/S/K/2005/12131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AEM, 1991, METHOD ENZYMOL, V194, P565; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; BAUER F, 1993, MOL CELL BIOL, V13, P5070, DOI 10.1128/MCB.13.8.5070; Bi E, 2001, CELL STRUCT FUNCT, V26, P529, DOI 10.1247/csf.26.529; Bi EF, 2012, GENETICS, V191, P347, DOI 10.1534/genetics.111.132886; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Boyne JR, 2000, J CELL SCI, V113, P4533; Brizzio V, 1998, J CELL BIOL, V141, P567, DOI 10.1083/jcb.141.3.567; Coll PM, 2007, EMBO J, V26, P1865, DOI 10.1038/sj.emboj.7601641; Colwill K, 1999, GENETICS, V152, P881; Corbett M, 2006, EUR J CELL BIOL, V85, P1201, DOI 10.1016/j.ejcb.2006.08.001; Devrekanli A, 2012, J CELL SCI, V125, P5453, DOI 10.1242/jcs.109157; Epp JA, 1997, CURR BIOL, V7, P921, DOI 10.1016/S0960-9822(06)00411-8; Fang XD, 2010, J CELL BIOL, V191, P1333, DOI 10.1083/jcb.201005134; Friesen H, 2006, MOL BIOL CELL, V17, P1306, DOI 10.1091/mbc.e05-06-0476; Friesen H, 2005, GENETICS, V170, P555, DOI 10.1534/genetics.104.040063; Galletta BJ, 2010, CURR OPIN BIOTECH, V21, P604, DOI 10.1016/j.copbio.2010.06.006; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Hentges P, 2005, YEAST, V22, P1013, DOI 10.1002/yea.1291; Jendretzki A, 2009, MOL GENET GENOMICS, V282, P437, DOI 10.1007/s00438-009-0476-0; Kamei T, 1998, J BIOL CHEM, V273, P28341, DOI 10.1074/jbc.273.43.28341; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Korinek WS, 2000, CURR BIOL, V10, P947, DOI 10.1016/S0960-9822(00)00626-6; Krause SA, 2012, J CELL SCI, V125, P2721, DOI 10.1242/jcs.100685; KURANDA MJ, 1991, J BIOL CHEM, V266, P19758; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Lippincott J, 1998, J CELL BIOL, V143, P1947, DOI 10.1083/jcb.143.7.1947; Lippincott J, 1998, J CELL BIOL, V140, P355, DOI 10.1083/jcb.140.2.355; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Meitinger F, 2010, J CELL SCI, V123, P1851, DOI 10.1242/jcs.063891; MUNN AL, 1995, MOL BIOL CELL, V6, P1721, DOI 10.1091/mbc.6.12.1721; Navarro P, 1997, BBA-PROTEIN STRUCT M, V1343, P187, DOI 10.1016/S0167-4838(97)00108-8; Nishihama R, 2009, J CELL BIOL, V185, P995, DOI 10.1083/jcb.200903125; Nkosi PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057846; Norden C, 2004, MOL MICROBIOL, V53, P469, DOI 10.1111/j.1365-2958.2004.04148.x; Onishi M, 2013, J CELL BIOL, V202, P311, DOI 10.1083/jcb.201302001; Palani S, 2012, J CELL SCI, V125, P3091, DOI 10.1242/jcs.106021; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Phillipsen P, 1991, METHODS ENZYMOL, V194, P169; Pinto IM, 2012, DEV CELL, V22, P1247, DOI 10.1016/j.devcel.2012.04.015; Pollard TD, 2010, CURR OPIN CELL BIOL, V22, P50, DOI 10.1016/j.ceb.2009.11.010; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Reyes A, 2007, J CELL SCI, V120, P1998, DOI 10.1242/jcs.005124; Sanchez-Diaz A, 2008, NAT CELL BIOL, V10, P395, DOI 10.1038/ncb1701; Sanchez-Diaz A, 2012, EMBO J, V31, P3620, DOI 10.1038/emboj.2012.224; Schmidt M, 2002, J CELL SCI, V115, P293; Shannon KB, 1999, MOL BIOL CELL, V10, P283, DOI 10.1091/mbc.10.2.283; SHAW JA, 1991, J CELL BIOL, V114, P111, DOI 10.1083/jcb.114.1.111; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sivadon P, 1997, FEBS LETT, V417, P21, DOI 10.1016/S0014-5793(97)01248-9; SIVADON P, 1995, MOL GEN GENET, V246, P485, DOI 10.1007/BF00290452; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Tolliday N, 2002, CURR BIOL, V12, P1864, DOI 10.1016/S0960-9822(02)01238-1; Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593; VerPlank L, 2005, MOL BIOL CELL, V16, P2529, DOI 10.1091/mbc.E04-12-1090; Wloka C, 2013, J CELL BIOL, V200, P271, DOI 10.1083/jcb.201208030; Wright DJ, 2008, GENETICS, V178, P1903, DOI 10.1534/genetics.107.082685; Xiong Y, 2007, THESIS LANCASTER U; Yoshida S, 2006, SCIENCE, V313, P108, DOI 10.1126/science.1126747; Yoshida S, 2009, GENE DEV, V23, P810, DOI 10.1101/gad.1785209; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181; Zhao HX, 2013, CELL REP, V4, P1213, DOI 10.1016/j.celrep.2013.08.024	64	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97663	10.1371/journal.pone.0097663	http://dx.doi.org/10.1371/journal.pone.0097663			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874185	Green Submitted, Green Published, gold			2022-12-25	WOS:000336790800010
J	Tornevi, A; Bergstedt, O; Forsberg, B				Tornevi, Andreas; Bergstedt, Olof; Forsberg, Bertil			Precipitation Effects on Microbial Pollution in a River: Lag Structures and Seasonal Effect Modification	PLOS ONE			English	Article							DRINKING-WATER TURBIDITY; GASTROINTESTINAL ILLNESS; ESCHERICHIA-COLI; RAINFALL; ASSOCIATION; INDICATOR; OUTBREAKS; DISEASE; RISK	Background: The river Gota Alv is a source of freshwater for 0.7 million swedes. The river is subject to contamination from sewer systems discharge and runoff from agricultural lands. Climate models projects an increase in precipitation and heavy rainfall in this region. This study aimed to determine how daily rainfall causes variation in indicators of pathogen loads, to increase knowledge of variations in river water quality and discuss implications for risk management. Methods: Data covering 7 years of daily monitoring of river water turbidity and concentrations of E. coli, Clostridium and coliforms were obtained, and their short-term variations in relation with precipitation were analyzed with time series regression and non-linear distributed lag models. We studied how precipitation effects varied with season and compared different weather stations for predictive ability. Results: Generally, the lowest raw water quality occurs 2 days after rainfall, with poor raw water quality continuing for several more days. A rainfall event of >15 mm/24-h (local 95 percentile) was associated with a three-fold higher concentration of E. coli and 30% higher turbidity levels (lag 2). Rainfall was associated with exponential increases in concentrations of indicator bacteria while the effect on turbidity attenuated with very heavy rainfall. Clear associations were also observed between consecutive days of wet weather and decreased water quality. The precipitation effect on increased levels of indicator bacteria was significant in all seasons. Conclusions: Rainfall elevates microbial risks year-round in this river and freshwater source and acts as the main driver of varying water quality. Heavy rainfall appears to be a better predictor of fecal pollution than water turbidity. An increase of wet weather and extreme events with climate change will lower river water quality even more, indicating greater challenges for drinking water producers, and suggesting better control of sources of pollution.	[Tornevi, Andreas; Forsberg, Bertil] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Bergstedt, Olof] Chalmers Univ Technol, Dept Civil & Environm Engn, S-41296 Gothenburg, Sweden	Umea University; Chalmers University of Technology	Tornevi, A (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.	andreas.tornevi@umu.se			Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) [10-104]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas)	This research was founded by The Swedish Water & Wastewater Association and The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), grant number 10-104. The funding is external to our organization. The project is entitled: Climate change, freshwater quality, treatment and distribution-risk assessment by health studies. (URL in Swedish: http://www.svensktvatten.se/FoU/SVU/Pagaende-projekt/Dricksvatten/SVU-projekt-10-104/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrom J, 2007, J WATER HEALTH, V5, P81, DOI 10.2166/wh.2007.139; Blaustein RA, 2013, WATER RES, V47, P569, DOI 10.1016/j.watres.2012.10.027; Cann KF, 2013, EPIDEMIOL INFECT, V141, P671, DOI 10.1017/S0950268812001653; Curriero FC, 2001, AM J PUBLIC HEALTH, V91, P1194, DOI 10.2105/AJPH.91.8.1194; Delpla I, 2009, ENVIRON INT, V35, P1225, DOI 10.1016/j.envint.2009.07.001; Drayna P, 2010, ENVIRON HEALTH PERSP, V118, P1439, DOI 10.1289/ehp.0901671; Egorov AI, 2003, INT J ENVIRON HEAL R, V13, P81, DOI 10.1080/0960312021000071567; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Gauthier F, 2001, WATER RES, V35, P2207, DOI 10.1016/S0043-1354(00)00506-6; Gilbert Marie-Line, 2006, Journal of Water and Health, V4, P225, DOI 10.2166/wh.2006.0019; Kistemann T, 2002, APPL ENVIRON MICROB, V68, P2188, DOI 10.1128/AEM.68.5.2188-2197.2002; Morris RD, 1996, AM J PUBLIC HEALTH, V86, P237, DOI 10.2105/AJPH.86.2.237; Nichols G, 2009, J WATER HEALTH, V7, P1, DOI 10.2166/wh.2009.143; Odonkor ST, 2013, MICROBIOL RES-ITALY, V4, DOI 10.4081/mr.2013.e2; Reynolds KA, 2008, REV ENVIRON CONTAM T, V192, P117, DOI 10.1007/978-0-387-71724-1_4; Schwartz J, 2000, J EPIDEMIOL COMMUN H, V54, P45, DOI 10.1136/jech.54.1.45; Schwartz J, 1997, EPIDEMIOLOGY, V8, P615, DOI 10.1097/00001648-199710000-00001; Signor R. S., 2005, Journal of Water and Health, V3, P453; Swedish Commission on Climate and Vulnerability, 2007, SWED GOV OFF REP, VSOU 2007:60; Team R, 2010, R LANG ENV STAT COMP; Thomas MK, 2006, INT J ENVIRON HEAL R, V16, P167, DOI 10.1080/09603120600641326; Tinker SC, 2010, J EXPO SCI ENV EPID, V20, P19, DOI 10.1038/jes.2008.68; Tornevi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069918; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	25	44	48	6	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98546	10.1371/journal.pone.0098546	http://dx.doi.org/10.1371/journal.pone.0098546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874010	Green Published, gold, Green Submitted			2022-12-25	WOS:000336790800048
J	van Gent, R; Di Sanza, C; van den Broek, NJF; Fleskens, V; Veenstra, A; Stout, GJ; Brenkman, AB				van Gent, Rogier; Di Sanza, Claudio; van den Broek, Niels J. F.; Fleskens, Veerle; Veenstra, Aukje; Stout, Gerdine J.; Brenkman, Arjan B.			SIRT1 Mediates FOXA2 Breakdown by Deacetylation in a Nutrient-Dependent Manner	PLOS ONE			English	Article							LIPID-METABOLISM; GENE-EXPRESSION; PROTEIN; TRANSCRIPTION; ACETYLATION; LIVER; DIFFERENTIATION; HOMEOSTASIS; ACTIVATION; HEPATOCYTE	The Forkhead transcription factor FOXA2 plays a fundamental role in controlling metabolic homeostasis in the liver during fasting. The precise molecular regulation of FOXA2 in response to nutrients is not fully understood. Here, we studied whether FOXA2 could be controlled at a post-translational level by acetylation. By means of LC-MS/MS analyses, we identified five acetylated residues in FOXA2. Sirtuin family member SIRT1 was found to interact with and deacetylate FOXA2, the latter process being dependent on the NAD+-binding catalytic site of SIRT1. Deacetylation by SIRT1 reduced protein stability of FOXA2 by targeting it towards proteasomal degradation, and inhibited transcription from the FOXA2-driven G6pase and CPT1a promoters. While mutation of the five identified acetylated residues weakly affected protein acetylation and stability, mutation of at least seven additional lysine residues was required to abolish acetylation and reduce protein levels of FOXA2. The importance of acetylation of FOXA2 became apparent upon changes in nutrient levels. The interaction of FOXA2 and SIRT1 was strongly reduced upon nutrient withdrawal in cell culture, while enhanced Foxa2 acetylation levels were observed in murine liver in vivo after starvation for 36 hours. Collectively, this study demonstrates that SIRT1 controls the acetylation level of FOXA2 in a nutrient-dependent manner and in times of nutrient shortage the interaction between SIRT1 and FOXA2 is reduced. As a result, FOXA2 is protected from degradation by enhanced acetylation, hence enabling the FOXA2 transcriptional program to be executed to maintain metabolic homeostasis.	[van Gent, Rogier; Di Sanza, Claudio; van den Broek, Niels J. F.; Veenstra, Aukje; Stout, Gerdine J.; Brenkman, Arjan B.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Mol Canc Res, Sect Metab Dis, Utrecht, Netherlands; [van Gent, Rogier; Di Sanza, Claudio; van den Broek, Niels J. F.; Veenstra, Aukje; Stout, Gerdine J.; Brenkman, Arjan B.] Netherlands Metabol Ctr, Utrecht, Netherlands; [van Gent, Rogier] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Fleskens, Veerle] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center	Brenkman, AB (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Dept Mol Canc Res, Sect Metab Dis, Utrecht, Netherlands.	a.b.brenkman@umcutrecht.nl			UMC Utrecht, The Netherlands	UMC Utrecht, The Netherlands(Netherlands Government)	This study was funded by the UMC Utrecht, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belaguli NS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048019; Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853; Canto C, 2011, COLD SH Q B, V76, P291, DOI 10.1101/sqb.2012.76.010439; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Grempler R, 2004, BIOCHEM J, V382, P471, DOI 10.1042/BJ20040160; Guarente L, 2011, CELL METAB, V14, P151, DOI 10.1016/j.cmet.2011.07.007; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Houtkooper RH, 2012, J CELL BIOL, V199, P205, DOI 10.1083/jcb.201207019; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Howell JJ, 2009, J BIOL CHEM, V284, P24816, DOI 10.1074/jbc.M109.042135; Kaestner KH, 1999, GENE DEV, V13, P495, DOI 10.1101/gad.13.4.495; Kohler S, 2010, J BIOL CHEM, V285, P464, DOI 10.1074/jbc.M109.063149; Lee CS, 2005, DEV BIOL, V278, P484, DOI 10.1016/j.ydbio.2004.10.012; Liu M, 2012, MOL CELL, V45, P171, DOI 10.1016/j.molcel.2011.11.018; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; MANGO SE, 1994, DEVELOPMENT, V120, P3019; Nakamura K, 2007, J BIOL CHEM, V282, P9768, DOI 10.1074/jbc.M610072200; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stafford JM, 2001, J BIOL CHEM, V276, P3811, DOI 10.1074/jbc.M009389200; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Thompson PR, 2001, J BIOL CHEM, V276, P33721, DOI 10.1074/jbc.M104736200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; von Meyenn F, 2013, CELL METAB, V17, P436, DOI 10.1016/j.cmet.2013.01.014; Wang HY, 2005, TRENDS MOL MED, V11, P262, DOI 10.1016/j.molmed.2005.04.003; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Wolfrum C, 2003, J CLIN INVEST, V112, P345, DOI 10.1172/JCI18698; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056; Zhang LP, 2005, CELL METAB, V2, P141, DOI 10.1016/j.cmet.2005.07.002	37	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e98438	10.1371/journal.pone.0098438	http://dx.doi.org/10.1371/journal.pone.0098438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24875183	Green Published, Green Submitted, gold			2022-12-25	WOS:000336790800039
J	Winkelmann, R; Sandrock, L; Kirberg, J; Jack, HM; Schuh, W				Winkelmann, Rebecca; Sandrock, Lena; Kirberg, Joerg; Jaeck, Hans-Martin; Schuh, Wolfgang			KLF2-A Negative Regulator of Pre-B Cell Clonal Expansion and B Cell Activation	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR-2; TRANSCRIPTION-FACTOR; T-CELLS; GENE-EXPRESSION; UP-REGULATION; IN-VIVO; RECEPTOR; QUIESCENCE; DIFFERENTIATION; CHAIN	Maturation as well as antigen-dependent activation of B cells is accompanied by alternating phases of proliferation and quiescence. We and others have previously shown that Kruppel-like factor 2 (KLF2), a regulator of T cell quiescence and migration, is upregulated in small resting precursor (pre)-B cells after assembly of the immature pre-B cell receptor (pre-BCR) and is downregulated upon antigen-induced proliferation of mature B cells. These findings suggest that KLF2, besides its function in maintaining follicular B cell identity, peripheral B cell homeostasis and homing of antigen-specific plasma cells to the bone marrow, also controls clonal expansion phases in the B cell lineage. Here, we demonstrate that enforced expression of KLF2 in primary pre-B cells results in a severe block of pre-BCR-induced proliferation, upregulation of the cell cycle inhibitors p21 and p27 and downregulation of c-myc. Furthermore, retroviral KLF2 transduction of primary B cells impairs LPS-induced activation, favors apoptosis and results in reduced abundance of factors, such as AID, IRF4 and BLIMP1, that control the antigen-dependent phase of B cell activation and plasma cell differentiation. Hence, we conclude that KLF2 is not only a key player in terminating pre-B cell clonal expansion but also a potent suppressor of B cell activation.	[Winkelmann, Rebecca; Sandrock, Lena; Jaeck, Hans-Martin; Schuh, Wolfgang] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, Dept Internal Med 3, Div Mol Immunol, D-91054 Erlangen, Germany; [Kirberg, Joerg] Paul Ehrlich Inst, Div Immunol, Langen, Germany	University of Erlangen Nuremberg; Paul Ehrlich Institute	Schuh, W (corresponding author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, Dept Internal Med 3, Div Mol Immunol, D-91054 Erlangen, Germany.	wschuh@molmed.uni-erlangen.de		Jack, Hans-Martin/0000-0002-6332-8463	IZKF [J21]; ELAN; DFG [FOR832]	IZKF; ELAN; DFG(German Research Foundation (DFG))	This project was funded in part by IZKF project J21 (to R. W.), intramural funding ELAN (to W. S.), and DFG research grant FOR832 (to H.-M.J.). IZKF: "Interdisziplinares Zentrum fur klinische Forschung, Universitat Erlangen" ELAN: "Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung" DFG: "Deutsche Forschungsgemeinschaft." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Bradl H, 2001, J IMMUNOL, V167, P6403, DOI 10.4049/jimmunol.167.11.6403; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Fruman DA, 2002, P NATL ACAD SCI USA, V99, P359, DOI 10.1073/pnas.012605099; Glynne R, 2000, IMMUNOL REV, V176, P216; Grayson JM, 2001, J IMMUNOL, V166, P795, DOI 10.4049/jimmunol.166.2.795; Hart GT, 2012, J IMMUNOL, V188, P521, DOI 10.4049/jimmunol.1101530; Hart GT, 2011, P NATL ACAD SCI USA, V108, P716, DOI 10.1073/pnas.1013168108; Hendriks RW, 2004, TRENDS IMMUNOL, V25, P249, DOI 10.1016/j.it.2004.02.011; Hess J, 2001, P NATL ACAD SCI USA, V98, P1745, DOI 10.1073/pnas.041492098; Hoek KL, 2010, IMMUNITY, V33, P254, DOI 10.1016/j.immuni.2010.07.016; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Metzner M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008883; Nutt SL, 2011, SEMIN IMMUNOL, V23, P341, DOI 10.1016/j.smim.2011.08.010; Schober SL, 1999, J IMMUNOL, V163, P3662; Schuh W, 2003, J IMMUNOL, V171, P3343, DOI 10.4049/jimmunol.171.7.3343; Schuh W, 2008, MOL IMMUNOL, V45, P362, DOI 10.1016/j.molimm.2007.06.154; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Vettermann C, 2006, SEMIN IMMUNOL, V18, P44, DOI 10.1016/j.smim.2006.01.001; Vettermann C, 2010, TRENDS IMMUNOL, V31, P176, DOI 10.1016/j.it.2010.02.004; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011; Winkelmann R, 2011, P NATL ACAD SCI USA, V108, P710, DOI 10.1073/pnas.1012858108; Wu JH, 2004, ONCOGENE, V23, P8088, DOI 10.1038/sj.onc.1207996; Wu JH, 2005, J IMMUNOL, V175, P3060, DOI 10.4049/jimmunol.175.5.3060; Yusuf I, 2003, TRENDS IMMUNOL, V24, P380, DOI 10.1016/S1471-4906(03)00141-8	31	21	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 29	2014	9	5							e97953	10.1371/journal.pone.0097953	http://dx.doi.org/10.1371/journal.pone.0097953			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UR	24874925	Green Published, Green Submitted, gold			2022-12-25	WOS:000336790800017
J	Chew, KS; Schmidt, TM; Rupp, AC; Kofuji, P; Trimarchi, JM				Chew, Kylie S.; Schmidt, Tiffany M.; Rupp, Alan C.; Kofuji, Paulo; Trimarchi, Jeffrey M.			Loss of G(q11) Genes Does Not Abolish Melanopsin Phototransduction	PLOS ONE			English	Article							EXPRESSING GANGLION-CELLS; G-PROTEINS; RESPONSES; DIVERSITY; DEFECTS; RETINA; MOUSE	In mammals, a subset of retinal ganglion cells (RGCs) expresses the photopigment melanopsin, which renders them intrinsically photosensitive (ipRGCs). These ipRGCs mediate various non-image-forming visual functions such as circadian photoentrainment and the pupillary light reflex (PLR). Melanopsin phototransduction begins with activation of a heterotrimeric G protein of unknown identity. Several studies of melanopsin phototransduction have implicated a G-protein of the G(q/11) family, which consists of Gna11, Gna14, Gnaq and Gna15, in melanopsin-evoked depolarization. However, the exact identity of the G(q/11) gene involved in this process has remained elusive. Additionally, whether G(q/11) G-proteins are necessary for melanopsin phototransduction in vivo has not yet been examined. We show here that the majority of ipRGCs express both Gna11 and Gna14, but neither Gnaq nor Gna15. Animals lacking the melanopsin protein have well-characterized deficits in the PLR and circadian behaviors, and we therefore examined these non-imaging forming visual functions in a variety of single and double mutants for G(q/11) family members. All G(q/11) mutant animals exhibited PLR and circadian behaviors indistinguishable from WT. In addition, we show persistence of ipRGC light-evoked responses in Gna11(-/-); Gna14(-/-) retinas using multielectrode array recordings. These results demonstrate that G(q), G(11), G(14), or G(15) alone or in combination are not necessary for melanopsin-based phototransduction, and suggest that ipRGCs may be able to utilize a G(q/11)-independent phototransduction cascade in vivo.	[Chew, Kylie S.; Schmidt, Tiffany M.; Rupp, Alan C.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Kofuji, Paulo] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA; [Trimarchi, Jeffrey M.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA	Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; Iowa State University	Chew, KS (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	kchew1@jhu.edu	Schmidt, Tiffany M/A-9660-2012; Schmidt, Tiffany/L-7598-2014; Kofuji, Paulo/AAR-7835-2021	Schmidt, Tiffany M/0000-0002-4791-6775; Schmidt, Tiffany/0000-0002-4791-6775; Kofuji, Paulo/0000-0002-4840-9986; Trimarchi, Jeffrey/0000-0001-7923-1538; Chew, Kylie/0000-0003-4752-009X; Rupp, Alan/0000-0001-5363-4494	National Institutes of Health [1R01EY019053, GM076430]; Open Access Promotion Fund of the Johns Hopkins University Libraries; NATIONAL EYE INSTITUTE [P30EY011374, R01EY019053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007231, R01GM076430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Open Access Promotion Fund of the Johns Hopkins University Libraries; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Health Grant: 1R01EY019053, National Institutes of Health Grant: GM076430. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailes HJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2987; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Davignon I, 2000, MOL CELL BIOL, V20, P797, DOI 10.1128/MCB.20.3.797-804.2000; Davignon I, 1996, GENOMICS, V31, P359, DOI 10.1006/geno.1996.0059; Dennis EA, 2011, INTERCELLULAR SIGNAL; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Goetz JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3824; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hardie RC, 2001, J EXP BIOL, V204, P3403; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Huang JH, 2010, CURR BIOL, V20, P189, DOI 10.1016/j.cub.2009.12.019; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Offermanns S, 1999, N-S ARCH PHARMACOL, V360, P5, DOI 10.1007/s002109900030; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; PARK DG, 1993, J BIOL CHEM, V268, P4573; Perez-Leighton CE, 2011, EUR J NEUROSCI, V33, P856, DOI 10.1111/j.1460-9568.2010.07583.x; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Schmidt TM, 2008, J NEUROPHYSIOL, V100, P371, DOI 10.1152/jn.00062.2008; Sekaran S, 2005, CURR BIOL, V15, P1099, DOI 10.1016/j.cub.2005.05.053; Sernagor E, 2001, PROG RETIN EYE RES, V20, P139, DOI 10.1016/S1350-9462(00)00024-0; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Sun C, 2008, J NEUROPHYSIOL, V100, P3253, DOI 10.1152/jn.90303.2008; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; WILKIE TM, 1991, P NATL ACAD SCI USA, V88, P10049, DOI 10.1073/pnas.88.22.10049; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567	32	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98356	10.1371/journal.pone.0098356	http://dx.doi.org/10.1371/journal.pone.0098356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870805	gold, Green Published, Green Submitted			2022-12-25	WOS:000336858300038
J	Grandone, E; Villani, M; Tiscia, GL; Dentali, F; Colaizzo, D; Cappucci, F; Fischetti, L; Ageno, W; Margaglione, M				Grandone, Elvira; Villani, Michela; Tiscia, Giovanni L.; Dentali, Francesco; Colaizzo, Donatella; Cappucci, Filomena; Fischetti, Lucia; Ageno, Walter; Margaglione, Maurizio			Clinical Utility of Antithrombotic Prophylaxis in ART Procedures: An Italian Experience	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; INTRACYTOPLASMIC SPERM INJECTION; ASSISTED CONCEPTION; BIRTH-RATES; THROMBOPHILIA; METAANALYSIS; OUTCOMES; HEPARIN; WOMEN	Background: The usefulness of antithrombotic prophylaxis in management of Assisted Reproductive Technologies (ART) is questionable. Objectives: We prospectively examined the contribution of an antithrombotic prophylaxis in influencing clinical pregnancy and live-birth in an unselected cohort of women approaching ART. Patients/Methods: 1107 women with fertility problems and a valid indication for ART were recruited. Baseline and follow-up information of obstetric outcomes and antithrombotic treatment were collected. Results and Conclusions: Median follow-up time was 34.5 months (range: 2-143). During the follow-up period, 595 (53.8%) women underwent ART (total 1234 cycles); 202 (33.9%) women achieved a pregnancy for a total of 255 clinical pregnancies. The concomitant use of LMWH and aspirin was significantly associated with a higher rate of clinical pregnancies (p: 0.003, OR: 4.9, 95% CI: 1.7-14.2). The pregnancy rate was also significantly increased by the use of LMWH alone (p: 0.005, OR: 2.6, 95% CI: 1.3-5.0). Carriership of inherited or acquired thrombophilia did not affect clinical outcomes of the ART. The efficacy of antithrombotic treatment was confirmed when the outcome "live-birth" was considered. Present data suggest a potential benefit of antithrombotic prophylaxis during ART in improving the number of live-births.	[Grandone, Elvira; Villani, Michela; Tiscia, Giovanni L.; Colaizzo, Donatella; Cappucci, Filomena; Fischetti, Lucia] IRCCS Casa Sollievo Sofferenza, Atherosclerosis & Thrombosis Unit, Foggia, Italy; [Dentali, Francesco; Ageno, Walter] Insubria Univ, Dept Clin Med, Varese, Italy; [Margaglione, Maurizio] Univ Foggia, Foggia, Italy	IRCCS Casa Sollievo Della Sofferenza; University of Insubria; University of Foggia	Grandone, E (corresponding author), IRCCS Casa Sollievo Sofferenza, Atherosclerosis & Thrombosis Unit, Foggia, Italy.	e.grandone@operapadrepio.it	Tiscia, Giovanni/AAC-8788-2019; COLAIZZO, DONATELLA/K-5654-2016; Grandone, Elvira/M-1127-2019; Villani, Michela/D-9169-2017	Tiscia, Giovanni/0000-0001-5896-2024; COLAIZZO, DONATELLA/0000-0001-6927-7428; Grandone, Elvira/0000-0002-8980-9783; Cappucci, Filomena/0000-0001-7745-7330; MARGAGLIONE, MAURIZIO/0000-0001-5627-9221; ageno, walter/0000-0002-1922-8879; Fischetti, Lucia/0000-0002-0297-1105; Villani, Michela/0000-0002-7571-1267	Italian Ministry of Health (Ricerca Corrente)	Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy)	The study was supported by grants from Italian Ministry of Health (Ricerca Corrente 2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dentali F, 2012, J THROMB HAEMOST, V10, P2075, DOI 10.1111/j.1538-7836.2012.04886.x; Dentali F, 2011, J THROMB HAEMOST, V9, P2503, DOI 10.1111/j.1538-7836.2011.04535.x; Di Nisio M, 2011, BLOOD, V118, P2670, DOI 10.1182/blood-2011-03-340216; Gilbert WM, 1999, OBSTET GYNECOL, V93, P9, DOI 10.1016/S0029-7844(98)00382-2; Grandone E, 2014, THROMB RES, V133, P168, DOI 10.1016/j.thromres.2013.11.016; Grandone E, 2011, J THROMB HAEMOST, V9, P496, DOI 10.1111/j.1538-7836.2011.04183.x; Grandone E, 2001, FERTIL STERIL, V76, P201, DOI 10.1016/S0015-0282(01)01832-5; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Kimberly Liu, 2012, Int J Gynaecol Obstet, V117, P95; Luke B, 2012, NEW ENGL J MED, V366, P2483, DOI 10.1056/NEJMoa1110238; Malizia BA, 2009, NEW ENGL J MED, V360, P236, DOI 10.1056/NEJMoa0803072; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Nelson SM, 2008, HUM REPROD UPDATE, V14, P623, DOI 10.1093/humupd/dmn031; Pandian Z, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003357.pub2; Ricci G, 2011, HUM REPROD, V26, P3068, DOI 10.1093/humrep/der261; Siristatidis CS, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004832.pub3, 10.1002/14651858.CD004832]; Zegers-Hochschild F, 2009, HUM REPROD, V24, P2683, DOI 10.1093/humrep/dep343	17	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e97604	10.1371/journal.pone.0097604	http://dx.doi.org/10.1371/journal.pone.0097604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24870449	Green Submitted, gold, Green Published			2022-12-25	WOS:000336858300015
J	Shen, ZZ; Wang, DS; Ruan, YZ; Xue, C; Zhang, J; Li, R; Shen, QR				Shen, Zongzhuan; Wang, Dongsheng; Ruan, Yunze; Xue, Chao; Zhang, Jian; Li, Rong; Shen, Qirong			Deep 16S rRNA Pyrosequencing Reveals a Bacterial Community Associated with Banana Fusarium Wilt Disease Suppression Induced by Bio-Organic Fertilizer Application	PLOS ONE			English	Article							MICROBIAL COMMUNITY; BIOLOGICAL-CONTROL; SOIL PROPERTIES; STRAIN G10; MUSA SPP.; ROOT-ROT; DIVERSITY; MANAGEMENT; PATHOGENS; COMPOST	Our previous work demonstrated that application of a bio-organic fertilizer (BIO) to a banana mono-culture orchard with serious Fusarium wilt disease effectively decreased the number of soil Fusarium sp. and controlled the soil-borne disease. Because bacteria are an abundant and diverse group of soil organisms that responds to soil health, deep 16 S rRNA pyrosequencing was employed to characterize the composition of the bacterial community to investigate how it responded to BIO or the application of other common composts and to explore the potential correlation between bacterial community, BIO application and Fusarium wilt disease suppression. After basal quality control, 137,646 sequences and 9,388 operational taxonomic units (OTUs) were obtained from the 15 soil samples. Proteobacteria, Acidobacteria, Bacteroidetes, Gemmatimonadetes and Actinobacteria were the most frequent phyla and comprised up to 75.3% of the total sequences. Compared to the other soil samples, BIO-treated soil revealed higher abundances of Gemmatimonadetes and Acidobacteria, while Bacteroidetes were found in lower abundance. Meanwhile, on genus level, higher abundances compared to other treatments were observed for Gemmatimonas and Gp4. Correlation and redundancy analysis showed that the abundance of Gemmatimonas and Sphingomonas and the soil total nitrogen and ammonium nitrogen content were higher after BIO application, and they were all positively correlated with disease suppression. Cumulatively, the reduced Fusarium wilt disease incidence that was seen after BIO was applied for 1-year might be attributed to the general suppression based on a shift within the bacteria soil community, including specific enrichment of Gemmatimonas and Sphingomonas.	[Shen, Zongzhuan; Xue, Chao; Zhang, Jian; Li, Rong; Shen, Qirong] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Key Lab Plant Nutr & Fertilizat Low Middle Reache, Natl Engn Res Ctr Organ Based Fertilizers,Jiangsu, Nanjing, Jiangsu, Peoples R China; [Ruan, Yunze] Hainan Univ, Coll Agr, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou, Peoples R China; [Wang, Dongsheng] Nanjing Inst Vegetable Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Hainan University	Shen, QR (corresponding author), Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Key Lab Plant Nutr & Fertilizat Low Middle Reache, Natl Engn Res Ctr Organ Based Fertilizers,Jiangsu, Nanjing, Jiangsu, Peoples R China.	shenqirong@njau.edu.cn	Shen, Qirong/AAB-6531-2020		National Natural Science Foundation of China [41101231, 31372142]; Natural Science Foundation of Hainan province [313045]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); 111 project [B12009]; Agricultural Ministry of China [201103004]; Innovative Research Team Development Plan of the Ministry of Education of China [IRT1256]; China Postdoctoral Science Foundation [2011M501248, 2012T50479, KJ2011007];  [ZDZX2013023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hainan province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); 111 project(Ministry of Education, China - 111 Project); Agricultural Ministry of China(Ministry of Agriculture & Rural Affairs); Innovative Research Team Development Plan of the Ministry of Education of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); 	This work was supported by the National Natural Science Foundation of China (41101231 and 31372142), Natural Science Foundation of Hainan province (313045), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), 111 project (B12009), the Agricultural Ministry of China (201103004), the Innovative Research Team Development Plan of the Ministry of Education of China (IRT1256), the China Postdoctoral Science Foundation (2011M501248 and 2012T50479), and the (KJ2011007) and The Central Financial Support to the Central and Western Nniversities to Specially Enhance the Comprehensive Strength (ZDZX2013023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Balkwill D.L., 2006, PROKARYOTES, P605, DOI DOI 10.1007/0-387-30747-8_23; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Bonanomi G, 2007, J PLANT PATHOL, V89, P311; BUNGE J, 1993, J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Butler D, 2013, NATURE, V504, P195, DOI 10.1038/504195a; CHAO A, 1984, SCAND J STAT, V11, P265; Chaudhry V, 2012, MICROB ECOL, V64, P450, DOI 10.1007/s00248-012-0025-y; Chen LH, 2011, BIORESOURCE TECHNOL, V102, P3900, DOI 10.1016/j.biortech.2010.11.126; Chen YF, 2013, PLANT PATHOL, V62, P112, DOI 10.1111/j.1365-3059.2012.02620.x; Cotxarrera L, 2002, SOIL BIOL BIOCHEM, V34, P467, DOI 10.1016/S0038-0717(01)00205-X; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; El-Hassan SA, 2006, J PHYTOPATHOL, V154, P148, DOI 10.1111/j.1439-0434.2006.01075.x; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Getha K, 2005, J IND MICROBIOL BIOT, V32, P24, DOI 10.1007/s10295-004-0199-5; Getha K, 2002, J IND MICROBIOL BIOT, V28, P303, DOI [10.1038/sj/jim/7000247, 10.1038/sj.jim.7000247]; Hamel C, 2005, PLANT SOIL, V268, P75, DOI 10.1007/s11104-004-0228-1; Hoper H, 1996, EUR J SOIL BIOL, V32, P41; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Kavino M, 2010, APPL SOIL ECOL, V45, P71, DOI 10.1016/j.apsoil.2010.02.003; Kyselkova M, 2009, ISME J, V3, P1127, DOI 10.1038/ismej.2009.61; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Leps J., 2005, AUSTRAL ECOL, V86, P6, DOI [10.1890/0012-9623(2005)86[6a:MAOEDU]2.0.CO;2, DOI 10.1111/J.1442-9993.2005.01433.X]; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Mallett KI, 1998, FOREST ECOL MANAG, V105, P37, DOI 10.1016/S0378-1127(97)00294-6; Mazzola M, 2004, ANNU REV PHYTOPATHOL, V42, P35, DOI 10.1146/annurev.phyto.42.040803.140408; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; Oyarzun PJ, 1998, APPL SOIL ECOL, V10, P151, DOI 10.1016/S0929-1393(98)00042-0; Perez-Piqueres A, 2006, SOIL BIOL BIOCHEM, V38, P460, DOI 10.1016/j.soilbio.2005.05.025; Poulsen PHB, 2013, SOIL BIOL BIOCHEM, V57, P784, DOI 10.1016/j.soilbio.2011.12.023; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qiu MH, 2012, BIOL FERT SOILS, V48, P807, DOI 10.1007/s00374-012-0675-4; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R Development Core Team, 2012, R LANG ENV STAT COMP; Raguchander T., 1997, Journal of Biological Control, V11, P101; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sanguin H, 2009, NEW PHYTOL, V184, P694, DOI 10.1111/j.1469-8137.2009.03010.x; Saravanan T, 2003, CROP PROT, V22, P1117, DOI 10.1016/S0261-2194(03)00146-7; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shen CC, 2013, SOIL BIOL BIOCHEM, V57, P204, DOI 10.1016/j.soilbio.2012.07.013; Shen ZZ, 2013, EUR J SOIL BIOL, V57, P1, DOI 10.1016/j.ejsobi.2013.03.006; SIVAMANI E, 1988, PLANT SOIL, V107, P3, DOI 10.1007/BF02371537; Sun HY, 2004, APPL ENVIRON MICROB, V70, P5868, DOI 10.1128/AEM.70.10.5868-5874.2004; Wachowska U, 2013, BIOCONTROL SCI TECHN, V23, P1110, DOI 10.1080/09583157.2013.812185; Wang BB, 2013, BIOL FERT SOILS, V49, P435, DOI 10.1007/s00374-012-0739-5; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Warnes GR, 2011, GPLOTS VARIOUS R PRO; WASHINGTON HG, 1984, WATER RES, V18, P653, DOI 10.1016/0043-1354(84)90164-7; Yin CT, 2013, APPL ENVIRON MICROB, V79, P7428, DOI 10.1128/AEM.01610-13; Zhao QY, 2011, APPL SOIL ECOL, V47, P67, DOI 10.1016/j.apsoil.2010.09.010	52	79	88	4	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 28	2014	9	5							e98420	10.1371/journal.pone.0098420	http://dx.doi.org/10.1371/journal.pone.0098420			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4TS	24871319	Green Submitted, Green Published, gold			2022-12-25	WOS:000336858300043
J	Bliss, KT; Tsukada, T; Novak, SM; Dorovkov, MV; Shah, SP; Nworu, C; Kostyukova, AS; Gregorio, CC				Bliss, Katherine T.; Tsukada, Takehiro; Novak, Stefanie Mares; Dorovkov, Maxim V.; Shah, Samar P.; Nworu, Chinedu; Kostyukova, Alla S.; Gregorio, Carol C.			Phosphorylation of tropomodulin1 contributes to the regulation of actin filament architecture in cardiac muscle	FASEB JOURNAL			English	Article						post-translational modification; sarcomere	BINDING PROTEIN-C; TROPOMYOSIN BINDING; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; POINTED ENDS; N-TERMINUS; TROPONIN-I; F-ACTIN; KINASE; TRPM7	Tropomodulin1 (Tmod1) is an actin-capping protein that plays an important role in actin filament pointed-end dynamics and length in striated muscle. No mechanisms have been identified to explain how Tmod1's functional properties are regulated. The purpose of this investigation was to explore the functional significance of the phosphorylation of Tmod1 at previously identified Thr54. Rat cardiomyocytes were assessed for phosphorylation of Tmod1 using Pro-Q Diamond staining and P-32 labeling. Green fluorescent protein-tagged phosphorylation-mimic (T54E) and phosphorylation-deficient (T54A) versions of Tmod1 were expressed in cultured cardiomyocytes, and the ability of these mutants to assemble and restrict actin lengths was observed. We report for the first time that Tmod1 is phosphorylated endogenously in cardiomyocytes, and phosphorylation at Thr54 causes a significant reduction in the ability of Tmod1 to assemble to the pointed end compared with that of the wild type (WT; 48 vs. 78%, respectively). In addition, overexpression of Tmod1-T54E restricts actin filament lengths by only similar to 3%, whereas Tmod1-WT restricts the lengths significantly by similar to 8%. Finally, Tmod1-T54E altered the actin filament-capping activity in polymerization assays. Taken together, our data suggest that pointed-end assembly and Tmod1's thin filament length regulatory function are regulated by its phosphorylation state.	[Bliss, Katherine T.; Tsukada, Takehiro; Novak, Stefanie Mares; Nworu, Chinedu; Gregorio, Carol C.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA; [Bliss, Katherine T.; Tsukada, Takehiro; Novak, Stefanie Mares; Nworu, Chinedu; Gregorio, Carol C.] Univ Arizona, Sarver Mol Cardiovasc Res Program, Tucson, AZ USA; [Dorovkov, Maxim V.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA; [Kostyukova, Alla S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; [Kostyukova, Alla S.] Washington State Univ, Sch Chem Engn & Bioengn, Pullman, WA USA	University of Arizona; University of Arizona; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Washington State University	Gregorio, CC (corresponding author), Dept Cellular & Mol Med, 1656 E Mabel St,MRB 315, Tucson, AZ 85724 USA.	gregorio@email.arizona.edu			U.S. National Institutes of Health [HL083146, HL108625, HL081386, GM081688, 1F31HL 117520]; American Heart Association [0825870G, 10PRE3780013, 12PRE11900038]; Grants-in-Aid for Scientific Research [25860147] Funding Source: KAKEN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083146, R01HL108625, R01HL081386, F31HL117520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081688] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	dThe authors thank Ellen Taylor, Marcus DiMarco, Verena Koenning, Katrina Garvey, and Laura Arguedas for generating rat cardiomyocyte cultures and for technical assistance, Lucy Kotlyanskaya for assistance with biochemistry, Dr. Mien-sheng Chu and Marcela Berumen for generating the GFP-Tmod1 adenovirus, Dr. Gregory Rogers and Dr. Daniel Buster for assistance with the <SUP>32</SUP>P phosphorylation analysis experiments and for providing llama GFP-binding protein conjugated beads, and the Rutgers Aresty Research Center for Undergraduates (New Brunswick, NJ, USA) that allowed S. P. S. to work in the laboratory of A. S. K. This work was supported by the U.S. National Institutes of Health (grants HL083146 and HL108625 to C. C. G., HL081386 to the late Dr. Jeffrey Walker, GM081688 to A. S. K., and predoctoral fellowship 1F31HL 117520 to S.M.N.) and the American Heart Association (grant 0825870G to T. T. and predoctoral fellowships 10PRE3780013 to K. T. B. and 12PRE11900038 to S.M.N.).	Almenar-Queralt A, 1999, J CELL SCI, V112, P1111; Anderson BR, 2010, J STRUCT BIOL, V170, P270, DOI 10.1016/j.jsb.2010.02.002; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Buster DW, 2013, J CELL BIOL, V201, P49, DOI 10.1083/jcb.201207183; Chu X, 2003, AM J PHYSIOL-HEART C, V284, pH1827, DOI 10.1152/ajpheart.00947.2002; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Cooper JA, 2008, INT REV CEL MOL BIO, V267, P183, DOI 10.1016/S1937-6448(08)00604-7; Cox PR, 2000, GENOMICS, V63, P97, DOI 10.1006/geno.1999.6061; Dorovkov M. V., 2008, Biofizika, V53, P943; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; FASMAN GD, 1989, TRENDS BIOCHEM SCI, V14, P295, DOI 10.1016/0968-0004(89)90068-6; Fowler VM, 2003, J BIOL CHEM, V278, P40000, DOI 10.1074/jbc.M306895200; Fritz-Six KL, 2003, J CELL BIOL, V163, P1033, DOI 10.1083/jcb.200308164; Gokhin DS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/103069; Greenfield NJ, 2005, BIOPHYS J, V88, P372, DOI 10.1529/biophysj.104.051128; Greenfield NJ, 2001, J MOL BIOL, V312, P833, DOI 10.1006/jmbi.2001.4982; GREGORIO CC, 1995, NATURE, V377, P83, DOI 10.1038/377083a0; GUSTAFSON TA, 1987, J BIOL CHEM, V262, P13316; Hanft LM, 2013, J PHYSIOL-LONDON, V591, P4535, DOI 10.1113/jphysiol.2013.258400; Hidalgo C, 2009, CIRC RES, V105, P631, DOI 10.1161/CIRCRESAHA.109.198465; Hollrigl A, 2007, DIFFERENTIATION, V75, P616, DOI 10.1111/j.1432-0436.2007.00163.x; Huang XP, 2002, EXP BIOL MED, V227, P1039, DOI 10.1177/153537020222701113; ITO M, 1995, DEV BIOL, V167, P317, DOI 10.1006/dbio.1995.1026; Kawajiri A, 2003, MOL BIOL CELL, V14, P1489, DOI 10.1091/mbc.E02-09-0612; Kim TY, 2012, BIOCHEM BIOPH RES CO, V417, P1030, DOI 10.1016/j.bbrc.2011.12.085; Kobayashi T, 2008, PFLUG ARCH EUR J PHY, V457, P37, DOI 10.1007/s00424-008-0511-8; Kotter S, 2013, CARDIOVASC RES, V99, P648, DOI 10.1093/cvr/cvt144; Kooij V, 2013, J MOL CELL CARDIOL, V60, P116, DOI 10.1016/j.yjmcc.2013.04.012; Kostyukova A, 2000, EUR J BIOCHEM, V267, P6470, DOI 10.1046/j.1432-1327.2000.01738.x; Kostyukova AS, 2006, BIOCHEMISTRY-US, V45, P12068, DOI 10.1021/bi060899i; Kostyukova AS, 2005, BIOCHEMISTRY-US, V44, P4905, DOI 10.1021/bi047468p; Kostyukova AS, 2004, J BIOL CHEM, V279, P5066, DOI 10.1074/jbc.M311186200; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Krieger I, 2002, BIOPHYS J, V83, P2716, DOI 10.1016/S0006-3495(02)75281-8; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; LeWinter MM, 2010, CIRCULATION, V121, P2137, DOI 10.1161/CIRCULATIONAHA.109.860171; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; Littlefield RS, 2008, SEMIN CELL DEV BIOL, V19, P511, DOI 10.1016/j.semcdb.2008.08.009; McKeown CR, 2008, CIRC RES, V103, P1241, DOI 10.1161/CIRCRESAHA.108.178749; Middelbeek J, 2010, CELL MOL LIFE SCI, V67, P875, DOI 10.1007/s00018-009-0215-z; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Ono Y, 2005, DEV BIOL, V282, P336, DOI 10.1016/j.ydbio.2005.03.015; Pappas CT, 2008, MOL BIOL CELL, V19, P1837, DOI 10.1091/mbc.E07-07-0690; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanov AG, 1999, CURR BIOL, V9, pR43, DOI 10.1016/S0960-9822(99)80006-2; Sah R, 2013, P NATL ACAD SCI USA, V110, pE3037, DOI 10.1073/pnas.1311865110; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Solaro RJ, 2011, J BIOL CHEM, V286, P9935, DOI 10.1074/jbc.R110.197731; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Su LT, 2011, BIOCHEM J, V434, P513, DOI 10.1042/BJ20101678; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; Sussman MA, 1998, CIRC RES, V82, P94; Sussman MA, 1998, J CLIN INVEST, V101, P51, DOI 10.1172/JCI1167; Wagner LM, 2002, MOL VIS, V8, P394; WEBER A, 1994, J CELL BIOL, V127, P1627, DOI 10.1083/jcb.127.6.1627; Weith A, 2012, J MOL CELL CARDIOL, V52, P219, DOI 10.1016/j.yjmcc.2011.09.019; Wijnker PJM, 2013, AM J PHYSIOL-HEART C, V304, pH260, DOI 10.1152/ajpheart.00498.2012; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Yamasaki R, 2002, CIRC RES, V90, P1181, DOI 10.1161/01.RES.0000021115.24712.99	63	7	7	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2014	28	9					3987	3995		10.1096/fj.13-246009	http://dx.doi.org/10.1096/fj.13-246009			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN8HU	24891520	Green Published			2022-12-25	WOS:000340845900016
J	Volkova, NA; Fomina, EG; Smolnikova, VV; Zinovieva, NA; Fomin, IK				Volkova, Natalia A.; Fomina, Elena G.; Smolnikova, Viktoryia V.; Zinovieva, Natalia A.; Fomin, Igor K.			The U3 Region of Moloney Murine Leukemia Virus Contains Position-independent Cis-acting Sequences Involved in the Nuclear Export of Full-length Viral Transcripts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG TERMINAL REPEAT; 5' RNA TERMINUS; RETROVIRAL VECTORS; R-REGION; SECONDARY STRUCTURE; LENTIVIRUS VECTOR; GENE-TRANSFER; EXPRESSION; GAG; SIGNAL	The distinguishing feature of self-inactivating (SIN) retroviral vectors is the deletion of the enhancer/promoter sequences in the U3 region of the 3' long terminal repeat. This design is used to overcome transcriptional interference and prevent downstream transcription from the 3' long terminal repeat. SIN vectors were derived from a number of different retroviruses. Studies of SIN vectors show that extensive U3 deletions in HIV-based vectors do not alter viral titers or the in vitro and in vivo properties of the vectors. However, deletion of the U3 sequences in gamma- and alpha-retroviruses correlates with defects in 3' RNA processing and reduces viral titers by >10-fold. Here, we studied the steps in the retroviral life cycle that are affected by the deletion of sequences in the 3' U3 region of Moloney murine leukemia virus-derived retroviral vectors. The results show that the amounts of both full-length and internal RNA transcripts of U3-minus vectors are reduced in the nuclei of transfected cells, an effect that is probably due to a general defect in 3' RNA processing. Furthermore, full-length RNA transcripts were also defective in terms of nuclear export. This defect was complemented by transferring the U3 region to another position within the retroviral vector, indicating that the U3 region contains position-independent cis-acting sequences that are required for the transport of full-length viral transcripts. The results also suggest that the leader region of Moloney murine leukemia virus contains inhibitory/regulatory sequences, which prevent export and mediate nuclear retention of full-length viral RNA.	[Fomina, Elena G.] Republ Res & Pract Ctr Epidemiol & Microbiol, Lab Biotechnol & Immunodiagnosis, Minsk 220114, BELARUS; [Smolnikova, Viktoryia V.] Republ Ctr Hematol & Bone Marrow Transplantat, Minsk 220116, BELARUS			n_zinovieva@mail.ru; ikfomin@mail.ru	Volkova, Natalia/AAE-3311-2019	Volkova, Natalia/0000-0001-7191-3550				Basyuk E, 2005, J MOL BIOL, V354, P330, DOI 10.1016/j.jmb.2005.09.071; Blissenbach M, 2010, J VIROL, V84, P6598, DOI 10.1128/JVI.02264-09; Butsch M, 1999, J VIROL, V73, P4847, DOI 10.1128/JVI.73.6.4847-4855.1999; Cupelli L, 1998, J VIROL, V72, P7807, DOI 10.1128/JVI.72.10.7807-7814.1998; CUPELLI LA, 1991, J VIROL, V65, P6961, DOI 10.1128/JVI.65.12.6961-6968.1991; Dangel AW, 2002, J VIROL, V76, P3292, DOI 10.1128/JVI.76.7.3292-3300.2002; DOUGHERTY JP, 1987, P NATL ACAD SCI USA, V84, P1197, DOI 10.1073/pnas.84.5.1197; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; FLAMANT F, 1993, J GEN VIROL, V74, P39, DOI 10.1099/0022-1317-74-1-39; Hlavaty J, 2004, J VIROL, V78, P1384, DOI 10.1128/JVI.78.3.1384-1392.2004; Hull S, 2002, J VIROL, V76, P10211, DOI 10.1128/JVI.76.20.10211-10218.2002; KAWAI S, 1984, MOL CELL BIOL, V4, P1172, DOI 10.1128/MCB.4.6.1172; Kharytonchyk SA, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-3; Klein D, 2000, GENE THER, V7, P458, DOI 10.1038/sj.gt.3301112; MARKOWITZ D, 1988, VIROLOGY, V167, P400, DOI 10.1016/S0042-6822(88)90101-8; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; OLSON P, 1992, J VIROL, V66, P1336, DOI 10.1128/JVI.66.3.1336-1343.1992; OLSON P, 1994, J VIROL, V68, P7060, DOI 10.1128/JVI.68.11.7060-7066.1994; Roberts TM, 2000, J VIROL, V74, P8111, DOI 10.1128/JVI.74.17.8111-8118.2000; Roberts TM, 2003, J VIROL, V77, P11973, DOI 10.1128/JVI.77.22.11973-11984.2003; Russell RA, 2001, J VIROL, V75, P6817, DOI 10.1128/JVI.75.15.6817-6824.2001; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schambach A, 2006, GENE THER, V13, P1524, DOI 10.1038/sj.gt.3302807; Schambach A, 2006, MOL THER, V13, P391, DOI 10.1016/j.ymthe.2005.08.012; Schambach A, 2007, MOL THER, V15, P1167, DOI 10.1038/sj.mt.6300152; Schomber T, 2004, BLOOD, V103, P4511, DOI 10.1182/blood-2003-07-2397; SHINNICK TM, 1981, NATURE, V293, P543, DOI 10.1038/293543a0; Sinn PL, 2005, GENE THER, V12, P1089, DOI 10.1038/sj.gt.3302570; Smagulova F, 2005, J MOL BIOL, V354, P1118, DOI 10.1016/j.jmb.2005.10.021; Trubetskoy AM, 1999, J VIROL, V73, P3477, DOI 10.1128/JVI.73.4.3477-3483.1999; YEE JK, 1987, P NATL ACAD SCI USA, V84, P5197, DOI 10.1073/pnas.84.15.5197; YU SF, 1986, P NATL ACAD SCI USA, V83, P3194, DOI 10.1073/pnas.83.10.3194; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	33	6	6	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20158	20169		10.1074/jbc.M113.545855	http://dx.doi.org/10.1074/jbc.M113.545855			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24878957	hybrid, Green Published			2022-12-25	WOS:000339395200029
J	Yamamoto-Tanaka, M; Motoyama, A; Miyai, M; Matsunaga, Y; Matsuda, J; Tsuboi, R; Hibino, T				Yamamoto-Tanaka, Mami; Motoyama, Akira; Miyai, Masashi; Matsunaga, Yukiko; Matsuda, Junko; Tsuboi, Ryoji; Hibino, Toshihiko			Mesotrypsin and Caspase-14 Participate in Prosaposin Processing POTENTIAL RELEVANCE TO EPIDERMAL PERMEABILITY BARRIER FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL DIFFERENTIATION; SAPOSINS; LEUKODYSTROPHY; IDENTIFICATION; MUTATIONS; PROTEINS; DISEASE; STORAGE; GENE; SKIN	A proteomics-based search for molecules interacting with caspase-14 identified prosaposin and epidermal mesotrypsin as candidates. Prosaposin is a precursor of four sphingolipid activator proteins (saposins A-D) that are essential for lysosomal hydrolysis of sphingolipids. Thus, we hypothesized that caspase-14 and mesotrypsin participate in processing of prosaposin. Because we identified a saposin A sequence as an interactor with these proteases, we prepared a specific antibody to saposin A and focused on saposin A-related physiological reactions. We found that mesotrypsin generated saposins A-D from prosaposin, and mature caspase-14 contributed to this process by activating mesotrypsinogen to mesotrypsin. Knockdown of these proteases markedly down-regulated saposin A synthesis in skin equivalent models. Saposin A was localized in granular cells, whereas prosaposin was present in the upper layer of human epidermis. The proximity ligation assay confirmed interaction between prosaposin, caspase-14, and mesotrypsin in the granular layer. Oil Red staining showed that the lipid envelope was significantly reduced in the cornified layer of skin from saposin A-deficient mice. Ultrastructural studies revealed severely disorganized cornified layer structure in both prosaposin- and saposin A-deficient mice. Overall, our results indicate that epidermal mesotrypsin and caspase-14 work cooperatively in prosaposin processing. We propose that they thereby contribute to permeability barrier formation in vivo.	[Hibino, Toshihiko] Shiseido Innovat Sci Res Ctr, Tsuzuki Ku, Yokohama, Kanagawa 2248558, Japan; [Yamamoto-Tanaka, Mami; Tsuboi, Ryoji] Tokyo Med Univ, Dept Dermatol, Shinjuku Ku, Tokyo 1600023, Japan; [Matsuda, Junko] Tokai Univ, Inst Glycosci, Hiratsuka, Kanagawa 2591292, Japan	Shiseido Company, Limited; Tokyo Medical University; Tokai University	Hibino, T (corresponding author), Shiseido Innovat Sci Res Ctr, Tsuzuki Ku, 2-2-1 Hayabuchi, Yokohama, Kanagawa 2248558, Japan.	toshihiko.hibino1@to.shiseido.co.jp						Alibardi L, 2004, J HISTOCHEM CYTOCHEM, V52, P1561, DOI 10.1369/jhc.4A6300.2004; ANDERSON RGW, 1977, J CELL BIOL, V72, P482, DOI 10.1083/jcb.72.2.482; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Dale B A, 1980, Curr Probl Dermatol, V10, P311; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Doering T, 1999, J BIOL CHEM, V274, P11038, DOI 10.1074/jbc.274.16.11038; Eckhart L, 2000, J INVEST DERMATOL, V115, P1148, DOI 10.1046/j.1523-1747.2000.00205.x; Fujita N, 1996, HUM MOL GENET, V5, P711, DOI 10.1093/hmg/5.6.711; Grabowski GA, 1997, BAILLIERE CLIN HAEM, V10, P635, DOI 10.1016/S0950-3536(97)80032-7; Hibino T, 2010, J CELL BIOCHEM, V109, P487, DOI 10.1002/jcb.22425; Hiraiwa M, 1997, ARCH BIOCHEM BIOPHYS, V341, P17, DOI 10.1006/abbi.1997.9958; HOROWITZ M, 1994, HUM MUTAT, V3, P1, DOI 10.1002/humu.1380030102; Ishida-Yamamoto A, 1998, EXP DERMATOL, V7, P1, DOI 10.1111/j.1600-0625.1998.tb00295.x; Jensen JM, 2009, GIORN ITAL DERMAT V, V144, P689; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; LIGHT A, 1989, TRENDS BIOCHEM SCI, V14, P110, DOI 10.1016/0968-0004(89)90133-3; Lippens S, 2000, CELL DEATH DIFFER, V7, P1218, DOI 10.1038/sj.cdd.4400785; Matsuda J, 2001, HUM MOL GENET, V10, P1191, DOI 10.1093/hmg/10.11.1191; Matsuda J, 2007, J NEUROCHEM, V103, P32, DOI 10.1111/j.1471-4159.2007.04709.x; Miyai M, 2014, J INVEST DERMATOL, V134, P1665, DOI 10.1038/jid.2014.3; Motoyama A, 2007, ANAL CHEM, V79, P3623, DOI 10.1021/ac062292d; Motoyama A, 2006, ANAL CHEM, V78, P5109, DOI 10.1021/ac060354u; Nakanishi J, 2010, J INVEST DERMATOL, V130, P944, DOI 10.1038/jid.2009.364; OBRIEN JS, 1991, FASEB J, V5, P301, DOI 10.1096/fasebj.5.3.2001789; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; PROKSCH E, 1993, BRIT J DERMATOL, V128, P473, DOI 10.1111/j.1365-2133.1993.tb00222.x; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; Sahin-Toth M, 2005, PROTEIN PEPTIDE LETT, V12, P457, DOI 10.2174/0929866054395356; Scharschmidt TC, 2009, J INVEST DERMATOL, V129, P2435, DOI 10.1038/jid.2009.104; Vaccaro AM, 1999, NEUROCHEM RES, V24, P307, DOI 10.1023/A:1022530508763; Vaccaro AM, 2010, HUM MOL GENET, V19, P2987, DOI 10.1093/hmg/ddq204; Van de Craen M, 1998, CELL DEATH DIFFER, V5, P838, DOI 10.1038/sj.cdd.4400444; Yamamoto M, 2012, J BIOL CHEM, V287, P32825, DOI 10.1074/jbc.M112.357467	34	13	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 18	2014	289	29					20026	20038		10.1074/jbc.M113.543421	http://dx.doi.org/10.1074/jbc.M113.543421			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL8NE	24872419	Green Published, hybrid			2022-12-25	WOS:000339395200018
J	Kudo-Sakamoto, Y; Akazawa, H; Ito, K; Takano, J; Yano, M; Yabumoto, C; Naito, AT; Oka, T; Lee, JK; Sakata, Y; Suzuki, J; Saido, TC; Komuro, I				Kudo-Sakamoto, Yoko; Akazawa, Hiroshi; Ito, Kaoru; Takano, Jiro; Yano, Masamichi; Yabumoto, Chizuru; Naito, Atsuhiko T.; Oka, Toru; Lee, Jong-Kook; Sakata, Yasushi; Suzuki, Jun-ichi; Saido, Takaomi C.; Komuro, Issei			Calpain-dependent Cleavage of N-cadherin Is Involved in the Progression of Post-myocardial Infarction Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; ANGIOTENSIN-II; MYOCARDIAL-INFARCTION; TYPE-1 RECEPTOR; PLASMA-MEMBRANE; CELL-DEATH; RAT-HEART; IN-VITRO; ACTIVATION; INHIBITION	Enzymatic proteolysis by calpains, Ca2+-dependent intracellular cysteine proteases, has been implicated in pathological processes such as cellular degeneration or death. Here, we investigated the role of calpain activation in the hearts subjected to myocardial infarction. We produced myocardial infarction in Cast(-/-) mice deficient for calpastatin, the specific endogenous inhibitory protein for calpains, and Cast(+/+) mice. The activity of cardiac calpains in Cast(+/+) mice was not elevated within 1 day but showed a gradual elevation after 7 days following myocardial infarction, which was further pronounced in Cast(-/-) mice. Although the prevalence of cardiomyocyte death was indistinguishable between Cast(-/-) and Cast(+/+) mice, Cast(-/-) mice exhibited profound contractile dysfunction and chamber dilatation and showed a significant reduction in survival rate after myocardial infarction as compared with Cast(+/+) mice. Notably, immunofluorescence revealed that at 28 days after myocardial infarction, calpains were activated in cardiomyocytes exclusively at the border zone and that Cast(-/-) mice showed higher intensity and a broader extent of calpain activation at the border zone than Cast(+/+) mice. In the border zone of Cast(-/-) mice, pronounced activation of calpains was associated with a decrease in N-cadherin expression and up-regulation of molecular markers for cardiac hypertrophy and fibrosis. In cultured rat neonatal cardiomyocytes, calpain activation by treatment with ionomycin induced cleavage of N-cadherin and decreased expression levels of beta-catenin and connexin 43, which was attenuated by calpain inhibitor. These results thus demonstrate that activation of calpains disassembles cell-cell adhesion at intercalated discs by degrading N-cadherin and thereby promotes left ventricular remodeling after myocardial infarction.	[Kudo-Sakamoto, Yoko; Yano, Masamichi; Yabumoto, Chizuru; Oka, Toru; Sakata, Yasushi] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Suita, Osaka 5650871, Japan; [Akazawa, Hiroshi; Suzuki, Jun-ichi] Univ Tokyo, Grad Sch Med, Dept Adv Clin Sci & Therapeut, Bunkyo Ku, Tokyo 1138655, Japan; [Ito, Kaoru] Chiba Univ, Dept Cardiovasc Sci & Med, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan; [Takano, Jiro; Saido, Takaomi C.] RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; [Naito, Atsuhiko T.; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; [Lee, Jong-Kook] Osaka Univ, Dept Cardiovasc Regenerat Med, Grad Sch Med, Suita, Osaka 5650871, Japan; [Akazawa, Hiroshi; Naito, Atsuhiko T.; Oka, Toru; Komuro, Issei] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; University of Tokyo; Chiba University; RIKEN; University of Tokyo; Osaka University; Japan Science & Technology Agency (JST)	Akazawa, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Adv Clin Sci & Therapeut, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	akazawah-tky@umin.ac.jp; komuro-tky@umin.ac.jp	Saido, Takaomi C/N-5472-2015; Ito, Kaoru/AAZ-3440-2021; Sado, Takaomi/AAN-2759-2021	Saido, Takaomi C/0000-0003-1970-6903; Sado, Takaomi/0000-0003-1970-6903; Akazawa, Hiroshi/0000-0002-3574-9607; Sakata, Yasushi/0000-0002-5618-4721	Japan Society for the Promotion of Science (KAKENHI) [21229010, 23390213, 24659390, 25-40014]; Health and Labor Sciences Research Grants; Japan Foundation for Applied Enzymology	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Health and Labor Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Japan Foundation for Applied Enzymology	This work was supported in part by grants from Japan Society for the Promotion of Science (KAKENHI 21229010, 23390213, 24659390, and 25-40014) and Health and Labor Sciences Research Grants (to I. K. and H. A.) and Japan Foundation for Applied Enzymology (to H. A.).	Artal-Sanz M, 2005, FEBS LETT, V579, P3287, DOI 10.1016/j.febslet.2005.03.052; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314; Chen M, 2001, J BIOL CHEM, V276, P30724, DOI 10.1074/jbc.M103701200; Chen Q, 2011, BIOCHEM BIOPH RES CO, V415, P533, DOI 10.1016/j.bbrc.2011.10.037; Dorn GW, 2009, NAT REV CARDIOL, V6, P283, DOI 10.1038/nrcardio.2009.12; Galvez AS, 2007, CIRC RES, V100, P1071, DOI 10.1161/01.RES.0000261938.28365.11; Gao WD, 1997, CIRC RES, V80, P393, DOI 10.1161/01.res.0000435855.49359.47; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Hernando V, 2010, J MOL CELL CARDIOL, V49, P271, DOI 10.1016/j.yjmcc.2010.02.024; Imahashi K, 2005, CIRC RES, V97, P916, DOI 10.1161/01.RES.0000187456.06162.cb; Inserte J, 2005, CIRC RES, V97, P465, DOI 10.1161/01.RES.0000181170.87738.f3; Jackson BM, 2002, J AM COLL CARDIOL, V40, P1160, DOI 10.1016/S0735-1097(02)02121-6; Jang YN, 2009, J NEUROSCI, V29, P5974, DOI 10.1523/JNEUROSCI.6178-08.2009; Kang MY, 2010, CIRC RES, V107, P903, DOI 10.1161/CIRCRESAHA.110.220772; Kawai S, 2011, EXP ANIM TOKYO, V60, P481, DOI 10.1538/expanim.60.481; Khalil PN, 2005, EUR J PHARMACOL, V528, P124, DOI 10.1016/j.ejphar.2005.10.032; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Letavernier E, 2008, CIRC RES, V102, P720, DOI 10.1161/CIRCRESAHA.107.160077; Liu XL, 2004, ANNU REV PHARMACOL, V44, P349, DOI 10.1146/annurev.pharmtox.44.101802.121804; Luo Y, 2003, J CELL SCI, V116, P1471, DOI 10.1242/jcs.00339; Ma J, 2012, J BIOL CHEM, V287, P27480, DOI 10.1074/jbc.M112.358929; Mani SK, 2009, AM J PHYSIOL-HEART C, V297, pH1744, DOI 10.1152/ajpheart.00338.2009; Matsumura Y, 1996, CIRC RES, V79, P447, DOI 10.1161/01.RES.79.3.447; Matsushita T, 1999, CIRC RES, V85, P1046; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Neuhof C, 2004, BIOL CHEM, V385, P1077, DOI 10.1515/BC.2004.139; Papp Z, 2000, CARDIOVASC RES, V45, P981, DOI 10.1016/S0008-6363(99)00374-0; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Saitoh T, 2006, CARDIOVASC PATHOL, V15, P130, DOI 10.1016/j.carpath.2006.01.003; Sandmann S, 2002, BRIT J PHARMACOL, V135, P1951, DOI 10.1038/sj.bjp.0704661; Sandmann S, 2001, BRIT J PHARMACOL, V132, P767, DOI 10.1038/sj.bjp.0703860; Sato N, 1995, BIOCHEM BIOPH RES CO, V217, P649, DOI 10.1006/bbrc.1995.2823; Scalia R, 2011, CIRC RES, V108, P1102, DOI 10.1161/CIRCRESAHA.110.229393; SCHAPER J, 1991, CIRCULATION, V83, P504, DOI 10.1161/01.CIR.83.2.504; Sedarous M, 2003, J BIOL CHEM, V278, P26031, DOI 10.1074/jbc.M302833200; Shumway SD, 1999, J BIOL CHEM, V274, P30874, DOI 10.1074/jbc.274.43.30874; STEENBERGEN C, 1987, CIRC RES, V60, P700, DOI 10.1161/01.RES.60.5.700; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Takahashi M, 2006, J CARDIOVASC PHARM, V47, P413; Takahashi M, 2005, CARDIOVASC RES, V65, P356, DOI 10.1016/j.cardiores.2004.09.022; Takano J, 2005, J BIOL CHEM, V280, P16175, DOI 10.1074/jbc.M414552200; Taneike M, 2011, J BIOL CHEM, V286, P32170, DOI 10.1074/jbc.M111.248088; Tsuji T, 2001, AM J PHYSIOL-HEART C, V281, pH1286, DOI 10.1152/ajpheart.2001.281.3.H1286; Wang XJ, 1999, J MOL CELL CARDIOL, V31, P333, DOI 10.1006/jmcc.1998.0886; Yoshida H, 2003, CARDIOVASC RES, V59, P419, DOI 10.1016/S0008-6363(03)00385-7; Yoshikawa Y, 2005, AM J PHYSIOL-HEART C, V288, pH1690, DOI 10.1152/ajpheart.00666.2004; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Zatz M, 2005, NEW ENGL J MED, V352, P2413, DOI 10.1056/NEJMra043361; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	54	34	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19408	19419		10.1074/jbc.M114.567206	http://dx.doi.org/10.1074/jbc.M114.567206			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24891510	hybrid, Green Published			2022-12-25	WOS:000339326800017
J	Pandey, KK; Bera, S; Korolev, S; Campbell, M; Yin, ZQ; Aihara, H; Grandgenett, DP				Pandey, Krishan K.; Bera, Sibes; Korolev, Sergey; Campbell, Mary; Yin, Zhiqi; Aihara, Hideki; Grandgenett, Duane P.			Rous Sarcoma Virus Synaptic Complex Capable of Concerted Integration Is Kinetically Trapped by Human Immunodeficiency Virus Integrase Strand Transfer Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTOTYPE FOAMY VIRUS; HIV-1 INTEGRASE; VIRAL-DNA; DISSOCIATION; BINDING; CONFORMATIONS; ORGANIZATION; RALTEGRAVIR; RESISTANCE; MECHANISM	We determined conditions to produce milligram quantities of the soluble Rous sarcoma virus (RSV) synaptic complex that is kinetically trapped by HIV strand transfer inhibitors (STIs). Concerted integration catalyzed by RSV integrase (IN) is effectively inhibited by HIV STIs. Optimized assembly of the RSV synaptic complex required IN, a gain-of-function 3'-OH-recessed U3 oligonucleotide, and an STI under specific conditions to maintain solubility of the trapped synaptic complex at 4 C. A C-terminal truncated IN (1-269 residues) produced a homogeneous population of trapped synaptic complex that eluted at similar to 151,000 Da upon Superdex 200 size-exclusion chromatography (SEC). Approximately 90% of input IN and DNA are incorporated into the trapped synaptic complex using either the C-terminally truncated IN or wild type IN (1-286 residues). No STI is present in the SEC running buffer suggesting the STI-trapped synaptic complex is kinetically stabilized. The yield of the trapped synaptic complex correlates with the dissociative half-life of the STI observed with HIV IN-DNA complexes. Dolutegravir, MK-2048, and MK-0536 are equally effective, whereas raltegravir is similar to 70% as effective. Without an STI present in the assembly mixture, no trapped synaptic complex was observed. Fluorescence and mass spectroscopy analyses demonstrated that the STI remains associated with the trapped complex. SEC-multiangle light scattering analyses demonstrated that wild type IN and the C-terminal IN truncation are dimers that acted as precursors to the tetramer. The purified STI-trapped synaptic complex contained a tetramer as shown by cross-linking studies. Structural studies of this three-domain RSV IN in complex with viral DNA may be feasible.	[Pandey, Krishan K.; Bera, Sibes; Grandgenett, Duane P.] St Louis Univ, Hlth Sci Ctr, Inst Mol Virol, St Louis, MO 63104 USA; [Korolev, Sergey] St Louis Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Campbell, Mary] St Louis Univ, Hlth Sci Ctr, Ctr World Hlth & Med, St Louis, MO 63104 USA; [Yin, Zhiqi; Aihara, Hideki] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	Saint Louis University; Saint Louis University; Saint Louis University; University of Minnesota System; University of Minnesota Twin Cities	Grandgenett, DP (corresponding author), St Louis Univ, Sch Med, Inst Mol Virol, 1100 S Grand Blvd, St Louis, MO 63104 USA.	grandgdp@slu.edu	Korolev, Sergey/ABA-7517-2020	Korolev, Sergey/0000-0001-9313-7126; Pandey, Krishan/0000-0002-3973-9844	National Institutes of Health [AI100682]; Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI100682] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saint Louis University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI100682 (to D. G.). This work was also supported by Saint Louis University.	Bera S, 2005, BIOCHEMISTRY-US, V44, P15106, DOI 10.1021/bi0508340; Bera S, 2011, J MOL BIOL, V410, P831, DOI 10.1016/j.jmb.2011.01.043; Bera S, 2009, J MOL BIOL, V389, P183, DOI 10.1016/j.jmb.2009.04.007; Bojja RS, 2011, J BIOL CHEM, V286, P17047, DOI 10.1074/jbc.M110.212571; Cherepanov P, 2011, CURR OPIN STRUC BIOL, V21, P249, DOI 10.1016/j.sbi.2010.12.005; Dar MJ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-94; DeAnda F, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0077448; Di Santo R, 2014, J MED CHEM, V57, P539, DOI 10.1021/jm400674a; Garvey EP, 2009, BIOCHEMISTRY-US, V48, P1644, DOI 10.1021/bi802141y; GRANDGENETT DP, 1978, VIROLOGY, V89, P119, DOI 10.1016/0042-6822(78)90046-6; Grobler JA, 2009, ANTIVIR THER, V14, pA27; Gupta K, 2012, STRUCTURE, V20, P1918, DOI 10.1016/j.str.2012.08.023; Hare S, 2012, EMBO J, V31, P3020, DOI 10.1038/emboj.2012.118; Hare S, 2011, MOL PHARMACOL, V80, P565, DOI 10.1124/mol.111.073189; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hightower KE, 2011, ANTIMICROB AGENTS CH, V55, P4552, DOI 10.1128/AAC.00157-11; Jurado KA, 2013, P NATL ACAD SCI USA, V110, P8690, DOI 10.1073/pnas.1300703110; Kessl JJ, 2011, NUCLEIC ACIDS RES, V39, P9009, DOI 10.1093/nar/gkr581; Koh Y, 2011, J VIROL, V85, P3677, DOI 10.1128/JVI.02541-10; Kotova S, 2010, J MOL BIOL, V399, P491, DOI 10.1016/j.jmb.2010.04.026; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Langley DR, 2008, BIOCHEMISTRY-US, V47, P13481, DOI 10.1021/bi801372d; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Li XA, 2011, VIROLOGY, V411, P194, DOI 10.1016/j.virol.2010.12.008; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; McCord M, 1998, PROTEIN EXPRES PURIF, V14, P167, DOI 10.1006/prep.1998.0954; Mohammed KD, 2011, J VIROL, V85, P4654, DOI 10.1128/JVI.02374-10; Pandey KK, 2007, J VIROL, V81, P12189, DOI 10.1128/JVI.02863-06; Pandey KK, 2011, BIOCHEMISTRY-US, V50, P9788, DOI 10.1021/bi201247f; Pandey KK, 2010, BIOCHEMISTRY-US, V49, P8376, DOI 10.1021/bi100514s; Peletskaya E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027751; Pereira HD, 2005, J MOL BIOL, V353, P584, DOI 10.1016/j.jmb.2005.08.045; Poirier JM, 2008, J CHROMATOGR B, V867, P277, DOI 10.1016/j.jchromb.2008.03.026; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Pommier Y, 2012, NAT REV DRUG DISCOV, V11, P25, DOI 10.1038/nrd3404; Quashie PK, 2013, ANTIMICROB AGENTS CH, V57, P6223, DOI 10.1128/AAC.01835-13; Shi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056892; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; Vora A, 2004, J BIOL CHEM, V279, P18670, DOI 10.1074/jbc.M314270200; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Xiang L, 2008, J MAGN RESON, V194, P147, DOI 10.1016/j.jmr.2008.06.006; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463	43	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 11	2014	289	28					19648	19658		10.1074/jbc.M114.573311	http://dx.doi.org/10.1074/jbc.M114.573311			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AL7PL	24872410	hybrid, Green Published			2022-12-25	WOS:000339326800037
J	Dufresnes, C; Stock, M; Brelsford, A; Perrin, N				Dufresnes, Christophe; Stoeck, Matthias; Brelsford, Alan; Perrin, Nicolas			Range-Wide Sex-Chromosome Sequence Similarity Supports Occasional XY Recombination in European Tree Frogs (Hyla arborea)	PLOS ONE			English	Article							EVOLUTION	In contrast with mammals and birds, most poikilothermic vertebrates feature structurally undifferentiated sex chromosomes, which may result either from frequent turnovers, or from occasional events of XY recombination. The latter mechanism was recently suggested to be responsible for sex-chromosome homomorphy in European tree frogs (Hyla arborea). However, no single case of male recombination has been identified in large-scale laboratory crosses, and populations from NW Europe consistently display sex-specific allelic frequencies with male-diagnostic alleles, suggesting the absence of recombination in their recent history. To address this apparent paradox, we extended the phylogeographic scope of investigations, by analyzing the sequences of three sex-linked markers throughout the whole species distribution. Refugial populations (southern Balkans and Adriatic coast) show a mix of X and Y alleles in haplotypic networks, and no more within-individual pairwise nucleotide differences in males than in females, testifying to recurrent XY recombination. In contrast, populations of NW Europe, which originated from a recent postglacial expansion, show a clear pattern of XY differentiation; the X and Y gametologs of the sex-linked gene Med15 present different alleles, likely fixed by drift on the front wave of expansions, and kept differentiated since. Our results support the view that sex-chromosome homomorphy in H. arborea is maintained by occasional or historical events of recombination; whether the frequency of these events indeed differs between populations remains to be clarified.	[Dufresnes, Christophe; Brelsford, Alan; Perrin, Nicolas] Univ Lausanne, Dept Ecol & Evolut Biophore Bldg, Lausanne, Switzerland; [Stoeck, Matthias] Leibniz Inst Freshwater Ecol & Inland Fisheries I, Berlin, Germany	University of Lausanne; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Stock, M (corresponding author), Leibniz Inst Freshwater Ecol & Inland Fisheries I, Berlin, Germany.	matthias.stoeck@igb-berlin.de	Stöck, Matthias/E-7245-2014; Perrin, Nicolas/AAA-3150-2020; Dufresnes, Christophe/U-1387-2019	Stöck, Matthias/0000-0003-4888-8371; Perrin, Nicolas/0000-0002-7756-6323	Swiss National Science Foundation [31003A_129894]; Faculty of Biology and Medicine; Fondation Agassiz; Fondation du 450e; Deutsche Forschungsgemeinschaft (DFG) [Sto 493/2-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Faculty of Biology and Medicine; Fondation Agassiz; Fondation du 450e; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was founded in part by the Swiss National Science Foundation (grant 31003A_129894 to NP), by the University of Lausanne (PhD fellowship from the Faculty of Biology and Medicine, grants from the Fondation Agassiz and the Fondation du 450e to CD), and by a Heisenberg-Fellowship (Sto 493/2-1) of the Deutsche Forschungsgemeinschaft (DFG) to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berset-Brandli L, 2008, P ROY SOC B-BIOL SCI, V275, P1577, DOI 10.1098/rspb.2008.0298; Brelsford A, 2013, EVOLUTION, V67, P2434, DOI 10.1111/evo.12151; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dufresnes C, 2013, MOL ECOL, V22, P5669, DOI 10.1111/mec.12513; Dufresnes C, 2011, EVOL BIOL, V38, P208, DOI 10.1007/s11692-011-9114-y; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grossen C, 2012, EVOLUTION, V66, P3155, DOI 10.1111/j.1558-5646.2012.01661.x; Guerrero RF, 2012, J EVOLUTION BIOL, V25, P1947, DOI 10.1111/j.1420-9101.2012.02591.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Perrin N, 2009, EVOLUTION, V63, P3043, DOI 10.1111/j.1558-5646.2009.00837.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Schartl M, 2004, CURR OPIN GENET DEV, V14, P634, DOI 10.1016/j.gde.2004.09.005; Stock M, 2013, SEX DEV, V7, P261, DOI 10.1159/000351089; Stock M, 2012, MOL PHYLOGENET EVOL, V65, P1, DOI 10.1016/j.ympev.2012.05.014; Stock M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001062; Volff JN, 2007, SEX DEV, V1, P85, DOI 10.1159/000100030	16	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e97959	10.1371/journal.pone.0097959	http://dx.doi.org/10.1371/journal.pone.0097959			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892652	gold, Green Published, Green Submitted			2022-12-25	WOS:000336911400028
J	Zeyhle, P; Bauer, JS; Kalinowski, J; Shin-ya, K; Gross, H; Heide, L				Zeyhle, Philipp; Bauer, Judith S.; Kalinowski, Joern; Shin-ya, Kazuo; Gross, Harald; Heide, Lutz			Genome-Based Discovery of a Novel Membrane-Bound 1,6-Dihydroxyphenazine Prenyltransferase from a Marine Actinomycete	PLOS ONE			English	Article							BIOSYNTHETIC GENE-CLUSTER; PHENAZINE BIOSYNTHESIS; MEVALONATE PATHWAY; HETEROLOGOUS EXPRESSION; ISOPRENOID PRODUCTION; ESCHERICHIA-COLI; NATURAL-PRODUCTS; PSEUDOMONAS; PRENYLATION; SYNTHASE	Recently, novel prenylated derivatives of 1,6-dihydroxyphenazine have been isolated from the marine sponge-associated Streptomyces sp. SpC080624SC-11. Genome sequencing of this strain now revealed a gene cluster containing all genes necessary for the synthesis of the phenazine and the isoprenoid moieties. Unexpectedly, however, the cluster did not contain a gene with similarity to previously investigated phenazine prenyltransferases, but instead a gene with modest similarity to the membrane-bound prenyltransferases of ubiquinone and menaquinone biosynthesis. Expression of this gene in E. coli and isolation of the membrane fraction proved that the encoded enzyme, Mpz10, catalyzes two successive prenylations of 1,6-dihydroxyphenazine. Mpz10 is the first example of a membrane-bound enzyme catalyzing the prenylation of a phenazine substrate, and one of few examples of membrane-bound enzymes involved in the prenylation of aromatic secondary metabolites in microorganisms.	[Zeyhle, Philipp; Bauer, Judith S.; Gross, Harald; Heide, Lutz] Univ Tubingen, Inst Pharmazeut, Tubingen, Germany; [Kalinowski, Joern] Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Germany; [Shin-ya, Kazuo] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tokyo, Japan	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Bielefeld; National Institute of Advanced Industrial Science & Technology (AIST)	Heide, L (corresponding author), Univ Tubingen, Inst Pharmazeut, Tubingen, Germany.	heide@uni-tuebingen.de	Shin-ya, Kazuo/L-9613-2018	Shin-ya, Kazuo/0000-0002-4702-0661; Heide, Lutz/0000-0001-7809-7453	German Federal Ministry of Education and Research (GenBioCom)	German Federal Ministry of Education and Research (GenBioCom)	This work has been supported by a grant from the German Federal Ministry of Education and Research (GenBioCom) to LH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja EG, 2008, J AM CHEM SOC, V130, P17053, DOI 10.1021/ja806325k; Awakawa T, 2011, CHEMBIOCHEM, V12, P439, DOI 10.1002/cbic.201000628; Bonitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027336; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brauer L, 2008, CHEMBIOCHEM, V9, P982, DOI 10.1002/cbic.200700575; BREITMAIER E, 1976, J ORG CHEM, V41, P2104, DOI 10.1021/jo00874a008; Bringmann G, 2007, J ORG CHEM, V72, P4198, DOI 10.1021/jo0703404; Brzostowicz PC, 2005, ENVIRON MICROBIOL, V7, P179, DOI 10.1111/j.1462-2920.2004.00681.x; Greenhagen BT, 2008, BIOCHEMISTRY-US, V47, P5281, DOI 10.1021/bi702480t; Gross F, 2006, ARCH MICROBIOL, V185, P28, DOI 10.1007/s00203-005-0059-3; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Hu J, 2011, J ANTIBIOT, V64, P221, DOI 10.1038/ja.2010.162; Itoh T, 2012, CHEMBIOCHEM, V13, P1132, DOI 10.1002/cbic.201200124; Itoh T, 2010, NAT CHEM, V2, P858, DOI [10.1038/NCHEM.764, 10.1038/nchem.764]; Izumikawa M, 2010, J NAT PROD, V73, P208, DOI 10.1021/np900747t; Kawasaki T, 2003, J ANTIBIOT, V56, P957, DOI 10.7164/antibiotics.56.957; Khan ST, 2010, FEMS MICROBIOL LETT, V304, P89, DOI 10.1111/j.1574-6968.2009.01886.x; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kitagawa W, 2013, CHEMBIOCHEM, V14, P1085, DOI 10.1002/cbic.201300167; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; Laursen JB, 2004, CHEM REV, V104, P1663, DOI 10.1021/cr020473j; Lo HC, 2012, J AM CHEM SOC, V134, P4709, DOI 10.1021/ja209809t; Mavrodi DV, 2013, ENVIRON MICROBIOL, V15, P675, DOI 10.1111/j.1462-2920.2012.02846.x; Mavrodi DV, 2010, APPL ENVIRON MICROB, V76, P866, DOI 10.1128/AEM.02009-09; Mavrodi DV, 1998, J BACTERIOL, V180, P2541, DOI 10.1128/JB.180.9.2541-2548.1998; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; MELZER M, 1994, BBA-LIPID LIPID MET, V1212, P93, DOI 10.1016/0005-2760(94)90193-7; Mentel M, 2009, CHEMBIOCHEM, V10, P2295, DOI 10.1002/cbic.200900323; Metzger U, 2009, P NATL ACAD SCI USA, V106, P14309, DOI 10.1073/pnas.0904897106; Nowicka B, 2010, BBA-BIOENERGETICS, V1797, P1587, DOI 10.1016/j.bbabio.2010.06.007; Ohara K, 2009, BIOCHEM J, V421, P231, DOI 10.1042/BJ20081968; Okamura E, 2010, P NATL ACAD SCI USA, V107, P11265, DOI 10.1073/pnas.1000532107; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; Poulter C. Dale, 2006, Phytochemistry Reviews, V5, P17, DOI 10.1007/s11101-005-4887-1; Romer A, 1982, ORG MAGN RESONANCE, V19, P66; Saleh O, 2012, MEDCHEMCOMM, V3, P1009, DOI 10.1039/c2md20045g; Saleh O, 2012, BEILSTEIN J ORG CHEM, V8, DOI 10.3762/bjoc.8.57; Saleh O, 2009, J BIOL CHEM, V284, P14439, DOI 10.1074/jbc.M901312200; Sambrook J, 2001, MOL CLONING LAB MANU; Sasaki K, 2008, PLANT PHYSIOL, V146, P1075, DOI 10.1104/pp.107.110544; Seeger K, 2011, MICROB BIOTECHNOL, V4, P252, DOI 10.1111/j.1751-7915.2010.00234.x; SHEN B, 1993, BIOCHEMISTRY-US, V32, P6656, DOI 10.1021/bi00077a019; SHIRLING E. B., 1966, INT J SYST BACTERIOL, V16, P313; Stec E, 2011, CHEMBIOCHEM, V12, P1724, DOI 10.1002/cbic.201100188; Suvarna K, 1998, J BACTERIOL, V180, P2782, DOI 10.1128/JB.180.10.2782-2787.1998; WOODSIDE AB, 1988, ORG SYNTH, V66, P211; Yu X, 2012, METHOD ENZYMOL, V516, P259, DOI 10.1016/B978-0-12-394291-3.00005-8; Zendah I, 2012, J NAT PROD, V75, P2, DOI 10.1021/np100818d	50	20	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2014	9	6							e99122	10.1371/journal.pone.0099122	http://dx.doi.org/10.1371/journal.pone.0099122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5ML	24892559	Green Published, Green Submitted, gold			2022-12-25	WOS:000336911400127
J	Grant-Downton, RT; Terhem, RB; Kapralov, MV; Mehdi, S; Rodriguez-Enriquez, MJ; Gurr, SJ; van Kan, JAL; Dewey, FM				Grant-Downton, Robert T.; Terhem, Razak B.; Kapralov, Maxim V.; Mehdi, Saher; Josefina Rodriguez-Enriquez, M.; Gurr, Sarah J.; van Kan, Jan A. L.; Dewey, Frances M.			A Novel Botrytis Species Is Associated with a Newly Emergent Foliar Disease in Cultivated Hemerocallis	PLOS ONE			English	Article							GENETIC-VARIATION; PLANT; HOST; INFECTION; ELLIPTICA; FUNGI; ARMILLARIA; DIVERSITY; PATHOGEN; SEED	Foliar tissue samples of cultivated daylilies (Hemerocallis hybrids) showing the symptoms of a newly emergent foliar disease known as 'spring sickness' were investigated for associated fungi. The cause(s) of this disease remain obscure. We isolated repeatedly a fungal species which proved to be member of the genus Botrytis, based on immunological tests. DNA sequence analysis of these isolates, using several different phyogenetically informative genes, indicated that they represent a new Botrytis species, most closely related to B. elliptica (lily blight, fire blight) which is a major pathogen of cultivated Lilium. The distinction of the isolates was confirmed by morphological analysis of asexual sporulating cultures. Pathogenicity tests on Hemerocallis tissues in vitro demonstrated that this new species was able to induce lesions and rapid tissue necrosis. Based on this data, we infer that this new species, described here as B. deweyae, is likely to be an important contributor to the development of 'spring sickness' symptoms. Pathogenesis may be promoted by developmental and environmental factors that favour assault by this necrotrophic pathogen. The emergence of this disease is suggested to have been triggered by breeding-related changes in cultivated hybrids, particularly the erosion of genetic diversity. Our investigation confirms that emergent plant diseases are important and deserve close monitoring, especially in intensively inbred plants.	[Grant-Downton, Robert T.; Kapralov, Maxim V.; Mehdi, Saher; Gurr, Sarah J.; Dewey, Frances M.] Univ Oxford, Dept Plant Sci, Oxford, England; [Terhem, Razak B.; van Kan, Jan A. L.] Wageningen Univ, Phytopathol Lab, NL-6700 AP Wageningen, Netherlands; [Josefina Rodriguez-Enriquez, M.] Univ La Laguna, Inst Bioorgan Antonio Gonzalez IUBO, Tenerife, Spain	University of Oxford; Wageningen University & Research; Universidad de la Laguna	Grant-Downton, RT (corresponding author), Univ Oxford, St Peters Coll, Oxford, England.	robert.grant-downton@spc.ox.ac.uk		van Kan, Jan/0000-0003-3563-1550; Kapralov, Maxim/0000-0001-7966-0295	British Hosta and Hemerocallis Society; Stanley Smith (UK) Horticultural Trust; Universiti Putra Malaysia; Ministry of Higher Education of Malaysia; 'Movilidad del Profesorado' Initiative, MEC, Spain [PR2007-0487]; Beca de Movilidad del Gobierno de Canarias; BBSRC [BB/E00282X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E00282X/1] Funding Source: researchfish; Cancer Research UK [16563, 10118, 11022] Funding Source: researchfish	British Hosta and Hemerocallis Society; Stanley Smith (UK) Horticultural Trust; Universiti Putra Malaysia; Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia); 'Movilidad del Profesorado' Initiative, MEC, Spain(Spanish Government); Beca de Movilidad del Gobierno de Canarias; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	This work was supported by a small grant from the British Hosta and Hemerocallis Society to develop research on this disease and a small grant from the Stanley Smith (UK) Horticultural Trust for other work on Hemerocallis. R.B.T. was supported by research grants from the Universiti Putra Malaysia and the Ministry of Higher Education of Malaysia. J.R.-E. acknowledges financial support under the 'Movilidad del Profesorado' (PR2007-0487) Initiative, MEC, Spain and Beca de Movilidad del Gobierno de Canarias. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Barnes SE, 2003, PHYTOPATHOLOGY, V93, P573, DOI 10.1094/PHYTO.2003.93.5.573; BERGERON S, 2001, DAYLILY J, V56, P434; BERGERON S, 2010, DAYLILY J, V65, P16; Blaedow KE, 2010, CAN J PLANT PATHOL, V32, P351, DOI 10.1080/07060661.2010.508629; Chang SeogWon, 2001, Plant Pathology Journal, V17, P305; Chiou AL, 2001, J PHYTOPATHOL, V149, P319, DOI 10.1046/j.1439-0434.2001.00627.x; Dewey FM, 2008, AM J ENOL VITICULT, V59, P47; Dewey FM, 2013, AM J ENOL VITICULT, V64, P291, DOI 10.5344/ajev.2012.12103; DIEZ A, 2000, EXPT APPL ACAROLOGY, V24, P85; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elad Y, 2004, BOTRYTIS: BIOLOGY, PATHOLOGY AND CONTROL, P223; FARETRA F, 1988, J GEN MICROBIOL, V134, P2543; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Furukawa Toshiko, 2005, Journal of General Plant Pathology, V71, P95, DOI 10.1007/s10327-004-0167-y; GRAY EG, 1975, PLANT PATHOL, V24, P105, DOI 10.1111/j.1365-3059.1975.tb01872.x; HARRISON JG, 1986, T BRIT MYCOL SOC, V86, P171, DOI 10.1016/S0007-1536(86)80135-8; HELLER RENE, 1953, ANN SCI NAT BOT 11E SER, V14, P1; Huang JB, 2001, MYCOL RES, V105, P833, DOI 10.1017/S0953756201004051; LAUNDON GF, 1978, NEW ZEAL J AGR RES, V21, P705, DOI 10.1080/00288233.1978.10427471; Li XP, 2012, MYCOLOGIA, V104, P650, DOI 10.3852/11-218; Lorbeer JW, 2004, BOTRYTIS: BIOLOGY, PATHOLOGY AND CONTROL, P273; Meyer UM, 2000, MYCOL RES, V104, P979, DOI 10.1017/S0953756200002501; Mueller DS, 2003, HORTSCIENCE, V38, P1137, DOI 10.21273/HORTSCI.38.6.1137; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ploch S, 2011, MOL ECOL, V20, P3692, DOI 10.1111/j.1365-294X.2011.05188.x; Rayner A, 2017, NATURAL INCLUSION; Redman RS, 2001, NEW PHYTOL, V151, P705, DOI 10.1046/j.0028-646x.2001.00210.x; Rodriguez-Enriquez MJ, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/pls055; Schardl CL, 2003, MOL ECOL, V12, P2861, DOI 10.1046/j.1365-294X.2003.01965.x; Schardl CL, 2004, ANNU REV PLANT BIOL, V55, P315, DOI 10.1146/annurev.arplant.55.031903.141735; Schnabel G, 2005, PLANT DIS, V89, P683, DOI 10.1094/PD-89-0683A; Schubert K, 2007, STUD MYCOL, P105, DOI 10.3114/sim.2007.58.05; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Shipunov A, 2008, AM J BOT, V95, P1096, DOI 10.3732/ajb.0800024; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Sowley ENK, 2010, EUR J PLANT PATHOL, V126, P61, DOI 10.1007/s10658-009-9524-1; Staats M, 2007, EUR J PLANT PATHOL, V117, P219, DOI 10.1007/s10658-006-9085-5; Staats M, 2005, MOL BIOL EVOL, V22, P333, DOI 10.1093/molbev/msi020; Staats M, 2007, FUNGAL GENET BIOL, V44, P52, DOI 10.1016/j.fgb.2006.07.003; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stukenbrock EH, 2012, P NATL ACAD SCI USA, V109, P10954, DOI 10.1073/pnas.1201403109; Tomkins JP, 2001, THEOR APPL GENET, V102, P489, DOI 10.1007/s001220051672; TOMPKINS CM, 1950, PHYTOPATHOLOGY, V40, P780; VANDERVLUGTBERGMANS CJB, 1993, MYCOL RES, V97, P1193, DOI 10.1016/S0953-7562(09)81284-7; Walker AS, 2011, PHYTOPATHOLOGY, V101, P1433, DOI 10.1094/PHYTO-04-11-0104; Williams-Woodward J. L., 2001, Plant Disease, V85, P1121, DOI 10.1094/PDIS.2001.85.10.1121C; WOOTEN J, 1972, P FLORIDA STATE HORT, V85, P438; Yang YL, 2012, TROP PLANT PATHOL, V37, P165, DOI 10.1590/S1982-56762012000300001; Zhang J, 2010, MYCOSCIENCE, V51, P421, DOI 10.1007/s10267-010-0057-4; Zhang J, 2010, MYCOLOGIA, V102, P1114, DOI 10.3852/09-217	51	27	32	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e89272	10.1371/journal.pone.0089272	http://dx.doi.org/10.1371/journal.pone.0089272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887415	Green Published, gold, Green Accepted			2022-12-25	WOS:000336956300002
J	Morris, KT; Nofchissey, RA; Pinchuk, IV; Beswick, EJ				Morris, Katherine T.; Nofchissey, Robert A.; Pinchuk, Irina V.; Beswick, Ellen J.			Chronic Macrophage Migration Inhibitory Factor Exposure Induces Mesenchymal Epithelial Transition and Promotes Gastric and Colon Cancers	PLOS ONE			English	Article							FACTOR MIF; CELLS; GROWTH; CD74; EXPRESSION; INVASION; MYOFIBROBLASTS; TRANSFORMATION; PROLIFERATION; FIBROBLASTS	Macrophage Migration Inhibitory Factor (MIF) is an inflammatory cytokine that is highly produced in gastrointestinal cancers. Since chronic inflammation is a risk factor for tumorigenesis in these cancers, in this study, the role of MIF in pro-tumorigenic events was examined. MIF and its receptor, CD74, were examined in gastric and colon tumors and found to be increased in most tumors with significantly higher expression in tumors from patients with lymph node metastasis. MIF was also found to be highly produced by cancer associated fibroblasts isolated from human tumors compared to fibroblasts from matched normal tissues from uninvolved areas. Fibroblast-produced MIF highly increased GI cancer cell proliferation, which was decreased upon neutralizing MIF or CD74. Chronic MIF treatment led to sustained proliferation and signaling events in non-transformed GI fibroblast cells, which was maintained upon removing MIF treatment for 8 weeks. Additionally, chronic treatment of normal GI cells expressing fibroblast markers for up to 16 weeks with MIF led to a drastic decrease of fibroblast markers with concurrent increase of epithelial markers. Transformation was examined by telomerase and focus forming assays. These results suggest the MIF promotes mesenchymal epithelial transition, cell transformation and tumorigenesis in GI cancers, and thus may be an important link between chronic inflammation and tumorigenesis.	[Pinchuk, Irina V.] Univ Texas Med Branch, Dept Internal Med, Div Gastroenterol & Hepatol, Galveston, TX 77555 USA; [Morris, Katherine T.] Univ New Mexico, Dept Surg, Albuquerque, NM 87131 USA; [Nofchissey, Robert A.; Beswick, Ellen J.] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of Texas System; University of Texas Medical Branch Galveston; University of New Mexico; University of New Mexico	Beswick, EJ (corresponding author), Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA.	ebeswick@salud.unm.edu	Pinchuk, Irina V/A-7227-2008	Pinchuk, Irina V/0000-0003-1505-5779	American Cancer Society [RSG-10-159-01-LIB]; United States National Institutes of Health (NIH) [1UL1RR031977-01]; University of New Mexico Clinical and Translational Sciences Center; NIH NCATS [KL2TR000072]; University of Texas Medical Branch KL2 Program; NATIONAL CANCER INSTITUTE [P30CA118100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000072, KL2TR000089] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031977] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI068712] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of New Mexico Clinical and Translational Sciences Center; NIH NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of Texas Medical Branch KL2 Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by American Cancer Society RSG-10-159-01-LIB (http://www.cancer.org/research/researchprogramsfunding/fundingopportunities/indexofgrants/researchgrantsforindependentinvestigators/research-scholar-grants), United States National Institutes of Health (NIH) 1UL1RR031977-01, University of New Mexico Clinical and Translational Sciences Center (http://www.nih.gov/), NIH NCATS (KL2TR000072), and the University of Texas Medical Branch KL2 Program (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Assuncao-Miranda I, 2010, FASEB J, V24, P218, DOI 10.1096/fj.09-139469; Beswick EJ, 2005, INFECT IMMUN, V73, P2736, DOI 10.1128/IAI.73.5.2736-2743.2005; Beswick EJ, 2008, INFECT IMMUN, V76, P3233, DOI 10.1128/IAI.01534-07; Beswick EJ, 2006, J IMMUNOL, V176, P6794, DOI 10.4049/jimmunol.176.11.6794; Beswick EJ, 2011, INFECT IMMUN, V79, P2737, DOI 10.1128/IAI.01146-10; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Burger-Kentischer A, 2006, ATHEROSCLEROSIS, V184, P28, DOI 10.1016/j.atherosclerosis.2005.03.028; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Camlica H, 2008, PATHOL ONCOL RES, V14, P79, DOI 10.1007/s12253-008-9002-7; Cvetkovic I, 2005, ENDOCRINOLOGY, V146, P2942, DOI 10.1210/en.2004-1393; Das R, 2013, P NATL ACAD SCI USA, V110, pE2997, DOI 10.1073/pnas.1301128110; Denz A, 2010, J SURG RES, V160, P29, DOI 10.1016/j.jss.2009.03.048; Dessein AF, 2010, CANCER RES, V70, P4644, DOI 10.1158/0008-5472.CAN-09-3828; Dewor M, 2007, FEBS LETT, V581, P4734, DOI 10.1016/j.febslet.2007.08.071; GILLEN CD, 1994, GUT, V35, P1590, DOI 10.1136/gut.35.11.1590; He XX, 2006, GUT, V55, P797, DOI 10.1136/gut.2005.078113; Kim Hae-Rim, 2010, Korean Journal of Internal Medicine, V25, P317, DOI 10.3904/kjim.2010.25.3.317; Lee H, 2008, AM J CLIN PATHOL, V129, P772, DOI 10.1309/GFCLLRH8A68XKMJN; Legendre H, 2003, MODERN PATHOL, V16, P491, DOI 10.1097/01.MP.0000068235.45178.C1; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Li GQ, 2009, WORLD J GASTROENTERO, V15, P5541, DOI 10.3748/wjg.15.5541; Liu YH, 2008, J IMMUNOL, V181, P6584, DOI 10.4049/jimmunol.181.9.6584; Lo MC, 2013, CANCER LETT, V335, P81, DOI 10.1016/j.canlet.2013.01.052; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Meyer-Siegler KL, 2006, J IMMUNOL, V177, P8730, DOI 10.4049/jimmunol.177.12.8730; Meyer-Siegler KL, 2006, J UROLOGY, V175, P1523, DOI 10.1016/S0022-5347(05)00650-6; Morand EF, 2005, FRONT BIOSCI-LANDMRK, V10, P12, DOI 10.2741/1501; Morris KT, 2014, BRIT J CANCER, V110, P1211, DOI 10.1038/bjc.2013.822; Nishihira J, 2009, CURR PHARM DESIGN, V15, P2104, DOI 10.2174/138161209788489113; Ogatai H, 2010, ONCOL REP, V24, P1479, DOI 10.3892/or_00001008; Ottaiano A, 2005, CANCER IMMUNOL IMMUN, V54, P781, DOI 10.1007/s00262-004-0636-3; Owens BMJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00307; Palumbo S, 2014, STEM CELLS DEV, V23, P852, DOI 10.1089/scd.2013.0294; Pei XJ, 2014, INT J MED SCI, V11, P106, DOI 10.7150/ijms.7264; Pinchuk IV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053798; Pinchuk IV, 2011, GASTROENTEROLOGY, V140, P2019, DOI 10.1053/j.gastro.2011.02.059; Reyes JL, 2006, INFECT IMMUN, V74, P3170, DOI 10.1128/IAI.01648-05; Saada JI, 2006, J IMMUNOL, V177, P5968, DOI 10.4049/jimmunol.177.9.5968; Shima Y, 2007, BIOCHEM BIOPH RES CO, V353, P60, DOI 10.1016/j.bbrc.2006.11.137; Sun B, 2005, CLIN CANCER RES, V11, P1050; Tas F, 2014, TUMOR BIOL, V35, P3327, DOI 10.1007/s13277-013-1438-z; Worthley DL, 2010, CANCER MICROENVIRON, V3, P117, DOI 10.1007/s12307-009-0033-8; Xia HHX, 2009, CANCER-AM CANCER SOC, V115, P5441, DOI 10.1002/cncr.24609; Yamaoka E, 2011, INT J ONCOL, V39, P5, DOI 10.3892/ijo.2011.1029; Zheng YX, 2012, WORLD J GASTROENTERO, V18, P2253, DOI 10.3748/wjg.v18.i18.2253	47	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98656	10.1371/journal.pone.0098656	http://dx.doi.org/10.1371/journal.pone.0098656			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887129	gold, Green Submitted, Green Published			2022-12-25	WOS:000336956300097
J	Zhu, HT; Zhuang, J; Feng, HL; Liang, RF; Wang, JY; Xie, LH; Zhu, P				Zhu, Hongtao; Zhuang, Jun; Feng, Hongli; Liang, Rongfeng; Wang, Jiangyong; Xie, Lianhui; Zhu, Ping			Cryo-EM Structure of Isomeric Molluscan Hemocyanin Triggered by Viral Infection	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENTS; FUNCTIONAL UNIT; CATECHOLOXIDASE ACTIVITY; PHENOLOXIDASE ACTIVITY; SCORPION HEMOCYANIN; ATOMIC STRUCTURES; IMMUNE-RESPONSE; SYSTEM; TYROSINASE; MECHANISM	Hemocyanins (Hcs) of arthropods and mollusks function not only as oxygen transporters, but also as phenoloxidases (POs). In invertebrates, PO is an important component in the innate immune cascade, where it functions as the initiator of melanin synthesis, a pigment involved in encapsulating and killing of pathogenic microbes. Although structures of Hc from several species of invertebrates have been reported, the structural basis for how PO activity is triggered by structural changes of Hc in vivo remains poorly understood. Here, we report a 6.8 angstrom cryo-electron microscopy (cryo-EM) structure of the isomeric form of hemocyanin, which was isolated from Abalone Shriveling syndrome-associated Virus (AbSV) infected abalone (Halitotis diversicolor), and build a pseudoatomic model of isomeric H. diversicolor hemocyanin 1 (HdH1). Our results show that, compared with native form of HdH1, the architecture of isomeric HdH1 turns into a more relaxed form. The interactions between certain functional units (FUs) present in the native form of Hc either decreased or were totally abolished in the isomeric form of Hc. As a result of that, native state Hc switches to its isomeric form, enabling it to play its role in innate immune responses against invading pathogens.	[Zhu, Hongtao; Feng, Hongli; Zhu, Ping] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Zhuang, Jun; Liang, Rongfeng; Xie, Lianhui] Fujian Agr & Forestry Univ, Inst Plant Virol, Fujian Prov Key Lab Plant Virol, Fuzhou, Peoples R China; [Zhuang, Jun; Xie, Lianhui] Fujian Agr & Forestry Univ, Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China; [Wang, Jiangyong] Chinese Fisheries Acad, South China Sea Fisheries Res Inst, Guangzhou, Guangdong, Peoples R China; [Zhu, Hongtao] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; Chinese Academy of Fishery Sciences; South China Sea Fisheries Research Institute, CAFS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xie, LH (corresponding author), Fujian Agr & Forestry Univ, Inst Plant Virol, Fujian Prov Key Lab Plant Virol, Fuzhou, Peoples R China.	fjxlh@126.com; zhup@ibp.ac.cn			National Basic Research Program of China [2010CB912400]; National Natural Science Foundation of China [31230018, 31172428, 81261120418]; Program for Distinguished Young Scientists/Taiwan Strait-West Coast [K8812007]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Distinguished Young Scientists/Taiwan Strait-West Coast	This work was supported by grants from the National Basic Research Program of China (2010CB912400), the National Natural Science Foundation of China (31230018, 31172428, 81261120418), and from the Program for Distinguished Young Scientists/Taiwan Strait-West Coast (K8812007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird S, 2007, BBA-PROTEINS PROTEOM, V1774, P1380, DOI 10.1016/j.bbapap.2007.08.019; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Coates CJ, 2011, DEV COMP IMMUNOL, V35, P155, DOI 10.1016/j.dci.2010.08.015; Cong Y, 2009, STRUCTURE, V17, P749, DOI 10.1016/j.str.2009.03.005; Cuff ME, 1998, J MOL BIOL, V278, P855, DOI 10.1006/jmbi.1998.1647; Decker H, 2004, DEV COMP IMMUNOL, V28, P673, DOI 10.1016/j.dci.2003.11.007; Decker H, 2000, TRENDS BIOCHEM SCI, V25, P392, DOI 10.1016/S0968-0004(00)01602-9; Decker H, 2007, INTEGR COMP BIOL, V47, P631, DOI 10.1093/icb/icm063; Decker H, 2007, GENE, V398, P183, DOI 10.1016/j.gene.2007.02.051; Gatsogiannis C, 2009, J MOL BIOL, V385, P963, DOI 10.1016/j.jmb.2008.10.080; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Harris JR, 1999, MICRON, V30, P597, DOI 10.1016/S0968-4328(99)00036-0; HELLING F, 1994, CANCER RES, V54, P197; Jaenicke E, 2004, MICRON, V35, P89, DOI 10.1016/j.micron.2003.10.027; Jaenicke E, 2008, FEBS J, V275, P1518, DOI 10.1111/j.1742-4658.2008.06311.x; Jaenicke E, 2011, IUBMB LIFE, V63, P183, DOI 10.1002/iub.435; Jaenicke E, 2010, BIOCHEM J, V426, P373, DOI 10.1042/BJ20091501; Jiang N, 2007, NAT IMMUNOL, V8, P1114, DOI 10.1038/ni1501; LAMM DL, 1993, UROL RES, V21, P33, DOI 10.1007/BF00295189; Lee SY, 2003, J BIOL CHEM, V278, P7927, DOI 10.1074/jbc.M209239200; Markl J, 2013, BBA-PROTEINS PROTEOM, V1834, P1840, DOI 10.1016/j.bbapap.2013.02.020; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; Nillius D, 2008, FEBS LETT, V582, P749, DOI 10.1016/j.febslet.2008.01.056; Perbandt M, 2003, BIOCHEMISTRY-US, V42, P6341, DOI 10.1021/bi020672x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rolff M, 2011, CHEM SOC REV, V40, P4077, DOI 10.1039/c0cs00202j; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Siddiqui NI, 2004, MICRON, V35, P91, DOI 10.1016/j.micron.2003.10.028; Siddiqui NI, 2006, BIOCHEM BIOPH RES CO, V348, P1138, DOI 10.1016/j.bbrc.2006.07.172; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Sugumaran H, 2002, PIGM CELL RES, V15, P2, DOI 10.1034/j.1600-0749.2002.00056.x; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Terwilliger NB, 2007, INTEGR COMP BIOL, V47, P662, DOI 10.1093/icb/icm039; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; van Holde KE, 2000, BIOPHYS CHEM, V86, P165, DOI 10.1016/S0301-4622(00)00154-X; Zhang QF, 2013, STRUCTURE, V21, P604, DOI 10.1016/j.str.2013.02.018; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhuang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013850	44	9	9	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2014	9	6							e98766	10.1371/journal.pone.0098766	http://dx.doi.org/10.1371/journal.pone.0098766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI6CB	24887432	Green Published, Green Submitted, gold			2022-12-25	WOS:000336956300105
J	Bailey-Downs, LC; Thorpe, JE; Disch, BC; Bastian, A; Hauser, PJ; Farasyn, T; Berry, WL; Hurst, RE; Ihnat, MA				Bailey-Downs, Lora C.; Thorpe, Jessica E.; Disch, Bryan C.; Bastian, Anja; Hauser, Paul J.; Farasyn, Taleah; Berry, William L.; Hurst, Robert E.; Ihnat, Michael A.			Development and Characterization of a Preclinical Model of Breast Cancer Lung Micrometastatic to Macrometastatic Progression	PLOS ONE			English	Article							TUMOR-GROWTH; ORTHOTOPIC MODEL; SUB-POPULATIONS; IN-VIVO; METASTASIS; CARCINOMA; CELLS; DORMANCY; INHIBITION; EXPRESSION	Most cancer patients die with metastatic disease, thus, good models that recapitulate the natural process of metastasis including a dormancy period with micrometastatic cells would be beneficial in developing treatment strategies. Herein we report a model of natural metastasis that balances time to complete experiments with a reasonable dormancy period, which can be used to better study metastatic progression. The basis for the model is a 4T1 triple negative syngeneic breast cancer model without resection of the primary tumor. A cell titration from 500 to 15,000 GFP tagged 4T1 cells implanted into fat pad number four of immune proficient eight week female BALB/cJ mice optimized speed of the model while possessing metastatic processes including dormancy and beginning of reactivation. The frequency of primary tumors was less than 50% in animals implanted with 500-1500 cells. Although implantation with over 10,000 cells resulted in 100% primary tumor development, the tumors and macrometastases formed were highly aggressive, lacked dormancy, and offered no opportunity for treatment. Implantation of 7,500 cells resulted in > 90% tumor take by 10 days; in 30-60 micrometastases in the lung (with many animals also having 2-30 brain micrometastases) two weeks post-implantation, with the first small macrometastases present at five weeks; many animals displaying macrometastases at five weeks and animals becoming moribund by six weeks post-implantation. Using the optimum of 7,500 cells the efficacy of a chemotherapeutic agent for breast cancer, doxorubicin, given at its maximal tolerated dose (MTD; 1 mg/kg weekly) was tested for an effect on metastasis. Doxorubicin treatment significantly reduced primary tumor growth and lung micrometastases but the number of macrometastases at experiment end was not significantly affected. This model should prove useful for development of drugs to target metastasis and to study the biology of metastasis.	[Bailey-Downs, Lora C.; Thorpe, Jessica E.; Disch, Bryan C.; Hauser, Paul J.; Farasyn, Taleah; Hurst, Robert E.; Ihnat, Michael A.] DormaTarg Inc, Oklahoma City, OK 73117 USA; [Thorpe, Jessica E.; Bastian, Anja; Ihnat, Michael A.] Univ Oklahoma, Coll Pharm, Dept Pharmaceut Sci, Oklahoma City, OK USA; [Hauser, Paul J.; Hurst, Robert E.] Univ Oklahoma, Coll Med, Dept Urol, Oklahoma City, OK USA; [Berry, William L.] Univ Oklahoma, Coll Med, Dept Cell Biol, Oklahoma City, OK 73190 USA; [Hurst, Robert E.] Oklahoma Coll Med, Dept Biochem & Mol Biol, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Ihnat, MA (corresponding author), DormaTarg Inc, Oklahoma City, OK 73117 USA.	mihnat@dormatarg.com		Berry, William/0000-0002-1661-5443; Hurst, Robert/0000-0003-0370-1817	Oklahoma Center for the Advancement of Science and Technology - Oklahoma Applied Research Support (OCAST-OARS) [AR11-073]; phase II NCI SBIR [2R44 CA135867-02]; NATIONAL CANCER INSTITUTE [R44CA135867] Funding Source: NIH RePORTER	Oklahoma Center for the Advancement of Science and Technology - Oklahoma Applied Research Support (OCAST-OARS); phase II NCI SBIR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by an Oklahoma Center for the Advancement of Science and Technology - Oklahoma Applied Research Support (OCAST-OARS) grant AR11-073 and a phase II NCI SBIR 2R44 CA135867-02 grant to M.A.I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sahaf O, 2010, ANN SURG, V252, P1037, DOI 10.1097/SLA.0b013e3181efc635; Almog N, 2006, FASEB J, V20, P947, DOI 10.1096/fj.05-3946fje; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Bausero MA, 2004, TUMOR BIOL, V25, P243, DOI 10.1159/000081387; BURNET M, 1957, BRIT MED J, V1, P779, DOI 10.1136/bmj.1.5022.779; Chow KS, 2011, JOVE-J VIS EXP, DOI 10.3791/3159; CLAYTON F, 1993, CANCER-AM CANCER SOC, V71, P1780, DOI 10.1002/1097-0142(19930301)71:5<1780::AID-CNCR2820710512>3.0.CO;2-2; Connolly EM, 2002, BRIT J CANCER, V87, P231, DOI 10.1038/sj.bjc.6600462; DAMATO R, 1993, MICROVASC RES, V46, P135, DOI 10.1006/mvre.1993.1042; Das Roy L, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2345; Erin N, 2004, ANTICANCER RES, V24, P1003; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; Gingrich JR, 1996, CANCER RES, V56, P4096; Grippo PJ, 2000, AM J PATHOL, V157, P805, DOI 10.1016/S0002-9440(10)64594-4; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Heimburg J, 2006, NEOPLASIA, V8, P939, DOI 10.1593/neo.06493; HEPPNER GH, 1978, CANCER RES, V38, P3758; Hiraga T, 2004, CLIN CANCER RES, V10, P4559, DOI 10.1158/1078-0432.CCR-03-0325; Ihnat MA, 1999, ONCOL RES, V11, P303; Kim EJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2927; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Li HT, 2007, J GENE MED, V9, P161, DOI 10.1002/jgm.1005; Lirdprapamongkol K, 2005, EUR J PHARM SCI, V25, P57, DOI 10.1016/j.ejps.2005.01.015; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; MAHONEY KH, 1985, J LEUKOCYTE BIOL, V38, P573, DOI 10.1002/jlb.38.5.573; Marabelle A, 2013, J CLIN INVEST, V123, P2447, DOI 10.1172/JCI64859; Melchior SW, 1997, CLIN CANCER RES, V3, P249; Mittempergher L, 2013, MOL ONCOL, V7, P987, DOI 10.1016/j.molonc.2013.07.006; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Nam JS, 2006, CANCER RES, V66, P6327, DOI 10.1158/0008-5472.CAN-06-0068; Naumov GN, 2003, BREAST CANCER RES TR, V82, P199, DOI 10.1023/B:BREA.0000004377.12288.3c; Nishikawa S, 2012, INT J ONCOL, V41, P979, DOI 10.3892/ijo.2012.1531; NKRUMAH FK, 1976, INT J CANCER, V17, P455, DOI 10.1002/ijc.2910170407; POLLACK VA, 1982, J NATL CANCER I, V69, P137; Pulaski B A, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2002s39; Pulaski BA, 1998, CANCER RES, V58, P1486; Samant RS, 2006, CANCER LETT, V235, P260, DOI 10.1016/j.canlet.2005.04.032; Sawant A, 2012, J IMMUNOL, V189, P4258, DOI 10.4049/jimmunol.1101855; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Tao K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-228; Toh B, 2012, IMMUNOL RES, V53, P229, DOI 10.1007/s12026-012-8288-4; VINEY JL, 1995, CANCER METAST REV, V14, P77, DOI 10.1007/BF00665792; WEBSTER MA, 1994, SEMIN CANCER BIOL, V5, P69; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wenzel J, 2010, CLIN EXP METASTAS, V27, P25, DOI 10.1007/s10585-009-9299-y; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; YUHAS JM, 1975, CANCER RES, V35, P242	52	50	50	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98624	10.1371/journal.pone.0098624	http://dx.doi.org/10.1371/journal.pone.0098624			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878664	Green Submitted, Green Published, gold			2022-12-25	WOS:000338101500075
J	Hayashi, Y; Kuroda, T; Kishimoto, H; Wang, CS; Iwama, A; Kimura, K				Hayashi, Yuki; Kuroda, Takao; Kishimoto, Hiroyuki; Wang, Changshan; Iwama, Atsushi; Kimura, Keiji			Downregulation of rRNA Transcription Triggers Cell Differentiation	PLOS ONE			English	Article							PROTEIN-SYNTHESIS INHIBITORS; POLYMERASE-I TRANSCRIPTION; GRANULOCYTE DIFFERENTIATION; TUMOR-SUPPRESSOR; ACTIVATES P53; CYCLE ARREST; HL-60 CELLS; DNA-DAMAGE; STEM-CELLS; NUCLEOLUS	Responding to various stimuli is indispensable for the maintenance of homeostasis. The downregulation of ribosomal RNA (rRNA) transcription is one of the mechanisms involved in the response to stimuli by various cellular processes, such as cell cycle arrest and apoptosis. Cell differentiation is caused by intra-and extracellular stimuli and is associated with the downregulation of rRNA transcription as well as reduced cell growth. The downregulation of rRNA transcription during differentiation is considered to contribute to reduced cell growth. However, the downregulation of rRNA transcription can induce various cellular processes; therefore, it may positively regulate cell differentiation. To test this possibility, we specifically downregulated rRNA transcription using actinomycin D or a siRNA for Pol I-specific transcription factor IA (TIF-IA) in HL-60 and THP-1 cells, both of which have differentiation potential. The inhibition of rRNA transcription induced cell differentiation in both cell lines, which was demonstrated by the expression of the common differentiation marker CD11b. Furthermore, TIF-IA knockdown in an ex vivo culture of mouse hematopoietic stem cells increased the percentage of myeloid cells and reduced the percentage of immature cells. We also evaluated whether differentiation was induced via the inhibition of cell cycle progression because rRNA transcription is tightly coupled to cell growth. We found that cell cycle arrest without affecting rRNA transcription did not induce differentiation. To the best of our knowledge, our results demonstrate the first time that the downregulation of rRNA levels could be a trigger for the induction of differentiation in mammalian cells. Furthermore, this phenomenon was not simply a reflection of cell cycle arrest. Our results provide a novel insight into the relationship between rRNA transcription and cell differentiation.	[Hayashi, Yuki; Kishimoto, Hiroyuki; Kimura, Keiji] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba Science City, Ibaraki, Japan; [Kuroda, Takao; Kishimoto, Hiroyuki] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba Science City, Ibaraki, Japan; [Wang, Changshan; Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba, Japan	University of Tsukuba; University of Tsukuba; Chiba University	Kimura, K (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba Science City, Ibaraki, Japan.	kekimura@tara.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Ali SA, 2008, P NATL ACAD SCI USA, V105, P6632, DOI 10.1073/pnas.0800970105; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Comai L, 2000, CELL GROWTH DIFFER, V11, P63; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Grummt I, 2013, NUCL GUARDIAN CELLUL; Huang Y, 2003, LEUKEMIA, V17, P2065, DOI 10.1038/sj.leu.2403141; IAPALUCCIESPINOZA S, 1979, FEBS LETT, V107, P281, DOI 10.1016/0014-5793(79)80390-7; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Jurate S GT, 2010, CENT EUR J BIOL, V5, P600; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Koizumi T, 2010, INT J HEMATOL, V91, P611, DOI 10.1007/s12185-010-0563-3; Kreiner G, 2013, CELL DEATH DIFFER, V20, P1455, DOI 10.1038/cdd.2013.66; Krichevsky AM, 1999, J BIOL CHEM, V274, P14295, DOI 10.1074/jbc.274.20.14295; Kumazawa T, 2011, J BIOL CHEM, V286, P20861, DOI 10.1074/jbc.M110.209916; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Kuroda T, 2011, EMBO J, V30, P1054, DOI 10.1038/emboj.2011.23; LARSON DE, 1993, P NATL ACAD SCI USA, V90, P7933, DOI 10.1073/pnas.90.17.7933; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; MARECHAL V, 1994, MOL CELL BIOL, V14, P7414, DOI 10.1128/MCB.14.11.7414; Okamoto A, 2010, BIOCHEM BIOPH RES CO, V394, P42, DOI 10.1016/j.bbrc.2010.02.065; PILZ RB, 1987, J CLIN INVEST, V79, P1006, DOI 10.1172/JCI112867; Poortinga G, 2004, EMBO J, V23, P3325, DOI 10.1038/sj.emboj.7600335; Poortinga G, 2011, NUCLEIC ACIDS RES, V39, P3267, DOI 10.1093/nar/gkq1205; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Saxena A, 2006, ONCOGENE, V25, P7274, DOI 10.1038/sj.onc.1209714; SCHWARTZ EL, 1988, J CELL PHYSIOL, V136, P526, DOI 10.1002/jcp.1041360319; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; WEIL SC, 1987, P NATL ACAD SCI USA, V84, P2057, DOI 10.1073/pnas.84.7.2057; Yamauchi T, 2008, GENES CELLS, V13, P27, DOI 10.1111/j.1365-2443.2007.01148.x; Ying GG, 2000, J BIOL CHEM, V275, P4152, DOI 10.1074/jbc.275.6.4152; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zhang Q, 2014, SCIENCE, V343, P298, DOI 10.1126/science.1246384	42	50	50	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98586	10.1371/journal.pone.0098586	http://dx.doi.org/10.1371/journal.pone.0098586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24879416	Green Submitted, Green Published, gold			2022-12-25	WOS:000338101500070
J	Zouikr, I; James, MH; Campbell, EJ; Clifton, VL; Beagley, KW; Dayas, CV; Hodgson, DM				Zouikr, Ihssane; James, Morgan H.; Campbell, Erin J.; Clifton, Vicki L.; Beagley, Kenneth W.; Dayas, Christopher V.; Hodgson, Deborah M.			Altered Formalin-Induced Pain and Fos Induction in the Periaqueductal Grey of Preadolescent Rats following Neonatal LPS Exposure	PLOS ONE			English	Article							STIMULATION-PRODUCED ANALGESIA; LATERAL HABENULAR NUCLEUS; C-FOS; DESCENDING MODULATION; INFANT RATS; SPINAL-CORD; ELECTRICAL-STIMULATION; NOCICEPTIVE RESPONSES; ENDOTOXIN CHALLENGE; GRAY-MATTER	Animal and human studies have demonstrated that early pain experiences can produce alterations in the nociceptive systems later in life including increased sensitivity to mechanical, thermal, and chemical stimuli. However, less is known about the impact of neonatal immune challenge on future responses to noxious stimuli and the reactivity of neural substrates involved in analgesia. Here we demonstrate that rats exposed to Lipopolysaccharide (LPS; 0.05 mg/kg IP, Salmonella enteritidis) during postnatal day (PND) 3 and 5 displayed enhanced formalin-induced flinching but not licking following formalin injection at PND 22. This LPS-induced hyperalgesia was accompanied by distinct recruitment of supraspinal regions involved in analgesia as indicated by significantly attenuated Fos-protein induction in the rostral dorsal periaqueductal grey (DPAG) as well as rostral and caudal axes of the ventrolateral PAG (VLPAG). Formalin injections were associated with increased Fos-protein labelling in lateral habenula (LHb) as compared to medial habenula (MHb), however the intensity of this labelling did not differ as a result of neonatal immune challenge. These data highlight the importance of neonatal immune priming in programming inflammatory pain sensitivity later in development and highlight the PAG as a possible mediator of this process.	[Zouikr, Ihssane; Hodgson, Deborah M.] Univ Newcastle, Sch Psychol, Lab Neuroimmunol, Newcastle, NSW 2300, Australia; [James, Morgan H.; Campbell, Erin J.; Dayas, Christopher V.] Univ Newcastle, Sch Biomed Sci & Pharm, Neurobiol Addict Lab, Newcastle, NSW 2300, Australia; [Clifton, Vicki L.] Univ Adelaide, Robinson Inst, Adelaide, SA, Australia; [Beagley, Kenneth W.] Queensland Univ Technol, Inst Hlth Biomed Innovat, Brisbane, Qld 4001, Australia	University of Newcastle; University of Newcastle; Robinson Research Institute; University of Adelaide; Queensland University of Technology (QUT)	Zouikr, I (corresponding author), Univ Newcastle, Sch Psychol, Lab Neuroimmunol, Newcastle, NSW 2300, Australia.	Ihssane.zouikr@uon.edu.au	Dayas, Chris/ABE-9173-2020; Clifton, Vicki/A-1445-2012; James, Morgan/AEM-8428-2022; Clifton, Vicki/AAV-2749-2021; Zouikr, Ihssane/X-9165-2019; Beagley, Kenneth/J-1129-2012	Clifton, Vicki/0000-0002-4892-6748; James, Morgan/0000-0001-9298-8607; Clifton, Vicki/0000-0002-4892-6748; Beagley, Kenneth/0000-0003-3112-6557; Dayas, Christopher/0000-0002-9175-3854; Campbell, Erin/0000-0002-4722-6897	Australian Research Council [ARC DP 09787599]	Australian Research Council(Australian Research Council)	This study was supported by a grant from the Australian Research Council (ARC DP 09787599). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHAJANIAN GK, 1977, BRAIN RES, V122, P229, DOI 10.1016/0006-8993(77)90291-8; ARAKI M, 1988, BRAIN RES, V441, P319, DOI 10.1016/0006-8993(88)91410-2; BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; Barr GA, 2013, EUR J PAIN, V17, P676, DOI 10.1002/j.1532-2149.2012.00245.x; BARR GA, 1992, BRAIN RES, V584, P83, DOI 10.1016/0006-8993(92)90881-9; Barr GA, 2011, J PAIN, V12, P263, DOI 10.1016/j.jpain.2010.09.005; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; BASBAUM AI, 1978, ANN NEUROL, V4, P451, DOI 10.1002/ana.410040511; Baulmann J, 2000, NEUROSCIENCE, V95, P813; Beggs S, 2012, BRAIN, V135, P404, DOI 10.1093/brain/awr288; BEITZ AJ, 1985, J COMP NEUROL, V237, P445, DOI 10.1002/cne.902370403; Boisse L, 2005, PAIN, V119, P133, DOI 10.1016/j.pain.2005.09.022; Butkevich IP, 2001, BRAIN RES, V915, P88, DOI 10.1016/S0006-8993(01)02819-0; CANNON JT, 1982, BRAIN RES, V243, P315, DOI 10.1016/0006-8993(82)90255-4; CARSTENS E, 1995, J NEUROPHYSIOL, V73, P2179, DOI 10.1152/jn.1995.73.6.2179; CODERRE TJ, 1994, NEUROREPORT, V5, P1337, DOI 10.1097/00001756-199406000-00011; COHEN SR, 1986, NEUROSCI LETT, V70, P165; COHEN SR, 1985, BRAIN RES, V359, P131, DOI 10.1016/0006-8993(85)91420-9; D'Mello R, 2008, BRIT J ANAESTH, V101, P8, DOI 10.1093/bja/aen088; DAFNY N, 1990, Neurological Research, V12, P117; Dayas CV, 2008, BIOL PSYCHIAT, V63, P152, DOI 10.1016/j.biopsych.2007.02.002; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; FARDIN V, 1984, BRAIN RES, V306, P105, DOI 10.1016/0006-8993(84)90360-3; Fitzgerald M, 2005, NAT REV NEUROSCI, V6, P507, DOI 10.1038/nrn1701; FITZGERALD M, 1984, NEUROSCIENCE, V13, P933, DOI 10.1016/0306-4522(84)90107-6; FITZGERALD M, 1986, DEV BRAIN RES, V24, P261, DOI 10.1016/0165-3806(86)90194-X; Gebhart GF, 2004, NEUROSCI BIOBEHAV R, V27, P729, DOI 10.1016/j.neubiorev.2003.11.008; Goffaux P, 2008, EUR J PAIN, V12, P945, DOI 10.1016/j.ejpain.2008.01.003; GUY ER, 1992, PAIN, V51, P81, DOI 10.1016/0304-3959(92)90012-Z; HERKENHAM M, 1977, J COMP NEUROL, V173, P123, DOI 10.1002/cne.901730107; Hodgson DM, 2001, PEDIATR RES, V50, P750, DOI 10.1203/00006450-200112000-00020; ITO M, 1985, BRAIN RES, V337, P245, DOI 10.1016/0006-8993(85)90060-5; JACQUET YF, 1974, SCIENCE, V185, P1055, DOI 10.1126/science.185.4156.1055; James MH, 2011, NEUROSCIENCE, V199, P235, DOI 10.1016/j.neuroscience.2011.09.047; Kovacs KJ, 1998, NEUROCHEM INT, V33, P287, DOI 10.1016/S0197-0186(98)00023-0; Laprairie JL, 2008, PEDIATR RES, V64, P625, DOI 10.1203/PDR.0b013e31818702d4; LI YQ, 1993, NEUROSCI LETT, V158, P55, DOI 10.1016/0304-3940(93)90611-N; Loyd DR, 2009, NEURAL PLAST, V2009, DOI 10.1155/2009/462879; MAHIEUX G, 1987, BRAIN RES, V406, P118, DOI 10.1016/0006-8993(87)90776-1; MAYER DJ, 1971, SCIENCE, V174, P1351, DOI 10.1126/science.174.4016.1351; MORGAN MM, 1991, BRAIN RES, V545, P17, DOI 10.1016/0006-8993(91)91264-2; MORGAN MM, 1989, BRAIN RES, V502, P61, DOI 10.1016/0006-8993(89)90461-7; NADEL L, 1990, ANN NY ACAD SCI, V608, P613, DOI 10.1111/j.1749-6632.1990.tb48912.x; NAGAO M, 1993, NEUROSCI LETT, V151, P37, DOI 10.1016/0304-3940(93)90039-N; NICHOLS DS, 1990, PAIN, V41, P347, DOI 10.1016/0304-3959(90)90011-2; Nilsson C, 2002, EUR J ENDOCRINOL, V146, P251, DOI 10.1530/eje.0.1460251; Okuda K, 2001, PAIN, V92, P107, DOI 10.1016/S0304-3959(00)00476-0; OLIVERAS JL, 1974, EXP BRAIN RES, V20, P32; Ren K, 2004, PAIN, V110, P588, DOI 10.1016/j.pain.2004.04.006; Ren K, 2002, PAIN, V100, P1, DOI 10.1016/S0304-3959(02)00368-8; REYNOLDS DV, 1969, SCIENCE, V164, P444, DOI 10.1126/science.164.3878.444; Ruda MA, 2000, SCIENCE, V289, P628, DOI 10.1126/science.289.5479.628; SHANKS N, 1995, J NEUROSCI, V15, P376, DOI 10.1523/jneurosci.15-01-00376.1995; Shanks N, 2000, P NATL ACAD SCI USA, V97, P5645, DOI 10.1073/pnas.090571897; Shelton L, 2012, J NEUROPHYSIOL, V107, P2633, DOI 10.1152/jn.00012.2012; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; VACCARINO AL, 1994, BRAIN RES, V666, P104, DOI 10.1016/0006-8993(94)90288-7; Walker AK, 2012, PSYCHONEUROENDOCRINO, V37, P1320, DOI 10.1016/j.psyneuen.2012.01.005; Walker AK, 2009, PSYCHONEUROENDOCRINO, V34, P1515, DOI 10.1016/j.psyneuen.2009.05.010; Walker FR, 2006, PHYSIOL BEHAV, V87, P126, DOI 10.1016/j.physbeh.2005.09.008; Walker FR, 2008, J PSYCHIATR RES, V42, P1094, DOI 10.1016/j.jpsychires.2007.12.006; Walker FR, 2009, J NEUROIMMUNOL, V207, P57, DOI 10.1016/j.jneuroim.2008.11.012; Walker SM, 2009, PAIN, V147, P99, DOI 10.1016/j.pain.2009.08.017; Wang S, 1984, PHYSL SCI, V4, P37; WHEELERACETO H, 1991, PSYCHOPHARMACOLOGY, V104, P35, DOI 10.1007/BF02244551; Wiedenmayer CP, 2001, BEHAV BRAIN RES, V126, P147, DOI 10.1016/S0166-4328(01)00260-1; WILLIAMS S, 1990, NEUROSCI LETT, V109, P309, DOI 10.1016/0304-3940(90)90013-Y; YI DK, 1995, PAIN, V60, P257, DOI 10.1016/0304-3959(94)00119-Y; YU LC, 1990, INT J NEUROSCI, V54, P245, DOI 10.3109/00207459008986640; Zouikr I, 2014, PSYCHONEUROENDOCRINO, V41, P1, DOI 10.1016/j.psyneuen.2013.11.016; Zouikr I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053384	71	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 30	2014	9	5							e98382	10.1371/journal.pone.0098382	http://dx.doi.org/10.1371/journal.pone.0098382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK0KM	24878577	Green Published, gold, Green Submitted			2022-12-25	WOS:000338101500054
J	Nieminen, MT; Novak-Frazer, L; Rautemaa, V; Rajendran, R; Sorsa, T; Ramage, G; Bowyer, P; Rautemaa, R				Nieminen, Mikko T.; Novak-Frazer, Lily; Rautemaa, Vilma; Rajendran, Ranjith; Sorsa, Timo; Ramage, Gordon; Bowyer, Paul; Rautemaa, Riina			A Novel Antifungal Is Active against Candida albicans Biofilms and Inhibits Mutagenic Acetaldehyde Production In Vitro	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TRANSCRIPTIONAL RESPONSE; SURFACE-PROTEINS; ACETYL-COENZYME; ORAL CANDIDOSIS; GENOME DATABASE; ALCOHOL; GROWTH; SUSCEPTIBILITY; IDENTIFICATION	The ability of C. albicans to form biofilms is a major virulence factor and a challenge for management. This is evident in biofilm-associated chronic oral-oesophageal candidosis, which has been shown to be potentially carcinogenic in vivo. We have previously shown that most Candida spp. can produce significant levels of mutagenic acetaldehyde (ACH). ACH is also an important mediator of candidal biofilm formation. We have also reported that D,L-2-hydroxyisocaproic acid (HICA) significantly inhibits planktonic growth of C. albicans. The aim of the present study was to investigate the effect of HICA on C. albicans biofilm formation and ACH production in vitro. Inhibition of biofilm formation by HICA, analogous control compounds or caspofungin was measured using XTT to measure biofilm metabolic activity and PicoGreen as a marker of biomass. Biofilms were visualised by scanning electron microscopy (SEM). ACH levels were measured by gas chromatography. Transcriptional changes in the genes involved in ACH metabolism were measured using RT-qPCR. The mean metabolic activity and biomass of all pre-grown (4, 24, 48 h) biofilms were significantly reduced after exposure to HICA (p<0.05) with the largest reductions seen at acidic pH. Caspofungin was mainly active against biofilms pre-grown for 4 h at neutral pH. Mutagenic levels (>40 mu M) of ACH were detected in 24 and 48 h biofilms at both pHs. Interestingly, no ACH production was detected from D-glucose in the presence of HICA at acidic pH (p<.05). Expression of genes responsible for ACH catabolism was up-regulated by HICA but down-regulated by caspofungin. SEM showed aberrant hyphae and collapsed hyphal structures during incubation with HICA at acidic pH. We conclude that HICA has potential as an antifungal agent with ability to inhibit C. albicans cell growth and biofilm formation. HICA also significantly reduces the mutagenic potential of C. albicans biofilms, which may be important when treating bacterial-fungal biofilm infections.	[Nieminen, Mikko T.; Rautemaa, Riina] Univ Helsinki, Res Unit Acetaldehyde & Canc, Helsinki, Finland; [Nieminen, Mikko T.; Sorsa, Timo] Univ Helsinki, Dept Periodontol, Inst Dent, SF-00300 Helsinki, Finland; [Nieminen, Mikko T.; Rautemaa, Riina] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Sorsa, Timo; Rautemaa, Riina] Univ Helsinki, Cent Hosp Finland, Dept Oral & Maxillofacial Dis, Helsinki, Finland; [Nieminen, Mikko T.; Novak-Frazer, Lily; Rautemaa, Vilma; Bowyer, Paul; Rautemaa, Riina] Univ Manchester, Univ S Manchester Hosp, Wythenshawe Hosp, Inst Inflammat & Repair,Manchester Acad Hlth Sci, Manchester, Lancs, England; [Rajendran, Ranjith; Ramage, Gordon] Univ Glasgow, Sch Med, Coll Med Vet & Life Sci, Infect & Immun Res Grp,Glasgow Dent Sch & Hosp, Glasgow, Lanark, Scotland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Glasgow	Rautemaa, R (corresponding author), Univ Helsinki, Res Unit Acetaldehyde & Canc, Helsinki, Finland.	riina.richardson@manchester.ac.uk	Frazer, LilyAnn Novak/O-1831-2017; Ramage, Gordon/AAX-1315-2020	Frazer, LilyAnn Novak/0000-0002-1434-3915; Rautemaa, Vilma/0000-0003-2493-2198; bowyer, paul/0000-0002-1083-9286; Rajendran, Ranjith/0000-0002-1069-7986; Nieminen, Mikko/0000-0001-6427-3196; Richardson, Riina/0000-0002-1071-6040	Yrjo Jahsson Foundation; Orion Research Foundation; Finnish Dental Society Apollonia; National Aspergillosis Centre, UK; EU; Helsinki University Central Hospital Research Foundation	Yrjo Jahsson Foundation; Orion Research Foundation; Finnish Dental Society Apollonia; National Aspergillosis Centre, UK; EU(European Commission); Helsinki University Central Hospital Research Foundation	MN received funding from Yrjo Jahsson Foundation (www.yjs.fi), Orion Research Foundation (http://www.orion.fi/Tutkimus-ja-tuotekehitys/Orion-Farmos-Tutkimussaatio/) and Finnish Dental Society Apollonia (www.apollonia.fi). R. Rautemaa, VR and LNF were supported by the National Aspergillosis Centre, UK (www.uhsm.nhs.uk/nac/Pages/default.aspx). PB received funding from EU framework 7 (http://cordis.europa.eu/fp7/home_en.html). TS was supported by Helsinki University Central Hospital Research Foundation (http://www.hus.fi/tutkijalle/tutkimusrahoitus/Sivut/default.aspx). GR and R. Rajendran received no funding towards this piece of work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 1996, NUCLEIC ACIDS RES, V24, P2623, DOI 10.1093/nar/24.13.2623; Bachmann SP, 2002, ANTIMICROB AGENTS CH, V46, P3591, DOI 10.1128/AAC.46.11.3591-3596.2002; Baillie GS, 1999, METHOD ENZYMOL, V310, P644; Bertram G, 1996, YEAST, V12, P115, DOI 10.1002/(SICI)1097-0061(199602)12:2<115::AID-YEA889>3.0.CO;2-E; BOEBEL KP, 1982, J NUTR, V112, P1929, DOI 10.1093/jn/112.10.1929; Brooks PJ, 2005, ALCOHOL, V35, P187, DOI 10.1016/j.alcohol.2005.03.009; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Carman AJ, 2008, EUKARYOT CELL, V7, P1733, DOI 10.1128/EC.00253-08; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Cornely OA, 2012, CLIN MICROBIOL INFEC, V18, P19, DOI 10.1111/1469-0691.12039; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crowley S, 2012, J APPL MICROBIOL, V113, P1417, DOI 10.1111/jam.12012; Crowley S, 2013, FOLIA MICROBIOL, V58, P291, DOI 10.1007/s12223-012-0209-3; Deresinski SC, 2003, CLIN INFECT DIS, V36, P1445, DOI 10.1086/375080; Dowd SE, 2011, J WOUND CARE, V20, P40, DOI 10.12968/jowc.2011.20.1.40; Erlandsen SL, 2004, J HISTOCHEM CYTOCHEM, V52, P1427, DOI 10.1369/jhc.4A6428.2004; Flores CL, 2000, FEMS MICROBIOL REV, V24, P507, DOI 10.1111/j.1574-6976.2000.tb00553.x; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Guo JH, 2012, BIOENGINEERED, V3, P104, DOI 10.4161/bbug.19624; Hennicke F, 2013, EUKARYOT CELL, V12, P604, DOI 10.1128/EC.00336-12; HIETALA PK, 1979, NUTR METAB, V23, P227; Homann N, 1997, CARCINOGENESIS, V18, P1739, DOI 10.1093/carcin/18.9.1739; Ingham CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035478; Inglis DO, 2012, NUCLEIC ACIDS RES, V40, pD667, DOI 10.1093/nar/gkr945; Kim J, 2011, J MICROBIOL, V49, P171, DOI 10.1007/s12275-011-1064-7; Kohler Gerwald A, 2012, Infect Dis Obstet Gynecol, V2012, P636474, DOI 10.1155/2012/636474; Kucharikova S, 2011, J MED MICROBIOL, V60, P1261, DOI 10.1099/jmm.0.032037-0; LAND GA, 1975, INFECT IMMUN, V12, P119, DOI 10.1128/IAI.12.1.119-127.1975; Hernaez ML, 2010, J PROTEOMICS, V73, P1404, DOI 10.1016/j.jprot.2010.02.008; Maestre O, 2008, APPL ENVIRON MICROB, V74, P702, DOI 10.1128/AEM.01805-07; Marstorp H, 1999, SOIL BIOL BIOCHEM, V31, P1443, DOI 10.1016/S0038-0717(99)00065-6; Martinez-Gomariz M, 2009, PROTEOMICS, V9, P2230, DOI 10.1002/pmic.200700594; Marttila E, 2013, MOL ORAL MICROBIOL, V28, P281, DOI 10.1111/omi.12024; Marttila E, 2013, OR SURG OR MED OR PA, V116, P61, DOI 10.1016/j.oooo.2013.02.009; Mero AA, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-1; Monteoliva L, 2011, J PROTEOME RES, V10, P502, DOI 10.1021/pr100710g; Mousa HAL, 1999, BURNS, V25, P145, DOI 10.1016/S0305-4179(98)00148-X; Mukherjee PK, 2006, INFECT IMMUN, V74, P3804, DOI 10.1128/IAI.00161-06; Nailis H, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-25; Nieminen MT, 2009, ORAL ONCOL, V45, pE245, DOI 10.1016/j.oraloncology.2009.08.002; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Odds FC, 1979, CANDIDA CANDIDOSIS; Park S, 2003, J BACTERIOL, V185, P1942, DOI 10.1128/JB.185.6.1942-1950.2003; Peng Giia-Sheun, 2009, Human Genomics, V3, P121; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaller M, 2011, J CLIN MICROBIOL, V49, P624, DOI 10.1128/JCM.02120-10; Pfaller MA, 2006, J CLIN MICROBIOL, V44, P760, DOI 10.1128/JCM.44.3.760-763.2006; Pierce JV, 2013, EUKARYOT CELL, V12, P37, DOI 10.1128/EC.00236-12; Ramage G, 2005, METH MOLEC MED, V118, P71; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Ramage G, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00220; Ramage G, 2009, CRIT REV MICROBIOL, V35, P340, DOI 10.3109/10408410903241436; Rautemaa R, 2007, ORAL ONCOL, V43, P607, DOI 10.1016/j.oraloncology.2006.07.005; Rautemaa R, 2011, CRIT REV MICROBIOL, V37, P328, DOI 10.3109/1040841X.2011.585606; Saint-Prix F, 2004, MICROBIOL-SGM, V150, P2209, DOI 10.1099/mic.0.26999-0; Sakko M, 2014, MYCOSES, V57, P214, DOI 10.1111/myc.12145; Sakko M, 2012, INT J ANTIMICROB AG, V39, P539, DOI 10.1016/j.ijantimicag.2012.02.006; Salaspuro M, 2009, SCAND J GASTROENTERO, V44, P912, DOI 10.1080/00365520902912563; Samaranayake LP, 2009, PERIODONTOL 2000, V49, P39, DOI 10.1111/j.1600-0757.2008.00291.x; Saravanan P, 2009, J HAZARD MATER, V162, P476, DOI 10.1016/j.jhazmat.2008.05.069; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Seneviratne CJ, 2008, PROTEOMICS, V8, P2936, DOI 10.1002/pmic.200701097; Setiadi ER, 2006, J MOL BIOL, V361, P399, DOI 10.1016/j.jmb.2006.06.040; Shirtliff ME, 2009, ANTIMICROB AGENTS CH, V53, P2392, DOI 10.1128/AAC.01551-08; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Stevens DA, 2004, ANTIMICROB AGENTS CH, V48, P3407, DOI 10.1128/AAC.48.9.3407-3411.2004; Stichternoth C, 2009, APPL ENVIRON MICROB, V75, P3663, DOI 10.1128/AEM.00098-09; Strijbis K, 2008, EUKARYOT CELL, V7, P610, DOI 10.1128/EC.00017-08; Strijbis K, 2009, FASEB J, V23, P2349, DOI 10.1096/fj.08-127985; Taff HT, 2013, FUTURE MICROBIOL, V8, P1325, DOI 10.2217/fmb.13.101; Thomas DP, 2006, PROTEOMICS, V6, P6033, DOI 10.1002/pmic.200600321; Tirosh A, 2005, NEW ENGL J MED, V353, P1454, DOI 10.1056/NEJMoa050080; Tumbarello Mario, 2012, PLoS One, V7, pe33705, DOI 10.1371/journal.pone.0033705; Uittamo J, 2009, INT J CANCER, V124, P754, DOI 10.1002/ijc.23976; Uittamo J, 2011, INT J CANCER, V129, P2038, DOI 10.1002/ijc.25844; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vediyappan G, 2010, ANTIMICROB AGENTS CH, V54, P2096, DOI 10.1128/AAC.01638-09; Vellucci VF, 2007, FUNGAL GENET BIOL, V44, P979, DOI 10.1016/j.fgb.2006.12.003; Vylkova S, 2011, MBIO, V2, DOI 10.1128/mBio.00055-11; WAIN WH, 1975, SABOURAUDIA, V13, P74; Walker LA, 2013, ANTIMICROB AGENTS CH, V57, P146, DOI 10.1128/AAC.01486-12; Walraven CJ, 2013, ANTIMICROB AGENTS CH, V57, P1, DOI 10.1128/AAC.01351-12; Westermarck HW, 1997, Patent, Patent No. [EP 0871438 B1, 0871438]; Wilson K., 2001, CURR PROTOC MOL BIOL, V71, P27, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]; WINSTEN S, 1956, J BACTERIOL, V71, P738, DOI 10.1128/JB.71.6.738-738.1956	86	21	21	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 27	2014	9	5							e97864	10.1371/journal.pone.0097864	http://dx.doi.org/10.1371/journal.pone.0097864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5NG	24867320	Green Published, gold, Green Accepted			2022-12-25	WOS:000336914100024
J	Yan, YF; Wang, H; Li, DF; Yang, XW; Wang, ZY; Qi, ZZ; Zhang, QW; Cui, BZ; Guo, ZB; Yu, C; Wang, J; Wang, J; Liu, GM; Song, YJ; Li, YR; Cui, YJ; Yang, RF				Yan, Yanfeng; Wang, Hu; Li, Dongfang; Yang, Xianwei; Wang, Zuyun; Qi, Zhizhen; Zhang, Qingwen; Cui, Baizhong; Guo, Zhaobiao; Yu, Chang; Wang, Jun; Wang, Jian; Liu, Guangming; Song, Yajun; Li, Yingrui; Cui, Yujun; Yang, Ruifu			Two-Step Source Tracing Strategy of Yersinia pestis and Its Historical Epidemiology in a Specific Region	PLOS ONE			English	Article							BACILLUS-ANTHRACIS; PLAGUE-TRANSMISSION; MAXIMUM-LIKELIHOOD; INSIGHTS; MICROEVOLUTION; EVOLUTION; DYNAMICS; CHINA; DNA; POLYMORPHISMS	Source tracing of pathogens is critical for the control and prevention of infectious diseases. Genome sequencing by high throughput technologies is currently feasible and popular, leading to the burst of deciphered bacterial genome sequences. Utilizing the flooding genomic data for source tracing of pathogens in outbreaks is promising, and challenging as well. Here, we employed Yersinia pestis genomes from a plague outbreak at Xinghai county of China in 2009 as an example, to develop a simple two-step strategy for rapid source tracing of the outbreak. The first step was to define the phylogenetic position of the outbreak strains in a whole species tree, and the next step was to provide a detailed relationship across the outbreak strains and their suspected relatives. Through this strategy, we observed that the Xinghai plague outbreak was caused by Y. pestis that circulated in the local plague focus, where the majority of historical plague epidemics in the Qinghai-Tibet Plateau may originate from. The analytical strategy developed here will be of great help in fighting against the outbreaks of emerging infectious diseases, by pinpointing the source of pathogens rapidly with genomic epidemiological data and microbial forensics information.	[Yan, Yanfeng; Yang, Xianwei; Guo, Zhaobiao; Song, Yajun; Cui, Yujun; Yang, Ruifu] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Wang, Hu; Wang, Zuyun; Qi, Zhizhen; Zhang, Qingwen; Cui, Baizhong] Qinghai Inst Endem Dis Prevent & Control, Xining, Peoples R China; [Yan, Yanfeng; Li, Dongfang; Yu, Chang; Wang, Jun; Wang, Jian; Li, Yingrui; Cui, Yujun; Yang, Ruifu] BGI Shenzhen, Shenzhen, Peoples R China; [Liu, Guangming] Natl Univ Def Technol, Sch Comp Sci, Changsha, Hunan, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Beijing Genomics Institute (BGI); National University of Defense Technology - China	Cui, YJ (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	cuiyujun.new@gmail.com; ruifuyang@gmail.com	Song, Yajun/F-3714-2011; Yang, Ruifu/A-2273-2011; Wang, Jun/A-7261-2013; Li, Yingrui/K-1064-2015; Song, Yajun/GQQ-0476-2022; Yu, Chang/AAE-8538-2019; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Song, Yajun/0000-0002-6628-2747; Yang, Ruifu/0000-0003-3219-7269; Song, Yajun/0000-0002-6628-2747; Wang, Jun/0000-0002-2113-5874; Li, Dongfang/0000-0002-6587-2892; Yang, Xianwei/0000-0003-4388-9674; Wang, Jun/0000-0002-8540-8931	State Key Development Program for Basic Research of China [2009CB522601]; Industry Research Special Foundation of China Ministry of Health [201202021]; National Natural Science Foundation of China [31000015]; National Key Program for Infectious Diseases of China [2012ZX10004215, 2013ZX10004221-002]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); Industry Research Special Foundation of China Ministry of Health; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Program for Infectious Diseases of China	This work was supported by the State Key Development Program for Basic Research of China (2009CB522601), the Industry Research Special Foundation of China Ministry of Health (201202021), the National Natural Science Foundation of China (31000015), and the National Key Program for Infectious Diseases of China (2012ZX10004215 and 2013ZX10004221-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P130; Budowle B, 2005, INT J LEGAL MED, V119, P317, DOI 10.1007/s00414-005-0535-y; Colman RE, 2009, EMERG INFECT DIS, V15, P1623, DOI 10.3201/eid1510.090188; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Cui YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002652; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Girard JM, 2004, P NATL ACAD SCI USA, V101, P8408, DOI 10.1073/pnas.0401561101; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Ji S., 1988, PLAGUE; Kaiser J, 2005, SCIENCE, V308, P31; Keim P, 2001, J CLIN MICROBIOL, V39, P4566, DOI 10.1128/JCM.39.12.4566-4567.2001; Koser CU, 2012, NEW ENGL J MED, V366, P2267, DOI 10.1056/NEJMoa1109910; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li M, 2005, EMERG INFECT DIS, V11, P1494, DOI 10.3201/eid1109.041147; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066567; Li YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006000; Li YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002166; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Prentice MB, 2007, LANCET, V369, P1196, DOI 10.1016/S0140-6736(07)60566-2; Read TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/science.1071837; Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643; Snitkin ES, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004129; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Takahashi H, 2004, EMERG INFECT DIS, V10, P117, DOI 10.3201/eid1001.030238; Wang H, 2011, CLIN INFECT DIS, V52, P185, DOI 10.1093/cid/ciq107; Yang R, 2012, J BIOTERR BIODEF S, VS3, DOI [10.4172/2157-2526.S3-007, DOI 10.4172/2157-2526.S3-007]; Zhou DS, 2006, MICROBES INFECT, V8, P273, DOI 10.1016/j.micinf.2005.06.006; Zhou DS, 2004, J BACTERIOL, V186, P5138, DOI [10.1128/JB.186.15.5138-5146.2004, 10.1128/jb.186.15.5138-5146.2004]	41	29	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85374	10.1371/journal.pone.0085374	http://dx.doi.org/10.1371/journal.pone.0085374			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24866893	Green Submitted, gold, Green Published			2022-12-25	WOS:000329866300074
J	Zhao, QH; Zhou, B; Ding, D; Teramukai, S; Guo, QH; Fukushima, M; Hong, Z				Zhao, Qianhua; Zhou, Bin; Ding, Ding; Teramukai, Satoshi; Guo, Qihao; Fukushima, Masanori; Hong, Zhen			Cognitive Decline in Patients with Alzheimer's Disease and Its Related Factors in a Memory Clinic Setting, Shanghai, China	PLOS ONE			English	Article							COMMUNITY POPULATION; OLDER PERSONS; COLOR-WORD; PROGRESSION; DEMENTIA; EDUCATION; PREDICT; AGE; TESTS; MODEL	Objectives: Progressive cognitive decline is a characteristic hallmark of AD. It is important to identify prognostic markers to improve patient care and long-term planning. We aimed to identify the characteristics of disease progression in AD patients, focusing on cognitive decline and its related factors. Methods: Clinically diagnosed AD patients in a memory clinic were followed. The mini-mental state examination (MMSE) and a battery of other neuropsychological tests were performed to assess the rate of cognitive decline and to analyze the related factors. Results: A total of 165 AD patients were analyzed for cognitive changes. The MMSE scores declined at a rate of 1.52 points per year. Most neuropsychological test scores deteriorated significantly over time. Younger and early-onset AD patients deteriorated more rapidly than older and late-onset patients in global cognition and executive function. Men declined faster in memory but slower in attention than women. Higher education was associated with more rapid deterioration in visuo-spatial ability. Family history, hypertension and cerebral vascular disease were also associated with disease progression. Conclusion: Attention, executive and visuo-spatial functions deteriorate at faster rates than other cognitive functions in AD patients. Age and age at onset were the main factors that associated with deterioration.	[Zhao, Qianhua; Guo, Qihao; Hong, Zhen] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200433, Peoples R China; [Zhou, Bin; Fukushima, Masanori] Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Kobe, Hyogo, Japan; [Zhao, Qianhua; Ding, Ding; Guo, Qihao; Hong, Zhen] Fudan Univ, Huashan Hosp, Inst Neurol, Shanghai 200433, Peoples R China; [Teramukai, Satoshi] Kyoto Univ Hosp, Translat Res Ctr, Dept Clin Trial Design & Management, Kyoto 606, Japan	Fudan University; Institute for Biomedical Research & Innovation (IBRI); Fudan University; Kyoto University	Zhou, B (corresponding author), Fdn Biomed Res & Innovat, Translat Res Informat Ctr, Kobe, Hyogo, Japan.	zhoubin@tri-kobe.org; profzhong@sina.com	Zhou, Bin/AAW-5985-2020; Teramukai, Satoshi/I-2249-2019	Teramukai, Satoshi/0000-0003-2184-0597	Natural Science Foundation of China [81200835]; National 973 Project [2013CB530900, 2013CB530904, 2011ZX09307-00103]; Eisai Co. Ltd.	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Project(National Basic Research Program of China); Eisai Co. Ltd.(Eisai Co Ltd)	The study was supported by Natural Science Foundation of China (81200835), National 973 Project (2013CB530900, 2013CB530904, 2011ZX09307-00103) and Eisai Co. Ltd. Eisai was not involved in the design and conduct of the study or in the data analysis and interpretation of the results.	Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bernick C, 2012, ARCH NEUROL; Bracco L., 1997, ALZ DIS ASSOC DIS, V12, P347; Buccione I, 2007, EUR J NEUROL, V14, P440, DOI 10.1111/j.1468-1331.2007.01693.x; Cao X, 2010, INT J GERIATR PSYCHI; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Chen PJ, 2001, ARCH GEN PSYCHIAT, V58, P853, DOI 10.1001/archpsyc.58.9.853; Clark CM, 1999, ARCH NEUROL-CHICAGO, V56, P857, DOI 10.1001/archneur.56.7.857; DEHOUWER J, 1994, PSYCHOL RES-PSYCH FO, V56, P293, DOI 10.1007/BF00419659; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; GRAF P, 1995, J CLIN EXP NEUROPSYC, V17, P390, DOI 10.1080/01688639508405132; Guo QH, 2009, ALZ DIS ASSOC DIS, V23, P253, DOI 10.1097/WAD.0b013e3181999e92; Guo Qihao LC, 2001, CHINESE J MENTAL HLT, V15, P13; Hall CB, 2007, NEUROLOGY, V69, P1657, DOI 10.1212/01.wnl.0000278163.82636.30; Helzner EP, 2007, ARCH NEUROL-CHICAGO, V64, P1749, DOI 10.1001/archneur.64.12.1749; Huan Yu QG, 2005, NEUROL DIS MENT HYGE, V5, P89; Junchao Lu QG, 2006, CHIN J CLIN PSYCHOL, V14, P118; Lin C GQ, 2011, CHINESE J BEHAV MED, V20, P11; Fernandez AL, 2009, CLIN NEUROPSYCHOL, V23, P501, DOI 10.1080/13854040802279675; Mangone CA, 2004, REV NEUROLOGIA, V38, P675, DOI 10.33588/rn.3807.2003542; Martins CAR, 2005, NEUROLOGY, V65, P1888, DOI 10.1212/01.wnl.0000188871.74093.12; Mielke MM, 2007, NEUROLOGY, V69, P1850, DOI 10.1212/01.wnl.0000279520.59792.fe; Mungas D, 2001, ARCH NEUROL-CHICAGO, V58, P1243, DOI 10.1001/archneur.58.8.1243; Musicco M, 2010, DEMENT GERIATR COGN, V30, P219, DOI 10.1159/000319533; Musicco M, 2009, J NEUROL, V256, P1288, DOI 10.1007/s00415-009-5116-4; Pavlik VN, 2006, DEMENT GERIATR COGN, V22, P367, DOI 10.1159/000095640; Qihao Guo CL, 2000, CHIN J CLIN PSYCHOL, V8, P205; Qihao Guo ZH, 2005, CHIN J NEUROMED, V4, P701; Qihao Guo ZH, 2006, CHIN MENT HLTH J, V20, P81; Regan C, 2006, NEUROLOGY, V67, P1357, DOI 10.1212/01.wnl.0000240129.46080.53; Roselli F, 2009, CLIN NEUROL NEUROSUR, V111, P327, DOI 10.1016/j.clineuro.2008.10.006; Sanz C, 2009, NEUROLOGY, V73, P1359, DOI 10.1212/WNL.0b013e3181bd80e9; Schmidt C, 2011, ARCH NEUROL-CHICAGO, V68, P1124, DOI 10.1001/archneurol.2011.189; Small BJ, 1997, J GERONTOL A-BIOL, V52, pM299, DOI 10.1093/gerona/52A.5.M299; Suh GH, 2004, INT J GERIATR PSYCH, V19, P817, DOI 10.1002/gps.1168; TIERNEY MC, 1988, NEUROLOGY, V38, P359, DOI 10.1212/WNL.38.3.359; Wilson RS, 2009, NEUROLOGY, V72, P460, DOI 10.1212/01.wnl.0000341782.71418.6c; Wilson RS, 1999, J GERONTOL B-PSYCHOL, V54, pP155, DOI 10.1093/geronb/54B.3.P155; Wilson RS, 2004, J NEUROL NEUROSUR PS, V75, P126; Wilson RS, 2004, NEUROLOGY, V63, P1198, DOI 10.1212/01.WNL.0000140488.65299.53; Wilson RS, 2003, NEUROLOGY, V61, P812, DOI 10.1212/01.WNL.0000083989.44027.05; [赵倩华 ZHAO Qianhua], 2007, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V15, P233; Zhou B, 2010, J ALZHEIMERS DIS, V22, P673, DOI 10.3233/JAD-2010-100318	43	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2014	9	4							e95755	10.1371/journal.pone.0095755	http://dx.doi.org/10.1371/journal.pone.0095755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DX	24870360	Green Submitted, gold, Green Published			2022-12-25	WOS:000335227400118
